PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bojarski, EF; Strauss, AC; Fagin, AP; Plantinga, TS; Hoischen, A; Veltman, J; Allsop, SA; Granadillo, VJA; William, A; Netea, MG; Dimitrakoff, J				Bojarski, Emeric F.; Strauss, Adam C.; Fagin, Adam P.; Plantinga, Theo S.; Hoischen, Alexander; Veltman, Joris; Allsop, Stephen A.; Granadillo, Victor J. Anciano; William, Arsani; Netea, Mihai G.; Dimitrakoff, Jordan			Novel PI3K gamma Mutation in a 44-Year-Old Man with Chronic Infections and Chronic Pelvic Pain	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE-GAMMA; CELL DEVELOPMENT; INFLAMMATION; PROSTATITIS; GAMMA; PI3K; TRANSFORMATION; PROLIFERATION; P110-GAMMA; ACTIVATION	A 44-year-old man is presented here with 14 years of chronic purulent sinusitis, a chronic fungal rash of the scrotum, and chronic pelvic pain. Treatment with antifungal therapy resulted in symptom improvement, however he was unable to establish an effective long-term treatment regimen, resulting in debilitating symptoms. He had undergone extensive work-up without identifying a clear underlying etiology, although Candida species were cultured from the prostatic fluid. 100 genes involved in the cellular immune response were sequenced and a missense mutation was identified in the Ras-binding domain of PI3K gamma. PI3K gamma is a crucial signaling element in leukotaxis and other leukocyte functions. We hypothesize that his mutation led to his chronic infections and pelvic pain.	[Bojarski, Emeric F.; Strauss, Adam C.; Allsop, Stephen A.; Granadillo, Victor J. Anciano; William, Arsani; Dimitrakoff, Jordan] Harvard Univ, Sch Med, Boston, MA 02138 USA; [Dimitrakoff, Jordan] Harvard Univ, Sch Med, Dept Surg Urol, Boston, MA USA; [Dimitrakoff, Jordan] Harvard Univ, Sch Med, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; [Dimitrakoff, Jordan] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Fagin, Adam P.] Harvard Univ, Sch Dent Med, Boston, MA 02115 USA; [Plantinga, Theo S.; Netea, Mihai G.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Med, NL-6525 ED Nijmegen, Netherlands; [Plantinga, Theo S.; Netea, Mihai G.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Nijmegen Inst Infect Inflammat & Immun, NL-6525 ED Nijmegen, Netherlands; [Hoischen, Alexander; Veltman, Joris] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Genet, NL-6525 ED Nijmegen, Netherlands	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard School of Dental Medicine; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Dimitrakoff, J (corresponding author), Harvard Univ, Sch Med, Boston, MA 02138 USA.	jordan.dimitrakoff@gmail.com	Hoischen, Alexander/D-1282-2013; Plantinga, Theo S./A-6895-2015; Netea, Mihai/N-5155-2014; Veltman, Joris A/F-5128-2010; Hoischen, Alexander/AGF-7293-2022	Hoischen, Alexander/0000-0002-8072-4476; Plantinga, Theo S./0000-0003-4990-6084; Veltman, Joris A/0000-0002-3218-8250; Hoischen, Alexander/0000-0002-8072-4476	Netherlands Organization for Scientific Research	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by a Vici Grant of the Netherlands Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar I, 2007, J EXP MED, V204, P2977, DOI 10.1084/jem.20070366; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barberis L, 2008, THROMB HAEMOSTASIS, V99, P279, DOI 10.1160/TH07-10-0632; Beer-Hammer S, 2010, J LEUKOCYTE BIOL, V87, P1083, DOI 10.1189/jlb.0809585; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Chai LYA, 2011, CLIN MICROBIOL INFEC, V17, P1546, DOI 10.1111/j.1469-0691.2011.03598.x; Collins MM, 2001, J GEN INTERN MED, V16, P656; Collins MM, 1998, J UROLOGY, V159, P1224, DOI 10.1016/S0022-5347(01)63564-X; Desireddi NV, 2008, J UROLOGY, V179, P1857, DOI 10.1016/j.juro.2008.01.028; Done JD, 2012, J UROLOGY, V187, P1473, DOI 10.1016/j.juro.2011.11.116; Ercolini AM, 2009, CLIN EXP IMMUNOL, V155, P1, DOI 10.1111/j.1365-2249.2008.03834.x; Garcon F, 2008, BLOOD, V111, P1464, DOI 10.1182/blood-2007-08-108050; Hickey FB, 2006, J BIOL CHEM, V281, P2441, DOI 10.1074/jbc.M511173200; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Ji H, 2007, BLOOD, V110, P2940, DOI 10.1182/blood-2007-04-086751; Kang S, 2006, P NATL ACAD SCI USA, V103, P1289, DOI 10.1073/pnas.0510772103; Krieger JN, 1999, JAMA-J AM MED ASSOC, V282, P236, DOI 10.1001/jama.282.3.236; Laffargue M, 2002, IMMUNITY, V16, P441, DOI 10.1016/S1074-7613(02)00282-0; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Quick ML, 2012, AM J PHYSIOL-REG I, V303, pR580, DOI 10.1152/ajpregu.00240.2012; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102	23	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68118	10.1371/journal.pone.0068118	http://dx.doi.org/10.1371/journal.pone.0068118			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861857	Green Published, gold, Green Submitted			2022-12-27	WOS:000321692000016
J	Chen, KC; Xie, HL; Cai, YJ				Chen, Kevin C.; Xie, Honglin; Cai, Yujie			Modes of Action of ADP-Ribosylated Elongation Factor 2 in Inhibiting the Polypeptide Elongation Cycle: A Modeling Study	PLOS ONE			English	Article							TRANSFER-RNA TRANSLOCATION; AMINOACYL-TRANSFERASE II; DIPHTHERIA-TOXIN; PROTEIN-SYNTHESIS; SACCHAROMYCES-CEREVISIAE; GUANINE-NUCLEOTIDES; KINETIC MECHANISM; GTPASE ACTIVITY; 80S RIBOSOME; BINDING	Despite the fact that ADP-ribosylation of eukaryotic elongation factor 2 (EF2) leads to inhibition of protein synthesis, the mechanism by which ADP-ribosylated EF2 (ADPR center dot EF2) causes this inhibition remains controversial. Here, we applied modeling approaches to investigate the consequences of various modes of ADPR center dot EF2 inhibitory actions on the two coupled processes, the polypeptide chain elongation and ADP-ribosylation of EF2. Modeling of experimental data indicates that ADPR center dot EF2 fully blocks the late-phase translocation of tRNAs; but the impairment in the translocation upstream process, mainly the GTP-dependent factor binding with the pretranslocation ribosome and/or the guanine nucleotide exchange in EF2, is responsible for the overall inhibition kinetics. The reduced ADPR center dot EF2-ribosome association spares the ribosome to bind and shield native EF2 against toxin attack, thereby deferring the inhibition of protein synthesis inhibition and inactivation of EF2. Minimum association with the ribosome also keeps ADPR center dot EF2 in an accessible state for toxins to catalyze the reverse reaction when nicotinamide becomes available. Our work underscores the importance of unveiling the interactions between ADPR center dot EF2 and the ribosome, and argues against that toxins inhibit protein synthesis through converting native EF2 to a competitive inhibitor to actively disable the ribosome.	[Chen, Kevin C.; Xie, Honglin; Cai, Yujie] Shantou Univ, Multidisciplinary Res Ctr, Shantou, Guangdong, Peoples R China	Shantou University	Chen, KC (corresponding author), Shantou Univ, Multidisciplinary Res Ctr, Shantou, Guangdong, Peoples R China.	ckchen@stu.edu.cn	Chen, Kevin/GYU-8963-2022		NSFC [31171092]; NSFGD [10151503]	NSFC(National Natural Science Foundation of China (NSFC)); NSFGD	Supported by NSFC (31171092) and NSFGD (10151503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERMEK E, 1972, FEBS LETT, V23, P95, DOI 10.1016/0014-5793(72)80293-X; BERMEK E, 1976, J BIOL CHEM, V251, P6544; BURNS G, 1986, FEBS LETT, V208, P217, DOI 10.1016/0014-5793(86)81021-3; COLLIER RJ, 1967, J MOL BIOL, V25, P83, DOI 10.1016/0022-2836(67)90280-X; DAVYDOVA EK, 1990, FEBS LETT, V261, P350, DOI 10.1016/0014-5793(90)80589-B; EVERSE J, 1970, J BIOL CHEM, V245, P899; GILL DM, 1969, COLD SPRING HARB SYM, V34, P595, DOI 10.1101/SQB.1969.034.01.068; GILL DM, 1969, J EXP MED, V129, P1, DOI 10.1084/jem.129.1.1; GILL DM, 1973, J BIOL CHEM, V248, P654; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; GOOR RS, 1967, J EXP MED, V126, P899, DOI 10.1084/jem.126.5.899; HUDSON TH, 1987, J BIOL CHEM, V262, P16484; HWANG YW, 1985, J BIOL CHEM, V260, P1498; IGLEWSKI BH, 1975, P NATL ACAD SCI USA, V72, P2284, DOI 10.1073/pnas.72.6.2284; Jorgensen R, 2005, NATURE, V436, P979, DOI 10.1038/nature03871; Jorgensen R, 2004, J BIOL CHEM, V279, P45919, DOI 10.1074/jbc.M406218200; LI BY, 1994, J BIOL CHEM, V269, P2652; MARZOUKI A, 1991, BIOCHIMIE, V73, P1151, DOI 10.1016/0300-9084(91)90159-X; MOEHRING TJ, 1968, J BACTERIOL, V96, P61, DOI 10.1128/JB.96.1.61-69.1968; MONTANARO L, 1976, BIOCHEM J, V156, P15, DOI 10.1042/bj1560015; MONTANARO L, 1971, BIOCHIM BIOPHYS ACTA, V238, P493, DOI 10.1016/0005-2787(71)90628-9; NURTEN R, 1980, EUR J BIOCHEM, V103, P551, DOI 10.1111/j.1432-1033.1980.tb05979.x; NYGARD O, 1985, BIOCHIM BIOPHYS ACTA, V824, P152, DOI 10.1016/0167-4781(85)90092-2; NYGARD O, 1990, J BIOL CHEM, V265, P6030; NYGARD O, 1984, EUR J BIOCHEM, V145, P345, DOI 10.1111/j.1432-1033.1984.tb08560.x; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; Pisareva VP, 2006, J BIOL CHEM, V281, P40224, DOI 10.1074/jbc.M607461200; RAEBURN S, 1968, P NATL ACAD SCI USA, V61, P1428, DOI 10.1073/pnas.61.4.1428; RAIMO G, 1995, J BIOL CHEM, V270, P21082, DOI 10.1074/jbc.270.36.21082; Ratje AH, 2010, NATURE, V468, P713, DOI 10.1038/nature09547; Rodnina MV, 2001, MOL BIOL+, V35, P559, DOI 10.1023/A:1010523026531; Savelsbergh A, 2000, J MOL BIOL, V300, P951, DOI 10.1006/jmbi.2000.3886; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; SITIKOV AS, 1984, FEBS LETT, V176, P406, DOI 10.1016/0014-5793(84)81207-7; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; SPERTI S, 1971, CHEM-BIOL INTERACT, V3, P141, DOI 10.1016/0009-2797(71)90094-9; Tang S, 2001, MOL CELL BIOCHEM, V223, P117, DOI 10.1023/A:1017914413081; Taylor DJ, 2007, EMBO J, V26, P2421, DOI 10.1038/sj.emboj.7601677; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Walker SE, 2008, P NATL ACAD SCI USA, V61, P1428; Wintermeyer W, 2001, COLD SPRING HARB SYM, V66, P449, DOI 10.1101/sqb.2001.66.449; YOULE RJ, 1979, J BIOL CHEM, V254, P1089; Zavialov AV, 2003, CELL, V114, P113, DOI 10.1016/S0092-8674(03)00478-1	44	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e66446	10.1371/journal.pone.0066446	http://dx.doi.org/10.1371/journal.pone.0066446			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861744	Green Published, Green Submitted, gold			2022-12-27	WOS:000321692000005
J	Li, ZK; Musich, PR; Cartwright, BM; Wang, H; Zou, Y				Li, Zhengke; Musich, Phillip R.; Cartwright, Brian M.; Wang, Hui; Zou, Yue			UV-Induced Nuclear Import of XPA Is Mediated by Importin-alpha 4 in An ATR-Dependent Manner	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; PIGMENTOSUM GROUP-A; COMPLEMENTATION GROUP-A; XERODERMA-PIGMENTOSUM; DNA-REPAIR; PROTEIN; BINDING; DAMAGE; RECOGNITION; EXPRESSION	Xeroderma pigmentosum Group A (XPA) is a crucial factor in mammalian nucleotide excision repair (NER) and nuclear import of XPA from the cytoplasm for NER is regulated in cellular DNA damage responses in S-phase. In this study, experiments were carried out to determine the transport mechanisms that are responsible for the UV (ultraviolet)-induced nuclear import of XPA. We found that, in addition to the nuclear localization signal (NLS) of XPA, importin-alpha 4 or/and importin-alpha 7 are required for the XPA nuclear import. Further investigation indicated that, importin-alpha 4 and importin-alpha 7 directly interacted with XPA in cells. Interestingly, the binding of importin-alpha 4 to XPA was dependent on UV-irradiation, while the binding of importin-alpha 7 was not, suggesting a role for importin-alpha 7 in nuclear translocation of XPA in the absence of DNA damage, perhaps with specificity to certain non-S-phases of the cell-cycle. Consistent with the previous report of a dependence of UV-induced XPA nuclear import on ataxia telangiectasia and Rad3-related protein (ATR) in S-phase, knockdown of ATR reduced the amount of XPA interacting with importin-alpha 4. In contrast, the GTPase XPA binding protein 1 (XAB1), previously proposed to be required for XPA nuclear import, showed no effect on the nuclear import of XPA in our siRNA knockdown analysis. In conclusion, our results suggest that upon DNA damage transport adaptor importin-alpha 4 imports XPA into the nucleus in an ATR-dependent manner, while XAB1 has no role in this process. In addition, these findings reveal a potential new therapeutic target for the sensitization of cancer cells to chemotherapy.	[Li, Zhengke; Musich, Phillip R.; Cartwright, Brian M.; Wang, Hui; Zou, Yue] E Tennessee State Univ, Dept Biomed Sci, JH Quillen Coll Med, Johnson City, TN 37614 USA	East Tennessee State University	Zou, Y (corresponding author), E Tennessee State Univ, Dept Biomed Sci, JH Quillen Coll Med, Johnson City, TN 37614 USA.	zouy@etsu.edu	Zou, Yue/ABA-8429-2020; Li, Zhengke/J-8527-2016	Li, Zhengke/0000-0001-5560-343X; Musich, Phillip/0000-0001-8816-4242	National Institutes of Health [R01CA86927]; NATIONAL CANCER INSTITUTE [R01CA086927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant R01CA86927. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels CL, 2007, BIOCHEM BIOPH RES CO, V356, P219, DOI 10.1016/j.bbrc.2007.02.125; Batty DP, 2000, GENE, V241, P193, DOI 10.1016/S0378-1119(99)00489-8; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; CORTES P, 1994, P NATL ACAD SCI USA, V91, P7633, DOI 10.1073/pnas.91.16.7633; CUOMO CA, 1994, P NATL ACAD SCI USA, V91, P6156, DOI 10.1073/pnas.91.13.6156; De S, 2012, J CELL SCI, V125, P2509, DOI 10.1242/jcs.101501; Fan W, 2010, MOL CELL, V39, P247, DOI 10.1016/j.molcel.2010.07.006; Gabriel G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1158; Gilljam KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049199; Huang ZM, 2012, P NATL ACAD SCI USA, V109, P553, DOI 10.1073/pnas.1118366109; Kang TH, 2011, NUCLEIC ACIDS RES, V39, P3176, DOI 10.1093/nar/gkq1318; Kang TH, 2010, P NATL ACAD SCI USA, V107, P4890, DOI 10.1073/pnas.0915085107; Knudsen NO, 2009, DNA REPAIR, V8, P682, DOI 10.1016/j.dnarep.2009.03.005; Kohler M, 1997, FEBS LETT, V417, P104, DOI 10.1016/S0014-5793(97)01265-9; KRAEMER KH, 1994, ARCH DERMATOL, V130, P1018, DOI 10.1001/archderm.130.8.1018; Kumar GR, 2011, MOL CELL BIOL, V31, P3113, DOI 10.1128/MCB.05402-11; Kumar GR, 2010, MOL CELL BIOL, V30, P4996, DOI 10.1128/MCB.00600-10; Le May N, 2010, MOL CELL, V38, P54, DOI 10.1016/j.molcel.2010.03.004; Lee TH, 2014, ONCOGENE, V33, P19, DOI 10.1038/onc.2012.539; Lee TH, 2012, ONCOGENE; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; Li Zhengke, 2011, Int J Biochem Mol Biol, V2, P138; Li ZK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028326; Liu Y, 2005, BIOCHEMISTRY-US, V44, P7361, DOI 10.1021/bi047598y; Liu YB, 2012, CARCINOGENESIS, V33, P1187, DOI 10.1093/carcin/bgs142; Liu Y, 2008, FASEB J, V22, P603, DOI 10.1096/fj.07-8598com; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; Mer G, 2000, CELL, V103, P449, DOI 10.1016/S0092-8674(00)00136-7; MIURA N, 1991, J BIOL CHEM, V266, P19786; MIYAMOTO I, 1992, J BIOL CHEM, V267, P12182; Nachury MV, 1998, P NATL ACAD SCI USA, V95, P582, DOI 10.1073/pnas.95.2.582; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Nitta M, 2000, NUCLEIC ACIDS RES, V28, P4212, DOI 10.1093/nar/28.21.4212; Orelli B, 2010, J BIOL CHEM, V285, P3705, DOI 10.1074/jbc.M109.067538; PARK CH, 1994, P NATL ACAD SCI USA, V91, P5017, DOI 10.1073/pnas.91.11.5017; Patrick SM, 2002, J BIOL CHEM, V277, P16096, DOI 10.1074/jbc.M200816200; Rademakers S, 2003, MOL CELL BIOL, V23, P5755, DOI 10.1128/MCB.23.16.5755-5767.2003; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Serrano MA, 2012, ONCOGENE, V29, P2165; Shell SM, 2009, J BIOL CHEM, V284, P24213, DOI 10.1074/jbc.M109.000745; Solimando L, 2009, J CELL SCI, V122, P83, DOI 10.1242/jcs.031062; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Vasquez KM, 2002, P NATL ACAD SCI USA, V99, P5848, DOI 10.1073/pnas.082193799; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; Wu X, 2007, ONCOGENE, V26, P757, DOI 10.1038/sj.onc.1209828; Wu XM, 2006, CANCER RES, V66, P2997, DOI 10.1158/0008-5472.CAN-05-3403; Yang ZG, 2006, BIOCHEMISTRY-US, V45, P15921, DOI 10.1021/bi061626q	52	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68297	10.1371/journal.pone.0068297	http://dx.doi.org/10.1371/journal.pone.0068297			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861882	Green Published, Green Submitted, gold			2022-12-27	WOS:000321692000020
J	Li, QJ; Liu, ZF; Dang, EL; Jin, L; He, Z; Yang, LT; Shi, XW; Wang, G				Li, Qiuju; Liu, Zhenfeng; Dang, Erle; Jin, Liang; He, Zheng; Yang, Luting; Shi, Xiaowei; Wang, Gang			Follicular Helper T Cells (Tfh) and IL-21 Involvement in the Pathogenesis of Bullous Pemphigoid	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATOID-ARTHRITIS; DISEASE; AUTOIMMUNITY; BLOCKADE; AUTOANTIBODIES; EXPRESSION; MATURATION; EXPANSION; MODELS	The pathogenesis of bullous pemphigoid (BP) is characterized by the T cell-dependent production of autoantibodies. Recent studies have indicated that follicular T helper cells (Tfh), the key modulator of B cell activation and autoantibody production, are critical in the development of several autoimmune diseases. Tfh cells perform their functions via IL-21, their hallmark cytokine. In the present study, the frequencies of Tfh cells were investigated in the peripheral blood samples of BP patients to evaluate whether Tfh cells involve in this clinical entity. Significantly higher Tfh cell counts were observed in the peripheral blood of BP patients than those in healthy controls (median: 11.25% vs. 4.95%, respectively; P < 0.001). Additionally, the serum IL-21 levels in BP patients were higher than those of the healthy controls (median: 103.98 pg/mL vs 46.77 pg/mL, respectively; P < 0.001). The frequencies of Tfh cells and IL-21 levels were both positively correlated with anti-BP180-NC16A autoantibody titers (R=0.712, P < 0.01 and R=0.578, P=0.030, respectively). After effective therapy, the frequencies of Tfh cells as well as the serum IL-21 levels in BP patients decreased along with clinical improvement. Most importantly, Tfh depleted CD4(+) T cells and anti-IL-21 neutralization antibody could inhibit the T cell-induced B cell activation and secretion of BP autoantibody in vitro. Those results suggest that Tfh cells play an important role in autoantibody production and are involved in the pathogenesis of BP.	[Li, Qiuju; Liu, Zhenfeng; Dang, Erle; Jin, Liang; He, Zheng; Yang, Luting; Shi, Xiaowei; Wang, Gang] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, Xian 710032, Peoples R China	Air Force Military Medical University	Wang, G (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, Xian 710032, Peoples R China.	xjwgang@fmmu.edu.cn	Liu, Zhenfeng/GWV-5162-2022; Wang, Gang/H-6710-2019	Wang, Gang/0000-0002-5842-8080; Dang, Erle/0000-0003-4761-6673	National Natural Science Foundation of China [30972805]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (30972805). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Bubier JA, 2009, P NATL ACAD SCI USA, V106, P1518, DOI 10.1073/pnas.0807309106; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Gowthaman U, 2010, INT REV IMMUNOL, V29, P403, DOI 10.3109/08830185.2010.496503; Grammer AC, 2003, J CLIN INVEST, V112, P1506, DOI 10.1172/JCI200319301; Herber D, 2007, J IMMUNOL, V178, P3822, DOI 10.4049/jimmunol.178.6.3822; Hu YL, 2009, J IMMUNOL, V182, P1421, DOI 10.4049/jimmunol.182.3.1421; Kasperkiewicz M, 2007, CLIN REV ALLERG IMMU, V33, P67, DOI 10.1007/s12016-007-0030-y; King C, 2009, NAT REV IMMUNOL, V9, P757, DOI 10.1038/nri2644; Kuchen S, 2007, J IMMUNOL, V179, P5886, DOI 10.4049/jimmunol.179.9.5886; Leighty L, 2007, ARCH DERMATOL RES, V299, P417, DOI 10.1007/s00403-007-0790-5; Li XY, 2012, BIOCHEM BIOPH RES CO, V422, P238, DOI 10.1016/j.bbrc.2012.04.133; Linterman MA, 2010, SEMIN IMMUNOPATHOL, V32, P183, DOI 10.1007/s00281-009-0194-z; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Liu Z, 2001, J DERMATOL, V28, P647, DOI 10.1111/j.1346-8138.2001.tb00055.x; Liu Z, 2008, J INVEST DERMATOL, V128, pE22; Ma J, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/827480; MACLENNAN ICM, 1992, IMMUNOL REV, V126, P143, DOI 10.1111/j.1600-065X.1992.tb00635.x; McHeyzer-Williams LJ, 2009, CURR OPIN IMMUNOL, V21, P266, DOI 10.1016/j.coi.2009.05.010; Mihai S, 2007, J CELL MOL MED, V11, P462, DOI 10.1111/j.1582-4934.2007.00033.x; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Nishie W, 2007, NAT MED, V13, P378, DOI 10.1038/nm1496; Okamoto T, 2003, J RHEUMATOL, V30, P1157; Olasz Edit B., 2008, V10, P141, DOI 10.1159/000131452; Saito R, 2005, J NEUROIMMUNOL, V170, P172, DOI 10.1016/j.jneuroim.2005.09.001; Schmidt E, 2000, ARCH DERMATOL, V136, P174, DOI 10.1001/archderm.136.2.174; Schmidt E, 2000, Adv Dermatol, V16, P113; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Sitaru C, 2005, EXP DERMATOL, V14, P861, DOI 10.1111/j.1600-0625.2005.00367.x; Sitaru C, 2009, J INVEST DERMATOL, V129, P822, DOI 10.1038/jid.2009.12; Spolski R, 2008, P NATL ACAD SCI USA, V105, P14028, DOI 10.1073/pnas.0804358105; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Spolski R, 2010, INT IMMUNOL, V22, P7, DOI 10.1093/intimm/dxp112; Tsuji-Abe Y, 2005, J DERMATOL SCI, V37, P145, DOI 10.1016/j.jdermsci.2004.10.007; Yancey KB, 2000, JAMA-J AM MED ASSOC, V284, P350, DOI 10.1001/jama.284.3.350; Young DA, 2007, ARTHRITIS RHEUM, V56, P1152, DOI 10.1002/art.22452; Yu D, 2010, TRENDS IMMUNOL, V31, P377, DOI 10.1016/j.it.2010.07.001; Yu D, 2009, CURR OPIN IMMUNOL, V21, P619, DOI 10.1016/j.coi.2009.09.013; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zillikens D, 1997, J INVEST DERMATOL, V109, P679, DOI 10.1111/1523-1747.ep12338088	41	34	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68145	10.1371/journal.pone.0068145	http://dx.doi.org/10.1371/journal.pone.0068145			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861861	Green Submitted, Green Published, gold			2022-12-27	WOS:000321425300044
J	Park, YH; Jang, JW; Yang, Y; Kim, JE; Kim, SY				Park, Young Ho; Jang, Jae-Won; Yang, Youngsoon; Kim, Jung Eun; Kim, SangYun			Reflections of Two Parallel Pathways between the Hippocampus and Neocortex in Transient Global Amnesia: A Cross-Sectional Study Using DWI and SPECT	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; PARAHIPPOCAMPAL CORTICES; RECIPROCAL CONNECTIONS; ENTORHINAL CORTEX; HYPOPERFUSION; ANATOMY; ACETAZOLAMIDE; SUBREGIONS; ACTIVATION; RETRIEVAL	Objectives: Two parallel pathways have been proposed between the hippocampus and neocortex. Recently, the anterior and posterior hippocampus showed distinct connectivity with different cortical areas in an fMRI study. We investigated whether the two parallel pathways could be confirmed in patients with transient global amnesia (TGA) which is a natural lesion model of a perturbation of the hippocampus. In addition, we evaluated the relationship between the location of the hippocampal lesion and various clinical variables. Methods: A consecutive series of 37 patients were identified from the TGA registry database of Seoul National University Bundang Hospital. Based on the location of the diffusion-weighted imaging (DWI) lesion along the anterior-posterior axis of the hippocampus, they were divided into the following three groups: head (n = 15), body (n = 15) or tail (n = 7). To evaluate which cortical regions showed hypoperfusion according to the location of the DWI lesion, their SPECT images were compared between two groups using statistical parametric mapping. We performed hierarchical cluster analysis to group demographic and clinical variables, including the location of the DWI lesion, into clusters. Results: Statistical parametric mapping analyses revealed that more anterior DWI lesions were associated with hypoperfusion of the anterior temporal and frontal areas, whereas more posterior lesions were associated with hypoperfusion of the posterior temporal, parietal, occipital and cerebellar areas. The difference was most prominent between the group of hippocampal lesions on the head and tail. Hierarchical cluster analysis demonstrated that vomiting was related to female gender and hippocampal head lesions, whereas vascular risk factors were related to male gender and hippocampal body lesions. Conclusions: We confirmed the parallel pathways between the hippocampus and neocortex with DWI and SPECT images of patients with TGA. Patients with hippocampal head lesions and body lesions were clustered within different groups of clinical variables.	[Park, Young Ho; Jang, Jae-Won; Kim, Jung Eun; Kim, SangYun] Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Park, Young Ho; Jang, Jae-Won; Kim, Jung Eun; Kim, SangYun] Seoul Natl Univ, Bundang Hosp, Clin Neurosci Ctr, Songnam, South Korea; [Yang, Youngsoon] Seoul Vet Hosp, Dept Neurol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul Veterans Hospital	Kim, SY (corresponding author), Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea.	neuroksy@snu.ac.kr						Agosti C, 2010, EUR NEUROL, V63, P291, DOI 10.1159/000292502; Bartsch T, 2006, BRAIN, V129, P2874, DOI 10.1093/brain/awl248; Bartsch T, 2010, LANCET NEUROL, V9, P205, DOI 10.1016/S1474-4422(09)70344-8; Burwell RD, 2000, ANN NY ACAD SCI, V911, P25; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Duvernoy H. M, 2005, HUMAN HIPPOCAMPUS FU; ESCOFIER B, 1994, COMPUT STAT DATA AN, V18, P121, DOI 10.1016/0167-9473(94)90135-X; EVANS J, 1993, J NEUROL NEUROSUR PS, V56, P1227, DOI 10.1136/jnnp.56.11.1227; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; GOLDENBERG G, 1991, NEUROLOGY, V41, P1748, DOI 10.1212/WNL.41.11.1748; HODGES JR, 1990, J NEUROL NEUROSUR PS, V53, P834, DOI 10.1136/jnnp.53.10.834; Jovin TG, 2000, J NEUROIMAGING, V10, P238, DOI 10.1111/jon2000104238; Jung HH, 1996, J NEUROL NEUROSUR PS, V61, P654, DOI 10.1136/jnnp.61.6.654-a; Kahn I, 2008, J NEUROPHYSIOL, V100, P129, DOI 10.1152/jn.00077.2008; LALOUX P, 1992, ARCH NEUROL-CHICAGO, V49, P543, DOI 10.1001/archneur.1992.00530290131022; Lepage M, 1998, HIPPOCAMPUS, V8, P313, DOI 10.1002/(SICI)1098-1063(1998)8:4<313::AID-HIPO1>3.0.CO;2-I; Libby LA, 2012, J NEUROSCI, V32, P6550, DOI 10.1523/JNEUROSCI.3711-11.2012; LIN KN, 1993, STROKE, V24, P1093, DOI 10.1161/01.STR.24.7.1093; LIPSITZ SR, 1994, BIOMETRICS, V50, P847, DOI 10.2307/2532798; MATSUDA H, 1993, CLIN NUCL MED, V18, P46, DOI 10.1097/00003072-199301000-00011; Meulman J., 2004, HDB QUANTITATIVE MET; Naber PA, 2001, HIPPOCAMPUS, V11, P99, DOI 10.1002/hipo.1028; Quinette P, 2006, BRAIN, V129, P1640, DOI 10.1093/brain/awl105; Ryoo I, 2012, NEURORADIOLOGY, V54, P329, DOI 10.1007/s00234-011-0889-4; Sakashita Y, 1997, J NEUROL NEUROSUR PS, V63, P605, DOI 10.1136/jnnp.63.5.605; Schacter DL, 1999, HIPPOCAMPUS, V9, P575, DOI 10.1002/(SICI)1098-1063(1999)9:5<575::AID-HIPO11>3.0.CO;2-K; Scharrer E, 1940, ARCH NEURO PSYCHIATR, V44, P483, DOI 10.1001/archneurpsyc.1940.02280090002001; Schmidtke K, 1998, J NUCL MED, V39, P155; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; STILLHARD G, 1990, J NEUROL NEUROSUR PS, V53, P339, DOI 10.1136/jnnp.53.4.339; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; SUZUKI WA, 1994, J NEUROSCI, V14, P1856, DOI 10.1523/JNEUROSCI.14-03-01856.1994; Takeuchi R, 1998, J NUCL MED, V39, P1360; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Warren JD, 2000, J CLIN NEUROSCI, V7, P57, DOI 10.1054/jocn.1998.0129; Winbeck K, 2005, J NEUROL NEUROSUR PS, V76, P438, DOI 10.1136/jnnp.2004.042432; Yang Y, 2009, J CLIN NEUROL, V5, P74, DOI 10.3988/jcn.2009.5.2.74	38	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67447	10.1371/journal.pone.0067447	http://dx.doi.org/10.1371/journal.pone.0067447			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861765	Green Published, gold, Green Submitted			2022-12-27	WOS:000321425300014
J	Cai, J; Xie, SL; Feng, J; Wang, FP; Xu, QF				Cai, Jin; Xie, Shulian; Feng, Jia; Wang, Feipeng; Xu, Qiufeng			Protective Effect of Polygonum orientale L. Extracts against Clavibater michiganense subsp sepedonicum, the Causal Agent of Bacterial Ring Rot of Potato	PLOS ONE			English	Article							PLANT ESSENTIAL OILS; ANTIMICROBIAL ACTIVITY; ANTIFUNGAL ACTIVITY; CHEMICAL-COMPOSITION; IN-VITRO; OPTIMIZATION; DISEASE; CINNAMOMUM; HERBICIDES; FUNGUS	The Polygonum orientale L. extracts were investigated for antibacterial activity against Clavibater michiganense subsp. sepedonicum (Spieckermann & Kotthoff) Davis et al., the causal agent of a serious disease called bacterial ring rot of potato. The results showed that the leaf extracts of P. orientale had significantly (p<0.05) greater antibacterial activity against C. michiganense subsp. sepedonicum than root, stem, flower extracts in vitro. According to the results of single factor experiments and L(27)3((13)) orthogonal experiments, optimum extraction conditions were A(1)B(3)C(1), extraction time 6 h, temperature 80 degrees C, solid to liquid ratio 1:10 (g:mL). The highest (p<0.05) antibacterial activity was observed when pH was 5, excluding the effect of control. The extracts were stable under ultraviolet (UV). In vivo analysis revealed that 50 mg/mL of P. orientale leaf extracts was effective in controlling decay. Under field conditions, 50 mg/ mL of P. orientale leaf extracts also improved growth parameters (whole plant length, shoot length, root length, plant fresh weight, shoot fresh weight, root fresh weight, dry weight, and number of leaves), in the 2010 and 2011 two growing seasons. Further solvent partition assays showed that the most active compounds were in the petroleum ether fractionation. Transmission electron microscopy (TEM) showed drastic ultrastructural changes caused by petroleum ether fractionation, including bacterial deformation, electron-dense particles, formation of vacuoles and lack of cytoplasmic materials. These results indicated that P. orientale extracts have strong antibacterial activity against C. michiganense subsp. sepedonicum and a promising effect in control of bacterial ring rot of potato disease.	[Cai, Jin; Xie, Shulian; Feng, Jia; Wang, Feipeng; Xu, Qiufeng] Shanxi Univ, Sch Life Sci, Taiyuan, Shanxi, Peoples R China	Shanxi University	Xie, SL (corresponding author), Shanxi Univ, Sch Life Sci, Taiyuan, Shanxi, Peoples R China.	xiesl@sxu.edu.cn						Abdel-Monaim MF, 2011, CROP PROT, V30, P185, DOI 10.1016/j.cropro.2010.09.016; Akhtar Y., 2008, Phytochemistry Reviews, V7, P77, DOI 10.1007/s11101-006-9048-7; Antony J., 2006, Sensor Review, V26, P227, DOI 10.1108/02602280610675519; Askarne L, 2012, CROP PROT, V40, P53, DOI 10.1016/j.cropro.2012.04.023; Aziz AN, 2013, J ETHNOPHARMACOL, V145, P798, DOI 10.1016/j.jep.2012.12.024; Bernardo-Gil MG, 2009, J SUPERCRIT FLUID, V49, P32, DOI 10.1016/j.supflu.2008.12.004; Brady N. C., 1984, NATURE PROPERTIES SO, P528; Cardoso RA, 2010, GENET MOL RES, V9, P231, DOI 10.4238/vol9-1gmr688; Carson Christine F, 2003, Commun Dis Intell Q Rep, V27 Suppl, pS143; Chao LK, 2005, J AGR FOOD CHEM, V53, P7274, DOI 10.1021/jf051151u; Cheikhyoussef A, 2009, FOOD CONTROL, V20, P553, DOI 10.1016/j.foodcont.2008.08.003; Chen YJ, 2012, J SCI FOOD AGR, V92, P1937, DOI 10.1002/jsfa.5565; Choi GJ, 2010, PLANT PATHOLOGY J, V26, P360, DOI 10.5423/PPJ.2010.26.4.360; Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564; De Corato U, 2010, CROP PROT, V29, P142, DOI 10.1016/j.cropro.2009.10.012; Demoz BT, 2006, BIOL CONTROL, V37, P68, DOI 10.1016/j.biocontrol.2005.11.010; Diez C, 2008, J CHROMATOGR A, V1180, P10, DOI 10.1016/j.chroma.2007.12.036; Elbadri Gamal Abdalla, 2008, Journal of Asia-Pacific Entomology, V11, P99, DOI 10.1016/j.aspen.2008.04.004; Fousek J, 2003, FOLIA MICROBIOL, V48, P682, DOI 10.1007/BF02993479; Fu WJ, 2005, FOREST BY PRODUCT SP, P40; Harish S, 2008, BIOCONTROL, V53, P555, DOI 10.1007/s10526-007-9098-9; Holley RA, 2005, FOOD MICROBIOL, V22, P273, DOI 10.1016/j.fm.2004.08.006; Ibrahim HR, 1996, J AGR FOOD CHEM, V44, P3799, DOI 10.1021/jf960133x; Ippolito A, 2000, CROP PROT, V19, P715, DOI 10.1016/S0261-2194(00)00095-8; Ismail S, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/269724, 10.1155/2013/696835]; Isman MB, 2000, CROP PROT, V19, P603, DOI 10.1016/S0261-2194(00)00079-X; Jia XY, 2010, CHROMATOGRAPHIA, V71, P839, DOI 10.1365/s10337-010-1547-4; Joshi S, 2008, BIORESOURCE TECHNOL, V99, P4603, DOI 10.1016/j.biortech.2007.07.030; Kagale S, 2004, PHYSIOL MOL PLANT P, V65, P91, DOI 10.1016/j.pmpp.2004.11.008; Khan MSA, 2011, PHYTOMEDICINE, V19, P48, DOI 10.1016/j.phymed.2011.07.005; Kilickap E, 2010, INT J ADV MANUF TECH, V49, P911, DOI 10.1007/s00170-009-2469-x; Knight SC, 1997, ANNU REV PHYTOPATHOL, V35, P349, DOI 10.1146/annurev.phyto.35.1.349; Li HJ, 2012, CURR MICROBIOL, V65, P156, DOI 10.1007/s00284-012-0135-2; Li Z, 2010, FOOD SCI BIOTECHNOL, V19, P1047, DOI 10.1007/s10068-010-0147-2; Liu RM, 2002, FOOD FERM IND, V29, P61; Liu YJ, 2004, MYCOPATHOLOGIA, V157, P185, DOI 10.1023/B:MYCO.0000020598.91469.d1; Mares D, 2005, MYCOPATHOLOGIA, V160, P85, DOI 10.1007/s11046-004-6635-2; Marino M, 2001, INT J FOOD MICROBIOL, V67, P187, DOI 10.1016/S0168-1605(01)00447-0; Mercan N, 2006, ANN MICROBIOL, V56, P373, DOI 10.1007/BF03175035; Michielin EMZ, 2009, BIORESOURCE TECHNOL, V100, P6615, DOI 10.1016/j.biortech.2009.07.061; Nishida M, 2006, J CHROMATOGR B, V842, P106, DOI 10.1016/j.jchromb.2006.07.039; Qasem JR, 1995, ANN APPL BIOL, V127, P215, DOI 10.1111/j.1744-7348.1995.tb06666.x; Qiu YE, 2004, XINJIANG AGR SCI, P88; SECOR GA, 1987, AM POTATO J, V64, P699; SIKKEMA J, 1995, MICROBIOL REV, V59, P201, DOI 10.1128/MMBR.59.2.201-222.1995; Smania A. Jr., 1999, International Journal of Medicinal Mushrooms, V1, P325; Soylu EM, 2006, MYCOPATHOLOGIA, V161, P119, DOI 10.1007/s11046-005-0206-z; Sun L, 2003, J CHROMATOGR A, V1014, P165, DOI 10.1016/S0021-9673(03)00574-0; Tanaka A, 2013, J WOOD SCI, V59, P155, DOI 10.1007/s10086-012-1310-6; Tao R, 2013, MOLECULES, V18, P2166, DOI 10.3390/molecules18022166; Tegegne G, 2008, CROP PROT, V27, P1052, DOI 10.1016/j.cropro.2007.12.007; Teixeira PC, 2007, INT J FOOD MICROBIOL, V118, P15, DOI 10.1016/j.ijfoodmicro.2007.05.008; van der Wolf JM, 2005, J PHYTOPATHOL, V153, P358, DOI 10.1111/j.1439-0434.2005.00985.x; Viswanathan MBG, 2012, FITOTERAPIA, V83, P1153, DOI 10.1016/j.fitote.2012.07.007; Wang B., 2012, NAT PROD RES DEV, V24, P23, DOI [10.16333/j.1001-6880.2012.s1.005, DOI 10.16333/J.1001-6880.2012.S1.005]; Wang HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029452, 10.1371/journal.pone.0041330, 10.1371/journal.pone.0038619]; Wang L, 2010, BIORESOURCE TECHNOL, V101, P5808, DOI 10.1016/j.biortech.2010.02.099; Wang L, 2010, DESALINATION, V254, P68, DOI 10.1016/j.desal.2009.12.012; Wang RuiXia, 2010, Acta Phytopathologica Sinica, V40, P66; Wei Y, 2009, J FOOD COMPOS ANAL, V22, P154, DOI 10.1016/j.jfca.2008.08.006; Wilson CL, 1997, PLANT DIS, V81, P204, DOI 10.1094/PDIS.1997.81.2.204; Wu GQ, 2008, CURR MICROBIOL, V57, P552, DOI 10.1007/s00284-008-9241-6; Xie BX, 2004, NONWOOD FOREST RES, V22, P5; Xiong JH, 2007, FOOD MACH, V23, P78; Yang DM, 2010, J CHIN I FOOD SCI TE, V10, P47; Yazaki Kazufumi, 2008, Phytochemistry Reviews, V7, P513, DOI 10.1007/s11101-007-9079-8; Zhang ZY, 2008, CROP PROT, V27, P920, DOI 10.1016/j.cropro.2007.11.012; [赵海伊 Zhao Haiyi], 2013, [食品科学, Food Science], V34, P236; Zheng XD, 2009, GANSU AGR SCI TECHN, V1, P11; Zhou W, 2010, CHROMATOGRAPHIA, V72, P719, DOI 10.1365/s10337-010-1747-y; 苏峰平, 2012, [中成药, Chinese Traditional Patent Medicine], V34, P938; 陈云, 2010, [山西农业科学, Journal of Shanxi Agricultural Sciences], V38, P140	72	8	9	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68480	10.1371/journal.pone.0068480	http://dx.doi.org/10.1371/journal.pone.0068480			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861908	Green Published, gold, Green Submitted			2022-12-27	WOS:000323350700088
J	Camus, SMJ; Rochais, C; Blois-Heulin, C; Li, Q; Hausberger, M; Bezard, E				Camus, Sandrine M. J.; Rochais, Celine; Blois-Heulin, Catherine; Li, Qin; Hausberger, Martine; Bezard, Erwan			Birth Origin Differentially Affects Depressive-Like Behaviours: Are Captive-Born Cynomolgus Monkeys More Vulnerable to Depression than Their Wild-Born Counterparts?	PLOS ONE			English	Article							MACAQUES MACACA-MULATTA; RHESUS MACAQUES; STEREOTYPIC BEHAVIOR; NONHUMAN-PRIMATES; SOCIAL-BEHAVIOR; COPING HYPOTHESIS; CUMULATIVE STRESS; EARLY EXPERIENCE; GENUS MACACA; TEMPERAMENT	Background: Adverse early-life experience might lead to the expression of abnormal behaviours in animals and the predisposition to psychiatric disorder (e.g. major depressive disorder) in Humans. Common breeding processes employ weaning and housing conditions different from what happens in the wild. Methods: The present study, therefore, investigated whether birth origin impacts the possible existence of spontaneous atypical/abnormal behaviours displayed by 40 captive-born and 40 wild-born socially-housed cynomolgus macaques in farming conditions using an unbiased ethological scan-sampling analysis followed by multifactorial correspondence and hierarchical clustering analyses. Results: We identified 10 distinct profiles (groups A to J) that significantly differed on several behaviours, body postures, body orientations, distances between individuals and locations in the cage. Data suggest that 4 captive-born and 1 wild-born animals (groups G and J) present depressive-like symptoms, unnatural early life events thereby increasing the risk of developing pathological symptoms. General differences were also highlighted between the captive- and wild-born populations, implying the expression of differential coping mechanisms in response to the same captive environment. Conclusions: Birth origin thus impacts the development of atypical ethologically-defined behavioural profiles, reminiscent of certain depressive-like symptoms. The use of unbiased behavioural observations might allow the identification of animal models of human mental/behavioural disorders and their most appropriate control groups.	[Camus, Sandrine M. J.; Bezard, Erwan] Univ Bordeaux, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France; [Camus, Sandrine M. J.; Bezard, Erwan] CNRS, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France; [Rochais, Celine; Blois-Heulin, Catherine] Univ Rennes 1, UMR CNRS Ethol Anim & Humaine 6552, Stn Biol Paimpont, F-35014 Rennes, France; [Li, Qin] Motac France, Floirac, France; [Hausberger, Martine] Univ Rennes 1, UMR CNRS Ethol Anim & Humaine 6552, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Universite de Rennes; Universite de Rennes	Bezard, E (corresponding author), Univ Bordeaux, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France.	erwan.bezard@u-bordeaux2.fr	Bezard, Erwan/ABD-5153-2021	Bezard, Erwan/0000-0002-0410-4638	Biotheque Primate - Centre National de la Recherche Scientifique Life Sciences Department; Motac Neuroscience Ltd., UK	Biotheque Primate - Centre National de la Recherche Scientifique Life Sciences Department; Motac Neuroscience Ltd., UK	This work was supported by Biotheque Primate - Centre National de la Recherche Scientifique Life Sciences Department (EB) and an unrestricted grant from Motac Neuroscience Ltd., UK (EB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Benhajali H, 2008, APPL ANIM BEHAV SCI, V112, P196, DOI 10.1016/j.applanim.2007.08.007; Bertrand M, 1969, BEHAV REPERTOIRE STU, P274; BOWLBY J, 1960, PSYCHOANAL STUD CHIL, V15, P9, DOI 10.1080/00797308.1960.11822566; Camus SMJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062141; CHAMPOUX M, 1994, LAB ANIM SCI, V44, P351; CHENEY DL, 1990, COGNITION, V37, P167, DOI 10.1016/0010-0277(90)90022-C; Claessens SEF, 2011, PSYCHOPHARMACOLOGY, V214, P141, DOI 10.1007/s00213-010-2118-y; CLARKE AS, 1988, INT J PRIMATOL, V9, P347, DOI 10.1007/BF02737382; COOPER JJ, 1993, ANIM BEHAV, V45, P616, DOI 10.1006/anbe.1993.1072; Coplan JD, 1996, P NATL ACAD SCI USA, V93, P1619, DOI 10.1073/pnas.93.4.1619; Daskalakis NP, 2012, PHYSIOL BEHAV, V106, P707, DOI 10.1016/j.physbeh.2012.01.015; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; de Waal F.B.M., 1990, PEACEMAKING PRIMATES; de Waal FBM, 2000, SCI AM, V282, P76, DOI 10.1038/scientificamerican0500-76; De Waal Frans, 2009, QUESTION ANIMAL CULT, P19; DEWAAL FBM, 1993, CHILD DEV, V64, P897, DOI 10.2307/1131225; DEWAAL FBM, 1989, AM J PRIMATOL, V19, P83, DOI 10.1002/ajp.1350190203; FORDHAM DP, 1991, ANIM PROD, V52, P287, DOI 10.1017/S0003356100012794; Freeman HD, 2010, AM J PRIMATOL, V72, P653, DOI 10.1002/ajp.20833; Fureix C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039280; Gilmer WS, 2003, J AFFECT DISORDERS, V75, P97, DOI 10.1016/S0165-0327(03)00046-6; HARLOW HF, 1965, P NATL ACAD SCI USA, V54, P90, DOI 10.1073/pnas.54.1.90; Hausberger M, 2012, NATURWISSENSCHAFTEN, V99, P291, DOI 10.1007/s00114-012-0902-8; Henry DB, 2005, J FAM PSYCHOL, V19, P121, DOI 10.1037/0893-3200.19.1.121; Henry S, 2012, PHYSIOL BEHAV, V106, P428, DOI 10.1016/j.physbeh.2012.02.025; Jensen KH, 1996, PHYSIOL BEHAV, V59, P741, DOI 10.1016/0031-9384(95)02159-0; Jiang J, 2013, J MED PRIMATOL, V42, P20, DOI 10.1111/jmp.12026; Latham NR, 2008, APPL ANIM BEHAV SCI, V110, P84, DOI 10.1016/j.applanim.2007.03.026; Lutz C, 2003, AM J PRIMATOL, V60, P1, DOI 10.1002/ajp.10075; Maestripieri D, 2000, BEHAV PROCESS, V49, P167, DOI 10.1016/S0376-6357(00)00083-8; MAESTRIPIERI D, 1991, DEV PSYCHOBIOL, V24, P571, DOI 10.1002/dev.420240805; Mason G, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P325, DOI [10.1079/9780851990040.0325, 10.1079/9780851990040.0000]; MASON GJ, 1991, ANIM BEHAV, V41, P1015, DOI 10.1016/S0003-3472(05)80640-2; Montaudouin S, 2004, BEHAV PROCESS, V67, P235, DOI 10.1016/j.beproc.2004.02.008; NAKAMICHI M, 1990, PRIMATES, V31, P213, DOI 10.1007/BF02380943; Nederhof E, 2012, PHYSIOL BEHAV, V106, P691, DOI 10.1016/j.physbeh.2011.12.008; Norscia I, 2011, PRIMATES, V52, P101, DOI 10.1007/s10329-010-0228-0; Novak MA, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P153, DOI 10.1079/9780851990040.0153; Palagi E, 2007, J ANTHROPOL SCI, V85, P63; Provencal N, 2012, J NEUROSCI, V32, P15626, DOI 10.1523/JNEUROSCI.1470-12.2012; Rommeck I, 2011, AM J PRIMATOL, V73, P692, DOI 10.1002/ajp.20953; Rommeck I, 2009, J AM ASSOC LAB ANIM, V48, P395; Rouff JH, 2005, AM J PRIMATOL, V67, P177, DOI 10.1002/ajp.20176; RUSHEN J, 1993, ANIM BEHAV, V45, P613, DOI 10.1006/anbe.1993.1071; Schino G, 1996, ANXIETY, V2, P186; SEAY B, 1962, J CHILD PSYCHOL PSYC, V3, P123, DOI 10.1111/j.1469-7610.1962.tb02047.x; Shivel CA, 2012, EXP NEUROL, V233, P87, DOI 10.1016/j.expneurol.2011.09.026; Siegel S, 1988, NONPARAMETRIC STAT B, V2; SOUTHWICK CH, 1967, BEHAVIOUR, V28, P182, DOI 10.1163/156853967X00235; STEVENSON-HINDE J, 1980, Primates, V21, P498, DOI 10.1007/BF02373838; Suomi SJ, 1997, BRIT MED BULL, V53, P170; Suomi SJ, 1991, NEUROBIOLOGY LEARNIN, P195; Suomi SJ, 2008, INTEGR PSYCHOL BEHAV, V42, P354, DOI 10.1007/s12124-008-9072-9; Thierry B, 2000, ETHOLOGY, V106, P713, DOI 10.1046/j.1439-0310.2000.00583.x; TINBERGEN N., 1952, QUART REV BIOL, V27, P1; Troisi A, 2002, STRESS, V5, P46, DOI 10.1080/10253890290012378; Vandeleest JJ, 2011, APPL ANIM BEHAV SCI, V132, P81, DOI 10.1016/j.applanim.2011.02.010; Veenema HC, 1997, NEUROBIOL AGING, V18, P509, DOI 10.1016/S0197-4580(97)00107-3; Zhang P, 2007, AM J PRIMATOL, V69, P1119, DOI 10.1002/ajp.20419	61	13	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67711	10.1371/journal.pone.0067711	http://dx.doi.org/10.1371/journal.pone.0067711			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861787	Green Published, gold, Green Submitted			2022-12-27	WOS:000323350700025
J	O'Connor, TD; Kiezun, A; Bamshad, M; Rich, SS; Smith, JD; Turner, E; Leal, SM; Akey, JM				O'Connor, Timothy D.; Kiezun, Adam; Bamshad, Michael; Rich, Stephen S.; Smith, Joshua D.; Turner, Emily; Leal, Suzanne M.; Akey, Joshua M.		NHLBIGO Exome Sequencing Project; Stat Anal Working Grp	Fine-Scale Patterns of Population Stratification Confound Rare Variant Association Tests	PLOS ONE			English	Article							COALESCENT SIMULATION; MISSING HERITABILITY; PREVALENCE; STRATEGIES	Advances in next-generation sequencing technology have enabled systematic exploration of the contribution of rare variation to Mendelian and complex diseases. Although it is well known that population stratification can generate spurious associations with common alleles, its impact on rare variant association methods remains poorly understood. Here, we performed exhaustive coalescent simulations with demographic parameters calibrated from exome sequence data to evaluate the performance of nine rare variant association methods in the presence of fine-scale population structure. We find that all methods have an inflated spurious association rate for parameter values that are consistent with levels of differentiation typical of European populations. For example, at a nominal significance level of 5%, some test statistics have a spurious association rate as high as 40%. Finally, we empirically assess the impact of population stratification in a large data set of 4,298 European American exomes. Our results have important implications for the design, analysis, and interpretation of rare variant genome-wide association studies.	[O'Connor, Timothy D.; Bamshad, Michael; Smith, Joshua D.; Turner, Emily; Akey, Joshua M.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Kiezun, Adam] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Kiezun, Adam] Harvard Univ, Brigham & Womens Hosp, Div Genet, Sch Med, Boston, MA 02115 USA; [Bamshad, Michael] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Rich, Stephen S.] Univ Virginia, Sch Med, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA; [Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	University of Washington; University of Washington Seattle; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Washington; University of Washington Seattle; University of Virginia; Baylor College of Medicine	O'Connor, TD (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	timothydoconnor@gmail.com; akeyj@u.washington.edu	Altshuler, David M/A-4476-2009; de Bakker, Paul IW/B-8730-2009; Barbalić, Maja/E-2161-2017	Altshuler, David M/0000-0002-7250-4107; de Bakker, Paul IW/0000-0001-7735-7858; Barbalić, Maja/0000-0001-8914-1691; Caan, Bette/0000-0002-5803-310X; Seshadri, Sudha/0000-0001-6135-2622; Ballantyne, Christie/0000-0002-6432-1730; Quinlan, Aaron/0000-0003-1756-0859; Bustamante, Carlos D./0000-0002-4187-7920; O'Connor, Timothy/0000-0002-0276-1896; Akey, Joshua/0000-0002-4411-1330; Rich, Stephen/0000-0003-3872-7793; Turner, Emily/0000-0001-9040-9229; Shendure, Jay/0000-0002-1516-1865	NHLBI [RC2 HL-103010, RC2 HL-102923, RC2 HL-102924, RC2 HL-102925, RC2 HL-102926]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102925, RC2HL102923, RC2HL103010, RC2HL102926, RC2HL102924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG008122] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding for GO ESP was provided by NHLBI grants RC2 HL-103010 (HeartGO), RC2 HL-102923 (LungGO) and RC2 HL-102924 (WHISP). The exome sequencing was performed through NHLBI grants RC2 HL-102925 (BroadGO) and RC2 HL-102926 (SeattleGO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Bhatia G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000954; Biswas S, 2009, AM J HUM GENET, V84, P641, DOI 10.1016/j.ajhg.2009.04.015; Boyle P, 2005, ANN ONCOL, V16, P481, DOI 10.1093/annonc/mdi098; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Ewing G, 2010, BIOINFORMATICS, V26, P2064, DOI 10.1093/bioinformatics/btq322; Farrell PM, 2008, J CYST FIBROS, V7, P450, DOI 10.1016/j.jcf.2008.03.007; Fleming DM, 2004, EUR J PUBLIC HEALTH, V14, P10, DOI 10.1093/eurpub/14.1.10; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; Hoffmann TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013584; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Peloso GM, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-64; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Roeder K, 2009, GENOMICS, V93, P1, DOI 10.1016/j.ygeno.2008.04.004; Rosenberg NA, 2006, GENETICS, V173, P1665, DOI 10.1534/genetics.105.055335; Roy-Gagnon MH, 2011, HUM GENET, V129, P521, DOI 10.1007/s00439-010-0945-x; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Tintle N, 2011, GENET EPIDEMIOL, V35, pS56, DOI 10.1002/gepi.20650; Ziv E, 2003, PHARMACOGENOMICS, V4, P431, DOI 10.1517/phgs.4.4.431.22758; Zondervan KT, 2002, HUM REPROD, V17, P1415, DOI 10.1093/humrep/17.6.1415	39	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e65834	10.1371/journal.pone.0065834	http://dx.doi.org/10.1371/journal.pone.0065834			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861739	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000323350700003
J	Sakai, N; Iwata, R; Yokoi, S; Butcher, RA; Clardy, J; Tomioka, M; Iino, Y				Sakai, Naoko; Iwata, Ryo; Yokoi, Saori; Butcher, Rebecca A.; Clardy, Jon; Tomioka, Masahiro; Iino, Yuichi			A Sexually Conditioned Switch of Chemosensory Behavior in C. elegans	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; COTURNIX-COTURNIX-JAPONICA; MATE-SEARCHING BEHAVIOR; SEX; PHEROMONE; CHEMOTAXIS; PLASTICITY; NEURONS; PROTEIN; TRA-1	In sexually reproducing animals, mating is essential for transmitting genetic information to the next generation and therefore animals have evolved mechanisms for optimizing the chance of successful mate location. In the soil nematode C. elegans, males approach hermaphrodites via the ascaroside pheromones, recognize hermaphrodites when their tails contact the hermaphrodites' body, and eventually mate with them. These processes are mediated by sensory signals specialized for sexual communication, but other mechanisms may also be used to optimize mate location. Here we describe associative learning whereby males use sodium chloride as a cue for hermaphrodite location. Both males and hermaphrodites normally avoid sodium chloride after associative conditioning with salt and starvation. However, we found that males become attracted to sodium chloride after conditioning with salt and starvation if hermaphrodites are present during conditioning. For this conditioning, which we call sexual conditioning, hermaphrodites are detected by males through pheromonal signaling and additional cue(s). Sex transformation experiments suggest that neuronal sex of males is essential for sexual conditioning. Altogether, these results suggest that C. elegans males integrate environmental, internal and social signals to determine the optimal strategy for mate location.	[Sakai, Naoko; Iwata, Ryo; Yokoi, Saori; Tomioka, Masahiro; Iino, Yuichi] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 113, Japan; [Butcher, Rebecca A.; Clardy, Jon] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	University of Tokyo; Harvard University; Harvard Medical School	Iino, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 113, Japan.	iino@biochem.s.u-tokyo.ac.jp	Yokoi, Saori/GSM-8778-2022; IINO, YUICHI/G-4962-2014; TOMIOKA, MASAHIRO/G-4890-2014	TOMIOKA, MASAHIRO/0000-0002-7537-714X; Iwata, Ryo/0000-0002-8356-8173; Sakai, Naoko/0000-0002-6311-5281	Ministry of Education, Culture, Sports, Science, and Technology, Japan; K99 Award from the National Institutes of Health [GM087533]; Grants-in-Aid for Scientific Research [25870172] Funding Source: KAKEN; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM087533] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); K99 Award from the National Institutes of Health; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Global Center of Excellence Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), and Grant-in-Aid for Scientific Research (B) and for Innovative Areas (Systems Molecular Ethology), Ministry of Education, Culture, Sports, Science, and Technology, Japan. RAB was supported by a K99 Award from the National Institutes of Health (GM087533). The funders had no roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2010, GENETICS, V186, P1309, DOI 10.1534/genetics.110.119768; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Barr Maureen M, 2006, WormBook, P1; Barrios A, 2008, CURR BIOL, V18, P1865, DOI 10.1016/j.cub.2008.10.050; Barrios A, 2012, NAT NEUROSCI, V15, P1675, DOI 10.1038/nn.3253; BRENNER S, 1974, GENETICS, V77, P71; Butcher RA, 2009, P NATL ACAD SCI USA, V106, P1875, DOI 10.1073/pnas.0810338106; Chasnov JR, 2007, P NATL ACAD SCI USA, V104, P6730, DOI 10.1073/pnas.0608050104; Cheung BHH, 2005, CURR BIOL, V15, P905, DOI 10.1016/j.cub.2005.04.017; Choi GB, 2011, CELL, V146, P1003, DOI 10.1016/j.cell.2011.07.041; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; DEBONO M, 1995, GENE DEV, V9, P155, DOI 10.1101/gad.9.2.155; DOMJAN M, 1986, J COMP PSYCHOL, V100, P413, DOI 10.1037/0735-7036.100.4.413; Domjan M, 2005, ANNU REV PSYCHOL, V56, P179, DOI 10.1146/annurev.psych.55.090902.141409; FARRIS HE, 1967, J EXP ANAL BEHAV, V10, P213, DOI 10.1901/jeab.1967.10-213; Gutierrez A, 2003, DEVELOPMENT, V130, P983, DOI 10.1242/dev.00320; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hoskins R, 1996, DEVELOPMENT, V122, P97; Hu P.J., 2007, DAUER, DOI [10.1895/wormbook.1.144.1, DOI 10.1895/WORMBOOK.1.144.1]; Ikeda DD, 2008, P NATL ACAD SCI USA, V105, P5260, DOI 10.1073/pnas.0711894105; Iwata R, 2011, P NATL ACAD SCI USA, V108, P7589, DOI 10.1073/pnas.1016232108; Izrayelit Y, 2012, ACS CHEM BIOL, V7, P1321, DOI 10.1021/cb300169c; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Lee KH, 2007, CURR BIOL, V17, P1858, DOI 10.1016/j.cub.2007.10.015; Lipton J, 2004, J NEUROSCI, V24, P7427, DOI 10.1523/JNEUROSCI.1746-04.2004; Mehra A, 1999, GENE DEV, V13, P1453, DOI 10.1101/gad.13.11.1453; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Portman DS, 2007, ADV GENET, V59, P1, DOI 10.1016/S0065-2660(07)59001-2; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618; Roberts SA, 2012, SCIENCE, V338, P1462, DOI 10.1126/science.1225638; Saeki S, 2001, J EXP BIOL, V204, P1757; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Simon JM, 2002, P NATL ACAD SCI USA, V99, P1598, DOI 10.1073/pnas.032225799; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Starostina NG, 2007, DEV CELL, V13, P127, DOI 10.1016/j.devcel.2007.05.008; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; Touhara K, 2007, ADV GENET, V59, P147, DOI 10.1016/S0065-2660(07)59006-1; Vellai T, 2006, GENETICS, V174, P309, DOI 10.1534/genetics.106.061499; White JQ, 2007, CURR BIOL, V17, P1847, DOI 10.1016/j.cub.2007.09.011; White JQ, 2012, NEURON, V75, P593, DOI 10.1016/j.neuron.2012.03.044; Yamada K, 2010, SCIENCE, V329, P1647, DOI 10.1126/science.1192020; Yamamoto D, 2007, ADV GENET, V59, P39, DOI 10.1016/S0065-2660(07)59002-4; Yi W, 2000, DEVELOPMENT, V127, P4469; Zarkower D, 2006, WORMBOOK, V1, P1, DOI DOI 10.1895/WORMBOOK.1.84.1	45	24	24	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68676	10.1371/journal.pone.0068676	http://dx.doi.org/10.1371/journal.pone.0068676			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861933	gold, Green Published, Green Submitted			2022-12-27	WOS:000323350700098
J	Zhuang, ZG; Wang, K; Cheng, XL; Qu, XY; Jiang, BQ; Li, ZD; Luo, JM; Shao, ZM; Duan, T				Zhuang, Zhigang; Wang, Kai; Cheng, Xiaolin; Qu, Xueying; Jiang, Beiqi; Li, Zhengdong; Luo, Jianming; Shao, Zhiming; Duan, Tao			LKB1 Inhibits Breast Cancer Partially through Repressing the Hedgehog Signaling Pathway	PLOS ONE			English	Article							EXPRESSION; CELLS; SUPPRESSOR; CARCINOMA; PROTEIN	Constitutive activation of the Hedgehog (Hh) signaling pathway has been implicated in the development of many human malignancies. Hh targets, such as Patched (PTCH), smoothened (SMO), Sonic hedgehog (SHH) and glioma-associated oncogene homologue 1 (GLI1), are markers of Hh signaling activation and expressed in most Hh-associated tumors. The protein kinase LKB1 has been shown to slow proliferation and induce cell-cycle arrest in many cell lines. In this study, we observed that activated LKB1 decreased the expression of factors related to Hh reporter activity in MDA-MB-231 breast cancer cells, including of SMO, SHH and GLI1. In contrast, LKB1 siRNA increased the expression of these target genes. The same results were shown to inhibit the Hh factors Sufu and Hip. Furthermore, we also observed negative correlation between LKB1 and glioma-associated oncogene homologue 1 (GLI1) in three breast cancer cell lines. Meanwhile, LKB1 siRNA rescued the inhibition of cell growth by 3-Keto-N'-(aminoethyl-N'-aminocaproyldihydrocinnamoyl) cyclopamine (KAAD-cyclopamine), an antagonist of the Hh element SMO, which suggests that LKB1 acts as the downstream of SMO. In vivo, LKB1 siRNA increased tumor growth in the mammary fat pad, and the expression levels of Hh displayed similar results in vitro. Overexpression of the LKB1 protein in human breast cancers is associated with the expression of Hh. We found that breast carcinomas with detectable Hh had weak or undetectable expression of LKB1, whereas tumors that expressed high levels of LKB1 had undetectable Hh signaling. In this study, we find that LKB1 are negatively correlated with the expression of Hh related transcription factors. These findings suggest that LKB1 may inhibit tumorigenesis by regulating Hh signaling in certain cancers.	[Zhuang, Zhigang; Wang, Kai; Cheng, Xiaolin; Qu, Xueying; Jiang, Beiqi; Li, Zhengdong; Duan, Tao] Tongji Univ, Dept Breast Surg, Shanghai Matern & Infant Hosp 1, Sch Med, Shanghai 200092, Peoples R China; [Luo, Jianming; Shao, Zhiming] Fudan Univ, Breast Canc Inst, Canc Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China	Tongji University; Fudan University	Duan, T (corresponding author), Tongji Univ, Dept Breast Surg, Shanghai Matern & Infant Hosp 1, Sch Med, Shanghai 200092, Peoples R China.	tduan@yahoo.com			Shanghai Science and Technology Committee [09zr1424800, 124119a4700]; Shanghai Health Bureau scientific research subject [20124164]	Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Shanghai Health Bureau scientific research subject	This study was supported by Shanghai Science and Technology Committee (grants 09zr1424800 and 124119a4700). Shanghai Health Bureau scientific research subject (20124164). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chuang PT, 2003, GENE DEV, V17, P342, DOI 10.1101/gad.1026303; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Esteller M, 2000, ONCOGENE, V19, P164, DOI 10.1038/sj.onc.1203227; Fenton H, 2006, APPL IMMUNOHISTO M M, V14, P146, DOI 10.1097/01.pai.0000176157.07908.20; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Huang SH, 2006, CARCINOGENESIS, V27, P1334, DOI 10.1093/carcin/bgi378; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Kubo M, 2007, NIHON RINSHO, V28, P142; Liu SL, 2005, BREAST CANCER RES, V7, P86, DOI 10.1186/bcr1021; Mori Y, 2006, ONCOLOGY-BASEL, V70, P378, DOI 10.1159/000098111; Mukherjee S, 2006, CANCER BIOL THER, V5, P674, DOI 10.4161/cbt.5.6.2906; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Sanchez P, 2005, CANCER RES, V65, P2990, DOI 10.1158/0008-5472.CAN-05-0439; Shaw A, 2009, ONCOGENE, V28, P4480, DOI 10.1038/onc.2009.294; Shen Z, 2002, CLIN CANCER RES, V8, P2085; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Terry MB, 2002, CANCER EPIDEM BIOMAR, V11, P1100; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Zhuang ZG, 2006, MOL CANCER RES, V4, P843, DOI 10.1158/1541-7786.MCR-06-0118	22	22	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67431	10.1371/journal.pone.0067431	http://dx.doi.org/10.1371/journal.pone.0067431			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861764	gold, Green Published, Green Submitted			2022-12-27	WOS:000323350700014
J	Kucharik, CJ; VanLoocke, A; Lenters, JD; Motew, MM				Kucharik, Christopher J.; VanLoocke, Andy; Lenters, John D.; Motew, Melissa M.			Miscanthus Establishment and Overwintering in the Midwest USA: A Regional Modeling Study of Crop Residue Management on Critical Minimum Soil Temperatures	PLOS ONE			English	Article							INTEGRATED BIOSPHERE SIMULATOR; WATER-USE EFFICIENCY; X-GIGANTEUS; ENERGY-BALANCE; CARBON BALANCE; CLIMATE-CHANGE; CORN-BELT; HEAT; PERFORMANCE; GENOTYPES	Miscanthus is an intriguing cellulosic bioenergy feedstock because its aboveground productivity is high for low amounts of agrochemical inputs, but soil temperatures below -3.5 degrees C could threaten successful cultivation in temperate regions. We used a combination of observed soil temperatures and the Agro-IBIS model to investigate how strategic residue management could reduce the risk of rhizome threatening soil temperatures. This objective was addressed using a historical (1978-2007) reconstruction of extreme minimum 10 cm soil temperatures experienced across the Midwest US and model sensitivity studies that quantified the impact of crop residue on soil temperatures. At observation sites and for simulations that had bare soil, two critical soil temperature thresholds (50% rhizome winterkill at-3.5 degrees C and -6.0 degrees C for different Miscanthus genotypes) were reached at rhizome planting depth (10 cm) over large geographic areas. The coldest average annual extreme 10 cm soil temperatures were between -8 degrees C to -11 degrees C across North Dakota, South Dakota, and Minnesota. Large portions of the region experienced 10 cm soil temperatures below -3.5 degrees C in 75% or greater for all years, and portions of North and South Dakota, Minnesota, and Wisconsin experienced soil temperatures below -6.0 degrees C in 50-60% of all years. For simulated management options that established varied thicknesses (1-5 cm) of miscanthus straw following harvest, extreme minimum soil temperatures increased by 2.5 degrees C to 6 degrees C compared to bare soil, with the greatest warming associated with thicker residue layers. While the likelihood of 10 cm soil temperatures reaching -3.5 degrees C was greatly reduced with 2-5 cm of surface residue, portions of the Dakotas, Nebraska, Minnesota, and Wisconsin still experienced temperatures colder than -3.5 degrees C in 50-80% of all years. Nonetheless, strategic residue management could help increase the likelihood of overwintering of miscanthus rhizomes in the first few years after establishment, although low productivity and biomass availability during these early stages could hamper such efforts.	[Kucharik, Christopher J.] Univ Wisconsin, Dept Agron, Madison, WI 53706 USA; [Kucharik, Christopher J.; Motew, Melissa M.] Univ Wisconsin, Nelson Inst Ctr Sustainabil & Global Environm, Madison, WI USA; [Kucharik, Christopher J.] Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Dept Energy, Madison, WI USA; [VanLoocke, Andy] Univ Illinois, Dept Atmospher Sci, Urbana, IL 61801 USA; [Lenters, John D.] Univ Nebraska, Sch Nat Resources, Lincoln, NE USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of Illinois System; University of Illinois Urbana-Champaign; University of Nebraska System; University of Nebraska Lincoln	Kucharik, CJ (corresponding author), Univ Wisconsin, Dept Agron, 1575 Linden Dr, Madison, WI 53706 USA.	kucharik@wisc.edu		Motew, Melissa/0000-0003-1686-4754; Lenters, John/0000-0002-6895-7592; Kucharik, Christopher/0000-0002-0400-758X; VanLoocke, Andy/0000-0002-7516-8479	U.S. Department of Energy's Office of Science through the Midwestern Regional Center for the National Institute for Climatic Change Research at Michigan Technological University [DE-FC02-06ER64158]; U.S. Department of Energy Great Lakes Bioenergy Research Center (Department of Energy Biological and Environmental Research Office of Science) [DE-FC02-07ER64494]; U.S. Department of Energy Biomass Program Office of Energy Efficiency and Renewable Energy [DE-AC05-76RL01830]	U.S. Department of Energy's Office of Science through the Midwestern Regional Center for the National Institute for Climatic Change Research at Michigan Technological University(United States Department of Energy (DOE)); U.S. Department of Energy Great Lakes Bioenergy Research Center (Department of Energy Biological and Environmental Research Office of Science)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); U.S. Department of Energy Biomass Program Office of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE))	This research was partially supported by the U.S. Department of Energy's Office of Science through the Midwestern Regional Center for the National Institute for Climatic Change Research at Michigan Technological University, under Award Number DE-FC02-06ER64158. This work was also funded in part by the U.S. Department of Energy Great Lakes Bioenergy Research Center (Department of Energy Biological and Environmental Research Office of Science DE-FC02-07ER64494) and U.S. Department of Energy Biomass Program Office of Energy Efficiency and Renewable Energy (DE-AC05-76RL01830). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASE JK, 1979, SOIL SCI SOC AM J, V43, P1229, DOI 10.2136/sssaj1979.03615995004300060036x; Amougou N, 2012, GCB BIOENERGY, V4, P698, DOI 10.1111/j.1757-1707.2012.01192.x; BRISTOW KL, 1986, AGR FOREST METEOROL, V36, P193, DOI 10.1016/0168-1923(86)90035-3; Campbell G.S., 1998, INTRO ENV BIOPHYSICS, Vsecond, DOI [10.1007/978-1-4612-1626-1, DOI 10.1007/978-1-4612-1626-1]; Cherkauer KA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003575; Cherkauer KA, 1999, J GEOPHYS RES-ATMOS, V104, P19599, DOI 10.1029/1999JD900337; CHUNG SO, 1987, WATER RESOUR RES, V23, P2175, DOI 10.1029/WR023i012p02175; Clemmensen AW, 2004, COMPOST SCI UTIL, V12, P219; Clifton-Brown JC, 2000, NEW PHYTOL, V148, P287, DOI 10.1046/j.1469-8137.2000.00764.x; Clifton-Brown JC, 2000, ANN BOT-LONDON, V86, P191, DOI 10.1006/anbo.2000.1183; Clifton-Brown JC, 2001, AGRON J, V93, P1013, DOI 10.2134/agronj2001.9351013x; COLLATZ GJ, 1992, AUST J PLANT PHYSIOL, V19, P519, DOI 10.1071/PP9920519; COLLATZ GJ, 1991, AGR FOREST METEOROL, V54, P107, DOI 10.1016/0168-1923(91)90002-8; Delire C, 1999, J GEOPHYS RES-ATMOS, V104, P16895, DOI 10.1029/1999JD900212; Dohleman FG, 2009, PLANT PHYSIOL, V150, P2104, DOI 10.1104/pp.109.139162; Donner SD, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001808; Dyer JL, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027258; El Maayar M, 2001, J GEOPHYS RES-ATMOS, V106, P14339, DOI 10.1029/2001JD900155; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Farrell AD, 2006, ANN APPL BIOL, V149, P337, DOI 10.1111/j.1744-7348.2006.00099.x; Flerchinger GN, 2012, T ASABE, V55, P1395; FLERCHINGER GN, 1991, T ASAE, V34, P2381, DOI 10.13031/2013.31883; Flerchinger GN, 2003, GEODERMA, V116, P217, DOI 10.1016/S0016-7061(03)00102-2; Foley JA, 1996, GLOBAL BIOGEOCHEM CY, V10, P603, DOI 10.1029/96GB02692; Gauder M, 2012, ANN APPL BIOL, V160, P126, DOI 10.1111/j.1744-7348.2011.00526.x; GREEF JM, 1993, ANGEW BOT, V67, P87; Heaton E, 2004, BIOMASS BIOENERG, V27, P21, DOI 10.1016/j.biombioe.2003.10.005; Heaton EA, 2008, GLOBAL CHANGE BIOL, V14, P2000, DOI 10.1111/j.1365-2486.2008.01662.x; Heaton EA, 2008, CURR OPIN BIOTECH, V19, P202, DOI 10.1016/j.copbio.2008.05.001; Heaton EA, 2010, ADV BOT RES, V56, P75, DOI 10.1016/S0065-2296(10)56003-8; Hillel D., 2003, INTRO ENV SOIL PHYS; Horton R, 1996, THEOR APPL CLIMATOL, V54, P27, DOI 10.1007/BF00863556; Hu Q, 2003, J APPL METEOROL, V42, P1139, DOI [10.1175/1520-0450(2003)042<1139:ADSTDA>2.0.CO;2, 10.1175/1520-0450(2003)042&lt;1139:ADSTDA&gt;2.0.CO;2]; Isard SA, 2007, ANN ASSOC AM GEOGR, V97, P467, DOI 10.1111/j.1467-8306.2007.00558.x; JORGENSEN U, 2001, MISCANTHUS ENERGY FI, P68; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI 10.1175/Bams-83-11-1631; Khanna M, 2008, BIOMASS BIOENERG, V32, P482, DOI 10.1016/j.biombioe.2007.11.003; Kucharik CJ, 2007, AGR FOREST METEOROL, V146, P134, DOI 10.1016/j.agrformet.2007.05.011; Kucharik CJ, 2006, AGRON J, V98, P1544, DOI 10.2134/agronj2006.0156; Kucharik CJ, 2006, ECOL MODEL, V196, P1, DOI 10.1016/j.ecolmodel.2005.11.031; Kucharik CJ, 2010, PHYS GEOGR, V31, P1, DOI 10.2747/0272-3646.31.1.1; Kucharik CJ, 2003, EARTH INTERACT, V7; Kucharik CJ, 2003, J ENVIRON QUAL, V32, P247, DOI 10.2134/jeq2003.0247; Kucharik CJ, 2000, GLOBAL BIOGEOCHEM CY, V14, P795, DOI 10.1029/1999GB001138; Kunkel KE, 1999, J GEOPHYS RES-ATMOS, V104, P19551, DOI 10.1029/1999JD900050; Kunkel KE, 2007, J ATMOS OCEAN TECH, V24, P64, DOI 10.1175/JTECH2017.1; Lenters JD, 2000, J GEOPHYS RES-ATMOS, V105, P22393, DOI 10.1029/2000JD900277; Lewandowski I, 2000, BIOMASS BIOENERG, V19, P209, DOI 10.1016/S0961-9534(00)00032-5; Li KY, 2005, J CLIMATE, V18, P3173, DOI 10.1175/JCLI3452.1; MathWorks, 2010, MATLAB 7 11; Miao Z, 2011, IND CROP PROD, V33, P504, DOI 10.1016/j.indcrop.2010.12.016; Miller DA, 1998, EARTH INTERACT, V2, P2, DOI DOI 10.1175/1087-3562(1998)002<0001:ACUSMS>2.3.C0;2; Molling CC, 2005, J AM WATER RESOUR AS, V41, P1289, DOI 10.1111/j.1752-1688.2005.tb03801.x; NUMATA M, 1974, FLORA VEGETATION JAP, P125; Portmann RW, 2009, P NATL ACAD SCI USA, V106, P7324, DOI 10.1073/pnas.0808533106; Price L, 2004, BIOMASS BIOENERG, V26, P3, DOI 10.1016/S0961-9534(03)00062-X; Pyter R, 2009, METHODS MOL BIOL, V581, P41, DOI 10.1007/978-1-60761-214-8_3; Pyter RJ, 2010, BIOMASS BIOENERG, V34, P1466, DOI 10.1016/j.biombioe.2010.04.014; Robertson GP, 2008, SCIENCE, V322, P49, DOI 10.1126/science.1161525; Sauer TJ, 1998, AGR FOREST METEOROL, V89, P155, DOI 10.1016/S0168-1923(97)00090-7; Sauer TJ, 1996, AGRON J, V88, P733, DOI 10.2134/agronj1996.00021962008800050009x; Sharratt BS, 2002, SOIL TILL RES, V64, P243, DOI 10.1016/S0167-1987(01)00260-4; Sharratt BS, 1998, SOIL TILL RES, V49, P243, DOI 10.1016/S0167-1987(98)00181-0; SHARRATT BS, 1992, AGR FOREST METEOROL, V57, P243, DOI 10.1016/0168-1923(92)90121-J; SHEN Y, 1990, SOIL SCI SOC AM J, V54, P653, DOI 10.2136/sssaj1990.03615995005400030005x; Simunek J, 2008, HYDRUS SOFTWARE SERI, V3, P330; Simunek J, 2008, VADOSE ZONE J, V7, P782, DOI 10.2136/vzj2007.0074; Sinha T, 2008, J HYDROMETEOROL, V9, P936, DOI 10.1175/2008JHM934.1; Sinha T, 2010, J HYDROMETEOROL, V11, P229, DOI 10.1175/2009JHM1141.1; Sinha T, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012188; Smith CM, 2013, J ENVIRON QUAL, V42, P219, DOI 10.2134/jeq2012.0210; Soylu ME, 2011, HYDROL EARTH SYST SC, V15, P787, DOI 10.5194/hess-15-787-2011; Steiner JL, 1996, THEOR APPL CLIMATOL, V54, P1, DOI 10.1007/BF00863553; SUI HJ, 1992, AGR FOREST METEOROL, V61, P281, DOI 10.1016/0168-1923(92)90054-8; TANNER CB, 1990, SOIL SCI SOC AM J, V54, P945, DOI 10.2136/sssaj1990.03615995005400040001x; Twine TE, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000599; Van Wijk W., 1963, PHYS PLANT ENV, P102; VanLoocke A, 2012, AGR FOREST METEOROL, V164, P82, DOI 10.1016/j.agrformet.2012.05.016; Vanloocke A, 2010, GCB BIOENERGY, V2, P180, DOI 10.1111/j.1757-1707.2010.01053.x; Wagenaar BM, 1997, BIOMASS BIOENERG, V12, P185, DOI 10.1016/S0961-9534(97)00009-3; Wilhelm WW, 2004, AGRON J, V96, P1, DOI 10.2134/agronj2004.0001; Zeri M, 2011, AGR ECOSYST ENVIRON, V144, P319, DOI 10.1016/j.agee.2011.09.006; Zheng Daolan, 1993, Climate Research, V2, P183, DOI 10.3354/cr002183; Zub HW, 2010, AGRON SUSTAIN DEV, V30, P201, DOI 10.1051/agro/2009034	85	28	29	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68847	10.1371/journal.pone.0068847	http://dx.doi.org/10.1371/journal.pone.0068847			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844244	Green Submitted, Green Published, gold			2022-12-27	WOS:000321733000029
J	Loughry, WJ; Perez-Heydrich, C; McDonough, CM; Oli, MK				Loughry, William J.; Perez-Heydrich, Carolina; McDonough, Colleen M.; Oli, Madan K.			Population Dynamics and Range Expansion in Nine-Banded Armadillos	PLOS ONE			English	Article							DASYPUS-NOVEMCINCTUS; SENSITIVITY-ANALYSIS; RECORDS; DISPERSAL; ELASTICITIES; SUCCESS; SPREAD; SPEED	Understanding why certain species can successfully colonize new areas while others do not is a central question in ecology. The nine-banded armadillo (Dasypus novemcinctus) is a conspicuous example of a successful invader, having colonized much of the southern United States in the last 200 years. We used 15 years (1992-2006) of capture-mark-recapture data from a population of armadillos in northern Florida in order to estimate, and examine relationships among, various demographic parameters that may have contributed to this ongoing range expansion. Modeling across a range of values for gamma, the probability of juveniles surviving in the population until first capture, we found that population growth rates varied from 0.80 for gamma = 0.1, to 1.03 for gamma = 1.0. Growth rates approached 1.0 only when gamma >= 0.80, a situation that might not occur commonly because of the high rate of disappearance of juveniles. Net reproductive rate increased linearly with gamma, but life expectancy (estimated at 3 years) was independent of gamma. We also found that growth rates were lower during a 3-year period of hardwood removal that removed preferred habitat than in the years preceding or following. Life-table response experiment (LTRE) analysis indicated the decrease in growth rate during logging was primarily due to changes in survival rates of adults. Likewise, elasticity analyses of both deterministic and stochastic population growth rates revealed that survival parameters were more influential on population growth than were those related to reproduction. Collectively, our results are consistent with recent theories regarding biological invasions which posit that populations no longer at the leading edge of range expansion do not exhibit strong positive growth rates, and that high reproductive output is less critical in predicting the likelihood of successful invasion than are life-history strategies that emphasize allocation of resources to future, as opposed to current, reproduction.	[Loughry, William J.; McDonough, Colleen M.] Valdosta State Univ, Dept Biol, Valdosta, GA 31698 USA; [Perez-Heydrich, Carolina] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA; [Oli, Madan K.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA	University System of Georgia; Valdosta State University; University of North Carolina; University of North Carolina Chapel Hill; State University System of Florida; University of Florida	Loughry, WJ (corresponding author), Valdosta State Univ, Dept Biol, Valdosta, GA 31698 USA.	jloughry@valdosta.edu			Earthwatch; American Philosophical Society; faculty research awards from Valdosta State University; University of Florida Open Access Publishing Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER	Earthwatch; American Philosophical Society; faculty research awards from Valdosta State University; University of Florida Open Access Publishing Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Field work was supported by Earthwatch, the American Philosophical Society, and faculty research awards from Valdosta State University. Publication supported by the University of Florida Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba Agustin Manuel, 2010, Edentata, V11, P135; Altwegg R, 2013, DIVERS DISTRIB, V19, P60, DOI 10.1111/j.1472-4642.2012.00943.x; Arim M, 2006, P NATL ACAD SCI USA, V103, P374, DOI 10.1073/pnas.0504272102; Audubon John James, 1854, QUADRUPEDS N AM, V3; Caswell, 2000, MATRIX POPULATION MO; Caswell H, 2005, AUST NZ J STAT, V47, P75, DOI 10.1111/j.1467-842X.2005.00373.x; CASWELL H, 1989, ECOL MODEL, V46, P221, DOI 10.1016/0304-3800(89)90019-7; Dobson FS, 2001, AM NAT, V158, P236, DOI 10.1086/321322; Eichler S. Erich, 2011, Edentata, V12, P7; Ellner SP, 2012, THEOR POPUL BIOL, V82, P283, DOI 10.1016/j.tpb.2012.03.005; Elton C., 1958; Freeman PW, 1998, SOUTHWEST NAT, V43, P491; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Haridas CV, 2005, AM NAT, V166, P481, DOI 10.1086/444444; Hofmann Joyce E., 2009, Transactions of the Illinois State Academy of Science, V102, P95; Hostetler JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034379; HUMPHREY SR, 1974, BIOSCIENCE, V24, P457, DOI 10.2307/1296853; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kot M, 1996, ECOLOGY, V77, P2027, DOI 10.2307/2265698; Loughry WJ, 2013, J MAMMAL, V94, P408, DOI 10.1644/12-MAMM-A-198.1; Loughry W.J., 2013, 9 BANDED ARMADILLO N; Loughry WJ, 1996, AM MIDL NAT, V135, P53, DOI 10.2307/2426871; Loughry WJ, 1998, CAN J ZOOL, V76, P1815, DOI 10.1139/cjz-76-10-1815; Loughry WJ, 2001, ACTA THERIOL, V46, P393, DOI 10.1007/BF03192446; McDonough CM, 1997, AM MIDL NAT, V138, P299, DOI 10.2307/2426823; McDonough CM, 2005, WILDLIFE SOC B, V33, P1198, DOI 10.2193/0091-7648(2005)33[1198:IOLMPO]2.0.CO;2; McDonough CM, 2007, SOUTHEAST NAT, V6, P381, DOI 10.1656/1528-7092(2007)6[381:PDONAI]2.0.CO;2; Neubert MG, 2000, ECOLOGY, V81, P1613, DOI 10.1890/0012-9658(2000)081[1613:DADCAS]2.0.CO;2; Peppler Richard D., 2008, P151; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; Platt SG, 1995, BRIMLEYANA, P89; Prodohl PA, 1996, P ROY SOC B-BIOL SCI, V263, P1643, DOI 10.1098/rspb.1996.0240; Rolland V, 2011, WILDLIFE RES, V38, P396, DOI 10.1071/WR10239; Royama T., 1992, ANAL POPULATION ECOL; Shigesada N., 1997, BIOL INVASIONS THEOR; Sol D, 2008, AM NAT, V172, pS63, DOI 10.1086/588304; Sol D, 2012, SCIENCE, V337, P580, DOI 10.1126/science.1221523; STEVENSON H M, 1974, Florida Field Naturalist, V2, P8; Stuart James N., 2007, Prairie Naturalist, V39, P163; Taulman JF, 1996, J BIOGEOGR, V23, P635, DOI 10.1111/j.1365-2699.1996.tb00024.x; Tuljapurkar S, 2003, AM NAT, V162, P489, DOI 10.1086/378648; Van Deelen TR, 2002, SOUTHWEST NAT, V47, P489; Whitaker Jr JO, 2010, MAMMALS INDIANA FIEL; Zenni RD, 2013, OIKOS, V122, P801, DOI 10.1111/j.1600-0706.2012.00254.x	44	9	10	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68311	10.1371/journal.pone.0068311	http://dx.doi.org/10.1371/journal.pone.0068311			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844183	Green Published, gold			2022-12-27	WOS:000321733000138
J	Tonk, L; Sampayo, EM; Weeks, S; Magno-Canto, M; Hoegh-Guldberg, O				Tonk, Linda; Sampayo, Eugenia M.; Weeks, Scarla; Magno-Canto, Marites; Hoegh-Guldberg, Ove			Host-Specific Interactions with Environmental Factors Shape the Distribution of Symbiodinium across the Great Barrier Reef	PLOS ONE			English	Article							CORAL GENUS MADRACIS; ALGAL ENDOSYMBIONTS; SYMBIONT DIVERSITY; BLEACHING SUSCEPTIBILITY; SCLERACTINIAN CORALS; SERIATOPORA-HYSTRIX; CLIMATE-CHANGE; CLADE-D; ZOOXANTHELLAE; PATTERNS	Background: The endosymbiotic dinoflagellates (genus Symbiodinium) within coral reef invertebrates are critical to the survival of the holobiont. The genetic variability of Symbiodinium may contribute to the tolerance of the symbiotic association to elevated sea surface temperatures (SST). To assess the importance of factors such as the local environment, host identity and biogeography in driving Symbiodinium distributions on reef-wide scales, data from studies on reef invertebrate-Symbiodinium associations from the Great Barrier Reef (GBR) were compiled. Methodology/Principal Findings: The resulting database consisted of 3717 entries from 26 studies. It was used to explore ecological patterns such as host-specificity and environmental drivers structuring community complexity using a multi-scalar approach. The data was analyzed in several ways: (i) frequently sampled host species were analyzed independently to investigate the influence of the environment on symbiont distributions, thereby excluding the influence of host specificity, (ii) host species distributions across sites were added as an environmental variable to determine the contribution of host identity on symbiont distribution, and (iii) data were pooled based on clade (broad genetic groups dividing the genus Symbiodinium) to investigate factors driving Symbiodinium distributions using lower taxonomic resolution. The results indicated that host species identity plays a dominant role in determining the distribution of Symbiodinium and environmental variables shape distributions on a host species-specific level. SST derived variables (especially SSTstdev) most often contributed to the selection of the best model. Clade level comparisons decreased the power of the predictive model indicating that it fails to incorporate the main drivers behind Symbiodinium distributions. Conclusions/Significance: Including the influence of different host species on Symbiodinium distributional patterns improves our understanding of the drivers behind the complexity of Symbiodinium-invertebrate symbioses. This will increase our ability to generate realistic models estimating the risk reefs are exposed to and their resilience in response to a changing climate.	[Tonk, Linda; Sampayo, Eugenia M.; Hoegh-Guldberg, Ove] Univ Queensland, ARC Ctr Excellence Coral Reef Studies, St Lucia, Qld, Australia; [Tonk, Linda; Sampayo, Eugenia M.; Hoegh-Guldberg, Ove] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Weeks, Scarla; Magno-Canto, Marites] Univ Queensland, Biophys Oceanog Grp, Sch Geog Planning & Environm Management, St Lucia, Qld, Australia; [Tonk, Linda; Hoegh-Guldberg, Ove] Univ Queensland, Global Change Inst, St Lucia, Qld, Australia	University of Queensland; University of Queensland; University of Queensland; University of Queensland	Tonk, L (corresponding author), Univ Queensland, ARC Ctr Excellence Coral Reef Studies, St Lucia, Qld, Australia.	l.tonk@uq.edu.au	Hoegh-Guldberg, Ove/ABA-5420-2020; Weeks, Scarla J/E-8632-2013	Hoegh-Guldberg, Ove/0000-0001-7510-6713; Weeks, Scarla J/0000-0002-0579-7069	Great Barrier Reef Foundation; Queensland Smart State Fellowship Award; ARC Centre of Excellence for Coral Reef Studies	Great Barrier Reef Foundation; Queensland Smart State Fellowship Award; ARC Centre of Excellence for Coral Reef Studies(Australian Research Council)	LT, SW and OHG were supported by funding from the Great Barrier Reef Foundation, the Queensland Smart State Fellowship Award (to OHG) and the ARC Centre of Excellence for Coral Reef Studies. EMS was supported by the ARC Centre of Excellence for Coral Reef Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alongi DM, 2011, CONT SHELF RES, V31, P1384, DOI 10.1016/j.csr.2011.05.018; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Bongaerts P, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-303; Bongaerts P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010871; Chen CA, 2005, CORAL REEFS, V24, P11, DOI 10.1007/s00338-004-0389-7; Chen CA, 2003, ZOOL STUD, V42, P540; Cooper TF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025536; Diekmann OE, 2003, CORAL REEFS, V22, P29, DOI 10.1007/s00338-002-0273-2; Diekmann OE, 2002, MAR ECOL PROG SER, V227, P221, DOI 10.3354/meps227221; Dove SG, 2008, PLANT CELL ENVIRON, V31, P1523, DOI 10.1111/j.1365-3040.2008.01852.x; Enriquez S, 2005, LIMNOL OCEANOGR, V50, P1025, DOI 10.4319/lo.2005.50.4.1025; Fabricius KE, 2004, MOL ECOL, V13, P2445, DOI 10.1111/j.1365-294X.2004.02230.x; Finney JC, 2010, MICROB ECOL, V60, P250, DOI 10.1007/s00248-010-9681-y; Frade PR, 2008, MOL ECOL, V17, P691, DOI 10.1111/j.1365-294X.2007.03612.x; Frade PR, 2008, LIMNOL OCEANOGR, V53, P2711, DOI 10.4319/lo.2008.53.6.2711; Goulet TL, 2008, MAR BIOL, V154, P795, DOI 10.1007/s00227-008-0972-5; Goulet TL, 2008, MAR ECOL PROG SER, V355, P45, DOI 10.3354/meps07214; Guest JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033353; Hill M, 2011, MOL PHYLOGENET EVOL, V59, P81, DOI 10.1016/j.ympev.2011.01.006; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Howells EJ, 2012, NAT CLIM CHANGE, V2, P116, DOI 10.1038/NCLIMATE1330; Howells EJ, 2009, CORAL REEFS, V28, P215, DOI 10.1007/s00338-008-0450-z; Iglesias-Prieto R, 2004, P ROY SOC B-BIOL SCI, V271, P1757, DOI 10.1098/rspb.2004.2757; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Jones A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010437; LaJeunesse TC, 2008, LIMNOL OCEANOGR, V53, P719, DOI 10.4319/lo.2008.53.2.0719; LaJeunesse TC, 2005, J PHYCOL, V41, P880, DOI 10.1111/j.0022-3646.2005.04231.x; LaJeunesse TC, 2004, MAR ECOL PROG SER, V284, P147, DOI 10.3354/meps284147; LaJeunesse TC, 2004, CORAL REEFS, V23, P596, DOI 10.1007/s00338-004-0428-4; LaJeunesse TC, 2003, LIMNOL OCEANOGR, V48, P2046, DOI 10.4319/lo.2003.48.5.2046; Lajeunesse TC, 2012, J PHYCOL, V48, P1380, DOI 10.1111/j.1529-8817.2012.01217.x; LaJeunesse TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029013; LaJeunesse TC, 2010, P ROY SOC B-BIOL SCI, V277, P2925, DOI 10.1098/rspb.2010.0385; LaJeunesse TC, 2010, J BIOGEOGR, V37, P785, DOI 10.1111/j.1365-2699.2010.02273.x; LaJeunesse TC, 2009, P ROY SOC B-BIOL SCI, V276, P4139, DOI 10.1098/rspb.2009.1405; Lee Z, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003802; Lien YT, 2007, CORAL REEFS, V26, P35, DOI 10.1007/s00338-006-0185-7; Lien YT, 2012, ZOOL SCI, V29, P173, DOI 10.2108/zsj.29.173; Loh WKW, 2001, MAR ECOL PROG SER, V222, P97, DOI 10.3354/meps222097; McGinley MP, 2012, MAR ECOL PROG SER, V462, P1, DOI 10.3354/meps09914; Middlebrook R, 2008, J EXP BIOL, V211, P1050, DOI 10.1242/jeb.013284; Mieog JC, 2007, CORAL REEFS, V26, P449, DOI 10.1007/s00338-007-0244-8; Mieog JC, 2009, MOL ECOL RESOUR, V9, P74, DOI 10.1111/j.1755-0998.2008.02222.x; Oliver TA, 2009, MAR ECOL PROG SER, V378, P93, DOI 10.3354/meps07871; Pochon X, 2007, CORAL REEFS, V26, P867, DOI 10.1007/s00338-007-0279-x; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; Rodriguez-Lanetty M, 2003, MAR BIOL, V143, P1193, DOI 10.1007/s00227-003-1165-x; Rodriguez-Lanetty M, 2003, MAR BIOL, V143, P501, DOI 10.1007/s00227-003-1105-9; ROWAN R, 1991, SCIENCE, V251, P1348, DOI 10.1126/science.251.4999.1348; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Sampayo EM, 2009, MOL ECOL, V18, P500, DOI 10.1111/j.1365-294X.2008.04037.x; Sampayo EM, 2007, MOL ECOL, V16, P3721, DOI 10.1111/j.1365-294X.2007.03403.x; Silverstein RN, 2011, MAR ECOL PROG SER, V422, P63, DOI 10.3354/meps08934; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stat M, 2008, CORAL REEFS, V27, P763, DOI 10.1007/s00338-008-0412-5; Stat M, 2009, CORAL REEFS, V28, P709, DOI 10.1007/s00338-009-0509-5; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Teneva L, 2012, CORAL REEFS, V31, P1, DOI 10.1007/s00338-011-0812-9; Thornhill DJ, 2006, MAR BIOL, V148, P711, DOI 10.1007/s00227-005-0114-2; Tonk L, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-7; Ulstrup KE, 2008, MAR ECOL PROG SER, V361, P139, DOI 10.3354/meps07360; Ulstrup KE, 2006, MAR ECOL PROG SER, V314, P135, DOI 10.3354/meps314135; Ulstrup KE, 2011, AQUAT BIOL, V12, P241, DOI 10.3354/ab00338; Ulstrup KE, 2003, MOL ECOL, V12, P3477, DOI 10.1046/j.1365-294X.2003.01988.x; van Oppen MJH, 2011, MOL ECOL, V20, P1647, DOI 10.1111/j.1365-294X.2011.05050.x; van Oppen MJH, 2005, CORAL REEFS, V24, P482, DOI 10.1007/s00338-005-0487-1; Van Oppen MJH, 2005, MOL ECOL, V14, P2403, DOI 10.1111/j.1365-294X.2005.02545.x; van Oppen MJH, 2004, MAR BIOL, V144, P1, DOI 10.1007/s00227-003-1187-4; van Oppen MJH, 2001, P ROY SOC B-BIOL SCI, V268, P1759, DOI 10.1098/rspb.2001.1733; van Woesik R, 2012, P ROY SOC B-BIOL SCI, V279, P2448, DOI 10.1098/rspb.2011.2621; Venn AA, 2008, BIOL BULL-US, V215, P243, DOI 10.2307/25470708; Warner ME, 2006, LIMNOL OCEANOGR, V51, P1887, DOI 10.4319/lo.2006.51.4.1887; Weeks SJ, 2010, CORAL REEFS, V29, P975, DOI 10.1007/s00338-010-0644-z; Weeks S, 2012, REMOTE SENS-BASEL, V4, P3781, DOI 10.3390/rs4123781; Wicks LC, 2010, MAR ECOL PROG SER, V400, P101, DOI 10.3354/meps08398	78	51	52	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68533	10.1371/journal.pone.0068533	http://dx.doi.org/10.1371/journal.pone.0068533			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844217	Green Published, Green Submitted, gold			2022-12-27	WOS:000321733000014
J	Njanpop-Lafourcade, BM; Hugonnet, S; Djogbe, H; Kodjo, A; N'douba, AK; Taha, MK; Stoeckel, P; Gessner, BD				Njanpop-Lafourcade, Berthe-Marie; Hugonnet, Stephane; Djogbe, Honore; Kodjo, Agbenoko; N'douba, Adele Kacou; Taha, Muhamed-Kheir; Stoeckel, Philippe; Gessner, Bradford D.			Mobile Microbiological Laboratory Support for Evaluation of a Meningitis Epidemic in Northern Benin	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS; BURKINA-FASO; MOLECULAR CHARACTERISTICS; MENINGOCOCCAL MENINGITIS; STREPTOCOCCUS-PNEUMONIAE; PNEUMOCOCCAL MENINGITIS; SEROGROUP W135; DISEASE; BELT; SEROTYPE-1	Background: Fixed laboratory capacity in Africa may be inadequate; mobile microbiological laboratories may address this issue but their utility has seldom been evaluated. Methods: During 2012, the Benin Ministry of Health requested mobile microbiological laboratory (LaboMobil (R)) support following the failure of polysaccharide meningococcal A+C vaccine to prevent an epidemic in five Northern districts. Within four days, the intervention was initiated. A fixed site in Northern Togo, Pasteur Institutes in Cote d'Ivoire and France, and a research laboratory in Burkina Faso provided additional laboratory support. Results: Local laboratories initially reported most cases to have Gram-positive diplococci suggestive of pneumococcal meningitis. The LaboMobil (R) evaluated 200 cerebrospinal fluid (CSF) samples and 59 stored isolates collected from 149 individuals. Of the 74 individuals with etiologic confirmation, 60 (81%) had NmW135 and 11 (15%) NmX identified; no pneumococci were identified. Testing in France on 30 NmW135 and 3 NmX confirmed the etiology in all cases. All five districts had crossed the epidemic threshold (10 cases per 100,000 per week), all had NmW135 identified and four had NmX identified. NmX were identified as X: ST-181: ccST-181: 5-1: 10-1: F1-31 and NmW135 as W: ST-11: ccST-11: 5: 2: F1-1. Conclusions: In an area with limited local laboratory capacity, a mobile microbiology laboratory intervention occurred in four days through the cooperation of four African and one European country. Results were different from those reported by local laboratories. Despite the introduction of serogroup A meningococcal and 13-valent pneumococcal conjugate vaccines, endemic and epidemic meningitis will continue in the region, emphasizing the usefulness of the LaboMobil (R) in the short and medium term.	[Njanpop-Lafourcade, Berthe-Marie; Stoeckel, Philippe] AMP, Paris, France; [Hugonnet, Stephane] World Hlth Org, Geneva, Switzerland; [Djogbe, Honore] Minist Hlth, Cotonou, Benin; [Kodjo, Agbenoko] Reg Hosp Lab, Dapaong, Togo; [N'douba, Adele Kacou] Inst Pasteur, Abidjan, Cote Ivoire; [Taha, Muhamed-Kheir] World Hlth Org, Inst Pasteur, Natl Meningococcal Reference Ctr, Collaborating Ctr, Paris, France; [Gessner, Bradford D.] AMP, Bur Liaison, Ferney Voltaire, France	Agence de Medecine Preventive; World Health Organization; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; World Health Organization	Gessner, BD (corresponding author), AMP, Bur Liaison, Ferney Voltaire, France.	bgessner@aamp.org		Kodjo, Angeli/0000-0002-7247-9765	World Health Organization, Geneva, Switzerland	World Health Organization, Geneva, Switzerland(World Health Organization)	The current evaluation was supported partially by funding from the World Health Organization, Geneva, Switzerland. Human resources were contributed by the Benin and Togo Ministries of Health and the Pasteur Institutes of Cote d'Ivoire and France. Employees from each of these funding sources contributed to the current investigation and to the drafting of the manuscript.	AJELLO GW, 1984, J CLIN MICROBIOL, V20, P55, DOI 10.1128/JCM.20.1.55-58.1984; Boisier P, 2007, CLIN INFECT DIS, V44, P657, DOI 10.1086/511646; Choi YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026190; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Delrieu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019513; Djibo S, 2003, TROP MED INT HEALTH, V8, P1118, DOI 10.1046/j.1360-2276.2003.01126.x; du Chatelet IP, 2005, CLIN INFECT DIS, V40, P17, DOI 10.1086/426436; Fox AJ, 2007, FEMS MICROBIOL REV, V31, P84, DOI 10.1111/j.1574-6976.2006.00048.x; Gagneux SP, 2002, J INFECT DIS, V185, P618, DOI 10.1086/339010; Gessner BD, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-22; Kristiansen PA, 2012, CLIN INFECT DIS; Leimkugel J, 2005, J INFECT DIS, V192, P192, DOI 10.1086/431151; Molesworth AM, 2002, T ROY SOC TROP MED H, V96, P242, DOI 10.1016/S0035-9203(02)90089-1; Mueller JE, 2007, EMERG INFECT DIS, V13, P847, DOI 10.3201/eid1306.061395; Mueller JE, 2006, EXPERT REV VACCINES, V5, P319, DOI 10.1586/14760584.5.3.319; Ndihokubwayo J.B.K., 2010, AFRICAN HLTH MONITOR, P47; Novak RT, 2012, LANCET INFECT DIS, V12, P757, DOI 10.1016/S1473-3099(12)70168-8; Taha MK, 2004, J CLIN MICROBIOL, V42, P4158, DOI 10.1128/JCM.42.9.4158-4163.2004; Taha MK, 2000, J CLIN MICROBIOL, V38, P855, DOI 10.1128/JCM.38.2.855-857.2000; Tikhomirov Eugene, 1997, World Health Statistics Quarterly, V50, P170; Traore Y, 2008, 1 FACTS, V1; Traore Y, 2009, CLIN INFECT DIS, V48, pS181, DOI 10.1086/596498; Traore Y, 2006, CLIN INFECT DIS, V43, P817, DOI 10.1086/507339; US Centers for Disease Control and Prevention, 2010, CDCSA201002; Yaro S, 2006, CLIN INFECT DIS, V43, P693, DOI 10.1086/506940	25	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68401	10.1371/journal.pone.0068401	http://dx.doi.org/10.1371/journal.pone.0068401			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844195	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000159
J	Andrello, M; Mouillot, D; Beuvier, J; Albouy, C; Thuiller, W; Manel, S				Andrello, Marco; Mouillot, David; Beuvier, Jonathan; Albouy, Camille; Thuiller, Wilfried; Manel, Stephanie			Low Connectivity between Mediterranean Marine Protected Areas: A Biophysical Modeling Approach for the Dusky Grouper Epinephelus marginatus	PLOS ONE			English	Article							REEF FISH METAPOPULATIONS; OCEAN CIRCULATION MODEL; PELAGIC LARVAL DURATION; CLIMATE-CHANGE SCENARIO; POPULATION CONNECTIVITY; RESERVE NETWORKS; FISHERIES MANAGEMENT; EMPIRICAL-EVALUATION; PISCES SERRANIDAE; BARRIER-REEF	Marine protected areas (MPAs) are major tools to protect biodiversity and sustain fisheries. For species with a sedentary adult phase and a dispersive larval phase, the effectiveness of MPA networks for population persistence depends on connectivity through larval dispersal. However, connectivity patterns between MPAs remain largely unknown at large spatial scales. Here, we used a biophysical model to evaluate connectivity between MPAs in the Mediterranean Sea, a region of extremely rich biodiversity that is currently protected by a system of approximately a hundred MPAs. The model was parameterized according to the dispersal capacity of the dusky grouper Epinephelus marginatus, an archetypal conservation-dependent species, with high economic importance and emblematic in the Mediterranean. Using various connectivity metrics and graph theory, we showed that Mediterranean MPAs are far from constituting a true, well-connected network. On average, each MPA was directly connected to four others and MPAs were clustered into several groups. Two MPAs (one in the Balearic Islands and one in Sardinia) emerged as crucial nodes for ensuring multi-generational connectivity. The high heterogeneity of MPA distribution, with low density in the South-Eastern Mediterranean, coupled with a mean dispersal distance of 120 km, leaves about 20% of the continental shelf without any larval supply. This low connectivity, here demonstrated for a major Mediterranean species, poses new challenges for the creation of a future Mediterranean network of well-connected MPAs providing recruitment to the whole continental shelf. This issue is even more critical given that the expected reduction of pelagic larval duration following sea temperature rise will likely decrease connectivity even more.	[Andrello, Marco; Manel, Stephanie] Univ Aix Marseille, Inst Rech Dev, Lab Populat Environm & Dev, UMR 151, Marseille, France; [Andrello, Marco; Thuiller, Wilfried] Univ Grenoble 1, CNRS, Lab Ecol Alpine, UMR 5119, Grenoble, France; [Mouillot, David] Univ Montpellier 2, UMR Ecol Syst Marins Cotiers 5119, Montpellier, France; [Mouillot, David] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Beuvier, Jonathan] Mercator Ocean, Ramonville Saint Agne, France; [Beuvier, Jonathan] Meteo France, Ctr Natl Rech Meteorol, Grp Etud Atmosphere Meteorol, UMR 3589,CNRS, Toulouse, France; [Albouy, Camille] Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada; [Manel, Stephanie] UMR Bot & Bioinformat Architecture Plantes 5120, Montpellier, France	UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; Universite de Montpellier; James Cook University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Meteo France; University of Quebec	Andrello, M (corresponding author), Univ Aix Marseille, Inst Rech Dev, Lab Populat Environm & Dev, UMR 151, Marseille, France.	marco.andrello@gmail.com	Thuiller, Wilfried/G-3283-2010; albouy, camille/ABD-2206-2021; Andrello, Marco/G-4197-2016; albouy, camille/H-9317-2012	Thuiller, Wilfried/0000-0002-5388-5274; albouy, camille/0000-0003-1629-2389; Andrello, Marco/0000-0001-7590-2736; albouy, camille/0000-0003-1629-2389	Fondation pour la Recherche sur la biodiversite; Fondation Total; Institut Universitaire de France; Marie Curie International Outgoing Fellowship (FISHECO) [IOF-GA-2009-236316]; Groupe de Mission Mercator Coriolis (GMMC) in the context of the SiMED project; Grand Equipement National de Calcul Intensif (GENCI) [010227]	Fondation pour la Recherche sur la biodiversite; Fondation Total; Institut Universitaire de France; Marie Curie International Outgoing Fellowship (FISHECO)(European Commission); Groupe de Mission Mercator Coriolis (GMMC) in the context of the SiMED project; Grand Equipement National de Calcul Intensif (GENCI)	This work was funded by 'Fondation pour la Recherche sur la biodiversite' (www.fondationbiodiversite.fr) and 'Fondation Total' (fondation.total.com) through the 'Fishconnect' project. SM and DM were funded by the Institut Universitaire de France (iuf.amue.fr). DM was supported by a Marie Curie International Outgoing Fellowship (FISHECO) with agreement number IOF-GA-2009-236316. The numerical work for NEMOMED12 was supported by the Groupe de Mission Mercator Coriolis (GMMC) in the context of the SiMED project. This work was granted access to the HPC resources of IDRIS (Institut du Developpement et des Ressources en Informatique Scientifique) of the Centre National de la Recherche Scientifique (CNRS) (project number 010227) made by Grand Equipement National de Calcul Intensif (GENCI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla A, 2009, ICES J MAR SCI, V66, P22, DOI 10.1093/icesjms/fsn164; Afonso P, 2011, BIOL CONSERV, V144, P2739, DOI 10.1016/j.biocon.2011.07.028; Albert CH, 2010, ECOGRAPHY, V33, P1028, DOI 10.1111/j.1600-0587.2010.06421.x; Albouy C, 2012, GLOBAL CHANGE BIOL, V18, P2995, DOI 10.1111/j.1365-2486.2012.02772.x; Allendorf FW, 2007, CONSERVATION GENETIC, Vxix; Almany GR, 2009, CORAL REEFS, V28, P339, DOI 10.1007/s00338-009-0484-x; Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; ARAKAWA A, 1981, MON WEATHER REV, V109, P18, DOI 10.1175/1520-0493(1981)109<0018:APEAEC>2.0.CO;2; Armsworth PR, 2002, ECOLOGY, V83, P1092, DOI 10.1890/0012-9658(2002)083[1092:RLPRAL]2.0.CO;2; Barnier B, 2006, OCEAN DYNAM, V56, P543, DOI 10.1007/s10236-006-0082-1; Basterretxea G, 2012, FISH OCEANOGR, V21, P291, DOI 10.1111/j.1365-2419.2012.00625.x; Bell JJ, 2008, BIOL CONSERV, V141, P2807, DOI 10.1016/j.biocon.2008.08.017; Berglund M, 2012, ECOL MODEL, V240, P105, DOI 10.1016/j.ecolmodel.2012.04.011; Berne S, 2004, GOLFE LION CARTE MOR; Beuvier J, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007679; Beuvier J, 2012, MERCATOR OCEAN QUART, V46, P60; Beuvier J, 2011, THESIS ECOLE POLYTEC; BLANKE B, 1993, J PHYS OCEANOGR, V23, P1363, DOI 10.1175/1520-0485(1993)023<1363:VOTTAO>2.0.CO;2; Bode M, 2006, MAR ECOL PROG SER, V308, P17, DOI 10.3354/meps308017; Bodilis P, 2003, CYBIUM, V27, P123; Boglione C, 2009, AQUACULTURE, V291, P48, DOI 10.1016/j.aquaculture.2009.02.041; Bonhommeau S, 2009, J FISH BIOL, V74, P1891, DOI 10.1111/j.1095-8649.2009.02298.x; Botsford LW, 2009, REV FISH BIOL FISHER, V19, P69, DOI 10.1007/s11160-008-9092-z; Botsford LW, 2001, ECOL LETT, V4, P144; Buston PM, 2011, P ROYAL SOC B; Christie MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015715; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Coll M., 2010, PLOS ONE, V5; Coll M, 2012, GLOBAL ECOL BIOGEOGR, V21, P465, DOI 10.1111/j.1466-8238.2011.00697.x; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; CSARDI G., 2006, INTERJOURNAL COMPLEX, V1695; Cunha ME, 2009, SCI MAR, V73, P201, DOI 10.3989/scimar.2009.73s1201; de Almeida Rodrigues Filho J, 2009, ENVIRON BIOL FISH, V85, P301; Di Franco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052108; DIFRANCO A, 2012, PLOS ONE, V7; Francour P, 2001, AQUAT CONSERV, V11, P155, DOI 10.1002/aqc.442; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18286, DOI 10.1073/pnas.0906473107; Garcia-Charton JA, 2008, J NAT CONSERV, V16, P193, DOI 10.1016/j.jnc.2008.09.007; Garcia-Charton JA, 2004, MAR BIOL, V144, P161, DOI 10.1007/s00227-003-1170-0; Gerber LR, 2005, CAN J FISH AQUAT SCI, V62, P863, DOI 10.1139/F05-046; Gerber LR, 2003, ECOL APPL, V13, pS47; Glamuzina B, 1998, SCI MAR, V62, P373; Gruss A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019960; Guidetti P, 2008, BIOL CONSERV, V141, P699, DOI 10.1016/j.biocon.2007.12.013; Halpern BS, 2003, ECOL APPL, V13, pS117; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Hastings A, 2006, P NATL ACAD SCI USA, V103, P6067, DOI 10.1073/pnas.0506651103; Hedgecock D, 2007, OCEANOGRAPHY, V20, P70, DOI 10.5670/oceanog.2007.30; Heemstra P.C., 1993, GROUPERS WORLD FAMIL, V16; Hereu B, 2006, MAR ECOL PROG SER, V325, P187, DOI 10.3354/meps325187; Herrmann MJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032442; Ingleby B, 2007, J MARINE SYST, V65, P158, DOI 10.1016/j.jmarsys.2005.11.019; Jacobi MN, 2012, ECOGRAPHY, V35, P1004, DOI 10.1111/j.1600-0587.2012.07281.x; Jacobi MN, 2011, ECOL APPL, V21, P1861, DOI 10.1890/10-0915.1; James MK, 2002, P ROY SOC B-BIOL SCI, V269, P2079, DOI 10.1098/rspb.2002.2128; Jones GP, 2005, CURR BIOL, V15, P1314, DOI 10.1016/j.cub.2005.06.061; Kaplan DM, 2006, ECOL APPL, V16, P2248, DOI 10.1890/1051-0761(2006)016[2248:DPRAEM]2.0.CO;2; Kaplan DM, 2009, ECOL APPL, V19, P433, DOI 10.1890/07-1705.1; Kininmonth S, 2011, ECOL MODEL, V222, P1272, DOI 10.1016/j.ecolmodel.2011.01.012; Kininmonth SJ, 2010, THEOR ECOL-NETH, V3, P75, DOI 10.1007/s12080-009-0055-3; LAMPERT W, 1989, FUNCT ECOL, V3, P21, DOI 10.2307/2389671; Largier JL, 2003, ECOL APPL, V13, pS71; Lasram FB, 2010, GLOBAL CHANGE BIOL, V16, P3233, DOI 10.1111/j.1365-2486.2010.02224.x; Leis JM, 2006, ADV MAR BIOL, V51, P57, DOI 10.1016/S0065-2881(06)51002-8; Lembo Giuseppe, 2002, Marine Life, V9, P37; Lett C, 2008, ENVIRON MODELL SOFTW, V23, P1210, DOI 10.1016/j.envsoft.2008.02.005; Macpherson E, 2006, MAR ECOL PROG SER, V327, P257, DOI 10.3354/meps327257; Madec G., 2017, NEMO OCEAN ENGINE; Maggio T, 2006, ITAL J ZOOL, V73, P275, DOI 10.1080/11250000600804599; Millot C, 2005, MEDITERRANEAN SEA; Monin AS, 1982, TURBULENCE OCEAN; Mouillot D, 2011, CURR BIOL, V21, P1044, DOI 10.1016/j.cub.2011.05.005; Mumby PJ, 2011, ECOL LETT, V14, P132, DOI 10.1111/j.1461-0248.2010.01562.x; Pairaud IL, 2011, J MARINE SYST, V88, P20, DOI 10.1016/j.jmarsys.2011.02.010; Pastor J, 2009, CR BIOL, V332, P732, DOI 10.1016/j.crvi.2009.03.010; Pebesma E., 2005, R NEWS, V5, P9; Pelc RA, 2010, P NATL ACAD SCI USA, V107, P18266, DOI 10.1073/pnas.0907368107; Peliz A, 2007, J MARINE SYST, V68, P215, DOI 10.1016/j.jmarsys.2006.11.007; PINARDI N, 1993, DEEP-SEA RES PT II, V40, P1299, DOI 10.1016/0967-0645(93)90071-T; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Renones O, 2007, J FISH BIOL, V71, P346, DOI 10.1111/j.1095-8649.2007.01482.x; Renones O, 2010, SCI MAR, V74, P523, DOI 10.3989/scimar.2010.74n3523; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Rixen M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022702; Rozenfeld AF, 2008, P NATL ACAD SCI USA, V105, P18824, DOI 10.1073/pnas.0805571105; Saenz-Agudelo P, 2009, MOL ECOL, V18, P1765, DOI 10.1111/j.1365-294X.2009.04109.x; Saenz-Agudelo P, 2011, P ROY SOC B-BIOL SCI, V278, P2954, DOI 10.1098/rspb.2010.2780; Sala E, 2012, PLOS ONE, V7; Schunter C, 2011, J EXP MAR BIOL ECOL, V401, P126, DOI 10.1016/j.jembe.2011.01.021; Selkoe KA, 2011, MAR ECOL PROG SER, V436, P291, DOI 10.3354/meps09238; Somot S, 2008, GLOBAL PLANET CHANGE, V63, P112, DOI 10.1016/j.gloplacha.2007.10.003; Somot S, 2006, CLIM DYNAM, V27, P851, DOI 10.1007/s00382-006-0167-z; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Spedicato M. T., 2000, Cahiers Options Mediterraneennes, V47, P227; Srinivasan UT, 2012, MAR POLICY, V36, P544, DOI 10.1016/j.marpol.2011.10.001; Swearer SE, 2002, B MAR SCI, V70, P251; Testor P, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002861; Tonani M, 2008, OCEAN SCI, V4, P1, DOI 10.5194/os-4-1-2008; Treml EA, 2008, LANDSCAPE ECOL, V23, P19, DOI 10.1007/s10980-007-9138-y; Treml EA, 2012, CONSERV LETT, V5, P441, DOI 10.1111/j.1755-263X.2012.00260.x; Treml EA, 2012, INTEGR COMP BIOL, V52, P525, DOI 10.1093/icb/ics101; Urban DL, 2009, ECOL LETT, V12, P260, DOI 10.1111/j.1461-0248.2008.01271.x; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; Werner FE, 2007, OCEANOGRAPHY, V20, P54, DOI 10.5670/oceanog.2007.29; Whitehead Peter J. P, 1986, FISHES N E ATLANTIC; Zabala M, 1997, SCI MAR, V61, P65	107	97	98	0	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68564	10.1371/journal.pone.0068564	http://dx.doi.org/10.1371/journal.pone.0068564			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861917	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000321692000030
J	Raimondi, I; Ciribilli, Y; Monti, P; Bisio, A; Pollegioni, L; Fronza, G; Inga, A; Campomenosi, P				Raimondi, Ivan; Ciribilli, Yari; Monti, Paola; Bisio, Alessandra; Pollegioni, Loredano; Fronza, Gilberto; Inga, Alberto; Campomenosi, Paola			P53 Family Members Modulate the Expression of PRODH, but Not PRODH2, via Intronic p53 Response Elements	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; DNA-BINDING DOMAIN; TRANSCRIPTION-FACTOR; PROLINE OXIDASE; MICROENVIRONMENTAL STRESS; P53-INDUCIBLE REGULATOR; GLUTAMINE-METABOLISM; GENE-EXPRESSION; TARGET GENES; IN-VIVO	The tumor suppressor p53 was previously shown to markedly up-regulate the expression of the PRODH gene, encoding the proline dehydrogenase (PRODH) enzyme, which catalyzes the first step in proline degradation. Also PRODH2, which degrades 4-hydroxy-L-proline, a product of protein (e. g. collagen) catabolism, was recently described as a p53 target. Here, we confirmed p53-dependent induction of endogenous PRODH in response to genotoxic damage in cell lines of different histological origin. We established that over-expression of TAp73 beta or TAp63 beta is sufficient to induce PRODH expression in p53-null cells and that PRODH expression parallels the modulation of endogenous p73 by genotoxic drugs in several cell lines. The p53, p63, and p73-dependent transcriptional activation was linked to specific intronic response elements (REs), among those predicted by bioinformatics tools and experimentally validated by a yeast-based transactivation assay. p53 occupancy measurements were validated in HCT116 and MCF7 human cell lines. Conversely, PRODH2 was not responsive to p63 nor p73 and, at best, could be considered a weak p53 target. In fact, minimal levels of PRODH2 transcript induction by genotoxic stress was observed exclusively in one of four p53 wild-type cell lines tested. Consistently, all predicted p53 REs in PRODH2 were poor matches to the p53 RE consensus and showed very weak responsiveness, only to p53, in the functional assay. Taken together, our results highlight that PRODH, but not PRODH2, expression is under the control of p53 family members, specifically p53 and p73. This supports a deeper link between proteins of the p53-family and metabolic pathways, as PRODH modulates the balance of proline and glutamate levels and those of their derivative alpha-keto-glutarate (alpha-KG) under normal and pathological (tumor) conditions.	[Raimondi, Ivan; Pollegioni, Loredano; Campomenosi, Paola] Univ Insubria, DBSV, Dept Biotechnol & Life Sci, Varese, Italy; [Ciribilli, Yari; Bisio, Alessandra; Inga, Alberto] Univ Trento, CIBIO, Ctr Integrat Biol, Lab Transcript Networks, Mattarello, Trento, Italy; [Monti, Paola; Fronza, Gilberto] IRCCS Azienda Osped Univ San Martino, IST, Ist Nazl Ric Canc, Dept Diag Pathol & Treatment High Technol Complex, I-16132 Genoa, Italy; [Pollegioni, Loredano; Campomenosi, Paola] ICRM CNR Milano, Politecn Milano, Ctr Interuniv Ric Biotecnol Prot, Prot Factory, Varese, Italy; [Pollegioni, Loredano; Campomenosi, Paola] Univ Insubria, Varese, Italy	University of Insubria; University of Trento; University of Genoa; IRCCS AOU San Martino IST; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); Polytechnic University of Milan; University of Insubria	Campomenosi, P (corresponding author), Univ Insubria, DBSV, Dept Biotechnol & Life Sci, Varese, Italy.	paola.campomenosi@uninsubria.it	Inga, Alberto/AAC-3815-2022; Monti, Paola/Y-1118-2019; Ciribilli, Yari/K-2751-2018; Campomenosi, Paola/C-9729-2011; Fronza, Gilberto/AAG-8735-2019	Inga, Alberto/0000-0002-8767-1637; Monti, Paola/0000-0002-1978-4998; Ciribilli, Yari/0000-0001-9231-379X; Campomenosi, Paola/0000-0002-8853-1134; Fronza, Gilberto/0000-0003-3722-553X; POLLEGIONI, LOREDANO/0000-0003-1733-7243; BISIO, Alessandra/0000-0002-3326-1923; Raimondi, Ivan/0000-0002-9522-2794	"FAR" (Fondi di Ateneo per la Ricerca) funds [9086, 5506]; Marie-Curie-Autonomous-Province-of-Trento (PAT) cofund grant [40101712]; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	"FAR" (Fondi di Ateneo per la Ricerca) funds; Marie-Curie-Autonomous-Province-of-Trento (PAT) cofund grant; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was partially supported by "FAR" (Fondi di Ateneo per la Ricerca) funds to Paola Campomenosi AIRC (Associazione Italiana per la Ricerca sul Cancro, www.airc.it) IG#9086 to Alberto Inga AIRC IG#5506 to Gilberto Fronza. Dr. Raimondi is a PhD student of the PhD course in Molecular and Cellular Biology of University of Insubria, Varese. He received a contribution "Contributo per attivita di formazione in biotecnologie" from CIB (Consorzio Interuniversitario Biotecnologie, http://www.cibiotech.it/) for accommodation during his stay at Cibio, TN. Yari Ciribilli is supported by a Marie-Curie-Autonomous-Province-of-Trento (PAT) cofund grant (#40101712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; Beckerman R., 2010, COLD SPRING HARBOR P, V2; Beno I, 2011, NUCLEIC ACIDS RES, V39, P1919, DOI 10.1093/nar/gkq1044; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Brady CA, 2010, J CELL SCI, V123, P2527, DOI 10.1242/jcs.064501; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Buontempo F, 2011, INVEST NEW DRUG, V29, P1303, DOI 10.1007/s10637-010-9486-3; Chang SS, 2008, INT J CANCER, V123, P2791, DOI 10.1002/ijc.23831; Chen C, 2012, J BIOL CHEM, V287, P7477, DOI 10.1074/jbc.M111.315820; Chen C, 2011, P NATL ACAD SCI USA, V108, P6456, DOI 10.1073/pnas.1013657108; Ciribilli Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010236; Cooper SK, 2008, J BIOL CHEM, V283, P10485, DOI 10.1074/jbc.M702181200; Dang CV, 2011, COLD SH Q B, V76, P369, DOI 10.1101/sqb.2011.76.011296; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; DeYoung MP, 2006, CANCER RES, V66, P9362, DOI 10.1158/0008-5472.CAN-06-1619; Dotsch V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004887; Donald SP, 2001, CANCER RES, V61, P1810; DOWNING SJ, 1977, J CELL PHYSIOL, V91, P369, DOI 10.1002/jcp.1040910306; DREWINKO B, 1976, CANCER RES, V36, P467; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Espinosa JM, 2001, MOL CELL, V8, P57, DOI 10.1016/S1097-2765(01)00283-0; Ethayathulla AS, 2012, P NATL ACAD SCI USA, V109, P6066, DOI 10.1073/pnas.1115463109; Gottlieb E, 2010, COLD SPRING HARBOR P, P2; Green DR, 2006, CELL, V126, P30, DOI 10.1016/j.cell.2006.06.032; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Hoh J, 2002, P NATL ACAD SCI USA, V99, P8467, DOI 10.1073/pnas.132268899; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; Inga A, 1997, ONCOGENE, V14, P1307, DOI 10.1038/sj.onc.1200952; Inga A, 2002, MOL CELL BIOL, V22, P8612, DOI 10.1128/MCB.22.24.8612-8625.2002; Jegga AG, 2008, P NATL ACAD SCI USA, V105, P944, DOI 10.1073/pnas.0704694105; Jordan JJ, 2012, P NATL ACAD SCI USA, V109, P14387, DOI 10.1073/pnas.1205971109; Jordan JJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000104; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Leroy B, 2013, NUCLEIC ACIDS RES, V41, pD962, DOI 10.1093/nar/gks1033; Liu W, 2012, P NATL ACAD SCI USA, V109, P8983, DOI 10.1073/pnas.1203244109; Maxwell SA, 2008, BIOCHEM BIOPH RES CO, V369, P308, DOI 10.1016/j.bbrc.2008.01.171; Menendez D, 2007, MOL CELL BIOL, V27, P2590, DOI 10.1128/MCB.01742-06; Menendez D, 2010, DISCOV MED, V10, P94; Menendez D, 2010, P NATL ACAD SCI USA, V107, P1500, DOI 10.1073/pnas.0909129107; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Nikulenkov F, 2012, CELL DEATH DIFFER, V19, P1992, DOI 10.1038/cdd.2012.89; Onisto M, 2005, INT J ONCOL, V27, P791; Osada M, 2005, MOL CELL BIOL, V25, P6077, DOI 10.1128/MCB.25.14.6077-6089.2005; Pandhare J, 2009, J CELL BIOCHEM, V107, P759, DOI 10.1002/jcb.22174; Petitjean A, 2005, ONCOGENE, V24, P512, DOI 10.1038/sj.onc.1208215; Petitjean Audrey, 2006, Bull Cancer, V93, pE126; Phang JM, 2008, AMINO ACIDS, V35, P681, DOI 10.1007/s00726-008-0063-4; Phang JM, 2008, J NUTR, V138, p2008S, DOI 10.1093/jn/138.10.2008S; Phang JM, 2010, ANNU REV NUTR, V30, P441, DOI 10.1146/annurev.nutr.012809.104638; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Rosenbluth JM, 2008, MOL CELL BIOL, V28, P5951, DOI 10.1128/MCB.00305-08; Rosenbluth JM, 2011, P NATL ACAD SCI USA, V108, P2076, DOI 10.1073/pnas.1011936108; Rosenbluth JM, 2009, AUTOPHAGY, V5, P114, DOI 10.4161/auto.5.1.7294; Sbisa E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S1-S20; Shalom-Feuerstein R, 2011, CELL DEATH DIFFER, V18, P887, DOI 10.1038/cdd.2010.159; Shinmen N, 2009, FEBS LETT, V583, P1916, DOI 10.1016/j.febslet.2009.04.041; Smeenk L, 2008, NUCLEIC ACIDS RES, V36, P3639, DOI 10.1093/nar/gkn232; Storici F, 2003, GENET ENG P, V25, P189; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; Tsunoda T, 1999, BIOINFORMATICS, V15, P622, DOI 10.1093/bioinformatics/15.7.622; Veprintsev DB, 2008, NUCLEIC ACIDS RES, V36, P1589, DOI 10.1093/nar/gkm1040; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Weinberg RL, 2005, J MOL BIOL, V348, P589, DOI 10.1016/j.jmb.2005.03.014; Westfall MD, 2003, MOL CELL BIOL, V23, P2264, DOI 10.1128/MCB.23.7.2264-2276.2003; Yoon KA, 2004, J HUM GENET, V49, P134, DOI 10.1007/s10038-003-0122-3; Zabirnyk O, 2010, CARCINOGENESIS, V31, P446, DOI 10.1093/carcin/bgp299	72	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e69152	10.1371/journal.pone.0069152	http://dx.doi.org/10.1371/journal.pone.0069152			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861960	Green Published, gold, Green Submitted			2022-12-27	WOS:000321692000036
J	Schreiber, K; Krekelberg, B				Schreiber, Kai; Krekelberg, Bart			The Statistical Analysis of Multi-Voxel Patterns in Functional Imaging	PLOS ONE			English	Article								The goal of multi-voxel pattern analysis (MVPA) in BOLD imaging is to determine whether patterns of activation across multiple voxels change with experimental conditions. MVPA is a powerful technique, its use is rapidly growing, but it poses serious statistical challenges. For instance, it is well-known that the slow nature of the BOLD response can lead to greatly exaggerated performance estimates. Methods are available to avoid this overestimation, and we present those here in tutorial fashion. We go on to show that, even with these methods, standard tests of significance such as Students' T and the binomial tests are invalid in typical MRI experiments. Only a carefully constructed permutation test correctly assesses statistical significance. Furthermore, our simulations show that performance estimates increase with both temporal as well as spatial signal correlations among multiple voxels. This dependence implies that a comparison of MVPA performance between areas, between subjects, or even between BOLD signals that have been preprocessed in different ways needs great care.	[Schreiber, Kai; Krekelberg, Bart] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Krekelberg, B (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	bart@vision.rutgers.edu	Krekelberg, Bart/N-7938-2019	Krekelberg, Bart/0000-0003-1083-6103	National Eye Institute [EY017605]; NATIONAL EYE INSTITUTE [R01EY017605] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute (EY017605). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Cristianini Nello, 2000, INTRO SUPPORT VECTOR; Efron B, 1994, INTRO BOOTSTRAP; Gardner JL, 2010, NEUROIMAGE, V49, P1953, DOI 10.1016/j.neuroimage.2009.07.004; Golland P, 2003, LECT NOTES COMPUT SC, V2732, P330; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kamitani Y, 2006, CURR BIOL, V16, P1096, DOI 10.1016/j.cub.2006.04.003; Kriegeskorte N, 2010, NEUROIMAGE, V49, P1965, DOI 10.1016/j.neuroimage.2009.09.059; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Mourao-Miranda J, 2006, NEUROIMAGE, V33, P1055, DOI 10.1016/j.neuroimage.2006.08.016; Mur M, 2009, SOC COGN AFFECT NEUR, V4, P101, DOI 10.1093/scan/nsn044; Nieuwenhuis S, 2011, NAT NEUROSCI, V14, P1105, DOI 10.1038/nn.2886; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Pereira Francisco, 2009, Neuroimage, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007	18	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e69328	10.1371/journal.pone.0069328	http://dx.doi.org/10.1371/journal.pone.0069328			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861966	Green Published, Green Submitted, gold			2022-12-27	WOS:000321692000042
J	Dong, XL; Zhai, YF; Hu, MY; Zhong, GH; Huang, WJ; Zheng, ZH; Han, PF				Dong, Xiaolin; Zhai, Yifan; Hu, Meiying; Zhong, Guohua; Huang, Wanjun; Zheng, Zhihua; Han, Pengfei			Proteomic and Properties Analysis of Botanical Insecticide Rhodojaponin III-Induced Response of the Diamondback Moth, Plutella xyllostella (L.)	PLOS ONE			English	Article							ODORANT-BINDING PROTEIN; APOLIPOPHORIN-III; CHEMOSENSORY PROTEIN; PHEROMONE-BINDING; EXPRESSION; ANTHERAEA; GENE	Background: Rhodojaponin III, as a botanical insecticide, affects a wide variety of biological processes in insects, including reduction of feeding, suspension of development, and oviposition deterring of adults in a dose-dependent manner. However, the mode of these actions remains obscure. Principal Findings: In this study, a comparative proteomic approach was adopted to examine the effect of rhodojaponin III on the Plutella xyllostella (L.). Following treating 48 hours, newly emergence moths were collected and protein samples were prepared. The proteins were separated by 2-DE, and total 31 proteins were significantly affected by rhodojaponin III compared to the control identified by MALDI-TOF/TOF-MS/MS. These differentially expressed proteins act in the nervous transduction, odorant degradation and metabolic change pathways. Further, gene expression patterns in treated and untreated moths were confirmed by qRT-PCR and western blot analysis. RNAi of the chemosensory protein (PxCSP) gene resulted in oviposition significantly increased on cabbage plants treated with rhodojaponin III. Conclusions: These rhodojaponin III-induced proteins and gene properties analysis would be essential for a better understanding of the potential molecular mechanism of the response to rhodojaponin III from moths of P. xylostella.	[Dong, Xiaolin; Hu, Meiying; Zhong, Guohua; Huang, Wanjun; Zheng, Zhihua; Han, Pengfei] South China Agr Univ, Coll Resources & Environm, Lab Insect Toxicol, Guangzhou, Guangdong, Peoples R China; [Zhai, Yifan] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China	South China Agricultural University; Sun Yat Sen University	Hu, MY (corresponding author), South China Agr Univ, Coll Resources & Environm, Lab Insect Toxicol, Guangzhou, Guangdong, Peoples R China.	humy@scau.edu.cn			National Natural Science Foundation, PR China [31071713]	National Natural Science Foundation, PR China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the National Natural Science Foundation, PR China (No. 31071713). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2012, CROP PROT, V38, P7, DOI 10.1016/j.cropro.2012.03.006; [Anonymous], 1988, HDB PLANTS PEST CONT; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Briand L, 2002, EUR J BIOCHEM, V269, P4586, DOI 10.1046/j.1432-1033.2002.03156.x; Campanacci V, 2003, P NATL ACAD SCI USA, V100, P5069, DOI 10.1073/pnas.0836654100; Castelo Branco M., 1997, Anais da Sociedade Entomologica do Brasil, V26, P75, DOI 10.1590/S0301-80591997000100010; Clyne PJ, 1999, NEURON, V22, P339, DOI 10.1016/S0896-6273(00)81094-6; Cui SY, 2006, PEPTIDES, V27, P1226, DOI 10.1016/j.peptides.2005.11.011; Dettloff M, 1998, IMMUNE STIMULATION L, P243; Dong XL, 2013, J INSECT PHYSIOL, V59, P26, DOI 10.1016/j.jinsphys.2012.11.004; Durand N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015026; Ellington WR, 2001, ANNU REV PHYSIOL, V63, P289, DOI 10.1146/annurev.physiol.63.1.289; Ge LQ, 2011, J PROTEOME RES, V10, P4597, DOI 10.1021/pr200414g; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Hovemann BT, 1997, GENE, V189, P213, DOI 10.1016/S0378-1119(96)00851-7; HU MY, 1993, J ECON ENTOMOL, V86, P706, DOI 10.1093/jee/86.3.706; Huang ZW, 2004, PESTIC BIOCHEM PHYS, V80, P85, DOI 10.1016/j.pestbp.2004.07.001; Irving P, 2004, CR BIOL, V327, P557, DOI 10.1016/j.crvi.2004.03.007; KLOCKE JA, 1991, PHYTOCHEMISTRY, V30, P1797, DOI 10.1016/0031-9422(91)85015-R; Konishi H, 2001, PROTEOMICS, V1, P1162, DOI 10.1002/1615-9861(200109)1:9<1162::AID-PROT1162>3.3.CO;2-J; Krieger J, 1999, SCIENCE, V286, P720, DOI 10.1126/science.286.5440.720; Lartigue A, 2002, J BIOL CHEM, V277, P32094, DOI 10.1074/jbc.M204371200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YX, 2010, J PROTEOME RES, V9, P5053, DOI 10.1021/pr100356t; Mitsumasu K, 2008, ZOOL SCI, V25, P693, DOI 10.2108/zsj.25.693; Niere M, 1999, BBA-PROTEIN STRUCT M, V1433, P16, DOI 10.1016/S0167-4838(99)00148-X; NISHIDA R, 1989, J CHEM ECOL, V15, P2565, DOI 10.1007/BF01014732; Picimbon JF, 2000, INSECT BIOCHEM MOLEC, V30, P233, DOI 10.1016/S0965-1748(99)00121-6; Picone D, 2001, EUR J BIOCHEM, V268, P4794, DOI 10.1046/j.1432-1327.2001.02408.x; PIMENTEL D, 1992, BIOSCIENCE, V42, P750, DOI 10.2307/1311994; PRESTWICH GD, 1989, EXPERIENTIA, V45, P263, DOI 10.1007/BF01951812; RENWICK JAA, 1994, ANNU REV ENTOMOL, V39, P377, DOI 10.1146/annurev.en.39.010194.002113; Rogers ME, 1999, J EXP BIOL, V202, P1625; ROTHSCHILD M, 1988, PHYTOCHEMISTRY, V27, P101, DOI 10.1016/0031-9422(88)80598-3; RYBCZYNSKI R, 1990, J BIOL CHEM, V265, P19712; Ryerse J, 1997, BBA-BIOMEMBRANES, V1327, P193, DOI 10.1016/S0005-2736(97)00058-8; Santos VC, 2011, NEOTROP ENTOMOL, V40, P264, DOI 10.1590/S1519-566X2011000200017; Schneider A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052007; Shelby KS, 2009, J INVERTEBR PATHOL, V101, P86, DOI 10.1016/j.jip.2009.05.002; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SHINFOON C, 1993, J APPL ENTOMOL, V116, P479, DOI 10.1111/j.1439-0418.1993.tb01224.x; SOULAGES JL, 1995, P NATL ACAD SCI USA, V92, P5650, DOI 10.1073/pnas.92.12.5650; Steinbrecht RA, 1996, CHEM SENSES, V21, P719, DOI 10.1093/chemse/21.6.719; STEINBRECHT RA, 1995, CELL TISSUE RES, V282, P203, DOI 10.1007/BF00319112; SUN DH, 1995, J NEUROBIOL, V26, P119, DOI 10.1002/neu.480260110; TALEKAR NS, 1993, ANNU REV ENTOMOL, V38, P275, DOI 10.1146/annurev.en.38.010193.001423; Tsuchihara K, 2005, CHEM SENSES, V30, P559, DOI 10.1093/chemse/bji049; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Vogt RG, 2005, MOL BASIS PHEROMONE; VOLLER A, 1980, P SOC EXP BIOL MED, V163, P402; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Whitten MMA, 2004, J IMMUNOL, V172, P2177, DOI 10.4049/jimmunol.172.4.2177; Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6; Zhang YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047611; Zhong GuoHua, 2000, Journal of South China Agricultural University, V21, P40	56	9	13	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67723	10.1371/journal.pone.0067723	http://dx.doi.org/10.1371/journal.pone.0067723			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861792	Green Published, gold, Green Submitted			2022-12-27	WOS:000321425300024
J	Galarraga, O; Wirtz, VJ; Santa-Ana-Tellez, Y; Korenromp, EL				Galarraga, Omar; Wirtz, Veronika J.; Santa-Ana-Tellez, Yared; Korenromp, Eline L.			Financing HIV Programming: How Much Should Low- And Middle-Income Countries and their Donors Pay?	PLOS ONE			English	Article							GLOBAL FUND; HEALTH; HIV/AIDS; PREVENTION; INNOVATION; PATENTS; POLICY; COSTS; AID	Global HIV control funding falls short of need. To maximize health outcomes, it is critical that national governments sustain reasonable commitments, and that international donor assistance be distributed according to country needs and funding gaps. We develop a country classification framework in terms of actual versus expected national domestic funding, considering resource needs and donor financing. With UNAIDS and World Bank data, we examine domestic and donor HIV program funding in relation to need in 84 low-and middle-income countries. We estimate expected domestic contributions per person living with HIV (PLWH) as a function of per capita income, relative size of the health sector, and per capita foreign debt service. Countries are categorized according to levels of actual versus expected domestic contributions, and resource gap. Compared to national resource needs (UNAIDS Investment Framework), we identify imbalances among countries in actual versus expected domestic and donor contributions: 17 countries, with relatively high HIV prevalence and GNI per capita, have domestic funding below expected (median per PLWH $143 and $376, respectively), yet total available funding including from donors would exceed the need ($368 and $305, respectively) if domestic contribution equaled expected. Conversely, 27 countries have actual domestic funding above the expected (medians $294 and $149) but total (domestic+donor) funding does not meet estimated need ($685 and $1,173). Across the 84 countries, in 2009, estimated resource need totaled $10.3 billion, actual domestic contributions $5.1 billion and actual donor contributions $3.7 billion. If domestic contributions would increase to the expected level in countries where the actual was below expected, total domestic contributions would increase to $7.4 billion, turning a funding gap of $1.5 billion into a surplus of $0.8 billion. Even with imperfect funding and resource-need data, the proposed country classification could help improve coherence and efficiency in domestic and international allocations.	[Galarraga, Omar] Brown Univ, Dept Hlth Serv Policy & Practice, Sch Publ Hlth, Providence, RI 02912 USA; [Galarraga, Omar; Wirtz, Veronika J.; Santa-Ana-Tellez, Yared] Mexican Sch Publ Hlth, Natl Inst Publ Hlth INSP, Cuernavaca, Morelos, Mexico; [Wirtz, Veronika J.] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Santa-Ana-Tellez, Yared] UIPS, WHO Collaborating Ctr Pharmaceut Policy & Regulat, Utrecht, Netherlands; [Korenromp, Eline L.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands	Brown University; Instituto Nacional de Salud Publica; Boston University; Utrecht University; Erasmus University Rotterdam; Erasmus MC	Galarraga, O (corresponding author), Brown Univ, Dept Hlth Serv Policy & Practice, Sch Publ Hlth, Providence, RI 02912 USA.	omar_galarraga@brown.edu	Wirtz, Veornika/AAG-9712-2019; Galarraga, Omar/N-1622-2019	Galarraga, Omar/0000-0002-9985-9266; Wirtz, Veronika J./0000-0002-0863-8768; Santa-Ana-Tellez, Yared/0000-0003-3086-446X	Bill and Melinda Gates Foundation through the INSP/Consortium for Research on HIV/AIDS and Tuberculosis (CISIDAT); United States National Institutes of Health (NIH)/Fogarty International Center [K01-TW008016-04]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041020] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [K01TW008016] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation through the INSP/Consortium for Research on HIV/AIDS and Tuberculosis (CISIDAT); United States National Institutes of Health (NIH)/Fogarty International Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The research was partially funded by the Bill and Melinda Gates Foundation through the INSP/Consortium for Research on HIV/AIDS and Tuberculosis (CISIDAT). Additional funding for Omar Galarraga was provided by United States National Institutes of Health (NIH)/Fogarty International Center (K01-TW008016-04). The opinions expressed in the paper do not reflect the views of any of the funding or the other organizations that supported or facilitated the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amico P, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-221; Andersen R, 2008, MODERN METHODS ROBUS, pxv; Bokhari FAS, 2007, HEALTH ECON, V16, P257, DOI 10.1002/hec.1157; Brugha R, 2005, TROP MED INT HEALTH, V10, P623, DOI 10.1111/j.1365-3156.2005.01437.x; Burton B, 2004, BRIT MED J, V328, P486, DOI 10.1136/bmj.328.7438.486; Cohen RL, 2012, J ACQUIR IMMUNE DEFI; Collier, 2007, BOTTOM BILLION WHY P, pXIII; Easterly W., 2006, WHITE MANS BURDEN WH; Galarraga O, 2011, PHARMACOECONOMICS, V29, P579, DOI 10.2165/11586120-000000000-00000; Garg CC, 2012, HEALTH AFFAIR, V31, P417, DOI 10.1377/hlthaff.2008.0815; Global Fund, 2010, VAL MON IMPR VAL MON; Global Fund, 2012, APPR GRANT AM DISB; Global Fund, 2011, POL EL CRIT COUNT FI; Hesterl V, 2009, 26 RES DEV I; Kaiser Family Foundation, 2012, FIN RESP AIDS LOW AN; Kaplan WA, 2012, HLTH POLICY; Kapp C, 2002, LANCET, V360, P1225, DOI 10.1016/S0140-6736(02)11294-3; Kerouedan D, 2010, Bull Soc Pathol Exot, V103, P119, DOI 10.1007/s13149-010-0051-2; Koenker R, 2005, QUANTILE REGRESSION, pxv; Lane C, 2007, HEALTH AFFAIR, V26, P935, DOI 10.1377/hlthaff.26.4.935; Leach-Kemon K, 2012, HEALTH AFFAIR, V31, P228, DOI 10.1377/hlthaff.2011.1154; Lordan G, 2011, SOC SCI MED, V73, P351, DOI 10.1016/j.socscimed.2011.05.045; Lu CL, 2010, LANCET, V375, P1375, DOI 10.1016/S0140-6736(10)60233-4; Munderi Paula, 2012, AIDS, V26 Suppl 2, pS97, DOI 10.1097/QAD.0b013e32835bdde6; Nations U, 2001, UN GEN ASS 26 SPEC S; Sachs J., 2005, END POVERTY EC POSSI, pxviii; Savedoff WD, 2007, HEALTH AFFAIR, V26, P962, DOI 10.1377/hlthaff.26.4.962; Saxenian H, 2011, HEALTH AFFAIR, V30, P1122, DOI 10.1377/hlthaff.2011.0332; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Shadlen KC, 2012, EUR J DEV RES, V24, P300, DOI 10.1057/ejdr.2012.9; Shadlen KC, 2009, COMP POLIT, V42, P41, DOI 10.5129/001041509X12911362972791; The Global Fund, 2011, 25 BOARD M ACCR GHAN; Thirumurthy H, 2012, HEALTH AFFAIR, V31, P1470, DOI 10.1377/hlthaff.2012.0217; UNAIDS, 2012, UNGASS COUNTR PROGR; UNAIDS, 2010, JOINT ACT RES UNAIDS; UNAIDS, 2012, TOG WE WILL END AIDS; UNAIDS, 2012, COUNTR REP DAT 2009; UNAIDS, 2010, 2010 UNAIDS REP GLOB; United Nations Economic and Social Commission for Asia and the Pacific, 2008, UNESPCAP UNAIDS EXP; WHO Commission on Macroeconomics and Health, 2001, MACR HLTH INV HLTH E; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Wirtz VJ, 2012, HLTH POLICY PLAN; World bank, 2011, DAT CAT; World Bank, 2010, COUNTR CLASS DAT; Zeitz PS, 2003, WHAT IS US FAIR SHAR	45	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67565	10.1371/journal.pone.0067565	http://dx.doi.org/10.1371/journal.pone.0067565			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	178DW	23861772	Green Published, gold			2022-12-27	WOS:000321425300017
J	Matlaf, LA; Harkins, LE; Bezrookove, V; Cobbs, CS; Soroceanu, L				Matlaf, Lisa A.; Harkins, Lualhati E.; Bezrookove, Vladimir; Cobbs, Charles S.; Soroceanu, Liliana			Cytomegalovirus pp71 Protein Is Expressed in Human Glioblastoma and Promotes Pro-Angiogenic Signaling by Activation of Stem Cell Factor	PLOS ONE			English	Article							UBIQUITIN-INDEPENDENT DEGRADATION; IE1 PROTEIN; GROWTH; LOCALIZATION; PROGRESSION; INFECTION; FAMILY; CYCLE; DAXX; P65	Glioblastoma multiforme (GBM) is a highly malignant primary central nervous system neoplasm characterized by tumor cell invasion, robust angiogenesis, and a mean survival of 15 months. Human cytomegalovirus (HCMV) infection is present in > 90% of GBMs, although the role the virus plays in GBM pathogenesis is unclear. We report here that HCMV pp71, a viral protein previously shown to promote cell cycle progression, is present in a majority of human GBMs and is preferentially expressed in the CD133+, cancer stem-like cell population. Overexpression of pp71 in adult neural precursor cells resulted in potent induction of stem cell factor (SCF), an important pro-angiogenic factor in GBM. Using double immunofluorescence, we demonstrate in situ co-localization of pp71 and SCF in clinical GBM specimens. pp71 overexpression in both normal and transformed glial cells increased SCF secretion and this effect was specific, since siRNA mediated knockdown of pp71 or treatment with the antiviral drug cidofovir resulted in decreased expression and secretion of SCF by HCMV-infected cells. pp71-induced upregulation of SCF resulted in downstream activation of its putative endothelial cell receptor, c-kit, and angiogenesis as measured by increased capillary tube formation in vitro. We demonstrate that pp71 induces a pro-inflammatory response via activation of NFKB signaling which drives SCF expression. Furthermore, we show that pp71 levels and NFKB activation are selectively augmented in the mesenchymal subtype of human GBMs, characterized by worst patient outcome, suggesting that HCMV pp71-induced paracrine signaling may contribute to the aggressive phenotype of this human malignancy.	[Matlaf, Lisa A.; Bezrookove, Vladimir; Cobbs, Charles S.; Soroceanu, Liliana] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA; [Harkins, Lualhati E.] Birmingham Vet Adm Hosp, Birmingham, AL USA; [Cobbs, Charles S.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA	California Pacific Medical Center; California Pacific Medical Center Research Institute; University of California System; University of California San Francisco	Soroceanu, L (corresponding author), Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA.	sorocel@cpmcri.org			American Brain Tumor Association; National Institutes of Health [R01NS070289-02, 1R21NS067395-01]; American Cancer Society [RSG-09-197-01]; Accelerated Brain Cancer Cure Foundation; Flaming Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS067395, R01NS070289] Funding Source: NIH RePORTER	American Brain Tumor Association; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Accelerated Brain Cancer Cure Foundation; Flaming Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	L.M. is the recipient of a fellowship from American Brain Tumor Association in honor of Joel A. Gingras Jr. These studies were supported by the National Institutes of Health, Grants R01NS070289-02 to C.S.C.; 1R21NS067395-01 to L.S., by American Cancer Society grant RSG-09-197-01 to C.S.C and by additional funds from the Accelerated Brain Cancer Cure Foundation and the Flaming Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Joshua C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000768; Barami K, 2010, J CLIN NEUROSCI, V17, P819, DOI 10.1016/j.jocn.2009.10.040; Baryawno N, 2011, J CLIN INVEST, V121, P4043, DOI 10.1172/JCI57147; Bhattacharjee B, 2012, J VIROL, V86, P6815, DOI 10.1128/JVI.00015-12; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Castillo JP, 2000, J VIROL, V74, P8028, DOI 10.1128/JVI.74.17.8028-8037.2000; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Cinatl J, 2004, FEMS MICROBIOL REV, V28, P59, DOI 10.1016/j.femsre.2003.07.005; Cobbs CS, 2002, CANCER RES, V62, P3347; Eyler CE, 2011, CELL, V146, P53, DOI 10.1016/j.cell.2011.06.006; Harkins L, 2002, LANCET, V360, P1557, DOI 10.1016/S0140-6736(02)11524-8; Hasegawa T, 2008, INVEST OPHTH VIS SCI, V49, P2178, DOI 10.1167/iovs.07-0632; Hwang JW, 2007, VIROLOGY, V367, P334, DOI 10.1016/j.virol.2007.05.037; Jin K, 2002, J CLIN INVEST, V110, P311, DOI 10.1172/JCI200215251; Kalejta RF, 2004, J CELL BIOCHEM, V93, P37, DOI 10.1002/jcb.20177; Kalejta RF, 2003, P NATL ACAD SCI USA, V100, P3263, DOI 10.1073/pnas.0538058100; Kalejta RF, 2003, MOL CELL BIOL, V23, P1885, DOI 10.1128/MCB.23.6.1885-1895.2003; Kalejta RF, 2002, FRONT BIOSCI-LANDMRK, V7, pD295, DOI 10.2741/kalejta; Lee HR, 2004, J VIROL, V78, P6527, DOI 10.1128/JVI.78.12.6527-6542.2004; Levesque-Sergerie JP, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-93; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Matsui J, 2004, J BIOL CHEM, V279, P18600, DOI 10.1074/jbc.M311643200; Maussang D, 2009, CANCER RES, V69, P2861, DOI 10.1158/0008-5472.CAN-08-2487; Melnick M, 2012, EXP MOL PATHOL, V92, P118, DOI 10.1016/j.yexmp.2011.10.011; Mitchell DA, 2008, NEURO-ONCOLOGY, V10, P10, DOI 10.1215/15228517-2007-035; Park DM, 2009, MOL CELLS, V28, P7, DOI 10.1007/s10059-009-0111-2; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Prados Michael D., 2000, Seminars in Oncology, V27, P1; Price RL, 2012, CANC RES; Purow B, 2004, HEMATOL ONCOL CLIN N, V18, P1161, DOI 10.1016/j.hoc.2004.05.003; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Ranganathan P, 2012, J VIROL, V86, P854, DOI 10.1128/JVI.06097-11; Reber L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004393; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; Saffert RT, 2007, J VIROL, V81, P9109, DOI 10.1128/JVI.00827-07; Samanta M, 2003, J UROLOGY, V170, P998, DOI 10.1097/01.ju.0000080263.46164.97; Sicurella C, 2001, BLOOD CELL MOL DIS, V27, P470, DOI 10.1006/bcmd.2001.0407; Slinger E, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001180; Soroceanu L, 2009, CNS CANC MODELS MARK; Soroceanu L, 2008, NATURE, V455, P391, DOI 10.1038/nature07209; Soroceanu L, 2011, CANCER RES, V71, P6643, DOI 10.1158/0008-5472.CAN-11-0744; Soroceanu L, 2011, VIRUS RES, V157, P193, DOI 10.1016/j.virusres.2010.10.026; Suhasini M, 1999, ONCOGENE, V18, P7360, DOI 10.1038/sj.onc.1203158; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Trgovcich J, 2006, J VIROL, V80, P951, DOI 10.1128/JVI.80.2.951-963.2006; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang XB, 2005, J VIROL, V79, P95, DOI 10.1128/JVI.79.1.95-105.2005; YUROCHKO AD, 1995, J VIROL, V69, P5391, DOI 10.1128/JVI.69.9.5391-5400.1995; Zafiropoulos A, 2003, CANCER LETT, V198, P77, DOI 10.1016/S0304-3835(03)00269-6	49	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68176	10.1371/journal.pone.0068176	http://dx.doi.org/10.1371/journal.pone.0068176			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861869	Green Submitted, Green Published, gold			2022-12-27	WOS:000321425300049
J	Mikami, S; Nakashima, A; Nakagawa, K; Maruhashi, T; Iwamoto, Y; Kajikawa, M; Matsumoto, T; Kihara, Y; Chayama, K; Noma, K; Ochi, M; Nishimura, M; Tsuji, K; Kato, Y; Goto, C; Higashi, Y				Mikami, Shinsuke; Nakashima, Ayumu; Nakagawa, Keigo; Maruhashi, Tatsuya; Iwamoto, Yumiko; Kajikawa, Masato; Matsumoto, Takeshi; Kihara, Yasuki; Chayama, Kazuaki; Noma, Kensuke; Ochi, Mitsuo; Nishimura, Masahiro; Tsuji, Koichiro; Kato, Yukio; Goto, Chikara; Higashi, Yukihito			Autologous Bone-Marrow Mesenchymal Stem Cell Implantation and Endothelial Function in a Rabbit Ischemic Limb Model	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; STROMAL CELLS; GROWTH; DISEASE; PROLIFERATION; ANGIOGENESIS; ACTIVATION; MECHANISMS; EXPRESSION; HINDLIMB	Background: The purpose of this study was to determine whether autologous mesenchymal stem cells (MSCs) implantation improves endothelial dysfunction in a rabbit ischemic limb model. Methods: We evaluated the effect of MSC implantation on limb blood flow (LBF) responses to acetylcholine (ACh), an endothelium-dependent vasodilator, and sodium nitroprusside (SNP), an endothelium-independent vasodilator, in rabbits with limb ischemia in which cultured MSCs were implanted (n = 20) or saline was injected as a control group (n = 20). LBF was measured using an electromagnetic flowmeter. A total of 10(6) MSCs were implanted into each ischemic limb. Results: Histological sections of ischemic muscle showed that capillary index (capillary/muscle fiber) was greater in the MSC implantation group than in the control group. Laser Doppler blood perfusion index was significantly increased in the MSC implantation group compared with that in the control group. LBF response to ACh was greater in the MSC group than in the control group. After administration of N-G-nitro-L-arginine, a nitric oxide synthase inhibitor, LBF response to ACh was similar in the MSC implantation group and control group. Vasodilatory effects of SNP in the two groups were similar. Conclusions: These findings suggest that MSC implantation induces angiogenesis and augments endothelium-dependent vasodilation in a rabbit ischemic model through an increase in nitric oxide production.	[Mikami, Shinsuke; Maruhashi, Tatsuya; Iwamoto, Yumiko; Kajikawa, Masato; Matsumoto, Takeshi; Kihara, Yasuki] Hiroshima Univ, Dept Cardiovasc Med, Grad Sch Biomed Sci, Hiroshima, Japan; [Nakashima, Ayumu; Noma, Kensuke; Higashi, Yukihito] Hiroshima Univ Hosp, Div Regenerat & Med, Hiroshima, Japan; [Nakagawa, Keigo; Chayama, Kazuaki] Hiroshima Univ, Dept Med & Mol Sci, Grad Sch Biomed Sci, Hiroshima, Japan; [Noma, Kensuke; Higashi, Yukihito] Hiroshima Univ, Dept Cardiovasc Regenerat & Med, Res Inst Radiat Biol & Med, Hiroshima, Japan; [Ochi, Mitsuo] Hiroshima Univ, Dept Orthoped Surg, Grad Sch Biomed Sci, Hiroshima, Japan; [Nishimura, Masahiro] Nagasaki Univ, Dept Prosthet Dent, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Tsuji, Koichiro] Two Cells Co Ltd, Hiroshima, Japan; [Kato, Yukio] Hiroshima Univ, Dept Dent & Med Biochem, Grad Sch Biomed Sci, Hiroshima, Japan; [Goto, Chikara] Hirohsima Int Univ, Hiroshima, Japan	Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University; Nagasaki University; Hiroshima University	Higashi, Y (corresponding author), Hiroshima Univ Hosp, Div Regenerat & Med, Hiroshima, Japan.	yhigashi@hiroshima-u.ac.jp	Chayama, Kazuaki/B-2493-2016; Nakashima, Ayumu/N-9158-2017; Higashi, Yukihito/G-5343-2019; Nishimura, Masahiro/ABD-7504-2020; Nakashima, Ayumu/CAF-0274-2022	Nakashima, Ayumu/0000-0002-7838-1494; Nishimura, Masahiro/0000-0001-5552-0693; Nakashima, Ayumu/0000-0002-7838-1494; Chayama, Kazuaki/0000-0002-5530-5341	Grants-in-Aid for Scientific Research [25670369] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Arras M, 1998, J CLIN INVEST, V101, P40, DOI 10.1172/JCI119877; BAUTERS C, 1995, CIRCULATION, V91, P2802, DOI 10.1161/01.CIR.91.11.2802; Beggs KJ, 2006, CELL TRANSPLANT, V15, P711, DOI 10.3727/000000006783981503; Boger RH, 1997, CIRCULATION, V95, P2068, DOI 10.1161/01.CIR.95.8.2068; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Fontana J, 2002, CIRC RES, V90, P866, DOI 10.1161/01.RES.0000016837.26733.BE; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; GILLUM RF, 1990, AM HEART J, V120, P1414, DOI 10.1016/0002-8703(90)90257-X; Higashi Y, 2004, CIRCULATION, V109, P1215, DOI 10.1161/01.CIR.0000121427.53291.78; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Igarashi A, 2007, TISSUE ENG, V13, P2405, DOI 10.1089/ten.2006.0340; Inoue S, 2006, TRANSPLANTATION, V81, P1589, DOI 10.1097/01.tp.0000209919.90630.7b; Iwase T, 2005, CARDIOVASC RES, V66, P543, DOI 10.1016/j.cardiores.2005.02.006; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; LUSCHER TF, 1990, AM J HYPERTENS, V3, P317, DOI 10.1093/ajh/3.4.317; Maitra B, 2004, BONE MARROW TRANSPL, V33, P597, DOI 10.1038/sj.bmt.1704400; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Miller VM, 1998, AM J PHYSIOL, V255, pH446; O'Neill TJ, 2005, CIRC RES, V97, P1027, DOI 10.1161/01.RES.0000189259.69645.25; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rajagopalan S, 2001, CIRCULATION, V104, P753, DOI 10.1161/hc3201.095192; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Santa Maria L, 2004, EXP CELL RES, V300, P418, DOI 10.1016/j.yexcr.2004.07.017; SESSA WC, 1994, CIRC RES, V74, P349, DOI 10.1161/01.RES.74.2.349; Shen BQ, 1999, J BIOL CHEM, V274, P33057, DOI 10.1074/jbc.274.46.33057; Shintani S, 2001, CIRCULATION, V103, P897, DOI 10.1161/01.CIR.103.6.897; Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Uematsu M, 1995, AM J PHYSIOL-CELL PH, V269, pC1371, DOI 10.1152/ajpcell.1995.269.6.C1371; VALLANCE P, 1989, LANCET, V2, P997; VANHOUTTE PM, 1989, HYPERTENSION, V13, P658, DOI 10.1161/01.HYP.13.6.658; Ziegelhoeffer T, 2004, CIRC RES, V94, P230, DOI 10.1161/01.RES.0000110419.50982.1C	39	16	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67739	10.1371/journal.pone.0067739	http://dx.doi.org/10.1371/journal.pone.0067739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861797	Green Submitted, Green Published, gold			2022-12-27	WOS:000323350700030
J	Nibert, ML; Duncan, R				Nibert, Max L.; Duncan, Roy			Bioinformatics of Recent Aqua- and Orthoreovirus Isolates from Fish: Evolutionary Gain or Loss of FAST and Fiber Proteins and Taxonomic Implications	PLOS ONE			English	Article							CELL-ATTACHMENT PROTEIN; REO-LIKE VIRUS; OYSTERS CRASSOSTREA-VIRGINICA; GRASS CARP REOVIRUS; CHINESE MITTEN CRAB; IMAGE-RECONSTRUCTION; ADENOVIRUS FIBER; CRYOELECTRON MICROSCOPY; ELECTRON CRYOMICROSCOPY; TRANSMEMBRANE PROTEIN	Family Reoviridae, subfamily Spinareovirinae, includes nine current genera. Two of these genera, Aquareovirus and Orthoreovirus, comprise members that are closely related and consistently share nine homologous proteins. Orthoreoviruses have 10 dsRNA genome segments and infect reptiles, birds, and mammals, whereas aquareoviruses have 11 dsRNA genome segments and infect fish. Recently, the first 10-segmented fish reovirus, piscine reovirus (PRV), has been identified and shown to be phylogenetically divergent from the 11-segmented viruses constituting genus Aquareovirus. We have recently extended results for PRV by showing that it does not encode a fusion-associated small transmembrane (FAST) protein, but does encode an outer-fiber protein containing a long N-terminal region of predicted alpha-helical coiled coil. Three recently characterized 11-segmented fish reoviruses, obtained from grass carp in China and sequenced in full, are also divergent from the viruses now constituting genus Aquareovirus, though not to the same extent as PRV. In the current study, we reexamined the sequences of these three recent isolates of grass carp reovirus (GCRV)-HZ08, GD108, and 104-for further clues to their evolution relative to other aqua- and orthoreoviruses. Structure-based fiber motifs in their encoded outer-fiber proteins were characterized, and other bioinformatics analyses provided evidence against the presence of a FAST protein among their encoded nonstructural proteins. Phylogenetic comparisons showed the combination of more distally branching, approved Aquareovirus and Orthoreovirus members, plus more basally branching isolates GCRV104, GCRV-HZ08/GD108, and PRV, constituting a larger, monophyletic taxon not suitably recognized by the current taxonomic hierarchy. Phylogenetics also suggested that the last common ancestor of all these viruses was a fiber-encoding, nonfusogenic virus and that the FAST protein family arose from at least two separate gain-of-function events. In addition, an apparent evolutionary correlation was found between the gain or loss of NS-FAST and outer-fiber proteins among more distally branching members of this taxon.	[Nibert, Max L.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02114 USA; [Duncan, Roy] Dalhousie Univ, Dept Microbiol & Immunol, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Duncan, Roy] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada	Harvard University; Harvard Medical School; Dalhousie University; Dalhousie University	Nibert, ML (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02114 USA.	mnibert@hms.harvard.edu; roy.duncan@dal.ca		Duncan, Roy/0000-0002-5162-5081	Canadian Institutes of Health Research [MOP-13723, MOP-100584]; Natural Sciences and Engineering Research Council of Canada [OGP1083745]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding provided by Canadian Institutes of Health Research grant numbers MOP-13723 and MOP-100584, and the Natural Sciences and Engineering Research Council of Canada grant number OGP1083745. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attoui H, 2002, J GEN VIROL, V83, P1941, DOI 10.1099/0022-1317-83-8-1941; Attoui H., 2012, VIRUS TAXONOMY, P541, DOI [DOI 10.1016/B978-0-12-384684-6.00051-3, 10.1016/B978-0-12-384684-6.00051-3]; Barton ES, 2001, CELL, V104, P441, DOI 10.1016/S0092-8674(01)00231-8; BASSELDUBY R, 1985, NATURE, V315, P421, DOI 10.1038/315421a0; Bokiej M, 2012, J VIROL, V86, P10270, DOI 10.1128/JVI.01338-12; Bonami JR, 1973, REV TRAV I SCI TECH, V37, P387; Boutilier J, 2011, CURR TOP MEMBR, V68, P107, DOI 10.1016/B978-0-12-385891-7.00005-2; Bowers HA, 2010, DIS AQUAT ORGAN, V93, P17, DOI 10.3354/dao02280; Calvo PG, 2005, J MOL BIOL, V354, P137, DOI 10.1016/j.jmb.2005.09.034; Chappell JD, 2002, EMBO J, V21, P1, DOI 10.1093/emboj/21.1.1; Cheng LP, 2010, J MOL BIOL, V397, P852, DOI 10.1016/j.jmb.2009.12.027; Corcoran JA, 2004, J VIROL, V78, P4342, DOI 10.1128/JVI.78.8.4342-4351.2004; Dawe S, 2002, J VIROL, V76, P2131, DOI 10.1128/JVI.76.5.2131-2140.2002; DELATORRE JC, 1991, BRIT MED BULL, V47, P838, DOI 10.1093/oxfordjournals.bmb.a072515; Deng XX, 2012, VIROLOGY, V422, P185, DOI 10.1016/j.virol.2011.09.029; DRYDEN KA, 1993, J CELL BIOL, V122, P1023, DOI 10.1083/jcb.122.5.1023; Duncan R, 1999, VIROLOGY, V260, P316, DOI 10.1006/viro.1999.9832; Duncan R, 2004, VIROLOGY, V319, P131, DOI 10.1016/j.virol.2003.10.025; Duncan R, 1996, VIROLOGY, V224, P453, DOI 10.1006/viro.1996.0552; Fan YD, 2012, COMPLETE GENOME SEQU; Fang Q, 1989, VIROL SIN, V3, P315; FURLONG DB, 1988, J VIROL, V62, P246, DOI 10.1128/JVI.62.1.246-256.1988; GREEN NM, 1983, EMBO J, V2, P1357, DOI 10.1002/j.1460-2075.1983.tb01592.x; Guardado-Calvo P, 2009, J GEN VIROL, V90, P672, DOI 10.1099/vir.0.008276-0; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo H, 2013, VIRUS RES, V171, P129, DOI 10.1016/j.virusres.2012.11.011; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Jaafar FM, 2008, VIROLOGY, V373, P310, DOI 10.1016/j.virol.2007.12.006; JOHNSON PT, 1977, J INVERTEBR PATHOL, V29, P201, DOI 10.1016/0022-2011(77)90194-X; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Ke F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-323; Key T, 2013, J GEN VIROL, V94, P1039, DOI 10.1099/vir.0.048637-0; Kim J, 2004, VIRUS RES, V101, P15, DOI 10.1016/j.virusres.2003.12.003; Kirchner E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000235; Kohl C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043106; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KROL RM, 1990, DIS AQUAT ORGAN, V8, P45, DOI 10.3354/dao008045; Lauber C, 2012, J VIROL, V86, P3905, DOI 10.1128/JVI.07174-11; LEE PWK, 1981, VIROLOGY, V108, P156, DOI 10.1016/0042-6822(81)90535-3; MAH DCW, 1990, VIROLOGY, V179, P95, DOI 10.1016/0042-6822(90)90278-Y; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Meyers TR, 2009, DIS AQUAT ORGAN, V88, P1, DOI 10.3354/dao02154; MEYERS TR, 1980, J FISH DIS, V3, P187, DOI 10.1111/j.1365-2761.1980.tb00443.x; MEYERS TR, 1979, J GEN VIROL, V43, P203, DOI 10.1099/0022-1317-43-1-203; MONTANIE H, 1993, J GEN VIROL, V74, P1555, DOI 10.1099/0022-1317-74-8-1555; NAGATA L, 1987, VIROLOGY, V160, P162, DOI 10.1016/0042-6822(87)90056-0; NAGATA L, 1984, NUCLEIC ACIDS RES, V12, P8699, DOI 10.1093/nar/12.22.8699; Nason EL, 2000, J VIROL, V74, P6546, DOI 10.1128/JVI.74.14.6546-6555.2000; NIBERT ML, 1990, J VIROL, V64, P2976, DOI 10.1128/JVI.64.6.2976-2989.1990; Nilsson EC, 2011, NAT MED, V17, P105, DOI 10.1038/nm.2267; Palacios G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011487; PAUL RW, 1989, VIROLOGY, V172, P382, DOI 10.1016/0042-6822(89)90146-3; Persson BD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001122; Racine T, 2009, J VIROL, V83, P5951, DOI 10.1128/JVI.00171-09; Reddy VS, 2010, SCIENCE, V329, P1071, DOI 10.1126/science.1187292; Reiter DM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002166; Rodgers SE, 1998, J VIROL, V72, P8597, DOI 10.1128/JVI.72.11.8597-8604.1998; Salsman J, 2005, J VIROL, V79, P8090, DOI 10.1128/JVI.79.13.8090-8100.2005; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Shmulevitz M, 2000, EMBO J, V19, P902, DOI 10.1093/emboj/19.5.902; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Thalmann CM, 2010, VIROLOGY, V402, P26, DOI 10.1016/j.virol.2009.11.048; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; van Raaij MJ, 1999, NATURE, V401, P935, DOI 10.1038/44880; Voon K, 2011, J GEN VIROL, V92, P2930, DOI 10.1099/vir.0.033498-0; Wang Q, 2012, J VIROL, V86, P12466, DOI 10.1128/JVI.02333-12; Ye X, 2012, VIRUS RES, V163, P275, DOI 10.1016/j.virusres.2011.10.014; Zhang S, 2004, J FISH DIS, V27, P687, DOI 10.1111/j.1365-2761.2004.00587.x; Zhang S, 2012, J FISH DIS, V35, P733, DOI 10.1111/j.1365-2761.2012.01398.x; Zhang X, 2005, VIROLOGY, V343, P25, DOI 10.1016/j.virol.2005.08.002; Zhang X, 2005, STRUCTURE, V13, P1545, DOI 10.1016/j.str.2005.07.012	71	56	62	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68607	10.1371/journal.pone.0068607	http://dx.doi.org/10.1371/journal.pone.0068607			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861926	Green Submitted, gold, Green Published			2022-12-27	WOS:000323350700093
J	Di Cello, F; Cope, L; Li, HL; Jeschke, J; Wang, W; Baylin, SB; Zahnow, CA				Di Cello, Francescopaolo; Cope, Leslie; Li, Huili; Jeschke, Jana; Wang, Wei; Baylin, Stephen B.; Zahnow, Cynthia A.			Methylation of the Claudin 1 Promoter Is Associated with Loss of Expression in Estrogen Receptor Positive Breast Cancer	PLOS ONE			English	Article							INVASIVE DUCTAL CARCINOMA; EPITHELIAL-CELLS; DNA-METHYLATION; JUNCTIONS; FEATURES; OCCLUDIN; SUBTYPE; BENIGN; TUMORS; GRADE	Downregulation of the tight junction protein claudin 1 is a frequent event in breast cancer and is associated with recurrence, metastasis, and reduced survival, suggesting a tumor suppressor role for this protein. Tumor suppressor genes are often epigenetically silenced in cancer. Downregulation of claudin 1 via DNA promoter methylation may thus be an important determinant in breast cancer development and progression. To investigate if silencing of claudin 1 has an epigenetic etiology in breast cancer we compared gene expression and methylation data from 217 breast cancer samples and 40 matched normal samples available through the Cancer Genome Atlas (TCGA). Moreover, we analyzed claudin 1 expression and methylation in 26 breast cancer cell lines. We found that methylation of the claudin 1 promoter CpG island is relatively frequent in estrogen receptor positive (ER+) breast cancer and is associated with low claudin 1 expression. In contrast, the claudin 1 promoter was not methylated in most of the ER-breast cancers samples and some of these tumors overexpress claudin 1. In addition, we observed that the demethylating agents, azacitidine and decitabine can upregulate claudin 1 expression in breast cancer cell lines that have a methylated claudin 1 promoter. Taken together, our results indicate that DNA promoter methylation is causally associated with downregulation of claudin 1 in a subgroup of breast cancer that includes mostly ER+ tumors, and suggest that epigenetic therapy to restore claudin 1 expression might represent a viable therapeutic strategy in this subtype of breast cancer.	[Di Cello, Francescopaolo; Cope, Leslie; Li, Huili; Jeschke, Jana; Wang, Wei; Baylin, Stephen B.; Zahnow, Cynthia A.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Johns Hopkins, Sch Med, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine	Zahnow, CA (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Johns Hopkins, Sch Med, Baltimore, MD 21218 USA.	zahnoci@jhmi.edu		Jeschke, Jana/0000-0002-6047-2558; Wang, Wei/0000-0003-1339-4080	Flight Attendant Medical Research Institute [062544_YCSA, 072156_CIA]; Safeway Foundation; Irving Hansen Foundation; Johns Hopkins Center in Urban Environmental Health Pilot Project Program; National Institutes of Health [P30 ES003819, P30 CA006973]; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES003819] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute; Safeway Foundation; Irving Hansen Foundation; Johns Hopkins Center in Urban Environmental Health Pilot Project Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the Flight Attendant Medical Research Institute (062544_YCSA, 072156_CIA), the Safeway Foundation, the Irving Hansen Foundation, the Johns Hopkins Center in Urban Environmental Health Pilot Project Program, and The National Institutes of Health (P30 ES003819, P30 CA006973). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchard AA, 2009, VIRCHOWS ARCH, V454, P647, DOI 10.1007/s00428-009-0770-6; Boireau S, 2007, CARCINOGENESIS, V28, P246, DOI 10.1093/carcin/bgl120; Brandes JC, 2007, ONCOGENE, V26, P6229, DOI 10.1038/sj.onc.1210433; Cataldo VD, 2009, EXPERT REV ANTICANC, V9, P875, DOI 10.1586/ERA.09.61; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; Gerhard R, 2012, BREAST, V21, P354, DOI 10.1016/j.breast.2012.03.001; Ghoshal K, 2005, MOL CELL BIOL, V25, P4727, DOI 10.1128/MCB.25.11.4727-4741.2005; Gupta IR, 2010, CLIN GENET, V77, P314, DOI 10.1111/j.1399-0004.2010.01397.x; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hoevel T, 2004, INT J CANCER, V108, P374, DOI 10.1002/ijc.11571; Ignatoski KMW, 1999, BREAST CANCER RES TR, V54, P173, DOI 10.1023/A:1006135331912; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kominsky SL, 2003, ONCOGENE, V22, P2021, DOI 10.1038/sj.onc.1206199; Kramer F, 2000, HUM GENET, V107, P249, DOI 10.1007/s004390000375; Kulawiec M, 2008, CANCER BIOL THER, V7, P1732, DOI 10.4161/cbt.7.11.6729; Lewis CM, 2005, CLIN CANCER RES, V11, P166; Lu SL, 2013, MODERN PATHOL, V26, P485, DOI 10.1038/modpathol.2012.187; Martinez-Estrada OM, 2006, BIOCHEM J, V394, P449, DOI 10.1042/BJ20050591; Mineta K, 2011, FEBS LETT, V585, P606, DOI 10.1016/j.febslet.2011.01.028; Morohashi S, 2007, INT J MOL MED, V20, P139; Myal Y, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/956897; Ogoshi K, 2011, GENOMICS, V98, P280, DOI 10.1016/j.ygeno.2011.07.003; Osanai M, 2007, CANCER SCI, V98, P1557, DOI 10.1111/j.1349-7006.2007.00569.x; Ricardo S, 2012, HISTOL HISTOPATHOL, V27, P1283, DOI 10.14670/HH-27.1283; Saitou M, 1998, J CELL BIOL, V141, P397, DOI 10.1083/jcb.141.2.397; Santos FPS, 2010, EXPERT REV ANTICANC, V10, P9, DOI [10.1586/ERA.09.164, 10.1586/era.09.164]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Stresemann C, 2006, CANCER RES, V66, P2794, DOI 10.1158/0008-5472.CAN-05-2821; Stresemann C, 2008, MOL CANCER THER, V7, P2998, DOI 10.1158/1535-7163.MCT-08-0411; Szasz AM, 2011, CLIN EXP METASTAS, V28, P55, DOI 10.1007/s10585-010-9357-5; Tokes AM, 2005, BREAST CANCER RES, V7, pR296, DOI 10.1186/bcr983; Tsai HC, 2012, CANCER CELL, V21, P430, DOI 10.1016/j.ccr.2011.12.029; Turksen K, 2011, BBA-REV CANCER, V1816, P73, DOI 10.1016/j.bbcan.2011.04.001; Yan PS, 2006, CLIN CANCER RES, V12, P6626, DOI 10.1158/1078-0432.CCR-06-0467; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930	39	37	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68630	10.1371/journal.pone.0068630	http://dx.doi.org/10.1371/journal.pone.0068630			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844228	Green Published, gold, Green Submitted			2022-12-27	WOS:000321733000019
J	Guo, XY; Li, FY; Yang, ZL; Dienes, Z				Guo, Xiuyan; Li, Fengying; Yang, Zhiliang; Dienes, Zoltan			Bidirectional Transfer between Metaphorical Related Domains in Implicit Learning of Form-Meaning Connections	PLOS ONE			English	Article							UNCONSCIOUS STRUCTURAL KNOWLEDGE; ACQUISITION; EMBODIMENT; MAPPINGS; SPEED; POWER; TIME	People can implicitly learn a connection between linguistic forms and meanings, for example between specific determiners (e.g. this, that...) and the type of nouns to which they apply. Li et al (2013) recently found that transfer of form-meaning connections from a concrete domain (height) to an abstract domain (power) was achieved in a metaphor-consistent way without awareness, showing that unconscious knowledge can be abstract and flexibly deployed. The current study aims to determine whether people transfer knowledge of form-meaning connections not only from a concrete domain to an abstract one, but also vice versa, consistent with metaphor representation being bi-directional. With a similar paradigm as used by Li et al, participants learnt form- meaning connections of different domains (concrete vs. abstract) and then were tested on two kinds of generalizations (same and different domain generalization). As predicted, transfer of form-meaning connections occurred bidirectionally when structural knowledge was unconscious. Moreover, the present study also revealed that more transfer occurred between metaphorically related domains when judgment knowledge was conscious (intuition) rather than unconscious (guess). Conscious and unconscious judgment knowledge may have different functional properties.	[Guo, Xiuyan] E China Normal Univ, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China; [Guo, Xiuyan; Yang, Zhiliang] E China Normal Univ, Sch Psychol & Cognit Sci, Shanghai 200062, Peoples R China; [Li, Fengying] Zhejiang Normal Univ, Dept Psychol, Jinhua, Peoples R China; [Dienes, Zoltan] Univ Sussex, Sackler Ctr Consciousness Sci, Brighton, E Sussex, England; [Dienes, Zoltan] Univ Sussex, Sch Psychol, Brighton, E Sussex, England	East China Normal University; East China Normal University; Zhejiang Normal University; University of Sussex; University of Sussex	Guo, XY (corresponding author), E China Normal Univ, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China.	xyguo2006@gmail.com		Dienes, Zoltan/0000-0001-7454-3161	National Natural Science Foundation of China [31271090]; Key Project Foundation for Research and Innovation of Shanghai Municipal Education Commission [12ZS046]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project Foundation for Research and Innovation of Shanghai Municipal Education Commission	National Natural Science Foundation of China (31271090) and Key Project Foundation for Research and Innovation of Shanghai Municipal Education Commission (12ZS046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN GTM, 1995, J EXP PSYCHOL LEARN, V21, P899, DOI 10.1037/0278-7393.21.4.899; Baguley T, 2012, SERIOUS STATS GUIDE; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Caramazza A, 2003, TRENDS COGN SCI, V7, P354, DOI 10.1016/S1364-6613(03)00159-1; Casasanto D, 2008, COGNITION, V106, P579, DOI 10.1016/j.cognition.2007.03.004; CHEESMAN J, 1986, CAN J PSYCHOL, V40, P343, DOI 10.1037/h0080103; CHEESMAN J, 1984, PERCEPT PSYCHOPHYS, V36, P387, DOI 10.3758/BF03202793; Chen WW, 2011, CONSCIOUS COGN, V20, P1751, DOI 10.1016/j.concog.2011.03.003; Dienes Z, 2005, PSYCHOL RES-PSYCH FO, V69, P338, DOI 10.1007/s00426-004-0208-3; Dienes Z, 2004, J CONSCIOUSNESS STUD, V11, P25; Dienes Z., 2008, UNDERSTANDING PSYCHO; Dienes Z, 2012, PLOS ONE, V7; Dienes Z., 2012, STAT LEARNING LANGUA, P337; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; Eitam B, 2010, SOC PERSONAL PSYCHOL, V4, P951, DOI 10.1111/j.1751-9004.2010.00309.x; Freedman D. G, 1979, HUMAN SOCIOBIOLOGY; Fu QF, 2010, CONSCIOUS COGN, V19, P478, DOI 10.1016/j.concog.2009.12.006; Giessner SR, 2007, ORGAN BEHAV HUM DEC, V104, P30, DOI 10.1016/j.obhdp.2006.10.001; Goldberg AdeleE., 1995, CONSTRUCTIONS CONSTR; Goschke T, 2007, J EXP PSYCHOL LEARN, V33, P394, DOI 10.1037/0278-7393.33.2.394; Guo XY, 2013, CONSCIOUS COGN, V22, P203, DOI 10.1016/j.concog.2012.12.001; Guo XY, 2011, CONSCIOUS COGN, V20, P417, DOI 10.1016/j.concog.2010.06.015; IJzerman H, 2011, PSYCHOL BULL, V137, P355, DOI 10.1037/a0022373; Jiang S, 2012, CONSCIOUS COGN, V21, P476, DOI 10.1016/j.concog.2011.12.009; Lakoff George, 2003, METAPHOR WE LIVE BY; Lakoff George., 1999, PHILOS FLESH EMBODIE; Lee SWS, 2012, J PERS SOC PSYCHOL, V103, P737, DOI 10.1037/a0029708; Lee SWS, 2010, PSYCHOL SCI, V21, P1423, DOI 10.1177/0956797610382788; Leung JHC, 2012, LANG LEARN, V62, P634, DOI 10.1111/j.1467-9922.2011.00637.x; Leung JHC, 2011, STUD SECOND LANG ACQ, V33, P33, DOI 10.1017/S0272263110000525; Li FY, 2013, CONSCIOUS COGN, V22, P174, DOI 10.1016/j.concog.2012.11.011; Mealor A, 2012, CONSCIOUS COGN, V21, P228, DOI 10.1016/j.concog.2011.12.001; Mealor AD, 2013, CONSCIOUS COGN, V22, P123, DOI 10.1016/j.concog.2012.11.009; Mealor AD, 2012, CONSCIOUS COGN, V21, P865, DOI 10.1016/j.concog.2012.03.001; National Language Committee, 1992, STAT WORD FREQ MOD C; Norman E, 2006, CONSCIOUS COGN, V15, P723, DOI 10.1016/j.concog.2005.06.003; REBER AS, 1969, J EXP PSYCHOL, V81, P115, DOI 10.1037/h0027454; REBER AS, 1989, J EXP PSYCHOL GEN, V118, P219, DOI 10.1037/0096-3445.118.3.219; Rohrmeier M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045885; Rohrmeier M, 2011, CONSCIOUS COGN, V20, P214, DOI 10.1016/j.concog.2010.07.004; Schneider IK, 2011, SOC PSYCHOL PERS SCI, V2, P474, DOI 10.1177/1948550610397895; Schubert TW, 2009, SOC COGNITION, V27, P1, DOI 10.1521/soco.2009.27.1.1; Schubert TW, 2005, J PERS SOC PSYCHOL, V89, P1, DOI 10.1037/0022-3514.89.1.1; SCHWARTZ B, 1982, SOC PSYCHOL QUART, V45, P114, DOI 10.2307/3033934; Scott RB, 2008, J EXP PSYCHOL LEARN, V34, P1264, DOI 10.1037/a0012943; Scott RB, 2010, CONSCIOUS COGN, V19, P391, DOI 10.1016/j.concog.2009.11.009; Scott RB, 2010, COGNITION, V114, P372, DOI 10.1016/j.cognition.2009.10.010; Sidis B., 1898, PSYCHOL SUGGESTION; Stroh M, 1908, AM J PSYCHOL, V19, P243, DOI 10.2307/1412764; Tomasello M, 2000, TRENDS COGN SCI, V4, P156, DOI 10.1016/S1364-6613(00)01462-5; Tunney RJ, 2001, J EXP PSYCHOL LEARN, V27, P614, DOI 10.1037//0278-7393.27.3.614; VanPatten B., 2004, FORM MEANING CONNECT, DOI [10.4324/9781410610607, DOI 10.4324/9781410610607]; Williams J., 2004, FORM MEANING CONNECT, P203; Williams JN, 2005, STUD SECOND LANG ACQ, V27, P269, DOI 10.1017/S0272263105050138; Williams JN, 2010, LANG LEARN, V60, P221, DOI 10.1111/j.1467-9922.2010.00607.x; Zhong CB, 2008, PSYCHOL SCI, V19, P838, DOI 10.1111/j.1467-9280.2008.02165.x; Ziori E, 2008, Q J EXP PSYCHOL, V61, P601, DOI 10.1080/17470210701255374	58	6	6	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68100	10.1371/journal.pone.0068100	http://dx.doi.org/10.1371/journal.pone.0068100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182HT	23844159	Green Published, Green Submitted, gold			2022-12-27	WOS:000321733000128
J	Porter, K; Lin, YZ; Liton, PB				Porter, Kristine; Lin, Yizhi; Liton, Paloma B.			Cathepsin B Is Up-Regulated and Mediates Extracellular Matrix Degradation in Trabecular Meshwork Cells Following Phagocytic Challenge	PLOS ONE			English	Article							LYSOSOMAL CYSTEINE PROTEASES; DISTINCT SIGNALING PATHWAYS; THYROID EPITHELIAL-CELLS; ELECTRON-MICROSCOPY; ENDOTHELIAL-CELLS; MEDFLY HEMOCYTES; ANTERIOR CHAMBER; PROCATHEPSIN-B; ORGAN-CULTURE; IN-VITRO	Cells in the trabecular meshwork (TM), a tissue responsible for draining aqueous humor out of the eye, are known to be highly phagocytic. Phagocytic activity in TM cells is thought to play an important role in outflow pathway physiology. However, the molecular mechanisms triggered by phagocytosis in TM cells are unknown. Here we investigated the effects of chronic phagocytic stress on lysosomal function using different phagocytic ligands (E. coli, carboxylated beads, collagen I-coated beads, and pigment). Lysotracker red co-localization and electron micrographs showed the maturation of E. coli-and collagen I-coated beads-containing phagosomes into phagolysosomes. Maturation of phagosomes into phagolysosomes was not observed with carboxylated beads or pigment particles. In addition, phagocytosis of E. coli and collagen I-coated beads led to increased lysosomal mass, and the specific up-regulation and activity of cathepsin B (CTSB). Higher levels of membrane-bound and secreted CTSB were also detected. Moreover, in vivo zymography showed the intralysosomal degradation of ECM components associated with active CTSB, as well as an overall increased gelatinolytic activity in phagocytically challenged TM cells. This increased gelatinolytic activity with phagocytosis was partially blocked with an intracellular CTSB inhibitor. Altogether, these results suggest a potential role of phagocytosis in outflow pathway tissue homeostasis through the up-regulation and/or proteolytic activation of extracellular matrix remodeling genes.	[Porter, Kristine; Lin, Yizhi; Liton, Paloma B.] Duke Univ, Dept Ophthalmol, Durham, NC 27708 USA	Duke University	Liton, PB (corresponding author), Duke Univ, Dept Ophthalmol, Durham, NC 27708 USA.	paloma.liton@dm.duke.edu	Liton, Paloma/K-4229-2019	Liton, Paloma/0000-0002-1440-3762	National Institutes of Health [R01EY020491, R21EY019137]; ARRA [R21EY019137-S, P30EY005722]; American Health Assistance Foundation [G2012022]; NATIONAL EYE INSTITUTE [R01EY020491, R21EY019137, P30EY005722] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation(BrightFocus Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants R01EY020491, R21EY019137, ARRA R21EY019137-S, P30EY005722, American Health Assistance Foundation (G2012022) and Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham LC, 2007, EXP CELL RES, V313, P1045, DOI 10.1016/j.yexcr.2006.12.019; Aisa MC, 2003, BBA-GEN SUBJECTS, V1621, P149, DOI 10.1016/S0304-4165(03)00054-0; BILL A, 1971, EXP EYE RES, V12, P275, DOI 10.1016/0014-4835(71)90149-7; BOND JS, 1987, ANNU REV BIOCHEM, V56, P333, DOI 10.1146/annurev.bi.56.070187.002001; Booth JW, 2001, SEMIN IMMUNOL, V13, P357, DOI 10.1006/smim.2001.0332; Bradley JMB, 1998, INVEST OPHTH VIS SCI, V39, P2649; Brix K, 2008, BIOCHIMIE, V90, P194, DOI 10.1016/j.biochi.2007.07.024; Broemme D, EXTRACELLULAR MATRIX, P23; BULLER C, 1990, INVEST OPHTH VIS SCI, V31, P2156; Cavallo-Medved D, 2009, EXP CELL RES, V315, P1234, DOI 10.1016/j.yexcr.2009.01.021; Giusti I, 2008, NEOPLASIA, V10, P481, DOI 10.1593/neo.08178; GRIERSON I, 1973, BRIT J OPHTHALMOL, V57, P400, DOI 10.1136/bjo.57.6.400; GRIERSON I, 1978, BRIT J OPHTHALMOL, V62, P694, DOI 10.1136/bjo.62.10.694; Hoffmann E, 2010, EUR J CELL BIOL, V89, P693, DOI 10.1016/j.ejcb.2010.04.006; IWAMOTO T, 1971, AM J OPHTHALMOL, V72, P420, DOI 10.1016/0002-9394(71)91315-8; Jane DT, 2006, BIOL CHEM, V387, P223, DOI 10.1515/BC.2006.030; JOHNSON DH, 1989, CURR EYE RES, V8, P1121, DOI 10.3109/02713688909000037; Keller KE, 2009, EXP EYE RES, V88, P676, DOI 10.1016/j.exer.2008.11.023; Kinchen JM, 2008, NAT REV MOL CELL BIO, V9, P781, DOI 10.1038/nrm2515; KOBAYASHI H, 1993, BIOCHIM BIOPHYS ACTA, V1178, P55, DOI 10.1016/0167-4889(93)90109-3; KOBAYASHI H, 1991, J BIOL CHEM, V266, P5147; Koblinski JE, 2002, J BIOL CHEM, V277, P32220, DOI 10.1074/jbc.M204708200; Lamprou I, 2005, BBA-MOL CELL RES, V1744, P1, DOI 10.1016/j.bbamcr.2004.09.031; Lamprou I, 2007, IMMUNOLOGY, V121, P314, DOI 10.1111/j.1365-2567.2007.02576.x; Leske MC, 2008, OPHTHALMOLOGY, V115, P85, DOI 10.1016/j.ophtha.2007.03.017; Li JH, 2009, AM J PATHOL, V175, P1124, DOI 10.2353/ajpath.2009.090113; Linke M, 2002, J CELL SCI, V115, P4877, DOI 10.1242/jcs.00184; Linke M, 2002, BIOL CHEM, V383, P773, DOI 10.1515/BC.2002.081; Liton PB, 2008, INVEST OPHTH VIS SCI, V49, P3961, DOI 10.1167/iovs.08-1915; Liton PB, 2005, INVEST OPHTH VIS SCI, V46, P183, DOI 10.1167/iovs.04-0330; Liu JA, 2004, ARTERIOSCL THROM VAS, V24, P1359, DOI 10.1161/01.ATV.0000134530.27208.41; LUDWIG T, 1994, EMBO J, V13, P3430, DOI 10.1002/j.1460-2075.1994.tb06648.x; Lutjen-Drecoll E, 1999, PROG RETIN EYE RES, V18, P91, DOI 10.1016/S1350-9462(98)00011-1; MACH L, 1994, J BIOL CHEM, V269, P13030; Madsen DH, 2011, J BIOL CHEM, V286, P26996, DOI 10.1074/jbc.M110.208033; MCCORMICK D, 1993, NEUROPATH APPL NEURO, V19, P146, DOI 10.1111/j.1365-2990.1993.tb00420.x; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Obermajer N, 2008, CONNECT TISSUE RES, V49, P193, DOI 10.1080/03008200802143158; Oh YK, 1996, J CELL BIOL, V132, P585, DOI 10.1083/jcb.132.4.585; Podgorski I, 2005, NEOPLASIA, V7, P207, DOI 10.1593/neo.04349; Porter KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034792; Premzl A, 2003, EXP CELL RES, V283, P206, DOI 10.1016/S0014-4827(02)00055-1; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; RAWLINGS ND, 1993, BIOCHEM J, V290, P205, DOI 10.1042/bj2900205; Roberts R, 2005, DRUG NEWS PERSPECT, V18, P605, DOI 10.1358/dnp.2005.18.10.949485; Rocken C, 2005, ANN RHEUM DIS, V64, P808, DOI 10.1136/ard.2004.030429; Rohen J W, 1968, Albrecht Von Graefes Arch Klin Exp Ophthalmol, V175, P143, DOI 10.1007/BF02385060; ROHEN JW, 1975, A GRAEF ARCH KLIN EX, V193, P95, DOI 10.1007/BF00419354; Rong YG, 2011, P NATL ACAD SCI USA, V108, P7826, DOI 10.1073/pnas.1013800108; Sameni M, 2000, NEOPLASIA, V2, P496, DOI 10.1038/sj.neo.7900116; SAMUELSON DA, 1984, AM J VET RES, V45, P2359; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; SCHLAGENHAUFF B, 1992, CANCER, V70, P1133, DOI 10.1002/1097-0142(19920901)70:5<1133::AID-CNCR2820700518>3.0.CO;2-O; SHABO AL, 1972, AM J OPHTHALMOL, V73, P25, DOI 10.1016/0002-9394(72)90300-5; SHIRATO S, 1989, INVEST OPHTH VIS SCI, V30, P2499; Sloane BF, 2005, SEMIN CANCER BIOL, V15, P149, DOI 10.1016/j.semcancer.2004.08.001; Spiga MG, 2010, INVEST OPHTH VIS SCI, V51, P3029, DOI 10.1167/iovs.09-4918; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Tektas OY, 2009, EXP EYE RES, V88, P769, DOI 10.1016/j.exer.2008.11.025; TRIPATHI RC, 1982, EXP EYE RES, V35, P611, DOI 10.1016/S0014-4835(82)80074-2; Tu C, 2008, CANCER RES, V68, P9147, DOI 10.1158/0008-5472.CAN-07-5127; VANBUSKIRK EM, 1978, AM J OPHTHALMOL, V85, P160; Vreemann A, 2009, BIOL CHEM, V390, P481, DOI 10.1515/BC.2009.055; YAMASHITA T, 1965, AM J OPHTHALMOL, V60, P427, DOI 10.1016/0002-9394(65)90706-3; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; ZHOU LL, 1995, INVEST OPHTH VIS SCI, V36, P787	66	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68668	10.1371/journal.pone.0068668	http://dx.doi.org/10.1371/journal.pone.0068668			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844232	gold, Green Published, Green Submitted			2022-12-27	WOS:000321733000022
J	Yao, DW; Xu, JR; Zhou, ZL; Li, ST; Yang, DJ				Yao, Da-Wei; Xu, Jia-Rong; Zhou, Zhen-Lei; Li, Shang-Tong; Yang, De-Ji			Microsatellite Instability in Chicken Lymphoma Induced by Gallid Herpesvirus 2	PLOS ONE			English	Article							MAREKS-DISEASE VIRUS; EPSTEIN-BARR-VIRUS; MISMATCH REPAIR GENES; GASTRIC CARCINOMAS; CANCER; DNA; INFECTION; CRITERIA; SERUM; P53	Microsatellite instability (MSI) has been found in a range of human tumors, and little is known of the links between MSI and herpesvirus. In order to investigate the relationship between MSI and Gallid herpesvirus 2 (GaHV-2)-induced lymphoma, fifteen Marek's disease (MD) lymphomas were analyzed through using 46 microsatellite markers, which were amplified by PCR from DNA specimens of lymphoma and normal muscular tissues from the same chicken. PCR products were evaluated by denaturing polyacrylamide gel electrophoresis for MSI analysis. MSI was proved in all lymphomas, at least in one locus. Thirty of the 46 microsatellite markers had microsatellite alterations. These results suggested that GaHV-2-induced lymphoma in chickens is related to MSI, and this is the first report to demonstrate that MSI is associated with the GaHV-2 induced lymphoma in chicken.	[Yao, Da-Wei; Xu, Jia-Rong; Zhou, Zhen-Lei; Li, Shang-Tong; Yang, De-Ji] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Yang, DJ (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China.	yangdeji63@sohu.com			National Natural Science Foundation of China [3087847]; 948 Ministry of Agriculture Project [2011-z20]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 948 Ministry of Agriculture Project; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by a grant from the National Natural Science Foundation of China (3087847), the 948 Ministry of Agriculture Project (2011-z20) and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajithdoss DK, 2009, VIRUS RES, V142, P57, DOI 10.1016/j.virusres.2009.01.008; Arzimanoglou II, 1998, CANCER-AM CANCER SOC, V82, P1808, DOI 10.1002/(SICI)1097-0142(19980515)82:10<1808::AID-CNCR2>3.0.CO;2-J; Boland CR, 1998, CANCER RES, V58, P5248; Chang MS, 2000, PATHOL INT, V50, P486, DOI 10.1046/j.1440-1827.2000.01072.x; Chang MS, 2003, J PATHOL, V199, P447, DOI 10.1002/path.1302; Cheng HH, 2008, STADLER GEN, P115, DOI 10.1007/978-0-387-76723-9_9; Damania B, 2004, NAT REV MICROBIOL, V2, P656, DOI 10.1038/nrmicro958; Deng XF, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-348; FISHEL R, 1995, CURR OPIN GENET DEV, V5, P382, DOI 10.1016/0959-437X(95)80055-7; Hag K, 2010, VET IMMUNOL IMMUNOP, V138, P292, DOI 10.1016/j.vetimm.2010.10.007; Hoffmann JS, 1998, INT J ONCOL, V12, P377; Honma M, 2000, MOL CARCINOGEN, V28, P203, DOI 10.1002/1098-2744(200008)28:4<203::AID-MC3>3.0.CO;2-1; Imai K, 2008, CARCINOGENESIS, V29, P673, DOI 10.1093/carcin/bgm228; Kaiser HE, 2008, SELECTED ASPECTS CAN, P169; Keohavong P, 2005, MICROSATELLITE INSTA, P293; Leung SY, 1999, BRIT J CANCER, V79, P582, DOI 10.1038/sj.bjc.6690092; Lu ZJ, 2010, VIRUS RES, V153, P250, DOI 10.1016/j.virusres.2010.08.010; Lupiani B, 2004, P NATL ACAD SCI USA, V101, P11815, DOI 10.1073/pnas.0404508101; Miturski R, 2002, EXP BIOL MED, V227, P579, DOI 10.1177/153537020222700805; Osterrieder N, 2006, NAT REV MICROBIOL, V4, P283, DOI 10.1038/nrmicro1382; Pagano JS, 2004, SEMIN CANCER BIOL, V14, P453, DOI 10.1016/j.semcancer.2004.06.009; Sanchez-Cespedes M, 1998, ANN ONCOL, V9, P113, DOI 10.1023/A:1008230331221; SANGUINETTI CJ, 1994, BIOTECHNIQUES, V17, P914; [尚月丽 SHANG Yue-li], 2009, [南京农业大学学报, Journal of Nanjing Agricultural University], V32, P115; Utting M, 2002, CLIN CANCER RES, V8, P35; Wu MS, 2000, GASTROENTEROLOGY, V118, P1031, DOI 10.1016/S0016-5085(00)70355-6; YEE CJ, 1994, CANCER RES, V54, P1641; Yoon BS, 2008, YONSEI MED J, V49, P272, DOI 10.3349/ymj.2008.49.2.272	28	1	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68058	10.1371/journal.pone.0068058	http://dx.doi.org/10.1371/journal.pone.0068058			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844155	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000135
J	Fan, NW; Hwang, DK; Ko, YC; Tseng, FC; Hung, KH; Liu, CJL				Fan, Nai-Wen; Hwang, De-Kuang; Ko, Yu-Chieh; Tseng, Fan-Chen; Hung, Kuo-Hsuan; Liu, Catherine Jui-Ling			Risk Factors for Progressive Visual Field Loss in Primary Angle-Closure Glaucoma: A Retrospective Cohort Study	PLOS ONE			English	Article							LONG-TERM PROGRESSION; INTRAOCULAR-PRESSURE; CHINESE PATIENTS; THICKNESS; BLINDNESS; DEFECTS	Purpose: To investigate risk factors associated with progressive visual field (VF) loss in primary angle closure glaucoma (PACG). Methods: We retrospectively reviewed medical record of PACG patients who had >= 5 reliable VF examinations (central 24-2 threshold test, Humphrey Field Analyzer) and >= 2 years of follow-up. Each VF was scored using Collaborative Initial Glaucoma Treatment Study system. Progression was defined if 3 consecutive follow-up VF tests had an increased score of >= 3 above the mean of the first 2 VF scores. Factors associated with VF progression were evaluated by Cox proportional hazards models. Results: A total of 89 eyes from 89 patients (mean age, 69.8 +/- 7.9 years), who received a mean of 6.9 +/- 2.3 VF tests (mean deviation at initial, -8.1 +/- 4.4 dB) with a mean follow-up of 63.9 +/- 23.9 months were included. VF progression was detected in 9 eyes (10%). The axial length (AL), anterior chamber depth, and intraocular pressure (IOP) in patients with and without progression were 22.5 +/- 0.6 and 23.1 +/- 0.9 mm, 2.5 +/- 0.3 and 2.5 +/- 0.3 mm, 14.8 +/- 2.4 and 14.3 +/- 2.3 mm Hg, respectively. AL was the only factor associated with progression in both Cox proportional hazards univariate (p = 0.031) and multivariate models (p = 0.023). Conclusion: When taking into account age, IOP, follow-up period, and number of VF tests, a shorter AL is the only factor associated with VF progression in this cohort of Chinese patients with PACG. Further studies are warranted to verify the role of AL in progressive VF loss in PACG.	[Fan, Nai-Wen; Ko, Yu-Chieh; Liu, Catherine Jui-Ling] Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan; [Fan, Nai-Wen; Ko, Yu-Chieh; Hung, Kuo-Hsuan] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Hwang, De-Kuang] Taoyuan Vet Hosp, Dept Ophthalmol, Tao Yuan, Taiwan; [Hwang, De-Kuang] Natl Yang Ming Univ, Dept Publ Hlth, Taipei 112, Taiwan; [Hwang, De-Kuang] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Ko, Yu-Chieh; Liu, Catherine Jui-Ling] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Tseng, Fan-Chen] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Tainan, Taiwan; [Tseng, Fan-Chen] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Hung, Kuo-Hsuan] Natl Yang Ming Univ Hosp, Dept Ophthalmol, Yilan, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan; University of North Carolina; University of North Carolina Chapel Hill	Liu, CJL (corresponding author), Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan.	jlliu@vghtpe.gov.tw	Tseng, Fan-Chen/D-2097-2010; Fan, Nai-Wen/ACB-0737-2022; Hwang, DK De-Kuang/J-3931-2016	Hwang, DK De-Kuang/0000-0001-6346-8485	Taipei Veterans General Hospital, Taipei, Taiwan [VGH 101A-022]	Taipei Veterans General Hospital, Taipei, Taiwan(Taipei Veterans General Hospital)	This research was supported by grants VGH 101A-022 from Taipei Veterans General Hospital, Taipei, Taiwan (http://www.vghtpe.gov.tw/doce/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alward WL, 1998, AM J OPHTHALMOL, V126, P498; Arora KS, 2012, INVEST OPHTH VIS SCI, V53, P6393, DOI 10.1167/iovs.12-10224; Aung T, 2005, ARCH OPHTHALMOL-CHIC, V123, P527, DOI 10.1001/archopht.123.4.527; Blackwell B, 2002, AM J OPHTHALMOL, V134, P499; Cook C, 2012, CAN J OPHTHALMOL, V47, P223, DOI 10.1016/j.jcjo.2012.02.003; Drance S, 2001, AM J OPHTHALMOL, V131, P699, DOI 10.1016/S0002-9394(01)00964-3; Foster PJ, 2004, BRIT J OPHTHALMOL, V88, P486, DOI 10.1136/bjo.2003.020016; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Heijl A, 2008, OPHTHALMOLOGY, V115, P1557, DOI 10.1016/j.ophtha.2008.02.005; Hong S, 2007, ARCH OPHTHALMOL-CHIC, V125, P1010, DOI 10.1001/archopht.125.8.1010; Hong S, 2007, AM J OPHTHALMOL, V143, P362, DOI 10.1016/j.ajo.2006.09.038; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Leske M Cristina, 2004, Curr Opin Ophthalmol, V15, P102; Lichter PR, 2001, OPHTHALMOLOGY, V108, P1943, DOI 10.1016/S0161-6420(01)00873-9; Loewen NA, 2010, INVEST OPHTH VIS SCI, V51, P933, DOI 10.1167/iovs.09-4218; Mansouri K, 2011, BRIT J OPHTHALMOL, V95, P627, DOI 10.1136/bjo.2010.192922; Maul EA, 2011, OPHTHALMOLOGY, V118, P1571, DOI 10.1016/j.ophtha.2011.01.016; Musch DC, 1999, OPHTHALMOLOGY, V106, P653, DOI 10.1016/S0161-6420(99)90147-1; Nolan WP, 2006, AM J OPHTHALMOL, V141, P896, DOI 10.1016/j.ajo.2005.12.008; Nouri-Mahdavi K, 2004, OPHTHALMOLOGY, V111, P1627, DOI 10.1016/j.ophtha.2004.02.017; Quek DTL, 2011, AM J OPHTHALMOL, V152, P463, DOI 10.1016/j.ajo.2011.02.023; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Rao A, 2012, AM J OPHTHALMOL, V153, P382, DOI 10.1016/j.ajo.2011.11.013; Roy A, 2012, OPHTHALMOLOGY, V119, P1937, DOI 10.1016/j.ophtha.2012.06.006; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Wang NL, 2002, CHINESE MED J-PEKING, V115, P1706	27	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e69772	10.1371/journal.pone.0069772	http://dx.doi.org/10.1371/journal.pone.0069772			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861982	gold, Green Published, Green Submitted			2022-12-27	WOS:000321692000051
J	Miller, CW; Fletcher, RJ; Gillespie, SR				Miller, Christine W.; Fletcher, Robert J., Jr.; Gillespie, Stephanie R.			Conspecific and Heterospecific Cues Override Resource Quality to Influence Offspring Production	PLOS ONE			English	Article							SOCIAL INFORMATION USE; PUBLIC INFORMATION; HABITAT SELECTION; ATTRACTION HYPOTHESIS; COMMUNITY STRUCTURE; RESIDENT BIRDS; MIGRANT; EVOLUTION; PREDATION; CONFLICT	Animals live in an uncertain world. To reduce uncertainty, animals use cues that can encode diverse information regarding habitat quality, including both non-social and social cues. While it is increasingly appreciated that the sources of potential information are vast, our understanding of how individuals integrate different types of cues to guide decision-making remains limited. We experimentally manipulated both resource quality (presence/absence of cactus fruit) and social cues (conspecific juveniles, heterospecific juveniles, no juveniles) for a cactus-feeding insect, Narnia femorata (Hemiptera: Coreidae), to ask how individuals responded to resource quality in the presence or absence of social cues. Cactus with fruit is a high-quality environment for juvenile development, and indeed we found that females laid 56% more eggs when cactus fruit was present versus when it was absent. However, when conspecific or heterospecific juveniles were present, the effects of resource quality on egg numbers vanished. Overall, N. femorata laid approximately twice as many eggs in the presence of heterospecifics than alone or in the presence of conspecifics. Our results suggest that the presence of both conspecific and heterospecific social cues can disrupt responses of individuals to environmental gradients in resource quality.	[Miller, Christine W.; Gillespie, Stephanie R.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA; [Fletcher, Robert J., Jr.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Miller, CW (corresponding author), Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA.	cwmiller@ufl.edu	Miller, Christine W./A-2001-2013	Miller, Christine W./0000-0003-1359-5624; Fletcher, Robert/0000-0003-1717-5707	NSF [IOS-0926855]	NSF(National Science Foundation (NSF))	This work was supported by NSF Grant IOS-0926855 to CWM. http://nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SAS MIXED MODELS; Beauchamp G, 1997, J ANIM ECOL, V66, P671, DOI 10.2307/5920; Betts MG, 2008, P ROY SOC B-BIOL SCI, V275, P2257, DOI 10.1098/rspb.2008.0217; Betts MG, 2010, CONDOR, V112, P265, DOI 10.1525/cond.2010.090244; Campobello D, 2011, BEHAV ECOL, V22, P422, DOI 10.1093/beheco/arq225; Chittka L, 2005, CURR BIOL, V15, pR869, DOI 10.1016/j.cub.2005.10.018; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Dawson EH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031444; Doligez B, 2003, ANIM BEHAV, V66, P973, DOI 10.1006/anbe.2002.2270; Dugatkin LA, 2005, ETHOL ECOL EVOL, V17, P327; Fletcher RJ, 2008, BIOL LETTERS, V4, P482, DOI 10.1098/rsbl.2008.0306; Fletcher RJ, 2008, ECOL APPL, V18, P1764, DOI 10.1890/07-1850.1; Fletcher RJ, 2007, J ANIM ECOL, V76, P598, DOI 10.1111/j.1365-2656.2007.01230.x; Fletcher RJ, 2006, AM NAT, V168, P207, DOI 10.1086/505764; Fletcher RJ, 2009, OIKOS, V118, P1139, DOI 10.1111/j.1600-0706.2009.17342.x; Forsman JT, 2002, P ROY SOC B-BIOL SCI, V269, P1619, DOI 10.1098/rspb.2002.2065; Forsman JT, 2007, BEHAV ECOL, V18, P888, DOI 10.1093/beheco/arm048; Giraldeau LA, 2002, PHILOS T R SOC B, V357, P1559, DOI 10.1098/rstb.2002.1065; Goodale E, 2012, ANIM BEHAV, V84, P919, DOI 10.1016/j.anbehav.2012.07.016; Goodale E, 2010, TRENDS ECOL EVOL, V25, P354, DOI 10.1016/j.tree.2010.01.002; Huang P, 2012, BEHAV ECOL, V23, P463, DOI 10.1093/beheco/arr212; Kendal RL, 2004, BEHAV ECOL, V15, P269, DOI 10.1093/beheco/arh008; Leadbeater E, 2007, CURR BIOL, V17, pR703, DOI 10.1016/j.cub.2007.06.012; McLennan DA, 2008, ANIM BEHAV, V75, P1731, DOI 10.1016/j.anbehav.2007.10.030; Mery F, 2009, CURR BIOL, V19, P730, DOI 10.1016/j.cub.2009.02.064; Miller CW, 2012, ANIM BEHAV, V83, P473, DOI 10.1016/j.anbehav.2011.11.022; Monkkonen M, 1999, EVOL ECOL, V13, P91; MONKKONEN M, 1990, OECOLOGIA, V85, P218, DOI 10.1007/BF00319404; Nageon-De Lestang F, 2009, FLA ENTOMOL, V92, P511, DOI 10.1653/024.092.0317; Nordell SE, 1998, ECOL LETT, V1, P74; Parejo D, 2005, BEHAV ECOL, V16, P96, DOI 10.1093/beheco/arh136; Pasqualone AA, 2011, ANIM BEHAV, V82, P281, DOI 10.1016/j.anbehav.2011.05.002; Pupin F, 2007, ANIM BEHAV, V74, P1683, DOI 10.1016/j.anbehav.2007.03.020; Rendell L, 2010, SCIENCE, V328, P208, DOI 10.1126/science.1184719; Rieucau G, 2011, PHILOS T R SOC B, V366, P949, DOI 10.1098/rstb.2010.0325; Seppanen JT, 2007, ECOLOGY, V88, P1622, DOI 10.1890/06-1757.1; TEMPLETON JJ, 1995, BEHAV ECOL, V6, P65, DOI 10.1093/beheco/6.1.65; Thomson RL, 2003, OECOLOGIA, V134, P431, DOI 10.1007/s00442-002-1140-0; van Bergen Y, 2004, P ROY SOC B-BIOL SCI, V271, P957, DOI 10.1098/rspb.2004.2684; Wagner RH, 2010, OIKOS, V119, P203, DOI 10.1111/j.1600-0706.2009.17315.x; Zeigler SL, 2011, BIODIVERS CONSERV, V20, P2779, DOI 10.1007/s10531-011-0107-z	41	11	11	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e70268	10.1371/journal.pone.0070268	http://dx.doi.org/10.1371/journal.pone.0070268			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861984	gold, Green Submitted, Green Published			2022-12-27	WOS:000321692000052
J	Mandava, P; Krumpelman, CS; Shah, JN; White, DL; Kent, TA				Mandava, Pitchaiah; Krumpelman, Chase S.; Shah, Jharna N.; White, Donna L.; Kent, Thomas A.			Quantification of Errors in Ordinal Outcome Scales Using Shannon Entropy: Effect on Sample Size Calculations	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; MODIFIED RANKIN SCALE; CEREBRAL-ARTERY INFARCTION; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; ENDOVASCULAR TREATMENT; STATISTICAL-ANALYSIS; RANDOMIZED-TRIAL; CLINICAL-TRIALS; LASER THERAPY	Objective: Clinical trial outcomes often involve an ordinal scale of subjective functional assessments but the optimal way to quantify results is not clear. In stroke, the most commonly used scale, the modified Rankin Score (mRS), a range of scores ("Shift") is proposed as superior to dichotomization because of greater information transfer. The influence of known uncertainties in mRS assessment has not been quantified. We hypothesized that errors caused by uncertainties could be quantified by applying information theory. Using Shannon's model, we quantified errors of the "Shift" compared to dichotomized outcomes using published distributions of mRS uncertainties and applied this model to clinical trials. Methods: We identified 35 randomized stroke trials that met inclusion criteria. Each trial's mRS distribution was multiplied with the noise distribution from published mRS inter-rater variability to generate an error percentage for "shift" and dichotomized cut-points. For the SAINT I neuroprotectant trial, considered positive by "shift" mRS while the larger follow-up SAINT II trial was negative, we recalculated sample size required if classification uncertainty was taken into account. Results: Considering the full mRS range, error rate was 26.1%+/- 5.31 (Mean +/- SD). Error rates were lower for all dichotomizations tested using cut-points (e.g. mRS 1; 6.8%+/- 2.89; overall p<0.001). Taking errors into account, SAINT I would have required 24% more subjects than were randomized. Conclusion: We show when uncertainty in assessments is considered, the lowest error rates are with dichotomization. While using the full range of mRS is conceptually appealing, a gain of information is counter-balanced by a decrease in reliability. The resultant errors need to be considered since sample size may otherwise be underestimated. In principle, we have outlined an approach to error estimation for any condition in which there are uncertainties in outcome assessment. We provide the user with programs to calculate and incorporate errors into sample size estimation.	[Mandava, Pitchaiah; Kent, Thomas A.] Michael E DeBakey Vet Affairs Med Ctr Comprehens, Houston, TX USA; [White, Donna L.] Houston Vet Affairs Hlth Serv Res Ctr Excellence, Clin Epidemiol & Comparat Effectiveness Program, Houston, TX USA; [Mandava, Pitchaiah; Krumpelman, Chase S.; Shah, Jharna N.; Kent, Thomas A.] Baylor Coll Med, Dept Neurol, Stroke Outcomes Lab, Houston, TX 77030 USA	Baylor College of Medicine	Mandava, P (corresponding author), Michael E DeBakey Vet Affairs Med Ctr Comprehens, Houston, TX USA.	pmandava@bcm.tmc.edu	White, Donna/AAZ-9349-2021; Mandava, Pitchaiah/B-6046-2013	White, Donna/0000-0003-0297-2949; Mandava, Pitchaiah/0000-0003-4957-4518; Kent, Thomas/0000-0002-9877-7584	Baylor College of Medicine Institutional Clinical and Translational Research Grant Program; Department of Veterans Affairs [VISN 16 PRG]; Institute for Clinical and Translational Research at the Baylor College of Medicine; National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases [K01 DK078154-05]; Houston VA HSR&D Center of Excellence [HFP90-020]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK078154, R03DK095082] Funding Source: NIH RePORTER	Baylor College of Medicine Institutional Clinical and Translational Research Grant Program; Department of Veterans Affairs(US Department of Veterans Affairs); Institute for Clinical and Translational Research at the Baylor College of Medicine; National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Houston VA HSR&D Center of Excellence; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded in part by the Baylor College of Medicine Institutional Clinical and Translational Research Grant Program (TAK) and Department of Veterans Affairs (VISN 16 PRG; PM). The Stroke Outcomes Laboratory was established through a grant from the pilot grant program of the Institute for Clinical and Translational Research at the Baylor College of Medicine to TAK. Dr. White's effort was supported in part by National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (K01 DK078154-05) and the Houston VA HSR&D Center of Excellence (HFP90-020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 2008, STROKE, V39, P87, DOI 10.1161/STROKEAHA.106.476648; Adams HP, 2005, STROKE, V36, P880, DOI 10.1161/01.STR.0000157668.39374.56; Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; [Anonymous], 2001, POINTS CONS CLIN INV; [Anonymous], STAT TOOLB US MAN; Babikian V, 2000, STROKE, V31, P358; Bath PMW, 2012, STROKE, V43, P1171, DOI 10.1161/STROKEAHA.111.641456; Broderick JP, 2013, NEW ENGL J MED, V368, P893, DOI 10.1056/NEJMoa1214300; Bruno A, 2010, STROKE, V41, P1048, DOI 10.1161/STROKEAHA.109.571562; Camerlingo M, 2005, STROKE, V36, P2415, DOI 10.1161/01.STR.0000185730.50480.e7; CAMPBELL MJ, 1995, BRIT MED J, V311, P1145, DOI 10.1136/bmj.311.7013.1145; Ciccone A, 2010, J NEUROINTERV SURG, V2, P74, DOI 10.1136/jnis.2009.001388; Ciccone A, 2013, NEW ENGL J MED, V368, P904, DOI 10.1056/NEJMoa1213701; Cobo E, 2010, STROKE, V41, pE143, DOI 10.1161/STROKEAHA.109.567404; COVER TM, 1991, ELEM INF THEORY, P00001, DOI DOI 10.3390/E7040253; Davalos A, 2012, LANCET, V380, P349, DOI 10.1016/S0140-6736(12)60813-7; Davis SM, 2008, LANCET NEUROL, V7, P299, DOI 10.1016/S1474-4422(08)70044-9; Diener HC, 2008, STROKE, V39, P1774, DOI 10.1161/STROKEAHA.107.506378; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Erdogmus D, 2010, INFORM SCI STAT, P219, DOI 10.1007/978-1-4419-1570-2_6; Franke CL, 1996, ACTA NEUROL SCAND, V93, P56; Furlan A, 1999, JAMA-J AM MED ASSOC, V282, P2003, DOI 10.1001/jama.282.21.2003; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Haley EC, 2010, STROKE, V41, P707, DOI 10.1161/STROKEAHA.109.572040; Hall CE, 2012, NEUROCRIT CARE, V16, P6, DOI 10.1007/s12028-011-9608-6; Heiss WD, 2012, STROKE, V43, P630, DOI 10.1161/STROKEAHA.111.628537; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Howard G, 2012, STROKE, V43, P664, DOI 10.1161/STROKEAHA.111.632935; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kidwell CS, 2013, NEW ENGL J MED, V368, P914, DOI 10.1056/NEJMoa1212793; Koziol JA, 2006, STROKE, V37, P2644, DOI 10.1161/01.STR.0000241106.81293.2b; Lai SM, 2001, NEUROEPIDEMIOLOGY, V20, P26, DOI 10.1159/000054754; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Lang W, 2013, INT J STROKE, V8, P95, DOI 10.1111/j.1747-4949.2012.00901.x; Lee YS, 2011, CEREBROVASC DIS, V32, P65, DOI 10.1159/000327036; Lees KR, 2013, STROKE, V44, P580, DOI 10.1161/STROKEAHA.111.000013; Lees KR, 2006, NEW ENGL J MED, V354, P588, DOI 10.1056/NEJMoa052980; MAAS AIR, 1983, J NEUROSURG, V58, P321, DOI 10.3171/jns.1983.58.3.0321; Mandava P, 2012, SPR SER TRANSL STROK, P833, DOI 10.1007/978-1-4419-9530-8_40; Mandava P, 2010, STROKE, V41, P765, DOI 10.1161/STROKEAHA.109.574103; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; MOTE VL, 1965, BIOMETRIKA, V52, P95, DOI 10.1093/biomet/52.1-2.95; Norman G, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5278; Ogawa A, 2007, STROKE, V38, P2633, DOI 10.1161/STROKEAHA.107.488551; Outcomes Working Group, 2007, STROKE, V38, P1911; Quinn TJ, 2009, INT J STROKE, V4, P200, DOI 10.1111/j.1747-4949.2009.00271.x; Quinn TJ, 2008, STROKE, V39, P2975, DOI 10.1161/STROKEAHA.108.515262; Quinn TJ, 2010, STROKE, V41, pE602, DOI 10.1161/STROKEAHA.110.590547; Quinn TJ, 2009, STROKE, V40, P762, DOI [10.1161/STROKEAHA.108.522516, 10.1161/STROKEAHA.109.557256]; Rosso C, 2012, STROKE, V43, P2343, DOI 10.1161/STROKEAHA.112.657122; Sandercock P, 2012, LANCET, V379, P2352, DOI 10.1016/S0140-6736(12)60768-5; Saver JL, 2007, STROKE, V38, P3055, DOI 10.1161/STROKEAHA.107.488536; Saver JL, 2011, STROKE, V42, P2356, DOI 10.1161/STROKEAHA.111.619122; Saver JL, 2010, STROKE, V41, P992, DOI 10.1161/STROKEAHA.109.571364; Saver JL, 2009, NEUROLOGY, V72, P1310, DOI 10.1212/01.wnl.0000341308.73506.b7; Savitz SI, 2007, STROKE, V38, P3205, DOI 10.1161/STROKEAHA.107.489351; Shannon Claude E., 1949, MATH THEORY COMMUNIC, P4; Sherman DG, 2001, NEUROLOGY, V57, P1428, DOI 10.1212/wnl.57.8.1428; Shinohara Y, 2009, CEREBROVASC DIS, V27, P485, DOI 10.1159/000210190; Shuaib A, 2007, NEW ENGL J MED, V357, P562, DOI 10.1056/NEJMoa070240; Srivastava MVP, 2012, NEUROL INDIA, V60, P23, DOI 10.4103/0028-3886.93584; Tilley BC, 2012, STROKE, V43, P935, DOI 10.1161/STROKEAHA.111.644864; Tilley BC, 1996, STROKE, V27, P2136, DOI 10.1161/01.STR.27.11.2136; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; WHITEHEAD J, 1993, STAT MED, V12, P2257, DOI 10.1002/sim.4780122404; Wilson JTL, 2007, NEUROSURGERY, V61, P123, DOI 10.1227/01.neu.0000279732.21145.9e; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2005, STROKE, V36, P777, DOI 10.1161/01.STR.0000157596.13234.95; Wilson JTL, 2002, STROKE, V33, P2243, DOI 10.1161/01.STR.0000027437.22450.BD; Zinkstok SM, 2012, LANCET, V380, P731, DOI 10.1016/S0140-6736(12)60949-0; Zivin JA, 2009, STROKE, V40, P1359, DOI 10.1161/STROKEAHA.109.547547	73	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67754	10.1371/journal.pone.0067754	http://dx.doi.org/10.1371/journal.pone.0067754			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861800	gold, Green Published, Green Submitted			2022-12-27	WOS:000321425300027
J	Piksa, K; Nowak, J; Zmihorski, M; Bogdanowicz, W				Piksa, Krzysztof; Nowak, Jakub; Zmihorski, Michal; Bogdanowicz, Wieslaw			Nonlinear Distribution Pattern of Hibernating Bats in Caves along an Elevational Gradient in Mountain (Carpathians, Southern Poland)	PLOS ONE			English	Article							SPECIES RICHNESS; ALTITUDINAL DISTRIBUTION; GLOBAL ANALYSIS; DIVERSITY; TEMPERATURE; EXTENSION; RANGE; AREA	Background: Thermal gradients along changes in elevation in mountainous environments are reflected by different biotas. Although there have been studies of elevation variation in bat assemblages in summer, winter changes in the same gradients remain unknown. Methodology/Principal Findings: The objective of this study was to document changes in the species composition of bats hibernating in caves along a temperate elevational gradient. We studied 70 caves between from 300 m to 1,930 m altitude along a slope of the Carpathian Mountains in southern Poland. We recorded changes in bats, including species richness, abundance, altitudinal distribution and dominance during consecutive winters between 2003 and 2009. Similarity of dominance of faunal structure was assessed by using the Bray-Curtis similarity index. We used the generalised additive model and rarefaction to study the variation in species richness, and generalized additive mixed models to examine the effect of abiotic factors on the qualitative and quantitative structure of bat assemblages. During 351 surveys we recorded 13,856 hibernating bats from 15 species. Species richness peaked around mid-elevation (1,100-1,400 m a.s.l.) with richness declining at both higher and lower elevations. Based on the results of a cluster analysis, we could distinguish among four altitudinal zones that differed in species richness and dominance structure. Conclusions/Significance: This is the first study documenting changes in species richness and variation of structure of bats hibernating in caves along an elevational gradient. The most surprising and key finding is the fact that changes in the structure of assemblages of hibernating bats along the altitudinal gradient occurred in jumps, forming zones similar to those observed in the vegetation zones. Moreover, species richness and dominance structure of assemblages of hibernating bats in the mountains depended not only on location above sea level, but also on local geomorphologic conditions which strongly affected the microclimate of the caves.	[Piksa, Krzysztof] Cracow Pedag Univ, Inst Biol, Krakow, Poland; [Nowak, Jakub] Cracow Caving Club, Krakow, Poland; [Zmihorski, Michal; Bogdanowicz, Wieslaw] Polish Acad Sci, Museum & Inst Zool, PL-00679 Warsaw, Poland	Pedagogical University of Cracow; Polish Academy of Sciences; Museum & Institute of Zoology of the Polish Academy of Sciences	Piksa, K (corresponding author), Cracow Pedag Univ, Inst Biol, Krakow, Poland.	krzychu@up.krakow.pl		Bogdanowicz, Wieslaw/0000-0003-1196-2494; Piksa, Krzysztof/0000-0001-5057-895X; Zmihorski, Michal/0000-0001-5137-1635; , Michal/0000-0002-2951-3462	Pedagogical University of Cracow	Pedagogical University of Cracow	Funding was provided by the Pedagogical University of Cracow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARATAUD M, 2004, RHINOLOPHE, V17, P11; Barry R. G., 1981, MOUNTAIN WEATHER CLI; Bhatt JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046237; BOGDANOWICZ W, 1983, ACTA THERIOL, V28, P357, DOI 10.4098/AT.arch.83-31; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Chawla A, 2008, J MT SCI-ENGL, V5, P157, DOI 10.1007/s11629-008-0079-y; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR, 1994, CHANGE MARINE COMMUN; Colwell RK, 2009, ESTIMATES STAT ESTIM; Fleming TH, 2003, BAT ECOLOGY, P156; Forero-Medina G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028535; GAISLER J, 1970, Bijdragen tot de Dierkunde, V40, P33; Georgiakakis P, 2010, HYSTRIX, V21, P43; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; GRAHAM GL, 1983, J MAMMAL, V64, P559, DOI 10.2307/1380511; Grytnes J., 2007, ENCY BIODIVERSITY, P1, DOI [DOI 10.1038/NCLIMATE1347, DOI 10.1016/B978-012226865-6/00503-1]; Harmata W., 1969, Acta Theriologica, V14, P49; HEANEY LR, 1989, J TROP ECOL, V5, P259, DOI 10.1017/S0266467400003643; Horacek Ivan, 2000, P11; Hutterer R., 2005, NATURSCHUTZ BIOL VIE, V28, P1; JUSTE J, 1995, J TROP ECOL, V11, P141; Kanuch P, 2006, BIOLOGIA, V61, P605, DOI 10.2478/s11756-006-0097-6; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Kunz T.H., 1982, P1; Lavrenchenko Leonid A., 2004, Bonner Zoologische Beitraege, V52, P127; LEWIS SE, 1995, J MAMMAL, V76, P481, DOI 10.2307/1382357; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Lourenco S, 2008, PARASITOL RES, V104, P127, DOI 10.1007/s00436-008-1170-6; Lyman C.P., 1982, HIBERNATION TORPOR M; MacArthur R.H., 1972, pvii; Margielewski W, 2003, GEOMORPHOLOGY, V54, P325, DOI 10.1016/S0169-555X(02)00375-6; Maryanto I, 2011, HYSTRIX, V22, P167, DOI 10.4404/Hystrix-22.1-4480; Mateo RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032586; MCCAIN C. M., 2010, ENCY LIFE SCI, DOI [DOI 10.1002/9780470015902.A0022548, 10.1002/9780470015902.a0022548]; McCain CM, 2007, GLOBAL ECOL BIOGEOGR, V16, P1, DOI 10.1111/j.1466-8238.2006.00263.x; McCain CM, 2007, ECOLOGY, V88, P76, DOI 10.1890/0012-9658(2007)88[76:AAMED]2.0.CO;2; McCain CM, 2010, GLOBAL ECOL BIOGEOGR, V19, P541, DOI 10.1111/j.1466-8238.2010.00528.x; McCain CM, 2009, GLOBAL ECOL BIOGEOGR, V18, P346, DOI 10.1111/j.1466-8238.2008.00443.x; Nagel A., 1991, Myotis, V29, P109; Niermann N, 2007, ACTA CHIROPTEROL, V9, P361; OWEN JG, 1990, J MAMMAL, V71, P1, DOI 10.2307/1381311; Patterson BD, 1996, J ZOOL, V240, P637, DOI 10.1111/j.1469-7998.1996.tb05313.x; Perry RW, 2012, ENVIRON REV, V21, P28, DOI DOI 10.1139/ER-2012-0042; Pierson E. D., 2001, SEASONAL PATTERNS BA; Piksa K, 2008, ACTA CHIROPTEROL, V10, P69, DOI 10.3161/150811008X331108; Piksa K, 2011, ACTA CHIROPTEROL, V13, P113, DOI 10.3161/150811011X578660; Price LW, 1981, MOUNTAINS MAN; Pulina M, 1974, KLIMA TATIER, P702; R Core Team, 2012, R LANG ENV STAT COMP; Rachmatulina I.K., 1989, P409; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rehak Zdenek, 2006, Lynx (Prague), V37, P201; Sachanowicz Konrad, 2006, Vespertilio, V9-10, P151; Sachanowicz K, 2006, ACTA CHIROPTEROL, V8, P543, DOI 10.3161/1733-5329(2006)8[543:FREOPK]2.0.CO;2; Sachanowicz Konrad, 2012, Acta Zoologica Cracoviensia, V55, P97, DOI 10.3409/azc.55_1.97; Sanchez-Cordero V, 2001, GLOBAL ECOL BIOGEOGR, V10, P63, DOI 10.1046/j.1466-822x.2001.00235.x; Schwilk DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031173; Siarzewski W, 1994, JASKINIE TATRZANSKIE, V5, P11; Siivonen Y, 2008, MAMMALIA, V72, P50, DOI 10.1515/MAMM.2008.003; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; Storz JF, 1996, SOUTHWEST NAT, V41, P322; Szewczak JM, 1998, GREAT BASIN NAT, V58, P66; Tuttle MD, 1977, NAT CAV MAN S P ALB, P108; Vetaas OR, 2002, GLOBAL ECOL BIOGEOGR, V11, P291, DOI 10.1046/j.1466-822X.2002.00297.x; Wang JJ, 2012, GLOBAL ECOL BIOGEOGR, V21, P743, DOI 10.1111/j.1466-8238.2011.00718.x; Warszynska J, 1995, POLISH CARPATHIANS N; Webb PI, 1996, CAN J ZOOL, V74, P761, DOI 10.1139/z96-087; Wigley T, 1976, SCI SPELEOLOGY, V3, P329; Wilkinson GS, 2002, AGING CELL, V1, P124, DOI 10.1046/j.1474-9728.2002.00020.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Woodward F.I., 1987, CLIMATE PLANT DISTRI	71	17	17	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68066	10.1371/journal.pone.0068066	http://dx.doi.org/10.1371/journal.pone.0068066			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861850	gold, Green Submitted, Green Published			2022-12-27	WOS:000321425300039
J	Schiffels, J; Pinkenburg, O; Schelden, M; Aboulnaga, EHAA; Baumann, MEM; Selmer, T				Schiffels, Johannes; Pinkenburg, Olaf; Schelden, Maximilian; Aboulnaga, El-Hussiny A. A.; Baumann, Marcus E. M.; Selmer, Thorsten			An Innovative Cloning Platform Enables Large-Scale Production and Maturation of an Oxygen-Tolerant [NiFe]-Hydrogenase from Cupriavidus necator in Escherichia coli	PLOS ONE			English	Article							RALSTONIA-EUTROPHA H16; OXIDOREDUCTASE COMPLEX I; NAD-REDUCING HYDROGENASE; ALCALIGENES-EUTROPHUS; ACTIVE-SITE; HETEROLOGOUS EXPRESSION; NUCLEOTIDE-SEQUENCE; NICKEL TRANSPORT; NIFE HYDROGENASE; PROTEIN	Expression of multiple heterologous genes in a dedicated host is a prerequisite for approaches in synthetic biology, spanning from the production of recombinant multiprotein complexes to the transfer of tailor-made metabolic pathways. Such attempts are often exacerbated, due in most cases to a lack of proper directional, robust and readily accessible genetic tools. Here, we introduce an innovative system for cloning and expression of multiple genes in Escherichia coli BL21 (DE3). Using the novel methodology, genes are equipped with individual promoters and terminators and subsequently assembled. The resulting multiple gene cassettes may either be placed in one vector or alternatively distributed among a set of compatible plasmids. We demonstrate the effectiveness of the developed tool by production and maturation of the NAD+ reducing soluble [NiFe]-hydrogenase (SH) from Cupriavidus necator H16 (formerly Ralstonia eutropha H16) in E. coli BL21Star (TM) (DE3). The SH (encoded in hoxFUYHI) was successfully matured by co-expression of a dedicated set of auxiliary genes, comprising seven hyp genes (hypC1D1E1A2B2F2X) along with hoxW, which encodes a specific endopeptidase. Deletion of genes involved in SH maturation reduced maturation efficiency substantially. Further addition of hoxN1, encoding a high-affinity nickel permease from C. necator, considerably increased maturation efficiency in E. coli. Carefully balanced growth conditions enabled hydrogenase production at high cell-densities, scoring mg.(Liter culture)(-1) yields of purified functional SH. Specific activities of up to 7.2 +/- 1.15 U.mg(-1) were obtained in cell-free extracts, which is in the range of the highest activities ever determined in C. necator extracts. The recombinant enzyme was isolated in equal purity and stability as previously achieved with the native form, yielding ultrapure preparations with anaerobic specific activities of up to 230 U.mg(-1). Owing to the combinatorial power exhibited by the presented cloning platform, the system might represent an important step towards new routes in synthetic biology.	[Schiffels, Johannes; Schelden, Maximilian; Aboulnaga, El-Hussiny A. A.; Baumann, Marcus E. M.; Selmer, Thorsten] Aachen Univ Appl Sci, Dept Chem & Biotechnol, Julich, Germany; [Pinkenburg, Olaf] Univ Marburg, Inst Immunol, Biomed Res Ctr BMFZ, D-35032 Marburg, Lahn, Germany	Philipps University Marburg	Selmer, T (corresponding author), Aachen Univ Appl Sci, Dept Chem & Biotechnol, Julich, Germany.	selmer@fh-aachen.de		Schiffels, Johannes/0000-0001-9674-9339	Federal Ministry of Education and Research (BMBF) [1780 x09]; University of Applied Sciences	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); University of Applied Sciences	This work was supported by the Federal Ministry of Education and Research (BMBF) within the funding program FHProfUnt (grant no. 1780 x09), and by internal research funds of the University of Applied Sciences to JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albracht SPJ, 2006, J BIOL INORG CHEM, V11, P88, DOI 10.1007/s00775-005-0039-8; Andersson M, 1998, BIOTECHNOL BIOENG, V57, P79, DOI 10.1002/(SICI)1097-0290(19980105)57:1<79::AID-BIT10>3.0.CO;2-3; Bleijlevens B, 2004, J BIOL CHEM, V279, P46686, DOI 10.1074/jbc.M406942200; Blokesch M, 2004, EUR J BIOCHEM, V271, P3428, DOI 10.1111/j.1432-1033.2004.04280.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braun M, 1998, BIOCHEMISTRY-US, V37, P1861, DOI 10.1021/bi971176p; Buhrke T, 2005, J BIOL CHEM, V280, P23791, DOI 10.1074/jbc.M503260200; Buhrke T, 1998, ARCH MICROBIOL, V170, P460, DOI 10.1007/s002030050667; Burgdorf T, 2005, J MOL MICROB BIOTECH, V10, P181, DOI 10.1159/000091564; Burgdorf T, 2005, J BACTERIOL, V187, P3122, DOI 10.1128/JB.187.9.3122-3132.2005; Burstel I, 2012, J BIOL CHEM; Cammack R., 2001, HYDROGEN FUEL LEARNI; Dernedde J, 1996, EUR J BIOCHEM, V235, P351, DOI 10.1111/j.1432-1033.1996.00351.x; DERNEDDE J, 1993, ARCH MICROBIOL, V159, P545, DOI 10.1007/BF00249034; Drapal N, 1998, BIOCHEMISTRY-US, V37, P2941, DOI 10.1021/bi9720078; Durmowicz MC, 1997, J BACTERIOL, V179, P3676, DOI 10.1128/jb.179.11.3676-3682.1997; EBERZ G, 1989, J BACTERIOL, V171, P1340, DOI 10.1128/jb.171.3.1340-1345.1989; EITINGER T, 1991, J BIOL CHEM, V266, P3222; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; English CM, 2009, DALTON T, P9970, DOI 10.1039/b913426n; Forzi L, 2007, BIOMETALS, V20, P565, DOI 10.1007/s10534-006-9048-5; FRIEDRICH B, 1981, J BACTERIOL, V145, P1144, DOI 10.1128/JB.145.3.1144-1149.1981; Friedrich B, 2011, CURR OPIN BIOTECHNOL; FRIEDRICH CG, 1982, J BACTERIOL, V149, P203, DOI 10.1128/JB.149.1.203-210.1982; FRIEDRICH CG, 1981, J GEN MICROBIOL, V122, P69; Fritsch J, 2011, NATURE, V479, P249, DOI 10.1038/nature10505; Goldet G, 2009, J AM CHEM SOC, V131, P14979, DOI [10.1021/ja905388j, 10.1021/ja905388i]; Happe RP, 2000, FEBS LETT, V466, P259, DOI 10.1016/S0014-5793(99)01799-8; Horch M, 2010, ANGEW CHEM INT EDIT, V49, P8026, DOI 10.1002/anie.201002197; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Inui M, 2008, APPL MICROBIOL BIOT, V77, P1305, DOI 10.1007/s00253-007-1257-5; Kim JYH, 2011, J BIOTECHNOL, V155, P312, DOI 10.1016/j.jbiotec.2011.07.007; Kim KJ, 2004, PROTEIN SCI, V13, P1698, DOI 10.1110/ps.04644504; Kohlstadt M, 2008, BIOCHEMISTRY-US, V47, P13036, DOI 10.1021/bi801307n; Korpimaki T, 2003, J MICROBIOL METH, V53, P37, DOI 10.1016/S0167-7012(02)00213-0; Krassen H, 2009, ACS NANO, V3, P4055, DOI 10.1021/nn900748j; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lauterbach L, 2013, FEBS J; Lauterbach L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025939; Lauterbach L, 2011, EUR J INORG CHEM, P1067, DOI 10.1002/ejic.201001053; Lenz O, 2007, FEBS LETT, V581, P3322, DOI 10.1016/j.febslet.2007.06.027; Lubner CE, 2010, BIOCHEMISTRY-US, V49, P10264, DOI 10.1021/bi1016167; Magalon A, 2000, J BIOL CHEM, V275, P21114, DOI 10.1074/jbc.M000987200; Magalon A, 2001, FEBS LETT, V499, P73, DOI 10.1016/S0014-5793(01)02525-X; MAIER T, 1993, J BACTERIOL, V175, P630, DOI 10.1128/JB.175.3.630-635.1993; MAIER T, 1995, EUR J BIOCHEM, V230, P133, DOI 10.1111/j.1432-1033.1995.tb20543.x; MCKENNA CE, 1991, BIOCHIM BIOPHYS ACTA, V1075, P109, DOI 10.1016/0304-4165(91)90082-R; Pandelia ME, 2012, BBA-BIOENERGETICS, V1817, P1565, DOI 10.1016/j.bbabio.2012.04.012; Parkin A, 2012, CURR OPIN CHEM BIOL, V16, P26, DOI 10.1016/j.cbpa.2012.01.012; Paschos A, 2001, FEBS LETT, V488, P9, DOI 10.1016/S0014-5793(00)02408-X; PIERIK AJ, 1992, EUR J BIOCHEM, V206, P697, DOI 10.1111/j.1432-1033.1992.tb16976.x; Pinske C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022830; Porthun A, 2002, ARCH MICROBIOL, V177, P159, DOI 10.1007/s00203-001-0371-5; RAGAN CI, 1982, BIOCHEMISTRY-US, V21, P590, DOI 10.1021/bi00532a027; Ratzka J, 2011, BIOCATAL BIOTRANSFOR, V29, P246, DOI 10.3109/10242422.2011.615393; Rucker P, 1997, PROTEIN ENG, V10, P967, DOI 10.1093/protein/10.8.967; SCHNEIDER K, 1976, BIOCHIM BIOPHYS ACTA, V452, P66, DOI 10.1016/0005-2744(76)90058-9; SCHNEIDER K, 1983, BIOCHEM J, V213, P391, DOI 10.1042/bj2130391; Schwartz E, 2003, J MOL BIOL, V332, P369, DOI 10.1016/S0022-2836(03)00894-5; Selmer T, 2008, World Intellectual Property Organization (WIPO) WO patent, Patent No. [WO 2008/095927 A1, 2008095927, WO2008095927 (A1)]; Soboh B, 2012, FEBS LETT, V586, P3882, DOI 10.1016/j.febslet.2012.09.019; Soboh B, 2010, FEBS LETT, V584, P4109, DOI 10.1016/j.febslet.2010.08.037; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sun JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010526; SWEENEY WV, 1980, ANNU REV BIOCHEM, V49, P139, DOI 10.1146/annurev.bi.49.070180.001035; Tatsumi H, 1999, ANAL CHEM, V71, P1753, DOI 10.1021/ac981003l; Theodoratou E, 2000, EUR J BIOCHEM, V267, P1995, DOI 10.1046/j.1432-1327.2000.01202.x; Thiemermann S, 1996, J BACTERIOL, V178, P2368, DOI 10.1128/jb.178.8.2368-2374.1996; van der Linden E, 2006, J BIOL INORG CHEM, V11, P247, DOI 10.1007/s00775-005-0075-4; Van der Linden E, 2004, J BIOL INORG CHEM, V9, P616, DOI 10.1007/s00775-004-0555-y; van der Linden E, 2004, EUR J BIOCHEM, V271, P801, DOI 10.1111/j.1432-1033.2004.03984.x; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1111/j.1574-6976.2001.tb00587.x; Vincent KA, 2005, P NATL ACAD SCI USA, V102, P16951, DOI 10.1073/pnas.0504499102; Wells MA, 2011, METAB ENG, V13, P445, DOI 10.1016/j.ymben.2011.01.004; Weyman PD, 2011, MICROBIOL-SGM, V157, P1363, DOI 10.1099/mic.0.044834-0; WILSON CM, 1979, ANAL BIOCHEM, V96, P263, DOI 10.1016/0003-2697(79)90581-5; Wolf I, 1998, ARCH MICROBIOL, V170, P451, DOI 10.1007/s002030050666; WOLFRAM L, 1995, J BACTERIOL, V177, P1840, DOI 10.1128/jb.177.7.1840-1843.1995; WU LF, 1989, MOL MICROBIOL, V3, P1709, DOI 10.1111/j.1365-2958.1989.tb00156.x; Zhao T, 2001, J BACTERIOL, V183, P6225, DOI 10.1128/JB.183.21.6225-6233.2001	81	17	18	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68812	10.1371/journal.pone.0068812	http://dx.doi.org/10.1371/journal.pone.0068812			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861944	Green Submitted, Green Published, gold			2022-12-27	WOS:000321425300080
J	Thumbi, DK; Beliveau, C; Cusson, M; Lapointe, R; Lucarotti, CJ				Thumbi, David K.; Beliveau, Catherine; Cusson, Michel; Lapointe, Renee; Lucarotti, Christopher J.			Comparative Genome Sequence Analysis of Choristoneura occidentalis Freeman and C. rosaceana Harris (Lepidoptera: Tortricidae) Alphabaculoviruses	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; ENVELOPE FUSION PROTEIN; OS INFECTIVITY FACTOR; SPRUCE BUDWORM; MULTICAPSID NUCLEOPOLYHEDROVIRUS; MITOCHONDRIAL-DNA; BACULOVIRUS; ORGANIZATION; GENE; APOPTOSIS	The complete genome sequences of Choristoneura occidentalis and C. rosaceana nucleopolyhedroviruses (ChocNPV and ChroNPV, respectively) (Baculoviridae: Alphabaculovirus) were determined and compared with each other and with those of other baculoviruses, including the genome of the closely related C. fumiferana NPV (CfMNPV). The ChocNPV genome was 128,446 bp in length (1147 bp smaller than that of CfMNPV), had a G+C content of 50.1%, and contained 148 open reading frames (ORFs). In comparison, the ChroNPV genome was 129,052 bp in length, had a G+C content of 48.6% and contained 149 ORFs. ChocNPV and ChroNPV shared 144 ORFs in common, and had a 77% sequence identity with each other and 96.5% and 77.8% sequence identity, respectively, with CfMNPV. Five homologous regions (hrs), with sequence similarities to those of CfMNPV, were identified in ChocNPV, whereas the ChroNPV genome contained three hrs featuring up to 14 repeats. Both genomes encoded three inhibitors of apoptosis (IAP-1, IAP-2, and IAP-3), as reported for CfMNPV, and the ChocNPV IAP-3 gene represented the most divergent functional region of this genome relative to CfMNPV. Two ORFs were unique to ChocNPV, and four were unique to ChroNPV. ChroNPV ORF chronpv38 is a eukaryotic initiation factor 5 (eIF-5) homolog that has also been identified in the C. occidentalis granulovirus (ChocGV) and is believed to be the product of horizontal gene transfer from the host. Based on levels of sequence identity and phylogenetic analysis, both ChocNPV and ChroNPV fall within group I alphabaculoviruses, where ChocNPV appears to be more closely related to CfMNPV than does ChroNPV. Our analyses suggest that it may be appropriate to consider ChocNPV and CfMNPV as variants of the same virus species.	[Thumbi, David K.; Lucarotti, Christopher J.] Nat Resources Canada, Canadian Forest Serv, Atlantic Forestry Ctr, Fredericton, NB, Canada; [Beliveau, Catherine; Cusson, Michel] Nat Resources Canada, Canadian Forest Serv, Laurentian Forestry Ctr, Quebec City, PQ, Canada; [Thumbi, David K.; Lapointe, Renee] Sylvar Technol Inc, Fredericton, NB, Canada	Natural Resources Canada; Canadian Forest Service; Natural Resources Canada; Canadian Forest Service	Lucarotti, CJ (corresponding author), Nat Resources Canada, Canadian Forest Serv, Atlantic Forestry Ctr, Fredericton, NB, Canada.	Christopher.Lucarotti@NRCan-RNCan.gc.ca	Cusson, Michel/AAG-9036-2019		Canadian Regulatory System for Biotechnology; Genomics Research and Development Initiative (Government of Canada) through the Canadian Forest Service	Canadian Regulatory System for Biotechnology; Genomics Research and Development Initiative (Government of Canada) through the Canadian Forest Service(Natural Resources CanadaCanadian Forest Service)	This research was funded by grants to CJ Lucarotti and M Cusson from the Canadian Regulatory System for Biotechnology and the Genomics Research and Development Initiative (Government of Canada) through the Canadian Forest Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso CL, 2001, J VIROL, V75, P11157, DOI 10.1128/JVI.75.22.11157-11165.2001; Ahrens CH, 1997, VIROLOGY, V229, P381, DOI 10.1006/viro.1997.8448; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arif B, 2011, VIRUSES-BASEL, V3, P2214, DOI 10.3390/v3112214; ARIF BM, 1986, J INVERTEBR PATHOL, V48, P180, DOI 10.1016/0022-2011(86)90121-7; AYRES MD, 1994, VIROLOGY, V202, P586, DOI 10.1006/viro.1994.1380; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0; Burleigh JS, 2002, FOREST ECOL MANAG, V168, P301, DOI 10.1016/S0378-1127(01)00748-4; Clem RJ, 2001, CELL DEATH DIFFER, V8, P137, DOI 10.1038/sj.cdd.4400821; Cohen David P. A., 2009, Virologica Sinica, V24, P359, DOI 10.1007/s12250-009-3059-7; Courtiade J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-357; DANG PT, 1992, CAN ENTOMOL, V124, P7, DOI 10.4039/Ent1247-1; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Oliveira JVD, 2006, J GEN VIROL, V87, P3233, DOI 10.1099/vir.0.82161-0; de Jong JG, 2005, J GEN VIROL, V86, P929, DOI 10.1099/vir.0.80490-0; Dong DJ, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-19; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; Duffy SP, 2006, J VIROL, V80, P6952, DOI 10.1128/JVI.00187-06; ELDRIDGE R, 1992, J VIROL, V66, P6563, DOI 10.1128/JVI.66.11.6563-6571.1992; Erlandson Martin A., 2009, Virologica Sinica, V24, P458, DOI 10.1007/s12250-009-3052-1; Escasa SR, 2006, J GEN VIROL, V87, P1917, DOI 10.1099/vir.0.81792-0; Eveleigh ES, 2007, P NATL ACAD SCI USA, V104, P16976, DOI 10.1073/pnas.0704301104; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FREEMAN TN, 1967, CAN ENTOMOL, V99, P449, DOI 10.4039/Ent99449-5; Garcia-Maruniak A, 2004, J VIROL, V78, P7036, DOI 10.1128/JVI.78.13.7036-7051.2004; Griffiths CM, 1999, J GEN VIROL, V80, P1055, DOI 10.1099/0022-1317-80-4-1055; Habib S, 2000, J VIROL, V74, P5182, DOI 10.1128/JVI.74.11.5182-5189.2000; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harvey G.T., 1985, P16; Hayakawa T, 1999, VIROLOGY, V262, P277, DOI 10.1006/viro.1999.9894; Herniou EA, 2004, J VIROL, V78, P3244, DOI 10.1128/JVI.78.7.3244-3251.2004; Herniou EA, 2003, ANNU REV ENTOMOL, V48, P211, DOI 10.1146/annurev.ento.48.091801.112756; Hoover K, 2011, SCIENCE, V333, P1401, DOI 10.1126/science.1209199; Hyink O, 2002, J GEN VIROL, V83, P957, DOI 10.1099/0022-1317-83-4-957; Ikeda M, 2004, VIROLOGY, V321, P359, DOI 10.1016/j.virol.2004.01.002; Garavaglia MJ, 2012, J VIROL, V86, P12069, DOI 10.1128/JVI.01873-12; Jehle JA, 2006, ARCH VIROL, V151, P1257, DOI 10.1007/s00705-006-0763-6; Kamita SG, 2005, P NATL ACAD SCI USA, V102, P2584, DOI 10.1073/pnas.0409457102; Kemp EM, 2011, J INVERTEBR PATHOL, V107, P202, DOI 10.1016/j.jip.2011.05.015; Kim EJ, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-96; Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; Lannan E, 2007, J VIROL, V81, P9319, DOI 10.1128/JVI.00247-07; Lauzon H.A.M., 2005, J GEN VIROL, V78, P7023; Lauzon HAM, 2004, J VIROL, V78, P7023, DOI 10.1128/JVI.78.13.7023-7035.2004; LEE HY, 1994, VIROLOGY, V202, P418, DOI 10.1006/viro.1994.1358; Li H, 2007, METHODS MOL BIOL, V338; LU A, 1995, J VIROL, V69, P975, DOI 10.1128/JVI.69.2.975-982.1995; Lucarotti CJ, 2004, CAN ENTOMOL, V136, P255; Lucarotti CJ, 1997, J INVERTEBR PATHOL, V70, P121, DOI 10.1006/jipa.1997.4665; Lumley LM, 2011, MOL PHYLOGENET EVOL, V58, P232, DOI 10.1016/j.ympev.2010.11.023; Lumley LM, 2010, SYST ENTOMOL, V35, P416, DOI 10.1111/j.1365-3113.2009.00514.x; Lung OY, 2003, J VIROL, V77, P328, DOI 10.1128/JVI.77.1.328-339.2003; Milks ML, 2003, VIROLOGY, V310, P224, DOI 10.1016/S0042-6822(03)00143-0; Monsma SA, 1996, J VIROL, V70, P4607, DOI 10.1128/JVI.70.7.4607-4616.1996; Moreau G, 2007, FOREST CHRON, V83, P105, DOI 10.5558/tfc83105-1; Moscardi F, 2011, MICROBES AND MICROBIAL TECHNOLOGY: AGRICULTURAL AND ENVIRONMENTAL APPLICATIONS, P415, DOI 10.1007/978-1-4419-7931-5_16; Nealis VG, 2009, CAN J FOREST RES, V39, P839, DOI 10.1139/X09-014; Nie ZM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-248; OReilly D.R., 1997, BACULOVIRUSES, P267, DOI DOI 10.1007/978-1-4899-1834-5_11; OREILLY DR, 1992, BACULOVIRUS EXPRESSI, V12; Peng K, 2012, J VIROL, V86, P4981, DOI 10.1128/JVI.06801-11; Perera O, 2007, J VIROL, V81, P4585, DOI 10.1128/JVI.02391-06; Razowski Jozef, 2008, Polish Journal of Entomology, V77, P245; Rohrmann G.F., 2019, BACULOVIRUS MOL BIOL; Royama T., 1992, Analytical population dynamics.; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sial AA, 2012, PEST MANAG SCI, V68, P462, DOI 10.1002/ps.2294; Simon O, 2012, J INVERTEBR PATHOL, V109, P117, DOI 10.1016/j.jip.2011.10.010; Slack JM, 2004, J GEN VIROL, V85, P211, DOI 10.1099/vir.0.19617-0; Sneath Peter H.A, 1973, NUMERICAL TAXONOMY; SPERLING FAH, 1994, MOL BIOL EVOL, V11, P656; Surakasi VP, 2011, J INSECT PHYSIOL, V57, P1537, DOI 10.1016/j.jinsphys.2011.08.006; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thumbi DK, 2011, VIRUSES-BASEL, V3, P2301, DOI 10.3390/v3112301; van Oers MM, 2011, J INVERTEBR PATHOL, V107, pS3, DOI 10.1016/j.jip.2011.05.001; Volney WJA, 2007, GLOBAL CHANGE BIOL, V13, P1630, DOI 10.1111/j.1365-2486.2007.01402.x; Wen RH, 2007, VIRUS GENES, V35, P443, DOI 10.1007/s11262-007-0086-z; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033; Wormleaton S, 2003, VIROLOGY, V311, P350, DOI 10.1016/S0042-6822(03)00149-1; Yang DH, 2004, J GEN VIROL, V85, P3569, DOI 10.1099/vir.0.80592-0	82	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68968	10.1371/journal.pone.0068968	http://dx.doi.org/10.1371/journal.pone.0068968			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861954	Green Published, Green Submitted, gold			2022-12-27	WOS:000321425300083
J	Fletcher, L; Evans, TM; Watts, LT; Jimenez, DF; Digicaylioglu, M				Fletcher, Lauren; Evans, Teresa M.; Watts, Lora Talley; Jimenez, David F.; Digicaylioglu, Murat			Rapamycin Treatment Improves Neuron Viability in an In Vitro Model of Stroke	PLOS ONE			English	Article							MAMMALIAN TARGET; ISCHEMIC-STROKE; AMYLOID-BETA; MTOR; PROTEIN; INVOLVEMENT; MECHANISMS; COMPLEX; GROWTH; DEATH	Ischemic stroke is the leading cause of serious, long-term adult disability and is associated with sensorimotor and cognitive impairments due to neuronal degeneration. Currently, recombinant tissue plasminogen activator (rTPA) is the only FDA-approved medical therapy for treatment of patients with acute ischemic stroke. However, rTPA can only be given within 3 hours of symptom onset, and only 2% of patients are eligible. Therefore, there is an urgent need for novel neuroprotective treatment options for ischemic stroke. An emerging treatment for a diverse range of neurological disorders associated with neurodegeneration is rapamycin, a key modulator of the mammalian target of rapamycin (mTOR) pathway. The mTOR pathway is the primary regulator of the cellular response to nutrient availability, changes in energy status and stress as seen following ischemia and reperfusion. However, rapamycin's effects on mTORC1 and mTORC2 are poorly understood in neurons. In the current study we show that rapamycin can prevent the activation of both mTORC1 and mTORC2 in cortical neurons and improve cell survival following oxygen glucose deprivation (OGD), an in vitro model of ischemic stroke. This work further supports the investigation of rapamycin as a novel neuroprotectant for ischemic stroke.	[Fletcher, Lauren; Evans, Teresa M.; Jimenez, David F.; Digicaylioglu, Murat] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurosurg, San Antonio, TX 78229 USA; [Watts, Lora Talley] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Digicaylioglu, M (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Neurosurg, San Antonio, TX 78229 USA.	muratd@uthscsa.edu	Watts, Lora Talley/A-2724-2012	Watts, Lora Talley/0000-0002-2337-1504; Evans, Teresa/0000-0002-3860-2205	University of Texas Health Science Center San Antonio; National Cancer Institute [P30 CA54174]; National Institute of Aging [P01AG19316]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG019316] Funding Source: NIH RePORTER	University of Texas Health Science Center San Antonio; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Images were generated in the Core Optical Imaging Facility, which is supported by the University of Texas Health Science Center San Antonio, a National Cancer Institute grant no. P30 CA54174 (Cancer Therapy and Research Center) and a National Institute of Aging grant no. P01AG19316. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adams H, 2005, STROKE, V36, P916, DOI 10.1161/01.STR.0000163257.66207.2d; Adams HP, 2001, EUR NEUROL, V45, P61; Arsham AM, 2006, CURR OPIN CELL BIOL, V18, P589, DOI 10.1016/j.ceb.2006.09.005; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Carloni S, 2010, AUTOPHAGY, V6, P366, DOI 10.4161/auto.6.3.11261; Chauhan A, 2011, BEHAV BRAIN RES, V225, P603, DOI 10.1016/j.bbr.2011.08.035; CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947; Chong ZZ, 2010, OXID MED CELL LONGEV, V3, P374, DOI 10.4161/oxim.3.6.14787; Cimarosti H, 2008, NEUROSCIENTIST, V14, P626, DOI 10.1177/1073858408322677; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Fahling M, 2009, ACTA PHYSIOL, V195, P205, DOI 10.1111/j.1748-1716.2008.01894.x; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Franke H, 2006, PHARMACOL THERAPEUT, V109, P297, DOI 10.1016/j.pharmthera.2005.06.002; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hermann DM, 2007, CIRCULATION, V116, P363, DOI 10.1161/CIRCULATIONAHA.107.712380; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kroczynska B, 2009, CYTOKINE, V48, P138, DOI 10.1016/j.cyto.2009.07.009; Li WM, 2007, CIRC RES, V100, P79, DOI 10.1161/01.RES.0000253094.03023.3f; Liebeskind DS, 2010, CURR OPIN NEUROL, V23, P36, DOI 10.1097/WCO.0b013e328334da32; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Matheny RW, 2009, EXP BIOL MED, V234, P1264, DOI 10.3181/0904-MR-138; Menzies FM, 2010, AUTOPHAGY, V6, P286, DOI 10.4161/auto.6.2.11078; Mullonkal CJ, 2007, J INVEST SURG, V20, P195, DOI 10.1080/08941930701366471; Neary JT, 2005, IUBMB LIFE, V57, P711, DOI 10.1080/15216540500319143; Niizuma K, 2009, J NEUROCHEM, V109, P133, DOI 10.1111/j.1471-4159.2009.05897.x; Oshiro N, 2004, GENES CELLS, V9, P359, DOI 10.1111/j.1356-9597.2004.00727.x; Read DE, 2009, CELL MOL LIFE SCI, V66, P2975, DOI 10.1007/s00018-009-0057-8; Rosner M, 2008, HUM MOL GENET, V17, P2934, DOI 10.1093/hmg/ddn192; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Sharp ZD, 2010, J GERONTOL A-BIOL, V65, P580, DOI 10.1093/gerona/glp212; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Stiles BL, 2009, ADV DRUG DELIVER REV, V61, P1276, DOI 10.1016/j.addr.2009.07.017; Towfighi A, 2011, STROKE, V42, P2351, DOI 10.1161/STROKEAHA.111.621904; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Xu YY, 2011, BRAIN RES, V1375, P49, DOI 10.1016/j.brainres.2010.12.029; Yuan Y, 2010, BRAIN RES, V1367; Zhao H, 2009, J CEREBR BLOOD F MET, V29, P873, DOI 10.1038/jcbfm.2009.13	42	42	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68281	10.1371/journal.pone.0068281	http://dx.doi.org/10.1371/journal.pone.0068281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861877	Green Submitted, Green Published, gold			2022-12-27	WOS:000323350700077
J	Gonzalo-Gobernado, R; Calatrava-Ferreras, L; Reimers, D; Herranz, AS; Rodriguez-Serrano, M; Miranda, C; Jimenez-Escrig, A; Diaz-Gil, JJ; Bazan, E				Gonzalo-Gobernado, Rafael; Calatrava-Ferreras, Lucia; Reimers, Diana; Sanchez Herranz, Antonio; Rodriguez-Serrano, Macarena; Miranda, Cristina; Jimenez-Escrig, Adriano; Jose Diaz-Gil, Juan; Bazan, Eulalia			Neuroprotective Activity of Peripherally Administered Liver Growth Factor in a Rat Model of Parkinson's Disease	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NEURAL STEM-CELLS; SPONTANEOUSLY HYPERTENSIVE-RATS; NEUROTROPHIC FACTOR PRODUCTION; GLYCATION END-PRODUCTS; BCL-X-L; DOPAMINERGIC-NEURONS; OXIDATIVE STRESS; FACTOR-ALPHA; TNF-ALPHA	Liver growth factor (LGF) is a hepatic mitogen purified some years ago that promotes proliferation of different cell types and the regeneration of damaged tissues, including brain tissue. Considering the possibility that LGF could be used as a therapeutic agent in Parkinson's disease, we analyzed its potential neuroregenerative and/or neuroprotective activity when peripherally administered to unilaterally 6-hydroxydopamine (6-OHDA)-lesioned rats. For these studies, rats subjected to nigrostriatal lesions were treated intraperitoneally twice a week with LGF (5 microg/rat) for 3 weeks. Animals were sacrificed 4 weeks after the last LGF treatment. The results show that LGF stimulates sprouting of tyrosine hydroxylase-positive terminals and increases tyrosine hydroxylase and dopamine transporter expression, as well as dopamine levels in the denervated striatum of 6-OHDA-lesioned rats. In this structure, LGF activates microglia and raises tumor necrosis factor-alpha protein levels, which have been reported to have a role in neuroregeneration and neuroprotection. Besides, LGF stimulates the phosphorylation of MAPK/ERK1/2 and CREB, and regulates the expression of proteins which are critical for cell survival such as Bcl2 and Akt. Because LGF partially protects dopamine neurons from 6-OHDA neurotoxicity in the substantia nigra, and reduces motor deficits in these animals, we propose LGF as a novel factor that may be useful in the treatment of Parkinson's disease.	[Gonzalo-Gobernado, Rafael; Calatrava-Ferreras, Lucia; Reimers, Diana; Sanchez Herranz, Antonio; Rodriguez-Serrano, Macarena; Miranda, Cristina; Bazan, Eulalia] Inst Ramon & Cajal Invest Sanitaria, Serv Neurobiol, Madrid, Spain; [Jimenez-Escrig, Adriano] Hosp Univ Ramon & Cajal, Serv Neurol, Madrid, Spain; [Jose Diaz-Gil, Juan] Inst Invest Sanitaria Puerta Hierro Majadahonda, Madrid, Spain	Hospital Universitario Ramon y Cajal	Bazan, E (corresponding author), Inst Ramon & Cajal Invest Sanitaria, Serv Neurobiol, Madrid, Spain.	eulalia.bazan@hrc.es	rodriguez, macarena/E-8790-2018; Gonzalo-Gobernado, Rafael/F-2675-2016; Calatrava Ferreras, Lucía/E-6320-2016; Reimers, Diana/K-6584-2017	rodriguez, macarena/0000-0003-3499-5926; Gonzalo-Gobernado, Rafael/0000-0002-6357-105X; Calatrava Ferreras, Lucía/0000-0003-1389-769X; Reimers, Diana/0000-0002-2837-099X; Jimenez-Escrig, Adriano/0000-0002-4927-1886	Spanish Fondo de Investigaciones Sanitarias [FISS PI060315]; Agencia Lain Entralgo [NDG7/09]; Agencia Lain Entralgo; FiBio Hospital Ramon y Cajal fellowship; Contrato de Personal de Apoyo a la Investigacion (FISS)	Spanish Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Agencia Lain Entralgo; Agencia Lain Entralgo; FiBio Hospital Ramon y Cajal fellowship; Contrato de Personal de Apoyo a la Investigacion (FISS)	This work was supported by the Spanish Fondo de Investigaciones Sanitarias (FISS PI060315) and Agencia Lain Entralgo (NDG7/09). LC and RG-G were the recipients of Agencia Lain Entralgo and FiBio Hospital Ramon y Cajal fellowships, respectively, and MRS was the recipient of a Contrato de Personal de Apoyo a la Investigacion (FISS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso-Oramas D, 2009, NEUROBIOL DIS, V36, P494, DOI 10.1016/j.nbd.2009.09.002; Aron L, 2011, TRENDS NEUROSCI, V34, P88, DOI 10.1016/j.tins.2010.11.001; Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; Barneda-Zahonero B, 2009, MOL BIOL CELL, V20, P5051, DOI 10.1091/mbc.E09-05-0424; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Batchelor PE, 2003, J CLIN NEUROSCI, V10, P523, DOI 10.1016/S0967-5868(03)00004-3; Batchelor PE, 2002, MOL CELL NEUROSCI, V21, P436, DOI 10.1006/mcne.2002.1185; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Boucher MJ, 2000, J CELL BIOCHEM, V79, P355, DOI 10.1002/1097-4644(20001201)79:3<355::AID-JCB20>3.3.CO;2-S; CARLSSON A, 1973, J PHARM PHARMACOL, V25, P437, DOI 10.1111/j.2042-7158.1973.tb09129.x; Chakrabarty K, 2007, EUR J NEUROSCI, V25, P1971, DOI 10.1111/j.1460-9568.2007.05457.x; Chertoff M, 2011, EXP NEUROL, V227, P237, DOI 10.1016/j.expneurol.2010.11.010; Chung YC, 2010, J IMMUNOL, V185, P1230, DOI 10.4049/jimmunol.1000208; Cohen AD, 2011, BRAIN RES, V1370, P80, DOI 10.1016/j.brainres.2010.11.006; Conde MV, 2011, AM J PHYSIOL-HEART C, V301, pH1153, DOI 10.1152/ajpheart.00886.2010; Condezo-Hoyos L, 2012, J HYPERTENS, V30, P1185, DOI 10.1097/HJH.0b013e328353824b; Condezo-Hoyos L, 2009, FREE RADICAL BIO MED, V46, P656, DOI 10.1016/j.freeradbiomed.2008.12.002; Creson TK, 2009, J MOL NEUROSCI, V37, P123, DOI 10.1007/s12031-008-9122-2; Deumens R, 2002, EXP NEUROL, V175, P303, DOI 10.1006/exnr.2002.7891; Diaz Gil JJ, 1994, GROWTH REGULAT, V4, P113; Diaz-Gil JJ, 1999, J HEPATOL, V30, P1065, DOI 10.1016/S0168-8278(99)80261-X; Diaz-Gil JJ, 2003, J HEPATOL, V38, P598, DOI 10.1016/S0168-8278(03)00030-8; Diaz-Gil JJ, 2009, HISTOL HISTOPATHOL, V24, P473, DOI 10.14670/HH-24.473; DIAZGIL JJ, 1986, BIOCHEM J, V235, P49, DOI 10.1042/bj2350049; DIAZGIL JJ, 1987, BIOCHEM J, V243, P443, DOI 10.1042/bj2430443; DIAZGIL JJ, 1988, HEPATOLOGY, V8, P484, DOI 10.1002/hep.1840080308; Figiel I, 2008, ACTA NEUROBIOL EXP, V68, P526; Frebel K, 2006, BIOCHEM SOC T, V34, P1287, DOI 10.1042/BST0341287; Fujino H, 2009, ACTA NEUROPATHOL, V117, P75, DOI 10.1007/s00401-008-0440-9; Gonzalez-Aparicio R, 2010, EXP NEUROL, V226, P136, DOI 10.1016/j.expneurol.2010.08.016; Gonzalo-Gobernado R, 2011, 14 C NAC SOC ESP NEU; Gonzalo-Gobernado R, 2009, J HISTOCHEM CYTOCHEM, V57, P491, DOI 10.1369/jhc.2009.952275; Hannila SS, 2008, EXP NEUROL, V209, P321, DOI 10.1016/j.expneurol.2007.06.020; He F, 2008, COLLOID SURFACE B, V61, P290, DOI 10.1016/j.colsurfb.2007.09.009; Herold S, 2011, MOL CELL NEUROSCI, V46, P79, DOI 10.1016/j.mcn.2010.08.008; Hung SY, 2010, NEUROPHARMACOLOGY, V58, P321, DOI 10.1016/j.neuropharm.2009.11.003; Kirik D, 2001, EUR J NEUROSCI, V13, P1589, DOI 10.1046/j.0953-816x.2001.01534.x; Kirik D, 1998, EXP NEUROL, V152, P259, DOI 10.1006/exnr.1998.6848; Kraft AD, 2009, NEUROTOXICOLOGY, V30, P785, DOI 10.1016/j.neuro.2009.07.001; Lee HT, 2010, J NEUROCHEM, V113, P79, DOI 10.1111/j.1471-4159.2010.06584.x; Leinninger GM, 2004, FASEB J, V18, P1544, DOI 10.1096/fj.04-1581fje; Lewis-Tuffin LJ, 2004, MOL CELL NEUROSCI, V25, P536, DOI 10.1016/j.mcn.2003.10.010; Liang JF, 2010, BRAIN RES, V1322, P8, DOI 10.1016/j.brainres.2010.01.083; Lim J, 2000, MOL CELL BIOCHEM, V212, P51, DOI 10.1023/A:1007148719497; Lin E, 2008, J NEUROSCI RES, V86, P108, DOI 10.1002/jnr.21478; LING EA, 1993, GLIA, V7, P9, DOI 10.1002/glia.440070105; Liste I, 2004, J NEUROSCI, V24, P10786, DOI 10.1523/JNEUROSCI.3208-04.2004; Liu LM, 2009, NUCL MED BIOL, V36, P941, DOI 10.1016/j.nucmedbio.2009.06.005; Lu J, 2010, BRAIN PATHOL, V20, P952, DOI 10.1111/j.1750-3639.2010.00397.x; Matsuzaki H, 1999, J NEUROCHEM, V73, P2037; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; MENA MA, 1995, CLIN NEUROPHARMACOL, V18, P410, DOI 10.1097/00002826-199510000-00004; Milligan SA, 1998, ARCH BIOCHEM BIOPHYS, V352, P255, DOI 10.1006/abbi.1998.0603; Mitchell HM, 2011, J NEUROCHEM, V117, P187, DOI 10.1111/j.1471-4159.2010.07103.x; Monville C, 2006, J NEUROSCI METH, V158, P219, DOI 10.1016/j.jneumeth.2006.06.001; Noshita N, 2001, J CEREBR BLOOD F MET, V21, P1442, DOI 10.1097/00004647-200112000-00009; Offen D, 2001, NEUROSCI LETT, V316, P129, DOI 10.1016/S0304-3940(01)02344-8; Park IH, 2004, MOL IMMUNOL, V40, P1203, DOI 10.1016/j.molimm.2003.11.027; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Perez-Crespo M, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-21; Polazzi E, 2002, REV NEUROSCIENCE, V13, P221; Predescu D, 2004, AM J PHYSIOL-LUNG C, V287, pL895, DOI 10.1152/ajplung.00075.2004; Ranaivo HR, 2010, BRAIN RES, V1313, P222, DOI 10.1016/j.brainres.2009.11.063; Reimers D, 2006, J HISTOCHEM CYTOCHEM, V54, P457, DOI 10.1369/jhc.5A6805.2005; Reimers D, 2012, CURR STEM CELL RES T, V7, P15, DOI 10.2174/157488812798483421; Rozas G, 1997, BRAIN RES PROTOC, V2, P75, DOI 10.1016/S1385-299X(97)00034-2; Sagare AP, 2011, J NEUROSCI RES, V89, P967, DOI 10.1002/jnr.22670; Sanders EJ, 2008, GEN COMP ENDOCR, V156, P613, DOI 10.1016/j.ygcen.2008.02.005; Schmitt KRL, 2010, BRAIN PATHOL, V20, P771, DOI 10.1111/j.1750-3639.2009.00358.x; Shah P, 2006, BRAIN RES, V1107, P13, DOI 10.1016/j.brainres.2006.05.097; Shein NA, 2008, BRAIN RES, V1244, P132, DOI 10.1016/j.brainres.2008.09.032; Shen LH, 2010, GLIA, V58, P1074, DOI 10.1002/glia.20988; SINGH J, 1986, J CHROMATOGR, V380, P321, DOI 10.1016/S0378-4347(00)83660-9; Smith BA, 2011, BRAIN RES, V1386, P70, DOI 10.1016/j.brainres.2011.02.003; Somoza B, 2006, CARDIOVASC RES, V69, P764, DOI 10.1016/j.cardiores.2005.08.021; Stanic D, 2004, BRAIN RES, V1023, P83, DOI 10.1016/j.brainres.2004.07.012; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Suzuki T, 2004, J NEUROSCI, V24, P1, DOI 10.1523/JNEUROSCI.3792-03.2004; Teismann P, 2004, CELL TISSUE RES, V318, P149, DOI 10.1007/s00441-004-0944-0; Teng FYH, 2006, J NEUROCHEM, V96, P1501, DOI 10.1111/j.1471-4159.2006.03663.x; Thornalley PJ, 1998, CELL MOL BIOL, V44, P1013; Wang W, 2003, J NEUROCHEM, V84, P189, DOI 10.1046/j.1471-4159.2003.01544.x; Wang Z, 2002, ACTA PHARMACOL SIN, V23, P974; Watson F, 2001, J BIOL CHEM, V276, P7661, DOI 10.1074/jbc.M006697200; Wree A, 2011, NEUROBIOL DIS, V41, P291, DOI 10.1016/j.nbd.2010.09.017; Yan M, 2011, NEUROCHEM INT, V58, P549, DOI 10.1016/j.neuint.2011.01.013; Yang XX, 2010, J MOL NEUROSCI, V42, P145, DOI 10.1007/s12031-010-9336-y; Yasuhara T, 2004, EUR J NEUROSCI, V19, P1494, DOI 10.1111/j.1460-9568.2004.03254.x; Yu XR, 2006, ACTA BIOCH BIOPH SIN, V38, P241, DOI 10.1111/j.1745-7270.2006.00152.x; Yuan HB, 2010, J NEUROSCI RES, V88, P1348, DOI 10.1002/jnr.22304; Zhang L, 2010, BRAIN RES, V1357, P157, DOI 10.1016/j.brainres.2010.08.007; Zhao H, 2006, MOL NEUROBIOL, V34, P249, DOI 10.1385/MN:34:3:249; Zheng WH, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-51; Zhu Y, 2002, J NEUROSCI, V22, P3898, DOI 10.1523/JNEUROSCI.22-10-03898.2002; Zhu ZH, 2006, BRAIN RES, V1114, P1, DOI 10.1016/j.brainres.2006.07.070; Ziv I, 1997, APOPTOSIS, V2, P149, DOI 10.1023/A:1026408313758	96	12	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67771	10.1371/journal.pone.0067771	http://dx.doi.org/10.1371/journal.pone.0067771			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861803	Green Published, Green Submitted, gold			2022-12-27	WOS:000323350700034
J	Hu, GZ; Witzig, TE; Gupta, M				Hu, Guangzhen; Witzig, Thomas E.; Gupta, Mamta			A Novel Missense (M206K) STAT3 Mutation in Diffuse Large B Cell Lymphoma Deregulates STAT3 Signaling	PLOS ONE			English	Article							COILED-COIL DOMAIN; ACTIVATION; EXPRESSION; INHIBITOR; LEUKEMIA; PROLIFERATION; TG101348; SEQUENCE; RECEPTOR	Persistent STAT3 activation has been found in activated B-cell like diffuse large B cell tumors (DLBCL). To investigate whether genetic mutations play a role in aberrant STAT3 signaling in DLBCL, we bi-directionally sequenced all 24 exons of the STAT3 gene in DLBCL tumors (n = 40). We identified 2 novel point mutations in 2 separate (2/40; 5%) patients at exon 7 and 24. Point mutation 2552G>A was a silent mutation in the stop codon. Another heterozygous mutation 857T > A encoded a methionine substitution by lysine at codon 206 (M206K) in the coiled-coil domain of STAT3. We performed site directed mutagenesis to mutate wild type (WT) STAT3 alpha and STAT3 beta at codon 206 and constructed stable cell lines by lentiviral transfection of STAT3 alpha(WT), STAT3 alpha(M206K), STAT3 beta(WT) and STAT3 beta(M206K) plasmids. The mutation was found to increase STAT3 phosphorylation in STAT3 alpha mutant cell lines with no effect on the STAT3 beta mutant cell line. Transcriptional activation was also increased in the STAT3 alpha mutant cells compared with STAT3 alpha(WT) cells as detected by a luciferase reporter assay. Moreover, STAT3 alpha(M206K) mutant cells were resistant to JAK2 pathway inhibition compared to STAT3 alpha(WT) cells. These results indicate that missense mutations in STAT3 increase signaling through the JAK/STAT pathway. JAK2 inhibitors may be useful in the patient with this STAT3 mutation as well as those with pathway activation by other mechanisms.	[Hu, Guangzhen; Witzig, Thomas E.; Gupta, Mamta] Mayo Clin, Div Hematol, Dept Internal Med, Rochester, MN 55905 USA	Mayo Clinic	Gupta, M (corresponding author), Mayo Clin, Div Hematol, Dept Internal Med, Rochester, MN 55905 USA.	gupta.mamta@mayo.edu	Hu, Guangzhen/B-2240-2015		Iowa/Mayo Lymphoma Specialized Program of Research Excellence [P50 CA097274, R01CA127433]; NATIONAL CANCER INSTITUTE [R01CA127433, P50CA097274] Funding Source: NIH RePORTER	Iowa/Mayo Lymphoma Specialized Program of Research Excellence; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported through Iowa/Mayo Lymphoma Specialized Program of Research Excellence (P50 CA097274) to MG; R01CA127433 to TEW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashizawa T, 2011, INT J ONCOL, V38, P1245, DOI 10.3892/ijo.2011.957; Ding BB, 2008, BLOOD, V111, P1515, DOI 10.1182/blood-2007-04-087734; Dumoutier L, 2009, J BIOL CHEM, V284, P26377, DOI 10.1074/jbc.M109.007955; Eyckerman S, 2000, FEBS LETT, V486, P33, DOI 10.1016/S0014-5793(00)02205-5; Gupta M, 2012, BLOOD, V120, P4400, DOI 10.1182/blood-2012-05-428466; Gupta M, 2012, BLOOD, V119, P2844, DOI 10.1182/blood-2011-10-388538; Gupta M, 2009, BLOOD, V113, P5206, DOI 10.1182/blood-2008-09-179762; Jerez A, 2012, BLOOD, V120, P3048, DOI 10.1182/blood-2012-06-435297; Koskela HLM, 2012, NEW ENGL J MED, V366, P1905, DOI 10.1056/NEJMoa1114885; Kumanovics A, 2010, J CLIN IMMUNOL, V30, P886, DOI 10.1007/s10875-010-9452-z; Lam LT, 2008, BLOOD, V111, P3701, DOI 10.1182/blood-2007-09-111948; Lasho TL, 2008, LEUKEMIA, V22, P1790, DOI 10.1038/leu.2008.56; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Ma J, 2003, J BIOL CHEM, V278, P29252, DOI 10.1074/jbc.M304196200; Ma J, 2006, CELL SIGNAL, V18, P1117, DOI 10.1016/j.cellsig.2005.06.016; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Pardanani A, 2011, J CLIN ONCOL, V29, P789, DOI 10.1200/JCO.2010.32.8021; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Redell MS, 2011, BLOOD, V117, P5701, DOI 10.1182/blood-2010-04-280123; Sato N, 2005, BIOCHEM BIOPH RES CO, V336, P617, DOI 10.1016/j.bbrc.2005.08.145; Scuto A, 2011, CANCER RES, V71, P3182, DOI 10.1158/0008-5472.CAN-10-2380; Werning G, 2008, CANCER CELL, V13, P311, DOI 10.1016/j.ccr.2008.02.009; Witzig TE, 2013, LEUKEMIA LYMPHOMA, V54, P397, DOI 10.3109/10428194.2012.708931; Wu ZL, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-31; Zhang T, 2000, MOL CELL BIOL, V20, P7132, DOI 10.1128/MCB.20.19.7132-7139.2000	25	18	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67851	10.1371/journal.pone.0067851	http://dx.doi.org/10.1371/journal.pone.0067851			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861822	Green Submitted, gold, Green Published			2022-12-27	WOS:000323350700050
J	Hunter, CS; Malik, RE; Witzmann, FA; Rhodes, SJ				Hunter, Chad S.; Malik, Raleigh E.; Witzmann, Frank A.; Rhodes, Simon J.			LHX3 Interacts with Inhibitor of Histone Acetyltransferase Complex Subunits LANP and TAF-1 beta to Modulate Pituitary Gene Regulation	PLOS ONE			English	Article							HOMEODOMAIN TRANSCRIPTION FACTOR; SET/TAF-I-BETA; ACTIVATING-FACTOR-I; ALPHA-ASSOCIATED PROTEIN; CREB-BINDING-PROTEIN; HORMONE DEFICIENCY; TRANSGENIC MICE; MOTOR-NEURON; P-LIM; ACETYLATION	LIM-homeodomain 3 (LHX3) is a transcription factor required for mammalian pituitary gland and nervous system development. Human patients and animal models with LHX3 gene mutations present with severe pediatric syndromes that feature hormone deficiencies and symptoms associated with nervous system dysfunction. The carboxyl terminus of the LHX3 protein is required for pituitary gene regulation, but the mechanism by which this domain operates is unknown. In order to better understand LHX3-dependent pituitary hormone gene transcription, we used biochemical and mass spectrometry approaches to identify and characterize proteins that interact with the LHX3 carboxyl terminus. This approach identified the LANP/pp32 and TAF-1 beta/SET proteins, which are components of the inhibitor of histone acetyltransferase (INHAT) multi-subunit complex that serves as a multifunctional repressor to inhibit histone acetylation and modulate chromatin structure. The protein domains of LANP and TAF-1 beta that interact with LHX3 were mapped using biochemical techniques. Chromatin immunoprecipitation experiments demonstrated that LANP and TAF-1 beta are associated with LHX3 target genes in pituitary cells, and experimental alterations of LANP and TAF-1 beta levels affected LHX3-mediated pituitary gene regulation. Together, these data suggest that transcriptional regulation of pituitary genes by LHX3 involves regulated interactions with the INHAT complex.	[Hunter, Chad S.; Rhodes, Simon J.] Indiana Univ Purdue Univ, Dept Biol, Indianapolis, IN 46205 USA; [Malik, Raleigh E.; Rhodes, Simon J.] Indiana Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA; [Witzmann, Frank A.; Rhodes, Simon J.] Indiana Univ Purdue Univ, Dept Cellular & Integrat Physiol, Indianapolis, IN 46205 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis	Rhodes, SJ (corresponding author), Indiana Univ Purdue Univ, Dept Biol, Indianapolis, IN 46205 USA.	srhodes@iupui.edu		Hunter, Chad/0000-0002-1644-447X	NIH [HD42024, ES018810, GM085218]; NSF; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [RC2ES018810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085218] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH HD42024 to SJR; an NSF graduate fellowship to REM; and NIH ES018810, GM085218 to FAW. Web sites: http://www.nsf.gov/; http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarid ET, 1996, DEVELOPMENT, V122, P3319; Bach I, 1999, NAT GENET, V22, P394, DOI 10.1038/11970; Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; BACH I, 1995, P NATL ACAD SCI USA, V92, P2720, DOI 10.1073/pnas.92.7.2720; Banerjee-Basu S, 2001, NUCLEIC ACIDS RES, V29, P3258, DOI 10.1093/nar/29.15.3258; Bechtold-Dalla Pozza S, 2012, HORM RES PAEDIAT, V77, P41, DOI 10.1159/000335929; Bhangoo APS, 2006, J CLIN ENDOCR METAB, V91, P747, DOI 10.1210/jc.2005-2360; Bonfig W, 2011, EUR J PEDIAT; Bridwell JL, 2001, GENE, V277, P239, DOI 10.1016/S0378-1119(01)00704-1; Colvin SC, 2011, P NATL ACAD SCI USA, V108, P173, DOI 10.1073/pnas.1009501108; Davis SW, 2010, MOL CELL ENDOCRINOL, V323, P4, DOI 10.1016/j.mce.2009.12.012; DROLET DW, 1991, GENE DEV, V5, P1739, DOI 10.1101/gad.5.10.1739; Eitoku M, 2008, CELL MOL LIFE SCI, V65, P414, DOI 10.1007/s00018-007-7305-6; Estanyol JM, 1999, J BIOL CHEM, V274, P33161, DOI 10.1074/jbc.274.46.33161; Gadd MS, 2011, J BIOL CHEM, V286, P42971, DOI 10.1074/jbc.M111.248559; Granger A, 2006, MOL ENDOCRINOL, V20, P2093, DOI 10.1210/me.2005-0184; Hashimoto K, 2005, MOL CELL ENDOCRINOL, V229, P11, DOI 10.1016/j.mce.2004.10.005; Hunter C, 2005, MOL BIOL REP, V32, P67, DOI 10.1007/s11033-004-7657-z; Ichijo T, 2008, MOL CELL ENDOCRINOL, V283, P19, DOI 10.1016/j.mce.2007.10.014; Jurata LW, 1996, P NATL ACAD SCI USA, V93, P11693, DOI 10.1073/pnas.93.21.11693; Karetsou Z, 2005, BIOCHEM BIOPH RES CO, V335, P322, DOI 10.1016/j.bbrc.2005.06.210; Kato K, 2007, NUCLEIC ACIDS RES, V35, P705, DOI 10.1093/nar/gkl1077; Kato K, 2011, J CELL SCI, V124, P3254, DOI 10.1242/jcs.083139; Kelberman D, 2009, ENDOCR REV, V30, P790, DOI 10.1210/er.2009-0008; Kim JY, 2012, FEBS LETT, V586, P3159, DOI 10.1016/j.febslet.2012.06.026; Kim JY, 2012, NUCLEIC ACIDS RES, V40, P75, DOI 10.1093/nar/gkr614; Kristrom B, 2009, J CLIN ENDOCR METAB, V94, P1154, DOI 10.1210/jc.2008-0325; Kular RK, 2009, J BIOL CHEM, V284, P7783, DOI 10.1074/jbc.M806150200; Kutney SN, 2004, J BIOL CHEM, V279, P30850, DOI 10.1074/jbc.M404969200; Lee IS, 2006, BIOL PHARM BULL, V29, P2395, DOI 10.1248/bpb.29.2395; LEW D, 1993, GENE DEV, V7, P683, DOI 10.1101/gad.7.4.683; Li M, 1996, BIOCHEMISTRY-US, V35, P6998, DOI 10.1021/bi960581y; Loven MA, 2004, MOL ENDOCRINOL, V18, P2649, DOI 10.1210/me.2003-0195; Loven MA, 2003, MOL ENDOCRINOL, V17, P67, DOI 10.1210/me.2002-0280; Macfarlan T, 2006, MOL ENDOCRINOL, V20, P335, DOI 10.1210/me.2005-0248; Matilla A, 2005, CEREBELLUM, V4, P7, DOI 10.1080/14734220410019020; Matilla A, 1997, NATURE, V389, P974, DOI 10.1038/40159; McGillivray SM, 2005, ENDOCRINOLOGY, V146, P2180, DOI 10.1210/en.2004-1566; Meier BC, 1999, MOL CELL ENDOCRINOL, V147, P65, DOI 10.1016/S0303-7207(98)00213-5; Mollard P, 2012, TRENDS ENDOCRIN MET, V23, P261, DOI 10.1016/j.tem.2012.02.004; NAGATA K, 1995, P NATL ACAD SCI USA, V92, P4279, DOI 10.1073/pnas.92.10.4279; Netchine I, 2000, NAT GENET, V25, P182, DOI 10.1038/76041; Ostendorff HP, 2002, NATURE, V416, P99, DOI 10.1038/416099a; Parker GE, 2000, J BIOL CHEM, V275, P23891, DOI 10.1074/jbc.M000377200; Parker GE, 2005, J CELL BIOCHEM, V94, P67, DOI 10.1002/jcb.20287; Pfaeffle RW, 2007, J CLIN ENDOCR METAB, V92, P1909, DOI 10.1210/jc.2006-2177; Prince KL, 2013, ENDOCRINOLOGY, V154, P738, DOI 10.1210/en.2012-1790; Prince KL, 2011, NAT REV ENDOCRINOL, V7, P727, DOI 10.1038/nrendo.2011.119; Rajab A, 2008, HUM MOL GENET, V17, P2150, DOI 10.1093/hmg/ddn114; ROBERSON MS, 1994, MOL CELL BIOL, V14, P2985, DOI 10.1128/MCB.14.5.2985; Savage JJ, 2007, GENE, V400, P44, DOI 10.1016/j.gene.2007.05.017; Schneider R, 2004, J BIOL CHEM, V279, P23859, DOI 10.1074/jbc.C400151200; SEIDAH NG, 1994, DNA CELL BIOL, V13, P1163, DOI 10.1089/dna.1994.13.1163; Seo SB, 2002, J BIOL CHEM, V277, P14005, DOI 10.1074/jbc.M112455200; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Sheng HZ, 1997, SCIENCE, V278, P1809, DOI 10.1126/science.278.5344.1809; Sheng HZ, 1996, SCIENCE, V272, P1004, DOI 10.1126/science.272.5264.1004; Sloop KW, 1999, MOL ENDOCRINOL, V13, P2212, DOI 10.1210/me.13.12.2212; Sloop KW, 2001, J BIOL CHEM, V276, P36311, DOI 10.1074/jbc.M103888200; Sobrier ML, 2012, J CLIN ENDOCR METAB, V97, pE503, DOI 10.1210/jc.2011-2095; Telese F, 2005, EMBO REP, V6, P77, DOI 10.1038/sj.embor.7400309; Thaler JP, 2002, CELL, V110, P237, DOI 10.1016/S0092-8674(02)00823-1; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Trivedi CM, 2010, DEV CELL, V19, P450, DOI 10.1016/j.devcel.2010.08.012; West BE, 2004, ENDOCRINOLOGY, V145, P4866, DOI 10.1210/en.2004-0598; ZHADANOV AB, 1995, DEV DYNAM, V202, P354, DOI 10.1002/aja.1002020405	67	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68898	10.1371/journal.pone.0068898	http://dx.doi.org/10.1371/journal.pone.0068898			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861948	Green Submitted, Green Published, gold			2022-12-27	WOS:000323350700105
J	Liang, Y; He, HS; Fraser, JS; Wu, ZW				Liang, Yu; He, Hong S.; Fraser, Jacob S.; Wu, ZhiWei			Thematic and Spatial Resolutions Affect Model-Based Predictions of Tree Species Distribution	PLOS ONE			English	Article							ECOLOGICAL PROCESSES; LANDSCAPE PATTERN; CHANGING SCALE; FOREST; HETEROGENEITY; SIMULATION; BIODIVERSITY; ECOSYSTEM; POPULATIONS; DYNAMICS	Subjective decisions of thematic and spatial resolutions in characterizing environmental heterogeneity may affect the characterizations of spatial pattern and the simulation of occurrence and rate of ecological processes, and in turn, model-based tree species distribution. Thus, this study quantified the importance of thematic and spatial resolutions, and their interaction in predictions of tree species distribution (quantified by species abundance). We investigated how model-predicted species abundances changed and whether tree species with different ecological traits (e. g., seed dispersal distance, competitive capacity) had different responses to varying thematic and spatial resolutions. We used the LANDIS forest landscape model to predict tree species distribution at the landscape scale and designed a series of scenarios with different thematic (different numbers of land types) and spatial resolutions combinations, and then statistically examined the differences of species abundance among these scenarios. Results showed that both thematic and spatial resolutions affected model-based predictions of species distribution, but thematic resolution had a greater effect. Species ecological traits affected the predictions. For species with moderate dispersal distance and relatively abundant seed sources, predicted abundance increased as thematic resolution increased. However, for species with long seeding distance or high shade tolerance, thematic resolution had an inverse effect on predicted abundance. When seed sources and dispersal distance were not limiting, the predicted species abundance increased with spatial resolution and vice versa. Results from this study may provide insights into the choice of thematic and spatial resolutions for model-based predictions of tree species distribution.	[Liang, Yu; He, Hong S.; Wu, ZhiWei] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Liaoning, Peoples R China; [He, Hong S.; Fraser, Jacob S.] Univ Missouri, Sch Nat Resources, Columbia, MO USA	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; University of Missouri System; University of Missouri Columbia	He, HS (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Liaoning, Peoples R China.	heh@missouri.edu	Wu, Zhiwei/AHC-9115-2022; Yu, Liang/AFO-1361-2022	Fraser, Jacob/0000-0002-4960-3713; He, Hong S./0000-0002-3983-2512	973 project [2011CB403206, 2012BAD22B04]; National Natural Science Foundation of China [41071120]	973 project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding for this research was provided by "the 973 project'' 2011CB403206, 2012BAD22B04, and the National Natural Science Foundation of China 41071120. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasekare P, 2008, ANNU REV ECOL EVOL S, V39, P479, DOI 10.1146/annurev.ecolsys.39.110707.173434; [Anonymous], 2004, FOOD WEBS LANDSCAPE; Bailey D, 2007, LANDSCAPE ECOL, V22, P461, DOI 10.1007/s10980-006-9035-9; Brotons L, 2004, LANDSCAPE ECOL, V19, P663, DOI 10.1007/s10980-005-0165-2; Buyantuyev A, 2007, LANDSCAPE ECOL, V22, P7, DOI 10.1007/s10980-006-9010-5; Castilla G, 2009, LANDSCAPE ECOL, V24, P15, DOI 10.1007/s10980-008-9310-z; Coreau A, 2009, ECOL LETT, V12, P1277, DOI 10.1111/j.1461-0248.2009.01392.x; COSTANZA R, 1994, LANDSCAPE ECOL, V9, P47, DOI 10.1007/BF00135078; Duelli P, 1997, AGR ECOSYST ENVIRON, V62, P81, DOI 10.1016/S0167-8809(96)01143-7; Dufour A, 2006, ECOGRAPHY, V29, P573, DOI 10.1111/j.0906-7590.2006.04605.x; DUNNING JB, 1992, OIKOS, V65, P169, DOI 10.2307/3544901; DUTILLEUL P, 1993, OIKOS, V66, P152, DOI 10.2307/3545210; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Hao Z.Q., 2001, J APPL ECOL, V12, P653, DOI DOI 10.1073/PNAS.221363798); He HS, 2008, FOREST ECOL MANAG, V254, P371, DOI 10.1016/j.foreco.2007.09.069; He HS, 1999, ECOL MODEL, V114, P213, DOI 10.1016/S0304-3800(98)00147-1; He HS, 2002, INT J GEOGR INF SCI, V16, P93, DOI 10.1080/13658810110075978; He HS, 1999, ECOSYSTEMS, V2, P308, DOI 10.1007/s100219900082; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; KADMON R, 1990, AM NAT, V135, P382, DOI 10.1086/285052; Kolasa J., 1991, ECOLOGICAL HETEROGEN, V86, P1, DOI DOI 10.1007/978-1-4612-3062-5_1; Kumar S, 2006, ECOLOGY, V87, P3186, DOI 10.1890/0012-9658(2006)87[3186:SHINAN]2.0.CO;2; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; LI H, 1995, OIKOS, V73, P280, DOI 10.2307/3545921; LI HB, 1994, ECOLOGY, V75, P2446, DOI 10.2307/1940898; Liang Y., 2011, CHINESE GEOGR SCI, V21, P1; Liang Y, 2012, LANDSCAPE ECOL, V27, P1031, DOI 10.1007/s10980-012-9759-7; Liang Y, 2011, ANN FOREST SCI, V68, P899, DOI 10.1007/s13595-011-0096-9; Lovett G. M., 2005, ECOSYSTEM FUNCTION H; Mladenoff D.J., 1999, SPATIAL MODELING FOR; Moorcroft PR, 2006, TRENDS ECOL EVOL, V21, P400, DOI 10.1016/j.tree.2006.04.009; Morin X, 2007, ECOLOGY, V88, P2280, DOI 10.1890/06-1591.1; Morin X, 2009, ECOLOGY, V90, P1301, DOI 10.1890/08-0134.1; Post WM, 1996, CLIMATIC CHANGE, V34, P253, DOI 10.1007/BF00224636; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; PULLIAM HR, 1991, AM NAT, V137, pS50, DOI 10.1086/285139; Purves D, 2008, SCIENCE, V320, P1452, DOI 10.1126/science.1155359; ROUGHGARDEN J, 1986, THEOR POPUL BIOL, V29, P235, DOI 10.1016/0040-5809(86)90010-9; Scheiter S, 2009, GLOBAL CHANGE BIOL, V15, P2224, DOI 10.1111/j.1365-2486.2008.01838.x; Shao GF, 1996, CAN J FOREST RES, V26, P206, DOI 10.1139/x26-024; Shao GF, 2003, GLOBAL PLANET CHANGE, V37, P307, DOI 10.1016/S0921-8181(02)00204-7; Stone R, 2006, SCIENCE, V313, P1379, DOI 10.1126/science.313.5792.1379; SUGIHARA G, 1990, NATURE, V344, P734, DOI 10.1038/344734a0; Syphard AD, 2004, ECOL MODEL, V180, P21, DOI 10.1016/j.ecolmodel.2004.01.017; Tischendorf L, 2001, LANDSCAPE ECOL, V16, P235, DOI 10.1023/A:1011112719782; Turner MG, 2001, LANDSAPE ECOLOGY THE; WERNER EE, 1983, ECOLOGY, V64, P1525, DOI 10.2307/1937507; Wiens JA, 2002, APPLYING LANDSCAPE ECOLOGY IN BIOLOGICAL CONSERVATION, P3; Wu JG, 2004, LANDSCAPE ECOL, V19, P125, DOI 10.1023/B:LAND.0000021711.40074.ae; Wu JG, 2002, LANDSCAPE ECOL, V17, P761, DOI 10.1023/A:1022995922992; [赵淑清 Zhao Shuqing], 2004, [生物多样性, Chinese Biodiversity], V12, P164	51	19	21	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67889	10.1371/journal.pone.0067889	http://dx.doi.org/10.1371/journal.pone.0067889			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861828	Green Published, Green Submitted, gold			2022-12-27	WOS:000323350700056
J	Liao, MH; Huang, JW; Zhang, T; Wu, H				Liao, Mingheng; Huang, Jiwei; Zhang, Tao; Wu, Hong			Transarterial Chemoembolization in Combination with Local Therapies for Hepatocellular Carcinoma: A Meta-Analysis	PLOS ONE			English	Article							PERCUTANEOUS ETHANOL INJECTION; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; RADIOFREQUENCY ABLATION; SURVIVAL BENEFIT; EMBOLIZATION; RADIOTHERAPY; TACE; LONG; CISPLATIN; HCC	Background: In previous randomized trials, transarterial chemoembolization (TACE) has shown an improvement of survival rate in hepatocellular carcinoma (HCC) when combined with radiofrequency ablation (RFA), percutaneous ethanol injection (PEI) or other therapies. The aim of this meta-analysis was to evaluate the effectiveness of combination therapy of TACE with RFA, PEI, radiotherapy (RT), three-dimensional conformal radiation therapy (3D-CRT) or High-Intensity Focused Ultrasound (HIFU). Methods: Randomized or nonrandomized studies comparing TACE combined with RFA, PEI, RT, 3D-CRT or HIFU with TACE alone for HCC were included. Meta-analysis was performed using a fix-effects model in RCTs and a random-effects model among the observational studies. Results: 10 randomized trials and 18 observational studies matched the selection criteria, including 2497 patients (682 in RCTs, 1815 in non-RCTs). Meta-analysis of RCTs showed that the combination of TACE and PEI ((RR)(1-)year=1.10, 95% CI=0.99-1.22, p=0.073; (RR)(3-)year=2.32, 95% CI=1.52-3.53, p<0.001), TACE+RT ((RR)(1-)year=1.37, 95% CI=1.11-1.70, p=0.004; (RR)(3-)year=2.32, 95% CI=1.44-3.75, p=0.001) were associated with higher survival rates. The results of observational studies were in good consistency with that of RCTs. Furthermore, TACE plus 3D-CRT ((RR)(1-)year=1.22, 95% CI=1.06-1.41, p=0.005; (RR)(3-)year=2.05, 95% CI=1.48-2.84, p<0.001) and TACE plus HIFU ((RR)(1-)year=1.16, 95% CI=1.01-1.33, p=0.033; (RR)(3-)year=1.66, 95%CI=1.12-2.45, p=0.011) have introduced marked survival benefit when pooling results from observational studies. Conclusions: This meta-analysis demonstrated that TACE combined with local treatments, especially PEI, HIFU or 3D-CRT could improve the overall survival status than performing TACE alone. Importantly, these results need to be validated in further high-quality clinical trials.	[Liao, Mingheng; Huang, Jiwei; Zhang, Tao; Wu, Hong] Sichuan Univ, Dept Hepatobiliary Pancreat Surg, West China Hosp, Chengdu 610064, Sichuan, Peoples R China	Sichuan University	Wu, H (corresponding author), Sichuan Univ, Dept Hepatobiliary Pancreat Surg, West China Hosp, Chengdu 610064, Sichuan, Peoples R China.	jingzhe_liao@qq.com	Liao, Mingheng/D-8934-2014	Liao, Mingheng/0000-0001-8627-2602				Aikata H, 2006, HEPATOLOGY, V44, p494A; Allgaier HP, 1998, INT J CANCER, V79, P601, DOI 10.1002/(SICI)1097-0215(19981218)79:6<601::AID-IJC8>3.0.CO;2-F; BARTOLOZZI C, 1995, RADIOLOGY, V197, P812, DOI 10.1148/radiology.197.3.7480761; Becker G, 2005, WORLD J GASTROENTERO, V11, P6104, DOI 10.3748/wjg.v11.i39.6104; Camma C, 2002, RADIOLOGY, V224, P47, DOI 10.1148/radiol.2241011262; Chapman WC, 2008, ANN SURG, V248, P617, DOI 10.1097/SLA.0b013e31818a07d4; Cheng BQ, 2008, JAMA-J AM MED ASSOC, V299, P1669, DOI 10.1001/jama.299.14.1669; Cheng JCH, 2001, INT J CANCER, V96, P243, DOI 10.1002/ijc.1022; Dettmer A, 2006, WORLD J GASTROENTERO, V12, P3707, DOI 10.3748/wjg.v12.i23.3707; Greten TF, 2005, BRIT J CANCER, V92, P1862, DOI 10.1038/sj.bjc.6602590; Gu Guo-Wen, 2009, Zhonghua Yi Xue Za Zhi, V89, P805; Guo WJ, 2003, WORLD J GASTROENTERO, V9, P1697, DOI 10.3748/wjg.v9.i8.1697; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Jin Cheng-bing, 2003, Zhonghua Zhongliu Zazhi, V25, P401; Kamada K, 2002, AM J SURG, V184, P284, DOI 10.1016/S0002-9610(02)00933-9; KATO T, 1994, CANCER CHEMOTH PHARM, V33, pS115, DOI 10.1007/BF00686681; Leng ZQ, 2000, CHIN J RAD ONCOL, V9, P99, DOI DOI 10.3760/J.ISSN:1004-4221.2000.02.007; Li Chuan-xing, 2009, Zhonghua Yi Xue Za Zhi, V89, P754; Li H, 2008, J S E U MED SCI EDI, V27, P368; [李玉 Li Yu], 2003, [中华放射肿瘤学杂志, Chinese Journal of Radiation Oncology], V12, P30; Liu JT., 2008, CHIN J MISDIAG, V8, P7333; Liu Meng-Zhong, 2005, Ai Zheng, V24, P82; Lu ZM, 2013, EUR J GASTROEN HEPAT, V25, P187, DOI 10.1097/MEG.0b013e32835a0a07; Lubienski A, 2004, ROFO-FORTSCHR RONTG, V176, P1794, DOI 10.1055/s-2004-813669; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Majno PE, 1997, ANN SURG, V226, P688, DOI 10.1097/00000658-199712000-00006; Marelli L, 2007, CARDIOVASC INTER RAD, V30, P6, DOI 10.1007/s00270-006-0062-3; Meng MB, 2009, RADIOTHER ONCOL, V92, P184, DOI 10.1016/j.radonc.2008.11.002; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Peng DaWei, 2009, China Tropical Medicine, V9, P1256; Qu ZQ, 2002, CHINESE GERMAN J CLI, V1, P28; Rahbari NN, 2011, ANN SURG, V253, P453, DOI 10.1097/SLA.0b013e31820d944f; Rammohan A, 2012, WORLD J RADIOL, V4, P405, DOI 10.4329/wjr.v4.i9.405; Reidy DL, 2004, ANTI-CANCER DRUG, V15, P427, DOI 10.1097/01.cad.0000127330.21686.26; Sahara S, 2012, CARDIOVASC INTER RAD, V35, P1363, DOI 10.1007/s00270-012-0352-x; Shang Y, 2007, SHIJIE HUAREN XIAOHU, V15, P3140, DOI DOI 10.3969/J.ISSN.1009-3079.2007.29.016; Shim SJ, 2005, LIVER INT, V25, P1189, DOI 10.1111/j.1478-3231.2005.01170.x; Song MJ, 2011, EUR J GASTROEN HEPAT, V23, P521, DOI 10.1097/MEG.0b013e328346d505; TANAKA K, 1991, RADIOLOGY, V179, P713, DOI 10.1148/radiology.179.3.1851313; Tanaka K, 1998, CANCER, V82, P78, DOI 10.1002/(SICI)1097-0142(19980101)82:1<78::AID-CNCR9>3.0.CO;2-G; Tiong L, 2011, BRIT J SURG, V98, P1210, DOI 10.1002/bjs.7669; Wang G, 2000, J CLIN ONCOL, V5, P380, DOI [10.1007/PL00012067, DOI 10.1007/PL00012067, 10.1007/PL0001206]; Wang GM, 1992, CHIN J RAD ONCOL, V1, P148; Wang N, 2011, MED ONCOL, V28, P1038, DOI 10.1007/s12032-010-9620-2; Wang W, 2010, LIVER INT, V30, P741, DOI 10.1111/j.1478-3231.2010.02221.x; Wang XH, 2006, SHAXI YIXUE ZAZHI, V35, P461, DOI DOI 10.3969/J.ISSN.1000-7377.2006.04.030; Wells GA, 2011, NEWCASTLE OTTAWA SCA; [吴德华 Wu Dehua], 2004, [中华消化杂志, Chinese Journal of Digestion], V24, P353; Wu Peihong, 1998, Zhonghua Zhongliu Zazhi, V20, P391; Xu GH, 2002, CLIN RADIOL, V21, P66; Xu J, 2006, SHANDONG YIYAO, V46, P19; Xue HZ, 1995, CHIN J RAD ONCOL, V4, P84; Yamamoto K, 1997, SEMIN ONCOL, V24, P50; Yan SS, 2012, DIGEST DIS SCI, V57, P3026, DOI 10.1007/s10620-012-2212-6; Yang P, 2008, ADV THER, V25, P787, DOI 10.1007/s12325-008-0079-x; Ye X, 2008, CANC RES CLIN, V20, P268; Zeng ZC, 2004, CANCER J, V10, P307, DOI 10.1097/00130404-200409000-00008; [张国喜 Zhang Guoxi], 2005, [中国超声医学杂志, Chinese Journal of Ultrasonic in Medical], V21, P71; Zhao MH, 2006, ZHONGHUA FANGSHE CHO, V15, P39, DOI DOI 10.3760/J.ISSN:1004-4221.2006.01.010; Zhao M, 2012, EUR J RADIOL, V81, P2717, DOI 10.1016/j.ejrad.2011.10.023; [赵锡立 Zhao Xili], 2004, [第四军医大学学报, Journal of the Fourth Military Medical University], V25, P1382; Zhou Ze-jian, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P1866; [朱志刚 ZHU Zhi-gang], 2009, [介入放射学杂志, Journal of Interventional Radiology], V18, P661; 宋仕茂, 2002, [中国肿瘤临床, Chinese Journal of Clinical Oncology], V29, P141; 兰东强, 2005, [中华放射肿瘤学杂志, Chinese Journal of Radiation Oncology], V14, P152	65	48	56	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68453	10.1371/journal.pone.0068453	http://dx.doi.org/10.1371/journal.pone.0068453			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844203	Green Published, Green Submitted, gold			2022-12-27	WOS:000321733000008
J	Cote, SC; Plante, A; Tardif, MR; Tremblay, MJ				Cote, Sandra C.; Plante, Audrey; Tardif, Melanie R.; Tremblay, Michel J.			Dectin-1/TLR2 and NOD2 Agonists Render Dendritic Cells Susceptible to Infection by X4-Using HIV-1 and Promote cis-Infection of CD4(+) T Cells	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; DC-SIGN; PRODUCTIVE INFECTION; DISTINCT SUBSETS; VAGINAL FLORA; VIRUS; TRANSMISSION; LYMPHOCYTES; ACTIVATION; MECHANISMS	HIV-1 pathogenesis is intimately linked with microbial infections and innate immunity during all stages of the disease. While the impact of microbial-derived products in transmission of R5-using virus to CD4(+) T cells by dendritic cells (DCs) has been addressed before, very limited data are available on the effect of such compounds on DC-mediated dissemination of X4-tropic variant. Here, we provide evidence that treatment of DCs with dectin-1/TLR2 and NOD2 ligands increases cis-infection of autologous CD4(+) T cells by X4-using virus. This phenomenon is most likely associated with an enhanced permissiveness of DCs to productive infection with X4 virus, which is linked to increased surface expression of CXCR4 and the acquisition of a maturation profile by DCs. The ensuing DC maturation enhances susceptibility of CD4(+) T cells to productive infection with HIV-1. This study highlights the crucial role of DCs at different stages of HIV-1 infection and particularly in spreading of viral strains displaying a X4 phenotype.	[Cote, Sandra C.; Plante, Audrey; Tardif, Melanie R.; Tremblay, Michel J.] Ctr Hosp Univ Quebec Pavillon CHUL, Quebec City, PQ, Canada; [Tremblay, Michel J.] Univ Laval, Dept Microbiol Infectiol & Immunol, Fac Med, Quebec City, PQ, Canada	Laval University; Laval University	Tremblay, MJ (corresponding author), Ctr Hosp Univ Quebec Pavillon CHUL, Quebec City, PQ, Canada.	michel.j.tremblay@crchul.ulaval.ca			Canadian Institutes of Health Research (CIHR) [MOP-79542]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was made possible through an operating grant to M.J.T. from the Canadian Institutes of Health Research (CIHR) (MOP-79542). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; Amati L, 2006, CURR PHARM DESIGN, V12, P4247, DOI 10.2174/138161206778743583; Arhel N, 2009, J CLIN INVEST, V119, P2965, DOI 10.1172/JCI38994; Arrighi JF, 2004, J EXP MED, V200, P1279, DOI 10.1084/jem.20041356; Ayinde D, 2012, NAT REV MICROBIOL, V10, P675, DOI 10.1038/nrmicro2862; Berg LM, 2012, ANN NY ACAD SCI; Blankson JN, 2002, ANNU REV MED, V53, P557, DOI 10.1146/annurev.med.53.082901.104024; Bonasio R, 2006, CURR OPIN IMMUNOL, V18, P503, DOI 10.1016/j.coi.2006.05.011; Bounou S, 2002, J VIROL, V76, P1004, DOI 10.1128/JVI.76.3.1004-1014.2002; CAMERON PU, 1992, SCIENCE, V257, P383, DOI 10.1126/science.1352913; Cantin R, 1997, J VIROL, V71, P1922, DOI 10.1128/JVI.71.3.1922-1930.1997; Cavrois M, 2006, J VIROL, V80, P1992, DOI 10.1128/JVI.80.4.1992-1999.2006; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Dong CS, 2007, J VIROL, V81, P11352, DOI 10.1128/JVI.01081-07; Dornadula G, 1999, VIROLOGY, V253, P10, DOI 10.1006/viro.1998.9465; Fackler OT, 2007, NAT REV IMMUNOL, V7, P310, DOI 10.1038/nri2041; Fiser AL, 2010, JAIDS-J ACQ IMM DEF, V53, P162, DOI 10.1097/QAI.0b013e3181c72033; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Geissmann F, 2008, IMMUNOL CELL BIOL, V86, P398, DOI 10.1038/icb.2008.19; Gilbert C, 2007, J IMMUNOL, V178, P2862, DOI 10.4049/jimmunol.178.5.2862; Gosselin A, 2010, J IMMUNOL, V184, P1604, DOI 10.4049/jimmunol.0903058; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Humrich JY, 2006, IMMUNOLOGY, V117, P238, DOI 10.1111/j.1365-2567.2005.02292.x; Izquierdo-Useros N, 2007, J VIROL, V81, P7559, DOI 10.1128/JVI.02572-06; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Kiertscher SM, 1996, J LEUKOCYTE BIOL, V59, P208, DOI 10.1002/jlb.59.2.208; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lin YL, 2005, JAIDS-J ACQ IMM DEF, V39, P530; Loisel-Meyer S, 2012, P NATL ACAD SCI USA, V109, P2549, DOI 10.1073/pnas.1121427109; MARGOLICK JB, 1987, J IMMUNOL, V138, P1719; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Moir S, 2011, ANNU REV PATHOL-MECH, V6, P223, DOI 10.1146/annurev-pathol-011110-130254; Moore JP, 2004, AIDS RES HUM RETROV, V20, P111, DOI 10.1089/088922204322749567; Ostrowski MA, 1999, J VIROL, V73, P6430, DOI 10.1128/JVI.73.8.6430-6435.1999; Oswald-Richter K, 2004, EUR J IMMUNOL, V34, P1705, DOI 10.1002/eji.200424892; POPE M, 1994, CELL, V78, P389, DOI 10.1016/0092-8674(94)90418-9; Pulendran B, 2001, TRENDS IMMUNOL, V22, P41, DOI 10.1016/S1471-4906(00)01794-4; Regoes RR, 2005, TRENDS MICROBIOL, V13, P269, DOI 10.1016/j.tim.2005.04.005; Ren WZ, 2010, J VIROL, V84, P340, DOI 10.1128/JVI.01865-09; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Salemi M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000950; Sanders RW, 2002, J VIROL, V76, P7812, DOI 10.1128/JVI.76.15.7812-7821.2002; Sewankambo N, 1997, LANCET, V350, P546, DOI 10.1016/S0140-6736(97)01063-5; Strober W, 2009, IMMUNITY, V31, P377, DOI 10.1016/j.immuni.2009.09.001; Su B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-S2-P182; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; Thibault S, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-42; Valera I, 2008, J IMMUNOL, V180, P5727, DOI 10.4049/jimmunol.180.8.5727; van der Vlist M, 2011, CURR OPIN HIV AIDS, V6, P348, DOI 10.1097/COH.0b013e328349a2d1; van Montfort T, 2008, J VIROL, V82, P7886, DOI 10.1128/JVI.00245-08; Wang JH, 2007, J VIROL, V81, P8933, DOI 10.1128/JVI.00878-07; Yamamoto T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000279	59	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67735	10.1371/journal.pone.0067735	http://dx.doi.org/10.1371/journal.pone.0067735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844079	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000088
J	Forster, M; Mahn, F; Gockel, U; Brosz, M; Freynhagen, R; Tolle, TR; Baron, R				Foerster, Matti; Mahn, Friederike; Gockel, Ulrich; Brosz, Mathias; Freynhagen, Rainer; Toelle, Thomas R.; Baron, Ralf			Axial Low Back Pain: One Painful Area - Many Perceptions and Mechanisms	PLOS ONE			English	Article							NEUROPATHIC PAIN; INTERVERTEBRAL DISC; SYMPTOM PROFILES; COMPONENTS; QUESTIONNAIRE; SENSITIVITY; DEPRESSION; SYSTEM	Axial low back pain can be considered as a syndrome with both nociceptive and neuropathic pain components (mixed-pain). Especially neuropathic pain comprises a therapeutic challenge in practical experience and may explain why pharmacotherapy in back pain is often disappointing for both the patient and the therapist. This survey uses epidemiological and clinical data on the symptomatology of 1083 patients with axial low back pain from a cross sectional survey (painDETECT). Objectives were (1) to estimate whether neuropathic pain contributes to axial low back pain and if so to what extent. (2) To detect subgroups of patients with typical sensory symptom profiles and to analyse their demographic data and co-morbidities. (3) To compare patients with and without prior intervertebral disc surgery (IVD). Neuropathic pain components could be detected in 12% of the entire cohort. Cluster analyses of these patients revealed five distinct subgroups of patients showing a characteristic sensory profile, i.e. a typical constellation and combination of symptoms. All subgroups occurred in relevant numbers and some showed distinct neuropathic characteristics while others showed nociceptive features. Post-IVD-surgery patients showed a tendency to score more "neuropathic'' than patients without surgery (not statistically significant). Axial low back pain has a high prevalence of co-morbidities with implication on therapeutic aspects. From these data it can be concluded that sensory profiles based on descriptor severity may serve as a better predictor for therapy assessment than pain intensity or sole diagnosis alone. Standardized phenotyping of pain symptoms with easy tools may help to develop an individualized therapy leading to a higher success rate in pharmacotherapy of axial low back pain.	[Foerster, Matti; Mahn, Friederike; Baron, Ralf] Univ Klinikum Schleswig Holstein, Neurol Klin, Sekt Neurol Schmerzforsch & Therapie, Kiel, Germany; [Gockel, Ulrich] Casquar GmbH, Bochum, Germany; [Brosz, Mathias] StatConsultGmbH, Magdeburg, Germany; [Freynhagen, Rainer] Benedictus Krankenhaus Tutzing, Zentrum Anasthesiol Intens Med Schmerztherapie &, Tutzing, Germany; [Toelle, Thomas R.] Tech Univ Munich, Neurol Klin, D-80290 Munich, Germany	University of Kiel; Schleswig Holstein University Hospital; Technical University of Munich	Forster, M (corresponding author), Univ Klinikum Schleswig Holstein, Neurol Klin, Sekt Neurol Schmerzforsch & Therapie, Campus Kiel, Kiel, Germany.	m.foerster@neurologie.uni-kiel.de	Yang, Bangxiang/G-2510-2014	Freynhagen, Rainer/0000-0002-3759-1508	Pfizer Germany	Pfizer Germany(Pfizer)	This research was supported by a grant from Pfizer Germany without restriction on publication. Data was collected within the PainDetect project, which was funded by Pfizer. The funder had no role in study design, analysis, decision to publish, or preparation of the manuscript.	Attal N, 2008, PAIN, V138, P343, DOI 10.1016/j.pain.2008.01.006; Attal N, 2011, EUR J PAIN, V15, P441, DOI 10.1016/j.ejpain.2011.03.005; Banik RK, 2004, PAIN, V112, P204, DOI 10.1016/j.pain.2004.08.026; Baron R, 2004, ORTHOPADE, V33, P568, DOI 10.1007/s00132-004-0645-0; Baron R, 2012, LANCET NEUROL, V11, P999, DOI 10.1016/S1474-4422(12)70189-8; Baron R, 2010, PAIN, V150, P420, DOI 10.1016/j.pain.2010.04.013; Baron R, 2010, LANCET NEUROL, V9, P807, DOI 10.1016/S1474-4422(10)70143-5; Baron R, 2009, PAIN, V146, P34, DOI 10.1016/j.pain.2009.06.001; Beith ID, 2011, PAIN, V152, P1511, DOI 10.1016/j.pain.2011.02.033; Brisby H, 2006, J BONE JOINT SURG AM, V88A, P68, DOI 10.2106/JBJS.E.01282; Courtney CA, 2010, J ORTHOP SPORT PHYS, V40, P818, DOI 10.2519/jospt.2010.3314; Cruz-Almeida Y, 2009, PAIN MED, V10, P1246, DOI 10.1111/j.1526-4637.2009.00713.x; Dworkin RH, 2007, J PAIN, V8, P118, DOI 10.1016/j.jpain.2006.06.005; Fishbain DA, 2008, PAIN MED, V9, P149, DOI 10.1111/j.1526-4637.2007.00302.x; Freemont AJ, 2009, RHEUMATOLOGY, V48, P5, DOI 10.1093/rheumatology/ken396; Freemont AJ, 1997, LANCET, V350, P178, DOI 10.1016/S0140-6736(97)02135-1; Freynhagen R, 2006, CURR MED RES OPIN, V22, P529, DOI 10.1185/030079906X89874; Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488; Freynhagen R, 2009, CURR PAIN HEADACHE R, V13, P185, DOI 10.1007/s11916-009-0032-y; Garcia-Cosamalon J, 2010, J ANAT, V217, P1, DOI 10.1111/j.1469-7580.2010.01227.x; Haanpaa M, 2011, PAIN, V152, P14, DOI 10.1016/j.pain.2010.07.031; Hays RD, 2005, SLEEP MED, V6, P41, DOI 10.1016/j.sleep.2004.07.006; Jensen TS, 2011, PAIN, V152, P2204, DOI 10.1016/j.pain.2011.06.017; Jensen TS, 2011, PAIN, V152, P12, DOI 10.1016/j.pain.2010.10.028; Junker U, 2008, CURR MED RES OPIN, V24, P1797, DOI 10.1185/03007990802121059; Khoromi S, 2005, J PAIN, V6, P829, DOI 10.1016/j.jpain.2005.08.002; Khoromi S, 2007, PAIN, V130, P66, DOI 10.1016/j.pain.2006.10.029; Konopka KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043526; Lowe B, 2004, J AFFECT DISORDERS, V81, P61, DOI 10.1016/S0165-0327(03)00198-8; Mahn F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018018; Meyer T, 2007, SPINE, V32, P2380, DOI 10.1097/BRS.0b013e3181557955; Miyamoto H, 2006, SPINE, V31, P4, DOI 10.1097/01.brs.0000192682.87267.2a; Schmidt CO, 2009, EUR J PAIN, V13, P1030, DOI 10.1016/j.ejpain.2008.12.003; Schnabel A, 2010, SCHMERZ, V24, P517, DOI 10.1007/s00482-010-0932-0; SULLIVAN MJL, 1992, PAIN, V50, P5, DOI 10.1016/0304-3959(92)90107-M; Takaso M, 2011, INT ORTHOP, V35, P67, DOI 10.1007/s00264-010-0986-8; Torrance N, 2006, J PAIN, V7, P281, DOI 10.1016/j.jpain.2005.11.008; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Woolf CJ, 1998, PAIN, V77, P227, DOI 10.1016/S0304-3959(98)00099-2	39	53	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68273	10.1371/journal.pone.0068273	http://dx.doi.org/10.1371/journal.pone.0068273			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844179	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000149
J	Hedtke, SM; Morgan, MJ; Cannatella, DC; Hillis, DM				Hedtke, Shannon M.; Morgan, Matthew J.; Cannatella, David C.; Hillis, David M.			Targeted Enrichment: Maximizing Orthologous Gene Comparisons across Deep Evolutionary Time	PLOS ONE			English	Article							ULTRACONSERVED ELEMENTS; PHYLOGENETIC ANALYSIS; MITOCHONDRIAL-DNA; EXON CAPTURE; GENOME; FROGS; SELECTION; INCONGRUENCE; GENERATION; THOUSANDS	Estimated phylogenies of evolutionarily diverse taxa will be well supported and more likely to be historically accurate when the analysis contains large amounts of data-many genes sequenced across many taxa. Inferring such phylogenies for non-model organisms is challenging given limited resources for whole-genome sequencing. We take advantage of genomic data from a single species to test the limits of hybridization-based enrichment of hundreds of exons across frog species that diverged up to 250 million years ago. Enrichment success for a given species depends greatly on the divergence time between it and the reference species, and the resulting alignment contains a significant proportion of missing data. However, our alignment generates a well-supported phylogeny of frogs, suggesting that this technique is a practical solution towards resolving relationships across deep evolutionary time.	[Hedtke, Shannon M.; Morgan, Matthew J.; Cannatella, David C.; Hillis, David M.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Hedtke, Shannon M.; Morgan, Matthew J.; Cannatella, David C.; Hillis, David M.] Univ Texas Austin, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; [Cannatella, David C.] Univ Texas Austin, Texas Nat Sci Ctr, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Hedtke, SM (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.	shannon.hedtke@gmail.com	Hillis, David/L-5421-2019; Morgan, Matt J/G-1067-2010	Hedtke, Shannon/0000-0002-7499-7662	National Science Foundation Early-concept Grant for Exploratory Research [DEB 0942956]	National Science Foundation Early-concept Grant for Exploratory Research	This work was funded by a National Science Foundation Early-concept Grant for Exploratory Research, DEB 0942956. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agilent Technologies Inc., 2010, SURESELECT TARGET EN; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amphibia Web, 2012, INF AMPH BIOL CONS; Ane C, 2007, MOL BIOL EVOL, V24, P412; Bewick AJ, 2012, SYST BIOL, V61, P913, DOI 10.1093/sysbio/sys039; Bi K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-403; Bossuyt Franky, 2009, P357; Burbano HA, 2010, SCIENCE, V328, P723, DOI 10.1126/science.1188046; Cho S, 2011, SYST BIOL, V60, P782, DOI 10.1093/sysbio/syr079; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Evans BJ, 2004, MOL PHYLOGENET EVOL, V33, P197, DOI 10.1016/j.ympev.2004.04.018; Faircloth BC, 2012, SYST BIOL, V61, P717, DOI 10.1093/sysbio/sys004; Ford Linda S., 1993, Herpetological Monographs, V7, P94, DOI 10.2307/1466954; George RD, 2011, GENOME RES, V21, P1686, DOI 10.1101/gr.121327.111; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Heath TA, 2008, J SYST EVOL, V46, P239, DOI 10.3724/SP.J.1002.2008.08016; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Hillis DM, 1996, NATURE, V383, P130, DOI 10.1038/383130a0; Hillis DM, 2003, SYST BIOL, V52, P124, DOI 10.1080/10635150390132911; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Hoegg S, 2004, MOL BIOL EVOL, V21, P1188, DOI 10.1093/molbev/msh081; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Irisarri I, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-626; Irisarri I, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-114; Krzywinski J, 2006, MOL PHYLOGENET EVOL, V39, P417, DOI 10.1016/j.ympev.2006.01.006; Kullberg M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000775; Kuo CH, 2008, MOL BIOL EVOL, V25, P2689, DOI 10.1093/molbev/msn213; Lemmon AR, 2012, SYST BIOL, V61, P727, DOI 10.1093/sysbio/sys049; Letsch HO, 2012, P ROY SOC B-BIOL SCI, V279, P3282, DOI 10.1098/rspb.2012.0744; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Libkind D, 2011, P NATL ACAD SCI USA, V108, P14539, DOI 10.1073/pnas.1105430108; Mason VC, 2011, GENOME RES, V21, P1695, DOI 10.1101/gr.120196.111; McCormack JE, 2012, GENOME RES, V22, P746, DOI 10.1101/gr.125864.111; Okou DT, 2007, NAT METHODS, V4, P907, DOI 10.1038/NMETH1109; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Philippe H, 2011, NATURE, V470, P255, DOI 10.1038/nature09676; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A, 2013, TRACER VERSION 1 6; Roche NimbleGen Inc., 2009, NIMBLEGEN ARR US GUI; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Sanderson MJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S3; Schmidt TR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-430; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Wiens JJ, 2011, SYST BIOL, V60, P719, DOI 10.1093/sysbio/syr025; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zwick MS, 1997, GENOME, V40, P138, DOI 10.1139/g97-020; Zwickl DJ, 2002, SYST BIOL, V51, P588, DOI 10.1080/10635150290102339; Zwickl DJ., 2006, THESIS	56	44	44	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67908	10.1371/journal.pone.0067908	http://dx.doi.org/10.1371/journal.pone.0067908			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844125	Green Published, gold			2022-12-27	WOS:000321341000118
J	Niu, LL; Zhang, YL; Qian, M; Meng, L; Xiao, Y; Wang, YY; Liu, X; Zheng, RQ; Zheng, HR				Niu, Lili; Zhang, Yanling; Qian, Ming; Meng, Long; Xiao, Yang; Wang, Yuanyuan; Liu, Xin; Zheng, Rongqin; Zheng, Hairong			Impact of Multiple Cardiovascular Risk Factors on Carotid Intima-Media Thickness and Elasticity	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; C-REACTIVE PROTEIN; MYOCARDIAL-INFARCTION; ARTERIAL STIFFNESS; METABOLIC SYNDROME; SMOKING-CESSATION; WAVE REFLECTION; YOUNG-ADULTS; DISEASE; EVENTS	Background: Carotid intima-media thickness (IMT) and elasticity have been shown to be independent predictors of cardiovascular disease (CVD). Cardiovascular risk factors (CVRFs) includes hypertension, dyslipidemia, diabetes, overweight and smoking. The objective was to investigate whether the clustering of three or more components of CVRFs has a greater impact on carotid IMT and elasticity than individual components of CVRFs. Methods: One hundred and seventy-three participants without clinical CVD were classified as the multiple CVRFs patients with three or more CVRFs (n = 55) and control group with two or less CVRFs (n = 118). Carotid IMT and elastic modulus were measured by B-mode ultrasound and vessel texture matching method (VTMM), respectively. Results: The multiple CVRFs conferred a disproportionate increase in carotid IMT (43%, p<0.0001) and elastic modulus (60%, p<0.0001), compared with control group. Multiple regression models, which included age, gender, as well as each individual component of CVRFs as continuous variables, showed that multiple CVRFs was an independent determinant of both IMT (p = 0.042) and elasticity (p = 0.008). In the analysis of variance adjusted with age, subjects with single, double, and multiple CVRFs, increased by 8.1%, 42.2%, and 66% for IMT, 54.6%, 94.3%, and 125.2% for elastic modulus, respectively, compared to subjects without CVRFs. Conclusions: The clustering of multiple CVRFs has a greater impact on carotid IMT and elasticity than individual components of CVRFs. This suggests that the components of CVRFs interact to synergistically impact carotid IMT and elasticity.	[Niu, Lili; Qian, Ming; Meng, Long; Xiao, Yang; Liu, Xin; Zheng, Hairong] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Paul C Lauterbur Res Ctr Biomed Imaging, Shenzhen, Peoples R China; [Zhang, Yanling; Zheng, Rongqin] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Ultrasound, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Yuanyuan] Fudan Univ, Dept Elect Engn, Shanghai 200433, Peoples R China	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Sun Yat Sen University; Fudan University	Zheng, RQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Ultrasound, Guangzhou 510275, Guangdong, Peoples R China.	zhengrongqin@hotmail.com; hr.zheng@siat.ac.cn	XIAO, YANG/GPW-5529-2022; Lv, Yuanjie/AER-0767-2022		National Research Program (973) from Ministry of Science and Technology, China [2011CB707903, 2013CB733800]; National Science Foundation Grants (NSFC) [81027006, 61020106008, 11002152, 11272329, 61031003, 61002001]	National Research Program (973) from Ministry of Science and Technology, China; National Science Foundation Grants (NSFC)	The work was supported by National Research Program (973 Grant Nos. 2011CB707903 and 2013CB733800) from Ministry of Science and Technology, China, and National Science Foundation Grants (NSFC Grant Nos. 81027006, 61020106008, 11002152, 11272329, 61031003 and 61002001). The funders of this work had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar J, 2001, J HYPERTENS, V19, P381, DOI 10.1097/00004872-200103000-00005; Assmann G, 1996, AM J CARDIOL, V77, P1179, DOI 10.1016/S0002-9149(96)00159-2; Bots ML, 1997, CIRCULATION, V96, P1432, DOI 10.1161/01.CIR.96.5.1432; Clarke R, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001177; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Davis PH, 2001, CIRCULATION, V104, P2815, DOI 10.1161/hc4601.099486; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Fagard RH, 2001, J AM COLL CARDIOL, V38, P227, DOI 10.1016/S0735-1097(01)01362-6; Frimodt-Moller M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041757; Ginsburg GS, 2007, J AM COLL CARDIOL, V50, P930, DOI 10.1016/j.jacc.2007.05.025; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Jatoi NA, 2007, HYPERTENSION, V49, P981, DOI 10.1161/HYPERTENSIONAHA.107.087338; KANNEL WB, 1988, AM J CARDIOL, V62, P1109, DOI 10.1016/0002-9149(88)90558-9; Kelly TN, 2008, CIRCULATION, V118, P1558, DOI 10.1161/CIRCULATIONAHA.107.723593; Koskinen J, 2009, CIRCULATION, V120, P229, DOI 10.1161/CIRCULATIONAHA.108.845065; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Li ZH, 1999, HYPERTENSION, V33, P116, DOI 10.1161/01.HYP.33.1.116; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Luc G, 1996, J LIPID RES, V37, P508; Magnussen CG, 2009, J AM COLL CARDIOL, V53, P860, DOI 10.1016/j.jacc.2008.09.061; Malloy MJ, 2012, CURR OPIN LIPIDOL, V23, P591, DOI 10.1097/MOL.0b013e328359f162; Manco M, 2010, ATHEROSCLEROSIS, V209, P463, DOI 10.1016/j.atherosclerosis.2009.10.014; Manisty C, 2010, J AM COLL CARDIOL, V56, P24, DOI 10.1016/j.jacc.2010.03.030; Mazzone T, 2006, JAMA-J AM MED ASSOC, V296, P2572, DOI 10.1001/jama.296.21.joc60158; Niu LL, 2012, ULTRASOUND MED BIOL, V38, P524, DOI 10.1016/j.ultrasmedbio.2011.12.010; Ooi EMM, 2008, CLIN SCI, V114, P611, DOI 10.1042/CS20070308; OROURKE MF, 1968, CIRC RES, V23, P567, DOI 10.1161/01.RES.23.4.567; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Ridker PM, 2001, CIRCULATION, V103, P1813, DOI 10.1161/01.CIR.103.13.1813; Rigotti NA, 2010, CIRCULATION, V121, P221, DOI 10.1161/CIRCULATIONAHA.109.869008; Sanz J, 2009, JACC-CARDIOVASC IMAG, V2, P286, DOI 10.1016/j.jcmg.2008.08.007; Scuteri A, 2004, J AM COLL CARDIOL, V43, P1388, DOI 10.1016/j.jacc.2003.10.061; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Stein JH, 2011, NEW ENGL J MED, V365, P1640, DOI 10.1056/NEJMc1109714; Urbina EM, 2002, AM J CARDIOL, V90, P953, DOI 10.1016/S0002-9149(02)02660-7; Weingartner O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013467; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yarnell JWG, 2001, ARTERIOSCL THROM VAS, V21, P1340, DOI 10.1161/hq0801.093505	38	10	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67809	10.1371/journal.pone.0067809	http://dx.doi.org/10.1371/journal.pone.0067809			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844099	gold, Green Submitted, Green Published			2022-12-27	WOS:000321341000102
J	Reynolds, CM; Li, ML; Gray, C; Vickers, MH				Reynolds, Clare M.; Li, Minglan; Gray, Clint; Vickers, Mark H.			Pre-Weaning Growth Hormone Treatment Ameliorates Bone Marrow Macrophage Inflammation in Adult Male Rat Offspring following Maternal Undernutrition	PLOS ONE			English	Article							ADIPOSE-TISSUE MACROPHAGES; INDUCED INSULIN-RESISTANCE; TUMOR-NECROSIS-FACTOR; NLRP3 INFLAMMASOME; OBESITY; DIFFERENTIATION; EXPRESSION; DISEASE; MICE; ACCUMULATION	Maternal undernutrition (UN) is associated with the development of obesity and metabolic complications in adult offspring. While the role of inflammation in obesity and related comorbidities has been well established, there is little evidence regarding the effects of maternal UN-induced programming on immune function in male adult offspring. This study examines the effects growth hormone (GH), which is known to induce anti-inflammatory effects, on maternal UN-induced bone marrow macrophage (BMM) function in adult male offspring. Sprague-Dawley rats were assigned to chow (C) or UN (50% ad libitum; UN) diet throughout gestation. Male C and UN pups received saline (CS/UNS) or GH (2.5 mu g/g/d; CGH/UNGH) from day 3-21. Bone marrow hematopoietic cells were differentiated to a macrophage phenotype in the presence of M-CSF (50 ng/ ml). Differentiated bone marrow macrophages (BMM) were stimulated with LPS (100 ng/ ml) for 6 h. UNS-derived BMM had significantly increased secretion and expression of IL-1 beta and IL-6 following LPS stimulation. This was accompanied by increased expression of IL-1R1, IL-6R and TLR4. Pre-weaning GH treatment reversed this pro-inflammatory phenotype. Furthermore UNGH displayed increased expression of markers of alternative (M2) macrophage activation, mannose receptor and PPAR gamma. This study demonstrates that fetal UN exposure primes hematopoietic immune cells to a more potent pro-inflammatory phenotype with heightened cytokine secretion and receptor expression. Furthermore these cells are pre-disposed to pro-inflammatory M1 macrophage phenotype which has wide-reaching and important effects in terms of obesity and metabolic disease.	[Vickers, Mark H.] Univ Auckland, Natl Res Ctr Growth & Dev, Liggins Inst, Auckland 1, New Zealand; Univ Auckland, Natl Res Ctr Growth & Dev, Gravida, Auckland 1, New Zealand	University of Auckland; University of Auckland	Vickers, MH (corresponding author), Univ Auckland, Natl Res Ctr Growth & Dev, Liggins Inst, Auckland 1, New Zealand.	m.vickers@auckland.ac.nz		Reynolds, Clare/0000-0001-5782-6303; Li, Minglan/0000-0002-3095-7490; Vickers, Mark/0000-0003-4876-9356	Gravida, National Centre for Growth and Development and the Health Research Council of New Zealand	Gravida, National Centre for Growth and Development and the Health Research Council of New Zealand	This work was funded by Gravida, National Centre for Growth and Development and the Health Research Council of New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage JA, 2008, FRONT HORM RES, V36, P73, DOI 10.1159/000115355; Badr G, 2011, CELL PHYSIOL BIOCHEM, V27, P381, DOI 10.1159/000327964; Cuesta S, 2011, REJUV RES, V14, P501, DOI 10.1089/rej.2011.1166; Dasu MR, 2009, ENDOCRINOLOGY, V150, P3457, DOI 10.1210/en.2008-1757; Franco C, 2007, J CLIN ENDOCR METAB, V92, P2644, DOI 10.1210/jc.2007-0068; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gray C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053505; GUARCELLO V, 1991, CELL IMMUNOL, V136, P291, DOI 10.1016/0008-8749(91)90353-D; Harford KA, 2011, P NUTR SOC, V70, P408, DOI 10.1017/S0029665111000565; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Koch JM, 2010, J ANIM SCI, V88, P1619, DOI 10.2527/jas.2009-2392; Liu L, 2010, PSYCHIAT RES, V176, P1, DOI 10.1016/j.psychres.2008.10.024; Lu CX, 2010, ENDOCRINOLOGY, V151, P2189, DOI 10.1210/en.2009-1194; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; McGillicuddy FC, 2011, DIABETES, V60, P1688, DOI 10.2337/db10-1278; Miyazawa K, 1998, J BIOCHEM, V124, P1130, DOI 10.1093/oxfordjournals.jbchem.a022231; Nagamatsu T, 2010, REPROD SCI, V17, P209, DOI 10.1177/1933719109349962; Naito M, 2008, PATHOL INT, V58, P143, DOI 10.1111/j.1440-1827.2007.02203.x; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Palmer AC, 2011, ADV NUTR, V2, P377, DOI 10.3945/an.111.000570; Remacle C, 2011, AM J CLIN NUTR, V94, p1846S, DOI 10.3945/ajcn.110.001651; Reynolds CM, 2012, MOL NUTR FOOD RES, V56, P1212, DOI 10.1002/mnfr.201200058; Reynolds CM, 2009, J NUTR, V139, P2351, DOI 10.3945/jn.109.113035; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; TAKAHASHI K, 1989, J LEUKOCYTE BIOL, V45, P87, DOI 10.1002/jlb.45.2.87; Takano A, 2001, DIABETES, V50, P1891, DOI 10.2337/diabetes.50.8.1891; Taylor PD, 2007, EXP PHYSIOL, V92, P287, DOI 10.1113/expphysiol.2005.032854; Thornburg KL, 2010, PLACENTA, V31, pS54, DOI 10.1016/j.placenta.2010.01.002; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vickers MH, 2011, WORLD J DIABETES, V2, P137, DOI 10.4239/wjd.v2.i9.137; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Vickers MH, 2002, J ENDOCRINOL, V175, P615, DOI 10.1677/joe.0.1750615; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246	34	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68262	10.1371/journal.pone.0068262	http://dx.doi.org/10.1371/journal.pone.0068262			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844177	Green Submitted, gold, Green Published			2022-12-27	WOS:000321341000148
J	Lau, WM; Doucet, M; Stadel, R; Huang, D; Weber, KL; Kominsky, SL				Lau, Wen Min; Doucet, Michele; Stadel, Ryan; Huang, David; Weber, Kristy L.; Kominsky, Scott L.			Enpp1: A Potential Facilitator of Breast Cancer Bone Metastasis	PLOS ONE			English	Article							INFANTILE ARTERIAL CALCIFICATION; INORGANIC PYROPHOSPHATE; PLASMA; HYPOPHOSPHATASIA; MINERALIZATION; HYDROXYAPATITE; PATHOGENESIS; OSTEOPONTIN; DISORDERS; MEMBRANE	Bone is the most common site of breast cancer metastasis and once established, it is frequently incurable. Critical to our ability to prevent and treat bone metastasis is the identification of the key factors mediating its establishment and understanding their biological function. To address this issue we previously carried out an in vivo selection process to isolate murine mammary tumor sublines possessing an enhanced ability to colonize the bone. A comparison of gene expression between parental cells and sublines by genome-wide cDNA microarray analysis revealed several potential mediators of bone metastasis, including the pyrophosphate-generating ectoenzyme Enpp1. By qRT-PCR and Western analysis we found that expression of Enpp1 was elevated in human breast cancer cell lines known to produce bone metastasis in animal models compared to non-metastatic and normal mammary epithelial cell lines. Further, in clinical specimens, levels of Enpp1 were significantly elevated in human primary breast tumors relative to normal mammary epithelium, with highest levels observed in breast-bone metastasis as determined by qRT-PCR and immunohistochemical analysis. To examine the potential role of Enpp1 in the development of bone metastasis, Enpp1 expression was stably increased in the breast cancer cell line MDA-MB-231 and the ability to colonize the bone following intracardiac and direct intratibial injection of athymic nude mice was determined. By both routes of administration, increased expression of Enpp1 enhanced the ability of MDA-MB-231 cells to form tumors in the bone relative to cells expressing vector alone, as determined by digital radiography and histological analysis. Taken together, these data suggest a potential role for Enpp1 in the development of breast cancer bone metastasis.	[Lau, Wen Min; Doucet, Michele; Stadel, Ryan; Huang, David; Weber, Kristy L.; Kominsky, Scott L.] Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD 21218 USA	Johns Hopkins University	Kominsky, SL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD 21218 USA.	kominsc@jhmi.edu						Addison WN, 2007, J BIOL CHEM, V282, P15872, DOI 10.1074/jbc.M701116200; Belleannee C, 2010, AM J PHYSIOL-CELL PH, V298, pC817, DOI 10.1152/ajpcell.00460.2009; Chirgwin JM, 2000, CRIT REV EUKAR GENE, V10, P159; Clemens TL, 2011, J BONE MINER RES, V26, P677, DOI 10.1002/jbmr.321; Fedde KN, 1999, J BONE MINER RES, V14, P2015, DOI 10.1359/jbmr.1999.14.12.2015; FLEISCH H, 1966, NATURE, V212, P901, DOI 10.1038/212901a0; Goldfine ID, 2008, ENDOCR REV, V29, P62, DOI 10.1210/er.2007-0004; Harmey D, 2004, AM J PATHOL, V164, P1199, DOI 10.1016/S0002-9440(10)63208-7; HUANG R, 1994, J CLIN INVEST, V94, P560, DOI 10.1172/JCI117370; Lau WM, 2010, INT J CANCER, V126, P876, DOI 10.1002/ijc.24780; Marchio C, 2008, J PATHOL, V215, P398, DOI 10.1002/path.2368; MEYER JL, 1973, CALC TISS RES, V13, P295, DOI 10.1007/BF02015419; Rodriguez C, 2000, GENE CHROMOSOME CANC, V27, P76, DOI 10.1002/(SICI)1098-2264(200001)27:1<76::AID-GCC10>3.0.CO;2-E; RUSSELL RGG, 1971, J CLIN INVEST, V50, P961, DOI 10.1172/JCI106589; Rutsch F, 2001, AM J PATHOL, V158, P543, DOI 10.1016/S0002-9440(10)63996-X; Rutsch F, 2003, NAT GENET, V34, P379, DOI 10.1038/ng1221; Saito T, 2011, BONE, V49, P913, DOI 10.1016/j.bone.2011.06.029	17	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e66752	10.1371/journal.pone.0066752	http://dx.doi.org/10.1371/journal.pone.0066752			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861746	Green Submitted, Green Published, gold			2022-12-27	WOS:000321425300006
J	Chesworth, R; Brown, RM; Kim, JH; Lawrence, AJ				Chesworth, Rose; Brown, Robyn M.; Kim, Jee Hyun; Lawrence, Andrew J.			The Metabotropic Glutamate 5 Receptor Modulates Extinction and Reinstatement of Methamphetamine-Seeking in Mice	PLOS ONE			English	Article							CUE-INDUCED REINSTATEMENT; LONG-TERM POTENTIATION; NUCLEUS-ACCUMBENS CORE; COCAINE-SEEKING; MGLUR5 RECEPTORS; FOOD-SEEKING; SYNAPTIC POTENTIATION; NMDA RECEPTORS; DRUG-ADDICTION; PROTEIN-KINASE	Methamphetamine (METH) is a highly addictive psychostimulant with no therapeutics registered to assist addicts in discontinuing use. Glutamatergic dysfunction has been implicated in the development and maintenance of addiction. We sought to assess the involvement of the metabotropic glutamate 5 receptor (mGlu5) in behaviours relevant to METH addiction because this receptor has been implicated in the actions of other drugs of abuse, including alcohol, cocaine and opiates. mGlu5 knockout (KO) mice were tested in intravenous self-administration, conditioned place preference and locomotor sensitization. Self-administration of sucrose was used to assess the response of KO mice to a natural reward. Acquisition and maintenance of self-administration, as well as the motivation to self-administer METH was intact in mGlu5 KO mice. Importantly, mGlu5 KO mice required more extinction sessions to extinguish the operant response for METH, and exhibited an enhanced propensity to reinstate operant responding following exposure to drug-associated cues. This phenotype was not present when KO mice were tested in an equivalent paradigm assessing operant responding for sucrose. Development of conditioned place preference and locomotor sensitization were intact in KO mice; however, conditioned hyperactivity to the context previously paired with drug was elevated in KO mice. These data demonstrate a role for mGlu5 in the extinction and reinstatement of METH-seeking, and suggests a role for mGlu5 in regulating contextual salience.	[Chesworth, Rose; Brown, Robyn M.; Kim, Jee Hyun; Lawrence, Andrew J.] Florey Inst Neurosci & Mental Hlth, Behav Neurosci Div, Parkville, Vic, Australia; [Chesworth, Rose; Brown, Robyn M.; Kim, Jee Hyun; Lawrence, Andrew J.] Univ Melbourne, Florey Dept Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Brown, Robyn M.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA	Florey Institute of Neuroscience & Mental Health; University of Melbourne; Medical University of South Carolina	Lawrence, AJ (corresponding author), Florey Inst Neurosci & Mental Hlth, Behav Neurosci Div, Parkville, Vic, Australia.	andrewjl@unimelb.edu.au	Brown, Robyn M/AAO-3694-2021; Kim, Jee Hyun/F-8777-2012	Brown, Robyn M/0000-0003-4167-3634; Kim, Jee Hyun/0000-0002-1299-4300; Chesworth, Rose/0000-0002-3758-9598	National Health and Medical Research Council (NHMRC) of Australia [APP1022201]; NHMRC; Australian Research Council Fellowship; Rotary Health Australia; Alan and Elizabeth Finkel Foundation	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Fellowship(Australian Research Council); Rotary Health Australia; Alan and Elizabeth Finkel Foundation	The present study was supported by a project grant (APP1022201) from the National Health and Medical Research Council (NHMRC) of Australia awarded to AL and JK, NHMRC fellowships and scholarships awarded to AL, RB, and RC, Australian Research Council Fellowship awarded to JK. RC also acknowledges support from Rotary Health Australia, as well as The Alan and Elizabeth Finkel Foundation. The authors acknowledge the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amen SL, 2011, NEUROPSYCHOPHARMACOL, V36, P871, DOI 10.1038/npp.2010.226; Aoki T, 2004, EUR J NEUROSCI, V20, P1633, DOI 10.1111/j.1460-9568.2004.03609.x; Ayala JE, 2009, NEUROPSYCHOPHARMACOL, V34, P2057, DOI 10.1038/npp.2009.30; Backstrom P, 2007, PSYCHOPHARMACOLOGY, V192, P571, DOI 10.1007/s00213-007-0753-8; Baker DA, 2003, NAT NEUROSCI, V6, P743, DOI 10.1038/nn1069; Ben-Shahar O, 2009, SYNAPSE, V63, P598, DOI 10.1002/syn.20640; Besheer J, 2008, ALCOHOL CLIN EXP RES, V32, P209, DOI 10.1111/j.1530-0277.2007.00570.x; Bespalov AY, 2005, NEUROPHARMACOLOGY, V49, P167, DOI 10.1016/j.neuropharm.2005.06.007; Beveridge TJR, 2011, NEUROSCI LETT, V496, P15, DOI 10.1016/j.neulet.2011.03.077; Bird M K, 2009, Curr Mol Pharmacol, V2, P83; Bird MK, 2008, INT J NEUROPSYCHOPH, V11, P765, DOI 10.1017/S1461145708008572; Bird MK, 2010, INT J NEUROPSYCHOPH, V13, P133, DOI 10.1017/S1461145709990162; Bird MK, 2009, TRENDS PHARMACOL SCI, V30, P617, DOI 10.1016/j.tips.2009.09.008; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brown Amanda L., 2011, International Journal of Neuropsychopharmacology, V14, P1099, DOI 10.1017/S1461145710001367; Brown R, 2012, INT STUD ASS SAN DIE, P1; Brown RM, 2012, DRUG ALCOHOL DEPEN, V123, P264, DOI 10.1016/j.drugalcdep.2011.11.002; Brown RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015889; Brown RM, 2009, NEUROPSYCHOPHARMACOL, V34, P844, DOI 10.1038/npp.2008.72; Busse CS, 2004, NEUROPSYCHOPHARMACOL, V29, P1971, DOI 10.1038/sj.npp.1300540; Cahir E, 2011, NEUROPSYCHOPHARMACOL, V36, P1505, DOI 10.1038/npp.2011.35; Cantin L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011592; Carroll FI, 2008, ANN NY ACAD SCI, V1141, P221, DOI 10.1196/annals.1441.015; Chaudhri N, 2008, BIOL PSYCHIAT, V64, P203, DOI 10.1016/j.biopsych.2008.03.007; Chen CC, 2012, NEUROSCI LETT, V524, P65, DOI 10.1016/j.neulet.2012.07.014; Chiamulera C, 2001, NAT NEUROSCI, V4, P873, DOI 10.1038/nn0901-873; Christensen CJ, 2008, PHARMACOL BIOCHEM BE, V91, P209, DOI 10.1016/j.pbb.2008.07.009; Christoffersen GRJ, 2008, BEHAV BRAIN RES, V191, P235, DOI 10.1016/j.bbr.2008.03.032; Cleva RM, 2012, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00093; Cleva RM, 2011, BEHAV NEUROSCI, V125, P10, DOI 10.1037/a0022339; Conklin CA, 2002, ADDICTION, V97, P155, DOI 10.1046/j.1360-0443.2002.00014.x; Cowen MS, 2007, PSYCHOPHARMACOLOGY, V190, P21, DOI 10.1007/s00213-006-0583-0; Cowen MS, 2005, J PHARMACOL EXP THER, V315, P590, DOI 10.1124/jpet.105.090449; D'Souza MS, 2011, NEUROPHARMACOLOGY, V61, P1399, DOI 10.1016/j.neuropharm.2011.08.028; Duncan JR, 2011, PHARM BIOCH BEHAV, V100, P811; Edwards S, 2011, ADDICT BIOL, V16, P450, DOI 10.1111/j.1369-1600.2010.00296.x; Eiler WJA, 2011, LIFE SCI, V89, P862, DOI 10.1016/j.lfs.2011.09.014; Eisch AJ, 1996, SYNAPSE, V22, P217, DOI 10.1002/(SICI)1098-2396(199603)22:3<217::AID-SYN3>3.0.CO;2-F; Ernst T, 2008, J NEUROIMMUNE PHARM, V3, P165, DOI 10.1007/s11481-008-9108-4; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fitzjohn SM, 1999, NEUROPHARMACOLOGY, V38, P1577, DOI 10.1016/S0028-3908(99)00123-9; Fontanez-Nuin DE, 2011, CEREB CORTEX, V21, P727, DOI 10.1093/cercor/bhq147; Galuska CM, 2011, BEHAV PHARMACOL, V22, P312, DOI 10.1097/FBP.0b013e3283473be4; Gass JT, 2009, PSYCHOPHARMACOLOGY, V204, P587, DOI 10.1007/s00213-009-1490-y; Gass JT, 2009, BIOL PSYCHIAT, V65, P717, DOI 10.1016/j.biopsych.2008.11.001; Gass JT, 2009, NEUROPSYCHOPHARMACOL, V34, P820, DOI 10.1038/npp.2008.140; Ghasemzadeh MB, 1999, J NEUROCHEM, V72, P157, DOI 10.1046/j.1471-4159.1999.0720157.x; Herrold AA, 2013, EUR NEUROPSYCHOPHARM, V23, P691, DOI 10.1016/j.euroneuro.2012.05.014; Herzig V, 2005, ADDICT BIOL, V10, P243, DOI 10.1080/13556210500223272; Hollander JA, 2007, J NEUROSCI, V27, P3535, DOI 10.1523/JNEUROSCI.3667-06.2007; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Iacovelli L, 2013, NEUROPHARMACOLOGY, V66, P24, DOI 10.1016/j.neuropharm.2012.05.005; Jia ZP, 1998, LEARN MEMORY, V5, P331; Jones JL, 2008, SYNAPSE, V62, P219, DOI 10.1002/syn.20486; KAIYA H, 1983, FOLIA PSYCHIAT NEU J, V37, P107; Kalivas PW, 2008, NEUROPSYCHOPHARMACOL, V33, P166, DOI 10.1038/sj.npp.1301564; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kasanetz F, 2010, SCIENCE, V328, P1709, DOI 10.1126/science.1187801; Kenny P, 2011, SUBST ABUSE TREAT PR, V6, DOI 10.1186/1747-597X-6-3; Knackstedt LA, 2010, J NEUROSCI, V30, P7984, DOI 10.1523/JNEUROSCI.1244-10.2010; Knackstedt LA, 2010, BIOL PSYCHIAT, V67, P81, DOI 10.1016/j.biopsych.2009.07.018; Knackstedt LA, 2009, CURR OPIN PHARMACOL, V9, P59, DOI 10.1016/j.coph.2008.12.003; Kumaresan V, 2009, BEHAV BRAIN RES, V202, P238, DOI 10.1016/j.bbr.2009.03.039; LaLumiere RT, 2012, EUR J NEUROSCI, V35, P614, DOI 10.1111/j.1460-9568.2012.07991.x; Lenoir M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000698; Lominac KD, 2006, DRUG ALCOHOL DEPEN, V85, P142, DOI 10.1016/j.drugalcdep.2006.04.003; Lu YM, 1997, J NEUROSCI, V17, P5196; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Martin-Fardon R, 2009, J PHARMACOL EXP THER, V329, P1084, DOI 10.1124/jpet.109.151357; McGeehan AJ, 2003, SYNAPSE, V47, P240, DOI 10.1002/syn.10166; McPherson CS, 2010, CEREB CORTEX, V20, P941, DOI 10.1093/cercor/bhp159; Mickiewicz AL, 2009, NEUROPSYCHOPHARMACOL, V34, P874, DOI 10.1038/npp.2008.111; Millan EZ, 2010, J NEUROSCI, V30, P4626, DOI 10.1523/JNEUROSCI.4933-09.2010; Moussawi K, 2011, P NATL ACAD SCI USA, V108, P385, DOI 10.1073/pnas.1011265108; Moussawi K, 2010, EUR J PHARMACOL, V639, P115, DOI 10.1016/j.ejphar.2010.01.030; Novak M, 2010, J NEUROSCI, V30, P11973, DOI 10.1523/JNEUROSCI.2550-10.2010; Olive MF, 2010, EUR J PHARMACOL, V639, P47, DOI 10.1016/j.ejphar.2010.01.029; Olive M Foster, 2009, Curr Drug Abuse Rev, V2, P83; Osborne MPH, 2008, ANN NY ACAD SCI, V1139, P206, DOI 10.1196/annals.1432.034; Parmentier-Batteur S, 2012, NEUROPHARMACOLOGY, V62, P1453, DOI 10.1016/j.neuropharm.2010.11.013; Pennay A, 2008, PREVENTION RES Q SEP, P1; Peters J, 2008, J NEUROSCI, V28, P6046, DOI 10.1523/JNEUROSCI.1045-08.2008; Pierce RC, 1996, J NEUROSCI, V16, P1550; REBERG D, 1972, Learning and Motivation, V3, P246, DOI 10.1016/0023-9690(72)90021-5; Rokosik SL, 2013, NEUROREPORT, V24, P152, DOI 10.1097/WNR.0b013e32835e11a2; ROMANO C, 1995, J COMP NEUROL, V355, P455, DOI 10.1002/cne.903550310; Sailasuta N, 2010, SUBST ABUS-RES TREAT, V4, P9, DOI 10.4137/SART.S4625; Schmidt HD, 2010, ANN NY ACAD SCI, V1187, P35, DOI 10.1111/j.1749-6632.2009.05144.x; SHIGEMOTO R, 1993, NEUROSCI LETT, V163, P53, DOI 10.1016/0304-3940(93)90227-C; Sinclair CM, 2012, PHARMACOL BIOCHEM BE, V101, P329, DOI 10.1016/j.pbb.2012.01.014; Soria G, 2008, PSYCHOPHARMACOLOGY, V199, P593, DOI 10.1007/s00213-008-1184-x; Stankeviciute NM, 2014, ADDICT BIOL, V19, P972, DOI 10.1111/adb.12064; Stoker AK, 2012, PSYCHOPHARMACOLOGY, V221, P317, DOI 10.1007/s00213-011-2578-8; Suto N, 2010, PSYCHOPHARMACOLOGY, V211, P267, DOI 10.1007/s00213-010-1890-z; Tessari M, 2004, EUR J PHARMACOL, V499, P121, DOI 10.1016/j.ejphar.2004.07.056; Torregrossa MM, 2010, J NEUROSCI, V30, P10526, DOI 10.1523/JNEUROSCI.2523-10.2010; Uys JD, 2010, PROG MOL BIOL TRANSL, V98, P367; Veeneman MMJ, 2011, PSYCHOPHARMACOLOGY, V214, P863, DOI 10.1007/s00213-010-2095-1; Wang XS, 2013, ADDICT BIOL, V18, P40, DOI 10.1111/j.1369-1600.2011.00432.x; Watterson LR, 2013, PSYCHOPHARMACOLOGY, V225, P151, DOI 10.1007/s00213-012-2804-z; Widholm J. J., 2011, J ADDICT RES THER S, VS1, P4; Xi Zheng-Xiong, 2008, Curr Drug Abuse Rev, V1, P303; Yan YJ, 2006, BEHAV BRAIN RES, V168, P137, DOI 10.1016/j.bbr.2005.11.030; Yang L, 2004, J NEUROSCI, V24, P10846, DOI 10.1523/JNEUROSCI.2496-04.2004; Yucel M, 2007, MOL PSYCHIATR, V12, P691, DOI 10.1038/sj.mp.4001955	105	41	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68371	10.1371/journal.pone.0068371	http://dx.doi.org/10.1371/journal.pone.0068371			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861896	Green Published, Green Submitted, gold			2022-12-27	WOS:000323350700082
J	Cruz, L; Meyers, C				Cruz, Linda; Meyers, Craig			Differential Dependence on Host Cell Glycosaminoglycans for Infection of Epithelial Cells by High-Risk HPV Types	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; MINOR CAPSID PROTEIN; HEPARAN-SULFATE; EXTRACELLULAR-MATRIX; HUMAN KERATINOCYTES; SURFACE-BINDING; CERVICAL-CANCER; L2; RECEPTOR; DNA	Human papillomavirus (HPV) infection is the leading cause of cervical cancer world-wide. Here, we show that native HPV particles produced in a differentiated epithelium have developed different strategies to infect the host. Using biochemical inhibition assays and glycosaminoglycan (GAG)-negative cells, we show that of the four most common cancer-causing HPV types, HPV18, HPV31, and HPV45 are largely dependent on GAGs to initiate infection. In contrast, HPV16 can bind and enter through a GAG-independent mechanism. Infections of primary human keratinocytes, natural host cells for HPV infections, support our conclusions. Further, this renders the different virus types differentially susceptible to carrageenan, a microbicide targeting virus entry. Our data demonstrates that ordered maturation of papillomavirus particles in a differentiating epithelium may alter the virus entry mechanism. This study should facilitate a better understanding of the attachment and infection by the main oncogenic HPV types, and development of inhibitors of HPV infection.	[Cruz, Linda; Meyers, Craig] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Meyers, C (corresponding author), Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA USA.	cmm10@psu.edu			PHS grant from the National Institute of Allergy and Infectious Disease [R01AI57988]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057988] Funding Source: NIH RePORTER	PHS grant from the National Institute of Allergy and Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a PHS grant from the National Institute of Allergy and Infectious Disease (R01AI57988). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, AIDS PATIENT CARE ST, V25, P265; Bauer PH, 1999, J VIROL, V73, P5826, DOI 10.1128/JVI.73.7.5826-5832.1999; Bienkowska-Haba M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000524; Buck CB, 2005, J VIROL, V79, P2839, DOI 10.1128/JVI.79.5.2839-2846.2005; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Buck CB, 2006, PLOS PATHOG, V2, P671, DOI 10.1371/journal.ppat.0020069; Cerqueira C., 2013, CELL MICROBIOL; Conway MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016405; Conway MJ, 2009, J VIROL, V83, P10515, DOI 10.1128/JVI.00731-09; Culp TD, 2006, VIROLOGY, V347, P147, DOI 10.1016/j.virol.2005.11.025; Culp TD, 2006, J VIROL, V80, P8940, DOI 10.1128/JVI.00724-06; Dasgupta J, 2011, J BIOL CHEM, V286, P2617, DOI 10.1074/jbc.M110.160184; Day PM, 2008, J VIROL, V82, P4638, DOI 10.1128/JVI.00143-08; Day PM, 2008, J VIROL, V82, P12565, DOI 10.1128/JVI.01631-08; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; Evander M, 1997, J VIROL, V71, P2449, DOI 10.1128/JVI.71.3.2449-2456.1997; Finnen RL, 2003, J VIROL, V77, P4818, DOI 10.1128/JVI.77.8.4818-4826.2003; Fligge C, 2001, J VIROL, V75, P7727, DOI 10.1128/JVI.75.16.7727-7731.2001; Giroglou T, 2001, J VIROL, V75, P1565, DOI 10.1128/JVI.75.3.1565-1570.2001; Johnson KM, 2009, J VIROL, V83, P2067, DOI 10.1128/JVI.02190-08; Kamper N, 2006, J VIROL, V80, P759, DOI 10.1128/JVI.80.2.759-768.2006; Kines RC, 2009, P NATL ACAD SCI USA, V106, P20458, DOI 10.1073/pnas.0908502106; Lembo D, 2008, ANTIMICROB AGENTS CH, V52, P1374, DOI 10.1128/AAC.01467-07; Luciani S, 2009, IMMUNOTHERAPY-UK, V1, P795, DOI 10.2217/IMT.09.48; McLaughlin-Drubin ME, 2003, VIROLOGY, V312, P1, DOI 10.1016/S0042-6822(03)00312-X; MEYERS C, 1992, SCIENCE, V257, P971, DOI 10.1126/science.1323879; Meyers C, 1997, J VIROL, V71, P7381, DOI 10.1128/JVI.71.10.7381-7386.1997; Neu U, 2010, CELL HOST MICROBE, V8, P309, DOI 10.1016/j.chom.2010.09.004; Patterson NA, 2005, J VIROL, V79, P6838, DOI 10.1128/JVI.79.11.6838-6847.2005; Pereira R, 2009, ARCH VIROL, V154, P187, DOI 10.1007/s00705-009-0310-3; Richards RM, 2006, P NATL ACAD SCI USA, V103, P1522, DOI 10.1073/pnas.0508815103; Sapp M, 1998, J VIROL, V72, P6186, DOI 10.1128/JVI.72.7.6186-6189.1998; Sapp M, 2009, VIROLOGY, V384, P400, DOI 10.1016/j.virol.2008.12.022; Sapp M, 2009, FEBS J, V276, P7206, DOI 10.1111/j.1742-4658.2009.07400.x; Schelhaas M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002657; Schiffman Mark, 2003, J Natl Cancer Inst Monogr, P14; Selinka HC, 2007, J VIROL, V81, P10970, DOI 10.1128/JVI.00998-07; Selinka HC, 2003, J VIROL, V77, P12961, DOI 10.1128/JVI.77.24.12961-12967.2003; Smith JL, 2007, J VIROL, V81, P9922, DOI 10.1128/JVI.00988-07; Surviladze Z, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002519; Talarico LB, 2007, VIROLOGY, V363, P473, DOI 10.1016/j.virol.2007.01.043; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; Woodham AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043519; Yang RC, 2003, J BIOL CHEM, V278, P12546, DOI 10.1074/jbc.M208691200; Yang RC, 2003, J VIROL, V77, P3531, DOI 10.1128/JVI.77.6.3531-3541.2003; Zhao KN, 1998, VIROLOGY, V243, P482, DOI 10.1006/viro.1998.9091; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	47	26	26	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68379	10.1371/journal.pone.0068379	http://dx.doi.org/10.1371/journal.pone.0068379			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861898	Green Published, gold, Green Submitted			2022-12-27	WOS:000323350700083
J	Dasgupta, K; Da Costa, D; Pillay, S; De Civita, M; Gougeon, R; Leong, A; Bacon, S; Stotland, S; Chetty, VT; Garfield, N; Majdan, A; Meltzer, S				Dasgupta, Kaberi; Da Costa, Deborah; Pillay, Sabrina; De Civita, Mirella; Gougeon, Rejeanne; Leong, Aaron; Bacon, Simon; Stotland, Stephen; Chetty, V. Tony; Garfield, Natasha; Majdan, Agnieszka; Meltzer, Sara			Strategies to Optimize Participation in Diabetes Prevention Programs following Gestational Diabetes: A Focus Group Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; INSULIN-RESISTANCE; RISK PERCEPTION; SELF-EFFICACY; MELLITUS; WOMEN; INTERVENTION; POPULATION; PREVALENCE; HISTORIES	Objective: We performed a qualitative study among women within 5 years of Gestational Diabetes (GDM) diagnosis. Our aim was to identify the key elements that would enhance participation in a type 2 diabetes (DM2) prevention program. Research Design and Methods: Potential participants received up to three invitation letters from their GDM physician. Four focus groups were held. Discussants were invited to comment on potential facilitators/barriers to participation and were probed on attitudes towards meal replacement and Internet/social media tools. Recurring themes were identified through qualitative content analysis of discussion transcripts. Results: Among the 1,201 contacted and 79 eligible/interested, 29 women attended a focus group discussion. More than half of discussants were overweight/obese, and less than half were physically active. For DM2 prevention, a strong need for social support to achieve changes in dietary and physical activity habits was expressed. In this regard, face-to-face interactions with peers and professionals were preferred, with adjunctive roles for Internet/social media. Further, direct participation of partners/spouses in a DM2 prevention program was viewed as important to enhance support for behavioural change at home. Discussants highlighted work and child-related responsibilities as potential barriers to participation, and emphasized the importance of childcare support to allow attendance. Meal replacements were viewed with little interest, with concerns that their use would provide a poor example of eating behaviour to children. Conclusions: Among women within 5 years of a GDM diagnosis who participated in a focus group discussion, participation in a DM2 prevention program would be enhanced by face-to-face interactions with professionals and peers, provision of childcare support, and inclusion of spouses/partners.	[Dasgupta, Kaberi; Da Costa, Deborah; Pillay, Sabrina; De Civita, Mirella; Gougeon, Rejeanne; Leong, Aaron; Garfield, Natasha; Majdan, Agnieszka; Meltzer, Sara] McGill Univ, Dept Med, Montreal, PQ, Canada; [Bacon, Simon] Concordia Univ, Dept Exercise Sci, Montreal, PQ, Canada; [Stotland, Stephen] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Chetty, V. Tony] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	McGill University; Concordia University - Canada; McGill University; McMaster University	Dasgupta, K (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.	kaberi.dasgupta@mcgill.ca	Bacon, Simon/B-2637-2012	Bacon, Simon/0000-0001-7075-0358	Canadian Institutes of Health Research (Institute of Circulatory and Respiratory Health and Institute of Gender and Health) [CAI 117789]	Canadian Institutes of Health Research (Institute of Circulatory and Respiratory Health and Institute of Gender and Health)	Funding was provided by the Canadian Institutes of Health Research (CAI 117789; Institute of Circulatory and Respiratory Health and Institute of Gender and Health). Sehar Manji, assistant to KD at the McGill University Health Centre Research Institute, provided important support in the preparation of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardini G, 2010, DIABETES CARE, V33, P411, DOI 10.2337/dc09-1342; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Booth ML, 2000, PREV MED, V31, P15, DOI 10.1006/pmed.2000.0661; Clark HD, 2003, DIABETES CARE, V26, P265, DOI 10.2337/diacare.26.2.265; Clausen TD, 2008, DIABETES CARE, V31, P340, DOI 10.2337/dc07-1596; Dasgupta K, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-125; Dietz PM, 2008, OBSTET GYNECOL, V112, P868, DOI 10.1097/AOG.0b013e318184db63; Egeland GM, 2010, DIABETIC MED, V27, P257, DOI 10.1111/j.1464-5491.2010.02944.x; Ferrara A, 2011, DIABETES CARE; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; Gorin AA, 2008, INT J OBESITY, V32, P1678, DOI 10.1038/ijo.2008.150; Jones EJ, 2012, JOGNN-J OBST GYN NEO, V41, P246, DOI 10.1111/j.1552-6909.2012.01339.x; Jovanovic L, 2001, JAMA-J AM MED ASSOC, V286, P2516, DOI 10.1001/jama.286.20.2516; Kim C, 2008, DIABETES EDUCATOR, V34, P719, DOI 10.1177/0145721708321005; Kim C, 2007, DIABETES CARE, V30, P2281, DOI 10.2337/dc07-0618; Krueger R. A., 1988, FOCUS GROUPS PRACTIC; Malcolm JC, 2006, DIABETIC MED, V23, P565, DOI 10.1111/j.1464-5491.2006.01840.x; Meltzer SJ, 2010, BJOG-INT J OBSTET GY, V117, P407, DOI 10.1111/j.1471-0528.2009.02475.x; Morrison MK, 2009, AUST NZ J OBSTET GYN, V49, P494, DOI 10.1111/j.1479-828X.2009.01056.x; Moses RG, 1996, DIABETES CARE, V19, P1348, DOI 10.2337/diacare.19.12.1348; Nicklas JM, 2011, BMC PREGNANCY CHILDB, P11; Ostbye T, 2009, AM J PREV MED, V37, P173, DOI 10.1016/j.amepre.2009.05.016; Pirkola J, 2010, J CLIN ENDOCR METAB, V95, P772, DOI 10.1210/jc.2009-1075; Pridjian G, 2010, OBSTET GYN CLIN N AM, V37, P255, DOI 10.1016/j.ogc.2010.02.017; Ratner RE, 2008, J CLIN ENDOCR METAB, V93, P4774, DOI 10.1210/jc.2008-0772; Stern SE, 2005, DIABETES, V54, P333, DOI 10.2337/diabetes.54.2.333; Sternfeld B, 1999, PREV MED, V28, P313, DOI 10.1006/pmed.1998.0470; WHITE E, 1991, AM J PREV MED, V7, P319, DOI 10.1016/S0749-3797(18)30905-X; Yun Shumei, 2007, Prev Chronic Dis, V4, pA07; Zehle K, 2008, DIABETES EDUCATOR, V34, P807, DOI 10.1177/0145721708323641	30	48	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67878	10.1371/journal.pone.0067878	http://dx.doi.org/10.1371/journal.pone.0067878			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861824	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000323350700052
J	Raoof, M; Cisneros, BT; Corr, SJ; Palalon, F; Curley, SA; Koshkina, NV				Raoof, Mustafa; Cisneros, Brandon T.; Corr, Stuart J.; Palalon, Flavio; Curley, Steven A.; Koshkina, Nadezhda V.			Tumor Selective Hyperthermia Induced by Short-Wave Capacitively-Coupled RF Electric-Fields	PLOS ONE			English	Article								There is a renewed interest in developing high-intensity short wave capacitively-coupled radiofrequency (RF) electric-fields for nanoparticle-mediated tumor-targeted hyperthermia. However, the direct thermal effects of such high-intensity electric-fields (13.56 MHZ, 600 W) on normal and tumor tissues are not completely understood. In this study, we investigate the heating behavior and dielectric properties of normal mouse tissues and orthotopically-implanted human hepatocellular and pancreatic carcinoma xenografts. We note tumor-selective hyperthermia (relative to normal mouse tissues) in implanted xenografts that can be explained on the basis of differential dielectric properties. Furthermore, we demonstrate that repeated RF exposure of tumor-bearing mice can result in significant anti-tumor effects compared to control groups without detectable harm to normal mouse tissues.	[Raoof, Mustafa; Cisneros, Brandon T.; Corr, Stuart J.; Palalon, Flavio; Curley, Steven A.; Koshkina, Nadezhda V.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Raoof, Mustafa] Univ Arizona, Hlth Sci Ctr, Dept Surg, Tucson, AZ USA; [Cisneros, Brandon T.; Corr, Stuart J.] Rice Univ, Dept Chem, Houston, TX USA; [Curley, Steven A.] Rice Univ, Dept Mech Engn & Mat Sci, Houston, TX 77251 USA	University of Texas System; UTMD Anderson Cancer Center; University of Arizona; University of Arizona Health Sciences; Rice University; Rice University	Koshkina, NV (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA.	nvkoshki@mdanderson.org	Raoof, Mustafa/D-1664-2012	CORR, STUART/0000-0002-9865-5309	National Institutes of Health (NIH) [U54CA143837]; NIH M. D. Anderson Cancer Center [CA016672]; Kanzius Research Foundation (SAC, Erie, Pennsylvania); NATIONAL CANCER INSTITUTE [U54CA143837, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH M. D. Anderson Cancer Center; Kanzius Research Foundation (SAC, Erie, Pennsylvania); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded from the National Institutes of Health (NIH) (U54CA143837), NIH M. D. Anderson Cancer Center Support grant CA016672, and an unrestricted research grant from the Kanzius Research Foundation (SAC, Erie, Pennsylvania). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora D, 2002, IEEE T BIO-MED ENG, V49, P629, DOI 10.1109/TBME.2002.1010846; CHEUNG AY, 1982, BRIT J CANCER, V45, P16; COLEY WB, 1991, CLIN ORTHOP RELAT R, P3; Corr SJ, 2012, ACS SYM SER, V1113, P81; Corr SJ, 2012, J PHYS CHEM C, V116, P24380, DOI 10.1021/jp309053z; Cruz-Monserrate Z, 2012, GUT, V61, P1315, DOI 10.1136/gutjnl-2011-300544; DEFORD JA, 1991, MED BIOL ENG COMPUT, V29, P197, DOI 10.1007/BF02447108; DICKSON JA, 1979, LANCET, V1, P202, DOI 10.1016/S0140-6736(79)90594-4; FAJARDO LF, 1984, CANCER RES, V44, P4826; GERWECK LE, 1985, CANCER RES, V45, P3408; Gladman AS, 2004, INT J HYPERTHER, V20, P539, DOI 10.1080/02656730410001668366; Glazer ES, 2010, CLIN CANCER RES, V16, P5712, DOI 10.1158/1078-0432.CCR-10-2055; Glazer ES, 2010, CANCER-AM CANCER SOC, V116, P3285, DOI 10.1002/cncr.25135; Haemmerich D, 2003, PHYSIOL MEAS, V24, P251, DOI 10.1088/0967-3334/24/2/302; KAWASHIMA E, 1963, Sanfujinka Chiryo, V6, P628; LEE CKK, 1989, RADIOL CLIN N AM, V27, P543; Nielsen OS, 2001, EUR J CANCER, V37, P1587, DOI 10.1016/S0959-8049(01)00193-9; Raoof M, 2013, BIOMATERIALS, V34, P1862, DOI 10.1016/j.biomaterials.2012.11.033; Raoof M, 2012, NANOMED-NANOTECHNOL, V8, P1096, DOI 10.1016/j.nano.2012.02.001; Raoof M, 2011, INT J HEPATOL, V2011, DOI 10.4061/2011/676957; Raoof M, 2012, INT J HYPERTHER, V28, P202, DOI 10.3109/02656736.2012.666318; REFINETTI R, 1988, Journal de Physiologie (Paris), V83, P300; SAPARETO SA, 1984, INT J RADIAT ONCOL, V10, P787, DOI 10.1016/0360-3016(84)90379-1; SMITH SR, 1986, IEEE T BIO-MED ENG, V33, P522, DOI 10.1109/TBME.1986.325740; SONG CW, 1986, INT J RADIAT ONCOL, V12, P365, DOI 10.1016/0360-3016(86)90352-4; van der Zee J, 2002, ANN ONCOL, V13, P1173, DOI 10.1093/annonc/mdf280; Yarmolenko PS, 2011, INT J HYPERTHER, V27, P320, DOI 10.3109/02656736.2010.534527	27	48	48	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68506	10.1371/journal.pone.0068506	http://dx.doi.org/10.1371/journal.pone.0068506			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861912	Green Published, gold, Green Submitted			2022-12-27	WOS:000323350700089
J	Chan, PL; Zheng, J; Liu, YP; Lam, KT; Xiang, Z; Mao, HW; Liu, Y; Qin, G; Lau, YL; Tu, WW				Chan, Ping-Lung; Zheng, Jian; Liu, Yinping; Lam, Kwok-Tai; Xiang, Zheng; Mao, Huawei; Liu, Yuan; Qin, Gang; Lau, Yu-Lung; Tu, Wenwei			TLR5 Signaling Enhances the Proliferation of Human Allogeneic CD40-Activated B Cell Induced CD4(hi)CD25(+) Regulatory T Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; NF-KAPPA-B; SUPPRESSIVE CAPACITY; FLAGELLIN; STIMULATION; EXPRESSION; ABSENCE; FOXP3; CYCLE; TCR	Although diverse functions of different toll-like receptors (TLR) on human natural regulatory T cells have been demonstrated recently, the role of TLR-related signals on human induced regulatory T cells remain elusive. Previously our group developed an ex vivo high-efficient system in generating human alloantigen-specific CD4(hi)CD25(+) regulatory T cells from naive CD4(+)CD25(-) T cells using allogeneic CD40-activated B cells as stimulators. In this study, we investigated the role of TLR5-related signals on the generation and function of these novel CD4(hi)CD25(+) regulatory T cells. It was found that induced CD4(hi)CD25(+) regulatory T cells expressed an up-regulated level of TLR5 compared to their precursors. The blockade of TLR5 using anti-TLR5 antibodies during the co-culture decreased CD4(hi)CD25(+) regulatory T cells proliferation by induction of S phase arrest. The S phase arrest was associated with reduced ERK1/2 phosphorylation. However, TLR5 blockade did not decrease the CTLA-4, GITR and FOXP3 expressions, and the suppressive function of CD4(hi)CD25(+) regulatory T cells. In conclusion, we discovered a novel function of TLR5-related signaling in enhancing the proliferation of CD4(hi)CD25(+) regulatory T cells by promoting S phase progress but not involved in the suppressive function of human CD40-activated B cell-induced CD4(hi)CD25(+) regulatory T cells, suggesting a novel role of TLR5-related signals in the generation of induced regulatory T cells.	[Chan, Ping-Lung; Zheng, Jian; Liu, Yinping; Lam, Kwok-Tai; Xiang, Zheng; Mao, Huawei; Liu, Yuan; Qin, Gang; Lau, Yu-Lung; Tu, Wenwei] Univ Hong Kong, Dept Paediat & Adolescent Med, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Tu, WW (corresponding author), Univ Hong Kong, Dept Paediat & Adolescent Med, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China.	wwtu@hku.hk	; Lau, Yu Lung/C-4322-2009	Chan, Ping Lung/0000-0002-5639-2117; Lau, Yu Lung/0000-0002-4780-0289; Liu, Yuan/0000-0003-4880-5185	NSFC/RGC Joint Research Scheme [N_HKU 747/11]; General Research Fund, Research Grants Council of Hong Kong [HKU 781211M]; Area of Excellence program [AoE/M-12/06]; University Grants Committee of Hong Kong Special Administrative Region	NSFC/RGC Joint Research Scheme(National Natural Science Foundation of China (NSFC)); General Research Fund, Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Area of Excellence program; University Grants Committee of Hong Kong Special Administrative Region	This work was supported in part by NSFC/RGC Joint Research Scheme (N_HKU 747/11), General Research Fund, Research Grants Council of Hong Kong (HKU 781211M); Area of Excellence program (AoE/M-12/06), University Grants Committee of Hong Kong Special Administrative Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alpdogan O, 2012, SEMIN ONCOL, V39, P629, DOI 10.1053/j.seminoncol.2012.10.001; [Anonymous], 2000, CHAMP CHIP TRANSCR F; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Caron G, 2005, J IMMUNOL, V175, P1551, DOI 10.4049/jimmunol.175.3.1551; Chen SC, 2004, J BIOL CHEM, V279, P13755, DOI 10.1074/jbc.M310064200; Collins K, 1997, P NATL ACAD SCI USA, V94, P2776, DOI 10.1073/pnas.94.7.2776; Corthay A, 2009, SCAND J IMMUNOL, V70, P326, DOI 10.1111/j.1365-3083.2009.02308.x; Crellin NK, 2005, J IMMUNOL, V175, P8051, DOI 10.4049/jimmunol.175.12.8051; Fallarino F, 2009, J IMMUNOL, V183, P6303, DOI 10.4049/jimmunol.0901577; Fournier B, 2009, INFECT IMMUN, V77, P4121, DOI 10.1128/IAI.00656-09; Gelman AE, 2004, J IMMUNOL, V172, P6065, DOI 10.4049/jimmunol.172.10.6065; Gogishvili T, 2013, EUR J IMMUNOL, V43, P188, DOI 10.1002/eji.201242824; He HQ, 2011, IMMUNOBIOLOGY, V216, P678, DOI 10.1016/j.imbio.2010.11.002; Huang F, 2010, ACTA BIOCH BIOPH SIN, V42, P325, DOI 10.1093/abbs/gmq025; Josefowicz SZ, 2009, J IMMUNOL, V182, P6648, DOI 10.4049/jimmunol.0803320; Kabelitz D, 2007, CURR OPIN IMMUNOL, V19, P39, DOI 10.1016/j.coi.2006.11.007; Kinnebrew MA, 2010, J INFECT DIS, V201, P534, DOI 10.1086/650203; Kuhn A, 2008, ARCH DERMATOL RES, V5, P5; Le Bras S, 2006, J CLIN INVEST, V116, P1473, DOI 10.1172/JCI28880; Lourenco EV, 2011, AUTOIMMUNITY, V44, P33, DOI 10.3109/08916931003782155; Lupino E, 2012, J IMMUNOL, V188, P2545, DOI 10.4049/jimmunol.1102938; Mansson A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-36; Marsland BJ, 2007, J IMMUNOL, V178, P3466, DOI 10.4049/jimmunol.178.6.3466; Milkova L, 2009, EXP DERMATOL, V21, P21; Neish AS, 2007, AM J PHYSIOL-GASTR L, V292, pG462, DOI 10.1152/ajpgi.00274.2006; Nishimoto S, 2006, EMBO REP, V7, P782, DOI 10.1038/sj.embor.7400755; Oberg HH, 2010, J IMMUNOL, V184, P4733, DOI 10.4049/jimmunol.0804279; Redmond WL, 2009, CRIT REV IMMUNOL, V29, P187, DOI 10.1615/CritRevImmunol.v29.i3.10; Salamone GV, 2010, LAB INVEST, V90, P1049, DOI 10.1038/labinvest.2010.77; Sansom DM, 2006, IMMUNOL REV, V212, P131, DOI 10.1111/j.0105-2896.2006.00419.x; Schafer KA, 1998, VET PATHOL, V35, P461, DOI 10.1177/030098589803500601; Schmidt A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002179; Schmidt-Weber CB, 1999, J IMMUNOL, V162, P238; Simone Rita, 2009, Open Microbiol J, V3, P1, DOI 10.2174/1874285800903010001; Soligo M, 2011, EUR J IMMUNOL, V41, P503, DOI 10.1002/eji.201040712; Song EJ, 2011, INT J MOL MED, V28, P115, DOI 10.3892/ijmm.2011.656; Steiner TS, 2010, CELL IMMUNOL, V264, P135, DOI 10.1016/j.cellimm.2010.05.012; Sun J, 2007, AM J PHYSIOL-GASTR L, V292, pG767, DOI 10.1152/ajpgi.00447.2006; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Szymczak-Workman AL, 2009, J IMMUNOL, V182, P5188, DOI 10.4049/jimmunol.0803123; Tu WW, 2008, BLOOD, V112, P2554, DOI 10.1182/blood-2008-04-152041; Vijay-Kumar M, 2006, AM J PATHOL, V169, P1686, DOI 10.2353/ajpath.2006.060345; von Boehmer H, 2008, NAT IMMUNOL, V9, P121, DOI 10.1038/ni0208-121; Wakamatsu E, 2013, P NATL ACAD SCI USA, V110, P1023, DOI 10.1073/pnas.1220688110; Wang L, 2008, P NATL ACAD SCI USA, V105, P9331, DOI 10.1073/pnas.0710441105; Zheng J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004943; Zheng JA, 2011, EUR J IMMUNOL, V41, P128, DOI 10.1002/eji.201040724; Zheng J, 2010, CELL MOL IMMUNOL, V7, P44, DOI 10.1038/cmi.2009.103	50	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67969	10.1371/journal.pone.0067969	http://dx.doi.org/10.1371/journal.pone.0067969			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844139	Green Published, gold, Green Submitted			2022-12-27	WOS:000321733000121
J	Enciso-Rodriguez, FE; Gonzalez, C; Rodriguez, EA; Lopez, CE; Landsman, D; Barrero, LS; Marino-Ramirez, L				Enciso-Rodriguez, Felix E.; Gonzalez, Carolina; Rodriguez, Edwin A.; Lopez, Camilo E.; Landsman, David; Stella Barrero, Luz; Marino-Ramirez, Leonardo			Identification of Immunity Related Genes to Study the Physalis peruviana - Fusarium oxysporum Pathosystem	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; DISEASE RESISTANCE GENES; LEUCINE-RICH REPEATS; NBS-LRR PROTEINS; ANTIINFLAMMATORY ACTIVITY; ATP-BINDING; IN-VITRO; SEQUENCES; KINASE; PERCEPTION	The Cape gooseberry (Physalis peruviana L) is an Andean exotic fruit with high nutritional value and appealing medicinal properties. However, its cultivation faces important phytosanitary problems mainly due to pathogens like Fusarium oxysporum, Cercospora physalidis and Alternaria spp. Here we used the Cape gooseberry foliar transcriptome to search for proteins that encode conserved domains related to plant immunity including: NBS (Nucleotide Binding Site), CC (Coiled-Coil), TIR (Toll/Interleukin-1 Receptor). We identified 74 immunity related gene candidates in P. peruviana which have the typical resistance gene (R-gene) architecture, 17 Receptor like kinase (RLKs) candidates related to PAMP-Triggered Immunity (PTI), eight (TIR-NBS-LRR, or TNL) and nine (CC-NBS-LRR, or CNL) candidates related to Effector-Triggered Immunity (ETI) genes among others. These candidate genes were categorized by molecular function (98%), biological process (85%) and cellular component (79%) using gene ontology. Some of the most interesting predicted roles were those associated with binding and transferase activity. We designed 94 primers pairs from the 74 immunity-related genes (IRGs) to amplify the corresponding genomic regions on six genotypes that included resistant and susceptible materials. From these, we selected 17 single band amplicons and sequenced them in 14 F. oxysporum resistant and susceptible genotypes. Sequence polymorphisms were analyzed through preliminary candidate gene association, which allowed the detection of one SNP at the PpIRG-63 marker revealing a nonsynonymous mutation in the predicted LRR domain suggesting functional roles for resistance.	[Enciso-Rodriguez, Felix E.; Stella Barrero, Luz; Marino-Ramirez, Leonardo] Colombian Corp Agr Res CORPOICA, CBB, Plant Mol Genet Lab, Bogota, Colombia; [Gonzalez, Carolina; Rodriguez, Edwin A.] Colombian Corp Agr Res CORPOICA, CBB, Mol Microbiol Lab, Bogota, Colombia; [Lopez, Camilo E.] Univ Nacl Colombia, Lab Fitopatol Mol, Dept Biol, Bogota, Colombia; [Landsman, David; Marino-Ramirez, Leonardo] NIH, Computat Biol Branch, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA; [Stella Barrero, Luz; Marino-Ramirez, Leonardo] PanAmer Bioinformat Inst, Santa Marta, Magdalena, Colombia	Corporacion Colombiana de Investigacion Agropecuaria, AGROSAVIA; Corporacion Colombiana de Investigacion Agropecuaria, AGROSAVIA; Universidad Nacional de Colombia; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Marino-Ramirez, L (corresponding author), Colombian Corp Agr Res CORPOICA, CBB, Plant Mol Genet Lab, Bogota, Colombia.	marino@ncbi.nlm.nih.gov	Landsman, David/C-5923-2009; Mariño-Ramírez, Leonardo/N-5395-2019; Landsman, David/GZK-5496-2022; Mariño-Ramírez, Leonardo/I-5759-2013	Landsman, David/0000-0002-9819-6675; Mariño-Ramírez, Leonardo/0000-0002-5716-8512; Mariño-Ramírez, Leonardo/0000-0002-5716-8512; Enciso-Rodriguez, Felix/0000-0002-3490-6586	Colombian Ministry of Agriculture [054/08072-2008L4787-3281, 054/08190-2008L7922-3322]; Intramural Research Program of the National Institutes of Health; National Library of Medicine; National Center for Biotechnology Information; NATIONAL LIBRARY OF MEDICINE [ZIALM082713, ZIALM000071] Funding Source: NIH RePORTER	Colombian Ministry of Agriculture; Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Center for Biotechnology Information; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Support for this research was provided by a grant from the Colombian Ministry of Agriculture Contract Nos. 054/08072-2008L4787-3281 to Luz Stella Barrero and 054/08190-2008L7922-3322 to Victor Manuel Nunez Zarantes. This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Library of Medicine, and National Center for Biotechnology Information. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bakker E, 2011, THEOR APPL GENET, V123, P493, DOI 10.1007/s00122-011-1602-z; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bedoya-Reina OC, 2010, GENE, V458, P27, DOI 10.1016/j.gene.2010.03.005; Bernal A, 2013, BIOPROSPECCION DESAR; Bonilla M, 2009, AGENDA PROSPECTIVA I; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Cho YG, 2000, THEOR APPL GENET, V100, P713, DOI 10.1007/s001220051343; CIAT, 1987, SIST EST EV GERM FRI; Collier SM, 2009, TRENDS PLANT SCI, V14, P521, DOI 10.1016/j.tplants.2009.08.001; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Couch BC, 2006, MOL PLANT MICROBE IN, V19, P288, DOI 10.1094/MPMI-19-0288; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; Eddy Sean R, 2009, Genome Inform, V23, P205; El-Bramawy MASA, 2009, TUNISIAN J PLANT PRO, V4, P29; Ellis JG, 1999, PLANT CELL, V11, P495, DOI 10.1105/tpc.11.3.495; Estupinan R, 2007, EFECTO AGENTE CAUSAL, P89; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fenyk S, 2012, J BIOL CHEM, V287, P4023, DOI 10.1074/jbc.M111.314450; Franco LA, 2007, BIOMEDICA, V27, P110, DOI 10.7705/biomedica.v27i1.237; Garzon-Martinez GA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-151; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gordon D., 2003, CURR PROTOC BIOINFOR, V11, P1, DOI DOI 10.1002/0471250953.BI1102S02; Gu Lianfeng, 2007, Journal of Genetics and Genomics, V34, P247, DOI 10.1016/S1673-8527(07)60026-5; Jauhar PP, 2006, CROP SCI, V46, P1841, DOI 10.2135/cropsci2005.07-0223; Jiang HY, 2007, PLANT SCI, V173, P253, DOI 10.1016/j.plantsci.2007.05.010; Jinling Liu, 2007, Journal of Genetics and Genomics, V34, P765, DOI 10.1016/S1673-8527(07)60087-3; Jones DA, 1997, ADV BOT RES, V24, P89; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kohler A, 2008, PLANT MOL BIOL, V66, P619, DOI 10.1007/s11103-008-9293-9; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li YQ, 2007, MOL PLANT MICROBE IN, V20, P1449, DOI 10.1094/MPMI-20-11-1449; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Martínez Fabio Ernesto, 2008, Agron. colomb., V26, P389; Martinez W, 2010, IMMUNOPHARM IMMUNOT, V32, P63, DOI 10.1080/08923970903143957; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; MENZEL M. Y., 1951, Proceedings of the American Philosophical Society, V95, P132; Meyers BC, 2005, CURR OPIN PLANT BIOL, V8, P129, DOI 10.1016/j.pbi.2005.01.002; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Mueller LA, 2005, PLANT PHYSIOL, V138, P1310, DOI 10.1104/pp.105.060707; Mun JH, 2009, MOL GENET GENOMICS, V282, P617, DOI 10.1007/s00438-009-0492-0; NAMIKI F, 1994, APPL ENVIRON MICROB, V60, P2684, DOI 10.1128/AEM.60.8.2684-2691.1994; Offord V, 2010, DEV COMP IMMUNOL, V34, P1035, DOI 10.1016/j.dci.2010.05.004; Pinto MD, 2009, J MED FOOD, V12, P278, DOI 10.1089/jmf.2008.0113; Plocik A, 2004, MOL PHYLOGENET EVOL, V31, P153, DOI 10.1016/S1055-7903(03)00274-4; Popenoe H, 1990, LOST CROPS INCAS LIT, P241; Postel S, 2009, SEMIN CELL DEV BIOL, V20, P1025, DOI 10.1016/j.semcdb.2009.06.002; Pritchard JK, 2000, GENETICS, V155, P945; Radwan O, 2008, MOL GENET GENOMICS, V280, P111, DOI 10.1007/s00438-008-0346-1; Rafiqi M, 2009, SEMIN CELL DEV BIOL, V20, P1017, DOI 10.1016/j.semcdb.2009.04.010; Ramadan MF, 2011, FOOD RES INT, V44, P1830, DOI 10.1016/j.foodres.2010.12.042; Rodrigues E, 2009, CIENCIA TECNOL ALIME, V29, P642, DOI 10.1590/S0101-20612009000300029; Rozen S, 2000, Methods Mol Biol, V132, P365; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schneider D, 2010, IEEE SPECTRUM, V47, P48, DOI 10.1109/MSPEC.2010.5372501; Shen KA, 1998, MOL PLANT MICROBE IN, V11, P815, DOI 10.1094/MPMI.1998.11.8.815; Simbaqueba J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026719; Simons G, 1998, PLANT CELL, V10, P1055, DOI 10.1105/tpc.10.6.1055; Soriano JM, 2005, THEOR APPL GENET, V110, P980, DOI 10.1007/s00122-005-1920-0; Tameling WIL, 2002, PLANT CELL, V14, P2929, DOI 10.1105/tpc.005793; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Wang Y, 2008, GENETICS, V180, P391, DOI 10.1534/genetics.108.087981; Wu SJ, 2009, FOOD CHEM TOXICOL, V47, P1132, DOI 10.1016/j.fct.2009.01.044; Wu SJ, 2005, BIOL PHARM BULL, V28, P963, DOI 10.1248/bpb.28.963; Yaish MWF, 2004, GENOME, V47, P650, DOI 10.1139/G04-027; Yang SH, 2008, THEOR APPL GENET, V116, P165, DOI 10.1007/s00122-007-0656-4; Yen CY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-46; Zhou T, 2004, MOL GENET GENOMICS, V271, P402, DOI 10.1007/s00438-004-0990-z; Zipfel C, 2008, CURR OPIN IMMUNOL, V20, P10, DOI 10.1016/j.coi.2007.11.003; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	79	36	44	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68500	10.1371/journal.pone.0068500	http://dx.doi.org/10.1371/journal.pone.0068500			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844210	gold, Green Published, Green Submitted			2022-12-27	WOS:000321733000011
J	Mochida, T; Kimura, T; Hiroya, S; Kitagawa, N; Gomi, H; Kondo, T				Mochida, Takemi; Kimura, Toshitaka; Hiroya, Sadao; Kitagawa, Norimichi; Gomi, Hiroaki; Kondo, Tadahisa			Speech Misperception: Speaking and Seeing Interfere Differently with Hearing	PLOS ONE			English	Article							HUMAN AUDITORY-CORTEX; MIRROR NEURONS; MOTOR CORTEX; PERCEPTION; INTEGRATION; EXCITABILITY; CONSONANTS; RESPONSES; LANGUAGE; OPINION	Speech perception is thought to be linked to speech motor production. This linkage is considered to mediate multimodal aspects of speech perception, such as audio-visual and audio-tactile integration. However, direct coupling between articulatory movement and auditory perception has been little studied. The present study reveals a clear dissociation between the effects of a listener's own speech action and the effects of viewing another's speech movements on the perception of auditory phonemes. We assessed the intelligibility of the syllables [pa], [ta], and [ka] when listeners silently and simultaneously articulated syllables that were congruent/incongruent with the syllables they heard. The intelligibility was compared with a condition where the listeners simultaneously watched another's mouth producing congruent/incongruent syllables, but did not articulate. The intelligibility of [ta] and [ka] were degraded by articulating [ka] and [ta] respectively, which are associated with the same primary articulator (tongue) as the heard syllables. But they were not affected by articulating [pa], which is associated with a different primary articulator (lips) from the heard syllables. In contrast, the intelligibility of [ta] and [ka] was degraded by watching the production of [pa]. These results indicate that the articulatory-induced distortion of speech perception occurs in an articulator-specific manner while visually induced distortion does not. The articulator-specific nature of the auditory-motor interaction in speech perception suggests that speech motor processing directly contributes to our ability to hear speech.	[Mochida, Takemi; Kimura, Toshitaka; Hiroya, Sadao; Kitagawa, Norimichi; Gomi, Hiroaki; Kondo, Tadahisa] NTT Corp, NTT Commun Sci Labs, Atsugi, Kanagawa, Japan	Nippon Telegraph & Telephone Corporation	Mochida, T (corresponding author), NTT Corp, NTT Commun Sci Labs, Atsugi, Kanagawa, Japan.	mochida.takemi@lab.ntt.co.jp	Gomi, Hiroaki/AEL-2645-2022	Gomi, Hiroaki/0000-0003-3541-2251	Nippon Telegraph; Telephone Corporation	Nippon Telegraph; Telephone Corporation	This work was supported by Nippon Telegraph and Telephone Corporation (http://www.ntt.co.jp/index_e.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROOKS PL, 1983, J ACOUST SOC AM, V74, P34, DOI 10.1121/1.389685; D'Ausillo A, 2009, CURR BIOL, V19, P381, DOI 10.1016/j.cub.2009.01.017; Devlin JT, 2007, BRAIN, V130, P610, DOI 10.1093/brain/awl331; EIMAS PD, 1971, SCIENCE, V171, P303, DOI 10.1126/science.171.3968.303; Fadiga L, 2002, EUR J NEUROSCI, V15, P399, DOI 10.1046/j.0953-816x.2001.01874.x; FOWLER CA, 1991, J EXP PSYCHOL HUMAN, V17, P816, DOI 10.1037/0096-1523.17.3.816; Galantucci B, 2006, PSYCHON B REV, V13, P361, DOI 10.3758/BF03193857; Gault RH, 1924, J ABNORMAL PSYCHOL S, V19, DOI DOI 10.1037/H0065752; Gick B, 2009, NATURE, V462, P502, DOI 10.1038/nature08572; Hickok G, 2008, BRAIN LANG, V107, P179, DOI 10.1016/j.bandl.2008.09.006; Hickok G, 2011, NEURON, V69, P407, DOI 10.1016/j.neuron.2011.01.019; Hickok G, 2010, LANG COGNITIVE PROC, V25, P749, DOI 10.1080/01690961003595572; Ito T, 2009, P NATL ACAD SCI USA, V106, P1245, DOI 10.1073/pnas.0810063106; Kaiser J, 2005, CEREB CORTEX, V15, P646, DOI 10.1093/cercor/bhh166; Kauramaki J, 2010, J NEUROSCI, V30, P1314, DOI 10.1523/JNEUROSCI.1950-09.2010; KUHL PK, 1975, SCIENCE, V190, P69, DOI 10.1126/science.1166301; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; LIBERMAN AM, 1985, COGNITION, V21, P1, DOI 10.1016/0010-0277(85)90021-6; Lotto AJ, 2009, TRENDS COGN SCI, V13, P110, DOI 10.1016/j.tics.2008.11.008; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Meister IG, 2007, CURR BIOL, V17, P1692, DOI 10.1016/j.cub.2007.08.064; MILLER GA, 1955, J ACOUST SOC AM, V27, P338, DOI 10.1121/1.1907526; Mottonen R, 2002, COGNITIVE BRAIN RES, V13, P417, DOI 10.1016/S0926-6410(02)00053-8; Mottonen R, 2009, J NEUROSCI, V29, P9819, DOI 10.1523/JNEUROSCI.6018-08.2009; Munhall KG, 2009, CURR BIOL, V19, P735, DOI 10.1016/j.cub.2009.03.019; Okada K, 2009, NEUROSCI LETT, V452, P219, DOI 10.1016/j.neulet.2009.01.060; Pulvermuller F, 2006, P NATL ACAD SCI USA, V103, P7865, DOI 10.1073/pnas.0509989103; Pulvermuller F, 2010, NAT REV NEUROSCI, V11, P351, DOI 10.1038/nrn2811; Sams M, 2005, COGNITIVE BRAIN RES, V23, P429, DOI 10.1016/j.cogbrainres.2004.11.006; Sato M, 2010, SPEECH COMMUN, V52, P533, DOI 10.1016/j.specom.2009.12.004; Scott SK, 2009, NAT REV NEUROSCI, V10, P295, DOI 10.1038/nrn2603; SEKIYAMA K, 1991, J ACOUST SOC AM, V90, P1797, DOI 10.1121/1.401660; Stevens K.N., 2000, ACOUSTIC PHONETICS, V30; Watkins K, 2004, J COGNITIVE NEUROSCI, V16, P978, DOI 10.1162/0898929041502616; Watkins KE, 2003, NEUROPSYCHOLOGIA, V41, P989, DOI 10.1016/S0028-3932(02)00316-0; WELLER M, 1993, J NEUROL, V240, P199, DOI 10.1007/BF00818705; Wilson SM, 2004, NAT NEUROSCI, V7, P701, DOI 10.1038/nn1263; Wilson SM, 2006, NEUROIMAGE, V33, P316, DOI 10.1016/j.neuroimage.2006.05.032; Zheng ZZ, 2010, J COGNITIVE NEUROSCI, V22, P1770, DOI 10.1162/jocn.2009.21324	39	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68619	10.1371/journal.pone.0068619	http://dx.doi.org/10.1371/journal.pone.0068619			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182HT	23844227	Green Published, gold, Green Submitted			2022-12-27	WOS:000321733000018
J	Zorick, T; Mandelkern, MA				Zorick, Todd; Mandelkern, Mark A.			Multifractal Detrended Fluctuation Analysis of Human EEG: Preliminary Investigation and Comparison with the Wavelet Transform Modulus Maxima Technique	PLOS ONE			English	Article							NEURONAL AVALANCHES; HUMAN BRAIN; FUNCTIONAL-STATE; SLEEP-APNEA; SIGNALS; OSCILLATIONS; DYNAMICS; CORTEX; SERIES	Recently, many lines of investigation in neuroscience and statistical physics have converged to raise the hypothesis that the underlying pattern of neuronal activation which results in electroencephalography (EEG) signals is nonlinear, with self-affine dynamics, while scalp-recorded EEG signals themselves are nonstationary. Therefore, traditional methods of EEG analysis may miss many properties inherent in such signals. Similarly, fractal analysis of EEG signals has shown scaling behaviors that may not be consistent with pure monofractal processes. In this study, we hypothesized that scalp-recorded human EEG signals may be better modeled as an underlying multifractal process. We utilized the Physionet online database, a publicly available database of human EEG signals as a standardized reference database for this study. Herein, we report the use of multifractal detrended fluctuation analysis on human EEG signals derived from waking and different sleep stages, and show evidence that supports the use of multifractal methods. Next, we compare multifractal detrended fluctuation analysis to a previously published multifractal technique, wavelet transform modulus maxima, using EEG signals from waking and sleep, and demonstrate that multifractal detrended fluctuation analysis has lower indices of variability. Finally, we report a preliminary investigation into the use of multifractal detrended fluctuation analysis as a pattern classification technique on human EEG signals from waking and different sleep stages, and demonstrate its potential utility for automatic classification of different states of consciousness. Therefore, multifractal detrended fluctuation analysis may be a useful pattern classification technique to distinguish among different states of brain function.	[Zorick, Todd] Greater Los Angeles Vet Adm Healthcare Syst, Dept Psychiat, Los Angeles, CA USA; [Mandelkern, Mark A.] Greater Los Angeles Vet Adm Healthcare Syst, Dept Imaging, Los Angeles, CA USA; [Zorick, Todd] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Mandelkern, Mark A.] Univ Calif Irvine, Dept Phys, Irvine, CA 92717 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California System; University of California Irvine	Zorick, T (corresponding author), Greater Los Angeles Vet Adm Healthcare Syst, Dept Psychiat, Los Angeles, CA USA.	tzorick@mednet.ucla.edu						Arciniegas DB, 2011, INT J PSYCHOPHYSIOL, V82, P41, DOI 10.1016/j.ijpsycho.2011.03.004; Arneodo A, 1998, J MATH PHYS, V39, P4142, DOI 10.1063/1.532489; Arneodo A., 2008, SCHOLARPEDIA, V3, P4103, DOI DOI 10.4249/SCHOLARPEDIA.4103; Coeurjolly J.-F., 2001, J STAT SOFTW, V5, P1, DOI 10.18637/jss.v005.i07; Dick O. E., 2012, Human Physiology, V38, P249, DOI 10.1134/S036211971202003X; Dick OE, 2012, NEUROCOMPUTING, V82, P207, DOI 10.1016/j.neucom.2011.11.013; Feder J, 1988, FRACTALS; Fisher A.J., 1997, MULTIFRACTALITY DEUT; Galaska R, 2007, J ELECTROCARDIOL S1, V40, pS41; Gao JB, 2011, COGN NEURODYNAMICS, V5, P171, DOI 10.1007/s11571-011-9151-3; Gireesh ED, 2008, P NATL ACAD SCI USA, V105, P7576, DOI 10.1073/pnas.0800537105; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Grech D, 2012, ACTA PHYS POL A, V121, pB34; Ichimaru Y, 1999, PSYCHIAT CLIN NEUROS, V53, P175, DOI 10.1046/j.1440-1819.1999.00527.x; Kantelhardt J.W., 2009, ENCY COMPLEXITY SYST, P3754; Kantelhardt JW, 2002, PHYSICA A, V316, P87, DOI 10.1016/S0378-4371(02)01383-3; Kantelhardt JW, 2003, PHYSICA A, V330, P240, DOI 10.1016/j.physa.2003.08.019; Kaplan AY, 2005, SIGNAL PROCESS, V85, P2190, DOI 10.1016/j.sigpro.2005.07.010; Kitzbichler MG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000314; Klaus A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019779; Lee JM, 2002, COMPUT BIOL MED, V32, P37, DOI 10.1016/S0010-4825(01)00031-2; Lee JS, 2007, CLIN NEUROPHYSIOL, V118, P2489, DOI 10.1016/j.clinph.2007.08.001; Lee JS, 2007, INT J CLIN EXP HYP, V55, P14, DOI 10.1080/00207140600995810; Makowiec D, 2009, PHYSICA A, V388, P3486, DOI 10.1016/j.physa.2009.05.005; MANDELBROT B, 1974, CR ACAD SCI A MATH, V278, P355; Mandelbrot B.B., 1997, WORKING PAPER; MANDELBROT BB, 1989, PURE APPL GEOPHYS, V131, P5, DOI 10.1007/BF00874478; MUZY JF, 1993, PHYS REV E, V47, P875, DOI 10.1103/PhysRevE.47.875; Nunez P, 2010, BRAIN MIND STRUCTURE; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; Oswiecimka P, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016103; Pan CP, 2004, PHYS LETT A, V329, P130, DOI 10.1016/j.physleta.2004.06.070; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Penzel T, 2003, IEEE T BIO-MED ENG, V50, P1143, DOI 10.1109/TBME.2003.817636; Petermann T, 2009, P NATL ACAD SCI USA, V106, P15921, DOI 10.1073/pnas.0904089106; Plenz D, 2007, TRENDS NEUROSCI, V30, P101, DOI 10.1016/j.tins.2007.01.005; Poil SS, 2012, J NEUROSCI, V32, P9817, DOI 10.1523/JNEUROSCI.5990-11.2012; Qianli M, 2005, SLEEP STAGE CHARACTE, P4526; Rowan AaT E, 2003, PRIMER EEG MINIATLAS; Schroeder M, 2009, FRACTALS CHAOS POWER; Schulz H, 2008, J CLIN SLEEP MED, V4, P99; Schwilden H, 2006, BEST PRACT RES-CLIN, V20, P31, DOI 10.1016/j.bpa.2005.09.001; Shew WL, 2013, NEUROSCIENTIST, V19, P88, DOI 10.1177/1073858412445487; Solovey G, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00044; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Stam CJ, 2004, HUM BRAIN MAPP, V22, P97, DOI 10.1002/hbm.20016; STANLEY HE, 1988, NATURE, V335, P405, DOI 10.1038/335405a0; Team RC, 2012, R LANG ENV STAT COMP; Varotsos PA, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.031106; Weisstein EW, 2013, SAMPLE VARIANCE DIST	50	62	62	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68360	10.1371/journal.pone.0068360	http://dx.doi.org/10.1371/journal.pone.0068360			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844189	gold, Green Published, Green Submitted			2022-12-27	WOS:000321733000141
J	Janssens, PLHR; Hursel, R; Martens, EAP; Westerterp-Plantenga, MS				Janssens, Pilou L. H. R.; Hursel, Rick; Martens, Eveline A. P.; Westerterp-Plantenga, Margriet S.			Acute Effects of Capsaicin on Energy Expenditure and Fat Oxidation in Negative Energy Balance	PLOS ONE			English	Article							RED-PEPPER; SUBSTRATE UTILIZATION; CATECHOLAMINE SECRETION; PUNGENT PRINCIPLE; CAPSICUM FRUITS; BODY-WEIGHT; METABOLISM; CARBOHYDRATE; WOMEN; RATS	Background: Addition of capsaicin (CAPS) to the diet has been shown to increase energy expenditure; therefore capsaicin is an interesting target for anti-obesity therapy. Aim: We investigated the 24 h effects of CAPS on energy expenditure, substrate oxidation and blood pressure during 25% negative energy balance. Methods: Subjects underwent four 36 h sessions in a respiration chamber for measurements of energy expenditure, substrate oxidation and blood pressure. They received 100% or 75% of their daily energy requirements in the conditions '100%CAPS', '100%Control', '75%CAPS' and '75%Control'. CAPS was given at a dose of 2.56 mg (1.03 g of red chili pepper, 39,050 Scoville heat units (SHU)) with every meal. Results: An induced negative energy balance of 25% was effectively a 20.5% negative energy balance due to adapting mechanisms. Diet-induced thermogenesis (DIT) and resting energy expenditure (REE) at 75% CAPS did not differ from DIT and REE at 100% Control, while at 75% Control these tended to be or were lower than at 100% Control (p = 0.05 and p = 0.02 respectively). Sleeping metabolic rate (SMR) at 75% CAPS did not differ from SMR at 100% CAPS, while SMR at 75% Control was lower than at 100% CAPS (p = 0.04). Fat oxidation at 75% CAPS was higher than at 100% Control (p = 0.03), while with 75% Control it did not differ from 100% Control. Respiratory quotient (RQ) was more decreased at 75% CAPS (p = 0.04) than at 75% Control (p = 0.05) when compared with 100% Control. Blood pressure did not differ between the four conditions. Conclusion: In an effectively 20.5% negative energy balance, consumption of 2.56 mg capsaicin per meal supports negative energy balance by counteracting the unfavorable negative energy balance effect of decrease in components of energy expenditure. Moreover, consumption of 2.56 mg capsaicin per meal promotes fat oxidation in negative energy balance and does not increase blood pressure significantly.	[Janssens, Pilou L. H. R.; Hursel, Rick; Martens, Eveline A. P.; Westerterp-Plantenga, Margriet S.] Maastricht Univ, Sch Nutr Toxicol & Metab NUTRIM, Dept Human Biol, Maastricht, Netherlands	Maastricht University	Janssens, PLHR (corresponding author), Maastricht Univ, Sch Nutr Toxicol & Metab NUTRIM, Dept Human Biol, Maastricht, Netherlands.	plhr.janssens@maastrichtuniversity.nl			McCormick EMEA; McCormick Science Institute	McCormick EMEA; McCormick Science Institute	The study was sponsored by McCormick EMEA and the McCormick Science Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was sponsored by McCormick EMEA and the McCormick Science Institute. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ahuja KDK, 2009, AM J CLIN NUTR, V90, P298, DOI 10.3945/ajcn.2009.27771; Astrup A, 2010, ANN NY ACAD SCI, V1190, P25, DOI 10.1111/j.1749-6632.2009.05272.x; Belza A, 2009, METABOLISM, V58, P1137, DOI 10.1016/j.metabol.2009.03.013; BROUWER E, 1957, ACTA PHYSIOL PHARM N, V6, P795; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370; Inoue N, 2007, BIOSCI BIOTECH BIOCH, V71, P380, DOI 10.1271/bbb.60341; KAWADA T, 1986, P SOC EXP BIOL MED, V183, P250; Lejeune MPGM, 2003, BRIT J NUTR, V90, P651, DOI 10.1079/BJN2003938; LICHTENBELT WDV, 1994, BRIT J NUTR, V72, P491, DOI 10.1079/BJN19940053; Lim K, 1997, MED SCI SPORT EXER, V29, P355, DOI 10.1097/00005768-199703000-00010; Ludy MJ, 2011, PHYSIOL BEHAV, V102, P251, DOI 10.1016/j.physbeh.2010.11.018; Matsumoto T, 2000, J NUTR SCI VITAMINOL, V46, P309, DOI 10.3177/jnsv.46.309; Plasqui G, 2011, INT J OBESITY, V35, P1124, DOI 10.1038/ijo.2010.250; Schoffelen PFM, 1997, J APPL PHYSIOL, V83, P2064, DOI 10.1152/jappl.1997.83.6.2064; SCHUTZ Y, 1992, AM J CLIN NUTR, V55, P670, DOI 10.1093/ajcn/55.3.670; Smeets AJ, 2013, J NUTR, V143, P442, DOI 10.3945/jn.112.170613; Smeets AJ, 2009, EUR J NUTR, V48, P229, DOI 10.1007/s00394-009-0006-1; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Szallasi A, 1999, PHARMACOL REV, V51, P159; WATANABE T, 1987, BIOCHEM BIOPH RES CO, V142, P259, DOI 10.1016/0006-291X(87)90479-7; WATANABE T, 1988, AM J PHYSIOL, V255, pE23, DOI 10.1152/ajpendo.1988.255.1.E23; Westerterp MR, 2008, PHYSIOL BEHAV, V93, P1039, DOI 10.1016/j.physbeh.2008.01.021; Westerterp-Plantenga MS, 2005, INT J OBESITY, V29, P682, DOI 10.1038/sj.ijo.0802862; World Health Organization, 2016, OB OV; Yoshioka M, 1995, J NUTR SCI VITAMINOL, V41, P647, DOI 10.3177/jnsv.41.647; Yoshioka M, 1999, BRIT J NUTR, V82, P115, DOI 10.1017/S0007114599001269; Yoshioka M, 1998, BRIT J NUTR, V80, P503, DOI 10.1017/S0007114598001597; Yoshioka M, 2004, BRIT J NUTR, V91, P991, DOI 10.1079/BJN20041148; Yoshioka M, 2001, BRIT J NUTR, V85, P203, DOI 10.1079/BJN2000224	30	57	58	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67786	10.1371/journal.pone.0067786	http://dx.doi.org/10.1371/journal.pone.0067786			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844093	Green Submitted, Green Published, gold			2022-12-27	WOS:000321341000097
J	MacKenzie, MG; Hamilton, DL; Pepin, M; Patton, A; Baar, K				MacKenzie, Matthew G.; Hamilton, David Lee; Pepin, Mark; Patton, Amy; Baar, Keith			Inhibition of Myostatin Signaling through Notch Activation following Acute Resistance Exercise	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; MESSENGER-RNA; KINASE PHOSPHORYLATION; INTRACELLULAR DOMAIN; PROTEIN-METABOLISM; PROMYOGENIC FACTOR; GENE-EXPRESSION; MICE; MASS; REGENERATION	Myostatin is a TGF beta family member and negative regulator of muscle size. Due to the complexity of the molecular pathway between myostatin mRNA/protein and changes in transcription, it has been difficult to understand whether myostatin plays a role in resistance exercise-induced skeletal muscle hypertrophy. To circumvent this problem, we determined the expression of a unique myostatin target gene, Mighty, following resistance exercise. Mighty mRNA increased by 6 h (82.9 +/- 24.21%) and remained high out to 48 h (56.5 +/- 19.67%) after resistance exercise. Further examination of the soleus, plantaris and tibialis anterior muscles showed that the change in Mighty mRNA at 6 h correlated with the increase in muscle size associated with this protocol (R-2 = 0.9996). The increase in Mighty mRNA occurred both independent of Smad2 phosphorylation and in spite of an increase in myostatin mRNA (341.8 +/- 147.14% at 3 h). The myostatin inhibitor SKI remained unchanged. However, activated Notch, another potential inhibitor of TGF beta signaling, increased immediately following resistance exercise (83 +/- 11.2%) and stayed elevated out to 6 h (78 +/- 16.6%). Electroportion of the Notch intracellular domain into the tibialis anterior resulted in an increase in Mighty mRNA (63 +/- 13.4%) that was equivalent to the canonical Notch target HES-1 (94.4 +/- 7.32%). These data suggest that acute resistance exercise decreases myostatin signaling through the activation of the TGF beta inhibitor Notch resulting in a decrease in myostatin transcriptional activity that correlates well with muscle hypertrophy.	[MacKenzie, Matthew G.; Hamilton, David Lee; Baar, Keith] Univ Dundee, Div Mol Physiol, Dundee, Scotland; [Hamilton, David Lee] Univ Stirling, Hlth & Exercise Sci Res Grp, Stirling FK9 4LA, Scotland; [Pepin, Mark; Baar, Keith] Univ Calif Davis, Davis, CA 95616 USA; [Patton, Amy; Baar, Keith] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Baar, Keith] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA	University of Dundee; University of Stirling; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Baar, K (corresponding author), Univ Dundee, Div Mol Physiol, Dundee, Scotland.	FMBlab@googlemail.com	Pepin, Mark/AAI-1950-2019	Pepin, Mark/0000-0003-0114-560X; Hamilton, David/0000-0002-5620-4788; Baar, Keith/0000-0001-9337-6186	BBSRC; Wellcome Trust [077426/Z/05/Z]; Hellman Family Foundation	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Hellman Family Foundation	DLH was funded by a BBSRC PhD studentship. The work was supported by a Wellcome Trust project grant to KB (077426/Z/05/Z) and the Hellman Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiho M, 2010, LIFE SCI, V86, P59, DOI 10.1016/j.lfs.2009.11.011; Baar K, 1999, AM J PHYSIOL-CELL PH, V276, pC120, DOI 10.1152/ajpcell.1999.276.1.C120; Blokzijl A, 2002, CURR BIOL, V12, P35, DOI 10.1016/S0960-9822(01)00623-6; Braga M, 2012, MOL CELL ENDOCRINOL, V350, P39, DOI 10.1016/j.mce.2011.11.019; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Chu JL, 2002, J BIOL CHEM, V277, P7587, DOI 10.1074/jbc.M111044200; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Dalbo VJ, 2011, J GERONTOL A-BIOL, V66, P855, DOI 10.1093/gerona/glr091; Davis E, 2004, CURR BIOL, V14, P1858, DOI 10.1016/j.cub.2004.09.079; Dong YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058554; Garma T, 2007, J APPL PHYSIOL, V102, P135, DOI 10.1152/japplphysiol.00776.2006; Guo SC, 2011, BBA-REV CANCER, V1815, P197, DOI 10.1016/j.bbcan.2010.12.002; Hulmi JJ, 2007, MED SCI SPORT EXER, V39, P289, DOI 10.1249/01.mss.0000241650.15006.6e; Hulmi JJ, 2013, AM J PHYSIOL-ENDOC M, V304, pE41, DOI 10.1152/ajpendo.00389.2012; Kim JS, 2007, J APPL PHYSIOL, V103, P1488, DOI 10.1152/japplphysiol.01194.2006; Kovacheva EL, 2010, ENDOCRINOLOGY, V151, P628, DOI 10.1210/en.2009-1177; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Louis E, 2007, J APPL PHYSIOL, V103, P1744, DOI 10.1152/japplphysiol.00679.2007; Marshall A, 2008, EXP CELL RES, V314, P1013, DOI 10.1016/j.yexcr.2008.01.004; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; McCroskery S, 2005, J CELL SCI, V118, P3531, DOI 10.1242/jcs.02482; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Morine KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009176; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pistilli EE, 2011, AM J PATHOL, V178, P1287, DOI 10.1016/j.ajpath.2010.11.071; Ross DA, 2001, MOL CELL BIOL, V21, P7537, DOI 10.1128/MCB.21.22.7537-7544.2001; Sakuma K, 2004, ACTA NEUROPATHOL, V108, P241, DOI 10.1007/s00401-004-0884-5; Salerno MS, 2009, EXP CELL RES, V315, P2012, DOI 10.1016/j.yexcr.2009.04.014; Serra C, 2013, J GERONTOL A-BIOL, V68, P17, DOI 10.1093/gerona/gls083; Sun DF, 2006, KIDNEY INT, V70, P453, DOI 10.1038/sj.ki.5001532; SUTRAVE P, 1990, GENE DEV, V4, P1462, DOI 10.1101/gad.4.9.1462; Sutrave P, 2000, GENE, V241, P107, DOI 10.1016/S0378-1119(99)00461-8; Terzis G, 2008, EUR J APPL PHYSIOL, V102, P145, DOI 10.1007/s00421-007-0564-y; Welle S, 2009, AM J PHYSIOL-ENDOC M, V296, pE567, DOI 10.1152/ajpendo.90862.2008; WONG TS, 1990, J APPL PHYSIOL, V69, P1718, DOI 10.1152/jappl.1990.69.5.1718; WONG TS, 1990, J APPL PHYSIOL, V69, P1709, DOI 10.1152/jappl.1990.69.5.1709; Yamaguchi A, 2006, PFLUG ARCH EUR J PHY, V453, P203, DOI 10.1007/s00424-006-0127-9	37	43	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68743	10.1371/journal.pone.0068743	http://dx.doi.org/10.1371/journal.pone.0068743			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844238	Green Published, gold			2022-12-27	WOS:000321341000179
J	VanDalen, KK; Hall, JS; Clark, L; McLean, RG; Smeraski, C				VanDalen, Kaci K.; Hall, Jeffrey S.; Clark, Larry; McLean, Robert G.; Smeraski, Cynthia			West Nile Virus Infection in American Robins: New Insights on Dose Response	PLOS ONE			English	Article							LOUIS-ENCEPHALITIS-VIRUS; NORTHEASTERN UNITED-STATES; HOST FEEDING PATTERNS; VECTOR COMPETENCE; DIPTERA-CULICIDAE; MOSQUITOS DIPTERA; AVIAN HOSTS; TRANSMISSION; BIRDS; AMPLIFICATION	West Nile virus (WNV) is a vector-borne pathogen that was first detected in the United States in 1999. The natural transmission cycle of WNV involves mosquito vectors and avian hosts, which vary in their competency to transmit the virus. American robins are an abundant backyard species in the United States and appear to have an important role in the amplification and dissemination of WNV. In this study we examine the response of American robins to infection with various WNV doses within the range of those administered by some natural mosquito vectors. Thirty American robins were assigned a WNV dosage treatment and needle inoculated with 10(0.95) PFU, 10(1.26) PFU, 10(2.15) PFU, or 10(3.15) PFU. Serum samples were tested for the presence of infectious WNV and/or antibodies, while oral swabs were tested for the presence of WNV RNA. Five of the 30 (17%) robins had neutralizing antibodies to WNV prior to the experiment and none developed viremia or shed WNV RNA. The proportion of WNV-seronegative birds that became viremic after WNV inoculation increased in a dose dependent manner. At the lowest dose, only 40% (2/5) of the inoculated birds developed productive infections while at the highest dose, 100% (7/7) of the birds became viremic. Oral shedding of WNV RNA followed a similar trend where robins inoculated with the lower two doses were less likely to shed viral RNA (25%) than robins inoculated with one of the higher doses (92%). Viremia titers and morbidity did not increase in a dose dependent manner; only two birds succumbed to infection and, interestingly, both were inoculated with the lowest dose of WNV. It is clear that the disease ecology of WNV is a complex interplay of hosts, vectors, and viral dose delivered.	[VanDalen, Kaci K.; Hall, Jeffrey S.; Clark, Larry; McLean, Robert G.] US Anim & Plant Hlth Inspect Serv, USDA, Wildlife Serv, Natl Wildlife Res Ctr, Ft Collins, CO USA; [Smeraski, Cynthia] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA	United States Department of Agriculture (USDA); Colorado State University	VanDalen, KK (corresponding author), US Anim & Plant Hlth Inspect Serv, USDA, Wildlife Serv, Natl Wildlife Res Ctr, Ft Collins, CO USA.	Kaci.vandalen@aphis.usda.gov		Hall, Jeffrey/0000-0001-5599-2826	United States Department of Agriculture	United States Department of Agriculture(United States Department of Agriculture (USDA))	This study was funded by the United States Department of Agriculture. The manuscript was reviewed for general policy statements committing the USDA to action, but otherwise the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, VERT EC BIRD SPEC; Apperson CS, 2004, VECTOR-BORNE ZOONOT, V4, P71, DOI 10.1089/153036604773083013; Beaty BC., 1995, VIRAL RICKETTSIAL CH, P189; Blitvich BJ, 2003, J CLIN MICROBIOL, V41, P1041, DOI 10.1128/JCM.41.3.1041-1047.2003; Clark L, 2006, J WILDLIFE DIS, V42, P14, DOI 10.7589/0090-3558-42.1.14; Fang Y, 2006, AM J TROP MED HYG, V75, P480, DOI 10.4269/ajtmh.2006.75.480; Goddard LB, 2002, EMERG INFECT DIS, V8, P1385, DOI 10.3201/eid0812.020536; Hamer GL, 2008, VECTOR-BORNE ZOONOT, V8, P57, DOI 10.1089/vbz.2007.0123; Hamer GL, 2009, AM J TROP MED HYG, V80, P268, DOI 10.4269/ajtmh.2009.80.268; Hayes EB, 2006, ANNU REV MED, V57, P181, DOI 10.1146/annurev.med.57.121304.131418; Kent R, 2009, J MED ENTOMOL, V46, P380, DOI 10.1603/033.046.0226; Kilpatrick AM, 2007, AUK, V124, P1121, DOI 10.1642/0004-8038(2007)124[1121:EOWNVT]2.0.CO;2; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Kilpatrick AM, 2010, VECTOR-BORNE ZOONOT, V10, P377, DOI 10.1089/vbz.2009.0029; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Komar N, 2002, EMERG INFECT DIS, V8, P741, DOI 10.3201/eid0807.020157; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; McLean RG, 2001, ANN NY ACAD SCI, V951, P54; MCLEAN RG, 1985, J MED ENTOMOL, V22, P232, DOI 10.1093/jmedent/22.2.232; MCLEAN RG, 1993, AM J TROP MED HYG, V49, P46, DOI 10.4269/ajtmh.1993.49.46; McLean RG, 2006, ORNITHOL MONOGR, P44; Molaei G, 2006, EMERG INFECT DIS, V12, P468, DOI 10.3201/eid1203.051004; Nemeth N, 2006, J WILDLIFE DIS, V42, P1, DOI 10.7589/0090-3558-42.1.1; Nemeth N, 2009, ARCH VIROL, V154, P783, DOI 10.1007/s00705-009-0369-x; Nemeth NM, 2009, AM J TROP MED HYG, V80, P864, DOI 10.4269/ajtmh.2009.80.864; Reisen WK, 2005, J MED ENTOMOL, V42, P367, DOI 10.1603/0022-2585(2005)042[0367:AHAMDC]2.0.CO;2; Reisen WK, 2006, J MED ENTOMOL, V43, P344, DOI 10.1603/0022-2585(2006)043[0344:OOWNVI]2.0.CO;2; Sallabanks R, 1999, BIRDS N AM, P28; Savage HM, 2007, VECTOR-BORNE ZOONOT, V7, P365, DOI 10.1089/vbz.2006.0602; Schneider BS, 2006, VIRAL IMMUNOL, V19, P74, DOI 10.1089/vim.2006.19.74; Simpson JE, 2012, P ROY SOC B-BIOL SCI, V279, P925, DOI 10.1098/rspb.2011.1282; Styer LM, 2006, AM J TROP MED HYG, V75, P337, DOI 10.4269/ajtmh.2006.75.337; Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2; Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130; Vanlandingham DL, 2004, AM J TROP MED HYG, V71, P120, DOI 10.4269/ajtmh.2004.71.120; Wheeler SS, 2012, AM J TROP MED HYG, V87, P559, DOI 10.4269/ajtmh.2012.11-0654	37	25	26	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68537	10.1371/journal.pone.0068537	http://dx.doi.org/10.1371/journal.pone.0068537			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844218	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000170
J	Zha, J; Li, BZ; Shen, MH; Hu, ML; Song, H; Yuan, YJ				Zha, Jian; Li, Bing-Zhi; Shen, Ming-Hua; Hu, Meng-Long; Song, Hao; Yuan, Ying-Jin			Optimization of CDT-1 and XYL1 Expression for Balanced Co-Production of Ethanol and Xylitol from Cellobiose and Xylose by Engineered Saccharomyces cerevisiae	PLOS ONE			English	Article							GLUCOSE REPRESSION; LIGNOCELLULOSIC MATERIALS; FERMENTATION; REDUCTASE; YEAST; TRANSFORMATION; BIOREFINERIES; DEHYDROGENASE; CHALLENGES; TRANSPORT	Production of ethanol and xylitol from lignocellulosic hydrolysates is an alternative to the traditional production of ethanol in utilizing biomass. However, the conversion efficiency of xylose to xylitol is restricted by glucose repression, causing a low xylitol titer. To this end, we cloned genes CDT-1 (encoding a cellodextrin transporter) and gh1-1 (encoding an intracellular beta-glucosidase) from Neurospora crassa and XYL1 (encoding a xylose reductase that converts xylose into xylitol) from Scheffersomyces stipitis into Saccharomyces cerevisiae, enabling simultaneous production of ethanol and xylitol from a mixture of cellobiose and xylose (main components of lignocellulosic hydrolysates). We further optimized the expression levels of CDT-1 and XYL1 by manipulating their promoters and copy-numbers, and constructed an engineered S. cerevisiae strain (carrying one copy of PGK1p-CDT1 and two copies of TDH3p-XYL1), which showed an 85.7% increase in xylitol production from the mixture of cellobiose and xylose than that from the mixture of glucose and xylose. Thus, we achieved a balanced co-fermentation of cellobiose (0.165 g/L/h) and xylose (0.162 g/L/h) at similar rates to co-produce ethanol (0.36 g/g) and xylitol (1.00 g/g).	[Zha, Jian; Li, Bing-Zhi; Shen, Ming-Hua; Hu, Meng-Long; Song, Hao; Yuan, Ying-Jin] Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Dept Pharmaceut Engn,Sch Chem Engn & Technol, Tianjin 300072, Peoples R China; [Song, Hao] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 639798, Singapore	Tianjin University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Yuan, YJ (corresponding author), Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Dept Pharmaceut Engn,Sch Chem Engn & Technol, Tianjin 300072, Peoples R China.	yjyuan@tju.edu.cn	Li, Bing-Zhi/I-6107-2013; Song, Hao/G-6207-2010	Li, Bing-Zhi/0000-0003-4121-3048; Song, Hao/0000-0001-5553-2539; Zha, Jian/0000-0001-8630-5208	National High Technology Research and Development Program ("863'' Program) [2012AA02A701]; National Natural Science Foundation of China [21020102040]; National Basic Research Program of China ("973'' Program) [2013CB733601]; International Joint Research Project of Tianjin [11ZCGHHZ00500]	National High Technology Research and Development Program ("863'' Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China ("973'' Program)(National Basic Research Program of China); International Joint Research Project of Tianjin	This work was funded by the National High Technology Research and Development Program ("863'' Program: 2012AA02A701), the National Natural Science Foundation of China (Major International Joint Research Project: 21020102040), the National Basic Research Program of China ("973'' Program: 2013CB733601), and International Joint Research Project of Tianjin (11ZCGHHZ00500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae SM, 2004, ENZYME MICROB TECH, V35, P545, DOI 10.1016/j.enzmictec.2004.08.006; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; Cheng HR, 2011, MICROB CELL FACT, V10, DOI [10.1186/1475-2859-10-5, 10.1186/1475-2859-10-43]; Cheng KK, 2010, APPL MICROBIOL BIOT, V87, P411, DOI 10.1007/s00253-010-2612-5; Chu BCH, 2007, BIOTECHNOL ADV, V25, P425, DOI 10.1016/j.biotechadv.2007.04.001; Demirbas MF, 2009, APPL ENERG, V86, pS151, DOI 10.1016/j.apenergy.2009.04.043; Du J, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks549; Eliasson A, 2000, APPL ENVIRON MICROB, V66, P3381, DOI 10.1128/AEM.66.8.3381-3386.2000; Fernando S, 2006, ENERG FUEL, V20, P1727, DOI 10.1021/ef060097w; FitzPatrick M, 2010, BIORESOURCE TECHNOL, V101, P8915, DOI 10.1016/j.biortech.2010.06.125; Galazka JM, 2010, SCIENCE, V330, P84, DOI 10.1126/science.1192838; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Granstrom TB, 2007, APPL MICROBIOL BIOT, V74, P277, DOI 10.1007/s00253-006-0761-3; Ha SJ, 2013, METAB ENG, V15, P134, DOI 10.1016/j.ymben.2012.11.005; Ha SJ, 2011, P NATL ACAD SCI USA, V108, P504, DOI 10.1073/pnas.1010456108; HALLBORN J, 1991, BIO-TECHNOL, V9, P1090, DOI 10.1038/nbt1191-1090; Hu CM, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-25; Huang CF, 2011, BIORESOURCE TECHNOL, V102, P3322, DOI 10.1016/j.biortech.2010.10.111; Jeppsson M, 2003, FEMS YEAST RES, V3, P167, DOI 10.1016/S1567-1356(02)00186-1; Jin YS, 2003, APPL BIOCHEM BIOTECH, V105, P277; Jojima T, 2010, APPL MICROBIOL BIOT, V85, P471, DOI 10.1007/s00253-009-2292-1; Kim YS, 1999, J BIOTECHNOL, V67, P159, DOI 10.1016/S0168-1656(98)00172-2; Ko BS, 2006, APPL ENVIRON MICROB, V72, P4207, DOI 10.1128/AEM.02699-05; Kumar S, 2009, J IND MICROBIOL BIOT, V36, P1483, DOI 10.1007/s10295-009-0636-6; Lee WJ, 2000, PROCESS BIOCHEM, V35, P1199, DOI 10.1016/S0032-9592(00)00165-5; Lee WJ, 2002, APPL MICROBIOL BIOT, V60, P186, DOI 10.1007/s00253-002-1085-6; Li SJ, 2010, MOL BIOSYST, V6, P2129, DOI 10.1039/c0mb00063a; Liu EK, 2010, BIOCHEM ENG J, V48, P204, DOI 10.1016/j.bej.2009.10.011; Lu CF, 2007, APPL ENVIRON MICROB, V73, P6072, DOI 10.1128/AEM.00955-07; Matsushika A, 2008, J BIOSCI BIOENG, V106, P306, DOI 10.1263/jbb.106.306; Matsushika A, 2009, APPL MICROBIOL BIOT, V84, P37, DOI 10.1007/s00253-009-2101-x; Nair NU, 2010, METAB ENG, V12, P462, DOI 10.1016/j.ymben.2010.04.005; Oh EJ, 2013, METAB ENG, V15, P226, DOI 10.1016/j.ymben.2012.09.003; Prakash G, 2011, BIORESOURCE TECHNOL, V102, P3304, DOI 10.1016/j.biortech.2010.10.074; Qin L, 2012, BIORESOURCE TECHNOL, V112, P319, DOI 10.1016/j.biortech.2012.02.134; Roca E, 1996, BIOTECHNOL BIOENG, V51, P317, DOI [10.1002/(SICI)1097-0290(19960805)51:3<317::AID-BIT7>3.0.CO;2-G, 10.1002/(SICI)1097-0290(19960805)51:3&lt;317::AID-BIT7&gt;3.0.CO;2-G]; Runquist D, 2009, APPL MICROBIOL BIOT, V82, P123, DOI 10.1007/s00253-008-1773-y; Runquist D, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-5; Shao Z. Y., 2009, NUCLEIC ACIDS RES, V37, P10; SIKORSKI RS, 1989, GENETICS, V122, P19; SKOOG K, 1990, APPL ENVIRON MICROB, V56, P3389, DOI 10.1128/AEM.56.11.3389-3394.1990; Stephanopoulos G, 2007, SCIENCE, V315, P801, DOI 10.1126/science.1139612; Subtil T, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-14; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Sun Y, 2002, BIORESOURCE TECHNOL, V83, P1, DOI 10.1016/S0960-8524(01)00212-7; THESTRUP HN, 1995, APPL ENVIRON MICROB, V61, P2043, DOI 10.1128/AEM.61.5.2043-2045.1995; TRUMBLY RJ, 1992, MOL MICROBIOL, V6, P15, DOI 10.1111/j.1365-2958.1992.tb00832.x; Wang XJ, 2012, EUR J NUTR, V51, P39, DOI 10.1007/s00394-012-0326-4; Westergaard SL, 2007, BIOTECHNOL BIOENG, V96, P134, DOI 10.1002/bit.21135; Xia JM, 2011, BIOTECHNOL BIOENG, V108, P12, DOI 10.1002/bit.22910; Zhong C, 2009, APPL MICROBIOL BIOT, V84, P667, DOI 10.1007/s00253-009-2001-0	51	27	34	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68317	10.1371/journal.pone.0068317	http://dx.doi.org/10.1371/journal.pone.0068317			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844185	Green Published, gold			2022-12-27	WOS:000321341000153
J	Grossmann, T; Vaish, A; Franz, J; Schroeder, R; Stoneking, M; Friederici, AD				Grossmann, Tobias; Vaish, Amrisha; Franz, Janett; Schroeder, Roland; Stoneking, Mark; Friederici, Angela D.			Emotional Voice Processing: Investigating the Role of Genetic Variation in the Serotonin Transporter across Development	PLOS ONE			English	Article							EARLY LANGUAGE-ACQUISITION; BRAIN RESPONSES; SOCIAL COGNITION; INFANTS; PROSODY; SPEECH; POLYMORPHISM; RECOGNITION; POTENTIALS; EXPRESSION	The ability to effectively respond to emotional information carried in the human voice plays a pivotal role for social interactions. We examined how genetic factors, especially the serotonin transporter genetic variation (5-HTTLPR), affect the neurodynamics of emotional voice processing in infants and adults by measuring event-related brain potentials (ERPs). The results revealed that infants distinguish between emotions during an early perceptual processing stage, whereas adults recognize and evaluate the meaning of emotions during later semantic processing stages. While infants do discriminate between emotions, only in adults was genetic variation associated with neurophysiological differences in how positive and negative emotions are processed in the brain. This suggests that genetic association with neurocognitive functions emerges during development, emphasizing the role that variation in serotonin plays in the maturation of brain systems involved in emotion recognition.	[Grossmann, Tobias] Max Planck Inst Human Cognit & Brain Sci, Early Social Dev Grp, Leipzig, Germany; [Vaish, Amrisha] Max Planck Inst Evolutionare Anthropol, Dept Dev & Comparit Psychol, D-04103 Leipzig, Germany; [Franz, Janett] Max Delbruck Ctr Mol Med, Berlin, Germany; [Schroeder, Roland; Stoneking, Mark] Max Planck Inst Evolutionare Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Friederici, Angela D.] Max Planck Inst Human Cognit & Brain Sci, Dept Neuropsychol, Leipzig, Germany	Max Planck Society; Max Planck Society; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Max Planck Society; Max Planck Society	Grossmann, T (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Early Social Dev Grp, Leipzig, Germany.	grossman@cbs.mpg.de	Grossmann, Tobias/H-6364-2019	Grossmann, Tobias/0000-0002-1116-6423				Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Banse R, 1996, J PERS SOC PSYCHOL, V70, P614, DOI 10.1037/0022-3514.70.3.614; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Belsky J, 2009, MOL PSYCHIATR, V14, P746, DOI 10.1038/mp.2009.44; Bostanov V, 2004, PSYCHOPHYSIOLOGY, V41, P259, DOI 10.1111/j.1469-8986.2003.00142.x; Canli T, 2007, NAT NEUROSCI, V10, P1103, DOI 10.1038/nn1964; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; COOPER RP, 1990, CHILD DEV, V61, P1584, DOI 10.2307/1130766; Csibra G., 2008, HDB DEV COGNITIVE NE, V2nd ed., P247; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; DeHaan M., 2007, INFANT EEG EVENT REL; Ebstein RP, 2006, MOL PSYCHIATR, V11, P427, DOI 10.1038/sj.mp.4001814; FERNALD A, 1985, INFANT BEHAV DEV, V8, P181, DOI 10.1016/S0163-6383(85)80005-9; Fernald A., 1992, ADAPTED MIND EVOLUTI, P391, DOI DOI 10.1007/BF00852474; Fox E., 2012, RAINY BRAIN SUNNY BR; Fox E, 2009, P ROYAL SOC B; Friederici AD, 2005, TRENDS COGN SCI, V9, P481, DOI 10.1016/j.tics.2005.08.008; Friedrich M, 2005, J COGNITIVE NEUROSCI, V17, P1785, DOI 10.1162/089892905774589172; Frith C, 2009, PHILOS T R SOC B, V364, P3453, DOI 10.1098/rstb.2009.0142; Gottlieb G, 2007, DEVELOPMENTAL SCI, V10, P1, DOI 10.1111/j.1467-7687.2007.00556.x; Grandjean D, 2005, NAT NEUROSCI, V8, P145, DOI 10.1038/nn1392; Grossmann T, 2005, NEUROREPORT, V16, P1825, DOI 10.1097/01.wnr.0000185964.34336.b1; Grossmann T, 2011, DEV COGN NEUROS-NETH, V1, P57, DOI 10.1016/j.dcn.2010.07.001; Grossmann T, 2010, NEURON, V65, P852, DOI 10.1016/j.neuron.2010.03.001; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Haworth CMA, 2010, MOL PSYCHIATR, V15, P1112, DOI 10.1038/mp.2009.55; Heberlein AS, 2009, EMOT REV, V1, P162, DOI 10.1177/1754073908100441; Heinz A, 2005, NAT NEUROSCI, V8, P20, DOI 10.1038/nn1366; Karmiloff-Smith A, 1998, TRENDS COGN SCI, V2, P389, DOI 10.1016/S1364-6613(98)01230-3; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; Kushnerenko E, 2002, NEUROREPORT, V13, P1843, DOI 10.1097/00001756-200210280-00002; Latinus M, 2011, CURR BIOL, V21, pR143, DOI 10.1016/j.cub.2010.12.033; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; McCrae RR, 2004, PERS INDIV DIFFER, V36, P587, DOI 10.1016/S0191-8869(03)00118-1; Meltzoff AN, 2007, DEVELOPMENTAL SCI, V10, P126, DOI 10.1111/j.1467-7687.2007.00574.x; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Parisel E, 2010, INT J PSYCHOPHYSIOL, V77, P239, DOI 10.1016/j.ijpsycho.2010.06.032; Peeters G., 1990, EUROPEAN REV SOCIAL, V1, P33, DOI [10.1080/14792779108401856, DOI 10.1080/14792779108401856]; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; PICTON TW, 1974, ELECTROEN CLIN NEURO, V36, P179, DOI 10.1016/0013-4694(74)90155-2; Quam C, 2012, CHILD DEV, V83, P236, DOI 10.1111/j.1467-8624.2011.01700.x; Quinque D, 2006, ANAL BIOCHEM, V353, P272, DOI 10.1016/j.ab.2006.03.021; Sauter DA, 2010, P NATL ACAD SCI USA, V107, P2408, DOI 10.1073/pnas.0908239106; Scherer K.R., 1988, P171; Scherer Klaus R., 1989, HDB PSYCHOPHYSIOLOGY; SCHERER KR, 1986, PSYCHOL BULL, V99, P143, DOI 10.1037/0033-2909.99.2.143; Scherer KR, 2001, J CROSS CULT PSYCHOL, V32, P76, DOI 10.1177/0022022101032001009; Schirmer A, 2006, TRENDS COGN SCI, V10, P24, DOI 10.1016/j.tics.2005.11.009; Schirmer A, 2003, J COGNITIVE NEUROSCI, V15, P1135, DOI 10.1162/089892903322598102; Schutter DJLG, 2004, INT J PSYCHOPHYSIOL, V53, P29, DOI 10.1016/j.ijpsycho.2004.01.003; Slater A, 2007, INTRO INFANT DEV; Spelke ES, 2007, DEVELOPMENTAL SCI, V10, P89, DOI 10.1111/j.1467-7687.2007.00569.x; Vaish A, 2008, PSYCHOL BULL, V134, P383, DOI 10.1037/0033-2909.134.3.383; Wambacq IJA, 2004, NEUROREPORT, V15, P555, DOI 10.1097/00001756-200403010-00034	55	13	13	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68377	10.1371/journal.pone.0068377	http://dx.doi.org/10.1371/journal.pone.0068377			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861897	gold, Green Published, Green Accepted			2022-12-27	WOS:000321692000026
J	Endeman, D; Klaassen, LJ; Kamermans, M				Endeman, Duco; Klaassen, Lauw J.; Kamermans, Maarten			Action Spectra of Zebrafish Cone Photoreceptors	PLOS ONE			English	Article							VISUAL PIGMENTS; BRACHYDANIO-RERIO; GAP-JUNCTIONS; SENSITIVITY; SYSTEM; ULTRAVIOLET; RETINA; CELLS; FISH	Zebrafish is becoming an increasingly popular model in the field of visual neuroscience. Although the absorption spectra of its cone photopigments have been described, the cone action spectra were still unknown. In this study we report the action spectra of the four types of zebrafish cone photoreceptors, determined by measuring voltage responses upon light stimulation using whole cell patch clamp recordings. A generic template of photopigment absorption spectra was fit to the resulting action spectra in order to establish the maximum absorption wavelength, the A2-based photopigment contribution and the size of the beta-wave of each cone-type. Although in general there is close correspondence between zebrafish cone action- and absorbance spectra, our data suggest that in the case of MWS- and LWS-cones there is appreciable contribution of A2-based photopigments and that the beta-wave for these cones is smaller than expected based on the absorption spectra.	[Endeman, Duco; Klaassen, Lauw J.; Kamermans, Maarten] Netherlands Inst Neurosci, Dept Retinal Signal Proc, Amsterdam, Netherlands; [Kamermans, Maarten] Univ Amsterdam, Acad Med Ctr, Dept Neurogenet, NL-1105 AZ Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Academic Medical Center Amsterdam	Kamermans, M (corresponding author), Netherlands Inst Neurosci, Dept Retinal Signal Proc, Amsterdam, Netherlands.	m.kamermans@nin.knaw.nl			Netherlands Organization for Scientific Research (NWO) [ALW-805.47.067]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was supported by a grant (ALW-805.47.067) from the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison WT, 2004, VISUAL NEUROSCI, V21, P945, DOI 10.1017/S0952523804216145; BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526; BEATTY DD, 1984, VISION RES, V24, P1563, DOI 10.1016/0042-6989(84)90314-6; Bilotta J, 2005, INT J DEV NEUROSCI, V23, P15, DOI 10.1016/j.ijdevneu.2004.09.004; Bilotta J, 2001, INT J DEV NEUROSCI, V19, P621, DOI 10.1016/S0736-5748(01)00050-8; BOWMAKER JK, 1980, J PHYSIOL-LONDON, V298, P501, DOI 10.1113/jphysiol.1980.sp013097; BRANCHEK T, 1984, J COMP NEUROL, V224, P107, DOI 10.1002/cne.902240109; Cameron DA, 2002, VISUAL NEUROSCI, V19, P365, DOI 10.1017/S0952523802192121; Chinen A, 2003, GENETICS, V163, P663; Dixon LJ, 2004, DOC OPHTHALMOL, V109, P17, DOI 10.1007/s10633-004-1124-y; Fadool JM, 2008, PROG RETIN EYE RES, V27, P89, DOI 10.1016/j.preteyeres.2007.08.002; Goldsmith P, 2003, SEMIN CELL DEV BIOL, V14, P11, DOI 10.1016/S1084-9521(02)00167-2; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Hamaoka T, 2002, GENESIS, V34, P215, DOI 10.1002/gene.10155; HAROSI FI, 1994, VISION RES, V34, P1359, DOI 10.1016/0042-6989(94)90134-1; Haug MF, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-8; KANEKO A, 1985, JPN J PHYSIOL, V35, P355, DOI 10.2170/jjphysiol.35.355; LOEW ER, 1976, VISION RES, V16, P891, DOI 10.1016/0042-6989(76)90217-0; LYTHGOE JN, 1989, J EXP BIOL, V146, P1; NAWROCKI L, 1985, VISION RES, V25, P1569, DOI 10.1016/0042-6989(85)90127-0; NG B, 1995, J NEUROSCI METH, V56, P37, DOI 10.1016/0165-0270(94)00087-W; Palacios AG, 1996, VISUAL NEUROSCI, V13, P411, DOI 10.1017/S0952523800008099; RAVIOLA E, 1973, P NATL ACAD SCI USA, V70, P1677, DOI 10.1073/pnas.70.6.1677; ROBINSON J, 1993, P NATL ACAD SCI USA, V90, P6009, DOI 10.1073/pnas.90.13.6009; Saszik S, 1999, VISION RES, V39, P1051, DOI 10.1016/S0042-6989(98)00237-5; Takechi M, 2005, J EXP BIOL, V208, P1337, DOI 10.1242/jeb.01532; TSUKAMOTO Y, 1992, VISION RES, V32, P1809, DOI 10.1016/0042-6989(92)90042-H; VANDIJK BW, 1984, VISION RES, V24, P211, DOI 10.1016/0042-6989(84)90123-8; Verweij J, 1996, VISION RES, V36, P3943, DOI 10.1016/S0042-6989(96)00142-3; WOOD P, 1992, J FISH BIOL, V41, P601, DOI 10.1111/j.1095-8649.1992.tb02686.x	30	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68540	10.1371/journal.pone.0068540	http://dx.doi.org/10.1371/journal.pone.0068540			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861916	Green Submitted, Green Published, gold			2022-12-27	WOS:000321425300068
J	Longo, F; Rampioni, G; Bondi, R; Imperi, F; Fimia, GM; Visca, P; Zennaro, E; Leoni, L				Longo, Francesca; Rampioni, Giordano; Bondi, Roslen; Imperi, Francesco; Fimia, Gian Maria; Visca, Paolo; Zennaro, Elisabetta; Leoni, Livia			A New Transcriptional Repressor of the Pseudomonas aeruginosa Quorum Sensing Receptor Gene lasR	PLOS ONE			English	Article							TETR FAMILY; MEXAB-OPRM; VIRULENCE; EXPRESSION; REGULATOR; BACTERIA; SYSTEMS; INFECTIONS; SEQUENCES; ELASTASE	Pseudomonas aeruginosa pathogenic potential is controlled via multiple regulatory pathways, including three quorum sensing (QS) systems. LasR is a key QS signal receptor since it acts as a global transcriptional regulator required for optimal expression of main virulence factors. P. aeruginosa modulates the QS response by integrating this cell density-dependent circuit to environmental and metabolic cues. Hence, QS also controls the adaptation to challenging environmental niches, such as infection sites. However, little is known about the molecular mechanisms connecting QS and other signalling pathways. In this work, DNA-affinity chromatography was used to identify new lasR transcriptional regulators. This approach led to the identification and functional characterization of the TetR-like transcriptional repressor PA3699. This protein was purified and shown to directly bind to the lasR promoter region in vitro. The induction of PA3699 expression in P. aeruginosa PAO1 cultures repressed lasR promoter activity and the production of LasR-dependent virulence factors, such as elastase, pyocyanin, and proteases. These findings suggest a role for PA3699 in P. aeruginosa pathogenicity. P. aeruginosa genome encodes at least 38 TetR-family proteins, and PA3699 is the eighth member of this group functionally characterized so far and the first one shown to bind the lasR promoter in vitro.	[Longo, Francesca; Rampioni, Giordano; Bondi, Roslen; Visca, Paolo; Zennaro, Elisabetta; Leoni, Livia] Univ Roma Tre, Dept Sci, Rome, Italy; [Imperi, Francesco] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, I-00185 Rome, Italy; [Fimia, Gian Maria] Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy	Italfarmaco; Roma Tre University; Sapienza University Rome; IRCCS Lazzaro Spallanzani	Leoni, L (corresponding author), Univ Roma Tre, Dept Sci, Rome, Italy.	livia.leoni@uniroma3.it	Fimia, Gian Maria/K-3232-2016; Imperi, Francesco/AAA-3671-2021; Rampioni, Giordano/AAA-4045-2021	Fimia, Gian Maria/0000-0003-4438-3325; Rampioni, Giordano/0000-0002-1735-8565; Longo, Francesca/0000-0002-8733-5959; Visca, Paolo/0000-0002-6128-7039	Ministry of University and Research of Italy (Futuro in Ricerca) [RBFR10LHD1]; University Roma Tre (Internationalization Project); Italian Cystic Fibrosis Research Foundation [FFC 14/2010, FFC 13/2011]	Ministry of University and Research of Italy (Futuro in Ricerca); University Roma Tre (Internationalization Project); Italian Cystic Fibrosis Research Foundation(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation)	This work was supported by grants from the Ministry of University and Research of Italy (Futuro in Ricerca 2010 - RBFR10LHD1; www.miur.it), University Roma Tre (Internationalization Project; www.uniroma3.it), and the Italian Cystic Fibrosis Research Foundation (FFC 14/2010 and FFC 13/2011; www.fibrosicisticaricerca.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albus AM, 1997, J BACTERIOL, V179, P3928, DOI 10.1128/jb.179.12.3928-3935.1997; Amara N, 2011, CHEM REV, V111, P195, DOI 10.1021/cr100101c; Ambrosi C, 2005, J BACTERIOL, V187, P5097, DOI 10.1128/JB.187.15.5097-5107.2005; Becher A, 2000, BIOTECHNIQUES, V29, P948, DOI 10.2144/00295bm04; COX CD, 1986, INFECT IMMUN, V52, P263, DOI 10.1128/IAI.52.1.263-270.1986; Driscoll JA, 2007, DRUGS, V67, P351, DOI 10.2165/00003495-200767030-00003; Duan K, 2007, J BACTERIOL, V189, P4827, DOI 10.1128/JB.00043-07; Dunn AK, 2007, ANAL BIOANAL CHEM, V387, P391, DOI 10.1007/s00216-006-0730-9; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Forster-Fromme K, 2010, FEMS MICROBIOL LETT, V308, P166, DOI 10.1111/j.1574-6968.2010.02005.x; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Galan B, 2011, MOL MICROBIOL, V79, P402, DOI 10.1111/j.1365-2958.2010.07450.x; Ghosh S, 2011, MOL MICROBIOL, V79, P1547, DOI 10.1111/j.1365-2958.2011.07544.x; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Imperi F, 2013, ANTIMICROB AGENTS CH, V57, P996, DOI 10.1128/AAC.01952-12; Imperi F, 2010, ENVIRON MICROBIOL, V12, P1630, DOI 10.1111/j.1462-2920.2010.02210.x; Imperi F, 2009, PROTEOMICS, V9, P1901, DOI 10.1002/pmic.200800618; Jimenez PN, 2012, MICROBIOL MOL BIOL R, V76, P46, DOI 10.1128/MMBR.05007-11; Kazakov AE, 2009, J BACTERIOL, V191, P52, DOI 10.1128/JB.01175-08; KESSLER E, 1982, INFECT IMMUN, V38, P716, DOI 10.1128/IAI.38.2.716-723.1982; Ledgham F, 2003, RES MICROBIOL, V154, P207, DOI 10.1016/S0923-2508(03)00024-X; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; MacEachran DP, 2008, INFECT IMMUN, V76, P3197, DOI 10.1128/IAI.00305-08; Mangwani N, 2012, J MOL MICROB BIOTECH, V22, P215, DOI 10.1159/000341847; Miller J.H., 1972, EXPT MOL GENETICS; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Morita Y, 2006, J BACTERIOL, V188, P8649, DOI 10.1128/JB.01342-06; OHMAN DE, 1980, J INFECT DIS, V142, P547, DOI 10.1093/infdis/142.4.547; Qiu DR, 2008, APPL ENVIRON MICROB, V74, P7422, DOI 10.1128/AEM.01369-08; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rampioni G, 2006, J BACTERIOL, V188, P815, DOI 10.1128/JB.188.2.815-819.2006; Rampioni G, 2007, MOL MICROBIOL, V66, P1557, DOI 10.1111/j.1365-2958.2007.06029.x; Rampioni G, 2009, FEMS MICROBIOL LETT, V301, P210, DOI 10.1111/j.1574-6968.2009.01817.x; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Rutherford ST, 2012, COLD SPRING HARB PER, p2(11); Sambrook J., 2002, MOL CLONING LAB MANU; Santos PM, 2002, RES MICROBIOL, V153, P527, DOI 10.1016/S0923-2508(02)01358-X; Schuster M, 2006, INT J MED MICROBIOL, V296, P73, DOI 10.1016/j.ijmm.2006.01.036; Smith RS, 2003, CURR OPIN MICROBIOL, V6, P56, DOI 10.1016/S1369-5274(03)00008-0; Soberon-Chavez G, 2005, CRIT REV MICROBIOL, V31, P171, DOI 10.1080/10408410591005138; SPAINK HP, 1987, PLANT MOL BIOL, V9, P27, DOI 10.1007/BF00017984; Venturi V, 2006, FEMS MICROBIOL REV, V30, P274, DOI 10.1111/j.1574-6976.2005.00012.x; Venturi V, 2011, MOL MICROBIOL, V82, P1060, DOI 10.1111/j.1365-2958.2011.07890.x; Williams P, 2007, PHILOS T R SOC B, V362, P1119, DOI 10.1098/rstb.2007.2039; Williams P, 2009, CURR OPIN MICROBIOL, V12, P182, DOI 10.1016/j.mib.2009.01.005; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Wolfgang MC, 2003, P NATL ACAD SCI USA, V100, P8484, DOI 10.1073/pnas.0832438100	48	15	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e69554	10.1371/journal.pone.0069554	http://dx.doi.org/10.1371/journal.pone.0069554			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861975	Green Published, gold, Green Submitted			2022-12-27	WOS:000321425300089
J	Loquai, C; Scheurich, V; Syring, N; Schmidtmann, I; Rietz, S; Werner, A; Grabbe, S; Beutel, ME				Loquai, Carmen; Scheurich, Vera; Syring, Nils; Schmidtmann, Irene; Rietz, Stephan; Werner, Andreas; Grabbe, Stephan; Beutel, Manfred E.			Screening for Distress in Routine Oncological Care-A Survey in 520 Melanoma Patients	PLOS ONE			English	Article							QUALITY-OF-LIFE; STEM-CELL TRANSPLANTATION; CANCER-PATIENTS; PSYCHOSOCIAL DISTRESS; PSYCHOLOGIC DISTRESS; EMOTIONAL DISTRESS; THERMOMETER; DEPRESSION; PREDICTORS; STRATEGIES	Introduction: Despite the increasing incidence of melanoma little is known about patients' emotional distress associated with this disease. Supplemented by the problem list (PL), the distress thermometer (DT) is a recommended screening instrument to measure psychosocial distress in cancer patients. Our objective was to explore the acceptance and the feasibility of the DT and PL as a concise screening tool in an ambulatory setting for routine care and to elucidate determinants of distress in melanoma patients with regard to sociodemographic and clinical variables. Methods: Consecutive melanoma outpatients were asked to complete the DT with the PL prior to their scheduled consultation. Demographic and clinical data were obtained from the patients' charts. Clinical data included melanoma stage, time since diagnosis, previous treatment, current treatment, and other cancer disease. Results: Out of 734 patients recruited into the study, 520 patients (71%) completed both the DT and the PL. Forty-seven percent met the >= 5 cut-off score for distress. Younger and employed patients reported higher distress than older and retired patients. A cut-off score of >= 5 was closely associated with self-reported emotional sources of distress, with practical problems, especially at work, family problems (dealing with the partner), and physical problems like pain, appearance, getting around, and nausea. Apart from higher distress under current systemic treatment, no associations were found between distress and clinical data. Conclusion: The DT together with the PL seems to be an economically reasonable screening tool to measure psychosocial distress in melanoma patients. In particular, younger melanoma patients who are currently employed are prone to experience distress at some point after diagnosis, but there appears to be almost no association between clinical data and the extent of distress. To characterize the impact of distress on disease outcome and quality of life in melanoma patients, further research is needed.	[Loquai, Carmen; Syring, Nils; Rietz, Stephan; Grabbe, Stephan] Johannes Gutenberg Univ Mainz, Dept Dermatol, D-55122 Mainz, Rhineland Palat, Germany; [Scheurich, Vera; Beutel, Manfred E.] Johannes Gutenberg Univ Mainz, Dept Psychosomat Med & Psychotherapy, D-55122 Mainz, Rhineland Palat, Germany; [Schmidtmann, Irene] Johannes Gutenberg Univ Mainz, Inst Med Biostat Epidemiol & Informat, D-55122 Mainz, Rhineland Palat, Germany; [Werner, Andreas] Tumor Ctr Rhineland Pfalz, Mainz, Rhineland Palat, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Loquai, C (corresponding author), Johannes Gutenberg Univ Mainz, Dept Dermatol, D-55122 Mainz, Rhineland Palat, Germany.	carmen.loquai@unimedizin-mainz.de	Loquai, Carmen/AAW-9241-2020; Grabe, Stephan/AAJ-4578-2021	Grabe, Stephan/0000-0002-6863-8719				Agresti A., 2007, INTRO CATEGORICAL DA, P372, DOI DOI 10.1002/0470114754; Atkinson TM, 2012, ANN SURG ONCOL; AWMF online, 2013, S3 GUID MAL MEL; Beutel ME, 2009, HAUTARZT, V60, P727, DOI 10.1007/s00105-009-1814-1; Blum A, 2003, PSYCHOTHER PSYCH MED, V53, P258; Brown JE, 2000, BRIT J CANCER, V83, P1448, DOI 10.1054/bjoc.2000.1471; Bultz BD, 2005, J CLIN ONCOL, V23, P6440, DOI 10.1200/JCO.2005.02.3259; German Cancer Society, 2010, ERH HAUTKR; Graves KD, 2007, LUNG CANCER, V55, P215, DOI 10.1016/j.lungcan.2006.10.001; Holland J, 1999, ONCOLOGY-NY, V13, P113; Jacobsen PB, 2005, CANCER-AM CANCER SOC, V103, P1494, DOI 10.1002/cncr.20940; Kasparian NA, 2011, PSYCHOONCOLOGY; Kasparian NA, 2009, ARCH DERMATOL, V145, P1415, DOI 10.1001/archdermatol.2009.308; Kendall J, 2011, PSYCHO-ONCOLOGY, V20, P594, DOI 10.1002/pon.1907; Kennard BD, 2004, J CLIN PSYCHOL MED S, V11, P31, DOI 10.1023/B:JOCS.0000016267.21912.74; Kneier AW, 2003, SURG CLIN N AM, V83, P417, DOI 10.1016/S0039-6109(02)00088-9; Lehto US, 2007, J PSYCHOSOM RES, V63, P9, DOI 10.1016/j.jpsychores.2007.01.001; Loquai C, 2008, EUR J DERMATOL, V18, P29; McDonald M V, 1999, Oncol Nurs Forum, V26, P593; Mehnert A, 2006, Z PSYCHIATR PSYCH PS, V54, P213, DOI 10.1024/1661-4747.54.3.213; Mergenthaler U, 2011, ANN ONCOL, V22, P931, DOI 10.1093/annonc/mdq455; Mertz BG, 2012, EUR J ONCOL NURS, V16, P439, DOI 10.1016/j.ejon.2011.10.001; Mosher CE, 2010, BONE MARROW TRANSPL, V45, P570, DOI 10.1038/bmt.2009.166; National Comprehensive Cancer Network, 2012, NCCN DISTR MAN CLIN; Newton-Bishop JA, 2004, J INVEST DERM SYMP P, V9, P152, DOI 10.1046/j.1087-0024.2003.09118.x; Ollerton I, 1995, J Psychiatr Ment Health Nurs, V2, P91, DOI 10.1111/j.1365-2850.1995.tb00148.x; Pelletier G, 2002, J NEURO-ONCOL, V57, P41, DOI 10.1023/A:1015728825642; Peppercorn JM, 2011, J CLIN ONCOL, V29, P755, DOI 10.1200/JCO.2010.33.1744; Prieto JM, 2005, J CLIN ONCOL, V23, P6063, DOI 10.1200/JCO.2005.05.751; Prieto JM, 2002, J CLIN ONCOL, V20, P1907, DOI 10.1200/JCO.2002.07.101; Roberts N, 2012, J CLIN PSYCHOL MED S; Roth AJ, 1998, CANCER, V82, P1904, DOI 10.1002/(SICI)1097-0142(19980515)82:10<1904::AID-CNCR13>3.0.CO;2-X; Simard EP, 2012, CA CANC J CLIN; Skarstein J, 2000, J PSYCHOSOM RES, V49, P27, DOI 10.1016/S0022-3999(00)00080-5; Sollner W, 2001, BRIT J CANCER, V84, P179, DOI 10.1054/bjoc.2000.1545; Stark D, 2002, J CLIN ONCOL, V20, P3137, DOI 10.1200/JCO.2002.08.549; Trask PC, 2001, J CLIN ONCOL, V19, P2844, DOI 10.1200/JCO.2001.19.11.2844; Tuinman MA, 2008, CANCER-AM CANCER SOC, V113, P870, DOI 10.1002/cncr.23622; Ziefle S, 2011, J IMMUNOTHER, V34, P403, DOI 10.1097/CJI.0b013e31821b7a4b	39	31	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e66800	10.1371/journal.pone.0066800	http://dx.doi.org/10.1371/journal.pone.0066800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	178DW	23861748	Green Published, gold, Green Submitted			2022-12-27	WOS:000321425300007
J	Barrett, CW; Singh, K; Motley, AK; Lintel, MK; Matafonova, E; Bradley, AM; Ning, W; Poindexter, SV; Parang, B; Reddy, VK; Chaturvedi, R; Fingleton, BM; Washington, MK; Wilson, KT; Davies, SS; Hill, KE; Burk, RF; Williams, CS				Barrett, Caitlyn W.; Singh, Kshipra; Motley, Amy K.; Lintel, Mary K.; Matafonova, Elena; Bradley, Amber M.; Ning, Wei; Poindexter, Shenika V.; Parang, Bobak; Reddy, Vishruth K.; Chaturvedi, Rupesh; Fingleton, Barbara M.; Washington, Mary K.; Wilson, Keith T.; Davies, Sean S.; Hill, Kristina E.; Burk, Raymond F.; Williams, Christopher S.			Dietary Selenium Deficiency Exacerbates DSS-Induced Epithelial Injury and AOM/DSS-Induced Tumorigenesis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; OXIDATIVE DNA-DAMAGE; ULCERATIVE-COLITIS; CROHNS-DISEASE; GLUTATHIONE-PEROXIDASE; INTESTINAL CANCER; MOUSE MODEL; GI-GPX; EXPRESSION; SELENOPROTEINS	Selenium (Se) is an essential micronutrient that exerts its functions via selenoproteins. Little is known about the role of Se in inflammatory bowel disease (IBD). Epidemiological studies have inversely correlated nutritional Se status with IBD severity and colon cancer risk. Moreover, molecular studies have revealed that Se deficiency activates WNT signaling, a pathway essential to intestinal stem cell programs and pivotal to injury recovery processes in IBD that is also activated in inflammatory neoplastic transformation. In order to better understand the role of Se in epithelial injury and tumorigenesis resulting from inflammatory stimuli, we examined colonic phenotypes in Se-deficient or -sufficient mice in response to dextran sodium sulfate (DSS)-induced colitis, and azoxymethane (AOM) followed by cyclical administration of DSS, respectively. In response to DSS alone, Se-deficient mice demonstrated increased morbidity, weight loss, stool scores, and colonic injury with a concomitant increase in DNA damage and increases in inflammation-related cytokines. As there was an increase in DNA damage as well as expression of several EGF and TGF-beta pathway genes in response to inflammatory injury, we sought to determine if tumorigenesis was altered in the setting of inflammatory carcinogenesis. Se-deficient mice subjected to AOM/DSS treatment to model colitis-associated cancer (CAC) had increased tumor number, though not size, as well as increased incidence of high grade dysplasia. This increase in tumor initiation was likely due to a general increase in colonic DNA damage, as increased 8-OHdG staining was seen in Se-deficient tumors and adjacent, non-tumor mucosa. Taken together, our results indicate that Se deficiency worsens experimental colitis and promotes tumor development and progression in inflammatory carcinogenesis.	[Barrett, Caitlyn W.; Singh, Kshipra; Motley, Amy K.; Lintel, Mary K.; Bradley, Amber M.; Ning, Wei; Poindexter, Shenika V.; Parang, Bobak; Reddy, Vishruth K.; Chaturvedi, Rupesh; Wilson, Keith T.; Hill, Kristina E.; Burk, Raymond F.; Williams, Christopher S.] Vanderbilt Univ, Sch Med, Dept Med, Div Gastroenterol, Nashville, TN 37212 USA; [Matafonova, Elena; Davies, Sean S.] Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Nashville, TN 37212 USA; [Barrett, Caitlyn W.; Poindexter, Shenika V.; Parang, Bobak; Fingleton, Barbara M.; Wilson, Keith T.; Williams, Christopher S.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Davies, Sean S.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Washington, Mary K.; Wilson, Keith T.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Wilson, Keith T.; Williams, Christopher S.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Singh, Kshipra; Chaturvedi, Rupesh; Wilson, Keith T.; Williams, Christopher S.] Vet Affairs Tennessee Valley Hlth Care Syst, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Williams, CS (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Gastroenterol, Nashville, TN 37212 USA.	christopher.williams@vanderbilt.edu	Williams, Christopher/W-3524-2019	Williams, Christopher/0000-0002-1541-579X; Reddy, Vishruth/0000-0002-9150-7784; Fingleton, Barbara/0000-0003-1132-0782; Wilson, Keith/0000-0003-4421-1830; Davies, Sean/0000-0001-9879-8062	National Institutes of Health [DK080221, R01DK82813, P50CA095103, R01AT004821, R01AT004821-S1, R01DK053620, P01CA028842, P01CA116087, 1F31CA167920]; Vanderbilt Digestive Disease Research Center [P30 DK058404]; Office of Medical Research, Department of Veterans Affair [1I01BX001426, 1I01BX001453, ACS-RSG 116552]; NCI [T32CA009592-26]; NCI Cancer Center Support Grant [P30CA068485]; NATIONAL CANCER INSTITUTE [P01CA116087, T32CA009592, R01CA190612, P01CA028842, P50CA095103, F31CA167920, P30CA068485] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT004821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK096718, K08DK080221, R01DK053620, R01DK082813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM062459, T32GM007347] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Digestive Disease Research Center; Office of Medical Research, Department of Veterans Affair; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the National Institutes of Health grants DK080221 (CSW), R01DK82813 (RFB), P50CA095103 (MKW), R01AT004821 (KTW), R01AT004821-S1 (KTW), R01DK053620 (KTW), P01CA028842 (KTW), P01CA116087 (KTW), 1F31CA167920 (CWB), and P30 DK058404 (Vanderbilt Digestive Disease Research Center), Merit Review Grants from the Office of Medical Research, Department of Veterans Affairs 1I01BX001426 (CSW) and 1I01BX001453 (KTW), and ACS-RSG 116552 (CSW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by an NCI T-32 Supplement T32CA009592-26. This publication was also supported in part by the NCI Cancer Center Support Grant P30CA068485 utilizing the Translational Pathology shared resource, which provided tissue processing and staining services. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NCI or the NIH.	Al-Taie OH, 2004, NUTR CANCER, V48, P6, DOI 10.1207/s15327914nc4801_2; Andoh A, 2005, NUTRITION, V21, P574, DOI 10.1016/j.nut.2004.08.025; Barrett CW, 2013, CANCER RES, V73, P1245, DOI 10.1158/0008-5472.CAN-12-3150; Barrett CW, 2011, CANCER RES, V71, P1302, DOI 10.1158/0008-5472.CAN-10-3317; Becker C, 2005, GUT, V54, P950, DOI 10.1136/gut.2004.061283; Beckett GJ, 2005, J ENDOCRINOL, V184, P455, DOI 10.1677/joe.1.05971; Bera S, 2013, MUTAGENESIS, V28, P127, DOI 10.1093/mutage/ges064; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Burk RF, 2008, FREE RADICAL BIO MED, V44, P1617, DOI 10.1016/j.freeradbiomed.2008.01.016; Carrier J, 2002, J NUTR, V132, P3146, DOI 10.1093/jn/131.10.3146; Chang SH, 2011, IMMUNITY, V35, P611, DOI 10.1016/j.immuni.2011.09.010; Cho Min Haeng, 2010, [Journal of Food Hygiene and Safety, 한국식품위생안전성학회지], V25, P269; Chu FF, 2004, CANCER RES, V64, P962, DOI 10.1158/0008-5472.CAN-03-2272; Circu ML, 2012, SEMIN CELL DEV BIOL, V23, P729, DOI 10.1016/j.semcdb.2012.03.014; CLARK LC, 1991, ARCH ENVIRON HEALTH, V46, P37, DOI 10.1080/00039896.1991.9937427; Combs GF, 1998, PHARMACOL THERAPEUT, V79, P179, DOI 10.1016/S0163-7258(98)00014-X; Damiani CR, 2007, J GASTROEN HEPATOL, V22, P1846, DOI 10.1111/j.1440-1746.2007.04890.x; Denson LA, 2013, INFLAMM BOWEL DIS, DOI [10.1097/MIB.0-b013e31828134b3, DOI 10.1097/MIB.0-B013E31828134B3]; Dincer Y, 2007, DIGEST DIS SCI, V52, P1636, DOI 10.1007/s10620-006-9386-8; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; Ferguson LR, 2012, MUTAT RES-FUND MOL M, V733, P100, DOI 10.1016/j.mrfmmm.2011.12.011; Florian S, 2001, FREE RADICAL RES, V35, P655, DOI 10.1080/10715760100301181; Frierson HF, 2002, AM J PATHOL, V161, P1315, DOI 10.1016/S0002-9440(10)64408-2; Gentschew L, 2012, NUTRIENTS, V4, P1247, DOI 10.3390/nu4091247; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Han PD, 1999, GASTROENTEROL CLIN N, V28, P423, DOI 10.1016/S0889-8553(05)70063-7; Hill KE, 2003, J BIOL CHEM, V278, P13640, DOI 10.1074/jbc.M300755200; Hill KE, 2004, J NUTR, V134, P157, DOI 10.1093/jn/134.1.157; Hoffenberg EJ, 1997, AM J CLIN NUTR, V65, P1482, DOI 10.1093/ajcn/65.5.1482; Hong MY, 2005, EXP BIOL MED, V230, P464; Huang Z, 2012, ANTIOXID REDOX SIGN, V16, P705, DOI 10.1089/ars.2011.4145; Irons R, 2006, J NUTR, V136, P1311, DOI 10.1093/jn/136.5.1311; Jaworska K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059051; Kadiiska MB, 2005, FREE RADICAL BIO MED, V38, P698, DOI 10.1016/j.freeradbiomed.2004.09.017; Kipp A, 2009, MOL NUTR FOOD RES, V53, P1561, DOI 10.1002/mnfr.200900105; Kipp AP, 2012, BBA-GEN SUBJECTS, V1820, P1588, DOI 10.1016/j.bbagen.2012.05.016; KIRSNER JB, 1979, JAMA-J AM MED ASSOC, V242, P1177; KIRSNER JB, 1991, DM-DIS MON, V37, P605, DOI 10.1016/S0011-5029(05)80013-6; KOH TS, 1983, J ASSOC OFF ANA CHEM, V66, P918; Koller FL, 2012, LAB INVEST, V92, P1749, DOI 10.1038/labinvest.2012.141; Krehl S, 2012, CARCINOGENESIS, V33, P620, DOI 10.1093/carcin/bgr288; Kuroki F, 2003, DIGEST DIS, V21, P266, DOI 10.1159/000073346; Langenskiod M, 2008, J SURG ONCOL, V97, P409, DOI 10.1002/jso.20961; LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6; Lin YM, 2002, ONCOGENE, V21, P4120, DOI 10.1038/sj.onc.1205518; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Mannick EE, 2004, CLIN IMMUNOL, V112, P247, DOI 10.1016/j.clim.2004.03.014; Milne GL, 2007, NAT PROTOC, V2, P221, DOI 10.1038/nprot.2006.375; MODJTAHEDI H, 1994, INT J ONCOL, V4, P277; Mork H, 2000, NUTR CANCER, V37, P108, DOI 10.1207/S15327914NC3701_14; Murawaki Y, 2008, CANCER LETT, V259, P218, DOI 10.1016/j.canlet.2007.10.019; Neurath MF, 2007, NAT MED, V13, P26, DOI 10.1038/nm0107-26; Ojuawo A, 2002, Cent Afr J Med, V48, P116; Okayasu I, 1996, GUT, V39, P87, DOI 10.1136/gut.39.1.87; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; PEGG AE, 1984, CANCER INVEST, V2, P223, DOI 10.3109/07357908409104376; RANNEM T, 1992, AM J CLIN NUTR, V56, P933, DOI 10.1093/ajcn/56.5.933; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Reimund JM, 2000, CLIN NUTR, V19, P43, DOI 10.1054/clnu.1999.0073; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; RINGSTAD J, 1993, SCAND J GASTROENTERO, V28, P605, DOI 10.3109/00365529309096096; Saltzman BS, 2008, CANCER RES, V68, P1236, DOI 10.1158/0008-5472.CAN-07-2144; Schrauzer G N, 1977, Adv Exp Med Biol, V91, P323; Seril DN, 2003, CARCINOGENESIS, V24, P353, DOI 10.1093/carcin/24.3.353; SHEEHAN TMT, 1990, CLIN CHEM, V36, P2124; Skrzypczak M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013091, DOI 10.1371/J0URNAL.P0NE.0013091]; Steinbrenner H, 2013, ANTIOXID REDOX SIGN, V19, P181, DOI 10.1089/ars.2013.5246; Stranges S, 2007, ANN INTERN MED, V147, P217, DOI 10.7326/0003-4819-147-4-200708210-00175; Stucchi AF, 2000, AM J PHYSIOL-GASTR L, V279, pG1298, DOI 10.1152/ajpgi.2000.279.6.G1298; Sturniolo GC, 1998, SCAND J GASTROENTERO, V33, P644, DOI 10.1080/00365529850171936; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Trivedi PP, 2013, CHEM-BIOL INTERACT, V201, P19, DOI 10.1016/j.cbi.2012.12.004; Vatn Morten H, 2009, Curr Gastroenterol Rep, V11, P481; Washington MK, 2013, GASTROENTEROLOGY; Yin F, 2012, ANTIOXID REDOX SIGN, V17, P1714, DOI 10.1089/ars.2012.4639; Ying Y, 2000, MOL ENDOCRINOL, V14, P1053, DOI 10.1210/me.14.7.1053	78	66	68	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67845	10.1371/journal.pone.0067845	http://dx.doi.org/10.1371/journal.pone.0067845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861820	gold, Green Published, Green Submitted			2022-12-27	WOS:000323350700048
J	Freed, LA; Cann, RL				Freed, Leonard A.; Cann, Rebecca L.			Females Lead Population Collapse of the Endangered Hawaii Creeper	PLOS ONE			English	Article							MISLEADING TREND ANALYSIS; PARENTAL CARE; SEX-RATIOS; BIRDS; EXTINCTION; DECLINE; COMPENSATION; CONSEQUENCES; REPRODUCTION; INVESTMENT	Population collapses result from drastic environmental changes, but the sexes may differ in vulnerability. Collapse of the endangered Hawaii creeper (Oreomystis mana) at Hakalau Forest National Wildlife Refuge resulted from food limitation associated with increased numbers of an introduced bird (Japanese white-eye, Zosterops japonicus), which competes with the creeper for food. Both creeper sexes had stunted bill growth and the greatest change in molt of native species in the community. With a surge in numbers of white-eyes, a recent cohort of adult females had very low survival after breeding, while adult males from the same cohort, and older females and males, continued to have high survival. Lower female survival resulted in a significantly more male-biased adult sex ratio. Recent low female survival was based on a great cost of reproduction, indicated by molt-breeding overlap that was previously avoided, and lower fat during the lengthy fledgling period. The difference in female survival between cohorts was associated with stunted bills from being reared in and then breeding in an increasingly poor food environment. Trend analysis of survey data indicate that the bird is declining throughout the refuge, with males being 72-80% of adults left six years after the white-eye increased. Competition over time was consistent with that previously documented over space on the Island of Hawaii. Adaptive management to recover the bird in this protected area needs to focus on improving both adult female survival and the adult sex ratio.	[Freed, Leonard A.] Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA; [Cann, Rebecca L.] Univ Hawaii Manoa, Dept Cell & Mol Biol, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Freed, LA (corresponding author), Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA.	lfreed@hawaii.edu			World Environment and Resources Program of the John D. and Catherine T. MacArthur Foundation [8900287]; Multiple Stressors of Wildlife Program of the Environmental Protection Agency [R82-9093]	World Environment and Resources Program of the John D. and Catherine T. MacArthur Foundation; Multiple Stressors of Wildlife Program of the Environmental Protection Agency	Funding was received from the World Environment and Resources Program of the John D. and Catherine T. MacArthur Foundation ($817,752)(8900287), and from the Multiple Stressors of Wildlife Program of the Environmental Protection Agency ($510,091)(R82-9093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1969, LIVING BIRD; Arnold KE, 2007, J AVIAN BIOL, V38, P356, DOI 10.1111/j.2007.0908-8857.03818.x; Arnqvist Goran, 2005, pUnpaginated; ATKINSON S, 1994, J REPROD FERTIL, V100, P225; Avise JC, 2008, P NATL ACAD SCI USA, V105, P11453, DOI 10.1073/pnas.0802504105; Baker AJ, 2004, P ROY SOC B-BIOL SCI, V271, P875, DOI 10.1098/rspb.2003.2663; BELL G, 1980, AM NAT, V116, P45, DOI 10.1086/283611; Breitwisch R., 1989, Current Ornithology, V6, P1; Camp RJ, 2010, CONDOR, V112, P196, DOI 10.1525/cond.2010.080113; Camp RJ, 2009, HCSU011 U HAW HIL HA; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; CHARNOV E L, 1982; CLUTTONBROCK TH, 1985, NATURE, V313, P131, DOI 10.1038/313131a0; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; DeGroot M.H., 2002, PROBABILITY STAT; Diamond J.M., 1984, P824; Donald PF, 2007, IBIS, V149, P671, DOI 10.1111/j.1474-919X.2007.00724.x; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; DRENT RH, 1980, ARDEA, V68, P225; FOSTER MS, 1975, CONDOR, V77, P304, DOI 10.2307/1366226; Freed LA, 2005, CONDOR, V107, P753, DOI 10.1650/7820.1; Freed Lenoard A., 2012, NeoBiota, V13, P43; Freed LA, 2008, J PARASITOL, V94, P1009, DOI 10.1645/GE-1378.1; Freed LA, 2013, CONDOR, V115, P442, DOI 10.1525/cond.2013.110165; Freed LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029834; Freed LA, 2010, CONDOR, V112, P213, DOI 10.1525/cond.2010.090092; Freed LA, 2009, CURR BIOL, V19, P1736, DOI 10.1016/j.cub.2009.08.044; Freed LA, 2009, EVOL ECOL RES, V11, P731; Freed LA, 2008, EVOL ECOL RES, V10, P931; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; GAMBINO P, 1987, J TROP ECOL, V3, P169, DOI 10.1017/S0266467400001942; Green RE, 2008, P ROY SOC B-BIOL SCI, V275, P2381, DOI 10.1098/rspb.2008.0473; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; GUSTAFSSON L, 1994, PHILOS T R SOC B, V346, P323, DOI 10.1098/rstb.1994.0149; Harrison F, 2009, J EVOLUTION BIOL, V22, P1800, DOI 10.1111/j.1420-9101.2009.01792.x; Hart PJ, 2003, AUK, V120, P82, DOI 10.1642/0004-8038(2003)120[0082:SADOMF]2.0.CO;2; Houston AI, 2005, TRENDS ECOL EVOL, V20, P33, DOI 10.1016/j.tree.2004.10.008; Hutchings JA, 2004, BIOSCIENCE, V54, P297, DOI 10.1641/0006-3568(2004)054[0297:MFPCCF]2.0.CO;2; Jones KS, 2009, AM NAT, V174, P122, DOI 10.1086/599299; Kalmbach Ellen, 2007, P133; LAURIE WA, 1990, J ANIM ECOL, V59, P529, DOI 10.2307/4879; Le Galliard JF, 2005, P NATL ACAD SCI USA, V102, P18231, DOI 10.1073/pnas.0505172102; Lens L, 1998, BIODIVERS CONSERV, V7, P869, DOI 10.1023/A:1008815606931; Lepson JK, 2002, BIRDS N AM; Liker A, 2005, EVOLUTION, V59, P890, DOI 10.1554/04-560; Lindsey GD, 2009, CONSERVATION BIOL HA; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; Medeiros MC, 2009, AUK, V126, P319, DOI 10.1525/auk.2009.08013; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; MOUNTAINSPRING S, 1985, ECOL MONOGR, V55, P219, DOI 10.2307/1942558; Moyle RG, 2009, P NATL ACAD SCI USA, V106, P1863, DOI 10.1073/pnas.0809861105; MURPHY ME, 1988, CAN J ZOOL, V66, P1403, DOI 10.1139/z88-206; Nur N., 1990, NATO ASI Series Series G Ecological Sciences, V24, P281; Payne R.B., 1972, P103; Peck RW, 2008, BIOL INVASIONS, V10, P1441, DOI 10.1007/s10530-008-9218-1; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Pratt Thane K., 2009, P552; REZNICK D, 1985, OIKOS, V44, P257, DOI 10.2307/3544698; RICHNER H, 1995, P NATL ACAD SCI USA, V92, P1192, DOI 10.1073/pnas.92.4.1192; ROBBINS CS, 1989, P NATL ACAD SCI USA, V86, P7658, DOI 10.1073/pnas.86.19.7658; Robinson RA, 2004, J ANIM ECOL, V73, P670, DOI 10.1111/j.0021-8790.2004.00841.x; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Russell EM, 2004, BEHAV ECOL, V15, P831, DOI 10.1093/beheco/arh088; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; SAVIDGE JA, 1987, ECOLOGY, V68, P660, DOI 10.2307/1938471; Scott J.M., 1986, STUD AVIAN BIOL, V9, P1; Scott SN, 2003, EVOLUTION, V57, P2147; Sherman PW, 2002, ECOLOGY, V83, P2816, DOI 10.1890/0012-9658(2002)083[2816:DOAPCT]2.0.CO;2; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Steifetten O, 2006, BIOL CONSERV, V132, P88, DOI 10.1016/j.biocon.2006.03.016; Stutchbury B.J.M., 2001, BEHAV ECOLOGY TROPIC; SWADDLE JP, 1994, P ROY SOC B-BIOL SCI, V255, P147, DOI 10.1098/rspb.1994.0021; Szabo P, 2006, OIKOS, V112, P612, DOI 10.1111/j.0030-1299.2006.14128.x; Tilman David, 2007, P84; VanderWerf EA, 1998, CONDOR, V100, P541, DOI 10.2307/1369721; West SA, 2009, MONOGR POPUL BIOL, V44, P162; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Woodruff DS, 2001, P NATL ACAD SCI USA, V98, P5471, DOI 10.1073/pnas.101093798; Woodworth BL, 2001, STUD AVIAN BIOL-SER, P164	81	3	3	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67914	10.1371/journal.pone.0067914	http://dx.doi.org/10.1371/journal.pone.0067914			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861831	Green Published, gold, Green Submitted			2022-12-27	WOS:000323350700059
J	Parra, M; Liu, X; Derrick, SC; Yang, A; Tian, JH; Kolibab, K; Kumar, S; Morris, SL				Parra, Marcela; Liu, Xia; Derrick, Steven C.; Yang, Amy; Tian, Jinhua; Kolibab, Kristopher; Kumar, Sanjai; Morris, Sheldon L.			Molecular Analysis of Non-Specific Protection against Murine Malaria Induced by BCG Vaccination	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS BCG; PLASMODIUM-FALCIPARUM; ANTIMICROBIAL PEPTIDE; MICE; CATHELICIDIN; INFECTION; EOSINOPHIL; TUBERCULOSIS; METAANALYSIS; MORTALITY	Although the effectiveness of BCG vaccination in preventing adult pulmonary tuberculosis (TB) has been highly variable, epidemiologic studies have suggested that BCG provides other general health benefits to vaccinees including reducing the impact of asthma, leprosy, and possibly malaria. To further evaluate whether BCG immunization protects against malarial parasitemia and to define molecular correlates of this non-specific immunity, mice were vaccinated with BCG and then challenged 2 months later with asexual blood stage Plasmodium yoelii 17XNL (PyNL) parasites. Following challenge with PyNL, significant decreases in parasitemia were observed in BCG vaccinated mice relative to naive controls. To identify immune molecules that may be associated with the BCG-induced protection, gene expression was evaluated by RT-PCR in i) naive controls, ii) BCG-vaccinated mice, iii) PyNL infected mice and iv) BCG vaccinated/PyNL infected mice at 0, 1, 5, and 9 days after the P. yoelii infection. The expression results showed that i) BCG immunization induces the expression of at least 18 genes including the anti-microbial molecules lactoferrin, eosinophil peroxidase, eosinophil major basic protein and the cathelicidin-related antimicrobial peptide (CRAMP); ii) an active PyNL infection suppresses the expression of important immune response molecules; and iii) the extent of PyNL-induced suppression of specific genes is reduced in BCG-vaccinated/PyNL infected mice. To validate the gene expression data, we demonstrated that pre-treatment of malaria parasites with lactoferrin or the cathelicidin LL-37 peptide decreases the level of PyNL parasitemias in mice. Overall, our study suggests that BCG vaccination induces the expression of non-specific immune molecules including antimicrobial peptides which may provide an overall benefit to vaccinees by limiting infections of unrelated pathogens such as Plasmodium parasites.	[Parra, Marcela; Liu, Xia; Derrick, Steven C.; Yang, Amy; Tian, Jinhua; Kolibab, Kristopher; Kumar, Sanjai; Morris, Sheldon L.] USFDA, Ctr Biol Evaluat & Review, Bethesda, MD USA	US Food & Drug Administration (FDA)	Morris, SL (corresponding author), USFDA, Ctr Biol Evaluat & Review, Bethesda, MD USA.	sheldon.morris@fda.hhs.gov			FDA	FDA(United States Department of Health & Human Services)	FDA internal funding supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AABY P, 1995, BRIT MED J, V311, P481, DOI 10.1136/bmj.311.7003.481; Aaby P, 2011, HUM VACCINES, V7, P120, DOI 10.4161/hv.7.1.13848; Chakravortty D, 2003, MICROBES INFECT, V5, P621, DOI 10.1016/S1286-4579(03)00096-0; Chromek M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046476; Cirioni O, 2008, SHOCK, V30, P443, DOI 10.1097/SHK.0b013e31816d2269; CLARK IA, 1976, NATURE, V259, P309, DOI 10.1038/259309a0; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; D'Avila H, 2007, INFECT IMMUN, V75, P1507, DOI 10.1128/IAI.01326-06; Dean SN, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-114; El-Zein M, 2010, INT J EPIDEMIOL, V39, P469, DOI 10.1093/ije/dyp307; FRITSCH G, 1987, EXP PARASITOL, V63, P1, DOI 10.1016/0014-4894(87)90072-5; Goter-Robinson C, 2006, VACCINE, V24, P3522, DOI 10.1016/j.vaccine.2006.02.005; Jenssen H, 2009, BIOCHIMIE, V91, P19, DOI 10.1016/j.biochi.2008.05.015; Kin NW, 2011, EUR J IMMUNOL, V41, P3006, DOI 10.1002/eji.201141606; Kovach MA, 2012, J IMMUNOL, V189, P304, DOI 10.4049/jimmunol.1103196; Leversen NA, 2012, SCAND J IMMUNOL, V75, P489, DOI 10.1111/j.1365-3083.2012.02683.x; LEVINE MI, 1946, AM REV TUBERC PULM, V53, P517; Lim J, 2009, CLIN VACCINE IMMUNOL, V16, P122, DOI 10.1128/CVI.00359-08; Malik A, 2012, CRIT REV MICROBIOL, V38, P168, DOI 10.3109/1040841X.2011.645519; Mendez-Samperio P, 2008, CLIN VACCINE IMMUNOL, V15, P1450, DOI 10.1128/CVI.00178-08; Mendez-Samperio P, 2010, PEPTIDES, V31, P1791, DOI 10.1016/j.peptides.2010.06.016; MenezesdeLimaJunior O, 1997, J LEUKOCYTE BIOL, V62, P778, DOI 10.1002/jlb.62.6.778; Merle CSC, 2010, EXPERT REV VACCINES, V9, P209, DOI 10.1586/ERV.09.161; Millington Owain R, 2006, J Biol, V5, P5, DOI 10.1186/jbiol34; Mollenkopf HJ, 2006, MICROBES INFECT, V8, P136, DOI 10.1016/j.micinf.2005.06.015; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Nizet V, 2003, SCAND J INFECT DIS, V35, P670, DOI 10.1080/00365540310015629; Olsen AW, 2004, SCAND J IMMUNOL, V60, P273, DOI 10.1111/j.0300-9475.2004.01471.x; ORTIZORTIZ L, 1975, J IMMUNOL, V114, P1424; POST CLA, 1992, REV SAUDE PUBL, V26, P369, DOI 10.1590/S0034-89101992000600001; Rivas-Santiago B, 2012, INT J ANTIMICROB AGE; Roth A, 2005, INT J EPIDEMIOL, V34, P540, DOI 10.1093/ije/dyh392; Shakibaei M, 1996, J EXP MED, V184, P1699, DOI 10.1084/jem.184.5.1699; SMRKOVSKI LL, 1978, J IMMUNOL, V121, P1257; Sonawane A, 2011, CELL MICROBIOL, V13, P1601, DOI 10.1111/j.1462-5822.2011.01644.x; TABBARA KF, 1975, AM J OPHTHALMOL, V79, P641, DOI 10.1016/0002-9394(75)90804-1; TRNKA L, 1994, TUBERCLE LUNG DIS, V75, P348, DOI 10.1016/0962-8479(94)90080-9; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; VELEMA JP, 1991, INT J EPIDEMIOL, V20, P474, DOI 10.1093/ije/20.2.474; WATERS LS, 1987, INFECT IMMUN, V55, P877, DOI 10.1128/IAI.55.4.877-881.1987; Were T, 2009, MICROBES INFECT, V11, P811, DOI 10.1016/j.micinf.2009.04.021; Williams SK, 2010, EXPERT OPIN PHARMACO, V11, P947, DOI 10.1517/14656561003657145; Wuerth K, 2011, EUR J IMMUNOL, V41, P2817, DOI 10.1002/eji.201142055; Zheng W, 2009, FOLIA PARASIT, V56, P242, DOI 10.14411/fp.2009.028	44	38	39	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e66115	10.1371/journal.pone.0066115	http://dx.doi.org/10.1371/journal.pone.0066115			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861742	Green Published, Green Submitted, gold			2022-12-27	WOS:000323350700005
J	Abolafya, M; Onmus, O; Sekercioglu, CH; Bilgin, R				Abolafya, Moris; Onmus, Ortac; Sekercioglu, Cagan H.; Bilgin, Rasit			Using Citizen Science Data to Model the Distributions of Common Songbirds of Turkey Under Different Global Climatic Change Scenarios	PLOS ONE			English	Article							RANGE SHIFTS; BIRDS; COMMUNITY; RESPONSES; PATTERNS; IMPACTS	In this study, we evaluated the potential impact of climate change on the distributions of Turkey's songbirds in the 21st century by modelling future distributions of 20 resident and nine migratory species under two global climate change scenarios. We combined verified data from an ornithological citizen science initiative (www.kusbank.org) with maximum entropy modeling and eight bioclimatic variables to estimate species distributions and projections for future time periods. Model predictions for resident and migratory species showed high variability, with some species projected to lose and others projected to gain suitable habitat. Our study helps improve the understanding of the current and potential future distributions of Turkey's songbirds and their responses to climate change, highlights effective strategies to maximize avian conservation efforts in the study region, and provides a model for using citizen science data for biodiversity research in a large developing country with few professional field biologists. Our results demonstrate that climate change will not affect every species equally in Turkey. Expected range reductions in some breeding species will increase the risk of local extinction, whereas others are likely to expand their ranges.	[Abolafya, Moris; Bilgin, Rasit] Bogazici Univ, Inst Environm Sci, Istanbul, Turkey; [Onmus, Ortac] Ege Univ, Dept Biol, Nat Hist Museum, Res & Applicat Ctr, Izmir, Turkey; [Sekercioglu, Cagan H.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Sekercioglu, Cagan H.] KuzeyDoga Dernegi, Kars, Turkey	Bogazici University; Ege University; Ministry of Culture & Tourism - Turkey; Ministry of Energy & Natural Resources - Turkey; Utah System of Higher Education; University of Utah	Bilgin, R (corresponding author), Bogazici Univ, Inst Environm Sci, Istanbul, Turkey.	rasit.bilgin@boun.edu.tr	Onmuş, Ortaç/I-4717-2015; Bilgin, Rasit/A-3129-2016; Sekercioglu, Cagan H/A-2331-2013	Sekercioglu, Cagan H/0000-0001-9639-294X; Sekercioglu, Cagan H./0000-0003-3193-0377	Research Fund of Bogazici University in Istanbul [11Y00D6]	Research Fund of Bogazici University in Istanbul(Bogazici University)	This study was supported by a grant (No: 11Y00D6) from the Research Fund of Bogazici University in Istanbul to RB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, KUSB BIRD DAT; Barbet-Massin M, 2012, GLOBAL CHANGE BIOL, V18, P881, DOI 10.1111/j.1365-2486.2011.02552.x; Barbet-Massin M, 2009, BIOL LETTERS, V5, P248, DOI 10.1098/rsbl.2008.0715; Bilgin R, 2012, ACTA CHIROPTEROL, V14, P425, DOI 10.3161/150811012X661747; Both C, 2005, GLOBAL CHANGE BIOL, V11, P1606, DOI 10.1111/j.1365-2486.2005.01038.x; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Bozdogan M., 2006, TURKIYENIN ONEMLI DO; Bradshaw WE, 2006, SCIENCE, V312, P1477, DOI 10.1126/science.1127000; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Collins M, 2001, CLIM DYNAM, V17, P61, DOI 10.1007/s003820000094; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Hurlbert AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031662; Jankowski JE, 2010, ECOLOGY, V91, P1877, DOI 10.1890/09-2063.1; Jonzen N, 2007, CLIM RES, V35, P177, DOI 10.3354/cr00724; Kesisoglu A, 2010, DISTRIBUTION PATTERN; Kirwan G.M., 2008, BIRDS TURKEY; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Marra PP, 2005, OECOLOGIA, V142, P307, DOI 10.1007/s00442-004-1725-x; McCarty JP, 2001, CONSERV BIOL, V15, P320, DOI 10.1046/j.1523-1739.2001.015002320.x; Menzel A, 2002, CLIMATIC CHANGE, V54, P379, DOI 10.1023/A:1016125215496; Monahan WB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042097; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Peh KSH, 2007, CONDOR, V109, P437, DOI 10.1650/0010-5422(2007)109[437:PEOCCO]2.0.CO;2; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Raes N, 2009, ECOGRAPHY, V32, P180, DOI 10.1111/j.1600-0587.2009.05800.x; Ramirez J, 2009, WORKING CLIMATE DATA; Rissler LJ, 2006, AM NAT, V167, P655, DOI 10.1086/503332; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Roselaar C.S., 1995, SONGBIRDS TURKEY ATL; Schaefer HC, 2008, GLOBAL ECOL BIOGEOGR, V17, P38, DOI 10.1111/j.1466-8238.2007.00341.x; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Sekercioglu CH, 2012, BIOL CONSERV, V151, P69, DOI 10.1016/j.biocon.2011.10.024; Sekercioglu CH, 2011, BIOL CONSERV, V144, P2752, DOI 10.1016/j.biocon.2011.06.025; Sekercioglu CH, 2002, ENVIRON CONSERV, V29, P282, DOI 10.1017/S0376892902000206; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Skelly DK, 2007, CONSERV BIOL, V21, P1353, DOI 10.1111/j.1523-1739.2007.00764.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Studds CE, 2007, CLIM RES, V35, P115, DOI 10.3354/cr00718; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Tryjanowski P, 2002, IBIS, V144, P62, DOI 10.1046/j.0019-1019.2001.00022.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Wood C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001220; Wormworth J, 2011, WINGED SENTINELS: BIRDS AND CLIMATE CHANGE, P1, DOI 10.1017/CBO9781139150026	47	20	21	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68037	10.1371/journal.pone.0068037	http://dx.doi.org/10.1371/journal.pone.0068037			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844151	Green Published, gold, Green Submitted			2022-12-27	WOS:000321733000126
J	Choi, K; Park, J; Lee, J; Han, EC; Choi, C				Choi, Kyungsun; Park, Junseong; Lee, Jungsul; Han, Eun Chun; Choi, Chulhee			Mutant Ubiquitin Attenuates Interleukin-1 beta- and Tumor Necrosis Factor-alpha-Induced Pro-Inflammatory Signaling in Human Astrocytic Cells	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; MITOCHONDRIAL DYNAMICS; POLYUBIQUITIN CHAINS; PROTEASOME; EXPRESSION; ACCUMULATION; DEGENERATION; INHIBITION; ACTIVATION; DISORDERS	A frameshift mutation of ubiquitin called ubiquitin(+1) (UBB+1) was found in the aging and Alzheimer's disease brains and thought to be associated with neuronal dysfuction and degeneration. Even though ubiquitylation has been known to regulate vital cellular functions mainly through proteasome-dependent degradation of polyubiquitinated substrates, proteolysis-independent roles of ubiquitylation have emerged as key mechanisms in various signaling cascades. In this study, we have investigated the effect of UBB+1 on proinflammatory signaling such as interleukin-1 beta (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha) in human astrocytes. Treatment with TNF-alpha and IL-1 beta induced expression of CCL2 and CXCL8 by human astrocytic cells; while ectopic expression of UBB+1 significantly abrogated the proinflammatory cytokine-induced expression of chemokines. Ectopic expression of UBB+1 suppressed TNF-alpha- and IL-1 beta-induced activation of NF-kappa B and JNK signaling pathway. Furthermore, we have demonstrated that polyubiquitylation of TRAFs and subsequent phosphorylation of TAK1 were significantly inhibited by stable expression of UBB+1. Collectively, these results suggest that UBB+1 may affect proinflammatory signaling in the central nervous system via inhibitory mechanisms of ubiquitin-dependent signaling in human astrocytes.	[Choi, Kyungsun; Park, Junseong; Lee, Jungsul; Choi, Chulhee] Korea Adv Inst Sci & Technol, Cell Signaling & BioImaging Lab, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Park, Junseong; Choi, Chulhee] Korea Adv Inst Sci & Technol, KI BioCentury, Taejon 305701, South Korea; [Han, Eun Chun; Choi, Chulhee] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Choi, K (corresponding author), Korea Adv Inst Sci & Technol, Cell Signaling & BioImaging Lab, Dept Bio & Brain Engn, Taejon 305701, South Korea.	ccbioks@kaist.ac.kr; cchoi@kaist.ac.kr	Lee, Jungsul/A-7851-2013; Park, Junseong/C-1973-2012; Choi, Chulhee/C-1642-2011	Lee, Jungsul/0000-0002-8600-5851; Choi, Chulhee/0000-0001-5542-9136	National Research Foundation of Korea (NRF) grant [2012R1A2A4A01007108]; Korea government(MEST)	National Research Foundation of Korea (NRF) grant(National Research Foundation of Korea); Korea government(MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant (No. 2012R1A2A4A01007108) funded by the Korea government(MEST) (to C.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Bajetto A, 2002, J NEUROCHEM, V82, P1311, DOI 10.1046/j.1471-4159.2002.01091.x; Chadwick L, 2012, NEUROPATH APPL NEURO, V38, P118, DOI 10.1111/j.1365-2990.2011.01236.x; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Choi C, 2002, MOL CELL BIOL, V22, P724, DOI 10.1128/MCB.22.3.724-736.2002; Choi KS, 2007, FEBS LETT, V581, P4691, DOI 10.1016/j.febslet.2007.08.065; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; de Pril R, 2006, NEUROBIOL AGING, V27, P515, DOI 10.1016/j.neurobiolaging.2005.04.016; de Pril R, 2004, HUM MOL GENET, V13, P1803, DOI 10.1093/hmg/ddh188; De Vrij FMS, 2001, FASEB J, V15, P2680, DOI 10.1096/fj.01-0438com; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Escobar-Henriques M, 2012, BIOCHIM BIOPHYS ACTA, V1833, P162; Fischer DF, 2003, FASEB J, V17, P2014, DOI 10.1096/fj.03-0205com; Fratta P, 2004, NEUROLOGY, V63, P1114, DOI 10.1212/01.WNL.0000138574.56908.5D; Hol EM, 2005, TRENDS MOL MED, V11, P488, DOI 10.1016/j.molmed.2005.09.001; Jones RW, 2001, LANCET, V358, P436, DOI 10.1016/S0140-6736(01)05667-7; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Lee J, 2010, BIOCHEM BIOPH RES CO, V391, P33, DOI 10.1016/j.bbrc.2009.10.155; Lindsten K, 2002, J CELL BIOL, V157, P417, DOI 10.1083/jcb.200111034; Majumder S, 1996, J NEUROSCI RES, V45, P758, DOI 10.1002/(SICI)1097-4547(19960915)45:6<758::AID-JNR12>3.0.CO;2-S; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Olive M, 2008, NEUROPATH APPL NEURO, V34, P76, DOI 10.1111/j.1365-2990.2007.00864.x; Owens T, 2005, BRAIN RES REV, V48, P178, DOI 10.1016/j.brainresrev.2004.12.007; Ransohoff RM, J CLIN INVEST, V122, P1164; Reddy PH, 2012, BBA-MOL BASIS DIS, V1822, P101, DOI 10.1016/j.bbadis.2011.10.016; Shaw JM, 2002, TRENDS CELL BIOL, V12, P178, DOI 10.1016/S0962-8924(01)02246-2; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Tan Z, 2007, CELL DEATH DIFFER, V14, P1721, DOI 10.1038/sj.cdd.4402180; Tank EMH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000382; van Leeuwen FW, 1998, SCIENCE, V279, P242, DOI 10.1126/science.279.5348.242; van Tijn P, 2007, J CELL SCI, V120, P1615, DOI 10.1242/jcs.03438; van Tijn P, 2012, NEUROCHEM INT, V61, P739, DOI 10.1016/j.neuint.2012.07.007; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Weninger SC, 2001, NAT MED, V7, P527, DOI 10.1038/87839; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yamasaki T, 2012, J SIGNAL TRANSDUCT	38	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67891	10.1371/journal.pone.0067891	http://dx.doi.org/10.1371/journal.pone.0067891			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844119	gold, Green Published, Green Submitted			2022-12-27	WOS:000321733000111
J	Edwards, MA; Derocher, AE; Nagy, JA				Edwards, Mark A.; Derocher, Andrew E.; Nagy, John A.			Home Range Size Variation in Female Arctic Grizzly Bears Relative to Reproductive Status and Resource Availability	PLOS ONE			English	Article							LONG-DISTANCE MOVEMENTS; BROWN BEARS; POPULATION-DYNAMICS; HABITAT SELECTION; CENTRAL AUSTRALIA; CENTRAL ALBERTA; URSUS-ARCTOS; BLACK BEARS; MULE DEER; STRATEGIES	The area traversed in pursuit of resources defines the size of an animal's home range. For females, the home range is presumed to be a function of forage availability. However, the presence of offspring may also influence home range size due to reduced mobility, increased nutritional need, and behavioral adaptations of mothers to increase offspring survival. Here, we examine the relationship between resource use and variation in home range size for female barren-ground grizzly bears (Ursus arctos) of the Mackenzie Delta region in Arctic Canada. We develop methods to test hypotheses of home range size that address selection of cover where cover heterogeneity is low, using generalized linear mixed-effects models and an information-theoretic approach. We found that the reproductive status of female grizzlies affected home range size but individually-based spatial availability of highly selected cover in spring and early summer was a stronger correlate. If these preferred covers in spring and early summer, a period of low resource availability for grizzly bears following den-emergence, were patchy and highly dispersed, females travelled farther regardless of the presence or absence of offspring. Increased movement to preferred covers, however, may result in greater risk to the individual or family.	[Edwards, Mark A.] Govt Alberta, Royal Alberta Museum, Edmonton, AB, Canada; [Edwards, Mark A.; Derocher, Andrew E.; Nagy, John A.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Edwards, MA (corresponding author), Govt Alberta, Royal Alberta Museum, Edmonton, AB, Canada.	mark.edwards@gov.ab.ca	Derocher, Andrew/J-4469-2012	Derocher, Andrew/0000-0002-1104-7774	University of Alberta; Inuvialuit Land Claim Wildlife Studies Implementation Fund; Alberta Cooperative Conservation Research Unit; Western Biophysical Program of the Government of Northwest Territories; Polar Continental Shelf Project; Endangered Species Recovery Fund - World Wildlife Fund; Lorraine Allison Scholarship Trust Fund; Circumpolar/Boreal Alberta Research Grant; Indian and Northern Affairs Canada Northern Scientific Training Program; Natural Sciences and Engineering Research Council of Canada; ConocoPhillips (North) Canada Limited; Government of Northwest Territories; Department of Environment and Natural Resources (Inuvik Region)	University of Alberta(University of Alberta); Inuvialuit Land Claim Wildlife Studies Implementation Fund; Alberta Cooperative Conservation Research Unit; Western Biophysical Program of the Government of Northwest Territories; Polar Continental Shelf Project(Natural Resources Canada); Endangered Species Recovery Fund - World Wildlife Fund; Lorraine Allison Scholarship Trust Fund; Circumpolar/Boreal Alberta Research Grant; Indian and Northern Affairs Canada Northern Scientific Training Program; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); ConocoPhillips (North) Canada Limited; Government of Northwest Territories; Department of Environment and Natural Resources (Inuvik Region)	Funding for this study was provided by the University of Alberta, Government of Northwest Territories, Department of Environment and Natural Resources (Inuvik Region), the Inuvialuit Land Claim Wildlife Studies Implementation Fund, ConocoPhillips (North) Canada Limited, Alberta Cooperative Conservation Research Unit, Western Biophysical Program of the Government of Northwest Territories, Polar Continental Shelf Project, Endangered Species Recovery Fund - World Wildlife Fund, Lorraine Allison Scholarship Trust Fund (http://www.arctic.ucalgary.ca/scholarships/the-lorraine-allison-memorial-scholarship), Circumpolar/Boreal Alberta Research Grant (http://www.ualberta.ca/ccinst/GRANTS/grants.html#cbar), Indian and Northern Affairs Canada Northern Scientific Training Program, and the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partially funded by ConocoPhillips (North) Canada Limited. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Agrell J, 1998, OIKOS, V83, P507, DOI 10.2307/3546678; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Anderson DP, 2005, LANDSCAPE ECOL, V20, P257, DOI 10.1007/s10980-005-0062-8; [Anonymous], 1987, BEARS BIOL MANAG; BALLARD WB, 1982, CAN FIELD NAT, V96, P1; Benson JF, 2006, ANIM BEHAV, V71, P685, DOI 10.1016/j.anbehav.2005.08.005; BEYER HL, 2005, HAWTHS ANAL TOOLS AR; BLANCHARD BM, 1991, BIOL CONSERV, V58, P41, DOI 10.1016/0006-3207(91)90044-A; Borger L, 2006, AM NAT, V168, P471, DOI 10.1086/507883; Boyce MS, 2003, ECOSCIENCE, V10, P421, DOI 10.1080/11956860.2003.11682790; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burt W. H., 1943, Journal of Mammalogy, V24, P346, DOI 10.2307/1374834; Chatterjee S., 2015, REGRESSION ANAL EXAM; CLARK BK, 1988, AM MIDL NAT, V120, P276, DOI 10.2307/2425999; CLUTTONBROCK TH, 1978, NATURE, V273, P191, DOI 10.1038/273191a0; Dahle B, 2003, J ZOOL, V260, P329, DOI 10.1017/S0952836903003753; Dahle B, 2003, J ANIM ECOL, V72, P660, DOI 10.1046/j.1365-2656.2003.00737.x; Dickman CR, 2001, WILDLIFE RES, V28, P493, DOI 10.1071/WR00023; Duda R. O., 1973, PATTERN CLASSIFICATI; Edwards MA, 2011, OECOLOGIA, V165, P877, DOI 10.1007/s00442-010-1869-9; Edwards MA, 2009, ANIM BEHAV, V77, P23, DOI 10.1016/j.anbehav.2008.09.025; Ferguson SH, 2000, ECOGRAPHY, V23, P193, DOI 10.1034/j.1600-0587.2000.230205.x; Forman R., 2014, ECOLOGICAL DESIGN PL, P217; Fryxell J.M., 1997, INDIVIDUAL BEHAV COM; Gillies CS, 2006, J ANIM ECOL, V75, P887, DOI 10.1111/j.1365-2656.2006.01106.x; Hahs AK, 2006, LANDSCAPE URBAN PLAN, V78, P435, DOI 10.1016/j.landurbplan.2005.12.005; HARESTAD AS, 1979, ECOLOGY, V60, P389, DOI 10.2307/1937667; Haythornthwaite AS, 2006, J ZOOL, V270, P543, DOI 10.1111/j.1469-7998.2006.00186.x; Hilderbrand GV, 1999, CAN J ZOOL, V77, P132, DOI 10.1139/cjz-77-1-132; Hooge PN, 1997, ANIMAL MOVEMENT EXTE; HOSMER DW, 1989, APPL LOGISTIC REGRES; HRDY SB, 1979, ETHOL SOCIOBIOL, V1, P13, DOI 10.1016/0162-3095(79)90004-9; Huberty C.J., 1994, APPL DISCRIMINANT AN; Illius A.W., 2006, LARGE HERBIVORE ECOL, P71; Kie JG, 1999, J MAMMAL, V80, P1114, DOI 10.2307/1383163; Kie JG, 2002, ECOLOGY, V83, P530, DOI 10.1890/0012-9658(2002)083[0530:LHADSE]2.0.CO;2; KOZAKIEWICZ M, 1993, LANDSCAPE ECOL, V8, P19, DOI 10.1007/BF00129864; Labisky RF, 1998, J WILDLIFE MANAGE, V62, P1329, DOI 10.2307/3801998; Lambert JDH, 1972, MACKENZIE DELTA AREA, P51; Letnic Mike, 2002, Australian Mammalogy, V23, P125; Liberg O, 1998, EUROPEAN ROE DEER: THE BIOLOGY OF SUCCESS, P221; LINDZEY FG, 1977, J WILDLIFE MANAGE, V41, P413, DOI 10.2307/3800510; Logan K.A., 2001, DESERT PUMA EVOLUTIO; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; MACHUTCHON A.G., 1996, GRIZZY BEAR HABITAT; Mackay JR, 1963, DEP MINES TECHNICAL, V8; Manly B.F.J., 2002, RESOURCE SELECTION A; Matson TK, 2007, J ZOOL, V271, P318, DOI 10.1111/j.1469-7998.2006.00216.x; McCune B., 2011, PC ORD MULTIVARIATE; McGarigal K., 1994, FRAGSTATS SPATIAL PA, V2, P128; MCLELLAN BN, 1995, CAN J ZOOL, V73, P704, DOI 10.1139/z95-082; McLoughlin PD, 2000, ECOSCIENCE, V7, P123, DOI 10.1080/11956860.2000.11682580; McLoughlin PD, 2003, ECOSCIENCE, V10, P11, DOI 10.1080/11956860.2003.11682744; McLoughlin Philip D., 1999, Ursus, V11, P79; MCNAB BK, 1963, AM NAT, V97, P133, DOI 10.1086/282264; MILNE BT, 1992, AM NAT, V139, P32, DOI 10.1086/285312; Ministry of Natural Resources, 2000, CAN DIG EL DAT; Munro RHM, 2006, J MAMMAL, V87, P1112, DOI 10.1644/05-MAMM-A-410R3.1; Nagy J.A., 1983, STUDY GRIZZLY BEARS; Nicholson MC, 1997, J MAMMAL, V78, P483, DOI 10.2307/1382900; Nielsen SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053721; Oftedal O.T., 1985, P215; Phillips MK, 1987, URSUS, V68, P1645; Porsild AE, 1980, VASCULAR PLANTS CONT; Powell R.A., 1997, ECOLOGY BEHAV N AM B; Rabe-Hesketh S, 2004, HDB STAT ANAL USING; REDPATH SM, 1995, J ANIM ECOL, V64, P652, DOI 10.2307/5807; REYNOLDS DG, 1980, INT C BEAR RES MANAG, V4, P181; Royall R., 1997, STAT EVIDENCE LIKELI; Said S, 2005, J ZOOL, V267, P301, DOI 10.1017/S0952836905007454; Sandell M., 1989, P164; SAUER PEGGY R., 1966, N Y FISH GAME J, V13, P125; Savage RE, 1931, FISHERY INVESTIGATIO, V2, P1; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Skrondal A., 2004, GEN LATENT VARIABLE; Swenson JE, 1997, NATURE, V386, P450, DOI 10.1038/386450a0; Unlimited Ducks, 2002, LOW MACK RIV DELT NW; Viereck LA, 1992, PNWGTR286 USDA; WIELGUS RB, 1995, J WILDLIFE MANAGE, V59, P552, DOI 10.2307/3802462; WISHART D, 1969, BIOMETRICS, V25, P165, DOI 10.2307/2528688; WOODBURY MR, 1996, CHEM IMMOBILIZATION; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; YOUNG BF, 1982, J WILDLIFE MANAGE, V46, P845, DOI 10.2307/3808217; Zar JH, 1999, BIOSTATISTICAL ANAL	84	16	16	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68130	10.1371/journal.pone.0068130	http://dx.doi.org/10.1371/journal.pone.0068130			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844162	gold, Green Published, Green Submitted			2022-12-27	WOS:000321733000130
J	Kang, DW; Park, JG; Ilhan, ZE; Wallstrom, G; LaBaer, J; Adams, JB; Krajmalnik-Brown, R				Kang, Dae-Wook; Park, Jin Gyoon; Ilhan, Zehra Esra; Wallstrom, Garrick; LaBaer, Joshua; Adams, James B.; Krajmalnik-Brown, Rosa			Reduced Incidence of Prevotella and Other Fermenters in Intestinal Microflora of Autistic Children	PLOS ONE			English	Article							GUT MICROBIOTA; DIVERSITY; MERCURY; GLUTATHIONE; BACTERIA; RATS	High proportions of autistic children suffer from gastrointestinal (GI) disorders, implying a link between autism and abnormalities in gut microbial functions. Increasing evidence from recent high-throughput sequencing analyses indicates that disturbances in composition and diversity of gut microbiome are associated with various disease conditions. However, microbiome-level studies on autism are limited and mostly focused on pathogenic bacteria. Therefore, here we aimed to define systemic changes in gut microbiome associated with autism and autism-related GI problems. We recruited 20 neurotypical and 20 autistic children accompanied by a survey of both autistic severity and GI symptoms. By pyrosequencing the V2/V3 regions in bacterial 16S rDNA from fecal DNA samples, we compared gut microbiomes of GI symptom-free neurotypical children with those of autistic children mostly presenting GI symptoms. Unexpectedly, the presence of autistic symptoms, rather than the severity of GI symptoms, was associated with less diverse gut microbiomes. Further, rigorous statistical tests with multiple testing corrections showed significantly lower abundances of the genera Prevotella, Coprococcus, and unclassified Veillonellaceae in autistic samples. These are intriguingly versatile carbohydrate-degrading and/or fermenting bacteria, suggesting a potential influence of unusual diet patterns observed in autistic children. However, multivariate analyses showed that autism-related changes in both overall diversity and individual genus abundances were correlated with the presence of autistic symptoms but not with their diet patterns. Taken together, autism and accompanying GI symptoms were characterized by distinct and less diverse gut microbial compositions with lower levels of Prevotella, Coprococcus, and unclassified Veillonellaceae.	[Kang, Dae-Wook; Ilhan, Zehra Esra; Krajmalnik-Brown, Rosa] Arizona State Univ, Swette Ctr Environm Biotechnol, Biodesign Inst, Tempe, AZ 85069 USA; [Park, Jin Gyoon; Wallstrom, Garrick; LaBaer, Joshua] Arizona State Univ, Virginia G Piper Ctr Personalized Diagnost, Biodesign Inst, Tempe, AZ USA; [Wallstrom, Garrick] Arizona State Univ, Dept Biomed Informat, Scottsdale, AZ USA; [Adams, James B.] Arizona State Univ, Sch Engn Matter Transport & Energy, Tempe, AZ USA; [Krajmalnik-Brown, Rosa] Arizona State Univ, Sch Sustainable Engn & Built Environm, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Krajmalnik-Brown, R (corresponding author), Arizona State Univ, Swette Ctr Environm Biotechnol, Biodesign Inst, Tempe, AZ 85069 USA.	Dr.Rosy@asu.edu	Krajmalnik-Brown, Rosa/AAA-4803-2021; Romanova, Raisa/O-5724-2018; Kang, Dae-Wook/AAP-3589-2020	Kang, Dae-Wook/0000-0002-2585-1974; Ilhan, Zehra Esra/0000-0002-3387-9424; Krajmalnik-Brown, Rosa/0000-0001-6064-3524	Autism Research Institute (San Diego, CA)	Autism Research Institute (San Diego, CA)	This research was funded by Autism Research Institute (San Diego, CA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J. B., 2008, Toxicological and Environmental Chemistry, V90, P739, DOI 10.1080/02772240701699294; Adams JB, 2007, J TOXICOL ENV HEAL A, V70, P1046, DOI 10.1080/15287390601172080; Adams JB, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-22; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Berg RD, 1996, TRENDS MICROBIOL, V4, P430, DOI 10.1016/0966-842X(96)10057-3; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chan D, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-34; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Collins SM, 2009, GASTROENTEROLOGY, V136, P2003, DOI 10.1053/j.gastro.2009.01.075; Crozier RH, 1997, ANNU REV ECOL SYST, V28, P243, DOI 10.1146/annurev.ecolsys.28.1.243; Daly K, 2012, BRIT J NUTR, V107, P989, DOI 10.1017/S0007114511003825; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dieterle F, 2010, NAT BIOTECHNOL, V28, P463, DOI 10.1038/nbt.1622; Duncan SH, 2002, APPL ENVIRON MICROB, V68, P5186, DOI 10.1128/AEM.68.10.5186-5190.2002; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Finegold SM, 2011, MED HYPOTHESES, V77, P270, DOI 10.1016/j.mehy.2011.04.032; Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gronow S, 2010, STAND GENOMIC SCI, V2, P57, DOI 10.4056/sigs.521107; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Hashizume K, 2003, J NUTR, V133, P3187, DOI 10.1093/jn/133.10.3187; Hooda S, 2012, J NUTR, V142, P1259, DOI 10.3945/jn.112.158766; Horvath K, 1999, J PEDIATR-US, V135, P559, DOI 10.1016/S0022-3476(99)70052-1; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Huws SA, 2011, ENVIRON MICROBIOL, V13, P1500, DOI 10.1111/j.1462-2920.2011.02452.x; Johnson CP, 2007, PEDIATRICS, V120, P1183, DOI 10.1542/peds.2007-2361; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kim YS, 2011, AM J PSYCHIAT, V168, P904, DOI 10.1176/appi.ajp.2011.10101532; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Li GZ, 2011, ENVIRON SCI TECHNOL, V45, P8359, DOI 10.1021/es2016523; Lonsdale D, 2002, NEUROENDOCRINOL LETT, V23, P303; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; MacFabe DF, 2011, BEHAV BRAIN RES, V217, P47, DOI 10.1016/j.bbr.2010.10.005; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; Minami T, 2007, ENVIRON TOXICOL PHAR, V24, P316, DOI 10.1016/j.etap.2007.08.004; Niehus R, 2006, J DEV BEHAV PEDIATR, V27, pS120, DOI 10.1097/00004703-200604002-00010; O'Toole PW, 2010, INT DAIRY J, V20, P281, DOI 10.1016/j.idairyj.2009.11.010; Parracho HMRT, 2005, J MED MICROBIOL, V54, P987, DOI 10.1099/jmm.0.46101-0; Piemonte F, 2001, EUR J CLIN INVEST, V31, P1007, DOI 10.1046/j.1365-2362.2001.00922.x; Potter DM, 2005, STAT MED, V24, P693, DOI 10.1002/sim.1931; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rajilic-Stojanovic M, 2011, GASTROENTEROLOGY, V141, P1792, DOI 10.1053/j.gastro.2011.07.043; Salazar N, 2008, APPL ENVIRON MICROB, V74, P4737, DOI 10.1128/AEM.00325-08; Sandler RH, 2000, J CHILD NEUROL, V15, P429, DOI 10.1177/088307380001500701; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schneider CK, 2006, J AUTISM DEV DISORD, V36, P1053, DOI 10.1007/s10803-006-0141-y; Selmer T, 2001, EUR J BIOCHEM, V268, P1363, DOI 10.1046/j.1432-1327.2001.02001.x; Sharp WG, 2013, J AUTISM DEV DISORD, DOI [10.1007/s10803-10013-11771-10805, DOI 10.1007/S10803-10013-11771-10805]; Simopoulos AP, 2011, MOL NEUROBIOL, V44, P203, DOI 10.1007/s12035-010-8162-0; Song YL, 2004, APPL ENVIRON MICROB, V70, P6459, DOI 10.1128/AEM.70.11.6459-6465.2004; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Sun Y, 2011, METHODS MOL BIOL, V733, P129, DOI 10.1007/978-1-61779-089-8_9; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Williams BL, 2012, MBIO, V3, DOI 10.1128/mBio.00261-11; Williams BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024585; Willing BP, 2011, NAT REV MICROBIOL, V9, P233, DOI 10.1038/nrmicro2536; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yap IKS, 2008, J PROTEOME RES, V7, P3718, DOI 10.1021/pr700864x; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhu YG, 2007, NEUROCHEM INT, V50, P671, DOI 10.1016/j.neuint.2006.12.013; Ziv-El M, 2011, APPL MICROBIOL BIOT, V92, P1063, DOI 10.1007/s00253-011-3388-y	70	547	593	1	181	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68322	10.1371/journal.pone.0068322	http://dx.doi.org/10.1371/journal.pone.0068322			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844187	Green Submitted, gold, Green Published			2022-12-27	WOS:000321733000140
J	Seabra, SG; Bras, PG; Zina, V; da Silva, EB; Rebelo, MT; Figueiredo, E; Mendel, Z; Paulo, OS; Franco, JC				Seabra, Sofia G.; Bras, Patricia G.; Zina, Vera; da Silva, Elsa Borges; Rebelo, Maria Teresa; Figueiredo, Elisabete; Mendel, Zvi; Paulo, Octavio S.; Franco, Jose Carlos			Molecular Evidence of Polyandry in the Citrus Mealybug, Planococcus citri (Hemiptera: Pseudococcidae)	PLOS ONE			English	Article							SCALE INSECTS; REPRODUCTIVE-BIOLOGY; GENOTYPING ERRORS; PRACTICAL GUIDE; CONSEQUENCES; EVOLUTION; CONFLICT; MICROSATELLITES; HETEROZYGOSITY; POPULATIONS	The occurrence of polyandry in Planococcus citri, presumed by earlier observations of mating behavior, was confirmed using microsatellite genotyping of pools of over 400 eggs resulting from controlled crosses of one female with two males. The genetic contribution of both mated males was confirmed in 13 out of 43 crosses. In three crosses it was possible to determine that only the first male fertilized the eggs, which may be due to sperm competition or unviable sperm supply. The microsatellite analysis also allowed the confirmation of aspects of the chromosomal inheritance detected previously in cytogenetic studies in Planococcus citri, namely that only one of the alleles is transmitted by the male, indicating that the males are functionally haploid, supporting the observation of Paternal Genome Elimination (PGE) in these insects.	[Seabra, Sofia G.; Bras, Patricia G.; Paulo, Octavio S.] Univ Lisbon, Fac Ciencias, Computat Biol & Populat Genom Grp, Ctr Biol Ambiental,Dept Biol Anim, Lisbon, Portugal; [Zina, Vera; da Silva, Elsa Borges; Franco, Jose Carlos] Univ Tecn Lisboa, Ctr Estudos Florestais, Inst Super Agron, P-1100 Lisbon, Portugal; [Rebelo, Maria Teresa] Univ Lisbon, Fac Ciencias, Ctr Estudos Ambiente & Mar, Dept Biol Anim, Lisbon, Portugal; [Figueiredo, Elisabete] Univ Tecn Lisboa, Ctr Engn Biossistemas, Inst Super Agron, P-1100 Lisbon, Portugal; [Mendel, Zvi] Agr Res Org, Volcani Ctr, Dept Entomol, IL-50250 Bet Dagan, Israel	Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Seabra, SG (corresponding author), Univ Lisbon, Fac Ciencias, Computat Biol & Populat Genom Grp, Ctr Biol Ambiental,Dept Biol Anim, Lisbon, Portugal.	sgseabra@fc.ul.pt	Paulo, Octávio/D-9921-2011; Figueiredo, Elisabete/AAY-8128-2020; Rebelo, MT/A-3772-2013; Seabra, Sofia G/B-3808-2013; Silva, Elsa Borges/A-3522-2012; Franco, José Carlos/B-8534-2009	Paulo, Octávio/0000-0001-5408-5212; Figueiredo, Elisabete/0000-0002-0795-4216; Rebelo, MT/0000-0002-2724-2195; Seabra, Sofia G/0000-0003-1413-2349; Silva, Elsa Borges/0000-0002-7000-3536; Franco, José Carlos/0000-0002-0898-3510; Zina, Vera/0000-0002-5202-881X	Fundacao para a Ciencia e a Tecnologia, Portugal [PTDC/AGR-AAM/099560/2008]	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was funded by Fundacao para a Ciencia e a Tecnologia, Portugal (http://www.fct.pt/;project PTDC/AGR-AAM/099560/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnqvist G, 2000, P NATL ACAD SCI USA, V97, P10460, DOI 10.1073/pnas.97.19.10460; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Arnqvist G, 2006, ETHOLOGY, V112, P748, DOI 10.1111/j.1439-0310.2006.01211.x; Belkhir K., GENETIX 4 05 LOGICIE; Ben-Dov Y., 1994, SYSTEMATIC CATALOGUE; Birkhead TR, 1998, SPERM COMPETITION SE; Boake CRB, 1996, ANNU REV ENTOMOL, V41, P211, DOI 10.1146/annurev.en.41.010196.001235; Boyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042040; Bretman A, 2005, MOL ECOL, V14, P2169, DOI 10.1111/j.1365-294X.2005.02556.x; BROWN SW, 1961, GENETICS, V46, P983; Chambers GK, 2000, COMP BIOCHEM PHYS B, V126, P455, DOI 10.1016/S0305-0491(00)00233-9; da Silva EB, 2013, J INSECT BEHAV, V26, P304, DOI 10.1007/s10905-012-9344-6; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; Franco JC, 2004, PHYTOPARASITICA, V32, P507, DOI 10.1007/BF02980445; FRANCO JC, 2004, ANAIS I SUPERIOR AGR, V49, P353; Franco JC, 2009, BIORATIONAL CONTROL OF ARTHROPOD PESTS: APPLICATION AND RESISTANCE MANAGEMENT, P233, DOI 10.1007/978-90-481-2316-2_10; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Hedrick PW, 1997, ANNU REV ECOL SYST, V28, P55, DOI 10.1146/annurev.ecolsys.28.1.55; Hoffman JI, 2005, MOL ECOL, V14, P599, DOI 10.1111/j.1365-294X.2004.02419.x; Hosken DJ, 2003, EVOL BIOL, V33, P173; Jones AG, 2010, MOL ECOL RESOUR, V10, P6, DOI 10.1111/j.1755-0998.2009.02778.x; Jones AG, 2003, MOL ECOL, V12, P2511, DOI 10.1046/j.1365-294X.2003.01928.x; Kempenaers B, 2007, ADV STUD BEHAV, V37, P189, DOI 10.1016/S0065-3454(07)37005-8; Lanier G.N., 1990, BEHAV MODIFYING CHEM, P25; Martins Renata F, 2012, J Genet, V91, pe75; Millar JG., 2005, ACS SYM SER, P11, DOI 10.1021/bk-2005-0906.ch002; NESTEL D, 1995, ENVIRON ENTOMOL, V24, P506, DOI 10.1093/ee/24.3.506; Normark BB, 2003, ANNU REV ENTOMOL, V48, P397, DOI 10.1146/annurev.ento.48.091801.112703; NUR U, 1990, DEVELOPMENT, P29; NUR U, 1977, GENETICS, V86, P149; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Price TAR, 2008, SCIENCE, V322, P1241, DOI 10.1126/science.1163766; R Development Core Team R, 2012, R LANG ENV STAT COMP; Ross L, 2010, BIOL REV, V85, P807, DOI 10.1111/j.1469-185X.2010.00127.x; Ross L, 2010, EVOL ECOL RES, V12, P89; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Silva E. B. da, 2009, IOBC/WPRS Bulletin, V41, P3; Simmons LW, 2007, MOL ECOL, V16, P4613, DOI 10.1111/j.1365-294X.2007.03528.x; Slate J, 2009, MOL ECOL, V18, P1815, DOI 10.1111/j.1365-294X.2009.04115.x; Suckling DM, 2000, CROP PROT, V19, P677, DOI 10.1016/S0261-2194(00)00090-9; Thornhill R, 2001, EVOLUTION INSECT MAT; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Tripet F, 2003, AM J TROP MED HYG, V68, P1; Walton VM, 2006, J ECON ENTOMOL, V99, P1280, DOI 10.1603/0022-0493-99.4.1280; Waterworth RA, 2012, J ECON ENTOMOL, V105, P949, DOI 10.1603/EC12002; Waterworth RA, 2011, ANN ENTOMOL SOC AM, V104, P249, DOI 10.1603/AN10139; Zeh JA, 1996, P ROY SOC B-BIOL SCI, V263, P1711, DOI 10.1098/rspb.1996.0250	49	5	6	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68241	10.1371/journal.pone.0068241	http://dx.doi.org/10.1371/journal.pone.0068241			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844173	gold, Green Published, Green Submitted			2022-12-27	WOS:000321733000134
J	Bi, YH; Zhong, HS; Xu, K; Zhang, Z; Qi, X; Xia, YH; Ren, L				Bi, Yonghua; Zhong, Hongshan; Xu, Ke; Zhang, Zhen; Qi, Xun; Xia, Yonghui; Ren, Ling			Development of a Novel Rabbit Model of Abdominal Aortic Aneurysm via a Combination of Periaortic Calcium Chloride and Elastase Incubation	PLOS ONE			English	Article							INDUCED SACCULAR ANEURYSMS; STENT-GRAFT MATERIAL; PERIARTERIAL APPLICATION; SIMULTANEOUS INHIBITION; CAROTID-ARTERY; RAT MODEL; KAPPA-B; INFLAMMATION; BIOCOMPATIBILITY; ENLARGEMENT	Background: The purpose of this study was to introduce a novel, simple and effective technique for creating a reliable rabbit model of abdominal aortic aneurysm (AAA) via a combination of periaortic calcium chloride (CaCl2) and elastase incubation. Methods: Forty-eight New Zealand white rabbits were divided into four groups. The AAA model was developed via a 20-minute periaortic incubation of CaCl2 (0.5 mol/L) and elastase (1 Unit/mu L) in a 1.5-cm aortic segment (Group CE). A single incubation of CaCl2 (Group C) or elastase (Group E) and a sham operation group (Sham Group) were used for the controls. Diameter was measured by serial digital subtraction angiography imaging on days 5, 15 and 30. Animals were sacrificed on day 5 and day 30 for histopathological and immunohistochemical studies. Results: All animals in Group CE developed aneurysm, with an average dilation ratio of 65.3% +/- 8.9% on day 5, 86.5% +/- 28.7% on day 15 and 203.6% +/- 39.1% on day 30. No aneurysm was found in Group C, and only one aneurysm was seen on day 5 in Group E. Group CE exhibited less intima-media thickness, endothelial recovery, elastin and smooth muscle cell (SMC) content, but stronger expression of matrix metalloproteinase-2, matrix metalloproteinase-9 and RAM11 compared to the controls. Conclusions: The novel rabbit model of AAA created by using a combination of periaortic CaCl2 and elastase incubation is simple and effective to perform and is valuable for elucidating AAA mechanisms and therapeutic interventions in experimental studies.	[Bi, Yonghua; Zhong, Hongshan; Xu, Ke; Qi, Xun; Xia, Yonghui; Ren, Ling] China Med Univ, Affiliated Hosp 1, Dept Radiol, Shenyang, Peoples R China; [Bi, Yonghua] Zhengzhou Univ, Dept Intervent Radiol, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China; [Zhong, Hongshan; Xu, Ke; Zhang, Zhen; Qi, Xun; Xia, Yonghui; Ren, Ling] Key Lab Diagnost Imaging & Intervent Radiol Liaon, Shenyang, Peoples R China; [Zhang, Zhen] China Med Univ, Affiliated Hosp 1, Dept Ultrasound, Shenyang, Peoples R China	China Medical University; Zhengzhou University; China Medical University	Xu, K (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Radiol, Shenyang, Peoples R China.	kexu@vip.sina.com			National Natural Science Foundations of China [81000654, 81171443, 81000620]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundations of China (Grant No. 81000654, 81171443 and 81000620). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANIDJAR S, 1990, CIRCULATION, V82, P973, DOI 10.1161/01.CIR.82.3.973; ANIDJAR S, 1992, J VASC SURG, V16, P139, DOI 10.1016/0741-5214(92)90101-D; Basalyga DM, 2004, CIRCULATION, V110, P3480, DOI 10.1161/01.CIR.0000148367.08413.E9; Chiou AC, 2001, J SURG RES, V99, P371, DOI 10.1006/jsre.2001.6207; Cloft HJ, 2000, RADIOLOGY, V214, P557, DOI 10.1148/radiology.214.2.r00fe21557; ERNST CB, 1993, NEW ENGL J MED, V328, P1167; Freestone T, 1997, ARTERIOSCL THROM VAS, V17, P10, DOI 10.1161/01.ATV.17.1.10; Fujiwara NH, 2005, J VASC INTERV RADIOL, V16, P1229, DOI 10.1097/01.RVI.0000171690.21149.8F; GERTZ SD, 1988, J CLIN INVEST, V81, P649, DOI 10.1172/JCI113368; HANKE H, 1990, CIRC RES, V67, P651, DOI 10.1161/01.RES.67.3.651; HELPERN VJ, 1994, J VASC SURG, V20, P51, DOI 10.1016/0741-5214(94)90175-9; Hoshina K, 2003, J VASC SURG, V37, P1067, DOI 10.1016/S0741-5214(03)70052-4; Huang GY, 2009, J HYPERTENS, V27, P1829, DOI 10.1097/HJH.0b013e32832db36b; Isenburg JC, 2007, CIRCULATION, V115, P1729, DOI 10.1161/CIRCULATIONAHA.106.672873; Jiao L, 2010, ACTA CARDIOL, V65, P499, DOI 10.1080/AC.65.5.2056235; Kallmes DF, 2002, AM J NEURORADIOL, V23, P295; Kobayashi H, 2004, EUR J VASC ENDOVASC, V28, P71, DOI 10.1016/j.ejvs.2004.03.015; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Mastoraki ST, 2012, ANN VASC SURG, V26, P250, DOI 10.1016/j.avsg.2011.09.003; Matsushita M, 1999, EUR SURG RES, V31, P305, DOI 10.1159/000008707; Miskolczi L, 1998, NEUROSURGERY, V43, P595, DOI 10.1097/00006123-199809000-00110; Miyake T, 2006, GENE THER, V13, P695, DOI 10.1038/sj.gt.3302704; Miyake T, 2007, CIRC RES, V101, P1175, DOI 10.1161/CIRCRESAHA.107.148668; Origuchi N, 1998, INT ANGIOL, V17, P113; Palmieri D, 2011, J SURG RES, V171, pE237, DOI 10.1016/j.jss.2011.07.041; Sasaki K, 2004, NEUROL MED-CHIR, V44, P467, DOI 10.2176/nmc.44.467; SCHULZ H, 1989, SCAND J CLIN LAB INV, V49, P381, DOI 10.3109/00365518909089111; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Short JG, 2001, AM J NEURORADIOL, V22, P1833; Sinha I, 2004, SURGERY, V136, P176, DOI 10.1016/j.surg.2004.04.010; Sinha I, 2006, ANN NY ACAD SCI, V1085, P367, DOI 10.1196/annals.1383.027; Tanaka A, 2009, J VASC SURG, V50, P1423, DOI 10.1016/j.jvs.2009.08.062; Tsuruda T, 2008, CIRC RES, V102, P1368, DOI 10.1161/CIRCRESAHA.108.173682; White JV, 1996, ANN NY ACAD SCI, V800, P97, DOI 10.1111/j.1749-6632.1996.tb33302.x; Yamaguchi T, 2001, J SURG RES, V95, P161, DOI 10.1006/jsre.2000.6025; Yasuda H, 2005, NEUROPATHOLOGY, V25, P66, DOI 10.1111/j.1440-1789.2004.00590.x; Zhang Q, 2011, J SURG RES, V167, pE385, DOI 10.1016/j.jss.2011.01.017; Zhong HS, 2009, J VASC SURG, V50, P1433, DOI 10.1016/j.jvs.2009.07.071; Zhong HS, 2009, J ENDOVASC THER, V16, P154, DOI 10.1583/08-2617.1	39	20	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68476	10.1371/journal.pone.0068476	http://dx.doi.org/10.1371/journal.pone.0068476			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844207	gold, Green Submitted, Green Published			2022-12-27	WOS:000321341000163
J	Dai, J; Zhai, HC; Zhou, A; Gong, Y; Luo, L				Dai, Junqiang; Zhai, Hongchang; Zhou, Anbang; Gong, Yongyuan; Luo, Lin			Asymmetric Correlation between Experienced Parental Attachment and Event-Related Potentials Evoked in Response to Parental Faces	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; BRAIN POTENTIALS; INTEGRATIVE THEORY; COGNITIVE CONTROL; DECISION-MAKING; SOCIAL-BEHAVIOR; FAMILIAR FACES; VISUAL-STIMULI; SELF-FACE; PERCEPTION	This study aims to explore the modulation effects of attachment relationships with parents on the neural correlates that are associated with parental faces. The event-related potentials elicited in 31 college students while viewing facial stimuli of their parents in two single oddball paradigms (father vs. unfamiliar male and mother vs. unfamiliar female) were measured. We found that enhanced P3a and P3b and attenuated N2b were elicited by parental faces; however, the N170 component failed to discriminate parental faces from unfamiliar faces. An experienced attachment relationship with the father was positively correlated to the P3a response associated with the father's face, whereas no correlation was found in the case of mothers. Further exploration in dipole source localization showed that, within the time window of the P300, distinctive brain regions were involved in the processing of parental faces; the father's face was located in the medial frontal gyrus, which might be involved in self effect, and the anterior cingulate gyrus was activated in response to the mother's face. This research is the first to demonstrate that neural mechanisms involved with parents can be modulated differentially by the qualities of the attachments to the parents. In addition, parental faces share a highly similar temporal pattern, but the origins of these neural responses are distinct, which could merit further investigation.	[Dai, Junqiang; Zhai, Hongchang; Zhou, Anbang; Gong, Yongyuan; Luo, Lin] Guangzhou Univ, Coll Educ, Dept Psychol, Guangzhou, Guangdong, Peoples R China	Guangzhou University	Zhai, HC (corresponding author), Guangzhou Univ, Coll Educ, Dept Psychol, Guangzhou, Guangdong, Peoples R China.	zhaihongchang@yahoo.com.cn			Humanities and Social Science of University in Guangdong Province [11WYXM040]; Humanities and Social Sciences Planning Fund of the Chinese Ministry of Education [12YJA190023]	Humanities and Social Science of University in Guangdong Province; Humanities and Social Sciences Planning Fund of the Chinese Ministry of Education	This research was supported by Humanities and Social Science of University in Guangdong Province (11WYXM040) and the Humanities and Social Sciences Planning Fund of the Chinese Ministry of Education (12YJA190023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman JM, 2001, ANN NY ACAD SCI, V935, P107, DOI 10.1111/j.1749-6632.2001.tb03476.x; Arsalidou M, 2010, BRAIN COGNITION, V74, P47, DOI 10.1016/j.bandc.2010.06.003; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; Bentin S, 2000, COGN NEUROPSYCHOL, V17, P35, DOI 10.1080/026432900380472; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bjorklund DF, 2006, DEV REV, V26, P213, DOI 10.1016/j.dr.2006.02.007; Bobes MA, 2007, BIOL PSYCHOL, V75, P146, DOI 10.1016/j.biopsycho.2007.01.006; Bowlby J, 1990, SECURE BASE PARENT C; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Caharel S, 2002, INT J NEUROSCI, V112, P1499, DOI 10.1080/00207450290158368; Campanella S, 2000, PSYCHOPHYSIOLOGY, V37, P796, DOI 10.1017/S0048577200991728; Cecchini M, 2011, INFANT BEHAV DEV, V34, P424, DOI 10.1016/j.infbeh.2011.04.002; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; Comerchero MD, 1999, CLIN NEUROPHYSIOL, V110, P24, DOI 10.1016/S0168-5597(98)00033-1; Craik FIM, 1999, PSYCHOL SCI, V10, P26, DOI 10.1111/1467-9280.00102; Dan O, 2012, BIOL PSYCHOL, V91, P212, DOI 10.1016/j.biopsycho.2012.06.003; Doherty NA, 2004, PERS RELATIONSHIP, V11, P469, DOI 10.1111/j.1475-6811.2004.00093.x; Edwards, 1992, CHILDREN DIFFERENT W; Eimer M, 2000, CLIN NEUROPHYSIOL, V111, P694, DOI 10.1016/S1388-2457(99)00285-0; Fassbender C, 2006, J PSYCHOPHYSIOL, V20, P286, DOI 10.1027/0269-8803.20.4.286; FIELD TM, 1984, INFANT BEHAV DEV, V7, P19, DOI 10.1016/S0163-6383(84)80019-3; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Fox CJ, 2009, NEUROIMAGE, V44, P569, DOI 10.1016/j.neuroimage.2008.09.011; Fries ABW, 2005, P NATL ACAD SCI USA, V102, P17237, DOI 10.1073/pnas.0504767102; Geary DC, 2000, PSYCHOL BULL, V126, P55, DOI 10.1037/0033-2909.126.1.55; Goto Y, 2005, NEUROREPORT, V16, P1329, DOI 10.1097/01.wnr.0000174404.86644.af; Grasso DJ, 2011, BIOL PSYCHOL, V86, P26, DOI 10.1016/j.biopsycho.2010.10.002; Grasso DJ, 2009, BIOL PSYCHOL, V81, P95, DOI 10.1016/j.biopsycho.2009.03.001; Guerra P, 2012, INT J PSYCHOPHYSIOL, V85, P79, DOI 10.1016/j.ijpsycho.2011.06.004; Han SH, 2008, NAT REV NEUROSCI, V9, P646, DOI 10.1038/nrn2456; Hodzic A, 2009, NEUROIMAGE, V45, P1264, DOI 10.1016/j.neuroimage.2009.01.027; Knight RT, 1997, J COGNITIVE NEUROSCI, V9, P75, DOI 10.1162/jocn.1997.9.1.75; Kubota JT, 2007, J EXP SOC PSYCHOL, V43, P738, DOI 10.1016/j.jesp.2006.10.023; Langeslag SJE, 2007, BIOL PSYCHOL, V76, P109, DOI 10.1016/j.biopsycho.2007.06.007; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Meijer EH, 2007, INT J PSYCHOPHYSIOL, V66, P231, DOI 10.1016/j.ijpsycho.2007.08.001; Mikulincer M, 2003, ADV EXP SOC PSYCHOL, V35, P53, DOI 10.1016/S0065-2601(03)01002-5; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; Oliver-Rodriguez JC, 1999, PSYCHOPHYSIOLOGY, V36, P176; Pesciarelli F, 2011, NEUROPSYCHOLOGIA, V49, P1154, DOI 10.1016/j.neuropsychologia.2011.02.003; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; Platek SM, 2006, HUM BRAIN MAPP, V27, P91, DOI 10.1002/hbm.20168; Platek SM, 2009, NEUROPSYCHOLOGIA, V47, P849, DOI 10.1016/j.neuropsychologia.2008.12.027; Polich J, 2003, BRAIN TOPOGR, V15, P141, DOI 10.1023/A:1022637732495; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Posamentier MT, 2003, NEUROPSYCHOL REV, V13, P113, DOI 10.1023/A:1025519712569; RAJA SN, 1992, J YOUTH ADOLESCENCE, V21, P471, DOI 10.1007/BF01537898; Ramasubbu R, 2007, CAN J PSYCHIAT, V52, P726, DOI 10.1177/070674370705201107; Ranganath C, 2003, NAT REV NEUROSCI, V4, P193, DOI 10.1038/nrn1052; Rossion B, 1999, CLIN NEUROPHYSIOL, V110, P449, DOI 10.1016/S1388-2457(98)00037-6; Rousselet GA, 2004, J VISION, V4, P13, DOI 10.1167/4.1.2; Rushworth MFS, 2007, TRENDS COGN SCI, V11, P168, DOI 10.1016/j.tics.2007.01.004; Saarela MV, 2007, CEREB CORTEX, V17, P230, DOI 10.1093/cercor/bhj141; Soltani Maryam, 2000, Critical Reviews in Neurobiology, V14, P199; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; Symons CS, 1997, PSYCHOL BULL, V121, P371, DOI 10.1037/0033-2909.121.3.371; Tanaka JW, 2006, J COGNITIVE NEUROSCI, V18, P1488, DOI 10.1162/jocn.2006.18.9.1488; Taylor MJ, 2009, HUM BRAIN MAPP, V30, P2008, DOI 10.1002/hbm.20646; Todorov A, 2008, SOC COGN AFFECT NEUR, V3, P119, DOI 10.1093/scan/nsn009; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Weisman O, 2012, BIOL PSYCHOL, V89, P533, DOI 10.1016/j.biopsycho.2011.11.008; Zhu Y, 2007, NEUROIMAGE, V34, P1310, DOI 10.1016/j.neuroimage.2006.08.047	65	4	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68795	10.1371/journal.pone.0068795	http://dx.doi.org/10.1371/journal.pone.0068795			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	176XV	23844240	Green Submitted, gold, Green Published			2022-12-27	WOS:000321341000180
J	Cao, YJ; Xian, M; Zou, HB; Zhang, HB				Cao, Yujin; Xian, Mo; Zou, Huibin; Zhang, Haibo			Metabolic Engineering of Escherichia coli for the Production of Xylonate	PLOS ONE			English	Article							D-XYLOSE METABOLISM; SACCHAROMYCES-CEREVISIAE; PSEUDOMONAS-FRAGI; ACID PRODUCTION; DEHYDROGENASE; GENES	Xylonate is a valuable chemical for versatile applications. Although the chemical synthesis route and microbial conversion pathway were established decades ago, no commercial production of xylonate has been obtained so far. In this study, the industrially important microorganism Escherichia coli was engineered to produce xylonate from xylose. Through the coexpression of a xylose dehydrogenase (xdh) and a xylonolactonase (xylC) from Caulobacter crescentus, the recombinant strain could convert 1 g/L xylose to 0.84 g/L xylonate and 0.10 g/L xylonolactone after being induced for 12 h. Furthermore, the competitive pathway for xylose catabolism in E. coli was blocked by disrupting two genes (xylA and xylB) encoding xylose isomerase and xylulose kinase. Under fed-batch conditions, the finally engineered strain produced up to 27.3 g/L xylonate and 1.7 g/L xylonolactone from 30 g/L xylose, about 88% of the theoretical yield. These results suggest that the engineered E. coli strain has a promising perspective for large-scale production of xylonate.	[Cao, Yujin; Xian, Mo; Zou, Huibin; Zhang, Haibo] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Key Lab Biobased Mat, Qingdao, Peoples R China	Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS	Xian, M (corresponding author), Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Key Lab Biobased Mat, Qingdao, Peoples R China.	xianmo@qibebt.ac.cn	Zhang, Haibo/ABB-0042-2022; Zou, Huibin/AAD-6159-2020	Zhang, Haibo/0000-0003-3728-9840; Zou, Huibin/0000-0002-0805-3022	National Defense Innovation Foundation of Chinese Academy of Sciences [CXJJ-11-M56]; National Natural Science Foundation of China [21202179]; Sci-Tech Development Project of Qingdao [12-4-1-45-nsh]; 'Twelfth Five-Year Plan' in National Science and Technology for the Rural Development [2012BAD32B06-2]; National High-Tech R&D Program of China [SS2013AA050703-2]	National Defense Innovation Foundation of Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sci-Tech Development Project of Qingdao; 'Twelfth Five-Year Plan' in National Science and Technology for the Rural Development; National High-Tech R&D Program of China(National High Technology Research and Development Program of China)	This work was supported by the National Defense Innovation Foundation of Chinese Academy of Sciences (No. CXJJ-11-M56), National Natural Science Foundation of China (No. 21202179), Sci-Tech Development Project of Qingdao (No. 12-4-1-45-nsh), 'Twelfth Five-Year Plan' in National Science and Technology for the Rural Development (No. 2012BAD32B06-2) and National High-Tech R&D Program of China (No. SS2013AA050703-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berghall S, 2007, FEMS MICROBIOL LETT, V277, P249, DOI 10.1111/j.1574-6968.2007.00969.x; BUCHERT J, 1986, BIOTECHNOL LETT, V8, P541, DOI 10.1007/BF01028079; BUCHERT J, 1988, APPL MICROBIOL BIOT, V29, P375, DOI 10.1007/BF00265822; BUCHERT J, 1988, APPL MICROBIOL BIOT, V27, P333; Cao YJ, 2011, APPL MICROBIOL BIOT, V91, P1545, DOI 10.1007/s00253-011-3304-5; Chemler JA, 2010, METAB ENG, V12, P96, DOI 10.1016/j.ymben.2009.07.003; Chun BW, 2006, APPL BIOCHEM BIOTECH, V131, P645, DOI 10.1385/ABAB:131:1:645; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DAVID JD, 1970, BIOCHIM BIOPHYS ACTA, V201, P497, DOI 10.1016/0304-4165(70)90171-6; Desai TA, 2010, APPL ENVIRON MICROB, V76, P1524, DOI 10.1128/AEM.01970-09; Governo AT, 2004, ELECTROCHIM ACTA, V49, P1535, DOI 10.1016/j.electacta.2003.11.013; ISHIZAKI H, 1973, J AGR CHEM SOC JPN, V47, P755, DOI 10.1271/nogeikagaku1924.47.755; Johnsen U, 2004, J BACTERIOL, V186, P6198, DOI 10.1128/JB.186.18.6198-6207.2004; Johnsen U, 2009, J BIOL CHEM, V284, P27290, DOI 10.1074/jbc.M109.003814; LIEN OG, 1959, ANAL CHEM, V31, P1363, DOI 10.1021/ac60152a035; Niu W, 2003, J AM CHEM SOC, V125, P12998, DOI 10.1021/ja036391+; Nygard Y, 2011, METAB ENG, V13, P383, DOI 10.1016/j.ymben.2011.04.001; Ramachandran S, 2006, FOOD TECHNOL BIOTECH, V44, P185; ROSENFELD SA, 1984, MOL GEN GENET, V194, P410, DOI 10.1007/BF00425552; Shimada T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020081; Stephens C, 2007, J BACTERIOL, V189, P2181, DOI 10.1128/JB.01438-06; Toivari M, 2012, METAB ENG, V14, P427, DOI 10.1016/j.ymben.2012.03.002; Toivari MH, 2012, APPL MICROBIOL BIOT, V96, P1, DOI 10.1007/s00253-012-4288-5; Toivari MH, 2010, APPL MICROBIOL BIOT, V88, P751, DOI 10.1007/s00253-010-2787-9; Vickers CE, 2012, BIOTECHNOL LETT, V34, P585, DOI 10.1007/s10529-011-0821-3; Werpy T., 2004, TOP VALUE ADDED CHEM, VI; Yang F, 2012, APPL MICROBIOL BIOT, V93, P487, DOI 10.1007/s00253-011-3712-6	27	30	35	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67305	10.1371/journal.pone.0067305	http://dx.doi.org/10.1371/journal.pone.0067305			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861757	Green Submitted, Green Published, gold			2022-12-27	WOS:000321425300010
J	Dwan, K; Gamble, C; Williamson, PR; Kirkham, JJ				Dwan, Kerry; Gamble, Carrol; Williamson, Paula R.; Kirkham, Jamie J.		Reporting Bias Grp	Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias - An Updated Review	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIALS; RESEARCH ETHICS COMMITTEE; CLINICAL-TRIALS; FOLLOW-UP; BIOMEDICAL-RESEARCH; SELECTION BIAS; IMPACT; COHORT; REGISTRATION; METAANALYSIS	Background: The increased use of meta-analysis in systematic reviews of healthcare interventions has highlighted several types of bias that can arise during the completion of a randomised controlled trial. Study publication bias and outcome reporting bias have been recognised as a potential threat to the validity of meta-analysis and can make the readily available evidence unreliable for decision making. Methodology/Principal Findings: In this update, we review and summarise the evidence from cohort studies that have assessed study publication bias or outcome reporting bias in randomised controlled trials. Twenty studies were eligible of which four were newly identified in this update. Only two followed the cohort all the way through from protocol approval to information regarding publication of outcomes. Fifteen of the studies investigated study publication bias and five investigated outcome reporting bias. Three studies have found that statistically significant outcomes had a higher odds of being fully reported compared to non-significant outcomes (range of odds ratios: 2.2 to 4.7). In comparing trial publications to protocols, we found that 40-62% of studies had at least one primary outcome that was changed, introduced, or omitted. We decided not to undertake meta-analysis due to the differences between studies. Conclusions: This update does not change the conclusions of the review in which 16 studies were included. Direct empirical evidence for the existence of study publication bias and outcome reporting bias is shown. There is strong evidence of an association between significant results and publication; studies that report positive or significant results are more likely to be published and outcomes that are statistically significant have higher odds of being fully reported. Publications have been found to be inconsistent with their protocols. Researchers need to be aware of the problems of both types of bias and efforts should be concentrated on improving the reporting of trials.	[Dwan, Kerry; Gamble, Carrol; Williamson, Paula R.; Kirkham, Jamie J.; Reporting Bias Grp] Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Dwan, K (corresponding author), Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England.	kerry.dwan@liverpool.ac.uk	Kirkham, Jamie/AAD-4490-2019; Williamson, Paula R/B-6425-2016; Dwan, Kerry/AAG-4726-2022; Gamble, Carrol/AAE-9895-2019; Dwan, Kerry/AFK-6469-2022	Kirkham, Jamie/0000-0003-2579-9325; Williamson, Paula R/0000-0001-9802-6636; Dwan, Kerry/0000-0001-6918-1215; Gamble, Carrol/0000-0002-3021-1955; Dwan, Kerry/0000-0001-6918-1215; von Elm, Erik/0000-0002-7412-0406; Easterbrook, Philippa/0000-0002-2603-5418	Medical Research Council (MRC); MRC [G0500952] Funding Source: UKRI; Medical Research Council [UD99999939, G0500952] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This updated review was funded by the Medical Research Council (MRC) hub for trial methodology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardy AH, 1998, BRIT J CLIN PHARMACO, V46, P147, DOI 10.1046/j.1365-2125.1998.00759.x; Blumle A, 2008, J MED ETHICS, V34, DOI 10.1136/jme.2008.024521; Bourgeois FT, 2010, ANN INTERN MED, V153, P158, DOI 10.7326/0003-4819-153-3-201008030-00006; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chappell L, 2005, COMP PUBLISHED VERSI; Cooper H, 1997, PSYCHOL METHODS, V2, P447, DOI 10.1037/1082-989X.2.4.447; Cronin E, 2004, INT J TECHNOL ASSESS, V20, P351, DOI 10.1017/S0266462304001175; de Jong JP, 2010, J CLIN EPIDEMIOL, V63, P1342, DOI 10.1016/j.jclinepi.2010.01.018; Decullier E, 2005, BMJ-BRIT MED J, V331, P19, DOI 10.1136/bmj.38488.385995.8F; Decullier E, 2007, J EPIDEMIOL COMMUN H, V61, P190, DOI 10.1136/jech.2006.048603; Decullier E, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-165; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; DICKERSIN K, 1987, CONTROL CLIN TRIALS, V8, P343, DOI 10.1016/0197-2456(87)90155-3; Dickersin K., 1993, ONLINE J CURR CLIN T, pDoc No 50; Djulbegovic B, 2011, J CLIN EPIDEMIOL, V64, P583, DOI 10.1016/j.jclinepi.2010.09.007; Dubben HH, 2005, BRIT MED J, V331, P433, DOI 10.1136/bmj.38478.497164.F7; Dwan K, 2010, ASSESSING POTENTIAL, V11; Dwan K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000031.pub2; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Egger M, 2001, SYSTEMATIC REV HLTH; Ewart R, 2009, ANN FAM MED, V7, P542, DOI 10.1370/afm.1017; Ghersi D, 2006, ISSUES DESIGN CONDUC; Hahn S, 2002, J EVAL CLIN PRACT, V8, P353, DOI 10.1046/j.1365-2753.2002.00314.x; Hall R, 2007, CAN J ANAESTH, V54, P380, DOI 10.1007/BF03022661; HEMMINKI E, 1980, BRIT MED J, V280, P833, DOI 10.1136/bmj.280.6217.833; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Huic M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025258; Hutton JL, 2000, J ROY STAT SOC C-APP, V49, P359, DOI 10.1111/1467-9876.00197; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Ioannidis JPA, 2001, P NATL ACAD SCI USA, V98, P831, DOI 10.1073/pnas.021529998; Jureidini JN, 2008, INT J RISK SAF MED, V29, P73, DOI DOI 10.3233/JRS-2008-0426; Kane RL, 2007, J CLIN EPIDEMIOL, V60, P241, DOI 10.1016/j.jclinepi.2006.06.016; Kirkham JJ, 2012, STAT MED, V31, P2179, DOI 10.1002/sim.5356; Kirkham JJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c365; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Matthews GA, 2011, J CLIN EPIDEMIOL, V64, P1317, DOI 10.1016/j.jclinepi.2011.03.013; McCormack J, 2005, BMJ-BRIT MED J, V331, P456, DOI 10.1136/bmj.331.7514.456-a; McKenzie JE, 2010, TRIALS, V11; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Menzel S, 2007, DEUT MED WOCHENSCHR, V132, P2313, DOI 10.1055/s-2007-991648; Mhaskar R, 2009, TREATMENT RELATED HA; Misakian AL, 1998, JAMA-J AM MED ASSOC, V280, P250, DOI 10.1001/jama.280.3.250; Olson CM, 2002, JAMA-J AM MED ASSOC, V287, P2825, DOI 10.1001/jama.287.21.2825; Pich J, 2003, LANCET, V361, P1015, DOI 10.1016/S0140-6736(03)12799-7; Ramsey S, 2008, ONCOLOGIST, V13, P925, DOI 10.1634/theoncologist.2008-0133; Rasmussen N, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-116; Reveiz L, 2012, J CLIN EPIDEMIOL, V65, P482, DOI 10.1016/j.jclinepi.2011.09.003; Reveiz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012484; Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1, DOI 10.1002/0470870168; Scherer RW, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000005.pub3, 10.1002/14651858.MR000005.pub4]; Soares HP, 2004, BRIT MED J, V328, P22, DOI 10.1136/bmj.328.7430.22; Song F, 2010, HLTH TECHNOL ASSESS, V14; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; Sune-Martin P, 2003, LANCET, V361, P2245, DOI 10.1016/S0140-6736(03)13751-8; Tharyan P, 2013, J CLIN EPIDEMIOL, V66, P10, DOI 10.1016/j.jclinepi.2011.11.011; Trikalinos TA, 2004, J CLIN EPIDEMIOL, V57, P1124, DOI 10.1016/j.jclinepi.2004.02.018; Turer AT, 2007, AM HEART J, V153, P674, DOI 10.1016/j.ahj.2007.01.005; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126; Viergever RF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014701; von Elm E, 2008, SWISS MED WKLY, V138, P197, DOI 2008/13/smw-12027; Williamson PR, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-9; Williamson PR, 2005, STAT METHODS MED RES, V14, P515, DOI 10.1191/0962280205sm415oa; Williamson PR, 2005, STAT MED, V24, P1547, DOI 10.1002/sim.2025; Wormald R, 1997, PUBLICATION BIAS EYE; Xuemei L, 2010, TRANSPARENCY CHINESE	68	418	421	4	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e66844	10.1371/journal.pone.0066844	http://dx.doi.org/10.1371/journal.pone.0066844			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	178DW	23861749	Green Published, Green Submitted, gold			2022-12-27	WOS:000321425300008
J	Ngaimisi, E; Habtewold, A; Minzi, O; Makonnen, E; Mugusi, S; Amogne, W; Yimer, G; Riedel, KD; Janabi, M; Aderaye, G; Mugusi, F; Bertilsson, L; Aklillu, E; Burhenne, J				Ngaimisi, Eliford; Habtewold, Abiy; Minzi, Omary; Makonnen, Eyasu; Mugusi, Sabina; Amogne, Wondwossen; Yimer, Getnet; Riedel, Klaus-Dieter; Janabi, Mohammed; Aderaye, Getachew; Mugusi, Ferdinand; Bertilsson, Leif; Aklillu, Eleni; Burhenne, Juergen			Importance of Ethnicity, CYP2B6 and ABCB1 Genotype for Efavirenz Pharmacokinetics and Treatment Outcomes: A Parallel-Group Prospective Cohort Study in Two Sub-Saharan Africa Populations	PLOS ONE			English	Article							HIV-POSITIVE PATIENTS; HIV-1-INFECTED PATIENTS; ADULT ETHIOPIANS; REFERENCE VALUES; PLASMA; EXPOSURE; TANZANIA; UGANDAN; AUTOINDUCTION; TUBERCULOSIS	Objectives: We evaluated the importance of ethnicity and pharmacogenetic variations in determining efavirenz pharmacokinetics, auto-induction and immunological outcomes in two African populations. Methods: ART naive HIV patients from Ethiopia (n = 285) and Tanzania (n = 209) were prospectively enrolled in parallel to start efavirenz based HAART. CD4+ cell counts were determined at baseline, 12, 24 and 48 weeks. Plasma and intracellular efavirenz and 8-hydroxyefvairenz concentrations were determined at week 4 and 16. Genotyping for common functional CYP2B6, CYP3A5, ABCB1, UGT2B7 and SLCO1B1 variant alleles were done. Result: Patient country, CYP2B6*6 and ABCB1 c.4036A>G (rs3842A>G) genotype were significant predictors of plasma and intracellular efavirenz concentration. CYP2B6*6 and ABCB1 c.4036A>G (rs3842) genotype were significantly associated with higher plasma efavirenz concentration and their allele frequencies were significantly higher in Tanzanians than Ethiopians. Tanzanians displayed significantly higher efavirenz plasma concentration at week 4 (p<0.0002) and week 16 (p = 0.006) compared to Ethiopians. Efavirenz plasma concentrations remained significantly higher in Tanzanians even after controlling for the effect of CYP2B6*6 and ABCB1 c.4036A>G genotype. Within country analyses indicated a significant decrease in the mean plasma efavirenz concentration by week 16 compared to week 4 in Tanzanians (p = 0.006), whereas no significant differences in plasma concentration over time was observed in Ethiopians (p = 0.84). Intracellular efavirenz concentration and patient country were significant predictors of CD4 gain during HAART. Conclusion: We report substantial differences in efavirenz pharmacokinetics, extent of auto-induction and immunologic recovery between Ethiopian and Tanzanian HIV patients, partly but not solely, due to pharmacogenetic variations. The observed inter-ethnic variations in efavirenz plasma exposure may possibly result in varying clinical treatment outcome or adverse event profiles between populations.	[Ngaimisi, Eliford; Habtewold, Abiy; Bertilsson, Leif; Aklillu, Eleni] Karolinska Inst, Dept Lab Med, Div Clin Pharmacol, Stockholm, Sweden; [Ngaimisi, Eliford; Minzi, Omary] Muhimbili Univ Hlth & Allied Sci, Sch Pharm, Pharmacol Unit, Dar Es Salaam, Tanzania; [Habtewold, Abiy; Makonnen, Eyasu; Yimer, Getnet] Univ Addis Ababa, Sch Med, Dept Pharmacol, Addis Ababa, Ethiopia; [Riedel, Klaus-Dieter] Heidelberg Univ, Dept Clin Pharmacol & Pharmacoepidemiol, Heidelberg, Germany; [Mugusi, Sabina] Karolinska Inst, Sodersjukhuset, Stockholm, Sweden; [Mugusi, Sabina] Muhimbili Natl Hosp, Dept Internal Med, Dar Es Salaam, Tanzania; [Amogne, Wondwossen] Karolinska Inst, Dept Med, Infect Dis Unit, Karolinska Univ Hosp, Huddinge, Sweden; [Amogne, Wondwossen; Aderaye, Getachew] Univ Addis Ababa, Sch Med, Dept Internal Med, Addis Ababa, Ethiopia; [Janabi, Mohammed; Mugusi, Ferdinand] Muhimbili Univ Hlth & Allied Sci, Dept Internal Med, Dar Es Salaam, Tanzania	Karolinska Institutet; Muhimbili University of Health & Allied Sciences; Addis Ababa University; Ruprecht Karls University Heidelberg; Karolinska Institutet; Sodersjukhuset Hospital; Karolinska Institutet; Karolinska University Hospital; Addis Ababa University; Muhimbili University of Health & Allied Sciences	Aklillu, E (corresponding author), Karolinska Inst, Dept Lab Med, Div Clin Pharmacol, Stockholm, Sweden.	Eleni.Aklillu@ki.se	Aklillu, Eleni/ABG-3461-2021; Burhenne, Jürgen/AAU-2769-2021; Amogne, Wondwossen/AGM-9855-2022; Degu, Wondwossen Amogne/GON-3590-2022	Burhenne, Jürgen/0000-0002-2190-1698; Aklillu, Eleni/0000-0002-9788-0790; Makonnen, Eyasu/0000-0002-9259-5288	EDCTP [CT.2005.32030.001]; Swedish research council [VR 3902, 521-2011-3437, 348-2011-7383]; Swedish International Development Cooperation Agency SIDA [SWE 2004-098, HIV-2006-031, SWE 2007-270]; Karolinska Institutet	EDCTP; Swedish research council(Swedish Research CouncilEuropean Commission); Swedish International Development Cooperation Agency SIDA; Karolinska Institutet(Karolinska Institutet)	This study is supported by grant from EDCTP (grant No. CT.2005.32030.001), Swedish research council (grant No. VR 3902, 521-2011-3437, 348-2011-7383), the Swedish International Development Cooperation Agency SIDA (grant No. SWE 2004-098, HIV-2006-031, SWE 2007-270) and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aklillu E, 2007, PHARMACOGENOMICS ADM, P99; Aklillu E, 2011, EUR J CLIN PHARMACOL, V67, P1139, DOI 10.1007/s00228-011-1065-9; Belanger AS, 2009, DRUG METAB DISPOS, V37, P1793, DOI 10.1124/dmd.109.027706; Burger D, 2006, BRIT J CLIN PHARMACO, V61, P148, DOI 10.1111/j.1365-2125.2005.02536.x; Burhenne J, 2010, ANTIMICROB AGENTS CH, V54, P4185, DOI 10.1128/AAC.00283-10; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Cho DY, 2011, ANTIMICROB AGENTS CH, V55, P1504, DOI 10.1128/AAC.00883-10; di Iulio J, 2009, PHARMACOGENET GENOM, V19, P300, DOI 10.1097/FPC.0b013e328328d577; Elens L, 2010, PHARMACOGENOMICS, V11, P1223, DOI 10.2217/PGS.10.94; Faucette SR, 2004, DRUG METAB DISPOS, V32, P348, DOI 10.1124/dmd.32.3.348; Faucette SR, 2007, J PHARMACOL EXP THER, V320, P72, DOI 10.1124/jpet.106.112136; Gebeyehu E, 2011, PHARMACOGENOMICS J, V11, P130, DOI 10.1038/tpj.2010.16; Gounden V, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-32; Habtewold A, 2012, PHARMACOGENOMICS J; Habtewold A, 2011, J ANTIMICROB CHEMOTH, V66, P2350, DOI 10.1093/jac/dkr304; Hardwick RJ, 2012, J INFECT DIS; Heil SG, 2012, THER DRUG MONIT, V34, P153, DOI 10.1097/FTD.0b013e31824868f3; Hodder S, 2012, HIV MED, V13, P406, DOI 10.1111/j.1468-1293.2012.00991.x; Jamshidi Y, 2010, J ANTIMICROB CHEMOTH, V65, P2614, DOI 10.1093/jac/dkq369; Kassu A, 2001, CLIN DIAGN LAB IMMUN, V8, P1171, DOI 10.1128/CDLI.8.6.1171-1176.2001; Lopez-Cortes LF, 2005, JAIDS-J ACQ IMM DEF, V39, P551; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; Maimbo M, 2012, EUR J CLIN PHARMACOL, V68, P267, DOI 10.1007/s00228-011-1118-0; Mugusi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040180; Mugusi SF, 2012, ANTIVIR THER, V17, P265, DOI 10.3851/IMP1956; Mukonzo JK, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-261; Mukonzo JK, 2009, BRIT J CLIN PHARMACO, V68, P690, DOI 10.1111/j.1365-2125.2009.03516.x; Ngaimisi E, 2010, CLIN PHARMACOL THER, V88, P676, DOI 10.1038/clpt.2010.172; Nyakutira C, 2008, EUR J CLIN PHARMACOL, V64, P357, DOI 10.1007/s00228-007-0412-3; Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038; Saathoff E, 2008, TROP MED INT HEALTH, V13, P612, DOI 10.1111/j.1365-3156.2008.02047.x; Schackman BR, 2007, JAIDS-J ACQ IMM DEF, V46, P547, DOI 10.1097/QAI.0b013e31815ac499; Stohr W, 2008, ANTIVIR THER, V13, P675; Swart Marelize, 2012, Frontiers in Genetics, V3, P236, DOI 10.3389/fgene.2012.00236; Tsegaye A, 1999, CLIN DIAGN LAB IMMUN, V6, P410, DOI 10.1128/CDLI.6.3.410-414.1999; Ward BA, 2003, J PHARMACOL EXP THER, V306, P287, DOI 10.1124/jpet.103.049601; Yimer G, 2012, PHARMACOGENOMICS J, V12, P499, DOI 10.1038/tpj.2011.34; Yimer G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027810	38	87	89	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67946	10.1371/journal.pone.0067946	http://dx.doi.org/10.1371/journal.pone.0067946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861838	gold, Green Published			2022-12-27	WOS:000321425300032
J	Xu, LJ; Jiang, T; Zhang, FJ; Han, JF; Liu, J; Zhao, H; Li, XF; Liu, RJ; Deng, YQ; Wu, XY; Zhu, SY; Qin, ED; Qin, CF				Xu, Li-Juan; Jiang, Tao; Zhang, Fu-Jun; Han, Jian-Feng; Liu, Juan; Zhao, Hui; Li, Xiao-Feng; Liu, Rui-Ju; Deng, Yong-Qiang; Wu, Xiao-Yan; Zhu, Shun-Ya; Qin, E-De; Qin, Cheng-Feng			Global Transcriptomic Analysis of Human Neuroblastoma Cells in Response to Enterovirus Type 71 Infection	PLOS ONE			English	Article							GENE-EXPRESSION; CYNOMOLGUS MONKEYS; IN-VITRO; NEUROLOGICAL MANIFESTATIONS; PROTEIN-SYNTHESIS; MOUTH-DISEASE; CHILDREN; OUTBREAK; HAND; FOOT	Human enterovirus type 71 (EV71) is the major pathogen of hand-foot-and-mouth disease (HFMD) and has been associated with severe neurological disease and even death in infants and young children. The pathogenesis of EV71 infection in the human central nervous system remains unclear. In this study, human whole genome microarray was employed to perform transcriptome profiling in SH-SY5Y human neuroblastoma cells infected with EV71. The results indicated that EV71 infection lead to altered expression of 161 human mRNAs, including 74 up-regulated genes and 87 down-regulated genes. Bioinformatics analysis indicated the possible roles of the differentially regulated mRNAs in selected pathways, including cell cycle/proliferation, apoptosis, and cytokine/chemokine responses. Finally, the microarray results were validated using real-time RT-PCR with high identity. Overall, our results provided fundamental information regarding the host response to EV71 infection in human neuroblastoma cells, and this finding will help explain the pathogenesis of EV71 infection and virus-host interaction.	[Xu, Li-Juan; Jiang, Tao; Han, Jian-Feng; Liu, Juan; Zhao, Hui; Li, Xiao-Feng; Deng, Yong-Qiang; Wu, Xiao-Yan; Zhu, Shun-Ya; Qin, E-De; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Xu, Li-Juan] PLA 404 Hosp, Weihai, Peoples R China; [Zhang, Fu-Jun] Rizhao Hosp Tradit Chinese Med, Rizhao, Peoples R China; [Liu, Rui-Ju] Liaocheng Peoples Hosp, Liaocheng, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	qincf@bmi.ac.cn	Qin, Cheng-Feng/I-6839-2019; Tao, Jiang/AAE-6623-2019	Qin, Cheng-Feng/0000-0002-0632-2807; Tao, Jiang/0000-0003-1908-2926	Beijing Natural Science Foundation [7122129, 7112108]; National Natural Science Foundation of China [31270195]; Beijing Nova Program of Science and Technology [2010B041]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nova Program of Science and Technology	This work was supported by the Beijing Natural Science Foundation (7122129, 7112108) and the National Natural Science Foundation of China (No.31270195). CFQ was supported by Beijing Nova Program of Science and Technology (No.2010B041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGOL VI, 1989, J VIROL, V63, P4034, DOI 10.1128/JVI.63.9.4034-4038.1989; Brandon NJ, 2007, BIOCHEM SOC T, V35, P1283, DOI 10.1042/BST0351283; Camargo LM, 2008, NOVART FDN SYMP, V289, P216; Camargo LM, 2008, NOVART FDN SYMP, V289, P238; Camargo Luiz M, 2008, Novartis Found Symp, V289, P208; Cao RY, 2011, J CLIN VIROL, V51, P242, DOI 10.1016/j.jcv.2011.05.002; Chakrabarti AK, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-219; Chan SL, 2000, J BIOL CHEM, V275, P17925, DOI 10.1074/jbc.C000146200; Chan SL, 1999, J BIOL CHEM, V274, P32461, DOI 10.1074/jbc.274.45.32461; Chang L, 2007, NEW ENGL J MED, V356, P1226, DOI 10.1056/NEJMoa065954; Chen CS, 2007, J VIROL, V81, P8996, DOI 10.1128/JVI.00236-07; Chen CY, 2001, AM J NEURORADIOL, V22, P200; CHUMAKOV M, 1979, ARCH VIROL, V60, P329, DOI 10.1007/BF01317504; Cordey S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002826; Dai YM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-77; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059; Fink J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000086; Gupta A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022730, 10.1371/journal.pone.0028691]; HAGIWARA A, 1984, ARCH VIROL, V79, P273, DOI 10.1007/BF01310816; Han JF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-106; HASHIMOTO I, 1978, ARCH VIROL, V56, P257, DOI 10.1007/BF01317855; HAYWARD JC, 1989, PEDIATR INFECT DIS J, V8, P611, DOI 10.1097/00006454-198909000-00009; Ho BC, 2011, CELL HOST MICROBE, V9, P58, DOI 10.1016/j.chom.2010.12.001; Hsueh C, 2000, MODERN PATHOL, V13, P1200, DOI 10.1038/modpathol.3880222; Huang HZ, 2007, DEVELOPMENT, V134, P979, DOI 10.1242/dev.02782; Huang SC, 2009, J MED VIROL, V81, P1241, DOI 10.1002/jmv.21502; Jeong SM, 2010, J BIOL CHEM, V285, P2340, DOI 10.1074/jbc.M109.026997; Khalid SS, 2011, HEPATOL INT, V5, P782, DOI 10.1007/s12072-011-9252-4; Khong WX, 2012, J VIROL, V86, P2121, DOI 10.1128/JVI.06103-11; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Kuo RL, 2002, J GEN VIROL, V83, P1367, DOI 10.1099/0022-1317-83-6-1367; LAMONICA N, 1989, J VIROL, V63, P2357, DOI 10.1128/JVI.63.5.2357-2360.1989; Leong WF, 2006, CELL MICROBIOL, V8, P565, DOI 10.1111/j.1462-5822.2005.00644.x; Li ML, 2002, VIROLOGY, V293, P386, DOI 10.1006/viro.2001.1310; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Nagata N, 2004, J GEN VIROL, V85, P2981, DOI 10.1099/vir.0.79883-0; Nagata N, 2002, J MED VIROL, V67, P207, DOI 10.1002/jmv.2209; Ng D K, 2001, Hong Kong Med J, V7, P193; Ong KC, 2008, J NEUROPATH EXP NEUR, V67, P532, DOI 10.1097/NEN.0b013e31817713e7; Porteous DJ, 2006, BIOL PSYCHIAT, V60, P123, DOI 10.1016/j.biopsych.2006.04.008; ROSS RA, 1983, J NATL CANCER I, V71, P741; Schoenebeck B, 2005, MOL CELL NEUROSCI, V30, P249, DOI 10.1016/j.mcn.2005.07.017; Shen WC, 2000, NEURORADIOLOGY, V42, P124, DOI 10.1007/s002340050030; Shih SR, 2008, J NEUROVIROL, V14, P53, DOI 10.1080/13550280701798980; Shih SR, 2004, J NEUROVIROL, V10, P293, DOI 10.1080/13550280490499551; Sukarieh R, 2010, J GEN VIROL, V91, P1224, DOI 10.1099/vir.0.018069-0; Tung WH, 2010, CELL SIGNAL, V22, P234, DOI 10.1016/j.cellsig.2009.09.018; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang Q, 2008, MOL CELL NEUROSCI, V37, P187, DOI 10.1016/j.mcn.2007.10.006; Wang SM, 1999, CLIN INFECT DIS, V29, P184, DOI 10.1086/520149; Wang XG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051667, 10.1371/journal.pone.0029469, 10.1371/journal.pone.0047703, 10.1371/journal.pone.0036274, 10.1371/journal.pone.0048069, 10.1371/journal.pone.0032405]; Wang YF, 2004, J VIROL, V78, P7916, DOI 10.1128/JVI.78.15.7916-7924.2004; Yao PP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051996; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48; Zhang Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059086, 10.1371/journal.pone.0056341]; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhu L, 2008, J LIPID RES, V49, P2197, DOI 10.1194/jlr.M800259-JLR200	59	18	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e65948	10.1371/journal.pone.0065948	http://dx.doi.org/10.1371/journal.pone.0065948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861741	Green Published, Green Submitted, gold			2022-12-27	WOS:000321425300005
J	Zhang, LL; Ma, N; Liu, QB; Ma, Y				Zhang, Lili; Ma, Ning; Liu, Qingbin; Ma, Yan			Genome-Wide Screening for Genes Associated with Valproic Acid Sensitivity in Fission Yeast	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; CELL-CYCLE ARREST; SCHIZOSACCHAROMYCES-POMBE; CALCINEURIN; TARGET; CANCER; INVOLVEMENT; TOLERANCE; INTEGRITY; ENDOSOME	We have been studying the action mechanisms of valproic acid (VPA) in fission yeast Schizosaccharomyces pombe by developing a genetic screen for mutants that show hypersensitivity to VPA. In the present study, we performed a genome-wide screen of 3004 haploid deletion strains and confirmed 148 deletion strains to be VPA sensitive. Of the 148 strains, 93 strains also showed sensitivity to another aliphatic acids HDAC inhibitor, sodium butyrate (SB), and 55 strains showed sensitivity to VPA but not to SB. Interestingly, we found that both VPA and SB treatment induced a marked increase in the transcription activity of Atf1 in wild-type cells. However, in clr6-1, a mutant allele the clr6(+) gene encoding class I HDAC, neither VPA- nor SB induced the activation of Atf1 transcription activity. We also found that VPA, but not SB, caused an increase in cytoplasmic Ca2+ level. We further found that the cytoplasmic Ca2+ increase was caused by Ca2+ influx from extracellular medium via Cch1-Yam8 channel complex. Altogether, our present study indicates that VPA and SB play similar but distinct roles in multiple physiological processes in fission yeast.	[Zhang, Lili; Ma, Ning; Liu, Qingbin; Ma, Yan] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Pharmacol & Pharmacogen, Kobe, Hyogo 657, Japan	Kobe University	Ma, Y (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Pharmacol & Pharmacogen, Kobe, Hyogo 657, Japan.	mayan@med.kobe-u.ac.jp			Japan Society for the Promotion of Science [22390048, 21790241]; Global COE Program A08 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global COE Program A08 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan	Financial support for this study was provided by Grant-in-Aid for Scientific Research, on Scientific Research (B) to Takayoshi Kuno (No. 22390048) and on Grant-in-Aid for Young Scientists (B) to Yan Ma (No. 21790241), from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/e-grants/grants.html). This work was also supported (in part) by the Global COE Program A08 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buchwald M, 2009, CANCER LETT, V280, P160, DOI 10.1016/j.canlet.2009.02.028; Calabresi P, 2007, TRENDS PHARMACOL SCI, V28, P188, DOI 10.1016/j.tips.2007.02.005; Calvo IA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006619; Chen HP, 2011, J CELL BIOCHEM, V112, P3246, DOI 10.1002/jcb.23251; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; Deng L, 2006, MOL BIOL CELL, V17, P4790, DOI 10.1091/mbc.E06-06-0526; Dokmanovic M, 2005, J CELL BIOCHEM, V96, P293, DOI 10.1002/jcb.20532; EMRICH HM, 1981, AM J PSYCHIAT, V138, P256; Fang Y, 2012, ANTIMICROB AGENTS CH, V56, P1949, DOI 10.1128/AAC.05126-11; FRANCESCHETTI S, 1986, BRAIN RES, V386, P1, DOI 10.1016/0006-8993(86)90135-6; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Grayson DR, 2010, MOL PHARMACOL, V77, P126, DOI 10.1124/mol.109.061333; Gurvich N, 2002, PHARMACOL THERAPEUT, V96, P45, DOI 10.1016/S0163-7258(02)00299-1; Han TX, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r60; Hirayama S, 2003, J BIOL CHEM, V278, P18078, DOI 10.1074/jbc.M212900200; Hrebackova J, 2010, CURR DRUG TARGETS, V11, P361, DOI 10.2174/138945010790711923; Johannessen CU, 2000, NEUROCHEM INT, V37, P103, DOI 10.1016/S0197-0186(00)00013-9; Kagami A, 2011, EMBO REP, V12, P1189, DOI 10.1038/embor.2011.188; Kennedy PJ, 2008, TOXICOL SCI, V106, P124, DOI 10.1093/toxsci/kfn153; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kim J, 2007, ANTICANCER RES, V27, P3285; Kita A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016842; Kramer OH, 2003, EMBO J, V22, P3411, DOI 10.1093/emboj/cdg315; Kunoh T, 2008, NUCLEIC ACIDS RES, V36, P3311, DOI 10.1093/nar/gkn203; Li CJ, 2005, J ANIM SCI, V83, P89; Ma Y., 2011, PLOS ONE, V6; Ma Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023422; Ma Y, 2010, MOL GENET GENOMICS, V284, P161, DOI 10.1007/s00438-010-0550-7; Ma Y, 2006, MOL BIOL CELL, V17, P5028, DOI 10.1091/mbc.E06-08-0688; Ma Y, 2009, GENES CELLS, V14, P1015, DOI 10.1111/j.1365-2443.2009.01327.x; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Marks PA, 2004, ADV CANCER RES, V91, P137, DOI 10.1016/S0065-230X(04)91004-4; Miller TA, 2003, J MED CHEM, V46, P5097, DOI 10.1021/jm0303094; Miyatake M, 2007, GENETICS, V175, P1695, DOI 10.1534/genetics.107.070946; Nakano K, 2002, J CELL SCI, V115, P4629, DOI 10.1242/jcs.00150; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Ryuko S, 2012, MOL GENET GENOMICS, V287, P651, DOI 10.1007/s00438-012-0705-9; Sandor V, 2002, CLIN CANCER RES, V8, P718; Saunders N, 1999, CANCER RES, V59, P399; Seaman MNJ, 1997, J CELL BIOL, V137, P79, DOI 10.1083/jcb.137.1.79; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Seaman MNJ, 2005, TRENDS CELL BIOL, V15, P68, DOI 10.1016/j.tcb.2004.12.004; Shi YF, 2011, MOL BIOL CELL, V22, P4093, DOI 10.1091/mbc.E11-05-0440; Sio SO, 2005, J BIOL CHEM, V280, P12231, DOI 10.1074/jbc.M414234200; Takeda K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022021; Takeda T, 1995, EMBO J, V14, P6193, DOI 10.1002/j.1460-2075.1995.tb00310.x; Toda T, 1996, MOL CELL BIOL, V16, P6752; Zhou X, 2010, J BIOL CHEM, V285, P32818, DOI 10.1074/jbc.M110.135764	48	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68738	10.1371/journal.pone.0068738	http://dx.doi.org/10.1371/journal.pone.0068738			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861937	Green Submitted, gold, Green Published			2022-12-27	WOS:000321425300077
J	Drahos, J; Wu, MX; Anderson, WF; Trivers, KF; King, J; Rosenberg, PS; Eheman, C; Cook, MB				Drahos, Jennifer; Wu, Manxia; Anderson, William F.; Trivers, Katrina F.; King, Jessica; Rosenberg, Philip S.; Eheman, Christie; Cook, Michael B.			Regional Variations in Esophageal Cancer Rates by Census Region in the United States, 1999-2008	PLOS ONE			English	Article							HISTOLOGY DIFFERENCES; OVERLAPPING REGIONS; NATIONAL PROGRAM; COMPARING TRENDS; GASTRIC CARDIA; SEER PROGRAM; EPIDEMIOLOGY; SURVEILLANCE; COMPLETENESS; CARCINOMAS	Background: Assessment of cancer incidence trends within the U.S. have mostly relied upon Surveillance, Epidemiology, and End Results (SEER) data, with implicit inference that such is representative of the general population. However, many cancer policy decisions are based at a more granular level. To help inform such, analyses of regional cancer incidence data are needed. Leveraging the unique resource of National Program of Cancer Registries (NPCR)-SEER, we assessed whether regional rates and trends of esophageal cancer significantly deviated from national estimates. Methods: From NPCR-SEER, we extracted cancer case counts and populations for whites aged 45-84 years by calendar year, histology, sex, and census region for the period 1999-2008. We calculated age-standardized incidence rates (ASRs), annual percent changes (APCs), and male-to-female incidence rate ratios (IRRs). Results: This analysis included 65,823 esophageal adenocarcinomas and 27,094 esophageal squamous cell carcinomas diagnosed during 778 million person-years. We observed significant geographic variability in incidence rates and trends, especially for esophageal adenocarcinomas in males: ASRs were highest in the Northeast (17.7 per 100,000) and Midwest (18.1). Both were significantly higher than the national estimate (16.0). In addition, the Northeast APC was 62% higher than the national estimate (3.19% vs. 1.97%). Lastly, IRRs remained fairly constant across calendar time, despite changes in incidence rates. Conclusion: Significant regional variations in esophageal cancer incidence trends exist in the U.S. Stable IRRs may indicate the predominant factors affecting incidence rates are similar in men and women.	[Drahos, Jennifer; Anderson, William F.; Rosenberg, Philip S.; Cook, Michael B.] NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Drahos, Jennifer] NCI, Canc Prevent Fellowship Program, Canc Prevent Div, NIH, Bethesda, MD 20892 USA; [Wu, Manxia; Trivers, Katrina F.; King, Jessica; Eheman, Christie] Ctr Dis Control & Prevent, Div Canc Prevent & Control, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centers for Disease Control & Prevention - USA	Drahos, J (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	jennifer.drahos@nih.gov	Cook, Michael B/A-5641-2009	Cook, Michael B/0000-0002-0533-7302; Rosenberg, Philip/0000-0001-6349-9126; Drahos, Jennifer/0000-0002-8454-9863	Intramural Program of the National Cancer Institute at the National Institutes of Health and Department of Health and Human Services [CA00350]; NATIONAL CANCER INSTITUTE [ZIACP010183] Funding Source: NIH RePORTER	Intramural Program of the National Cancer Institute at the National Institutes of Health and Department of Health and Human Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Program of the National Cancer Institute at the National Institutes of Health and Department of Health and Human Services (CA00350). There are no financial disclosures from any of the authors. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2012, CANC FACTS FIG; [Anonymous], SAS 9 2; [Anonymous], 2000, CENSUS DATA SURVEILL; Bollschweiler E, 2001, CANCER, V92, P549, DOI 10.1002/1097-0142(20010801)92:3<549::AID-CNCR1354>3.0.CO;2-L; Brown Linda Morris, 2002, Surg Oncol Clin N Am, V11, P235, DOI 10.1016/S1055-3207(02)00002-9; Centers for Disease Control and Prevention, NAT PROGR CANC REG U; Centers for Disease Control and Prevention. National Program of Cancer Registries (NPCR), TECHN NOT USCS PUBL; Centers for Disease Control and Prevention. National Program of Cancer Registries (NPCR), TECHN NOT STAT METH; Cook MB, 2009, BRIT J CANCER, V101, P855, DOI 10.1038/sj.bjc.6605246; Edgren G, 2013, GUT; Hankey BF, 1999, CANCER EPIDEM BIOMAR, V8, P1117; Kubo A, 2004, AM J GASTROENTEROL, V99, P582, DOI 10.1111/j.1572-0241.2004.04131.x; Kubo A, 2002, CANCER, V95, P2096, DOI 10.1002/cncr.10940; Li Y, 2008, BIOMETRICS, V64, P1280, DOI 10.1111/j.1541-0420.2008.01002.x; Li Y, 2008, BIOMETRICAL J, V50, P608, DOI 10.1002/bimj.200710430; Surveillance Epidemiology and End Results (SEER) Program, SEER STAT DAT INC SE; Surveillance Epidemiology and End Results (SEER) Program, SEER STAT DAT INC SE; Surveillance Research Program National Cancer Institute, SEER STAT SOFTW VERS; Thoburn KK, 2007, CANCER-AM CANCER SOC, V109, P1607, DOI 10.1002/cncr.22566; Tiwari RC, 2006, STAT METHODS MED RES, V15, P547, DOI 10.1177/0962280206070621; Tiwari Ram C, 2010, J Data Sci, V8, P471; Trivers KF, 2008, INT J CANCER, V123, P1422, DOI 10.1002/ijc.23691; Walters Kimberly A, 2011, J Data Sci, V8, P631; Wingo PA, 2003, CANCER CAUSE CONTROL, V14, P175, DOI 10.1023/A:1023002322935; Wu XC, 2006, CANCER-AM CANCER SOC, V106, P683, DOI 10.1002/cncr.21542; Wu XC, 2007, CANCER CAUSE CONTROL, V18, P585, DOI 10.1007/s10552-007-9000-1; Younes M, 2002, SCAND J GASTROENTERO, V37, P1359, DOI 10.1080/003655202762671215; ZIPPIN C, 1995, CANCER, V76, P2343, DOI 10.1002/1097-0142(19951201)76:11<2343::AID-CNCR2820761124>3.0.CO;2-#	28	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67913	10.1371/journal.pone.0067913	http://dx.doi.org/10.1371/journal.pone.0067913			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861830	Green Published, gold, Green Submitted			2022-12-27	WOS:000323350700058
J	Lamb, R; Ablett, MP; Spence, K; Landberg, G; Sims, AH; Clarke, RB				Lamb, Rebecca; Ablett, Matthew P.; Spence, Katherine; Landberg, Goeran; Sims, Andrew H.; Clarke, Robert B.			Wnt Pathway Activity in Breast Cancer Sub-Types and Stem-Like Cells	PLOS ONE			English	Article							MEDIATES RADIATION-RESISTANCE; SIGNALING PATHWAY; BETA-CATENIN; HISTOLOGIC GRADE; GROWTH-FACTOR; EXPRESSION; GENE; PROTEIN; POPULATION; MARKER	Introduction: Wnt signalling has been implicated in stem cell regulation however its role in breast cancer stem cell regulation remains unclear. Methods: We used a panel of normal and breast cancer cell lines to assess Wnt pathway gene and protein expression, and for the investigation of Wnt signalling within stem cell-enriched populations, mRNA and protein expression was analysed after the selection of anoikis-resistant cells. Finally, cell lines and patient-derived samples were used to investigate Wnt pathway effects on stem cell activity in vitro. Results: Wnt pathway signalling increased in cancer compared to normal breast and in both cell lines and patient samples, expression of Wnt pathway genes correlated with estrogen receptor (ER) expression. Furthermore, specific Wnt pathway genes were predictive for recurrence within subtypes of breast cancer. Canonical Wnt pathway genes were increased in breast cancer stem cell-enriched populations in comparison to normal breast stem cell-enriched populations. Furthermore in cell lines, the ligand Wnt3a increased whilst the inhibitor DKK1 reduced mammosphere formation with the greatest inhibitory effects observed in ER+ve breast cancer cell lines. In patient-derived metastatic breast cancer samples, only ER-ve mammospheres were responsive to the ligand Wnt3a. However, the inhibitor DKK1 efficiently inhibited both ER+ve and ER-ve breast cancer but not normal mammosphere formation, suggesting that the Wnt pathway is aberrantly activated in breast cancer mammospheres. Conclusions: Collectively, these data highlight differential Wnt signalling in breast cancer subtypes and activity in patient-derived metastatic cancer stem-like cells indicating a potential for Wnt-targeted treatment in breast cancers.	[Lamb, Rebecca; Landberg, Goeran] Univ Manchester, Breakthrough Breast Canc Res Unit, Manchester, Lancs, England; [Ablett, Matthew P.; Spence, Katherine; Clarke, Robert B.] Univ Manchester, Breast Biol Grp, Manchester, Lancs, England; [Sims, Andrew H.] Edinburgh Canc Res Ctr, Appl Bioinformat Canc, Edinburgh, Midlothian, Scotland	University of Manchester; University of Manchester; University of Edinburgh	Lamb, R (corresponding author), Univ Manchester, Breakthrough Breast Canc Res Unit, Manchester, Lancs, England.	rlamb@picr.man.ac.uk; Robert.clarke@manchester.ac.uk	Clarke, Robert/AAA-3442-2021; spence, kath/C-1599-2019; Sims, Andrew/E-4819-2012	Clarke, Robert/0000-0001-5407-3123; spence, kath/0000-0002-8137-165X; Sims, Andrew/0000-0001-9082-3665	Breast Cancer Campaign; Breast Cancer Now [EDN-DIXON] Funding Source: researchfish	Breast Cancer Campaign; Breast Cancer Now	The study was supported by Breast Cancer Campaign (R.B. Clarke) (http://www.breastcancercampaign.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ayyanan A, 2006, P NATL ACAD SCI USA, V103, P3799, DOI 10.1073/pnas.0600065103; Brisken C, 2000, GENE DEV, V14, P650; Calza S, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1517; Chen MS, 2007, J CELL SCI, V120, P468, DOI 10.1242/jcs.03348; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Clarke RB, 2005, DEV BIOL, V277, P443, DOI 10.1016/j.ydbio.2004.07.044; Collu GM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1671; Dejmek J, 2005, CANCER RES, V65, P9142, DOI 10.1158/0008-5472.CAN-05-1710; Dejmek J, 2005, CLIN CANCER RES, V11, P520; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; El-Tanani M, 2001, J BIOL CHEM, V276, P41675, DOI 10.1074/jbc.M103966200; Farnie G, 2007, JNCI-J NATL CANCER I, V99, P616, DOI 10.1093/jnci/djk133; Goel S, 2012, J BIOL CHEM, V287, P16454, DOI 10.1074/jbc.M112.362137; Gurney A, 2012, P NATL ACAD SCI USA, V109, P11717, DOI 10.1073/pnas.1120068109; Harrison H, 2010, CANCER RES, V70, P709, DOI 10.1158/0008-5472.CAN-09-1681; Howe LR, 2004, CANCER BIOL THER, V3, P36, DOI 10.4161/cbt.3.1.561; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jonsson M, 2002, CANCER RES, V62, P409; Kakarala M, 2008, J CLIN ONCOL, V26, P2813, DOI 10.1200/JCO.2008.16.3931; KALER P, 2009, CANC MICROENVIRON; Khalil S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033421; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; Klopocki E, 2004, INT J ONCOL, V25, P641; Leandersson K, 2006, NUCLEIC ACIDS RES, V34, P3988, DOI 10.1093/nar/gkl571; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lopez-Knowles E, 2010, CANCER EPIDEM BIOMAR, V19, P301, DOI 10.1158/1055-9965.EPI-09-0741; MacDonald BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023537; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Rask K, 2003, BRIT J CANCER, V89, P1298, DOI 10.1038/sj.bjc.6601265; Rieger ME, 2010, MOL CELL BIOL, V30, P4267, DOI 10.1128/MCB.01418-09; Shaw FL, 2012, J MAMMARY GLAND BIOL, V17, P111, DOI 10.1007/s10911-012-9255-3; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Sims AH, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-42; Singh JK, 2013, CLIN CANCER RES, V19, P643, DOI 10.1158/1078-0432.CCR-12-1063; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Su HY, 2010, INT J CANCER, V127, P555, DOI 10.1002/ijc.25083; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; Veeck J, 2008, CARCINOGENESIS, V29, P991, DOI 10.1093/carcin/bgn076; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Xie D, 2001, CANCER RES, V61, P8917; Zhang J, 2010, ONCOGENE, V29, P539, DOI 10.1038/onc.2009.339; Zhou XL, 2010, ACTA PHARMACOL SIN, V31, P202, DOI 10.1038/aps.2009.200	51	100	104	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67811	10.1371/journal.pone.0067811	http://dx.doi.org/10.1371/journal.pone.0067811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861811	gold, Green Published, Green Submitted			2022-12-27	WOS:000323350700039
J	Yim, SA; Lim, YS; Kim, JW; Hwang, SB				Yim, Seung-Ae; Lim, Yun-Sook; Kim, Jong-Wook; Hwang, Soon B.			Nonstructural 5A Protein of Hepatitis C Virus Interacts with Pyruvate Carboxylase and Modulates Viral Propagation	PLOS ONE			English	Article							MEDIATED APOPTOSIS; INFECTIOUS VIRUS; LIPID DROPLET; CELL-DEATH; MITOCHONDRIA; REPLICATION; PROMOTER; BINDING; CORE; NS5A	Hepatitis C virus (HCV) is highly dependent on cellular factors for its own propagation. By employing tandem affinity purification method, we identified pyruvate carboxylase (PC) as a cellular partner for NS5A protein. NS5A interacted with PC through the N-terminal region of NS5A and the biotin carboxylase domain of PC. PC expression was decreased in cells expressing NS5A and HCV-infected cells. Promoter activity of PC was also decreased by NS5A protein. However, FAS expression was increased in cells expressing NS5A and cell culture grown HCV (HCVcc)-infected cells. Silencing of PC promoted fatty acid synthase (FAS) expression level. These data suggest HCV may modulate PC via NS5A protein for its own propagation.	[Yim, Seung-Ae; Lim, Yun-Sook; Kim, Jong-Wook; Hwang, Soon B.] Hallym Univ, Ilsong Inst Life Sci, Natl Res Lab Hepatitis Virus C, Anyang, South Korea	Hallym University	Hwang, SB (corresponding author), Hallym Univ, Ilsong Inst Life Sci, Natl Res Lab Hepatitis Virus C, Anyang, South Korea.	sbhwang@hallym.ac.kr			Ministry of Education, Science and Technology, Korea [2008-2004100, 2012026351]; National R&D Program for Cancer Control, Ministry for Health and Welfare, Korea [1020290]	Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National R&D Program for Cancer Control, Ministry for Health and Welfare, Korea	This work was supported by Basic Science Research Program (2012026351) and Biotechnology Development (2008-2004100) from the Ministry of Education, Science and Technology, Korea, and by the National R&D Program (1020290) for Cancer Control, Ministry for Health and Welfare, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnoult D, 2004, P NATL ACAD SCI USA, V101, P7988, DOI 10.1073/pnas.0401897101; Boonsaen T, 2007, BIOCHEM J, V405, P359, DOI 10.1042/BJ20070276; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Boya P, 2004, BBA-BIOENERGETICS, V1659, P178, DOI 10.1016/j.bbabio.2004.08.007; Clippinger AJ, 2008, J VIROL, V82, P6798, DOI 10.1128/JVI.00154-08; Cun W, 2010, J VIROL, V84, P11532, DOI 10.1128/JVI.01021-10; Depla M, 2010, CELL MOL LIFE SCI, V67, P3151, DOI 10.1007/s00018-010-0373-z; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; Garcia-Arcos I, 2010, LIPIDS, V45, P1101, DOI 10.1007/s11745-010-3492-2; Jackel-Cram C, 2007, J HEPATOL, V46, P999, DOI 10.1016/j.jhep.2006.10.019; Jitrapakdee S, 1999, BIOCHEM J, V340, P1, DOI 10.1042/bj3400001; Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; Lim YS, 2011, J BIOL CHEM, V286, P11290, DOI 10.1074/jbc.M110.194472; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Lonardo A, 2006, J VIRAL HEPATITIS, V13, P73, DOI 10.1111/j.1365-2893.2005.00669.x; Macdonald A, 2004, J GEN VIROL, V85, P2485, DOI 10.1099/vir.0.80204-0; Marin-Valencia I, 2010, MOL GENET METAB, V101, P9, DOI 10.1016/j.ymgme.2010.05.004; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moon HS, 2006, MOL CELLS, V21, P7; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Nomura-Takigawa Y, 2006, J GEN VIROL, V87, P1935, DOI 10.1099/vir.0.81701-0; Ogawa K, 2009, P JPN ACAD B-PHYS, V85, P217, DOI 10.2183/pjab.85.217; Park CY, 2009, J HEPATOL, V51, P853, DOI 10.1016/j.jhep.2009.06.026; Park CY, 2009, J BIOL CHEM, V284, P9237, DOI 10.1074/jbc.M808773200; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; ROBINSON BH, 1984, AM J HUM GENET, V36, P283; Romero-Brey I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003056; Syed GH, 2010, TRENDS ENDOCRIN MET, V21, P33, DOI 10.1016/j.tem.2009.07.005; Takahara Y, 2008, WORLD J GASTROENTERO, V14, P2010, DOI 10.3748/wjg.14.2010; Wang JD, 2006, FEBS LETT, V580, P4392, DOI 10.1016/j.febslet.2006.07.002	31	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68170	10.1371/journal.pone.0068170	http://dx.doi.org/10.1371/journal.pone.0068170			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861867	Green Published, Green Submitted, gold			2022-12-27	WOS:000323350700074
J	Rabahi, T; Fargier, P; Sarraj, AR; Clouzeau, C; Massarelli, R				Rabahi, Tahar; Fargier, Patrick; Sarraj, Ahmad Rifai; Clouzeau, Cyril; Massarelli, Raphael			Effect of Action Verbs on the Performance of a Complex Movement	PLOS ONE			English	Article							MOTOR SYSTEM; LANGUAGE; REPRESENTATIONS; PERCEPTION; CORTEX; BRAIN; ACTIVATION; SIMULATION; ATTENTION; GESTURES	The interaction between language and motor action has been approached by studying the effect of action verbs, kinaesthetic imagery and mental subtraction upon the performance of a complex movement, the squat vertical jump (SVJ). The time of flight gave the value of the height of the SVJ and was measured with an Optojump (R) and a Myotest (R) apparatuses. The results obtained by the effects of the cognitive stimuli showed a statistically significant improvement of the SVJ performance after either loudly or silently pronouncing, hearing or reading the verb saute (jump in French language). Action verbs specific for other motor actions (pince = pinch, leche = lick) or non-specific (bouge = move) showed no or little effect. A meaningless verb for the French subjects (tiao = jump in Chinese) showed no effect as did reve (dream), tombe (fall) and stop. The verb gagne (win) improved significantly the SVJ height, as did its antonym perds (lose) suggesting a possible influence of affects in the subjects' performance. The effect of the specific action verb jump upon the heights of SVJ was similar to that obtained after kinaesthetic imagery and after mental subtraction of two digits numbers from three digits ones; possibly, in the latter, because of the intervention of language in calculus. It appears that the effects of the specific action verb jump did seem effective but not totally exclusive for the enhancement of the SVJ performance. The results imply an interaction among language and motor brain areas in the performance of a complex movement resulting in a clear specificity of the corresponding action verb. The effect upon performance may probably be influenced by the subjects' intention, increased attention and emotion produced by cognitive stimuli among which action verbs.	[Rabahi, Tahar; Fargier, Patrick; Massarelli, Raphael] Univ Lyon 1, CRIS, EA 647, F-69622 Villeurbanne, France; [Sarraj, Ahmad Rifai] Univ Libanaise Rafic Hariri, Dept Physiotherapie, Fac Sante Publ 1, Hadath Beyrouth, Lebanon; [Clouzeau, Cyril] Inst Super Osteopathie ISOSTEO, Unite Rech, Limonest Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Rabahi, T (corresponding author), Univ Lyon 1, CRIS, EA 647, F-69622 Villeurbanne, France.	taharrabahi@gmail.com	Sarraj, Ahmad Rifai/H-2548-2018	Sarraj, Ahmad Rifai/0000-0003-4719-890X				Andersen RA, 2009, NEURON, V63, P568, DOI 10.1016/j.neuron.2009.08.028; Aziz-Zadeh L, 2006, CURR BIOL, V16, P1818, DOI 10.1016/j.cub.2006.07.060; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Bedny M, 2011, ANN NY ACAD SCI, V1224, P81, DOI 10.1111/j.1749-6632.2011.06013.x; Boulenger V, 2006, J COGNITIVE NEUROSCI, V18, P1607, DOI 10.1162/jocn.2006.18.10.1607; Boulenger V, 2009, CEREB CORTEX, V19, P1905, DOI 10.1093/cercor/bhn217; Buccino G, 2005, COGNITIVE BRAIN RES, V24, P355, DOI 10.1016/j.cogbrainres.2005.02.020; Cappa SF, 2012, CORTEX, V48, P785, DOI 10.1016/j.cortex.2012.04.010; Casartelli N, 2010, J STRENGTH COND RES, V24, P3186, DOI 10.1519/JSC.0b013e3181d8595c; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Dalla Volta R, 2009, EXP BRAIN RES, V196, P403, DOI 10.1007/s00221-009-1864-8; Decety J, 2006, BRAIN RES, V1079, P4, DOI 10.1016/j.brainres.2005.12.115; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; DRISKELL JE, 1994, J APPL PSYCHOL, V79, P481, DOI 10.1037/0021-9010.79.4.481; Fernandino L, 2010, BRAIN LANG, V112, P44, DOI 10.1016/j.bandl.2009.02.003; Fink PW, 2000, EXP BRAIN RES, V134, P9, DOI 10.1007/s002210000439; Fischer MH, 2008, Q J EXP PSYCHOL, V61, P825, DOI 10.1080/17470210701623605; Frak V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009728; Gallese V, 2005, COGN NEUROPSYCHOL, V22, P455, DOI 10.1080/02643290442000310; Garagnani M, 2008, EUR J NEUROSCI, V27, P492, DOI 10.1111/j.1460-9568.2008.06015.x; Gentilucci M, 1998, EUR J NEUROSCI, V10, P752, DOI 10.1046/j.1460-9568.1998.00060.x; Gentilucci M, 2008, J PHYSIOL-PARIS, V102, P21, DOI 10.1016/j.jphysparis.2008.03.002; Gentilucci M, 2008, Q J EXP PSYCHOL, V61, P944, DOI 10.1080/17470210701625683; Gentilucci M, 2006, NEUROSCI BIOBEHAV R, V30, P949, DOI 10.1016/j.neubiorev.2006.02.004; Gentilucci M, 2012, BEHAV BRAIN RES, V233, P130, DOI 10.1016/j.bbr.2012.04.036; Guillot A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00247; Hall C. R., 1997, J MENTAL IMAG, V21, P143, DOI DOI 10.1037/T07979-000; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Hauk O, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00149; Havas DA, 2007, PSYCHON B REV, V14, P436, DOI 10.3758/BF03194085; Hickok G, 2009, PHYS LIFE REV, V6, P121, DOI 10.1016/j.plrev.2009.06.001; Hoyek N, 2009, LEARN INDIVID DIFFER, V19, P555, DOI 10.1016/j.lindif.2009.07.003; HUBLEY CL, 1983, EUR J APPL PHYSIOL O, V50, P247, DOI 10.1007/BF00422163; INGVAR DH, 1977, ANN NEUROL, V2, P230, DOI 10.1002/ana.410020309; JEANNEROD M, 1995, NEUROPSYCHOLOGIA, V33, P1419, DOI 10.1016/0028-3932(95)00073-C; Kazui H, 2000, PSYCHIAT CLIN NEUROS, V54, P479, DOI 10.1046/j.1440-1819.2000.00739.x; Kemmerer D, 2008, BRAIN LANG, V107, P16, DOI 10.1016/j.bandl.2007.09.003; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lin JFL, 2012, CEREB CORTEX, V22, P1851, DOI 10.1093/cercor/bhr263; Lotze M, 2006, J PHYSIOL-PARIS, V99, P386, DOI 10.1016/j.jphysparis.2006.03.012; Mahon BZ, 2008, J PHYSIOL-PARIS, V102, P59, DOI 10.1016/j.jphysparis.2008.03.004; Moseley R, 2012, CEREB CORTEX, V22, P1634, DOI 10.1093/cercor/bhr238; Nazir TA, 2008, Q J EXP PSYCHOL, V61, P933, DOI 10.1080/17470210701625667; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Peran P, 2010, BRAIN RES, V1328, P89, DOI 10.1016/j.brainres.2010.02.082; Perry HM, 1939, ARCH PSYCHOL, V4, P5; Pinheiro J, 2001, MIXED EFFECTS MODELS; Postle N, 2008, NEUROIMAGE, V43, P634, DOI 10.1016/j.neuroimage.2008.08.006; Pulvermuller F, 2001, TRENDS COGN SCI, V5, P517, DOI 10.1016/S1364-6613(00)01803-9; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; Pulvermuller F, 2005, EUR J NEUROSCI, V21, P793, DOI 10.1111/j.1460-9568.2005.03900.x; Pulvermuller F, 2010, NAT REV NEUROSCI, V11, P351, DOI 10.1038/nrn2811; Rizzolatti G, 2010, SO QUEL CHE FAI CERV; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Sackett RS, 1935, J GEN PSYCHOL, V13, P113, DOI 10.1080/00221309.1935.9917869; Schuster C, 2011, BMC MED, V17, P9; Shtyrov Y, 2012, NEUROPSYCHOLOGIA, V50, P2605, DOI 10.1016/j.neuropsychologia.2012.07.012; Talairach J., 1988, COPLANAR STEREOTAXIC; Tettamanti M, 2005, J COGNITIVE NEUROSCI, V17, P273, DOI 10.1162/0898929053124965; Tranel D, 2003, COGN NEUROPSYCHOL, V20, P409, DOI 10.1080/02643290244000248; Tschentscher N, 2012, NEUROIMAGE, V59, P3139, DOI 10.1016/j.neuroimage.2011.11.037; van Dam WO, 2010, NEUROIMAGE, V53, P1318, DOI 10.1016/j.neuroimage.2010.06.071; VANSOEST AJ, 1993, BIOL CYBERN, V69, P195, DOI 10.1007/BF00198959; Vogt S, 1996, COGNITIVE BRAIN RES, V3, P79, DOI 10.1016/0926-6410(95)00032-1; Willems RM, 2007, BRAIN LANG, V101, P278, DOI 10.1016/j.bandl.2007.03.004; Willems RM, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00116; Wulf G, 2002, PSYCHON B REV, V9, P185, DOI 10.3758/BF03196276; Zatsiorsky V., 1983, BIOMECHANICS 8 B, V56, P1152; Zwaan RA, 2004, COGNITIVE SCI, V28, P611, DOI 10.1016/j.cogsci.2004.03.004	69	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68687	10.1371/journal.pone.0068687	http://dx.doi.org/10.1371/journal.pone.0068687			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182HT	23844233	Green Submitted, gold, Green Published			2022-12-27	WOS:000321733000023
J	Rantamaki, T; Kemppainen, S; Autio, H; Staven, S; Koivisto, H; Kojima, M; Antila, H; Miettinen, PO; Karkkainen, E; Karpova, N; Vesa, L; Lindemann, L; Hoener, MC; Tanila, H; Castren, E				Rantamaki, Tomi; Kemppainen, Susanna; Autio, Henri; Staven, Saara; Koivisto, Hennariikka; Kojima, Masami; Antila, Hanna; Miettinen, Pasi O.; Karkkainen, Elisa; Karpova, Nina; Vesa, Liisa; Lindemann, Lothar; Hoener, Marius C.; Tanila, Heikki; Castren, Eero			The Impact of Bdnf Gene Deficiency to the Memory Impairment and Brain Pathology of APPswe/PS1dE9 Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; NEUROTROPHIC-FACTOR; AMYLOID DEPOSITION; MESSENGER-RNA; CHOLINERGIC NEURONS; DECREASED-LEVELS; PARIETAL CORTEX; CELL-SURVIVAL; WILD-TYPE; EXPRESSION	Brain-derived neurotrophic factor (BDNF) importantly regulates learning and memory and supports the survival of injured neurons. Reduced BDNF levels have been detected in the brains of Alzheimer's disease (AD) patients but the exact role of BDNF in the pathophysiology of the disorder remains obscure. We have recently shown that reduced signaling of BDNF receptor TrkB aggravates memory impairment in APPswe/PS1dE9 (APdE9) mice, a model of AD. The present study examined the influence of Bdnf gene deficiency (heterozygous knockout) on spatial learning, spontaneous exploratory activity and motor coordination/balance in middle-aged male and female APdE9 mice. We also studied brain BDNF protein levels in APdE9 mice in different ages showing progressive amyloid pathology. Both APdE9 and Bdnf mutations impaired spatial learning in males and showed a similar trend in females. Importantly, the effect was additive, so that double mutant mice performed the worst. However, APdE9 and Bdnf mutations influenced spontaneous locomotion in contrasting ways, such that locomotor hyperactivity observed in APdE9 mice was normalized by Bdnf deficiency. Obesity associated with Bdnf deficiency did not account for the reduced hyperactivity in double mutant mice. Bdnf deficiency did not alter amyloid plaque formation in APdE9 mice. Before plaque formation (3 months), BDNF protein levels where either reduced (female) or unaltered (male) in the APdE9 mouse cortex. Unexpectedly, this was followed by an age-dependent increase in mature BDNF protein. Bdnf mRNA and phospho-TrkB levels remained unaltered in the cortical tissue samples of middle-aged APdE9 mice. Immunohistological studies revealed increased BDNF immunoreactivity around amyloid plaques indicating that the plaques may sequester BDNF protein and prevent it from activating TrkB. If similar BDNF accumulation happens in human AD brains, it would suggest that functional BDNF levels in the AD brains are even lower than reported, which could partially contribute to learning and memory problems of AD patients.	[Rantamaki, Tomi; Autio, Henri; Antila, Hanna; Karpova, Nina; Vesa, Liisa; Tanila, Heikki; Castren, Eero] Univ Helsinki, Ctr Neurosci, Helsinki, Finland; [Kemppainen, Susanna; Staven, Saara; Koivisto, Hennariikka; Miettinen, Pasi O.; Karkkainen, Elisa; Tanila, Heikki] Univ Eastern Finland, AI Virtanen Inst, Kuopio, Finland; [Kojima, Masami] Natl Inst Adv Ind Sci & Technol, Res Inst Cell Engn, Osaka, Japan; [Lindemann, Lothar; Hoener, Marius C.] F Hoffmann La Roche & Co Ltd, Discovery Neurosci, CH-4002 Basel, Switzerland; [Tanila, Heikki] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland	University of Helsinki; University of Eastern Finland; National Institute of Advanced Industrial Science & Technology (AIST); Roche Holding; Kuopio University Hospital; University of Eastern Finland	Castren, E (corresponding author), Univ Helsinki, Ctr Neurosci, Helsinki, Finland.	eero.castren@helsinki.fi	Karpova, Nina/L-6724-2013; Hoener, Marius C/I-6464-2012	Karpova, Nina/0000-0002-3197-4559; Hoener, Marius C/0000-0001-6510-6250; Castren, Eero/0000-0002-1402-2791; Rantamaki, Tomi/0000-0002-0052-1434; Antila, Hanna/0000-0001-8317-4564; Kemppainen, Susanna/0000-0001-5372-1918	EU [FP6-037831, HEALTH-F2-2007-201159]; Academy of Finland Center of Excellence program; Sigrid Juselius Foundation	EU(European Commission); Academy of Finland Center of Excellence program(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This study was supported by EU 6th Framework program grant FP6-037831, EU 7th Framework program grant HEALTH-F2-2007-201159, Academy of Finland Center of Excellence program and Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenstein HJ, 2008, ARCH NEUROL-CHICAGO, V65, P1509, DOI 10.1001/archneur.65.11.1509; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Burbach GJ, 2004, J NEUROSCI, V24, P2421, DOI 10.1523/JNEUROSCI.5599-03.2004; Castello NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039566; Chen KS, 1997, J NEUROSCI, V17, P7288; Connor B, 1997, MOL BRAIN RES, V49, P71, DOI 10.1016/S0169-328X(97)00125-3; Di Lieto A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032869; Durany N, 2000, INT J DEV NEUROSCI, V18, P807, DOI 10.1016/S0736-5748(00)00046-0; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Fahnestock M, 2002, J NEURAL TRANSM-SUPP, P241; Ferrer I, 1999, J NEUROPATH EXP NEUR, V58, P729, DOI 10.1097/00005072-199907000-00007; FISCHER W, 1987, NATURE, V329, P65, DOI 10.1038/329065a0; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; HEFTI F, 1986, J NEUROSCI, V6, P2155; Hock C, 2000, ARCH NEUROL-CHICAGO, V57, P846, DOI 10.1001/archneur.57.6.846; Holsinger RMD, 2000, MOL BRAIN RES, V76, P347, DOI 10.1016/S0169-328X(00)00023-1; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Jankowsky JL, 2004, NEUROBIOL AGING, V25, P885, DOI 10.1016/j.neurobiolaging.2003.09.008; Kadir A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.06.015; Karpova NN, 2010, CELL MOL NEUROBIOL, V30, P1117, DOI 10.1007/s10571-010-9544-6; Karpova NN, 2009, EUR NEUROPSYCHOPHARM, V19, P97, DOI 10.1016/j.euroneuro.2008.09.002; Kemppainen S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.11.006; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; Kolbeck R, 1999, J NEUROCHEM, V72, P1930, DOI 10.1046/j.1471-4159.1999.0721930.x; Li LY, 2008, J MOL NEUROSCI, V34, P157, DOI 10.1007/s12031-007-9022-x; Lindholm P, 2007, NATURE, V448, P73, DOI 10.1038/nature05957; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Michalski B, 2003, MOL BRAIN RES, V111, P148, DOI 10.1016/S0169-328X(03)00003-2; Minkeviciene R, 2008, J NEUROCHEM, V105, P584, DOI 10.1111/j.1471-4159.2007.05147.x; Murer MG, 1999, NEUROSCIENCE, V88, P1015, DOI 10.1016/S0306-4522(98)00219-X; MURRAY KD, 1994, NEUROSCIENCE, V60, P37, DOI 10.1016/0306-4522(94)90202-X; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; NarisawaSaito M, 1996, NEUROREPORT, V7, P2925, DOI 10.1097/00001756-199611250-00024; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Peng S, 2009, J NEUROSCI, V29, P9321, DOI 10.1523/JNEUROSCI.4736-08.2009; Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x; PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rantamaki T, 2007, NEUROPSYCHOPHARMACOL, V32, P2152, DOI 10.1038/sj.npp.1301345; Rantamaki T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020567; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Savonenko A, 2005, NEUROBIOL DIS, V18, P602, DOI 10.1016/j.nbd.2004.10.022; Schindowski K, 2008, GENES BRAIN BEHAV, V7, P43, DOI 10.1111/j.1601-183X.2007.00378.x; Szapacs ME, 2004, NEUROBIOL DIS, V16, P572, DOI 10.1016/j.nbd.2004.04.010; Tong LQ, 2001, J BIOL CHEM, V276, P17301, DOI 10.1074/jbc.M010450200; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; Uutela M, 2012, GENES BRAIN BEHAV, V11, P513, DOI 10.1111/j.1601-183X.2012.00784.x	50	42	44	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68722	10.1371/journal.pone.0068722	http://dx.doi.org/10.1371/journal.pone.0068722			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844236	Green Published, gold, Green Submitted			2022-12-27	WOS:000321733000024
J	Nesler, KR; Sand, RI; Symmes, BA; Pradhan, SJ; Boin, NG; Laun, AE; Barbee, SA				Nesler, Katherine R.; Sand, Robert I.; Symmes, Breanna A.; Pradhan, Sarala J.; Boin, Nathan G.; Laun, Anna E.; Barbee, Scott A.			The miRNA Pathway Controls Rapid Changes in Activity-Dependent Synaptic Structure at the Drosophila melanogaster Neuromuscular Junction	PLOS ONE			English	Article							RECEPTOR TYROSINE PHOSPHATASES; CONTROLS DENDRITIC PLASTICITY; ACTIVITY-REGULATED MICRORNA; ACTIN NUCLEATION FACTOR; GENOME-WIDE ANALYSIS; MOTOR AXON GUIDANCE; TRANSCRIPTION FACTOR; II RECEPTOR; GROWTH; EXPRESSION	It is widely accepted that long-term changes in synapse structure and function are mediated by rapid activity-dependent gene transcription and new protein synthesis. A growing amount of evidence suggests that the microRNA (miRNA) pathway plays an important role in coordinating these processes. Despite recent advances in this field, there remains a critical need to identify specific activity-regulated miRNAs as well as their key messenger RNA (mRNA) targets. To address these questions, we used the larval Drosophila melanogaster neuromuscular junction (NMJ) as a model synapse in which to identify novel miRNA-mediated mechanisms that control activity-dependent synaptic growth. First, we developed a screen to identify miRNAs differentially regulated in the larval CNS following spaced synaptic stimulation. Surprisingly, we identified five miRNAs (miRs-1, -8, -289, -314, and -958) that were significantly downregulated by activity. Neuronal misexpression of three miRNAs (miRs-8, -289, and -958) suppressed activity-dependent synaptic growth suggesting that these miRNAs control the translation of biologically relevant target mRNAs. Functional annotation cluster analysis revealed that putative targets of miRs-8 and -289 are significantly enriched in clusters involved in the control of neuronal processes including axon development, pathfinding, and growth. In support of this, miR-8 regulated the expression of a wingless 3'UTR (wg 3' untranslated region) reporter in vitro. Wg is an important presynaptic regulatory protein required for activity-dependent axon terminal growth at the fly NMJ. In conclusion, our results are consistent with a model where key activity-regulated miRNAs are required to coordinate the expression of genes involved in activity-dependent synaptogenesis.	[Nesler, Katherine R.; Sand, Robert I.; Symmes, Breanna A.; Pradhan, Sarala J.; Boin, Nathan G.; Laun, Anna E.; Barbee, Scott A.] Univ Denver, Dept Biol Sci, Denver, CO 80208 USA; [Nesler, Katherine R.; Sand, Robert I.; Symmes, Breanna A.; Pradhan, Sarala J.; Boin, Nathan G.; Laun, Anna E.; Barbee, Scott A.] Univ Denver, Eleanor Roosevelt Inst, Denver, CO 80208 USA; [Barbee, Scott A.] Univ Denver, Mol & Cellular Biophys Program, Denver, CO 80208 USA; [Barbee, Scott A.] Univ Colorado, Colorado Intellectual & Dev Disabil Res Ctr IDDRC, Aurora, CO USA	University of Denver; University of Denver; University of Denver; University of Colorado System; University of Colorado Anschutz Medical Campus	Barbee, SA (corresponding author), Univ Denver, Dept Biol Sci, Denver, CO 80208 USA.	scott.barbee@du.edu			National Institutes of Health [R01DA26048]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026048] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by a project grant from the National Institutes of Health (R01DA26048) to SAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026; Ataman B, 2006, P NATL ACAD SCI USA, V103, P7841, DOI 10.1073/pnas.0600387103; Baudet ML, 2013, SEMIN CELL DEV BIOL, V24, P146, DOI 10.1016/j.semcdb.2012.11.004; Bayat V, 2011, CURR OPIN NEUROBIOL, V21, P182, DOI 10.1016/j.conb.2010.08.014; Bejarano F, 2012, DEVELOPMENT, V139, P2821, DOI 10.1242/dev.079939; Bredy TW, 2011, NEUROBIOL LEARN MEM, V96, P89, DOI 10.1016/j.nlm.2011.04.004; Ceman S, 2011, PHARMACOL THERAPEUT, V130, P26, DOI 10.1016/j.pharmthera.2011.01.004; Crowner D, 2002, DEVELOPMENT, V129, P1317; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; Desai CJ, 1997, DEVELOPMENT, V124, P1941; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Freeman A, 2011, MOL CELL NEUROSCI, V46, P535, DOI 10.1016/j.mcn.2010.12.010; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; Gates MA, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-37; GINIGER E, 1994, DEVELOPMENT, V120, P1385; Godenschwege TA, 2002, NAT NEUROSCI, V5, P1294, DOI 10.1038/nn976; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Jin P, 2004, NAT CELL BIOL, V6, P1048, DOI 10.1038/ncb1104-1048; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Karr J, 2009, J CELL BIOL, V185, P685, DOI 10.1083/jcb.200902062; Karres JS, 2007, CELL, V131, P136, DOI 10.1016/j.cell.2007.09.020; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; Kwon C, 2005, P NATL ACAD SCI USA, V102, P18986, DOI 10.1073/pnas.0509535102; Lee K, 2012, J NEUROSCI, V32, P5678, DOI 10.1523/JNEUROSCI.6471-11.2012; Lin TY, 2009, DEVELOPMENT, V136, P3099, DOI 10.1242/dev.033324; Lippi G, 2011, J CELL BIOL, V194, P889, DOI 10.1083/jcb.201103006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loya CM, 2009, NAT METHODS, V6, P897, DOI 10.1038/nmeth.1402; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; McNeill E, 2012, NEURON, V75, P363, DOI 10.1016/j.neuron.2012.07.005; Menon KP, 2004, NEURON, V44, P663, DOI 10.1016/j.neuron.2004.10.028; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Pawson C, 2008, J NEUROSCI, V28, P11111, DOI 10.1523/JNEUROSCI.0833-08.2008; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pradhan SJ, 2012, J CELL SCI, V125, P6105, DOI 10.1242/jcs.113043; Rehwinkel J, 2006, MOL CELL BIOL, V26, P2965, DOI 10.1128/MCB.26.8.2965-2975.2006; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Roche JP, 2002, J NEUROSCI, V22, P6471, DOI 10.1523/jneurosci.22-15-06471.2002; Rohrbough J, 2000, J NEUROSCI, V20, P6868, DOI 10.1523/JNEUROSCI.20-18-06868.2000; Ruiz-Canada C, 2004, NEURON, V42, P567, DOI 10.1016/S0896-6273(04)00255-7; Ryazansky SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-371; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Shen K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001842; Siegel G, 2011, CURR OPIN GENET DEV, V21, P491, DOI 10.1016/j.gde.2011.04.008; Silver SJ, 2007, P NATL ACAD SCI USA, V104, P18151, DOI 10.1073/pnas.0706673104; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Sun KL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002515; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Thornton JE, 2012, RNA, V18, P1875, DOI 10.1261/rna.034538.112; Tsurudome K, 2010, NEURON, V68, P879, DOI 10.1016/j.neuron.2010.11.016; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Vo NK, 2010, CURR OPIN NEUROBIOL, V20, P457, DOI 10.1016/j.conb.2010.04.002; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yao J, 2006, J NEUROSCI, V26, P8137, DOI 10.1523/JNEUROSCI.1183-06.2006; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X	71	29	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68385	10.1371/journal.pone.0068385	http://dx.doi.org/10.1371/journal.pone.0068385			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844193	Green Submitted, Green Published, gold			2022-12-27	WOS:000321341000157
J	Spaniol, V; Wyder, S; Aebi, C				Spaniol, Violeta; Wyder, Stefan; Aebi, Christoph			RNA-Seq-Based Analysis of the Physiologic Cold Shock-Induced Changes in Moraxella catarrhalis Gene Expression	PLOS ONE			English	Article							BRO BETA-LACTAMASE; ESCHERICHIA-COLI; BRANHAMELLA-CATARRHALIS; NEISSERIA-MENINGITIDIS; NASOPHARYNGEAL COLONIZATION; SERUM RESISTANCE; IV PILI; TEMPERATURE; PROTEIN; VIRULENCE	Background: Moraxella catarrhalis, a major nasopharyngeal pathogen of the human respiratory tract, is exposed to rapid downshifts of environmental temperature when humans breathe cold air. The prevalence of pharyngeal colonization and respiratory tract infections caused by M. catarrhalis is greatest in winter. We investigated how M. catarrhalis uses the physiologic exposure to cold air to regulate pivotal survival systems that may contribute to M. catarrhalis virulence. Results: In this study we used the RNA-seq techniques to quantitatively catalogue the transcriptome of M. catarrhalis exposed to a 26 degrees C cold shock or to continuous growth at 37 degrees C. Validation of RNA-seq data using quantitative RT-PCR analysis demonstrated the RNA-seq results to be highly reliable. We observed that a 26 degrees C cold shock induces the expression of genes that in other bacteria have been related to virulence a strong induction was observed for genes involved in high affinity phosphate transport and iron acquisition, indicating that M. catarrhalis makes a better use of both phosphate and iron resources after exposure to cold shock. We detected the induction of genes involved in nitrogen metabolism, as well as several outer membrane proteins, including ompA, m35-like porin and multidrug efflux pump (acrAB) indicating that M. catarrhalis remodels its membrane components in response to downshift of temperature. Furthermore, we demonstrate that a 26 degrees C cold shock enhances the induction of genes encoding the type IV pili that are essential for natural transformation, and increases the genetic competence of M. catarrhalis, which may facilitate the rapid spread and acquisition of novel virulence-associated genes. Conclusion: Cold shock at a physiologically relevant temperature of 26 degrees C induces in M. catarrhalis a complex of adaptive mechanisms that could convey novel pathogenic functions and may contribute to enhanced colonization and virulence.	[Spaniol, Violeta; Aebi, Christoph] Univ Bern, Inst Infect Dis, Bern, Switzerland; [Wyder, Stefan] Univ Bern, Dept Clin Res, Bern, Switzerland; [Aebi, Christoph] Univ Bern, Inselspital, Dept Pediat, CH-3010 Bern, Switzerland	University of Bern; University of Bern; University of Bern; University Hospital of Bern	Spaniol, V (corresponding author), Univ Bern, Inst Infect Dis, Bern, Switzerland.	violeta.spaniol@ifik.unibe.ch	Kummer, Juerg/B-3322-2011	Wyder, Stefan/0000-0002-3412-0292; Aebi, Christoph/0000-0003-3554-7949	Swiss National Science Foundation (SNF) [3100A0-102246, 3100A0-116053]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Science Foundation (SNF) grants 3100A0-102246 and 3100A0-116053 (to CA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas FE, 2002, MOL MICROBIOL, V46, P749, DOI 10.1046/j.1365-2958.2002.03193.x; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhave Devayani P., 2007, Infectious Disorders - Drug Targets, V7, P140; Boddey JA, 2006, INFECT IMMUN, V74, P5374, DOI 10.1128/IAI.00569-06; Bootsma HJ, 2000, MOL MICROBIOL, V36, P93, DOI 10.1046/j.1365-2958.2000.01828.x; Bootsma HJ, 1996, ANTIMICROB AGENTS CH, V40, P966, DOI 10.1128/AAC.40.4.966; BUTLER CA, 1991, J BACTERIOL, V173, P5793, DOI 10.1128/jb.173.18.5793-5799.1991; CATLIN BW, 1990, CLIN MICROBIOL REV, V3, P293, DOI 10.1128/CMR.3.4.293-320.1990; Collyn F, 2002, INFECT IMMUN, V70, P6196, DOI 10.1128/IAI.70.11.6196-6205.2002; de Vries SPW, 2010, J BACTERIOL, V192, P3574, DOI 10.1128/JB.00121-10; de Vries SPW, 2009, MICROBIOL MOL BIOL R, V73, P389, DOI 10.1128/MMBR.00007-09; Dubnau D, 1999, ANNU REV MICROBIOL, V53, P217, DOI 10.1146/annurev.micro.53.1.217; Faden H, 1997, J INFECT DIS, V175, P1440, DOI 10.1086/516477; Farewell A, 1998, J BACTERIOL, V180, P4704, DOI 10.1128/JB.180.17.4704-4710.1998; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; Gillespie JJ, 2011, INFECT IMMUN, V79, P4286, DOI 10.1128/IAI.00207-11; Griffiths NJ, 2007, CELL MICROBIOL, V9, P2968, DOI 10.1111/j.1462-5822.2007.01038.x; Gunasekera TS, 2008, J BACTERIOL, V190, P3712, DOI 10.1128/JB.01990-07; Gupta N, 2011, INDIAN J PATHOL MICR, V54, P769, DOI 10.4103/0377-4929.91496; Han YP, 2005, MICROBES INFECT, V7, P335, DOI 10.1016/j.micinf.2004.11.005; Heiniger N, 2005, INFECT IMMUN, V73, P8247, DOI 10.1128/IAI.73.12.8247-8255.2005; Hendley JO, 2005, APMIS, V113, P213, DOI 10.1111/j.1600-0463.2005.apm1130310.x; Hendrickx APA, 2008, MICROBIOL-SGM, V154, P3212, DOI 10.1099/mic.0.2008/020891-0; Hill DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045452; Hsu SF, 2012, J MICROBIOL IMMUNOL, V45, P134, DOI 10.1016/j.jmii.2011.09.004; Jetter M, 2010, J ANTIMICROB CHEMOTH, V65, P2089, DOI 10.1093/jac/dkq312; Jones PG, 1996, P NATL ACAD SCI USA, V93, P76, DOI 10.1073/pnas.93.1.76; Khan MA, 2010, J ANTIMICROB CHEMOTH, V65, P91, DOI 10.1093/jac/dkp401; Konkel ME, 2000, MICROBES INFECT, V2, P157, DOI 10.1016/S1286-4579(00)00272-0; Kristo A, 2006, PEDIATR INFECT DIS J, V25, P108, DOI 10.1097/01.inf.0000201048.65828.b5; Lamarche MG, 2008, J BACTERIOL, V190, P5256, DOI 10.1128/JB.01536-07; Lamarche MG, 2005, INFECT IMMUN, V73, P4138, DOI 10.1128/IAI.73.7.4138-4145.2005; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Llobet E, 2009, ANTIMICROB AGENTS CH, V53, P298, DOI 10.1128/AAC.00657-08; Lopez-Garcia P, 2000, BIOESSAYS, V22, P738; Luke NR, 2007, INFECT IMMUN, V75, P5559, DOI 10.1128/IAI.00946-07; Luke NR, 2004, INFECT IMMUN, V72, P6262, DOI 10.1128/IAI.72.11.6262-6270.2004; LUNDBERG JON, 1995, NAT MED, V1, P370, DOI 10.1038/nm0495-370; MBAKI N, 1987, TOHOKU J EXP MED, V153, P111, DOI 10.1620/tjem.153.111; Meier PS, 2006, FEMS MICROBIOL LETT, V262, P72, DOI 10.1111/j.1574-6968.2006.00365.x; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; Morrissey I, 2008, J ANTIMICROB CHEMOTH, V62, pII97, DOI 10.1093/jac/dkn356; Motin VL, 2004, J BACTERIOL, V186, P6298, DOI 10.1128/JB.186.18.6298-6305.2004; Murphy TF, 2009, CLIN INFECT DIS, V49, P124, DOI 10.1086/599375; Nikaido H, 1996, J BACTERIOL, V178, P5853, DOI 10.1128/jb.178.20.5853-5859.1996; Palmu AAI, 2004, CLIN INFECT DIS, V38, P234, DOI 10.1086/380642; Perez-Gutierrez C, 2010, INFECT IMMUN, V78, P2768, DOI 10.1128/IAI.01417-09; Phadtare S, 1999, CURR OPIN MICROBIOL, V2, P175, DOI 10.1016/S1369-5274(99)80031-9; PRUGNOLA A, 1995, MICROBIOL-UK, V141, P2529, DOI 10.1099/13500872-141-10-2529; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reines M, 2012, J BACTERIOL, V194, P3173, DOI 10.1128/JB.00308-12; Revai K, 2006, PEDIATRICS, V117, P1823, DOI 10.1542/peds.2005-1983; Rouadi P, 1999, J APPL PHYSIOL, V87, P400, DOI 10.1152/jappl.1999.87.1.400; Rozen S, 2000, Methods Mol Biol, V132, P365; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Samant S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040037; SARUBBI FA, 1990, AM J MED, V88, pS9, DOI 10.1016/0002-9343(90)90254-B; SCHRYVERS AB, 1989, INFECT IMMUN, V57, P2425, DOI 10.1128/IAI.57.8.2425-2429.1989; Smith-Vaughan H, 2006, BMC EAR NOSE THROAT, V6, DOI 10.1186/1472-6815-6-10; Spaniol V, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-182; Spaniol V, 2009, J INFECT DIS, V200, P1593, DOI 10.1086/644640; Stevanin TM, 2005, INFECT IMMUN, V73, P3322, DOI 10.1128/IAI.73.6.3322-3329.2005; STRALEY SC, 1995, TRENDS MICROBIOL, V3, P310, DOI 10.1016/S0966-842X(00)88960-X; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; VANHARE GF, 1987, PEDIATR INFECT DIS J, V6, P92, DOI 10.1097/00006454-198701000-00047; Verhaegh SJC, 2011, MICROBIOL-SGM, V157, P169, DOI 10.1099/mic.0.042929-0; Wang W, 2007, INFECT IMMUN, V75, P4959, DOI 10.1128/IAI.00073-07; WANNER BL, 1993, J CELL BIOCHEM, V51, P47, DOI 10.1002/jcb.240510110; Weber Michael H. W., 2003, Science Progress, V86, P9, DOI 10.3184/003685003783238707; WEISER JN, 1991, INFECT IMMUN, V59, P2252, DOI 10.1128/IAI.59.7.2252-2258.1991; White-Ziegler CA, 2007, J BACTERIOL, V189, P5429, DOI 10.1128/JB.01929-06; Xu H, 2008, LETT APPL MICROBIOL, V47, P290, DOI 10.1111/j.1472-765X.2008.02429.x	74	15	15	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68298	10.1371/journal.pone.0068298	http://dx.doi.org/10.1371/journal.pone.0068298			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844181	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000321341000150
J	Taft, RA; Low, BE; Byers, SL; Murray, SA; Kutny, P; Wiles, MV				Taft, Robert A.; Low, Benjamin E.; Byers, Shannon L.; Murray, Stephen A.; Kutny, Peter; Wiles, Michael V.			The Perfect Host: A Mouse Host Embryo Facilitating More Efficient Germ Line Transmission of Genetically Modified Embryonic Stem Cells	PLOS ONE			English	Article							TRANSGENIC MICE; GENE; VASA; EXPRESSION; KARYOTYPE; HOMOLOG; CULTURE; PROTEIN	There is a continual need to improve efficiency in creating precise genetic modifications in mice using embryonic stem cells (ESCs). We describe a novel approach resulting in 100% germline transmission from competent injected ESCs. We developed an F1 mouse host embryo (Perfect Host, PH) that selectively ablates its own germ cells via tissue-specific induction of diphtheria toxin. This approach allows competent microinjected ESCs to fully dominate the germline, eliminating competition for this critical niche in the developing and adult animal. This is in contrast to conventional methods, where competition from host germ cells results in offspring derived from host cells and ESCs, necessitating extensive breeding of chimeras and genotyping to identify germline. The germline transmission process is also complicated by variability in the actual number of ESCs that colonize the germline niche and the proportion that are germline competent. To validate the PH approach we used ESC lines derived from 129 F1, BALB/cByJ, and BTBR backgrounds as well as an iPS line. Resulting chimeric males produced 194 offspring, all paternally derived from the introduced stem cells, with no offspring being derived from the host genome. We further tested this approach using eleven genetically modified C57BL/6N ESC lines (International Knockout Mouse Consortium). ESC germline transmission was observed in 9/11 (82%) lines using PH blastocysts, compared to 6/11 (55%) when conventional host blastocysts were used. Furthermore, less than 35% (83/240) of mice born in the first litters from conventional chimeras were confirmed to be of ESC-origin. By comparison, 100% (137/137) of the first litter offspring of PH chimeras were confirmed as ESC-derived. Together, these data demonstrate that the PH approach increases the probability of germline transmission and speeds the generation of ESC derived animals from chimeras. Collectively, this approach reduces the time and costs inherent in the production of genetically modified animals.	[Taft, Robert A.; Low, Benjamin E.; Byers, Shannon L.; Murray, Stephen A.; Kutny, Peter; Wiles, Michael V.] Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Wiles, MV (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	Michael.Wiles@jax.org		Taft, Robert/0000-0002-3634-3342; wiles, michael/0000-0002-3620-8386	National Center for Research Resources/Office of the Director, NIH [R21 RR031289, OD011190]; Jackson Laboratory; Seed Grant from the Maine Technology Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR031289] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U42OD011185, R24OD011190] Funding Source: NIH RePORTER	National Center for Research Resources/Office of the Director, NIH; Jackson Laboratory; Seed Grant from the Maine Technology Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by Grant Number R21 RR031289 (M.V.W.) and OD011190 (R.T. and S.M.) from the National Center for Research Resources/Office of the Director, NIH, and by The Jackson Laboratory. This work was also supported by a Seed Grant from the Maine Technology Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Bendel-Stenzel M, 1998, SEMIN CELL DEV BIOL, V9, P393, DOI 10.1006/scdb.1998.0204; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; BREITMAN ML, 1990, MOL CELL BIOL, V10, P474, DOI 10.1128/MCB.10.2.474; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Ewen KA, 2010, MOL CELL ENDOCRINOL, V323, P76, DOI 10.1016/j.mce.2009.12.013; FUJIWARA Y, 1994, P NATL ACAD SCI USA, V91, P12258, DOI 10.1073/pnas.91.25.12258; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Guo JL, 2005, IN VITRO CELL DEV-AN, V41, P278; Longo L, 1997, TRANSGENIC RES, V6, P321, DOI 10.1023/A:1018418914106; Markoulaki S, 2009, NAT BIOTECHNOL, V27, P169, DOI 10.1038/nbt.1520; MCLAREN A, 1992, ANDROLOGIA, V24, P243; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nagy A., 2002, MANIPULATING MOUSE E; Ogawa T, 2000, INT J ANDROL, V23, P57, DOI 10.1046/j.1365-2605.2000.00017.x; Ostermeier GC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002792; Petkov PM, 2004, GENOMICS, V83, P902, DOI 10.1016/j.ygeno.2003.11.007; Suzuki H, 1997, EXP ANIM TOKYO, V46, P17, DOI 10.1538/expanim.46.17; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Wiles MV, 2010, METHODS MOL BIOL, V602, P23, DOI 10.1007/978-1-60761-058-8_2; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Wu S, 2006, DEVELOPMENT, V133, P581, DOI 10.1242/dev.02236; Zohni K, 2012, HUM REPROD, V27, P44, DOI 10.1093/humrep/der357	26	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67826	10.1371/journal.pone.0067826	http://dx.doi.org/10.1371/journal.pone.0067826			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844102	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000104
J	Decker, C; Olu, K; Arnaud-Haond, S; Duperron, S				Decker, Carole; Olu, Karine; Arnaud-Haond, Sophie; Duperron, Sebastien			Physical Proximity May Promote Lateral Acquisition of Bacterial Symbionts in Vesicomyid Clams	PLOS ONE			English	Article							REDUCTIVE GENOME EVOLUTION; CHEMOAUTOTROPHIC BACTERIA; OLIGONUCLEOTIDE PROBES; GIANT POCKMARK; SEEP; BIVALVIA; RECOMBINATION; PLIOCARDIINAE; ENDOSYMBIONT; RESPIRATION	Vesicomyid clams harbor intracellular sulfur-oxidizing bacteria that are predominantly maternally inherited and co-speciate with their hosts. Genome recombination and the occurrence of non-parental strains were recently demonstrated in symbionts. However, mechanisms favoring such events remain to be identified. In this study, we investigated symbionts in two phylogenetically distant vesicomyid species, Christineconcha regab and Laubiericoncha chuni, which sometimes co-occur at a cold-seep site in the Gulf of Guinea. We showed that each of the two species harbored a single dominant bacterial symbiont strain. However, for both vesicomyid species, the symbiont from the other species was occasionally detected in the gills using fluorescence in situ hybridization and gene sequences analyses based on six symbiont marker genes. Symbiont strains co-occurred within a single host only at sites where both host species were found; whereas one single symbiont strain was detected in C. regab specimens from a site where no L. chuni individuals had been observed. These results suggest that physical proximity favored the acquisition of non-parental symbiont strains in Vesicomyidae. Over evolutionary time, this could potentially lead to genetic exchanges among symbiont species and eventually symbiont displacement. Symbiont densities estimated using 3D fluorescence in situ hybridization varied among host species and sites, suggesting flexibility in the association despite the fact that a similar type of metabolism is expected in all symbionts.	[Decker, Carole; Olu, Karine; Arnaud-Haond, Sophie] IFREMER, Ctr Brest, Lab Environm Profond, REM EEP, Plouzane, France; [Duperron, Sebastien] UPMC CNRS IRD MNHN, UMR Systemat Adaptat Evolut Adaptat Milieux Extre, Paris, France; [Duperron, Sebastien] Univ Paris 06, Paris, France	Ifremer; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Decker, C (corresponding author), IFREMER, Ctr Brest, Lab Environm Profond, REM EEP, Plouzane, France.	carole.decker@ifremer.fr	Duperron, Sebastien/C-4712-2011; Arnaud-Haond, Sophie/B-2479-2008	Arnaud-Haond, Sophie/0000-0001-5814-8452; Olu, Karine/0000-0002-4906-4131; duperron, sebastien/0000-0002-6422-6821	ANR [ANR06BDV005, GDR2907]; German Research Foundation Research Center Ocean Margins/Center for Marine Environmental Sciences at the University Bremen for the Meteor cruises	ANR(French National Research Agency (ANR)); German Research Foundation Research Center Ocean Margins/Center for Marine Environmental Sciences at the University Bremen for the Meteor cruises	This work was done with the support of the ANR Deep Oases (ANR06BDV005) and GDR Ecchis (GDR2907) projects for scientific collaborations and of the German Research Foundation Research Center Ocean Margins/Center for Marine Environmental Sciences at the University Bremen for the Meteor cruises. No other current external funding sources have been obtained for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; [Anonymous], 2010, R LANG ENV STAT COMP; ARP AJ, 1984, PHYSIOL ZOOL, V57, P648, DOI 10.1086/physzool.57.6.30155991; Audzijonyte A, 2012, SYST BIODIVERS, V10, P403, DOI 10.1080/14772000.2012.744112; BEGUN DJ, 1991, GENETICS, V129, P1147; Cambon-Bonavita MA, 2009, DEEP-SEA RES PT II, V56, P2248, DOI 10.1016/j.dsr2.2009.04.007; CARY SC, 1993, P NATL ACAD SCI USA, V90, P5695, DOI 10.1073/pnas.90.12.5695; CAVANAUGH CM, 1983, NATURE, V302, P58, DOI 10.1038/302058a0; Decker C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033359; Decker C, 2012, CR BIOL, V335, P261, DOI 10.1016/j.crvi.2012.03.002; DISTEL DL, 1988, J BACTERIOL, V170, P2506, DOI 10.1128/jb.170.6.2506-2510.1988; Doyle J. J., 1987, PHYTOCHEM B, P11; Drummond AJ, 2009, GENEIOUS WEBSITE GEN; Duperron S, 2005, APPL ENVIRON MICROB, V71, P1694, DOI 10.1128/AEM.71.4.1694-1700.2005; Duperron S, 2011, GEOBIOLOGY, V9, P481, DOI 10.1111/j.1472-4669.2011.00300.x; Endow K, 1988, HEREDITY, V42, P50; Fiala-Medioni A, 1987, SYMBIOSIS, V4, P63; FIALAMEDIONI A, 1984, CR ACAD SCI III-VIE, V298, P487; FIALAMEDIONI A, 1988, OCEANOL ACTA, V11, P185; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fujiwara Yoshihiro, 2000, Venus the Japanese Journal of Malacology, V59, P307; Goffredi SK, 2002, MAR ECOL PROG SER, V225, P227, DOI 10.3354/meps225227; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Halary S, 2008, 3D FISH QUANTIFICATI, P1; HENTSCHEL U, 1993, MAR ECOL PROG SER, V94, P35, DOI 10.3354/meps094035; Hurtado LA, 2003, APPL ENVIRON MICROB, V69, P2058, DOI 10.1128/AEM.69.4.2058-2064.2003; Krylova EM, 2011, ZOOSYSTEMA, V33, P83, DOI 10.5252/z2011n1a4; Krylova EM, 2010, J MOLLUS STUD, V76, P107, DOI 10.1093/mollus/eyp052; Krylova EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009957; Kuwahara H, 2008, EXTREMOPHILES, V12, P365, DOI 10.1007/s00792-008-0141-2; Kuwahara H, 2007, CURR BIOL, V17, P881, DOI 10.1016/j.cub.2007.04.039; Kuwahara H, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-285; Little CTS, 2003, TRENDS ECOL EVOL, V18, P582, DOI 10.1016/j.tree.2003.08.009; LUTZ RA, 1993, REV GEOPHYS, V31, P211, DOI 10.1029/93RG01280; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Marcon Y, MARINE ECOLOGY; Newton ILG, 2007, SCIENCE, V315, P998, DOI 10.1126/science.1138438; Newton ILG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-585; Olu-Le Roy K, 2007, DEEP-SEA RES PT I, V54, P1890, DOI 10.1016/j.dsr.2007.07.004; Ondreas H, 2005, GEO-MAR LETT, V25, P281, DOI 10.1007/s00367-005-0213-6; Peek AS, 1998, P NATL ACAD SCI USA, V95, P9962, DOI 10.1073/pnas.95.17.9962; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Roeselers G, 2012, APPL MICROBIOL BIOT, V94, P1, DOI 10.1007/s00253-011-3819-9; Roy KOL, 2007, MAR ECOL-EVOL PERSP, V28, P115, DOI 10.1111/j.1439-0485.2006.00145.x; Sibuet M, 1998, DEEP-SEA RES PT II, V45, P517, DOI 10.1016/S0967-0645(97)00074-X; SMITH CR, 1989, NATURE, V341, P27, DOI 10.1038/341027a0; Stewart FJ, 2008, MOL BIOL EVOL, V25, P673, DOI 10.1093/molbev/msn010; Stewart FJ, 2009, ENVIRON MICROBIOL, V11, P2136, DOI 10.1111/j.1462-2920.2009.01933.x; Stewart FJ, 2009, MOL BIOL EVOL, V26, P1391, DOI 10.1093/molbev/msp049; Thiele J, 1931, VALDIVIA; Von Cosel R, 2008, ZOOSTYSTEMA; von Cosel R, 2009, DEEP-SEA RES PT II, V56, P2350, DOI 10.1016/j.dsr2.2009.04.016; Wenzhofer F., 2012, BIOGEOSCIENCES DISCU, V9, P8337, DOI DOI 10.5194/BG-9-5031-2012; Wilmot DB, 1992, OXYGEN NITROGEN DEPE	58	21	23	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e64830	10.1371/journal.pone.0064830	http://dx.doi.org/10.1371/journal.pone.0064830			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861734	Green Published, gold			2022-12-27	WOS:000321692000002
J	Nagao, Y				Nagao, Yoshiro			Decreasing Fertility Rate Correlates with the Chronological Increase and Geographical Variation in Incidence of Kawasaki Disease in Japan	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DENGUE TRANSMISSION; CORONARY ANEURYSMS; RISK-FACTORS; INFECTIONS; CHILDREN; HOSPITALIZATIONS; EPIDEMIOLOGY; SEASONALITY; VARIABILITY	Background: Kawasaki disease (KD) is a common cause of acquired paediatric heart disease in developed countries. KD was first identified in the 1960s in Japan, and has been steadily increasing since it was first reported. The aetiology of KD has not been defined, but is assumed to be infection-related. The present study sought to identify the factor(s) that mediate the geographical variation and chronological increase of KD in Japan. Methods and Findings: Based upon data reported between 1979 and 2010 from all 47 prefectures in Japan, the incidence and mean patient age at the onset of KD were estimated. Using spatial and time-series analyses, incidence and mean age were regressed against climatic/socioeconomic variables. Both incidence and mean age of KD were inversely correlated with the total fertility rate (TFR; i.e., the number of children that would be born to one woman). The extrapolation of a time-series regressive model suggested that KD emerged in the 1960s because of a dramatic decrease in TFR in the 1940s through the 1950s. Conclusions: Mean patient age is an inverse surrogate for the hazard of contracting the aetiologic agent. Therefore, the observed negative correlation between mean patient age and TFR suggests that a higher TFR is associated with KD transmission. This relationship may be because a higher TFR facilitates sibling-to-sibling transmission. Additionally, the observed inverse correlation between incidence and TFR implies a paradoxical "negative'' correlation between the incidence and the hazard of contracting the aetiologic agent. It was hypothesized that a decreasing TFR resulted in a reduced hazard of contracting the agent for KD, thereby increasing KD incidence.	Onoda Hosp, Minamisoma City, Fukushima, Japan		Nagao, Y (corresponding author), Onoda Hosp, Minamisoma City, Fukushima, Japan.	in_the_pacific214@yahoo.co.jp		Nagao, Yoshiro/0000-0003-3411-0729				ANDERSON R M, 1991; ANSELIN L, 1992, REG SCI URBAN ECON, V22, P509, DOI 10.1016/0166-0462(92)90042-Y; BELL DM, 1981, NEW ENGL J MED, V304, P1568, DOI 10.1056/NEJM198106253042603; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Bronstein DE, 2000, PEDIATR INFECT DIS J, V19, P1087, DOI 10.1097/00006454-200011000-00012; Burgner D, 2005, INT J INFECT DIS, V9, P185, DOI 10.1016/j.ijid.2005.03.002; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; Burns JC, 2005, EPIDEMIOLOGY, V16, P220, DOI 10.1097/01.ede.0000152901.06689.d4; Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1; Chang LY, 2004, JAMA-J AM MED ASSOC, V291, P222, DOI 10.1001/jama.291.2.222; Chang LY, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e88; Chang RKR, 2002, PEDIATR INFECT DIS J, V21, P1150, DOI 10.1097/00006454-200212000-00013; Checkley W, 2009, EPIDEMIOLOGY, V20, P194, DOI 10.1097/EDE.0b013e3181961a9b; Coleman PG, 2001, LANCET, V357, P1284, DOI 10.1016/S0140-6736(00)04410-X; Daniels LB, 2012, CURR OPIN CARDIOL, V27, P572, DOI 10.1097/HCO.0b013e3283588f06; ESRI Japan, 2012, CIT TOWNS VILL JAP; FUJITA Y, 1989, PEDIATRICS, V84, P666; FURUSHO K, 1984, LANCET, V2, P1055; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; Harnden A, 2009, PEDIATR INFECT DIS J, V28, P21, DOI 10.1097/INF.0b013e3181812ca4; Holman RC, 2010, PEDIATR INFECT DIS J, V29, P483, DOI 10.1097/INF.0b013e3181cf8705; Iemura M, 2000, HEART, V83, P307, DOI 10.1136/heart.83.3.307; Inaba H, 2008, MATH MODEL NAT PHENO, V3, P194, DOI 10.1051/mmnp:2008050; Kao AS, 2008, PEDIATR INFECT DIS J, V27, P981, DOI 10.1097/INF.0b013e31817acf4f; KATO H, 1975, J PEDIATR-US, V86, P892, DOI 10.1016/S0022-3476(75)80220-4; Kawasaki T, 1967, Arerugi, V16, P178; Khor CC, 2011, NAT GENET, V43, P1241, DOI 10.1038/ng.981; Khor CC, 2011, J MED GENET, V48, P467, DOI 10.1136/jmg.2010.086611; Kim JJ, 2011, HUM GENET, V129, P487, DOI 10.1007/s00439-010-0937-x; Lanphear BP, 1998, PEDIATR INFECT DIS J, V17, P792, DOI 10.1097/00006454-199809000-00008; Lee YC, 2012, NAT GENET, V44, P522, DOI 10.1038/ng.2227; MAY RM, 1985, MATH BIOSCI, V77, P141, DOI 10.1016/0025-5564(85)90093-8; MCLEAN AR, 1988, EPIDEMIOL INFECT, V100, P111, DOI 10.1017/S0950268800065614; Ministry of Health Labor and Welfare, 1986, SURV PHYS DENT PHARM; Ministry of Health Labour and Welfare, 1975, SPEC REP DYN DEM SUR; Ministry of Internal Affairs and Communications, 1975, EST POP; Ministry of Internal Affairs and Communications, 1975, STAT IND SOC LIF; MUSO E, 1993, CLIN NEPHROL, V40, P7; Nagao Y, 2008, EPIDEMIOL INFECT, V136, P843, DOI 10.1017/S0950268807008990; Nagao Y, 2008, P NATL ACAD SCI USA, V105, P2238, DOI 10.1073/pnas.0709029105; Nakamura Y, 2008, J EPIDEMIOL, V18, P273, DOI 10.2188/jea.JE2008030; Nakamura Y, 2008, PEDIATR INT, V50, P287, DOI 10.1111/j.1442-200X.2008.02572.x; Nakamura Y, 2012, J EPIDEMIOL, V22, P216, DOI 10.2188/jea.JE20110126; Newburger JW, 2004, PEDIATRICS, V114, P1708, DOI 10.1542/peds.2004-2182; NEWBURGER JW, 1986, NEW ENGL J MED, V315, P341, DOI 10.1056/NEJM198608073150601; OKANO M, 1990, J MED VIROL, V32, P53, DOI 10.1002/jmv.1890320109; Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220; Pisati M, 2001, STATA TECHNICAL B, V55, P33; Pitzer VE, 2012, P ROY SOC B-BIOL SCI, V279, P2736, DOI 10.1098/rspb.2011.2464; Pitzer VE, 2011, J R SOC INTERFACE, V8, P1584, DOI 10.1098/rsif.2011.0062; Pitzer VE, 2009, J THEOR BIOL, V260, P175, DOI 10.1016/j.jtbi.2009.06.008; Pitzer VE, 2009, SCIENCE, V325, P290, DOI 10.1126/science.1172330; Rodo X, 2011, SCI REP-UK, V1, DOI 10.1038/srep00152; Rowley AH, 2011, J INFECT DIS, V203, P1021, DOI 10.1093/infdis/jiq136; Shingadia D, 2002, LANCET INFECT DIS, V2, P310, DOI 10.1016/S1473-3099(02)00265-7; Suenaga T, 2009, J PEDIATR-US, V155, P266, DOI 10.1016/j.jpeds.2009.03.013; TAUBERT KA, 1991, J PEDIATR-US, V119, P279, DOI 10.1016/S0022-3476(05)80742-5; The World Bank, 2012, FERT RAT TOT BIRTHS; Tsai FJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016853; Tsuchida S, 1996, ACTA PAEDIATR, V85, P995, DOI 10.1111/j.1651-2227.1996.tb14201.x; TULJAPURKAR S, 1991, THEOR POPUL BIOL, V40, P322, DOI 10.1016/0040-5809(91)90059-O; Turkay S, 2006, J NATL MED ASSOC, V98, P1350; Uehara R, 2003, ACTA PAEDIATR, V92, P694, DOI 10.1080/08035320310002768; University Corporation for Atmospheric Research, 2012, GLOB SUMM DAY MONTH; YANAGAWA H, 1995, ARCH PEDIAT ADOL MED, V149, P779, DOI 10.1001/archpedi.1995.02170200069011; Yanagawa H, 2004, EPIDEMIOLOGY KAWASAK, P17; Zerr DM, 2005, NEW ENGL J MED, V352, P768, DOI 10.1056/NEJMoa042207	67	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e67934	10.1371/journal.pone.0067934	http://dx.doi.org/10.1371/journal.pone.0067934			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861836	gold, Green Published, Green Submitted			2022-12-27	WOS:000321692000013
J	Sallustio, F; Serino, G; Costantino, V; Curci, C; Cox, SN; De Palma, G; Schena, FP				Sallustio, Fabio; Serino, Grazia; Costantino, Vincenzo; Curci, Claudia; Cox, Sharon N.; De Palma, Giuseppe; Schena, Francesco P.			miR-1915 and miR-1225-5p Regulate the Expression of CD133, PAX2 and TLR2 in Adult Renal Progenitor Cells	PLOS ONE			English	Article							STEM-CELLS; STEM/PROGENITOR CELLS; KIDNEY REPAIR; MICRORNAS; ACTIVATION; TARGETS; BIOLOGY; INJURY; MOUSE	Adult renal progenitor cells (ARPCs) were recently identified in the cortex of the renal parenchyma and it was demonstrated that they were positive for PAX2, CD133, CD24 and exhibited multipotent differentiation ability. Recent studies on stem cells indicated that microRNAs (miRNAs), a class of noncoding small RNAs that participate in the regulation of gene expression, may play a key role in stem cell self-renewal and differentiation. Distinct sets of miRNAs are specifically expressed in pluripotent stem cells but not in adult tissues, suggesting a role for miRNAs in stem cell self-renewal. We compared miRNA expression profiles of ARPCs with that of mesenchymal stem cells (MSCs) and renal proximal tubular cells (RPTECs) finding distinct sets of miRNAs that were specifically expressed in ARPCs. In particular, miR-1915 and miR-1225-5p regulated the expression of important markers of renal progenitors, such as CD133 and PAX2, and important genes involved in the repair mechanisms of ARPCs, such as TLR2. We demonstrated that the expression of both the renal stem cell markers CD133 and PAX2 depends on lower miR-1915 levels and that the increase of miR-1915 levels improved capacity of ARPCs to differentiate into adipocyte-like and epithelial-like cells. Finally, we found that the low levels of miR-1225-5p were responsible for high TLR2 expression in ARPCs. Therefore, together, miR-1915 and miR-1225-5p seem to regulate important traits of renal progenitors: the stemness and the repair capacity.	[Sallustio, Fabio; Serino, Grazia; Costantino, Vincenzo; Cox, Sharon N.; Schena, Francesco P.] Univ Bari, Dept Emergency & Organ Transplantat, Bari, Italy; [Sallustio, Fabio; Curci, Claudia; De Palma, Giuseppe; Schena, Francesco P.] CARSO Consortium, Bari, Italy; [Sallustio, Fabio] Univ Salento, Dept Sci Biol & Environm Sci & Technol, Lecce, Italy; [Schena, Francesco P.] European Res Ctr Kidney Dis, Schena Fdn, Bari, Italy	Universita degli Studi di Bari Aldo Moro; University of Salento	Schena, FP (corresponding author), Univ Bari, Dept Emergency & Organ Transplantat, Bari, Italy.	paolo.schena@uniba.it	Sallustio, Fabio/D-2326-2011; Serino, Grazia/K-2255-2018; Schena, Francesco P/K-6982-2016; Curci, Claudia/A-6918-2013; Cox, Sharon Natasha/H-1306-2015; Sallustio, Fabio/AFP-7212-2022; De Palma, Giuseppe/J-4860-2018	Sallustio, Fabio/0000-0002-5132-6532; Serino, Grazia/0000-0002-2971-0802; Schena, Francesco P/0000-0001-7927-5207; Curci, Claudia/0000-0003-2055-7837; Cox, Sharon Natasha/0000-0002-8488-440X; Sallustio, Fabio/0000-0002-5132-6532; De Palma, Giuseppe/0000-0002-6108-096X	Ministero dell'Istruzione, dell'Universita e della Ricerca (MiUR) [PRIN 2008M9WSJX, PON-REC ONEV 134/2011, FIRB RBAP11B2SX]; Regione Puglia [44/09 BISIMANE, 2006 PS 144/06]	Ministero dell'Istruzione, dell'Universita e della Ricerca (MiUR)(Ministry of Education, Universities and Research (MIUR)); Regione Puglia(Regione Puglia)	This study was supported by a grant from Ministero dell'Istruzione, dell'Universita e della Ricerca (MiUR) (PRIN 2008M9WSJX; PON-REC ONEV 134/2011; FIRB RBAP11B2SX) and "Regione Puglia'' (Progetto strategico 44/09 BISIMANE; Progetto strategico 2006 PS 144/06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Angelotti ML, 2012, STEM CELLS, V30, P1714, DOI 10.1002/stem.1130; Bauer N, 2008, CELLS TISSUES ORGANS, V188, P127, DOI 10.1159/000112847; Bussolati B, 2005, AM J PATHOL, V166, P545, DOI 10.1016/S0002-9440(10)62276-6; Bussolati B, 2009, CURR STEM CELL RES T, V4, P2, DOI 10.2174/157488809787169129; Camussi G, 2010, CURR OPIN NEPHROL HY, V19, P7, DOI 10.1097/MNH.0b013e328332fb6f; Cheng LC, 2005, NEURON, V46, P363, DOI 10.1016/j.neuron.2005.04.027; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Dressler GR, 1999, INT J DEV BIOL, V43, P463; DRESSLER GR, 1992, P NATL ACAD SCI USA, V89, P1179, DOI 10.1073/pnas.89.4.1179; Ferrell CM, 2005, STEM CELLS, V23, P644, DOI 10.1634/stemcells.2004-0198; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Imgrund M, 1999, KIDNEY INT, V56, P1423, DOI 10.1046/j.1523-1755.1999.00663.x; Katoh M, 2008, CURR DRUG TARGETS, V9, P565, DOI 10.2174/138945008784911750; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kemp CR, 2007, DEV DYNAM, V236, P2011, DOI 10.1002/dvdy.21198; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lindgren D, 2011, AM J PATHOL, V178, P828, DOI 10.1016/j.ajpath.2010.10.026; Maeshima A, 2002, J AM SOC NEPHROL, V13, P2850, DOI 10.1097/01.ASN.0000035086.93977.E9; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; Procino G, 2011, CELL PHYSIOL BIOCHEM, V28, P683, DOI 10.1159/000335762; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Sagrinati C, 2006, J AM SOC NEPHROL, V17, P2443, DOI 10.1681/ASN.2006010089; Sallustio F, 2013, KIDNEY INT, V83, P392, DOI 10.1038/ki.2012.413; Sallustio F, 2010, FASEB J, V24, P514, DOI 10.1096/fj.09-136481; Shmelkov SV, 2005, INT J BIOCHEM CELL B, V37, P715, DOI 10.1016/j.biocel.2004.08.010; Simone S, 2012, AM J PHYSIOL-RENAL, V303, pF23, DOI 10.1152/ajprenal.00328.2011; Strauss WM, 2006, MAMM GENOME, V17, P833, DOI 10.1007/s00335-006-0025-7; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Van Raay TJ, 2005, NEURON, V46, P23, DOI 10.1016/j.neuron.2005.02.023	33	40	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68296	10.1371/journal.pone.0068296	http://dx.doi.org/10.1371/journal.pone.0068296			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861881	Green Published, gold, Green Submitted			2022-12-27	WOS:000321692000019
J	Su, B; Peng, XH; Jiang, DM; Wu, J; Qiao, B; Li, WC; Qi, XT				Su, Bao; Peng, Xiaohua; Jiang, Dianming; Wu, Jun; Qiao, Bo; Li, Weichao; Qi, Xiaotong			In Vitro and In Vivo Evaluations of Nano-Hydroxyapatite/Polyamide 66/Glass Fibre (n-HA/PA66/GF) as a Novel Bioactive Bone Screw	PLOS ONE			English	Article							COMPOSITE SCAFFOLDS; MAGNESIUM ALLOYS; BIOCOMPATIBILITY; STRENGTH; IMPLANTS	In this study, we prepared nano-hydroxyapatite/polyamide 66/glass fibre (n-HA/PA66/GF) bioactive bone screws. The microstructure, morphology and coating of the screws were characterised, and the adhesion, proliferation and viability of MC3T3-E1 cells on n-HA/PA66/GF scaffolds were determined using scanning electron microscope, CCK-8 assays and cellular immunofluorescence analysis. The results confirmed that n-HA/PA66/GF scaffolds were biocompatible and had no negative effect on MC3T3-E1 cells in vitro. To investigate the in vivo biocompatibility, internal fixation properties and osteogenesis of the bioactive screws, both n-HA/PA66/GF screws and metallic screws were used to repair intercondylar femur fractures in dogs. General photography, CT examination, micro-CT examination, histological staining and biomechanical assays were performed at 4, 8, 12 and 24 weeks after operation. The n-HA/PA66/GF screws exhibited good biocompatibility, high mechanical strength and extensive osteogenesis in the host bone. Moreover, 24 weeks after implantation, the maximum push-out load of the bioactive screws was greater than that of the metallic screws. As shown by their good cytocompatibility, excellent biomechanical strength and fast formation and ingrowth of new bone, n-HA/PA66/GF screws are thus suitable for orthopaedic clinical applications.	[Su, Bao; Jiang, Dianming; Wu, Jun; Qiao, Bo; Li, Weichao; Qi, Xiaotong] Chongqing Med Univ, Dept Orthopaed, Affiliated Hosp 1, Chongqing, Peoples R China; [Peng, Xiaohua] Shanghai Jiao Tong Univ, Dept Resp Med, Xinhua Hosp, Sch Med, Shanghai 200030, Peoples R China	Chongqing Medical University; Shanghai Jiao Tong University	Jiang, DM (corresponding author), Chongqing Med Univ, Dept Orthopaed, Affiliated Hosp 1, Chongqing, Peoples R China.	jdm571026@vip.163.com			Chongqing Committee of Science and Technology [CSTC2009AB5080]	Chongqing Committee of Science and Technology	This research was supported by the Tackling Project of the Chongqing Committee of Science and Technology (No. CSTC2009AB5080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2011, J MATER SCI-MATER M, V22, P1825, DOI 10.1007/s10856-011-4361-0; Benli S, 2008, J BIOMECH, V41, P3229, DOI 10.1016/j.jbiomech.2008.08.003; Carisey A, 2013, CURR BIOL, V23, P271, DOI 10.1016/j.cub.2013.01.009; Completo A, 2008, J BIOMECH, V41, P560, DOI 10.1016/j.jbiomech.2007.10.006; Drynda A, 2013, J BIOMED MATER RES A, V101, P33, DOI 10.1002/jbm.a.34300; Duan YH, 2012, ARCH MED SCI, V8, P199, DOI 10.5114/aoms.2012.28545; Ferguson SJ, 1996, MED ENG PHYS, V18, P241, DOI 10.1016/1350-4533(95)00041-0; FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689; Hirst LS, 2004, PHYS REV LETT, V93, P931; HOFMANN GO, 1995, ARCH ORTHOP TRAUM SU, V114, P123, DOI 10.1007/BF00443385; Huang D, 2011, J BIOMAT SCI-POLYM E, V22, P931, DOI 10.1163/092050610X496576; Jansen J, 2011, BIOMATERIALS, V32, P4994, DOI 10.1016/j.biomaterials.2011.03.062; Jie W, 2004, EUR POLYM J, V40, P509, DOI 10.1016/j.eurpolymj.2003.10.028; Kim HM, 2002, KEY ENG MATER, V218-2, P621, DOI 10.4028/www.scientific.net/KEM.218-220.621; Klein CPAT DA, 2004, J BIOMED MATER RES, V14, P769; KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306; Kunzler TP, 2007, BIOMATERIALS, V28, P5000, DOI 10.1016/j.biomaterials.2007.08.009; Lee WT, 2012, J BIOMED MATER RES B, V100B, P1044, DOI 10.1002/jbm.b.32669; Li JD, 2009, J MATER SCI-MATER M, V20, P1031, DOI 10.1007/s10856-008-3664-2; Li Y., 1994, J MATER SCI-MATER M, V5, P252, DOI DOI 10.1007/BF00122393); Liu QH, 2008, BIOMATERIALS, V29, P4792, DOI 10.1016/j.biomaterials.2008.08.039; Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0; Peng QM, 2012, J MECH BEHAV BIOMED, V10, P128, DOI 10.1016/j.jmbbm.2012.02.024; Polimeni G, 2008, CLIN IMPLANT DENT R, V10, P99, DOI 10.1111/j.1708-8208.2007.00067.x; Qu YL, 2010, INT J NANOMED, V5, P429; Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039; Uhthoff H K, 1973, J Bone Joint Surg Br, V55, P633; Wang HN, 2007, BIOMATERIALS, V28, P3338, DOI 10.1016/j.biomaterials.2007.04.014; Wang H, 2009, J POLYM SCI POL CHEM, V47, P658, DOI 10.1002/pola.23171; Wang JL, 2012, J BIOMED MATER RES B, V100B, P1691, DOI 10.1002/jbm.b.32707; Wang L, 2010, BIOMATERIALS, V31, P1691, DOI 10.1016/j.biomaterials.2009.11.053; Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049; Xu LP, 2009, BIOMATERIALS, V30, P1512, DOI 10.1016/j.biomaterials.2008.12.001	33	20	22	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68342	10.1371/journal.pone.0068342	http://dx.doi.org/10.1371/journal.pone.0068342			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861888	Green Submitted, Green Published, gold			2022-12-27	WOS:000321692000022
J	Gauthier, N; Wu, JW; Wang, SP; Allard, P; Mamer, OA; Sweetman, L; Moser, AB; Kratz, L; Alvarez, F; Robitaille, Y; Lepine, F; Mitchell, GA				Gauthier, Nicolas; Wu, Jiang Wei; Wang, Shu Pei; Allard, Pierre; Mamer, Orval A.; Sweetman, Lawrence; Moser, Ann B.; Kratz, Lisa; Alvarez, Fernando; Robitaille, Yves; Lepine, Francois; Mitchell, Grant A.			A Liver-Specific Defect of Acyl-CoA Degradation Produces Hyperammonemia, Hypoglycemia and a Distinct Hepatic Acyl-CoA Pattern	PLOS ONE			English	Article							COENZYME-A PROFILES; RAT-LIVER; LYASE HL; 3-HYDROXY-3-METHYLGLUTARYL-COA LYASE; PYRUVATE-CARBOXYLASE; DEFICIENT MICE; METABOLISM; QUANTIFICATION; SPECTROMETRY; INHIBITION	Most conditions detected by expanded newborn screening result from deficiency of one of the enzymes that degrade acyl-coenzyme A (CoA) esters in mitochondria. The role of acyl-CoAs in the pathophysiology of these disorders is poorly understood, in part because CoA esters are intracellular and samples are not generally available from human patients. We created a mouse model of one such condition, deficiency of 3-hydroxy-3-methylglutaryl-CoA lyase (HL), in liver (HLLKO mice). HL catalyses a reaction of ketone body synthesis and of leucine degradation. Chronic HL deficiency and acute crises each produced distinct abnormal liver acyl-CoA patterns, which would not be predictable from levels of urine organic acids and plasma acylcarnitines. In HLLKO hepatocytes, ketogenesis was undetectable. Carboxylation of [2-C-14] pyruvate diminished following incubation of HLLKO hepatocytes with the leucine metabolite 2-ketoisocaproate (KIC). HLLKO mice also had suppression of the normal hyperglycemic response to a systemic pyruvate load, a measure of gluconeogenesis. Hyperammonemia and hypoglycemia, cardinal features of many inborn errors of acyl-CoA metabolism, occurred spontaneously in some HLLKO mice and were inducible by administering KIC. KIC loading also increased levels of several leucine-related acyl-CoAs and reduced acetyl-CoA levels. Ultrastructurally, hepatocyte mitochondria of KIC-treated HLLKO mice show marked swelling. KIC-induced hyperammonemia improved following administration of carglumate (N-carbamyl-L-glutamic acid), which substitutes for the product of an acetyl-CoA-dependent reaction essential for urea cycle function, demonstrating an acyl-CoA-related mechanism for this complication.	[Gauthier, Nicolas; Wu, Jiang Wei; Wang, Shu Pei; Allard, Pierre; Alvarez, Fernando; Mitchell, Grant A.] Univ Montreal, CHU St Justine, Ctr Rech, Montreal, PQ, Canada; [Gauthier, Nicolas; Wu, Jiang Wei; Wang, Shu Pei; Allard, Pierre; Alvarez, Fernando; Mitchell, Grant A.] Univ Montreal, CHU St Justine, Dept Pediat, Montreal, PQ, Canada; [Robitaille, Yves] Univ Montreal, CHU St Justine, Dept Pathol, Montreal, PQ, Canada; [Gauthier, Nicolas; Mitchell, Grant A.] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada; [Mamer, Orval A.] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ, Canada; [Sweetman, Lawrence] Baylor Res Inst, Inst Metab Dis, Dallas, TX USA; [Moser, Ann B.; Kratz, Lisa] Johns Hopkins Sch Med, Kennedy Krieger Inst, Hugo W Moser Res Inst, Baltimore, MD USA; [Lepine, Francois] INRS Inst Armand Frappier, Laval, PQ, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; McGill University; Baylor Scott & White Health; Baylor University Medical Center; Johns Hopkins University; Johns Hopkins Medicine; Kennedy Krieger Institute; University of Quebec; Institut national de la recherche scientifique (INRS)	Mitchell, GA (corresponding author), Univ Montreal, CHU St Justine, Ctr Rech, Montreal, PQ, Canada.	grant.mitchell@recherche-ste-justine.qc.ca		alvarez, fernando/0000-0002-0534-5142	CIHR grant [178978]; Fondation Go bursary	CIHR grant(Canadian Institutes of Health Research (CIHR)); Fondation Go bursary	Funding was provided by CIHR grant 178978 to GM (cihr-irsc.gc.ca) and Fondation Go bursary to NG (lafondationgo.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHMARINA LI, 1994, J BIOL CHEM, V269, P31929; Barritt G. J., 1985, PYRUVATE CARBOXYLASE, P179; Chandler RJ, 2009, FASEB J, V23, P1252, DOI 10.1096/fj.08-121848; CORKEY BE, 1982, J BIOL CHEM, V257, P9668; CORKEY BE, 1990, PROG CLIN BIOL RES, V321, P217; CORKEY BE, 1988, J CLIN INVEST, V82, P782, DOI 10.1172/JCI113679; COUDE FX, 1979, J CLIN INVEST, V64, P1544, DOI 10.1172/JCI109614; DiMauro S, 2006, MITOCHONDRIAL MED; Fung C-H, 1971, THESIS CASE W RESERV; Gao L, 2007, J CHROMATOGR B, V853, P303, DOI 10.1016/j.jchromb.2007.03.029; Harris SR, 2011, J BIOL CHEM, V286, P5895, DOI 10.1074/jbc.M110.196808; Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709; KELLEHER JK, 1985, ANAL BIOCHEM, V151, P55, DOI 10.1016/0003-2697(85)90052-1; Levrat V, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-2; Lieu YK, 1997, AM J PHYSIOL-ENDOC M, V272, pE359, DOI 10.1152/ajpendo.1997.272.3.E359; Mack M, 2006, FEBS J, V273, P2012, DOI 10.1111/j.1742-4658.2006.05218.x; MARTINREQUERO A, 1983, J BIOL CHEM, V258, P3673; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Minkler PE, 2006, ANAL BIOCHEM, V352, P24, DOI 10.1016/j.ab.2006.02.015; MITCHELL GA, 1993, J BIOL CHEM, V268, P4376; Mitchell GA, 2001, METABOLIC MOL BASIS, P2327; Mitchell GA, 2008, MOL GENET METAB, V94, P4, DOI 10.1016/j.ymgme.2007.12.005; Palladino AA, 2012, MOL GENET METAB, V107, P679, DOI 10.1016/j.ymgme.2012.10.007; Puisac B, 2005, BIOPHYS CHEM, V115, P241, DOI 10.1016/j.bpc.2004.12.031; Roe C, 1989, METABOLIC BASIS INHE, P889; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Sweetman L., 2001, METABOLIC MOL BASES, P2125; THOMPSON GN, 1990, EUR J PEDIATR, V149, P346, DOI 10.1007/BF02171564; Wang SP, 1998, HUM MOL GENET, V7, P2057, DOI 10.1093/hmg/7.13.2057; WIMHURST JM, 1970, BIOCHEM J, V120, P79, DOI 10.1042/bj1200079; Zeczycki Tonya N, 2010, Open Enzym Inhib J, V3, P8; Zhang YM, 2007, CHEM BIOL, V14, P291, DOI 10.1016/j.chembiol.2007.01.013; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	33	64	65	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e60581	10.1371/journal.pone.0060581	http://dx.doi.org/10.1371/journal.pone.0060581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861731	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000321425300001
J	Li, YH; Guo, XH; Xue, Q; Zhu, M; Gao, L; Wang, Y				Li, Yanhua; Guo, Xinhong; Xue, Qiao; Zhu, Mei; Gao, Lei; Wang, Yu			Single Cell Gene Profiling Revealed Heterogeneity of Paracrine Effects of Bone Marrow Cells in Mouse Infarcted Hearts	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; HEMATOPOIETIC STEM-CELLS; ISCHEMIC-MYOCARDIUM; MONONUCLEAR-CELLS; CLINICAL-TRIAL; DOUBLE-BLIND; TRANSPLANTATION; REGENERATION; MECHANISMS; CYTOKINES	It is now recognized that transplantation of bone marrow cells (BMCs) into infarcted hearts has the capacity to improve the cardiac function through paracrine effects. However, detailed expression levels of paracrine factors in BMCs in infarcted hearts are poorly described. By use of laser capture microdissection combined with real-time PCR, we depicted the expression profiles of paracrine factors in infarcted hearts versus normal hearts. Consistent with the in vivo observation, a similar expression pattern was evidenced in cultured BMCs. Furthermore, BMCs displayed heterogeneity of paracrine effects in infarcted hearts as analyzed at the single cell level using single cell PCR. Interestingly, the CD45(+) subpopulation showed higher expression levels of angiogenic factors compared to other subpopulations. Finally, most angiogenic factors were induced under the microenvironment of infarction. Our study demonstrated the heterogeneity of paracrine effects in BMCs at single cell level in infarcted hearts, highlighting preferential expression of angiogenic factors in the CD45+ subpopulation. These findings broaden our understanding of paracrine effects of BMCs in vivo, and offer new insights into BMCs therapy in myocardial infarction (MI).	[Li, Yanhua; Guo, Xinhong; Xue, Qiao; Zhu, Mei; Gao, Lei; Wang, Yu] Chinese Peoples Liberat Army PLA, Gen Hosp, Inst Geriatr Cardiol, Beijing, Peoples R China		Wang, Y (corresponding author), Chinese Peoples Liberat Army PLA, Gen Hosp, Inst Geriatr Cardiol, Beijing, Peoples R China.	Wangyu301hospital@yahoo.cn			National High-Tech R&D Program of China (863 Program) [2006AA02Z469]	National High-Tech R&D Program of China (863 Program)	This work was supported by the National High-Tech R&D Program of China (863 Program, 2006AA02Z469). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Deb A, 2003, CIRCULATION, V107, P1247, DOI 10.1161/01.CIR.0000061910.39145.F0; Fuchs S, 2003, J AM COLL CARDIOL, V41, P1721, DOI 10.1016/S0735-1097(03)00328-0; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Hamano K, 2001, JPN CIRC J, V65, P845, DOI 10.1253/jcj.65.845; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Kamihata H, 2001, CIRCULATION, V104, P1046, DOI 10.1161/hc3501.093817; Kinnaird T, 2004, CIRC RES, V95, P354, DOI 10.1161/01.RES.0000137878.26174.66; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Ohnishi S, 2007, STEM CELLS, V25, P1166, DOI 10.1634/stemcells.2006-0347; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Ripa RS, 2006, CIRCULATION, V113, P1983, DOI 10.1161/CIRCULATIONAHA.105.610469; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Takahashi M, 2006, AM J PHYSIOL-HEART C, V291, pH886, DOI 10.1152/ajpheart.00142.2006; Tomita S, 1999, CIRCULATION, V100, P247, DOI 10.1161/01.cir.100.suppl_2.ii-247; Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Yoon YS, 2005, J CLIN INVEST, V115, P326, DOI 10.1172/JCI200522326	23	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68270	10.1371/journal.pone.0068270	http://dx.doi.org/10.1371/journal.pone.0068270			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861876	gold, Green Published, Green Submitted			2022-12-27	WOS:000321425300053
J	Stegeman, S; Jolly, LA; Premarathne, S; Gecz, J; Richards, LJ; Mackay-Sim, A; Wood, SA				Stegeman, Shane; Jolly, Lachlan A.; Premarathne, Susitha; Gecz, Jozef; Richards, Linda J.; Mackay-Sim, Alan; Wood, Stephen A.			Loss of Usp9x Disrupts Cortical Architecture, Hippocampal Development and TGF beta-Mediated Axonogenesis	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; FAM DEUBIQUITYLATING ENZYME; CELL-CELL JUNCTIONS; NEURAL STEM-CELLS; DEUBIQUITINATING ENZYME; TRANSFORMING GROWTH-FACTOR-BETA-1; PROTEIN TRAFFICKING; EXPRESSION ANALYSIS; NERVOUS-SYSTEM; LIQUID FACETS	The deubiquitylating enzyme Usp9x is highly expressed in the developing mouse brain, and increased Usp9x expression enhances the self-renewal of neural progenitors in vitro. USP9X is a candidate gene for human neurodevelopmental disorders, including lissencephaly, epilepsy and X-linked intellectual disability. To determine if Usp9x is critical to mammalian brain development we conditionally deleted the gene from neural progenitors, and their subsequent progeny. Mating Usp9x(loxP/loxP) mice with mice expressing Cre recombinase from the Nestin promoter deleted Usp9x throughout the entire brain, and resulted in early postnatal lethality. Although the overall brain architecture was intact, loss of Usp9x disrupted the cellular organization of the ventricular and sub-ventricular zones, and cortical plate. Usp9x absence also led to dramatic reductions in axonal length, in vivo and in vitro, which could in part be explained by a failure in Tgf-beta signaling. Deletion of Usp9x from the dorsal telencephalon only, by mating with Emx1-cre mice, was compatible with survival to adulthood but resulted in reduction or loss of the corpus callosum, a dramatic decrease in hippocampal size, and disorganization of the hippocampal CA3 region. This latter phenotypic aspect resembled that observed in Doublecortin knock-out mice, which is an Usp9x interacting protein. This study establishes that Usp9x is critical for several aspects of CNS development, and suggests that its regulation of Tgf-beta signaling extends to neurons.	[Stegeman, Shane; Premarathne, Susitha; Mackay-Sim, Alan; Wood, Stephen A.] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Brisbane, Qld 4111, Australia; [Jolly, Lachlan A.; Gecz, Jozef] South Australian Pathol Womens & Childrens Hosp, Neurogenet Res Program, Adelaide, SA, Australia; [Jolly, Lachlan A.; Gecz, Jozef] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia; [Richards, Linda J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Richards, Linda J.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia	Griffith University; University of Adelaide; University of Queensland; University of Queensland	Wood, SA (corresponding author), Griffith Univ, Eskitis Inst Cell & Mol Therapies, Brisbane, Qld 4111, Australia.	s.wood@griffith.edu.au	Gecz, Jozef/X-3469-2019; Wood, Stephen A/E-8357-2011; Mackay-Sim, Alan/C-3431-2008; Jolly, Lachlan/B-5892-2015; Richards AO, Linda/P-6372-2014	Gecz, Jozef/0000-0002-7884-6861; Wood, Stephen A/0000-0002-2576-7457; Mackay-Sim, Alan/0000-0003-4446-5371; Jolly, Lachlan/0000-0003-4538-2658; Richards AO, Linda/0000-0002-7590-7390; Premarathne, Susitha/0000-0003-0018-5554	National Health and Medical Research Council of Australia [APP1009248, APP628952, APP250340]; Women's and Children's Hospital Foundation; Australian Government Department of Health and Ageing	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Women's and Children's Hospital Foundation; Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	This work was supported by a grant from the National Health and Medical Research Council of Australia APP1009248 to SAW, APP628952 and APP250340 to JG, a grant from the Women's and Children's Hospital Foundation to LAJ, and a grant to AMS from the Australian Government Department of Health and Ageing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KM, 2005, ESSAYS BIOCHEM, V41, P49, DOI 10.1042/EB0410049; Brault V, 2001, DEVELOPMENT, V128, P1253; Brown GM, 1998, HUM MOL GENET, V7, P97, DOI 10.1093/hmg/7.1.97; Caronia G, 2010, J NEUROSCI, V30, P6291, DOI 10.1523/JNEUROSCI.0550-10.2010; Chastagner P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002735; Chen X, 2002, GENE DEV, V16, P289, DOI 10.1101/gad.961502; Cheng PL, 2011, P NATL ACAD SCI USA, V108, P18430, DOI 10.1073/pnas.1115907108; Choe EA, 2007, J NEUROSCI, V27, P9503, DOI 10.1523/JNEUROSCI.1408-07.2007; Corbett MA, 2010, AM J HUM GENET, V87, P371, DOI 10.1016/j.ajhg.2010.08.001; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Dupont S, 2012, FEBS LETT, V586, P1913, DOI 10.1016/j.febslet.2012.03.037; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Dwyer ND, 2010, CELL, V142, P21, DOI 10.1016/j.cell.2010.06.024; FISCHERVIZE JA, 1992, DEVELOPMENT, V116, P985; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Friocourt G, 2005, MOL CELL NEUROSCI, V28, P153, DOI 10.1016/j.mcn.2004.09.005; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Ikeda W, 1999, J CELL BIOL, V146, P1117, DOI 10.1083/jcb.146.5.1117; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Isaka F, 1999, EUR J NEUROSCI, V11, P2582, DOI 10.1046/j.1460-9568.1999.00699.x; ISHIHARA A, 1994, BRAIN RES, V639, P21, DOI 10.1016/0006-8993(94)91759-0; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; Jolly LA, 2009, MOL BIOL CELL, V10, P1091; Jones MH, 1996, HUM MOL GENET, V5, P1695, DOI 10.1093/hmg/5.11.1695; Katz EJ, 2010, BIOCHEM SOC T, V38, P21, DOI 10.1042/BST0380021; Ke YH, 2007, MOL CELL BIOL, V27, P6706, DOI 10.1128/MCB.01225-07; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Lee SMK, 2000, DEVELOPMENT, V127, P457; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Lim KL, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S13; Machon O, 2003, NEUROSCIENCE, V122, P129, DOI 10.1016/S0306-4522(03)00519-0; Millard SM, 2006, J CELL BIOL, V173, P463, DOI 10.1083/jcb.200602082; Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016; Mouchantaf R, 2006, J BIOL CHEM, V281, P38738, DOI 10.1074/jbc.M605959200; Murray RZ, 2004, MOL BIOL CELL, V15, P1591, DOI 10.1091/mbc.E03-08-0630; Oddo S, 2008, J CELL MOL MED, V12, P363, DOI 10.1111/j.1582-4934.2008.00276.x; Overstreet E, 2004, DEVELOPMENT, V131, P5355, DOI 10.1242/dev.01434; Pantaleon M, 2001, MECH DEVELOP, V109, P151, DOI 10.1016/S0925-4773(01)00551-2; Pasinetti GM, 2001, J NEUROSCI RES, V65, P471, DOI 10.1002/jnr.1176; Perez-Mancera PA, 2012, NATURE, V486, P266, DOI 10.1038/nature11114; Piper M, 2010, J NEUROSCI, V30, P9127, DOI 10.1523/JNEUROSCI.6167-09.2010; Pramparo T, 2010, J NEUROSCI, V30, P3002, DOI 10.1523/JNEUROSCI.4851-09.2010; Qiu L, 2000, J BIOL CHEM, V275, P35734, DOI 10.1074/jbc.M007300200; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rogers N, 2010, NEUROPATH APPL NEURO, V36, P113, DOI [10.1111/j.1365-2990.2009.01063.x, 10.1111/j.1365-2990.2010.01063.x]; Rott R, 2011, P NATL ACAD SCI USA, V108, P18666, DOI 10.1073/pnas.1105725108; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Sometani A, 2001, J NEUROSCI RES, V66, P369, DOI 10.1002/jnr.1229; Staropoli JF, 2005, J MOL NEUROSCI, V27, P175, DOI 10.1385/JMN:27:2:175; Stinchfield MJ, 2012, DEVELOPMENT, V139, P2721, DOI 10.1242/dev.077206; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Taya S, 1999, GENES CELLS, V4, P757, DOI 10.1046/j.1365-2443.1999.00297.x; Taya S, 1998, J CELL BIOL, V142, P1053, DOI 10.1083/jcb.142.4.1053; Theard D, 2010, EMBO J, V29, P1499, DOI 10.1038/emboj.2010.46; Todi SV, 2011, TRENDS NEUROSCI, V34, P370, DOI 10.1016/j.tins.2011.05.004; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tuoc TC, 2010, CELL CYCLE, V9, P3174, DOI 10.4161/cc.9.16.12551; Vogel T, 2010, CEREB CORTEX, V20, P661, DOI 10.1093/cercor/bhp134; Wood SA, 1997, MECH DEVELOP, V63, P29, DOI 10.1016/S0925-4773(97)00672-2; Xu J, 2005, J NEUROSCI RES, V80, P47, DOI 10.1002/jnr.20429; Xu ZJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009725; Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4; Zhadanov AB, 1999, CURR BIOL, V9, P880, DOI 10.1016/S0960-9822(99)80392-3; Zhou YX, 2003, J BIOL CHEM, V278, P42313, DOI 10.1074/jbc.M308287200	69	54	55	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68287	10.1371/journal.pone.0068287	http://dx.doi.org/10.1371/journal.pone.0068287			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861879	Green Published, Green Submitted, gold			2022-12-27	WOS:000321425300055
J	Wang, L; Deng, F; Ren, WJ; Yang, WY				Wang, Li; Deng, Fei; Ren, Wan-Jun; Yang, Wen-Yu			Effects of Shading on Starch Pasting Characteristics of Indica Hybrid Rice (Oryza sativa L.)	PLOS ONE			English	Article							PHOTOSYNTHETIC CAPACITY; AMYLOSE CONTENT; VISCOSITY; CULTIVARS; RESPONSES; RVA	Rice is an important staple crop throughout the world, but environmental stress like low-light conditions can negatively impact crop yield and quality. Using pot experiments and field experiments, we studied the effects of shading on starch pasting viscosity and starch content with six rice varieties for three years, using the Rapid Visco Analyser to measure starch pasting viscosity. Shading at different growth stages and in different rice varieties all affected the starch pasting characteristics of rice. The effects of shading on starch pasting viscosity at middle and later growth stages were greater than those at earlier stages. Shading enhanced breakdown but reduced hold viscosity and setback at tillering-elongation stage. Most pasting parameters changed significantly with shading after elongation stage. Furthermore, the responses of different varieties to shading differed markedly. The change scope of starch pasting viscosity in Dexiang 4103 was rather small after heading, while that in IIyou 498 and Gangyou 906 was small before heading. We observed clear tendencies in peak viscosity, breakdown, and pasting temperature of the five rice varieties with shading in 2010 and 2011. Correlation analysis indicated that the rice amylose content was negatively correlated with breakdown, but was positively correlated with setback. Based on our results, IIyou 498, Gangyou 906, and Dexiang 4103 had higher shade endurance, making these varieties most suitable for high-quality rice cultivation in low-light regions.	[Wang, Li; Deng, Fei; Ren, Wan-Jun; Yang, Wen-Yu] Sichuan Agr Univ, Minist Agr, Key Lab Crop Ecophysiol & Farming Syst Southwest, Chengdu, Peoples R China	Ministry of Agriculture & Rural Affairs; Sichuan Agricultural University	Ren, WJ (corresponding author), Sichuan Agr Univ, Minist Agr, Key Lab Crop Ecophysiol & Farming Syst Southwest, Chengdu, Peoples R China.	rwjun@126.com	Deng, Fei/GQP-1228-2022; Zhou, Yu/HHN-3071-2022	yang, wenyu/0000-0001-5885-3450; Deng, Fei/0000-0003-3996-9698	Ministry of Science and Technology of the People's Republic of China [2006BAD02A05, 2011BAD16B05-04, 2012BAD04B13-2]; Science and Technology Department of Sichuan Province [2011YZGG-24]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Science and Technology Department of Sichuan Province	This study was partially supported by the Ministry of Science and Technology of the People's Republic of China, http://www.most.gov.cn/ (2006BAD02A05, 2011BAD16B05-04 and 2012BAD04B13-2) and the Science and Technology Department of Sichuan Province, http://www.scst.gov.cn/info/(2011YZGG-24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AACC, 2000, DET PAST PROP RIC RA; Bao Jin-Song, 2006, Acta Genetica Sinica, V33, P1007, DOI 10.1016/S0379-4172(06)60136-4; Bao JS, 2004, J AGR FOOD CHEM, V52, P6010, DOI 10.1021/jf049234i; Cai KunZheng, 1999, Chinese Journal of Applied Ecology, V10, P193; Chaturvedi G. S., 1989, Philippine Journal of Crop Science, V14, P61; [邓飞 DENG Fei], 2009, [四川农业大学学报, Journal of Sichuan Agricultural University], V27, P265; Franklin KA, 2005, ANN BOT-LONDON, V96, P169, DOI 10.1093/aob/mci165; Gregoriou K, 2007, PHOTOSYNTHETICA, V45, P172, DOI 10.1007/s11099-007-0029-x; Hawksworth D, 1985, RICE DIS; Huang WX, 1998, AGR NATURAL RESOURCE, P157; Huylenbroeck J. M. van, 2001, International Turfgrass Society Research Journal, V9, P353; JARVIS CE, 1993, J SCI FOOD AGR, V63, P53, DOI 10.1002/jsfa.2740630109; Jiang D, 2009, J AGRON CROP SCI, V195, P89, DOI 10.1111/j.1439-037X.2008.00353.x; Jiao DM, 2001, PHOTOSYNTHETICA, V39, P167, DOI 10.1023/A:1013758504857; Jin L, 2010, J CEREAL SCI, V51, P159, DOI 10.1016/j.jcs.2009.11.007; Li Tian, 2006, Rice Science, V13, P51; Liu Qi-hua, 2009, Yingyong Shengtai Xuebao, V20, P2135; McGrance SJ, 1998, STARCH-STARKE, V50, P158, DOI 10.1002/(SICI)1521-379X(199804)50:4<158::AID-STAR158>3.0.CO;2-7; Singh N, 2006, FOOD HYDROCOLLOID, V20, P532, DOI 10.1016/j.foodhyd.2005.05.003; Steel R. G. D., 1980, Principles and procedures of statistics, a biometrical approach.; Thangaraj M., 1990, Madras Agricultural Journal, V77, P220; VENKATESWARLU B, 1977, PLANT SOIL, V46, P713, DOI 10.1007/BF00015937; Viji MM, 1997, J AGRON CROP SCI, V178, P193, DOI 10.1111/j.1439-037X.1997.tb00490.x; Wan XiangYuan, 2004, Acta Agronomica Sinica, V30, P1185; Wang H, 2007, SCI HORTIC-AMSTERDAM, V112, P66, DOI 10.1016/j.scienta.2006.12.007; Wang XQ, 2010, AGR SCI CHINA, V9, P1101, DOI 10.1016/S1671-2927(09)60196-6; Yan CJ, 2011, THEOR APPL GENET, V122, P63, DOI 10.1007/s00122-010-1423-5; Yao YL, 2000, SOIL SCI PLANT NUTR, V46, P631, DOI 10.1080/00380768.2000.10409128; Zaidul ISM, 2007, FOOD CHEM, V102, P1105, DOI 10.1016/j.foodchem.2006.06.056; Zhu DF, 2000, BRIDGING RICE YIELD, P69	30	38	39	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68220	10.1371/journal.pone.0068220	http://dx.doi.org/10.1371/journal.pone.0068220			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861872	gold, Green Published, Green Submitted			2022-12-27	WOS:000321425300051
J	Yoon, YJ; Chang, S; Kim, OY; Kang, BK; Park, J; Lim, JH; Huang, JY; Kim, YK; Byun, JH; Gho, YS				Yoon, Yae Jin; Chang, Soeun; Kim, Oh Youn; Kang, Bo-Kyeong; Park, Jaesung; Lim, Jae-Hong; Huang, Jung Yun; Kim, Yoon-Keun; Byun, Jae Ho; Gho, Yong Song			Three-Dimensional Imaging of Hepatic Sinusoids in Mice Using Synchrotron Radiation Micro-Computed Tomography	PLOS ONE			English	Article							MICROCOMPUTED TOMOGRAPHY; LIVER-REGENERATION; CIRRHOSIS; RAT; MICROCIRCULATION; RECONSTRUCTION; ARTERY; MOUSE; MODEL	Hepatic sinusoid, the smallest vessel in the liver, plays important roles in hepatic microcirculation. Although the structure of the hepatic sinusoids affects diverse functions of the liver, little is known about morphological alterations in the sinusoids under pathological conditions. In this study, we show that the structure of hepatic sinusoids can be identified three-dimensionally in normal and carbon tetrachloride-injured mouse liver, using the absorption mode of synchrotron radiation micro-computed tomography. We observed that the hepatic sinusoidal structure on tomographic slice images was similar to that on histological images of normal and acutely injured mice. Moreover, centrilobular necrosis and structural alterations of the sinusoids in the necrotic region were detectable on tomographic slice and volume-rendered images of the acutely injured mice. Furthermore, quantitative analyses on 3D volume-rendered images of the injured sinusoid revealed decrease in the volume of the sinusoid and connectivity of the sinusoidal network. Our results suggest that the use of synchrotron radiation micro-computed tomography may improve our understanding of the pathogenesis of hepatic diseases by detecting the hepatic sinusoids and their alterations in three-dimensional structures of the damaged liver.	[Yoon, Yae Jin] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang, South Korea; [Chang, Soeun] Pohang Univ Sci & Technol, Dept Mat Sci & Engn, Pohang, South Korea; [Kim, Oh Youn; Kim, Yoon-Keun; Gho, Yong Song] Pohang Univ Sci & Technol, Dept Life Sci, Pohang, South Korea; [Kang, Bo-Kyeong; Byun, Jae Ho] Univ Ulsan, Asan Med Ctr, Coll Med, Dept Radiol, Seoul, South Korea; [Kang, Bo-Kyeong; Byun, Jae Ho] Univ Ulsan, Asan Med Ctr, Coll Med, Res Inst Radiol, Seoul, South Korea; [Park, Jaesung] Pohang Univ Sci & Technol, Dept Mech Engn, Pohang, South Korea; [Lim, Jae-Hong; Huang, Jung Yun] Pohang Univ Sci & Technol, Pohang Accelerator Lab, Pohang, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Gho, YS (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Pohang, South Korea.	ysgho@postech.ac.kr			National Research Foundation of Korea (NRF); Korea government (MEST) [20120005634, A120273]; Ministry of Health and Welfare	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 20120005634) and by the Ministry of Health and Welfare grant funded by the Korea government (MEST) (No. A120273). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley MD, 2002, AM J PHYSIOL-REG I, V282, pR1267, DOI 10.1152/ajpregu.00560.2001; Bentley MD, 2007, ANAT REC, V290, P277, DOI 10.1002/ar.20422; Braet Filip, 2002, Comp Hepatol, V1, P1, DOI 10.1186/1476-5926-1-1; Cao AH, 2005, PHYTOTHER RES, V19, P932, DOI 10.1002/ptr.1757; Den Buijs JO, 2006, ANN BIOMED ENG, V34, P1420, DOI 10.1007/s10439-006-9150-4; Donthamsetty S, 2007, HEPATOLOGY, V45, P391, DOI 10.1002/hep.21530; Duan JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053507; FRASER R, 1995, HEPATOLOGY, V21, P863, DOI 10.1016/0270-9139(95)90542-1; Heinzer S, 2006, NEUROIMAGE, V32, P626, DOI 10.1016/j.neuroimage.2006.03.043; Hoehme S, 2010, P NATL ACAD SCI USA, V107, P10371, DOI 10.1073/pnas.0909374107; Hwu Y, 2004, BIOPHYS J, V87, P4180, DOI 10.1529/biophysj.103.034991; Iredale JP, 2003, BMJ-BRIT MED J, V327, P143, DOI 10.1136/bmj.327.7407.143; Kim JW, 2007, INT J CARDIOL, V114, P166, DOI 10.1016/j.ijcard.2005.12.010; MARTINEZCALVA I, 1984, J APPL TOXICOL, V4, P270, DOI 10.1002/jat.2550040513; Masyuk TV, 2004, AM J PATHOL, V165, P1719, DOI 10.1016/S0002-9440(10)63427-X; Masyuk TV, 2003, AM J PATHOL, V162, P1175, DOI 10.1016/S0002-9440(10)63913-2; Meuli R, 2004, EUR RADIOL, V14, P1550, DOI 10.1007/s00330-004-2361-x; Momose A, 2000, RADIOLOGY, V217, P593, DOI 10.1148/radiology.217.2.r00oc14593; Oda M, 2003, CLIN HEMORHEOL MICRO, V29, P167; Oinonen T, 1998, BIOCHEM J, V329, P17, DOI 10.1042/bj3290017; Onori P, 2000, J HEPATOL, V33, P555, DOI 10.1034/j.1600-0641.2000.033004555.x; Plouraboue F, 2004, J MICROSC-OXFORD, V215, P139, DOI 10.1111/j.0022-2720.2004.01362.x; Rappaport A M, 1966, Rev Int Hepatol, V16, P813; Sarin H, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-14; Simeonova PP, 2001, TOXICOL APPL PHARM, V177, P112, DOI 10.1006/taap.2001.9304; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Teutsch HF, 2005, HEPATOLOGY, V42, P317, DOI 10.1002/hep.20764; Teutsch HF, 1999, HEPATOLOGY, V29, P494, DOI 10.1002/hep.510290243; Vanheule E, 2008, LIVER INT, V28, P107, DOI 10.1111/j.1478-3231.2007.01629.x; Vollmar B, 2009, PHYSIOL REV, V89, P1269, DOI 10.1152/physrev.00027.2008; Weston Anne E, 2009, J Chem Biol, V3, P101, DOI 10.1007/s12154-009-0033-7; Yoneyama H, 2007, MED MOL MORPHOL, V40, P191, DOI 10.1007/s00795-007-0371-x; Zhu XY, 2007, AM J PHYSIOL-HEART C, V293, pH1997, DOI 10.1152/ajpheart.00362.2007	33	21	21	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68600	10.1371/journal.pone.0068600	http://dx.doi.org/10.1371/journal.pone.0068600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861925	Green Published, Green Submitted, gold			2022-12-27	WOS:000321425300074
J	Dunne, KA; Allam, A; McIntosh, A; Houston, SA; Cerovic, V; Goodyear, CS; Roe, AJ; Beatson, SA; Milling, SW; Walker, D; Wall, DM				Dunne, Karl A.; Allam, Amr; McIntosh, Anne; Houston, Stephanie A.; Cerovic, Vuk; Goodyear, Carl S.; Roe, Andrew J.; Beatson, Scott A.; Milling, Simon W.; Walker, Daniel; Wall, Daniel M.			Increased S-Nitrosylation and Proteasomal Degradation of Caspase-3 during Infection Contribute to the Persistence of Adherent Invasive Escherichia coli (AIEC) in Immune Cells	PLOS ONE			English	Article							DENDRITIC CELL; CROHNS-DISEASE; ILEAL MUCOSA; UBIQUITIN LIGASE; STRAIN LF82; E.-COLI; SALMONELLA; APOPTOSIS; TYPHIMURIUM; INFLAMMATION	Adherent invasive Escherichia coli (AIEC) have been implicated as a causative agent of Crohn's disease (CD) due to their isolation from the intestines of CD sufferers and their ability to persist in macrophages inducing granulomas. The rapid intracellular multiplication of AIEC sets it apart from other enteric pathogens such as Salmonella Typhimurium which after limited replication induce programmed cell death (PCD). Understanding the response of infected cells to the increased AIEC bacterial load and associated metabolic stress may offer insights into AIEC pathogenesis and its association with CD. Here we show that AIEC persistence within macrophages and dendritic cells is facilitated by increased proteasomal degradation of caspase-3. In addition S-nitrosylation of pro- and active forms of caspase-3, which can inhibit the enzymes activity, is increased in AIEC infected macrophages. This S-nitrosylated caspase-3 was seen to accumulate upon inhibition of the proteasome indicating an additional role for S-nitrosylation in inducing caspase-3 degradation in a manner independent of ubiquitination. In addition to the autophagic genetic defects that are linked to CD, this delay in apoptosis mediated in AIEC infected cells through increased degradation of caspase-3, may be an essential factor in its prolonged persistence in CD patients.	[Dunne, Karl A.; Allam, Amr; McIntosh, Anne; Houston, Stephanie A.; Cerovic, Vuk; Goodyear, Carl S.; Roe, Andrew J.; Milling, Simon W.; Walker, Daniel; Wall, Daniel M.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Beatson, Scott A.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [Beatson, Scott A.] Univ Queensland, Australian Infect Dis Res Ctr, St Lucia, Qld, Australia	University of Glasgow; University of Queensland; University of Queensland	Wall, DM (corresponding author), Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.	donal.wall@glasgow.ac.uk	Beatson, Scott/B-6985-2013	Beatson, Scott/0000-0002-1806-3283; roe, andrew/0000-0003-3698-6134; Walker, Daniel/0000-0002-4206-2942; Allam, Amr/0000-0002-8743-3639; Goodyear, Carl/0000-0001-5926-5941	Tenovus-Scotland Pump-priming award; BBSRC - Biotechnology and Biological Sciences Research Council [BB/K008005/1]; BBSRC [BB/K008005/1] Funding Source: UKRI; MRC [MR/K021095/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K008005/1] Funding Source: researchfish; Medical Research Council [MR/K021095/1] Funding Source: researchfish	Tenovus-Scotland Pump-priming award; BBSRC - Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Tenovus-Scotland Pump-priming award (http://www.tenovus-scotland.org.uk/) and by the BBSRC - Biotechnology and Biological Sciences Research Council Grant number BB/K008005/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMANO F, 1995, FEBS LETT, V368, P425, DOI 10.1016/0014-5793(95)00700-J; Angot A, 2007, PLOS PATHOG, V3, P1, DOI 10.1371/journal.ppat.0030003; Ashare A, 2007, J IMMUNOL, V179, P505, DOI 10.4049/jimmunol.179.1.505; Baumgart DC, 2005, GUT, V54, P228, DOI 10.1136/gut.2004.040360; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; Boudeau J, 1999, INFECT IMMUN, V67, P4499, DOI 10.1128/IAI.67.9.4499-4509.1999; Bringer MA, 2006, CELL MICROBIOL, V8, P471, DOI 10.1111/j.1462-5822.2005.00639.x; Bueno SM, 2012, IMMUNOLOGY, V137, P28, DOI 10.1111/j.1365-2567.2012.03614.x; Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; Chen M, 2007, BLOOD, V109, P4360, DOI 10.1182/blood-2006-11-056424; Choi YE, 2009, J BIOL CHEM, V284, P12772, DOI 10.1074/jbc.M807550200; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Cooper KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022260; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Forsberg M, 2003, J LEUKOCYTE BIOL, V74, P620, DOI 10.1189/jlb.1202586; Glasser AL, 2001, INFECT IMMUN, V69, P5529, DOI 10.1128/IAI.69.9.5529-5537.2001; Grant AJ, 2008, IMMUNOLOGY, V125, P28, DOI 10.1111/j.1365-2567.2008.02814.x; Gusarov I, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003181; Hicks SW, 2010, CURR OPIN MICROBIOL, V13, P41, DOI 10.1016/j.mib.2009.11.008; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hwang J, 2011, BBA-REV CANCER, V1816, P147, DOI 10.1016/j.bbcan.2011.05.005; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Jiang ZL, 2009, WOUND REPAIR REGEN, V17, P224, DOI 10.1111/j.1524-475X.2009.00459.x; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Kint CI, 2012, TRENDS MICROBIOL, V20, P577, DOI 10.1016/j.tim.2012.08.009; Lai YC, 2011, CIRC RES, V109, P1375, DOI 10.1161/CIRCRESAHA.111.256479; Lee CM, 2008, J BIOL CHEM, V283, P889, DOI 10.1074/jbc.M708821200; Li JR, 1997, BIOCHEM BIOPH RES CO, V240, P419, DOI 10.1006/bbrc.1997.7672; Lin DYW, 2011, J BIOL CHEM, V286, P441, DOI 10.1074/jbc.M110.167643; LIU LM, 1995, ADV EXP MED BIOL, V371, P271; Maejima Y, 2005, J MOL CELL CARDIOL, V38, P163, DOI 10.1016/j.yjmcc.2004.10.012; MANNICK JB, 1994, CELL, V79, P1137, DOI 10.1016/0092-8674(94)90005-1; Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054; Martinez-Medina M, 2009, J CLIN MICROBIOL, V47, P3968, DOI 10.1128/JCM.01484-09; Miquel S, 2010, PLOS ONE, P5; Mitchell DA, 2005, NAT CHEM BIOL, V1, P154, DOI 10.1038/nchembio720; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Nakamura T, 2010, MOL CELL, V39, P184, DOI 10.1016/j.molcel.2010.07.002; Raso T, 2011, CURR MICROBIOL, V63, P131, DOI 10.1007/s00284-011-9947-8; Rolhion N, 2005, J BACTERIOL, V187, P2286, DOI 10.1128/JB.187.7.2286-2296.2005; Rossig L, 1999, J BIOL CHEM, V274, P6823, DOI 10.1074/jbc.274.11.6823; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sasaki M, 2007, LAB INVEST, V87, P1042, DOI 10.1038/labinvest.3700661; Savidge TC, 2011, NAT MED, V17, P1136, DOI 10.1038/nm.2405; Seth D, 2012, SCIENCE, V336, P470, DOI 10.1126/science.1215643; Song M, 2013, MOL MICROBIOL, V87, P609, DOI 10.1111/mmi.12119; Soundararajan V, 2011, INNATE IMMUN-LONDON, V17, P548, DOI 10.1177/1753425910377099; Srikanth CV, 2010, SCIENCE, V330, P390, DOI 10.1126/science.1194598; Stagg AJ, 2003, GUT, V52, P1522, DOI 10.1136/gut.52.10.1522; Tan MJ, 2006, NEOPLASIA, V8, P1042, DOI 10.1593/neo.06568; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Wall DM, 2007, CELL MICROBIOL, V9, P2299, DOI 10.1111/j.1462-5822.2007.00960.x; Wine E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-180; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; Zeigler MM, 2003, J BIOL CHEM, V278, P12894, DOI 10.1074/jbc.M213125200; Zhang Y, 2006, MOL MICROBIOL, V62, P786, DOI 10.1111/j.1365-2958.2006.05407.x	62	23	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68386	10.1371/journal.pone.0068386	http://dx.doi.org/10.1371/journal.pone.0068386			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861899	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000323350700084
J	Babbs, CF; Shi, RY				Babbs, Charles F.; Shi, Riyi			Subtle Paranodal Injury Slows Impulse Conduction in a Mathematical Model of Myelinated Axons	PLOS ONE			English	Article							MAMMALIAN SPINAL-CORD; POTASSIUM CHANNELS; NERVE-FIBERS; ACTION-POTENTIALS; IONIC CURRENTS; COMPRESSION; AFTERPOTENTIALS; DEMYELINATION; SIMULATIONS; COMPUTATION	This study explores in detail the functional consequences of subtle retraction and detachment of myelin around the nodes of Ranvier following mild-to-moderate crush or stretch mediated injury. An equivalent electrical circuit model for a series of equally spaced nodes of Ranvier was created incorporating extracellular and axonal resistances, paranodal resistances, nodal capacitances, time varying sodium and potassium currents, and realistic resting and threshold membrane potentials in a myelinated axon segment of 21 successive nodes. Differential equations describing membrane potentials at each nodal region were solved numerically. Subtle injury was simulated by increasing the width of exposed nodal membrane in nodes 8 through 20 of the model. Such injury diminishes action potential amplitude and slows conduction velocity from 19.1 m/sec in the normal region to 7.8 m/sec in the crushed region. Detachment of paranodal myelin, exposing juxtaparanodal potassium channels, decreases conduction velocity further to 6.6 m/sec, an effect that is partially reversible with potassium ion channel blockade. Conduction velocity decreases as node width increases or as paranodal resistance falls. The calculated changes in conduction velocity with subtle paranodal injury agree with experimental observations. Nodes of Ranvier are highly effective but somewhat fragile devices for increasing nerve conduction velocity and decreasing reaction time in vertebrate animals. Their fundamental design limitation is that even small mechanical retractions of myelin from very narrow nodes or slight loosening of paranodal myelin, which are difficult to notice at the light microscopic level of observation, can cause large changes in myelinated nerve conduction velocity.	[Babbs, Charles F.] Purdue Univ, Dept Basic Med Sci, Ctr Paralysis Res, W Lafayette, IN 47907 USA; Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Babbs, CF (corresponding author), Purdue Univ, Dept Basic Med Sci, Ctr Paralysis Res, W Lafayette, IN 47907 USA.	babbs@purdue.edu						Babbs CF, 1999, CIRCULATION, V100, P2146, DOI 10.1161/01.CIR.100.21.2146; BASSER PJ, 1993, MED BIOL ENG COMPUT, V31, pS87, DOI 10.1007/BF02446655; BLIGHT AR, 1985, NEUROSCIENCE, V15, P13, DOI 10.1016/0306-4522(85)90119-8; Boron W.F., 2005, MED PHYSL; Brophy JJ, 1966, BASIC ELECT SCI; CHIU SY, 1981, J PHYSIOL-LONDON, V313, P415, DOI 10.1113/jphysiol.1981.sp013674; Crawford DK, 2009, NEUROSCIENCE, V164, P1407, DOI 10.1016/j.neuroscience.2009.09.069; Di Fiori MSH, 1981, ATLAS HUMAN HISTOLOG; ffrench-Constant C, 2004, SCIENCE, V304, P688, DOI 10.1126/science.1097851; FITZHUGH R, 1962, BIOPHYS J, V2, P11, DOI 10.1016/S0006-3495(62)86837-4; Fu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006705; Geddes L. A., 1975, PRINCIPLES APPL BIOM; Giuliodori MJ, 2004, ADV PHYSIOL EDUC, V28, P80, DOI 10.1152/advan.00045.2003; GOLDMAN L, 1968, BIOPHYS J, V8, P596, DOI 10.1016/S0006-3495(68)86510-5; Hartline DK, 2007, CURR BIOL, V17, pR29, DOI 10.1016/j.cub.2006.11.042; Horresh I, 2008, J NEUROSCI, V28, P14213, DOI 10.1523/JNEUROSCI.3398-08.2008; Lovas G, 2000, BRAIN, V123, P308, DOI 10.1093/brain/123.2.308; McDonald JW, 2006, J NEUROTRAUM, V23, P345, DOI 10.1089/neu.2006.23.345; McIntyre CC, 2002, J NEUROPHYSIOL, V87, P995, DOI 10.1152/jn.00353.2001; MCNEAL DR, 1976, IEEE T BIO-MED ENG, V23, P329, DOI 10.1109/TBME.1976.324593; MOORE JW, 1978, BIOPHYS J, V21, P147, DOI 10.1016/S0006-3495(78)85515-5; Nashmi R, 2001, BRAIN RES REV, V38, P165, DOI 10.1016/S0165-0173(01)00134-5; Nygren A, 1999, J THEOR BIOL, V199, P329, DOI 10.1006/jtbi.1999.0962; Ong HH, 2010, NEUROIMAGE, V51, P1360, DOI 10.1016/j.neuroimage.2010.03.063; Ouyang H, 2010, J NEUROTRAUM, V27, P1109, DOI 10.1089/neu.2010.1271; ROPER J, 1989, J PHYSIOL-LONDON, V416, P93; Shi R, 2002, NEUROSCIENCE, V110, P765, DOI 10.1016/S0306-4522(01)00596-6; Shi R, 1996, J NEUROPHYSIOL, V76, P1572, DOI 10.1152/jn.1996.76.3.1572; Shi RY, 2011, NEUROSCI BULL, V27, P36, DOI 10.1007/s12264-011-1048-y; Shi YZ, 2011, J NEUROCHEM, V117, P554, DOI 10.1111/j.1471-4159.2011.07226.x; SHRAGER P, 1987, J PHYSIOL-LONDON, V392, P587, DOI 10.1113/jphysiol.1987.sp016798; STEPHANOVA DI, 1995, BIOL CYBERN, V73, P275, DOI 10.1007/BF00201429; Stephanova DI, 1997, BIOL CYBERN, V76, P311, DOI 10.1007/s004220050342; Sun W, 2012, J NEUROTRAUM, V29, P1; Sun WJ, 2010, J NEUROPHYSIOL, V103, P469, DOI 10.1152/jn.00154.2009; WAXMAN SG, 1985, SCIENCE, V228, P1502, DOI 10.1126/science.2409596; Waxman SG, 2006, NAT REV NEUROSCI, V7, P932, DOI 10.1038/nrn2023; Zhu F, 2006, J APPL PHYSIOL, V100, P717, DOI 10.1152/japplphysiol.00669.2005	38	47	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67767	10.1371/journal.pone.0067767	http://dx.doi.org/10.1371/journal.pone.0067767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844090	gold, Green Submitted, Green Published			2022-12-27	WOS:000321733000102
J	Chen, YC; Chu, LY; Yang, SF; Chen, HL; Yet, SF; Wu, KK				Chen, Yen-Chung; Chu, Ling-Yun; Yang, Shu-Fan; Chen, Hua-Ling; Yet, Shaw-Fang; Wu, Kenneth K.			Prostacyclin and PPAR alpha Agonists Control Vascular Smooth Muscle Cell Apoptosis and Phenotypic Switch through Distinct 14-3-3 Isoforms	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; SERUM RESPONSE FACTOR; GROWTH-FACTOR; ENDOTHELIAL-CELLS; DELTA ACTIVATION; PROTEINS; SURVIVAL; STRESS; FAMILY; CYCLOOXYGENASE-2	We hypothesized that prostacyclin (PGI(2)) protects vascular smooth muscle cell (VSMC) against apoptosis and phenotypic switch through peroxisome proliferator-activated receptor-alpha (PPAR alpha) activation and 14-3-3 upregulation. Here we showed that transfection of rat aortic VSMC, A-10, with PGI(2)-producing vectors, Ad-COPI, resulted in attenuated H2O2-induced apoptosis accompanied by a selective increase in 14-3-3 beta and 14-3-3 theta expression. Carbaprostacyclin (cPGI(2)) and Wy14,643 exerted a similar effect. The effects of PGI(2) were abrogated by MK886, a PPAR alpha antagonist, but not GSK3787, a PPAR delta antagonist. PPAR alpha transfection upregulated 14-3-3 beta and theta expression and attenuated H2O2-induced apoptosis. H2O2-induced 14-3-3 beta but not 14-3-3 theta degradation was blocked by a caspase 3 inhibitor. Furthermore, 14-3-3 beta but not 14-3-3 theta overexpression reduced, while 14-3-3 beta siRNA aggravated apoptosis. VSMC contractile proteins and serum response factor (SRF) were reduced in H2O2-treated A-10 cells which were concurrently prevented by caspase 3 inhibitor. By contrast, PGI(2) prevented H2O2-induced SM22 alpha and Calponin-1 degradation without influencing SRF. cPGI(2) and Wy14,643 also effectively blocked VSMC phenotypic switch induced by growth factors (GFs). GFs suppressed 14-3-3 beta, theta, epsilon and eta isoforms and cPGI(2) prevented the decline of beta, theta and eta, but not epsilon. 14-3-3 theta siRNA abrogated the protective effect of cPGI(2) on SM22 alpha and Calponin-1 while 14-3-3 theta or 14-3-3 beta overexpression partially restored SM22 alpha. These results indicated that PGI(2) protects VSMCs via PPAR alpha by upregulating 14-3-3 beta and 14-3-3 theta. 14-3-3 beta upregulation confers resistance to apoptosis whereas 14-3-3 theta and beta upregulation protects SM22 alpha and Calponin-1 from degradation.	[Chen, Yen-Chung; Chu, Ling-Yun; Yang, Shu-Fan; Chen, Hua-Ling; Yet, Shaw-Fang; Wu, Kenneth K.] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Miaoli, Taiwan; [Wu, Kenneth K.] Natl Tsing Hua Univ, Coll Life Sci, Inst Biotechnol, Hsinchu, Taiwan; [Wu, Kenneth K.] China Med Univ, Metabol Med Res Ctr, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Tsing Hua University; China Medical University Taiwan	Wu, KK (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Miaoli, Taiwan.	kkgo@nhri.org.tw	Yang, Shufan/AAF-7942-2021; Yet, Shaw-Fang/B-1067-2010; Yang, Shufan/AAI-6707-2021; Chu, Liang-Yin/B-3915-2009; Yet, Shaw-Fang/O-8583-2019	Yang, Shufan/0000-0003-0531-2903; 	National Health Research Institutes of Taiwan	National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan)	This work was supported by intramural grants from National Health Research Institutes of Taiwan (http://english.nhri.org.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adderley SR, 1999, J BIOL CHEM, V274, P5038, DOI 10.1074/jbc.274.8.5038; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; CORJAY MH, 1989, J BIOL CHEM, V264, P10501; Daynes RA, 2002, NAT REV IMMUNOL, V2, P748, DOI 10.1038/nri912; Feil S, 2004, CIRC RES, V94, P863, DOI 10.1161/01.RES.0000126417.38728.F6; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Fuenzalida K, 2007, J BIOL CHEM, V282, P37006, DOI 10.1074/jbc.M700447200; Hao CM, 1999, AM J PHYSIOL-RENAL, V277, pF352, DOI 10.1152/ajprenal.1999.277.3.F352; Hao CM, 2002, J BIOL CHEM, V277, P21341, DOI 10.1074/jbc.M200695200; Huang JC, 2007, HUM REPROD, V22, P807, DOI 10.1093/humrep/del429; Huang JC, 2004, HUM REPROD, V19, P2900, DOI 10.1093/humrep/deh524; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Kuzelova K, 2009, J CELL BIOCHEM, V106, P673, DOI 10.1002/jcb.22061; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; LINDNER V, 1991, P NATL ACAD SCI USA, V88, P3739, DOI 10.1073/pnas.88.9.3739; Liou JY, 2006, ARTERIOSCL THROM VAS, V26, P1481, DOI 10.1161/01.ATV.0000223875.14120.93; McCormick SM, 2000, ANN BIOMED ENG, V28, P824, DOI 10.1114/1.1289472; MONCADA S, 1978, PHARMACOL REV, V30, P293; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Nishida W, 2002, J BIOL CHEM, V277, P7308, DOI 10.1074/jbc.M111824200; Orr AW, 2010, J VASC RES, V47, P168, DOI 10.1159/000250095; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; SHORE P, 1995, EUR J BIOCHEM, V229, P1, DOI 10.1111/j.1432-1033.1995.tb20430.x; Shyue SK, 2001, CIRCULATION, V103, P2090; Tsai MC, 2009, CIRC RES, V105, P471, DOI 10.1161/CIRCRESAHA.109.193656; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; VANPUTTEN V, 1994, CIRC RES, V75, P1126, DOI 10.1161/01.RES.75.6.1126; Wang L, 2010, CIRC RES, V106, P514, DOI 10.1161/CIRCRESAHA.109.202762; Wu JS, 2009, J CELL PHYSIOL, V220, P58, DOI 10.1002/jcp.21730; Wu KK, 1998, P ASSOC AM PHYSICIAN, V110, P163; Yu HX, 2011, ARTERIOSCL THROM VAS, V31, P2402, DOI 10.1161/ATVBAHA.111.235622; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	34	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e69702	10.1371/journal.pone.0069702	http://dx.doi.org/10.1371/journal.pone.0069702			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844263	Green Published, gold, Green Submitted			2022-12-27	WOS:000321733000036
J	Hayama, S; Nakiri, S; Nakanishi, S; Ishii, N; Uno, T; Kato, T; Konno, F; Kawamoto, Y; Tsuchida, S; Ochiai, K; Omi, T				Hayama, Shin-ichi; Nakiri, Sachie; Nakanishi, Setsuko; Ishii, Naomi; Uno, Taiki; Kato, Takuya; Konno, Fumiharu; Kawamoto, Yoshi; Tsuchida, Shuichi; Ochiai, Kazuhiko; Omi, Toshinori			Concentration of Radiocesium in the Wild Japanese Monkey (Macaca fuscata) over the First 15 Months after the Fukushima Daiichi Nuclear Disaster	PLOS ONE			English	Article							CHERNOBYL; RADIATION; ABUNDANCE; ACCIDENT; MACAQUES; BOAR	Following the massive earthquake that struck eastern Japan on March 11, 2011, a nuclear reactor core meltdown occurred at the Fukushima Daiichi Nuclear Power Plant, operated by Tokyo Electric Power Company, and was followed by the release of large amounts of radioactive materials. The objective of this study was to measure the concentration of radiocesium Cs-134 and Cs-137 in the muscle of Japanese monkeys (Macaca fuscata) inhabiting the forest area of Fukushima City and to determine the change in concentration over time as well as the relationship with the level of soil contamination. Cesium concentrations in the muscle of monkeys captured at locations with 100,000-300,000 Bq/m(2) were 6,000-25,000 Bq/kg in April 2011 and decreased over 3 months to around 1,000 Bq/kg. However, the concentration increased again to 2,000-3,000 Bq/kg in some animals during and after December 2011 before returning to 1,000 Bq/kg in April 2012, after which it remained relatively constant. This pattern of change in muscle radiocesium concentration was similar to that of the change in radiocesium concentration in atmospheric fallout. Moreover, the monkeys feed on winter buds and the cambium layer of tree bark potentially containing higher concentrations of radiocesium than that in the diet during the rest of the year. The muscle radiocesium concentration in the monkeys related significantly with the level of soil contamination at the capture locations.	[Hayama, Shin-ichi; Nakiri, Sachie; Ishii, Naomi; Uno, Taiki; Kato, Takuya; Tsuchida, Shuichi; Ochiai, Kazuhiko; Omi, Toshinori] Nippon Vet & Life Sci Univ, Tokyo, Japan; [Nakanishi, Setsuko] Conservat & Anim Welf Trust, Tokyo, Japan; [Konno, Fumiharu] Shin Fukushima Agr Cooperat, Fukushima, Japan; [Kawamoto, Yoshi] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan	Nippon Veterinary & Life Science University; Kyoto University	Hayama, S (corresponding author), Nippon Vet & Life Sci Univ, Tokyo, Japan.	hayama@nvlu.ac.jp		Omi, Toshinori/0000-0001-9303-2746; HAYAMA, Shin-ichi/0000-0002-4882-7969; OCHIAI, Kazuhiko/0000-0002-5736-0598	Cooperative Research Grant of Primate Research Institute, Kyoto University; Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan	Cooperative Research Grant of Primate Research Institute, Kyoto University; Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan)	This study was supported by the Cooperative Research Grant of Primate Research Institute, Kyoto University and the Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], RES 3 AIRB MON SURV; Beresford NA, 2004, J RADIOL PROT, V24, pA89, DOI 10.1088/0952-4746/24/4A/006; Beresford Nicholas A., 2011, Integrated Environmental Assessment and Management, V7, P371, DOI 10.1002/ieam.238; EIKELMANN I M H, 1990, Rangifer, P35; Enari H, 2013, PRIMATES IN PRESS; Fukushima Prefecture, 2012, MANAGEMENT PLAN JAPA, P34; Hayama S, 2011, J VET MED SCI, V73, P809, DOI 10.1292/jvms.10-0420; Hiyama A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00570; Hohmann U, 2005, EUR J WILDLIFE RES, V51, P263, DOI 10.1007/s10344-005-0108-x; Imaki H, 2000, BIOSPH CONSERV, V3, P1; Iwamoto M., 1987, PRIMATE RES, V3, P18, DOI 10.2354/psj.3.18; Japanese Ministry of Education, RES MON ENV RAD LEV; Japanese Ministry of Environment, 2012, JAP RED LIST; Kinoshita N, 2011, P NATL ACAD SCI USA, V108, P19526, DOI 10.1073/pnas.1111724108; KOYAMA N, 1992, PRIMATES, V33, P33, DOI 10.1007/BF02382761; Moller AP, 2013, ECOL INDIC, V24, P75, DOI 10.1016/j.ecolind.2012.06.001; Moller AP, 2012, ENVIRON POLLUT, V164, P36, DOI 10.1016/j.envpol.2012.01.008; Primate Research Institute, KYOT U GUID FIEL RES; ROSOFF B, 1963, RADIAT RES, V19, P643, DOI 10.2307/3571485; Strebl F, 2007, J ENVIRON RADIOACTIV, V98, P137, DOI 10.1016/j.jenvrad.2006.02.009; Suzuki A., 1965, Primates, V6, P31, DOI 10.1007/BF01794458; Tagami K, 2011, SCI TOTAL ENVIRON, V409, P4885, DOI 10.1016/j.scitotenv.2011.07.067; Tsuji Y, 2006, AM J PRIMATOL, V68, P1068, DOI 10.1002/ajp.20307; WADA K, 1980, Primates, V21, P468, DOI 10.1007/BF02373835; WATANUKI Y, 1994, PRIMATES, V35, P15, DOI 10.1007/BF02381482; WATANUKI Y, 1993, PRIMATES, V34, P419, DOI 10.1007/BF02382651; Yablokov AV, 2009, ANN NY ACAD SCI, V1181, P255, DOI 10.1111/j.1749-6632.2009.04830.x; Yoshida S, 2011, RADIAT PROT DOSIM, V146, P326, DOI 10.1093/rpd/ncr181	28	26	27	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68530	10.1371/journal.pone.0068530	http://dx.doi.org/10.1371/journal.pone.0068530			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844216	Green Published, Green Submitted, gold			2022-12-27	WOS:000321733000013
J	Lee, YH; Zimmerman, JN; Custodio, W; Xiao, YZ; Basiri, T; Hatibovic-Kofman, S; Siqueira, WL				Lee, Young Ho; Zimmerman, Jason N.; Custodio, William; Xiao, Yizhi; Basiri, Tayebeh; Hatibovic-Kofman, Sahza; Siqueira, Walter L.			Proteomic Evaluation of Acquired Enamel Pellicle during In Vivo Formation	PLOS ONE			English	Article							PROLINE-RICH PROTEINS; MASS-SPECTROMETRY; BINDING DOMAINS; IDENTIFICATION; STATHERIN; HISTATINS; VITRO; HYDROXYAPATITE; COMPONENTS; COMPLEXES	Acquired enamel pellicle (AEP) is a protein film that forms on the enamel surface of teeth by selective adsorption of proteins and peptides present in the mouth. This protein film forms the interface between enamel and the damage oral biofilm, which modulates the attachment of bacteria found in oral biofilm. The overall goal of this study was to gain insight into the biological formation of the human in vivo AEP. This study hypothesized that AEP is created by the formation of successive protein layers, which consist of initial binding to enamel and subsequent protein-protein interactions. This hypothesis was examined by observing quantitative and qualitative changes in pellicle composition during the first two hours of AEP formation in the oral cavity. Quantitative mass spectrometry approaches were used to generate an AEP protein profile for each time-point studied. Relative proteomic quantification was carried out for the 50 proteins observed in all four time-points. Notably, the abundance of important salivary proteins, such as histatin 1, decrease with increasing of the AEP formation, while other essential proteins such as statherin showed constant relative abundance in all time-points. In summary, this is the first study that investigates the dynamic process to the AEP formation by using proteomic approaches. Our data demonstrated that there are significant qualitative and quantitative proteome changes during the AEP formation, which in turn will likely impact the development of oral biofilms.	[Siqueira, Walter L.] Univ Western Ontario, Dept Biochem, London, ON, Canada; Univ Western Ontario, Sch Dent, Schulich Sch Med & Dent, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Siqueira, WL (corresponding author), Univ Western Ontario, Dept Biochem, London, ON, Canada.	walter.siqueira@uwo.ca	Siqueira, Walter/ABE-4069-2021; Custodio, William/B-8257-2014; Siqueira, Walter/ABE-8924-2020	Custodio, William/0000-0003-1416-1414; Siqueira, Walter/0000-0003-1921-3658	Natural Sciences and Engineering Research Council of Canada (NSERC grant) [371813]; Canadian Institutes of Health Research, (CIHR grant) [106657, 97577]; Canada Foundation for Innovation-Leaders Opportunity Fund (CFI-LOF grant) [25116]; CIHR New Investigator Award [113166]; Ontario Dental Association (ODA); CIHR Schulich Dentistry undergraduate dental student scholarship; CIHR undergraduate scholarship	Natural Sciences and Engineering Research Council of Canada (NSERC grant); Canadian Institutes of Health Research, (CIHR grant)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation-Leaders Opportunity Fund (CFI-LOF grant); CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR)); Ontario Dental Association (ODA); CIHR Schulich Dentistry undergraduate dental student scholarship; CIHR undergraduate scholarship	This research was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC grant #371813), the Canadian Institutes of Health Research, (CIHR grant #106657 and grant #97577), and the Canada Foundation for Innovation-Leaders Opportunity Fund (CFI-LOF grant #25116). WLS is recipient of a CIHR New Investigator Award (grant #113166). JNZ is recipient of an Ontario Dental Association (ODA) and CIHR Schulich Dentistry undergraduate dental student scholarship. YHL is recipient of a CIHR undergraduate scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHASHIMI I, 1989, ARCH ORAL BIOL, V34, P289, DOI 10.1016/0003-9969(89)90070-8; BENNICK A, 1983, ARCH ORAL BIOL, V28, P19, DOI 10.1016/0003-9969(83)90022-5; Carlen A, 1998, CARIES RES, V32, P447, DOI 10.1159/000016486; Castagnola M, 2004, J BIOL CHEM, V279, P41436, DOI 10.1074/jbc.M404322200; Duan XT, 2009, J PROTEOME RES, V8, P2838, DOI 10.1021/pr900001t; EDGERTON M, 1992, J PROSTHET DENT, V68, P683, DOI 10.1016/0022-3913(92)90387-P; EGGEN KH, 1982, SCAND J DENT RES, V90, P182; EGGEN KH, 1983, SCAND J DENT RES, V91, P439; Helmerhorst EJ, 2006, ARCH ORAL BIOL, V51, P1061, DOI 10.1016/j.archoralbio.2006.06.005; Helmerhorst EJ, 2010, J PROTEOME RES, V9, P5413, DOI 10.1021/pr100653r; Iontcheva I, 1997, J DENT RES, V76, P734, DOI 10.1177/00220345970760030501; Iontcheva I, 2000, J DENT RES, V79, P732; KOUSVELARI EE, 1980, J DENT RES, V59, P1430, DOI 10.1177/00220345800590081201; Li J, 2004, J DENT RES, V83, P60, DOI 10.1177/154405910408300112; Li J, 2003, ORAL MICROBIOL IMMUN, V18, P183, DOI 10.1034/j.1399-302X.2003.00065.x; MAYHALL C W, 1975, Alabama Journal of Medical Sciences, V12, P252; McDonald EE, 2011, J DENT RES, V90, P268, DOI 10.1177/0022034510388653; Oppenheim FG, 2007, ANN NY ACAD SCI, V1098, P22, DOI 10.1196/annals.1384.030; RYKKE M, 1990, SCAND J DENT RES, V98, P129; Schupbach P, 2001, EUR J ORAL SCI, V109, P60, DOI 10.1034/j.1600-0722.2001.00925.x; Siqueira WL, 2007, ANN NY ACAD SCI, V1098, P504, DOI 10.1196/annals.1384.023; Siqueira WL, 2007, J PROTEOME RES, V6, P2152, DOI 10.1021/pr060580k; Siqueira WL, 2012, PROTEOMICS, V12, P3426, DOI 10.1002/pmic.201100665; Siqueira WL, 2009, ARCH ORAL BIOL, V54, P437, DOI 10.1016/j.archoralbio.2009.01.011; Vitorino R, 2004, BIOCHEM BIOPH RES CO, V320, P342, DOI 10.1016/j.bbrc.2004.05.169; Vitorino R, 2008, J SEP SCI, V31, P523, DOI 10.1002/jssc.200700486; Vitorino R, 2007, BIOMED CHROMATOGR, V21, P1107, DOI 10.1002/bmc.830; Yao Y, 2001, ARCH ORAL BIOL, V46, P293, DOI 10.1016/S0003-9969(00)00134-5; Yao Y, 2003, J BIOL CHEM, V278, P5300, DOI 10.1074/jbc.M206333200	29	56	58	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67919	10.1371/journal.pone.0067919	http://dx.doi.org/10.1371/journal.pone.0067919			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844127	Green Published, Green Submitted, gold			2022-12-27	WOS:000321733000114
J	Chaban, B; Albert, A; Links, MG; Gardy, J; Tang, P; Hill, JE				Chaban, Bonnie; Albert, Arianne; Links, Matthew G.; Gardy, Jennifer; Tang, Patrick; Hill, Janet E.			Characterization of the Upper Respiratory Tract Microbiomes of Patients with Pandemic H1N1 Influenza	PLOS ONE			English	Article							CPN60; DIVERSITY; SEQUENCE; TOOL; REPRESENTATION; COMMUNITIES; IMPROVEMENT; LIBRARIES; TARGET	The upper respiratory tract microbiome has an important role in respiratory health. Influenza A is a common viral infection that challenges that health, and a well-recognized sequela is bacterial pneumonia. Given this connection, we sought to characterize the upper respiratory tract microbiota of individuals suffering from the pandemic H1N1 influenza A outbreak of 2009 and determine if microbiome profiles could be correlated with patient characteristics. We determined the microbial profiles of 65 samples from H1N1 patients by cpn60 universal target amplification and sequencing. Profiles were examined at the phylum and nearest neighbor "species" levels using the characteristics of patient gender, age, originating health authority, sample type and designation (STAT/non-STAT). At the phylum level, Actinobacteria-, Firmicutes- and Proteobacteria-dominated microbiomes were observed, with none of the patient characteristics showing significant profile composition differences. At the nearest neighbor "species" level, the upper respiratory tract microbiomes were composed of 13-20 "species" and showed a trend towards increasing diversity with patient age. Interestingly, at an individual level, most patients had one to three organisms dominant in their microbiota. A limited number of discrete microbiome profiles were observed, shared among influenza patients regardless of patient status variables. To assess the validity of analyses derived from sequence read abundance, several bacterial species were quantified by quantitative PCR and compared to the abundance of cpn60 sequence read counts obtained in the study. A strong positive correlation between read abundance and absolute bacterial quantification was observed. This study represents the first examination of the upper respiratory tract microbiome using a target other than the 16S rRNA gene and to our knowledge, the first thorough examination of this microbiome during a viral infection.	[Chaban, Bonnie; Links, Matthew G.; Hill, Janet E.] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Microbiol, Saskatoon, SK S7N 0W0, Canada; [Albert, Arianne] Womens Hlth Res Inst, Vancouver, BC, Canada; [Links, Matthew G.] Agr & Agri Food Canada, Saskatoon Res Ctr, Saskatoon, SK, Canada; [Gardy, Jennifer; Tang, Patrick] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Tang, Patrick] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada	University of Saskatchewan; Agriculture & Agri Food Canada; University of British Columbia	Hill, JE (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Dept Vet Microbiol, Saskatoon, SK S7N 0W0, Canada.	janet.hill@usask.ca	Hill, Janet E./B-5001-2011; Links, Matthew G./P-4949-2019; Albert, Arianne/AAG-7518-2019	Hill, Janet E./0000-0002-2187-6277; Links, Matthew G./0000-0003-1917-6789; Albert, Arianne/0000-0002-3050-0888; Quigley, Bonnie/0000-0003-3787-0993; Gardy, Jennifer/0000-0001-7255-7631; Tang, Patrick/0000-0003-1583-5484	Genome BC; BC Centre for Disease Control; British Columbia Provincial Health Services Authority Laboratories; Canadian Institutes of Health Research	Genome BC; BC Centre for Disease Control; British Columbia Provincial Health Services Authority Laboratories; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funding for this project was provided by Genome BC, BC Centre for Disease Control, the British Columbia Provincial Health Services Authority Laboratories and the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Biesbroek G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032942; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Chaban B, 2012, MICROB ECOL, V63, P348, DOI 10.1007/s00248-011-9931-7; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Director-General Who, 2011, 64 WORLD HLTH ASS WO, P49; Frank DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010598; Girard MP, 2010, VACCINE, V28, P4895, DOI [10.1016/j.vaccine.2010.05.031, 10.1016/j.vaccine.2010.07.034]; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Greninger AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013381; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hill JE, 2010, APPL ENVIRON MICROB, V76, P4550, DOI 10.1128/AEM.01510-09; Hill JE, 2006, ENVIRON MICROBIOL, V8, P741, DOI 10.1111/j.1462-2920.2005.00944.x; Hill JE, 2004, GENOME RES, V14, P1669, DOI 10.1101/gr.2649204; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; JEYNES BJ, 1975, ANAT REC, V182, P289, DOI 10.1002/ar.1091820303; Kindt R, 2012, VEGAN COMM EC PACK R; Lee DH, 1996, APPL ENVIRON MICROB, V62, P3112, DOI 10.1128/AEM.62.9.3112-3120.1996; Lemon KP, 2010, MBIO, V1, DOI 10.1128/mBio.00129-10; Links MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049755; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Marcet-Houben M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-646; Martinez D, 2004, NAT BIOTECHNOL, V22, P899, DOI 10.1038/nbt0704-899b; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219; Palacios G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008540; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; R Development Core Team, 2012, R LANG ENV STAT COMP; Schellenberg J, 2011, METHODS MOL BIOL, V733, P143, DOI 10.1007/978-1-61779-089-8_10; Schellenberg J, 2009, APPL ENVIRON MICROB, V75, P2889, DOI 10.1128/AEM.01640-08; Schellenberg JJ, 2011, APPL ENVIRON MICROB, V77, P4066, DOI 10.1128/AEM.02943-10; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Ursell LK, 2012, J ALLERGY CLIN IMMUN, V129, P1204, DOI 10.1016/j.jaci.2012.03.010; Xu J, 2007, P NATL ACAD SCI USA, V104, P18730, DOI 10.1073/pnas.0706756104; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	37	48	52	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e69559	10.1371/journal.pone.0069559	http://dx.doi.org/10.1371/journal.pone.0069559			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844261	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000193
J	Herskovits, AZ; Locascio, JJ; Peskind, ER; Li, G; Hyman, BT				Herskovits, Adrianna Z.; Locascio, Joseph J.; Peskind, Elaine R.; Li, Ge; Hyman, Bradley T.			A Luminex Assay Detects Amyloid beta Oligomers in Alzheimer's Disease Cerebrospinal Fluid	PLOS ONE			English	Article							A-BETA; NATIONAL INSTITUTE; PRECURSOR PROTEIN; NEUROPATHOLOGIC ASSESSMENT; ASSOCIATION GUIDELINES; ANALYTICAL PLATFORMS; CLINICAL-DIAGNOSIS; TOTAL TAU; PEPTIDE; BRAIN	Amyloid beta (a beta) protein assembles into larger protein aggregates during the pathogenesis of Alzheimer's disease (AD) and there is increasing evidence that soluble a beta oligomers are a critical pathologic species. Diagnostic evaluations rely on the measurement of increased tau and decreased a beta 42 in the cerebrospinal fluid (CSF) from AD patients and evidence for oligomeric a beta in patient CSF is conflicting. In this study, we have adapted a monoclonal single antibody sandwich ELISA assay to a Luminex platform and found that this assay can detect oligomerized a beta 42 and sAPP alpha fragments. We evaluated oligomeric a beta reactivity in 20 patients with AD relative to 19 age matched controls and compared these values with a commercially available Alzbio3 kit that detects tau, phosphorylated tau and a beta 42 on the same diagnostic platform. We found that CSF samples of patients with AD had elevated a beta oligomers compared to control subjects (p < 0.05) and the ratio of a beta oligomers to a beta 42 was also significantly elevated (p < 0.0001). Further research to develop high sensitivity analytical platforms and rigorous methods of developing stable assay standards will be needed before the analysis of oligomeric a beta becomes a routine diagnostic assay for the evaluation of late onset AD patients.	[Herskovits, Adrianna Z.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Locascio, Joseph J.] Massachusetts Gen Hosp, Alzheimers Dis Res Ctr, Memory Disorders Unit, Boston, MA 02114 USA; [Locascio, Joseph J.] Massachusetts Gen Hosp, Alzheimers Dis Res Ctr, Movement Disorders Unit, Boston, MA 02114 USA; [Peskind, Elaine R.; Li, Ge] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Peskind, Elaine R.] Vet Affairs Puget Sound Hlth Care Syst, Mental Illness Res & Educ Clin Ctr, Seattle, WA USA; [Herskovits, Adrianna Z.; Hyman, Bradley T.] Massachusetts Gen Hosp, Mass Gen Inst Neurodegenerat Dis, Dept Neurol, Charlestown, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Harvard University; Massachusetts General Hospital	Herskovits, AZ (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	azherskovits@partners.org			NIH [P50AG05134, 2T32HL007627-26]; NIH/NIA [P50 AG005136]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005136, P50AG005134, R01AG015339] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by NIH P50AG05134 (B.T.H.) and 2T32HL007627-26 (A.Z.H.) and NIH/NIA P50 AG005136 (E.P. and G.L.). BTH is a consultant for Takeda Pharmaceutical Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beach TG, 2012, J NEUROPATH EXP NEUR, V71, P266, DOI 10.1097/NEN.0b013e31824b211b; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bombois S, 2013, CURR ALZHEIMER RES, V10, P357, DOI 10.2174/1567205011310040002; Brinkmalm G, 2013, BRAIN RES; Bruggink KA, 2013, ANAL BIOCHEM, V433, P112, DOI 10.1016/j.ab.2012.09.014; Buchhave P, 2012, ARCH GEN PSYCHIAT, V69, P98, DOI 10.1001/archgenpsychiatry.2011.155; Chasseigneaux S, 2012, J NEUROCHEM, V120, P99, DOI 10.1111/j.1471-4159.2011.07584.x; Esparza TJ, 2013, ANN NEUROL, V73, P104, DOI 10.1002/ana.23748; Fagan AM, 2011, ARCH NEUROL-CHICAGO, V68, P1137, DOI 10.1001/archneurol.2011.105; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fukumoto H, 2010, FASEB J, V24, P2716, DOI 10.1096/fj.09-150359; Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102; Hock C, 1998, EUR NEUROL, V39, P111, DOI 10.1159/000007917; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Irwin DJ, 2012, ARCH NEUROL-CHICAGO, V69, P1018, DOI 10.1001/archneurol.2012.26; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Kasai T, 2012, BIOCHEM BIOPH RES CO, V422, P375, DOI 10.1016/j.bbrc.2012.04.146; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Le Bastard N, 2013, J ALZHEIMERS DIS, V33, P117, DOI 10.3233/JAD-2012-121246; Lee EB, 2006, J BIOL CHEM, V281, P4292, DOI 10.1074/jbc.M511018200; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lewczuk P, 2010, MOL PSYCHIATR, V15, P138, DOI 10.1038/mp.2008.84; Mattsson N, 2012, NEUROLOGY, V78, P468, DOI 10.1212/WNL.0b013e3182477eed; Mattsson N, 2011, ALZHEIMERS DEMENT, V7, P386, DOI 10.1016/j.jalz.2011.05.2243; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Santos AN, 2007, J ALZHEIMERS DIS, V11, P117; Olsson A, 2005, CLIN CHEM, V51, P336, DOI 10.1373/clinchem.2004.039347; Olsson A, 2003, EXP NEUROL, V183, P74, DOI 10.1016/S0014-4886(03)00027-X; PALMERT MR, 1990, NEUROLOGY, V40, P1028, DOI 10.1212/WNL.40.7.1028; Puttfarcken PS, 1996, EXP NEUROL, V138, P73, DOI 10.1006/exnr.1996.0048; ROHER AE, 1993, P NATL ACAD SCI USA, V90, P10836, DOI 10.1073/pnas.90.22.10836; Santos AN, 2012, J ALZHEIMERS DIS, V29, P171, DOI 10.3233/JAD-2012-111361; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shaw LM, 2011, ACTA NEUROPATHOL, V121, P597, DOI 10.1007/s00401-011-0808-0; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Stine WB, 2011, METHODS MOL BIOL, V670, P13, DOI 10.1007/978-1-60761-744-0_2; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Vanderstichele H, 2005, STANDARDIZED MULTIPA, P183; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wechsler D, 1983, MANUAL WECHSLER MEMO; Yang T, 2013, ALZHEIMERS DEMENT, V9, P99, DOI 10.1016/j.jalz.2012.11.005; Zetterberg Henrik, 2008, Handb Clin Neurol, V89, P261, DOI 10.1016/S0072-9752(07)01224-9; [No title captured]	48	43	44	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67898	10.1371/journal.pone.0067898	http://dx.doi.org/10.1371/journal.pone.0067898			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844122	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000115
J	Martini, M; Canella, R; Fesce, R; Rossi, ML				Martini, Marta; Canella, Rita; Fesce, Riccardo; Rossi, Maria Lisa			The Amplitude and Inactivation Properties of the Delayed Potassium Currents Are Regulated by Protein Kinase Activity in Hair Cells of the Frog Semicircular Canals	PLOS ONE			English	Article							IONIC CURRENTS; BKCA CHANNEL; CA2+ CURRENT; PHOSPHORYLATION; MODULATION; CALCIUM; ACTIVATION; MECHANISMS; ATP	In hair cells dissected from the frog crista ampullaris, the combination of a calcium-dependent (IKCa) and a purely voltage-dependent component (IKV) gives rise to the delayed potassium current complex (IKD). These currents have been recently reported to display slow depolarization-induced inactivation and biphasic inactivation removal by hyperpolarization. The amplitude and inactivation kinetics of both IKCa and IKV are drastically modulated by a previously unrecognized mechanism of protein phosphorylation (sensitive to kinase inhibitors H89 and KT5823), which does not interfere with the transient potassium current (IA) or the calcium current (ICa). IKD amplitude was stable in cells patched with pipettes containing 8 mM ATP or under perforated-patch; under these conditions, a 10 min treatment with 10 mu M H89 or 1-10 mu M KT5823 reduced IKD amplitude by a mean of 67% at +40 mV. Similarly affected was the isolated IKV component (ICa blocked with Cd2+). Thus, a large potassium conductance can be activated by depolarization, but it is made available to the cell to a variable extent that depends on membrane potential and protein kinase activity. The total gKD ranged 4.6-44.0 nS in control cells, according to the level of steady-state inactivation, and was reduced to 1.4-2.7 nS after protein kinase inhibition. When sinusoidal membrane potential changes in the -70/-10 mV range were applied, to mimic receptor response to hair bundle deflection, IKD proved the main current dynamically activated and the only one regulated by PK: H89 decreased the total outward charge during each cycle by 60%. Phosphorylation appears to control both the amount of IKCa and IKV conductance activated by depolarization and the fraction thereof which can be rescued by removal of inactivation. The balance between the depolarizing transduction current and the repolarizing potassium current, and eventually the transmitter release at the cytoneural junction, are therefore modulated by a phosphorylation-mediated process.	[Martini, Marta; Canella, Rita; Rossi, Maria Lisa] Univ Ferrara, Dipartimento Sci Vita & Biotecnol, I-44100 Ferrara, Italy; [Fesce, Riccardo] Insubria Univ, Ctr Neurosci, Varese, Italy; [Fesce, Riccardo] Insubria Univ, DISTA, Varese, Italy	University of Ferrara; University of Insubria; University of Insubria	Rossi, ML (corresponding author), Univ Ferrara, Dipartimento Sci Vita & Biotecnol, I-44100 Ferrara, Italy.	rsm@unife.it		fesce, riccardo/0000-0001-9473-896X; Rossi, Maria Lisa/0000-0002-9057-7422	Ferrara University	Ferrara University	Local funds to MLR from the Ferrara University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almanza A, 2007, J NEUROPHYSIOL, V97, P1188, DOI 10.1152/jn.00849.2006; Bahring R, 2011, J PHYSIOL-LONDON, V589, P461, DOI 10.1113/jphysiol.2010.191965; BELLUZZI O, 1991, PROG BIOPHYS MOL BIO, V55, P1, DOI 10.1016/0079-6107(91)90009-H; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; COVARRUBIAS M, 1994, NEURON, V13, P1403, DOI 10.1016/0896-6273(94)90425-1; HIDAKA H, 1992, ANNU REV PHARMACOL, V32, P377, DOI 10.1146/annurev.pharmtox.32.1.377; Hou SW, 2009, PHYSIOLOGY, V24, P26, DOI 10.1152/physiol.00032.2008; HUANG XY, 1993, CELL, V75, P1145, DOI 10.1016/0092-8674(93)90324-J; Jagger DJ, 1999, PFLUG ARCH EUR J PHY, V437, P409, DOI 10.1007/s004240050795; Jagger DJ, 1999, NEUROSCI LETT, V263, P145, DOI 10.1016/S0304-3940(99)00128-7; Jerng HH, 2004, MOL CELL NEUROSCI, V27, P343, DOI 10.1016/j.mcn.2004.06.011; Jonas EA, 1996, CURR OPIN NEUROBIOL, V6, P318, DOI 10.1016/S0959-4388(96)80114-0; Light PE, 2000, P NATL ACAD SCI USA, V97, P9058, DOI 10.1073/pnas.160068997; Lv P, 2010, J NEUROPHYSIOL, V103, P2494, DOI 10.1152/jn.00017.2010; Martini M, 2000, BIOPHYS J, V78, P1240, DOI 10.1016/S0006-3495(00)76681-1; Martini M, 2007, EUR BIOPHYS J BIOPHY, V36, P779, DOI 10.1007/s00249-007-0172-0; Martini M, 2009, AM J PHYSIOL-REG I, V296, pR1585, DOI 10.1152/ajpregu.90981.2008; Martini M, 2009, PFLUG ARCH EUR J PHY, V457, P1327, DOI 10.1007/s00424-008-0598-y; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; Park KS, 2008, PHYSIOLOGY, V23, P49, DOI 10.1152/physiol.00031.2007; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; Roeper J, 1997, J NEUROSCI, V17, P3379; Schubert R, 2001, TRENDS PHARMACOL SCI, V22, P505, DOI 10.1016/S0165-6147(00)01775-2; Shin KS, 2004, NEURON, V41, P737, DOI 10.1016/S0896-6273(04)00083-2	25	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67784	10.1371/journal.pone.0067784	http://dx.doi.org/10.1371/journal.pone.0067784			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844092	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000096
J	Nogeire, TM; Davis, FW; Duggan, JM; Crooks, KR; Boydston, EE				Nogeire, Theresa M.; Davis, Frank W.; Duggan, Jennifer M.; Crooks, Kevin R.; Boydston, Erin E.			Carnivore Use of Avocado Orchards across an Agricultural-Wildland Gradient	PLOS ONE			English	Article							OCCUPANCY; BIODIVERSITY; DYNAMICS; MAMMALS	Wide-ranging species cannot persist in reserves alone. Consequently, there is growing interest in the conservation value of agricultural lands that separate or buffer natural areas. The value of agricultural lands for wildlife habitat and connectivity varies as a function of the crop type and landscape context, and quantifying these differences will improve our ability to manage these lands more effectively for animals. In southern California, many species are present in avocado orchards, including mammalian carnivores. We examined occupancy of avocado orchards by mammalian carnivores across agricultural-wildland gradients in southern California with motion-activated cameras. More carnivore species were detected with cameras in orchards than in wildland sites, and for bobcats and gray foxes, orchards were associated with higher occupancy rates. Our results demonstrate that agricultural lands have potential to contribute to conservation by providing habitat or facilitating landscape connectivity.	[Nogeire, Theresa M.; Duggan, Jennifer M.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Davis, Frank W.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Crooks, Kevin R.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Boydston, Erin E.] US Geol Survey, Western Ecol Res Ctr, Thousand Oaks, CA USA	University of Washington; University of Washington Seattle; University of California System; University of California Santa Barbara; Colorado State University; United States Department of the Interior; United States Geological Survey	Nogeire, TM (corresponding author), Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA.	tnogeire@gmail.com	Davis, Frank W./B-7010-2009	Davis, Frank W./0000-0002-4643-5718	The Bren School at UCSB, Orange County Great Park Corporation, and the U.S.G.S	The Bren School at UCSB, Orange County Great Park Corporation, and the U.S.G.S	Partial funding for this study was provided by The Bren School at UCSB, Orange County Great Park Corporation, and the U.S.G.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beier P, 2008, ARIZONA MISSING LINK; Beier P, 2006, CONNECTIVITY CONSERV, P555, DOI DOI 10.1046/J.1523-1739.2003.01458.X; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Borchert M, 2008, CALIF FISH GAME, V94, P61; Brosi BJ, 2006, ENDANGERED SPECIES A, V2, P256; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Conservation International, 2010, BIOD HOTSP; Cosentino BJ, 2011, LANDSCAPE ECOLOGY, V26, P1; Cox RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014508; Crooks K. R., 2006, CONNECTIVITY CONSERV; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Daily GC, 2003, CONSERV BIOL, V17, P1814, DOI 10.1111/j.1523-1739.2003.00298.x; Donovan T.M., 2007, EXERCISES OCCUPANCY; Duggan JM, 2011, LANDSCAPE ECOL, V26, P1477, DOI 10.1007/s10980-011-9652-9; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fedriani JM, 2001, ECOGRAPHY, V24, P325, DOI 10.1034/j.1600-0587.2001.240310.x; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Homer C, 2004, PHOTOGRAMM ENG REM S, V70, P829, DOI 10.14358/PERS.70.7.829; Keeley J.E., 2000, N AM TERRESTRIAL VEG, P203; Landis JD, 2003, WE WILL GROW BASELIN; Linkie M, 2007, BIOL CONSERV, V137, P20, DOI 10.1016/j.biocon.2007.01.016; Lopez-Bao JV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014569; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Muntifering JR, 2006, ANIM CONSERV, V9, P103, DOI 10.1111/j.1469-1795.2005.00008.x; Negroes N, 2010, J WILDLIFE MANAGE, V74, P1195, DOI 10.2193/2009-256; Padial JM, 2002, MAMM BIOL, V67, P137, DOI 10.1078/1616-5047-00021; Ray J. C., 2005, LARGE CARNIVORES CON; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Shapira I, 2007, ANIMAL CONSERVATION, V11, P1; Singleton P.H., 2002, LANDSCAPE PERMEABILI; Thibault KM, 2010, J MAMMAL, V91, P787, DOI 10.1644/09-MAMM-S-142.1	32	14	14	3	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68025	10.1371/journal.pone.0068025	http://dx.doi.org/10.1371/journal.pone.0068025			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844147	Green Submitted, Green Published, gold			2022-12-27	WOS:000321341000129
J	Ananthakrishnan, R; Kumar, K; Ganesh, M; Kumar, AMV; Krishnan, N; Swaminathan, S; Edginton, M; Arunagiri, K; Gupta, D				Ananthakrishnan, Ramya; Kumar, Kaliyaperumal; Ganesh, Marimuthu; Kumar, Ajay M. V.; Krishnan, Nalini; Swaminathan, Sowmya; Edginton, Mary; Arunagiri, K.; Gupta, Devesh			The Profile and Treatment Outcomes of the Older (Aged 60 Years and Above) Tuberculosis Patients in Tamilnadu, South India	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; PREVALENCE	Background: With changing demographic patterns in the context of a high tuberculosis (TB) burden country, like India, there is very little information on the clinical and demographic factors associated with poor treatment outcome in the sub-group of older TB patients. The study aimed to assess the proportion of older TB patients (60 years of age and more), to compare the type of TB and treatment outcomes between older TB patients and other TB patients (less than 60 years of age) and to describe the demographic and clinical characteristics of older TB patients and assess any associations with TB treatment outcomes. Methods: A retrospective cohort study involving a review of records from April to June 2011 in the 12 selected districts of Tamilnadu, India. Demographic, clinical and WHO defined disease classifications and treatment outcomes of all TB patients aged 60 years and above were extracted from TB registers maintained routinely by Revised National TB Control Program (RNTCP). Results: Older TB patients accounted for 14% of all TB patients, of whom 47% were new sputum positive. They had 38% higher risk of unfavourable treatment outcomes as compared to all other TB patients (Relative risk (RR)-1.4, 95% CI 1.2-1.6). Among older TB patients, the risk for unfavourable treatment outcomes was higher for those aged 70 years and more (RR 1.5, 95% CI 1.2-1.9), males (RR 1.5, 95% CI 1.0-2.1), re-treatment patients (RR 2.5, 95% CI 1.9-3.2) and those who received community-based Direct Observed Treatment (RR 1.4, 95% CI 1.1-1.9). Conclusion: Treatment outcomes were poor in older TB patients warranting special attention to this group - including routine assessment and recording of co-morbidities, a dedicated recording, reporting and monitoring of outcomes for this age-group and collaboration with National programme of non-communicable diseases for comprehensive management of co-morbidities.	[Ananthakrishnan, Ramya; Kumar, Kaliyaperumal; Ganesh, Marimuthu; Krishnan, Nalini] REACH, Madras, Tamil Nadu, India; [Kumar, Ajay M. V.] Int Union TB & Lung Dis Union, South East Asia Reg Off, New Delhi, India; [Swaminathan, Sowmya] Natl Inst Res TB, Madras, Tamil Nadu, India; [Edginton, Mary] Int Union TB & Lung Dis Union, Paris, France; [Arunagiri, K.] State TB Off, Madras, Tamil Nadu, India; [Gupta, Devesh] Govt India, Cent TB Div, Minist Hlth & Family Welf, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	Ananthakrishnan, R (corresponding author), REACH, Madras, Tamil Nadu, India.	ramyardr@gmail.com		Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531	Operational Research by Centre for Operational Research, International Union Against Tuberculosis and Lung Disease; Union South-East Asia Office, New Delhi, India; Operational Research Unit, Medecins sans Frontieres, Brussels Operational Center, Luxembourg; Department for International Development, UK	Operational Research by Centre for Operational Research, International Union Against Tuberculosis and Lung Disease; Union South-East Asia Office, New Delhi, India; Operational Research Unit, Medecins sans Frontieres, Brussels Operational Center, Luxembourg; Department for International Development, UK	This research was supported through an Operational Research by Centre for Operational Research, International Union Against Tuberculosis and Lung Disease; The Union South-East Asia Office, New Delhi, India; the Operational Research Unit, Medecins sans Frontieres, Brussels Operational Center, Luxembourg. Funding for this course came from an anonymous donor and the Department for International Development, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora V K, 2003, Indian J Chest Dis Allied Sci, V45, P231; Balakrishnan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046502; Bhushan B, 2012, INT J TUBERC LUNG D, V16, P1210, DOI 10.5588/ijtld.11.0778; Central TB Division, 2011, RNTCP PERF REP IND 2; Central Tuberculosis Division, 2012, TUB IND 2012 ANN REP; Chan-Yeung M, 2002, INT J TUBERC LUNG D, V6, P771; Gaur S. N., 2004, Indian Journal of Tuberculosis, V51, P83; Geeta Pardeshi, 2007, Indian Journal of Community Medicine, V32, P292; Gholamali G., 2007, Journal of Medical Sciences (Pakistan), V7, P888; Gopi PG, 2003, INT J TUBERC LUNG D, V7, P1154; Leung CC, 2002, J AM GERIATR SOC, V50, P1219, DOI 10.1046/j.1532-5415.2002.50308.x; Monthly Bulletin on Family Welfare Directorate of Family welfare Tamil Nadu, 2006, MONTHL B FAM WELF DI; MORRIS CDW, 1990, THORAX, V45, P912, DOI 10.1136/thx.45.12.912; Mukherjee A, 2008, J INDIAN ACAD GERIAT, V4, P60; Rajagopalan S, 2001, CLIN INFECT DIS, V33, P1034, DOI 10.1086/322671; Registrar General and Census Commissioner, 2012, ANN HLTH SURV 2010 1; Sood R, 2000, J INDIAN ACAD CLIN M, V5, P156; Subramani R, 2008, INT J TUBERC LUNG D, V12, P916; Toure NO, 2010, REV MAL RESPIR, V27, P1062, DOI 10.1016/j.rmr.2010.04.017; Viswanathan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041367; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; Zachariah R, 2012, INT J TUBERC LUNG D, V16, P714, DOI 10.5588/ijtld.11.0635	23	44	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e67288	10.1371/journal.pone.0067288	http://dx.doi.org/10.1371/journal.pone.0067288			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861755	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000321692000007
J	Khalid, T; White, P; Costello, B; Persad, R; Ewen, R; Johnson, E; Probert, CS; Ratcliffe, N				Khalid, Tanzeela; White, Paul; Costello, Ben De Lacy; Persad, Raj; Ewen, Richard; Johnson, Emmanuel; Probert, Chris S.; Ratcliffe, Norman			A Pilot Study Combining a GC-Sensor Device with a Statistical Model for the Identification of Bladder Cancer from Urine Headspace	PLOS ONE			English	Article							BIOMARKERS; EXPRESSION; CARCINOMA; DIAGNOSIS	There is a need to reduce the number of cystoscopies on patients with haematuria. Presently there are no reliable biomarkers to screen for bladder cancer. In this paper, we evaluate a new simple in-house fabricated, GC-sensor device in the diagnosis of bladder cancer based on volatiles. Sensor outputs from 98 urine samples were used to build and test diagnostic models. Samples were taken from 24 patients with transitional (urothelial) cell carcinoma (age 27-91 years, median 71 years) and 74 controls presenting with urological symptoms, but without a urological malignancy (age 29-86 years, median 64 years); results were analysed using two statistical approaches to assess the robustness of the methodology. A two-group linear discriminant analysis method using a total of 9 time points (which equates to 9 biomarkers) correctly assigned 24/24 (100%) of cancer cases and 70/74 (94.6%) controls. Under leave-one-out cross-validation 23/24 (95.8%) of cancer cases were correctly predicted with 69/74 (93.2%) of controls. For partial least squares discriminant analysis, the correct leave-one-out cross-validation prediction values were 95.8% (cancer cases) and 94.6% (controls). These data are an improvement on those reported by other groups studying headspace gases and also superior to current clinical techniques. This new device shows potential for the diagnosis of bladder cancer, but the data must be reproduced in a larger study.	[Khalid, Tanzeela; Johnson, Emmanuel; Probert, Chris S.] Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England; [White, Paul; Costello, Ben De Lacy; Ewen, Richard; Ratcliffe, Norman] Univ W England, Inst Biosensor Technol, Bristol BS16 1QY, Avon, England; [Persad, Raj] North Bristol NHS Trust, Bristol Urol Inst, Bristol, Avon, England	University of Liverpool; University of West England; North Bristol NHS Trust	Probert, CS (corresponding author), Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England.	Chris.Probert@liverpool.ac.uk	Khalid, Tanzeela/N-1848-2015; de Lacy Costello, Ben/ABG-2043-2021; De Lacy Costello, Ben/I-8259-2019; Khalid, Tanzeela/AAX-3520-2020	Khalid, Tanzeela/0000-0003-3503-7762; de Lacy Costello, Ben/0000-0003-2999-6801; Khalid, Tanzeela/0000-0003-3503-7762; White, Paul/0000-0002-7503-9896; Probert, Christopher/0000-0003-4550-0239				Abogunrin F, 2012, CANCER-AM CANCER SOC, V118, P2641, DOI 10.1002/cncr.26544; Agah M, 2006, J MICROELECTROMECH S, V15, P1371, DOI 10.1109/JMEMS.2006.879708; ANGELO J, 2001, MED HYPOTHESES, V57, P429, DOI DOI 10.1054/MEHY.2001.1335.PUBMED:11601863; Babjuk M, 2011, EUR UROL, V59, P997, DOI 10.1016/j.eururo.2011.03.017; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Budman LI, 2008, CUAJ-CAN UROL ASSOC, V2, P212; *CANC RES UK, 2012, BLADD CANC UK INC ST; Carnell DM, 2004, INT J RADIAT ONCOL, V58, P500, DOI 10.1016/j.ijrobp.2003.09.064; Costello BPD, 2003, SENSOR ACTUAT B-CHEM, V92, P159, DOI [10.1016/S0925-4005(03)00258-2, 10.1016/SO925-4005(03)00258-2]; Gakis G, 2010, CURR OPIN UROL, V20, P388, DOI 10.1097/MOU.0b013e32833cc9f4; Jacobs BL, 2012, UROL ONCOL-SEMIN ORI, V30, P81, DOI 10.1016/j.urolonc.2011.08.011; KELLY JD, 2009, BMJ-BRIT MED J, V338, P227, DOI DOI 10.1136/BMJ.B227.PUBMED:19151065; Lokeshwar VB, 2005, UROLOGY, V66, P35, DOI 10.1016/j.urology.2005.08.064; MCKAY JA, 1995, FEBS LETT, V374, P270, DOI 10.1016/0014-5793(95)01126-Y; Mostafid H, 2010, BJU INT, V105, P585, DOI 10.1111/j.1464-410X.2009.09108.x; Noyes K, 2008, CURR OPIN UROL, V18, P533, DOI 10.1097/MOU.0b013e32830b8910; Phillips Michael, 2007, Cancer Biomarkers, V3, P95; Phillips M, 2010, J BREATH RES, V4, DOI 10.1088/1752-7155/4/2/026003; Rodgers M, 2006, HEALTH TECHNOL ASSES, V10, pIII; Roos Peter H, 2005, Expert Opin Drug Metab Toxicol, V1, P187, DOI 10.1517/17425255.1.2.187; Smith S, 2008, J BREATH RES, V2, DOI 10.1088/1752-7155/2/3/037022; Smith S, 2010, IEEE SENS J, V10, P92, DOI 10.1109/JSEN.2009.2035771; *SOFTW VERN TECHN, 2013, VERN MINIGC PLUS GAS; Spanel P, 1999, RAPID COMMUN MASS SP, V13, P1354, DOI 10.1002/(SICI)1097-0231(19990730)13:14<1354::AID-RCM641>3.0.CO;2-J; Stenzl A, 2008, CURR OPIN UROL, V18, P488, DOI 10.1097/MOU.0b013e32830b8925; Weber CM, 2011, ANALYST, V136, P359, DOI 10.1039/c0an00382d; Willis CM, 2010, CANCER BIOMARK, V8, P145, DOI 10.3233/CBM-2011-0208; Willis CM, 2004, BMJ-BRIT MED J, V329, P712, DOI 10.1136/bmj.329.7468.712; Zampolli S, 2005, SENSOR ACTUAT B-CHEM, V105, P400, DOI 10.1016/j.snb.2004.06.036	29	37	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e69602	10.1371/journal.pone.0069602	http://dx.doi.org/10.1371/journal.pone.0069602			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861976	Green Published, gold, Green Submitted			2022-12-27	WOS:000321692000047
J	Casarin, R; Squazzoni, F				Casarin, Roberto; Squazzoni, Flaminio			Being on the Field When the Game Is Still Under Way. The Financial Press and Stock Markets in Times of Crisis	PLOS ONE			English	Article							BAD-NEWS; MEDIA; INFORMATION; IMPACT; VOLATILITY; CONTAGION; SENTIMENT; INSIGHTS; PRICES	This paper looks at the relationship between negative news and stock markets in times of global crisis, such as the 2008/2009 period. We analysed one year of front page banner headlines of three financial newspapers, the Wall Street Journal, Financial Times, and Il Sole24ore to examine the influence of bad news both on stock market volatility and dynamic correlation. Our results show that the press and markets influenced each other in generating market volatility and in particular, that the Wall Street Journal had a crucial effect both on the volatility and correlation between the US and foreign markets. We also found significant differences between newspapers in their interpretation of the crisis, with the Financial Times being significantly pessimistic even in phases of low market volatility. Our results confirm the reflexive nature of stock markets. When the situation is uncertain and unpredictable, market behaviour may even reflect qualitative, big picture, and subjective information such as streamers in a newspaper, whose economic and informative value is questionable.	[Casarin, Roberto] Univ Ca Foscari, Dept Econ, Venice, Italy; [Squazzoni, Flaminio] Univ Brescia, Dept Econ & Business, Brescia, Italy	Universita Ca Foscari Venezia; University of Brescia	Casarin, R (corresponding author), Univ Ca Foscari, Dept Econ, Venice, Italy.	r.casarin@unive.it	Casarin, Roberto/D-5894-2014	Casarin, Roberto/0000-0003-1746-9190; Squazzoni, Flaminio/0000-0002-6503-6077	Italian Ministry of Education, University and Research (MIUR); European Union [SYRTO-SSH-2012-320270]	Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); European Union(European Commission)	Roberto Casarin acknowledges financial support by a PRIN 2010-11 grant by the Italian Ministry of Education, University and Research (MIUR) and by the European Union, Seventh Framework Programme FP7/2007-2013 under grant agreement SYRTO-SSH-2012-320270. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann J, 2008, J FINANC STABIL, V4, P329, DOI 10.1016/j.jfs.2008.09.002; [Anonymous], 1998, J ECON BUS, DOI DOI 10.1016/S0148-6195(98)00004-6; Balduzzi P, 2001, J FINANC QUANT ANAL, V36, P523, DOI 10.2307/2676223; BARBER BM, 1993, J FINANC QUANT ANAL, V28, P273, DOI 10.2307/2331290; Beber A, 2010, REV FINANC, V14, P119, DOI 10.1093/rof/rfp006; Boero R, 2010, JASSS-J ARTIF SOC S, V13, DOI 10.18564/jasss.1620; Bollen J, 2011, J COMPUT SCI-NETH, V2, P1, DOI 10.1016/j.jocs.2010.12.007; BORGES B, 1999, SIMPLE HEURISTICS MA, P59; Brenner M, 2009, J FINANC QUANT ANAL, V44, P1265, DOI 10.1017/S002210900999038X; Cetina KK, 2002, AM J SOCIOL, V107, P905, DOI 10.1086/341045; Chiang TC, 2007, J INT MONEY FINANC, V26, P1206, DOI 10.1016/j.jimonfin.2007.06.005; Cipriani M, 2008, BE J THEOR ECON, V8; Clark GL, 2004, REV INT POLIT ECON, V11, P289, DOI 10.1080/09692290420001672813; Coval JD, 2001, J FINANC, V56, P1887, DOI 10.1111/0022-1082.00393; Dougal C, 2012, REV FINANC STUD, V25, P639, DOI 10.1093/rfs/hhr133; Doyle G., 2006, JOURNALISM, V7, P433, DOI DOI 10.1177/1464884906068361; Dror Y, 2012, PLOS ONE, V7; Engelberg JE, 2011, J FINANC, V66, P67, DOI 10.1111/j.1540-6261.2010.01626.x; Engle R, 2002, J BUS ECON STAT, V20, P339, DOI 10.1198/073500102288618487; ENGLE RF, 1982, ECONOMETRICA, V50, P987, DOI 10.2307/1912773; ENGLE RF, 1993, J FINANC, V48, P1749, DOI 10.2307/2329066; Entman R, 1996, J COMMUN, V43, P51; Forbes KJ, 2002, J FINANC, V57, P2223, DOI 10.1111/0022-1082.00494; Gentzkow M, 2010, ECONOMETRICA, V78, P35, DOI 10.3982/ECTA7195; Goodman PS, 2011, BAD NEWS AM BUSINESS, P94; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Griffin JM, 2011, REV FINANC STUD, V24, P3941, DOI 10.1093/rfs/hhr099; Jondeau E, 2006, J INT MONEY FINANC, V25, P827, DOI 10.1016/j.jimonfin.2006.04.007; Kahneman D, 2000, CHOICES VALUES FRAME; Kleinnijenhuis J, 2013, JOURNALISM, V14, P271, DOI 10.1177/1464884912468375; Knorr Cetina K, 2007, THEOR CULT SOC, V22, P213; Knorr Cetina K., 2005, SOCIOLOGY FINANCIAL; Koutmos G, 1995, J INT MONEY FINANC, V14, P747, DOI 10.1016/0261-5606(95)00031-3; LIU P, 1990, J FINANC QUANT ANAL, V25, P399, DOI 10.2307/2330704; Longin F, 2001, J FINANC, V56, P649, DOI 10.1111/0022-1082.00340; Mondria J, 2006, WORKING PAPERS U TOR; Morris S, 1999, OXFORD REV ECON POL, V15, P52, DOI 10.1093/oxrep/15.3.52; Nofsinger J, 2005, J BEHAV FINANC, V6, P144, DOI 10.1207/s15427579jpfm0603_4; Oberlechner T, 2004, J ECON PSYCHOL, V25, P407, DOI 10.1016/s0167-4870(02)00189-7; Parsons W., 1989, POWER FINANCIAL PRES; PEARCE DK, 1985, J BUS, V58, P49, DOI 10.1086/296282; Pixley J, 2002, BRIT J SOCIOL, V53, P41, DOI 10.1080/00071310120109320; Preda A, 2007, J ECON SURV, V21, P506, DOI 10.1111/j.1467-6419.2007.00512.x; Preis T, 2010, PHILOS T R SOC A, V368, P5707, DOI 10.1098/rsta.2010.0284; Pritamani M, 2001, J BANK FINANC, V25, P631, DOI 10.1016/S0378-4266(00)00091-1; Reinhart CM, 2009, THIS TIME IS DIFFERENT: EIGHT CENTURIES OF FINANCIAL FOLLY, P1; Schifferes S., 2011, BAD NEWS AM BUSINESS, P148; Schindler M., 2007, RUMORS FINANCIAL MAR; Severin W, 2005, COMMUNICATION THEORI; Shiller RJ, 2005, IRRATIONAL EXUBERANCE-SECOND EDITION, P1; Shiller RJ, 2002, FINANC ANAL J, V58, P18, DOI 10.2469/faj.v58.n3.2535; Soroka SN, 2006, J POLIT, V68, P372, DOI 10.1111/j.1468-2508.2006.00413.x; Stickle S. E., 1994, FINANCIAL ANAL J, P57; Suk-Joong Kim, 2001, J MULTINATL FINANC M, V11, P117; Suttles G, 2010, FRONT PAGE EC; Tambini D, 2010, JOURNALISM STUD, V11, P158, DOI 10.1080/14616700903378661; Tan SJ, 2004, J CONSUM MARK, V21, P343, DOI 10.1108/07363760410549168; Tetlock PC, 2008, J FINANC, V63, P1437, DOI 10.1111/j.1540-6261.2008.01362.x; Tetlock PC, 2007, J FINANC, V62, P1139, DOI 10.1111/j.1540-6261.2007.01232.x; Tetlock PC, 2011, REV FINANC STUD, V24, P1481, DOI 10.1093/rfs/hhq141; Tetlock PC, 2010, REV FINANC STUD, V23, P3520, DOI 10.1093/rfs/hhq052; Thaler R.H, 1993, ADV BEHAV FINANCE; Thrift N, 2001, ECON SOC, V30, P412, DOI 10.1080/03085140120089045; Tickell A, 1995, ENVIRON PLANN D, V14, P5; Tivegna M, 2004, NEWS EXCHANGE RATE D; Tse Y, 1999, J FUTURES MARKETS, V19, P911, DOI 10.1002/(SICI)1096-9934(199912)19:8<911::AID-FUT4>3.3.CO;2-H; Veronesi P, 1999, REV FINANC STUD, V12, P975, DOI 10.1093/rfs/12.5.975	68	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67721	10.1371/journal.pone.0067721	http://dx.doi.org/10.1371/journal.pone.0067721			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	178DW	23861791	Green Published, gold, Green Submitted			2022-12-27	WOS:000321425300023
J	Lu, Q; Hua, J; Kassir, MM; Delproposto, Z; Dai, YM; Sun, JY; Haacke, M; Hu, JN				Lu, Qing; Hua, Jia; Kassir, Mohammad M.; Delproposto, Zachary; Dai, Yongming; Sun, Jingyi; Haacke, Mark; Hu, Jiani			Imaging Lymphatic System in Breast Cancer Patients with Magnetic Resonance Lymphangiography	PLOS ONE			English	Article							NODE METASTASES; CT LYMPHOGRAPHY; MR LYMPHOGRAPHY; SENTINEL NODE; DRAINAGE; LYMPHOSCINTIGRAPHY; LOCALIZATION; EXPERIENCE; CARCINOMA; TOXICITY	Objective: To investigate the feasibility of gadolinium (Gd) contrast-enhanced magnetic resonance lymphangiography (MRL) in breast cancer patients within a typical clinical setting, and to establish a Gd-MRL protocol and identify potential MRL biomarkers for differentiating metastatic from non-metastatic lymph nodes. Materials and Methods: 32 patients with unilateral breast cancer were enrolled and divided into 4 groups of 8 patients. Groups I, II, and III received 1.0, 0.5, and 0.3 ml of intradermal contrast; group IV received two 0.5 ml doses of intradermal contrast. MRL images were acquired on a 3.0 T system and evaluated independently by two radiologists for the number and size of enhancing lymph nodes, lymph node contrast uptake kinetics, lymph vessel size, and contrast enhancement patterns within lymph nodes. Results: Group III patients had a statistically significant decrease in the total number of enhancing axillary lymph nodes and lymphatic vessels compared to all other groups. While group IV patients had a statistically significant faster time to reach the maximum peak enhancement over group I and II (by 3 minutes), there was no other statistically significant difference between imaging results between groups I, II, and IV. 27 out of 128 lymphatic vessels (21%) showed dilatation, and all patients with dilated lymphatic vessels were pathologically proven to have metastases. Using the pattern of enhancement defects as the sole criterion for identifying metastatic lymph nodes during Gd-MRL interpretation, and using histopathology as the gold standard, the sensitivity and specificity were estimated to be 86% and 95%, respectively. Conclusion: Gd-MRL can adequately depict the lymphatic system, can define sentinel lymph nodes, and has the potential to differentiate between metastatic and non-metastatic lymph nodes in breast cancer patients.	[Lu, Qing; Hua, Jia] Shanghai Jiao Tong Univ, Sch Med, Shanghai Renji Hosp, Dept Radiol, Shanghai 200030, Peoples R China; [Kassir, Mohammad M.; Sun, Jingyi; Haacke, Mark; Hu, Jiani] Wayne State Univ, Dept Radiol, Detroit, MI 48202 USA; [Delproposto, Zachary] Henry Ford Hosp, Dept Radiol, Detroit, MI 48202 USA; [Dai, Yongming] Philips Healthcare, MR Business, Shanghai, Peoples R China	Shanghai Jiao Tong University; Wayne State University; Henry Ford Health System; Henry Ford Hospital; Philips; Philips Healthcare	Hua, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Renji Hosp, Dept Radiol, Shanghai 200030, Peoples R China.	jhu@med.wayne.edu; Jill_huajia@163.com			National Natural Science Foundation of China [81271638]; National Basic Research Program of China (973 Program) [2012CB932600]; Shanghai Shen-kang Hospital Development Centre [SHDC12012112]; Shanghai Leading Academic Discipline Project [S30203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Shanghai Shen-kang Hospital Development Centre; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work is supported by National Natural Science Foundation of China (81271638); National Basic Research Program of China (973 Program: 2012CB932600); Frontier technology project of Shanghai Shen-kang Hospital Development Centre (SHDC12012112); and Shanghai Leading Academic Discipline Project (S30203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aukema TS, 2009, EUR J NUCL MED MOL I, V36, P1896, DOI 10.1007/s00259-009-1211-0; Blumgart EI, 2011, BREAST CANCER RES TR, V130, P699, DOI 10.1007/s10549-011-1737-2; Chagpar AB, 2005, SURGERY, V138, P56, DOI 10.1016/j.surg.2005.03.003; Choi SH, 2006, RADIOLOGY, V241, P753, DOI 10.1148/radiol.2413051979; Choi WH, 2011, BRIT J RADIOL, V84, P593, DOI 10.1259/bjr/56324742; COHAN RH, 1991, INVEST RADIOL, V26, P224, DOI 10.1097/00004424-199103000-00005; Couto D, 2004, EUR J GYNAECOL ONCOL, V25, P568; Fitzgibbons PL, 2000, ARCH PATHOL LAB MED, V124, P966; Fowler JC, 2009, EJSO-EUR J SURG ONC, V35, P1041, DOI 10.1016/j.ejso.2009.02.018; Herborn CU, 2003, J MAGN RESON IMAGING, V18, P328, DOI 10.1002/jmri.10357; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kobayashi H, 2004, J NATL CANCER I, V96, P703, DOI 10.1093/jnci/djh124; Krag D, 1998, NEW ENGL J MED, V339, P941, DOI 10.1056/NEJM199810013391401; Liu NF, 2010, BRIT J SURG, V97, P359, DOI 10.1002/bjs.6893; Liu NF, 2009, J VASC SURG, V49, P980, DOI 10.1016/j.jvs.2008.11.029; Lohrmann C, 2008, MICROVASC RES, V76, P42, DOI 10.1016/j.mvr.2008.03.003; Lohrmann C, 2011, EUR J RADIOL, V80, P576, DOI 10.1016/j.ejrad.2009.10.021; Lu Q, 2012, EUR J VASC ENDOVASC, V43, P106, DOI 10.1016/j.ejvs.2011.09.007; Lu Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050319; Lu Q, 2010, EUR J RADIOL, V73, P365, DOI 10.1016/j.ejrad.2008.10.041; NAKAJIMA T, 1987, Nippon Acta Radiologica, V47, P565; Nathanson SD, 2001, ANN SURG ONCOL, V8, P837; NIENDORF HP, 1991, MAGNET RESON MED, V22, P222, DOI 10.1002/mrm.1910220212; Notohamiprodjo M, 2009, EUR RADIOL, V19, P2771, DOI 10.1007/s00330-009-1461-z; Overgaard M, 2007, RADIOTHER ONCOL, V82, P247, DOI 10.1016/j.radonc.2007.02.001; Ruehm SG, 2001, RADIOLOGY, V220, P816, DOI 10.1148/radiol.2203010090; Runge VM, 2002, INVEST RADIOL, V37, P393, DOI 10.1097/00004424-200207000-00006; Shu YL, 2011, LARYNGOSCOPE, V121, P724, DOI 10.1002/lary.21404; Stephenson N J, 1995, Australas Radiol, V39, P54, DOI 10.1111/j.1440-1673.1995.tb00232.x; Suga K, 2004, RADIOLOGY, V230, P543, DOI 10.1148/radiol.2302021380; Suga K, 2003, ACTA RADIOL, V44, P35; Taillefer R, 1998, J NUCL MED, V39, P459; Tanis PJ, 2001, J AM COLL SURGEONS, V192, P399, DOI 10.1016/S1072-7515(00)00776-6; Teal CB, 2005, AM J SURG, V190, P567, DOI 10.1016/j.amjsurg.2005.06.012; Turner RR, 2000, CANCER-AM CANCER SOC, V89, P574, DOI 10.1002/1097-0142(20000801)89:3<574::AID-CNCR12>3.0.CO;2-Y; Veronesi U, 1999, JNCI-J NATL CANCER I, V91, P368, DOI 10.1093/jnci/91.4.368; VONESCHENBACH AC, 1985, UROL CLIN N AM, V12, P715; Wu HT, 2010, ACTA OTO-LARYNGOL, V130, P503, DOI 10.3109/00016480903253595; Yuen S, 2002, ACTA RADIOL, V43, P579, DOI 10.1034/j.1600-0455.2002.430608.x	39	17	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e69701	10.1371/journal.pone.0069701	http://dx.doi.org/10.1371/journal.pone.0069701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861979	gold, Green Published, Green Submitted			2022-12-27	WOS:000321425300090
J	Sanyal, T; Kumar, V; Nag, TC; Jain, S; Sreenivas, V; Wadhwa, S				Sanyal, Tania; Kumar, Vivek; Nag, Tapas Chandra; Jain, Suman; Sreenivas, Vishnu; Wadhwa, Shashi			Prenatal Loud Music and Noise: Differential Impact on Physiological Arousal, Hippocampal Synaptogenesis and Spatial Behavior in One Day-Old Chicks	PLOS ONE			English	Article							BRAIN NOREPINEPHRINE CONCENTRATIONS; PROTEIN-PROTEIN INTERACTIONS; COMPLEX RHYTHM STIMULUS; LONG-TERM POTENTIATION; PIGEON COLUMBA-LIVIA; MEMORY CONSOLIDATION; POSTSYNAPTIC DENSITY; ALZHEIMERS-DISEASE; RESTRAINT STRESS; MEMBRANE-PROTEIN	Prenatal auditory stimulation in chicks with species-specific sound and music at 65 dB facilitates spatial orientation and learning and is associated with significant morphological and biochemical changes in the hippocampus and brainstem auditory nuclei. Increased noradrenaline level due to physiological arousal is suggested as a possible mediator for the observed beneficial effects following patterned and rhythmic sound exposure. However, studies regarding the effects of prenatal high decibel sound (110 dB; music and noise) exposure on the plasma noradrenaline level, synaptic protein expression in the hippocampus and spatial behavior of neonatal chicks remained unexplored. Here, we report that high decibel music stimulation moderately increases plasma noradrenaline level and positively modulates spatial orientation, learning and memory of one day-old chicks. In contrast, noise at the same sound pressure level results in excessive increase of plasma noradrenaline level and impairs the spatial behavior. Further, to assess the changes at the molecular level, we have quantified the expression of functional synapse markers: synaptophysin and PSD-95 in the hippocampus. Compared to the controls, both proteins show significantly increased expressions in the music stimulated group but decrease in expressions in the noise group. We propose that the differential increase of plasma noradrenaline level and altered expression of synaptic proteins in the hippocampus are responsible for the observed behavioral consequences following prenatal 110 dB music and noise stimulation.	[Sanyal, Tania; Kumar, Vivek; Nag, Tapas Chandra; Wadhwa, Shashi] All India Inst Med Sci, Dept Anat, New Delhi 110029, India; [Jain, Suman] All India Inst Med Sci, Dept Physiol, New Delhi, India; [Sreenivas, Vishnu] All India Inst Med Sci, Dept Biostat, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Wadhwa, S (corresponding author), All India Inst Med Sci, Dept Anat, New Delhi 110029, India.	shashiwadhwa@hotmail.com	KUMAR, VIVEK/AAE-7170-2021; NAG, TAPAS CHANDRA/R-6285-2019	KUMAR, VIVEK/0000-0002-5897-4495; NAG, TAPAS CHANDRA/0000-0002-6962-0844	Department of Biotechnology, Goverment of India [BT/PR10651/Med/30/102/2008]; Department of Biotechnology, Goverment of India [BT/PR10651/Med/30/102/2008]	Department of Biotechnology, Goverment of India; Department of Biotechnology, Goverment of India	This work was supported by the Department of Biotechnology, Goverment of India, grant number: BT/PR10651/Med/30/102/2008. (URL 1: http://dbtneuro.ncbs.res.in/node/12; URL 2: http://dbtindia.nic.in/index.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2011, EXP GERONTOL, V46, P53, DOI 10.1016/j.exger.2010.10.001; ALDRIDGE D, 1994, BIOMED PHARMACOTHER, V48, P275, DOI 10.1016/0753-3322(94)90172-4; Azmi S, 2000, TUMOR BIOL, V21, P3, DOI 10.1159/000030105; Baker KB, 2002, LEARN MEMORY, V9, P58, DOI 10.1101/lm.46102; Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; BERGMANN M, 1993, DEV BRAIN RES, V74, P235, DOI 10.1016/0165-3806(93)90009-Y; Bisagno V, 2004, PHARMACOL BIOCHEM BE, V78, P541, DOI 10.1016/j.pbb.2004.04.023; Bowman RE, 2001, BRAIN RES, V904, P279, DOI 10.1016/S0006-8993(01)02474-X; Braun K, 1999, BEHAV BRAIN RES, V98, P211, DOI 10.1016/S0166-4328(98)00086-2; BURESOVA O, 1964, PHYSIOL BOHEMOSLOV, V13, P220; CALAKOS N, 1994, J BIOL CHEM, V269, P24534; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; Calakos N, 1996, PHYSIOL REV, V76, P1; Calhoun ME, 1998, NEUROBIOL AGING, V19, P599, DOI 10.1016/S0197-4580(98)00098-0; CASINI G, 1986, J COMP NEUROL, V245, P454, DOI 10.1002/cne.902450403; Chaudhury S, 2008, BRAIN RES, V1191, P96, DOI 10.1016/j.brainres.2007.11.021; Chaudhury S, 2010, DEV NEUROSCI-BASEL, V32, P114, DOI 10.1159/000279758; Chaudhury S, 2009, SYNAPSE, V63, P152, DOI 10.1002/syn.20585; Chaudhury S, 2006, J CHEM NEUROANAT, V32, P117, DOI 10.1016/j.jchemneu.2006.07.002; CHEN KS, 1995, NEUROSCIENCE, V68, P19, DOI 10.1016/0306-4522(95)00099-5; Chikahisa S, 2006, BEHAV BRAIN RES, V169, P312, DOI 10.1016/j.bbr.2006.01.021; COHEN GM, 1978, ACTA OTO-LARYNGOL, V86, P342, DOI 10.3109/00016487809124756; COLL CG, 1984, CHILD DEV, V55, P1005, DOI 10.2307/1130152; COLLIAS N, 1953, BEHAVIOUR, V5, P175, DOI 10.1163/156853953X00104; Cordero MI, 2003, HORM BEHAV, V44, P338, DOI 10.1016/S0018-506X(03)00160-0; De Wied D, 1991, Methods Achiev Exp Pathol, V15, P167; DECASPER AJ, 1980, SCIENCE, V208, P1174, DOI 10.1126/science.7375928; Dehnhard N, 2011, J COMP PHYSIOL B, V181, P83, DOI 10.1007/s00360-010-0508-4; Del Giudice M, 2011, DEV PSYCHOBIOL, V53, P214, DOI 10.1002/dev.20506; Dhabhar FS, 1997, NEUROENDOCRINOLOGY, V65, P360, DOI 10.1159/000127196; Di Marco S, 2009, J NEUROSCI, V29, P13691, DOI 10.1523/JNEUROSCI.3854-09.2009; DMITRIEVA LP, 1994, BEHAV NEURAL BIOL, V61, P19, DOI 10.1016/S0163-1047(05)80040-8; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; El-Hussein AE, 2000, SCIENCE, V290, P1364; Feltenstein MW, 2003, PHYSIOL BEHAV, V78, P489, DOI 10.1016/S0031-9384(03)00030-1; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Field SE, 2007, NEUROBIOL LEARN MEM, V88, P321, DOI 10.1016/j.nlm.2007.04.001; Frick KM, 2003, NEUROBIOL AGING, V24, P615, DOI 10.1016/S0197-4580(02)00138-0; Gibbs ME, 2001, EUR J NEUROSCI, V14, P1369, DOI 10.1046/j.0953-816x.2001.01742.x; Gibbs ME, 2000, NEUROSCIENCE, V95, P913; GILBERT DB, 1989, PHARMACOL BIOCHEM BE, V34, P439, DOI 10.1016/0091-3057(89)90340-7; GOLD PE, 1978, BEHAV BIOL, V24, P168, DOI 10.1016/S0091-6773(78)93045-6; GOLD PE, 1978, BEHAV BIOL, V23, P509, DOI 10.1016/S0091-6773(78)91614-0; GOTTLIEB G, 1978, J COMP PHYSIOL PSYCH, V92, P375, DOI 10.1037/h0077473; GRABS D, 1994, EUR J NEUROSCI, V6, P1765, DOI 10.1111/j.1460-9568.1994.tb00569.x; Griefahn B, 1986, NOISE POLLUTION EFFE, P265; HORNE JA, 1994, SLEEP, V17, P146, DOI 10.1093/sleep/17.2.146; HOSKINS C, 1988, J MUSIC THER, V25, P73, DOI 10.1093/jmt/25.2.73; Hunt CA, 1996, J NEUROSCI, V16, P1380; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; Jain Suman, 2004, Indian Journal of Physiology and Pharmacology, V48, P174; Johnson JK, 1998, NEUROL RES, V20, P666; Jones TA, 2006, J NEUROPHYSIOL, V96, P128, DOI 10.1152/jn.00599.2005; Kagan J, 1999, BIOL PSYCHIAT, V46, P1536, DOI 10.1016/S0006-3223(99)00137-7; Kauser H, 2011, DEV NEUROSCI-BASEL, V33, P48, DOI 10.1159/000322449; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kim H, 2006, BRAIN DEV-JPN, V28, P109, DOI 10.1016/j.braindev.2005.05.008; Kohl Z, 2002, GENES BRAIN BEHAV, V1, P46, DOI 10.1046/j.1601-1848.2001.00009.x; KUGLER J, 1990, INT J NEUROSCI, V51, P233, DOI 10.3109/00207459008999705; Lazic M, 2007, DEV PSYCHOBIOL, V49, P548, DOI 10.1002/dev.20230; Leventhall H G, 2004, Noise Health, V6, P59; Lewis TL, 2009, OPTOMETRY VISION SCI, V86, P640, DOI 10.1097/OPX.0b013e3181a7296b; LICKLITER R, 1992, Q J EXP PSYCHOL-B, V44B, P199; Liu XY, 1996, DEMENTIA, V7, P128, DOI 10.1159/000106867; LORD TR, 1993, PERCEPT MOTOR SKILL, V76, P451, DOI 10.2466/pms.1993.76.2.451; Manire CA, 2007, COMP BIOCHEM PHYS A, V148, P926, DOI 10.1016/j.cbpa.2007.09.017; MCGAUGH JL, 1983, ANNU REV PSYCHOL, V34, P297, DOI 10.1146/annurev.ps.34.020183.001501; Men DS, 1999, NEUROBIOL LEARN MEM, V71, P289, DOI 10.1006/nlme.1998.3880; Metzger M, 1998, J COMP NEUROL, V395, P380; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; MOCKEL M, 1994, EUR J APPL PHYSIOL, V68, P451, DOI 10.1007/BF00599512; MORTON LL, 1990, J MUSIC THER, V27, P195, DOI 10.1093/jmt/27.4.195; NAVONE F, 1986, J CELL BIOL, V103, P2511, DOI 10.1083/jcb.103.6.2511; PORTER D, 1984, J EXP PSYCHOL ANIM B, V10, P138; Puelles L., 2007, CHICK BRAIN STEREOTA, V1st; QUERLEU D, 1984, Journal de Gynecologie Obstetrique et biologie de la Reproduction, V13, P125; Quirarte GL, 1998, BRAIN RES, V808, P134, DOI 10.1016/S0006-8993(98)00795-1; Rabinowitz PM, 2000, AM FAM PHYSICIAN, V61, P2749; Rao S, 1999, NIMBUS RECORDS ROTTE; Rauscher FH, 1997, NEUROL RES, V19, P2; Reznick JS, 1989, PERSPECTIVES BEHAV I, P17; RIBATTI D, 1993, ANN ANAT, V175, P85; Rickard NS, 2009, J COMP PSYCHOL, V123, P217, DOI 10.1037/a0015117; Rogers L. J., 1995, DEV BRAIN BEHAV CHIC; Rogers LJ, 2008, BRAIN RES BULL, V76, P235, DOI 10.1016/j.brainresbull.2008.02.001; ROGERS LJ, 1990, BEHAV BRAIN RES, V38, P211, DOI 10.1016/0166-4328(90)90176-F; ROGERS LJ, 1982, NATURE, V297, P223, DOI 10.1038/297223a0; ROGERS LJ, 1991, NEUROSCI LETT, V121, P63, DOI 10.1016/0304-3940(91)90650-I; Ross JC, 2012, P 2 COMPMUSIC WORKSH, P133; SAITO S, 1994, J NEUROSCI RES, V39, P57, DOI 10.1002/jnr.490390108; SAUNDERS JC, 1973, BRAIN RES, V63, P59, DOI 10.1016/0006-8993(73)90076-0; Schmitt U, 2009, NEUROSCIENCE, V162, P234, DOI 10.1016/j.neuroscience.2009.04.046; SCHRECKENBERG G M, 1987, Bulletin New Jersey Academy of Science, V32, P77; SHERRY DF, 1992, TRENDS NEUROSCI, V15, P298, DOI 10.1016/0166-2236(92)90080-R; SHORS TJ, 1992, SCIENCE, V257, P537, DOI 10.1126/science.1636089; Sleigh MJ, 1996, J COMP PSYCHOL, V110, P233, DOI 10.1037/0735-7036.110.3.233; Smith TD, 2000, J NEUROSCI, V20, P6587, DOI 10.1523/JNEUROSCI.20-17-06587.2000; Stillman MJ, 1998, PHYSIOL BEHAV, V64, P605, DOI 10.1016/S0031-9384(98)00091-2; Strasser R, 1997, BEHAV NEUROSCI, V111, P1245, DOI 10.1037/0735-7044.111.6.1245; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011; Toukhsati SR, 2005, BEHAV BRAIN RES, V159, P105, DOI 10.1016/j.bbr.2004.10.007; Toukhsati SR, 2004, J COMP PSYCHOL, V118, P65, DOI 10.1037/0735-7036.118.1.65; Toukhsati SR, 2001, J COMP PSYCHOL, V115, P132, DOI 10.1037/0735-7036.115.2.132; TSAI HM, 1981, J COMP NEUROL, V198, P275, DOI 10.1002/cne.901980207; Vickers CA, 2006, BRAIN RES, V1090, P89, DOI 10.1016/j.brainres.2006.03.075; Volman SF, 1997, BRAIN BEHAV EVOLUT, V49, P110, DOI 10.1159/000112985; Wadhwa S, 1999, INT J DEV NEUROSCI, V17, P239, DOI 10.1016/S0736-5748(99)00005-2; Watanabe S, 1999, BEHAV PROCESS, V47, P53, DOI 10.1016/S0376-6357(99)00049-2; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; WILD JM, 1993, J COMP NEUROL, V337, P32; Xu HY, 2004, J NEUROCHEM, V91, P1380, DOI 10.1111/j.1471-4159.2004.02827.x; Yan Z, 1999, NAT NEUROSCI, V2, P13, DOI 10.1038/4516; Yao WD, 2004, NEURON, V41, P625, DOI 10.1016/S0896-6273(04)00048-0; Zuckerman M, 1991, PSYCHOBIOLOGY PERSON, P408; [No title captured], DOI DOI 10.12697/SSS.2009.37.3-4.03	117	30	33	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67347	10.1371/journal.pone.0067347	http://dx.doi.org/10.1371/journal.pone.0067347			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861759	Green Submitted, Green Published, gold			2022-12-27	WOS:000321425300012
J	Schultze, A; Pregitzer, P; Walter, MF; Woods, DF; Marinotti, O; Breer, H; Krieger, J				Schultze, Anna; Pregitzer, Pablo; Walter, Marika F.; Woods, Daniel F.; Marinotti, Osvaldo; Breer, Heinz; Krieger, Juergen			The Co-Expression Pattern of Odorant Binding Proteins and Olfactory Receptors Identify Distinct Trichoid Sensilla on the Antenna of the Malaria Mosquito Anopheles gambiae	PLOS ONE			English	Article							VECTOR MOSQUITO; EXPRESSION PATTERN; COMPARATIVE GENOMICS; GENES; IDENTIFICATION; NEURONS; ACTIVATION; HOMOLOGS; REVEALS; DISEASE	The initial steps of odorant recognition in the insect olfactory system involve odorant binding proteins (OBPs) and odorant receptors (ORs). While large families of OBPs have been identified in the malaria vector A. gambiae, little is known about their expression pattern in the numerous sensory hairs of the female antenna. We applied whole mount fluorescence in Situ hybridization (WM-FISH) and fluorescence immunohistochemistry (WM-FIHC) to investigate the sensilla co-expression of eight A. gambiae OBPs (AgOBPs), most notably AgOBP1 and AgOBP4, which all have abundant transcripts in female antenna. WM-FISH analysis of female antennae using AgOBP-specific probes revealed marked differences in the number of cells expressing each various AgOBPs. Testing combinations of AgOBP probes in two-color WM-FISH resulted in distinct cellular labeling patterns, indicating a combinatorial expression of AgOBPs and revealing distinct AgOBP requirements for various functional sensilla types. WM-FIHC with antisera to AgOBP1 and AgOBP4 confirmed expression of the respective proteins by support cells and demonstrated a location of OBPs within sensilla trichodea. Based on the finding that AgOBP1 and AgOBP4 as well as the receptor type AgOR2 are involved in the recognition of indole, experiments were performed to explore if the AgOBP-types and AgOR2 are co-expressed in distinct olfactory sensilla. Applying two-color WM-FISH with AgOBP-specific probes and probes specific for AgOR2 revealed a close association of support cells bearing transcripts for AgOBP1 and AgOBP4 and neurons with a transcript for the receptor AgOR2. Moreover, combined WM-FISH/-FIHC approaches using an AgOR2-specific riboprobe and AgOBP-specific antisera revealed the expression of the "ligand-matched" AgOBP1, AgOBP4 and AgOR2 to single trichoid hairs. This result substantiates the notion that a specific response to indole is mediated by an interplay of the proteins.	[Schultze, Anna; Pregitzer, Pablo; Breer, Heinz; Krieger, Juergen] Univ Hohenheim, Inst Physiol, Stuttgart, Germany; [Walter, Marika F.; Marinotti, Osvaldo] Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92717 USA; [Woods, Daniel F.] Inscent Inc, Irvine, CA USA	University Hohenheim; University of California System; University of California Irvine	Krieger, J (corresponding author), Univ Hohenheim, Inst Physiol, Stuttgart, Germany.	juergen.krieger@uni-hohenheim.de		Marinotti, Osvaldo/0000-0002-7173-7160	European Community [FP7-222927]	European Community(European Commission)	This work was supported by a grant from the European Community's Seventh Framework Programme project ENAROMaTIC (FP7/2007-2013; agreement FP7-222927) to JK and MFW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Andronopoulou E, 2006, INSECT MOL BIOL, V15, P797, DOI 10.1111/j.1365-2583.2006.00685.x; Angerer LM, 1992, IN SITU HYBRIDIZATIO, P2; Biessmann H, 2005, INSECT MOL BIOL, V14, P575, DOI 10.1111/j.1365-2583.2005.00590.x; Biessmann H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009471; Blackwell A, 2000, ANN TROP MED PARASIT, V94, P389, DOI 10.1080/00034983.2000.11813554; Blomquist GJ, 2003, INSECT PHEROMONE BIO; Boakye DA, 2004, ANN TROP MED PARASIT, V98, P501, DOI 10.1179/000349804225003514; Bohbot JD, 2011, CHEM SENSES, V36, P149, DOI 10.1093/chemse/bjq105; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Davrazou F, 2011, J BIOL CHEM, V286, P34175, DOI 10.1074/jbc.M111.274712; Forstner Maike, 2009, Int J Biol Sci, V5, P745; Fox AN, 2002, CHEM SENSES, V27, P453, DOI 10.1093/chemse/27.5.453; Fox AN, 2001, P NATL ACAD SCI USA, V98, P14693, DOI 10.1073/pnas.261432998; Grosse-Wilde E, 2007, EUR J NEUROSCI, V25, P2364, DOI 10.1111/j.1460-9568.2007.05512.x; Grosse-Wilde E, 2006, CHEM SENSES, V31, P547, DOI 10.1093/chemse/bjj059; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Hallem EA, 2004, NATURE, V427, P212, DOI 10.1038/427212a; HekmatScafe DS, 1997, J NEUROSCI, V17, P1616; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Iatrou K, 2008, INSECT BIOCHEM MOLEC, V38, P268, DOI 10.1016/j.ibmb.2007.11.008; Justice RW, 2003, INSECT MOL BIOL, V12, P581, DOI 10.1046/j.1365-2583.2003.00443.x; Kwon HW, 2006, P NATL ACAD SCI USA, V103, P13526, DOI 10.1073/pnas.0601107103; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; Maida R, 2005, J NEUROCYTOL, V34, P149, DOI 10.1007/s11068-005-5054-8; Manoharan M, 2013, GENOME BIOL EVOL, V5, P163, DOI 10.1093/gbe/evs131; Meijerink J, 2000, J CHEM ECOL, V26, P1367, DOI 10.1023/A:1005475422978; MENG LZ, 1989, J COMP PHYSIOL A, V165, P139, DOI 10.1007/BF00619188; Nardi JB, 2003, CELL TISSUE RES, V313, P321, DOI 10.1007/s00441-003-0766-5; Ott SR, 2008, J NEUROSCI METH, V172, P220, DOI 10.1016/j.jneumeth.2008.04.031; Pelletier J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010090; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pitts RJ, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-26; Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271; Qiao HL, 2011, CELL MOL LIFE SCI, V68, P1799, DOI 10.1007/s00018-010-0539-8; Qiu YT, 2006, CHEM SENSES, V31, P845, DOI 10.1093/chemse/bjl027; Schultze A, 2012, INSECT MOL BIOL, V21, P187, DOI 10.1111/j.1365-2583.2011.01125.x; Schymura D, 2010, INT J BIOL SCI, V6, P614; Shanbhag SR, 2005, ARTHROPOD STRUCT DEV, V34, P153, DOI 10.1016/j.asd.2005.01.003; Shanbhag SR, 2001, MICROSC RES TECHNIQ, V55, P297, DOI 10.1002/jemt.1179; STEINBRE.RA, 1970, Z MORPHOL TIERE, V68, P93; Swarup S, 2011, GENES BRAIN BEHAV, V10, P648, DOI 10.1111/j.1601-183X.2011.00704.x; Syed Z, 2006, P NATL ACAD SCI USA, V103, P16538, DOI 10.1073/pnas.0607874103; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Vieira FG, 2011, GENOME BIOL EVOL, V3, P476, DOI 10.1093/gbe/evr033; Vogt RG, 2002, J CHEM ECOL, V28, P2371, DOI 10.1023/A:1021009311977; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; WHITE GB, 1974, T ROY SOC TROP MED H, V68, P278, DOI 10.1016/0035-9203(74)90035-2; WILLIAMS MC, 1965, T ROY SOC TROP MED H, V59, P300, DOI 10.1016/0035-9203(65)90012-X; Xu PX, 2003, INSECT MOL BIOL, V12, P549, DOI 10.1046/j.1365-2583.2003.00440.x; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Xu YL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-632; Zhou JJ, 2004, GENE, V327, P117, DOI 10.1016/j.gene.2003.11.007; Zwiebel LJ, 2004, INSECT BIOCHEM MOLEC, V34, P645, DOI 10.1016/j.ibmb.2004.03.017	55	25	27	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e69412	10.1371/journal.pone.0069412	http://dx.doi.org/10.1371/journal.pone.0069412			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861970	Green Published, gold			2022-12-27	WOS:000321425300086
J	Worliczek, HL; Ruttkowski, B; Schwarz, L; Witter, K; Tschulenk, W; Joachim, A				Worliczek, Hanna Lucia; Ruttkowski, Baerbel; Schwarz, Lukas; Witter, Kirsti; Tschulenk, Waltraud; Joachim, Anja			Isospora suis in an Epithelial Cell Culture System - An In Vitro Model for Sexual Development in Coccidia	PLOS ONE			English	Article							TOXOPLASMA-GONDII; APICOMPLEXAN PARASITES; SMALL-INTESTINE; PORCINE; SWINE; PIGLETS; MICROSCOPY; INFECTION; IPEC-J2; BIESTER	Coccidian parasites are of major importance in animal production, public health and food safety. The most frequently used representative in basic research on this group is Toxoplasma gondii. Although this parasite is well investigated there is no adequate in vitro model for its sexual development available and knowledge on this important life cycle phase is therefore scarce. The use of Isospora suis, a sister taxon to T. gondii and the causative agent of piglet coccidiosis, could provide a solution for this. In the present study an in vitro model for neonatal porcine coccidiosis in cells representative for the in vivo situation in the piglet gut was developed and evaluated. The parasite development was investigated by light and transmission electron microscopy and optimum culture conditions were evaluated. Intestinal porcine epithelial cells (IPEC-J2) adequately representing the natural host cells supported the development of all endogenous life cycle stages of I. suis, including gametocytes and oocysts. A concentration of 5% fetal calf serum in the culture medium led to highest gametocyte densities on day 12 post infection. Low infection doses (<= 1 sporozoite for 100 host cells) were best for oocyst and gametocyte development. The presented system can also be used for immunostaining with established antibodies developed against T. gondii (in our case, anti-TgIMC3 antibodies directed against the inner membrane complex 3). The complete life cycle of I. suis in a cell line representing the natural host cell type and species provides a unique model among coccidian parasites and can be used to address a wide range of topics, especially with regard to the sexual development of coccidia.	[Worliczek, Hanna Lucia; Ruttkowski, Baerbel; Schwarz, Lukas; Joachim, Anja] Univ Vet Med Vienna, Dept Pathobiol, Inst Parasitol, Vienna, Austria; [Witter, Kirsti; Tschulenk, Waltraud] Univ Vet Med Vienna, Dept Pathobiol, Inst Anat Histol & Embryol, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Worliczek, HL (corresponding author), Univ Vet Med Vienna, Dept Pathobiol, Inst Parasitol, Vienna, Austria.	hanna.worliczek@vetmeduni.ac.at	Schwarz, Lukas/AAH-3294-2021	Witter, Kirsti/0000-0001-5388-8208; Joachim, Anja/0000-0003-3082-6885; Schwarz, Lukas/0000-0002-4716-4913; Worliczek, Hanna Lucia/0000-0003-1372-5062	Vetmeduni Vienna Profillinien of the University of Veterinary Medicine Vienna [PP16110262]	Vetmeduni Vienna Profillinien of the University of Veterinary Medicine Vienna	This project was funded by the Vetmeduni Vienna Profillinien start-up financing of the University of Veterinary Medicine Vienna (PP16110262). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson-White BR, 2011, CELL MICROBIOL, V13, P18, DOI 10.1111/j.1462-5822.2010.01514.x; Barbosa BF, 2012, VET PARASITOL, V187, P44, DOI 10.1016/j.vetpar.2011.12.039; BERSCHNEIDER H M, 1989, Gastroenterology, V96, pA41; Boothroyd JC, 2009, INT J PARASITOL, V39, P935, DOI 10.1016/j.ijpara.2009.02.003; Brosnahan AJ, 2012, VET MICROBIOL, V156, P229, DOI 10.1016/j.vetmic.2011.10.017; Clark EL, 2012, J BIOSCIENCES, V37, P879, DOI 10.1007/s12038-012-9251-1; Clark JD, 2012, VACCINE, V30, P2683, DOI 10.1016/j.vaccine.2012.02.002; Daugschies A, 2001, PARASITOL RES, V87, P409, DOI 10.1007/s004360100378; FAYER R, 1984, P HELM SOC WASH, V51, P154; Ferguson DJP, 2008, EUKARYOT CELL, V7, P698, DOI 10.1128/EC.00021-08; Ferguson DJP, 2009, MEM I OSWALDO CRUZ, V104, P133, DOI 10.1590/S0074-02762009000200003; FERGUSON DJ, 1974, ACTA PATH MICRO IM B, VB 82, P167; Ferguson DJP, 2003, INT J PARASITOL, V33, P1329, DOI 10.1016/S0020-7519(03)00185-1; Ferguson DJP, 2002, TRENDS PARASITOL, V18, P355, DOI 10.1016/S1471-4922(02)02330-9; FERGUSON DJP, 1980, ACTA PATH MICRO IM B, V88, P151; Gabner S, 2012, MICROSC RES TECHNIQ, V75, P408, DOI 10.1002/jemt.21071; Geens MM, 2011, CYTOTECHNOLOGY, V63, P415, DOI 10.1007/s10616-011-9362-9; Gubbels MJ, 2004, MOL BIOCHEM PARASIT, V137, P99, DOI 10.1016/j.molbiopara.2004.05.007; Hanig S, 2012, PARASITOL INT, V61, P391, DOI 10.1016/j.parint.2012.01.010; HARLEMAN JH, 1984, VET PARASITOL, V17, P27, DOI 10.1016/0304-4017(84)90062-1; Hermosilla C, 2002, PARASITOL RES, V88, P301, DOI 10.1007/s00436-001-0531-1; Hermosilla C, 2008, PARASITOL RES, V102, P777, DOI 10.1007/s00436-007-0849-4; Hirai M, 2008, CURR BIOL, V18, P607, DOI 10.1016/j.cub.2008.03.045; Joachim A, 2011, PARASITOL RES, V109, P1653, DOI 10.1007/s00436-011-2438-9; Kijlstra A, 2008, INT J PARASITOL, V38, P1359, DOI 10.1016/j.ijpara.2008.06.002; Kurth M, 2008, PARASITOL RES, V102, P819, DOI 10.1007/s00436-007-0868-1; LINDSAY DS, 1980, J PARASITOL, V66, P771, DOI 10.2307/3280667; Lindsay DS, 1998, J PARASITOL, V84, P635, DOI 10.2307/3284741; LINDSAY DS, 1991, AM J VET RES, V52, P471; LINDSAY DS, 1987, VET PARASITOL, V24, P301, DOI 10.1016/0304-4017(87)90052-5; LINDSAY DS, 1984, J PROTOZOOL, V31, P152, DOI 10.1111/j.1550-7408.1984.tb04306.x; LINDSAY DS, 1983, J PARASITOL, V69, P783, DOI 10.2307/3281162; Liu XY, 2013, VET PARASITOL, V193, P1, DOI 10.1016/j.vetpar.2012.12.019; Matuschka F.-R., 1981, Zoologische Beitraege, V26, P405; Mengel H, 2012, PARASITOL RES, V110, P1347, DOI 10.1007/s00436-011-2633-8; Meyer C, 1999, VET PARASITOL, V82, P277, DOI 10.1016/S0304-4017(99)00027-8; Muller J, 2013, INT J PARASITOL, V43, P115, DOI 10.1016/j.ijpara.2012.08.004; Mundt HC, 2007, PARASITOL RES, V100, P401, DOI 10.1007/s00436-006-0314-9; Mundt HC, 2006, PARASITOL RES, V98, P167, DOI 10.1007/s00436-005-0030-x; NAKAO M, 1991, PARASITOLOGY, V103, P23, DOI 10.1017/S0031182000059242; PELSTER B, 1971, Z PARASITENK, V37, P267; Schierack P, 2006, HISTOCHEM CELL BIOL, V125, P293, DOI 10.1007/s00418-005-0067-z; Sharman PA, 2010, PARASITE IMMUNOL, V32, P590, DOI 10.1111/j.1365-3024.2010.01209.x; Staggs SE, 2009, J VIS EXP, P1420, DOI [10.3791/1420, DOI 10.3791/1420.PUBMED:19888193]; STUART BP, 1982, CAN J COMP MED, V46, P317; Woodcroft BJ, 2012, TRENDS PARASITOL, V28, P546, DOI 10.1016/j.pt.2012.08.008; Worliczek HL, 2010, PARASITOLOGY, V137, P1637, DOI 10.1017/S0031182010000557; Worliczek HL, 2010, PARASITE IMMUNOL, V32, P232, DOI 10.1111/j.1365-3024.2009.01184.x; Worliczek HL, 2009, PARASITOL RES, V105, pS157, DOI 10.1007/s00436-009-1507-9	49	27	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e69797	10.1371/journal.pone.0069797	http://dx.doi.org/10.1371/journal.pone.0069797			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861983	Green Published, gold, Green Submitted			2022-12-27	WOS:000321425300092
J	Bondzio, A; Lodemann, U; Weise, C; Einspanier, R				Bondzio, Angelika; Lodemann, Ulrike; Weise, Christoph; Einspanier, Ralf			Cry1Ab Treatment Has No Effects on Viability of Cultured Porcine Intestinal Cells, but Triggers Hsp70 Expression	PLOS ONE			English	Article							THURINGIENSIS TOXIN CRY1AB; GENETICALLY-MODIFIED MAIZE; HEAT-SHOCK RESPONSE; BACILLUS-THURINGIENSIS; EPITHELIAL-CELLS; IN-VITRO; MOLECULAR CHAPERONES; IMMUNE-RESPONSE; HNRNP K; HEAT-SHOCK-PROTEIN-70	In vitro testing can contribute to reduce the risk that the use of genetically modified (GM) crops and their proteins show unintended toxic effects. Here we introduce a porcine intestinal cell culture (IPEC-J2) as appropriate in vitro model and tested the possible toxic potential of Cry1Ab protein, commonly expressed in GM-maize. For comprehensive risk assessment we used WST-1 conversion and ATP content as metabolic markers for proliferation, lactate dehydrogenase release as indicator for cells with compromised membrane and transepithelial electrical resistance as parameter indicating membrane barrier function. The results were compared to the effects of valinomycin, a potassium ionophore, known to induce cytotoxic effects in most mammalian cell types. Whereas no toxicity was observed after Cry1Ab treatment, valinomycin induced a decrease in IPEC-J2 viability. This was confirmed by dynamic monitoring of cellular responses. Additionally, two dimensional differential in-gel electrophoresis was performed. Only three proteins were differentially expressed. The functions of these proteins were associated with responses to stress. The up-regulation of heat shock protein Hsp70 was verified by Western blotting as well as by enzyme-linked immunosorbent assay and may be related to a protective function. These findings suggest that the combination of in vitro testing and proteomic analysis may serve as a promising tool for mechanism based safety assessment.	[Bondzio, Angelika; Einspanier, Ralf] Free Univ Berlin, Inst Vet Biochem, Berlin, Germany; [Lodemann, Ulrike] Free Univ Berlin, Inst Vet Physiol, Berlin, Germany; [Weise, Christoph] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany	Free University of Berlin; Free University of Berlin; Free University of Berlin	Bondzio, A (corresponding author), Free Univ Berlin, Inst Vet Biochem, Berlin, Germany.	bondzio@zedat.fu-berlin.de			Deutsche Forschungsgemeinschaft (DFG) [SFB 852/1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was funded by the Deutsche Forschungsgemeinschaft (DFG) through grant SFB 852/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi R, 2013, PHARMACOLOGY, V91, P104, DOI 10.1159/000345930; Arya R, 2007, J BIOSCIENCES, V32, P595, DOI 10.1007/s12038-007-0059-3; Bendiek J., 2006, Journal fuer Verbraucherschutz und Lebensmittelsicherheit/Journal of Consumer Protection and Food Safety, V1, P241, DOI 10.1007/s00003-006-0041-2; Bolkent S, 2002, TOXICOL IN VITRO, V16, P159, DOI 10.1016/S0887-2333(01)00108-4; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Bomsztyk K, 1997, FEBS LETT, V403, P113, DOI 10.1016/S0014-5793(97)00041-0; Bondzio A, 2008, FOOD CHEM TOXICOL, V46, P1976, DOI 10.1016/j.fct.2008.01.038; Cencic A, 2010, INT J FOOD MICROBIOL, V141, pS4, DOI 10.1016/j.ijfoodmicro.2010.03.026; Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; Chowdhury EH, 2003, VET HUM TOXICOL, V45, P72; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; de Vendomois JS, 2009, INT J BIOL SCI, V5, P706; Devriendt B, 2010, DEV COMP IMMUNOL, V34, P1175, DOI 10.1016/j.dci.2010.06.009; Dokladny K, 2006, AM J PHYSIOL-GASTR L, V290, pG204, DOI 10.1152/ajpgi.00401.2005; Dorsch JA, 2002, INSECT BIOCHEM MOLEC, V32, P1025, DOI 10.1016/S0965-1748(02)00040-1; EFSA, 2008, FOOD CHEM TOXICOL, V46, P2, DOI DOI 10.1016/J.FCT.2008.02.008; EFSA (European Food Safety Agency), 2010, EFSA J, V8, P1699; Finamore A, 2008, J AGR FOOD CHEM, V56, P11533, DOI 10.1021/jf802059w; Flannagan RD, 2005, INSECT BIOCHEM MOLEC, V35, P33, DOI 10.1016/j.ibmb.2004.10.001; Gomez I, 2002, FEBS LETT, V513, P242, DOI 10.1016/S0014-5793(02)02321-9; Gomez I, 2006, J BIOL CHEM, V281, P34032, DOI 10.1074/jbc.M604721200; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Heinemann JA, 2011, ENVIRON INT, V37, P1285, DOI 10.1016/j.envint.2011.05.006; Hirata I, 2009, DIGESTION, V79, P243, DOI 10.1159/000215352; Hoffmann F, 2004, ADV BIOCHEM ENG BIOT, V89, P143; Hua G, 2004, J BIOL CHEM, V279, P28051, DOI 10.1074/jbc.M400237200; Hug K, 2008, MEDICINA-LITHUANIA, V44, P87, DOI 10.3390/medicina44020012; Inai Y, 1997, CELL STRUCT FUNCT, V22, P555, DOI 10.1247/csf.22.555; JEHLE JA, 2007, PRODUCTION BT TOXIN; Ke N, 2011, METHODS MOL BIOL, V740, P33, DOI 10.1007/978-1-61779-108-6_6; Kilic A, 2008, FOOD CHEM TOXICOL, V46, P1164, DOI 10.1016/j.fct.2007.11.016; Ku NO, 2010, NAT CELL BIOL, V12, P876, DOI 10.1038/ncb2091; Lanneau D, 2008, J CELL MOL MED, V12, P743, DOI 10.1111/j.1582-4934.2008.00273.x; Laubitz D, 2006, EXP PHYSIOL, V91, P867, DOI 10.1113/expphysiol.2006.033365; Li CY, 2000, J BIOL CHEM, V275, P25665, DOI 10.1074/jbc.M906383199; Liang P, 1997, J CELL SCI, V110, P1431; Luber-Narod J, 2001, TOXICOL IN VITRO, V15, P571, DOI 10.1016/S0887-2333(01)00067-4; Ludwig D, 1999, DIGEST DIS SCI, V44, P1440, DOI 10.1023/A:1026616221950; Lutz B, 2005, J AGR FOOD CHEM, V53, P1453, DOI 10.1021/jf049222x; Marques-Santos LF, 2006, CELL BIOL INT, V30, P197, DOI 10.1016/j.cellbi.2005.10.021; Mesnage R, 2013, J APPL TOXICOL, V33, P695, DOI 10.1002/jat.2712; Mukhopadhyay I, 2003, J BIOCHEM MOL TOXIC, V17, P249, DOI 10.1002/jbt.10086; Musch MW, 1996, AM J PHYSIOL-CELL PH, V270, pC429, DOI 10.1152/ajpcell.1996.270.2.C429; Nguyen Thu Hang, 2004, IOBC-WPRS Bulletin, V27, P125; Niles Andrew L, 2009, Curr Chem Genomics, V3, P33, DOI 10.2174/1875397300903010033; Nunez-Valdez ME, 2001, BBA-PROTEIN STRUCT M, V1546, P122, DOI 10.1016/S0167-4838(01)00132-7; Omary M B, 1998, Subcell Biochem, V31, P105; Paul V, 2010, TRANSGENIC RES, V19, P683, DOI 10.1007/s11248-009-9339-z; Phipps RH, 2003, J DAIRY SCI, V86, P4070, DOI 10.3168/jds.S0022-0302(03)74019-3; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Ryoo IJ, 2006, BIOL PHARM BULL, V29, P817, DOI 10.1248/bpb.29.817; Sagstad A, 2007, J FISH DIS, V30, P201, DOI 10.1111/j.1365-2761.2007.00808.x; Schierack P, 2006, HISTOCHEM CELL BIOL, V125, P293, DOI 10.1007/s00418-005-0067-z; Shi HJ, 2011, J PROTEOMICS, V75, P339, DOI 10.1016/j.jprot.2011.07.025; Shimada N, 2003, J VET MED SCI, V65, P187, DOI 10.1292/jvms.65.187; Starsichova A, 2009, BIOL PROCED ONLINE, V11, P316, DOI 10.1007/s12575-009-9017-9; Stumpff F, 2007, J MEMBRANE BIOL, V219, P37, DOI 10.1007/s00232-007-9059-3; Su CY, 1998, J MOL CELL CARDIOL, V30, P587, DOI 10.1006/jmcc.1997.0622; Tavaria M, 1996, CELL STRESS CHAPERON, V1, P23, DOI 10.1379/1466-1268(1996)001<0023:AHSGTT>2.3.CO;2; Urcan E, 2010, DENT MATER, V26, P51, DOI 10.1016/j.dental.2009.08.007; Vistejnova L, 2009, NEUROENDOCRINOL LETT, V30, P121; von Kries C, 2012, BIOTECHNOL J, V7, P569, DOI 10.1002/biot.201100321; Walsh MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027177; Windoffer R, 2011, J CELL BIOL, V194, P669, DOI 10.1083/jcb.201008095; Zhong X, 2012, CELL STRESS CHAPERON, V17, P495, DOI 10.1007/s12192-012-0326-6	65	8	8	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67079	10.1371/journal.pone.0067079	http://dx.doi.org/10.1371/journal.pone.0067079			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861753	Green Published, Green Submitted, gold			2022-12-27	WOS:000323350700009
J	Dugas, M; Fritz, F; Krumm, R; Breil, B				Dugas, Martin; Fritz, Fleur; Krumm, Rainer; Breil, Bernhard			Automated UMLS-Based Comparison of Medical Forms	PLOS ONE			English	Article							SNOMED-CT; CONTROLLED TERMINOLOGIES; CLINICAL-RESEARCH; ALIGNMENT; SYSTEMS; NETWORK; CARE	Medical forms are very heterogeneous: on a European scale there are thousands of data items in several hundred different systems. To enable data exchange for clinical care and research purposes there is a need to develop interoperable documentation systems with harmonized forms for data capture. A prerequisite in this harmonization process is comparison of forms. So far - to our knowledge - an automated method for comparison of medical forms is not available. A form contains a list of data items with corresponding medical concepts. An automatic comparison needs data types, item names and especially item with these unique concept codes from medical terminologies. The scope of the proposed method is a comparison of these items by comparing their concept codes (coded in UMLS). Each data item is represented by item name, concept code and value domain. Two items are called identical, if item name, concept code and value domain are the same. Two items are called matching, if only concept code and value domain are the same. Two items are called similar, if their concept codes are the same, but the value domains are different. Based on these definitions an open-source implementation for automated comparison of medical forms in ODM format with UMLS-based semantic annotations was developed. It is available as package compareODM from http://cran.r-project.org. To evaluate this method, it was applied to a set of 7 real medical forms with 285 data items from a large public ODM repository with forms for different medical purposes (research, quality management, routine care). Comparison results were visualized with grid images and dendrograms. Automated comparison of semantically annotated medical forms is feasible. Dendrograms allow a view on clustered similar forms. The approach is scalable for a large set of real medical forms.	[Dugas, Martin; Fritz, Fleur; Krumm, Rainer; Breil, Bernhard] Univ Munster, Inst Med Informat, D-48149 Munster, Germany	University of Munster	Dugas, M (corresponding author), Univ Munster, Inst Med Informat, D-48149 Munster, Germany.	dugas@uni-muenster.de	Fritz, Fleur G.S./A-8178-2013	Fritz, Fleur G.S./0000-0002-9005-6766	German Research Foundation (DFG) [DU 352/5-1]; German Ministry for Research and Education (BMBF) [01EZ0941A]	German Research Foundation (DFG)(German Research Foundation (DFG)); German Ministry for Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF))	This work is supported by German Research Foundation (DFG Grant DU 352/5-1) and German Ministry for Research and Education (BMBF Grant 01EZ0941A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allones JL, 2013, LECT NOTES COMPUTER; Andrews JE, 2008, J BIOMED INFORM, V41, P1062, DOI 10.1016/j.jbi.2008.01.010; Baorto D, 2009, J BIOMED INFORM, V42, P494, DOI 10.1016/j.jbi.2009.03.005; Breil B, 2012, APPL CLIN INFORM, V3, P276, DOI 10.4338/ACI-2012-03-RA-0011; Chiang Michael F, 2006, AMIA Annu Symp Proc, P131; Dolin RH, 2006, J AM MED INFORM ASSN, V13, P30, DOI 10.1197/jamia.M1888; Dugas M, 2009, J AM MED INFORM ASSN, V16, P400, DOI 10.1197/jamia.M2882; Dziuballe P, 2012, STUD HLTH TECHNOL IN, V180, P564; ELFADLY A, 2007, AMIA ANN S P, V11, P216; Friedman J ., ELEMENTS STAT LEARNI; Fung BCM, 2003, SIAM PROC S, P59; Hwang JC, 2006, OPHTHALMOLOGY, V113, P511, DOI 10.1016/j.ophtha.2006.01.017; Kush RD., INTEROPERABILITY REV; Garcia MM, 2012, INT J MED INFORM, V81, P566, DOI 10.1016/j.ijmedinf.2012.02.007; Olsen NS, 2010, ACCIDENT ANAL PREV, V42, P437, DOI 10.1016/j.aap.2009.09.005; Pathak J, 2011, J AM MED INFORM ASSN, V18, P376, DOI 10.1136/amiajnl-2010-000061; Schober D, 2012, BIOMED SEMANTICS S2, V21, pS4; Schulz S, 2009, BIOINFORMATICS, V25, pI69, DOI 10.1093/bioinformatics/btp194; Steinbach M., 2000, COMP DOCUMENT CLUSTE; Weng CH, 2012, J AM MED INFORM ASSN, V19, P684, DOI 10.1136/amiajnl-2012-000878; Yu S, 2012, J BIOMED INFORM, V45, P408, DOI 10.1016/j.jbi.2011.12.001	21	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67883	10.1371/journal.pone.0067883	http://dx.doi.org/10.1371/journal.pone.0067883			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	204FO	23861827	Green Submitted, Green Published, gold			2022-12-27	WOS:000323350700055
J	Kenny, JG; Moran, J; Kolar, SL; Ulanov, A; Li, Z; Shaw, LN; Josefsson, E; Horsburgh, MJ				Kenny, John G.; Moran, Josephine; Kolar, Stacey L.; Ulanov, Alexander; Li, Zhong; Shaw, Lindsey N.; Josefsson, Elisabet; Horsburgh, Malcolm J.			Mannitol Utilisation is Required for Protection of Staphylococcus aureus from Human Skin Antimicrobial Fatty Acids	PLOS ONE			English	Article							BACILLUS-SUBTILIS; ANTIBACTERIAL ACTIVITY; STRESS RESISTANCE; OXIDATIVE STRESS; IN-VIVO; VIRULENCE; EXPRESSION; LIPIDS; STARVATION; ABSCESSES	Mannitol (Mtl) fermentation, with the subsequent production of acid, is a species signature of Staphylococcus aureus, and discriminates it from most other members of the genus. Inactivation of the gene mtlD, encoding Mtl-1-P dehydrogenase was found to markedly reduce survival in the presence of the antimicrobial fatty acid, linoleic acid. We demonstrate that the sugar alcohol has a potentiating action for this membrane-acting antimicrobial. Analysis of cellular metabolites revealed that, during exponential growth, the mtlD mutant accumulated high levels of Mtl and Mtl-P. The latter metabolite was not detected in its isogenic parent strain or a deletion mutant of the entire mtlABFD operon. In addition, the mtlD mutant strain exhibited a decreased MIC for H2O2, however virulence was unaffected in a model of septic arthritis.	[Kenny, John G.; Moran, Josephine; Horsburgh, Malcolm J.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Kolar, Stacey L.; Shaw, Lindsey N.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL USA; [Ulanov, Alexander; Li, Zhong] Univ Illinois, Roy J Carver Biotechnol Ctr, Urbana, IL 61801 USA; [Josefsson, Elisabet] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden	University of Liverpool; State University System of Florida; University of South Florida; University of Illinois System; University of Illinois Urbana-Champaign; University of Gothenburg	Horsburgh, MJ (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.	M.J.Horsburgh@liverpool.ac.uk	Horsburgh, Malcolm J/H-9657-2013; Kenny, John/HCI-1952-2022; Shaw, Lindsey/AAI-1741-2020	Kenny, John/0000-0003-2994-6169; Shaw, Lindsey/0000-0002-0629-8990; Moran, Josephine/0000-0002-8278-9548	BBSRC grant [BB/D003563/1]; National Institute of Allergies and Infectious Diseases [AI090350]; BBSRC [BB/D003563/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D003563/1, 975395] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090350, R01AI080626] Funding Source: NIH RePORTER	BBSRC grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute of Allergies and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by BBSRC grant BB/D003563/1 (MJH) and in part AI090350 (LNS) from the National Institute of Allergies and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSARI MNA, 1970, LIPIDS, V5, P838, DOI 10.1007/BF02531977; Bergsson G, 2001, APMIS, V109, P670, DOI 10.1034/j.1600-0463.2001.d01-131.x; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; BREMELL T, 1991, INFECT IMMUN, V59, P2615, DOI 10.1128/IAI.59.8.2615-2623.1991; CAMPBELL IM, 1983, J CLIN MICROBIOL, V18, P408, DOI 10.1128/JCM.18.2.408-415.1983; Chaturvedi V, 1997, J BACTERIOL, V179, P157, DOI 10.1128/jb.179.1.157-162.1997; Chiang YJ, 2005, J AM SOC HORTIC SCI, V130, P605, DOI 10.21273/JASHS.130.4.605; Clarke SR, 2007, CELL HOST MICROBE, V1, P199, DOI 10.1016/j.chom.2007.04.005; Dawe AL, 2009, MICROBIOL-SGM, V155, P3913, DOI 10.1099/mic.0.029033-0; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Do TQ, 2008, J IMMUNOL, V181, P4177, DOI 10.4049/jimmunol.181.6.4177; Drake DR, 2008, J LIPID RES, V49, P4, DOI 10.1194/jlr.R700016-JLR200; DYE ES, 1981, INFECT IMMUN, V32, P98, DOI 10.1128/IAI.32.1.98-104.1981; EDWARDS KG, 1981, J BACTERIOL, V146, P1020, DOI 10.1128/JB.146.3.1020-1029.1981; ENGLER HD, 1992, J MED MICROBIOL, V37, P238, DOI 10.1099/00222615-37-4-238; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; GALBRAITH H, 1973, J APPL BACTERIOL, V36, P659, DOI 10.1111/j.1365-2672.1973.tb04151.x; GALBRAITH H, 1973, J APPL BACTERIOL, V36, P647, DOI 10.1111/j.1365-2672.1973.tb04150.x; GALBRAITH H, 1973, J APPL BACTERIOL, V36, P635, DOI 10.1111/j.1365-2672.1973.tb04149.x; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; GREENWAY DLA, 1979, J GEN MICROBIOL, V115, P233, DOI 10.1099/00221287-115-1-233; Grkovic S, 2003, MICROBIOL-SGM, V149, P785, DOI 10.1099/mic.0.25951-0; GueroutFleury AM, 1995, GENE, V167, P335, DOI 10.1016/0378-1119(95)00652-4; Horsburgh MJ, 2001, INFECT IMMUN, V69, P3744, DOI 10.1128/IAI.69.6.3744-3754.2001; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Horsburgh MJ, 2004, INFECT IMMUN, V72, P3073, DOI 10.1128/IAI.72.5.3073-3076.2004; Horsburgh MJ, 2001, MICROBIOL-SGM, V147, P2933, DOI 10.1099/00221287-147-11-2933; Josefsson E, 2008, MICROB PATHOGENESIS, V44, P103, DOI 10.1016/j.micpath.2007.08.010; Kelsey JA, 2006, LIPIDS, V41, P951, DOI 10.1007/s11745-006-5048-z; Kenny JG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004344; Kohler T, 2009, J BACTERIOL, V191, P4482, DOI 10.1128/JB.00221-09; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Massey RC, 2006, NAT REV MICROBIOL, V4, P953, DOI 10.1038/nrmicro1551; Mishra NN, 2011, ANTIMICROB AGENTS CH, V55, P526, DOI 10.1128/AAC.00680-10; NIEMAN C, 1954, BACTERIOL REV, V18, P147, DOI 10.1128/MMBR.18.2.147-163.1954; Pappas A, 2002, J INVEST DERMATOL, V118, P164, DOI 10.1046/j.0022-202x.2001.01612.x; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; SAIER MH, 1976, J BIOL CHEM, V251, P3834; Solomon PS, 2007, TRENDS MICROBIOL, V15, P257, DOI 10.1016/j.tim.2007.04.002; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; Watanabe S, 2003, J BACTERIOL, V185, P4816, DOI 10.1128/JB.185.16.4816-4824.2003; Watson SP, 1998, J BACTERIOL, V180, P1750, DOI 10.1128/JB.180.7.1750-1758.1998; Wisselink HW, 2005, APPL ENVIRON MICROB, V71, P1507, DOI 10.1128/AEM.71.3.1507-1514.2005; Won SR, 2007, FEBS LETT, V581, P4999, DOI 10.1016/j.febslet.2007.09.045; Xia JG, 2010, BIOINFORMATICS, V26, P2342, DOI 10.1093/bioinformatics/btq418; Zheng CJ, 2005, FEBS LETT, V579, P5157, DOI 10.1016/j.febslet.2005.08.028	46	12	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67698	10.1371/journal.pone.0067698	http://dx.doi.org/10.1371/journal.pone.0067698			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861785	Green Submitted, gold, Green Published			2022-12-27	WOS:000323350700024
J	Yafai, Y; Iandiev, I; Lange, J; Yang, XM; Wiedemann, P; Bringmann, A; Eichler, W				Yafai, Yousef; Iandiev, Ianors; Lange, Johannes; Yang, Xiu Mei; Wiedemann, Peter; Bringmann, Andreas; Eichler, Wolfram			Basic Fibroblast Growth Factor Contributes to a Shift in the Angioregulatory Activity of Retinal Glial (Muller) Cells	PLOS ONE			English	Article							UP-REGULATION; EXPRESSION; BFGF; ANGIOGENESIS; NEOVASCULARIZATION; PROLIFERATION; CNTF; DEGENERATION; INFLAMMATION; SUPPRESSION	Basic fibroblast growth factor (bFGF) is a pleiotropic cytokine with pro-angiogenic and neurotrophic effects. The angioregulatory role of this molecule may become especially significant in retinal neovascularization, which is a hallmark of a number of ischemic eye diseases. This study was undertaken to reveal expression characteristics of bFGF, produced by retinal glial (Muller) cells, and to determine conditions under which glial bFGF may stimulate the proliferation of retinal microvascular endothelial cells. Immunofluorescence labeling detected bFGF in Muller cells of the rat retina and in acutely isolated Muller cells with bFGF levels, which increased after ischemia-reperfusion in postischemic retinas. In patients with proliferative diabetic retinopathy or myopia, the immunoreactivity of bFGF co-localized to glial fibrillary acidic protein (GFAP)-positive cells in surgically excised retinal tissues. RT-PCR and ELISA analyses indicated that cultured Muller cells produce bFGF, which is elevated under hypoxia or oxidative stress, as well as under stimulation with various growth factors and cytokines, including pro-inflammatory factors. When retinal endothelial cells were cultured in the presence of media from hypoxia (0.2%)-conditioned Muller cells, a distinct picture of endothelial cell proliferation emerged. Media from 24-h cultured Muller cells inhibited proliferation, whereas 72-h conditioned media elicited a stimulatory effect. BFGF-neutralizing antibodies suppressed the enhanced endothelial cell proliferation to a similar extent as anti-VEGF antibodies. Furthermore, phosphorylation of extracellular signal-regulated kinases (ERK-1/-2) in retinal endothelial cells was increased when the cells were cultured in 72-h conditioned media, while neutralizing bFGF attenuated the activation of this signaling pathway. These data provide evidence that retinal (glial) Muller cells are major sources of bFGF in the ischemic retina. Muller cells under physiological conditions or transient hypoxia seem to provide an anti-angiogenic environment, but long-lasting hypoxia causes the release of bFGF, which might significantly co-stimulate neovascularization in the retina.	[Yafai, Yousef; Iandiev, Ianors; Wiedemann, Peter; Bringmann, Andreas; Eichler, Wolfram] Univ Leipzig, Fac Med, Dept Ophthalmol, D-04109 Leipzig, Germany; [Yafai, Yousef; Iandiev, Ianors; Wiedemann, Peter; Bringmann, Andreas; Eichler, Wolfram] Univ Leipzig, Hosp Eye, Fac Med, D-04109 Leipzig, Germany; [Lange, Johannes] Stavanger Univ Hosp, Norwegian Ctr Movement Disorders, Stavanger, Norway; [Yang, Xiu Mei] Fourth Mil Med Univ, Xijing Hosp, Dept Ophthalmol, Eye Inst Ophthalmol,Chinese PLA, Xian 710032, Shaanxi Provinc, Peoples R China	Leipzig University; Leipzig University; Stavanger University Hospital; Air Force Military Medical University	Eichler, W (corresponding author), Univ Leipzig, Fac Med, Dept Ophthalmol, D-04109 Leipzig, Germany.	eichwolf@rz.uni-leipzig.de	Yang, XM/AAM-9762-2020	Lange, Johannes/0000-0003-0604-4891	Deutsche Forschungsgemeinschaft [Wi 880/13-2, RE 849/1-1]; Ernst und Berta Grimmke Stiftung, Dusseldorf, Germany	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ernst und Berta Grimmke Stiftung, Dusseldorf, Germany	This work was supported by Deutsche Forschungsgemeinschaft (Wi 880/13-2 and RE 849/1-1) (http://www.dfg.de) and Ernst und Berta Grimmke Stiftung, Dusseldorf, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu El-Asrar AM, 2004, EYE, V18, P306, DOI 10.1038/sj.eye.6700642; Amin RH, 1997, INVEST OPHTH VIS SCI, V38, P36; Behzadian MA, 1995, GLIA, V15, P480, DOI 10.1002/glia.440150411; Bringmann A, 1997, GLIA, V19, P311, DOI 10.1002/(SICI)1098-1136(199704)19:4<311::AID-GLIA4>3.0.CO;2-#; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Bullard LE, 2003, INVEST OPHTH VIS SCI, V44, P1722, DOI 10.1167/iovs.01-1193; Cao W, 1997, EXP EYE RES, V65, P241, DOI 10.1006/exer.1997.0328; Castellon R, 2002, EXP EYE RES, V74, P523, DOI 10.1006/exer.2001.1161; DAMORE PA, 1994, INVEST OPHTH VIS SCI, V35, P3974; Eichler W, 2004, NEUROREPORT, V15, P1633, DOI 10.1097/01.wnr.0000133071.00786.a4; Eichler W, 2004, EXP CELL RES, V299, P68, DOI 10.1016/j.yexcr.2004.05.020; Eichler W, 2001, NEUROREPORT, V12, P4103, DOI 10.1097/00001756-200112210-00048; FAKTOROVICH EG, 1990, NATURE, V347, P83, DOI 10.1038/347083a0; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gao H, 1996, EXP EYE RES, V62, P181, DOI 10.1006/exer.1996.0022; Geller SF, 2001, INVEST OPHTH VIS SCI, V42, P1363; Gilbert C, 1997, LANCET, V350, P12, DOI 10.1016/S0140-6736(97)01107-0; GOSPODAROWICZ D, 1983, J CELL BIOL, V97, P1677, DOI 10.1083/jcb.97.6.1677; Hollborn M, 2004, GRAEF ARCH CLIN EXP, V242, P414, DOI 10.1007/s00417-004-0879-x; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Kempen JH, 2004, ARCH OPHTHALMOL-CHIC, V122, P552; Kruchkova Y, 2001, J NEUROCHEM, V77, P1641, DOI 10.1046/j.1471-4159.2001.00390.x; Lange J, 2008, INVEST OPHTH VIS SCI, V49, P5161, DOI 10.1167/iovs.08-2201; Limb GA, 2002, INVEST OPHTH VIS SCI, V43, P864; Liu CD, 1998, J NEUROSCI, V18, P1337; MILLER JW, 1994, AM J PATHOL, V145, P574; MONTESANO R, 1986, P NATL ACAD SCI USA, V83, P7297, DOI 10.1073/pnas.83.19.7297; Mori K, 2002, INVEST OPHTH VIS SCI, V43, P2001; PERRY J, 1995, CURR EYE RES, V14, P585, DOI 10.3109/02713689508998406; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; REICHENBACH A, 1995, GLIA, V13, P195, DOI 10.1002/glia.440130306; Rivera JC, 2008, EXP EYE RES, V86, P314, DOI 10.1016/j.exer.2007.11.003; SOUBRANE G, 1994, CURR EYE RES, V13, P183, DOI 10.3109/02713689408995776; STAVRI GT, 1995, CIRCULATION, V92, P11, DOI 10.1161/01.CIR.92.1.11; TCHENG M, 1994, EXP CELL RES, V212, P30, DOI 10.1006/excr.1994.1114; TSUBOI R, 1990, J EXP MED, V172, P245, DOI 10.1084/jem.172.1.245; Vinores SA, 1997, HISTOL HISTOPATHOL, V12, P99; Walsh N, 2001, EXP EYE RES, V72, P495, DOI 10.1006/exer.2000.0984; WEN R, 1995, J NEUROSCI, V15, P7377; Yafai Y, 2004, MICROCIRCULATION, V11, P577, DOI 10.1080/10739680490503375; Yafai Y, 2007, GLIA, V55, P642, DOI 10.1002/glia.20495; Yan Q, 2001, IN VITRO CELL DEV-AN, V37, P45; Yoshida A, 1999, INVEST OPHTH VIS SCI, V40, P1624; Yoshida S, 2004, GRAEF ARCH CLIN EXP, V242, P409, DOI 10.1007/s00417-004-0874-2; Yoshida S, 2003, J LEUKOCYTE BIOL, V73, P137, DOI 10.1189/jlb.0302117	46	19	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68773	10.1371/journal.pone.0068773	http://dx.doi.org/10.1371/journal.pone.0068773			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861940	Green Published, Green Submitted, gold			2022-12-27	WOS:000323350700101
J	Bastos, RG; Suarez, CE; Laughery, JM; Johnson, WC; Ueti, MW; Knowles, DP				Bastos, Reginaldo G.; Suarez, Carlos E.; Laughery, Jacob M.; Johnson, Wendell C.; Ueti, Massaro W.; Knowles, Donald P.			Differential Expression of Three Members of the Multidomain Adhesion CCp Family in Babesia bigemina, Babesia bovis and Theileria equi	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; IN-VITRO; SEXUAL DEVELOPMENT; GENOME-SEQUENCE; PROTEIN; GENES; TRANSMISSION; PARASITES; MALARIA; MIDGUT	Members of the CCp protein family have been previously described to be expressed on gametocytes of apicomplexan Plasmodium parasites. Knocking out Plasmodium CCp genes blocks the development of the parasite in the mosquito vector, making the CCp proteins potential targets for the development of a transmission-blocking vaccine. Apicomplexans Babesia bovis and Babesia bigemina are the causative agents of bovine babesiosis, and apicomplexan Theileria equi causes equine piroplasmosis. Bovine babesiosis and equine piroplasmosis are the most economically important parasite diseases that affect worldwide cattle and equine industries, respectively. The recent sequencing of the B. bovis and T. equi genomes has provided the opportunity to identify novel genes involved in parasite biology. Here we characterize three members of the CCp family, named CCp1, CCp2 and CCp3, in B. bigemina, B. bovis and T. equi. Using B. bigemina as an in vitro model, expression of all three CCp genes and proteins was demonstrated in temperature-induced sexual stages. Transcripts for all three CCp genes were found in vivo in blood stages of T. equi, and transcripts for CCp3 were detected in vivo in blood stages of B. bovis. However, no protein expression was detected in T. equi blood stages or B. bovis blood stages or B. bovis tick stages. Collectively, the data demonstrated a differential pattern of expression of three orthologous genes of the multidomain adhesion CCp family by B. bigemina, B. bovis and T. equi. The novel CCp members represent potential targets for innovative approaches to control bovine babesiosis and equine piroplasmosis.	[Bastos, Reginaldo G.; Laughery, Jacob M.; Knowles, Donald P.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Suarez, Carlos E.; Johnson, Wendell C.; Ueti, Massaro W.; Knowles, Donald P.] ARS, Anim Dis Res Unit, USDA, Pullman, WA USA	Washington State University; United States Department of Agriculture (USDA)	Bastos, RG (corresponding author), Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA.	rgbastos@vetmed.wsu.edu			USDA-ARS (United States Department of Agriculture - Agricultural Research Service) CRIS project	USDA-ARS (United States Department of Agriculture - Agricultural Research Service) CRIS project	This work was supported by USDA-ARS (United States Department of Agriculture - Agricultural Research Service) CRIS project number. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastos RG, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-57; Becker CAM, 2010, MOL BIOCHEM PARASIT, V174, P36, DOI 10.1016/j.molbiopara.2010.06.011; Becker CAM, 2013, EXP PARASITOL, V133, P51, DOI 10.1016/j.exppara.2012.10.007; Bishop R, 2004, PARASITOLOGY, V129, pS271, DOI 10.1017/S0031182003004748; Bock R, 2004, PARASITOLOGY, V129, pS247, DOI 10.1017/S0031182004005190; Bousema JT, 2007, PARASITE IMMUNOL, V29, P309, DOI 10.1111/j.1365-3024.2007.00948.x; Brayton KA, 2007, PLOS PATHOG, V3, P1401, DOI 10.1371/journal.ppat.0030148; Delrieu I, 2002, MOL BIOCHEM PARASIT, V121, P11, DOI 10.1016/S0166-6851(02)00016-6; Dessens JT, 2004, TRENDS PARASITOL, V20, P102, DOI 10.1016/j.pt.2004.01.002; Dixon MWA, 2008, TRENDS PARASITOL, V24, P168, DOI 10.1016/j.pt.2008.01.004; ERP EE, 1978, AM J TROP MED HYG, V27, P1061, DOI 10.4269/ajtmh.1978.27.1061; Ferreri LM, 2012, INT J PARASITOL, V42, P131, DOI 10.1016/j.ijpara.2011.10.004; Friedhoff K T, 1990, Rev Sci Tech, V9, P1187; Gardner MJ, 2005, SCIENCE, V309, P134, DOI 10.1126/science.1110439; Goff WL, 1998, ANN NY ACAD SCI, V849, P161, DOI 10.1111/j.1749-6632.1998.tb11046.x; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Hunfeld KP, 2008, INT J PARASITOL, V38, P1219, DOI 10.1016/j.ijpara.2008.03.001; Kappmeyer LS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-603; Lavazec C, 2009, MOL BIOCHEM PARASIT, V163, P1, DOI 10.1016/j.molbiopara.2008.09.002; Mair GR, 2006, SCIENCE, V313, P667, DOI 10.1126/science.1125129; Mair GR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000767; MEHLHORN H, 1984, ADV PARASIT, V23, P37, DOI 10.1016/S0065-308X(08)60285-7; Mosqueda J, 2004, INT J PARASITOL, V34, P1229, DOI 10.1016/j.ijpara.2004.07.003; Pain A, 2005, SCIENCE, V309, P131, DOI 10.1126/science.1110418; Pradel G, 2006, EXP PARASITOL, V112, P263, DOI 10.1016/j.exppara.2005.11.010; Pradel G, 2004, J EXP MED, V199, P1533, DOI 10.1084/jem.20031274; Raine JD, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030030; Ribeiro MFB, 1998, VET PARASITOL, V76, P19, DOI 10.1016/S0304-4017(97)00205-7; Schwint ON, 2009, ANTIMICROB AGENTS CH, V53, P4327, DOI 10.1128/AAC.00404-09; Simon N, 2009, J BIOL CHEM, V284, P14537, DOI 10.1074/jbc.M808472200; Sinden RE, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-70; Stiller D, 2002, J MED ENTOMOL, V39, P667, DOI 10.1603/0022-2585-39.4.667; Suarez CE, 2011, PARASITOLOGY, V138, P809, DOI 10.1017/S0031182011000321; Suarez CE, 2003, MOL BIOCHEM PARASIT, V127, P101, DOI 10.1016/S0166-6851(02)00311-0; Templeton TJ, 2010, MOL BIOL EVOL, V27, P235, DOI 10.1093/molbev/msp226; Ueti MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044713; Ueti MW, 2003, J CLIN MICROBIOL, V41, P5803, DOI 10.1128/JCM.41.12.5803-5809.2003; VEGA CA, 1985, AM J VET RES, V46, P416; Young JA, 2005, MOL BIOCHEM PARASIT, V143, P67, DOI 10.1016/j.molbiopara.2005.05.007	39	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67765	10.1371/journal.pone.0067765	http://dx.doi.org/10.1371/journal.pone.0067765			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844089	Green Published, Green Submitted, gold			2022-12-27	WOS:000321733000101
J	Dias, ACF; Dini-Andreote, F; Hannula, SE; Andreote, FD; Silva, MDPE; Salles, JF; de Boer, W; van Veen, J; van Elsas, JD				Franco Dias, Armando Cavalcante; Dini-Andreote, Francisco; Hannula, Silja Emilia; Andreote, Fernando Dini; Pereira e Silva, Michele de Cassia; Salles, Joana Falcao; de Boer, Wietse; van Veen, Johannes; van Elsas, Jan Dirk			Different Selective Effects on Rhizosphere Bacteria Exerted by Genetically Modified versus Conventional Potato Lines	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; BURKHOLDERIA-CEPACIA COMPLEX; MICROBIAL-POPULATIONS; COMMUNITY STRUCTURE; SOIL TYPE; SP-NOV.; PLANT; DIVERSITY; GROWTH; CARBON	Background: In this study, we assessed the actively metabolizing bacteria in the rhizosphere of potato using two potato cultivars, i.e. the genetically-modified (GM) cultivar Modena (having tubers with altered starch content) and the near-isogenic non-GM cultivar Karnico. To achieve our aims, we pulse-labelled plants at EC90 stage with C-13-CO2 and analysed their rhizosphere microbial communities 24 h, 5 and 12 days following the pulse. In the analyses, phospholipid fatty acid/stable isotope probing (PLFA-SIP) as well as RNA-SIP followed by reverse transcription and PCR-DGGE and clone library analysis, were used to determine the bacterial groups that actively respond to the root-released C-13 labelled carbonaceous compounds. Methodology/Principal findings: The PLFA-SIP data revealed major roles of bacteria in the uptake of root-released C-13 carbon, which grossly increased with time. Gram-negative bacteria, including members of the genera Pseudomonas and Burkholderia, were strong accumulators of the C-13-labeled compounds at the two cultivars, whereas Gram-positive bacteria were lesser responders. PCR-DGGE analysis of cDNA produced from the two cultivar types showed that these had selected different bacterial, alpha-and betaproteobacterial communities at all time points. Moreover, an effect of time was observed, indicating dynamism in the structure of the active bacterial communities. PCR-DGGE as well as clone library analyses revealed that the main bacterial responders at cultivar Karnico were taxonomically affiliated with the genus Pseudomonas, next to Gluconacetobacter and Paracoccus. Cultivar Modena mainly attracted Burkholderia, next to Moraxella-like (Moraxellaceae family) and Sphingomonas types. Conclusions/Significance: Based on the use of Pseudomonas and Burkholderia as proxies for differentially-selected bacterial genera, we conclude that the selective forces exerted by potato cultivar Modena on the active bacterial populations differed from those exerted by cultivar Karnico.	[Franco Dias, Armando Cavalcante; Dini-Andreote, Francisco; Pereira e Silva, Michele de Cassia; Salles, Joana Falcao; van Elsas, Jan Dirk] Univ Groningen RUG, Dept Microbial Ecol, Ctr Ecol & Evolutionary Studies CEES, Groningen, Netherlands; [Hannula, Silja Emilia; de Boer, Wietse; van Veen, Johannes] Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands; [Franco Dias, Armando Cavalcante; Andreote, Fernando Dini] Univ Sao Paulo, Dept Soil Sci, ESALQ USP, Piracicaba, Brazil	University of Groningen; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Universidade de Sao Paulo	Dini-Andreote, F (corresponding author), Univ Groningen RUG, Dept Microbial Ecol, Ctr Ecol & Evolutionary Studies CEES, Groningen, Netherlands.	f.dini.andreote@rug.nl	Dias, Armando Cavalcante Franco/F-5878-2012; Salles, Joana Falcao/AAG-7070-2020; Falcao Salles, Joana/A-7313-2008; de Boer, Wietse/C-2737-2011; Andreote, Fernando Dini/B-8499-2012; Dini-Andreote, Francisco/M-6176-2017; Hannula, Silja Emilia/C-7462-2012; van Veen, Johannes A/C-3697-2011; de Cassia Pereira e Silva, Michele/D-3918-2016; Dias, Armando Cavalcante Franco/O-1477-2019; KNAW, NIOO-KNAW/A-4320-2012	Dias, Armando Cavalcante Franco/0000-0002-2651-6270; Salles, Joana Falcao/0000-0003-4317-7263; Falcao Salles, Joana/0000-0003-4317-7263; de Boer, Wietse/0000-0002-5380-2993; Andreote, Fernando Dini/0000-0002-9883-9968; Dini-Andreote, Francisco/0000-0002-6654-0769; Hannula, Silja Emilia/0000-0003-1398-2018; de Cassia Pereira e Silva, Michele/0000-0002-6426-8474; Dias, Armando Cavalcante Franco/0000-0002-2651-6270; KNAW, NIOO-KNAW/0000-0002-3835-159X	Netherlands Organisation for Scientific Research (NWO)-ERGO program; FAPESP [2008/54013-8]	Netherlands Organisation for Scientific Research (NWO)-ERGO program(Netherlands Organization for Scientific Research (NWO)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Netherlands Organisation for Scientific Research (NWO)-ERGO program and FAPESP (Proc. 2008/54013-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreote FD, 2009, APPL ENVIRON MICROB, V75, P3396, DOI 10.1128/AEM.00491-09; Baldani JI, 1997, SOIL BIOL BIOCHEM, V29, P911, DOI 10.1016/S0038-0717(96)00218-0; Bardgett RD, 1999, FUNCT ECOL, V13, P650, DOI 10.1046/j.1365-2435.1999.00362.x; Bernard L, 2007, ENVIRON MICROBIOL, V9, P752, DOI 10.1111/j.1462-2920.2006.01197.x; Boersma FGH, 2009, APPL ENVIRON MICROB, V75, P1979, DOI 10.1128/AEM.02489-08; BOSCHKER H. T. S., 2004, MOL MICROBIAL ECOLOG, P1673; Brons JK, 2008, APPL ENVIRON MICROB, V74, P2717, DOI 10.1128/AEM.02195-07; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Costa R, 2006, FEMS MICROBIOL ECOL, V56, P236, DOI 10.1111/j.1574-6941.2005.00026.x; Costa R, 2007, ENVIRON MICROBIOL, V9, P2260, DOI 10.1111/j.1462-2920.2007.01340.x; Dalmastri C, 1999, MICROBIAL ECOL, V38, P273, DOI 10.1007/s002489900177; de Almeida CV, 2009, WORLD J MICROB BIOT, V25, P1757, DOI 10.1007/s11274-009-0073-8; De Bruijn FJ, 2013, MOL MICROBIAL ECOLOG, P746; de Vetten N, 2003, NAT BIOTECHNOL, V21, P439, DOI 10.1038/nbt801; Dias ACF, 2012, SOIL BIOL BIOCHEM, V50, P85, DOI 10.1016/j.soilbio.2012.03.006; DiCello F, 1997, APPL ENVIRON MICROB, V63, P4485, DOI 10.1128/AEM.63.11.4485-4493.1997; Dini-Andreote F, 2013, PLANT SOIL, V373, P1, DOI 10.1007/s11104-013-1687-z; Dohrmann AB, 2005, APPL ENVIRON MICROB, V71, P7750, DOI 10.1128/AEM.71.12.7750-7758.2005; Drigo B, 2010, P NATL ACAD SCI USA, V107, P10938, DOI 10.1073/pnas.0912421107; Duineveld BM, 1998, APPL ENVIRON MICROB, V64, P4950; Elliott GN, 2007, NEW PHYTOL, V173, P168, DOI 10.1111/j.1469-8137.2006.01894.x; FROSTEGARD A, 1993, APPL ENVIRON MICROB, V59, P3605; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; Ghosh W, 2006, SYST APPL MICROBIOL, V29, P396, DOI 10.1016/j.syapm.2005.10.004; GLEIXNER G, 1998, 214 NAT M AM CHEM SO, V707, P34; Gomes NCM, 2001, PLANT SOIL, V232, P167, DOI 10.1023/A:1010350406708; Gorley C.K., 2006, GETTING STARTED PRIM; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Gschwendtner S, 2011, FEMS MICROBIOL ECOL, V76, P564, DOI 10.1111/j.1574-6941.2011.01073.x; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Haichar FE, 2012, FEMS MICROBIOL ECOL, V81, P291, DOI 10.1111/j.1574-6941.2012.01345.x; Haichar FE, 2008, ISME J, V2, P1221, DOI 10.1038/ismej.2008.80; Hannula SE, 2012, NEW PHYTOL, V194, P784, DOI 10.1111/j.1469-8137.2012.04089.x; Hannula SE, 2010, SOIL BIOL BIOCHEM, V42, P2211, DOI 10.1016/j.soilbio.2010.08.020; Hardoim PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030438; Inceoglu O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023321; Inceoglu O, 2010, APPL ENVIRON MICROB, V76, P3675, DOI 10.1128/AEM.00040-10; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kropf S, 2004, J STAT PLAN INFER, V125, P31, DOI 10.1016/j.jspi.2003.07.021; Kumar R, 2012, B ENVIRON CONTAM TOX, V88, P781, DOI 10.1007/s00128-012-0578-y; Kuzyakov Y, 2000, J PLANT NUTR SOIL SC, V163, P421, DOI 10.1002/1522-2624(200008)163:4<421::AID-JPLN421>3.0.CO;2-R; Lu Y, 2006, ENVIRON MICROBIOL, V9, P474; Luvizotto DM, 2010, WORLD J MICROB BIOT, V26, P1829, DOI 10.1007/s11274-010-0364-0; Lynch JM, 1994, APPL SOIL ECOL, V1, P193, DOI 10.1016/0929-1393(94)90010-8; Manefield M, 2002, APPL ENVIRON MICROB, V68, P5367, DOI 10.1128/AEM.68.11.5367-5373.2002; Mauclaire L, 2003, J MICROBIOL METH, V55, P635, DOI 10.1016/S0167-7012(03)00205-7; Mendes R, 2007, APPL ENVIRON MICROB, V73, P7259, DOI 10.1128/AEM.01222-07; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Neal AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035498; Ogita N, 2006, BIOSCI BIOTECH BIOCH, V70, P2325, DOI 10.1271/bbb.60299; Prosser JI, 2006, CURR OPIN BIOTECH, V17, P98, DOI 10.1016/j.copbio.2006.01.001; RADEMAKER JLW, 1999, MOL MICROBIAL ECOLOG, P1; Ramette A, 2005, APPL ENVIRON MICROB, V71, P1193, DOI 10.1128/AEM.71.3.1193-1201.2005; Rangel-Castro JI, 2005, ENVIRON MICROBIOL, V7, P828, DOI 10.1111/j.1462-2920.2005.00756.x; Rasche F, 2006, FEMS MICROBIOL ECOL, V56, P219, DOI 10.1111/j.1574-6941.2005.00027.x; Rasche F, 2009, NEW PHYTOL, V181, P802, DOI 10.1111/j.1469-8137.2008.02744.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salles JF, 2002, APPL ENVIRON MICROB, V68, P1595, DOI 10.1128/AEM.68.4.1595-1603.2002; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Semenov AV, 2012, SOIL BIOL BIOCHEM, V49, P88, DOI 10.1016/j.soilbio.2012.02.016; Sessitsch A, 2005, INT J SYST EVOL MICR, V55, P1187, DOI 10.1099/ijs.0.63149-0; Smyth EM, 2011, J APPL MICROBIOL, V111, P683, DOI 10.1111/j.1365-2672.2011.05079.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van Overbeek L, 2008, FEMS MICROBIOL ECOL, V64, P283, DOI 10.1111/j.1574-6941.2008.00469.x; Vandenkoornhuyse P, 2007, P NATL ACAD SCI USA, V104, P16970, DOI 10.1073/pnas.0705902104	66	26	27	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67948	10.1371/journal.pone.0067948	http://dx.doi.org/10.1371/journal.pone.0067948			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844136	Green Published, Green Submitted, gold			2022-12-27	WOS:000321733000119
J	Wang, ZY; Zhang, PX; Kou, YH; Yin, XF; Han, N; Jiang, BG				Wang, Zhiyong; Zhang, Peixun; Kou, Yuhui; Yin, Xiaofeng; Han, Na; Jiang, Baoguo			Hedysari Extract Improves Regeneration after Peripheral Nerve Injury by Enhancing the Amplification Effect	PLOS ONE			English	Article							GROWTH-FACTOR DELIVERY; SPINAL-CORD; AXON GROWTH; SCHWANN; CONDUITS; CELLS; RATS	Radix Hedysari is an herbal preparation frequently used in traditional Chinese medicine. It can promote regeneration after peripheral nerve injury, but its effect on the amplification ratio (the ratio of distal to proximal fibers) during peripheral nerve regeneration has not yet been examined. In this study, we explored the effect of Hedysari extract on the amplification ratio in the peripheral nerve. Male Sprague-Dawley rats were separated into three groups at random: normal group (without surgery), model group (given sleeve nerve bridging surgery, but without adjuvant treatment) and treatment group (given sleeve nerve bridging surgery and then given Hedysari extract as adjuvant treatment). Twelve weeks after surgery, general observations, electrophysiological examination, histological analysis, morphometric measurements, and amplification ratio calculations were made. The results showed that nerve conduction velocity, the fiber and axon diameter, the g-ratio, the number of regenerating nerve fibers and the amplification ratio were better in the treatment group than in the model group, suggesting that Hedysari extract can effectively promote the growth of lateral buds in the proximal nerve stump and substantially improve the amplification effect during peripheral nerve regeneration.	[Wang, Zhiyong; Zhang, Peixun; Kou, Yuhui; Yin, Xiaofeng; Han, Na; Jiang, Baoguo] Peking Univ, Dept Trauma & Orthoped, Peoples Hosp, Beijing 100871, Peoples R China	Peking University	Zhang, PX (corresponding author), Peking Univ, Dept Trauma & Orthoped, Peoples Hosp, Beijing 100871, Peoples R China.	zhangpeixun@126.com; jiangbaoguo@vip.sina.com		Jiang, Baoguo/0000-0001-8436-5266; Kou, Yuhui/0000-0003-1523-825X; Han, Na/0000-0002-2472-8245; Yin, Xiaofeng/0000-0001-9932-642X	National Natural Science Fund [31171150, 31271284, 81171146, 30971526, 30801169]; Beijing City Science and Technology New Star Classification [A-2008-10]; Educational Ministry New Century Excellent Talents Support Project [BMU 20110270]; National Eleven Five State Science and Technology Support Program [2007BAI04B06]; National Natural Science Youth Science Fund [31100860]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Beijing City Science and Technology New Star Classification; Educational Ministry New Century Excellent Talents Support Project; National Eleven Five State Science and Technology Support Program; National Natural Science Youth Science Fund	This study was supported by National Natural Science Fund (31171150, 31271284, 81171146, 30971526, 30801169), Beijing City Science and Technology New Star Classification (A-2008-10), Educational Ministry New Century Excellent Talents Support Project (BMU 20110270), National Eleven Five State Science and Technology Support Program (2007BAI04B06) and National Natural Science Youth Science Fund (31100860). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; Berger A, 1999, UNFALLCHIRURG, V102, P59, DOI 10.1007/s001130050373; Blesch A, 1999, J NEUROSCI, V19, P3556; Cui XM, 1998, TCM PHARM CLIN, V14, P19; Ide C, 1996, NEUROSCI RES, V25, P101; IDE C, 1983, ARCH HISTOL JAPON, V46, P243, DOI 10.1679/aohc.46.243; Jiang BG, 2007, EUR NEUROL, V58, P12, DOI 10.1159/000102161; [姜保国 Jiang Baoguo], 2002, [中华显微外科杂志, Chinese Journal of Microsurgery], V25, P38; Jiang BG, 2006, ARTIF CELL BLOOD SUB, V34, P55, DOI 10.1080/10731190500430149; Jin Z.S., 2004, CHIN J TCM WM CRIT C, V11, P141; Madduri S, 2012, J CONTROL RELEASE, V161, P274, DOI 10.1016/j.jconrel.2011.11.036; RUTISHAUSER U, 1985, J NEUROSCI RES, V13, P123, DOI 10.1002/jnr.490130109; SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0; Song QH, 2000, J ETHNOPHARMACOL, V73, P111, DOI 10.1016/S0378-8741(00)00273-7; Su KX, 2005, J YOUJIANG MINZU COL, V4, P445; Sun HY, 2012, NEUROL RES, V34, P491, DOI 10.1179/1743132812Y.0000000037; Torigoe K, 1996, EXP NEUROL, V137, P301, DOI 10.1006/exnr.1996.0030; Tuszynski MH, 1996, EXP NEUROL, V137, P157, DOI 10.1006/exnr.1996.0016; [魏光如 Wei Guangru], 2004, [中华手外科杂志, Chinese Journal of Hand Surgery], V20, P177; Wei SY, 2009, AM J CHINESE MED, V37, P57, DOI 10.1142/S0192415X09006618; Wei SY, 2009, J ETHNOPHARMACOL, V123, P51, DOI 10.1016/j.jep.2009.02.030; [杨德梅 Yang Demei], 2006, [中华手外科杂志, Chinese Journal of Hand Surgery], V22, P308; Ye JH, 1997, EXP NEUROL, V143, P70, DOI 10.1006/exnr.1996.6353; Yu CS, 2009, NEUROIMAGE, V47, P451, DOI 10.1016/j.neuroimage.2009.04.066; Zhang J. P., 1998, CHIN J INT MED, V18, P76; Zhang PX, 2011, ARTIF CELL BLOOD SUB, V39, P39, DOI 10.3109/10731199.2010.494583; Zhang PX, 2005, J RECONSTR MICROSURG, V21, P565, DOI 10.1055/s-2005-922437; Zhang ZH, 2005, J JILIN MED, V26, P132; Zheng HJ, 1991, J LANZHOU U, V37, P82	29	21	24	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67921	10.1371/journal.pone.0067921	http://dx.doi.org/10.1371/journal.pone.0067921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844128	Green Submitted, Green Published, gold			2022-12-27	WOS:000321733000115
J	Ert, E; Yechiam, E; Arshavsky, O				Ert, Eyal; Yechiam, Eldad; Arshavsky, Olga			Smokers' Decision Making: More than Mere Risk Taking	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; UNIVERSITY-STUDENTS; SENSATION SEEKING; PREFRONTAL CORTEX; FORGONE PAYOFFS; SELF-REGULATION; SMOKING; ADOLESCENTS; PERSONALITY; EVENTS	The fact that smoking is bad for people's health has become common knowledge, yet a substantial amount of people still smoke. Previous studies that sought to better understand this phenomenon have found that smoking is associated with the tendency to take risk in other areas of life as well. The current paper explores factors that may underlie this tendency. An experimental analysis shows that smokers are more easily tempted by immediate high rewards compared to nonsmokers. Thus the salience of risky alternatives that produce large rewards most of the time can direct smokers to make bad choices even in an abstract situation such as the Iowa Gambling Task. These findings suggest that the risk taking behavior associated with smoking is not related to the mere pursuit of rewards but rather reflects a tendency to yield to immediate temptation.	[Ert, Eyal] Hebrew Univ Jerusalem, Fac Agr Food & Environm, Dept Agr Econ & Management, IL-76100 Rehovot, Israel; [Yechiam, Eldad; Arshavsky, Olga] Technion Israel Inst Technol, Fac Ind Engn & Management, IL-32000 Haifa, Israel	Hebrew University of Jerusalem; Technion Israel Institute of Technology	Ert, E (corresponding author), Hebrew Univ Jerusalem, Fac Agr Food & Environm, Dept Agr Econ & Management, IL-76100 Rehovot, Israel.	eyal.ert@mail.huji.ac.il	, Eyal/AAW-1928-2020	, Eyal/0000-0001-6507-3532	Israel Science Foundation [244/06]; Max Wertheimer Minerva Center for Cognitive Studies; Hebrew University of Jerusalem	Israel Science Foundation(Israel Science Foundation); Max Wertheimer Minerva Center for Cognitive Studies; Hebrew University of Jerusalem	The research was supported in part by the Israel Science Foundation (Grant No. 244/06) and by the Max Wertheimer Minerva Center for Cognitive Studies. The first author was also supported by a grant from the Hebrew University of Jerusalem. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aklin WM, 2005, BEHAV RES THER, V43, P215, DOI 10.1016/j.brat.2003.12.007; Baumeister RF, 1994, LOSING CONTROL WHY P, DOI 10.5860/choice.32-6508; Baumeister RF, 2006, J PERS, V74, P1773, DOI 10.1111/j.1467-6494.2006.00428.x; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1999, J NEUROSCI, V19, P5473; Caroselli JS, 2006, APPL NEUROPSYCHOL, V13, P203, DOI 10.1207/s15324826an1304_1; CARTON S, 1994, ADDICT BEHAV, V19, P219, DOI 10.1016/0306-4603(94)90026-4; DIFRANZA JR, 1986, NEW YORK STATE J MED, V86, P464; Dillow I, 1981, HLTH ED J, V40, P14; Ert E, 2007, J BEHAV DECIS MAKING, V20, P305, DOI 10.1002/bdm.556; EYSENCK SBG, 1985, PERS INDIV DIFFER, V6, P21, DOI 10.1016/0191-8869(85)90026-1; Glicksohn J, 1998, PERS INDIV DIFFER, V25, P1085, DOI 10.1016/S0191-8869(98)00096-8; Glicksohn J, 2007, EUR J PERSONALITY, V21, P225, DOI 10.1002/per.609; Glicksohn J, 2010, PERS INDIV DIFFER, V48, P557, DOI 10.1016/j.paid.2009.12.006; Grosskopf B, 2006, INT J GAME THEORY, V34, P285, DOI 10.1007/s00182-006-0015-8; Hahn A, 1998, ANXIETY STRESS COPIN, V11, P93, DOI 10.1080/10615809808248307; Hertwig R, 2004, PSYCHOL SCI, V15, P534, DOI 10.1111/j.0956-7976.2004.00715.x; Israeli Ministry of Health, MIN HLTH REP SMOK IS; Johnson MW, 2007, EXP CLIN PSYCHOPHARM, V15, P187, DOI 10.1037/1064-1297.15.2.187; King Brian, 2011, Morbidity and Mortality Weekly Report, V60, P1207; Lane SD, 2004, PSYCHOPHARMACOLOGY, V172, P68, DOI 10.1007/s00213-003-1628-2; Lejuez CW, 2003, EXP CLIN PSYCHOPHARM, V11, P26, DOI 10.1037/1064-1297.11.1.26; Lerman DC, 2006, J APPL BEHAV ANAL, V39, P227, DOI 10.1901/jaba.2006.90-05; MCKENNA FP, 1993, BRIT J PSYCHOL, V84, P389, DOI 10.1111/j.2044-8295.1993.tb02490.x; MCMANUS IC, 1982, PSYCHOL MED, V12, P349, DOI 10.1017/S0033291700046687; Mitchell SH, 1999, PSYCHOPHARMACOLOGY, V146, P455, DOI 10.1007/PL00005491; Muraven M, 2000, PSYCHOL BULL, V126, P247, DOI 10.1037/0033-2909.126.2.247; RAVEN J, 1989, PSYCHOL TEST B, V2, P7; Reynolds B, 2003, BEHAV PROCESS, V64, P333, DOI 10.1016/S0376-6357(03)00168-2; Slovic P, 2000, J BEHAV DECIS MAKING, V13, P259, DOI 10.1002/(SICI)1099-0771(200004/06)13:2<259::AID-BDM336>3.0.CO;2-6; Steptoe A, 2002, ADDICTION, V97, P1561, DOI 10.1046/j.1360-0443.2002.00269.x; Sutton SR, 1997, ADDICT BEHAV, V4, P331; Truchil R, 1981, WOMEN HLTH, V41, P1; US Department of Health and Human Services, 2010, TOB SMOK CAUS DIS BI; Valois RF, 1999, J ADOLESCENT HEALTH, V25, P328, DOI 10.1016/S1054-139X(99)00051-8; Verdejo-Garcia A, 2007, DRUG ALCOHOL DEPEN, V90, P2, DOI 10.1016/j.drugalcdep.2007.02.004; VISCUSI WK, 1990, J POLIT ECON, V98, P1253, DOI 10.1086/261733; Wakefield MA, 2000, BRIT MED J, V321, P333, DOI 10.1136/bmj.321.7257.333; WEST R, 1987, BRIT J ADDICT, V82, P407; Yechiam E, 2006, J BEHAV DECIS MAKING, V19, P1, DOI 10.1002/bdm.509; Yechiam E, 2005, PSYCHOL SCI, V16, P973, DOI 10.1111/j.1467-9280.2005.01646.x; Yechiam E, 2005, J BEHAV DECIS MAKING, V18, P97, DOI 10.1002/bdm.487	44	23	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68064	10.1371/journal.pone.0068064	http://dx.doi.org/10.1371/journal.pone.0068064			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	176XV	23844156	gold, Green Published, Green Submitted			2022-12-27	WOS:000321341000136
J	Williams, TR; Moyne, AL; Harris, LJ; Marco, ML				Williams, Thomas R.; Moyne, Anne-Laure; Harris, Linda J.; Marco, Maria L.			Season, Irrigation, Leaf Age, and Escherichia coli Inoculation Influence the Bacterial Diversity in the Lettuce Phyllosphere	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; PSEUDOMONAS-SYRINGAE; PERSISTENCE; O157/H7; SOIL; VARIABILITY; POPULATIONS; SURVIVAL; O157-H7; LEAVES	The developmental and temporal succession patterns and disturbance responses of phyllosphere bacterial communities are largely unknown. These factors might influence the capacity of human pathogens to persist in association with those communities on agriculturally-relevant plants. In this study, the phyllosphere microbiota was identified for Romaine lettuce plants grown in the Salinas Valley, CA, USA from four plantings performed over 2 years and including two irrigation methods and inoculations with an attenuated strain of Escherichia coli O157:H7. High-throughput DNA pyrosequencing of the V5 to V9 variable regions of bacterial 16S rRNA genes recovered in lettuce leaf washes revealed that the bacterial diversity in the phyllosphere was distinct for each field trial but was also strongly correlated with the season of planting. Firmicutes were generally most abundant in early season (June) plantings and Proteobacteria comprised the majority of bacteria recovered later in the year (August and October). Comparisons within individual field trials showed that bacterial diversity differed between sprinkler (overhead) and drip (surface) irrigated lettuce and increased over time as the plants grew. The microbiota were also distinct between control and E. coli O157:H7-inoculated plants and between E. coli O157: H7-inoculated plants with and without surviving pathogen cells. The bacterial inhabitants of the phyllosphere therefore appear to be affected by seasonal, irrigation, and biological factors in ways that are relevant for assessments of fresh produce food safety.	[Williams, Thomas R.; Moyne, Anne-Laure; Harris, Linda J.; Marco, Maria L.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [Moyne, Anne-Laure; Harris, Linda J.] Univ Calif Davis, Western Ctr Food Safety, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Marco, ML (corresponding author), Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA.	mmarco@ucdavis.edu	Marco, Maria/H-2322-2014; Harris, Linda J/B-5030-2011	Harris, Linda J/0000-0002-1911-752X	Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture [2010-65201-20572]; Center for Produce Safety; California Lettuce and Leafy Greens Research Board; U.S. Food and Drug Administration [U01-002-527]	Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture; Center for Produce Safety; California Lettuce and Leafy Greens Research Board; U.S. Food and Drug Administration	This project was partially supported by the Agriculture and Food Research Initiative Grant 2010-65201-20572 from the USDA National Institute of Food and Agriculture (http://www.csrees.usda.gov/). This project was also supported by The Center for Produce Safety (https://cps.ucdavis.edu/), the California Lettuce and Leafy Greens Research Board (http://www.calgreens.org/about-us.html), and the U.S. Food and Drug Administration, Project No. U01-002-527 (www.fda.gov). The funders had no role in study design, data collections and analysis, decision to publish, or preparation of the manuscript.	Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Barker-Reid F, 2009, J FOOD PROTECT, V72, P458, DOI 10.4315/0362-028X-72.3.458; Bell CW, 2009, MICROB ECOL, V58, P827, DOI 10.1007/s00248-009-9529-5; Biesbroek G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032942; Bowers RM, 2012, ATMOS ENVIRON, V50, P41, DOI 10.1016/j.atmosenv.2012.01.005; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Centers for Disease Control and Prevention, 2010, INV UPD MULT OUTBR H; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Choi S, 2011, J APPL MICROBIOL, V111, P1465, DOI 10.1111/j.1365-2672.2011.05175.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cooley MB, 2006, J FOOD PROTECT, V69, P2329, DOI 10.4315/0362-028X-69.10.2329; Cuiv PO, 2011, MICROB ECOL, V61, P353, DOI 10.1007/s00248-010-9771-x; De Costa DM, 2006, J AGRON CROP SCI, V192, P209, DOI 10.1111/j.1439-037X.2006.00207.x; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; Doyle MP, 2008, J APPL MICROBIOL, V105, P317, DOI 10.1111/j.1365-2672.2008.03746.x; ERCOLANI G L, 1979, Zentralblatt fuer Bakteriologie Parasitenkunde Infektionskrankheiten und Hygiene Zweite Naturwissenschaftliche Abteilung Mikrobiologie der Landwirtschaft der Technologie und des Umweltschutzes, V134, P402; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Finkel OM, 2011, APPL ENVIRON MICROB, V77, P7647, DOI 10.1128/AEM.05565-11; GRIFFIN PM, 1991, EPIDEMIOL REV, V13, P60, DOI 10.1093/oxfordjournals.epirev.a036079; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Heaton JC, 2008, J APPL MICROBIOL, V104, P613, DOI 10.1111/j.1365-2672.2007.03587.x; HIRANO SS, 1989, APPL ENVIRON MICROB, V55, P623, DOI 10.1128/AEM.55.3.623-630.1989; Hirano SS, 2000, MICROBIOL MOL BIOL R, V64, P624, DOI 10.1128/MMBR.64.3.624-653.2000; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Hunter PJ, 2010, APPL ENVIRON MICROB, V76, P8117, DOI 10.1128/AEM.01321-10; Ibekwe AM, 2009, LETT APPL MICROBIOL, V49, P784, DOI 10.1111/j.1472-765X.2009.02745.x; Islam M, 2004, J FOOD PROTECT, V67, P1365, DOI 10.4315/0362-028X-67.7.1365; Jackson CR, 2011, MICROB ECOL, V61, P113, DOI 10.1007/s00248-010-9742-2; Kadivar H, 2003, MICROBIAL ECOL, V45, P353, DOI 10.1007/s00248-002-1065-5; Knief C, 2012, ISME J, V6, P1378, DOI 10.1038/ismej.2011.192; Knief C, 2010, ISME J, V4, P719, DOI 10.1038/ismej.2010.9; Koopman MM, 2010, APPL ENVIRON MICROB, V76, P1851, DOI 10.1128/AEM.02440-09; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lambais MR, 2006, SCIENCE, V312, P1917, DOI 10.1126/science.1124696; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Larsen P, 2012, J BIOTECHNOL, V160, P17, DOI 10.1016/j.jbiotec.2012.03.009; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; Lipson DA, 2004, APPL ENVIRON MICROB, V70, P2867, DOI 10.1128/AEM.70.5.2867-2879.2004; Lopez-Velasco G, 2011, J APPL MICROBIOL, V110, P1203, DOI 10.1111/j.1365-2672.2011.04969.x; Lopez-Velasco G, 2012, INT J FOOD MICROBIOL, V153, P351, DOI 10.1016/j.ijfoodmicro.2011.11.026; Lopez-Velasco G, 2010, FOOD MICROBIOL, V27, P476, DOI 10.1016/j.fm.2009.12.010; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Morris CE, 2002, PHYLLOSPHERE MICROBIOLOGY, P365; Moyne AL, 2011, FOOD MICROBIOL, V28, P1417, DOI 10.1016/j.fm.2011.02.001; PEDERSEN JC, 1992, APPL ENVIRON MICROB, V58, P1064, DOI 10.1128/AEM.58.3.1064-1066.1992; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rastogi G, 2012, ISME J, V6, P1812, DOI 10.1038/ismej.2012.32; Rastogi G, 2010, J MICROBIOL METH, V83, P127, DOI 10.1016/j.mimet.2010.08.006; Redford AJ, 2010, ENVIRON MICROBIOL, V12, P2885, DOI 10.1111/j.1462-2920.2010.02258.x; Redford AJ, 2009, MICROB ECOL, V58, P189, DOI 10.1007/s00248-009-9495-y; Reisberg EE, 2012, ANTON LEEUW INT J G, V101, P551, DOI 10.1007/s10482-011-9669-8; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Sakai M, 2004, J MICROBIOL METH, V59, P81, DOI 10.1016/j.mimet.2004.06.005; Smith Birgitte, 2011, Open Microbiol J, V5, P14, DOI 10.2174/1874285801105010014; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Telias A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-81; Tilden J, 1996, AM J PUBLIC HEALTH, V86, P1142, DOI 10.2105/AJPH.86.8_Pt_1.1142; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Whipps JM, 2008, J APPL MICROBIOL, V105, P1744, DOI 10.1111/j.1365-2672.2008.03906.x; WILSON M, 1994, APPL ENVIRON MICROB, V60, P4468, DOI 10.1128/AEM.60.12.4468-4477.1994; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206; Yang CH, 2001, P NATL ACAD SCI USA, V98, P3889, DOI 10.1073/pnas.051633898; Zhang BG, 2008, FEMS MICROBIOL LETT, V284, P102, DOI 10.1111/j.1574-6968.2008.01178.x; Zwielehner J, 2008, MOL NUTR FOOD RES, V52, P614, DOI 10.1002/mnfr.200700158	68	94	98	1	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68642	10.1371/journal.pone.0068642	http://dx.doi.org/10.1371/journal.pone.0068642			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844230	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000176
J	Redpath, CJ; Khalil, MB; Drozdzal, G; Radisic, M; McBride, HM				Redpath, Calum J.; Khalil, Maroun Bou; Drozdzal, Gregory; Radisic, Milica; McBride, Heidi M.			Mitochondrial Hyperfusion during Oxidative Stress Is Coupled to a Dysregulation in Calcium Handling within a C2C12 Cell Model	PLOS ONE			English	Article							POSTOPERATIVE ATRIAL-FIBRILLATION; SARCOPLASMIC-RETICULUM; ENDOPLASMIC-RETICULUM; HEART-MITOCHONDRIA; NA+-CA2+ EXCHANGER; SIGNAL TRANSMISSION; RYANODINE RECEPTORS; CARDIAC MYOCYTES; SKELETAL-MUSCLE; PULMONARY VEINS	Atrial Fibrillation is the most common sustained cardiac arrhythmia worldwide harming millions of people every year. Atrial Fibrillation (AF) abruptly induces rapid conduction between atrial myocytes which is associated with oxidative stress and abnormal calcium handling. Unfortunately this new equilibrium promotes perpetuation of the arrhythmia. Recently, in addition to being the major source of oxidative stress within cells, mitochondria have been observed to fuse, forming mitochondrial networks and attach to intracellular calcium stores in response to cellular stress. We sought to identify a potential role for rapid stimulation, oxidative stress and mitochondrial hyperfusion in acute changes to myocyte calcium handling. In addition we hoped to link altered calcium handling to increased sarcoplasmic reticulum (SR)-mitochondrial contacts, the so-called mitochondrial associated membrane (MAM). We selected the C2C12 murine myotube model as it has previously been successfully used to investigate mitochondrial dynamics and has a myofibrillar system similar to atrial myocytes. We observed that rapid stimulation of C2C12 cells resulted in mitochondrial hyperfusion and increased mitochondrial colocalisation with calcium stores. Inhibition of mitochondrial fission by transfection of mutant DRP1K38E resulted in similar effects on mitochondrial fusion, SR colocalisation and altered calcium handling. Interestingly the effects of 'forced fusion' were reversed by co-incubation with the reducing agent N-Acetyl cysteine (NAC). Subsequently we demonstrated that oxidative stress resulted in similar reversible increases in mitochondrial fusion, SR-colocalisation and altered calcium handling. Finally, we believe we have identified that myocyte calcium handling is reliant on baseline levels of reactive oxygen species as co-incubation with NAC both reversed and retarded myocyte response to caffeine induced calcium release and re-uptake. Based on these results we conclude that the coordinate regulation of mitochondrial fusion and MAM contacts may form a point source for stress-induced arrhythmogenesis. We believe that the MAM merits further investigation as a therapeutic target in AF-induced remodelling.	[Redpath, Calum J.; Khalil, Maroun Bou; Drozdzal, Gregory] Univ Ottawa, Inst Heart, Cellular Electrophysiol Lab, Ottawa, ON, Canada; [Radisic, Milica] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [McBride, Heidi M.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada	University of Ottawa; University of Ottawa Heart Institute; University of Toronto; McGill University	Redpath, CJ (corresponding author), Univ Ottawa, Inst Heart, Cellular Electrophysiol Lab, Ottawa, ON, Canada.	credpath@ottawaheart.ca	McBride, Heidi M/C-1162-2008; McBride, Heidi M./ABD-5774-2021	McBride, Heidi M/0000-0003-4666-2280; McBride, Heidi M./0000-0003-4666-2280	University of Ottawa Heart Institute Foundation	University of Ottawa Heart Institute Foundation	The University of Ottawa Heart Institute Foundation funded this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ME, 1998, CHEM-BIOL INTERACT, V112, P1; Aon MA, 2007, J BIOL CHEM, V282, P21889, DOI 10.1074/jbc.M702841200; Ashrafian H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001000; Baines CP, 2010, ANNU REV PHYSIOL, V72, P61, DOI 10.1146/annurev-physiol-021909-135929; Balaban RS, 2009, BBA-BIOENERGETICS, V1787, P1334, DOI 10.1016/j.bbabio.2009.05.011; BAYSAL K, 1994, AM J PHYSIOL, V266, pC800, DOI 10.1152/ajpcell.1994.266.3.C800; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Bravo R, 2011, J CELL SCI, V124, P2143, DOI 10.1242/jcs.080762; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Bukowska A, 2008, EXP BIOL MED, V233, P558, DOI 10.3181/0706-RM-155; Bunch TJ, 2010, HEART RHYTHM, V7, P433, DOI 10.1016/j.hrthm.2009.12.004; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; CARAFOLI E, 1974, J MOL CELL CARDIOL, V6, P361, DOI 10.1016/0022-2828(74)90077-7; Carnes CA, 2001, CIRC RES, V89, pE32, DOI 10.1161/hh1801.097644; Carnes CA, 2007, J BIOL CHEM, V282, P28063, DOI 10.1074/jbc.M704893200; Castaldo P, 2009, PROG NEUROBIOL, V87, P58, DOI 10.1016/j.pneurobio.2008.09.017; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen Y, 2012, CIRC RES, V111, P863, DOI 10.1161/CIRCRESAHA.112.266585; Chen Y, 2011, CIRC RES, V109, P1327, DOI 10.1161/CIRCRESAHA.111.258723; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Cheng H, 1996, AM J PHYSIOL, V270, pC148; Csordas G, 2001, TRENDS CARDIOVAS MED, V11, P269, DOI 10.1016/S1050-1738(01)00123-2; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Dash RK, 2008, J PHYSIOL-LONDON, V586, P3267, DOI 10.1113/jphysiol.2008.151977; David G, 1998, J PHYSIOL-LONDON, V509, P59, DOI 10.1111/j.1469-7793.1998.059bo.x; Davidson SM, 2006, CELL CALCIUM, V40, P561, DOI 10.1016/j.ceca.2006.08.017; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; de Brito OM, 2010, EMBO J, V29, P2715, DOI 10.1038/emboj.2010.177; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Dudley SC, 2005, CIRCULATION, V112, P1266, DOI 10.1161/CIRCULATIONAHA.105.538108; Fryer MW, 1996, J PHYSIOL-LONDON, V493, P357, DOI 10.1113/jphysiol.1996.sp021388; Garcia-Perez C, 2008, J BIOL CHEM, V283, P32771, DOI 10.1074/jbc.M803385200; Garcia-Perez C, 2011, AM J PHYSIOL-HEART C, V301, pH1907, DOI 10.1152/ajpheart.00397.2011; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Griffiths EJ, 2009, J MOL CELL CARDIOL, V46, P789, DOI 10.1016/j.yjmcc.2009.03.001; Hom JR, 2007, J CELL PHYSIOL, V212, P498, DOI 10.1002/jcp.21051; Iglewski M, 2010, CURR HYPERTENS REP, V12, P418, DOI 10.1007/s11906-010-0147-x; JUNG DW, 1995, J BIOL CHEM, V270, P672, DOI 10.1074/jbc.270.2.672; Kim YM, 2005, CIRC RES, V97, P629, DOI 10.1161/01.RES.0000183735.09871.61; Kim YM, 2008, J AM COLL CARDIOL, V51, P68, DOI 10.1016/j.jacc.2007.07.085; Kohlhaas M, 2010, CIRCULATION, V122, P2273, DOI 10.1161/CIRCULATIONAHA.110.968057; KOSOWER NS, 1995, METHOD ENZYMOL, V251, P123, DOI 10.1016/0076-6879(95)51116-4; Kowaltowski AJ, 1999, FREE RADICAL BIO MED, V26, P463, DOI 10.1016/S0891-5849(98)00216-0; Kuo TY, 2012, P NATL ACAD SCI USA, V109, P11160, DOI 10.1073/pnas.1111334109; Langelaan MLP, 2011, J TISSUE ENG REGEN M, V5, P529, DOI 10.1002/term.345; Lim G, 2008, CARDIOVASC RES, V77, P256, DOI 10.1093/cvr/cvm012; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; Mihm MJ, 2001, CIRCULATION, V104, P174, DOI 10.1161/01.CIR.104.2.174; Minamino T, 2010, J MOL CELL CARDIOL, V48, P1105, DOI 10.1016/j.yjmcc.2009.10.026; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060; Nattel S, 1999, CARDIOVASC RES, V42, P298, DOI 10.1016/S0008-6363(99)00022-X; Nattel S, 2012, EUR HEART J, V33, P1870, DOI 10.1093/eurheartj/ehs079; Ngoh GA, 2012, J BIOL CHEM, V287, P20321, DOI 10.1074/jbc.M112.359174; Odagiri K, 2009, J MOL CELL CARDIOL, V46, P989, DOI 10.1016/j.yjmcc.2008.12.022; Ozaydin M, 2008, EUR HEART J, V29, P625, DOI 10.1093/eurheartj/ehn011; Papanicolaou KN, 2011, MOL CELL BIOL, V31, P1309, DOI 10.1128/MCB.00911-10; Park H, 2008, J TISSUE ENG REGEN M, V2, P279, DOI 10.1002/term.93; Perez-Lugones A, 2003, J CARDIOVASC ELECTR, V14, P803, DOI 10.1046/j.1540-8167.2003.03075.x; Ramlawi B, 2007, ANN THORAC SURG, V84, P1166, DOI 10.1016/j.athoracsur.2007.04.126; Reilly SN, 2011, CIRCULATION, V124, P1107, DOI 10.1161/CIRCULATIONAHA.111.029223; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; ROUSSEAU E, 1988, ARCH BIOCHEM BIOPHYS, V267, P75, DOI 10.1016/0003-9861(88)90010-0; Ryder KM, 1999, AM J CARDIOL, V84, p131R; Saotome M, 2008, P NATL ACAD SCI USA, V105, P20728, DOI 10.1073/pnas.0808953105; Schauss AC, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-100; Schild L, 2006, BBA-MOL BASIS DIS, V1762, P608, DOI 10.1016/j.bbadis.2006.03.005; Shen T, 2007, J BIOL CHEM, V282, P23354, DOI 10.1074/jbc.M702657200; Shimano M, 2009, HEART RHYTHM, V6, P935, DOI 10.1016/j.hrthm.2009.03.012; Shutt TE, 2012, BIOCHIM BIOPHYS ACTA, V1833, P417; Shutt T, 2012, EMBO REP, V13, P909, DOI 10.1038/embor.2012.128; Soubannier V, 2009, BBA-MOL CELL RES, V1793, P154, DOI 10.1016/j.bbamcr.2008.07.008; STERN MD, 1992, BIOPHYS J, V63, P497, DOI 10.1016/S0006-3495(92)81615-6; Szalai G, 2000, J BIOL CHEM, V275, P15305, DOI 10.1074/jbc.275.20.15305; Tandon N, 2011, J TISSUE ENG REGEN M, V5, pE115, DOI 10.1002/term.377; Tang YG, 1997, NEURON, V18, P483, DOI 10.1016/S0896-6273(00)81248-9; Thijssen VLJL, 2001, CARDIOVASC RES, V52, P14, DOI 10.1016/S0008-6363(01)00367-4; Todd DM, 2003, CIRCULATION, V108, P3108, DOI 10.1161/01.CIR.0000104567.72914.BF; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; Van Wagoner DR, 2008, J CARDIOVASC PHARM, V52, P306, DOI 10.1097/FJC.0b013e31817f9398; Venetucci LA, 2008, CARDIOVASC RES, V77, P285, DOI 10.1093/cvr/cvm009; Wang HJ, 2000, J CELL BIOL, V150, P1489, DOI 10.1083/jcb.150.6.1489; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Yan Y, 2008, CARDIOVASC RES, V77, P432, DOI 10.1093/cvr/cvm047; Yang F, 2003, J CELL BIOL, V163, P511, DOI 10.1083/jcb.200307027; Zhang T, 2010, CIRC RES, V106, P354, DOI 10.1161/CIRCRESAHA.109.207423; Zima AV, 2006, CARDIOVASC RES, V71, P310, DOI 10.1016/j.cardiores.2006.02.019; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	91	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e69165	10.1371/journal.pone.0069165	http://dx.doi.org/10.1371/journal.pone.0069165			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861961	Green Published, Green Submitted, gold			2022-12-27	WOS:000321692000037
J	Alastalo, H; von Bonsdorff, MB; Raikkonen, K; Pesonen, AK; Osmond, C; Barker, DJP; Heinonen, K; Kajantie, E; Eriksson, JG				Alastalo, Hanna; von Bonsdorff, Mikaela B.; Raikkonen, Katri; Pesonen, Anu-Katriina; Osmond, Clive; Barker, David J. P.; Heinonen, Kati; Kajantie, Eero; Eriksson, Johan G.			Early Life Stress and Physical and Psychosocial Functioning in Late Adulthood	PLOS ONE			English	Article							QUALITY-OF-LIFE; ADVERSE CHILDHOOD EXPERIENCES; EARLY PARENTAL LOSS; LIVING-CONDITIONS; HEALTH; CHILDREN; MORTALITY; CONSEQUENCES; DETERMINANTS; TRAJECTORIES	Background: Severe stress experienced in early life may have long-term effects on adult physiological and psychological health and well-being. We studied physical and psychosocial functioning in late adulthood in subjects separated temporarily from their parents in childhood during World War II. Methods: The 1803 participants belong to the Helsinki Birth Cohort Study, born 1934-44. Of them, 267 (14.8%) had been evacuated abroad in childhood during WWII and the remaining subjects served as controls. Physical and psychosocial functioning was assessed with the Short Form 36 scale (SF-36) between 2001 and 2004. A test for trends was based on linear regression. All analyses were adjusted for age at clinical examination, social class in childhood and adulthood, smoking, alcohol intake, physical activity, body mass index, cardiovascular disease and diabetes. Results: Physical functioning in late adulthood was lower among the separated men compared to non-separated men (b = -0.40, 95% confidence interval [95% CI]: -0.71 to -0.08). Those men separated in school age (>7 years) and who were separated for a duration over 2 years had the highest risk for lower physical functioning (b = -0.89, 95% CI: -1.58 to -0.20) and (b = -0.65, 95% CI: -1.25 to -0.05), respectively). Men separated for a duration over 2 years also had lower psychosocial functioning (b = -0.70, 95% CI: -1.35 to -0.06). These differences in physical and psychosocial functioning were not observed among women. Conclusion: Early life stress may increase the risk for impaired physical functioning in late adulthood among men. Timing and duration of the separation influenced the physical and psychosocial functioning in late adulthood.	[Alastalo, Hanna; Kajantie, Eero; Eriksson, Johan G.] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Alastalo, Hanna] Univ Helsinki, Hjelt Inst, Helsinki, Finland; [Alastalo, Hanna; Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland; [von Bonsdorff, Mikaela B.] Univ Jyvaskyla, Gerontol Res Ctr, Jyvaskyla, Finland; [von Bonsdorff, Mikaela B.] Univ Jyvaskyla, Dept Hlth Sci, Jyvaskyla, Finland; [Raikkonen, Katri; Pesonen, Anu-Katriina; Heinonen, Kati] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Pesonen, Anu-Katriina; Eriksson, Johan G.] Univ Helsinki, Inst Clin Med, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Osmond, Clive; Barker, David J. P.] MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Barker, David J. P.] King Saud Univ, Chair Fetal Programming, Riad, Saudi Arabia; [Kajantie, Eero] Univ Helsinki, Cent Hosp, Hosp Children & Adolescents, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Vasa Cent Hosp, Vaasa, Finland	Finland National Institute for Health & Welfare; University of Helsinki; Folkhalsan Research Center; University of Jyvaskyla; University of Jyvaskyla; University of Helsinki; University of Helsinki; King Saud University; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Vaasa Central Hospital	Alastalo, H (corresponding author), Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland.	hanna.alastalo@thl.fi	von Bonsdorff, Mikaela/A-5218-2015	von Bonsdorff, Mikaela/0000-0001-8530-5230; Heinonen, Kati/0000-0002-1262-5599; Raikkonen, Katri/0000-0003-3124-3470; Pesonen, Anu-Katriina/0000-0002-0662-6261; Eriksson, Johan/0000-0002-2516-2060; Osmond, Clive/0000-0002-9054-4655	Juho Vainio Foundation; Yrjo Jahnsson Foundation; Academy of Finland [127437, 129306, 130326, 134791, 263924, 140278, 129911, 135132, 129457, 257239, 129369, 129907, 135072, 129255, 126775]; Emil Aaltonen Foundation; Novo Nordisk Foundation; Signe and Ane Gyllenberg Foundation; Jalmari and Rauha Ahokas Foundation; Samfundet Folkhalsan; Finska Lakaresallskapet; Sigrid Juselius Foundation; Medical Research Council [MC_UU_12011/3, MC_UU_12011/4, MC_UP_A620_1017] Funding Source: researchfish; MRC [MC_UP_A620_1017, MC_UU_12011/4, MC_UU_12011/3] Funding Source: UKRI	Juho Vainio Foundation; Yrjo Jahnsson Foundation; Academy of Finland(Academy of Finland); Emil Aaltonen Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Signe and Ane Gyllenberg Foundation; Jalmari and Rauha Ahokas Foundation; Samfundet Folkhalsan; Finska Lakaresallskapet; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was financially supported by the Juho Vainio Foundation, the Yrjo Jahnsson Foundation, Academy of Finland grants 127437, 129306, 130326, 134791 and 263924 to EK; 140278, 129911, 135132 and 129457 to KR; 257239 to MBvB; 129369, 129907, 135072, 129255 and 126775 to JGE, Emil Aaltonen Foundation, Novo Nordisk Foundation, Signe and Ane Gyllenberg Foundation, Jalmari and Rauha Ahokas Foundation, Samfundet Folkhalsan, Finska Lakaresallskapet, Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto AM., 1995, RAND 36 ITEM HLTH SU; Aalto AM, 1999, RAND 36 MEASURE HLTH; Adams J, 2004, J EPIDEMIOL COMMUN H, V58, P1028, DOI 10.1136/jech.2004.019679; Alastalo H, 2012, J HUM HYPERTENS, DOI [10.1038/jhh.2012.6, DOI 10.1038/JHH.2012.6.EPUB]; Alastalo H, 2012, PSYCHOSOM MED, V74, P583, DOI 10.1097/PSY.0b013e31825b3d76; Alastalo H, 2009, ANN MED, V41, P66, DOI 10.1080/07853890802301983; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Carpenter LL, 2007, BIOL PSYCHIAT, V62, P1080, DOI 10.1016/j.biopsych.2007.05.002; Central Statistical Office of Finland, 1989, CLASS SOC GROUPS HDB, V17; Cirulli F, 2003, NEUROSCI BIOBEHAV R, V27, P73, DOI 10.1016/S0149-7634(03)00010-1; Corso PS, 2008, AM J PUBLIC HEALTH, V98, P1094, DOI 10.2105/AJPH.2007.119826; DiPietro L, 1996, MED SCI SPORT EXER, V28, P596, DOI 10.1097/00005768-199605000-00010; Draper B, 2008, J AM GERIATR SOC, V56, P262, DOI 10.1111/j.1532-5415.2007.01537.x; Edwards VJ, 2004, AP PRA H PS, P81; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Fagundes CP, 2011, SOC PERSONAL PSYCHOL, V5, P891, DOI 10.1111/j.1751-9004.2011.00392.x; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Foster D, 2003, AGING MENT HEALTH, V7, P398, DOI 10.1080/1360786031000150711; Gunnar MR, 2000, MINN SYM CHILD PSYCH, V31, P163; Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305; Irving SM, 2006, J AGING HEALTH, V18, P458, DOI 10.1177/0898264305280994; Kajantie E, 2006, PSYCHONEUROENDOCRINO, V31, P151, DOI 10.1016/j.psyneuen.2005.07.002; Kaplan G A, 1992, Ann Epidemiol, V2, P823; Korosi A, 2012, BEHAV BRAIN RES, V227, P400, DOI 10.1016/j.bbr.2011.07.037; Krause N, 1998, J AGING HEALTH, V10, P395, DOI 10.1177/089826439801000401; Lachman ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013297; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; LUNDBERG O, 1993, SOC SCI MED, V36, P1047, DOI 10.1016/0277-9536(93)90122-K; Luo Y, 2005, J GERONTOL B-PSYCHOL, V60, pS93, DOI 10.1093/geronb/60.2.S93; Maier EH, 2000, INT J BEHAV DEV, V24, P183, DOI 10.1080/016502500383304; Martikainen P, 1999, SOC SCI MED, V49, P499, DOI 10.1016/S0277-9536(99)00135-5; Miller GE, 2011, PSYCHOL BULL; Nemeroff CB, 2004, J CLIN PSYCHIAT, V65, P18; Otte C, 2005, PSYCHONEUROENDOCRINO, V30, P80, DOI 10.1016/j.psyneuen.2004.06.002; Pesonen AK, 2007, AM J EPIDEMIOL, V166, P1126, DOI 10.1093/aje/kwm254; Pesonen AK, 2011, ANN MED, V43, P320, DOI 10.3109/07853890.2010.549146; Pesonen AK, 2010, PSYCHONEUROENDOCRINO, V35, P758, DOI 10.1016/j.psyneuen.2009.10.017; Rahkonen O, 1997, SOC SCI MED, V44, P327, DOI 10.1016/S0277-9536(96)00102-5; Raikkonen K, 2011, J PSYCHIATR RES, V45, P332, DOI 10.1016/j.jpsychires.2010.07.003; Repetti RL, 2002, PSYCHOL BULL, V128, P330, DOI 10.1037/0033-2909.128.2.330; ROWE JW, 1987, SCIENCE, V237, P143, DOI 10.1126/science.3299702; Rusby JSM, 2008, ATTACH HUM DEV, V10, P207, DOI 10.1080/14616730802113737; Singh-Manoux A, 2004, INT J EPIDEMIOL, V33, P1072, DOI 10.1093/ije/dyh224; Spirduso WW, 2001, MED SCI SPORT EXER, V33, pS598, DOI 10.1097/00005768-200106001-00028; Verma R, 2011, IND PSYCHIAT J, V20, P4, DOI DOI 10.4103/0972-6748.98407; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Willcox BJ, 2006, JAMA-J AM MED ASSOC, V296, P2343, DOI 10.1001/jama.296.19.2343	48	41	42	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e69011	10.1371/journal.pone.0069011	http://dx.doi.org/10.1371/journal.pone.0069011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	178DW	23861956	Green Published, gold, Green Submitted			2022-12-27	WOS:000321425300084
J	Feng, J; Zhao, T; Zhang, Y; Ma, Y; Jiang, YR				Feng, Jing; Zhao, Tong; Zhang, Yan; Ma, Yan; Jiang, Yanrong			Differences in Aqueous Concentrations of Cytokines in Macular Edema Secondary to Branch and Central Retinal Vein Occlusion	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; PROLIFERATIVE DIABETIC-RETINOPATHY; INTRAVITREAL TRIAMCINOLONE; BEVACIZUMAB AVASTIN; INTERLEUKIN-6; EXPRESSION; NEOVASCULARIZATION; RANIBIZUMAB; POPULATION; STATES	Purpose: This study investigates the differential aqueous concentrations of interleukin 6, 8, 1 beta (IL-6, IL-8, IL-1 beta, respectively), serum amyloid A (SAA), transforming growth factor (TGF)-beta, basic fibroblast growth factor (bFGF), and vascular endothelial growth factor (VEGF) in eyes with macular edema as a result of a branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO) Principal Findings: Significantly higher concentrations of IL-6, IL-8, IL-1 beta, TGF-beta, bFGF, SAA, and VEGF were found in the aqueous humor of CRVO and BRVO patients than in the aqueous humor of control patients. A significant correlation was observed between the concentration of bFGF and the inner central macular thickness (CMT) of BRVO patients (r = 0.688; P = 0.02). A significant correlation was observed between the concentration of SAA and both the full and outer CMT of the ischemic group (r = 0.545 and 0.683, respectively; P = 0.04 and 0.01, respectively). In the non-ischemic group, the level of IL-6 was significantly associated with inner CMT (r = 0.560; P = 0.03). The full and outer CMT was significantly reduced in CRVO patients when compared with BRVO patients (P = 0.02 and 0.02, respectively) after injection of intravitreal bevacizumab (IVB) at 4 weeks. Significance: Serum amyloid A as a major protein involved in the acute and chronic stages of inflammation, and IL-6 and bFGF were significantly associated with the extent of macular edema in patients with RVO. Besides VEGF, other inflammatory cytokines and angiogenesic factors may be associated with RVO. This finding may have implications for the medical treatment of RVO.	[Jiang, Yanrong] Peking Univ, Dept Ophthalmol, Peoples Hosp, Beijing 100871, Peoples R China; Minist Educ, Key Lab Vis Loss & Restorat, Beijing, Peoples R China	Peking University	Jiang, YR (corresponding author), Peking Univ, Dept Ophthalmol, Peoples Hosp, Beijing 100871, Peoples R China.	drjyr@vip.sina.com		Feng, Jing/0000-0002-7658-9865	People's Hospital of Peking University [RDC2012-21]; Ph.D. Programs Foundation of Ministry of Education of China [20110001110042]; EFSD/CDS/Lilly grant	People's Hospital of Peking University; Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); EFSD/CDS/Lilly grant	This study was supported by the study and development fund of the People's Hospital of Peking University (No. RDC2012-21), Ph.D. Programs Foundation of Ministry of Education of China (No. 20110001110042, http://www.cutech.edu.cn/cn/rootfiles/2011/12/05/1322550574368276-1322550574468608. xls), and an EFSD/CDS/Lilly grant (http://www.europeandiabetesfoundation.org/Lilly/EFSD-CDS-Lilly-Recipients.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, ARCH OPHTHALMOL, V115, P486; Boyd SR, 2002, ARCH OPHTHALMOL-CHIC, V120, P1644; Campochiaro PA, 2008, MOL THER, V16, P791, DOI 10.1038/mt.2008.10; Channa R, 2011, CLIN OPHTHALMOL, V5, P705, DOI 10.2147/OPTH.S7632; Clarkson J G, 1994, Trans Am Ophthalmol Soc, V92, P203; Cugati S, 2006, ARCH OPHTHALMOL-CHIC, V124, P726, DOI 10.1001/archopht.124.5.726; DAMORE PA, 1994, INVEST OPHTH VIS SCI, V35, P3974; Ding XY, 2011, RETINA-J RET VIT DIS, V31, P838, DOI 10.1097/IAE.0b013e3181f4420d; Frank RN, 1996, AM J OPHTHALMOL, V122, P393, DOI 10.1016/S0002-9394(14)72066-5; Funk M, 2009, INVEST OPHTH VIS SCI, V50, P1025, DOI 10.1167/iovs.08-2510; HAYREH SS, 1983, OPHTHALMOLOGY, V90, P458; HOLZINGER C, 1993, IMMUNOL LETT, V35, P109, DOI 10.1016/0165-2478(93)90078-G; Hung KH, 2010, J OCUL PHARMACOL TH, V26, P85, DOI 10.1089/jop.2009.0090; Jones LL, 2011, IMMUNOL RES, V51, P5, DOI 10.1007/s12026-011-8209-y; Kaneda S, 2011, INVEST OPHTH VIS SCI, V52, P2982, DOI 10.1167/iovs.10-6299; Klein R, 2000, Trans Am Ophthalmol Soc, V98, P133; Lee WJ, 2012, BRIT J OPHTHALMOL, V96, P1426, DOI 10.1136/bjophthalmol-2012-301913; Ma Y, 2011, AM J OPHTHALMOL, V152, P678, DOI 10.1016/j.ajo.2011.03.007; Noma H, 2008, EYE, V22, P42, DOI 10.1038/sj.eye.6702498; Nuti E, 2011, RETINA-J RET VIT DIS, V31, P1863, DOI 10.1097/IAE.0b013e318219de8b; Park CH, 2003, AM J OPHTHALMOL, V136, P419, DOI 10.1016/S0002-9394(03)00228-9; Rogers S, 2010, OPHTHALMOLOGY, V117, P313, DOI [10.1016/j.ophtha.2009.07.017, 10.1016/j.ophtha.2010.01.060]; SIVALINGAM A, 1990, ARCH OPHTHALMOL-CHIC, V108, P869, DOI 10.1001/archopht.1990.01070080113046; Sohn HJ, 2011, AM J OPHTHALMOL, V152, P686, DOI 10.1016/j.ajo.2011.03.033; Spaide RF, 2009, AM J OPHTHALMOL, V147, P298, DOI 10.1016/j.ajo.2008.08.016; Stahl A, 2010, EUR J OPHTHALMOL, V20, P180, DOI 10.1177/112067211002000125; Suzuki Y, 2011, JPN J OPHTHALMOL, V55, P256, DOI 10.1007/s10384-011-0004-8; Tanaka T, 2012, ANNU REV PHARMACOL, V52, P199, DOI 10.1146/annurev-pharmtox-010611-134715; Turello M, 2010, J THROMB THROMBOLYS, V29, P459, DOI 10.1007/s11239-009-0384-5; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Upragarin N, 2005, VET IMMUNOL IMMUNOP, V106, P39, DOI 10.1016/j.vetimm.2005.01.004; Urieli-Shoval S, 2000, CURR OPIN HEMATOL, V7, P64, DOI 10.1097/00062752-200001000-00012; Zittermann SI, 2006, AM J PATHOL, V168, P835, DOI 10.2353/ajpath.2006.050479; 1995, OPHTHALMOLOGY, V102, P1425	34	35	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68149	10.1371/journal.pone.0068149	http://dx.doi.org/10.1371/journal.pone.0068149			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861862	gold, Green Submitted, Green Published			2022-12-27	WOS:000321425300045
J	Raso, GM; Simeoli, R; Russo, R; Iacono, A; Santoro, A; Paciello, O; Ferrante, MC; Canani, RB; Calignano, A; Meli, R				Raso, Giuseppina Mattace; Simeoli, Raffaele; Russo, Roberto; Iacono, Anna; Santoro, Anna; Paciello, Orlando; Ferrante, Maria Carmela; Canani, Roberto Berni; Calignano, Antonio; Meli, Rosaria			Effects of Sodium Butyrate and Its Synthetic Amide Derivative on Liver Inflammation and Glucose Tolerance in an Animal Model of Steatosis Induced by High Fat Diet	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; GROWTH-FACTOR 21; INSULIN-RESISTANCE; HEPATIC STEATOSIS; PPAR-GAMMA; METABOLISM; MICE; TRANSCRIPTION; DYSFUNCTION; INHIBITION	Background & Aims: Nonalcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease. Insulin resistance (IR) appears to be critical in its pathogenesis. We evaluated the effects of sodium butyrate (butyrate) and its synthetic derivative N-(1-carbamoyl-2-phenyl-ethyl) butyramide (FBA) in a rat model of insulin resistance and steatosis induced by high-fat diet (HFD). Methods: After weaning, young male Sprague-Dawley rats were divided into 4 groups receiving different diets for 6 weeks: 1. control group (standard diet); 2. HFD; 3. HFD plus butyrate (20 mg/kg/die) and 4. HFD plus FBA (42.5 mg/Kg/die, the equimolecular dose of butyrate). Liver tissues of the rats were analyzed by Western blot and real-time PCR. Insulin resistance, liver inflammation and Toll-like pattern modifications were determined. Results: Evaluation of these two preparations of butyrate showed a reduction of liver steatosis and inflammation in HFD fed animals. The compounds showed a similar potency in the normalisation of several variables, such as transaminases, homeostasis model assessment for insulin resistance index, and glucose tolerance. Both treatments significantly reduced hepatic TNF-alpha expression and restored GLUTs and PPARs, either in liver or adipose tissue. Finally, FBA showed a higher potency in reducing pro-inflammatory parameters in the liver, via suppression of Toll-like receptors and NF-kappa B activation. Conclusions: Our results demonstrated a protective effect of butyrate in limiting molecular events underlying the onset of IR and NAFLD, suggesting a potential clinical relevance for this substance. In particular, its derivative, FBA, could represent an alternative therapeutic option to sodium butyrate, sharing a comparable efficacy, but a better palatability and compliance.	[Raso, Giuseppina Mattace; Simeoli, Raffaele; Russo, Roberto; Iacono, Anna; Santoro, Anna; Calignano, Antonio; Meli, Rosaria] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Paciello, Orlando; Ferrante, Maria Carmela] Univ Naples Federico II, Dept Vet Med & Anim Prod, Naples, Italy; [Canani, Roberto Berni] Univ Naples Federico II, Dept Translat Med, Pediat Sect, Naples, Italy; [Canani, Roberto Berni] Univ Naples Federico II, European Lab Invest Food Induced Dis, Naples, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; University of Naples Federico II	Meli, R (corresponding author), Univ Naples Federico II, Dept Pharm, Naples, Italy.	meli@unina.it	Santoro, Anna/G-3609-2014; Canani, Roberto Berni/AAC-4810-2022; russo, roberto/A-3193-2012; Calignano, Antonio/K-2542-2018; Simeoli, Raffaele/J-1101-2018	Santoro, Anna/0000-0003-0187-7050; Canani, Roberto Berni/0000-0002-5169-9574; russo, roberto/0000-0001-5950-1617; Simeoli, Raffaele/0000-0002-3989-7703; Mattace Raso, Giuseppina/0000-0002-5254-139X; CALIGNANO, Antonio/0000-0002-1742-3179; Meli, Rosaria/0000-0002-6246-6813; Santoro, Anna/0000-0002-2276-5659	AIFA [FARM6FJ728]	AIFA	This study was partially supported by AIFA 2006 (Project number: FARM6FJ728). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beauvieux Marie-Christine, 2008, BMC Physiology, V8, P19, DOI 10.1186/1472-6793-8-19; BINDER HJ, 1989, GASTROENTEROLOGY, V96, P989, DOI 10.1016/0016-5085(89)91614-4; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Canani RB, 2004, GASTROENTEROLOGY, V127, P630, DOI 10.1053/j.gastro.2004.03.071; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; Chatterjee PK, 2010, BRIT J PHARMACOL, V160, P1889, DOI 10.1111/j.1476-5381.2010.00739.x; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; De Minicis S, 2011, EXPERT REV GASTROENT, V5, P179, DOI [10.1586/EGH.11.28, 10.1586/egh.11.28]; Ehses JA, 2010, DIABETOLOGIA, V53, P1795, DOI 10.1007/s00125-010-1747-3; Esposito E, 2009, J NUTR, V139, P905, DOI 10.3945/jn.108.101808; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gurnell M, 2003, CLIN ENDOCRINOL, V59, P267, DOI 10.1046/j.1365-2265.2003.01767.x; Harano Y, 2006, LIVER INT, V26, P613, DOI 10.1111/j.1478-3231.2006.01265.x; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Li HT, 2012, DIABETES, V61, P797, DOI 10.2337/db11-0846; Li L, 2011, HEPATOLOGY, V54, P1620, DOI 10.1002/hep.24552; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Mangian HF, 2009, JPEN-PARENTER ENTER, V33, P607, DOI 10.1177/0148607109336599; Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Rencurel F, 1996, BIOCHEM J, V314, P903, DOI 10.1042/bj3140903; Ritzhaupt A, 1998, J PHYSIOL-LONDON, V513, P719, DOI 10.1111/j.1469-7793.1998.719ba.x; Roy Claude C, 2006, Nutr Clin Pract, V21, P351, DOI 10.1177/0115426506021004351; SARDESAI WM, 1968, CLIN CHEM, V14, P156; Senn JJ, 2003, J BIOL CHEM, V278, P13740, DOI 10.1074/jbc.M210689200; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Svegliati-Baroni G, 2006, AM J PATHOL, V169, P846, DOI 10.2353/ajpath.2006.050953; Tiganis T, 2013, FEBS J, V280, P445, DOI 10.1111/j.1742-4658.2012.08563.x; Wang YX, 2010, CELL RES, V20, P124, DOI 10.1038/cr.2010.13; Woo YC, 2013, CLIN ENDOCRINOL, V78, P489, DOI 10.1111/cen.12095	39	109	114	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68626	10.1371/journal.pone.0068626	http://dx.doi.org/10.1371/journal.pone.0068626			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861927	Green Published, Green Submitted, gold			2022-12-27	WOS:000321425300075
J	Rex, K; Jeffries, S; Brown, ML; Carlson, T; Coxon, A; Fajardo, F; Frank, B; Gustin, D; Kamb, A; Kassner, PD; Li, S; Li, YH; Morgenstern, K; Plant, M; Quon, K; Ruefli-Brasse, A; Schmidt, J; Swearingen, E; Walker, N; Wang, ZL; Watson, JEV; Wickramasinghe, D; Wong, M; Xu, GF; Wesche, H				Rex, Karen; Jeffries, Shawn; Brown, Matthew L.; Carlson, Timothy; Coxon, Angela; Fajardo, Flordeliza; Frank, Brendon; Gustin, Darin; Kamb, Alexander; Kassner, Paul D.; Li, Shyun; Li, Yihong; Morgenstern, Kurt; Plant, Matthew; Quon, Kim; Ruefli-Brasse, Astrid; Schmidt, Joanna; Swearingen, Elissa; Walker, Nigel; Wang, Zhulun; Watson, J. E. Vivienne; Wickramasinghe, Dineli; Wong, Mariwil; Xu, Guifen; Wesche, Holger			Sphingosine Kinase Activity Is Not Required for Tumor Cell Viability	PLOS ONE			English	Article							INHIBITS ANGIOGENESIS; CANCER-CELLS; SPHINGOSINE-1-PHOSPHATE; GROWTH; XENOGRAFTS; RECEPTORS; DISCOVERY; APOPTOSIS; TARGETS	Sphingosine kinases (SPHKs) are enzymes that phosphorylate the lipid sphingosine, leading to the formation of sphingosine-1-phosphate (S1P). In addition to the well established role of extracellular S1P as a mitogen and potent chemoattractant, SPHK activity has been postulated to be an important intracellular regulator of apoptosis. According to the proposed rheostat theory, SPHK activity shifts the intracellular balance from the pro-apoptotic sphingolipids ceramide and sphingosine to the mitogenic S1P, thereby determining the susceptibility of a cell to apoptotic stress. Despite numerous publications with supporting evidence, a clear experimental confirmation of the impact of this mechanism on tumor cell viability in vitro and in vivo has been hampered by the lack of suitable tool reagents. Utilizing a structure based design approach, we developed potent and specific SPHK1/2 inhibitors. These compounds completely inhibited intracellular S1P production in human cells and attenuated vascular permeability in mice, but did not lead to reduced tumor cell growth in vitro or in vivo. In addition, siRNA experiments targeting either SPHK1 or SPHK2 in a large panel of cell lines failed to demonstrate any statistically significant effects on cell viability. These results show that the SPHK rheostat does not play a major role in tumor cell viability, and that SPHKs might not be attractive targets for pharmacological intervention in the area of oncology.	[Rex, Karen; Jeffries, Shawn; Coxon, Angela; Fajardo, Flordeliza; Frank, Brendon; Li, Shyun; Ruefli-Brasse, Astrid; Schmidt, Joanna; Watson, J. E. Vivienne; Wickramasinghe, Dineli; Wong, Mariwil; Wesche, Holger] Amgen Inc, Oncol Res, Thousand Oaks, CA 91320 USA; [Brown, Matthew L.; Gustin, Darin; Li, Yihong] Amgen Inc, Med Chem, San Francisco, CA USA; [Carlson, Timothy; Xu, Guifen] Amgen Inc, Pharmacokinet & Drug Metab, San Francisco, CA USA; [Kamb, Alexander] Amgen Inc, Discovery Sci, San Francisco, CA USA; [Kassner, Paul D.; Swearingen, Elissa] Amgen Inc, Genome Anal Unit, San Francisco, CA USA; [Morgenstern, Kurt; Plant, Matthew; Walker, Nigel; Wang, Zhulun] Amgen Inc, Mol Struct & Characterizat, Cambridge, MA USA; [Quon, Kim] Amgen Inc, Therapeut Innovat Unit, Seattle, WA USA	Amgen; Amgen; Amgen; Amgen; Amgen; Amgen; Amgen	Wesche, H (corresponding author), Amgen Inc, Oncol Res, Thousand Oaks, CA 91320 USA.	hwesche@amgen.com	Wang, Zhong Lin/E-2176-2011; wang, jie/GRS-0942-2022	Wang, Zhong Lin/0000-0002-5530-0380; Kassner, Paul/0000-0002-1471-1191	Amgen Inc.	Amgen Inc.(Amgen)	All authors have an affiliation to the commercial funder of this research (Amgen Inc.). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Babij C, 2011, CANCER RES, V71, P5818, DOI 10.1158/0008-5472.CAN-11-0778; Berdyshev EV, 2006, CELL SIGNAL, V18, P1779, DOI 10.1016/j.cellsig.2006.01.018; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Chipuk JE, 2012, CELL, V148, P988, DOI 10.1016/j.cell.2012.01.038; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; English D, 1999, J HEMATOTH STEM CELL, V8, P627, DOI 10.1089/152581699319795; French KJ, 2003, CANCER RES, V63, P5962; Hedges LV, 2014, STAT METHODS META AN; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Kapitonov D, 2009, CANCER RES, V69, P6915, DOI 10.1158/0008-5472.CAN-09-0664; LaMontagne K, 2006, CANCER RES, V66, P221, DOI 10.1158/0008-5472.CAN-05-2001; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; MILES AA, 1952, J PHYSIOL-LONDON, V118, P228, DOI 10.1113/jphysiol.1952.sp004789; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Nemoto S, 2009, J BIOL CHEM, V284, P10422, DOI 10.1074/jbc.M900735200; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Orr Gandy KA, 2012, BIOCH BIOPHYS ACTA; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Polverino A, 2006, CANCER RES, V66, P8715, DOI 10.1158/0008-5472.CAN-05-4665; Schnute ME, 2012, BIOCHEM J, V444, P79, DOI 10.1042/BJ20111929; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; Wang Z, 2013, STRUCTURE, V21, P798, DOI 10.1016/j.str.2013.02.025	23	42	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68328	10.1371/journal.pone.0068328	http://dx.doi.org/10.1371/journal.pone.0068328			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861887	Green Published, Green Submitted, gold			2022-12-27	WOS:000321425300058
J	Desmond, NA; Nyirenda, D; Dube, Q; Mallewa, M; Molyneux, E; Lalloo, DG; Heyderman, RS				Desmond, Nicola A.; Nyirenda, Deborah; Dube, Queen; Mallewa, MacPherson; Molyneux, Elizabeth; Lalloo, David G.; Heyderman, Robert S.			Recognising and Treatment Seeking for Acute Bacterial Meningitis in Adults and Children in Resource-Poor Settings: A Qualitative Study	PLOS ONE			English	Article							DECISION-MAKING; HEALTH-CARE; LAY EPIDEMIOLOGY; BEHAVIOR; FEVER; BLANTYRE; DISTRICT; ILLNESS; MALARIA; DISEASE	Objective: High mortality burden from Acute Bacterial Meningitis (ABM) in resource-poor settings has been frequently blamed on delays in treatment seeking. We explored treatment-seeking pathways from household to primary health care and referral for ABM in Malawi. Design: A cross-sectional qualitative study using narrative in-depth interviews, semi-structured interviews and focus group discussions. Participants: Adults and children with proven and probable acute bacterial meningitis and/or their carers; adults from urban and peri-urban communities; and primary health care workers (HCW). Setting: Queen Elizabeth Central Hospital (QECH), urban and peri-urban private and government primary health centres and communities in Blantyre District, Malawi. Results: Whilst communities associated meningitis with a stiff neck, in practice responses focused on ability to recognise severe illness. Misdiagnosis of meningitis as malaria was common. Subsequent action by families depended on the extent to which normal social life was disrupted by the illness and depended on the age and social position of the sufferer. Seizures and convulsions were considered severe symptoms but were often thought to be malaria. Presumptive malaria treatment at home often delayed formal treatment seeking. Further delays in treatment seeking were caused by economic barriers and perceptions of inefficient or inadequate primary health services. Conclusions: Given the difficulties in diagnosis of meningitis where malaria is common, any intervention for ABM at primary level must focus on recognising severe illness, and encouraging action at the household, community and primary health levels. Overcoming barriers to recognition and social constraints at community level require broad community-based strategies and may provide a route to addressing poor clinical outcomes.	[Desmond, Nicola A.; Nyirenda, Deborah; Mallewa, MacPherson; Heyderman, Robert S.] Malawi Liverpool Wellcome Trust Res Programme, Blantyre, Malawi; [Desmond, Nicola A.; Lalloo, David G.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Dube, Queen; Molyneux, Elizabeth] Univ Malawi, Queen Elizabeth Cent Hosp, Blantyre, Malawi; [Dube, Queen; Molyneux, Elizabeth] Univ Malawi, Coll Med, Blantyre, Malawi	University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; University of Malawi; University of Malawi	Desmond, NA (corresponding author), Malawi Liverpool Wellcome Trust Res Programme, Blantyre, Malawi.	ndesmond@liverpool.ac.uk	Desmond, Nicola/ABA-6504-2020; Desmond, Nicola/GYQ-8574-2022	Desmond, Nicola/0000-0002-2874-8569; Heyderman, Robert/0000-0003-4573-449X; Nyirenda, Deborah/0000-0002-5867-4687; Lalloo, David/0000-0001-7680-2200	Meningitis Research Foundation, UK; MLW Clinical Research Programme Core grant from the Wellcome Trust, UK	Meningitis Research Foundation, UK(Meningitis Research Foundation (MRF)); MLW Clinical Research Programme Core grant from the Wellcome Trust, UK	The research was funded by the Meningitis Research Foundation, UK (http://www.meningitis.org) and the MLW Clinical Research Programme Core grant from the Wellcome Trust, UK (www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All researchers are independent from the funders. The corresponding author, Nicola Desmond, had full access to all the data in the study and had final responsibility for the decision to publish.	Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; Berkley JA, 2001, LANCET, V357, P1753, DOI 10.1016/S0140-6736(00)04897-2; Brennan CA, 2003, BRIT J GEN PRACT, V53, P626; Chuma J, 2007, TROP MED INT HEALTH, V12, P673, DOI 10.1111/j.1365-3156.2007.01825.x; College of Medicine UoM, 2008, ETAT MAL PROJ REP EV; Crump JA, 2003, EMERG INFECT DIS, V9, P539, DOI 10.3201/eid0905.020428; Farr AC, 2005, J HLTH COMMUNICATION, V10; Filmer D, 2005, HEALTH POLICY PLANN, V20, P337, DOI 10.1093/heapol/czi043; Foley EE, 2008, MED ANTHROPOL Q, V22, P257, DOI 10.1111/j.1548-1387.2008.00025.x; FRANKEL S, 1991, BRIT J GEN PRACT, V41, P428; Gordon SB, 2000, CLIN INFECT DIS, V31, P53, DOI 10.1086/313910; Granier S, 1998, BRIT MED J, V316, P276, DOI 10.1136/bmj.316.7127.276; Gray A, 2008, WHAT ARE PREREQUISIT; Green E C, 1996, Med Anthropol, V17, P83; Haddad S, 1998, SOC SCI MED, V47, P381, DOI 10.1016/S0277-9536(98)00075-6; Hatchett LA, 2004, AIDS CARE, V16, P827, DOI 10.1080/09540120412331290112; Holtz TH, 2003, T ROY SOC TROP MED H, V97, P491, DOI 10.1016/S0035-9203(03)80003-2; Hunt K, 2001, INT J EPIDEMIOL, V30, P442, DOI 10.1093/ije/30.3.442; Kuipers M, 1994, SNAKES INFECT CHEST; Maglio A-ST., 2005, QUALITATIVE RES, V5, P475, DOI [10.1177/1468794105056924, DOI 10.1177/1468794105056924]; Molyneux CS, 2002, J BIOSOC SCI, V34, P109, DOI 10.1017/S0021932002001098; Molyneux E, 1998, TROP MED INT HEALTH, V3, P610, DOI 10.1046/j.1365-3156.1998.00278.x; Molyneux EM, 2002, LANCET, V360, P211, DOI 10.1016/S0140-6736(02)09458-8; Pelton S. I., 2010, Journal of Adolescent Health, V46, pS9, DOI 10.1016/j.jadohealth.2009.11.220; Pokhrel S, 2004, HEALTH POLICY PLANN, V19, P218, DOI 10.1093/heapol/czh027; Pool R, 2001, WOMEN INFERTILITY SU; Sauerborn R, 1996, Health Transit Rev, V6, P131; Scarborough M, 2007, NEW ENGL J MED, V357, P2441, DOI 10.1056/NEJMoa065711; Seale C., 1999, QUALITY QUALITATIVE; Sen A., 1990, PERSISTENT INEQUALIT; Shin SH, 2012, EXPERT OPIN PHARMACO, V13, P2189, DOI 10.1517/14656566.2012.724399; Sigauque B, 2008, ACTA TROP, V105, P21, DOI 10.1016/j.actatropica.2007.01.006; Smith KP, 2008, ANNU REV SOCIOL, V34, P405, DOI 10.1146/annurev.soc.34.040507.134601; Tanner M, 1998, SOC SCI MED, V46, P523, DOI 10.1016/S0277-9536(97)00195-0; Tolhurst R, 2008, SOC SCI MED, V66, P1106, DOI 10.1016/j.socscimed.2007.11.032; UNDP, 2011, MAL COUNTR PROF HUM; Vaahtera M, 2000, PAEDIATR PERINAT EP, V14, P363, DOI 10.1046/j.1365-3016.2000.00308.x	37	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68163	10.1371/journal.pone.0068163	http://dx.doi.org/10.1371/journal.pone.0068163			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	204FO	23861864	Green Published, Green Accepted, gold			2022-12-27	WOS:000323350700073
J	Misra, SK; Biswas, J; Kondaiah, P; Bhattacharya, S				Misra, Santosh K.; Biswas, Joydeep; Kondaiah, Paturu; Bhattacharya, Santanu			Gene Transfection in High Serum Levels: Case Studies with New Cholesterol Based Cationic Gemini Lipids	PLOS ONE			English	Article							IN-VITRO; DNA; DELIVERY; CELLS; EFFICIENCY; LIPOPLEXES; LIPOSOMES; MEMBRANE; THERAPY; VECTORS	Background: Six new cationic gemini lipids based on cholesterol possessing different positional combinations of hydroxyethyl (-CH2CH2OH) and oligo-oxyethylene -(CH2CH2O)(n)- moieties were synthesized. For comparison the corresponding monomeric lipid was also prepared. Each new cationic lipid was found to form stable, clear suspensions in aqueous media. Methodology/Principal Findings: To understand the nature of the individual lipid aggregates, we have studied the aggregation properties using transmission electron microscopy (TEM), dynamic light scattering (DLS), zeta potential measurements and X-ray diffraction (XRD). We studied the lipid/DNA complex (lipoplex) formation and the release of the DNA from such lipoplexes using ethidium bromide. These gemini lipids in presence of a helper lipid, 1, 2-dioleoyl phophatidyl ethanol amine (DOPE) showed significant enhancements in the gene transfection compared to several commercially available transfection agents. Cholesterol based gemini having -CH2-CH2-OH groups at the head and one oxyethylene spacer was found to be the most effective lipid, which showed transfection activity even in presence of high serum levels (50%) greater than Effectene, one of the potent commercially available transfecting agents. Most of these geminis protected plasmid DNA remarkably against DNase I in serum, although the degree of stability was found to vary with their structural features. Conclusions/Significance: -OH groups present on the cationic headgroups in combination with oxyethylene linkers on cholesterol based geminis, gave an optimized combination of new genera of gemini lipids possessing high transfection efficiency even in presence of very high percentage of serum. This property makes them preferential transfection reagents for possible in vivo studies.	[Misra, Santosh K.; Biswas, Joydeep; Bhattacharya, Santanu] Indian Inst Sci, Dept Organ Chem, Bangalore 560012, Karnataka, India; [Kondaiah, Paturu] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India; [Bhattacharya, Santanu] JNCASR, Chem Biol Unit, Bangalore, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Bhattacharya, S (corresponding author), Indian Inst Sci, Dept Organ Chem, Bangalore 560012, Karnataka, India.	sb@orgchem.iisc.ernet.in	Mishra, Santosh/S-7516-2017; Biswas, Joydeep/N-1534-2013; Bhattacharya, Santanu/N-6531-2019; BHATTACHARYA, SANTANU/E-9739-2010; Bhattacharya, Santanu/GRS-4780-2022	Mishra, Santosh/0000-0001-8616-2606; Biswas, Joydeep/0000-0002-8055-3187; Bhattacharya, Santanu/0000-0001-9040-8971; BHATTACHARYA, SANTANU/0000-0001-9040-8971; Misra, Santosh K./0000-0002-3313-4895	Department of Science and Technology; CSIR, New Delhi	Department of Science and Technology(Department of Science & Technology (India)); CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Department of Science and Technology. J.B. thanks the CSIR, New Delhi, for the award of a research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WF, 1998, NATURE, V392, P25; Bajaj A, 2008, J MED CHEM, V51, P2533, DOI 10.1021/jm7010436; Bajaj A, 2008, BIOMACROMOLECULES, V9, P991, DOI 10.1021/bm700930y; Bajaj A, 2008, BBA-BIOMEMBRANES, V1778, P1222, DOI 10.1016/j.bbamem.2007.12.010; Bajaj A, 2007, BIOCONJUGATE CHEM, V18, P1537, DOI 10.1021/bc070010q; Banerjee R, 1999, J MED CHEM, V42, P4292, DOI 10.1021/jm9806446; Banerjee R, 2001, J MED CHEM, V44, P4176, DOI 10.1021/jm000466s; Benatti CR, 2007, CHEM PHYS LIPIDS, V145, P27, DOI 10.1016/j.chemphyslip.2006.10.002; Betker JL, 2013, THER DELIV, V4, P453, DOI [10.4155/tde.13.16, 10.4155/TDE.13.16]; Beyer U, 2001, PHARM RES-DORDR, V18, P29, DOI 10.1023/A:1011018525121; Bhattacharya S, 2004, BIOCONJUGATE CHEM, V15, P508, DOI 10.1021/bc0340215; Bhattacharya S, 1998, BIOCHEMISTRY-US, V37, P7764, DOI 10.1021/bi971772j; Bhattacharya S, 2003, J PHYS CHEM B, V107, P3719, DOI 10.1021/jp0272771; Bhattacharya S, 2009, CHEM COMMUN, P4632, DOI 10.1039/b900666b; Billinton N, 2001, ANAL BIOCHEM, V291, P175, DOI 10.1006/abio.2000.5006; Braun CS, 2005, J PHARM SCI-US, V94, P423, DOI 10.1002/jps.20251; Candiani G, 2008, J GENE MED, V10, P637, DOI 10.1002/jgm.1186; Candiani G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013430; Cardoso AMS, 2011, BBA-BIOMEMBRANES, V1808, P341, DOI 10.1016/j.bbamem.2010.09.026; Chae HY, 2005, EXP MOL MED, V37, P513, DOI 10.1038/emm.2005.64; CRYSTAL RG, 1994, NAT GENET, V8, P42, DOI 10.1038/ng0994-42; Curiel TJ, 1997, GENE THER, V4, P1284, DOI 10.1038/sj.gt.3300538; Dileep PV, 2001, FEBS LETT, V509, P327, DOI 10.1016/S0014-5793(01)03193-3; Ding W, 2008, INT J PHARMACEUT, V354, P196, DOI 10.1016/j.ijpharm.2007.10.051; Duchler M, 2001, J GENE MED, V3, P115; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; FELGNER PL, 1989, NATURE, V337, P387, DOI 10.1038/337387a0; GAO X, 1991, BIOCHEM BIOPH RES CO, V179, P280, DOI 10.1016/0006-291X(91)91366-K; Ghosh YK, 2002, BIOCONJUGATE CHEM, V13, P378, DOI 10.1021/bc010048h; Ghosh YK, 2000, FEBS LETT, V473, P341, DOI 10.1016/S0014-5793(00)01558-1; Guo B, 2001, BIOTECHNIQUES, V31, P314, DOI 10.2144/01312st02; Hasegawa S, 2002, BIOORG MED CHEM LETT, V12, P1299, DOI 10.1016/S0960-894X(02)00119-1; Hattori Y, 2005, CANCER GENE THER, V12, P796, DOI 10.1038/sj.cgt.7700844; Hattori Y, 2007, J CONTROL RELEASE, V120, P122, DOI 10.1016/j.jconrel.2007.04.012; Hirsch-Lerner D, 2005, BBA-BIOMEMBRANES, V1714, P71, DOI 10.1016/j.bbamem.2005.04.008; Kerner M, 2001, BBA-MOL CELL BIOL L, V1532, P128, DOI 10.1016/S1388-1981(01)00118-4; Kim D, 2011, MACROMOL RES, V19, P573, DOI 10.1007/s13233-011-0606-5; KNOWLES MR, 1995, NEW ENGL J MED, V333, P823, DOI 10.1056/NEJM199509283331302; Marty R, 2009, NUCLEIC ACIDS RES, V37, P849, DOI 10.1093/nar/gkn1003; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakanishi M, 2003, CURR MED CHEM, V10, P1289, DOI 10.2174/0929867033457395; Percot A, 2004, INT J PHARMACEUT, V278, P143, DOI 10.1016/j.ijpharm.2004.03.003; Perouzel E, 2003, BIOCONJUGATE CHEM, V14, P884, DOI 10.1021/bc034068q; Rajesh M, 2007, J AM CHEM SOC, V129, P11408, DOI 10.1021/ja0704683; Resina S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006058; Reynier P, 2004, J DRUG TARGET, V12, P25, DOI 10.1080/10611860410001683040; Riquelme BD, 2006, J BIOCHEM BIOPH METH, V68, P31, DOI 10.1016/j.jbbm.2005.12.009; Rittner K, 2002, MOL THER, V5, P104, DOI 10.1006/mthe.2002.0523; Rodriguez-Pulido A, 2008, J PHYS CHEM B, V112, P2187, DOI 10.1021/jp7095828; Simberg D, 2001, J BIOL CHEM, V276, P47453, DOI 10.1074/jbc.M105588200; Sochanik A, 2000, CANCER GENE THER, V7, P513, DOI 10.1038/sj.cgt.7700167; Tang MX, 1996, BIOCONJUGATE CHEM, V7, P703, DOI 10.1021/bc9600630; Wang J, 2002, J CONTROL RELEASE, V83, P157, DOI 10.1016/S0168-3659(02)00180-3; YANG YP, 1994, NAT GENET, V7, P362, DOI 10.1038/ng0794-362; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407; Yla-Herttuala S, 2000, LANCET, V355, P213, DOI 10.1016/S0140-6736(99)04180-X; Zelphati O, 1996, P NATL ACAD SCI USA, V93, P11493, DOI 10.1073/pnas.93.21.11493	57	21	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68305	10.1371/journal.pone.0068305	http://dx.doi.org/10.1371/journal.pone.0068305			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861884	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000323350700078
J	Welch, DB; Seitz, AR				Welch, Dan B.; Seitz, Aaron R.			Processing Irrelevant Location Information: Practice and Transfer Effects in a Simon Task	PLOS ONE			English	Article							STIMULUS-RESPONSE COMPATIBILITY; S-R COMPATIBILITY; ACTIVATION; INTERFERENCE; ACCOUNT; DISPLAY; CODES; TIME; CUE	How humans produce cognitively driven fine motor movements is a question of fundamental importance in how we interact with the world around us. For example, we are exposed to a constant stream of information and we must select the information that is most relevant by which to guide our actions. In the present study, we employed a well-known behavioral assay called the Simon task to better understand how humans are able to learn to filter out irrelevant information. We trained subjects for four days with a visual stimulus presented, alternately, in central and lateral locations. Subjects responded with one hand moving a joystick in either the left or right direction. They were instructed to ignore the irrelevant location information and respond based on color (e.g. red to the right and green to the left). On the fifth day, an additional testing session was conducted where the task changed and the subjects had to respond by shape (e.g. triangle to the right and rectangle to the left). They were instructed to ignore the color and location, and respond based solely on the task relevant shape. We found that the magnitude of the Simon effect decreases with training, however it returns in the first few trials after a break. Furthermore, task-defined associations between response direction and color did not significantly affect the Simon effect based on shape, and no significant associative learning from the specific stimulus-response features was found for the centrally located stimuli. We discuss how these results are consistent with a model involving route suppression/gating of the irrelevant location information. Much of the learning seems to be driven by subjects learning to suppress irrelevant location information, however, this seems to be an active inhibition process that requires a few trials of experience to engage.	[Welch, Dan B.] So Illinois Univ, Sch Dent Med, Dept Growth Dev & Struct, Alton, IL USA; [Welch, Dan B.; Seitz, Aaron R.] Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA	Southern Illinois University System; Southern Illinois University; University of California System; University of California Riverside	Welch, DB (corresponding author), So Illinois Univ, Sch Dent Med, Dept Growth Dev & Struct, Alton, IL USA.	dwelch@siue.edu						Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; GUIARD Y, 1994, PSYCHOL RES-PSYCH FO, V56, P210, DOI 10.1007/BF00419709; HASBROUCQ T, 1991, J EXP PSYCHOL HUMAN, V17, P246, DOI 10.1037/0096-1523.17.1.246; HEDGE A, 1975, ACTA PSYCHOL, V39, P427, DOI 10.1016/0001-6918(75)90041-4; Hommel B, 2004, PSYCHOL RES-PSYCH FO, V68, P1, DOI 10.1007/s00426-003-0132-y; HOMMEL B, 1993, PSYCHOL RES-PSYCH FO, V55, P270, DOI 10.1007/BF00419687; Iani C, 2009, MEM COGNITION, V37, P358, DOI 10.3758/MC.37.3.358; Nicoletti Umilta C, 1989, J EXPT PSYCHOL HUMAN, V15, P164; Notebaert W, 2001, PSYCHOL RES-PSYCH FO, V65, P170, DOI 10.1007/s004260000054; OLEARY MJ, 1994, PSYCHOL RES-PSYCH FO, V56, P196, DOI 10.1007/BF00419707; PASHLER H, 1991, J EXP PSYCHOL LEARN, V17, P20, DOI 10.1037/0278-7393.17.1.20; PROCTOR RW, 1993, J EXP PSYCHOL LEARN, V19, P922, DOI 10.1037/0278-7393.19.4.922; Proctor RW, 1999, MEM COGNITION, V27, P63, DOI 10.3758/BF03201214; PROCTOR RW, 1995, ACTA PSYCHOL, V90, P275, DOI 10.1016/0001-6918(95)00030-X; Proctor RW, 2012, J EXPT PSYCHOL; Seitz AR, 2009, NEURON, V61, P700, DOI 10.1016/j.neuron.2009.01.016; SIMON JR, 1972, J EXP PSYCHOL, V92, P405, DOI 10.1037/h0032269; SIMON JR, 1973, J EXP PSYCHOL, V101, P175, DOI 10.1037/h0035766; SIMON JR, 1970, J EXP PSYCHOL, V85, P311, DOI 10.1037/h0029522; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; SIMON JR, 1990, ACTA PSYCHOL, V73, P159, DOI 10.1016/0001-6918(90)90077-S; SIMON JR, 1969, J APPL PSYCHOL, V53, P433, DOI 10.1037/h0028034; Soetens E, 2010, ATTEN PERCEPT PSYCHO, V72, P895, DOI 10.3758/APP.72.4.895; STOFFER TH, 1991, PSYCHOL RES-PSYCH FO, V53, P127, DOI 10.1007/BF01371820; Sturmer B, 2002, J EXP PSYCHOL HUMAN, V28, P1345, DOI 10.1037//0096-1523.28.6.1345; Tagliabue M, 2002, MEM COGNITION, V30, P18, DOI 10.3758/BF03195261; Tagliabue M, 2000, J EXP PSYCHOL HUMAN, V26, P648, DOI 10.1037//0096-1523.26.2.648; UMILTA C, 1987, PSYCHOL RES-PSYCH FO, V49, P81, DOI 10.1007/BF00308672; Umilta C, 1990, STIMULUS RESPONSE CO, P508; Umilta C, 1985, ATTENTION PERFORMANC; Valle-Inclan F, 2002, ATTENTION PERFORM, V19, P474	31	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e64993	10.1371/journal.pone.0064993	http://dx.doi.org/10.1371/journal.pone.0064993			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	204FO	23861735	Green Published, Green Submitted, gold			2022-12-27	WOS:000323350700002
J	Aloisi, A; Barca, A; Romano, A; Guerrieri, S; Storelli, C; Rinaldi, R; Verri, T				Aloisi, Alessandra; Barca, Amilcare; Romano, Alessandro; Guerrieri, Sara; Storelli, Carlo; Rinaldi, Rosaria; Verri, Tiziano			Anti-Aggregating Effect of the Naturally Occurring Dipeptide Carnosine on A beta 1-42 Fibril Formation	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; LIGAND EFFICIENCY; MOUSE MODEL; AMINO-ACID; HOMOCARNOSINE; NEUROTOXICITY; A-BETA(1-42); INHIBITORS	Carnosine is an endogenous dipeptide abundant in the central nervous system, where by acting as intracellular pH buffering molecule, Zn/Cu ion chelator, antioxidant and anti-crosslinking agent, it exerts a well-recognized multi-protective homeostatic function for neuronal and non-neuronal cells. Carnosine seems to counteract proteotoxicity and protein accumulation in neurodegenerative conditions, such as Alzheimer's Disease (AD). However, its direct impact on the dynamics of AD-related fibril formation remains uninvestigated. We considered the effects of carnosine on the formation of fibrils/aggregates of the amyloidogenic peptide fragment A beta 1-42, a major hallmark of AD injury. Atomic force microscopy and thioflavin T assays showed inhibition of A beta 1-42 fibrillogenesis in vitro and differences in the aggregation state of A beta 1-42 small pre-fibrillar structures (monomers and small oligomers) in the presence of carnosine. in silico molecular docking supported the experimental data, calculating possible conformational carnosine/A beta 1-42 interactions. Overall, our results suggest an effective role of carnosine against A beta 1-42 aggregation.	[Aloisi, Alessandra; Guerrieri, Sara; Rinaldi, Rosaria] Ist Nanosci Lecce, NNL, CNR, Lecce, Italy; [Barca, Amilcare; Romano, Alessandro; Guerrieri, Sara; Storelli, Carlo; Verri, Tiziano] Univ Salento, Dept Biol & Environm Sci & Technol DiSTeBA, Lecce, Italy; [Rinaldi, Rosaria] Univ Salento, Math & Phys E De Giorgi Dept, Lecce, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); University of Salento; University of Salento	Rinaldi, R (corresponding author), Ist Nanosci Lecce, NNL, CNR, Lecce, Italy.	ross.rinaldi@unisalento.it; tiziano.verri@unisalento.it	aloisi, alessandra/O-1432-2015; Verri, Tiziano/K-1442-2013; RINALDI, ROSARIA/N-3560-2015; Romano, Alessandro/AAN-8124-2020; Barca, Amilcare/I-1281-2019	aloisi, alessandra/0000-0002-9654-2108; Verri, Tiziano/0000-0003-4983-2767; RINALDI, ROSARIA/0000-0003-2798-9341; Barca, Amilcare/0000-0002-3117-2724; Romano, Alessandro/0000-0003-2766-8847	University of Salento; fondi ex-60%; Progetto Strategico PS105; Fondazione Umberto Veronesi	University of Salento; fondi ex-60%; Progetto Strategico PS105; Fondazione Umberto Veronesi(Fondazione Umberto Veronesi)	This work was partially supported by grants from the University of Salento (http://www.unisalento.it), fondi ex-60% (2009-2012; to TV and CS), Progetto Strategico PS105 (2009-2012; to RR) and Fondazione Umberto Veronesi (http://www.fondazioneveronesi.it/) (2011; to RR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Zapatero C, 2005, DRUG DISCOV TODAY, V10, P464, DOI 10.1016/S1359-6446(05)03386-6; Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Amijee H, 2009, BIOCHEM SOC T, V37, P692, DOI 10.1042/BST0370692; Andringa G, 2004, FASEB J, V18, P932, DOI 10.1096/fj.03-0829fje; Arimon M, 2005, FASEB J, V19, P1344, DOI 10.1096/fj.04-3137fje; Arisi I, 2011, J ALZHEIMERS DIS, V24, P721, DOI 10.3233/JAD-2011-101881; Attanasio F, 2009, BIOCHEMISTRY-US, V48, P6522, DOI 10.1021/bi900343n; Bakardjiev A, 1998, GLIA, V24, P346, DOI 10.1002/(SICI)1098-1136(199811)24:3<346::AID-GLIA9>3.0.CO;2-#; Bakardjiev A, 2000, BIOCHEMISTRY-MOSCOW+, V65, P779; Balion CM, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-38; Bellia F, 2012, AMINO ACIDS, V43, P153, DOI 10.1007/s00726-011-1178-6; Bettens K, 2010, HUM MOL GENET, V19, pR4, DOI 10.1093/hmg/ddq142; Blackley HKL, 2000, J MOL BIOL, V298, P833, DOI 10.1006/jmbi.2000.3711; Boldyrev AA, 2010, REJUV RES, V13, P156, DOI 10.1089/rej.2009.0923; Calabrese EJ, 2008, CRIT REV TOXICOL, V38, P419, DOI 10.1080/10408440802003991; Chini MG, 2009, J PEPT SCI, V15, P229, DOI 10.1002/psc.1095; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Cornelli U, 2010, NEURODEGENER DIS, V7, P193, DOI 10.1159/000295663; Corona C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017971; Daniel H, 2004, PFLUG ARCH EUR J PHY, V447, P610, DOI 10.1007/s00424-003-1101-4; De Marchis S, 2000, J COMP NEUROL, V426, P378, DOI 10.1002/1096-9861(20001023)426:3<378::AID-CNE3>3.0.CO;2-1; DeMarchis S, 1997, NEUROSCI LETT, V237, P37, DOI 10.1016/S0304-3940(97)00800-8; Fernandez-Busquets X, 2010, CURR ALZHEIMER RES, V7, P428, DOI 10.2174/156720510791383787; Fonteh AN, 2007, AMINO ACIDS, V32, P213, DOI 10.1007/s00726-006-0409-8; Fu QL, 2008, CELL MOL NEUROBIOL, V28, P307, DOI 10.1007/s10571-007-9235-0; Fung SY, 2003, BIOPHYS J, V85, P537, DOI 10.1016/S0006-3495(03)74498-1; Gallant S, 2000, BIOCHEMISTRY-MOSCOW+, V65, P866; Garcia-Sosa AT, 2008, J CHEM INF MODEL, V48, P2074, DOI 10.1021/ci800242z; Garcia-Sosa AT, 2010, J COMPUT CHEM, V31, P174, DOI 10.1002/jcc.21306; Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009; Guha R, 2006, J CHEM INF MODEL, V46, P991, DOI 10.1021/ci050400b; Guiotto A, 2005, J MED CHEM, V48, P6156, DOI 10.1021/jm050507q; Hasegawa K, 1999, BIOCHEMISTRY-US, V38, P15514, DOI 10.1021/bi991161m; Herculano B, 2013, J ALZHEIMERS DIS, V33, P983, DOI 10.3233/JAD-2012-121324; Hetenyi C, 2007, BIOINFORMATICS, V23, P2678, DOI 10.1093/bioinformatics/btm431; Hickman SE, 2010, CNS NEUROL DISORD-DR, V9, P168, DOI 10.2174/187152710791011982; Hipkiss AR, 2007, J ALZHEIMERS DIS, V11, P229; Hipkiss AR, 2011, MOL ASPECTS MED, V32, P267, DOI 10.1016/j.mam.2011.10.004; Hipkiss AR, 2009, ADV FOOD NUTR RES, V57, P87, DOI 10.1016/S1043-4526(09)57003-9; Hipkiss AR, 2009, EXPERT REV NEUROTHER, V9, P583, DOI [10.1586/ern.09.32, 10.1586/ERN.09.32]; Hipkiss AR, 2009, EXP GERONTOL, V44, P237, DOI 10.1016/j.exger.2008.11.001; Hipkiss AR, 1998, ANN NY ACAD SCI, V854, P37, DOI 10.1111/j.1749-6632.1998.tb09890.x; Hobart LJ, 2004, LIFE SCI, V75, P1379, DOI 10.1016/j.lfs.2004.05.002; Hoffmann AM, 1996, NEUROSCI LETT, V215, P29, DOI 10.1016/S0304-3940(96)12937-2; Hopkins AL, 2004, DRUG DISCOV TODAY, V9, P430, DOI 10.1016/S1359-6446(04)03069-7; Junn E, 2003, P NATL ACAD SCI USA, V100, P2047, DOI 10.1073/pnas.0438021100; Karpuj M, 2004, AMINO ACIDS, V26, P373, DOI 10.1007/s00726-004-0082-8; Katzman R., 1978, ALZHEIMERS DIS SENIL; Kawahara M, 2011, METALLOMICS, V3, P726, DOI 10.1039/c1mt00015b; Kawahara Masahiro, 2007, Recent Pat CNS Drug Discov, V2, P145, DOI 10.2174/157488907780832698; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; KOHEN R, 1988, P NATL ACAD SCI USA, V85, P3175, DOI 10.1073/pnas.85.9.3175; Koyama H, 2011, J CLIN TOXICOL S, VS3; Kulebyakin K, 2012, AMINO ACIDS, V43, P91, DOI 10.1007/s00726-011-1135-4; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Liu DX, 2006, BIOCHEMISTRY-US, V45, P10963, DOI 10.1021/bi060955f; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Mastrangelo IA, 2006, J MOL BIOL, V358, P106, DOI 10.1016/j.jmb.2006.01.042; Mayeux R, 2011, NEUROBIOL AGING, V32, pS10, DOI 10.1016/j.neurobiolaging.2011.09.004; Mitew S, 2010, ACTA NEUROPATHOL, V119, P567, DOI 10.1007/s00401-010-0657-2; Munch G, 1997, BBA-MOL BASIS DIS, V1360, P17, DOI 10.1016/S0925-4439(96)00062-2; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Ohkawara T, 2006, WORLD J GASTROENTERO, V12, P6178, DOI 10.3748/wjg.v12.i38.6178; Ono K, 2011, J NEUROCHEM, V117, P19, DOI 10.1111/j.1471-4159.2011.07187.x; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Park KM, 2010, CELL SIGNAL, V22, P519, DOI 10.1016/j.cellsig.2009.11.006; Perrin RJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016032, 10.1371/journal.pone.0018850]; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Preston JE, 1998, NEUROSCI LETT, V242, P105, DOI 10.1016/S0304-3940(98)00058-5; Reddy V Prakash, 2005, Sci Aging Knowledge Environ, V2005, ppe12, DOI 10.1126/sageke.2005.18.pe12; Rezai-Zadeh K, 2011, CURR ALZHEIMER RES, V8, P156, DOI 10.2174/156720511795256017; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Tabakman R, 2002, J NEUROSCI RES, V68, P463, DOI 10.1002/jnr.10228; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Wang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027649; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wiesehan K, 2008, PROTEIN ENG DES SEL, V21, P241, DOI 10.1093/protein/gzm054; Yan H, 2008, MOL VIS, V14, P2282; YOSHIKAWA T, 1991, BIOCHIM BIOPHYS ACTA, V1115, P15, DOI 10.1016/0304-4165(91)90005-2	82	49	49	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68159	10.1371/journal.pone.0068159	http://dx.doi.org/10.1371/journal.pone.0068159			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844165	Green Published, gold, Green Submitted			2022-12-27	WOS:000321733000132
J	Cheng, AS; Morsch, M; Murata, Y; Ghazanfari, N; Reddel, SW; Phillips, WD				Cheng, Anson; Morsch, Marco; Murata, Yui; Ghazanfari, Nazanin; Reddel, Stephen W.; Phillips, William D.			Sequence of Age-Associated Changes to the Mouse Neuromuscular Junction and the Protective Effects of Voluntary Exercise	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTORS; MUSCLE-FIBERS; OLD RATS; MICE; DENSITY	Loss of connections between motor neurons and skeletal muscle fibers contribute to motor impairment in old age, but the sequence of age-associated changes that precede loss of the neuromuscular synapse remains uncertain. Here we determine changes in the size of neuromuscular synapses within the tibialis anterior muscle across the life span of C57BL/6J mice. Immunofluorescence, confocal microscopy and morphometry were used to measure the area occupied by nerve terminal synaptophysin staining and postsynaptic acetylcholine receptors at motor endplates of 2, 14, 19, 22, 25 and 28month old mice. The key findings were: 1) At middle age (14-months) endplate acetylcholine receptors occupied 238 +/- 11 mu m(2) and nerve terminal synaptophysin 168 +/- 14 mu m(2) (mean +/- SEM). 2) Between 14-months and 19-months (onset of old age) the area occupied by postsynaptic acetylcholine receptors declined 30%. At many endplates the large acetylcholine receptor plaque became fragmented into multiple smaller acetylcholine receptor clusters. 3) Between 19- and 25-months, the fraction of endplate acetylcholine receptors covered by synaptophysin fell 21%. By 28-months, half of the endplates imaged retained <= 50 mu m(2) area of synaptophysin staining. 4) Within aged muscles, the degree to which an endplate remained covered by synaptophysin did not depend upon the total area of acetylcholine receptors, nor upon the number of discrete receptor clusters. 5) Voluntary wheel-running exercise, beginning late in middle-age, prevented much of the age-associated loss of nerve terminal synaptophysin. In summary, a decline in the area of endplate acetylcholine receptor clusters at the onset of old age was followed by loss of nerve terminal synaptophysin from the endplate. Voluntary running exercise, begun late in middle age, substantially inhibited the loss of nerve terminal from aging motor endplates.	[Cheng, Anson; Morsch, Marco; Murata, Yui; Ghazanfari, Nazanin; Phillips, William D.] Univ Sydney, Physiol & Bosch Inst, Sydney, NSW 2006, Australia; [Reddel, Stephen W.] Concord Hosp, Dept Mol Med, Concord, NSW, Australia	University of Sydney; Concord Repatriation General Hospital	Phillips, WD (corresponding author), Univ Sydney, Physiol & Bosch Inst, Sydney, NSW 2006, Australia.	billp@physiol.usyd.edu.au		Reddel, Stephen/0000-0002-0169-3350; Morsch, Marco/0000-0001-9484-8050; Phillips, William/0000-0002-5405-8422	National Health and Medical Research Council (Australia) [570930]	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	The work presented was supported by a project grant from the National Health and Medical Research Council (Australia; http://www.nhmrc.gov.au/; grant number 570930). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIZONO N, 1984, ACTA PATHOL JAPON, V34, P1243; BaliceGordon RJ, 1997, MUSCLE NERVE, pS83; CAMPBELL MJ, 1973, J NEUROL NEUROSUR PS, V36, P174, DOI 10.1136/jnnp.36.2.174; Chai RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028090; Chipman PH, 2010, EUR J NEUROSCI, V31, P238, DOI 10.1111/j.1460-9568.2009.07049.x; COURTNEY J, 1981, J PHYSIOL-LONDON, V320, P435, DOI 10.1113/jphysiol.1981.sp013960; Deschenes MR, 2006, NEUROSCIENCE, V137, P1277, DOI 10.1016/j.neuroscience.2005.10.042; Deschenes MR, 2003, J NEUROBIOL, V57, P246, DOI 10.1002/neu.10271; Fahim MA, 1997, J APPL PHYSIOL, V83, P59, DOI 10.1152/jappl.1997.83.1.59; FERTUCK HC, 1976, J CELL BIOL, V69, P144, DOI 10.1083/jcb.69.1.144; Flurkey K, 2007, MOUSE BIOMEDICAL RES, P637, DOI DOI 10.1016/B978-012369454-6/50074-1; Harrison DE, 2008, BASELINE LIFE SPAN D; HOLLOSZY JO, 1985, J APPL PHYSIOL, V59, P826, DOI 10.1152/jappl.1985.59.3.826; Kadhiresan VA, 1996, J PHYSIOL-LONDON, V493, P543, DOI 10.1113/jphysiol.1996.sp021402; LAND BR, 1980, P NATL ACAD SCI-BIOL, V77, P3736, DOI 10.1073/pnas.77.6.3736; Li Y, 2011, J NEUROSCI, V31, P14910, DOI 10.1523/JNEUROSCI.3590-11.2011; Ling SM, 2009, ARCH PHYS MED REHAB, V90, P1237, DOI 10.1016/j.apmr.2008.09.565; Messi ML, 2003, J NEUROSCI, V23, P1351, DOI 10.1523/JNEUROSCI.23-04-01351.2003; Miller RA, 2000, J GERONTOL A-BIOL, V55, pB117, DOI 10.1093/gerona/55.3.B117; Morsch M, 2013, J PHYSIOL-LONDON, V591, P2747, DOI 10.1113/jphysiol.2013.251827; Morsch M, 2012, EXP NEUROL, V237, P286, DOI 10.1016/j.expneurol.2012.06.034; Prakash YS, 1998, MUSCLE NERVE, V21, P887, DOI 10.1002/(SICI)1097-4598(199807)21:7<887::AID-MUS6>3.0.CO;2-2; ROSENHEIMER JL, 1990, INT J DEV NEUROSCI, V8, P643, DOI 10.1016/0736-5748(90)90059-B; Rowan SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029082; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; STALBERG E, 1975, J NEUROL NEUROSUR PS, V38, P874, DOI 10.1136/jnnp.38.9.874; Urbanchek MG, 2001, J GERONTOL A-BIOL, V56, pB191, DOI 10.1093/gerona/56.5.B191; Valdez G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034640; Valdez G, 2010, P NATL ACAD SCI USA, V107, P14863, DOI 10.1073/pnas.1002220107	29	49	50	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67970	10.1371/journal.pone.0067970	http://dx.doi.org/10.1371/journal.pone.0067970			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844140	Green Published, gold, Green Submitted			2022-12-27	WOS:000321733000122
J	Jeru, I; Hentgen, V; Cochet, E; Duquesnoy, P; Le Borgne, G; Grimprel, E; Stojanovic, KS; Karabina, S; Grateau, G; Amselem, S				Jeru, Isabelle; Hentgen, Veronique; Cochet, Emmanuelle; Duquesnoy, Philippe; Le Borgne, Gaelle; Grimprel, Emmanuel; Stojanovic, Katia Stankovic; Karabina, Sonia; Grateau, Gilles; Amselem, Serge			The Risk of Familial Mediterranean Fever in MEFV Heterozygotes: A Statistical Approach	PLOS ONE			English	Article							DIAGNOSTIC-VALUE; CLINICAL SPECTRUM; ARMENIAN PATIENTS; CARRIER RATES; GENE ANALYSIS; LARGE COHORT; MUTATIONS; POPULATION; FREQUENCY; INFLAMMATION	Background: Familial Mediterranean fever (FMF) is an autosomal recessive autoinflammatory disorder due to MEFV mutations and one of the most frequent Mediterranean genetic diseases. The observation of many heterozygous patients in whom a second mutated allele was excluded led to the proposal that heterozygosity could be causal. However, heterozygosity might be coincidental in many patients due to the very high rate of mutations in Mediterranean populations. Objective: To better delineate the pathogenicity of heterozygosity in order to improve genetic counselling and disease management. Methods: Complementary statistical approaches were used: estimation of FMF prevalence at population levels, genotype comparison in siblings from 63 familial forms, and genotype study in 557 patients from four Mediterranean populations. Results: At the population level, we did not observe any contribution of heterozygosity to disease prevalence. In affected siblings of patients carrying two MEFV mutations, 92% carry two mutated alleles, whereas 4% are heterozygous with typical FMF diagnosis. We demonstrated statistically that patients are more likely to be heterozygous than healthy individuals, as shown by the higher ratio heterozygous carriers/non carriers in patients (p < 10(-7) - p < 0.003). The risk for heterozygotes to develop FMF was estimated between 2.1x10(-3) and 5.8x10(-3) and the relative risk, as compared to non carriers, between 6.3 and 8.1. Conclusions: This is the first statistical demonstration that heterozygosity is not responsible for classical Mendelian FMF per se, but constitutes a susceptibility factor for clinically-similar multifactorial forms of the disease. We also provide a first estimate of the risk for heterozygotes to develop FMF.	[Jeru, Isabelle; Duquesnoy, Philippe; Le Borgne, Gaelle; Karabina, Sonia; Amselem, Serge] INSERM, UMR S933, Paris, France; [Jeru, Isabelle; Le Borgne, Gaelle; Grimprel, Emmanuel; Karabina, Sonia; Grateau, Gilles; Amselem, Serge] Univ Paris 06, UMR S933, Paris, France; [Jeru, Isabelle; Cochet, Emmanuelle; Amselem, Serge] Hop Trousseau, AP HP, Serv Genet & Embryol Med, F-75571 Paris, France; [Jeru, Isabelle; Cochet, Emmanuelle; Duquesnoy, Philippe; Karabina, Sonia; Grateau, Gilles; Amselem, Serge] UPMC, AP HP, INSERM, Dept Hosp Univ Inflammat Immunopathol Biotherapy, Paris, France; [Jeru, Isabelle; Cochet, Emmanuelle; Duquesnoy, Philippe; Karabina, Sonia; Grateau, Gilles; Amselem, Serge] CNRS, Paris, France; [Hentgen, Veronique] Ctr Hosp Versailles, CeReMAI, Le Chesnay, France; [Grimprel, Emmanuel] Hop Trousseau, AP HP, Serv Pediat Gen, F-75571 Paris, France; [Stojanovic, Katia Stankovic; Grateau, Gilles] Hop Tenon, Ctr Reference Amyloses Origine Inflammatoire & Fi, F-75970 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Centre Hospitalier de Versailles; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Jeru, I (corresponding author), INSERM, UMR S933, Paris, France.	isabelle.jeru@trs.aphp.fr	HENTGEN, Véronique/AAR-1348-2021		Institut national de la sante et de la recherche medicale (INSERM); Universite Pierre et Marie Curie Paris; Agence Nationale pour la Recherche (ANR) [06-MRAR-010-02]	Institut national de la sante et de la recherche medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre et Marie Curie Paris; Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR))	This work was supported by grants from the Institut national de la sante et de la recherche medicale (INSERM); the Universite Pierre et Marie Curie Paris 6; and the Agence Nationale pour la Recherche (ANR) [06-MRAR-010-02]. The funders had no rule in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Idir D, 2011, RHEUMATOLOGY, V50, P2306, DOI 10.1093/rheumatology/ker328; Aksentijevich I, 1997, CELL, V90, P797; Al-Alami JR, 2003, SAUDI MED J, V24, P1055; Aldea A, 2004, AM J MED GENET A, V124A, P67, DOI 10.1002/ajmg.a.20296; Bernot A, 1998, HUM MOL GENET, V7, P1317, DOI 10.1093/hmg/7.8.1317; Bernot A, 1997, NAT GENET, V17, P25; Booth DR, 2000, QJM-INT J MED, V93, P217, DOI 10.1093/qjmed/93.4.217; Booty MG, 2009, ARTHRITIS RHEUM-US, V60, P1851, DOI 10.1002/art.24569; Caglar MK, 2008, ACTA REUMATOL PORT, V33, P415; Cazeneuve C, 1999, AM J HUM GENET, V65, P88, DOI 10.1086/302459; Cazeneuve C, 2003, ARTHRITIS RHEUM-US, V48, P2324, DOI 10.1002/art.11102; Centola M, 2000, BLOOD, V95, P3223, DOI 10.1182/blood.V95.10.3223; Diaz A, 2004, ARTHRITIS RHEUM-US, V50, P3679, DOI 10.1002/art.20600; Dode C, 2000, AM J MED GENET, V92, P241, DOI 10.1002/(SICI)1096-8628(20000605)92:4<241::AID-AJMG3>3.3.CO;2-7; Federici S, 2012, ANN RHEUM DIS, V71, P1961, DOI 10.1136/annrheumdis-2011-200977; Giaglis S, 2007, CLIN GENET, V71, P458, DOI 10.1111/j.1399-0004.2007.00789.x; Hentgen V, 2013, ARTHRITIS RHEUM; Kalyoncu M, 2006, CLIN EXP RHEUMATOL, V24, pS120; KHACHADURIAN A K, 1974, Birth Defects Original Article Series, V10, P62; Kone-Paut I, 2009, RHEUMATOLOGY, V48, P840, DOI 10.1093/rheumatology/kep121; Lachmann HJ, 2006, RHEUMATOLOGY, V45, P746, DOI 10.1093/rheumatology/kei279; Livneh A, 1997, ARTHRITIS RHEUM-US, V40, P1879, DOI 10.1002/art.1780401023; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marek-Yagel D, 2009, ARTHRITIS RHEUM-US, V60, P1862, DOI 10.1002/art.24570; Moradian MM, 2010, J HUM GENET, V55, P389, DOI 10.1038/jhg.2010.52; Ozen S, 1999, Curr Opin Rheumatol, V11, P393, DOI 10.1097/00002281-199909000-00011; Ozen S, 2003, J RHEUMATOL, V30, P2014; ROGERS DB, 1989, AM J MED GENET, V34, P168, DOI 10.1002/ajmg.1320340206; Samuels J, 1998, MEDICINE, V77, P268, DOI 10.1097/00005792-199807000-00005; Sarkisian T, 2008, Georgian Med News, P105; SOHAR E, 1967, AM J MED, V43, P227, DOI 10.1016/0002-9343(67)90167-2; Stoffels M, 2013, ANN RHEUM DIS; Stoffman N, 2000, EUR J HUM GENET, V8, P307, DOI 10.1038/sj.ejhg.5200446; Tchernitchko D, 2005, ARTHRITIS RHEUM-US, V52, P3603, DOI 10.1002/art.21408; Touitou I, 2001, EUR J HUM GENET, V9, P473, DOI 10.1038/sj.ejhg.5200658; Touitou I, 2013, J MED GENET; van Gijn ME, 2008, EUR J HUM GENET, V16, P1404, DOI 10.1038/ejhg.2008.135; Yilmaz E, 2001, EUR J HUM GENET, V9, P553, DOI 10.1038/sj.ejhg.5200674; ZEMER D, 1986, NEW ENGL J MED, V314, P1001, DOI 10.1056/NEJM198604173141601	39	41	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68431	10.1371/journal.pone.0068431	http://dx.doi.org/10.1371/journal.pone.0068431			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844200	Green Submitted, gold, Green Published			2022-12-27	WOS:000321733000005
J	Korner-Nievergelt, F; Brinkmann, R; Niermann, I; Behr, O				Korner-Nievergelt, Fraenzi; Brinkmann, Robert; Niermann, Ivo; Behr, Oliver			Estimating Bat and Bird Mortality Occurring at Wind Energy Turbines from Covariates and Carcass Searches Using Mixture Models	PLOS ONE			English	Article							MIGRATORY BATS; FATALITY; RADAR; ABUNDANCE; PATTERNS; IMPACTS; FARMS	Environmental impacts of wind energy facilities increasingly cause concern, a central issue being bats and birds killed by rotor blades. Two approaches have been employed to assess collision rates: carcass searches and surveys of animals prone to collisions. Carcass searches can provide an estimate for the actual number of animals being killed but they offer little information on the relation between collision rates and, for example, weather parameters due to the time of death not being precisely known. In contrast, a density index of animals exposed to collision is sufficient to analyse the parameters influencing the collision rate. However, quantification of the collision rate from animal density indices (e.g. acoustic bat activity or bird migration traffic rates) remains difficult. We combine carcass search data with animal density indices in a mixture model to investigate collision rates. In a simulation study we show that the collision rates estimated by our model were at least as precise as conventional estimates based solely on carcass search data. Furthermore, if certain conditions are met, the model can be used to predict the collision rate from density indices alone, without data from carcass searches. This can reduce the time and effort required to estimate collision rates. We applied the model to bat carcass search data obtained at 30 wind turbines in 15 wind facilities in Germany. We used acoustic bat activity and wind speed as predictors for the collision rate. The model estimates correlated well with conventional estimators. Our model can be used to predict the average collision rate. It enables an analysis of the effect of parameters such as rotor diameter or turbine type on the collision rate. The model can also be used in turbine-specific curtailment algorithms that predict the collision rate and reduce this rate with a minimal loss of energy production.	[Korner-Nievergelt, Fraenzi] Oikostat GmbH, Ettiswil, Switzerland; [Korner-Nievergelt, Fraenzi] Swiss Ornithol Inst, Sempach, Switzerland; [Brinkmann, Robert; Niermann, Ivo] Leibniz Univ Hannover, Inst Umweltplanung, D-30167 Hannover, Germany; [Brinkmann, Robert] Freiburg Inst Appl Anim Ecol, Freiburg, Germany; [Behr, Oliver] Univ Erlangen Nurnberg, Inst Tierphysiol, D-91054 Erlangen, Germany	Swiss Ornithological Institute; Leibniz University Hannover; University of Erlangen Nuremberg	Behr, O (corresponding author), Univ Erlangen Nurnberg, Inst Tierphysiol, D-91054 Erlangen, Germany.	obehr@biologie.uni-erlangen.de		Korner-Nievergelt, Franzi/0000-0001-9081-3563	German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety [FKZ 0327638]; Germany Ministry for environmental protection	German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety; Germany Ministry for environmental protection	The research was funded by the German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (FKZ 0327638 A, B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Franzi Korner-Nievergelt is employed by oikostat GmbH. This company carried out a part of the research in the project as a contractor but did not fund the project. The research has solely been funded by the Germany Ministry for environmental protection. There are, hence, no conflicts regarding employment, consultancy, patents, products in development or marketed products etc, neither does this alter our adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], 2010, AUTOMATISCHE RUFANAL; Arnett E.B., 2009, PATTERNS BAT FATALIT; Arnett EB, 2008, J WILDLIFE MANAGE, V72, P61, DOI 10.2193/2007-221; Arnett EB, 2011, FRONT ECOL ENVIRON, V9, P209, DOI 10.1890/100103; Baerwald EF, 2011, J WILDLIFE MANAGE, V75, P1103, DOI 10.1002/jwmg.147; Baerwald EF, 2009, J MAMMAL, V90, P1341, DOI 10.1644/09-MAMM-S-104R.1; Baerwald EF, 2009, J WILDLIFE MANAGE, V73, P1077, DOI 10.2193/2008-233; Behr O, 2011, ENTWICKLUNG METHODEN, P354; Behr O., 2011, METHODEN UNTERSUCHUN, P287; Bernardino J, 2013, NEW ZEAL J ZOOL, V40, P63, DOI 10.1080/03014223.2012.758155; Bispo R, 2012, ENV ECOLOGICAL STAT; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; Brinkmann R., 2011, ENTWICKLUNG METHODEN; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Bruderer B, 1997, NATURWISSENSCHAFTEN, V84, P1, DOI 10.1007/s001140050338; Bruderer B, 1997, NATURWISSENSCHAFTEN, V84, P45, DOI 10.1007/s001140050348; BWE BW, 2012, INST WIND DEUTSCHL; Carrete M, 2009, BIOL CONSERV, V142, P2954, DOI 10.1016/j.biocon.2009.07.027; De Lucas M., 2007, BIRDS WIND FARMS RIS; Dulac Perrine, 2010, Symbioses, V25, P32; Eichhorn M, 2012, ECOL SOC, V17, DOI 10.5751/ES-04594-170201; Guinard E, 2012, BIOL CONSER IN PRESS; Higgins K. F., 2007, BIRDS AND WIND FARMS, V275, P153; Hull CL, 2010, AUSTRALAS J ENV MAN, V17, P77, DOI 10.1080/14486563.2010.9725253; Huso M, 2012, DATA SERIES US GEOLO, V729; Huso MMP, 2011, ENVIRONMETRICS, V22, P318, DOI 10.1002/env.1052; Johnson GD, 2004, WILDLIFE SOC B, V32, P1278, DOI 10.2193/0091-7648(2004)032[1278:BACACM]2.0.CO;2; Kerns J., 2005, RELATIONSHIPS BATS W, P24; Kery M, 2005, ECOL APPL, V15, P1450, DOI 10.1890/04-1120; Kery M, 2010, J ANIM ECOL, V79, P453, DOI 10.1111/j.1365-2656.2009.01632.x; Kery M, 2009, J APPL ECOL, V46, P1163, DOI 10.1111/j.1365-2664.2009.01724.x; Korner-Nievergelt F, 2011, WILDLIFE BIOL, V17, P350, DOI 10.2981/10-121; Kunz TH, 2007, J WILDLIFE MANAGE, V71, P2449, DOI 10.2193/2007-270; Kunz TH, 2007, FRONT ECOL ENVIRON, V5, P315, DOI 10.1890/1540-9295(2007)5[315:EIOWED]2.0.CO;2; Liechti F, 1995, J FIELD ORNITHOL, V66, P457; Liechti F, 2006, J ORNITHOL, V147, P202, DOI 10.1007/s10336-006-0061-9; Lunn D., 2009, BUGS PROJECT EVOLUTI, P1; Madders M, 2006, IBIS, V148, P43, DOI 10.1111/j.1474-919X.2006.00506.x; Niermann I., 2011, SYSTEMATISCHE SCHLAG, P40; Osborn RG, 2000, AM MIDL NAT, V143, P41, DOI 10.1674/0003-0031(2000)143[0041:BMAWWT]2.0.CO;2; R Development Core Team, 2012, R LANG ENV STAT COMP; Rawlings JO, 1998, APPL REGRESSION ANAL, DOI 10.1007/b98890; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Rydell J, 2010, ACTA CHIROPTEROL, V12, P261, DOI 10.3161/150811010X537846; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Santos SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025383; Schaub M, 2012, BIOL CONSERV, V155, P111, DOI 10.1016/j.biocon.2012.06.021; Solymos P, 2012, ENVIRONMETRICS ONLIN; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Weller TJ, 2012, J WILDLIFE MANAGE, V76, P619, DOI 10.1002/jwmg.260	50	40	41	3	154	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67997	10.1371/journal.pone.0067997	http://dx.doi.org/10.1371/journal.pone.0067997			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844144	Green Submitted, Green Published, gold			2022-12-27	WOS:000321733000123
J	Carabajal, AP; Sterli, J; Muller, J; Hilger, A				Paulina Carabajal, Ariana; Sterli, Juliana; Mueller, Johannes; Hilger, Andre			Neuroanatomy of the Marine Jurassic Turtle Plesiochelys etalloni (Testudinata, Plesiochelyidae)	PLOS ONE			English	Article							ANATOMY; EAR; ENDOCAST; REPTILES; HEARING; BRAIN	Turtles are one of the least explored clades regarding endocranial anatomy with few available descriptions of the brain and inner ear of extant representatives. In addition, the paleoneurology of extinct turtles is poorly known and based on only a few natural cranial endocasts. The main goal of this study is to provide for the first time a detailed description of the neuroanatomy of an extinct turtle, the Late Jurassic Plesiochelys etalloni, including internal carotid circulation, cranial endocast and inner ear, based on the first digital 3D reconstruction using micro CT scans. The general shape of the cranial endocast of P. etalloni is tubular, with poorly marked cephalic and pontine flexures. Anteriorly, the olfactory bulbs are clearly differentiated suggesting larger bulbs than in any other described extinct or extant turtle, and indicating a higher capacity of olfaction in this taxon. The morphology of the inner ear of P. etalloni is comparable to that of extant turtles and resembles those of slow-moving terrestrial vertebrates, with markedly low, short and robust semicircular canals, and a reduced lagena. In P. etalloni the arterial pattern is similar to that found in extant cryptodires, where all the internal carotid branches are protected by bone. As the knowledge of paleoneurology in turtles is scarce and the application of modern techniques such as 3D reconstructions based on CT scans is almost unexplored in this clade, we hope this paper will trigger similar investigations of this type in other turtle taxa.	[Paulina Carabajal, Ariana] Consejo Nacl Invest Cient & Tecn, Museo Carmen Funes, Neuquen, Argentina; [Sterli, Juliana] Consejo Nacl Invest Cient & Tecn, Museo Egidio Feruglio, Trelew, Chubut, Argentina; [Mueller, Johannes] Humboldt Univ, Museum Naturkunde, Leibniz Inst Evolut & Biodiversitatsforsch, D-10099 Berlin, Germany; [Hilger, Andre] Helmholtz Zentrum Mat & Energie, Berlin, Germany	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB)	Carabajal, AP (corresponding author), Consejo Nacl Invest Cient & Tecn, Museo Carmen Funes, Neuquen, Argentina.	a.paulinacarabajal@conicet.gov.ar	Sterli, Juliana/I-3526-2019; Müller, Johannes/A-6293-2017	Müller, Johannes/0000-0001-5801-856X; Sterli, Juliana/0000-0003-2942-5558; Hilger, Andre/0000-0002-6454-7967; Paulina Carabajal, Ariana/0000-0002-7820-4770	Ale-Arg fellowship	Ale-Arg fellowship	This study was partially financed by an Ale-Arg fellowship to JS. No additional funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT PHILIP W., 1967, TULANE STUD ZOOL, V14, P81; [Anonymous], 1979, B AM MUS NAT HIST, V164, P67; Bardet Nathalie, 1995, Palaeovertebrata (Montpellier), V24, P177; Billon-Bruyat JP, 2005, PALAEOGEOGR PALAEOCL, V216, P359, DOI 10.1016/j.palaeo.2004.11.011; Boistel R, 2010, BIOL LETTERS, V6, P740, DOI 10.1098/rsbl.2010.0322; Brinkman D.B., 1991, Journal of Vertebrate Paleontology, V11, P302; Brinkman Donald B., 2013, P147; Brochu CA, 2000, J VERTEBR PALEONTOL, V20, P1, DOI 10.1671/0272-4634(2000)020[0001:ADREFT]2.0.CO;2; Buchholtz EA, 1999, BRAIN RES BULL, V48, P351, DOI 10.1016/S0361-9230(98)00174-9; Buffetaut Eric, 1994, Geobios Memoire Special (Villeurbanne), V16, P259; Carabajal AP, 2012, ANAT REC, V295, P2141, DOI 10.1002/ar.22572; Carabajal Ariana Paulina, 2012, [古脊椎动物学报, Vertebrata Palasiatica], V50, P85; Christensen-Dalsgaard J, 2012, P ROY SOC B-BIOL SCI, V279, P2816, DOI 10.1098/rspb.2012.0290; David R, 2010, CR PALEVOL, V9, P397, DOI 10.1016/j.crpv.2010.07.012; de Broin France, 1994, Geobios Memoire Special (Villeurbanne), V16, P167; Edinger T., 1934, PSYCH NEUROL BLADEN, V3-4, P396; Edinger T, 1929, FOSSILEN GEHIME ERGE, V28, P249; Evans DC, 2009, ANAT REC, V292, P1315, DOI 10.1002/ar.20984; Franzosa J, 2005, J VERTEBR PALEONTOL, V25, P859, DOI 10.1671/0272-4634(2005)025[0859:CEOTCT]2.0.CO;2; GAFFNEY E S, 1975, Bulletin of the American Museum of Natural History, V155, P387; Gaffney E.S., 1976, Bulletin Am Mus nat Hist, V157, P487; Gaffney E.S., 1982, American Museum Novitates, P1; Gaffney E.S., 1975, American Museum Novitates, VNo. 2574, P1; Gaffney E.S., 1977, American Museum Novitates, VNo. 2639, P1; GAFFNEY E S, 1968, Fieldiana Geology, V16, P193; Gaffney Eugene S., 1995, American Museum Novitates, V3130, P1; Holliday CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030471; Hopson J.A., 1979, P39; Jamniczky HA, 2004, ANIM BIOL, V54, P417, DOI 10.1163/1570756042729537; Jamniczky HA, 2007, J MORPHOL, V268, P571, DOI 10.1002/jmor.10539; Joyce Walter G., 2007, Bulletin of the Peabody Museum of Natural History, V48, P3, DOI 10.3374/0079-032X(2007)48[3:PROMT]2.0.CO;2; Joyce WG, 2004, J PALEONTOL, V78, P989, DOI 10.1666/0022-3360(2004)078<0989:DAPFTC>2.0.CO;2; LENHARDT M L, 1985, Journal of Auditory Research, V25, P66; Manley GA, 2010, J EXP BIOL, V213, P1876, DOI 10.1242/jeb.040196; McDowell S. B., 1961, Bulletin of the Museum of Comparative Zoology, V125, P23; Miyashita Tetsuto, 2013, P71; PARSONS TS, 1959, EVOLUTION, V13, P175, DOI 10.2307/2405871; Rogers SW, 1998, NEURON, V21, P673, DOI 10.1016/S0896-6273(00)80585-1; Sanders RK, 2005, ACTA PALAEONTOL POL, V50, P601; Sedlmayr JC, 2002, THESIS OHIO U OHIO; Sereno PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001230; Sterli J, 2007, PALAEONTOGR ABT A, V281, P1; Sterli J, 2010, CAN J EARTH SCI, V47, P1337, DOI 10.1139/E10-061; Sterli J, 2010, J VERTEBR PALEONTOL, V30, P351, DOI 10.1080/02724631003617597; Thewissen JGM, 2008, SENSORY EVOLUTION ON THE THRESHOLD: ADAPTATIONS IN SECONDARILY AQUATIC VERTEBRATES, P1; Walsh SA, 2009, P ROY SOC B-BIOL SCI, V276, P1355, DOI 10.1098/rspb.2008.1390; Weber EG, 1978, B AM MUS NAT HIST; Wersall J., 1974, P123; Witmer LM, 2008, ANATOMICAL IMAGING: TOWARDS A NEW MORPHOLOGY, P67, DOI 10.1007/978-4-431-76933-0_6; Witmer LM, 2009, ANAT REC, V292, P1266, DOI 10.1002/ar.20983; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048; Wyneken J, 2001, NMFSSEFSC470 NOAA, DOI DOI 10.1007/SPRINGERREFERENCE_; ZANGERL R, 1960, FIELDIANA GEOLOGY ME, V3, P281, DOI DOI 10.5962/BHL.TITLE.5245	53	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e69264	10.1371/journal.pone.0069264	http://dx.doi.org/10.1371/journal.pone.0069264			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844257	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000189
J	Vandam, R; Kaptijn, E; Vanschoenwinkel, B				Vandam, Ralf; Kaptijn, Eva; Vanschoenwinkel, Bram			Disentangling the Spatio-Environmental Drivers of Human Settlement: An Eigenvector Based Variation Decomposition	PLOS ONE			English	Article							ECOLOGICAL DATA; AUTOCORRELATION; FRAMEWORK; SELECTION; MATRICES; BIOLOGY	The relative importance of deterministic and stochastic processes driving patterns of human settlement remains controversial. A main reason for this is that disentangling the drivers of distributions and geographic clustering at different spatial scales is not straightforward and powerful analytical toolboxes able to deal with this type of data are largely deficient. Here we use a multivariate statistical framework originally developed in community ecology, to infer the relative importance of spatial and environmental drivers of human settlement. Using Moran's eigenvector maps and a dataset of spatial variation in a set of relevant environmental variables we applied a variation partitioning procedure based on redundancy analysis models to assess the relative importance of spatial and environmental processes explaining settlement patterns. We applied this method on an archaeological dataset covering a 15 km(2) area in SW Turkey spanning a time period of 8000 years from the Late Neolithic/Early Chalcolithic up to the Byzantine period. Variation partitioning revealed both significant unique and commonly explained effects of environmental and spatial variables. Land cover and water availability were the dominant environmental determinants of human settlement throughout the study period, supporting the theory of the presence of farming communities. Spatial clustering was mainly restricted to small spatial scales. Significant spatial clustering independent of environmental gradients was also detected which can be indicative of expansion into unsuitable areas or an unexpected absence in suitable areas which could be caused by dispersal limitation. Integrating historic settlement patterns as additional predictor variables resulted in more explained variation reflecting temporal autocorrelation in settlement locations.	[Vandam, Ralf; Kaptijn, Eva] Univ Leuven, Sagalassos Archaeol Res Project, Fac Arts, Louvain, Belgium; [Vanschoenwinkel, Bram] Univ Leuven, Lab Aquat Ecol Evolut & Conservat, Louvain, Belgium	KU Leuven; KU Leuven	Vandam, R (corresponding author), Univ Leuven, Sagalassos Archaeol Res Project, Fac Arts, Louvain, Belgium.	ralf.vandam@arts.kuleuven.be	Vandam, Ralf/CAF-3469-2022; Vanschoenwinkel, Bram/I-9021-2019	Vandam, Ralf/0000-0002-9542-8477; Vanschoenwinkel, Bram/0000-0002-8973-6297	Research Fund Flanders (FWO); Flemish Ministry for Science Policy [07/01]; Belgian Science Policy Office [IAP 07/09]; University of Leuven Research Fund [GOA 13/04]	Research Fund Flanders (FWO)(FWO); Flemish Ministry for Science Policy; Belgian Science Policy Office(Belgian Federal Science Policy Office); University of Leuven Research Fund	B. Vanschoenwinkel is supported by a postdoctoral fellowship of the Research Fund Flanders (FWO). M. Waelkens received a 'Methusalem 07/01 grant' from the Flemish Ministry for Science Policy which helped to make this research possible and supports the doctoral research of R. Vandam and the postdoctoral research of E. Kaptijn. The research theme forms part of the IAP 07/09 (Belgian Science Policy Office) and GOA 13/04 (University of Leuven Research Fund) projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeler DG, 2009, ECOLOGY, V90, P3245, DOI 10.1890/07-0391.1; Baird D., 2005, CATALHOYUK PERSPECTI, P55; Balkan-Atli N, 2001, ANATOLIA ANTIQUA, V9, P193; Binckley CA, 2005, BIOL LETTERS, V1, P370, DOI 10.1098/rsbl.2005.0310; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Dale PER, 2012, WETL ECOL MANAG, V20, P165, DOI 10.1007/s11273-012-9264-4; Degryse P, 2008, SAGALASSOS 6 GEO BIO, P53; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; During B., 2006, CONSTRUCTING COMMUNI; During Bleda S., 2011, PREHISTORY ASIA MINO; Duru R, 1996, KURUCAY HOYUK; Duru R, 2008, ARCHAEOZOOLOGY NEAR, VVIII, P367; Duru R, 1994, KURUCAY HOYUK; Esin Ufuk, 1998, TUBA AR, P95; Fernandes R, 2011, J ARCHAEOL SCI, V38, P2293, DOI 10.1016/j.jas.2011.03.035; Guillot G, 2013, METHODS ECO IN PRESS; Halstead P., 1989, BAD YEAR EC CULTURAL, P68, DOI DOI 10.1017/CBO9780511521218.006; HAYDEN B, 1990, J ANTHROPOL ARCHAEOL, V9, P31, DOI 10.1016/0278-4165(90)90005-X; Helbaek H, 1970, EXCAVATIONS HACILAR; Helbak H., 1970, EXCAVATIONS HACILAR, P189; Heratsi M, 1184, JERMANTS MKHITARUTIU; Hillman G. C., 1989, FORAGING FARMING EVO, P207; Hodder I., 2005, INHABITING CATALHOYU, V38, P1; Johnson M., 1996, OXFORD J ARCHAEOL, V15, P267; Johnson M., 2004, EXPLAINING SOCIAL CH, P65; Jones G, 2005, WORLD ARCHAEOL, V37, P164, DOI 10.1080/00438240500094564; Kaptijn E, 2013, ANATOLICA IN PRESS; Kaptijn E., 2012, NEWS ARCHAEOLOGY ANA, V10, P142; Keegan W, 1987, ADV ARCHAEOLOGICAL M, V19; Kis M, 1989, J ISLAM ACAD SCI, V2, P37; Kowalewski SA, 2008, J ARCHAEOL RES, V16, P225, DOI 10.1007/s10814-008-9020-8; Kuussaari M, 2009, TRENDS ECOL EVOL, V24, P564, DOI 10.1016/j.tree.2009.04.011; Lee Richard B., 1969, ENV CULTURAL BEHAV; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P., 2012, NUMERICAL ECOLOGY; Lehmann G., 2004, TEL AVIV, V31, P141; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Logue JB, 2011, TRENDS ECOL EVOL, V26, P482, DOI 10.1016/j.tree.2011.04.009; Luis JR, 2004, AM J HUM GENET, V74, P532, DOI 10.1086/382286; MANTEL N, 1967, CANCER RES, V27, P209; MCNEILL WH, 1984, POPUL DEV REV, V10, P1, DOI 10.2307/1973159; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Nhiwatiwa T, 2011, FRESHWATER BIOL, V56, P1992, DOI 10.1111/j.1365-2427.2011.02630.x; Peatfield A., 1992, CAMB ARCHAEOL J, V2, P59, DOI DOI 10.1017/S0959774300000482; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Perles C., 2001, EARLY NEOLITHIC GREE, DOI 10.1017/CBO9780511612855; Renfrew C, 1986, INTRO PEER POLICY IN; Russell N., 2005, INHABITING CATALHOYU, P99; Slatkin M, 2012, SERIAL FOUNDER EFFEC; SOKAL RR, 1978, BIOL J LINN SOC, V10, P199, DOI 10.1111/j.1095-8312.1978.tb00013.x; SOKAL RR, 1978, BIOL J LINN SOC, V10, P229, DOI 10.1111/j.1095-8312.1978.tb00014.x; Tilman D, 1997, SPATIAL ECOLOGY ROLE; Tir J, 1998, J PEACE RES, V35, P319, DOI 10.1177/0022343398035003004; Umurtak G., 2012, NEWS ARCHAEOLOGY ANA, V10, P21; Vandam R, 2013, NEWS ARCHAEOLOGY ANA, P13; Vanschoenwinkel B, 2008, ECOGRAPHY, V31, P567, DOI 10.1111/j.0906-7590.2008.05442.x; Vanschoenwinkel B, 2007, OIKOS, V116, P1255, DOI 10.1111/j.2007.0030-1299.15860.x; Verhaert G, 2006, J STRUCT GEOL, V28, P1067, DOI 10.1016/j.jsg.2006.03.013; Winegardner AK, 2012, TRENDS ECOL EVOL, V27, P253, DOI 10.1016/j.tree.2012.01.007; WOBST HM, 1974, AM ANTIQUITY, V39, P147, DOI 10.2307/279579	67	8	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67726	10.1371/journal.pone.0067726	http://dx.doi.org/10.1371/journal.pone.0067726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	176XV	23844076	Green Submitted, Green Published, gold			2022-12-27	WOS:000321341000085
J	Wang, SW; DelProposto, Z; Wang, HY; Ding, XW; Ji, CH; Wang, B; Xu, MS				Wang, Shiwei; DelProposto, Zachary; Wang, Haoyu; Ding, Xuewei; Ji, Conghua; Wang, Bei; Xu, Maosheng			Differentiation of Breast Cancer from Fibroadenoma with Dual-Echo Dynamic Contrast-Enhanced MRI	PLOS ONE			English	Article							PERFUSION; PERMEABILITY; RESOLUTION; LESIONS; QUANTIFICATION; ACQUISITION; TUMORS	Dynamic contrast-enhanced magnetic resonance imaging (DCE MRI) of the breast is a routinely used imaging method which is highly sensitive for detecting breast malignancy. Specificity, though, remains suboptimal. Dynamic susceptibility contrast magnetic resonance imaging (DSC MRI), an alternative dynamic contrast imaging technique, evaluates perfusion-related parameters unique from DCE MRI. Previous work has shown that the combination of DSC MRI with DCE MRI can improve diagnostic specificity, though an additional administration of intravenous contrast is required. Dual-echo MRI can measure both T1W DCE MRI and T-2*W DSC MRI parameters with a single contrast bolus, but has not been previously implemented in breast imaging. We have developed a dual-echo gradient-echo sequence to perform such simultaneous measurements in the breast, and use it to calculate the semi-quantitative T1W and T-2*W related parameters such as peak enhancement ratio, time of maximal enhancement, regional blood flow, and regional blood volume in 20 malignant lesions and 10 benign fibroadenomas in 38 patients. Imaging parameters were compared to surgical or biopsy obtained tissue samples. Receiver operating characteristic (ROC) curves and area under the ROC curves were calculated for each parameter and combination of parameters. The time of maximal enhancement derived from DCE MRI had a 90% sensitivity and 69% specificity for predicting malignancy. When combined with DSC MRI derived regional blood flow and volume parameters, sensitivity remained unchanged at 90% but specificity increased to 80%. In conclusion, we show that dual-echo MRI with a single administration of contrast agent can simultaneously measure both T1W and T-2*W related perfusion and kinetic parameters in the breast and the combination of DCE MRI and DSC MRI parameters improves the diagnostic performance of breast MRI to differentiate breast cancer from benign fibroadenomas.	[Wang, Shiwei; Ding, Xuewei; Xu, Maosheng] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Dept Radiol, Hangzhou, Zhejiang, Peoples R China; [DelProposto, Zachary] Henry Ford Hosp, Dept Radiol, Detroit, MI 48202 USA; [Wang, Haoyu] Peking Univ, Beijing Key Lab Med Phys & Engn, Beijing 100871, Peoples R China; [Ji, Conghua] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Clin Evaluat & Anal Ctr, Hangzhou, Zhejiang, Peoples R China; [Wang, Bei] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Dept Breast Dis, Hangzhou, Zhejiang, Peoples R China	Zhejiang Chinese Medical University; Henry Ford Health System; Henry Ford Hospital; Peking University; Zhejiang Chinese Medical University; Zhejiang Chinese Medical University	Wang, HY (corresponding author), Peking Univ, Beijing Key Lab Med Phys & Engn, Beijing 100871, Peoples R China.	benfox.w@gmail.com; xumaosh@yahoo.com.cn			Zhejiang Provincial Bureau of Health, Hangzhou, China [2011KYA121]	Zhejiang Provincial Bureau of Health, Hangzhou, China	This research was supported by the Zhejiang Provincial Bureau of Health, Hangzhou, China (2011KYA121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbier EL, 2001, J MAGN RESON IMAGING, V13, P496, DOI 10.1002/jmri.1073; Benner T, 1997, MAGN RESON IMAGING, V15, P307, DOI 10.1016/S0730-725X(96)00392-X; Bluemke DA, 2004, JAMA-J AM MED ASSOC, V292, P2735, DOI 10.1001/jama.292.22.2735; Calamante F, 1999, J CEREBR BLOOD F MET, V19, P701, DOI 10.1097/00004647-199907000-00001; de Bazelaire C, 2006, EUR RADIOL, V16, P2083, DOI 10.1007/s00330-006-0198-1; Evelhoch JL, 1999, JMRI-J MAGN RESON IM, V10, P254, DOI 10.1002/(SICI)1522-2586(199909)10:3<254::AID-JMRI5>3.0.CO;2-9; Gilles R, 1996, J COMPUT ASSIST TOMO, V20, P9, DOI 10.1097/00004728-199601000-00003; Henderson E, 1998, MAGN RESON IMAGING, V16, P1057, DOI 10.1016/S0730-725X(98)00130-1; Huang W, 2004, RADIOLOGY, V232, P585, DOI 10.1148/radiol.2322030547; Kim EJ, 2004, MAGN RESON IMAGING, V22, P307, DOI 10.1016/j.mri.2004.01.012; Kuhl CK, 2007, RADIOLOGY, V244, P672, DOI 10.1148/radiol.2443051661; Kvistad KA, 2000, RADIOLOGY, V216, P545, DOI 10.1148/radiology.216.2.r00au36545; Li J, 2009, MED PHYS, V36, P3786, DOI 10.1118/1.3152113; Liney GP, 1999, JMRI-J MAGN RESON IM, V10, P945, DOI 10.1002/(SICI)1522-2586(199912)10:6<945::AID-JMRI6>3.3.CO;2-9; Ludemann L, 2009, ANN BIOMED ENG, V37, P749, DOI 10.1007/s10439-009-9645-x; Makkat S, 2007, J MAGN RESON IMAGING, V25, P1159, DOI 10.1002/jmri.20937; Moy L, 2009, AM J ROENTGENOL, V193, P986, DOI 10.2214/AJR.08.1229; Mussurakis S, 1998, RADIOLOGY, V206, P465, DOI 10.1148/radiology.206.2.9457201; Peters NHGM, 2008, RADIOLOGY, V246, P116, DOI 10.1148/radiol.2461061298; SHAMES DM, 1993, MAGNET RESON MED, V29, P616, DOI 10.1002/mrm.1910290506; Taillieu F, 2006, RADIOLOGY, V241, P737, DOI 10.1148/radiol.2413051168; Vassiou K, 2009, EUR J RADIOL, V70, P69, DOI 10.1016/j.ejrad.2008.01.012; Wang HY, 2010, MED PHYS, V37, P4971, DOI 10.1118/1.3483094; Yang XY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/732848; Yu YM, 2010, RADIOLOGY, V257, P47, DOI 10.1148/radiol.10092169	25	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67731	10.1371/journal.pone.0067731	http://dx.doi.org/10.1371/journal.pone.0067731			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844077	Green Submitted, Green Published, gold			2022-12-27	WOS:000321341000086
J	Yu, Y; Shen, H; Zeng, LL; Ma, QM; Hu, DW				Yu, Yang; Shen, Hui; Zeng, Ling-Li; Ma, Qiongmin; Hu, Dewen			Convergent and Divergent Functional Connectivity Patterns in Schizophrenia and Depression	PLOS ONE			English	Article							DEFAULT-MODE; DISCRIMINATIVE ANALYSIS; NETWORK CONNECTIVITY; MAJOR DEPRESSION; BIPOLAR DISORDER; WORKING-MEMORY; LOW-FREQUENCY; BRAIN; NEUROANATOMY; 1ST-EPISODE	Major depression and schizophrenia are two of the most serious psychiatric disorders and share similar behavioral symptoms. Whether these similar behavioral symptoms underlie any convergent psychiatric pathological mechanisms is not yet clear. To address this issue, this study sought to investigate the whole-brain resting-state functional magnetic resonance imaging (MRI) of major depression and schizophrenia by using multivariate pattern analysis. Thirty-two schizophrenic patients, 19 major depressive disorder patients and 38 healthy controls underwent resting-state functional MRI scanning. A support vector machine in conjunction with intrinsic discriminant analysis was used to solve the multi-classification problem, resulting in a correct classification rate of 80.9% via leave-one-out cross-validation. The depression and schizophrenia groups both showed altered functional connections associated with the medial prefrontal cortex, anterior cingulate cortex, thalamus, hippocampus, and cerebellum. However, the prefrontal cortex, amygdala, and temporal poles were found to be affected differently by major depression and schizophrenia. Our preliminary study suggests that altered connections within or across the default mode network and the cerebellum may account for the common behavioral symptoms between major depression and schizophrenia. In addition, connections associated with the prefrontal cortex and the affective network showed promise as biomarkers for discriminating between the two disorders.	[Yu, Yang; Shen, Hui; Zeng, Ling-Li; Ma, Qiongmin; Hu, Dewen] Natl Univ Def Technol, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China	National University of Defense Technology - China	Hu, DW (corresponding author), Natl Univ Def Technol, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China.	dwhu@nudt.edu.cn	Hu, Dewen/D-1978-2015; Hu, Dewen/AAN-8511-2020	Zeng, Ling-Li/0000-0002-0515-256X	National Basic Research Program of China [2011CB707802]; National Science Foundation of China [61003202]; National High-Tech Program of China [2012AA011601]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Program of China(National High Technology Research and Development Program of China)	This work was supported by the National Basic Research Program of China (Grant No 2011CB707802), the National Science Foundation of China (Grant No 61003202), and the National High-Tech Program of China (Grant No 2012AA011601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Anand A, 2005, NEUROPSYCHOPHARMACOL, V30, pS159; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P943; Angelucci F, 2005, MOL PSYCHIATR, V10, P345, DOI 10.1038/sj.mp.4001637; APA, 2000, DIAGN STAT MAN MENT; Barch DM, 2003, BIOL PSYCHIAT, V53, P376, DOI 10.1016/S0006-3223(02)01674-8; Bearden CE, 2001, BIPOLAR DISORD, V3, P106, DOI 10.1034/j.1399-5618.2001.030302.x; Bluhm R, 2009, PSYCHIAT CLIN NEUROS, V63, P754, DOI 10.1111/j.1440-1819.2009.02030.x; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Boksman K, 2005, SCHIZOPHR RES, V75, P247, DOI 10.1016/j.schres.2004.09.025; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Buchanan RW, 1998, AM J PSYCHIAT, V155, P1049, DOI 10.1176/ajp.155.8.1049; Buchsbaum MS, 1998, SCHIZOPHRENIA BULL, V24, P343, DOI 10.1093/oxfordjournals.schbul.a033331; Ding SL, 2009, J COMP NEUROL, V514, P595, DOI 10.1002/cne.22053; ELKIS H, 1995, ARCH GEN PSYCHIAT, V52, P735; Fan Y, 2007, IEEE T MED IMAGING, V26, P93, DOI 10.1109/TMI.2006.886812; Fox MD, 2008, P HDB, P575; Friston KJ, 1998, SCHIZOPHR RES, V30, P115, DOI 10.1016/S0920-9964(97)00140-0; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Guo WB, 2011, J AFFECT DISORDERS, V135, P326, DOI 10.1016/j.jad.2011.06.048; Hafner H, 2005, EUR ARCH PSY CLIN N, V255, P167, DOI 10.1007/s00406-005-0584-8; Hamazaki K, 2012, J PSYCHIATR RES, V46, P1024, DOI 10.1016/j.jpsychires.2012.04.012; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Heckers S, 2002, ARCH GEN PSYCHIAT, V59, P521, DOI 10.1001/archpsyc.59.6.521; Hinkley LBN, 2011, BIOL PSYCHIAT, V70, P1134, DOI 10.1016/j.biopsych.2011.06.029; Honey GD, 2005, BRAIN, V128, P2597, DOI 10.1093/brain/awh632; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; Ilonen T, 1999, PSYCHIAT RES, V87, P183, DOI 10.1016/S0165-1781(99)00061-X; Jafri MJ, 2007, BIOMEDICAL IMAGING N, P468; Kawasaki Y, 2007, NEUROIMAGE, V34, P235, DOI 10.1016/j.neuroimage.2006.08.018; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kohler C, 1998, BIOL PSYCHIAT, V43, P165, DOI 10.1016/S0006-3223(97)00033-4; Koshino H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022909; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Landro NI, 2001, NEUROPSY NEUROPSY BE, V14, P233; LIDDLE PF, 1987, BRIT J PSYCHIAT, V151, P145, DOI 10.1192/bjp.151.2.145; LIDDLE PF, 1987, PSYCHOL MED, V17, P49, DOI 10.1017/S0033291700012976; Liu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040968; Maier W, 2002, SCHIZOPHR RES, V57, P259, DOI 10.1016/S0920-9964(01)00288-2; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; Meda SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007911; Menon V, 2001, NEUROIMAGE, V13, P433, DOI 10.1006/nimg.2000.0699; Merriam EP, 1999, AM J PSYCHIAT, V156, P780; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Morch N, 1997, LECT NOTES COMPUT SC, V1230, P259; Mulholland C, 2000, ADV PSYCHIAT TREAT, V6, P169, DOI [10.1192/apt.6.3.169, DOI 10.1192/APT.6.3.169]; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Pagani M, 2009, PSYCHIAT RES-NEUROIM, V173, P8, DOI 10.1016/j.pscychresns.2008.07.016; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; Picard H, 2008, SCHIZOPHRENIA BULL, V34, P155, DOI 10.1093/schbul/sbm049; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Robins L.N., 1991, PSYCHIAT DISORDERS A; Salvador R, 2010, HUM BRAIN MAPP, V31, P2003, DOI 10.1002/hbm.20993; Savitz J, 2009, NEUROSCI BIOBEHAV R, V33, P699, DOI 10.1016/j.neubiorev.2009.01.004; Schmahmann JD, 2006, BRAIN, V129, P290, DOI 10.1093/brain/awh729; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Shen H, 2010, NEUROIMAGE, V49, P3110, DOI 10.1016/j.neuroimage.2009.11.011; Siever LJ, 2008, AM J PSYCHIAT, V165, P429, DOI 10.1176/appi.ajp.2008.07111774; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Talamini LM, 2005, ARCH GEN PSYCHIAT, V62, P485, DOI 10.1001/archpsyc.62.5.485; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Os J, 1999, SOC PSYCH PSYCH EPID, V34, P459, DOI 10.1007/s001270050220; Vapnik V., 1995, NATURES STAT LEARNIN; Wang Y, 2010, PATTERN RECOGN, V43, P3580, DOI 10.1016/j.patcog.2010.05.021; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Woodward ND, 2011, SCHIZOPHR RES, V130, P86, DOI 10.1016/j.schres.2011.03.010; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Zhu CZ, 2008, NEUROIMAGE, V40, P110, DOI 10.1016/j.neuroimage.2007.11.029	74	31	31	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68250	10.1371/journal.pone.0068250	http://dx.doi.org/10.1371/journal.pone.0068250			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844175	gold, Green Published, Green Submitted			2022-12-27	WOS:000321341000147
J	Nakamura, S; Nagano, S; Nagao, H; Ishidou, Y; Yokouchi, M; Abematsu, M; Yamamoto, T; Komiya, S; Setoguchi, T				Nakamura, Shunsuke; Nagano, Satoshi; Nagao, Hiroko; Ishidou, Yasuhiro; Yokouchi, Masahiro; Abematsu, Masahiko; Yamamoto, Takuya; Komiya, Setsuro; Setoguchi, Takao			Arsenic Trioxide Prevents Osteosarcoma Growth by Inhibition of GLI Transcription via DNA Damage Accumulation	PLOS ONE			English	Article							HEDGEHOG SIGNALING PATHWAY; KAPPA-B ACTIVATION; CELL-DEATH; MUTATIONS; TARGET; CANCER; MEDULLOBLASTOMA; APOPTOSIS; PROMOTER; SURVIVAL	The Hedgehog pathway is activated in various types of malignancies. We previously reported that inhibition of SMO or GLI prevents osteosarcoma growth in vitro and in vivo. Recently, it has been reported that arsenic trioxide (ATO) inhibits cancer growth by blocking GLI transcription. In this study, we analyzed the function of ATO in the pathogenesis of osteosarcoma. Real-time PCR showed that ATO decreased the expression of Hedgehog target genes, including PTCH1, GLI1, and GLI2, in human osteosarcoma cell lines. WST-1 assay and colony formation assay revealed that ATO prevented osteosarcoma growth. These findings show that ATO prevents GLI transcription and osteosarcoma growth in vitro. Flow cytometric analysis showed that ATO promoted apoptotic cell death. Comet assay showed that ATO treatment increased accumulation of DNA damage. Western blot analysis showed that ATO treatment increased the expression of gamma H2AX, cleaved PARP, and cleaved caspase-3. In addition, ATO treatment decreased the expression of Bcl-2 and Bcl-xL. These findings suggest that ATO treatment promoted apoptotic cell death caused by accumulation of DNA damage. In contrast, Sonic Hedgehog treatment decreased the expression of gamma H2AX induced by cisplatin treatment. ATO re-induced the accumulation of DNA damage attenuated by Sonic Hedgehog treatment. These findings suggest that ATO inhibits the activation of Hedgehog signaling and promotes apoptotic cell death in osteosarcoma cells by accumulation of DNA damage. Finally, examination of mouse xenograft models showed that ATO administration prevented the growth of osteosarcoma in nude mice. Because ATO is an FDA-approved drug for treatment of leukemia, our findings suggest that ATO is a new therapeutic option for treatment of patients with osteosarcoma.	[Nakamura, Shunsuke; Nagano, Satoshi; Nagao, Hiroko; Yokouchi, Masahiro; Abematsu, Masahiko; Yamamoto, Takuya; Komiya, Setsuro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Orthopaed Surg, Kagoshima 890, Japan; [Ishidou, Yasuhiro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Med Joint Mat, Kagoshima 890, Japan; [Abematsu, Masahiko; Setoguchi, Takao] Kagoshima Univ, Grad Sch Med & Dent Sci, Near Future Locomotor Organ Med Creat Course Kusu, Kagoshima 890, Japan	Kagoshima University; Kagoshima University; Kagoshima University	Setoguchi, T (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Near Future Locomotor Organ Med Creat Course Kusu, Kagoshima 890, Japan.	setoro@m2.kufm.kagoshima-u.ac.jp		Nagano, Satoshi/0000-0003-2015-1730	Ministry of Health, Labour and Welfare of Japan;  [19591725];  [20591786];  [21591919];  [21591920];  [22591663];  [23592195];  [201201976]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); ; ; ; ; ; ; 	The authors wish to thank the Joint-research laboratory of Kagoshima University Graduate School of Medical and Dental Sciences. This work was supported by Grants-in-Aid for Scientific Research (KAKENHI) (C) 19591725, (C) 20591786, (C) 21591919, (C) 21591920, (C) 22591663, and (C) 23592195, a Grant-in-Aid from the Ministry of Health, Labour and Welfare of Japan for the Third Term Comprehensive Control Research for Cancer, and Scientific Research on Priority Areas 201201976 to H. Nagao from the Grants-in-Aid for JSPS Fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Beauchamp E, 2009, J BIOL CHEM, V284, P9074, DOI 10.1074/jbc.M806233200; Beauchamp EM, 2011, J CLIN INVEST, V121, P148, DOI 10.1172/JCI42874; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Bigelow RLH, 2004, J BIOL CHEM, V279, P1197, DOI 10.1074/jbc.M310589200; Bisht S, 2010, CURR OPIN INVEST DR, V11, P1387; Cavigelli M, 1996, EMBO J, V15, P6269, DOI 10.1002/j.1460-2075.1996.tb01017.x; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; DORFMAN HD, 1995, CANCER, V75, P203, DOI 10.1002/1097-0142(19950101)75:1+<203::AID-CNCR2820751308>3.0.CO;2-V; Giafis N, 2006, CANCER RES, V66, P6763, DOI 10.1158/0008-5472.CAN-05-3699; Hirotsu M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-5; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Iwamoto Y, 2009, J ORTHOP SCI, V14, P397, DOI 10.1007/s00776-009-1347-6; Jung HS, 2006, FEBS LETT, V580, P4969, DOI 10.1016/j.febslet.2006.07.077; Kager L, 2006, J CLIN ONCOL, V24, P1535, DOI 10.1200/JCO.2005.04.2978; Kapahi P, 2000, J BIOL CHEM, V275, P36062, DOI 10.1074/jbc.M007204200; KHATIB ZA, 1993, CANCER RES, V53, P5535; Kim J, 2013, CANCER CELL, V23, P23, DOI 10.1016/j.ccr.2012.11.017; Kim J, 2010, P NATL ACAD SCI USA, V107, P13432, DOI 10.1073/pnas.1006822107; Lee Y, 2007, ONCOGENE, V26, P6442, DOI 10.1038/sj.onc.1210467; Lengfelder E, 2012, LEUKEMIA, V26, P433, DOI 10.1038/leu.2011.245; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Mathieu J, 2006, INT J CANCER, V119, P1723, DOI 10.1002/ijc.21970; Mazumdar T, 2011, CANCER RES, V71, P5904, DOI 10.1158/0008-5472.CAN-10-4173; Nagao H, 2011, J PATHOL, V224, P169, DOI 10.1002/path.2880; Narita S, 2008, CLIN CANCER RES, V14, P5769, DOI 10.1158/1078-0432.CCR-07-4282; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Pan D, 2012, LEUKEMIA RES, V36, P742, DOI 10.1016/j.leukres.2012.02.012; Plesca D, 2007, CELL CYCLE, V6, P1147, DOI 10.4161/cc.6.10.4259; Regl G, 2004, CANCER RES, V64, P7724, DOI 10.1158/0008-5472.CAN-04-1085; Robarge KD, 2009, BIOORG MED CHEM LETT, V19, P5576, DOI 10.1016/j.bmcl.2009.08.049; ROBERTS WM, 1989, CANCER RES, V49, P5407; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Sheng T, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-29; Singh RR, 2011, ONCOGENE, V30, P4874, DOI 10.1038/onc.2011.195; SWEETNAM R, 1982, BRIT J HOSP MED, V28, P112; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Tostar U, 2006, J PATHOL, V208, P17, DOI 10.1002/path.1882; Tremblay MR, 2009, J MED CHEM, V52, P4400, DOI 10.1021/jm900305z; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Williams JA, 2003, P NATL ACAD SCI USA, V100, P4616, DOI 10.1073/pnas.0732813100; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Xu Y, 2012, CLIN CANCER RES, V18, P1291, DOI 10.1158/1078-0432.CCR-11-0950; Yang W, 2013, J ORTHOP RES, V31, P502, DOI 10.1002/jor.22230; Zwerner JP, 2008, ONCOGENE, V27, P3282, DOI 10.1038/sj.onc.1210991	48	57	58	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e69466	10.1371/journal.pone.0069466	http://dx.doi.org/10.1371/journal.pone.0069466			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861973	Green Published, gold, Green Submitted			2022-12-27	WOS:000321692000046
J	Arts, DL; Visscher, S; Opstelten, W; Korevaar, JC; Abu-Hanna, A; van Weert, HCPM				Arts, Derk L.; Visscher, Stefan; Opstelten, Wim; Korevaar, Joke C.; Abu-Hanna, Ameen; van Weert, Henk C. P. M.			Frequency and Risk Factors for Under- and Over-Treatment in Stroke Prevention for Patients with Non-Valvular Atrial Fibrillation in General Practice	PLOS ONE			English	Article							EURO HEART SURVEY; ANTITHROMBOTIC TREATMENT; MANAGEMENT; ANTICOAGULATION; GUIDELINES	Objective: To determine adequacy of antithrombotic treatment in patients with non-valvular atrial fibrillation. To determine risk factors for under- and over-treatment. Design: Retrospective, cross-sectional study of electronic health records from 36 general practitioners in 2008. Setting: General practice in the Netherlands. Subjects: Primary care physicians (n = 36) and patients (n = 981) aged 65 years and over. Main Outcome Measures: Rates of adequate, under and over-treatment, risk factors for under and over-treatment. Results: Of the 981 included patients with a mean of age 78, 18% received no antithrombotic treatment (under-treatment), 13% received antiplatelet drugs and 69% received oral anticoagulation (OAC). Further, 43% of the included patients were treated adequately, 26% were under-treated, and 31% were over-treated. Patients with a previous ischaemic stroke were at high risk for under-treatment (OR 2.4, CI 1.6-3.5), whereas those with contraindications for OAC were at high risk for over-treatment (OR 37.0, CI 18.1-79.9). Age over 75 (OR 0.2, CI: 0.1-0.3]), diabetes (OR 0.1, CI: 0.1-0.3), heart failure (OR 0.2, CI: 0.10.3), hypertension (OR 0.1, CI: 0.1-0.2) and previous ischaemic stroke (OR 0.04, CI: 0.02-0.11) protected against over-treatment. Conclusions: In general practice, CHADS2-criteria are being used, but the antithrombotic treatment of patients with atrial fibrillation frequently deviates from guidelines on this topic. Patients with previous stroke are at high risk of not being prescribed OAC. Contraindications for OAC, however, seem to be frequently overlooked.	[Arts, Derk L.; van Weert, Henk C. P. M.] Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, NL-1105 AZ Amsterdam, Netherlands; [Arts, Derk L.; Abu-Hanna, Ameen] Univ Amsterdam, Acad Med Ctr, Dept Med Informat, NL-1105 AZ Amsterdam, Netherlands; [Visscher, Stefan; Korevaar, Joke C.] Netherlands Inst Hlth Serv Res, Utrecht, Netherlands; [Opstelten, Wim] Dutch Coll Gen Practitioners, Utrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Institute for Health Services Research	Arts, DL (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	d.l.arts@amc.nl		Arts, Derk/0000-0001-5702-5856; Abu-Hanna, Ameen/0000-0003-4324-7954				Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; (CCMO) CCoRIHS, 2013, WMO DOES YOUR STUD H; de Lusignan S, 2005, J PUBLIC HEALTH-UK, V27, P85, DOI 10.1093/pubmed/fdh201; DeWilde S, 2006, HEART, V92, P1064, DOI 10.1136/hrt.2005.069492; Dinh T, 2007, INT J CLIN PRACT, V61, P24, DOI 10.1111/j.1742-1241.2006.01241.x; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Fuster V, 2006, J AM COLL CARDIOL, V48, P854, DOI 10.1016/j.jacc.2006.07.009; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Gorin L, 2011, CHEST, V140, P911, DOI 10.1378/chest.10-2436; Harrell Jr F. E., 2012, RMS REGRESSION MODEL; Hart RG, 2007, ANN INTERNAL MED; Heiberger RM, 2011, HH STAT AN DAT DISPL; Lin HJ, 1996, STROKE, V27, P1760, DOI 10.1161/01.STR.27.10.1760; Nieuwlaat R, 2005, EUR HEART J, V26, P2422, DOI 10.1093/eurheartj/ehi505; Nieuwlaat R, 2006, EUR HEART J, V27, P3018, DOI 10.1093/eurheartj/ehl015; Ogilvie IM, 2011, THROMB HAEMOSTASIS, V106, P34, DOI 10.1160/TH10-10-0674; Ogilvie IM, 2011, AM J CARDIOL, V108, P151, DOI 10.1016/j.amjcard.2011.02.353; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Team R. D. C, 2011, R LANG ENV STAT COMP; Verheij R.A., 2009, LANDELIJK INFORMATIE; Wess ML, 2008, J GEN INTERN MED, V23, P411, DOI 10.1007/s11606-007-0477-9; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	22	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67806	10.1371/journal.pone.0067806	http://dx.doi.org/10.1371/journal.pone.0067806			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861809	Green Published, gold, Green Submitted			2022-12-27	WOS:000321425300031
J	Lysenko, A; Urban, M; Bennett, L; Tsoka, S; Janowska-Sejda, E; Rawlings, CJ; Hammond-Kosack, KE; Saqi, M				Lysenko, Artem; Urban, Martin; Bennett, Laura; Tsoka, Sophia; Janowska-Sejda, Elzbieta; Rawlings, Chris J.; Hammond-Kosack, Kim E.; Saqi, Mansoor			Network-Based Data Integration for Selecting Candidate Virulence Associated Proteins in the Cereal Infecting Fungus Fusarium graminearum	PLOS ONE			English	Article							PHI-BASE; REVEALS; ANNOTATION; FGDB	The identification of virulence genes in plant pathogenic fungi is important for understanding the infection process, host range and for developing control strategies. The analysis of already verified virulence genes in phytopathogenic fungi in the context of integrated functional networks can give clues about the underlying mechanisms and pathways directly or indirectly linked to fungal pathogenicity and can suggest new candidates for further experimental investigation, using a 'guilt by association' approach. Here we study 133 genes in the globally important Ascomycete fungus Fusarium graminearum that have been experimentally tested for their involvement in virulence. An integrated network that combines information from gene co-expression, predicted protein-protein interactions and sequence similarity was employed and, using 100 genes known to be required for virulence, we found a total of 215 new proteins potentially associated with virulence of which 29 are annotated as hypothetical proteins. The majority of these potential virulence genes are located in chromosomal regions known to have a low recombination frequency. We have also explored the taxonomic diversity of these candidates and found 25 sequences, which are likely to be fungal specific. We discuss the biological relevance of a few of the potentially novel virulence associated genes in detail. The analysis of already verified virulence genes in phytopathogenic fungi in the context of integrated functional networks can give clues about the underlying mechanisms and pathways directly or indirectly linked to fungal pathogenicity and can suggest new candidates for further experimental investigation, using a 'guilt by association' approach.	[Lysenko, Artem; Janowska-Sejda, Elzbieta; Rawlings, Chris J.; Saqi, Mansoor] Rothamsted Res, Dept Computat & Syst Biol, Harpenden, Herts, England; [Bennett, Laura; Tsoka, Sophia] Kings Coll London, Dept Informat, Sch Nat & Math Sci, London, England; [Urban, Martin; Janowska-Sejda, Elzbieta; Hammond-Kosack, Kim E.] Rothamsted Res, Dept Plant Biol & Crop Sci, Harpenden, Herts, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of London; King's College London; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Hammond-Kosack, KE (corresponding author), Rothamsted Res, Dept Plant Biol & Crop Sci, Harpenden, Herts, England.	kim.hammond-kosack@rothamsted.ac.uk	; Urban, Martin/G-6004-2010	Tsoka, Sophia/0000-0001-8403-1282; Rawlings, Christopher/0000-0003-3702-1633; Urban, Martin/0000-0003-2440-4352; Saqi, Mansoor/0000-0003-1222-475X; Lysenko, Artem/0000-0002-1441-0604; Hammond-Kosack, kim/0000-0002-9699-485X	BBSRC through the Institute Strategic Programme 20:20 Wheat(R) [BB/J/00426X/1]; BBSRC [BB/I000488/1, BB/G015716/1]; Leverhulme Trust [RPG-2012-686]; BBSRC National Capability [BB/J/004383/1]; BBSRC [BBS/E/C/00005192, BB/G014159/2, BB/G014159/1, BBS/E/C/00005203, BB/G013969/1, BBS/E/C/00004941, BB/F006012/1, BB/F006039/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G014159/2, BB/G015716/1, BB/G013969/1, BBS/E/C/00004941, BB/F006012/1, BBS/E/C/00005192, BB/G014159/1, BB/I000488/1, BB/F006039/1, BBS/E/C/00005203] Funding Source: researchfish	BBSRC through the Institute Strategic Programme 20:20 Wheat(R)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leverhulme Trust(Leverhulme Trust); BBSRC National Capability(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	MS, MU and KHK are supported by the BBSRC (http://www.bbsrc.ac.uk) through the Institute Strategic Programme 20:20 Wheat (R) (grant BB/J/00426X/1). In addition the PHI-base project receives support from the BBSRC grant BB/I000488/1 and AL was supported by BBSRC grant BB/G015716/1. ST acknowledges support from the Leverhulme Trust (http://www.leverhulme.ac.uk, grant RPG-2012-686). The PHI-base project also receives support as a BBSRC National Capability (BB/J/004383/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniw J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-447; Baldwin TK, 2006, MOL PLANT MICROBE IN, V19, P1451, DOI 10.1094/MPMI-19-1451; Beacham A, 2011, THESIS EXETER U EXET; Bennett Laura, 2012, Computational Methods in Systems Biology. Proceedings of the 10th International Conference, CMSB 2012, P69, DOI 10.1007/978-3-642-33636-2_6; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Brown NA, 2011, J PATHOG, V2011, DOI 10.4061/2011/626345; Brown NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033731; Chen JC, 2006, BIOINFORMATICS, V22, P2283, DOI 10.1093/bioinformatics/btl370; Coleman JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000618; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; DESJARDINS AE, 2006, FUSARIUM MYCOTOXINS; Dyer RB, 2005, J AGR FOOD CHEM, V53, P9281, DOI 10.1021/jf051441a; Gale LR, 2005, GENETICS, V171, P985, DOI 10.1534/genetics.105.044842; Gardiner DM, 2009, FUNGAL GENET BIOL, V46, P604, DOI 10.1016/j.fgb.2009.04.004; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; Guldener U, 2006, NUCLEIC ACIDS RES, V34, pD456, DOI 10.1093/nar/gkj026; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; Kohler J, 2006, BIOINFORMATICS, V22, P1383, DOI 10.1093/bioinformatics/btl081; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Liu GM, 2009, BIOINFORMATICS, V25, P1891, DOI 10.1093/bioinformatics/btp311; Liu XP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013021; Lysenko A, 2009, BRIEF BIOINFORM, V10, P676, DOI 10.1093/bib/bbp047; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; McCormick SP, 2010, APPL ENVIRON MICROB, V76, P136, DOI 10.1128/AEM.02017-09; McCormick SP, 2004, APPL ENVIRON MICROB, V70, P2044, DOI 10.1128/AEM.70.4.2044-2051.2004; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Nunes CC, 2012, MOL PLANT PATHOL, V13, P519, DOI 10.1111/j.1364-3703.2011.00766.x; Obayashi T, 2007, NUCLEIC ACIDS RES, V35, pD863, DOI 10.1093/nar/gkl783; Rep M, 2010, CURR OPIN PLANT BIOL, V13, P420, DOI 10.1016/j.pbi.2010.04.004; Rispail N, 2009, FUNGAL GENET BIOL, V46, P287, DOI 10.1016/j.fgb.2009.01.002; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Saitoh H, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002711; Schneider D, 2010, IEEE SPECTRUM, V47, P48, DOI 10.1109/MSPEC.2010.5372501; Seong KY, 2009, MOL MICROBIOL, V72, P354, DOI 10.1111/j.1365-2958.2009.06649.x; SIEGEL S., 1956, NONPARAMETRIC STAT B; Son H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002310; Urban M, 2013, FUSARIUM: GENOMICS, MOLECULAR AND CELLULAR BIOLOGY, P43; Wang CF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002460; Winnenburg R, 2008, NUCLEIC ACIDS RES, V36, pD572, DOI 10.1093/nar/gkm858; Winnenburg R, 2006, NUCLEIC ACIDS RES, V34, pD459, DOI 10.1093/nar/gkj047; Wise Roger P., 2007, V406, P347; Wolfe CJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-227; Wong P, 2011, NUCLEIC ACIDS RES, V39, pD637, DOI 10.1093/nar/gkq1016; Yu HY, 2008, MICROBIOL-SGM, V154, P392, DOI 10.1099/mic.0.2007/012260-0; Yuen GY, 2007, INT J FOOD MICROBIOL, V119, P126, DOI 10.1016/j.ijfoodmicro.2007.07.033; Zhao XM, 2009, J PROTEOME RES, V8, P4714, DOI 10.1021/pr900415b	47	10	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67926	10.1371/journal.pone.0067926	http://dx.doi.org/10.1371/journal.pone.0067926			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861834	Green Published, gold, Green Submitted			2022-12-27	WOS:000323350700062
J	Ksenofontov, AL; Paalme, V; Arutyunyan, AM; Semenyuk, PI; Fedorova, NV; Rumvolt, R; Baratova, LA; Jarvekulg, L; Dobrov, EN				Ksenofontov, Alexander L.; Paalme, Viiu; Arutyunyan, Alexander M.; Semenyuk, Pavel I.; Fedorova, Natalia V.; Rumvolt, Reet; Baratova, Ludmila A.; Jaervekuelg, Lilian; Dobrov, Eugeny N.			Partially Disordered Structure in Intravirus Coat Protein of Potyvirus Potato Virus A	PLOS ONE			English	Article							TOBACCO-MOSAIC-VIRUS; CIRCULAR-DICHROISM	Potyviruses represent the most biologically successful group of plant viruses, but to our knowledge, this work is the first detailed study of physicochemical characteristics of potyvirus virions. We measured the UV absorption, far and near UV circular dichroism spectra, intrinsic fluorescence spectra, and differential scanning calorimetry (DSC) melting curves of intact particles of a potato virus A (PVA). PVA virions proved to have a peculiar combination of physicochemical properties. The intravirus coat protein (CP) subunits were shown to contain an unusually high fraction of disordered structures, whereas PVA virions had an almost normal thermal stability. Upon heating from 20 degrees C to 55 degrees C, the fraction of disordered structures in the intravirus CP further increased, while PVA virions remained intact at up to 55 degrees C, after which their disruption (and DSC melting) started. We suggest that the structure of PVA virions below 55 degrees C is stabilized by interactions between the remaining structured segments of intravirus CP. It is not improbable that the biological efficiency of PVA relies on the disordered structure of intravirus CP.	[Ksenofontov, Alexander L.; Arutyunyan, Alexander M.; Semenyuk, Pavel I.; Fedorova, Natalia V.; Baratova, Ludmila A.; Dobrov, Eugeny N.] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia; [Paalme, Viiu; Rumvolt, Reet; Jaervekuelg, Lilian] Tallinn Univ Technol, Inst Gene Technol, EE-19086 Tallinn, Estonia; [Paalme, Viiu; Rumvolt, Reet; Jaervekuelg, Lilian] Competence Ctr Canc Res, Tallinn, Estonia	Lomonosov Moscow State University; Tallinn University of Technology; Competence Centre for Cancer Research	Jarvekulg, L (corresponding author), Tallinn Univ Technol, Inst Gene Technol, EE-19086 Tallinn, Estonia.	lilian.jarvekulg@ttu.ee; dobrov@belozersky.msu.ru	Arutyunyan, Alexander/G-8654-2012; Ksenofontov, Alexander/AAH-1774-2021; Semenyuk, Pavel I/E-2974-2012; Ksenofontov, Alexander L/D-6747-2012	Ksenofontov, Alexander/0000-0003-1585-7907; Semenyuk, Pavel I/0000-0001-7759-6445; Ksenofontov, Alexander L/0000-0003-1585-7907	Competence Center for Cancer Research [1.7]; Russian Foundation for Basic Research Program [12-04-01472-a, 13-04-00290-a];  [AR11121]	Competence Center for Cancer Research; Russian Foundation for Basic Research Program; 	This work has been supported by Grant no. 1.7 from the Competence Center for Cancer Research and Project AR11121 (Estonia) and by the Russian Foundation for Basic Research Program (project no's. 12-04-01472-a and 13-04-00290-a http://www.rfbr.ru). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Baratova LA, 2001, J VIROL, V75, P9696, DOI 10.1128/JVI.75.20.9696-9702.2001; Clare DK, 2010, J STRUCT BIOL, V171, P303, DOI 10.1016/j.jsb.2010.06.011; DOBROV EN, 1977, BIOCHIM BIOPHYS ACTA, V475, P623, DOI 10.1016/0005-2787(77)90323-9; Dobrov EN, 2014, J BIOMOL STRUCT DYN, V32, P701, DOI 10.1080/07391102.2013.788983; Gabrenaite-Verkhovskaya R, 2008, J GEN VIROL, V89, P829, DOI 10.1099/vir.0.83406-0; Gibbs A, 2010, ANNU REV PHYTOPATHOL, V48, P205, DOI 10.1146/annurev-phyto-073009-114404; GOODMAN RM, 1975, VIROLOGY, V68, P287, DOI 10.1016/0042-6822(75)90272-X; Habchi J, 2012, MOL BIOSYST, V8, P69, DOI 10.1039/c1mb05204g; HOMER RB, 1975, BIOCHIM BIOPHYS ACTA, V378, P296, DOI 10.1016/0005-2787(75)90117-3; JOHNSON KH, 1992, J BIOMOL STRUCT DYN, V9, P733, DOI 10.1080/07391102.1992.10507952; Kendall A, 2008, J VIROL, V82, P9546, DOI 10.1128/JVI.00895-08; Kendall A, 2013, VIROLOGY, V436, P173, DOI 10.1016/j.virol.2012.11.008; Ksenofontov AL, 2006, MOL BIOL+, V40, P172; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Longhi S, 2012, ADV EXP MED BIOL, V725, P126, DOI 10.1007/978-1-4614-0659-4_8; Makarov VV, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060942, DOI 10.1371/J0URNAL.P0NE.0060942]; NAMBA K, 1989, J MOL BIOL, V208, P307, DOI 10.1016/0022-2836(89)90391-4; Nemykh MA, 2008, VIROLOGY, V373, P61, DOI 10.1016/j.virol.2007.11.024; Orlov VN, 1998, FEBS LETT, V433, P307, DOI 10.1016/S0014-5793(98)00924-7; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Shukla S, 2013, MOL PHARMACEUT, V10, P33, DOI 10.1021/mp300240m; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; TIKCHONENKO TI, 1966, J MOL BIOL, V18, P58, DOI 10.1016/S0022-2836(66)80076-1; Tollin P, 1988, PLANT VIRUSES, V4, P51; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Torrance L, 2006, J MOL BIOL, V357, P1, DOI 10.1016/j.jmb.2005.12.021; Uversky VN, 2013, BBA-PROTEINS PROTEOM, V1834, P932, DOI 10.1016/j.bbapap.2012.12.008; Wei TY, 2010, J VIROL, V84, P799, DOI 10.1128/JVI.01824-09; Woody RW, 2009, J AM CHEM SOC, V131, P8234, DOI 10.1021/ja901218m	29	17	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67830	10.1371/journal.pone.0067830	http://dx.doi.org/10.1371/journal.pone.0067830			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844104	Green Submitted, gold, Green Published			2022-12-27	WOS:000321733000105
J	Manriquez, PH; Jara, ME; Mardones, ML; Navarro, JM; Torres, R; Lardies, MA; Vargas, CA; Duarte, C; Widdicombe, S; Salisbury, J; Lagos, NA				Manriquez, Patricio H.; Elisa Jara, Maria; Loreto Mardones, Maria; Navarro, Jorge M.; Torres, Rodrigo; Lardies, Marcos A.; Vargas, Cristian A.; Duarte, Cristian; Widdicombe, Stephen; Salisbury, Joseph; Lagos, Nelson A.			Ocean Acidification Disrupts Prey Responses to Predator Cues but Not Net Prey Shell Growth in Concholepas concholepas (loco)	PLOS ONE			English	Article							CALCIFICATION RATE; CARBONIC-ACID; BEHAVIOR; CO2; FISH; TEMPERATURE; SEAWATER; DISSOCIATION; POPULATIONS; GASTROPODA	Background: Most research on Ocean Acidification (OA) has largely focused on the process of calcification and the physiological trade-offs employed by calcifying organisms to support the building of calcium carbonate structures. However, there is growing evidence that OA can also impact upon other key biological processes such as survival, growth and behaviour. On wave-swept rocky shores the ability of gastropods to self-right after dislodgement, and rapidly return to normal orientation, reduces the risk of predation. Methodology/Principal Findings: The impacts of OA on this self-righting behaviour and other important parameters such as growth, survival, shell dissolution and shell deposition in Concholepas concholepas (loco) were investigated under contrasting pCO(2) levels. Although no impacts of OA on either growth or net shell calcification were found, the results did show that OA can significantly affect self-righting behaviour during the early ontogeny of this species with significantly faster righting times recorded for individuals of C. concholepas reared under increased average pCO(2) concentrations (+/- SE) (716 +/- 12 and 1036 +/- 14 mu atm CO2) compared to those reared at concentrations equivalent to those presently found in the surface ocean (388 +/- 8 mu atm CO2). When loco were also exposed to the predatory crab Acanthocyclus hassleri, righting times were again increased by exposure to elevated CO2, although self-righting times were generally twice as fast as those observed in the absence of the crab. Conclusions and Significance: These results suggest that self-righting in the early ontogeny of C. concholepas will be positively affected by pCO(2) levels expected by the end of the 21st century and beginning of the next one. However, as the rate of self-righting is an adaptive trait evolved to reduce lethal predatory attacks, our result also suggest that OA may disrupt prey responses to predators in nature.	[Manriquez, Patricio H.; Elisa Jara, Maria; Loreto Mardones, Maria; Navarro, Jorge M.] Univ Austral Chile, Inst Ciencias Marinas & Limnol, LECOT, Fac Ciencias, Valdivia, Chile; [Manriquez, Patricio H.; Elisa Jara, Maria; Loreto Mardones, Maria; Navarro, Jorge M.] Univ Austral Chile, Lab Costero Recursos Acuat Calfuco, Fac Ciencias, Valdivia, Chile; [Torres, Rodrigo] CIEP, Coyhaique, Chile; [Lardies, Marcos A.] Univ Adolfo Ibanez, Fac Artes Liberales, Santiago, Chile; [Vargas, Cristian A.] Univ Concepcion, Lab Funcionamiento Ecosistemas Acuat LAFE, Unidad Sistemas Acuat, Ctr Ciencias Ambientales EULA, Concepcion, Chile; [Duarte, Cristian] Univ Andres Bello, Fac Ecol & Recursos Nat, Dept Ecol & Biodiversidad, Santiago, Chile; [Widdicombe, Stephen] Plymouth Marine Lab, Plymouth, Devon, England; [Salisbury, Joseph] Univ New Hampshire, Ocean Proc Anal Lab, Durham, NH 03824 USA; [Lagos, Nelson A.] Univ Santo Tomas, Fac Ciencias, Santiago, Chile	Universidad Austral de Chile; Universidad Austral de Chile; Universidad Adolfo Ibanez; Universidad de Concepcion; Universidad Andres Bello; Plymouth Marine Laboratory; University System Of New Hampshire; University of New Hampshire; Universidad Santo Tomas	Manriquez, PH (corresponding author), Univ Austral Chile, Inst Ciencias Marinas & Limnol, LECOT, Fac Ciencias, Valdivia, Chile.	patriciohmanriquez@gmail.com	Lardies, Marco A/R-6203-2017; Duarte, Cristian/I-4013-2016; Navarro, Jorge/B-7928-2008	Lardies, Marco A/0000-0003-3525-1830; Navarro, Jorge/0000-0001-9920-190X; Manriquez, Patricio/0000-0001-6586-764X; Duarte, Cristian/0000-0002-7033-3551; Vargas, Cristian A./0000-0002-1486-3611; Mardones, Maria Loreto/0000-0001-5216-4240	Programa de Investigacion Asociativa, PIA-CONICYT-CHILE [ACT-132]; Project Fondecyt Grant [1090624]; project Fondecyt [1080023]; NERC UK Ocean Acidification Programme; NERC [pml010004] Funding Source: UKRI; Natural Environment Research Council [pml010004] Funding Source: researchfish	Programa de Investigacion Asociativa, PIA-CONICYT-CHILE; Project Fondecyt Grant(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); project Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); NERC UK Ocean Acidification Programme; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was mainly funded by the Programa de Investigacion Asociativa, PIA-CONICYT-CHILE (Grant Anillos ACT-132, to P.H.M., N.A.L., C.A.V., M.A.L., R.T. & J.M.N.) and the Project Fondecyt Grant 1090624 (to N.L., C.V., M.A.L., R.T. and P.H.M.). Additional financial support came from project Fondecyt 1080023 to P.H.M., N.A.L and Dr. Juan Carlos Castilla. SW acknowledges financial support from the NERC UK Ocean Acidification Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz G, 2012, J EXP MAR BIOL ECOL, V412, P20, DOI 10.1016/j.jembe.2011.10.014; Amaral V, 2012, MAR ECOL PROG SER, V445, P117, DOI 10.3354/meps09487; [Anonymous], 2009, BIOGEOSCI DISCUSS, DOI DOI 10.5194/BGD-6-3109-2009; Bibby R, 2007, BIOLOGY LETT, V3, P699, DOI 10.1098/rsbl.2007.0457; Briffa M, 2012, MAR POLLUT BULL, V64, P1519, DOI 10.1016/j.marpolbul.2012.05.032; Bryan PJ, 1997, J CHEM ECOL, V23, P645, DOI 10.1023/B:JOEC.0000006401.97339.b9; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Caparroy P, 1998, MAR ECOL PROG SER, V168, P109, DOI 10.3354/meps168109; Castaneda LE, 2004, EVOL ECOL RES, V6, P579; Castilla J.C., 1979, Biodiversity: a challenge for development research and policy, V12, P115; Castilla JC, 1999, TRENDS ECOL EVOL, V14, P280, DOI 10.1016/S0169-5347(99)01602-X; Checkley DM, 2009, SCIENCE, V324, P1683, DOI 10.1126/science.1169806; Cripps IL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022736; Dalesman S, 2011, J EXP BIOL, V214, P2528, DOI 10.1242/jeb.058024; de la Haye KL, 2012, J EXP MAR BIOL ECOL, V412, P134, DOI 10.1016/j.jembe.2011.11.013; Devine BM, 2012, CORAL REEFS, V31, P229, DOI 10.1007/s00338-011-0837-0; Dickson A. G., 1994, ORNLCDIAC74 DOE; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Dixson DL, 2010, ECOL LETT, V13, P68, DOI 10.1111/j.1461-0248.2009.01400.x; Domenici P, 2012, BIOL LETTERS, V8, P78, DOI 10.1098/rsbl.2011.0591; DUBOIS R, 1980, VELIGER, V23, P83; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Ferrari MCO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031478; Ferrari MCO, 2011, ECOL LETT, V14, P1143, DOI 10.1111/j.1461-0248.2011.01683.x; Franc A, 1968, TRAITE ZOOLOGIE ANAT, VV, P178; Gazeau F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028554; Gooding RA, 2009, P NATL ACAD SCI USA, V106, P9316, DOI 10.1073/pnas.0811143106; Haraldsson C, 1997, DEEP-SEA RES PT I, V44, P2031, DOI 10.1016/S0967-0637(97)00088-5; Huaquin LG, 2000, J MED APPL MALACOLOG, V10, P145; Jacobsen HP, 2004, OIKOS, V104, P43, DOI 10.1111/j.0030-1299.2004.12369.x; Karnik V, 2012, J EXP BIOL, V215, P536, DOI 10.1242/jeb.061432; Kleitman N, 1941, BIOL BULL-US, V80, P292, DOI 10.2307/1537716; Leclercq N, 2000, GLOB CHANGE BIOL, V6, P329, DOI 10.1046/j.1365-2486.2000.00315.x; Leiva GE, 2002, REV FISH BIOL FISHER, V11, P283; Lewis E., 1998, PROGRAM DEV CO2 SYST, P21; Manriquez PH, 2008, AQUACULTURE, V279, P99, DOI 10.1016/j.aquaculture.2008.03.031; Manriquez PH, 2013, MAR ECOL PROG SER, V472, P169, DOI 10.3354/meps10055; Manriquez PH, 2009, P NATL ACAD SCI USA, V106, P16298, DOI 10.1073/pnas.0908655106; Manzello DP, 2010, LIMNOL OCEANOGR, V55, P239, DOI 10.4319/lo.2010.55.1.0239; Martin S, 2009, GLOBAL CHANGE BIOL, V15, P2089, DOI 10.1111/j.1365-2486.2009.01874.x; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Melzner F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024223; MINITAB Inc, 2003, NATURE CLIM CHANGE, V14; Morley SA, 2012, MAR ECOL PROG SER, V450, P81, DOI 10.3354/meps09577; Munday PL, 2010, P NATL ACAD SCI USA, V107, P12930, DOI 10.1073/pnas.1004519107; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; NAVARRETE SA, 1988, J EXP MAR BIOL ECOL, V118, P115, DOI 10.1016/0022-0981(88)90235-3; NAVARRO JM, 1994, COMP BIOCHEM PHYS A, V108, P39, DOI 10.1016/0300-9629(94)90051-5; Navarro JM, 2013, CHEMOSPHERE, V90, P1242, DOI 10.1016/j.chemosphere.2012.09.063; Navarro JM, 2010, MAR BIOL, V157, P1967, DOI 10.1007/s00227-010-1465-x; Nienhuis S, 2010, P ROY SOC B-BIOL SCI, V277, P2553, DOI 10.1098/rspb.2010.0206; Nilsson GE, 2012, NAT CLIM CHANGE, V2, P201, DOI [10.1038/nclimate1352, 10.1038/NCLIMATE1352]; Orr MV, 2007, J EXP BIOL, V210, P4150, DOI 10.1242/jeb.010173; PALMER AR, 1981, NATURE, V292, P150, DOI 10.1038/292150a0; Peck LS, 2008, MAR ECOL PROG SER, V358, P181, DOI 10.3354/meps07336; Ramajo L, 2012, J MAR BIOL IN PRESS; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Rodolfo-Metalpa R, 2011, NATURE CLIM CHANGE, V1, P308; Salisbury J., 2008, EOS T AM GEOPHYS UN, V89, P513, DOI [10.1029/2008EO500001, DOI 10.1029/2008EO500001]; Seuront L, 2011, PHYSICA A, V390, P250, DOI 10.1016/j.physa.2010.09.025; Storch D, 2009, J EXP BIOL, V212, P1371, DOI 10.1242/jeb.030205; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Vermeij G.J., 1993, NATURAL HIST SHELLS; Widdicombe S, 2008, J EXP MAR BIOL ECOL, V366, P187, DOI 10.1016/j.jembe.2008.07.024; Wilson RW, 2009, SCIENCE, V323, P359, DOI 10.1126/science.1157972; Wood HL, 2008, P ROY SOC B-BIOL SCI, V275, P1767, DOI 10.1098/rspb.2008.0343	67	55	55	0	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68643	10.1371/journal.pone.0068643	http://dx.doi.org/10.1371/journal.pone.0068643			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844231	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000321733000021
J	Smits, JGC; van Beek, JKL				Smits, Johannes G. C.; van Beek, Jan K. L.			ECO: A Generic Eutrophication Model Including Comprehensive Sediment-Water Interaction	PLOS ONE			English	Article							ORGANIC-MATTER MINERALIZATION; EARLY DIAGENETIC PROCESSES; NORTH-SEA; ECOSYSTEM MODEL; DISTURBED SEDIMENTS; NUTRIENT DYNAMICS; KINETIC-MODELS; LAKE VELUWE; PHOSPHORUS; COASTAL	The content and calibration of the comprehensive generic 3D eutrophication model ECO for water and sediment quality is presented. Based on a computational grid for water and sediment, ECO is used as a tool for water quality management to simulate concentrations and mass fluxes of nutrients (N, P, Si), phytoplankton species, detrital organic matter, electron acceptors and related substances. ECO combines integral simulation of water and sediment quality with sediment diagenesis and closed mass balances. Its advanced process formulations for substances in the water column and the bed sediment were developed to allow for a much more dynamic calculation of the sediment-water exchange fluxes of nutrients as resulting from steep concentration gradients across the sediment-water interface than is possible with other eutrophication models. ECO is to more accurately calculate the accumulation of organic matter and nutrients in the sediment, and to allow for more accurate prediction of phytoplankton biomass and water quality in response to mitigative measures such as nutrient load reduction. ECO was calibrated for shallow Lake Veluwe (The Netherlands). Due to restoration measures this lake underwent a transition from hypertrophic conditions to moderately eutrophic conditions, leading to the extensive colonization by submerged macrophytes. ECO reproduces observed water quality well for the transition period of ten years. The values of its process coefficients are in line with ranges derived from literature. ECO's calculation results underline the importance of redox processes and phosphate speciation for the nutrient return fluxes. Among other things, the results suggest that authigenic formation of a stable apatite-like mineral in the sediment can contribute significantly to oligotrophication of a lake after a phosphorus load reduction.	[Smits, Johannes G. C.; van Beek, Jan K. L.] Deltares, Marine & Coastal Syst, Delft, Netherlands	Deltares	Smits, JGC (corresponding author), Deltares, Marine & Coastal Syst, Delft, Netherlands.	johannes.smits@deltares.nl		van Beek, Jan/0000-0002-4019-7202	Strategic Research program of Deltares	Strategic Research program of Deltares	This study was funded by the Strategic Research program of Deltares (wwww.deltares.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the Strategic Research program of Deltares, the employer of all authors. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Aguilera DR, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000899; Anschutz P, 2007, ESTUAR COAST SHELF S, V72, P447, DOI 10.1016/j.ecss.2006.11.012; Arndt S, 2011, J MARINE SYST, V84, P49, DOI 10.1016/j.jmarsys.2010.08.005; BANKS RB, 1977, J ENV ENG DIV-ASCE, V103, P489; Berner R.A., 1980, EARLY DIAGENESIS THE; Blauw AN, 2009, HYDROBIOLOGIA, V618, P175, DOI 10.1007/s10750-008-9575-x; BOERS P, 1991, WATER RES, V25, P591, DOI 10.1016/0043-1354(91)90131-9; Boers PCM, 1998, WATER SCI TECHNOL, V37, P31, DOI 10.2166/wst.1998.0169; Boudreau B. P., 1997, MODELLING TRANSPORT, V171, DOI 10.1016/s0264-8172(98)80005-6; Boudreau BP, 1996, COMPUT GEOSCI, V22, P479, DOI 10.1016/0098-3004(95)00115-8; Brigolin D, 2011, J MARINE SYST, V87, P239, DOI 10.1016/j.jmarsys.2011.04.006; Brinkman AG, 1986, THESIS TU TWENTE ENS; BURDIGE DJ, 1991, J MAR RES, V49, P727, DOI 10.1357/002224091784995710; Burger DF, 2008, ECOL MODEL, V211, P411, DOI 10.1016/j.ecolmodel.2007.09.028; Canavan RW, 2006, GEOCHIM COSMOCHIM AC, V70, P2836, DOI 10.1016/j.gca.2006.03.012; Dale AW, 2008, J MAR RES, V66, P127, DOI 10.1357/002224008784815775; Dauwe B, 2001, MAR ECOL PROG SER, V215, P13, DOI 10.3354/meps215013; DEJONGE VN, 1993, HYDROBIOLOGIA, V253, P151, DOI 10.1007/BF00050735; Deltares, 2013, D WAT QUAL WAT QUAL; DiToro D, 2001, SEDIMENT FLUX MODELI; Dittrich M, 2009, ECOL MODEL, V220, P2751, DOI 10.1016/j.ecolmodel.2009.07.015; Guss S, 1998, ESTUAR COAST SHELF S, V46, P143, DOI 10.1006/ecss.1997.0265; Hochard S, 2010, ECOL MODEL, V221, P1687, DOI 10.1016/j.ecolmodel.2010.04.002; Hosper H., 1986, HYDROBIOL B, P183, DOI DOI 10.1007/BF02291162; JAGTMAN E, 1992, HYDROBIOLOGIA, V233, P187, DOI 10.1007/BF00016107; Janse JH, 2010, ECOL MODEL, V221, P654, DOI 10.1016/j.ecolmodel.2009.07.023; Janse J.H, 2005, MODEL STUDIES EUTROP; Jeppesen E, 2005, FRESHWATER BIOL, V50, P1747, DOI 10.1111/j.1365-2427.2005.01415.x; Lancelot C, 2005, MAR ECOL PROG SER, V289, P63, DOI 10.3354/meps289063; Lewis GN, 2007, ECOL MODEL, V209, P121, DOI 10.1016/j.ecolmodel.2007.06.015; Los FJ, 2007, J MARINE SYST, V64, P201, DOI 10.1016/j.jmarsys.2006.03.009; Los FJ, 2009, THESIS WAGENINGEN U; Luff R, 2000, DEEP-SEA RES PT II, V47, P3039, DOI 10.1016/S0967-0645(00)00058-8; Luff R, 2004, CONT SHELF RES, V24, P1099, DOI 10.1016/j.csr.2004.03.010; Mort HP, 2010, GEOCHIM COSMOCHIM AC, V74, P1350, DOI 10.1016/j.gca.2009.11.016; Mortimer CH, 1941, J ECOL, V29, P280, DOI 10.2307/2256395; Neumann T, 2008, J MARINE SYST, V74, P592, DOI 10.1016/j.jmarsys.2008.05.003; Patsch J, 2008, CONT SHELF RES, V28, P767, DOI 10.1016/j.csr.2007.12.013; Raick C, 2005, J MARINE SYST, V55, P177, DOI 10.1016/j.jmarsys.2004.09.005; Reed DC, 2011, LIMNOL OCEANOGR, V56, P1075, DOI 10.4319/lo.2011.56.3.1075; RUARDIJ P, 1995, NETH J SEA RES, V33, P453, DOI 10.1016/0077-7579(95)90057-8; SANTSCHI P, 1990, MAR CHEM, V30, P269, DOI 10.1016/0304-4203(90)90076-O; SCHINK DR, 1977, MAR GEOL, V23, P133, DOI 10.1016/0025-3227(77)90086-X; Slomp CP, 2007, BIOGEOSCIENCES, V4, P155, DOI 10.5194/bg-4-155-2007; Slomp CP, 1996, J MAR RES, V54, P1179, DOI 10.1357/0022240963213745; Slomp CP, 1998, LIMNOL OCEANOGR, V43, P832, DOI 10.4319/lo.1998.43.5.0832; SMITS JGC, 1993, HYDROBIOLOGIA, V253, P281, DOI 10.1007/BF00050749; Soetaert K, 1996, GEOCHIM COSMOCHIM AC, V60, P1019, DOI 10.1016/0016-7037(96)00013-0; Soetaert K, 1996, J MAR RES, V54, P1207, DOI 10.1357/0022240963213808; Soetaert K, 2000, EARTH-SCI REV, V51, P173, DOI 10.1016/S0012-8252(00)00004-0; Soetaert K, 2009, HYDROBIOLOGIA, V629, P239, DOI 10.1007/s10750-009-9777-x; Stumm W, 1996, AQUATIC CHEM; Trolle D, 2008, ECOL MODEL, V219, P138, DOI 10.1016/j.ecolmodel.2008.08.005; Van Der Molen DT, 1998, WATER RES, V32, P3281, DOI 10.1016/S0043-1354(98)00117-1; Van Eck GTM, 1986, SEDIMENTS WATER INTE, P289; Van Koningsveld M, 2010, BEIJ CHIN P WODCON 1; VANDERBORGHT JP, 1977, LIMNOL OCEANOGR, V22, P787, DOI 10.4319/lo.1977.22.5.0787; VANDERBORGHT JP, 1977, LIMNOL OCEANOGR, V22, P794, DOI 10.4319/lo.1977.22.5.0794; VANDERMOLEN DT, 1994, HYDROBIOLOGIA, V275, P479, DOI 10.1007/BF00026736; Wang YF, 1996, GEOCHIM COSMOCHIM AC, V60, P2993, DOI 10.1016/0016-7037(96)00140-8; WANNINKHOF R, 1992, J GEOPHYS RES-OCEANS, V97, P7373, DOI 10.1029/92JC00188; WEISS RF, 1970, DEEP-SEA RES, V17, P721, DOI 10.1016/0011-7471(70)90037-9; WESTRICH JT, 1984, LIMNOL OCEANOGR, V29, P236, DOI 10.4319/lo.1984.29.2.0236; Wijsman JWM, 2002, ESTUAR COAST SHELF S, V54, P403, DOI 10.1006/ecss.2000.0655	64	23	23	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68104	10.1371/journal.pone.0068104	http://dx.doi.org/10.1371/journal.pone.0068104			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844160	Green Published, gold			2022-12-27	WOS:000321733000129
J	Dantas, TJ; Daly, OM; Conroy, PC; Tomas, M; Wang, YF; Lalor, P; Dockery, P; Ferrando-May, E; Morrison, CG				Dantas, Tiago J.; Daly, Owen M.; Conroy, Pauline C.; Tomas, Martin; Wang, Yifan; Lalor, Pierce; Dockery, Peter; Ferrando-May, Elisa; Morrison, Ciaran G.			Calcium-Binding Capacity of Centrin2 Is Required for Linear POC5 Assembly but Not for Nucleotide Excision Repair	PLOS ONE			English	Article							GROUP-C PROTEIN; MOLECULAR-CLONING; DNA-REPAIR; CELL-CYCLE; CENTROSOME; COMPLEX; DUPLICATION; GENE; PHOSPHORYLATION; BIOGENESIS	Centrosomes, the principal microtubule-organising centres in animal cells, contain centrins, small, conserved calcium-binding proteins unique to eukaryotes. Centrin2 binds to xeroderma pigmentosum group C protein (XPC), stabilising it, and its presence slightly increases nucleotide excision repair (NER) activity in vitro. In previous work, we deleted all three centrin isoforms present in chicken DT40 cells and observed delayed repair of UV-induced DNA lesions, but no centrosome abnormalities. Here, we explore how centrin2 controls NER. In the centrin null cells, we expressed centrin2 mutants that cannot bind calcium or that lack sites for phosphorylation by regulatory kinases. Expression of any of these mutants restored the UV sensitivity of centrin null cells to normal as effectively as expression of wild-type centrin. However, calcium-binding-deficient and T118A mutants showed greatly compromised localisation to centrosomes. XPC recruitment to laser-induced UV-like lesions was only slightly slower in centrin-deficient cells than in controls, and levels of XPC and its partner HRAD23B were unaffected by centrin deficiency. Interestingly, we found that overexpression of the centrin interactor POC5 leads to the assembly of linear, centrin-dependent structures that recruit other centrosomal proteins such as PCM-1 and NEDD1. Together, these observations suggest that assembly of centrins into complex structures requires calcium binding capacity, but that such assembly is not required for centrin activity in NER.	[Dantas, Tiago J.; Daly, Owen M.; Conroy, Pauline C.; Wang, Yifan; Morrison, Ciaran G.] Natl Univ Ireland Galway, Sch Nat Sci, Ctr Chromosome Biol, Galway, Ireland; [Lalor, Pierce; Dockery, Peter] Natl Univ Ireland Galway, Sch Med, Galway, Ireland; [Tomas, Martin; Ferrando-May, Elisa] Univ Konstanz, Bioimaging Ctr, Constance, Germany; [Tomas, Martin] Univ Konstanz, Dept Phys, Ctr Appl Photon, Constance, Germany	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; University of Konstanz; University of Konstanz	Morrison, CG (corresponding author), Natl Univ Ireland Galway, Sch Nat Sci, Ctr Chromosome Biol, Galway, Ireland.	Ciaran.Morrison@nuigalway.ie	Morrison, Ciaran/AAH-2034-2019; Morrison, Ciaran/B-6568-2008	Morrison, Ciaran/0000-0003-2401-7029; Morrison, Ciaran/0000-0003-2401-7029; Dockery, Peter/0000-0001-5103-6589; Dantas, Tiago J./0000-0002-0120-4895	Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BD/40940/2007]; National Biophotonics and Imaging Platform Ireland; Science Foundation Ireland [08/IN.1/B1029, 10/IN. 1/B2972]	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); National Biophotonics and Imaging Platform Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	TJD received a predoctoral fellowship from the Fundacao para a Ciencia e a Tecnologia, Portugal (SFRH/BD/40940/2007; www.fct.pt). The authors are indebted to a Programme for Research in Third Level Institutions (PRTLI) 4 grant to fund the National Biophotonics and Imaging Platform Ireland (www.nbipireland.ie) for the TEM. This work was supported by Science Foundation Ireland Principal Investigator awards 08/IN.1/B1029 and 10/IN. 1/B2972 (www.sfi.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acu ID, 2010, CANCER RES, V70, P3320, DOI 10.1158/0008-5472.CAN-09-3800; Alieva IB, 2004, CELL BIOL INT, V28, P139, DOI 10.1016/j.cellbi.2003.11.013; Araki M, 2001, J BIOL CHEM, V276, P18665, DOI 10.1074/jbc.M100855200; Araki M, 2000, MUTAT RES-DNA REPAIR, V459, P147, DOI 10.1016/S0921-8777(99)00067-1; Araujo SJ, 2001, MOL CELL BIOL, V21, P2281, DOI 10.1128/MCB.21.7.2281-2291.2001; Azimzadeh J, 2009, J CELL BIOL, V185, P101, DOI 10.1083/jcb.200808082; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bouissou A, 2009, J CELL BIOL, V187, P327, DOI 10.1083/jcb.200905060; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Camenisch U, 2009, EMBO J, V28, P2387, DOI 10.1038/emboj.2009.187; Charbonnier JB, 2007, J MOL BIOL, V373, P1032, DOI 10.1016/j.jmb.2007.08.046; Conroy PC, 2012, CELL CYCLE, V11, P3769, DOI 10.4161/cc.21986; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Dantas TJ, 2012, CELL MOL LIFE SCI, V69, P2979, DOI 10.1007/s00018-012-0961-1; Dantas TJ, 2011, J CELL BIOL, V193, P307, DOI 10.1083/jcb.201012093; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; Delaval B, 2011, CELL CYCLE, V10, P3964, DOI 10.4161/cc.10.22.18150; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; ERRABOLU R, 1994, J CELL SCI, V107, P9; Geimer S, 2005, EUKARYOT CELL, V4, P1253, DOI 10.1128/EC.4.7.1253-1263.2005; GEISER JR, 1991, CELL, V65, P949, DOI 10.1016/0092-8674(91)90547-C; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Hart PE, 1999, GENOMICS, V60, P111, DOI 10.1006/geno.1999.5880; HUANG B, 1988, J CELL BIOL, V107, P133, DOI 10.1083/jcb.107.1.133; Keller LC, 2009, MOL BIOL CELL, V20, P1150, DOI 10.1091/mbc.E08-06-0619; Kilmartin JV, 2003, J CELL BIOL, V162, P1211, DOI 10.1083/jcb.200307064; Klein UR, 2009, J CELL SCI, V122, P3312, DOI 10.1242/jcs.050245; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kohlmaier G, 2009, CURR BIOL, V19, P1012, DOI 10.1016/j.cub.2009.05.018; Krasikova YS, 2012, BIOCHEMISTRY-MOSCOW+, V77, P346, DOI 10.1134/S0006297912040050; LEE VD, 1993, P NATL ACAD SCI USA, V90, P11039, DOI 10.1073/pnas.90.23.11039; Li S, 2006, J CELL BIOL, V173, P867, DOI 10.1083/jcb.200603153; Lukasiewicz KB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021291; Lutz W, 2001, J BIOL CHEM, V276, P20774, DOI 10.1074/jbc.M101324200; Majumder S, 2010, MOL BIOL CELL, P2; Middendorp S, 1997, P NATL ACAD SCI USA, V94, P9141, DOI 10.1073/pnas.94.17.9141; Middendorp S, 2000, J CELL BIOL, V148, P405, DOI 10.1083/jcb.148.3.405; Mikule K, 2007, NAT CELL BIOL, V9, P160, DOI 10.1038/ncb1529; Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345; Nishi R, 2005, MOL CELL BIOL, V25, P5664, DOI 10.1128/MCB.25.13.5664-5674.2005; Paoletti A, 1996, J CELL SCI, V109, P3089; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Popescu A, 2003, J BIOL CHEM, V278, P40252, DOI 10.1074/jbc.M302546200; Renaud E, 2011, DNA REPAIR, V10, P835, DOI 10.1016/j.dnarep.2011.05.003; Salisbury JL, 2002, CURR BIOL, V12, P1287, DOI 10.1016/S0960-9822(02)01019-9; Salisbury JL, 2004, CURR BIOL, V14, pR27, DOI 10.1016/j.cub.2003.12.019; SALISBURY JL, 1984, J CELL BIOL, V99, P962, DOI 10.1083/jcb.99.3.962; SANDERS MA, 1994, J CELL BIOL, V124, P795, DOI 10.1083/jcb.124.5.795; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; STEARNS T, 1994, CELL, V76, P623, DOI 10.1016/0092-8674(94)90503-7; Strnad P, 2008, TRENDS CELL BIOL, V18, P389, DOI 10.1016/j.tcb.2008.06.004; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Sugasawa K, 2010, MUTAT RES-FUND MOL M, V685, P29, DOI 10.1016/j.mrfmmm.2009.08.004; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Tang CJC, 2009, NAT CELL BIOL, V11, P825, DOI 10.1038/ncb1889; Thompson JR, 2006, J BIOL CHEM, V281, P18746, DOI 10.1074/jbc.M513667200; Trautlein D, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp932; Trojan P, 2008, BBA-MOL CELL RES, V1783, P1248, DOI 10.1016/j.bbamcr.2008.01.006; UZAWA M, 1995, DEV BIOL, V171, P51, DOI 10.1006/dbio.1995.1259; Veeraraghavan S, 2002, J BIOL CHEM, V277, P28564, DOI 10.1074/jbc.M112232200; Vonderfecht T, 2011, MOL BIOL CELL, V22, P2221, DOI 10.1091/mbc.E11-02-0151; Wang QE, 2007, NUCLEIC ACIDS RES, V35, P5338, DOI 10.1093/nar/gkm550; WOLFF A, 1992, EUR J CELL BIOL, V59, P425; Wolfrum U, 1998, EXP CELL RES, V242, P10, DOI 10.1006/excr.1998.4038; Wood RD, 1996, ANNU REV BIOCHEM, V65, P135, DOI 10.1146/annurev.bi.65.070196.001031	69	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68487	10.1371/journal.pone.0068487	http://dx.doi.org/10.1371/journal.pone.0068487			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844208	gold, Green Published, Green Submitted			2022-12-27	WOS:000321341000164
J	Gmiterek, A; Wojtowicz, H; Mackiewicz, P; Radwan-Oczko, M; Kantorowicz, M; Chomyszyn-Gajewska, M; Fraszczak, M; Bielecki, M; Olczak, M; Olczak, T				Gmiterek, Anna; Wojtowicz, Halina; Mackiewicz, Pawel; Radwan-Oczko, Malgorzata; Kantorowicz, Malgorzata; Chomyszyn-Gajewska, Maria; Fraszczak, Magdalena; Bielecki, Marcin; Olczak, Mariusz; Olczak, Teresa			The Unique hmuY Gene Sequence as a Specific Marker of Porphyromonas gingivalis	PLOS ONE			English	Article							REAL-TIME PCR; CORONARY-HEART-DISEASE; PERIODONTAL PATHOGENS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; QUANTITATIVE DETECTION; BACTEROIDES-FORSYTHUS; PREVOTELLA-INTERMEDIA; BACTERIAL DIVERSITY; PLAQUE; PRIMERS	Porphyromonas gingivalis, a major etiological agent of chronic periodontitis, acquires heme from host hemoproteins using the HmuY hemophore. The aim of this study was to develop a specific P. gingivalis marker based on a hmuY gene sequence. Subgingival samples were collected from 66 patients with chronic periodontitis and 40 healthy subjects and the entire hmuY gene was analyzed in positive samples. Phylogenetic analyses demonstrated that both the amino acid sequence of the HmuY protein and the nucleotide sequence of the hmuY gene are unique among P. gingivalis strains/isolates and show low identity to sequences found in other species (below 50 and 56%, respectively). In agreement with these findings, a set of hmuY gene-based primers and standard/real-time PCR with SYBR Green chemistry allowed us to specifically detect P. gingivalis in patients with chronic periodontitis (77.3%) and healthy subjects (20%), the latter possessing lower number of P. gingivalis cells and total bacterial cells. Isolates from healthy subjects possess the hmuY gene-based nucleotide sequence pattern occurring in W83/W50/A7436 (n = 4), 381/ATCC 33277 (n = 3) or TDC60 (n = 1) strains, whereas those from patients typically have TDC60 (n = 21), W83/W50/A7436 (n = 17) and 381/ATCC 33277 (n = 13) strains. We observed a significant correlation between periodontal index of risk of infectiousness (PIRI) and the presence/absence of P. gingivalis (regardless of the hmuY gene-based sequence pattern of the isolate identified [r = 0.43; P = 0.0002] and considering particular isolate pattern [r = 0.38; P = 0.0012]). In conclusion, we demonstrated that the hmuY gene sequence or its fragments may be used as one of the molecular markers of P. gingivalis.	[Gmiterek, Anna; Wojtowicz, Halina; Bielecki, Marcin; Olczak, Mariusz; Olczak, Teresa] Univ Wroclaw, Fac Biotechnol, Biochem Lab, PL-50138 Wroclaw, Poland; [Mackiewicz, Pawel] Univ Wroclaw, Fac Biotechnol, Dept Genom, PL-50138 Wroclaw, Poland; [Radwan-Oczko, Malgorzata] Wroclaw Med Univ, Unit Oral Pathol, Dept Periodontol, Wroclaw, Poland; [Kantorowicz, Malgorzata; Chomyszyn-Gajewska, Maria] Jagiellonian Univ, Coll Med, Dept Periodontol & Oral Med, Krakow, Poland; [Fraszczak, Magdalena] Univ Environm & Life Sci, Inst Genet, Wroclaw, Poland	University of Wroclaw; University of Wroclaw; Wroclaw Medical University; Jagiellonian University; Collegium Medicum Jagiellonian University; Wroclaw University of Environmental & Life Sciences	Olczak, T (corresponding author), Univ Wroclaw, Fac Biotechnol, Biochem Lab, PL-50138 Wroclaw, Poland.	Teresa.Olczak@biotech.uni.wroc.pl	Frąszczak, Magdalena/A-2614-2017	Fraszczak, Magdalena/0000-0002-8012-4980	Ministry of Science and Higher Education/National Science Center (Poland) [N N303 518438]; Wroclaw Research Center EIT+ under the project "Biotechnologies and advanced medical technologies - BioMed'' [POIG 01.01.02-02-003/08/00]; European Regional Development Fund (Operational Program Innovative Economy) [1.1.2]	Ministry of Science and Higher Education/National Science Center (Poland); Wroclaw Research Center EIT+ under the project "Biotechnologies and advanced medical technologies - BioMed''; European Regional Development Fund (Operational Program Innovative Economy)	This study was supported by grant no. N N303 518438 from the Ministry of Science and Higher Education/National Science Center (Poland) and by Wroclaw Research Center EIT+ under the project "Biotechnologies and advanced medical technologies - BioMed'' (POIG 01.01.02-02-003/08/00) financed from the European Regional Development Fund (Operational Program Innovative Economy, 1.1.2) ( to TO). The funders had no role in study design, data collection and analysis, and preparation of the manuscript. The decision to publish was made by the authors, following IP review.	Abiko Y, 2010, J PERIODONTAL RES, V45, P389, DOI 10.1111/j.1600-0765.2009.01250.x; Amano A, 2000, J DENT RES, V79, P1664, DOI 10.1177/00220345000790090501; Bahekar AA, 2007, AM HEART J, V154, P830, DOI 10.1016/j.ahj.2007.06.037; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Botta GA, 2000, J ANTIMICROB CHEMOTH, V43, P1523; Boutaga K, 2006, J CLIN PERIODONTOL, V33, P427, DOI 10.1111/j.1600-051X.2006.00925.x; Boutaga K, 2003, J CLIN MICROBIOL, V41, P4950, DOI 10.1128/JCM.41.11.4950-4954.2003; Byrne SJ, 2009, ORAL MICROBIOL IMMUN, V24, P469, DOI 10.1111/j.1399-302X.2009.00544.x; Craig RG, 2003, J PERIODONTOL, V74, P1007, DOI 10.1902/jop.2003.74.7.1007; Criscuolo A, 2011, MOL PHYLOGENET EVOL, V61, P944, DOI 10.1016/j.ympev.2011.08.029; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Doungudomdacha S, 2000, J MED MICROBIOL, V49, P861, DOI 10.1099/0022-1317-49-10-861; FARRELLY V, 1995, APPL ENVIRON MICROB, V61, P2798, DOI 10.1128/AEM.61.7.2798-2801.1995; Gaetti-Jardim E, 2009, J MED MICROBIOL, V58, P1568, DOI 10.1099/jmm.0.013383-0; Geerts SO, 2004, J PERIODONTOL, V75, P1274, DOI 10.1902/jop.2004.75.9.1274; Graves DT, 2000, CURR OPIN INFECT DIS, V13, P227, DOI 10.1097/00001432-200006000-00005; GRENIER D, 1987, J CLIN MICROBIOL, V25, P738, DOI 10.1128/JCM.25.4.738-740.1987; Griffen AL, 1998, J CLIN MICROBIOL, V36, P3239, DOI 10.1128/JCM.36.11.3239-3242.1998; Griffen AL, 1999, J CLIN MICROBIOL, V37, P4028, DOI 10.1128/JCM.37.12.4028-4033.1999; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guyodo H, 2012, FEMS IMMUNOL MED MIC, V64, P175, DOI 10.1111/j.1574-695X.2011.00877.x; Haffajee AD, 1998, J CLIN PERIODONTOL, V25, P346, DOI 10.1111/j.1600-051X.1998.tb02454.x; Hajishengallis G, 2011, J ORAL BIOSCI, V53, P233, DOI 10.2330/joralbiosci.53.233; Huelsenbeck JP, 2004, MOL BIOL EVOL, V21, P1123, DOI 10.1093/molbev/msh123; Humphrey LL, 2008, J GEN INTERN MED, V23, P2079, DOI 10.1007/s11606-008-0787-6; Hyvarinen K, 2009, INNATE IMMUN-LONDON, V15, P195, DOI 10.1177/1753425908101920; Igboin CO, 2009, J CLIN MICROBIOL, V47, P3073, DOI 10.1128/JCM.00569-09; 윤정호, 2008, Journal of Periodontal & Implant Science, V38, P143; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Katz J, 2009, J DENT RES, V88, P575, DOI 10.1177/0022034509338032; Kim HS, 2010, J CLIN MICROBIOL, V48, P545, DOI 10.1128/JCM.01631-09; Kirakodu SS, 2008, OPEN DENT J, V2, P49, DOI 10.2174/1874210600802010049; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P755; KRIEG NR, 2001, BERGEYS MANUAL SYSTE, V1, P33; Kroes I, 1999, P NATL ACAD SCI USA, V96, P14547, DOI 10.1073/pnas.96.25.14547; Kuboniwa M, 2004, ORAL MICROBIOL IMMUN, V19, P168, DOI 10.1111/j.0902-0055.2004.00135.x; Kuboniwa M, 2010, PERIODONTOL 2000, V52, P38, DOI 10.1111/j.1600-0757.2009.00311.x; Kumar PS, 2006, J CLIN MICROBIOL, V44, P3665, DOI 10.1128/JCM.00317-06; Laine ML, 1998, ORAL MICROBIOL IMMUN, V13, P322, DOI 10.1111/j.1399-302X.1998.tb00714.x; LAMONT RJ, 1995, INFECT IMMUN, V63, P3878, DOI 10.1128/IAI.63.10.3878-3885.1995; Lange D E, 1978, Dtsch Zahnarztl Z, V33, P8; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lyons SR, 2000, J CLIN MICROBIOL, V38, P2362; Maeda H, 2003, FEMS IMMUNOL MED MIC, V39, P81, DOI 10.1016/S0928-8244(03)00224-4; Marcelino SL, 2010, ANAEROBE, V16, P629, DOI 10.1016/j.anaerobe.2010.08.007; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Marsh PD, 2004, CARIES RES, V38, P204, DOI 10.1159/000077756; Martin FE, 2002, J CLIN MICROBIOL, V40, P1698, DOI 10.1128/JCM.40.5.1698-1704.2002; Meurman JH, 2004, CRIT REV ORAL BIOL M, V15, P403, DOI 10.1177/154411130401500606; Moon JH, 2012, FEMS IMMUNOL MED MIC, V64, P425, DOI 10.1111/j.1574-695X.2011.00889.x; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; NEIDERS ME, 1989, J PERIODONTAL RES, V24, P192, DOI 10.1111/j.1600-0765.1989.tb02005.x; Nonnenmacher C, 2004, J MICROBIOL METH, V59, P117, DOI 10.1016/j.mimet.2004.06.006; Olczak T, 2008, ARCH MICROBIOL, V189, P197, DOI 10.1007/s00203-007-0309-7; Olczak T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-134; Page RC, 2007, J PERIODONTOL, V78, P1387, DOI 10.1902/jop.2007.060264; Park SN, 2011, J MICROBIOL, V49, P315, DOI 10.1007/s12275-011-1028-y; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rocas IN, 2012, J CLIN MICROBIOL, V50, P1721, DOI 10.1128/JCM.00531-12; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosenstein ED, 2004, INFLAMMATION, V28, P311, DOI 10.1007/s10753-004-6641-z; Sabbah W, 2010, INT DENT J, V60, P370, DOI 10.1922/IDJ_2480Sabbah05; Sakamoto M, 2001, MICROBIOL IMMUNOL, V45, P39, DOI 10.1111/j.1348-0421.2001.tb01272.x; Shoemaker NB, 2001, APPL ENVIRON MICROB, V67, P561, DOI 10.1128/AEM.67.2.561-568.2001; Smalley JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017182; Suzuki J, 2010, EXPERT OPIN THER TAR, V14, P1023, DOI 10.1517/14728222.2010.511616; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tran SD, 1999, J CLIN MICROBIOL, V37, P3504, DOI 10.1128/JCM.37.11.3504-3508.1999; van Winkelhoff AJ, 2002, J CLIN PERIODONTOL, V29, P1023, DOI 10.1034/j.1600-051X.2002.291107.x; Vitkov L, 2005, ORAL MICROBIOL IMMUN, V20, P317, DOI 10.1111/j.1399-302X.2005.00233.x; Watanabe T, 2011, J BACTERIOL, V193, P4259, DOI 10.1128/JB.05269-11; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wojtowicz H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000419; Wojtowicz H, 2009, BIOCHEM BIOPH RES CO, V383, P178, DOI 10.1016/j.bbrc.2009.03.148; Yilmaz O, 2006, INFECT IMMUN, V74, P703, DOI 10.1128/IAI.74.1.703-710.2006; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	79	14	14	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67719	10.1371/journal.pone.0067719	http://dx.doi.org/10.1371/journal.pone.0067719			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844074	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000083
J	Axiak-Bechtel, SM; Kumar, SR; Hansen, SA; Bryan, JN				Axiak-Bechtel, Sandra M.; Kumar, Senthil R.; Hansen, Sarah A.; Bryan, Jeffrey N.			Y-chromosome DNA Is Present in the Blood of Female Dogs Suggesting the Presence of Fetal Microchimerism	PLOS ONE			English	Article							CELL MICROCHIMERISM; MATERNAL PLASMA; CANCER; IMMUNOLOGY; CHIMERISM; MODELS; KIDNEY; WOMEN; LIVER; SERUM	Fetal microchimerism has been suggested to play contradictory roles in women's health, with factors including age of the recipient, time elapsed since microchimerism occurred, and microchimeric cell type modulating disease. Both beneficial and harmful effects have been identified in wound healing and tissue regeneration, immune mediated disease, and cancer. This area of research is relatively new, and hindered by the time course from occurrence of fetal microchimerism to the multifactorial development of disease. Dogs represent an excellent model for study of fetal microchimerism, as they share our environment, have a naturally condensed lifespan, and spontaneously develop immune-mediated diseases and cancers similar to their human counterparts. However, fetal microchimerism has not been described in dogs. These experiments sought preliminary evidence that dogs develop fetal microchimerism following pregnancy. We hypothesized that Y chromosomal DNA would be detected in the peripheral blood mononuclear cells of female dogs collected within two months of parturition. We further hypothesized that Y chromosomal DNA would be detected in banked whole blood DNA samples from parous female Golden Retrievers with at least one male puppy in a prior litter. Amplification of DNA extracted from five female Golden Retrievers that had whelped within the two months prior to collection revealed strong positive bands for the Y chromosome. Of banked, parous samples, 36% yielded positive bands for the Y chromosome. This is the first report of persistent Y chromosomal DNA in post-partum female dogs and these results suggest that fetal microchimerism occurs in the canine species. Evaluation of the contributions of fetal microchimeric cells to disease processes in dogs as a model for human disease is warranted.	[Axiak-Bechtel, Sandra M.; Kumar, Senthil R.; Hansen, Sarah A.; Bryan, Jeffrey N.] Univ Missouri, Comparat Oncol & Epigenet Lab, Dept Vet Med & Surg, Columbia, MO 65211 USA; [Kumar, Senthil R.] Harry S Truman Vet Hosp, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital	Bryan, JN (corresponding author), Univ Missouri, Comparat Oncol & Epigenet Lab, Dept Vet Med & Surg, Columbia, MO 65211 USA.	bryanjn@missouri.edu		Bryan, Jeffrey/0000-0002-6820-9850; Axiak-Bechtel, Sandra/0000-0002-7773-5959	University of Missouri College of Veterinary Medicine Committee on Research; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R25OD010951] Funding Source: NIH RePORTER	University of Missouri College of Veterinary Medicine Committee on Research; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would also like to acknowledge the University of Missouri College of Veterinary Medicine Committee on Research for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyon C, 2011, EUR J OBSTET GYN R B, V158, P148, DOI 10.1016/j.ejogrb.2011.05.008; CAIN GR, 1989, AM J VET RES, V50, P1282; Cirello V, 2010, INT J CANCER, V126, P2874, DOI 10.1002/ijc.24993; Dubernard G, 2009, INT J CANCER, V124, P1054, DOI 10.1002/ijc.24036; Fleming JM, 2011, J VET INTERN MED, V25, P187, DOI 10.1111/j.1939-1676.2011.0695.x; FOURNEL C, 1992, LUPUS, V1, P133, DOI 10.1177/096120339200100303; Fugazzola L, 2012, J CLIN ENDOCR METAB, V97, P1452, DOI 10.1210/jc.2011-3160; Fugazzola L, 2011, NAT REV ENDOCRINOL, V7, P89, DOI 10.1038/nrendo.2010.216; Gadi VK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001706; Gadi VK, 2007, CANCER RES, V67, P9035, DOI 10.1158/0008-5472.CAN-06-4209; Graham PA, 2001, VET CLIN N AM-SMALL, V31, P915, DOI 10.1016/S0195-5616(01)50005-4; Graves SS, 2008, BIOL BLOOD MARROW TR, V14, P1201, DOI 10.1016/j.bbmt.2008.08.005; Hansen K, 2004, EUR J CANCER, V40, P858, DOI 10.1016/j.ejca.2003.11.031; Houfflin-Debarge V, 2000, FETAL DIAGN THER, V15, P102, DOI 10.1159/000020985; Jayaraman S, 2010, J IMMUNOL, V184, P3008, DOI 10.4049/jimmunol.0903615; Kallenbach LR, 2011, CANCER RES, V71, P8, DOI 10.1158/0008-5472.CAN-10-0618; Kennedy LJ, 2006, TISSUE ANTIGENS, V68, P82, DOI 10.1111/j.1399-0039.2006.00614.x; Lee ESM, 2010, MOL HUM REPROD, V16, P869, DOI 10.1093/molehr/gaq067; Lee TH, 2001, TRANSFUSION, V41, P276, DOI 10.1046/j.1537-2995.2001.41020276.x; LIEGEOIS A, 1977, TRANSPLANT P, V9, P273; Lo YMD, 2000, CLIN CHEM, V46, P1903; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897; Nassar D, 2012, FASEB J, V26, P149, DOI 10.1096/fj.11-180695; Nelson JL, 2012, TRENDS IMMUNOL, V33, P421, DOI 10.1016/j.it.2012.03.002; O'Donoghue K, 2008, REPROD BIOMED ONLINE, V16, P382, DOI 10.1016/S1472-6483(10)60600-1; Olivier M, 1998, ANIM GENET, V29, P146, DOI 10.1046/j.1365-2052.1998.00299.x; Rowell JL, 2011, TRENDS MOL MED, V17, P380, DOI 10.1016/j.molmed.2011.02.004; Smid M, 1999, CLIN CHEM, V45, P1570; Stikvoort A, 2013, BIOL BLOOD MARROW TR, V19, P838, DOI 10.1016/j.bbmt.2013.02.015; Turin L, 2007, VET RES COMMUN, V31, P205, DOI 10.1007/s11259-007-0095-3; Turin Lauretta, 2007, Biotechnology Journal, V2, P486, DOI 10.1002/biot.200600218; Villamil JA, 2009, J CANCER EPIDEMIOL, V2009, DOI [10.1155/2009/591753, 10.1155/2009/747803]; Wang Y, 2004, BIOCHEM BIOPH RES CO, V325, P961, DOI 10.1016/j.bbrc.2004.10.105; Yan Z, 2005, AM J MED, V118, P899, DOI 10.1016/j.amjmed.2005.03.037	35	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68114	10.1371/journal.pone.0068114	http://dx.doi.org/10.1371/journal.pone.0068114			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861856	gold, Green Submitted, Green Published			2022-12-27	WOS:000321692000015
J	Tschandl, P; Berghoff, AS; Preusser, M; Burgstaller-Muehlbacher, S; Pehamberger, H; Okamoto, I; Kittler, H				Tschandl, Philipp; Berghoff, Anna Sophie; Preusser, Matthias; Burgstaller-Muehlbacher, Sebastian; Pehamberger, Hubert; Okamoto, Ichiro; Kittler, Harald			NRAS and BRAF Mutations in Melanoma-Associated Nevi and Uninvolved Nevi	PLOS ONE			English	Article							DYSPLASTIC MELANOCYTIC NEVI; MALIGNANT-MELANOMA; CUTANEOUS MELANOMA; TUMOR PROGRESSION; METASTATIC MELANOMA; SENESCENCE; LESIONS; BENIGN; IGFBP7; GENE	According to the prevailing multistep model of melanoma development, oncogenic BRAF or NRAS mutations are crucial initial events in melanoma development. It is not known whether melanocytic nevi that are found in association with a melanoma are more likely to carry BRAF or NRAS mutations than uninvolved nevi. By laser microdissection we were able to selectively dissect and genotype cells either from the nevus or from the melanoma part of 46 melanomas that developed in association with a nevus. In 25 cases we also genotyped a control nevus of the same patients. Available tissue was also immunostained using the BRAFV600E-mutation specific antibody VE1. The BRAFV600E mutation was found in 63.0% of melanomas, 65.2% of associated nevi and 50.0% of control nevi. No significant differences in the distribution of BRAF or NRAS mutations could be found between melanoma and associated nevi or between melanoma associated nevi and control nevi. In concordant cases immunohistochemistry showed a higher expression (intensity of immunohistochemistry) of the mutated BRAFV600E-protein in melanomas compared to their associated nevi. In this series the presence of a BRAF- or NRAS mutation in a nevus was not associated with the risk of malignant transformation. Our findings do not support the current traditional model of stepwise tumor progression.	[Tschandl, Philipp; Burgstaller-Muehlbacher, Sebastian; Pehamberger, Hubert; Okamoto, Ichiro; Kittler, Harald] Med Univ Vienna, Dept Dermatol, Vienna, Austria; [Berghoff, Anna Sophie; Preusser, Matthias] Med Univ Vienna, Inst Neurol, Vienna, Austria; [Berghoff, Anna Sophie; Preusser, Matthias] Med Univ Vienna, Ctr Comprehens Canc, Vienna, Austria; [Preusser, Matthias] Med Univ Vienna, Dept Med 1, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Kittler, H (corresponding author), Med Univ Vienna, Dept Dermatol, Vienna, Austria.	harald.kittler@meduniwien.ac.at	Preusser, Matthias/C-8530-2011; Kittler, Harald/K-7574-2013; Kittler, Harald/AAK-1502-2020; Burgstaller-Muehlbacher, Sebastian/W-6686-2019	Preusser, Matthias/0000-0003-3541-2315; Burgstaller-Muehlbacher, Sebastian/0000-0003-4640-3510; Berghoff, Anna Sophie/0000-0001-9379-6797; Tschandl, Philipp/0000-0003-0391-7810; KITTLER, HARALD/0000-0002-0051-8016	Margaretha-Hehberger Foundation [11095]	Margaretha-Hehberger Foundation	This study was supported by grant number 11095 of the Margaretha-Hehberger Foundation (principle investigator: Harald Kittler; recipient: Philipp Tschandl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bevona C, 2003, ARCH DERMATOL, V139, P1620, DOI 10.1001/archderm.139.12.1620; Capper D, 2012, ACTA NEUROPATHOL, V123, P223, DOI 10.1007/s00401-011-0887-y; Capper D, 2011, ACTA NEUROPATHOL, V122, P11, DOI 10.1007/s00401-011-0841-z; CLARK WH, 1978, ARCH DERMATOL, V114, P732, DOI 10.1001/archderm.114.5.732; CLARK WH, 1984, HUM PATHOL, V15, P1147, DOI 10.1016/S0046-8177(84)80310-X; CLEMENTE C, 1991, HUM PATHOL, V22, P313, DOI 10.1016/0046-8177(91)90078-4; Colomba E, 2013, J MOL DIAGN, V15, P94, DOI 10.1016/j.jmoldx.2012.09.001; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DeCarlo K, 2010, HUM PATHOL, V41, P886, DOI 10.1016/j.humpath.2009.12.002; Demunter A, 2001, J INVEST DERMATOL, V117, P1483, DOI 10.1046/j.0022-202x.2001.01601.x; DEWIT PEJ, 1993, EUR J CANCER, V29A, P831, DOI 10.1016/S0959-8049(05)80419-8; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Dong JL, 2003, CANCER RES, V63, P3883; Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Goel VK, 2006, J INVEST DERMATOL, V126, P154, DOI 10.1038/sj.jid.5700026; GREENE MH, 1985, NEW ENGL J MED, V312, P91, DOI 10.1056/NEJM198501103120205; Greene VR, 2009, J INVEST DERMATOL, V129, P1483, DOI 10.1038/jid.2008.374; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hussein MR, 2005, J CLIN PATHOL, V58, P453, DOI 10.1136/jcp.2004.019422; Koperek O, 2012, AM J SURG PATHOL, V36, P844, DOI 10.1097/PAS.0b013e318246b527; Loewe R, 2004, J INVEST DERMATOL, V123, P733, DOI 10.1111/j.0022-202X.2004.23402.x; Long GV, 2013, AM J SURG PATHOL, V37, P61, DOI 10.1097/PAS.0b013e31826485c0; Meyer LJ, 1996, J AM ACAD DERMATOL, V34, P618, DOI 10.1016/S0190-9622(96)80061-2; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Omholt K, 2003, CLIN CANCER RES, V9, P6483; Papp T, 2005, MELANOMA RES, V15, P401, DOI 10.1097/00008390-200510000-00008; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Pollock PM, 2002, CANCER CELL, V2, P5, DOI 10.1016/S1535-6108(02)00089-2; Poynter JN, 2006, MELANOMA RES, V16, P267, DOI 10.1097/01.cmr.0000222600.73179.f3; Pozo L, 2001, AM J CLIN PATHOL, V115, P194; RHODES AR, 1989, MODERN PATHOL, V2, P306; Rosso Ritchie, 2009, J Invest Dermatol, V129, P1318, DOI 10.1038/jid.2009.107; Schrama D, 2010, J INVEST DERMATOL, V130, P897, DOI 10.1038/jid.2009.304; Scurr LL, 2010, CELL, V141, P717, DOI 10.1016/j.cell.2010.04.021; STOLZ W, 1989, CANCER-AM CANCER SOC, V63, P550, DOI 10.1002/1097-0142(19890201)63:3<550::AID-CNCR2820630325>3.0.CO;2-A; Thomas NE, 2006, MELANOMA RES, V16, P97, DOI 10.1097/01.cmr.0000215035.38436.87; Tsao H, 2003, ARCH DERMATOL, V139, P282, DOI 10.1001/archderm.139.3.282; Uribe P, 2003, AM J DERMATOPATH, V25, P365, DOI 10.1097/00000372-200310000-00001; Uribe P, 2009, AM J DERMATOPATH, V31, P354, DOI 10.1097/DAD.0b013e318185d205; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Wu JL, 2007, AM J DERMATOPATH, V29, P534, DOI 10.1097/DAD.0b013e3181584950; Yancovitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029336; Zalaudek I, 2011, J INVEST DERMATOL, V131, P542, DOI 10.1038/jid.2010.332	47	55	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e69639	10.1371/journal.pone.0069639	http://dx.doi.org/10.1371/journal.pone.0069639			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861977	gold, Green Submitted, Green Published			2022-12-27	WOS:000321692000048
J	Wang, YJ; Zhang, CJ; Hao, QN; Sha, AH; Zhou, R; Zhou, XA; Yuan, LP				Wang, Yejian; Zhang, Chanjuan; Hao, Qinnan; Sha, Aihua; Zhou, Rong; Zhou, Xinan; Yuan, Longping			Elucidation of miRNAs-Mediated Responses to Low Nitrogen Stress by Deep Sequencing of Two Soybean Genotypes	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; GENE-EXPRESSION; COMPUTATIONAL IDENTIFICATION; ARABIDOPSIS-THALIANA; PLANT MICRORNAS; USE EFFICIENCY; TARGET GENES; SHORT RNAS; TIME; PREDICTION	Nitrogen (N) is a major limiting factor in crop production, and plant adaptive responses to low N are involved in many post-transcriptional regulation. Recent studies indicate that miRNAs play important roles in adaptive responses. However, miRNAs in soybean adaptive responses to N limitation have been not reported. We constructed sixteen libraries to identify low N-responsive miRNAs on a genome-wide scale using samples from 2 different genotypes (low N sensitive and low N tolerant) subjected to various periods of low nitrogen stress. Using high-throughput sequencing technology (Illumina-Solexa), we identified 362 known miRNAs variants belonging to 158 families and 90 new miRNAs belonging to 55 families. Among these known miRNAs variants, almost 50% were not different from annotated miRNAs in miRBase. Analyses of their expression patterns showed 150 known miRNAs variants as well as 2 novel miRNAs with differential expressions. These differentially expressed miRNAs between the two soybean genotypes were compared and classified into three groups based on their expression patterns. Predicted targets of these miRNAs were involved in various metabolic and regulatory pathways such as protein degradation, carbohydrate metabolism, hormone signaling pathway, and cellular transport. These findings suggest that miRNAs play important roles in soybean response to low N and contribute to the understanding of the genetic basis of differences in adaptive responses to N limitation between the two soybean genotypes. Our study provides basis for expounding the complex gene regulatory network of these miRNAs.	[Wang, Yejian; Yuan, Longping] Cent S Univ, Long Ping Branch, Grad Sch, Changsha, Hunan, Peoples R China; [Wang, Yejian; Zhang, Chanjuan; Hao, Qinnan; Sha, Aihua; Zhou, Rong; Zhou, Xinan] Chinese Acad Agr Sci, Key Lab Oil Crop Biol, Minist Agr, Oil Crops Res Inst, Wuhan, Peoples R China; [Yuan, Longping] Natl Hybrid Rice R&D Ctr, Changsha, Hunan, Peoples R China; [Hao, Qinnan] Chinese Acad Agr Sci, Grad Sch, Beijing 100193, Peoples R China; [Wang, Yejian] Hunan Acad Agr Sci, Inst Crops Res, Changsha, Hunan, Peoples R China	Central South University; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Graduate School, CAAS; Hunan Academy of Agricultural Sciences	Zhou, XA (corresponding author), Chinese Acad Agr Sci, Key Lab Oil Crop Biol, Minist Agr, Oil Crops Res Inst, Wuhan, Peoples R China.	zhouocri@sina.com; lpyuan@hhrrc.ac.cn			special funds from the major issue of National Transgenic Project [2011ZX08004-005]; modern agricultural technology system [CARS-040PS08]; National Natural Science Foundation of China [31201153]; Crop Germplasm Resource Protection Project [NB07-2130315-06, NB08-2130315- (25-31)-06]	special funds from the major issue of National Transgenic Project; modern agricultural technology system; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Crop Germplasm Resource Protection Project	This work was funded by special funds from the major issue of National Transgenic Project (2011ZX08004-005), the modern agricultural technology system (CARS-040PS08), the National Natural Science Foundation of China (No. 31201153) and the Crop Germplasm Resource Protection Project (NB07-2130315-06, NB08-2130315- (25-31)-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2008, J BIOL CHEM, V283, P15932, DOI 10.1074/jbc.M801406200; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Aung K, 2006, PLANT PHYSIOL, V141, P1000, DOI 10.1104/pp.106.078063; Barakat Abdelali, 2007, BMC Genomics, V8, P481, DOI 10.1186/1471-2164-8-481; Bari R, 2006, PLANT PHYSIOL, V141, P988, DOI 10.1104/pp.106.079707; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bi YM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-281; BONGUEBARTELSMAN M, 1995, PLANT PHYSIOL BIOCH, V33, P539; Bonnet E, 2004, P NATL ACAD SCI USA, V101, P11511, DOI 10.1073/pnas.0404025101; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chalker-Scott L, 1999, PHOTOCHEM PHOTOBIOL, V70, P1, DOI 10.1111/j.1751-1097.1999.tb01944.x; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen R, 2009, J INTEGR PLANT BIOL, V51, P1071, DOI 10.1111/j.1744-7909.2009.00887.x; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chiou TJ, 2006, PLANT CELL, V18, P412, DOI 10.1105/tpc.105.038943; Dezulian T., 2005, GENOME BIOL, V6, pP13, DOI DOI 10.1186/GB-2005-6-11-P13; Diaz U, 2006, PLANT CELL PHYSIOL, V47, P74, DOI 10.1093/pcp/pci225; Ding D, 2009, ANN BOT-LONDON, V103, P29, DOI 10.1093/aob/mcn205; Ding L, 2005, ANN BOT-LONDON, V96, P925, DOI 10.1093/aob/mci244; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Frink CR, 1999, P NATL ACAD SCI USA, V96, P1175, DOI 10.1073/pnas.96.4.1175; Fujii H, 2005, CURR BIOL, V15, P2038, DOI 10.1016/j.cub.2005.10.016; Geiger M, 1998, PLANT CELL ENVIRON, V21, P253, DOI 10.1046/j.1365-3040.1998.00277.x; Gifford ML, 2008, P NATL ACAD SCI USA, V105, P803, DOI 10.1073/pnas.0709559105; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gutierrez L, 2009, PLANT CELL, V21, P3119, DOI 10.1105/tpc.108.064758; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Hao QN, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-525; Harper J.E., 1987, SOYBEANS IMPROVEMENT, P497; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hirel B, 2007, J EXP BOT, V58, P2369, DOI 10.1093/jxb/erm097; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hsieh LC, 2009, PLANT PHYSIOL, V151, P2120, DOI 10.1104/pp.109.147280; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Joshi T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S14; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; KHAMIS S, 1990, PLANT PHYSIOL, V94, P1436, DOI 10.1104/pp.94.3.1436; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; Kulcheski FR, 2010, ANAL BIOCHEM, V406, P185, DOI 10.1016/j.ab.2010.07.020; Kwak PB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-457; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Li BS, 2011, J EXP BOT, V62, P3765, DOI 10.1093/jxb/err051; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li T, 2011, NUCLEIC ACIDS RES, V39, P2821, DOI 10.1093/nar/gkq1047; Lian XM, 2006, PLANT MOL BIOL, V60, P617, DOI 10.1007/s11103-005-5441-7; Liang G, 2010, PLANT J, V62, P1046, DOI 10.1111/j.1365-313X.2010.04216.x; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu C, 2008, P NATL ACAD SCI USA, V105, P4951, DOI 10.1073/pnas.0708743105; Mette MF, 2002, PLANT PHYSIOL, V130, P6, DOI 10.1104/pp.007047; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Ono K, 1996, PLANT CELL PHYSIOL, V37, P1083, DOI 10.1093/oxfordjournals.pcp.a029057; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Peng MS, 2007, PLANT MOL BIOL, V65, P775, DOI 10.1007/s11103-007-9241-0; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Song C, 2010, PLANT BIOLOGY, V12, P927, DOI 10.1111/j.1438-8677.2009.00300.x; Song CP, 2005, PLANT CELL, V17, P2384, DOI 10.1105/tpc.105.033043; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-25; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Todd CD, 2004, PLANTA, V219, P1003, DOI 10.1007/s00425-004-1305-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vidal EA, 2010, P NATL ACAD SCI USA, V107, P4477, DOI 10.1073/pnas.0909571107; Wang XJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r65; Wang YW, 2009, BIOCHEM BIOPH RES CO, V378, P799, DOI 10.1016/j.bbrc.2008.11.140; Wei B, 2009, FUNCT INTEGR GENOMIC, V9, P499, DOI 10.1007/s10142-009-0128-9; Xu ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028009; Zeng HQ, 2010, J PLANT PHYSIOL, V167, P1289, DOI 10.1016/j.jplph.2010.04.017; Zhang BH, 2008, PLANTA, V229, P161, DOI 10.1007/s00425-008-0818-x; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107	78	36	41	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e67423	10.1371/journal.pone.0067423	http://dx.doi.org/10.1371/journal.pone.0067423			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861762	Green Submitted, Green Published, gold			2022-12-27	WOS:000321692000008
J	Ichinose, G; Saito, M; Suzuki, S				Ichinose, Genki; Saito, Masaya; Suzuki, Shinsuke			Collective Chasing Behavior between Cooperators and Defectors in the Spatial Prisoner's Dilemma	PLOS ONE			English	Article							INDIRECT RECIPROCITY; CONTINGENT MOVEMENT; EVOLUTION; ASSORTMENT; MIGRATION; MECHANISM; ALTRUISM; DRIVEN; CHAOS; GAMES	Cooperation is one of the essential factors for all biological organisms in major evolutionary transitions. Recent studies have investigated the effect of migration for the evolution of cooperation. However, little is known about whether and how an individuals' cooperativeness coevolves with mobility. One possibility is that mobility enhances cooperation by enabling cooperators to escape from defectors and form clusters; the other possibility is that mobility inhibits cooperation by helping the defectors to catch and exploit the groups of cooperators. In this study we investigate the coevolutionary dynamics by using the prisoner's dilemma game model on a lattice structure. The computer simulations demonstrate that natural selection maintains cooperation in the form of evolutionary chasing between the cooperators and defectors. First, cooperative groups grow and collectively move in the same direction. Then, mutant defectors emerge and invade the cooperative groups, after which the defectors exploit the cooperators. Then other cooperative groups emerge due to mutation and the cycle is repeated. Here, it is worth noting that, as a result of natural selection, the mobility evolves towards directional migration, but not to random or completely fixed migration. Furthermore, with directional migration, the rate of global population extinction is lower when compared with other cases without the evolution of mobility (i.e., when mobility is preset to random or fixed). These findings illustrate the coevolutionary dynamics of cooperation and mobility through the directional chasing between cooperators and defectors.	[Ichinose, Genki; Saito, Masaya] Anan Natl Coll Technol, Anan, Tokushima, Japan; [Suzuki, Shinsuke] Hokkaido Univ, Grad Sch Letters, Sapporo, Hokkaido, Japan; [Suzuki, Shinsuke] Riken Brain Sci Inst, Lab Integrated Theoret Neurosci, Wako, Saitama, Japan; [Suzuki, Shinsuke] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA	Hokkaido University; RIKEN; California Institute of Technology	Ichinose, G (corresponding author), Anan Natl Coll Technol, Anan, Tokushima, Japan.	igenki@gmail.com	Ichinose, Genki/G-6442-2015		JSPS KAKENHI [232648]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant-in-Aid for JSPS Fellows Number 232648. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktipis CA, 2004, J THEOR BIOL, V231, P249, DOI 10.1016/j.jtbi.2004.06.020; Cong R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035776; Droz M, 2009, EUR PHYS J B, V71, P579, DOI 10.1140/epjb/e2009-00160-1; ENQUIST M, 1993, ANIM BEHAV, V45, P747, DOI 10.1006/anbe.1993.1089; Eriksson A, 2005, J THEOR BIOL, V232, P399, DOI 10.1016/j.jtbi.2004.08.020; Hamilton IM, 2005, P ROY SOC B-BIOL SCI, V272, P2259, DOI 10.1098/rspb.2005.3248; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Helbing D, 2008, ADV COMPLEX SYST, V11, P641, DOI 10.1142/S0219525908001866; Helbing D, 2009, P NATL ACAD SCI USA, V106, P3680, DOI 10.1073/pnas.0811503106; Henn BM, 2012, P NATL ACAD SCI USA, V109, P17758, DOI 10.1073/pnas.1212380109; Ichinose G, 2007, P 2007 IEEE S ART LI, P236; Ichinose G, 2008, ECOL MODEL, V210, P221, DOI 10.1016/j.ecolmodel.2007.07.025; Janssen MA, 2006, J THEOR BIOL, V243, P134, DOI 10.1016/j.jtbi.2006.06.012; Jiang LL, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036108; Killingback T, 2006, P ROY SOC B-BIOL SCI, V273, P1477, DOI 10.1098/rspb.2006.3476; Le Galliard JF, 2005, AM NAT, V165, P206, DOI 10.1086/427090; Majeski S. J., 1999, Complexity, V5, P16, DOI 10.1002/(SICI)1099-0526(199909/10)5:1<16::AID-CPLX3>3.0.CO;2-M; Masuda N, 2003, PHYS LETT A, V313, P55, DOI 10.1016/S0375-9601(03)00693-5; Masuda N, 2007, P R SOC B, V274, P1815, DOI 10.1098/rspb.2007.0294; Meloni S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.067101; Nakamaru M, 1997, J THEOR BIOL, V184, P65, DOI 10.1006/jtbi.1996.0243; NOWAK M, 1993, P NATL ACAD SCI USA, V90, P5091, DOI 10.1073/pnas.90.11.5091; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ono S, 2003, J THEOR BIOL, V220, P55, DOI 10.1006/jtbi.2003.3144; Pepper JW, 2007, ARTIF LIFE, V13, P1, DOI 10.1162/artl.2007.13.1.1; Pepper JW, 2002, AM NAT, V160, P205, DOI 10.1086/341018; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2006, J EVOLUTION BIOL, V19, P726, DOI 10.1111/j.1420-9101.2005.01063.x; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Sicardi EA, 2009, J THEOR BIOL, V256, P240, DOI 10.1016/j.jtbi.2008.09.022; Sober E., 1998, OTHERS EVOLUTION PSY; Suzuki S, 2008, J THEOR BIOL, V252, P686, DOI 10.1016/j.jtbi.2008.02.007; Suzuki S, 2008, THEOR POPUL BIOL, V73, P426, DOI 10.1016/j.tpb.2007.12.005; Suzuki S, 2011, J THEOR BIOL, V287, P42, DOI 10.1016/j.jtbi.2011.07.019; Szolnoki A, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036110; Szolnoki A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/043036; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Vainstein MH, 2007, J THEOR BIOL, V244, P722, DOI 10.1016/j.jtbi.2006.09.012; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040218; Wang Z, 2012, SCI REP-UK, V2, DOI 10.1038/srep00369; Wang Z, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.037101; Wang Z, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.011149; Wang Z, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021115; Watts D.J., 1999, SMALL WORLDS DYNAMIC; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Yang HX, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.065101	51	5	5	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67702	10.1371/journal.pone.0067702	http://dx.doi.org/10.1371/journal.pone.0067702			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861786	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000321425300022
J	Ferro, M; Bruzzese, D; Perdona, S; Marino, A; Mazzarella, C; Perruolo, G; D'Esposito, V; Cosimato, V; Buonerba, C; Di Lorenzo, G; Musi, G; De Cobelli, O; Chun, FK; Terracciano, D				Ferro, Matteo; Bruzzese, Dario; Perdona, Sisto; Marino, Ada; Mazzarella, Claudia; Perruolo, Giuseppe; D'Esposito, Vittoria; Cosimato, Vincenzo; Buonerba, Carlo; Di Lorenzo, Giuseppe; Musi, Gennaro; De Cobelli, Ottavio; Chun, Felix K.; Terracciano, Daniela			Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) Significantly Improve Prostate Cancer Detection at Initial Biopsy in a Total PSA Range of 2-10 ng/ml	PLOS ONE			English	Article							ISOFORM P2PSA; MULTICENTER; PREDICTION; SERUM; DERIVATIVES; VALIDATION; OUTCOMES	Many efforts to reduce prostate specific antigen (PSA) overdiagnosis and overtreatment have been made. To this aim, Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) have been proposed as new more specific biomarkers. We evaluated the ability of phi and PCA3 to identify prostate cancer (PCa) at initial prostate biopsy in men with total PSA range of 2-10 ng/ml. The performance of phi and PCA3 were evaluated in 300 patients undergoing first prostate biopsy. ROC curve analyses tested the accuracy (AUC) of phi and PCA3 in predicting PCa. Decision curve analyses (DCA) were used to compare the clinical benefit of the two biomarkers. We found that the AUC value of phi (0.77) was comparable to those of %p2PSA (0.76) and PCA3 (0.73) with no significant differences in pairwise comparison (%p2PSA vs phi p = 0.673, %p2PSA vs. PCA3 p = 0.417 and phi vs. PCA3 p = 0.247). These three biomarkers significantly outperformed fPSA (AUC = 0.60), %fPSA (AUC = 0.62) and p2PSA (AUC = 0.63). At DCA, phi and PCA3 exhibited a very close net benefit profile until the threshold probability of 25%, then phi index showed higher net benefit than PCA3. Multivariable analysis showed that the addition of phi and PCA3 to the base multivariable model (age, PSA, %fPSA, DRE, prostate volume) increased predictive accuracy, whereas no model improved single biomarker performance. Finally we showed that subjects with active surveillance (AS) compatible cancer had significantly lower phi and PCA3 values (p < 0.001 and p = 0.01, respectively). In conclusion, both phi and PCA3 comparably increase the accuracy in predicting the presence of PCa in total PSA range 2-10 ng/ml at initial biopsy, outperforming currently used %fPSA.	[Perdona, Sisto] Fdn G Pascale, Urol Unit, Naples, Italy; [Bruzzese, Dario] Univ Naples Federico II, Dept Prevent Med Sci, Naples, Italy; [Ferro, Matteo] Univ Naples Federico II, Urol Unit, Naples, Italy; [Marino, Ada; Mazzarella, Claudia; Perruolo, Giuseppe; D'Esposito, Vittoria; Cosimato, Vincenzo; Terracciano, Daniela] Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy; [Buonerba, Carlo; Di Lorenzo, Giuseppe] Univ Naples Federico II, Oncol Unit, Naples, Italy; [Ferro, Matteo; Musi, Gennaro; De Cobelli, Ottavio] European Inst Oncol, Div Urol, Milan, Italy; [Chun, Felix K.] Univ Med Ctr Hamburg Eppendorf, Dept Urol, Hamburg, Germany	IRCCS Fondazione Pascale; University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; IRCCS European Institute of Oncology (IEO); University of Hamburg; University Medical Center Hamburg-Eppendorf	Terracciano, D (corresponding author), Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy.	daniela.terracciano@unina.it	Terracciano, Daniela/AAB-9521-2022; DE COBELLI, OTTAVIO/O-2315-2017; Buonerba, Carlo/J-6095-2018; giuseppe, perruolo/AAW-3869-2021; D'Esposito, Vittoria/K-7633-2016; Chun, Felix/M-4652-2015; Bruzzese, Dario/H-4621-2012; perdonà, sisto/AAB-9017-2019; Ferro, Matteo/K-3705-2018; MUSI, Gennaro/AAP-8884-2020	Terracciano, Daniela/0000-0003-4296-429X; DE COBELLI, OTTAVIO/0000-0002-0699-8620; Buonerba, Carlo/0000-0002-1806-442X; D'Esposito, Vittoria/0000-0002-3675-8062; Chun, Felix/0000-0001-8486-9536; Bruzzese, Dario/0000-0001-9911-4646; MUSI, Gennaro/0000-0003-0833-9183; Ferro, Matteo/0000-0002-9250-7858; GIUSEPPE, DI LORENZO/0000-0001-7414-1568; Perruolo, Giuseppe/0000-0003-0479-8729				Auprich M, 2011, EUR UROL, V60, P1045, DOI 10.1016/j.eururo.2011.08.003; Auprich M, 2010, EUR UROL, V58, P727, DOI 10.1016/j.eururo.2010.06.038; Catalona WJ, 2011, J UROLOGY, V185, P1650, DOI 10.1016/j.juro.2010.12.032; Durand X, 2012, BJU INT, V110, P43, DOI 10.1111/j.1464-410X.2011.10682.x; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Ferro M, 2012, CLIN CHIM ACTA, V413, P1274, DOI 10.1016/j.cca.2012.04.017; Groskopf J, 2006, CLIN CHEM, V52, P1089, DOI 10.1373/clinchem.2005.063289; Guazzoni G, 2012, EUR UROL, V61, P455, DOI 10.1016/j.eururo.2011.10.038; Guazzoni G, 2011, EUR UROL, V60, P214, DOI 10.1016/j.eururo.2011.03.052; Guo WG, 2009, BIOMETRIKA, V96, P1012, DOI 10.1093/biomet/asp048; Hansen J, 2013, EUR UROL, V63, P201, DOI 10.1016/j.eururo.2012.07.030; Isharwal S, 2011, UROLOGY, V77, pe761; Lazzeri M, 2013, EUR UROL, V63, P986, DOI 10.1016/j.eururo.2013.01.011; Loeb S, 2006, J UROLOGY, V175, P902, DOI 10.1016/S0022-5347(05)00327-7; Perdona S, 2013, PROSTATE, V73, P227, DOI 10.1002/pros.22561; Scattoni V, 2013, J UROLOGY, V190, P496, DOI 10.1016/j.juro.2013.02.3184; Semjonow A, 2010, CLIN BIOCHEM, V43, P926, DOI 10.1016/j.clinbiochem.2010.04.062; Stephan C, 2013, CLIN CHEM, V59, P280, DOI 10.1373/clinchem.2012.195560; Stephan C, 2013, CLIN CHEM, V59, P306, DOI 10.1373/clinchem.2012.195784; Steyerberg EW, 2008, MED DECIS MAKING, V28, P146, DOI 10.1177/0272989X07312725; Tosoian JJ, 2012, J UROLOGY, V188, P1131, DOI 10.1016/j.juro.2012.06.009; Tosoian JJ, 2010, J UROLOGY, V183, P534, DOI 10.1016/j.juro.2009.10.003; Tuck MK, 2009, J PROTEOME RES, V8, P113, DOI 10.1021/pr800545q; van den Bergh RCN, 2010, BJU INT, V105, P956, DOI 10.1111/j.1464-410X.2009.08887.x; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361	25	79	86	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67687	10.1371/journal.pone.0067687	http://dx.doi.org/10.1371/journal.pone.0067687			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861782	gold, Green Submitted, Green Published			2022-12-27	WOS:000323350700021
J	Li, GQ; Liu, D; Zhang, Y; Qian, YY; Zhang, H; Guo, SY; Sunagawa, M; Hisamitsu, T; Liu, YQ				Li, Guoqing; Liu, Dan; Zhang, Yu; Qian, Yayun; Zhang, Hua; Guo, Shiyu; Sunagawa, Masataka; Hisamitsu, Tadashi; Liu, Yanqing			Celastrol Inhibits Lipopolysaccharide-Stimulated Rheumatoid Fibroblast-Like Synoviocyte Invasion through Suppression of TLR4/NF-kappa B-Mediated Matrix Metalloproteinase-9 Expression	PLOS ONE			English	Article							NF-KAPPA-B; AUTOIMMUNE ARTHRITIS; GENE-EXPRESSION; SYNOVIAL FIBROBLASTS; TUMOR-CELLS; PATHWAYS; METALLOPROTEINASES; ANGIOGENESIS; MEDIATORS; MIGRATION	Invasion of fibroblast-like synoviocytes (FLSs) is critical in the pathogenesis of rheumatoid arthritis (RA). The metalloproteinases (MMPs) and activator of Toll-like receptor 4 (TLR4)/nuclear factor-kB (NF-kB) pathway play a critical role in RA-FLS invasion induced by lipopolysaccharide (LPS). The present study aimed to explore the anti-invasive activity of celastrol on LPS-stimulated human RA-FLSs, and to elucidate the mechanism involved. We investigated the effect of celastrol on LPS-induced FLS migration and invasion as well as MMP expression and explored the upstream signal transduction. Results showed that celastrol suppressed LPS-stimulated FLS migration and invasion by inhibiting MMP-9 expression and activity. Furthermore, our results revealed that celastrol inhibited the transcriptional activity of MMP-9 by suppressing the binding activity of NF-kB in the MMP-9 promoter, and suppressed the TLR4/MyD88/NF-kB pathway. Administration of celastrol (0.5 mg/kg and 1 mg/kg, intraperitoneally) daily for 3 weeks in a collagen-induced arthritis rat model markedly alleviated the clinical signs, synovial hyperplasia and inflammatory cell infiltration of joints. In conclusion, celastrol might inhibit FLS migration and invasion induced by LPS by suppressing TLR4/NF-kB-mediated MMP-9 expression, providing a theoretical foundation for the clinical treatment of RA with celastrol.	[Li, Guoqing; Zhang, Yu] Yangzhou Univ, Dept Rheumatol, Clin Med Coll, Yangzhou, Jiangsu, Peoples R China; [Liu, Dan] Yangzhou Univ, Dept Pathol, Clin Med Coll, Yangzhou, Jiangsu, Peoples R China; [Qian, Yayun; Zhang, Hua; Liu, Yanqing] Yangzhou Univ, Inst Combining Chinese Tradit & Western Med, Coll Med, Yangzhou, Jiangsu, Peoples R China; [Guo, Shiyu; Sunagawa, Masataka; Hisamitsu, Tadashi] Showa Univ, Sch Med, Dept Physiol, Tokyo 142, Japan	Yangzhou University; Yangzhou University; Yangzhou University; Showa University	Liu, YQ (corresponding author), Yangzhou Univ, Inst Combining Chinese Tradit & Western Med, Coll Med, Yangzhou, Jiangsu, Peoples R China.	yanqingliu126@163.com	Sunagawa, Masataka/ABE-4996-2021		National Natural Science Foundation of China [81173603]; Postgraduate Research and Innovation Project of Jiangsu Province [CXZZ11-0998]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postgraduate Research and Innovation Project of Jiangsu Province	This study was supported by grants from National Natural Science Foundation of China (no. 81173603), and Postgraduate Research and Innovation Project of Jiangsu Province (no. CXZZ11-0998). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi-Roodsaz S, 2007, ARTHRITIS RHEUM, V56, P2957, DOI 10.1002/art.22848; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Cameron M, 2009, PHYTOTHER RES, V23, P1647, DOI 10.1002/ptr.3006; Cascao R, 2012, AUTOIMMUN REV, V11, P856, DOI 10.1016/j.autrev.2012.02.022; FASSBENDER HG, 1983, J PATHOL, V139, P399, DOI 10.1002/path.1711390314; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Gupta SC, 2010, CANCER METAST REV, V29, P405, DOI 10.1007/s10555-010-9235-2; Jing YY, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-98; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Karouzakis E, 2009, NAT REV RHEUMATOL, V5, P266, DOI 10.1038/nrrheum.2009.55; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Lefevre S, 2009, NAT MED, V15, P1414, DOI 10.1038/nm.2050; Li GQ, 2012, INT IMMUNOPHARMACOL, V14, P422, DOI 10.1016/j.intimp.2012.08.016; Magnani M., 2000, Current Drug Targets, V1, P387, DOI 10.2174/1389450003349056; Moon SK, 2004, J CELL PHYSIOL, V198, P417, DOI 10.1002/jcp.10435; Murphy G, 2008, NAT CLIN PRACT RHEUM, V4, P128, DOI 10.1038/ncprheum0727; Nanjundaiah SM, 2012, J BIOL CHEM, V287, P22216, DOI 10.1074/jbc.M112.356816; Ou YQ, 2011, RHEUMATOL INT, V31, P1479, DOI 10.1007/s00296-010-1506-2; Park HJ, 2011, J ETHNOPHARMACOL, V137, P1240, DOI 10.1016/j.jep.2011.07.052; Philippe L, 2012, J IMMUNOL, V188, P454, DOI 10.4049/jimmunol.1102348; SATO H, 1993, ONCOGENE, V8, P395; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; Smolen JS, 2003, NAT REV DRUG DISCOV, V2, P473, DOI 10.1038/nrd1109; Sumariwalla PF, 2003, ARTHRITIS RES THER, V5, pR32, DOI 10.1186/ar608; Tolboom TCA, 2002, ANN RHEUM DIS, V61, P975, DOI 10.1136/ard.61.11.975; Tong L, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2268; Tsubaki T, 2005, ARTHRITIS RES THER, V7, pR825, DOI 10.1186/ar1751; van Vollenhoven RF, 2009, NAT REV RHEUMATOL, V5, P531, DOI 10.1038/nrrheum.2009.182; Venkatesha SH, 2011, J BIOL CHEM, V286, P15138, DOI 10.1074/jbc.M111.226365; Westra J, 2004, ANN RHEUM DIS, V63, P1453, DOI 10.1136/ard.2003.013011; Woo JH, 2003, CANCER RES, V63, P3430; Yu H, 2012, INT IMMUNOPHARMACOL, V13, P499, DOI 10.1016/j.intimp.2012.05.015	36	71	76	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68905	10.1371/journal.pone.0068905	http://dx.doi.org/10.1371/journal.pone.0068905			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861949	Green Published, Green Submitted, gold			2022-12-27	WOS:000323350700106
J	Ng, XW; Huang, YY; Chen, HH; Burnett, JC; Boey, FYC; Venkatraman, SS				Ng, Xu Wen; Huang, Yingying; Chen, Horng H.; Burnett, John C., Jr.; Boey, Freddy Y. C.; Venkatraman, Subbu S.			Cenderitide-Eluting Film for Potential Cardiac Patch Applications	PLOS ONE			English	Article							CHIMERIC NATRIURETIC PEPTIDE; MYOCARDIAL-INFARCTION; HEART-FAILURE; SUPPORT DEVICE; CD-NP; FIBROBLASTS; SYSTEM; CARDIOTROPHIN-1; DEGRADATION; NESIRITIDE	Cenderitide, also known as CD-NP, is a designer peptide developed by combining native mammalian c-type natriuretic peptide (CNP) and the C-terminus isolated from the dendroapis natriuretic peptide (DNP) of the venom from the green mamba. In early studies, intravenous and subcutaneous infusion of cenderitide was reported to reduce left ventricular (LV) mass and ameliorate cardiac remodelling. In this work, biodegradable polymeric films encapsulating CD-NP were developed and were investigated for their in vitro release and degradation characteristics. Subsequently, the bioactivity of released peptide and its effects on human cardiac fibroblast (HCF) were explored. We achieved sustained release from three films with low, intermediate and high release profiles for 30 days. Moreover, the bioactivity of released peptide was verified from the elevated production of cyclic guanosine monophospate (cGMP). The CD-NP released from films was able to inhibit the proliferation of hypertrophic HCF as well as suppress DNA synthesis in HCF. Furthermore, the sustained delivery from films showed comparable or superior suppressive actions on hypertrophic HCF compared to daily infusion of CD-NP. The results suggest that these films could be used to inhibit fibrosis and reduce cardiac remodelling via local delivery as cardiac patches.	[Ng, Xu Wen; Huang, Yingying; Boey, Freddy Y. C.; Venkatraman, Subbu S.] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore; [Chen, Horng H.; Burnett, John C., Jr.] Mayo Clin, Div Cardiovasc Dis & Internal Med, Rochester, MN USA	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Mayo Clinic	Venkatraman, SS (corresponding author), Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.	assubbu@ntu.edu.sg	Venkatraman, Subramanian/A-2228-2011; Boey, Freddy Yin Chiang/G-2618-2017	Venkatraman, Subramanian/0000-0002-8693-1070; 	National Research Foundation - Competitive Research Programme [NRF-CRP 2-2007-01]	National Research Foundation - Competitive Research Programme	This work was supported by the following grant: The National Research Foundation - Competitive Research Programme, http://www.nrf.gov.sg/(NRF-CRP 2-2007-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abassi Z, 2004, PHARMACOL THERAPEUT, V102, P223, DOI 10.1016/j.pharmthera.2004.04.004; ALI SAM, 1993, BIOMATERIALS, V14, P648, DOI 10.1016/0142-9612(93)90063-8; Aronson D, 2004, AM HEART J, V148, DOI 10.1016/j.ahj.2004.05.027; Aronson D, 2012, PHARMACOL THERAPEUT, V135, P1, DOI 10.1016/j.pharmthera.2012.03.002; Asakura M, 2004, CIRC J, V68, P95, DOI 10.1253/circj.68.95; Barletta G, 1998, HYPERTENSION, V31, P802, DOI 10.1161/01.HYP.31.3.802; Baudino TA, 2006, AM J PHYSIOL-HEART C, V291, pH1015, DOI 10.1152/ajpheart.00023.2006; Bristow MR, 2002, CIRCULATION, V106, P1430, DOI 10.1161/01.CIR.0000034024.61382.42; Burnett JC, 2009, PCT Patent Application No PCT, Patent No. 046095; Chen HH, 2009, HEART, V95, P1315, DOI 10.1136/hrt.2008.153916; Chen HH, 2002, CIRCULATION, V105, P999, DOI 10.1161/hc0802.104282; Chen HH, 2002, J AM COLL CARDIOL, V40, P1186, DOI 10.1016/S0735-1097(02)02127-7; Chen HH, 2006, EUR HEART J SUPPL, V8, pE18, DOI 10.1093/eurheartj/sul026; Dickey DM, 2011, J MOL CELL CARDIOL, V51, P67, DOI 10.1016/j.yjmcc.2011.03.013; Freed DH, 2003, CARDIOVASC RES, V60, P365, DOI 10.1016/S0008-6363(03)00534-0; FURUYA M, 1992, BIOCHEM BIOPH RES CO, V183, P964, DOI 10.1016/S0006-291X(05)80284-0; Holmes JW, 2005, ANNU REV BIOMED ENG, V7, P223, DOI 10.1146/annurev.bioeng.7.060804.100453; HUNT PJ, 1994, J CLIN ENDOCR METAB, V78, P1428, DOI 10.1210/jc.78.6.1428; Kitakaze M, 2007, LANCET, V370, P2102; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Liao SY, 2010, J CARD FAIL, V16, P590, DOI 10.1016/j.cardfail.2010.02.007; Lisy O, 2008, J AM COLL CARDIOL, V52, P60, DOI 10.1016/j.jacc.2008.02.077; Liu KL, 2011, MOL PHARMACEUT, V8, P2173, DOI 10.1021/mp200513b; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; Mann DL, 2007, ANN THORAC SURG, V84, P1226, DOI 10.1016/j.athoracsur.2007.03.095; Mann DL, 2012, J THORAC CARDIOV SUR, V143, P1036, DOI 10.1016/j.jtcvs.2011.06.014; Mattos C, 2001, CURR OPIN STRUC BIOL, V11, P761, DOI 10.1016/S0959-440X(01)00278-0; Mazzaferri EL, 2012, AM HEART J, V163, P812, DOI 10.1016/j.ahj.2012.02.013; Michaels AD, 2003, CIRCULATION, V107, P2697, DOI 10.1161/01.CIR.0000070547.88378.EA; Mitrovic V, 2006, EUR HEART J, V27, P2823, DOI 10.1093/eurheartj/ehl337; Miyagi Y, 2011, BIOMATERIALS, V32, P1280, DOI 10.1016/j.biomaterials.2010.10.007; Nikolic SD, 2009, J CARD FAIL, V15, P790, DOI 10.1016/j.cardfail.2009.05.014; Nishikimi T, 2006, CARDIOVASC RES, V69, P318, DOI 10.1016/j.cardiores.2005.10.001; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Rose RA, 2010, CURR OPIN INVEST DR, V11, P349; Schmitt M, 2004, ARTERIOSCL THROM VAS, V24, P911, DOI 10.1161/01.ATV.zhq0504.7914; Snider P, 2009, CIRC RES, V105, P934, DOI 10.1161/CIRCRESAHA.109.201400; Socki T, 2005, J AM COLL CARDIOL, V45, P608, DOI 10.1016/j.jacc.2004.10.067; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Tamargo J, 2011, NAT REV DRUG DISCOV, V10, P536, DOI 10.1038/nrd3431; Tonnessen T, 2005, EUR J HEART FAIL, V7, P704, DOI 10.1016/j.ejheart.2005.07.005; Tsai EJ, 2009, PHARMACOL THERAPEUT, V122, P216, DOI 10.1016/j.pharmthera.2009.02.009; van de Weert M, 2000, PHARM RES-DORDR, V17, P1159, DOI 10.1023/A:1026498209874; WOODWARD SC, 1985, J BIOMED MATER RES, V19, P437, DOI 10.1002/jbm.820190408	44	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68346	10.1371/journal.pone.0068346	http://dx.doi.org/10.1371/journal.pone.0068346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861890	Green Published, gold			2022-12-27	WOS:000323350700081
J	Ball, G; Boardman, JP; Arichi, T; Merchant, N; Rueckert, D; Edwards, AD; Counsell, SJ				Ball, Gareth; Boardman, James P.; Arichi, Tomoki; Merchant, Nazakat; Rueckert, Daniel; Edwards, A. David; Counsell, Serena J.			Testing the Sensitivity of Tract-Based Spatial Statistics to Simulated Treatment Effects in Preterm Neonates	PLOS ONE			English	Article							TERM-EQUIVALENT AGE; WHITE-MATTER; PREMATURE-INFANTS; POWER CALCULATION; BRAIN; BIRTH; ERYTHROPOIETIN; OUTCOMES; DISEASE; FMRI	Early neuroimaging may provide a surrogate marker for brain development and outcome after preterm birth. Tract-Based Spatial Statistics (TBSS) is an advanced Diffusion Tensor Image (DTI) analysis technique that is sensitive to the effects of prematurity and may provide a quantitative marker for neuroprotection following perinatal brain injury or preterm birth. Here, we test the sensitivity of TBSS to detect diffuse microstructural differences in the developing white matter of preterm infants at term-equivalent age by modelling a 'treatment' effect as a global increase in fractional anisotropy (FA). As proof of concept we compare these simulations to a real effect of increasing age at scan. 3-Tesla, 15-direction diffusion tensor imaging (DTI) was acquired from 90 preterm infants at term-equivalent age. Datasets were randomly assigned to 'treated' or 'untreated' groups of increasing size and voxel-wise increases in FA were used to simulate global treatment effects of increasing magnitude in all 'treated' maps. 'Treated' and 'untreated' FA maps were compared using TBSS. Predictions from simulated data were then compared to exemplar TBSS group comparisons based on increasing postmenstrual age at scan. TBSS proved sensitive to global differences in FA within a clinically relevant range, even in relatively small group sizes, and simulated data were shown to predict well a true biological effect of increasing age on white matter development. These data confirm that TBSS is a sensitive tool for detecting global group-wise differences in FA in this population.	[Ball, Gareth; Arichi, Tomoki; Merchant, Nazakat; Edwards, A. David; Counsell, Serena J.] Kings Coll London, Ctr Dev Brain, Div Imaging Sci & Biomed Engn, London WC2R 2LS, England; [Boardman, James P.] Univ Edinburgh, MRC, Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Rueckert, Daniel] Univ London Imperial Coll Sci Technol & Med, Dept Comp, Biomed Image Anal Grp, London, England	University of London; King's College London; University of Edinburgh; Imperial College London	Ball, G (corresponding author), Kings Coll London, Ctr Dev Brain, Div Imaging Sci & Biomed Engn, London WC2R 2LS, England.	gareth.ball@kcl.ac.uk	Edwards, Anthony/HCI-9626-2022; counsell, serena j/I-9012-2014; Boardman, James/K-5472-2015; Arichi, Tomoki/AFR-9798-2022	Arichi, Tomoki/0000-0002-3550-1644; Ball, Gareth/0000-0003-3509-1435; Counsell, Serena/0000-0002-8033-5673; Rueckert, Daniel/0000-0002-5683-5889; Merchant, Nazakat/0000-0001-7520-3169; Boardman, James/0000-0003-3904-8960; Edwards, Anthony David/0000-0003-4801-7066	National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, and at Imperial College London; MRC; EPSRC; Garfield Weston Foundation; MRC [G1002033, MR/K006355/1] Funding Source: UKRI; Medical Research Council [G1002033, MR/K006355/1] Funding Source: researchfish	National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, and at Imperial College London; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Garfield Weston Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, and at Imperial College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. Funding for the research was supplied by MRC, EPSRC and the Garfield Weston Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Als H, 2004, PEDIATRICS, V113, P846, DOI 10.1542/peds.113.4.846; Anjari M, 2007, NEUROIMAGE, V35, P1021, DOI 10.1016/j.neuroimage.2007.01.035; Ball G, 2012, CEREB CORTEX, V22, P1016, DOI 10.1093/cercor/bhr176; Ball G, 2010, NEUROIMAGE, V53, P94, DOI 10.1016/j.neuroimage.2010.05.055; Bierer R, 2006, PEDIATRICS, V118, pE635, DOI 10.1542/peds.2005-3186; Boardman JP, 2010, NEUROIMAGE, V52, P409, DOI 10.1016/j.neuroimage.2010.04.261; Boardman JP, 2006, NEUROIMAGE, V32, P70, DOI 10.1016/j.neuroimage.2006.03.029; Brown MS, 2009, PEDIATRICS, V124, pE681, DOI 10.1542/peds.2008-2701; Counsell SJ, 2008, BRAIN, V131, P3201, DOI 10.1093/brain/awn268; Counsell SJ, 2003, PEDIATRICS, V112, P1, DOI 10.1542/peds.112.1.1; Delobel-Ayoub M, 2009, PEDIATRICS, V123, P1485, DOI 10.1542/peds.2008-1216; Dyet LE, 2006, PEDIATRICS, V118, P536, DOI 10.1542/peds.2005-1866; Huppi PS, 1998, PEDIATR RES, V44, P584; Inder TE, 2005, PEDIATRICS, V115, P286, DOI 10.1542/peds.2004-0326; Joyce KE, 2012, NEUROINFORMATICS, V10, P351, DOI 10.1007/s12021-012-9152-3; Kostovic I, 2010, ACTA PAEDIATR, V99, P1119, DOI 10.1111/j.1651-2227.2010.01811.x; Krishnan ML, 2007, PEDIATRICS, V120, pE604, DOI 10.1542/peds.2006-3054; Limperopoulos C, 2010, NAT REV NEUROL, V6, P301, DOI 10.1038/nrneurol.2010.66; Maitre NL, 2012, JAMA-J AM MED ASSOC, V307, P304, DOI 10.1001/jama.2011.2026; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; McAnulty G, 2009, ACTA PAEDIATR, V98, P1920, DOI 10.1111/j.1651-2227.2009.01492.x; Milgrom J, 2010, PEDIATR RES, V67, P330, DOI 10.1203/PDR.0b013e3181cb8e2f; Mumford JA, 2008, NEUROIMAGE, V39, P261, DOI 10.1016/j.neuroimage.2007.07.061; Murphy K, 2004, NEUROIMAGE, V22, P879, DOI 10.1016/j.neuroimage.2004.02.005; Neubauer AP, 2010, ANN NEUROL, V67, P657, DOI 10.1002/ana.21977; Olivier P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007128; Porter EJ, 2010, PEDIATR RES, V68, P205, DOI 10.1203/00006450-201011001-00399; Rathbone R, 2011, NEUROLOGY, V77, P1510, DOI 10.1212/WNL.0b013e318233b215; Rose SE, 2008, MAGN RESON MED, V60, P761, DOI 10.1002/mrm.21689; Short EJ, 2003, PEDIATRICS, V112, pE359, DOI 10.1542/peds.112.5.e359; Skiold B, 2010, ACTA PAEDIATR, V99, P842, DOI 10.1111/j.1651-2227.2009.01634.x; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Tusor N, 2012, PEDIATR RES, DOI [10.1038/pr.2012.40;10.1038/pr.2012.40, DOI 10.1038/PR.2012.40;10.1038/PR.2012.40]; Van Hecke W, 2009, NEUROIMAGE, V46, P692, DOI 10.1016/j.neuroimage.2009.02.032; van Kooij BJM, 2012, AM J NEURORADIOL, V33, P188, DOI 10.3174/ajnr.A2723; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Welin AK, 2007, PEDIATR RES, V61, P153, DOI 10.1203/01.pdr.0000252546.20451.1a	39	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67706	10.1371/journal.pone.0067706	http://dx.doi.org/10.1371/journal.pone.0067706			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844070	gold, Green Published			2022-12-27	WOS:000321733000096
J	Drecktrah, D; Hall, LS; Hoon-Hanks, LL; Samuels, DS				Drecktrah, Dan; Hall, Laura S.; Hoon-Hanks, Laura L.; Samuels, D. Scott			An Inverted Repeat in the ospC Operator Is Required for Induction in Borrelia burgdorferi	PLOS ONE			English	Article							OUTER-SURFACE PROTEIN; LYME-DISEASE SPIROCHETE; RESPONSE REGULATOR RRP2; GENE-EXPRESSION; ESCHERICHIA-COLI; MAMMALIAN INFECTION; CIRCULAR PLASMID; VIRULENCE FACTOR; DNA GYRASE; RPOS	Borrelia burgdorferi, the spirochete that causes Lyme disease, differentially regulates synthesis of the outer membrane lipoprotein OspC to infect its host. OspC is required to establish infection but then repressed in the mammal to avoid clearance by the adaptive immune response. Inverted repeats (IR) upstream of the promoter have been implicated as an operator to regulate ospC expression. We molecularly dissected the distal inverted repeat (dIR) of the ospC operator by site-directed mutagenesis at its endogenous location on the circular plasmid cp26. We found that disrupting the dIR but maintaining the proximal IR prevented induction of OspC synthesis by DNA supercoiling, temperature, and pH. Moreover, the base-pairing potential of the two halves of the dIR was more important than the nucleotide sequence in controlling OspC levels. These results describe a cis-acting element essential for the expression of the virulence factor OspC.	[Drecktrah, Dan; Hall, Laura S.; Hoon-Hanks, Laura L.; Samuels, D. Scott] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Samuels, D. Scott] Univ Montana, Ctr Biomol Struct & Dynam, Missoula, MT 59812 USA	University of Montana System; University of Montana; University of Montana System; University of Montana	Samuels, DS (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.	scott.samuels@umontana.edu	Samuels, D Scott/B-7549-2012	Samuels, D Scott/0000-0001-8352-7593	Public Health Service [AI051486, P20 GM103546]; National Institutes of Health; Watkins Scholarship from The University of Montana; Undergraduate Research Internship through the National Science Foundation EPSCoR program [EPS-0701906]; Davidson Honors College; Honors Fellowship through the Montana Integrative Learning Experience for Students (MILES) program from the Howard Hughes Medical Institute-Undergraduate Science Education Program [52005905]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103546] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Watkins Scholarship from The University of Montana; Undergraduate Research Internship through the National Science Foundation EPSCoR program; Davidson Honors College; Honors Fellowship through the Montana Integrative Learning Experience for Students (MILES) program from the Howard Hughes Medical Institute-Undergraduate Science Education Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Public Health Service grants AI051486 to D.S.S. and P20 GM103546 to the Center for Biomolecular Structure and Dynamics from the National Institutes of Health. L.L.H.-H. was supported by a Watkins Scholarship from The University of Montana, an Undergraduate Research Internship through the National Science Foundation EPSCoR program under Grant EPS-0701906, an Undergraduate Research Award from the Davidson Honors College, and an Honors Fellowship through the Montana Integrative Learning Experience for Students (MILES) program under Grant 52005905 from the Howard Hughes Medical Institute-Undergraduate Science Education Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alverson J, 2003, MOL MICROBIOL, V48, P1665, DOI 10.1046/j.1365-2958.2003.03537.x; Archambault L, 2013, BIOCHEM BIOPH RES CO, V433, P73, DOI 10.1016/j.bbrc.2013.02.063; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; Battisti JM, 2008, INFECT IMMUN, V76, P5228, DOI 10.1128/IAI.00410-08; Beaurepaire C, 2007, MOL MICROBIOL, V63, P443, DOI 10.1111/j.1365-2958.2006.05533.x; BENACH JL, 1983, NEW ENGL J MED, V308, P740, DOI 10.1056/NEJM198303313081302; Boardman BK, 2008, INFECT IMMUN, V76, P3844, DOI 10.1128/IAI.00467-08; Bono JL, 2000, J BACTERIOL, V182, P2445, DOI 10.1128/JB.182.9.2445-2452.2000; Brisson D, 2012, ANNU REV GENET, V46, P515, DOI 10.1146/annurev-genet-011112-112140; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Burtnick MN, 2007, MOL MICROBIOL, V65, P277, DOI 10.1111/j.1365-2958.2007.05813.x; Caimano MJ, 2004, INFECT IMMUN, V72, P6433, DOI 10.1128/IAI.72.11.6433-6445.2004; Calmano MJ, 2007, MOL MICROBIOL, V65, P1193, DOI 10.1111/j.1365-2958.2007.05860.x; Carroll JA, 1999, INFECT IMMUN, V67, P3181, DOI 10.1128/IAI.67.7.3181-3187.1999; Damman CJ, 2000, J BACTERIOL, V182, P6791, DOI 10.1128/JB.182.23.6791-6797.2000; Dorman CJ, 2013, NAT REV MICROBIOL, V11, P349, DOI 10.1038/nrmicro3007; DRLICA K, 1978, J MOL BIOL, V120, P145, DOI 10.1016/0022-2836(78)90061-X; Dykhuizen DE, 2008, AM J TROP MED HYG, V78, P806, DOI 10.4269/ajtmh.2008.78.806; Earnhart CG, 2005, INFECT IMMUN, V73, P7869, DOI 10.1128/IAI.73.12.7869-7877.2005; Earnhart CG, 2011, CLIN VACCINE IMMUNOL, V18, P901, DOI 10.1128/CVI.05004-11; Earnhart CG, 2010, MOL MICROBIOL, V76, P393, DOI 10.1111/j.1365-2958.2010.07103.x; Eggers CH, 2004, J BACTERIOL, V186, P7390, DOI 10.1128/JB.186.21.7390-7402.2004; Fisher MA, 2005, P NATL ACAD SCI USA, V102, P5162, DOI 10.1073/pnas.0408536102; FUCHS R, 1992, MOL MICROBIOL, V6, P503, DOI 10.1111/j.1365-2958.1992.tb01495.x; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P4474, DOI 10.1073/pnas.73.12.4474; Gilbert MA, 2007, MOL MICROBIOL, V63, P1259, DOI 10.1111/j.1365-2958.2007.05593.x; Grimm D, 2004, P NATL ACAD SCI USA, V101, P3142, DOI 10.1073/pnas.0306845101; Hatfield GW, 2002, ANNU REV GENET, V36, P175, DOI 10.1146/annurev.genet.36.032902.111815; Hoon-Hanks LL, 2012, FEMS IMMUNOL MED MIC, V66, P157, DOI 10.1111/j.1574-695X.2012.00996.x; Hubner A, 2001, P NATL ACAD SCI USA, V98, P12724, DOI 10.1073/pnas.231442498; Hyde JA, 2007, J BACTERIOL, V189, P437, DOI 10.1128/JB.01109-06; Hyde JA, 2010, INFECT IMMUN, V78, P265, DOI 10.1128/IAI.01018-09; Hyde JA, 2009, MOL MICROBIOL, V74, P1344, DOI 10.1111/j.1365-2958.2009.06951.x; Kenedy MR, 2012, FEMS IMMUNOL MED MIC, V66, P1, DOI 10.1111/j.1574-695X.2012.00980.x; Knight SW, 2000, J BACTERIOL, V182, P2048, DOI 10.1128/JB.182.7.2048-2051.2000; Lagal V, 2006, MICROBES INFECT, V8, P645, DOI 10.1016/j.micinf.2005.08.017; LANE RS, 1991, ANNU REV ENTOMOL, V36, P587, DOI 10.1146/annurev.en.36.010191.003103; Liang FT, 2004, INFECT IMMUN, V72, P5759, DOI 10.1128/IAI.72.10.5759-5767.2004; Liang FT, 2002, J EXP MED, V196, P275, DOI 10.1084/jem.20020770; Lybecker MC, 2007, MOL MICROBIOL, V64, P1075, DOI 10.1111/j.1365-2958.2007.05716.x; Lybecker MC, 2010, MOL MICROBIOL, V78, P622, DOI 10.1111/j.1365-2958.2010.07374.x; MARCONI RT, 1993, J BACTERIOL, V175, P926, DOI 10.1128/JB.175.4.926-932.1993; MARGOLIS N, 1994, GENE, V143, P105, DOI 10.1016/0378-1119(94)90613-0; MARGOLIS N, 1994, J BACTERIOL, V176, P6427, DOI 10.1128/JB.176.21.6427-6432.1994; MAXWELL A, 1993, MOL MICROBIOL, V9, P681, DOI 10.1111/j.1365-2958.1993.tb01728.x; McDowell JV, 2002, INFECT IMMUN, V70, P4196, DOI 10.1128/IAI.70.8.4196-4203.2002; Montgomery RR, 1996, J EXP MED, V183, P261, DOI 10.1084/jem.183.1.261; Onder O, 2012, J BIOL CHEM, V287, P16860, DOI 10.1074/jbc.M111.290775; Ouyang Z, 2011, PLOS PATHOG, V7, DOI DOI 10.1371/J0URNAL.PPAT.1001272; Ouyang ZM, 2009, MOL MICROBIOL, V74, P1331, DOI 10.1111/j.1365-2958.2009.06945.x; Pal U, 2000, J CLIN INVEST, V106, P561, DOI 10.1172/JCI9427; Pal U, 2004, CELL, V119, P457, DOI 10.1016/j.cell.2004.10.027; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; Piesman J., 2010, BORRELIA MOL BIOL HO, P251; Radolf JD, 2008, MOL MICROBIOL, V69, P1, DOI 10.1111/j.1365-2958.2008.06226.x; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Ramamoorthi N, 2005, NATURE, V436, P573, DOI 10.1038/nature03812; SADZIENE A, 1993, INFECT IMMUN, V61, P2192, DOI 10.1128/IAI.61.5.2192-2195.1993; Saier MH, 2008, CRIT REV BIOCHEM MOL, V43, P89, DOI [10.1080/10409230801921262, 10.1080/10409230801921262 ]; Samuels D S, 1995, Methods Mol Biol, V47, P253; Samuels DS, 2011, ANNU REV MICROBIOL, V65, P479, DOI 10.1146/annurev.micro.112408.134040; SAMUELS DS, 1994, J BACTERIOL, V176, P6045, DOI 10.1128/jb.176.19.6045-6049.1994; SAMUELS DS, 1993, ANTIMICROB AGENTS CH, V37, P46, DOI 10.1128/AAC.37.1.46; Schwan TG, 2003, BIOCHEM SOC T, V31, P108, DOI 10.1042/BST0310108; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Seinost G, 1999, INFECT IMMUN, V67, P3518, DOI 10.1128/IAI.67.7.3518-3524.1999; Seshu J, 2004, INFECT IMMUN, V72, P1580, DOI 10.1128/IAI.72.3.1580-1586.2004; Singh SK, 2004, LANCET INFECT DIS, V4, P575; STEERE AC, 1983, NEW ENGL J MED, V308, P733, DOI 10.1056/NEJM198303313081301; STEVENSON B, 1995, INFECT IMMUN, V63, P4535, DOI 10.1128/IAI.63.11.4535-4539.1995; Stewart PE, 2006, INFECT IMMUN, V74, P3547, DOI 10.1128/IAI.00158-06; Tilly K, 1997, MOL MICROBIOL, V25, P361, DOI 10.1046/j.1365-2958.1997.4711838.x; Tilly K, 2013, MOL MICROBI IN PRESS; Tilly K, 2007, INFECT IMMUN, V75, P1517, DOI 10.1128/IAI.01725-06; Tilly K, 2006, INFECT IMMUN, V74, P3554, DOI 10.1128/IAI.01950-05; Troxell B, 2013, INFECT IMMU IN PRESS; Wormser GP, 2008, J INFECT DIS, V198, P1358, DOI 10.1086/592279; Xu HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001104; Xu QL, 2008, MOL MICROBIOL, V69, P15, DOI 10.1111/j.1365-2958.2008.06264.x; Xu QL, 2007, MOL MICROBIOL, V64, P220, DOI 10.1111/j.1365-2958.2007.05636.x; Xu QL, 2006, INFECT IMMUN, V74, P5177, DOI 10.1128/IAI.00713-06; Yang XF, 2000, MOL MICROBIOL, V37, P1470, DOI 10.1046/j.1365-2958.2000.02104.x; Yang XFF, 2005, J BACTERIOL, V187, P4822, DOI 10.1128/JB.187.14.4822-4829.2005; Yang XFF, 2004, J EXP MED, V199, P641, DOI 10.1084/jem.20031960; Yang XFF, 2003, P NATL ACAD SCI USA, V100, P11001, DOI 10.1073/pnas.1834315100; Zhang JR, 1997, CELL, V89, P275, DOI 10.1016/S0092-8674(00)80206-8; Zhiming OY, 2008, MICROBIOL-SGM, V154, P2641, DOI 10.1099/mic.0.2008/019992-0	87	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68799	10.1371/journal.pone.0068799	http://dx.doi.org/10.1371/journal.pone.0068799			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844242	Green Published, Green Submitted, gold			2022-12-27	WOS:000321733000027
J	Pan, XF; Zhang, K; Yang, XA; Liang, JY; Sun, HX; Li, XJ; Zou, Y; Xu, QQ; An, G; Li, G; Xu, QH				Pan, Xingfei; Zhang, Ka; Yang, Xiaoan; Liang, Jiayi; Sun, Haixia; Li, Xuejun; Zou, Yong; Xu, Qingqiang; An, Geng; Li, Gang; Xu, Qihuan			Relapse Rate and Associated-Factor of Recurrence after Stopping NUCs Therapy with Different Prolonged Consolidation Therapy in HBeAg Positive CHB Patients	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; E-ANTIGEN SEROCONVERSION; PACIFIC CONSENSUS STATEMENT; VIRUS DNA; NATURAL-HISTORY; DURABILITY; MANAGEMENT; INFECTION; GENOTYPES; LEVEL	Background: Many chronic hepatitis B (CHB) patients recur after off-therapy and have to accept prolonged consolidation therapy with NUCs. We investigated the rate of HBV relapse after stopping NUCs therapy with different time period of prolonged consolidation therapy in HBeAg positive CHB patients, and analyzed the associated-factor of recurrence. Methods: We recruited 162 HBeAg-positive CHB patients who met the standard of stopping NUCs therapy recommended by the 2005 APASL. Patients in group A, without the prolonged consolidation therapy, were as controls. Patients in group B were divided into 3 subgroups (group B1, 7 (range 3-11) months of the prolonged consolidation therapy; group B2, 17 (range 13-20) months of the prolonged consolidation therapy; group B3, 28 (range 25-34) months of the prolonged consolidation therapy). Virologic relapse was defined as an increase in serum HBV DNA to > 10(3) copies/ml after off-therapy. Results: One hundred and thirty-six patients (group A, 40 patients; group B1, 54 patients; group B2, 23 patients; group B3, 19 patients) were eligible for this study. The cumulative rates of relapse in group B at 6 months and 48 months were 29.2%, 41.7% after off-therapy, respectively. The cumulative rates of relapse in group B were statistically lower than that in group A at the same time periods. The cumulative rate of relapse in group B3 or group B2 was statistically lower than that in group B1, respectively. On multivariate analysis by Cox's proportional hazard model, age at off-therapy, baseline ALT and the different time period of the prolonged consolidation therapy were associated with the relapse of HBV after off-therapy. Conclusions: Consolidation therapy with NUCs after HBeAg seroconversion should be further prolonged. Age at off-therapy, ALT at baseline and the time period of the prolonged consolidation therapy could provide information to direct anti-viral therapy.	[Pan, Xingfei; Zhang, Ka; Yang, Xiaoan; Sun, Haixia; Li, Xuejun; Li, Gang; Xu, Qihuan] Sun Yat Sen Univ, Dept Infect Dis, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Liang, Jiayi] Sun Yat Sen Univ, Ultrasound Div, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Zou, Yong] Sun Yat Sen Univ, Dept Blood Transfus, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Xu, Qingqiang] Zhengzhou Childrens Hosp, Dept Dermatol, Zhengzhou, Peoples R China; [An, Geng] Guangzhou Med Univ, Dept Reprod Med Ctr, Affiliated Hosp 3, Key Lab Major Obstet Dis Guangdong Prov, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Guangzhou Medical University	Xu, QH (corresponding author), Sun Yat Sen Univ, Dept Infect Dis, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China.	xqh0303@yahoo.com.cn			Guangdong Natural Science Foundation [S2011010004680]; Program for New Century Excellent Talents in University [NCET-04-0797]; Medical Research Fund of Guangdong Pharmaceutical Association [2011G23, 2012GRS01]; National Natural Science Fund of China [81000180]	Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Medical Research Fund of Guangdong Pharmaceutical Association; National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This work was supported by research grants from the Project Supported by Guangdong Natural Science Foundation (Grant No. S2011010004680), Program for New Century Excellent Talents in University (NCET-04-0797), Medical Research Fund of Guangdong Pharmaceutical Association (Grant No. 2011G23, 2012GRS01), and National Natural Science Fund of China (Grant No. 81000180). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chien RN, 2003, HEPATOLOGY, V38, P1267, DOI 10.1053/jhep.2003.50458; Chu CM, 2007, GASTROENTEROLOGY, V133, P1458, DOI 10.1053/j.gastro.2007.08.039; Dandri Maura, 2005, Hepatology, V42, P1453, DOI 10.1002/hep.20976; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Glebe D, 2007, WORLD J GASTROENTERO, V13, P8, DOI 10.3748/wjg.v13.i1.8; Hoofnagle JH, 2007, HEPATOLOGY, V45, P1056, DOI 10.1002/hep.21627; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; Kao JH, 2000, GASTROENTEROLOGY, V118, P554, DOI 10.1016/S0016-5085(00)70261-7; Kao JH, 2004, J MED VIROL, V72, P363, DOI 10.1002/jmv.10534; Ke WM, 2011, J VIRAL HEPATITIS, V18, P637, DOI 10.1111/j.1365-2893.2011.01444.x; Lee CM, 2002, J HEPATOL, V37, P669, DOI 10.1016/S0168-8278(02)00267-2; Liaw YF, 2005, LIVER INT, V25, P472, DOI 10.1111/j.1478-3231.2005.01134.x; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Orito E, 2001, HEPATOLOGY, V34, P590, DOI 10.1053/jhep.2001.27221; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Reijnders JGP, 2010, GASTROENTEROLOGY, V139, P491, DOI 10.1053/j.gastro.2010.03.059; Song MJ, 2012, WORLD J GASTROENTERO, V18, P6277, DOI 10.3748/wjg.v18.i43.6277; van Nunen AB, 2003, GUT, V52, P420, DOI 10.1136/gut.52.3.420; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Xu XW, 2005, CLIN MICROBIOL INFEC, V11, P52, DOI 10.1111/j.1469-0691.2004.01029.x; Yan J, 2011, HEPAT MON, V11, P358	25	21	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68568	10.1371/journal.pone.0068568	http://dx.doi.org/10.1371/journal.pone.0068568			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844222	Green Published, Green Submitted, gold			2022-12-27	WOS:000321733000015
J	Tomonaga, Y; Risch, L; Szucs, TD; Ambuehl, PM				Tomonaga, Yuki; Risch, Lorenz; Szucs, Thomas D.; Ambuehl, Patrice M.			The Prevalence of Chronic Kidney Disease in a Primary Care Setting: A Swiss Cross-Sectional Study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; EVALUATION PROGRAM KEEP; SERUM CREATININE; NATIONAL-HEALTH; CARDIOVASCULAR-DISEASE; LIPOCALIN NGAL; ESTIMATED GFR; MEDICAL-CARE; CYSTATIN C; CKD	Chronic kidney disease (CKD) often remains clinically silent and therefore undiagnosed until a progressed stage is reached. Our aim was to estimate the prevalence of CKD in a primary care setting in Switzerland. A multicenter, cross-sectional study with randomly selected general practitioners was performed. Adults visiting their general physician's cabinet during defined periods were asked to participate. Baseline information was reported on a questionnaire, urine and blood samples were analyzed in a central laboratory. Renal status was assessed using the Kidney Disease: Improving Global Outcomes (KDIGO) classification. Extrapolation of results to national level was adjusted for age and gender. One thousand individuals (57% females) with a mean age of 57 +/- 17 years were included. Overall, 41% of the patients had normal estimated glomerular filtration rate (eGFR) and albumin creatinine ratio (ACR), whereas 36% of the subjects had slightly reduced excretory renal function with physiological albuminuria based on normal ACR. Almost one fourth of the subjects (23%) had either a substantially reduced eGFR or high levels of ACR. About 10% of the patients had a substantially reduced eGFR of <60 ml/min/1.73 m(2), and 17% showed relevant proteinuria (ACR >30 mg/g creatinine). Extrapolation to national level suggests that about 18% of primary care patients may suffer from CKD. CKD prevalence in a primary care population is therefore high, and preventive interventions may be advisable, in particular as CKD prevalence is likely to rise over the next decades.	[Tomonaga, Yuki] Univ Zurich, Inst Social & Prevent Med, CH-8006 Zurich, Switzerland; [Risch, Lorenz] Lab Med Zentren Dr Risch, Liebefeld, Switzerland; [Risch, Lorenz] Med Univ Innsbruck, Div Clin Biochem, Ctr Chem & Biomed Innsbruck, A-6020 Innsbruck, Austria; [Szucs, Thomas D.] Univ Basel, European Ctr Pharmaceut Med, Basel, Switzerland; [Ambuehl, Patrice M.] Stadtspital Waid, Div Renal, Zurich, Switzerland	University of Zurich; Medical University of Innsbruck; University of Basel	Tomonaga, Y (corresponding author), Univ Zurich, Inst Social & Prevent Med, CH-8006 Zurich, Switzerland.	yuki.tomonaga@uzh.ch	Risch, Lorenz/D-4629-2011	Risch, Lorenz/0000-0003-2692-6699; Szucs, Thomas/0000-0003-0195-3316	Abbott AG, Switzerland	Abbott AG, Switzerland	The authors gratefully acknowledge support by an unrestricted scientific grant from Abbott AG, Switzerland, providing the reagents for this study (https://www.abbott.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Aly Z, 2010, J AM SOC NEPHROL, V21, P1961, DOI 10.1681/ASN.2009121210; Allen AS, J GEN INTERNAL MED, V26, P386; Bommer J, 2002, NEPHROL DIAL TRANSPL, V17, P8, DOI 10.1093/ndt/17.suppl_11.8; Bottomley MJ, NEPHRON, V117, pc348; Chen YC, PLOS ONE, V7; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Culleton BF, 1999, KIDNEY INT, V56, P2214, DOI 10.1046/j.1523-1755.1999.00773.x; Damman K, 2008, EUR J HEART FAIL, V10, P997, DOI 10.1016/j.ejheart.2008.07.001; Eknoyan G, 2004, KIDNEY INT, V66, P1310, DOI 10.1111/j.1523-1755.2004.00894.x; Figueiredo Estevao L, 2008, Congest Heart Fail, V14, P234, DOI 10.1111/j.1751-7133.2008.00008.x; Forni V, 2011, SWISS MED WKLY, V141, p21S; Giavarina D, CLIN NEPHROLOGY S1, V74, P358; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.020; Hallan SI, JAMA, V308, P2349; Hemmelgarn BR, 2006, KIDNEY INT, V69, P2155, DOI 10.1038/sj.ki.5000270; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2010, AM J KIDNEY DIS, V55, P622, DOI 10.1053/j.ajkd.2010.02.337; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levey AS, ANN INTERNAL MED, V154, P65; Levin A, 2008, CAN MED ASSOC J, V179, P1154, DOI 10.1503/cmaj.080351; Locatelli F, 2006, J NEPHROL, V19, P6; Matsushita K, 1941, JAMA-J AM MED ASSOC, V307, P1941; Matsushita K, AM J KIDNEY DIS; McCullough PA, 2008, AM HEART J, V156, P277, DOI 10.1016/j.ahj.2008.02.024; McCullough PA, 2008, AM J KIDNEY DIS, V51, pS38, DOI 10.1053/j.ajkd.2007.12.017; Mucsi I, 2008, J NEPHROL, V21, pS84; Murphree DD, 2010, J AM BOARD FAM MED, V23, P542, DOI 10.3122/jabfm.2010.04.090129; O'Hare AM, 2006, J AM SOC NEPHROL, V17, P846, DOI 10.1681/ASN.2005090986; Powe NR, 2009, AM J KIDNEY DIS, V53, pS37, DOI 10.1053/j.ajkd.2008.07.056; Rigalleau V, 2007, NEPHROL DIAL TRANSPL, V22, P813, DOI 10.1093/ndt/gfl649; Risch L, 2007, CLIN CHIM ACTA, V378, P71, DOI 10.1016/j.cca.2006.10.015; Roderick PJ, 2009, AM J KIDNEY DIS, V53, P950, DOI 10.1053/j.ajkd.2008.12.036; Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009; Ryan TP, 2009, AM J NEPHROL, V29, P620, DOI 10.1159/000194455; Selvin E, 2009, EUR HEART J, V30, P1918, DOI 10.1093/eurheartj/ehp195; Smith DH, 2004, J AM SOC NEPHROL, V15, P1300, DOI 10.1097/01.ASN.0000125670.64996.BB; Stevens LA, 2011, AM J KIDNEY DIS, V57, pS9, DOI 10.1053/j.ajkd.2010.11.007; Stevens LA, 2010, ADV CHRONIC KIDNEY D, V17, P293, DOI 10.1053/j.ackd.2010.03.010; Swiss Federal Office of Public Health (FOPH), KOST TRANSPL MED; Szewczyk M, 2009, TRANSPL P, V41, P3242, DOI 10.1016/j.transproceed.2009.08.018; Tamura MK, 2011, AM J KIDNEY DIS, V57, pS17, DOI 10.1053/j.ajkd.2010.11.008; Thorp Micah L, 2006, Dis Manag, V9, P115, DOI 10.1089/dis.2006.9.115; Ting SMS, 2009, NEPHRON CLIN PRACT, V112, pC121, DOI 10.1159/000214206; Wang HE, AM J NEPHROLOGY, V34, P330; Weiner DE, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-26; Wetzels JFM, 2007, KIDNEY INT, V72, P632, DOI 10.1038/sj.ki.5002374; Whaley-Connell A, 2009, AM J KIDNEY DIS, V53, pS11, DOI 10.1053/j.ajkd.2009.01.004; Whaley-Connell AT, 2008, AM J KIDNEY DIS, V51, pS13, DOI 10.1053/j.ajkd.2007.12.016; White SL, 2005, ADV CHRONIC KIDNEY D, V12, P5, DOI 10.1053/j.ackd.2004.10.009; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117	53	17	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67848	10.1371/journal.pone.0067848	http://dx.doi.org/10.1371/journal.pone.0067848			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844110	Green Submitted, Green Published, gold			2022-12-27	WOS:000321733000107
J	Assouline, S; Or, D				Assouline, Shmuel; Or, Dani			Plant Water Use Efficiency over Geological Time - Evolution of Leaf Stomata Configurations Affecting Plant Gas Exchange	PLOS ONE			English	Article							ATMOSPHERIC CO2; CONDUCTANCE; DIFFUSION; PHOTOSYNTHESIS; OPTIMIZATION; ASSIMILATION; ENRICHMENT; DENSITY; CARBON; MODEL	Plant gas exchange is a key process shaping global hydrological and carbon cycles and is often characterized by plant water use efficiency (WUE - the ratio of CO2 gain to water vapor loss). Plant fossil record suggests that plant adaptation to changing atmospheric CO2 involved correlated evolution of stomata density (d) and size (s), and related maximal aperture, a(max). We interpreted the fossil record of s and d correlated evolution during the Phanerozoic to quantify impacts on gas conductance affecting plant transpiration, E, and CO2 uptake, A, independently, and consequently, on plant WUE. A shift in stomata configuration from large s-low d to small s-high d in response to decreasing atmospheric CO2 resulted in large changes in plant gas exchange characteristics. The relationships between gas conductance, g(ws), A and E and maximal relative transpiring leaf area, (a(max).d), exhibited hysteretic-like behavior. The new WUE trend derived from independent estimates of A and E differs from established WUE-CO2 trends for atmospheric CO2 concentrations exceeding 1,200 ppm. In contrast with a nearly-linear decrease in WUE with decreasing CO2 obtained by standard methods, the newly estimated WUE trend exhibits remarkably stable values for an extended geologic period during which atmospheric CO2 dropped from 3,500 to 1,200 ppm. Pending additional tests, the findings may affect projected impacts of increased atmospheric CO2 on components of the global hydrological cycle.	[Assouline, Shmuel] ARO Volcani Ctr, Inst Soil Water & Environm Sci, Dept Environm Phys & Irrigat, Bet Dagan, Israel; [Or, Dani] Swiss Fed Inst Technol, Inst Terr Ecosyst ITES, Dept Environm Sci D UWIS, Zurich, Switzerland	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Swiss Federal Institutes of Technology Domain; ETH Zurich	Assouline, S (corresponding author), ARO Volcani Ctr, Inst Soil Water & Environm Sci, Dept Environm Phys & Irrigat, Bet Dagan, Israel.	vwshmuel@agri.gov.il	Or, Dani/D-8768-2012	Or, Dani/0000-0002-3236-2933	Israeli Ministry of Agriculture Fund	Israeli Ministry of Agriculture Fund	Supported by Chief Scientist of the Israeli Ministry of Agriculture Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Assouline S, 2010, WATER RESOUR RES, V46, DOI 10.1029/2010WR009121; Ball J.T., 1987, PROGR PHOTOSYNTHESIS, P221, DOI [10.1007/978-94-017-0519-6_48, DOI 10.1007/978-94-017-0519-6_48]; BANGE GGJ, 1953, ACTA BOT NEERL, V2, P255; Beerling DJ, 1997, BOT J LINN SOC, V124, P137, DOI 10.1006/bojl.1997.0098; Beerling DJ, 2001, NATURE, V410, P352, DOI 10.1038/35066546; Berner RA, 2001, AM J SCI, V301, P182, DOI 10.2475/ajs.301.2.182; Berner RA, 2009, AM J SCI, V309, P603, DOI 10.2475/07.2009.03; Berry JA, 2010, CURR OPIN PLANT BIOL, V13, P232, DOI 10.1016/j.pbi.2010.04.013; Brodribb TJ, 2011, SCIENCE, V331, P582, DOI 10.1126/science.1197985; Brown HT, 1900, PHILOS T R SOC LON B, V193, P223, DOI 10.1098/rstb.1900.0014; Cooke J.R., 1967, ACTA BIOTHEOR, V17, P95, DOI [DOI 10.1007/BF01625092, 10.1007/BF01625092]; Cooke JR, 1969, ASAE ANN M; Cowan I. R., 1977, Advances in Botanical Research, V4, P117, DOI 10.1016/S0065-2296(08)60370-5; Cowan I R, 1977, Symp Soc Exp Biol, V31, P471; de Boer HJ, 2011, P NATL ACAD SCI USA, V108, P4041, DOI 10.1073/pnas.1100555108; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; FARQUHAR GD, 1984, AUST J PLANT PHYSIOL, V11, P539, DOI 10.1071/PP9840539; Franks PJ, 2009, GEOBIOLOGY, V7, P227, DOI 10.1111/j.1472-4669.2009.00193.x; Franks PJ, 2007, PLANT PHYSIOL, V143, P78, DOI 10.1104/pp.106.089367; Franks PJ, 2009, P NATL ACAD SCI USA, V106, P10343, DOI 10.1073/pnas.0904209106; Franks PJ, 2001, PLANT PHYSIOL, V125, P935, DOI 10.1104/pp.125.2.935; Haworth M, 2011, J EXP BOT, V62, P2419, DOI 10.1093/jxb/err086; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Katul G, 2010, ANN BOT-LONDON, V105, P431, DOI 10.1093/aob/mcp292; Katul GG, 2000, PLANT CELL ENVIRON, V23, P1313, DOI 10.1046/j.1365-3040.2000.00641.x; KELLER KENNETH H., 1967, MATH BIOSCI, V1, P421, DOI 10.1016/0025-5564(67)90012-0; Korner C, 2003, PHILOS T ROY SOC A, V361, P2023, DOI 10.1098/rsta.2003.1241; Lammertsma EI, 2011, P NATL ACAD SCI USA, V108, P4035, DOI 10.1073/pnas.1100371108; LEUNING R, 1995, PLANT CELL ENVIRON, V18, P339, DOI 10.1111/j.1365-3040.1995.tb00370.x; MEIDNER H, 1975, J EXP BOT, V26, P666, DOI 10.1093/jxb/26.5.666; Mora CI, 1996, SCIENCE, V271, P1105, DOI 10.1126/science.271.5252.1105; Oki T, 2006, SCIENCE, V313, P1068, DOI 10.1126/science.1128845; PARKHURST DF, 1994, NEW PHYTOL, V126, P449, DOI 10.1111/j.1469-8137.1994.tb04244.x; PARLANGE JY, 1970, PLANT PHYSIOL, V46, P337, DOI 10.1104/pp.46.2.337; Piel C, 2002, J EXP BOT, V53, P2423, DOI 10.1093/jxb/erf095; Raven JA, 2002, NEW PHYTOL, V153, P371, DOI 10.1046/j.0028-646X.2001.00334.x; Roelfsema MRG, 2013, NEW PHYTOL, V197, P11, DOI 10.1111/nph.12050; Royer D.L., 2004, GSA TODAY, V14, P4, DOI DOI 10.1130/1052-5173(2004)014; . SCARTH G. W., 1927, PROTOPLASMA, V2, P498, DOI 10.1007/BF01604752; SCHLUNDER EU, 1988, CHEM ENG SCI, V43, P2685, DOI 10.1016/0009-2509(88)80012-5; Scotese C.R., 1994, PANGEA PALEOCLIMATE, V288, P57, DOI DOI 10.1130/SPE288-P57; Sellers PJ, 1997, SCIENCE, V275, P502, DOI 10.1126/science.275.5299.502; Shahraeeni E, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR011857; Sperry JS, 2003, INT J PLANT SCI, V164, pS115, DOI 10.1086/368398; Suzuki M., 1968, J CHEM ENG JAPAN, V1, DOI [10.1252/jcej.1.26, DOI 10.1252/JCEJ.1.26]; Tanner C.B., 1983, LIMITATIONS EFFICIEN; TING IP, 1963, AM J BOT, V50, P866, DOI 10.2307/2439773; VANDEWATER PK, 1994, SCIENCE, V264, P239, DOI 10.1126/science.264.5156.239; VONCAEMMERER S, 1981, PLANTA, V153, P376, DOI 10.1007/BF00384257; WAGGONER PE, 1965, SCIENCE, V150, P1413, DOI 10.1126/science.150.3702.1413; White F. M., 2006, VISCOUS FLUID FLOW	53	24	24	1	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67757	10.1371/journal.pone.0067757	http://dx.doi.org/10.1371/journal.pone.0067757			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844085	Green Published, gold			2022-12-27	WOS:000321341000092
J	Heegaard, PMH; Miller, I; Sorensen, NS; Soerensen, KE; Skovgaard, K				Heegaard, Peter M. H.; Miller, Ingrid; Sorensen, Nanna Skall; Soerensen, Karen Elisabeth; Skovgaard, Kerstin			Pig alpha 1-Acid Glycoprotein: Characterization and First Description in Any Species as a Negative Acute Phase Protein	PLOS ONE			English	Article							ACID-SOLUBLE GLYCOPROTEIN; C-REACTIVE PROTEIN; ALPHA(1)-ACID GLYCOPROTEIN; ACTINOBACILLUS-PLEUROPNEUMONIAE; ALPHA1-ACID GLYCOPROTEIN; SERUM-HAPTOGLOBIN; INFECTION; HEALTH; GENES; MODEL	The serum protein alpha 1-acid glycoprotein (AGP), also known as orosomucoid, is generally described as an archetypical positive acute phase protein. Here, porcine AGP was identified, purified and characterized from pooled pig serum. It was found to circulate as a single chain glycoprotein having an apparent molecular weight of 43 kDa by SDS-PAGE under reducing conditions, of which approximately 17 kDa were accounted for by N-bound oligosaccharides. Those data correspond well with the properties of the protein predicted from the single porcine AGP gene (ORM1, Q29014 (UniProt)), containing 5 putative glycosylation sites. A monoclonal antibody (MAb) was produced and shown to quantitatively and specifically react with all microheterogenous forms of pig AGP as analyzed by 2-D electrophoresis. This MAb was used to develop an immunoassay (ELISA) for quantification of AGP in pig serum samples. The adult serum concentrations of pig AGP were in the range of 1-3 mg/ml in a number of conventional pig breeds while it was lower in Gottingen and Ossabaw minipigs (in the 0.3 to 0.6 mg/ml range) and higher in young (2-5 days old) conventional pigs (mean: 6.6 mg/ml). Surprisingly, pig AGP was found to behave as a negative acute phase protein during a range of experimental infections and aseptic inflammation with significant decreases in serum concentration and in hepatic ORM1 expression during the acute phase response. To our knowledge this is the first description in any species of AGP being a negative acute phase protein.	[Heegaard, Peter M. H.; Sorensen, Nanna Skall; Skovgaard, Kerstin] Tech Univ Denmark, Natl Vet Inst, Innate Immunol Grp, Frederiksberg, Denmark; [Miller, Ingrid] Univ Vet Med Vienna, Dept Biomed Sci, Inst Med Biochem, Vienna, Austria; [Soerensen, Karen Elisabeth] Univ Copenhagen, Dept Vet Dis Biol, Sect Pathol, Frederiksberg, Denmark	Technical University of Denmark; University of Veterinary Medicine Vienna; University of Copenhagen	Heegaard, PMH (corresponding author), Tech Univ Denmark, Natl Vet Inst, Innate Immunol Grp, Frederiksberg, Denmark.	pmhh@vet.dtu.dk	; Heegaard, Peter/E-9794-2015	Miller, Ingrid/0000-0002-7192-0109; Heegaard, Peter/0000-0003-4506-4932; skovgaard, kerstin/0000-0001-5663-4879	EU [QLK5-2001-02219]	EU(European Commission)	The study was partly supported by EU shared cost project QLK5-2001-02219. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akerstrom B, 2000, BBA-PROTEIN STRUCT M, V1482, P1, DOI 10.1016/S0167-4838(00)00137-0; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Asai T, 1999, VET IMMUNOL IMMUNOP, V70, P143, DOI 10.1016/S0165-2427(99)00069-0; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Carpintero R, 2005, INFECT IMMUN, V73, P3184, DOI 10.1128/IAI.73.5.3184-3187.2005; Ceciliani F, 2007, CURR PROTEIN PEPT SC, V8, P91, DOI 10.2174/138920307779941497; CHARLWOOD PA, 1976, BIOCHIM BIOPHYS ACTA, V453, P81, DOI 10.1016/0005-2795(76)90252-X; CHIU KM, 1977, IMMUNOLOGY, V32, P997; COOPER R, 1986, J BIOL CHEM, V261, P1849; COSTELLO MJ, 1984, CLIN EXP IMMUNOL, V55, P465; COUPERWHITE S, 1994, ANIM GENET, V25, P285, DOI 10.1111/j.1365-2052.1994.tb00208.x; DENTE L, 1987, EMBO J, V6, P2289, DOI 10.1002/j.1460-2075.1987.tb02503.x; Eckersall PD, 1996, VET IMMUNOL IMMUNOP, V51, P377, DOI 10.1016/0165-2427(95)05527-4; Fournier T, 2000, BBA-PROTEIN STRUCT M, V1482, P157, DOI 10.1016/S0167-4838(00)00153-9; GODING JW, 1980, J IMMUNOL METHODS, V39, P285, DOI 10.1016/0022-1759(80)90230-6; Greiner LL, 2001, J ANIM SCI, V79, P1272; Heegaard PMH, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-50; Heegaard PMH, 1998, COMP BIOCHEM PHYS B, V119, P365, DOI 10.1016/S0305-0491(97)00362-3; HEEGAARD PMH, 1986, MARKER PROTEINS INFL, V3, P275; Henryon M, 2006, ANIM SCI, V82, P597, DOI 10.1079/ASC200671; HEUKESHOVEN J, 1985, ELECTROPHORESIS, V6, P103, DOI 10.1002/elps.1150060302; Hochepied T, 2003, CYTOKINE GROWTH F R, V14, P25, DOI 10.1016/S1359-6101(02)00054-0; ITOH H, 1993, CAN J VET RES, V57, P74; Jungersen G, 1999, INT J PARASITOL, V29, P1307, DOI 10.1016/S0020-7519(99)00078-8; Kahlisch D, 2009, VET RES, V40, DOI 10.1051/vetres/2009043; Klitgaard K, 2012, PLOS ONE, DOI [10.1371/journal.pone.0035549, DOI 10.1371/J0URNAL.P0NE.0035549]; KOJ A, 1984, BIOCHEM J, V224, P505, DOI 10.1042/bj2240505; KREMER JMH, 1988, PHARMACOL REV, V40, P1; LAMPREAVE F, 1982, COMP BIOCHEM PHYS B, V72, P215, DOI 10.1016/0305-0491(82)90037-2; LAMPREAVE F, 1984, INT J BIOCHEM, V16, P47, DOI 10.1016/0020-711X(84)90049-1; LAMPREAVE F, 1994, ELECTROPHORESIS, V15, P672, DOI 10.1002/elps.1150150195; Lecchi C, 2013, VET J, V196, P47, DOI 10.1016/j.tvjl.2012.07.022; Ligresti G, 2012, PLOS ONE, DOI [10.1371/journal.pone.0041387, DOI 10.1371/J0URNAL.P0NE.0041387]; Mackiewicz A, 1993, ACUTE PHASE PROTEINS, P107; MANIL L, 1986, J IMMUNOL METHODS, V90, P25, DOI 10.1016/0022-1759(86)90379-0; Miller I, 2004, PROTEOMICS, V4, P257, DOI 10.1002/pmic.200300546; Miller I, 2006, ELECTROPHORESIS, V27, P1626, DOI 10.1002/elps.200500744; Miller Ingrid, 2012, Methods Mol Biol, V854, P373, DOI 10.1007/978-1-61779-573-2_26; Miller I, 2009, RES VET SCI, V86, P362, DOI 10.1016/j.rvsc.2008.05.018; MORTENSEN RF, 1983, J IMMUNOL, V130, P885; Nakano M, 2004, GLYCOBIOLOGY, V14, P431, DOI 10.1093/glycob/cwh034; Ongay S, 2010, ANAL BIOANAL CHEM, V398, P845, DOI 10.1007/s00216-010-3948-5; Petersen HH, 2004, VET RES, V35, P163, DOI 10.1051/vetres:2004002; Petersen HH, 2002, PREV VET MED, V54, P325, DOI 10.1016/S0167-5877(02)00054-5; Riber U, 2011, VET MICROBIOL, V149, P406, DOI 10.1016/j.vetmic.2010.11.028; Rodgaard T, 2013, VET IMMUNOL IMMUNOP, V151, P325, DOI 10.1016/j.vetimm.2012.11.002; SCHMID K, 1977, BIOCHIM BIOPHYS ACTA, V492, P291, DOI 10.1016/0005-2795(77)90080-0; Skovgaard K, 2013, INNATE IMMUN-LONDON, V19, P531, DOI 10.1177/1753425912473668; Skovgaard K, 2010, INNATE IMMUN-LONDON, V16, P343, DOI 10.1177/1753425909342730; Skovgaard K, 2009, VET RES, V40, DOI 10.1051/vetres/2009006; Soerensen KE, 2012, APMIS, V120, P909, DOI 10.1111/j.1600-0463.2012.02917.x; Son DS, 1996, VET QUART, V18, P10, DOI 10.1080/01652176.1996.9694603; Sorensen NS, 2006, VET IMMUNOL IMMUNOP, V113, P157, DOI 10.1016/j.vetimm.2006.04.008; STONE RT, 1987, DEV GENET, V8, P295, DOI 10.1002/dvg.1020080411; Tecles F, 2007, CAN J VET RES, V71, P161; Theilgaard-Monch K, 2005, J LEUKOCYTE BIOL, V78, P462, DOI 10.1189/jlb.0105042; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANDIJK W, 1995, GLYCOCONJUGATE J, V12, P227, DOI 10.1007/BF00731324; Yang YQ, 2012, VET MICROBIOL, V158, P237, DOI 10.1016/j.vetmic.2012.01.021	59	25	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68110	10.1371/journal.pone.0068110	http://dx.doi.org/10.1371/journal.pone.0068110			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844161	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000138
J	Horovitz, SG; Gallea, C; Najee-ullah, MA; Hallett, M				Horovitz, Silvina G.; Gallea, Cecile; Najee-ullah, Muslimah 'Ali; Hallett, Mark			Functional Anatomy of Writing with the Dominant Hand	PLOS ONE			English	Article							VENTRAL PREMOTOR AREAS; SUPPLEMENTARY MOTOR AREA; BASAL GANGLIA; PARIETAL CORTEX; CEREBRAL-CORTEX; MACAQUE MONKEY; RHESUS-MONKEY; WRITERS CRAMP; DORSAL; BRAIN	While writing performed by any body part is similar in style, indicating a common program, writing with the dominant hand is particularly skilled. We hypothesized that this skill utilizes a special motor network supplementing the motor equivalence areas. Using functional magnetic resonance imaging in 13 normal subjects, we studied nine conditions: writing, zigzagging and tapping, each with the right hand, left hand and right foot. We identified brain regions activated with the right (dominant) hand writing task, exceeding the activation common to right-hand use and the writing program, both identified without right-hand writing itself. Right-hand writing significantly differed from the other tasks. First, we observed stronger activations in the left dorsal prefrontal cortex, left intraparietal sulcus and right cerebellum. Second, the left anterior putamen was required to initiate all the tested tasks, but only showed sustained activation during the right-hand writing condition. Lastly, an exploratory analysis showed clusters in the left ventral premotor cortex and inferior and superior parietal cortices were only significantly active for right-hand writing. The increased activation with right-hand writing cannot be ascribed to increased effort, since this is a well-practiced task much easier to perform than some of the other tasks studied. Because parietal-premotor connections code for particular skills, it would seem that the parietal and premotor regions, together with basal ganglia-sustained activation likely underlie the special skill of handwriting with the dominant hand.	[Horovitz, Silvina G.; Gallea, Cecile; Najee-ullah, Muslimah 'Ali; Hallett, Mark] NINDS, Human Motor Control Sect, Med Neurol Branch, NIH, Bethesda, MD 20892 USA; [Gallea, Cecile] Hop La Pitie Salpetriere, Ctr Neuroimagerie Rech, INSERM, Paris, France	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute of Neurological Disorders & Stroke (NINDS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Horovitz, SG (corresponding author), NINDS, Human Motor Control Sect, Med Neurol Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	silvina.horovitz@nih.gov		GALLEA, Cecile/0000-0001-8070-8794; Horovitz, Silvina G./0000-0002-5501-5918	The NINDS Intramural Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002669] Funding Source: NIH RePORTER	The NINDS Intramural Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The NINDS Intramural Program supported this work. The funder had no role in study design, data collection and analysis, or preparation of the manuscript.	Aguirre GK, 2000, MED RAD DIA IMG, P369; BARBAS H, 1987, J COMP NEUROL, V256, P211, DOI 10.1002/cne.902560203; Brendel B, 2010, NEUROIMAGE, V50, P1219, DOI 10.1016/j.neuroimage.2010.01.039; BRINKMAN C, 1984, J NEUROSCI, V4, P918; Brinkman C, 1979, J NEUROPHYSCIOLOGY, V42, P19; Brownsett SLE, 2010, CEREB CORTEX, V20, P517, DOI 10.1093/cercor/bhp120; Cauda F, 2011, HUM BRAIN MAPP, V32, P1566, DOI 10.1002/hbm.21132; Davare M, 2006, J NEUROSCI, V26, P2260, DOI 10.1523/JNEUROSCI.3386-05.2006; De Smet HJ, 2007, FOLIA PHONIATR LOGO, V59, P165, DOI 10.1159/000102927; De Smet HJ, 2011, BRAIN COGNITION, V76, P424, DOI 10.1016/j.bandc.2010.12.006; Debaere F, 2004, NEUROPSYCHOLOGIA, V42, P855, DOI 10.1016/j.neuropsychologia.2003.12.010; Delnooz CCS, 2013, HUM BRAIN MAPP, V34, P613, DOI 10.1002/hbm.21464; Delnooz CCS, 2012, MOVEMENT DISORD, V27, P1425, DOI 10.1002/mds.25029; Doyon J, 2009, BEHAV BRAIN RES, V199, P61, DOI 10.1016/j.bbr.2008.11.012; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; DUM RP, 1991, J NEUROSCI, V11, P667; Dum RP, 2003, J NEUROPHYSIOL, V89, P634, DOI 10.1152/jn.00626.2002; ECCLES JC, 1982, ACTA BIOL ACAD SCI H, V33, P157; Exner S., 1881, UNTERSUCHUNGEN LOKAL; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Fulbright RK, 1999, AM J NEURORADIOL, V20, P1925; Glover S, 2012, EUR J NEUROSCI, V35, P909, DOI 10.1111/j.1460-9568.2012.08018.x; Hallett M, 2009, ANN NEUROL, V66, P125, DOI 10.1002/ana.21762; Henson RN, 2005, ANOVAS SPM TECHNICAL; Hoshi E, 2007, CURR OPIN NEUROBIOL, V17, P234, DOI 10.1016/j.conb.2007.02.003; Humphrey DR, 1979, CENTRAL REPRESENTATI; Johnson SH, 2003, PROG BRAIN RES, V142, P127; Katanoda K, 2001, HUM BRAIN MAPP, V13, P34, DOI 10.1002/hbm.1023; Lashley KS, 1930, PSYCHOL REV, V37, P1, DOI 10.1037/h0074134; Lehericy S, 2005, P NATL ACAD SCI USA, V102, P12566, DOI 10.1073/pnas.0502762102; LUPPINO G, 1991, J COMP NEUROL, V311, P463, DOI 10.1002/cne.903110403; Matsuo K, 2000, COGNITIVE BRAIN RES, V9, P281, DOI 10.1016/S0926-6410(00)00008-2; Mayka MA, 2006, NEUROIMAGE, V31, P1453, DOI 10.1016/j.neuroimage.2006.02.004; Nieder A, 2005, NAT REV NEUROSCI, V6, P177, DOI 10.1038/nrn1626; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Preuss TM, 1996, J COMP NEUROL, V371, P649, DOI 10.1002/(SICI)1096-9861(19960805)371:4<649::AID-CNE12>3.0.CO;2-E; Ramnani N, 2006, CEREB CORTEX, V16, P811, DOI 10.1093/cercor/bhj024; Rijntjes M, 1999, J NEUROSCI, V19, P8043; Rizzolatti G, 1998, ELECTROEN CLIN NEURO, V106, P283, DOI 10.1016/S0013-4694(98)00022-4; Rizzolatti G, 2003, EXP BRAIN RES, V153, P146, DOI 10.1007/s00221-003-1588-0; Rizzolatti G, 2002, CURR OPIN NEUROBIOL, V12, P149, DOI 10.1016/S0959-4388(02)00308-2; Roux FE, 2009, ANN NEUROL, V66, P537, DOI 10.1002/ana.21804; Rushworth MFS, 2006, CEREB CORTEX, V16, P1418, DOI 10.1093/cercor/bhj079; Sakata H, 1997, TRENDS NEUROSCI, V20, P350, DOI 10.1016/S0166-2236(97)01067-9; Sanes JN, 1997, ADV NEUROL, V73, P277; Schmahmann JD, 1999, NEUROIMAGE, V10, P233, DOI 10.1006/nimg.1999.0459; Schubotz RI, 2003, NEUROIMAGE, V20, pS120, DOI 10.1016/j.neuroimage.2003.09.014; Sugihara G, 2006, NEUROIMAGE, V32, P1837, DOI 10.1016/j.neuroimage.2006.05.035; Tanji J, 1996, EUR NEUROL, V36, P13, DOI 10.1159/000118878; Tanne-Gariepy J, 2002, EXP BRAIN RES, V145, P91, DOI 10.1007/s00221-002-1078-9; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25; Woollacott MH, 2001, MOTOR CONTROL THEORY, Vx	54	26	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67931	10.1371/journal.pone.0067931	http://dx.doi.org/10.1371/journal.pone.0067931			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844132	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000122
J	Jiang, JY; Wu, XF; Tang, HL; Luo, GX				Jiang, Jieyun; Wu, Xianfang; Tang, Hengli; Luo, Guangxiang			Apolipoprotein E Mediates Attachment of Clinical Hepatitis C Virus to Hepatocytes by Binding to Cell Surface Heparan Sulfate Proteoglycan Receptors	PLOS ONE			English	Article							NONSTRUCTURAL PROTEIN 5A; TARGET-CELLS; INFECTION; GLYCOSAMINOGLYCANS; PARTICLES; CULTURE; GLYCOPROTEIN; INTERACTS; INHIBIT; DOMAIN	Our previous studies demonstrated that the cell culture-grown hepatitis C virus of genotype 2a (HCVcc) uses apolipoprotein E (apoE) to mediate its attachment to the surface of human hepatoma Huh-7.5 cells. ApoE mediates HCV attachment by binding to the cell surface heparan sulfate (HS) which is covalently attached to the core proteins of proteoglycans (HSPGs). In the present study, we further determined the physiological importance of apoE and HSPGs in the HCV attachment using a clinical HCV of genotype 1b (HCV1b) obtained from hepatitis C patients and human embryonic stem cell-differentiated hepatocyte-like cells (DHHs). DHHs were found to resemble primary human hepatocytes. Similar to HCVcc, HCV1b was found to attach to the surface of DHHs by the apoE-mediated binding to the cell surface HSPGs. The apoE-specific monoclonal antibody, purified HSPGs, and heparin were all able to efficiently block HCV1b attachment to DHHs. Similarly, the removal of heparan sulfate from cell surface by treatment with heparinase suppressed HCV1b attachment to DHHs. More significantly, HCV1b attachment was potently inhibited by a synthetic peptide derived from the apoE receptor-binding region as well as by an HSPG-binding peptide. Likewise, the HSPG-binding peptide prevented apoE from binding to heparin in a dose-dependent manner, as determined by an in vitro heparin pull-down assay. Collectively, these findings demonstrate that HSPGs serve as major HCV attachment receptors on the surface of human hepatocytes to which the apoE protein ligand on the HCV envelope binds.	[Jiang, Jieyun; Luo, Guangxiang] Univ Kentucky, Coll Med, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40536 USA; [Wu, Xianfang; Tang, Hengli] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Luo, Guangxiang] Univ Alabama Birmingham, Sch Med, Dept Microbiol, Birmingham, AL 35294 USA; [Luo, Guangxiang] Peking Univ, Coll Basic Med Sci, Dept Microbiol, Beijing 100871, Peoples R China	University of Kentucky; State University System of Florida; Florida State University; University of Alabama System; University of Alabama Birmingham; Peking University	Luo, GX (corresponding author), Univ Kentucky, Coll Med, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40536 USA.	gluo@uab.edu	Wu, Xianfang/O-5004-2019; Wu, Xianfang/HII-9315-2022; Tang, Hengli/F-2085-2014	Wu, Xianfang/0000-0002-2995-935X; 	National Institutes of Health [AI097318, AI091953]; NSFC [81130082]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091953, R01AI097318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSFC(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI097318 and AI091953. It is also partially supported by NSFC (81130082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Basu A, 2004, J VIROL, V78, P4478, DOI 10.1128/JVI.78.9.4478-4486.2004; Benga WJA, 2010, HEPATOLOGY, V51, P43, DOI 10.1002/hep.23278; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Carlsson P, 2008, J BIOL CHEM, V283, P20008, DOI 10.1074/jbc.M801652200; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; Chung CS, 1998, J VIROL, V72, P1577, DOI 10.1128/JVI.72.2.1577-1585.1998; COMPTON T, 1993, VIROLOGY, V193, P834, DOI 10.1006/viro.1993.1192; Cun W, 2010, J VIROL, V84, P11532, DOI 10.1128/JVI.01021-10; Da Costa D, 2012, J VIROL, V86, P11919, DOI 10.1128/JVI.01066-12; de Witte L, 2007, P NATL ACAD SCI USA, V104, P19464, DOI 10.1073/pnas.0703747104; Gastaminza P, 2010, J VIROL, V84, P10999, DOI 10.1128/JVI.00526-10; Hallak LK, 2000, VIROLOGY, V271, P264, DOI 10.1006/viro.2000.0293; Hu YP, 2011, NAT CHEM, V3, P557, DOI 10.1038/nchem.1073; Jiang JY, 2012, J VIROL, V86, P8987, DOI 10.1128/JVI.00004-12; Jiang JY, 2012, J VIROL, V86, P7256, DOI 10.1128/JVI.07222-11; Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09; Joyce JG, 1999, J BIOL CHEM, V274, P5810, DOI 10.1074/jbc.274.9.5810; Kalia M, 2009, J VIROL, V83, P12714, DOI 10.1128/JVI.00717-09; Kern A, 2003, J VIROL, V77, P11072, DOI 10.1128/JVI.77.20.11072-11081.2003; KOKENYESI R, 1994, J BIOL CHEM, V269, P12304; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Lee TY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009945; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Liu Jia, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P1025, DOI 10.3969/j.issn.1672-7347.2011.11.001; Liu SF, 2012, HEPATOLOGY, V56, P484, DOI 10.1002/hep.25665; Luo GXG, 2004, MIL DRUG TH, P67; Mahley RW, 1999, J LIPID RES, V40, P1; Melnikova I, 2011, NAT REV DRUG DISCOV, V10, P93, DOI 10.1038/nrd3361; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Morikawa K, 2007, J MED VIROL, V79, P714, DOI 10.1002/jmv.20842; Okamoto K, 2012, J GEN VIROL, V93, P761, DOI 10.1099/vir.0.037853-0; Salvador B, 2013, J VIROL, V87, P3295, DOI 10.1128/JVI.01621-12; Schulze A, 2007, HEPATOLOGY, V46, P1759, DOI 10.1002/hep.21896; Schwartz RE, 2012, P NATL ACAD SCI USA, V109, P2544, DOI 10.1073/pnas.1121400109; Shafti-Keramat S, 2003, J VIROL, V77, P13125, DOI 10.1128/JVI.77.24.13125-13135.2003; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Tellinghuisen TL, 2002, CURR OPIN MICROBIOL, V5, P419, DOI 10.1016/S1369-5274(02)00341-7; WHO, 1998, LANCET, V351, P1415; Wu XF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002617	42	34	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67982	10.1371/journal.pone.0067982	http://dx.doi.org/10.1371/journal.pone.0067982			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844141	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000125
J	He, CY; Stroink, A; Vogel, L; Wang, CX				He, Chunyan; Stroink, Ann; Vogel, Laura; Wang, Chen Xu			Temperature Increase Exacerbates Apoptotic Neuronal Death in Chemically-Induced Ischemia	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; CYTOCHROME-C; CEREBRAL-ISCHEMIA; ACUTE STROKE; UP-REGULATION; ACTIVATION; HYPERTHERMIA; MECHANISMS; PROTEIN; AZIDE	It is well-established that hyperthermia increases neuronal death and worsens stroke outcome. However, little is known about the mechanisms of how hyperthermia is involved in this neuronal death process. In the present study, we examined how temperature increase exacerbates neuronal death using a model of chemical ischemia. Chemical ischemia was induced by treating SH-SY5Y neuroblastoma cells with sodium azide and deoxyglucose. Temperature increase was treated by placing the cells at 37 degrees C (control) and 41 degrees C (experimental). Cell survival was determined by trypan blue assay and ATP levels were measured with ATP assay kits. Protein expression was detected by western blot. Treatment with sodium azide resulted in cell death in a dose-responsive manner. Increased temperature worsened the ATP depletion and cell volume shrinkage. Temperature increase also enhanced ER stress as demonstrated by the elevated level of phospho-eIF2 alpha and C/EBP homologous protein (CHOP). Inhibition of CHOP expression significantly decreased sodium azide-induced neuronal death. In addition, the increased temperature intensified the activation of caspase-3, an apoptotic effector protease, and inhibition of capspase-3 significantly reduced cell death. These findings support that temperature increase worsened the neuronal death by depleting intracellular ATP, inducing ER stress response and activating apoptotic signal transduction.	[He, Chunyan; Vogel, Laura; Wang, Chen Xu] Illinois State Univ, Sch Biol Sci, Normal, IL 61761 USA; [He, Chunyan; Stroink, Ann; Wang, Chen Xu] Cent Illinois Neurosci Fdn, Bloomington, IL USA	Illinois State University	Wang, CX (corresponding author), Illinois State Univ, Sch Biol Sci, Normal, IL 61761 USA.	cwang3@ilstu.edu		Vogel, Laura/0000-0002-9305-175X	Keith and Nita Kattner Graduate Fellowship; National Institutes of health [R15NS072858]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS072858] Funding Source: NIH RePORTER	Keith and Nita Kattner Graduate Fellowship; National Institutes of health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study received support from a Keith and Nita Kattner Graduate Fellowship: http://scholarshipfinder.illinoisstate.edu/scholarships/Dr__Keith_and_Nita_Kattner_Graduate_Fellowship_in_Neuroscience.shtml and the National Institutes of health (R15NS072858). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO H, 1990, BIOCHEM BIOPH RES CO, V172, P300, DOI 10.1016/S0006-291X(05)80209-8; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; AZZIMONDI G, 1995, STROKE, V26, P2040, DOI 10.1161/01.STR.26.11.2040; Bortner CD, 1998, BIOCHEM PHARMACOL, V56, P1549, DOI 10.1016/S0006-2952(98)00225-1; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; DeGracia DJ, 2004, J NEUROCHEM, V91, P1, DOI 10.1111/j.1471-4159.2004.02703.x; Duan SR, 2010, NEUROSCI LETT, V475, P132, DOI 10.1016/j.neulet.2010.03.058; Feldenberg LR, 1996, AM J PHYSIOL, V276, pF837; Garnier P, 2003, J NEUROSCI, V23, P7967; Ginsberg MD, 1998, STROKE, V29, P529, DOI 10.1161/01.STR.29.2.529; Groenendyk J, 2010, CIRC RES, V107, P1185, DOI 10.1161/CIRCRESAHA.110.227033; Halterman MW, 2008, MOL CELL NEUROSCI, V38, P125, DOI 10.1016/j.mcn.2008.01.014; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Harriman JF, 2002, CELL DEATH DIFFER, V9, P734, DOI 10.1038/sj.cdd.4401029; Hotokezaka Y, 2009, CELL DEATH DIFFER, V16, P1505, DOI 10.1038/cdd.2009.90; Kim DS, 2008, IMMUNOPHARM IMMUNOT, V30, P257, DOI [10.1080/08923970701812530, 10.1080/08923970701812530 ]; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kraig RP, 1998, CEREBROVASC DIS, P249; Leary SC, 2002, J BIOL CHEM, V277, P11321, DOI 10.1074/jbc.M112303200; Liu HJ, 2009, NEUROL SCI, V30, P227, DOI 10.1007/s10072-009-0086-y; Logue SE, 2009, NAT PROTOC, V4, P1383, DOI 10.1038/nprot.2009.143; Long AC, 2004, EXP BIOL MED, V229, P1072, DOI 10.1177/153537020422901012; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Melani A, 2005, NEUROCHEM INT, V47, P442, DOI 10.1016/j.neuint.2005.05.014; NIEMINEN AL, 1994, AM J PHYSIOL, V267, pC67, DOI 10.1152/ajpcell.1994.267.1.C67; Noor R, 2005, STROKE, V36, P665, DOI 10.1161/01.STR.0000155684.20864.58; Noor R, 2003, NEUROSCI LETT, V349, P130, DOI 10.1016/S0304-3940(03)00802-4; Noor R, 2007, ATHEROSCLEROSIS, V192, P92, DOI 10.1016/j.atherosclerosis.2006.06.023; Parkinson FE, 2004, J NEUROCHEM, V88, P1305, DOI 10.1046/j.1471-4159.2003.02266.x; Pegg CC, 2010, J NEUROSCI METH, V187, P8, DOI 10.1016/j.jneumeth.2009.12.002; Qamirani E, 2006, AM J PHYSIOL-HEART C, V290, pH1617, DOI 10.1152/ajpheart.00746.2005; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Robinson GL, 2010, ONCOGENE, DOI [10.1038/onc.2012.13, DOI 10.1038/0NC.2012.13]; Siniscalchi A, 2006, ANN NY ACAD SCI, V1090, P445, DOI 10.1196/annals.1378.047; Song JH, 2005, J BIOL CHEM, V280, P12896, DOI 10.1074/jbc.M412139200; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tafani M, 2000, AM J PATHOL, V156, P2111, DOI 10.1016/S0002-9440(10)65082-1; Vantieghem A, 1998, FEBS LETT, V440, P19, DOI 10.1016/S0014-5793(98)01416-1; Verfaillie T, 2010, INT J CELL BIOL, V2010; Wang CX, 2006, CELL DEATH DIFFER, V13, P1203, DOI 10.1038/sj.cdd.4401804; Wang CX, 2009, INT J STROKE, V4, P274, DOI 10.1111/j.1747-4949.2009.00317.x; Welsh FA, 1998, CEREBROVASC DIS, P217	44	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68796	10.1371/journal.pone.0068796	http://dx.doi.org/10.1371/journal.pone.0068796			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861942	Green Submitted, Green Published, gold			2022-12-27	WOS:000321692000032
J	Jahnke, HG; Steel, D; Fleischer, S; Seidel, D; Kurz, R; Vinz, S; Dahlenborg, K; Sartipy, P; Robitzki, AA				Jahnke, Heinz-Georg; Steel, Daniella; Fleischer, Stephan; Seidel, Diana; Kurz, Randy; Vinz, Silvia; Dahlenborg, Kerstin; Sartipy, Peter; Robitzki, Andrea A.			A Novel 3D Label-Free Monitoring System of hES-Derived Cardiomyocyte Clusters: A Step Forward to In Vitro Cardiotoxicity Testing	PLOS ONE			English	Article							MICROCAVITY CHIP; HEART-TISSUE; CELLS; DIFFERENTIATION; SIMILARITIES; PROLONGATION; ARRHYTHMIA; TAUOPATHY; TOXICITY; CULTURES	Unexpected adverse effects on the cardiovascular system remain a major challenge in the development of novel active pharmaceutical ingredients (API). To overcome the current limitations of animal-based in vitro and in vivo test systems, stem cell derived human cardiomyocyte clusters (hCMC) offer the opportunity for highly predictable pre-clinical testing. The three-dimensional structure of hCMC appears more representative of tissue milieu than traditional monolayer cell culture. However, there is a lack of long-term, real time monitoring systems for tissue-like cardiac material. To address this issue, we have developed a microcavity array (MCA)-based label-free monitoring system that eliminates the need for critical hCMC adhesion and outgrowth steps. In contrast, feasible field potential derived action potential recording is possible immediately after positioning within the microcavity. Moreover, this approach allows extended observation of adverse effects on hCMC. For the first time, we describe herein the monitoring of hCMC over 35 days while preserving the hCMC structure and electrophysiological characteristics. Furthermore, we demonstrated the sensitive detection and quantification of adverse API effects using E4031, doxorubicin, and noradrenaline directly on unaltered 3D cultures. The MCA system provides multi-parameter analysis capabilities incorporating field potential recording, impedance spectroscopy, and optical read-outs on individual clusters giving a comprehensive insight into induced cellular alterations within a complex cardiac culture over days or even weeks.	[Jahnke, Heinz-Georg; Fleischer, Stephan; Seidel, Diana; Kurz, Randy; Vinz, Silvia; Robitzki, Andrea A.] Ctr Biotechnol & Biomed BBZ, Leipzig, Germany; [Steel, Daniella; Dahlenborg, Kerstin; Sartipy, Peter] Cellartis AB, Cellectis Stem Cells, Gothenburg, Sweden	Takara Bio Inc.; Cellartis	Robitzki, AA (corresponding author), Ctr Biotechnol & Biomed BBZ, Leipzig, Germany.	andrea.robitzki@bbz.uni-leipzig.de		Jahnke, Heinz-Georg/0000-0001-6615-7092	European Community; Cosmetics Europe [266753]; German Federal Ministry of Education and Research (BMBF) [BiMiHySS FKZ 16SV5052]; Free State of Saxony; European Union (SMWK/EFRE)	European Community(European Commission); Cosmetics Europe; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Free State of Saxony; European Union (SMWK/EFRE)	The research leading to these results has received funding from the European Community's Seventh Framework Program ([FP7/2007-2013]) and Cosmetics Europe under Grant Agreement No. 266753 (SCR&Tox) as well as by the German Federal Ministry of Education and Research (BMBF, Project: BiMiHySS FKZ 16SV5052). The image acquisition facility (confocal microscope) was funded by the Free State of Saxony and the European Union (SMWK/EFRE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson H, 2010, J BIOTECHNOL, V150, P175, DOI 10.1016/j.jbiotec.2010.06.023; Asp J, 2010, J MOL CELL BIOL, V2, P276, DOI 10.1093/jmcb/mjq022; Berridge BR, 2009, AM HEART J, V158, P21, DOI 10.1016/j.ahj.2009.04.020; BOHM M, 1995, J AM COLL CARDIOL, V25, P146, DOI 10.1016/0735-1097(94)00353-R; Braam SR, 2010, STEM CELL RES, V4, P107, DOI 10.1016/j.scr.2009.11.004; Burridge PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018293; Eckes J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-337; Guglin M, 2009, EUROPACE, V11, P1579, DOI 10.1093/europace/eup300; Haas S, 2010, LAB CHIP, V10, P2965, DOI [10.1039/c0lc00008f, 10.1039/c01c00008f]; Halbach MD, 2003, CELL PHYSIOL BIOCHEM, V13, P271, DOI 10.1159/000074542; Jahnke HG, 2012, BIOSENS BIOELECTRON, V32, P250, DOI 10.1016/j.bios.2011.12.026; Jahnke HG, 2009, LAB CHIP, V9, P1422, DOI 10.1039/b819754g; Jonsson M.K., 2012, J MOL CELL CARDIOL; Kamakura T, 2013, CIRC J, V77, P1307, DOI 10.1253/circj.CJ-12-0987; Kloss D, 2008, LAB CHIP, V8, P879, DOI 10.1039/b800394g; Kloss D, 2008, BIOSENS BIOELECTRON, V23, P1473, DOI 10.1016/j.bios.2008.01.003; Krinke D, 2010, BIOSENS BIOELECTRON, V26, P162, DOI 10.1016/j.bios.2010.06.002; Krinke D, 2009, BIOSENS BIOELECTRON, V24, P2798, DOI 10.1016/j.bios.2009.02.006; Lee P, 2012, CIRC RES, V110, P1556, DOI 10.1161/CIRCRESAHA.111.262535; Lu HR, 2001, J CARDIOVASC ELECTR, V12, P93, DOI 10.1046/j.1540-8167.2001.00093.x; Mandenius CF, 2011, J APPL TOXICOL, V31, P191, DOI 10.1002/jat.1663; Nalos L, 2012, BRIT J PHARMACOL, V165, P467, DOI 10.1111/j.1476-5381.2011.01558.x; Narsinh K, 2011, CIRC RES, V108, P1146, DOI 10.1161/CIRCRESAHA.111.240374; Omata T, 2005, J PHARMACOL SCI, V99, P531, DOI 10.1254/jphs.QT-C12; Otsuji TG, 2010, STEM CELL RES, V4, P201, DOI 10.1016/j.scr.2010.01.002; Pointon A, 2013, TOXICOL SCI; Redfern WS, 2003, CARDIOVASC RES, V58, P32, DOI 10.1016/S0008-6363(02)00846-5; Reppel M, 2007, CELL PHYSIOL BIOCHEM, V19, P213, DOI 10.1159/000100628; Rothermel A, 2005, CELL PHYSIOL BIOCHEM, V16, P51, DOI 10.1159/000087731; Sheppard RJ, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00019; Steel D, 2009, CURR OPIN DRUG DISC, V12, P133; Synnergren J, 2008, STEM CELLS, V26, P1831, DOI 10.1634/stemcells.2007-1033; Synnergren J, 2012, PHYSIOL GENOMICS, V44, P245, DOI 10.1152/physiolgenomics.00118.2011; Ungrin MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001565; Vidarsson H, 2010, STEM CELL REV REP, V6, P108, DOI 10.1007/s12015-010-9113-x; Ye L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053764; Zhang JH, 2012, CIRC RES, V111, P1125, DOI 10.1161/CIRCRESAHA.112.273144; Zhu WZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005407	38	24	25	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68971	10.1371/journal.pone.0068971	http://dx.doi.org/10.1371/journal.pone.0068971			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861955	Green Published, gold, Green Submitted			2022-12-27	WOS:000321692000034
J	Gebremedhin, D; Terashvili, M; Wickramasekera, N; Zhang, DX; Rau, N; Miura, H; Harder, DR				Gebremedhin, Debebe; Terashvili, Maia; Wickramasekera, Nadi; Zhang, David X.; Rau, Nicole; Miura, Hiroto; Harder, David R.			Redox Signaling via Oxidative Inactivation of PTEN Modulates Pressure-Dependent Myogenic Tone in Rat Middle Cerebral Arteries	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; REACTIVE OXYGEN; SUPEROXIDE; SHEAR; PATHOPHYSIOLOGY; INHIBITOR; ISCHEMIA; ZSTK474; CELLS	The present study examined the level of generation of reactive oxygen species (ROS) and roles of inactivation of the phosphatase PTEN and the PI3K/Akt signaling pathway in response to an increase in intramural pressure-induced myogenic cerebral arterial constriction. Step increases in intraluminal pressure of cannulated cerebral arteries induced myogenic constriction and concomitant formation of superoxide (O2(center dot)(-)) and its dismutation product hydrogen peroxide (H2O2) as determined by fluorescent HPLC analysis, microscopic analysis of intensity of dihydroethidium fluorescence and attenuation of pressure-induced myogenic constriction by pretreatment with the ROS scavenger 4,hydroxyl-2,2,6,6-tetramethylpiperidine-1-oxyl (tempol) or Mito-tempol or MitoQ in the presence or absence of PEG-catalase. An increase in intraluminal pressure induced oxidation of PTEN and activation of Akt. Pharmacological inhibition of endogenous PTEN activity potentiated pressure-dependent myogenic constriction and caused a reduction in NPo of a 238 pS arterial kappa(Ca) channel current and an increase in [Ca2+](i) level in freshly isolated cerebral arterial muscle cells (CAMCs), responses that were attenuated by Inhibition of the PI3K/Akt pathway. These findings demonstrate an increase in intraluminal pressure induced increase in ROS production triggered redox-sensitive signaling mechanism emanating from the cross-talk between oxidative inactivation of PTEN and activation of the PI3K/Akt signaling pathway that involves in the regulation of pressure-dependent myogenic cerebral arterial constriction.	[Gebremedhin, Debebe; Terashvili, Maia; Wickramasekera, Nadi; Rau, Nicole; Harder, David R.] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Zhang, David X.; Miura, Hiroto] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; [Gebremedhin, Debebe; Terashvili, Maia; Wickramasekera, Nadi; Zhang, David X.; Rau, Nicole; Miura, Hiroto; Harder, David R.] Med Coll Wisconsin, Cardiovasc Res Ctr, Milwaukee, WI 53226 USA; [Harder, David R.] Clement Zablocki VA Med Ctr, Milwaukee, WI USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Gebremedhin, D (corresponding author), Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	mariyei@mcw.edu	Terashvili, Maia/AAX-6817-2021		National Institutes of Health/National Heart, Lung and Blood Institute (NIH/NHLBI) [RO1 HL033833, PO1 HL059996, RO1 HL105997, R01 HL092105]; VA Research Career Scientist Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092105, R01HL033833, P01HL059996, R01HL105997] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung and Blood Institute (NIH/NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); VA Research Career Scientist Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the National Institutes of Health/National Heart, Lung and Blood Institute (NIH/NHLBI) Grants RO1 HL033833, PO1 HL059996, RO1 HL105997, R01 HL092105 and also by the VA Research Career Scientist Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzai K, 2011, CANCER SCI, V102, P1176, DOI 10.1111/j.1349-7006.2011.01916.x; Bayliss WM, 1902, J PHYSIOL-LONDON, V28, P220; Carnevale D, 2012, CARDIOVASC RES, V93, P200, DOI 10.1093/cvr/cvr288; Clarke DD, 1989, BASIC NEUROCHEMISTRY, P565; Doppenberg EMR, 1998, SURG NEUROL, V49, P650, DOI 10.1016/S0090-3019(97)00355-8; Duong HQ, 2012, ONCOL REP, V27, P182, DOI 10.3892/or.2011.1503; FOLKOW B, 1964, CIRC RES, V15, P279; Gebremedhin D, 2003, J NEUROSCI, V23, P1678; Gebremedhin D, 2008, AM J PHYSIOL-HEART C, V294, pH107, DOI 10.1152/ajpheart.01416.2006; Gebremedhin D, 2010, J CEREBR BLOOD F MET, V30, P1777, DOI 10.1038/jcbfm.2010.70; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARDER DR, 1984, CIRC RES, V55, P197, DOI 10.1161/01.RES.55.2.197; Huang A, 1998, CIRC RES, V83, P960; Kong DX, 2010, ACTA PHARMACOL SIN, V31, P1189, DOI 10.1038/aps.2010.150; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Lehoux S, 2006, CARDIOVASC RES, V71, P269, DOI 10.1016/j.cardiores.2006.05.008; Liu B, 2009, BBA-BIOMEMBRANES, V1788, P2174, DOI 10.1016/j.bbamem.2009.07.016; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Mendoza SA, 2010, AM J PHYSIOL-HEART C, V298, pH466, DOI 10.1152/ajpheart.00854.2009; Myers MP, 1997, P NATL ACAD SCI USA, V94, P9052, DOI 10.1073/pnas.94.17.9052; Oudit GY, 2009, CARDIOVASC RES, V82, P250, DOI 10.1093/cvr/cvp014; Oudit GY, 2004, J MOL CELL CARDIOL, V37, P449, DOI 10.1016/j.yjmcc.2004.05.015; Phillips SA, 2006, J APPL PHYSIOL, V100, P1117, DOI 10.1152/japplphysiol.00994.2005; Schmid AC, 2004, FEBS LETT, V566, P35, DOI 10.1016/j.febslet.2004.03.102; SIESJO BK, 1992, J NEUROSURG, V77, P337, DOI 10.3171/jns.1992.77.3.0337; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Ungvari Z, 2003, ARTERIOSCL THROM VAS, V23, P418, DOI 10.1161/01.ATV.0000061735.85377.40; Wan XP, 2011, J BIOL CHEM, V286, P2843, DOI 10.1074/jbc.M110.125526; Zagorac D, 2005, STROKE, V36, P2589, DOI 10.1161/01.STR.0000189997.84161.95; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4; Zielonka J, 2012, J BIOL CHEM, V287, P2984, DOI 10.1074/jbc.M111.309062	33	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68498	10.1371/journal.pone.0068498	http://dx.doi.org/10.1371/journal.pone.0068498			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861911	Green Published, Green Submitted, gold			2022-12-27	WOS:000321425300065
J	Hristov, KL; Afeli, SAY; Parajuli, SP; Cheng, QP; Rovner, ES; Petkov, GV				Hristov, Kiril L.; Afeli, Serge A. Y.; Parajuli, Shankar P.; Cheng, Qiuping; Rovner, Eric S.; Petkov, Georgi V.			Neurogenic Detrusor Overactivity Is Associated with Decreased Expression and Function of the Large Conductance Voltage- and Ca2+-Activated K+ Channels	PLOS ONE			English	Article							LOWER URINARY-TRACT; BLADDER SMOOTH-MUSCLE; DIFFERENTIAL REGULATION; GENE-TRANSFER; TOLERABILITY; INCONTINENCE; ACTIVATION; CALCIUM; SAFETY; RATS	Patients suffering from a variety of neurological diseases such as spinal cord injury, Parkinson's disease, and multiple sclerosis often develop neurogenic detrusor overactivity (NDO), which currently lacks a universally effective therapy. Here, we tested the hypothesis that NDO is associated with changes in detrusor smooth muscle (DSM) large conductance Ca2+-activated K+ (BK) channel expression and function. DSM tissue samples from 33 patients were obtained during open bladder surgeries. NDO patients were clinically characterized preoperatively with pressure-flow urodynamics demonstrating detrusor overactivity, in the setting of a clinically relevant neurological condition. Control patients did not have overactive bladder and did not have a clinically relevant neurological disease. We conducted quantitative polymerase chain reactions (qPCR), perforated patch-clamp electrophysiology on freshly-isolated DSM cells, and functional studies on DSM contractility. qPCR experiments revealed that DSM samples from NDO patients showed decreased BK channel mRNA expression in comparison to controls. Patch-clamp experiments demonstrated reduced whole cell and transient BK currents (TBKCs) in freshly-isolated DSM cells from NDO patients. Functional studies on DSM contractility showed that spontaneous phasic contractions had a decreased sensitivity to iberiotoxin, a selective BK channel inhibitor, in DSM strips isolated from NDO patients. These results reveal the novel finding that NDO is associated with decreased DSM BK channel expression and function leading to increased DSM excitability and contractility. BK channel openers or BK channel gene transfer could be an alternative strategy to control NDO. Future clinical trials are needed to evaluate the value of BK channel opening drugs or gene therapies for NDO treatment and to identify any possible adverse effects.	[Hristov, Kiril L.; Afeli, Serge A. Y.; Parajuli, Shankar P.; Cheng, Qiuping; Petkov, Georgi V.] Univ S Carolina, Dept Drug Discovery & Biomed Sci, South Carolina Coll Pharm, Columbia, SC 29208 USA; [Rovner, Eric S.; Petkov, Georgi V.] Med Univ S Carolina, Charleston, SC 29425 USA	Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Medical University of South Carolina	Petkov, GV (corresponding author), Univ S Carolina, Dept Drug Discovery & Biomed Sci, South Carolina Coll Pharm, Columbia, SC 29208 USA.	petkov@cop.sc.edu			National Institutes of Health [DK084284]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084284] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institutes of Health DK084284 grant to GVP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4; Afeli SAY, 2012, AM J PHYSIOL-RENAL, V303, pF559, DOI 10.1152/ajprenal.00615.2011; Andersson KE, 2004, PHARMACOL REV, V56, P581, DOI 10.1124/pr.56.4.4; Armstrong RB, 2007, INT UROL NEPHROL, V39, P1069, DOI 10.1007/s11255-006-9157-7; Aydin M, 2012, BJU INT, V110, pE402, DOI 10.1111/j.1464-410X.2012.11137.x; Brading AF, 1997, UROLOGY, V50, P57, DOI 10.1016/S0090-4295(97)00591-8; Brown SM, 2008, AM J PHYSIOL-RENAL, V295, pF1149, DOI 10.1152/ajprenal.00440.2007; Brubaker L, 2008, J UROLOGY, V180, P217, DOI 10.1016/j.juro.2008.03.028; CARDENAS DD, 1995, PARAPLEGIA, V33, P326, DOI 10.1038/sc.1995.73; Chang SH, 2010, AM J PHYSIOL-RENAL, V298, pF1416, DOI 10.1152/ajprenal.00595.2009; Christ GJ, 2001, AM J PHYSIOL-REG I, V281, pR1699, DOI 10.1152/ajpregu.2001.281.5.R1699; Conte A, 2012, EUR J NEUROL, V19, P725, DOI 10.1111/j.1468-1331.2011.03618.x; Gras J, 2012, DRUG TODAY, V48, P25, DOI 10.1358/dot.2012.48.1.1738056; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hashitani H, 2004, BRIT J PHARMACOL, V141, P183, DOI 10.1038/sj.bjp.0705602; Hayase M, 2009, J UROLOGY, V181, P2355, DOI 10.1016/j.juro.2009.01.013; Heppner TJ, 1997, AM J PHYSIOL-CELL PH, V273, pC110; Herrera GM, 2002, J PHYSIOL-LONDON, V541, P483, DOI 10.1113/jphysiol.2002.017707; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; Hristov KL, 2012, AM J PHYSIOL-CELL PH, V302, pC1632, DOI 10.1152/ajpcell.00417.2011; Hristov KL, 2011, AM J PHYSIOL-CELL PH, V301, pC903, DOI 10.1152/ajpcell.00495.2010; Kuo HC, 2010, EUR UROL, V58, P919, DOI 10.1016/j.eururo.2010.09.007; Kuo YC, 2013, INT J UROL, V20, P40, DOI 10.1111/j.1442-2042.2012.03035.x; Layne JJ, 2010, AM J PHYSIOL-REG I, V298, pR378, DOI 10.1152/ajpregu.00458.2009; Li LK, 2008, BJU INT, V101, P1588, DOI 10.1111/j.1464-410X.2008.07522.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Melman A, 2008, GENE THER, V15, P364, DOI 10.1038/sj.gt.3303093; Melman A, 2007, ISR MED ASSOC J, V9, P143; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; Nardi A, 2008, CURR MED CHEM, V15, P1126, DOI 10.2174/092986708784221412; Nitti VW, 2007, J UROLOGY, V178, P2488, DOI 10.1016/j.juro.2007.08.033; Oefelein MG, 2011, DRUG SAFETY, V34, P733, DOI 10.2165/11592790-000000000-00000; Oger S, 2011, BJU INT, V108, P604, DOI 10.1111/j.1464-410X.2010.09935.x; Petkov GV, 2012, NAT REV UROL, V9, P30, DOI 10.1038/nrurol.2011.194; Petkov GV, 2005, AM J PHYSIOL-CELL PH, V288, pC1255, DOI 10.1152/ajpcell.00381.2004; Petkov GV, 2001, J PHYSIOL-LONDON, V537, P443, DOI 10.1111/j.1469-7793.2001.00443.x; Soder RP, 2011, EUR J PHARMACOL, V670, P252, DOI 10.1016/j.ejphar.2011.08.013; Sprossmann F, 2009, FEBS J, V276, P1680, DOI 10.1111/j.1742-4658.2009.06900.x; Staskin DR, 2009, J UROLOGY, V181, P1764, DOI 10.1016/j.juro.2008.11.125; Stewart WF, 2002, WORLD J UROL, V20, P327, DOI 10.1007/s00345-002-0301-4; Thorneloe KS, 2005, AM J PHYSIOL-RENAL, V289, pF604, DOI 10.1152/ajprenal.00060.2005; Tyagi P, 2010, IDRUGS, V13, P713; Wagg Adrian, 2006, Am J Geriatr Pharmacother, V4, P14, DOI 10.1016/j.amjopharm.2006.03.004; Xin WK, 2012, AM J PHYSIOL-CELL PH, V302, pC1361, DOI 10.1152/ajpcell.00432.2011; Zinner N, 2006, INT J CLIN PRACT, V60, P119, DOI 10.1111/j.1368-5031.2005.00770.x	45	42	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68052	10.1371/journal.pone.0068052	http://dx.doi.org/10.1371/journal.pone.0068052			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861849	Green Published, Green Submitted, gold			2022-12-27	WOS:000321425300038
J	Shao, L; Fan, XH; Cheng, NT; Wu, LH; Cheng, YY				Shao, Li; Fan, Xiaohui; Cheng, Ningtao; Wu, Leihong; Cheng, Yiyu			Determination of Minimum Training Sample Size for Microarray-Based Cancer Outcome Prediction-An Empirical Assessment	PLOS ONE			English	Article							EXPRESSION PATTERNS; CLASSIFICATION; CHEMOTHERAPY; SURVIVAL	The promise of microarray technology in providing prediction classifiers for cancer outcome estimation has been confirmed by a number of demonstrable successes. However, the reliability of prediction results relies heavily on the accuracy of statistical parameters involved in classifiers. It cannot be reliably estimated with only a small number of training samples. Therefore, it is of vital importance to determine the minimum number of training samples and to ensure the clinical value of microarrays in cancer outcome prediction. We evaluated the impact of training sample size on model performance extensively based on 3 large-scale cancer microarray datasets provided by the second phase of MicroArray Quality Control project (MAQC-II). An SSNR-based (scale of signal-to-noise ratio) protocol was proposed in this study for minimum training sample size determination. External validation results based on another 3 cancer datasets confirmed that the SSNR-based approach could not only determine the minimum number of training samples efficiently, but also provide a valuable strategy for estimating the underlying performance of classifiers in advance. Once translated into clinical routine applications, the SSNR-based protocol would provide great convenience in microarray-based cancer outcome prediction in improving classifier reliability.	[Shao, Li; Fan, Xiaohui; Wu, Leihong] Zhejiang Univ, Sch Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310003, Zhejiang, Peoples R China; [Cheng, Ningtao] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Cheng, Ningtao] Emory Univ, Atlanta, GA 30322 USA; [Cheng, Yiyu] Zhejiang Univ, Coll Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; University System of Georgia; Georgia Institute of Technology; Emory University; Zhejiang University	Fan, XH (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.	fanxh@zju.edu.cn; chengyy@zju.edu.cn	Wu, Leihong/AAM-9483-2020; FAN, Xiaohui/F-6458-2010	Wu, Leihong/0000-0002-4093-3708; FAN, Xiaohui/0000-0002-6336-3007	National Science Foundation of China [30830121, 81173465]; Zhejiang Provincial Natural Science Foundation of China [R2080693]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported by the National Science Foundation of China (30830121, 81173465) and the Zhejiang Provincial Natural Science Foundation of China (R2080693). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayers M, 2004, J CLIN ONCOL, V22, P2284, DOI 10.1200/JCO.2004.05.166; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; de Valpine P, 2009, BIOSTATISTICS, V10, P424, DOI 10.1093/biostatistics/kxp001; DeRisi J, 1996, NAT GENET, V14, P457; Dobbin KK, 2008, CLIN CANCER RES, V14, P108, DOI 10.1158/1078-0432.CCR-07-0443; Dobbin KK, 2007, BIOSTATISTICS, V8, P101, DOI 10.1093/biostatistics/kxj036; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Fan XH, 2010, CLIN CANCER RES, V16, P629, DOI 10.1158/1078-0432.CCR-09-1815; Figueroa RL, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-8; Fu WJJ, 2005, BIOINFORMATICS, V21, P63, DOI 10.1093/bioinformatics/bth461; Gadbury GL, 2004, STAT METHODS MED RES, V13, P325, DOI 10.1191/0962280204sm369ra; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hwang DH, 2002, BIOINFORMATICS, V18, P1184, DOI 10.1093/bioinformatics/18.9.1184; Kim KY, 2009, J BIOSCI BIOENG, V108, P252, DOI 10.1016/j.jbiosc.2009.03.017; Kundu S, 1998, STAT PROBABIL LETT, V37, P19, DOI 10.1016/S0167-7152(98)00094-7; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Mukherjee S, 2003, J COMPUT BIOL, V10, P119, DOI 10.1089/106652703321825928; Popovici V, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2468; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Symmans WF, 2010, J CLIN ONCOL, V28, P4111, DOI 10.1200/JCO.2010.28.4273; The MicroArray Quality Control Consortium, 2010, PHARMACOGENOMICS J, pS5; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Van Niel TG, 2005, REMOTE SENS ENVIRON, V98, P468, DOI 10.1016/j.rse.2005.08.011; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1	24	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68579	10.1371/journal.pone.0068579	http://dx.doi.org/10.1371/journal.pone.0068579			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861920	Green Submitted, gold, Green Published			2022-12-27	WOS:000321425300071
J	Vassall, KA; Bessonov, K; De Avila, M; Polverini, E; Harauz, G				Vassall, Kenrick A.; Bessonov, Kyrylo; De Avila, Miguel; Polverini, Eugenia; Harauz, George			The Effects of Threonine Phosphorylation on the Stability and Dynamics of the Central Molecular Switch Region of 18.5-kDa Myelin Basic Protein	PLOS ONE			English	Article							AZE AZETIDINE-2-CARBOXYLIC ACID; LINEAR EXTRAPOLATION METHOD; RANDOM COIL TRANSITIONS; SECONDARY STRUCTURE; MULTIPLE-SCLEROSIS; ALPHA-HELIX; CHEMICAL-SHIFT; IMMUNODOMINANT EPITOPE; KDA ISOFORM; BINDING	The classic isoforms of myelin basic protein (MBP) are essential for the formation and maintenance of myelin in the central nervous system of higher vertebrates. The protein is involved in all facets of the development, compaction, and stabilization of the multilamellar myelin sheath, and also interacts with cytoskeletal and signaling proteins. The predominant 18.5-kDa isoform of MBP is an intrinsically-disordered protein that is a candidate auto-antigen in the human demyelinating disease multiple sclerosis. A highly-conserved central segment within classic MBP consists of a proline-rich region (murine 18.5-kDa sequence -T92-P93-R94-T95-P96-P97-P98-S99-) containing a putative SH3-ligand, adjacent to a region that forms an amphipathic alpha-helix (P82-I90) upon interaction with membranes, or under membrane-mimetic conditions. The T92 and T95 residues within the proline-rich region can be post-translationally modified through phosphorylation by mitogen-activated protein (MAP) kinases. Here, we have investigated the structure of the a-helical and proline-rich regions in dilute aqueous buffer, and have evaluated the effects of phosphorylation at T92 and T95 on the stability and dynamics of the alpha-helical region, by utilizing four 36-residue peptides (S72-S107) with differing phosphorylation status. Nuclear magnetic resonance spectroscopy reveals that both the alpha-helical as well as the proline-rich regions are disordered in aqueous buffer, whereas they are both structured in a lipid environment (cf., Ahmed et al., Biochemistry 51, 7475-9487, 2012). Thermodynamic analysis of trifluoroethanol-titration curves monitored by circular dichroism spectroscopy reveals that phosphorylation, especially at residue T92, impedes formation of the amphipathic alpha-helix. This conclusion is supported by molecular dynamics simulations, which further illustrate that phosphorylation reduces the folding reversibility of the alpha-helix upon temperature perturbation and affect the global structure of the peptides through altered electrostatic interactions. The results support the hypothesis that the central conserved segment of MBP constitutes a molecular switch in which the conformation and/or intermolecular interactions are mediated by phosphorylation/dephosphorylation at T92 and T95.	[Vassall, Kenrick A.; Bessonov, Kyrylo; De Avila, Miguel; Harauz, George] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Polverini, Eugenia] Univ Parma, Dept Phys, I-43100 Parma, Italy	University of Guelph; University of Parma	Harauz, G (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	gharauz@uoguelph.ca		Polverini, Eugenia/0000-0003-1665-2129; Harauz, George/0000-0002-6114-9947	Natural Sciences and Engineering Research Council of Canada [RG121541]; Multiple Sclerosis Society of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Multiple Sclerosis Society of Canada	This work was supported by the Natural Sciences and Engineering Research Council of Canada (Discovery Grant RG121541 to GH; http://www.nserc-crsng.gc.ca/). GH is a Tier 1 Canada Research Chair. KAV and MDA were recipients of a Postdoctoral Fellowship and of a Doctoral Studentship, respectively, from the Multiple Sclerosis Society of Canada (http://mssociety.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MAM, 2007, BIOCHEMISTRY-US, V46, P9700, DOI 10.1021/bi700632x; Ahmed MAM, 2012, BIOCHEMISTRY-US, V51, P7475, DOI 10.1021/bi300998x; Ahmed MAM, 2010, BIOPHYS J, V99, P1247, DOI 10.1016/j.bpj.2010.06.022; Andrew CD, 2002, BIOCHEMISTRY-US, V41, P1897, DOI 10.1021/bi0113216; Bamm VV, 2011, BIOPHYS J, V101, P1248, DOI 10.1016/j.bpj.2011.07.035; Bates IR, 2004, J BIOL CHEM, V279, P5757, DOI 10.1074/jbc.M311504200; Bauer NG, 2009, GLIA, V57, P1691, DOI 10.1002/glia.20885; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Bertolucci CM, 2008, BIOCHEMISTRY-US, V47, P548, DOI 10.1021/bi702103n; Bessonov K, 2013, J MOL GRAPH MODEL, V39, P118, DOI 10.1016/j.jmgm.2012.11.006; Bessonov K, 2010, PHYTOCHEMISTRY, V71, P502, DOI 10.1016/j.phytochem.2009.12.010; Boggs JM, 2006, CELL MOL LIFE SCI, V63, P1945, DOI 10.1007/s00018-006-6094-7; Boggs J. M., 2008, MYELIN BASIC PROTEIN; Boggs JM, 2006, BIOCHEMISTRY-US, V45, P391, DOI 10.1021/bi0519194; BOLEN DW, 1988, BIOCHEMISTRY-US, V27, P8069, DOI 10.1021/bi00421a015; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Camilloni C, 2012, BIOCHEMISTRY-US, V51, P2224, DOI 10.1021/bi3001825; Chellgren BW, 2004, BIOCHEMISTRY-US, V43, P5864, DOI 10.1021/bi049922v; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cubellis MV, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S8; DeBruin LS, 2007, NEUROCHEM RES, V32, P213, DOI 10.1007/s11064-006-9137-4; DeBruin LS, 2005, J NEUROSCI RES, V80, P211, DOI 10.1002/jnr.20452; DEIBLER GE, 1990, PROTEINS, V7, P32, DOI 10.1002/prot.340070104; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doig AJ, 2008, PROG MOL BIOL TRANSL, V83, P1, DOI 10.1016/S0079-6603(08)00601-6; ERICKSON AK, 1990, J BIOL CHEM, V265, P19728; Errington Neil, 2006, V340, P3; Fares C, 2006, FEBS J, V273, P601, DOI 10.1111/J.1742-4658.2005.05093.X; Fatemeh MD, 2012, BIOINFORMATICS, V28, pi75, DOI DOI 10.1093/BI0INF0RMATICS/BTS209; Fields RD, 2005, NEUROSCIENTIST, V11, P528, DOI 10.1177/1073858405282304; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Garcia-Alai MM, 2007, BIOCHEMISTRY-US, V46, P10405, DOI 10.1021/bi7007917; Harauz G, 2004, MICRON, V35, P503, DOI 10.1016/j.micron.2004.04.005; Harauz G, 2013, J NEUROCHEM, V125, P334, DOI 10.1111/jnc.12195; Harauz G, 2009, BIOCHEMISTRY-US, V48, P8094, DOI 10.1021/bi901005f; Harauz G, 2009, CURR PROTEIN PEPT SC, V10, P196, DOI 10.2174/138920309788452218; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hill CMD, 2005, BIOCHEMISTRY-US, V44, P16672, DOI 10.1021/bi050646+; Hill CMD, 2005, BIOCHEM BIOPH RES CO, V329, P362, DOI 10.1016/j.bbrc.2005.01.151; Hirschberg D, 2003, J PROTEIN CHEM, V22, P177, DOI 10.1023/A:1023479131488; HOLTZER ME, 1992, BIOPOLYMERS, V32, P1589, DOI 10.1002/bip.360321116; HOLTZER ME, 1992, BIOPOLYMERS, V32, P1675, DOI 10.1002/bip.360321209; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ioannidou K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030775; JASANOFF A, 1994, BIOCHEMISTRY-US, V33, P2129, DOI 10.1021/bi00174a020; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kanelis V, 2000, J BIOMOL NMR, V16, P253, DOI 10.1023/A:1008355012528; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kim JK, 2003, MOL CELL PROTEOMICS, V2, P453, DOI 10.1074/mcp.M200050-MCP200; Klose DP, 2010, BIOINFORMATICS, V26, P2624, DOI 10.1093/bioinformatics/btq480; Koehler J, 2012, MATERIALS, V5, P1774, DOI 10.3390/ma5101774; Lam SL, 2003, BIOPOLYMERS, V69, P270, DOI 10.1002/bip.10354; Li F, 2013, J PHYS CHEM B, V117, P3560, DOI 10.1021/jp4007334; Libich DS, 2008, BIOPHYS J, V94, P4847, DOI 10.1529/biophysj.107.125823; Libich DS, 2010, BIOCHEM CELL BIOL, V88, P143, DOI [10.1139/o09-123, 10.1139/O09-123]; Libich DS, 2004, J BIOMOL NMR, V29, P545, DOI 10.1023/B:JNMR.0000034348.99658.d7; Mansiaux Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018401; MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Medveczky P, 2006, FEBS LETT, V580, P545, DOI 10.1016/j.febslet.2005.12.067; Miller RH, 1996, TRENDS NEUROSCI, V19, P92, DOI 10.1016/S0166-2236(96)80036-1; Miron VE, 2011, BBA-MOL BASIS DIS, V1812, P184, DOI 10.1016/j.bbadis.2010.09.010; Murray TJ, 2009, J NEUROL SCI, V277, pS3, DOI 10.1016/S0022-510X(09)70003-6; Musse AA, 2006, P NATL ACAD SCI USA, V103, P4422, DOI 10.1073/pnas.0509158103; Narayanan R, 2008, J AM CHEM SOC, V130, P11477, DOI 10.1021/ja803221c; NELSON J W, 1986, Proteins Structure Function and Genetics, V1, P211, DOI 10.1002/prot.340010303; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; PERSAUD R, 1988, BIOCHIM BIOPHYS ACTA, V966, P357, DOI 10.1016/0304-4165(88)90085-2; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; Polverini E, 2008, BIOCHEMISTRY-US, V47, P267, DOI 10.1021/bi701336n; Polverini E, 2011, BBA-BIOMEMBRANES, V1808, P674, DOI 10.1016/j.bbamem.2010.11.030; RAMWANI JJ, 1989, BIOCHEMISTRY-US, V28, P6538, DOI 10.1021/bi00442a002; RANDALL CS, 1985, BIOCHEMISTRY-US, V24, P1998, DOI 10.1021/bi00329a030; Ronga L, 2008, J PEPT SCI, V14, P1096, DOI 10.1002/psc.1046; Rubenstein E, 2008, J NEUROPATH EXP NEUR, V67, P1035, DOI 10.1097/NEN.0b013e31818add4a; Rubin SM, 2013, TRENDS BIOCHEM SCI, V38, P12, DOI 10.1016/j.tibs.2012.10.007; SANCHO J, 1992, J MOL BIOL, V224, P749, DOI 10.1016/0022-2836(92)90559-3; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; SCHULZ P, 1988, BIOCHEMISTRY-US, V27, P7793, DOI 10.1021/bi00420a031; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Simons M, 2012, BBA-MOL CELL BIOL L, V1821, P1146, DOI 10.1016/j.bbalip.2012.01.011; Smith GST, 2012, J NEUROSCI RES, V90, P28, DOI 10.1002/jnr.22733; Smith GS, 2012, NEUROPSYCHOPHARMACOL, V37, P1, DOI 10.1038/npp.2011.233; Sobottka B, 2011, GLIA, V59, P1841, DOI 10.1002/glia.21228; SolerGonzalez AS, 1997, EUR J BIOCHEM, V249, P724, DOI 10.1111/j.1432-1033.1997.t01-1-00724.x; Srinivasan R, 1999, P NATL ACAD SCI USA, V96, P14258, DOI 10.1073/pnas.96.25.14258; Stariha RL, 1997, J NEUROCHEM, V68, P945; Stys PK, 2011, TRENDS NEUROSCI, V34, P393, DOI 10.1016/j.tins.2011.06.004; Stys PK, 2010, CAN J NEUROL SCI, V37, pS16, DOI 10.1017/S0317167100022393; Tait AR, 2008, FEBS LETT, V582, P2685, DOI 10.1016/j.febslet.2008.06.050; Tait S, 2010, P NATL ACAD SCI USA, V107, P17627, DOI 10.1073/pnas.1008242107; Tizzano B, 2005, PROTEINS, V59, P72, DOI 10.1002/prot.20395; Tompa P, 2009, BIOESSAYS, V31, P328, DOI 10.1002/bies.200800151; Tsutsui S, 2009, ANN NEUROL, V66, P711, DOI 10.1002/ana.21845; ULMER JB, 1984, DEV NEUROSCI-BASEL, V6, P345, DOI 10.1159/000112361; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; VARTANIAN T, 1986, SCIENCE, V234, P1395, DOI 10.1126/science.2431483; VUISTER GW, 1993, J BIOMOL NMR, V3, P67; Wang YJ, 2002, PROTEIN SCI, V11, P852, DOI 10.1110/ps.3180102; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zhang CC, 2012, J PROTEOME RES, V11, P4791, DOI 10.1021/pr201196e; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197; [No title captured]	109	29	30	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68175	10.1371/journal.pone.0068175	http://dx.doi.org/10.1371/journal.pone.0068175			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861868	Green Published, gold			2022-12-27	WOS:000321425300048
J	Wen, XT; Rangarajan, G; Ding, MZ				Wen, Xiaotong; Rangarajan, Govindan; Ding, Mingzhou			Is Granger Causality a Viable Technique for Analyzing fMRI Data?	PLOS ONE			English	Article							BOLD HEMODYNAMIC-RESPONSES; EVENT-RELATED FMRI; FUNCTIONAL MRI; NEURONAL MECHANISMS; ALPHA OSCILLATIONS; TIME-SERIES; HUMAN BRAIN; CONNECTIVITY; ATTENTION; NETWORK	Multivariate neural data provide the basis for assessing interactions in brain networks. Among myriad connectivity measures, Granger causality (GC) has proven to be statistically intuitive, easy to implement, and generate meaningful results. Although its application to functional MRI (fMRI) data is increasing, several factors have been identified that appear to hinder its neural interpretability: (a) latency differences in hemodynamic response function (HRF) across different brain regions, (b) low-sampling rates, and (c) noise. Recognizing that in basic and clinical neuroscience, it is often the change of a dependent variable (e.g., GC) between experimental conditions and between normal and pathology that is of interest, we address the question of whether there exist systematic relationships between GC at the fMRI level and that at the neural level. Simulated neural signals were convolved with a canonical HRF, down-sampled, and noise-added to generate simulated fMRI data. As the coupling parameters in the model were varied, fMRI GC and neural GC were calculated, and their relationship examined. Three main results were found: (1) GC following HRF convolution is a monotonically increasing function of neural GC; (2) this monotonicity can be reliably detected as a positive correlation when realistic fMRI temporal resolution and noise level were used; and (3) although the detectability of monotonicity declined due to the presence of HRF latency differences, substantial recovery of detectability occurred after correcting for latency differences. These results suggest that Granger causality is a viable technique for analyzing fMRI data when the questions are appropriately formulated.	[Wen, Xiaotong; Ding, Mingzhou] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32610 USA; [Rangarajan, Govindan] Indian Inst Sci, Dept Math, Bangalore 560012, Karnataka, India; [Rangarajan, Govindan] Indian Inst Sci, Ctr Neurosci, Bangalore 560012, Karnataka, India	State University System of Florida; University of Florida; Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Ding, MZ (corresponding author), Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32610 USA.	mding@bme.ufl.edu			NIH [MH079388, MH097320]; DST Center for Mathematical Biology; UGC Centre for Advanced Studies; DST IRHPA Center for Neuroscience; J.C. Bose Fellowship; Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097320, R01MH079388] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DST Center for Mathematical Biology; UGC Centre for Advanced Studies; DST IRHPA Center for Neuroscience; J.C. Bose Fellowship; Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH grants MH079388 and MH097320. GR was also supported by the DST Center for Mathematical Biology, UGC Centre for Advanced Studies, DST IRHPA Center for Neuroscience and J.C. Bose Fellowship. XW was also supported by the Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; Bandettini PA, 1997, NMR BIOMED, V10, P197, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<197::AID-NBM466>3.0.CO;2-S; Biswal BB, 2010, CEREB CORTEX, V20, P2188, DOI 10.1093/cercor/bhp284; Bollimunta A, 2008, J NEUROSCI, V28, P9976, DOI 10.1523/JNEUROSCI.2699-08.2008; Bollimunta A, 2011, J NEUROSCI, V31, P4935, DOI 10.1523/JNEUROSCI.5580-10.2011; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Bressler SL, 2008, J NEUROSCI, V28, P10056, DOI 10.1523/JNEUROSCI.1776-08.2008; Bressler SL, 2011, NEUROIMAGE, V58, P323, DOI 10.1016/j.neuroimage.2010.02.059; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Casanova R, 2008, NEUROIMAGE, V40, P1606, DOI 10.1016/j.neuroimage.2008.01.011; Chang C, 2008, NEUROIMAGE, V43, P90, DOI 10.1016/j.neuroimage.2008.06.030; Chen YH, 2006, J NEUROSCI METH, V150, P228, DOI 10.1016/j.jneumeth.2005.06.011; Cohen ER, 2004, NEUROIMAGE, V23, P613, DOI 10.1016/j.neuroimage.2004.06.021; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Curtis CE, 2005, NEUROIMAGE, V26, P177, DOI 10.1016/j.neuroimage.2005.01.040; Dale AM, 1997, HUM BRAIN MAPP, V5, P329, DOI 10.1002/(SICI)1097-0193(1997)5:5<329::AID-HBM1>3.0.CO;2-5; David O, 2011, NEUROIMAGE, V58, P306, DOI 10.1016/j.neuroimage.2009.09.073; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; Davis TL, 1998, P NATL ACAD SCI USA, V95, P1834, DOI 10.1073/pnas.95.4.1834; Deshpande G, 2010, NEUROIMAGE, V52, P884, DOI 10.1016/j.neuroimage.2009.11.060; Ding M., 2006, HDB TIME SERIES ANAL, P437, DOI DOI 10.1002/9783527609970.CH17; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Evdokimidis I, 2001, COGNITIVE BRAIN RES, V12, P89, DOI 10.1016/S0926-6410(01)00037-4; Feinberg DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015710; Florin E, 2010, NEUROIMAGE, V50, P577, DOI 10.1016/j.neuroimage.2009.12.050; Friston KJ, 2013, CURR OPIN NEUROBIOL, V23, P172, DOI 10.1016/j.conb.2012.11.010; Friston KJ, 2011, NEUROIMAGE, V58, P303, DOI 10.1016/j.neuroimage.2009.09.031; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gelfand I, 1959, AM MATH SOC TRANSL S, V2, P99; GEWEKE J, 1982, J AM STAT ASSOC, V77, P304, DOI 10.2307/2287238; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hamilton JP, 2011, MOL PSYCHIATR, V16, P763, DOI 10.1038/mp.2010.46; Handwerker DA, 2004, NEUROIMAGE, V21, P1639, DOI 10.1016/j.neuroimage.2003.11.029; Hu SQ, 2012, NEUROCOMPUTING, V76, P44, DOI 10.1016/j.neucom.2010.10.017; Hu SQ, 2011, IEEE T NEURAL NETWOR, V22, P829, DOI 10.1109/TNN.2011.2123917; Jiao Q, 2011, HUM BRAIN MAPP, V32, P154, DOI 10.1002/hbm.21065; Katwal SB, 2013, NEUROIMAGE, V66, P436, DOI 10.1016/j.neuroimage.2012.10.052; Kay KN, 2008, HUM BRAIN MAPP, V29, P142, DOI 10.1002/hbm.20379; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Luchtmann M, 2010, EXP BRAIN RES, V204, P1, DOI 10.1007/s00221-010-2277-4; Magon S, 2009, NEUROIMAGE, V45, P702, DOI 10.1016/j.neuroimage.2008.12.059; Marrelec G, 2003, HUM BRAIN MAPP, V19, P1, DOI 10.1002/hbm.10100; McDowell JE, 2005, NEUROREPORT, V16, P663, DOI 10.1097/00001756-200505120-00002; Menon RS, 1998, P NATL ACAD SCI USA, V95, P10902, DOI 10.1073/pnas.95.18.10902; Miao XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025546; NAKAMURA K, 1994, J NEUROPHYSIOL, V71, P1206, DOI 10.1152/jn.1994.71.3.1206; Nalatore H, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.031123; Nalatore H, 2009, J NEUROSCI METH, V179, P131, DOI 10.1016/j.jneumeth.2009.01.013; Nishitani N, 2002, NEURON, V36, P1211, DOI 10.1016/S0896-6273(02)01089-9; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Roebroeck A, 2011, NEUROIMAGE, V58, P296, DOI 10.1016/j.neuroimage.2009.09.036; Rogers BP, 2010, MAGN RESON IMAGING, V28, P1058, DOI 10.1016/j.mri.2010.03.002; ROLLS E T, 1992, P143; Rolls ET, 2000, ANNU REV PSYCHOL, V51, P599, DOI 10.1146/annurev.psych.51.1.599; Rolls ET, 2000, HIPPOCAMPUS, V10, P380, DOI 10.1002/1098-1063(2000)10:4<380::AID-HIPO4>3.0.CO;2-0; Rolls ET, 2000, NEURON, V27, P205, DOI 10.1016/S0896-6273(00)00030-1; Rypma B, 2006, NEUROIMAGE, V33, P969, DOI 10.1016/j.neuroimage.2006.05.065; Schippers MB, 2011, NEUROIMAGE, V57, P22, DOI 10.1016/j.neuroimage.2011.02.008; Schmolesky MT, 2000, NAT NEUROSCI, V3, P384, DOI 10.1038/73957; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sestieri C, 2008, FRONT HUM NEUROSCI, V1, DOI 10.3389/neuro.09.001.2007; Seth AK, 2013, NEUROIMAGE, V65, P540, DOI 10.1016/j.neuroimage.2012.09.049; Shokri-Kojori E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00411; Smith SM, 2012, NEUROIMAGE, V59, P1228, DOI 10.1016/j.neuroimage.2011.08.015; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Steffener J, 2010, NEUROIMAGE, V49, P2113, DOI 10.1016/j.neuroimage.2009.11.014; Wager TD, 2005, NEUROIMAGE, V26, P99, DOI 10.1016/j.neuroimage.2005.01.011; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wen XT, 2013, J NEUROSCI, V33, P6444, DOI 10.1523/JNEUROSCI.4939-12.2013; Wen XT, 2012, NEUROIMAGE, V60, P1587, DOI 10.1016/j.neuroimage.2012.01.079; Wen XT, 2012, J NEUROSCI, V32, P1284, DOI 10.1523/JNEUROSCI.2817-11.2012; Witt ST, 2009, BRAIN IMAGING BEHAV, V3, P220, DOI 10.1007/s11682-009-9064-5; Zang ZX, 2012, J NEUROSCI METH, V203, P418, DOI 10.1016/j.jneumeth.2011.10.006; Zhou ZY, 2009, BRAIN RES, V1289, P22, DOI 10.1016/j.brainres.2009.06.096	76	56	58	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67428	10.1371/journal.pone.0067428	http://dx.doi.org/10.1371/journal.pone.0067428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861763	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000323350700013
J	Lin, WY; Brock, IW; Connley, D; Cramp, H; Tucker, R; Slate, J; Reed, MWR; Balasubramanian, SP; Cannon-Albright, LA; Camp, NJ; Cox, A				Lin, Wei-Yu; Brock, Ian W.; Connley, Dan; Cramp, Helen; Tucker, Rachel; Slate, Jon; Reed, Malcolm W. R.; Balasubramanian, Sabapathy P.; Cannon-Albright, Lisa A.; Camp, Nicola J.; Cox, Angela			Associations of ATR and CHEK1 Single Nucleotide Polymorphisms with Breast Cancer	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; REPAIR PATHWAY GENES; SUSCEPTIBILITY LOCI; RISK; METAANALYSIS; POPULATION; HAPLOTYPE; CHK1	DNA damage and replication checkpoints mediated by the ATR-CHEK1 pathway are key to the maintenance of genome stability, and both ATR and CHEK1 have been proposed as potential breast cancer susceptibility genes. Many novel variants recently identified by the large resequencing projects have not yet been thoroughly tested in genome-wide association studies for breast cancer susceptibility. We therefore used a tagging SNP (tagSNP) approach based on recent SNP data available from the 1000 genomes projects, to investigate the roles of ATR and CHEK1 in breast cancer risk and survival. ATR and CHEK1 tagSNPs were genotyped in the Sheffield Breast Cancer Study (SBCS; 1011 cases and 1024 controls) using Illumina GoldenGate assays. Untyped SNPs were imputed using IMPUTE2, and associations between genotype and breast cancer risk and survival were evaluated using logistic and Cox proportional hazard regression models respectively on a per allele basis. Significant associations were further examined in a meta-analysis of published data or confirmed in the Utah Breast Cancer Study (UBCS). The most significant associations for breast cancer risk in SBCS came from rs6805118 in ATR (p=7.6x10(-5)) and rs2155388 in CHEK1 (p=3.1x10(-6)), but neither remained significant after meta-analysis with other studies. However, meta-analysis of published data revealed a weak association between the ATR SNP rs1802904 (minor allele frequency is 12%) and breast cancer risk, with a summary odds ratio (confidence interval) of 0.90 (0.83-0.98) [p=0.0185] for the minor allele. Further replication of this SNP in larger studies is warranted since it is located in the target region of 2 microRNAs. No evidence of any survival effects of ATR or CHEK1 SNPs were identified. We conclude that common alleles of ATR and CHEK1 are not implicated in breast cancer risk or survival, but we cannot exclude effects of rare alleles and of common alleles with very small effect sizes.	[Lin, Wei-Yu; Brock, Ian W.; Connley, Dan; Cramp, Helen; Cox, Angela] Univ Sheffield, Inst Canc Studies, Dept Oncol, CRUK YCR Canc Res Ctr, Sheffield, S Yorkshire, England; [Tucker, Rachel; Slate, Jon] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Reed, Malcolm W. R.; Balasubramanian, Sabapathy P.] Univ Sheffield, Acad Unit Surg Oncol, Dept Oncol, CRUK YCR Canc Res Ctr, Sheffield, S Yorkshire, England; [Cannon-Albright, Lisa A.; Camp, Nicola J.] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT USA	University of Sheffield; University of Sheffield; University of Sheffield; Utah System of Higher Education; University of Utah	Cox, A (corresponding author), Univ Sheffield, Inst Canc Studies, Dept Oncol, CRUK YCR Canc Res Ctr, Sheffield, S Yorkshire, England.	a.cox@shef.ac.uk	Lin, Wei-Yu/F-4505-2010; balasubramanian, saba prakash/H-2830-2019; Slate, Jon/D-2925-2012; Reed, Malcolm Walter/AAG-9219-2020	Lin, Wei-Yu/0000-0002-9267-7988; balasubramanian, saba prakash/0000-0001-5953-2843; Slate, Jon/0000-0003-3356-5123; Reed, Malcolm Walter/0000-0001-7442-2132; Cox, Angela/0000-0002-5138-1099; albright, lisa/0000-0003-2602-3668	Yorkshire Cancer Research Programme [S305PA, S299]; University of Utah Huntsman Cancer Institute (HCI); HCI Cancer Center Support grant from the NCI [P30 CA42014]; NCI SEER program [HHSN261201000026C]; Utah State Department of Health; University of Utah;  [R01CA163353]; NATIONAL CANCER INSTITUTE [R01CA163353, P30CA042014] Funding Source: NIH RePORTER	Yorkshire Cancer Research Programme; University of Utah Huntsman Cancer Institute (HCI); HCI Cancer Center Support grant from the NCI; NCI SEER program; Utah State Department of Health; University of Utah; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Yorkshire Cancer Research Programme award S305PA and equipment award S299. Data collection for the UBCS was made possible by the Utah Population DataBase (UPDB) and the Utah Cancer Resgistry (UCR). Partial support for all datasets within the UPDB was provided by the University of Utah Huntsman Cancer Institute (HCI) and the HCI Cancer Center Support grant, P30 CA42014 from the NCI. The UCR is funded by contract HHSN261201000026C from the NCI SEER program with additional support from the Utah State Department of Health and the University of Utah. NJC acknowledges support from R01CA163353. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Brady K, 2006, CANCER EPIDEM BIOMAR, V15, P1306, DOI 10.1158/1055-9965.EPI-05-0959; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barroso E, 2009, BREAST CANCER RES TR, V118, P655, DOI 10.1007/s10549-009-0439-5; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Enders GH, 2008, J BIOL CHEM, V283, P17749, DOI 10.1074/jbc.R800021200; Haiman CA, 2008, HUM MOL GENET, V17, P825, DOI 10.1093/hmg/ddm354; Han JL, 2009, BREAST CANCER RES TR, V115, P613, DOI 10.1007/s10549-008-0089-z; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Lin WY, 2011, J MED GENET, V48, P477, DOI 10.1136/jmedgenet-2011-100018; Loizidou MA, 2010, BREAST CANCER RES TR, V121, P147, DOI 10.1007/s10549-009-0518-7; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Olson JE, 2011, BREAST CANCER RES TR, V125, P221, DOI 10.1007/s10549-010-0950-8; Pooley KA, 2008, CANCER EPIDEM BIOMAR, V17, P3482, DOI 10.1158/1055-9965.EPI-08-0594; Shephard ND, 2009, CANCER RES, V69, P2724, DOI 10.1158/0008-5472.CAN-08-4266; Sinha S, 2011, MOL ONCOL, V5, P454, DOI 10.1016/j.molonc.2011.06.005; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837; Yu W, 2008, NAT GENET, V40, P124, DOI 10.1038/ng0208-124; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	24	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68578	10.1371/journal.pone.0068578	http://dx.doi.org/10.1371/journal.pone.0068578			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844225	Green Published, gold, Green Accepted			2022-12-27	WOS:000321733000017
J	Bode, C; Yang, XP; Kiu, H; Klinman, DM				Bode, Christian; Yang, Xiang-Ping; Kiu, Hiu; Klinman, Dennis M.			Suppressive Oligodeoxynucleotides Promote the Development of Th17 Cells	PLOS ONE			English	Article							T-HELPER-CELLS; CANDIDA-ALBICANS INFECTIONS; CYTOKINE GM-CSF; TGF-BETA; HOST-DEFENSE; T(H)17 CELLS; MICE; DIFFERENTIATION; INFLAMMATION; GENERATION	Synthetic oligonucleotides containing repetitive TTAGGG motifs mimic the immunosuppressive activity of telomeric DNA. These suppressive oligonucleotides (Sup ODN) are effective in the treatment/prevention of various inflammatory and autoimmune diseases in mice. The therapeutic activity of Sup ODN was originally attributed to the inhibition of Th1 cell activation. Current results indicate that Sup ODN also promote the maturation of naive CD4(+) T cells into Th17 effectors. The generation of Th17 cells is linked to the prolonged activation of signal transducer and activator of transcription (STAT) 3 mediated by suppressor of cytokine signaling 3 (SOCS3) inhibition. In vivo studies show that treatment with Sup ODN promotes Th17 responsiveness under physiological conditions, increasing host resistance to Candida albicans infection. These findings support the development of Sup ODN to suppress pathological inflammatory conditions and improve host resistance to fungal pathogens.	[Bode, Christian; Kiu, Hiu; Klinman, Dennis M.] NCI, Canc & Inflammat Program, NIH, Frederick, MD 21701 USA; [Yang, Xiang-Ping] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Klinman, DM (corresponding author), NCI, Canc & Inflammat Program, NIH, Frederick, MD 21701 USA.	klinmand@mail.nih.gov	Bode, Christian/AAL-1486-2021	Bode, Christian/0000-0002-0830-870X; Yang, Xiang-Ping/0000-0001-9003-1772	National Institutes of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC010853] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Cheng X, 2008, J MOL CELL CARDIOL, V45, P168, DOI 10.1016/j.yjmcc.2008.04.003; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Dejima T, 2011, INFECT IMMUN, V79, P4503, DOI 10.1128/IAI.05799-11; Dong L, 2005, ARTHRITIS RHEUM-US, V52, P651, DOI 10.1002/art.20810; Dong L, 2004, ARTHRITIS RHEUM-US, V50, P1686, DOI 10.1002/art.20263; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Fujimoto C, 2009, CLIN EXP IMMUNOL, V156, P528, DOI 10.1111/j.1365-2249.2009.03918.x; Ghoreschi K, 2011, TRENDS IMMUNOL, V32, P395, DOI 10.1016/j.it.2011.06.007; Ghoreschi K, 2011, J IMMUNOL, V186, P4234, DOI 10.4049/jimmunol.1003668; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gladiator A, 2013, J IMMUNOL, V190, P521, DOI 10.4049/jimmunol.1202924; Gursel I, 2003, J IMMUNOL, V171, P1393, DOI 10.4049/jimmunol.171.3.1393; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hernandez-Santos N, 2012, CELL HOST MICROBE, V11, P425, DOI 10.1016/j.chom.2012.04.008; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Huber S, 2011, IMMUNITY, V34, P554, DOI 10.1016/j.immuni.2011.01.020; Ikeuchi H, 2011, CANCER PREV RES, V4, P752, DOI 10.1158/1940-6207.CAPR-10-0290; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jacob N, 2009, J IMMUNOL, V182, P2532, DOI 10.4049/jimmunol.0802948; Kang HK, 2007, J IMMUNOL, V178, P7849, DOI 10.4049/jimmunol.178.12.7849; Kimura A, 2007, P NATL ACAD SCI USA, V104, P12099, DOI 10.1073/pnas.0705268104; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; MacCallum DM, 2005, MYCOSES, V48, P151, DOI 10.1111/j.1439-0507.2005.01121.x; Maddur MS, 2012, AM J PATHOL, V181, P8, DOI 10.1016/j.ajpath.2012.03.044; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Odds FC, 2000, MICROBIOL-SGM, V146, P1881, DOI 10.1099/00221287-146-8-1881; Peck A, 2010, INFECT IMMUN, V78, P32, DOI 10.1128/IAI.00929-09; Peters A, 2011, CURR OPIN IMMUNOL, V23, P702, DOI 10.1016/j.coi.2011.08.007; Qin HW, 2009, J IMMUNOL, V183, P97, DOI 10.4049/jimmunol.0801986; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sato T, 2008, J IMMUNOL, V180, P7648, DOI 10.4049/jimmunol.180.11.7648; Shirota H, 2005, J IMMUNOL, V174, P4579, DOI 10.4049/jimmunol.174.8.4579; Shirota H, 2004, J IMMUNOL, V173, P5002, DOI 10.4049/jimmunol.173.8.5002; Spellberg B, 2005, J INFECT DIS, V192, P336, DOI 10.1086/430952; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zhang Z, 2009, J IMMUNOL, V183, P3160, DOI 10.4049/jimmunol.0900385	47	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67991	10.1371/journal.pone.0067991	http://dx.doi.org/10.1371/journal.pone.0067991			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844143	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000127
J	Campagne, P; Kruger, M; Pasquet, R; Le Ru, B; Van den Berg, J				Campagne, Pascal; Kruger, Marlene; Pasquet, Remy; Le Ru, Bruno; Van den Berg, Johnnie			Dominant Inheritance of Field-Evolved Resistance to Bt Corn in Busseola fusca	PLOS ONE			English	Article							PINK-BOLLWORM LEPIDOPTERA; BACILLUS-THURINGIENSIS; INSECT RESISTANCE; COTTON BOLLWORM; GENETIC-BASIS; STEM BORER; MAIZE; CROPS; SUPPRESSION; NOCTUIDAE	Transgenic crops expressing Bacillus thuringiensis (Bt) toxins have been adopted worldwide, notably in developing countries. In spite of their success in controlling target pests while allowing a substantial reduction of insecticide use, the sustainable control of these pest populations is threatened by the evolution of resistance. The implementation of the "high dose/refuge" strategy for managing insect resistance in transgenic crops aims at delaying the evolution of resistance to Bt crops in pest populations by promoting survival of susceptible insects. However, a crucial condition for the "high dose/refuge" strategy to be efficient is that the inheritance of resistance should be functionally recessive. Busseola fusca developed high levels of resistance to the Bt toxin Cry 1Ab expressed in Bt corn in South Africa. To test whether the inheritance of B. fusca resistance to the Bt toxin could be considered recessive we performed controlled crosses with this pest and evaluated its survival on Bt and non-Bt corn. Results show that resistance of B. fusca to Bt corn is dominant, which refutes the hypothesis of recessive inheritance. Survival on Bt corn was not lower than on non-Bt corn for both resistant larvae and the F-1 progeny from resistant x susceptible parents. Hence, resistance management strategies of B. fusca to Bt corn must address non-recessive resistance.	[Campagne, Pascal; Pasquet, Remy; Le Ru, Bruno] CNRS, Lab Evolut Genome & Speciat, Unit Rech IRD 072, UPR9034, Gif Sur Yvette, France; [Campagne, Pascal; Pasquet, Remy; Le Ru, Bruno] Univ Paris 11, Orsay, France; [Kruger, Marlene; Van den Berg, Johnnie] North West Univ, Unit Environm Sci & Management, Potchefstroom, South Africa; [Campagne, Pascal; Pasquet, Remy; Le Ru, Bruno] Int Ctr Insect Physiol & Ecol, Noctuid Stem Borers Biodivers Africa Project, Div Environm Hlth, Nairobi, Kenya; [Campagne, Pascal] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; North West University - South Africa; International Centre of Insect Physiology & Ecology (ICIPE); Rutgers State University New Brunswick	Campagne, P (corresponding author), CNRS, Lab Evolut Genome & Speciat, Unit Rech IRD 072, UPR9034, Gif Sur Yvette, France.	campagne@aesop.rutgers.edu	PASQUET, Remy/J-6746-2016; Van den Berg, Johnnie/M-7256-2013; Le Ru, bruno/K-3480-2016; LE RU, BRUNO/C-5862-2011	Van den Berg, Johnnie/0000-0002-6831-3180; Le Ru, bruno/0000-0002-4208-3727; 	Biosafety South Africa [08-001]	Biosafety South Africa	This study was funded by Biosafety South Africa (Grant 08-001) and the authors accordingly give due credit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony VM, 2012, CURR OPIN BIOTECH, V23, P278, DOI 10.1016/j.copbio.2011.11.020; Baxter SW, 2005, INSECT MOL BIOL, V14, P327, DOI 10.1111/j.1365-2583.2005.00563.x; Bourguet D, 1998, J EVOLUTION BIOL, V11, P103, DOI 10.1046/j.1420-9101.1998.11010103.x; Bourguet D, 1996, GENETICS, V143, P407; Bourguet D, 2000, J ECON ENTOMOL, V93, P1588, DOI 10.1603/0022-0493-93.6.1588; Carriere Y, 2003, P NATL ACAD SCI USA, V100, P1519, DOI 10.1073/pnas.0436708100; Carriere Y, 2001, J ECON ENTOMOL, V94, P1571, DOI 10.1603/0022-0493-94.6.1571; Charlesworth B, 1998, CURR BIOL, V8, pR502, DOI 10.1016/S0960-9822(98)70318-5; Davison AC, 1997, BOOTSTRAP METHODS TH; EPA-SAP US [US Environmental Protection Agency - Scientific Advisory Panel], 1998, FIN REP SUBP BAC THU; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; GOULD F, 1995, J ECON ENTOMOL, V88, P1545, DOI 10.1093/jee/88.6.1545; Heckel DG, 2007, J INVERTEBR PATHOL, V95, P192, DOI 10.1016/j.jip.2007.03.008; Huang Fangneng, 2006, Insect Science, V13, P73, DOI 10.1111/j.1744-7917.2006.00070.x; Huang FN, 2011, ENTOMOL EXP APPL, V140, P1, DOI 10.1111/j.1570-7458.2011.01138.x; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Janmaat AF, 2005, P ROY SOC B-BIOL SCI, V272, P1031, DOI 10.1098/rspb.2004.3040; Kruger M, 2012, AFR ENTOMOL, V20, P35, DOI 10.4001/003.020.0105; Kruger M, 2011, ENVIRON ENTOMOL, V40, P477, DOI 10.1603/EN09220; Kruger M, 2012, J APPL ENTOMOL, V136, P38, DOI 10.1111/j.1439-0418.2011.01616.x; Liu YB, 1997, APPL ENVIRON MICROB, V63, P2218, DOI 10.1128/AEM.63.6.2218-2223.1997; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Nair R, 2010, J INVERTEBR PATHOL, V104, P31, DOI 10.1016/j.jip.2010.01.004; OHH BK, 1970, GENETICS, V66, P517; Onstad D. W., 2007, INSECT RESISTANCE MA; Pilcher CD, 2002, J ECON ENTOMOL, V95, P878, DOI 10.1603/0022-0493-95.5.878; R Development Core Team, 2012, R LANG ENV STAT COMP; Siegfried Blair D., 2007, American Entomologist, V53, P208; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Subramanya G, 2011, ENTOMOL RES, V41, P18, DOI 10.1111/j.1748-5967.2010.00313.x; Tabashnik BE, 2003, J ECON ENTOMOL, V96, P1031, DOI 10.1603/0022-0493-96.4.1031; Tabashnik BE, 2002, J ECON ENTOMOL, V95, P1018, DOI 10.1603/0022-0493-95.5.1018; Tabashnik BE, 1998, PHILOS T R SOC B, V353, P1751, DOI 10.1098/rstb.1998.0327; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2010, SOUTHWEST ENTOMOL, V35, P417, DOI 10.3958/059.035.0326; Tabashnik BE, 2010, SCIENCE, V330, P189, DOI 10.1126/science.1196864; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Tabashnik BE, 2009, P NATL ACAD SCI USA, V106, P11889, DOI 10.1073/pnas.0901351106; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; Venables WN., 2002, MODERN APPL STAT S 4; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Wu XY, 2009, J INVERTEBR PATHOL, V102, P44, DOI 10.1016/j.jip.2009.06.006; Zhang HN, 2012, P NATL ACAD SCI USA, V109, P10275, DOI 10.1073/pnas.1200156109	46	49	53	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e69675	10.1371/journal.pone.0069675	http://dx.doi.org/10.1371/journal.pone.0069675			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844262	Green Submitted, Green Published, gold			2022-12-27	WOS:000321341000194
J	Huttmann, S; Buchhaupt, M; Schrader, J				Huettmann, Sonja; Buchhaupt, Markus; Schrader, Jens			Identification of a Caldariomyces fumago Mutant Secreting an Inactive Form of Chloroperoxidase Lacking the Heme Group and N-Glycans	PLOS ONE			English	Article							GLYCOSYLATION; PEROXIDASE; ENZYME; EXPRESSION; PROTEINS; AMYLASE; ROLES	By mutant colony screening of Caldariomyces fumago a mutant was isolated which was slightly greenish on fructose minimal medium and grew slower in comparison to the wild type. The supernatant samples lacked the Soret band typical for the heme group of the CPO and nearly no CPO activity was detected. SDS-PAGE analysis of mutant culture supernatant samples showed production of a 38-40 kDa protein while wild type samples contain the 42 kDa CPO protein. Protein identification using nanoLC-ESI-MS/MS was performed and based on three peptides the protein in the mutant culture was identified as CPO. No differences in the CPO gene sequences of wild type and mutant were found indicating a post-translational defect in protein maturation. Deglycosylation experiments using CPO from wild type and mutant were carried out. After removing N-linked oligosaccharides from wild type CPO a protein band at 38-40 kDa was detected. Our results reveal that the mutant protein lacks the heme group as well as the N-glycans.	[Huettmann, Sonja; Buchhaupt, Markus; Schrader, Jens] DECHEMA Res Inst, Frankfurt, Germany		Schrader, J (corresponding author), DECHEMA Res Inst, Frankfurt, Germany.	schrader@dechema.de		Buchhaupt, Markus/0000-0003-2720-5973	German Federal Ministry of Economics and Technology (BMWi) by the German Federation of Industrial Research Associations "Otto von Guericke" e.V. (AiF) [16152 N]	German Federal Ministry of Economics and Technology (BMWi) by the German Federation of Industrial Research Associations "Otto von Guericke" e.V. (AiF)	This project has been funded by the German Federal Ministry of Economics and Technology (BMWi) by the German Federation of Industrial Research Associations "Otto von Guericke" e.V. (AiF) (project number 16152 N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXLEY MJ, 1986, J BIOL CHEM, V261, P5058; Bao LG, 2001, ARCH BIOCHEM BIOPHYS, V386, P17, DOI 10.1006/abbi.2000.2187; Bennett JW, 1991, APPL MOL GENETICS FU; Buchhaupt M, 2012, APPL ENVIRON MICROB, V78, P5923, DOI 10.1128/AEM.00570-12; CARMICHAEL RD, 1989, APPL ENVIRON MICROB, V55, P17, DOI 10.1128/AEM.55.1.17-20.1989; Conesa A, 2001, J BIOL CHEM, V276, P17635, DOI 10.1074/jbc.M010571200; De Groot PWJ, 2005, FUNGAL GENET BIOL, V42, P657, DOI 10.1016/j.fgb.2005.04.002; Desnick RJ, 1998, BIOCHEM J, V332, P798; GRIFFIN BW, 1991, PEROXIDASES CHEM BIO, V2, P85; HAGER LP, 1966, J BIOL CHEM, V241, P1769; Haines WR, 1994, THESIS U ILLINOIS UR; Hansson M, 2006, ARCH BIOCHEM BIOPHYS, V445, P214, DOI 10.1016/j.abb.2005.08.009; IMPERIALI B, 1995, P NATL ACAD SCI USA, V92, P97, DOI 10.1073/pnas.92.1.97; KENIGSBERG P, 1987, ARCH BIOCHEM BIOPHYS, V254, P409, DOI 10.1016/0003-9861(87)90118-4; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATTHEWS CR, 1993, ANNU REV BIOCHEM, V62, P653, DOI 10.1146/annurev.bi.62.070193.003253; Mechref Y, 2002, CHEM REV, V102, P321, DOI 10.1021/cr0103017; MORRIS DR, 1966, J BIOL CHEM, V241, P1763; NAUSEEF WM, 1992, BLOOD, V80, P2622; PICKARD MA, 1991, J IND MICROBIOL, V7, P235, DOI 10.1007/BF01577650; PICKARD MA, 1982, CAN J MICROBIOL, V28, P1382, DOI 10.1139/m82-205; RADEMACHER TW, 1988, ANNU REV BIOCHEM, V57, P785, DOI 10.1146/annurev.bi.57.070188.004033; Roth J, 2002, CHEM REV, V102, P285, DOI 10.1021/cr000423j; SAE ASW, 1979, PHYTOCHEMISTRY, V18, P1785, DOI 10.1016/0031-9422(79)83052-6; Sambrook J., 2001, MOL CLONING LAB MANU; Shental-Bechor D, 2008, P NATL ACAD SCI USA, V105, P8256, DOI 10.1073/pnas.0801340105; Sundaramoorthy M, 1995, STRUCTURE, V3, P1367, DOI 10.1016/S0969-2126(01)00274-X; Tams JW, 1999, BBA-PROTEIN STRUCT M, V1432, P214, DOI 10.1016/S0167-4838(99)00103-X; TERASHIMA M, 1994, EUR J BIOCHEM, V226, P249, DOI 10.1111/j.1432-1033.1994.tb20048.x; Yanez E, 1998, BIOCHEM J, V329, P65, DOI 10.1042/bj3290065; Yazbik V, 2010, PROCESS BIOCHEM, V45, P279, DOI 10.1016/j.procbio.2009.09.006; ZONG Q, 1995, BIOCHEMISTRY-US, V34, P12420, DOI 10.1021/bi00038a040	33	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67857	10.1371/journal.pone.0067857	http://dx.doi.org/10.1371/journal.pone.0067857			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844113	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000111
J	Leandro, MJ; Sychrova, H; Prista, C; Loureiro-Dias, MC				Leandro, Maria Jose; Sychrova, Hana; Prista, Catarina; Loureiro-Dias, Maria C.			ZrFsy1, a High-Affinity Fructose/H+ Symporter from Fructophilic Yeast Zygosaccharomyces rouxii	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-CHARACTERIZATION; GENE; TRANSPORT; GLUCOSE; IDENTIFICATION; TRANSFORMATION; EXPRESSION; SYSTEMS; STRAIN	Zygosaccharomyces rouxii is a fructophilic yeast than can grow at very high sugar concentrations. We have identified an ORF encoding a putative fructose/H+ symporter in the Z. rouxii CBS 732 genome database. Heterologous expression of this ORF in a S. cerevisiae strain lacking its own hexose transporters (hxt-null) and subsequent kinetic characterization of its sugar transport activity showed it is a high-affinity low-capacity fructose/H+ symporter, with K-m 0.45 +/- 0.07 mM and V-max 0.57 +/- 0.02 mmol h(-1) (gdw)(-1). We named it ZrFsy1. This protein also weakly transports xylitol and sorbose, but not glucose or other hexoses. The expression of ZrFSY1 in Z. rouxii is higher when the cells are cultivated at extremely low fructose concentrations (<0.2%) and on non-fermentable carbon sources such as mannitol and xylitol, where the cells have a prolonged lag phase, longer duplication times and change their microscopic morphology. A clear phenotype was determined for the first time for the deletion of a fructose/H+ symporter in the genome where it occurs naturally. The effect of the deletion of ZrFSY1 in Z. rouxii cells is only evident when the cells are cultivated at very low fructose concentrations, when the ZrFsy1 fructose symporter is the main active fructose transporter system.	[Leandro, Maria Jose; Prista, Catarina; Loureiro-Dias, Maria C.] Univ Tecn Lisboa, Inst Super Agron, CBAA, P-1100 Lisbon, Portugal; [Leandro, Maria Jose; Sychrova, Hana] Inst Physiol AS CR, Dept Membrane Transport, Vvi, Prague, Czech Republic	Universidade de Lisboa; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Leandro, MJ (corresponding author), Univ Tecn Lisboa, Inst Super Agron, CBAA, P-1100 Lisbon, Portugal.	mjleandro@isa.utl.pt	Prista, Catarina/N-7079-2013; Loureiro-Dias, Maria C/N-7331-2013; Prista, C./H-9049-2019; Leandro, Maria/K-5461-2015; Sychrova, Hana/B-1350-2012	Prista, Catarina/0000-0001-9307-1905; Loureiro-Dias, Maria C/0000-0002-6340-2416; Prista, C./0000-0001-9307-1905; Leandro, Maria/0000-0002-2254-4610; Sychrova, Hana/0000-0001-5967-5019	Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BPD/41812/2007, SFRH/BPD/85143/2012]; Research Project "Improvement of fructose fermentation by industrial Saccharomyces cerevisiae strains'' [PTDC/AGR-ALI/112802/2009]; Czech MSMT LC531 [GACR P503/10/0307, AV0Z 50110509, RVO6798582]	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Research Project "Improvement of fructose fermentation by industrial Saccharomyces cerevisiae strains''; Czech MSMT LC531	This work was supported by Fundacao para a Ciencia e Tecnologia, Portugal (Post-Doctoral fellowships SFRH/BPD/41812/2007 to M.J.L. and SFRH/BPD/85143/2012 to C.P., FCT Ciencia 2007 and Research Project "Improvement of fructose fermentation by industrial Saccharomyces cerevisiae strains'' (PTDC/AGR-ALI/112802/2009)) and Czech MSMT LC531, GACR P503/10/0307, AV0Z 50110509 and RVO6798582 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjos J, 2012, BIOCHIM BIOPHYS ACTA, V1828, P201; ARNOLD WN, 1974, J BACTERIOL, V120, P886, DOI 10.1128/JB.120.2.886-894.1974; de Sousa HR, 2004, YEAST, V21, P519, DOI 10.1002/yea.1118; Diezemann A, 2003, CURR GENET, V43, P281, DOI 10.1007/s00294-003-0392-5; Doehlemann G, 2005, FUNGAL GENET BIOL, V42, P601, DOI 10.1016/j.fgb.2005.03.001; EMMERICH W, 1983, J GEN MICROBIOL, V129, P3311; Fell JW, 2000, YEASTS TAXONOMIC STU, Vxviii; Galeote V, 2010, MICROBIOL-SGM, V156, P3754, DOI 10.1099/mic.0.041673-0; Goncalves P, 2000, J BACTERIOL, V182, P5628, DOI 10.1128/JB.182.19.5628-5630.2000; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Kinclova O, 2001, MOL MICROBIOL, V40, P656, DOI 10.1046/j.1365-2958.2001.02412.x; Kinclova-Zimmermannova O, 2005, J BIOL CHEM, V280, P30638, DOI 10.1074/jbc.M506341200; Leandro MJ, 2011, MICROBIOL-SGM, V157, P601, DOI 10.1099/mic.0.044446-0; Leandro MJ, 2009, FEMS YEAST RES, V9, P511, DOI 10.1111/j.1567-1364.2009.00509.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOUREIRODIAS MC, 1984, BIOCHEM J, V222, P293, DOI 10.1042/bj2220293; Maresova L, 2007, BIOTECHNIQUES, V43, P667, DOI 10.2144/000112620; Martorell P, 2007, INT J FOOD MICROBIOL, V114, P234, DOI 10.1016/j.ijfoodmicro.2006.09.014; Novo M, 2009, P NATL ACAD SCI USA, V106, P16333, DOI 10.1073/pnas.0904673106; Ok T, 1997, J GEN APPL MICROBIOL, V43, P39, DOI 10.2323/jgam.43.39; Palma M, 2007, J MOL MICROB BIOTECH, V12, P241, DOI 10.1159/000099645; Palma M, 2009, FEMS YEAST RES, V9, P526, DOI 10.1111/j.1567-1364.2009.00511.x; Pina C, 2004, MICROBIOL-SGM, V150, P2429, DOI 10.1099/mic.0.26979-0; Pribylova L, 2003, J MICROBIOL METH, V55, P481, DOI 10.1016/S0167-7012(03)00197-0; Pribylova L, 2007, FEMS YEAST RES, V7, P1285, DOI 10.1111/j.1567-1364.2007.00308.x; Pribylova L, 2007, CHROMOSOME RES, V15, P439, DOI 10.1007/s10577-007-1136-z; Saier MH, 2000, MOL MICROBIOL, V35, P699, DOI 10.1046/j.1365-2958.2000.01759.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SousaDias S, 1996, MICROBIOL-UK, V142, P1733, DOI 10.1099/13500872-142-7-1733; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Zaragoza O, 2003, J MICROBIOL METH, V52, P141, DOI 10.1016/S0167-7012(02)00154-9	33	20	20	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68165	10.1371/journal.pone.0068165	http://dx.doi.org/10.1371/journal.pone.0068165			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844167	gold, Green Published			2022-12-27	WOS:000321341000141
J	Nerandzic, MM; Rackaityte, E; Jury, LA; Eckart, K; Donskey, CJ				Nerandzic, Michelle M.; Rackaityte, Elze; Jury, Lucy A.; Eckart, Kevin; Donskey, Curtis J.			Novel Strategies for Enhanced Removal of Persistent Bacillus anthracis Surrogates and Clostridium difficile Spores from Skin	PLOS ONE			English	Article							VANCOMYCIN-RESISTANT ENTEROCOCCUS; CHLORHEXIDINE GLUCONATE; HAND HYGIENE; MANAGEMENT; EFFICACY; CONTAMINATION; DISINFECTION; RECOGNITION; STERILOX(R); INFECTION	Background: Removing spores of Clostridium difficile and Bacillus anthracis from skin is challenging because they are resistant to commonly used antimicrobials and soap and water washing provides only modest efficacy. We hypothesized that hygiene interventions incorporating a sporicidal electrochemically generated hypochlorous acid solution (Vashe (R)) would reduce the burden of spores on skin. Methods: Hands of volunteers were inoculated with non-toxigenic C. difficile spores or B. anthracis spore surrogates to assess the effectiveness of Vashe solution for reducing spores on skin. Reduction in spores was compared for Vashe hygiene interventions versus soap and water (control). To determine the effectiveness of Vashe solution for removal of C. difficile spores from the skin of patients with C. difficile infection (CDI), reductions in levels of spores on skin were compared for soap and water versus Vashe bed baths. Results: Spore removal from hands was enhanced with Vashe soak (>2.5 log(10) reduction) versus soap and water wash or soak (similar to 2.0 log(10) reduction; P <= 0.05) and Vashe wipes versus alcohol wipes (P <= 0.01). A combined approach of soap and water wash followed by soaking in Vashe removed >3.5 log(10) spores from hands (P <= 0.01 compared to washing or soaking alone). Bed baths using soap and water (N =26 patients) did not reduce the percentage of positive skin cultures for CDI patients (64% before versus 57% after bathing; P =0.5), whereas bathing with Vashe solution (N =21 patients) significantly reduced skin contamination (54% before versus 8% after bathing; P =0.0001). Vashe was well-tolerated with no evidence of adverse effects on skin. Conclusions: Vashe was safe and effective for reducing the burden of B. anthracis surrogates and C. difficile spores on hands. Bed baths with Vashe were effective for reducing C. difficile on skin. These findings suggest a novel strategy to reduce the burden of spores on skin.	[Nerandzic, Michelle M.; Rackaityte, Elze; Eckart, Kevin] Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH USA; [Jury, Lucy A.; Donskey, Curtis J.] Cleveland Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Cleveland, OH USA; [Donskey, Curtis J.] Case Western Reserve Univ, Sch Med, Cleveland, OH USA	Geriatric Research Education & Clinical Center; Case Western Reserve University	Nerandzic, MM (corresponding author), Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH USA.	michellenerandzi@aim.com			Department of Veterans Affairs	Department of Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a Merit Review grant from the Department of Veterans Affairs to CJD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Society for Testing and Materials, 2006, E117406 ASTM; Olsen S J, 2000, MMWR CDC Surveill Summ, V49, P1; Barbut F, 2009, INFECT CONT HOSP EP, V30, P507, DOI 10.1086/597232; BETTIN K, 1994, INFECT CONT HOSP EP, V15, P697; Bobulsky GS, 2008, CLIN INFECT DIS, V46, P447, DOI 10.1086/525267; Borer A, 2007, J HOSP INFECT, V67, P149, DOI 10.1016/j.jhin.2007.07.023; Boyce JM, 2002, AM J INFECT CONTROL, V30, pS1, DOI 10.1067/mic.2002.130391; Climo MW, 2009, CRIT CARE MED, V37, P1858, DOI 10.1097/CCM.0b013e31819ffe6d; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Edmonds SL, 2013, INFECT CONT HOSP EP, V34, P302, DOI 10.1086/669521; Fawley WN, 2007, INFECT CONT HOSP EP, V28, P920, DOI 10.1086/519201; Franz DR, 1997, JAMA-J AM MED ASSOC, V278, P399, DOI 10.1001/jama.278.5.399; Friedlander AM, 2000, CURR CLIN TOPICS INF, V20, P335; Gerding DN, 2008, CLIN INFECT DIS, V46, pS43, DOI 10.1086/521861; Greenberg David L, 2010, Investig Genet, V1, P4, DOI 10.1186/2041-2223-1-4; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Jabbar U, 2010, INFECT CONT HOSP EP, V31, P565, DOI 10.1086/652772; Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353; Jury LA, 2011, INFECT CONT HOSP EP, V32, P181, DOI 10.1086/657911; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Majcher MR, 2008, APPL ENVIRON MICROB, V74, P676, DOI 10.1128/AEM.01715-07; Muto CA, 2007, CLIN INFECT DIS, V45, P1266, DOI 10.1086/522654; Nerandzic MM, 2009, J CLIN MICROBIOL, V47, P397, DOI 10.1128/JCM.01591-08; Niezgoda JA, 2010, ADV SKIN WOUND CARE, V23, P352, DOI 10.1097/01.ASW.0000383198.35815.a2; Oughton MT, 2009, INFECT CONT HOSP EP, V30, P939, DOI 10.1086/605322; Poxton IR, 2001, CLIN MICROBIOL INFEC, V7, P421, DOI 10.1046/j.1198-743x.2001.00287.x; Selkon JB, 1999, J HOSP INFECT, V41, P59, DOI 10.1016/S0195-6701(99)90038-5; Sethi AK, 2009, INFECT CONT HOSP EP, V30, P13, DOI 10.1086/592710; Setlow P, 2007, TRENDS MICROBIOL, V15, P172, DOI 10.1016/j.tim.2007.02.004; Shetty N, 1999, J HOSP INFECT, V41, P101, DOI 10.1016/S0195-6701(99)90046-4; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; Swartz MN, 2001, NEW ENGL J MED, V345, P1621, DOI 10.1056/NEJMra012892; Vernon MO, 2006, ARCH INTERN MED, V166, P306, DOI 10.1001/archinte.166.3.306; Weber DJ, 2003, JAMA-J AM MED ASSOC, V289, P1274, DOI 10.1001/jama.289.10.1274	35	16	17	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68706	10.1371/journal.pone.0068706	http://dx.doi.org/10.1371/journal.pone.0068706			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844234	gold, Green Published, Green Submitted			2022-12-27	WOS:000321341000177
J	von Tscharner, V; Enders, H; Maurer, C				von Tscharner, Vinzenz; Enders, Hendrik; Maurer, Christian			Subspace Identification and Classification of Healthy Human Gait	PLOS ONE			English	Article							MOVEMENT PATTERNS; VARIABILITY	Purpose: The classification between different gait patterns is a frequent task in gait assessment. The base vectors were usually found using principal component analysis (PCA) is replaced by an iterative application of the support vector machine (SVM). The aim was to use classifyability instead of variability to build a subspace (SVM space) that contains the information about classifiable aspects of a movement. The first discriminant of the SVM space will be compared to a discriminant found by an independent component analysis (ICA) in the SVM space. Methods: Eleven runners ran using shoes with different midsoles. Kinematic data, representing the movements during stance phase when wearing the two shoes, was used as input to a PCA and SVM. The data space was decomposed by an iterative application of the SVM into orthogonal discriminants that were able to classify the two movements. The orthogonal discriminants spanned a subspace, the SVM space. It represents the part of the movement that allowed classifying the two conditions. The data in the SVM space was reconstructed for a visual assessment of the movement difference. An ICA was applied to the data in the SVM space to obtain a single discriminant. Cohen's d effect size was used to rank the PCA vectors that could be used to classify the data, the first SVM discriminant or the ICA discriminant. Results: The SVM base contains all the information that discriminates the movement of the two shod conditions. It was shown that the SVM base contains some redundancy and a single ICA discriminant was found by applying an ICA in the SVM space. Conclusions: A combination of PCA, SVM and ICA is best suited to extract all parts of the gait pattern that discriminates between the two movements and to find a discriminant for the classification of dichotomous kinematic data.	[von Tscharner, Vinzenz; Enders, Hendrik; Maurer, Christian] Univ Calgary, Human Performance Lab, Fac Kinesiol, Calgary, AB, Canada	University of Calgary	von Tscharner, V (corresponding author), Univ Calgary, Human Performance Lab, Fac Kinesiol, Calgary, AB, Canada.	tvvon@ucalgary.ca	Maurer, Christian/AAS-9688-2020	Maurer, Christian/0000-0002-8426-813X	National Sciences and Engineering Resource Council; da Vinci Foundation; Biomechanigg Research Inc.	National Sciences and Engineering Resource Council; da Vinci Foundation; Biomechanigg Research Inc.	The project was supported by National Sciences and Engineering Resource Council, the da Vinci Foundation and the Biomechanigg Research Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaqtash M, 2011, IEEE ENG MED BIO, P453, DOI 10.1109/IEMBS.2011.6090063; Barton JG, 1997, GAIT POSTURE, V5, P28, DOI 10.1016/S0966-6362(96)01070-3; BATES BT, 1983, J BIOMECH, V16, P181, DOI 10.1016/0021-9290(83)90125-2; Begg R, 2005, J BIOMECH, V38, P401, DOI 10.1016/j.jbiomech.2004.05.002; Bishop C. M., 2007, J ELECT IMAGING, V2nd, DOI 10.1117/1.2819119; Cappellini G, 2006, J NEUROPHYSIOL, V95, P3426, DOI 10.1152/jn.00081.2006; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cohen J.E., 1988, STAT POWER ANAL BEHA; Daffertshofer A, 2004, CLIN BIOMECH, V19, P415, DOI 10.1016/j.clinbiomech.2004.01.005; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Eskofier BM, 2011, COMPUT METHOD BIOMEC, P37; Gu SC, 2010, NEUROCOMPUTING, V73, P1669, DOI 10.1016/j.neucom.2009.09.021; Guidetti L, 1996, J ELECTROMYOGR KINES, V6, P37, DOI 10.1016/1050-6411(95)00015-1; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Janssen D, 2011, HUM MOVEMENT SCI, V30, P966, DOI 10.1016/j.humov.2010.08.010; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; JUTTEN C, 1991, SIGNAL PROCESS, V24, P1, DOI 10.1016/0165-1684(91)90079-X; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Lozano-Ortiz CA, 2010, IEEE ENG MED BIO, P1413, DOI 10.1109/IEMBS.2010.5626715; Maurer C, 2012, GAIT POSTURE, V36, P40, DOI 10.1016/j.gaitpost.2011.12.023; Nigg BM, 2012, J BIOMECH, V45, P1692, DOI 10.1016/j.jbiomech.2012.03.027; RAMSEY J. O., 2005, FUNCTIONAL DATA ANAL; Theodoridis S, 2009, PATTERN RECOGNITION, 4RTH EDITION, P1; Troje NF, 2002, J VISION, V2, P371, DOI 10.1167/2.5.2; von Tscharner V, 2010, J ELECTROMYOGR KINES, V20, P676, DOI 10.1016/j.jelekin.2009.11.005; von Tscharner Vinzenz, 2009, J Electromyogr Kinesiol, V19, pe334, DOI 10.1016/j.jelekin.2008.07.001	26	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e65063	10.1371/journal.pone.0065063	http://dx.doi.org/10.1371/journal.pone.0065063			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861736	gold, Green Published, Green Submitted			2022-12-27	WOS:000321692000003
J	Hukic, DS; Frisen, L; Backlund, L; Lavebratt, C; Landen, M; Traskman-Bendz, L; Edman, G; Schalling, M; Osby, U				Hukic, Dzana Sudic; Frisen, Louise; Backlund, Lena; Lavebratt, Catharina; Landen, Mikael; Traskman-Bendz, Lil; Edman, Gunnar; Schalling, Martin; Osby, Urban			Cognitive Manic Symptoms in Bipolar Disorder Associated with Polymorphisms in the DAOA and COMT Genes	PLOS ONE			English	Article							FACIAL EMOTION RECOGNITION; MAJOR DEPRESSIVE DISORDER; AMINO-ACID OXIDASE; WORKING-MEMORY; PREFRONTAL COGNITION; MOOD EPISODES; G72/G30 LOCUS; I DISORDER; SCHIZOPHRENIA; GENOTYPE	Introduction: Bipolar disorder is characterized by severe mood symptoms including major depressive and manic episodes. During manic episodes, many patients show cognitive dysfunction. Dopamine and glutamate are important for cognitive processing, thus the COMT and DAOA genes that modulate the expression of these neurotransmitters are of interest for studies of cognitive function. Methodology: Focusing on the most severe episode of mania, a factor was found with the combined symptoms of talkativeness, distractibility, and thought disorder, considered a cognitive manic symptoms (CMS) factor. 488 patients were genotyped, out of which 373 (76%) had talkativeness, 269 (55%) distractibility, and 372 (76%) thought disorder. 215 (44%) patients were positive for all three symptoms, thus showing CMS (Table 1). As population controls, 1,044 anonymous blood donors (ABD) were used. Case-case and case-control design models were used to investigate genetic associations between cognitive manic symptoms in bipolar 1 disorder and SNPs in the COMT and DAOA genes. Results: The finding of this study was that cognitive manic symptoms in patients with bipolar 1 disorder was associated with genetic variants in the DAOA and COMT genes. Nominal association for DAOA SNPs and COMT SNPs to cognitive symptoms factor in bipolar 1 disorder was found in both allelic (Table 2) and haplotypic (Table 3) analyses. Genotypic association analyses also supported our findings. However, only one association, when CMS patients were compared to ABD controls, survived correction for multiple testing by max (T) permutation. Data also suggested interaction between SNPs rs2391191 in DAOA and rs5993883 in COMT in the case-control model. Conclusion: Identifying genes associated with cognitive functioning has clinical implications for assessment of prognosis and progression. Our finding are consistent with other studies showing genetic associations between the COMT and DAOA genes and impaired cognition both in psychiatric disorders and in the general population.	[Hukic, Dzana Sudic; Backlund, Lena; Lavebratt, Catharina; Schalling, Martin; Osby, Urban] Karolinska Inst, Dept Mol Med & Surg, Neurogenet Unit, Stockholm, Sweden; [Hukic, Dzana Sudic; Lavebratt, Catharina; Schalling, Martin; Osby, Urban] Karolinska Univ Hosp, Ctr Mol Med, Stockholm, Sweden; [Hukic, Dzana Sudic; Edman, Gunnar; Osby, Urban] Tiohundra AB, Dept Psychiat, Norrtalje, Sweden; [Frisen, Louise; Backlund, Lena; Landen, Mikael] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Landen, Mikael] Gothenburg Univ, Sahlgrenska Acad, Dept Neurosci & Psychol, S-41124 Gothenburg, Sweden; [Traskman-Bendz, Lil] Univ Lund Hosp, Dept Clin Sci, S-22185 Lund, Sweden; [Edman, Gunnar; Osby, Urban] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Ctr Family Med CeFam, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Gothenburg; Lund University; Skane University Hospital; Karolinska Institutet	Hukic, DS (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Neurogenet Unit, Stockholm, Sweden.	dzana.hukic@ki.se	Schalling, Martin/F-1518-2015; Landen, Mikael/AAD-7917-2020	Schalling, Martin/0000-0001-5011-2922; Lavebratt, Catharina/0000-0003-4987-2718; Backlund, Lena/0000-0001-9399-5024	Karolinska Institutet; Swedish Research Council; Soderstrom-Konigska Foundation; Psychiatry Southwest, Stockholm; Stockholm County Council	Karolinska Institutet(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission); Soderstrom-Konigska Foundation; Psychiatry Southwest, Stockholm; Stockholm County Council(Stockholm County Council)	This project was supported by grants from Karolinska Institutet, the Swedish Research Council, the Soderstrom-Konigska Foundation, and Psychiatry Southwest, Stockholm. Financial support was also provided through the regional agreement on medical training and clinical research (ALF) between the Stockholm County Council and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler M, 2012, INT J PSYCHIAT CLIN; Andreou D, 2012, EUR ARCH PSY CLIN N, V262, P549, DOI 10.1007/s00406-012-0313-z; Backlund L, 2011, BIPOLAR DISORD, V13, P500, DOI 10.1111/j.1399-5618.2011.00952.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bellgrove MA, 2005, EXP BRAIN RES, V163, P352, DOI 10.1007/s00221-004-2180-y; Burdick KE, 2010, ACTA PSYCHIAT SCAND, V122, P499, DOI 10.1111/j.1600-0447.2010.01590.x; Burnet PWJ, 2008, MOL PSYCHIATR, V13, P658, DOI 10.1038/mp.2008.47; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; Chen YS, 2004, MOL PSYCHIATR, V9, P87, DOI 10.1038/sj.mp.4001453; Craddock N, 2001, BIPOLAR DISORD, V3, P284, DOI 10.1034/j.1399-5618.2001.30604.x; Craddock N, 2006, EUR J HUM GENET, V14, P660, DOI 10.1038/sj.ejhg.5201549; Dalvie S, 2010, AFR J PSYCHIATRY, V13, P297; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Rocca CCD, 2009, REV BRAS PSIQUIATR, V31, P171, DOI 10.1590/S1516-44462009000200015; Dickinson D, 2009, NEUROSCIENCE, V164, P72, DOI 10.1016/j.neuroscience.2009.05.014; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Ekman CJ, 2010, ACTA PSYCHIAT SCAND, V122, P507, DOI 10.1111/j.1600-0447.2010.01586.x; Freedman R, 1997, P NATL ACAD SCI USA, V94, P587, DOI 10.1073/pnas.94.2.587; Goldberg TE, 2003, ARCH GEN PSYCHIAT, V60, P889, DOI 10.1001/archpsyc.60.9.889; Goldman-Rakic PS, 1999, BIOL PSYCHIAT, V46, P650, DOI 10.1016/S0006-3223(99)00130-4; Gomez L, 2009, AM J MED GENET B, V150B, P1007, DOI 10.1002/ajmg.b.30904; Hattori E, 2003, AM J HUM GENET, V72, P1131, DOI 10.1086/374822; Jiao HY, 2007, J NEUROCHEM, V103, P840, DOI 10.1111/j.1471-4159.2007.04840.x; Kirov G, 1998, MOL PSYCHIATR, V3, P342, DOI 10.1038/sj.mp.4000385; Korostishevsky M, 2004, BIOL PSYCHIAT, V56, P169, DOI 10.1016/j.biopsych.2004.04.006; KREMEN WS, 1994, SCHIZOPHRENIA BULL, V20, P103, DOI 10.1093/schbul/20.1.103; Lelli-Chiesa G, 2011, PSYCHOL MED, V41, P779, DOI 10.1017/S0033291710001431; Li F, 2009, NEW ENGL J MED, V361, P302, DOI 10.1056/NEJMcibr0902052; Maj M, 1998, AM J PSYCHIAT, V155, P30, DOI 10.1176/ajp.155.1.30; Malhotra AK, 1996, NEUROPSYCHOPHARMACOL, V14, P301, DOI 10.1016/0893-133X(95)00137-3; Malhotra AK, 2002, AM J PSYCHIAT, V159, P652, DOI 10.1176/appi.ajp.159.4.652; McCullumsmith RE, 2002, NEUROPSYCHOPHARMACOL, V26, P368, DOI 10.1016/S0893-133X(01)00370-0; Meador-Woodruff JH, 2001, BRAIN RES BULL, V55, P631, DOI 10.1016/S0361-9230(01)00523-8; Mier D, 2010, MOL PSYCHIATR, V15, P918, DOI 10.1038/mp.2009.36; Muller DJ, 2011, BIPOLAR DISORD, V13, P198, DOI 10.1111/j.1399-5618.2011.00905.x; Nicodemus KK, 2007, HUM GENET, V120, P889, DOI 10.1007/s00439-006-0257-3; Niculescu AB, 2010, AM J MED GENET B, V153B, P847, DOI 10.1002/ajmg.b.31076; Nixon DC, 2011, BIOL PSYCHIAT, V69, P1006, DOI 10.1016/j.biopsych.2010.10.031; Palomino A, 2007, SCHIZOPHR RES, V95, P174, DOI 10.1016/j.schres.2007.06.012; Papolos DF, 1998, MOL PSYCHIATR, V3, P346, DOI 10.1038/sj.mp.4000410; Perlis RH, 2006, AM J PSYCHIAT, V163, P217, DOI 10.1176/appi.ajp.163.2.217; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schiffer HH, 2002, MOL NEUROBIOL, V25, P191, DOI 10.1385/MN:25:2:191; Schulze TG, 2005, AM J PSYCHIAT, V162, P2101, DOI 10.1176/appi.ajp.162.11.2101; Schumacher J, 2004, MOL PSYCHIATR, V9, P203, DOI 10.1038/sj.mp.4001421; Shifman S, 2004, AM J MED GENET B, V128B, P61, DOI 10.1002/ajmg.b.30032; Smoller Jordan W, 2007, Curr Psychiatry Rep, V9, P504, DOI 10.1007/s11920-007-0069-8; Soeiro-de-Souza MG, 2012, J AFFECT DISORDERS, V136, P370, DOI 10.1016/j.jad.2011.11.021; Sole B, 2011, ACTA PSYCHIAT SCAND; Soronen P, 2008, BIOL PSYCHIAT, V64, P438, DOI 10.1016/j.biopsych.2008.03.028; Tsai GC, 2002, ANNU REV PHARMACOL, V42, P165, DOI 10.1146/annurev.pharmtox.42.082701.160735; WEINBERGER DR, 1988, ARCH GEN PSYCHIAT, V45, P609; Williams NM, 2006, ARCH GEN PSYCHIAT, V63, P366, DOI 10.1001/archpsyc.63.4.366; Zou FG, 2005, SCHIZOPHR RES, V73, P257, DOI 10.1016/j.schres.2004.01.015	54	4	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67450	10.1371/journal.pone.0067450	http://dx.doi.org/10.1371/journal.pone.0067450			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861766	Green Submitted, Green Published, gold			2022-12-27	WOS:000321425300015
J	Lameira, AR; Hardus, ME; Nouwen, KJJM; Topelberg, E; Delgado, RA; Spruijt, BM; Sterck, EHM; Knott, CD; Wich, SA				Lameira, Adriano R.; Hardus, Madeleine E.; Nouwen, Kim J. J. M.; Topelberg, Eva; Delgado, Roberto A.; Spruijt, Berry M.; Sterck, Elisabeth H. M.; Knott, Cheryl D.; Wich, Serge A.			Population-Specific Use of the Same Tool-Assisted Alarm Call between Two Wild Orangutan Populations (Pongopygmaeus wurmbii) Indicates Functional Arbitrariness	PLOS ONE			English	Article							VOCALIZATIONS; CULTURES; REPERTOIRE; EVOLUTION; DIALECTS; SOUND	Arbitrariness is an elementary feature of human language, yet seldom an object of comparative inquiry. While arbitrary signals for the same function are relatively frequent between animal populations across taxa, the same signal with arbitrary functions is rare and it remains unknown whether, in parallel with human speech, it may involve call production in animals. To investigate this question, we examined a particular orangutan alarm call - the kiss-squeak - and two variants - hand and leaf kiss-squeaks. In Tuanan (Central Kalimantan, Indonesia), the acoustic frequency of unaided kiss-squeaks is negatively related to body size. The modified variants are correlated with perceived threat and are hypothesized to increase the perceived body size of the sender, as the use of a hand or leaves lowers the kiss-squeak's acoustic frequency. We examined the use of these variants in the same context in another orangutan population of the same sub-species and with partially similar habitat at Cabang Panti (West Kalimantan, Indonesia). Identical analyses of data from this site provided similar results for unaided kiss-squeaks but dissimilar results for hand and leaf kiss-squeaks. Unaided kiss-squeaks at Cabang Panti were emitted as commonly and showed the same relationship to body size as in Tuanan. However, at Cabang Panti, hand kiss-squeaks were extremely rare, while leaf-use neither conveyed larger body size nor was related to perceived threat. These findings indicate functional discontinuity between the two sites and therefore imply functional arbitrariness of leaf kiss-squeaks. These results show for the first time the existence of animal signals involving call production with arbitrary function. Our findings are consistent with previous studies arguing that these orangutan call variants are socially learned and reconcile the role of gestures and calls within evolutionary theories based on common ancestry for speech and music.	[Lameira, Adriano R.; Nouwen, Kim J. J. M.; Topelberg, Eva; Spruijt, Berry M.; Sterck, Elisabeth H. M.] Univ Utrecht, Utrecht, Netherlands; [Lameira, Adriano R.; Hardus, Madeleine E.] Pongo Fdn, Oudewater, Netherlands; [Hardus, Madeleine E.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Nouwen, Kim J. J. M.; Topelberg, Eva] Wageningen Univ, Adaptat Physiol Grp, NL-6700 AP Wageningen, Netherlands; [Delgado, Roberto A.] Univ So Calif, Los Angeles, CA 90033 USA; [Sterck, Elisabeth H. M.] Biomed Primate Res Ctr, Rijswijk, Netherlands; [Knott, Cheryl D.] Boston Univ, Dept Anthropol, Boston, MA 02215 USA; [Wich, Serge A.] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Res Ctr Evolutionary Anthropol & Palaeoecol, Liverpool L3 5UX, Merseyside, England	Utrecht University; University of Amsterdam; Wageningen University & Research; University of Southern California; Boston University; Liverpool John Moores University	Lameira, AR (corresponding author), Univ Utrecht, Utrecht, Netherlands.	adriano@orangutan.nl	Sterck, Elisabeth/C-1063-2011	Sterck, Elisabeth/0000-0003-1101-6027; Lameira, Adriano/0000-0003-3071-4824; Wich, Serge/0000-0003-3954-5174	Fundacao para a Ciencia e Tecnologia [SFRH/BD/44437/2008]; Pongo Foundation; CDK from the 16 National Science Foundation [0936199]; National Geographic Society; Leakey Foundation; US Fish and Wildlife Service	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Pongo Foundation; CDK from the 16 National Science Foundation; National Geographic Society(National Geographic Society); Leakey Foundation; US Fish and Wildlife Service(US Fish & Wildlife Service)	This study was financially supported by Fundacao para a Ciencia e Tecnologia (SFRH/BD/44437/2008), Wenner-Gren Foundation for Anthropological Research, Dr. J.L. Dobberke voor Vergelijkende Psychologie, Lucie Burgers Foundation for Comparative Behaviour Research, Schure-Beijerinck-Popping Fonds, Ruggles-Gates Fund for Anthropological Scholarship of the Royal Anthropological Institute of Great Britain and Ireland, and Fundacao Calouste Gulbenkian. KN and ET were financially supported by Pongo Foundation. Orangutan fieldwork at Cabang Panti was supported by grants to CDK from the 16 National Science Foundation (0936199), the National Geographic Society, the Leakey Foundation and the US Fish and Wildlife Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora N, 2010, P NATL ACAD SCI USA, V107, P21376, DOI 10.1073/pnas.1010169107; Boesch C, 2003, EVOL ANTHROPOL, V12, P82, DOI 10.1002/evan.10106; Brown S, 2000, ORIGINS OF MUSIC, P271; Catchpole Clive K, 2003, BIRD SONG BIOL THEME; Crystal D, 2002, LANGUAGE DEATH; Davidson SM, 2002, J MAMMAL, V83, P526, DOI 10.1644/1545-1542(2002)083<0526:GAIVIV>2.0.CO;2; Davila-Ross M, 2011, EMOTION, V11, P1013, DOI 10.1037/a0022594; de A, 2004, SCIENCE, V306; Dindo M, 2011, BIOL LETTERS, V7, P181, DOI 10.1098/rsbl.2010.0637; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; FORD JKB, 1991, CAN J ZOOL, V69, P1454, DOI 10.1139/z91-206; Hardus ME, 2009, P ROY SOC B-BIOL SCI, V276, P3689, DOI 10.1098/rspb.2009.1027; Hardus Madeleine E., 2009, P49; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; Hobolth A, 2011, GENOME RES, V21, P349, DOI 10.1101/gr.114751.110; Hockett C.F., 1968, ANIMAL COMMUNICATION, P61; InoueNakamura N, 1997, J COMP PSYCHOL, V111, P159, DOI 10.1037/0735-7036.111.2.159; Johnson AE, 2005, BIOL CONSERV, V121, P495, DOI 10.1016/j.biocon.2004.06.002; Krutzen M, 2011, CURR BIOL, V21, P1808, DOI 10.1016/j.cub.2011.09.017; Lameira AR, 2008, INT J PRIMATOL, V29, P615, DOI 10.1007/s10764-008-9253-x; Lameira AR, 2012, EVOL BIOL, V39, P415, DOI 10.1007/s11692-011-9151-6; Lameira AR., 2010, J EVOL PSYCHOL, V8, P309; Lameira AR, J ACOUST SO IN PRESS; Marshall AJ, 1999, ANIM BEHAV, V58, P825, DOI 10.1006/anbe.1999.1219; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; MORRICE MG, 1994, POLAR BIOL, V14, P441; Noad MJ, 2000, NATURE, V408, P537, DOI 10.1038/35046199; Notman H, 2005, ANIM BEHAV, V70, P177, DOI 10.1016/j.anbehav.2004.08.024; Oller DK, 2013, P NATL ACAD SCI USA, V110, P6318, DOI 10.1073/pnas.1300337110; Owren MJ, 2001, EVOL ANTHROPOL, V10, P58, DOI 10.1002/evan.1014; RALLS K, 1985, CAN J ZOOL, V63, P1050, DOI 10.1139/z85-157; Sapolsky RM, 2006, CURR ANTHROPOL, V47, P641, DOI 10.1086/504162; Saussure Ferdinandde., 1983, COURSE GEN LINGUISTI; Schel AM, 2009, J COMP PSYCHOL, V123, P136, DOI 10.1037/a0014280; Schneider C, 2008, INT J PRIMATOL, V29, P601, DOI 10.1007/s10764-007-9181-1; van Schaik CP, 2006, BEHAVIOUR, V143, P839, DOI 10.1163/156853906778017944; van Schaik Carel P., 2009, P299; van Schaik CP, 2005, PRIMATES, V46, P249, DOI 10.1007/s10329-005-0134-z; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; van Schaik CP, 1999, PRIMATES, V40, P69, DOI 10.1007/BF02557703; WASER PM, 1986, AM J PRIMATOL, V10, P135, DOI 10.1002/ajp.1350100205; Weilgart L, 1997, BEHAV ECOL SOCIOBIOL, V40, P277, DOI 10.1007/s002650050343; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Wich SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036180; Wright TF, 1996, P ROY SOC B-BIOL SCI, V263, P867, DOI 10.1098/rspb.1996.0128	45	18	19	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e69749	10.1371/journal.pone.0069749	http://dx.doi.org/10.1371/journal.pone.0069749			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861981	Green Published, gold			2022-12-27	WOS:000321425300091
J	Mugyenyi, CK; Elliott, SR; McCallum, FJ; Anders, RF; Marsh, K; Beeson, JG				Mugyenyi, Cleopatra K.; Elliott, Salenna R.; McCallum, Fiona J.; Anders, Robin F.; Marsh, Kevin; Beeson, James G.			Antibodies to Polymorphic Invasion-Inhibitory and Non-Inhibitory Epitopes of Plasmodium falciparum Apical Membrane Antigen 1 in Human Malaria	PLOS ONE			English	Article							VACCINE-CANDIDATE; CLINICAL MALARIA; ERYTHROCYTE INVASION; MEROZOITE ANTIGENS; IMMUNE-RESPONSES; AMA1; PROTECTION; TRANSMISSION; ASSOCIATION; CHILDREN	Background: Antibodies to P. falciparum apical membrane protein 1 (AMA1) may contribute to protective immunity against clinical malaria by inhibiting blood stage growth of P. falciparum, and AMA1 is a leading malaria vaccine candidate. Currently, there is limited knowledge of the acquisition of strain-specific and cross-reactive antibodies to AMA1 in humans, or the acquisition of invasion-inhibitory antibodies to AMA1. Methodology/Findings: We examined the acquisition of human antibodies to specific polymorphic invasion-inhibitory and non-inhibitory AMA1 epitopes, defined by the monoclonal antibodies 1F9 and 2C5, respectively. Naturally acquired antibodies were measured in cohorts of Kenyan children and adults. Antibodies to the invasion-inhibitory 1F9 epitope and non-inhibitory 2C5 epitope were measured indirectly by competition ELISA. Antibodies to the 1F9 and 2C5 epitopes were acquired by children and correlated with exposure, and higher antibody levels and prevalence were observed with increasing age and with active P. falciparum infection. Of note, the prevalence of antibodies to the inhibitory 1F9 epitope was lower than antibodies to AMA1 or the 2C5 epitope. Antibodies to AMA1 ectodomain, the 1F9 or 2C5 epitopes, or a combination of responses, showed some association with protection from P. falciparum malaria in a prospective longitudinal study. Furthermore, antibodies to the invasion-inhibitory 1F9 epitope were positively correlated with parasite growth-inhibitory activity of serum antibodies. Conclusions/Significance: Individuals acquire antibodies to functional, polymorphic epitopes of AMA1 that may contribute to protective immunity, and these findings have implications for AMA1 vaccine development. Measuring antibodies to the 1F9 epitope by competition ELISA may be a valuable approach to assessing human antibodies with invasion-inhibitory activity in studies of acquired immunity and vaccine trials of AMA1.	[Mugyenyi, Cleopatra K.; Marsh, Kevin] Kenya Govt Med Res Ctr, Ctr Geog Med, Coast, Kilifi, Kenya; [Elliott, Salenna R.; Beeson, James G.] Burnet Inst, Melbourne, Vic, Australia; [McCallum, Fiona J.; Beeson, James G.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [Anders, Robin F.] La Trobe Univ, Bundoora, Vic 3086, Australia; [Beeson, James G.] Monash Univ, Clayton, Vic 3800, Australia	Kenya Medical Research Institute; Burnet Institute; Walter & Eliza Hall Institute; La Trobe University; Monash University	Beeson, JG (corresponding author), Burnet Inst, Melbourne, Vic, Australia.	beeson@burnet.edu.au		Anders, Robin/0000-0002-0693-4547	Wellcome Trust, UK; National Health and Medical Research Council of Australia; Australian Research Council; Victorian State Government Operational Infrastructure; PATH Malaria Vaccine Initiative; US Agency for International Development	Wellcome Trust, UK(Wellcome Trust); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Victorian State Government Operational Infrastructure; PATH Malaria Vaccine Initiative; US Agency for International Development(United States Agency for International Development (USAID))	Funding was provided by the Wellcome Trust, UK (project grant; http://www.wellcome.ac.uk/); National Health and Medical Research Council of Australia (project grant; Infrastructure for Research Institutes Support Scheme grant; http://www.nhmrc.gov.au/); Australian Research Council (Future Fellowship to JB; http://www.arc.gov.au/); Victorian State Government Operational Infrastructure Support grant (http://www.vic.gov.au/); PATH Malaria Vaccine Initiative (http://www.malariavaccine.org/); and US Agency for International Development (http://www.usaid.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; Barry AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008497; Beeson JG, 2008, TRENDS PARASITOL, V24, P578, DOI 10.1016/j.pt.2008.08.008; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; Chelimo K, 2005, PEDIATR INFECT DIS J, V24, P680, DOI 10.1097/01.inf.0000172151.28851.fd; Coley AM, 2006, INFECT IMMUN, V74, P2628, DOI 10.1128/IAI.74.5.2628-2636.2006; Coley AM, 2001, PROTEIN ENG, V14, P691, DOI 10.1093/protein/14.9.691; Coley AM, 2007, PLOS PATHOG, V3, P1308, DOI 10.1371/journal.ppat.0030138; Collins CR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000273; Cortes A, 2005, INFECT IMMUN, V73, P422, DOI 10.1128/IAI.73.1.422-430.2005; Cortes A, 2003, INFECT IMMUN, V71, P1416, DOI 10.1128/IAI.71.3.1416-1426.2003; Crewther PE, 1996, INFECT IMMUN, V64, P3310, DOI 10.1128/IAI.64.8.3310-3317.1996; Dodoo D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-142; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Drew DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051023; Duan JH, 2008, P NATL ACAD SCI USA, V105, P7857, DOI 10.1073/pnas.0802328105; Dutta S, 2007, P NATL ACAD SCI USA, V104, P12488, DOI 10.1073/pnas.0701464104; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Gray JC, 2007, CLIN CHEM, V53, P1244, DOI 10.1373/clinchem.2006.081695; Healer J, 2004, MOL MICROBIOL, V52, P159, DOI 10.1111/j.1365-2958.2003.03974.x; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Johnson AH, 2004, INFECT IMMUN, V72, P2762, DOI 10.1128/IAI.72.5.2762-2771.2004; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; Kusi KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008110; Lamarque M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001276; Mackintosh CL, 2008, INT J PARASITOL, V38, P1445, DOI 10.1016/j.ijpara.2008.03.009; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; Mbogo CM, 2003, AM J TROP MED HYG, V68, P734; MBOGO CNM, 1995, AM J TROP MED HYG, V52, P201, DOI 10.4269/ajtmh.1995.52.201; McCallum FJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003571; Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006; Ndungu FM, 2002, PARASITE IMMUNOL, V24, P77, DOI 10.1046/j.0141-9838.2001.00440.x; Nebie I, 2008, INFECT IMMUN, V76, P759, DOI 10.1128/IAI.01147-07; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Ouattara A, 2013, J INFECT DIS, V207, P511, DOI 10.1093/infdis/jis709; Persson KEM, 2008, J CLIN INVEST, V118, P342, DOI 10.1172/JCI32138; Persson KEM, 2006, J CLIN MICROBIOL, V44, P1665, DOI 10.1128/JCM.44.5.1665-1673.2006; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; Polley SD, 2003, GENETICS, V165, P555; Reddy SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032242; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; Richard D, 2010, J BIOL CHEM, V285, P14815, DOI 10.1074/jbc.M109.080770; Richards JS, 2010, CLIN INFECT DIS, V51, pE50, DOI 10.1086/656413; Richards JS, 2009, IMMUNOL CELL BIOL, V87, P377, DOI 10.1038/icb.2009.27; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; Siegrist CA, 2009, NAT REV IMMUNOL, V9, P185, DOI 10.1038/nri2508; Srinivasan P, 2011, P NATL ACAD SCI USA, V108, P13275, DOI 10.1073/pnas.1110303108; Stanisic DI, 2009, INFECT IMMUN, V77, P1165, DOI 10.1128/IAI.01129-08; Takala SL, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000257; Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115; THOMAS AW, 1994, AM J TROP MED HYG, V51, P730, DOI 10.4269/ajtmh.1994.51.730; Tonkin ML, 2011, SCIENCE, V333, P463, DOI 10.1126/science.1204988; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; Wilson S, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-67	55	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68304	10.1371/journal.pone.0068304	http://dx.doi.org/10.1371/journal.pone.0068304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861883	Green Published, gold			2022-12-27	WOS:000321425300057
J	Peng, LM; Li, P; Chen, J; Yan, K; Huo, FY; Han, LN; Li, C; Tan, S; Jiang, XD				Peng, Lingmei; Li, Peng; Chen, Jian; Yan, Ke; Huo, Fuyuan; Han, Lina; Li, Can; Tan, Sheng; Jiang, Xiaodan			Association between Transforming Growth Factor-Beta 1 T869C Polymorphism and Ischemic Stroke: A Meta-Analysis	PLOS ONE			English	Article							CEREBRAL INFARCTION; TGF-BETA-1; DEMENTIA; RISK	Objective: To explore the association between transforming growth factor-beta1 (TGF-beta 1) T869C polymorphism and risk of ischemic stroke (IS) by performing a meta-analysis based on published articles. Methods: Systematic electronic searches of PubMed, Science Direct, BIOSIS Previews, Chinese Biomedical Database, Chinese National Knowledge Infrastructure, and WANFANG Database were performed. The strength of the association was calculated by pooled odds ratios (ORs) with 95% confidence intervals (95%CIs). Subgroup analysis was conducted to explore potential sources of heterogeneity. Sensitivity analysis was performed to elucidate the stability of the outcomes. Publication bias was evaluated by Begg's funnel plot and Egger's test. Results: A total of 6 studies involving 1701 cases were included. The overall estimates did not show any significant association between TGF-beta 1 T869C polymorphism and risk of IS under all genetic models (C vs. T: OR = 1.08,95% CI = 0.881.32; CC vs. TT: OR = 1.17,95% CI = 0.79-1.72; CT vs. TT: OR = 0.91, 95% CI = 0.68-1.22; CC+CT vs. TT: OR = 0.99, 95% CI = 0.73-1.35; CC vs. CT+TT: OR = 1.23, 95% CI = 0.95-1.59). Similar lacking associations were observed in subgroup analysis based on ethnicity and source of controls. When stratified by study design, significant increased association of IS risk was found in cohort studies under genetic models except recessive model(C vs. T: OR = 1.18, 95% CI = 1.05-1.32; CC vs. TT: OR = 1.40, 95% CI = 1.10-1.77; CT vs. TT: OR = 1.23, 95% CI = 1.02-1.49; CC+CT vs. TT: OR = 1.27, 95% CI = 1.03-1.57; CC vs. CT+TT, OR = 1.21, 95% CI = 0.99-1.47), whereas in case-control studies a significant decreased risk was detected under heterozygote comparison(CT vs. CC: OR = 0.72, 95% CI = 0.57-0.92). However, after correction for multiple testing, the associations were observed to be null significant in both cohort and case-control subgroups among all genetic models. Conclusion: This meta-analysis suggested that current epidemiological studies of TGF-beta 1 T869C polymorphism are too inconsistent to draw a conclusion on the association with IS susceptibility. Given the small sample size and remarkable between-study heterogeneity, further well-designed prospective large-scale studies are warranted.	[Peng, Lingmei; Li, Peng; Yan, Ke; Jiang, Xiaodan] Southern Med Univ, Neurosurg Inst Guangdong Prov, Guangdong Prov Key Lab Brain Funct Repair & Regen, Natl Key Clin Specialty,Dept Neurosurg,Zhujiang H, Guangzhou, Guangdong, Peoples R China; [Chen, Jian; Huo, Fuyuan; Han, Lina; Li, Can; Tan, Sheng] Southern Med Univ, Zhujiang Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Peng, Lingmei] First Peoples Hosp Foshan, Dept Neurol, Foshan, Peoples R China; [Li, Peng] First Peoples Hosp Guangzhou, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; South China University of Technology	Tan, S (corresponding author), Southern Med Univ, Zhujiang Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China.	tansheng18@126.com; jiangxiao_dan@163.com	tan, sheng/GSN-2599-2022	/0000-0002-5091-7218	National Key Clinic Department; Natural Science Fund of China [81171179, 81272439]; Funds for Key Sci-Tech Research Projects of Guangdong [2008A030201019]; Funds for Key Sci-Tech Research Projects of Guangzhou [9B52120112-2009J1-C418-2, 2008A1-E4011-6]	National Key Clinic Department; Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Funds for Key Sci-Tech Research Projects of Guangdong; Funds for Key Sci-Tech Research Projects of Guangzhou	This work was supported by grants from the funds for National Key Clinic Department, the Natural Science Fund of China (No. 81171179 and 81272439), the Funds for Key Sci-Tech Research Projects of Guangdong (No. 2008A030201019) and Guangzhou (No. 9B52120112-2009J1-C418-2, No. 2008A1-E4011-6) to Professor Xiaodan Jiang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attia J, 2003, J CLIN EPIDEMIOL, V56, P297, DOI 10.1016/S0895-4356(03)00011-8; Chen CL, 2007, J CELL SCI, V120, P3509, DOI 10.1242/jcs.006916; DerSimonian R, 1996, STAT MED, V15, P1237, DOI 10.1002/(SICI)1097-0258(19960630)15:12<1237::AID-SIM301>3.0.CO;2-N; Dichgans M, 2007, LANCET NEUROL, V6, P149, DOI 10.1016/S1474-4422(07)70028-5; Dobolyi A, 2012, INT J MOL SCI, V13, P8219, DOI 10.3390/ijms13078219; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Katakami N, 2011, DIABETES RES CLIN PR, V94, pE57, DOI 10.1016/j.diabres.2011.08.005; Kim Y, 2006, STROKE, V37, P2843, DOI 10.1161/01.STR.0000244782.76917.87; Liang H, 2010, THESIS CENTRAL S U; [梁辉 LIANG Hui], 2011, [激光生物学报, Acta Laser Biology Sinica], V20, P523; Liu Y, 2010, CHINA MODERN MED, V17, P9; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; MANTEL N, 1959, J NATL CANCER I, V22, P719; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Peila R, 2004, NEUROBIOL AGING, V25, pS539, DOI 10.1016/S0197-4580(04)81783-4; Peila R, 2007, NEUROBIOL AGING, V28, P1367, DOI 10.1016/j.neurobiolaging.2006.06.004; Peng ZX, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-100; Peng ZX, 2009, THESIS GUANGZHOU MED; Shah R, 2006, HUM GENET, V119, P61, DOI 10.1007/s00439-005-0112-y; Sie MPS, 2006, STROKE, V37, P2667, DOI 10.1161/01.STR.0000244779.30070.1a; Tao HM, 2011, CAN J NEUROL SCI, V38, P869, DOI 10.1017/S0317167100012452; Tao HM, 2010, CAN J NEUROL SCI, V37, P803, DOI 10.1017/S0317167100051477; van der Spuy WJ, 2012, REV NEUROSCIENCE, V23, P269, DOI 10.1515/revneuro-2012-0028; Wells GA, 2011, NEWCASTLE OTTAWA SCA; Xie Yiqun, 2009, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V34, P1166; Yamada Y, 2000, ARTHRITIS RHEUM, V43, P452, DOI 10.1002/1529-0131(200002)43:2<452::AID-ANR28>3.0.CO;2-C; Zeng KM, 2008, THESIS CENTRAL S U	27	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67738	10.1371/journal.pone.0067738	http://dx.doi.org/10.1371/journal.pone.0067738			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861796	gold, Green Submitted, Green Published			2022-12-27	WOS:000321425300026
J	Carmean, CM; Bobe, AM; Yu, JC; Volden, PA; Brady, MJ				Carmean, Christopher M.; Bobe, Alexandria M.; Yu, Justin C.; Volden, Paul A.; Brady, Matthew J.			Refeeding-Induced Brown Adipose Tissue Glycogen Hyper-Accumulation in Mice Is Mediated by Insulin and Catecholamines	PLOS ONE			English	Article							COLD-EXPOSURE; NOREPINEPHRINE TURNOVER; ENERGY-EXPENDITURE; METABOLIC SYNDROME; FAT THERMOGENESIS; SKELETAL-MUSCLE; GLUCOSE; RATS; RESISTANCE; OBESITY	Brown adipose tissue (BAT) generates heat during adaptive thermogenesis through a combination of oxidative metabolism and uncoupling protein 1-mediated electron transport chain uncoupling, using both free-fatty acids and glucose as substrate. Previous rat-based work in 1942 showed that prolonged partial fasting followed by refeeding led to a dramatic, transient increase in glycogen stores in multiple fat depots. In the present study, the protocol was replicated in male CD1 mice, resulting in a 2000-fold increase in interscapular BAT (IBAT) glycogen levels within 4-12 hours (hr) of refeeding, with IBAT glycogen stores reaching levels comparable to fed liver glycogen. Lesser effects occurred in white adipose tissues (WAT). Over the next 36 hr, glycogen levels dissipated and histological analysis revealed an over-accumulation of lipid droplets, suggesting a potential metabolic connection between glycogenolysis and lipid synthesis. 24 hr of total starvation followed by refeeding induced a robust and consistent glycogen over-accumulation similar in magnitude and time course to the prolonged partial fast. Experimentation demonstrated that hyperglycemia was not sufficient to drive glycogen accumulation in IBAT, but that elevated circulating insulin was sufficient. Additionally, pharmacological inhibition of catecholamine production reduced refeeding-induced IBAT glycogen storage, providing evidence of a contribution from the central nervous system. These findings highlight IBAT as a tissue that integrates both canonically-anabolic and catabolic stimulation for the promotion of glycogen storage during recovery from caloric deficit. The preservation of this robust response through many generations of animals not subjected to food deprivation suggests that the over-accumulation phenomenon plays a critical role in IBAT physiology.	[Carmean, Christopher M.; Bobe, Alexandria M.; Volden, Paul A.; Brady, Matthew J.] Univ Chicago, Comm Mol Metab & Nutr, Chicago, IL 60637 USA; [Yu, Justin C.; Brady, Matthew J.] Univ Chicago, Dept Med, Sect Endocrinol Diabet & Metab, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Brady, MJ (corresponding author), Univ Chicago, Comm Mol Metab & Nutr, Chicago, IL 60637 USA.	mbrady1@uchicago.edu			National Institutes of Health [RO1-DK064772, P60-DK020595]; Kovler Diabetes Center Leadership Board Studentship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064772, P60DK020595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kovler Diabetes Center Leadership Board Studentship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health RO1-DK064772, P60-DK020595, and the Kovler Diabetes Center Leadership Board Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNUM CP, 1958, AM J PHYSIOL, V195, P301, DOI 10.1152/ajplegacy.1958.195.2.301; BARRETT EJ, 1994, METABOLISM, V43, P285, DOI 10.1016/0026-0495(94)90094-9; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bremer AA, 2012, PEDIATRICS, V129, P557, DOI 10.1542/peds.2011-2912; BRODIE BB, 1966, J PHARMACOL EXP THER, V154, P493; Burcelin R, 2000, DIABETES, V49, P1635, DOI 10.2337/diabetes.49.10.1635; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2012, NATURE, V488, P286, DOI 10.1038/488286a; Castillo M, 2011, DIABETES, V60, P1082, DOI 10.2337/db10-0758; Cettour-Rose P, 2005, DIABETES, V54, P751, DOI 10.2337/diabetes.54.3.751; Cinti S, 2011, ANN MED, V43, P104, DOI 10.3109/07853890.2010.535557; DESAUTELS M, 1988, AM J PHYSIOL, V255, pE120, DOI 10.1152/ajpendo.1988.255.2.E120; DULLOO AG, 1990, AM J CLIN NUTR, V52, P415, DOI 10.1093/ajcn/52.3.415; Farkas V, 1999, ARCH BIOCHEM BIOPHYS, V365, P54, DOI 10.1006/abbi.1999.1157; FAWCETT DW, 1948, ENDOCRINOLOGY, V42, P454, DOI 10.1210/endo-42-6-454; FAWCETT DW, 1949, ENDOCRINOLOGY, V45, P609, DOI 10.1210/endo-45-6-609; FELIPE A, 1990, BIOCHEM INT, V21, P537; FOSTER DO, 1980, CAN J PHYSIOL PHARM, V58, P915, DOI 10.1139/y80-140; FOSTER DO, 1982, CAN J PHYSIOL PHARM, V60, P747, DOI 10.1139/y82-104; GLICK Z, 1989, PHYSIOL BEHAV, V45, P243, DOI 10.1016/0031-9384(89)90125-X; GLICK Z, 1985, AM J PHYSIOL, V249, pE519, DOI 10.1152/ajpendo.1985.249.5.E519; Guerra C, 2001, J CLIN INVEST, V108, P1205, DOI 10.1172/JCI200113103; Hammond LE, 2005, J BIOL CHEM, V280, P25629, DOI 10.1074/jbc.M503181200; HOLNESS MJ, 1991, BIOCHEM J, V277, P429, DOI 10.1042/bj2770429; IGUCHI A, 1989, METABOLISM, V38, P1216, DOI 10.1016/0026-0495(89)90162-5; Jakus PB, 2008, J LIPID RES, V49, P332, DOI 10.1194/jlr.M700316-JLR200; Jurczak MJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE952, DOI 10.1152/ajpendo.00559.2006; Jurczak MJ, 2012, J BIOL CHEM, V287, P2558, DOI 10.1074/jbc.M111.316760; Karhunen LJ, 2008, REGUL PEPTIDES, V149, P70, DOI 10.1016/j.regpep.2007.10.008; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kochan Z, 1997, METABOLISM, V46, P10, DOI 10.1016/S0026-0495(97)90160-8; LEVIN BE, 1995, AM J PHYSIOL-REG I, V268, pR389, DOI 10.1152/ajpregu.1995.268.2.R389; MCCORMACK JG, 1983, PROG LIPID RES, V21, P195, DOI 10.1016/0163-7827(82)90009-1; Mounien L, 2010, FASEB J, V24, P1747, DOI 10.1096/fj.09-144923; MURALIDHARA DV, 1994, AM J PHYSIOL, V266, pR1907; Rahman SM, 2012, J BIOL CHEM, V287, P34349, DOI 10.1074/jbc.M112.410613; Robin JP, 2008, J NUTR, V138, P861, DOI 10.1093/jn/138.5.861; RODIN J, 1990, INT J OBESITY, V14, P303; Saha PK, 2004, J BIOL CHEM, V279, P35150, DOI 10.1074/jbc.M405499200; SHACKNEY SE, 1966, J BIOL CHEM, V241, P4004; SHIBATA H, 1989, AM J PHYSIOL, V257, pR96, DOI 10.1152/ajpregu.1989.257.1.R96; SHIKAMA H, 1978, AM J PHYSIOL, V235, pE354, DOI 10.1152/ajpendo.1978.235.4.E354; SIDMAN RL, 1954, ANAT RECORD, V118, P487, DOI 10.1002/ar.1091180303; SIDMAN RL, 1956, ANAT REC, V124, P723, DOI 10.1002/ar.1091240408; Skarulis MC, 2010, J CLIN ENDOCR METAB, V95, P256, DOI 10.1210/jc.2009-0543; Stephens M, 2011, CLIN ENDOCRINOL, V74, P661, DOI 10.1111/j.1365-2265.2011.04018.x; STORLIEN LH, 1986, AM J PHYSIOL, V251, pE576, DOI 10.1152/ajpendo.1986.251.5.E576; Swoap SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004038; Teruel T, 1996, BIOCHEM J, V319, P627, DOI 10.1042/bj3190627; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; TUERKISCHER E, 1946, J PHYSIOL-LONDON, V104, P361, DOI 10.1113/jphysiol.1946.sp004128; Tuerkischer E, 1942, J PHYSIOL-LONDON, V100, P385, DOI 10.1113/jphysiol.1942.sp003950; Ugleholdt R, 2011, DAN MED BULL, V58; Vaughan CH, 2012, AM J PHYSIOL-REG I, V302, pR1049, DOI 10.1152/ajpregu.00640.2011; Wang W, 2007, ARCH BIOCHEM BIOPHYS, V457, P264, DOI 10.1016/j.abb.2006.10.017; WERTHEIMER E, 1945, J PHYSIOL-LONDON, V103, P359, DOI 10.1113/jphysiol.1945.sp004084; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; YOUNG JB, 1982, J CLIN INVEST, V69, P1061, DOI 10.1172/JCI110541; Zhang WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037103	59	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67807	10.1371/journal.pone.0067807	http://dx.doi.org/10.1371/journal.pone.0067807			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861810	Green Submitted, Green Published, gold			2022-12-27	WOS:000323350700038
J	Leotoing, L; Wauquier, F; Guicheux, J; Miot-Noirault, E; Wittrant, Y; Coxam, V				Leotoing, Laurent; Wauquier, Fabien; Guicheux, Jerome; Miot-Noirault, Elisabeth; Wittrant, Yohann; Coxam, Veronique			The Polyphenol Fisetin Protects Bone by Repressing NF-kappa B and MKP-1-Dependent Signaling Pathways in Osteoclasts	PLOS ONE			English	Article							RECEPTOR ACTIVATOR; CELL-PROLIFERATION; IN-VIVO; DIFFERENTIATION; INFLAMMATION; RANKL; EXPRESSION; FLAVONOIDS; INHIBITOR; DISEASE	Osteoporosis is a bone pathology leading to increase fractures risk and challenging quality of life. Since current treatments could exhibit deleterious side effects, the use of food compounds derived from plants represents a promising innovative alternative due to their potential therapeutic and preventive activities against human diseases. In this study, we investigated the ability of the polyphenol fisetin to counter osteoporosis and analyzed the cellular and molecular mechanisms involved. In vivo, fisetin consumption significantly prevented bone loss in estrogen deficiency and inflammation mice osteoporosis models. Indeed, bone mineral density, micro-architecture parameters and bone markers were positively modulated by fisetin. Consistent with in vivo results, we showed that fisetin represses RANKL-induced osteoclast differentiation and activity as demonstrated by an inhibition of multinucleated cells formation, TRAP activity and differentiation genes expression. The signaling pathways NF-kappa B, p38 MAPK, JNK and the key transcription factors c-Fos and NFATc1 expressions induced by RANKL, were negatively regulated by fisetin. We further showed that fisetin inhibits the constitutive proteasomal degradation of MKP-1, the phosphatase that deactivates p38 and JNK. Consistently, using shRNA stable cell lines, we demonstrated that impairment of MKP-1 decreases fisetin potency. Taken together, these results strongly support that fisetin should be further considered as a bone protective agent.	[Leotoing, Laurent; Wauquier, Fabien; Miot-Noirault, Elisabeth; Wittrant, Yohann; Coxam, Veronique] Clermont Univ, Univ Auvergne, Clermont Ferrand, France; [Leotoing, Laurent; Wauquier, Fabien; Wittrant, Yohann; Coxam, Veronique] INRA, UMR 1019, Unite Nutr Humaine, CRNH Auvergne, Clermont Ferrand, France; [Guicheux, Jerome] Univ Nantes, UFR Odontol, Nantes, France; [Guicheux, Jerome] NSERM, UMRS 791, LIOAD, Nantes, France; [Miot-Noirault, Elisabeth] INSERM, UMR 990, Clermont Ferrand, France	Universite Clermont Auvergne (UCA); INRAE; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Nantes Universite; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	Coxam, V (corresponding author), Clermont Univ, Univ Auvergne, Clermont Ferrand, France.	veronique.coxam@clermont.inra.fr	Miot-Noirault, Elisabeth/Y-2272-2019; guicheux, Jerome/F-7767-2013	guicheux, Jerome/0000-0003-2754-3024	FEDER (Fonds Europeens de Developpement Regional); Conseil Regional Auvergne through the network of Nutravita, a cluster of excellence in nutrition in Auvergne	FEDER (Fonds Europeens de Developpement Regional)(European Commission); Conseil Regional Auvergne through the network of Nutravita, a cluster of excellence in nutrition in Auvergne(Region Auvergne-Rhone-Alpes)	This work was supported by grants to L.L. from FEDER (Fonds Europeens de Developpement Regional) and Conseil Regional Auvergne through the network of Nutravita, a cluster of excellence in nutrition in Auvergne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Arai Y, 2000, J NUTR, V130, P2243; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Billard MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017940; BISKOBING DM, 1995, J BONE MINER RES, V10, P1025; Boutros T, 2008, PHARMACOL REV, V60, P261, DOI 10.1124/pr.107.00106; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Breinholt V, 1998, CHEM RES TOXICOL, V11, P622, DOI 10.1021/tx970170y; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Brown K, 2009, MUTAGENESIS, V24, P391, DOI 10.1093/mutage/gep022; Carlson J, 2009, AM J PATHOL, V175, P1564, DOI 10.2353/ajpath.2009.090035; Chien CS, 2010, MOL CELL BIOCHEM, V333, P169, DOI 10.1007/s11010-009-0217-z; Choi SW, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/810563; David JP, 2002, J CELL SCI, V115, P4317, DOI 10.1242/jcs.00082; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Gao YH, 2007, J CLIN INVEST, V117, P122, DOI 10.1172/JCI30074; Geraets L, 2009, BIOCHEM BIOPH RES CO, V382, P598, DOI 10.1016/j.bbrc.2009.03.071; Goh FY, 2012, EUR J PHARMACOL, V679, P109, DOI 10.1016/j.ejphar.2012.01.002; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Ikeda F, 2008, J BONE MINER RES, V23, P907, DOI 10.1359/JBMR.080211; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Khan N, 2008, CANCER RES, V68, P8555, DOI 10.1158/0008-5472.CAN-08-0240; Khosla S, 2012, J CLIN ENDOCR METAB, V97, P2272, DOI 10.1210/jc.2012-1027; Lawan A, 2012, CELL MOL LIFE SCI; Lee JD, 2009, INT IMMUNOPHARMACOL, V9, P268, DOI 10.1016/j.intimp.2008.11.005; Lee SE, 2002, BONE, V30, P71, DOI 10.1016/S8756-3282(01)00657-3; Leotoing L, 2011, J BIOL CHEM, V286, P32277, DOI 10.1074/jbc.M111.236448; Liu SH, 2010, J AGR FOOD CHEM; Mahalingam CD, 2011, J ENDOCRINOL, V211, P145, DOI 10.1530/JOE-11-0144; Maher P, 2006, P NATL ACAD SCI USA, V103, P16568, DOI 10.1073/pnas.0607822103; Maher P, 2011, HUM MOL GENET, V20, P261, DOI 10.1093/hmg/ddq460; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; Mundy GR, 2007, NUTR REV, V65, pS147, DOI 10.1301/nr.2007.dec.S147-S151; Novack DV, 2011, CELL RES, V21, P169, DOI 10.1038/cr.2010.159; Redlich K, 2012, NAT REV DRUG DISCOV, V11, P234, DOI 10.1038/nrd3669; Rizzoli Rene, 2011, Expert Rev Clin Pharmacol, V4, P593; Sakai E, 2013, J PHARMACOL SCI, V121, P288, DOI 10.1254/jphs.12243FP; Sung B, 2007, MOL PHARMACOL, V71, P1703, DOI 10.1124/mol.107.034512; Takatsuna H, 2005, J BONE MINER RES, V20, P653, DOI 10.1359/JBMR.041213; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wancket LM, 2012, LIFE SCI, V90, P237, DOI 10.1016/j.lfs.2011.11.017; Wei S, 2001, ENDOCRINOLOGY, V142, P1290, DOI 10.1210/en.142.3.1290; Zand RSR, 2000, BREAST CANCER RES TR, V62, P35, DOI 10.1023/A:1006422302173	47	48	50	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68388	10.1371/journal.pone.0068388	http://dx.doi.org/10.1371/journal.pone.0068388			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861901	Green Submitted, Green Published, gold			2022-12-27	WOS:000323350700085
J	Margolskee, E; Jobanputra, V; Lewis, SK; Alobeid, B; Green, PHR; Bhagat, G				Margolskee, Elizabeth; Jobanputra, Vaidehi; Lewis, Suzanne K.; Alobeid, Bachir; Green, Peter H. R.; Bhagat, Govind			Indolent Small Intestinal CD4+T-cell Lymphoma Is a Distinct Entity with Unique Biologic and Clinical Features	PLOS ONE			English	Article							T-CELL LYMPHOMA; REFRACTORY CELIAC-DISEASE; GASTROINTESTINAL INVOLVEMENT; CLINICOPATHOLOGICAL FEATURES; LYMPHOPROLIFERATIVE DISORDER; MYCOSIS-FUNGOIDES; REGULATORY CELLS; FOLLOW-UP; ENTEROPATHY; INFILTRATION	Enteropathy-associated T-cell lymphomas (EATL) are rare and generally aggressive types of peripheral T-cell lymphomas. Rare cases of primary, small intestinal CD4+ T-cell lymphomas with indolent behavior have been described, but are not well characterized. We describe morphologic, phenotypic, genomic and clinical features of 3 cases of indolent primary small intestinal CD4+ T-cell lymphomas. All patients presented with diarrhea and weight loss and were diagnosed with celiac disease refractory to a gluten free diet at referring institutions. Small intestinal biopsies showed crypt hyperplasia, villous atrophy and a dense lamina propria infiltrate of small-sized CD4+ T-cells often with CD7 downregulation or loss. Gastric and colonic involvement was also detected (n = 2 each). Persistent, clonal TCR beta gene rearrangement products were detected at multiple sites. SNP array analysis showed relative genomic stability, early in disease course, and non-recurrent genetic abnormalities, but complex changes were seen at disease transformation (n = 1). Two patients are alive with persistent disease (4.6 and 2.5 years post-diagnosis), despite immunomodulatory therapy; one died due to bowel perforation related to large cell transformation 11 years post-diagnosis. Unique pathobiologic features warrant designation of indolent small intestinal CD4+ T-cell lymphoma as a distinct entity, greater awareness of which would avoid misdiagnosis as EATL or an inflammatory disorder, especially celiac disease.	[Margolskee, Elizabeth; Jobanputra, Vaidehi; Alobeid, Bachir; Bhagat, Govind] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY 10027 USA; [Lewis, Suzanne K.; Green, Peter H. R.; Bhagat, Govind] Columbia Univ, Dept Med, Med Ctr, Celiac Dis Ctr, New York, NY USA	Columbia University; Columbia University	Bhagat, G (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY 10027 USA.	gb96@columbia.edu	Bhagat, Govind/AAE-9493-2021	Bhagat, Govind/0000-0001-6250-048X; Margolskee, Elizabeth/0000-0001-8597-0636				Agace WW, 2000, CURR OPIN CELL BIOL, V12, P563, DOI 10.1016/S0955-0674(00)00132-0; Au WY, 2009, BLOOD, V113, P3931, DOI 10.1182/blood-2008-10-185256; Baumgartner AK, 2003, LAB INVEST, V83, P1509, DOI 10.1097/01.LAB.0000090157.13040.58; Beier UH, 2011, CURR OPIN IMMUNOL, V23, P670, DOI 10.1016/j.coi.2011.07.002; Burke JS, 2011, ARCH PATHOL LAB MED, V135, P1283, DOI 10.5858/arpa.2011-0145-RA; Cannons JL, 2013, TRENDS IMMUNOL, V34, P200, DOI 10.1016/j.it.2013.01.001; CARBONNEL F, 1994, CANCER, V73, P1286, DOI 10.1002/1097-0142(19940215)73:4<1286::AID-CNCR2820730425>3.0.CO;2-9; Carbonnel F, 1999, GUT, V45, P662, DOI 10.1136/gut.45.5.662; Carey MJ, 1999, AM J CLIN PATHOL, V112, P696; CERFBENSUSSAN N, 1987, EUR J IMMUNOL, V17, P1279, DOI 10.1002/eji.1830170910; Chan JKC, 2011, AM J SURG PATHOL, V35, P1557, DOI 10.1097/PAS.0b013e318222dfcd; Chott A, 1998, AM J PATHOL, V153, P1483, DOI 10.1016/S0002-9440(10)65736-7; Corazza GR, 1997, LANCET, V350, P106, DOI 10.1016/S0140-6736(97)01042-8; Delabie J, 2011, BLOOD, V118, P148, DOI 10.1182/blood-2011-02-335216; Deleeuw RJ, 2007, GASTROENTEROLOGY, V132, P1902, DOI 10.1053/j.gastro.2007.03.036; DOMIZIO P, 1993, AM J SURG PATHOL, V17, P429, DOI 10.1097/00000478-199305000-00001; EGAWA N, 1995, CANCER, V75, P1728, DOI 10.1002/1097-0142(19950401)75:7<1728::AID-CNCR2820750727>3.0.CO;2-9; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Harel S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042302; HERRMANN R, 1980, CANCER, V46, P215, DOI 10.1002/1097-0142(19800701)46:1<215::AID-CNCR2820460136>3.0.CO;2-6; Hirakawa K, 1996, GASTROENTEROLOGY, V111, P778, DOI 10.1053/gast.1996.v111.pm8780585; Isaacson PG, 2005, J PATHOL, V205, P255, DOI 10.1002/path.1703; ISAACSON PG, 2008, WHO CLASSIFICATION T, P289; Kaneki T, 1999, J GASTROENTEROL, V34, P253, DOI 10.1007/s005350050253; Kohno S, 2003, HISTOPATHOLOGY, V43, P135, DOI 10.1046/j.1365-2559.2003.01659.x; LAABI Y, 1992, EMBO J, V11, P3897, DOI 10.1002/j.1460-2075.1992.tb05482.x; Lavergne A, 1998, HISTOPATHOLOGY, V32, P271; Malamut G, 2013, DIGEST LIVER DIS, V45, P377, DOI 10.1016/j.dld.2012.12.001; Malamut G, 2009, GASTROENTEROLOGY, V136, P81, DOI 10.1053/j.gastro.2008.09.069; Mansoor A, 2011, BLOOD, V117, P1447, DOI 10.1182/blood-2010-08-302737; Mitchell TJ, 2005, IMMUNOLOGY, V114, P301, DOI 10.1111/j.1365-2567.2005.02091.x; MOREB J, 1983, CANCER, V51, P487, DOI 10.1002/1097-0142(19830201)51:3<487::AID-CNCR2820510321>3.0.CO;2-L; Nakamura S, 2003, CANCER, V97, P2462, DOI 10.1002/cncr.11415; Nikpour P, 2012, J BIOSCIENCES, V37, P85, DOI 10.1007/s12038-011-9174-2; Ranheim EA, 2000, AM J SURG PATHOL, V24, P296, DOI 10.1097/00000478-200002000-00017; Rickert RC, 2011, IMMUNOL REV, V244, P115, DOI 10.1111/j.1600-065X.2011.01067.x; Pinilla SMR, 2009, AM J SURG PATHOL, V33, P81, DOI 10.1097/PAS.0b013e31818e52fe; Sharaiha RZ, 2012, CANCER-AM CANCER SOC, V118, P3786, DOI 10.1002/cncr.26700; Shevach EM, 2006, IMMUNITY, V25, P195, DOI 10.1016/j.immuni.2006.08.003; SLATER DN, 1984, J ROY SOC MED, V77, P114, DOI 10.1177/014107688407700209; Svrcek M, 2007, VIRCHOWS ARCH, V451, P1091, DOI 10.1007/s00428-007-0475-7; TOKUNAGA O, 1993, CANCER, V71, P708, DOI 10.1002/1097-0142(19930201)71:3<708::AID-CNCR2820710309>3.0.CO;2-P; Toyota S, 2002, INT J HEMATOL, V75, P314, DOI 10.1007/BF02982049; Tse E, 2012, AM J HEMATOL, V87, P663, DOI 10.1002/ajh.23213; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; van Loosdregt J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019047; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; Velagapudi P, 2011, AM J MED SCI, V341, P508, DOI 10.1097/MAJ.0b013e31821389da; Verbeek WHM, 2009, CYTOM PART B-CLIN CY, V76B, P367, DOI 10.1002/cyto.b.20481; Verkarre V, 2003, GUT, V52, P205, DOI 10.1136/gut.52.2.205; Zettl A, 2002, AM J PATHOL, V161, P1635, DOI 10.1016/S0002-9440(10)64441-0; Zivny J, 2004, DIGEST DIS SCI, V49, P551, DOI 10.1023/B:DDAS.0000026297.25591.62	53	52	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68343	10.1371/journal.pone.0068343	http://dx.doi.org/10.1371/journal.pone.0068343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861889	Green Submitted, Green Published, gold			2022-12-27	WOS:000323350700080
J	Rocha, FL; Roque, ALR; de Lima, JS; Cheida, CC; Lemos, FG; de Azevedo, FC; Arrais, RC; Bilac, D; Herrera, HM; Mourao, G; Jansen, AM				Rocha, Fabiana Lopes; Rodrigues Roque, Andre Luiz; de Lima, Juliane Saab; Cheida, Carolina Carvalho; Lemos, Frederico Gemesio; de Azevedo, Fernanda Cavalcanti; Arrais, Ricardo Corassa; Bilac, Daniele; Herrera, Heitor Miraglia; Mourao, Guilherme; Jansen, Ana Maria			Trypanosoma cruzi Infection in Neotropical Wild Carnivores (Mammalia: Carnivora): At the Top of the T-cruzi Transmission Chain	PLOS ONE			English	Article							COATI NASUA-NASUA; TRIATOMINE BUGS; CHAGAS-DISEASE; EVANSI KINETOPLASTIDA; ORAL-TRANSMISSION; PANTANAL REGION; AMAZON BASIN; MANED WOLF; RESERVOIR; RANGELI	Little is known on the role played by Neotropical wild carnivores in the Trypanosoma cruzi transmission cycles. We investigated T. cruzi infection in wild carnivores from three sites in Brazil through parasitological and serological tests. The seven carnivore species examined were infected by T. cruzi, but high parasitemias detectable by hemoculture were found only in two Procyonidae species. Genotyping by Mini-exon gene, PCR-RFLP (1f8/Akw21I) and kDNA genomic targets revealed that the raccoon (Procyon cancrivorus) harbored TcI and the coatis (Nasua nasua) harbored TcI, TcII, TcIII-IV and Trypanosoma rangeli, in single and mixed infections, besides four T. cruzi isolates that displayed odd band patterns in the Mini-exon assay. These findings corroborate the coati can be a bioaccumulator of T. cruzi Discrete Typing Units (DTU) and may act as a transmission hub, a connection point joining sylvatic transmission cycles within terrestrial and arboreal mammals and vectors. Also, the odd band patterns observed in coatis' isolates reinforce that T. cruzi diversity might be much higher than currently acknowledged. Additionally, we assembled our data with T. cruzi infection on Neotropical carnivores' literature records to provide a comprehensive analysis of the infection patterns among distinct carnivore species, especially considering their ecological traits and phylogeny. Altogether, fifteen Neotropical carnivore species were found naturally infected by T. cruzi. Species diet was associated with T. cruzi infection rates, supporting the hypothesis that predator-prey links are important mechanisms for T. cruzi maintenance and dispersion in the wild. Distinct T. cruzi infection patterns across carnivore species and study sites were notable. Musteloidea species consistently exhibit high parasitemias in different studies which indicate their high infectivity potential. Mesocarnivores that feed on both invertebrates and mammals, including the coati, a host that can be bioaccumulator of T. cruzi DTU's, seem to take place at the top of the T. cruzi transmission chain.	[Rocha, Fabiana Lopes; Rodrigues Roque, Andre Luiz; Bilac, Daniele; Jansen, Ana Maria] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Tripanosomatideos, BR-21045900 Rio De Janeiro, Brazil; [Rocha, Fabiana Lopes] TRIADE, Inst Brasileiro Med Conservacao, Recife, PE, Brazil; [Rocha, Fabiana Lopes; Lemos, Frederico Gemesio; de Azevedo, Fernanda Cavalcanti; Arrais, Ricardo Corassa] PCMC, Araguari, MG, Brazil; [de Lima, Juliane Saab] Univ Fed Mato Grosso do Sul, Programa Posgrad Ecol & Conservacao, Campo Grande, MS, Brazil; [Cheida, Carolina Carvalho] Inst Pesquisas Cananeia IPeC, Programa Pesquisa Vida Selvagem, Projeto Carnivoros, Sao Paulo, Brazil; [Lemos, Frederico Gemesio] UFG, Dept Ciencias Biol, Catalao, Go, Brazil; [Arrais, Ricardo Corassa] Univ Sao Paulo, Dept Med Prevent & Saude Anim, Sao Paulo, Brazil; [Herrera, Heitor Miraglia] Univ Catolica Dom Bosco, Campo Grande, MS, Brazil; [Mourao, Guilherme] Embrapa Pantanal, Lab Vida Selvagem, Empresa Brasileira Pesquisa Agr, Corumba, MS, Brazil	Fundacao Oswaldo Cruz; Universidade Federal de Mato Grosso do Sul; Universidade Federal de Goias; Universidade de Sao Paulo; Universidade Catolica Dom Bosco (UCDB); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Jansen, AM (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Tripanosomatideos, BR-21045900 Rio De Janeiro, Brazil.	jansen@ioc.fiocruz.br	Roque, André Luiz Rodrigues/W-7528-2019; Azevedo, Fernanda/AAB-4277-2019; Rocha, Fabiana/J-5471-2015; Mourão, Guilherme M/C-3319-2013; Azevedo, Fernanda Cavalcanti/J-1734-2014; Herrera, Heitor Miraglia/K-3759-2012; Lemos, Frederico Gemesio/G-1991-2014	Azevedo, Fernanda/0000-0002-2424-6860; Mourão, Guilherme M/0000-0002-8300-4191; Azevedo, Fernanda Cavalcanti/0000-0002-2424-6860; Herrera, Heitor Miraglia/0000-0003-2404-8765; Lemos, Frederico Gemesio/0000-0002-3027-5713; Rocha, Fabiana Lopes/0000-0003-0819-6290; Roque, Andre/0000-0002-8740-052X; Jansen, Ana Maria/0000-0001-5804-6210	ChagasEpiNet [223034]; Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT) [9777.256.476.13022008]; National Research Center for the Conservation of Natural Predators - CENAP/ICMBio; Wildlife Conservation Society [OWOH 2008_001]; Consorcio Capim Branco de Energia; CNPq Edital Universal [014/2008]; PDJ-CNPq [150608/2013-6]; Smithsonian Institution; Neotropical Grassland Conservancy; Idea Wild. U.S. Fish and Wildlife Service; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	ChagasEpiNet; Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT)(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); National Research Center for the Conservation of Natural Predators - CENAP/ICMBio; Wildlife Conservation Society; Consorcio Capim Branco de Energia; CNPq Edital Universal(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PDJ-CNPq; Smithsonian Institution(Smithsonian Institution); Neotropical Grassland Conservancy; Idea Wild. U.S. Fish and Wildlife Service; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was funded by ChagasEpiNet 223034. Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT) - 9777.256.476.13022008. National Research Center for the Conservation of Natural Predators - CENAP/ICMBio. Wildlife Conservation Society - OWOH 2008_001. Consorcio Capim Branco de Energia. CNPq Edital Universal 014/2008. PDJ-CNPq 150608/2013-6. Smithsonian Institution. Neotropical Grassland Conservancy. Idea Wild. U.S. Fish and Wildlife Service. A doctoral grant was provided by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) to FLR and CCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouheif E, 1999, EVOL ECOL RES, V1, P895; Agnarsson I, 2010, MOL PHYLOGENET EVOL, V54, P726, DOI 10.1016/j.ympev.2009.10.033; Albuquerque R D, 1968, Rev Bras Biol, V28, P457; ALBUQUERQUE R D R, 1970, Revista do Instituto de Medicina Tropical de Sao Paulo, V12, P375; Alho Cleber J.R., 2012, Animals, V2, P591, DOI 10.3390/ani2040591; Aliaga C, 2011, INFECT GENET EVOL, V11, P1155, DOI 10.1016/j.meegid.2010.11.013; Alves FM, 2011, VECTOR-BORNE ZOONOT, V11, P835, DOI 10.1089/vbz.2010.0096; [Anonymous], 2002, WHO TECHN REP SER; Araujo CAC, 2011, EXP PARASITOL, V127, P308, DOI 10.1016/j.exppara.2010.07.013; BARRETTO M P, 1972, Revista Brasileira de Biologia, V32, P413; Barretto M. P, 1971, Revta Inst Med trop S Paulo, V13, P346; BARRETTO M P, 1970, Revista Brasileira de Biologia, V30, P431; Barretto M.P., 1979, Revista do Instituto Adolfo Lutz, V39, P25; Bianchi RC, 2009, THESIS FEDERAL U MAT; Brown EL, 2010, VECTOR-BORNE ZOONOT, V10, P757, DOI 10.1089/vbz.2009.0009; CAMARGO MARIO E., 1966, REV INST MED TROP SAO PAULO, V8, P227; Cardinal MV, 2008, INT J PARASITOL, V38, P1533, DOI 10.1016/j.ijpara.2008.04.010; Ceballos LA, 2006, ACTA TROP, V98, P286, DOI 10.1016/j.actatropica.2006.06.003; Chagas C, 1909, MEM I OSWALDO CRUZ, V1, P159, DOI DOI 10.1590/S0074-02761909000200008; Courtenay O, 2006, J ZOOL, V268, P45, DOI 10.1111/j.1469-7998.2005.00021.x; Ramirez JD, 2012, INFECT GENET EVOL, V12, P1743, DOI 10.1016/j.meegid.2012.06.018; DAVIS DS, 1980, J WILDLIFE DIS, V16, P403, DOI 10.7589/0090-3558-16.3.403; Deane L. M., 1964, Revista Brasileira de Malariologia, V16, P27; DEANE LEONIDAS M., 1961, REV INST MED TROP SAO PAULO, V3, P15; Diniz JAF, 1998, EVOLUTION, V52, P1247, DOI 10.1111/j.1558-5646.1998.tb02006.x; Dray S, 2007, J STAT SOFTW, V22, P120; Fernandes O, 2001, T ROY SOC TROP MED H, V95, P97, DOI 10.1016/S0035-9203(01)90350-5; FERRIOLLI F JR, 1968, Revista do Instituto de Medicina Tropical de Sao Paulo, V10, P354; Gaunt M, 2000, MEM I OSWALDO CRUZ, V95, P557, DOI 10.1590/S0074-02762000000400019; GITTLEMAN JL, 1982, BEHAV ECOL SOCIOBIOL, V10, P57, DOI 10.1007/BF00296396; Herrera HM, 2008, T ROY SOC TROP MED H, V102, P1133, DOI 10.1016/j.trstmh.2008.04.041; Herrera HM, 2011, T ROY SOC TROP MED H, V105, P380, DOI 10.1016/j.trstmh.2011.04.008; Hirsch BT, 2011, MAMMALIA, V75, P301, DOI 10.1515/MAMM.2011.030; Hirsch BT, 2011, MOL ECOL, V20, P409, DOI 10.1111/j.1365-294X.2010.04940.x; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000300; IBAMA, 2005, PLAN MAN PARQ NAC SE, P1; Jacomo ATDA, 2004, J ZOOL, V262, P99; Jansen AM, 2010, ELSEV INSIGHT, P249, DOI 10.1016/B978-0-12-384876-5.00011-3; Jean Desbiez Arnaud Leonard, 2010, Small Carnivore Conservation, V42, P14; Desbiez ALJ, 2010, BIOTROPICA, V42, P372, DOI 10.1111/j.1744-7429.2009.00601.x; Jombart T, 2010, BIOINFORMATICS, V26, P1907, DOI 10.1093/bioinformatics/btq292; LAINSON R, 1979, T ROY SOC TROP MED H, V73, P193, DOI 10.1016/0035-9203(79)90211-6; Lemos F.G., 2011, MIDDLE SIZED CARNIVO, P143; Letnic M, 2012, BIOL REV, V87, P390, DOI 10.1111/j.1469-185X.2011.00203.x; Lewis MD, 2009, AM J TROP MED HYG, V81, P1041, DOI 10.4269/ajtmh.2009.09-0305; Lisboa CV, 2009, VET PARASITOL, V165, P19, DOI 10.1016/j.vetpar.2009.07.002; Machado EMM, 2001, AM J TROP MED HYG, V65, P958, DOI 10.4269/ajtmh.2001.65.958; Marcili A, 2009, PARASITOLOGY, V136, P641, DOI 10.1017/S0031182009005861; Martinelli M. M., 2010, NATUREZA LINE, V8, P150; Martins R, 2008, REV BRAS ZOOL, V25, P427, DOI 10.1590/S0101-81752008000300007; Mazza S, 1940, MISION ESTUD PATOL R, V45, P119; Mendes PC, 2008, HYGEIA REV BRAS GEO, V3, P176; MILES MA, 1981, T ROY SOC TROP MED H, V75, P667, DOI 10.1016/0035-9203(81)90145-0; MORAN PAP, 1948, J ROY STAT SOC B, V10, P243; Mortara Renato A., 2008, V47, P101; NEGHME A, 1962, AN C INT DOENCA CHAG, V3, P1069; Noireau F, 2009, VET RES, V40, DOI 10.1051/vetres/2009009; Nowak R. M., 2005, WALKERS CARNIVORES W; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Patz JA, 2000, INT J PARASITOL, V30, P1395, DOI 10.1016/S0020-7519(00)00141-7; Perez E, 2013, INFECT GENET EVOL, V13, P116, DOI 10.1016/j.meegid.2012.09.014; PIETROKOVSKY SM, 1991, J PARASITOL, V77, P643, DOI 10.2307/3283177; Queirolo D, 2007, ACTA THERIOL, V52, P391, DOI 10.1007/BF03194237; Rademaker V, 2009, ACTA TROP, V111, P102, DOI 10.1016/j.actatropica.2009.02.006; Rocha FL, 2013, PARASITOLOGY, V140, P160, DOI 10.1017/S0031182012001539; Roellig DM, 2010, PARASITOLOGY, V137, P959, DOI 10.1017/S0031182009991995; Roellig DM, 2009, INT J PARASITOL, V39, P1603, DOI 10.1016/j.ijpara.2009.06.007; Roellig DM, 2009, J PARASITOL, V95, P360, DOI 10.1645/GE-1740.1; Roque ALR, 2008, AM J TROP MED HYG, V79, P742, DOI 10.4269/ajtmh.2008.79.742; Rozas M, 2007, AM J TROP MED HYG, V77, P647, DOI 10.4269/ajtmh.2007.77.647; Rozas M, 2007, J INFECT DIS, V195, P1381, DOI 10.1086/513440; Sano EE, 2010, ENVIRON MONIT ASSESS, V166, P113, DOI 10.1007/s10661-009-0988-4; Shikanai-Yasuda MA, 2012, CLIN INFECT DIS, V54, P845, DOI 10.1093/cid/cir956; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Thioulouse J, 1995, ENVIRON ECOL STAT, V2, P1, DOI 10.1007/BF00452928; Thomas ME, 2007, MEM I OSWALDO CRUZ, V102, P559, DOI 10.1590/S0074-02762007005000068; Tibayrenc M, 2010, ADV EXP MED BIOL, V673, P200; Toso A, 2011, REV MED CHILE, V139, P258, DOI /S0034-98872011000200017; TRAVI BL, 1994, AM J TROP MED HYG, V50, P557, DOI 10.4269/ajtmh.1994.50.557; Vallejo GA, 1999, ACTA TROP, V72, P203, DOI 10.1016/S0001-706X(98)00085-0; Vynne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028939; Whiting D'Andurain Carlos, 1946, REV CHILENA HIG Y MED PREVENT, V8, P69; WISNIVESKYCOLLI C, 1992, T ROY SOC TROP MED H, V86, P38, DOI 10.1016/0035-9203(92)90433-D; Yoshida N, 2011, TRENDS PARASITOL, V27, P459, DOI 10.1016/j.pt.2011.06.006; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	86	57	60	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67463	10.1371/journal.pone.0067463	http://dx.doi.org/10.1371/journal.pone.0067463			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861767	Green Submitted, Green Published, gold			2022-12-27	WOS:000323350700015
J	Tremmel, DM; Resad, S; Little, CJ; Wesley, CS				Tremmel, Daniel M.; Resad, Sedat; Little, Christopher J.; Wesley, Cedric S.			Notch and PKC Are Involved in Formation of the Lateral Region of the Dorso-Ventral Axis in Drosophila Embryos	PLOS ONE			English	Article							PROTEIN-KINASE-C; TOLL-LIKE RECEPTORS; CELL-FATE; LIGAND ENDOCYTOSIS; DOWN-REGULATION; NUCLEAR ACCESS; CROSS-TALK; GERM-LINE; DELTA; CACTUS	The Notch gene encodes an evolutionarily conserved cell surface receptor that generates regulatory signals based on interactions between neighboring cells. In Drosophila embryos it is normally expressed at a low level due to strong negative regulation. When this negative regulation is abrogated neurogenesis in the ventral region is suppressed, the development of lateral epidermis is severely disrupted, and the dorsal aminoserosa is expanded. Of these phenotypes only the antineurogenic phenotype could be linked to excess canonical Notch signaling. The other phenotypes were linked to high levels of Notch protein expression at the surface of cells in the lateral regions indicating that a non-canonical Notch signaling activity normally functions in these regions. Results of our studies reported here provide evidence. They show that Notch activities are inextricably linked to that of Pkc98E, the homolog of mammalian PKC delta. Notch and Pkc98E up-regulate the levels of the phosphorylated form of I kappa BCactus, a negative regulator of Toll signaling, and Mothers against dpp (MAD), an effector of Dpp signaling. Our data suggest that in the lateral regions of the Drosophila embryos Notch activity, in conjunction with Pkc98E activity, is used to form the slopes of the opposing gradients of Toll and Dpp signaling that specify cell fates along the dorso-ventral axis.	[Wesley, Cedric S.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Wesley, CS (corresponding author), Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.	cswesley@wisc.edu		Tremmel, Daniel/0000-0002-1725-5582	NIH [1 R21 HD062928]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD062928] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The study was supported by NIH 1 R21 HD062928 (to CSW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelsadik A, 2011, HUM IMMUNOL, V72, P1188, DOI 10.1016/j.humimm.2011.08.015; Ahimou F, 2004, J CELL BIOL, V167, P1217, DOI 10.1083/jcb.200407100; Alkon DL, 2007, TRENDS PHARMACOL SCI, V28, P51, DOI 10.1016/j.tips.2006.12.002; ANDERSON KV, 1985, CELL, V42, P779, DOI 10.1016/0092-8674(85)90274-0; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; ASHBURNER M, 2004, DROSOPHHILA LAB HDB, P1409; Baker R, 1996, DEVELOPMENT, V122, P617; Bardin AJ, 2006, DEV CELL, V10, P245, DOI 10.1016/j.devcel.2005.12.017; Bardot B, 2005, EXP CELL RES, V304, P202, DOI 10.1016/j.yexcr.2004.10.030; Bayat V, 2011, CURR OPIN NEUROBIOL, V21, P182, DOI 10.1016/j.conb.2010.08.014; BELVIN MP, 1995, GENE DEV, V9, P783, DOI 10.1101/gad.9.7.783; Ben-Yaacov S, 2001, J CELL BIOL, V152, P1, DOI 10.1083/jcb.152.1.1; Besse F, 2009, GENE DEV, V23, P195, DOI 10.1101/gad.505709; Beverly LJ, 2005, CANCER RES, V65, P7159, DOI 10.1158/0008-5472.CAN-05-1664; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083/jcb.200305112; Brennan K, 1997, GENETICS, V147, P177; Bynagari-Settipalli Yamini S., 2010, Cardiovascular & Hematological Disorders - Drug Targets, V10, P292; CABRERA CV, 1990, DEVELOPMENT, V110, P733; CAMPOSORTEGA JA, 1997, EMBRYONIC DEV DROSOP, P405; Chanut-Delalande H, 2006, PLOS BIOL; Costa RM, 2003, CURR BIOL, V13, P1348, DOI 10.1016/S0960-9822(03)00492-5; Cowden J, 2002, DEVELOPMENT, V129, P1785; Cruz C, 2009, GENETICS, V183, P1005, DOI 10.1534/genetics.109.107748; Dansereau DA, 2002, DEVELOPMENT, V129, P5553, DOI 10.1242/dev.00153; Dasu MR, 2012, CLIN SCI, V122, P203, DOI 10.1042/CS20110357; de Barry J, 2010, EXP GERONTOL, V45, P64, DOI 10.1016/j.exger.2009.10.015; DECELIS JF, 1994, MECH DEVELOP, V46, P109, DOI 10.1016/0925-4773(94)90080-9; Delon I, 2003, MECH DEVELOP, V120, P747, DOI 10.1016/S0925-4773(03)00081-9; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; Fernandez NQ, 2001, DEVELOPMENT, V128, P2963; Fischer DF, 2005, FASEB J, V19, P1451, DOI 10.1096/fj.04-3395.com; FORTINI ME, 1993, NATURE, V365, P555, DOI 10.1038/365555a0; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; GEISLER R, 1992, CELL, V71, P613, DOI 10.1016/0092-8674(92)90595-4; Gho M, 1996, DEVELOPMENT, V122, P1673; GOVIND S, 1993, DEVELOPMENT, V117, P135; Hanke ML, 2011, CLIN SCI, V121, P367, DOI 10.1042/CS20110164; Harlow E., 1999, USING ANTIBODIES LAB; Hayward P, 2005, DEVELOPMENT, V132, P1819, DOI 10.1242/dev.01724; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; Heitzler P, 2010, CURR TOP DEV BIOL, V92, P457, DOI 10.1016/S0070-2153(10)92014-0; Hertzog P, 2008, IMMUNITY, V29, P663, DOI 10.1016/j.immuni.2008.10.006; Ishikura N, 2005, P NATL ACAD SCI USA, V102, P886, DOI 10.1073/pnas.0408612101; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kankel MW, 2007, GENETICS, V177, P2493, DOI 10.1534/genetics.107.080994; KIDD S, 1992, CELL, V71, P623, DOI 10.1016/0092-8674(92)90596-5; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; Koivunen J, 2006, CANCER LETT, V235, P1, DOI 10.1016/j.canlet.2005.03.033; Lall S, 2001, ANNU REV GENET, V35, P407, DOI 10.1146/annurev.genet.35.102401.090832; Langdon T, 2006, DEV DYNAM, V235, P998, DOI 10.1002/dvdy.20735; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; LeComte M, 2006, DEV DYNAM, V235, P411, DOI 10.1002/dvdy.20650; Lee MR, 2008, EXPERT OPIN THER TAR, V12, P535, DOI 10.1517/14728222.12.5.535 ; Lieber T, 2002, GENE DEV, V16, P209, DOI 10.1101/gad.942302; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; Loegering Daniel J, 2011, Enzyme Res, V2011, P537821, DOI 10.4061/2011/537821; Lopez-Schier H, 2001, GENE DEV, V15, P1393, DOI 10.1101/gad.200901; LYMAN D, 1993, P NATL ACAD SCI USA, V90, P10395, DOI 10.1073/pnas.90.21.10395; Major RJ, 2005, DEVELOPMENT, V132, P3823, DOI 10.1242/dev.01957; Mishra-Gorur K, 2002, J CELL BIOL, V159, P313, DOI 10.1083/jcb.200203117; Mok LP, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-6; Morel V, 2000, GENE DEV, V14, P377; Moresco EMY, 2011, CURR BIOL, V21, pR488, DOI 10.1016/j.cub.2011.05.039; Moussian B, 2005, CURR BIOL, V15, pR887, DOI 10.1016/j.cub.2005.10.026; Muir A, 2011, J BIOL CHEM, V286, P41905, DOI 10.1074/jbc.R111.299768; Munger JS, 2011, COLD SPRING HARB PER, V3, P1; Norga KK, 2003, CURR BIOL, V13, P1388, DOI 10.1016/S0960-9822(03)00546-3; O'Connor MB, 2006, DEVELOPMENT, V133, P183; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; Parks AL, 2000, DEVELOPMENT, V127, P1373; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; Pear WS, 2004, CURR OPIN HEMATOL, V11, P426, DOI 10.1097/01.moh.0000143965.90813.70; Poulson DF, 1937, P NATL ACAD SCI USA, V23, P133, DOI 10.1073/pnas.23.3.133; Reach M, 1996, DEV BIOL, V180, P353, DOI 10.1006/dbio.1996.0308; ROSENTHAL A, 1987, EMBO J, V6, P433, DOI 10.1002/j.1460-2075.1987.tb04773.x; Roth S, 2003, PHILOS T ROY SOC B, V358, P1317, DOI 10.1098/rstb.2003.1325; ROTH S, 1991, DEVELOPMENT, V112, P371; Roth S, 2001, CURR BIOL, V11, pR779, DOI 10.1016/S0960-9822(01)00469-9; Sambrook J., 2001, MOL CLONING LAB MANU; Samon JB, 2008, BLOOD, V112, P1813, DOI 10.1182/blood-2008-03-144980; SCHAEFFER E, 1989, CELL, V57, P403, DOI 10.1016/0092-8674(89)90915-X; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Shepherd A, 2010, DEV DYNAM, V239, P1220, DOI 10.1002/dvdy.22262; Shepherd AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008063; Shieh BH, 2002, J BIOCHEM, V132, P523, DOI 10.1093/oxfordjournals.jbchem.a003252; Song XQ, 2007, DEVELOPMENT, V134, P1071, DOI 10.1242/dev.003392; Spector D. L., 1998, CELLS LAB MANUAL; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Suhir H, 2010, CLIN REV ALLERG IMMU, V38, P11, DOI 10.1007/s12016-009-8135-0; Sullivan W, 2000, DROSOPHILA PROTOCOLS, P697; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Takizawa T, 2003, NUCLEIC ACIDS RES, V31, P5723, DOI 10.1093/nar/gkg778; Tien AC, 2009, J CELL BIOL, V184, P621, DOI 10.1083/jcb.200811141; Torres IL, 2003, DEV CELL, V5, P547, DOI 10.1016/S1534-5807(03)00272-7; Umulis D, 2009, DEVELOPMENT, V136, P3715, DOI 10.1242/dev.031534; Vallejo JG, 2011, CLIN SCI, V121, P1, DOI 10.1042/CS20100539; Wang J, 2011, BIRTH DEFECTS RES A, V91, P441, DOI 10.1002/bdra.20785; Wesley CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021876; Wesley CS, 1999, MOL CELL BIOL, V19, P5743; Wesley CS, 2003, MOL CELL BIOL, V23, P5581, DOI 10.1128/MCB.23.16.5581-5593.2003; Wesley CS, 2000, J BIOL CHEM, V275, P9099, DOI 10.1074/jbc.275.13.9099; Wesley CS, 2000, J CELL BIOL, V149, P683, DOI 10.1083/jcb.149.3.683; WHALEN AM, 1993, J CELL BIOL, V123, P523, DOI 10.1083/jcb.123.3.523; Wilkin MB, 2005, MOL MEMBR BIOL, V22, P279, DOI 10.1080/09687860500129778; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096	110	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67789	10.1371/journal.pone.0067789	http://dx.doi.org/10.1371/journal.pone.0067789			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861806	Green Submitted, gold, Green Published			2022-12-27	WOS:000323350700036
J	Vargas-Ortiz, E; Espitia-Rangel, E; Tiessen, A; Delano-Frier, JP				Vargas-Ortiz, Erandi; Espitia-Rangel, Eduardo; Tiessen, Axel; Paul Delano-Frier, John			Grain Amaranths Are Defoliation Tolerant Crop Species Capable of Utilizing Stem and Root Carbohydrate Reserves to Sustain Vegetative and Reproductive Growth after Leaf Loss	PLOS ONE			English	Article							TISSUE-SPECIFIC EXPRESSION; CHENOPODIUM-RUBRUM; BIOMASS ALLOCATION; MECHANICAL INJURY; NICOTIANA-TABACUM; DROUGHT TOLERANCE; SUCROSE SYNTHASE; STARCH SYNTHESIS; PLANT TOLERANCE; POTATO-TUBERS	Tolerance to defoliation can be defined as the degree to which productivity is affected by photosynthetic area reduction. This trait was studied in grain amaranth (Amaranthus cruentus and A. hypochondriacus), which are considered to be a highly defoliation-tolerant species. The physiological and biochemical responses to increasing levels of mechanical leaf removal up to total defoliation were quantified. Tolerance appeared to be dependent on various factors: (i) amount of lost tissue; (ii) mechanics of leaf tissue removal; (iii) environment, and (iv) species tested. Thus, grain amaranth was found to be a highly tolerant species under green-house conditions when leaf tissue loss was performed by gradual perforation. However, tolerance was compromised under similar conditions when defoliation was done by gradual cutting of the leaf. Also tolerance in completely defoliated plants tended to decrease under field conditions, where differences between A. cruentus and A. hypochondriacus were observed. All non-structural carbohydrate (NSC) levels were reduced in stems and roots of totally defoliated amaranths one day after treatment. Such depletion probably provided the carbon (C) resources needed to sustain the early recovery process in the absence of photosynthetic capacity. This was corroborated by shading of intact plants, which produced the same rapid and drastic reduction of NSC levels in these tissues. These results emphasize the role of stored NSCs, particularly starch, in buffering the impact of severe defoliation in amaranth. The fall in sucrose synthase and cell wall invertase activity observed in stems and roots soon after defoliation was consistent with their predicted shift from sink to source tissues. It is concluded that mobilization of C stores in stems and roots, is a physiologically important trait underlying tolerance to defoliation in grain amaranth.	[Vargas-Ortiz, Erandi; Tiessen, Axel; Paul Delano-Frier, John] Ctr Invest & Estudios Avanzados, Unidad Irapuato, Unidad Biotecnol & Ingn Genet Plantas, Guanajuato, Mexico; [Espitia-Rangel, Eduardo] Inst Nacl Invest Forestales Agr & Pecuarias, Guanajuato, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Delano-Frier, JP (corresponding author), Ctr Invest & Estudios Avanzados, Unidad Irapuato, Unidad Biotecnol & Ingn Genet Plantas, Guanajuato, Mexico.	jdelano@ira.cinvestav.mx	Délano-Frier, John/B-5768-2015; Tiessen, Axel/AAF-2113-2020; Tiessen, Axel/D-5959-2011	Tiessen, Axel/0000-0001-5572-4274; Tiessen, Axel/0000-0001-5572-4274; Vargas-Ortiz, Erandi/0000-0002-9784-8248	European Union through the Amaranth-Future Food project [FP6-032263]; Mexico Tierra de Amaranto A. C.; Deborah Presser-Velder Foundation; Consejo Nacional de Ciencia y Tecnologia (CONACYT Mexico); JDF scholarship; CONACYT scholarship [205326]	European Union through the Amaranth-Future Food project; Mexico Tierra de Amaranto A. C.; Deborah Presser-Velder Foundation; Consejo Nacional de Ciencia y Tecnologia (CONACYT Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); JDF scholarship; CONACYT scholarship(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the European Union through the Amaranth-Future Food project (FP6-032263; to JDF). Financial support by Mexico Tierra de Amaranto A. C. and The Deborah Presser-Velder Foundation is also acknowledged. It was also supported by grants from the Consejo Nacional de Ciencia y Tecnologia (CONACYT Mexico) to AT and JDF and CONACYT scholarships to EVO (No. 205326). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2000, TRENDS PLANT SCI, V5, P309, DOI 10.1016/S1360-1385(00)01679-4; Akiyama R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030015; Akubugwo IE, 2007, AFR J BIOTECHNOL, V6, P2833; ANDERSEN RA, 1969, PHYTOCHEMISTRY, V8, P2139, DOI 10.1016/S0031-9422(00)88172-8; Castrillon-Arbelaez PA, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-163; Huerta-Ocampo JA, 2011, CURR NUTR FOOD SCI, V7, P1, DOI 10.2174/157340111794941076; [Anonymous], GLOB BIOGEOCHEM CYCL; Araus JL, 2008, CRIT REV PLANT SCI, V27, P377, DOI 10.1080/07352680802467736; BERNFELD P, 1955, METHOD ENZYMOL, V1, P149, DOI 10.1016/0076-6879(55)01021-5; Bilgin DD, 2010, PLANT CELL ENVIRON, V33, P1597, DOI 10.1111/j.1365-3040.2010.02167.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brenner D. M., 2000, Plant Breeding Reviews, V19, P227, DOI 10.1002/9780470650172.ch7; Cabrera-Bosquet L, 2012, J INTEGR PLANT BIOL, V54, P312, DOI 10.1111/j.1744-7909.2012.01116.x; Delaney KJ, 2008, PLANT ECOL, V199, P187, DOI 10.1007/s11258-008-9423-0; Delano-Frier JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-363; Delano-Frier JP, 2004, J CHEM ECOL, V30, P1001, DOI 10.1023/B:JOEC.0000028464.36353.bb; Delano- Frier JP, 2012, ARTIFICIAL PHOTOSYNT, P155; Fang XW, 2008, ECOL RES, V23, P863, DOI 10.1007/s11284-007-0449-x; Fornoni J, 2011, FUNCT ECOL, V25, P399, DOI 10.1111/j.1365-2435.2010.01805.x; Gassmann AJ, 2004, J ECOL, V92, P882, DOI 10.1111/j.0022-0477.2004.00920.x; Geigenberger P, 1998, PLANTA, V205, P428, DOI 10.1007/s004250050340; GODT DE, 1995, J PLANT PHYSIOL, V146, P231, DOI 10.1016/S0176-1617(11)82046-8; HELMS TC, 1994, CAN J PLANT SCI, V74, P699, DOI 10.4141/cjps94-126; Herbers K, 1998, CURR OPIN PLANT BIOL, V1, P207, DOI 10.1016/S1369-5266(98)80106-4; Hernandez-Casillas J.M., 2010, CONSERVACION USO REC; Hikosaka K, 2005, ANN BOT-LONDON, V95, P1025, DOI 10.1093/aob/mci111; Hikosaka K, 2005, ANN BOT-LONDON, V95, P521, DOI 10.1093/aob/mci050; HILL RM, 1982, J AGR FOOD CHEM, V30, P465, DOI 10.1021/jf00111a014; Hochwender CG, 2012, OECOLOGIA, V169, P49, DOI 10.1007/s00442-011-2176-9; Ida TY, 2012, ANN BOT-LONDON, V109, P237, DOI 10.1093/aob/mcr273; Kaplan I, 2008, ECOLOGY, V89, P392, DOI 10.1890/07-0471.1; Kaplan I, 2008, ECOL LETT, V11, P841, DOI 10.1111/j.1461-0248.2008.01200.x; Kosola KR, 2001, OECOLOGIA, V129, P65, DOI 10.1007/s004420100694; Lee JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012306; Li WH, 2012, WEED BIOL MANAG, V12, P40, DOI 10.1111/j.1445-6664.2012.00432.x; Marshall DL, 2005, ANN BOT-LONDON, V95, P1049, DOI 10.1093/aob/mci116; McCormick AJ, 2008, ANN BOT-LONDON, V101, P89, DOI 10.1093/aob/mcm258; Mir RR, 2012, THEOR APPL GENET, V125, P625, DOI 10.1007/s00122-012-1904-9; Monneveux P, 2008, J AGR SCI-CAMBRIDGE, V146, P287, DOI 10.1017/S0021859608007818; Moreira X, 2012, J ECOL, V100, P810, DOI 10.1111/j.1365-2745.2011.01938.x; Moreno DM, 1999, GENET RESOUR CROP EV, V46, P225, DOI 10.1023/A:1008605531633; Myers JA, 2007, J ECOL, V95, P383, DOI 10.1111/j.1365-2745.2006.01207.x; NELSON ND, 1984, CAN J FOREST RES, V14, P924, DOI 10.1139/x84-164; Nielsen TH, 1997, PLANT PHYSIOL, V113, P503, DOI 10.1104/pp.113.2.503; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; Orians CM, 2011, OECOLOGIA, V167, P1, DOI 10.1007/s00442-011-1968-2; Papakosta, 2006, P NAT SCI MATICA SRP, V110, P123; PATTERSON DT, 1977, PLANT PHYSIOL, V59, P384, DOI 10.1104/pp.59.3.384; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rivera-Solis G, 2012, PLANT ECOL, V213, P303, DOI 10.1007/s11258-011-9977-0; ROITSCH T, 1995, PLANT PHYSIOL, V108, P285, DOI 10.1104/pp.108.1.285; SAEBO A, 1995, PLANT CELL TISS ORG, V41, P177, DOI 10.1007/BF00051588; SEGURANIETO M, 1992, J AGR FOOD CHEM, V40, P1553, DOI 10.1021/jf00021a016; Shukla S, 2006, PLANT FOOD HUM NUTR, V61, P23, DOI 10.1007/s11130-006-0004-x; Silla F, 2008, TREES-STRUCT FUNCT, V22, P785, DOI 10.1007/s00468-008-0239-2; Silva-Sanchez C, 2008, J AGR FOOD CHEM, V56, P1233, DOI 10.1021/jf072911z; Stevens MT, 2008, FUNCT ECOL, V22, P40, DOI 10.1111/j.1365-2435.2007.01356.x; Stowe KA, 2000, ANNU REV ECOL SYST, V31, P565, DOI 10.1146/annurev.ecolsys.31.1.565; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Suwa T, 2008, AM J BOT, V95, P434, DOI 10.3732/ajb.95.4.434; Synkova H, 2006, PLANT SCI, V171, P607, DOI 10.1016/j.plantsci.2006.06.002; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; Tang JY, 2006, J EXP BOT, V57, P527, DOI 10.1093/jxb/erj032; Taylor JRN, 2002, PSEUDOCEREALS AND LESS COMMON CEREALS, P25; Tiessen A, 2002, PLANT CELL, V14, P2191, DOI 10.1105/tpc.003640; Tiffin P, 2000, EVOL ECOL, V14, P523, DOI 10.1023/A:1010881317261; Umashankara KB, 2007, THESIS U AGR SCI DHA; WANG F, 1993, PLANT PHYSIOL, V101, P321, DOI 10.1104/pp.101.1.321; WEAVER SE, 1980, CAN J PLANT SCI, V60, P1215, DOI 10.4141/cjps80-175; WELTER SC, 1991, ENVIRON ENTOMOL, V20, P1537, DOI 10.1093/ee/20.6.1537; Wright DP, 1998, PLANT CELL ENVIRON, V21, P209, DOI 10.1046/j.1365-3040.1998.00280.x; Wyka T, 2000, ARCT ANTARCT ALP RES, V32, P438, DOI 10.2307/1552393; Zeller SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011405; [No title captured]	74	25	26	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67879	10.1371/journal.pone.0067879	http://dx.doi.org/10.1371/journal.pone.0067879			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861825	gold, Green Published, Green Submitted			2022-12-27	WOS:000323350700053
J	Viscidi, EW; Triche, EW; Pescosolido, MF; McLean, RL; Joseph, RM; Spence, SJ; Morrow, EM				Viscidi, Emma W.; Triche, Elizabeth W.; Pescosolido, Matthew F.; McLean, Rebecca L.; Joseph, Robert M.; Spence, Sarah J.; Morrow, Eric M.			Clinical Characteristics of Children with Autism Spectrum Disorder and Co-Occurring Epilepsy	PLOS ONE			English	Article							UNITED-STATES; PREVALENCE; RESOURCE; SEIZURES; ABNORMALITIES; EPIDEMIOLOGY; DISABILITIES; INDIVIDUALS; REGRESSION; DIAGNOSIS	Objectives: To estimate the prevalence of epilepsy in children with Autism Spectrum Disorder (ASD) and to determine the demographic and clinical characteristics of children with ASD and epilepsy in a large patient population. Methods: Cross-sectional study using four samples of children with ASD for a total of 5,815 participants with ASD. The prevalence of epilepsy was estimated from a population-based sample. Children with and without epilepsy were compared on demographic and clinical characteristics. Multivariate logistic regression was used to examine the association between demographic and clinical characteristics and epilepsy. Results: The average prevalence of epilepsy in children with ASD 2-17 years was 12.5%; among children aged 13 years and older, 26% had epilepsy. Epilepsy was associated with older age, lower cognitive ability, poorer adaptive and language functioning, a history of developmental regression and more severe ASD symptoms. The association between epilepsy and the majority of these characteristics appears to be driven by the lower IQ of participants with epilepsy. In a multivariate regression model, only age and cognitive ability were independently associated with epilepsy. Children age 10 or older had 2.35 times the odds of being diagnosed with epilepsy (p <.001) and for a one standard deviation increase in IQ, the odds of having epilepsy decreased by 47% (p <.001). Conclusion: This is among the largest studies to date of patients with ASD and co-occurring epilepsy. Based on a representative sample of children with ASD, the average prevalence of epilepsy is approximately 12% and reaches 26% by adolescence. Independent associations were found between epilepsy and older age and lower cognitive ability. Other risk factors, such as poor language and developmental regression, are not associated with epilepsy after controlling for IQ. These findings can help guide prognosis and alert clinicians to patients with ASD who are at increased risk for epilepsy.	[Viscidi, Emma W.; Triche, Elizabeth W.] Brown Univ, Div Biol & Med, Dept Epidemiol, Providence, RI 02912 USA; [Viscidi, Emma W.; Pescosolido, Matthew F.; Morrow, Eric M.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Mol Med Lab, Providence, RI 02912 USA; [Viscidi, Emma W.; Pescosolido, Matthew F.; Morrow, Eric M.] Brown Univ, Inst Brain Sci, Mol Med Lab, Providence, RI 02912 USA; [Pescosolido, Matthew F.; McLean, Rebecca L.; Morrow, Eric M.] Brown Univ, Sch Med, Dev Disorders Genet Res Program, Emma Pendleton Bradley Hosp, Providence, RI 02912 USA; [Pescosolido, Matthew F.; McLean, Rebecca L.; Morrow, Eric M.] Brown Univ, Sch Med, Dept Psychiat & Human Behav, Providence, RI 02912 USA; [McLean, Rebecca L.] Brown Univ, Mem Hosp Rhode Isl, Neurodev Ctr, Dept Pediat,Med Sch, Pawtucket, RI 02860 USA; [Joseph, Robert M.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Joseph, Robert M.; Spence, Sarah J.; Morrow, Eric M.] Autism Consortium, Boston, MA USA; [Spence, Sarah J.] Harvard Univ, Sch Med, Dept Neurol, Boston Childrens Hosp, Boston, MA 02115 USA	Brown University; Brown University; Brown University; Brown University; Brown University; Brown University; Boston University; Harvard University; Boston Children's Hospital; Harvard Medical School	Morrow, EM (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Mol Med Lab, Providence, RI 02912 USA.	eric_morrow@brown.edu	Triche, Elizabeth/I-4986-2014; Morrow, Eric/J-2767-2013	Morrow, Eric/0000-0003-3430-3520; Joseph, Robert/0000-0001-6879-0254; Pescosolido, Matthew/0000-0002-5994-0123	NIMH [1K23MH080954-05]; Career Award in Medical Science from the Burroughs Wellcome Fund; T32 pre-doctoral training grant [5T32MH019927-18]; Brown University Institute for Brain Science pre-doctoral funding; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019927, K23MH080954, U24MH081810] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Career Award in Medical Science from the Burroughs Wellcome Fund; T32 pre-doctoral training grant; Brown University Institute for Brain Science pre-doctoral funding; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	EMM has received support from NIMH, 1K23MH080954-05, and a Career Award in Medical Science from the Burroughs Wellcome Fund. EWV has received support from a T32 pre-doctoral training grant, 5T32MH019927-18, and Brown University Institute for Brain Science pre-doctoral funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiet C, 2008, BIOL PSYCHIAT, V64, P577, DOI 10.1016/j.biopsych.2008.04.030; [Anonymous], 1993, EPILEPSIA, V34, P592; APA, 2000, DIAGNOSTIC STAT MANU; Baio Jon, 2012, Morbidity and Mortality Weekly Report, V61, P1; Berg AT, 2012, EPILEPSY BEHAV, V23, P193, DOI 10.1016/j.yebeh.2012.01.015; Blumberg S.J., 2009, VITAL HLTH STAT, V1; Boltor PF, 2011, BRIT J PSYCHIAT, V198, P289, DOI 10.1192/bjp.bp.109.076877; Canitano R, 2005, J CHILD NEUROL, V20, P27, DOI 10.1177/08830738050200010401; Canitano R, 2007, EUR CHILD ADOLES PSY, V16, P61, DOI 10.1007/s00787-006-0563-2; Cuccaro ML, 2011, J AUTISM DEV DISORD; Danielsson S, 2005, EPILEPSIA, V46, P918, DOI 10.1111/j.1528-1167.2005.57504.x; Deonna T, 2006, EPILEPSIA, V47, P79, DOI 10.1111/j.1528-1167.2006.00697.x; DEYKIN EY, 1979, AM J PSYCHIAT, V136, P1310; Dunn L.M., 1981, PEABODY PICTURE VOCA; ELLENBERG JH, 1984, ANN NEUROL, V15, P127, DOI 10.1002/ana.410150204; Elliott C, 2007, DIFFERENTIAL ABILITY; FARAONE SV, 1995, J AM ACAD CHILD PSY, V34, P1001, DOI 10.1097/00004583-199508000-00009; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Forsgren L, 2005, EUR J NEUROL, V12, P245, DOI 10.1111/j.1468-1331.2004.00992.x; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Gotham K, 2009, J AUTISM DEV DISORD, V39, P693, DOI 10.1007/s10803-008-0674-3; Hara H, 2007, BRAIN DEV-JPN, V29, P486, DOI 10.1016/j.braindev.2006.12.012; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; HAUSER WA, 1994, EPILEPSIA, V35, pS1, DOI 10.1111/j.1528-1157.1994.tb05932.x; Hishinuma ES, 2000, ASSESSMENT, V7, P17, DOI 10.1177/107319110000700102; Hrdlicka M, 2004, EUR CHILD ADOLES PSY, V13, P209, DOI 10.1007/s00787-004-0353-7; Kielinen M, 2004, AUTISM, V8, P49, DOI 10.1177/1362361304040638; Kogan MD, 2009, PEDIATRICS, V124, P1395, DOI 10.1542/peds.2009-1522; Lajonchere CM, 2010, NEURON, V68, P187, DOI 10.1016/j.neuron.2010.10.009; Levy SE, 2010, J DEV BEHAV PEDIATR, V31, P267, DOI 10.1097/DBP.0b013e3181d5d03b; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Maski KP, 2011, CURR OPIN PEDIATR, V23, P609, DOI 10.1097/MOP.0b013e32834c9282; Mouridsen SE, 1999, DEV MED CHILD NEUROL, V41, P110, DOI 10.1017/S0012162299000213; Mullen E. M, 1995, MULLEN SCALES EARLY; Neale BM, 2012, NATURE; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; O'Roak B.J., 2012, NATURE; OLSSON I, 1988, ARCH NEUROL-CHICAGO, V45, P666, DOI 10.1001/archneur.1988.00520300086024; Pavone P, 2004, NEUROPEDIATRICS, V35, P207, DOI 10.1055/s-2004-821079; Pickett J, 2011, J CHILD NEUROL, V26, P932, DOI 10.1177/0883073811402203; Rapin I, 1998, ANN NEUROL, V43, P7, DOI 10.1002/ana.410430106; Risi S, 2006, J AM ACAD CHILD PSY, V45, P1094, DOI 10.1097/01.chi.0000227880.42780.0e; Roid GH., 2003, STANFORD BINET INTEL, V5th; ROSSI PG, 1995, BRAIN DEV-JPN, V17, P169, DOI 10.1016/0387-7604(95)00019-8; Rutter M, 2003, ADI R AUTISM DIAGNOS, V60; Schieve L. A., 2006, Morbidity and Mortality Weekly Report, V55, P481; Simons, 2010, SFARI BAS SSC RES WE; Sparrow S. S., 2005, VINELAND ADAPTIVE BE, V2nd, DOI [10.1037/t15164-000, DOI 10.1037/T15164-000]; Spence SJ, 2009, PEDIATR RES, V65, P599, DOI 10.1203/PDR.0b013e31819e7168; Tuchman R, 2002, LANCET NEUROL, V1, P352, DOI 10.1016/S1474-4422(02)00160-6; TUCHMAN RF, 1991, PEDIATRICS, V88, P1219; Tuchman R, 2011, CURR NEUROL NEUROSCI, V11, P428, DOI 10.1007/s11910-011-0195-x; Tuchman R, 2010, BRAIN DEV-JPN, V32, P709, DOI 10.1016/j.braindev.2010.04.008; Turk J, 2009, ACTA PAEDIATR, V98, P675, DOI 10.1111/j.1651-2227.2008.01184.x; U.S. Department of Health and Human Services MaCHB, 2009, HLTH WELL BEING CHIL; Van Eeghen AM, 2013, DEV MED CHILD NEUROL, V55, P146, DOI 10.1111/dmcn.12044; Veeramah KR, 2012, AM J HUM GENET, V90, P502, DOI 10.1016/j.ajhg.2012.01.006; VOLKMAR FR, 1990, J AM ACAD CHILD PSY, V29, P127, DOI 10.1097/00004583-199001000-00020; Wechsler D., 1967, WPPSI MANUAL WECHSLE; Wechsler D., 2011, WASI 2 WECHSLER ABBR; WONG V, 1993, J CHILD NEUROL, V8, P316, DOI 10.1177/088307389300800405	61	133	136	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67797	10.1371/journal.pone.0067797	http://dx.doi.org/10.1371/journal.pone.0067797			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861807	Green Published, Green Submitted, gold			2022-12-27	WOS:000323350700037
J	Hassounah, NB; Nagle, R; Saboda, K; Roe, DJ; Dalkin, BL; McDermott, KM				Hassounah, Nadia B.; Nagle, Ray; Saboda, Kathylynn; Roe, Denise J.; Dalkin, Bruce L.; McDermott, Kimberly M.			Primary Cilia Are Lost in Preinvasive and Invasive Prostate Cancer	PLOS ONE			English	Article							BETA-CATENIN EXPRESSION; E-CADHERIN; INTRAEPITHELIAL NEOPLASIA; ALPHA-CATENIN; INHIBITION; CARCINOMA; DISEASE; PROTEIN; LESIONS; CELLS	Prostate cancer is the second most commonly diagnosed cancer in men worldwide. Little is known about the role of primary cilia in preinvasive and invasive prostate cancer. However, reduced cilia expression has been observed in human cancers including pancreatic cancer, renal cell carcinoma, breast cancer, cholangiocarcinoma, and melanoma. The aim of this study was to characterize primary cilia expression in preinvasive and invasive human prostate cancer, and to investigate the correlation between primary cilia and the Wnt signaling pathway. Human prostate tissues representative of stages of prostate cancer formation (normal prostate, prostatic intraepithelial neoplasia (PIN), and invasive prostate cancer (including perineural invasion)) were stained for ciliary proteins. The frequency of primary cilia was determined. A decrease in the percentage of ciliated cells in PIN, invasive cancer and perineural invasion lesions was observed when compared to normal. Cilia lengths were also measured to indirectly test functionality. Cilia were shorter in PIN, cancer, and perineural invasion lesions, suggesting dysfunction. Primary cilia have been shown to suppress the Wnt pathway. Increased Wnt signaling has been implicated in prostate cancer. Therefore, we investigated a correlation between loss of primary cilia and increased Wnt signaling in normal prostate and in preinvasive and invasive prostate cancer. To investigate Wnt signaling in our cohort, serial tissue sections were stained for beta-catenin as a measure of Wnt signaling. Nuclear beta-catenin was analyzed and Wnt signaling was found to be higher in un-ciliated cells in the normal prostate, PIN, a subset of invasive cancers, and perineural invasion. Our results suggest that cilia normally function to suppress the Wnt signaling pathway in epithelial cells and that cilia loss may play a role in increased Wnt signaling in some prostate cancers. These results suggest that cilia are dysfunctional in human prostate cancer, and increase Wnt signaling occurs in a subset of cancers.	[Hassounah, Nadia B.; Saboda, Kathylynn; Roe, Denise J.; McDermott, Kimberly M.] Univ Arizona, Ctr Canc, Tucson, AZ 85721 USA; [Nagle, Ray; McDermott, Kimberly M.] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ USA; [McDermott, Kimberly M.] Univ Arizona, Inst Bio5, Tucson, AZ USA; [Dalkin, Bruce L.] Univ Washington, Dept Urol, Seattle, WA 98195 USA	University of Arizona; University of Arizona; University of Arizona; University of Washington; University of Washington Seattle	McDermott, KM (corresponding author), Univ Arizona, Ctr Canc, Tucson, AZ 85721 USA.	kmcdermott@azcc.arizona.edu			Science Foundation of Arizona; Cancer Biology Training Grant (NIH) [T32CA009213]; University of Arizona Cancer Center Support Grant (NIH) [P30CA023074]; R00 (NIH-NICHD) [R00HD056965]; Better than Ever Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R00HD056965] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009213, P30CA023074] Funding Source: NIH RePORTER	Science Foundation of Arizona; Cancer Biology Training Grant (NIH); University of Arizona Cancer Center Support Grant (NIH); R00 (NIH-NICHD); Better than Ever Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Science Foundation of Arizona (http://www.sfaz.org), the Cancer Biology Training Grant (NIH; T32CA009213), the University of Arizona Cancer Center Support Grant (NIH; P30CA023074), an R00 (NIH-NICHD; R00HD056965); and the Better than Ever Foundation (http://azcc.arizona.edu/outreach/bte). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltomaa S, 2005, ANTICANCER RES, V25, P4707; Arenas MI, 2000, HISTOCHEM J, V32, P659, DOI 10.1023/A:1004111331752; Assikis VJ, 2004, CLIN CANCER RES, V10, P6770, DOI 10.1158/1078-0432.CCR-04-0275; Bismar TA, 2004, AM J CLIN PATHOL, V121, P557, DOI 10.1309/447049GV52H7D258; BN R, 2013, CANC RES; Buschhorn HM, 2005, PROSTATE, V64, P341, DOI 10.1002/pros.20247; Chai H, 2009, ANN CLIN LAB SCI, V39, P331; Chen GP, 2004, CANCER-AM CANCER SOC, V101, P1345, DOI 10.1002/cncr.20518; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; de Medina SGD, 1998, HUM PATHOL, V29, P1005, DOI 10.1016/S0046-8177(98)90208-8; Egeberg Dorte L, 2012, Cilia, V1, P15, DOI 10.1186/2046-2530-1-15; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Freedland SJ, 2005, JAMA-J AM MED ASSOC, V294, P433, DOI 10.1001/jama.294.4.433; Goeman L, 2003, PROSTATE CANCER P D, V6, P305, DOI 10.1038/sj.pcan.4500681; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Han YG, 2009, NAT MED, V15, P1062, DOI 10.1038/nm.2020; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hassounah NB, 2012, CLIN CANCER RES, V18, P2429, DOI 10.1158/1078-0432.CCR-11-0755; Horvath LG, 2005, INT J CANCER, V113, P415, DOI 10.1002/ijc.20599; Jaggi M, 2005, UROL ONCOL-SEMIN ORI, V23, P402, DOI 10.1016/j.urolonc.2005.03.024; Kapoor A, 2012, CAN J UROL, V19, P10; Karlou M, 2012, PROSTATE, V72, P1638, DOI 10.1002/pros.22517; Kim J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027410; Lancaster MA, 2011, NAT CELL BIOL, V13, P700, DOI 10.1038/ncb2259; Lancaster MA, 2009, CURR OPIN GENET DEV, V19, P220, DOI 10.1016/j.gde.2009.04.008; Long RM, 2005, CLIN SCI, V108, P1, DOI 10.1042/CS20040241; Morgan TM, 2009, CLIN CANCER RES, V15, P677, DOI 10.1158/1078-0432.CCR-08-1754; Morita N, 1999, BRIT J CANCER, V79, P1879, DOI 10.1038/sj.bjc.6690299; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; OHTSUKI Y, 1979, Japanese Journal of Clinical Electron Microscopy, V12, P81; Pan JM, 2007, CELL, V129, P1255, DOI 10.1016/j.cell.2007.06.018; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Sakai I, 2004, UROL ONCOL, V4, P27; Schmidt LJ, 2007, PROSTATE, V67, P1111, DOI 10.1002/pros.20602; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schraml P, 2009, MODERN PATHOL, V22, P31, DOI 10.1038/modpathol.2008.132; Seeley ES, 2009, CANCER RES, V69, P422, DOI 10.1158/0008-5472.CAN-08-1290; THEISS M, 1995, PROSTATE, V27, P13, DOI 10.1002/pros.2990270104; van Leenders GJLH, 2001, J PATHOL, V195, P563, DOI 10.1002/path.993; VERHAGEN APM, 1992, CANCER RES, V52, P6182; Whitaker HC, 2008, PROSTATE, V68, P1196, DOI 10.1002/pros.20780; Willemarck N, 2010, CANCER RES, V70, P9453, DOI 10.1158/0008-5472.CAN-10-2324; Wong SY, 2009, NAT MED, V15, P1055, DOI 10.1038/nm.2011; Yuan K, 2010, J HISTOCHEM CYTOCHEM, V58, P857, DOI 10.1369/jhc.2010.955856; Zhang JX, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-50	45	86	88	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68521	10.1371/journal.pone.0068521	http://dx.doi.org/10.1371/journal.pone.0068521			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844214	gold, Green Published, Green Submitted			2022-12-27	WOS:000321341000168
J	Nosworthy, N; Bugden, S; Archibald, L; Evans, B; Ansari, D				Nosworthy, Nadia; Bugden, Stephanie; Archibald, Lisa; Evans, Barrie; Ansari, Daniel			A Two-Minute Paper-and-Pencil Test of Symbolic and Nonsymbolic Numerical Magnitude Processing Explains Variability in Primary School Children's Arithmetic Competence	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; WORKING-MEMORY; PHONOLOGICAL AWARENESS; SKILLS; DISABILITIES; READINESS; JUDGMENTS; NUMBERS	Recently, there has been a growing emphasis on basic number processing competencies (such as the ability to judge which of two numbers is larger) and their role in predicting individual differences in school-relevant math achievement. Children's ability to compare both symbolic (e.g. Arabic numerals) and nonsymbolic (e.g. dot arrays) magnitudes has been found to correlate with their math achievement. The available evidence, however, has focused on computerized paradigms, which may not always be suitable for universal, quick application in the classroom. Furthermore, it is currently unclear whether both symbolic and nonsymbolic magnitude comparison are related to children's performance on tests of arithmetic competence and whether either of these factors relate to arithmetic achievement over and above other factors such as working memory and reading ability. In order to address these outstanding issues, we designed a quick (2 minute) paper-and- pencil tool to assess children's ability to compare symbolic and nonsymbolic numerical magnitudes and assessed the degree to which performance on this measure explains individual differences in achievement. Children were required to cross out the larger of two, single-digit numerical magnitudes under time constraints. Results from a group of 160 children from grades 1-3 revealed that both symbolic and nonsymbolic number comparison accuracy were related to individual differences in arithmetic achievement. However, only symbolic number comparison performance accounted for unique variance in arithmetic achievement. The theoretical and practical implications of these findings are discussed which include the use of this measure as a possible tool for identifying students at risk for future difficulties in mathematics.	[Nosworthy, Nadia; Bugden, Stephanie; Ansari, Daniel] Univ Western Ontario, Dept Psychol, Numer Cognit Lab, London, ON, Canada; [Archibald, Lisa] Univ Western Ontario, Dept Psychol, Sch Commun Sci & Disorders, London, ON, Canada; [Evans, Barrie] Thames Valley Dist Sch Board, Psychol Serv, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Ansari, D (corresponding author), Univ Western Ontario, Dept Psychol, Numer Cognit Lab, London, ON, Canada.	daniel.ansari@uwo.ca	Nosworthy, Nadia/AAR-1757-2021; Ansari, Daniel/B-2832-2009	Ansari, Daniel/0000-0002-7625-618X	Natural Sciences and Engineering Research Council of Canada (NSERC); The Canadian Institutes for Health Research (CIHR)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); The Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was funded by Operating grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) (http://www.nserc-crsng.gc.ca/index_eng.asp) and The Canadian Institutes for Health Research (CIHR) (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloway T.P., 2007, AUTOMATED WORKING ME; Berg DH, 2008, J EXP CHILD PSYCHOL, V99, P288, DOI 10.1016/j.jecp.2007.12.002; Brannon EM, 2006, CURR OPIN NEUROBIOL, V16, P222, DOI 10.1016/j.conb.2006.03.002; BUCKLEY PB, 1974, J EXP PSYCHOL, V103, P1131, DOI 10.1037/h0037361; Bugden S, 2011, COGNITION, V118, P32, DOI 10.1016/j.cognition.2010.09.005; Chard DJ, 2005, ASSES EFF INTERV, V30, P3, DOI 10.1177/073724770503000202; Cordes S, 2001, PSYCHON B REV, V8, P698, DOI 10.3758/BF03196206; De Smedt B, 2011, J EXP CHILD PSYCHOL, V108, P278, DOI 10.1016/j.jecp.2010.09.003; De Smedt B, 2010, DEVELOPMENTAL SCI, V13, P508, DOI 10.1111/j.1467-7687.2009.00897.x; De Smedt B, 2009, J EXP CHILD PSYCHOL, V103, P469, DOI 10.1016/j.jecp.2009.01.010; DEHAENE S, 1992, COGNITION, V44, P1, DOI 10.1016/0010-0277(92)90049-N; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; DeStefano D, 2004, EUR J COGN PSYCHOL, V16, P353, DOI 10.1080/09541440244000328; Duncan GJ, 2007, DEV PSYCHOL, V43, P1428, DOI 10.1037/0012-1649.43.6.1428; Durand M, 2005, J EXP CHILD PSYCHOL, V91, P113, DOI 10.1016/j.jecp.2005.01.003; GEARY DC, 1993, PSYCHOL BULL, V114, P345, DOI 10.1037/0033-2909.114.2.345; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Holloway ID, 2009, J EXP CHILD PSYCHOL, V103, P17, DOI 10.1016/j.jecp.2008.04.001; Kalaman DA, 2007, EUR J COGN PSYCHOL, V19, P187, DOI 10.1080/09541440600713445; Koponen T, 2007, J EXP CHILD PSYCHOL, V97, P220, DOI 10.1016/j.jecp.2007.03.001; Mazzocco MMM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023749; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P320, DOI 10.1037/0097-7403.9.3.320; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; Okamoto Y, 1996, MONOGR SOC RES CHILD, V61, P27, DOI 10.1111/j.1540-5834.1996.tb00536.x; Parsons S., 2005, DOES NUMERACY MATTER; Romano E, 2010, DEV PSYCHOL, V46, P995, DOI 10.1037/a0018880; Rousselle L, 2007, COGNITION, V102, P361, DOI 10.1016/j.cognition.2006.01.005; SEKULER R, 1977, CHILD DEV, V48, P630, DOI 10.1111/j.1467-8624.1977.tb01208.x; STANOVICH KE, 1984, J EXP CHILD PSYCHOL, V38, P175, DOI 10.1016/0022-0965(84)90120-6; STARKEY P, 1980, SCIENCE, V210, P1033, DOI 10.1126/science.7434014; VELLUTINO FR, 1987, MERRILL PALMER QUART, V33, P321; Wechsler D., 2011, WASI 2 WECHSLER ABBR; WILLIAMS JP, 1984, J LEARN DISABIL, V17, P240, DOI 10.1177/002221948401700413; Woodcock R. W., 2001, WOODCOCK JOHNSON 3 T; WYNN K, 1992, NATURE, V358, P749, DOI 10.1038/358749a0; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9; Zorzi M, 1999, 21 ANN C COGN SCI SO	37	92	94	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67918	10.1371/journal.pone.0067918	http://dx.doi.org/10.1371/journal.pone.0067918			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	176XV	23844126	Green Published, gold			2022-12-27	WOS:000321341000119
J	Sims-Robinson, C; Hur, J; Hayes, JM; Dauch, JR; Keller, PJ; Brooks, SV; Feldman, EL				Sims-Robinson, Catrina; Hur, Junguk; Hayes, John M.; Dauch, Jacqueline R.; Keller, Peter J.; Brooks, Susan V.; Feldman, Eva L.			The Role of Oxidative Stress in Nervous System Aging	PLOS ONE			English	Article							CUZN-SUPEROXIDE-DISMUTASE; MITOCHONDRIAL DYSFUNCTION; MOTOR AXONOPATHY; MUSCLE ATROPHY; SCHWANN-CELLS; GENECHIP DATA; LIFE-SPAN; MICE; NEURONS; DEGENERATION	While oxidative stress is implicated in aging, the impact of oxidative stress on aging in the peripheral nervous system is not well understood. To determine a potential mechanism for age-related deficits in the peripheral nervous system, we examined both functional and morphological changes and utilized microarray technology to compare normal aging in wildtype mice to effects in copper/zinc superoxide dismutase-deficient (Sod1(-/-)) mice, a mouse model of increased oxidative stress. Sod1(-/-) mice exhibit a peripheral neuropathy phenotype with normal sensory nerve function and deficits in motor nerve function. Our data indicate that a decrease in the synthesis of cholesterol, which is vital to myelin formation, correlates with the structural deficits in axons, myelin, and the cell body of motor neurons in the Sod1(+/+) mice at 30 months and the Sod1(-/-) mice at 20 months compared with mice at 2 months. Collectively, we have demonstrated that the functional and morphological changes within the peripheral nervous system in our model of increased oxidative stress are manifested earlier and resemble the deficits observed during normal aging.	[Sims-Robinson, Catrina; Hur, Junguk; Hayes, John M.; Dauch, Jacqueline R.; Keller, Peter J.; Feldman, Eva L.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Brooks, Susan V.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Feldman, EL (corresponding author), Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA.	efeldman@umich.edu	Hur, Junguk/J-6229-2019	Hur, Junguk/0000-0002-0736-2149; Brooks, Susan/0000-0003-1954-967X; Robinson, Catrina/0000-0003-4776-5839; Feldman, Eva/0000-0002-9162-2694	National Institute of Aging (NIA) [AG-020591]; Aging Training Grant (NIA) [T32-AG000114]; Nathan Shock Center's Functional Assessment Core (NIA) [AG-013283]; Animal Models of Diabetic Complications Consortium (NIH) [U01-DK076160]; Juvenile Diabetes Research Foundation Postdoctoral Fellowship; Program for Neurology Research and Discovery; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK076160, P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013283, P01AG020591, T32AG000114] Funding Source: NIH RePORTER	National Institute of Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Aging Training Grant (NIA); Nathan Shock Center's Functional Assessment Core (NIA); Animal Models of Diabetic Complications Consortium (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation Postdoctoral Fellowship(Juvenile Diabetes Research Foundation); Program for Neurology Research and Discovery; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding Information/Grant Support: This work was supported by grants from the National Institute of Aging (NIA, AG-020591), Aging Training Grant (NIA T32-AG000114), Nathan Shock Center's Functional Assessment Core (NIA, AG-013283), Animal Models of Diabetic Complications Consortium (NIH U01-DK076160), the A. Alfred Taubman Medical Research Institute, a Juvenile Diabetes Research Foundation Postdoctoral Fellowship [to JH], and the Program for Neurology Research and Discovery. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Bokov A, 2004, MECH AGEING DEV, V125, P811, DOI 10.1016/j.mad.2004.07.009; Boulis NM, 2002, J NEUROSURG, V96, P212, DOI 10.3171/spi.2002.96.2.0212; Clement AB, 2009, J NEUROCHEM, V111, P669, DOI 10.1111/j.1471-4159.2009.06360.x; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; de Chaves EIP, 1997, J BIOL CHEM, V272, P30766, DOI 10.1074/jbc.272.49.30766; Fischer LR, 2012, EXP NEUROL, V233, P163, DOI 10.1016/j.expneurol.2011.09.020; Fischer LR, 2010, ACTA NEUROPATHOL, V119, P249, DOI 10.1007/s00401-009-0631-z; Flood DG, 1999, AM J PATHOL, V155, P663, DOI 10.1016/S0002-9440(10)65162-0; Fu Q, 1998, J NEUROCHEM, V71, P549; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Hoke A, 2006, J NEUROSCI, V26, P9646, DOI 10.1523/JNEUROSCI.1620-06.2006; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang TT, 2000, J GERONTOL A-BIOL, V55, pB5; Huang TT, 1997, ARCH BIOCHEM BIOPHYS, V344, P424, DOI 10.1006/abbi.1997.0237; Hur J, 2009, BIOINFORMATICS, V25, P838, DOI 10.1093/bioinformatics/btp049; Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308; Larkin LM, 2011, AM J PHYSIOL-REG I, V301, pR1400, DOI 10.1152/ajpregu.00093.2011; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; Liu JP, 2010, MOL CELL NEUROSCI, V43, P33, DOI 10.1016/j.mcn.2009.07.013; Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Perez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003; Peters A, 2002, J NEUROCYTOL, V31, P581, DOI 10.1023/A:1025731309829; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Roubenoff R, 2001, CAN J APPL PHYSIOL, V26, P78, DOI 10.1139/h01-006; Russell JW, 2002, FASEB J, V16, P1738, DOI 10.1096/fj.01-1027com; Salmon AB, 2010, FREE RADICAL BIO MED, V48, P642, DOI 10.1016/j.freeradbiomed.2009.12.015; Salzer JL, 2003, NEURON, V40, P297, DOI 10.1016/S0896-6273(03)00628-7; Sartor MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-538; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sentman ML, 2006, J BIOL CHEM, V281, P6904, DOI 10.1074/jbc.M510764200; Shefner JM, 1999, NEUROLOGY, V53, P1239, DOI 10.1212/WNL.53.6.1239; Sims-Robinson C, 2012, DIABETOLOGIA; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Sullivan KA, 2007, NEUROBIOL DIS, V28, P276, DOI 10.1016/j.nbd.2007.07.022; Toews AD, 1997, NEUROCHEM RES, V22, P1271, DOI 10.1023/A:1021941215310; Van Remmen H, 2004, FREE RADICAL BIO MED, V36, P1625, DOI 10.1016/j.freeradbiomed.2004.03.016; Van Remmen H, 2003, EXERC SPORT SCI REV, V31, P149, DOI 10.1097/00003677-200307000-00009; Vandervoort AA, 2002, MUSCLE NERVE, V25, P17, DOI 10.1002/mus.1215; Verheijen MHG, 2003, GENE DEV, V17, P2450, DOI 10.1101/gad.1116203; Viader A, 2013, NEURON, V77, P886, DOI 10.1016/j.neuron.2013.01.012; Vincent AM, 2007, ENDOCRINOLOGY, V148, P548, DOI 10.1210/en.2006-0073; Vincent AM, 2009, DIABETES, V58, P2376, DOI 10.2337/db09-0047	46	33	34	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68011	10.1371/journal.pone.0068011	http://dx.doi.org/10.1371/journal.pone.0068011			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844146	Green Submitted, Green Published, gold			2022-12-27	WOS:000321341000128
J	Watanabe, T; Hiasa, Y; Tokumoto, Y; Hirooka, M; Abe, M; Ikeda, Y; Matsuura, B; Chung, RT; Onji, M				Watanabe, Takao; Hiasa, Yoichi; Tokumoto, Yoshio; Hirooka, Masashi; Abe, Masanori; Ikeda, Yoshio; Matsuura, Bunzo; Chung, Raymond T.; Onji, Morikazu			Protein Kinase R Modulates c-Fos and c-Jun Signaling to Promote Proliferation of Hepatocellular Carcinoma with Hepatitis C Virus Infection	PLOS ONE			English	Article							TUMOR-SUPPRESSOR FUNCTION; INITIATION-FACTOR EIF-2; MALIGNANT-TRANSFORMATION; GENE-EXPRESSION; CELL-LINE; PKR; LIVER; RNA; INTERLEUKIN-8; REPLICATION	Double-stranded RNA-activated protein kinase R (PKR) is known to be upregulated by hepatitis C virus (HCV) and overexpressed in hepatocellular carcinoma (HCC). However, the precise roles of PKR in HCC with HCV infection remain unclear. Two HCV replicating cell lines (JFH-1 and H77s), generated by transfection of Huh7.5.1 cells, were used for experiments reported here. PKR expression was modulated with siRNA and a PKR expression plasmid, and cancer-related genes were assessed by real-time PCR and Western blotting; cell lines were further analyzed using a proliferation assay. Modulation of genes by PKR was also assessed in 34 human HCC specimens. Parallel changes in c-Fos and c-Jun gene expression with PKR were observed. Levels of phosphorylated c-Fos and c-Jun were upregulated by an increase of PKR, and were related to levels of phosphorylated JNK1 and Erk1/2. DNA binding activities of c-Fos and c-Jun also correlated with PKR expression, and cell proliferation was dependent on PKR-modulated c-Fos and c-Jun expression. Coordinate expression of c-Jun and PKR was confirmed in human HCC specimens with HCV infection. PKR upregulated c-Fos and c-Jun activities through activation of Erk1/2 and JNK1, respectively. These modulations resulted in HCC cell proliferation with HCV infection. These findings suggest that PKR-related proliferation pathways could be an attractive therapeutic target.	[Watanabe, Takao; Hiasa, Yoichi; Tokumoto, Yoshio; Hirooka, Masashi; Abe, Masanori; Ikeda, Yoshio; Matsuura, Bunzo; Onji, Morikazu] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime, Japan; [Chung, Raymond T.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Chung, Raymond T.] Harvard Univ, Sch Med, Boston, MA USA	Ehime University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Hiasa, Y (corresponding author), Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime, Japan.	hiasa@m.ehime-u.ac.jp	Hiasa, Yoichi/ABD-2759-2021	Hiasa, Yoichi/0000-0003-4117-339X	Japan Society for the Promotion of Science, KAKENHI [24590980]; Program for Enhancing Systematic Education in Graduate School from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Japanese Ministry of Health, Labor and Welfare, Japan	Japan Society for the Promotion of Science, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Program for Enhancing Systematic Education in Graduate School from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Japanese Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by the following: a Grant-in-Aid for Scientific Research, Japan Society for the Promotion of Science, KAKENHI 24590980 (to Y.H.); the Program for Enhancing Systematic Education in Graduate School from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to T.W.); and by a Grant-in-Aid for Scientific Research and Development from the Japanese Ministry of Health, Labor and Welfare, Japan (to Y.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 1997, HEPATOLOGY, V26, pS62, DOI 10.1002/hep.510260711; Behrens A, 2002, EMBO J, V21, P1782, DOI 10.1093/emboj/21.7.1782; Chang KS, 2006, J VIROL, V80, P7364, DOI 10.1128/JVI.00586-06; Chang QS, 2009, J HEPATOL, V50, P323, DOI 10.1016/j.jhep.2008.07.037; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Chung RT, 2001, P NATL ACAD SCI USA, V98, P9847, DOI 10.1073/pnas.171319698; Clemens MJ, 1997, J INTERF CYTOK RES, V17, P503, DOI 10.1089/jir.1997.17.503; Deb A, 2001, J IMMUNOL, V166, P6170, DOI 10.4049/jimmunol.166.10.6170; DONZE O, 1995, EMBO J, V14, P3828, DOI 10.1002/j.1460-2075.1995.tb00052.x; Eferl R, 1999, J CELL BIOL, V145, P1049, DOI 10.1083/jcb.145.5.1049; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; Gale M, 2000, MICROBIOL MOL BIOL R, V64, P239, DOI 10.1128/MMBR.64.2.239-280.2000; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Gollob JA, 2006, SEMIN ONCOL, V33, P392, DOI 10.1053/j.seminoncol.2006.04.002; Hiasa Y, 2003, AM J GASTROENTEROL, V98, P2528, DOI 10.1016/S0002-9270(03)01696-4; Hiasa Y, 2008, HEPATOLOGY, V48, P59, DOI 10.1002/hep.22289; Hideshima T, 2003, BLOOD, V101, P703, DOI 10.1182/blood-2002-06-1874; KOROMILAS AE, 1992, SCIENCE, V257, P1685, DOI 10.1126/science.1382315; LAMPH WW, 1988, NATURE, V334, P629, DOI 10.1038/334629a0; Maeda S, 2008, CANCER SCI, V99, P836, DOI 10.1111/j.1349-7006.2008.00763.x; Masumoto T, 1998, HEPATO-GASTROENTEROL, V45, P1630; MEURS EF, 1993, P NATL ACAD SCI USA, V90, P232, DOI 10.1073/pnas.90.1.232; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; Murayama T, 1997, J VIROL, V71, P5692, DOI 10.1128/JVI.71.7.5692-5695.1997; Ning Y, 2011, INT J CANCER, V128, P2038, DOI 10.1002/ijc.25562; Nishina H, 2004, J BIOCHEM, V136, P123, DOI 10.1093/jb/mvh117; Ohta H, 2006, CLIN EXP METASTAS, V23, P381, DOI 10.1007/s10585-006-9047-5; Okuda K, 1998, J GASTROEN HEPATOL, V13, pS294, DOI 10.1111/j.1440-1746.1998.tb01896.x; Pflugheber J, 2002, P NATL ACAD SCI USA, V99, P4650, DOI 10.1073/pnas.062055699; Polyak SJ, 2001, J VIROL, V75, P6095, DOI 10.1128/JVI.75.13.6095-6106.2001; PROUD CG, 1995, TRENDS BIOCHEM SCI, V20, P241, DOI 10.1016/S0968-0004(00)89025-8; REICHMANN E, 1992, CELL, V71, P1103, DOI 10.1016/S0092-8674(05)80060-1; Renard P, 2001, Nucleic Acids Res, V29, pE21, DOI 10.1093/nar/29.4.e21; Rivas-Estilla AM, 2002, J VIROL, V76, P10637, DOI 10.1128/JVI.76.21.10637-10653.2002; RYSECK RP, 1991, ONCOGENE, V6, P533; SAMUEL CE, 1979, P NATL ACAD SCI USA, V76, P600, DOI 10.1073/pnas.76.2.600; Schultz RM, 2003, PROG DRUG RES, V60, P59; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Takada Y, 2007, ONCOGENE, V26, P1201, DOI 10.1038/sj.onc.1209906; Tokumoto Y, 2007, J MED VIROL, V79, P1120, DOI 10.1002/jmv.20902; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; WILLIAMS BRG, 1995, SEMIN VIROL, V6, P191, DOI 10.1006/smvy.1995.0024; Yi M, 2006, P NATL ACAD SCI USA, V103, P2310, DOI 10.1073/pnas.0510727103; Yi MK, 2004, J VIROL, V78, P7904, DOI 10.1128/JVI.78.15.7904-7915.2004; Yoon CH, 2009, P NATL ACAD SCI USA, V106, P7852, DOI 10.1073/pnas.0812148106; Yuen MF, 2001, CANCER, V91, P106, DOI 10.1002/1097-0142(20010101)91:1<106::AID-CNCR14>3.0.CO;2-2; Zhao DZ, 2001, J BIOL CHEM, V276, P44464, DOI 10.1074/jbc.M104942200; Zhao LJ, 2005, EXP CELL RES, V305, P23, DOI 10.1016/j.yexcr.2004.12.024	48	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67750	10.1371/journal.pone.0067750	http://dx.doi.org/10.1371/journal.pone.0067750			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844083	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000091
J	Parn, K; Viru, L; Lehto, T; Oskolkov, N; Langel, U; Merits, A				Paern, Kalle; Viru, Liane; Lehto, Taavi; Oskolkov, Nikita; Langel, Ulo; Merits, Andres			Transfection of Infectious RNA and DNA/RNA Layered Vectors of Semliki Forest Virus by the Cell-Penetrating Peptide Based Reagent PepFect6	PLOS ONE			English	Article							IN-VITRO; GENE; REPLICATION; DELIVERY; EXPRESSION; MEMBRANE; COMPLEXES; SIRNA	Viral vectors have a wide variety of applications ranging from fundamental studies of viruses to therapeutics. Recombinant viral vectors are usually constructed using methods of reverse genetics to obtain the genetic material of the viral vector. The physicochemical properties of DNA and RNA make them unable to access cells by themselves, and they require assistance to achieve intracellular delivery. Non-viral delivery vectors can be used for this purpose if they enable efficient intracellular delivery without interfering with the viral life cycle. In this report, we utilize Semliki Forest virus (genus alphavirus) based RNA and DNA vectors to study the transfection efficiency of the non-viral cell-penetrating peptide-based delivery vector PepFect6 in comparison with that of the cationic liposome-based Lipofectamine 2000, and assess their impact on viral replication. The optimal conditions for transfection were determined for both reagents. These results demonstrate, for the first time, the ability of PepFect6 to transport large (13-19 kbp) constructs across the cell membrane. Curiously, DNA molecules delivered using the PepFect6 reagent were found to be transported to the cell nucleus approximately 1.5 hours later than DNA molecules delivered using the Lipofectamine 2000 reagent. Finally, although both PepFect6 and Lipofectamine 2000 reagents can be used for alphavirus research, PepFect6 is preferred because it does not induce changes in the normal cellular phenotype and it does not affect the normal replication-infection cycle of viruses in previously transfected cells.	[Paern, Kalle; Viru, Liane; Lehto, Taavi; Oskolkov, Nikita; Langel, Ulo; Merits, Andres] Univ Tartu, Inst Technol, EE-50090 Tartu, Estonia; [Langel, Ulo] Stockholm Univ, Dept Neurochem, S-10691 Stockholm, Sweden	University of Tartu; Stockholm University	Parn, K (corresponding author), Univ Tartu, Inst Technol, Ulikooli 18, EE-50090 Tartu, Estonia.	kalleparn@hotmail.com	Lehto, Taavi/B-7798-2010; Merits, Andres/H-3125-2015; Oskolkov, Nikita/AAJ-8377-2020	Lehto, Taavi/0000-0002-7131-2998; Merits, Andres/0000-0001-8193-0071; Langel, Ulo/0000-0001-6107-0844	Estonian Government [SF0180027s08]; EU trough the European Regional Development Fund through the Centre of Excellence of Chemical Biology; ESF [7407, 9421]	Estonian Government; EU trough the European Regional Development Fund through the Centre of Excellence of Chemical Biology; ESF(European Commission)	The work was supported by the Estonian Government through the targeted financing SF0180027s08, by the EU trough the European Regional Development Fund through the Centre of Excellence of Chemical Biology, by ESF grant 7407 and by ESF grant 9421. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andaloussi SEL, 2011, NUCLEIC ACIDS RES, V39, P3972, DOI 10.1093/nar/gkq1299; Andaloussi SEL, 2011, METHODS MOL BIOL, V683, P361, DOI 10.1007/978-1-60761-919-2_26; Atkins GJ, 1999, J GEN VIROL, V80, P2287, DOI 10.1099/0022-1317-80-9-2287; Barry G, 2009, J GEN VIROL, V90, P1382, DOI 10.1099/vir.0.007336-0; Berglund P, 1999, VACCINE, V17, P497, DOI 10.1016/S0264-410X(98)00224-2; Biesold SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028131; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Breakwell L, 2007, J VIROL, V81, P8677, DOI 10.1128/JVI.02411-06; Campeau P, 2001, GENE THER, V8, P1387, DOI 10.1038/sj.gt.3301532; Dalby B, 2004, METHODS, V33, P95, DOI 10.1016/j.ymeth.2003.11.023; Dubensky TW, 1996, J VIROL, V70, P508, DOI 10.1128/JVI.70.1.508-519.1996; El Andaloussi SA, 2012, CURR GENE THER, V12, P161; Gorchakov R, 2008, J VIROL, V82, P10088, DOI 10.1128/JVI.01011-08; GRIMLEY PM, 1968, J VIROL, V2, P1326, DOI 10.1128/JVI.2.11.1326-1338.1968; HERWEIJER H, 1995, HUM GENE THER, V6, P1161, DOI 10.1089/hum.1995.6.9-1161; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Huang SH, 2013, BIOTECHNOL ADV, V31, P208, DOI 10.1016/j.biotechadv.2012.10.001; Lee HJ, 2001, BIOCONJUGATE CHEM, V12, P995, DOI 10.1021/bc0155061; LILJESTROM P, 1991, J VIROL, V65, P4107; Liu BR, 2012, GENE, V505, P37, DOI 10.1016/j.gene.2012.05.053; Lundberg P, 2007, FASEB J, V21, P2664, DOI 10.1096/fj.06-6502com; Lundstrom K, 2003, EXPERT OPIN BIOL TH, V3, P771, DOI 10.1517/14712598.3.5.771; Mohr S, 2010, ANNU REV BIOCHEM, V79, P37, DOI 10.1146/annurev-biochem-060408-092949; Pooga M, 1998, FASEB J, V12, P67, DOI 10.1096/fasebj.12.1.67; Quetglas JI, 2010, VIRUS RES, V153, P179, DOI 10.1016/j.virusres.2010.07.027; Salonen A, 2003, J VIROL, V77, P1691, DOI 10.1128/JVI.77.3.1691-1702.2003; Samal SK, 2012, CHEM SOC REV, V41, P7147, DOI 10.1039/c2cs35094g; Smerdou C, 1999, CURR OPIN MOL THER, V1, P244; Spuul P, 2007, J VIROL, V81, P872, DOI 10.1128/JVI.01785-06; Spuul P, 2010, J VIROL, V84, P7543, DOI 10.1128/JVI.00477-10; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Tamberg N, 2007, J GEN VIROL, V88, P1225, DOI 10.1099/vir.0.82436-0; Trotard M, 2009, FASEB J, V23, P3780, DOI 10.1096/fj.09-131920; Varjak M, 2010, J VIROL, V84, P2352, DOI 10.1128/JVI.01540-09; Viru L, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-243; Zhao H, 2012, J HEPATOL, V56, P326, DOI 10.1016/j.jhep.2011.07.026; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	37	3	3	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e69659	10.1371/journal.pone.0069659	http://dx.doi.org/10.1371/journal.pone.0069659			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861978	gold, Green Published, Green Submitted			2022-12-27	WOS:000321692000049
J	Ibanez, AE; Smaldini, P; Coria, LM; Delpino, MV; Pacfico, LGG; Oliveira, SC; Risso, GS; Pasquevich, KA; Fossati, CA; Giambartolomei, GH; Docena, GH; Cassataro, J				Ibanez, Andres E.; Smaldini, Paola; Coria, Lorena M.; Delpino, Maria V.; Pacfico, Lucila G. G.; Oliveira, Sergio C.; Risso, Gabriela S.; Pasquevich, Karina A.; Alberto Fossati, Carlos; Giambartolomei, Guillermo H.; Docena, Guillermo H.; Cassataro, Juliana			Unlipidated Outer Membrane Protein Omp16 (U-Omp16) from Brucella spp. as Nasal Adjuvant Induces a Th1 Immune Response and Modulates the Th2 Allergic Response to Cow's Milk Proteins	PLOS ONE			English	Article							MONOPHOSPHORYL-LIPID-A; FOOD ALLERGY; IN-VIVO; VACCINE; ABORTUS; LIPOPOLYSACCHARIDE; CLASSIFICATION; IMMUNOTHERAPY; PROTECTION; INFECTION	The discovery of novel mucosal adjuvants will help to develop new formulations to control infectious and allergic diseases. In this work we demonstrate that U-Omp16 from Brucella spp. delivered by the nasal route (i.n.) induced an inflammatory immune response in bronchoalveolar lavage (BAL) and lung tissues. Nasal co-administration of U-Omp16 with the model antigen (Ag) ovalbumin (OVA) increased the amount of Ag in lung tissues and induced OVA-specific systemic IgG and T helper (Th) 1 immune responses. The usefulness of U-Omp16 was also assessed in a mouse model of food allergy. U-Omp16 i.n. administration during sensitization ameliorated the hypersensitivity responses of sensitized mice upon oral exposure to Cow's Milk Protein (CMP), decreased clinical signs, reduced anti-CMP IgE serum antibodies and modulated the Th2 response in favor of Th1 immunity. Thus, U-Omp16 could be used as a broad Th1 mucosal adjuvant for different Ag formulations.	[Ibanez, Andres E.; Coria, Lorena M.; Delpino, Maria V.; Risso, Gabriela S.; Pasquevich, Karina A.; Giambartolomei, Guillermo H.; Cassataro, Juliana] Univ Buenos Aires, Fac Med, Hosp Clin Jose de San Martin, Lab Inmunogenet,INIGEM CONICET, Buenos Aires, DF, Argentina; [Smaldini, Paola; Alberto Fossati, Carlos; Docena, Guillermo H.] Univ Nacl la Plata, Fac Ciencias Exactas, Lab Invest Sistema Inmune LISI, Buenos Aires, DF, Argentina; [Pacfico, Lucila G. G.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil; [Alberto Fossati, Carlos] Univ Buenos Aires, Fac Farm & Bioquim, Inst Estudios Inmunidad Humoral IDEHU CONICET, RA-1113 Buenos Aires, DF, Argentina	University of Buenos Aires; National University of La Plata; Universidade Federal de Minas Gerais; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Cassataro, J (corresponding author), Univ Buenos Aires, Fac Med, Hosp Clin Jose de San Martin, Lab Inmunogenet,INIGEM CONICET, Buenos Aires, DF, Argentina.	jucassataro@yahoo.com.ar	Oliveira, Sergio Costa/AAG-5408-2021; Pacífico, Lucila G G/H-9542-2014	Oliveira, Sergio Costa/0000-0003-4062-5577; Delpino, M. Victoria/0000-0003-2077-8509; Cassataro, Juliana/0000-0002-7122-869X; Smaldini, Paola/0000-0002-2734-516X; Pasquevich, Karina Alejandra/0000-0003-4448-0977	Bill and Melinda Gates Foundation through the Grand Challenges Explorations Initiative; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT-Argentina) [1163, 1670]; ANPCyT/CNPq PICT [18]; Universidad de Buenos Aires; PICT [25417, 2202]; CNPq/Prosul [490485/2007-3]; CNPq/ANPCyT [490528/2008-2]; INCT/Vacinas	Bill and Melinda Gates Foundation through the Grand Challenges Explorations Initiative; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT-Argentina)(ANPCyT); ANPCyT/CNPq PICT(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)ANPCyT); Universidad de Buenos Aires(University of Buenos Aires); PICT(ANPCyT); CNPq/Prosul(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq/ANPCyT(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)ANPCyT); INCT/Vacinas	This work was supported by grants from the Bill and Melinda Gates Foundation through the Grand Challenges Explorations Initiative; from the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT-Argentina): PICT 2010 No 1163, PICT 2006 No 1670, ANPCyT/CNPq PICT 2008 No 18 and from the Universidad de Buenos Aires: (to JC); and PICT 2004 No 25417 and PICT 2008 No 2202 (to GD). This work was also supported by grants from CNPq/Prosul#490485/2007-3, CNPq/ANPCyT#490528/2008-2, and INCT/Vacinas (to SCO). The funders had no role in experimental design, data collection and analysis, decision to publish, or preparation of the manuscript.	CAROZZI S, 1989, J CLIN MICROBIOL, V27, P1748, DOI 10.1128/JCM.27.8.1748-1753.1989; CESKA M, 1972, IMMUNOCHEMISTRY, V9, P1021, DOI 10.1016/0019-2791(72)90112-7; Cianferoni A, 2012, IMMUNOL ALLERGY CLIN, V32, P165, DOI 10.1016/j.iac.2011.10.002; Cox E, 2006, VET RES, V37, P511, DOI 10.1051/vetres:2006014; Cox JC, 1997, VACCINE, V15, P248, DOI 10.1016/S0264-410X(96)00183-1; Crameri R, 2006, CURR OPIN IMMUNOL, V18, P761, DOI 10.1016/j.coi.2006.09.001; Reboucas JD, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/474605; Freytag LC, 2005, VACCINE, V23, P1804, DOI 10.1016/j.vaccine.2004.11.010; Garcia TCM, 2008, ACTA TROP, V106, P162, DOI 10.1016/j.actatropica.2008.03.003; Giambartolomei GH, 2004, J IMMUNOL, V173, P4635, DOI 10.4049/jimmunol.173.7.4635; HENRICSON BE, 1993, INFECT IMMUN, V61, P2325, DOI 10.1128/IAI.61.6.2325-2333.1993; Hessel EM, 2005, J EXP MED, V202, P1563, DOI 10.1084/jem.20050631; Host A, 1994, Pediatr Allergy Immunol, V5, P1; Hurtado PR, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-34; Johansen P, 2005, CLIN EXP ALLERGY, V35, P1591, DOI 10.1111/j.1365-2222.2005.02384.x; Lawson LB, 2011, CURR OPIN IMMUNOL, V23, P414, DOI 10.1016/j.coi.2011.03.009; Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595; MYERS KR, 1995, INFECT IMMUN, V63, P168, DOI 10.1128/IAI.63.1.168-174.1995; Pashine A, 2005, NAT MED, V11, pS63, DOI 10.1038/nm1210; Pasquevich KA, 2010, J IMMUNOL, V184, P5200, DOI 10.4049/jimmunol.0902209; Pasquevich KA, 2009, INFECT IMMUN, V77, P436, DOI 10.1128/IAI.01151-08; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Sampson HA, 2000, J PEDIATR GASTR NUTR, V30, pS87, DOI 10.1097/00005176-200001001-00013; Sampson HA, 1999, J ALLERGY CLIN IMMUN, V103, P717, DOI 10.1016/S0091-6749(99)70411-2; Schijns VEJC, 2000, CURR OPIN IMMUNOL, V12, P456, DOI 10.1016/S0952-7915(00)00120-5; Seder RA, 2000, NATURE, V406, P793, DOI 10.1038/35021239; Sesardic D, 2006, VACCINE S2, V24; Sicherer SH, 2004, J ALLERGY CLIN IMMUN, V114, P1146, DOI 10.1016/j.jaci.2004.07.034; Smaldini P, 2012, INT ARCH ALLERGY IMM, V158, P335, DOI 10.1159/000333562; Steinhagen F, 2011, VACCINE, V29, P3341, DOI 10.1016/j.vaccine.2010.08.002; Zygmunt BM, 2009, J IMMUNOL, V183, P6933, DOI 10.4049/jimmunol.0901144	31	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e69438	10.1371/journal.pone.0069438	http://dx.doi.org/10.1371/journal.pone.0069438			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861971	Green Submitted, gold, Green Published			2022-12-27	WOS:000321425300087
J	Lin, JS; Ma, LS; Lai, EM				Lin, Jer-Sheng; Ma, Lay-Sun; Lai, Erh-Min			Systematic Dissection of the Agrobacterium Type VI Secretion System Reveals Machinery and Secreted Components for Subcomplex Formation	PLOS ONE			English	Article							ICMF FAMILY PROTEIN; PATHOGENICITY ISLAND; TAIL; GENE; VIRULENCE; REQUIRES; ENCODES; COMPLEX; LOCUS; FORMS	The type VI secretion system (T6SS) is widely distributed in pathogenic Proteobacteria. Sequence and structural analysis of T6SS reveals a resemblance to the T4 bacteriophage tail, in which an outer sheath structure contracts an internal tube for injecting nucleic acid into bacterial cells. However, the molecular details of how this phage tail-like T6SS structure is assembled in vivo and executed for exoprotein or effector secretion remain largely unknown. Here, we used a systematic approach to identify T6SS machinery and secreted components and investigate the interaction among the putative sheath and tube components of Agrobacterium tumefaciens. We showed that 14 T6SS components play essential roles in the secretion of the T6SS hallmark exoprotein Hcp. In addition, we discovered a novel T6SS exoprotein, Atu4347, that is dispensable for Hcp secretion. Interestingly, Atu4347 and the putative tube components, Hcp and VgrG, are mainly localized in the cytoplasm but also detected on the bacterial surface. Atu4342 (TssB) and Atu4341 (TssC(41)) interact with and stabilize each other, which suggests that they are functional orthologs of the sheath components TssB (VipA) and TssC (VipB), respectively. Importantly, TssB interacts directly with the three exoproteins (Hcp, VgrG, and Atu4347), in which Hcp also interacts directly with VgrG-1 on co-purification from Escherichia coli. Further co-immunoprecipitation and pulldown assays revealed these subcomplex(es) in A. tumefaciens and thereby support T6SS functioning as a contractile phage tail-like structure.	[Lin, Jer-Sheng; Ma, Lay-Sun; Lai, Erh-Min] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan; [Ma, Lay-Sun; Lai, Erh-Min] Natl Chung Hsing Univ, Taiwan Int Grad Program, Mol & Biol Agr Sci Program, Taipei, Taiwan; [Ma, Lay-Sun; Lai, Erh-Min] Acad Sinica, Taipei 115, Taiwan; [Ma, Lay-Sun; Lai, Erh-Min] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan	Academia Sinica - Taiwan; National Chung Hsing University; Academia Sinica - Taiwan; National Chung Hsing University	Lai, EM (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan.	emlai@gate.sinica.edu.tw	Ma, Lay-Sun/ABH-3013-2020; Lai, Erh-Min/ABG-9558-2020	Ma, Lay-Sun/0000-0003-4349-228X; Lai, Erh-Min/0000-0003-3630-8683	National Science Council [NSC 98-2311-B-001 -002 -MY3]; Academia Sinica	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	This work was in part supported by a National Science Council grant (NSC 98-2311-B-001 -002 -MY3) and a grant from Academia Sinica to EML. JSL and LSM were in part supported by Academia Sinica Summit project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksyuk AA, 2009, EMBO J, V28, P821, DOI 10.1038/emboj.2009.36; Anderson LB, 1996, P NATL ACAD SCI USA, V93, P8889, DOI 10.1073/pnas.93.17.8889; Aschtgen MS, 2008, J BACTERIOL, V190, P7523, DOI 10.1128/JB.00945-08; Aubert D, 2010, J BIOL CHEM, V285, P35988, DOI 10.1074/jbc.M110.120402; Ballister ER, 2008, P NATL ACAD SCI USA, V105, P3733, DOI 10.1073/pnas.0712247105; Basler M, 2012, SCIENCE, V337, P815, DOI 10.1126/science.1222901; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Broms JE, 2009, J BACTERIOL, V191, P2431, DOI 10.1128/JB.01759-08; Brunet YR, 2013, CELL REP, V3, P36, DOI 10.1016/j.celrep.2012.11.027; Cascales E, 2004, SCIENCE, V304, P1170, DOI 10.1126/science.1095211; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Cascales E, 2012, PHILOS T R SOC B, V367, P1102, DOI 10.1098/rstb.2011.0209; de Bruin OM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-1; de Bruin OM, 2011, MICROBIOL-SGM, V157, P3483, DOI 10.1099/mic.0.052308-0; Dudley EG, 2006, MOL MICROBIOL, V61, P1267, DOI 10.1111/j.1365-2958.2006.05281.x; Durand E, 2012, J BIOL CHEM IN PRESS; EMORY SA, 1990, J BACTERIOL, V172, P4472, DOI 10.1128/jb.172.8.4472-4481.1990; English G, 2012, MOL MICROBIOL, V86, P921, DOI 10.1111/mmi.12028; Felisberto-Rodrigues C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002386; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Hachani A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193045; Holland IB, 2010, METHODS MOL BIOL, V619, P1, DOI 10.1007/978-1-60327-412-8_1; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Jia YH, 2002, GENE, V284, P113, DOI 10.1016/S0378-1119(02)00385-2; Jobichen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012910; Kapitein N, 2013, CURR OPIN M IN PRESS; Kapitein N, 2013, MOL MICROBIOL, V87, P1013, DOI 10.1111/mmi.12147; Lai EM, 1998, J BACTERIOL, V180, P2711, DOI 10.1128/JB.180.10.2711-2717.1998; Lai EM, 2006, PROTEOMICS, V6, P4130, DOI 10.1002/pmic.200600254; Leiman PG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-355; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Leiman PG, 2004, CELL, V118, P419, DOI 10.1016/j.cell.2004.07.022; LeRoux M, 2012, P NATL ACAD SCI USA, V109, P19804, DOI 10.1073/pnas.1213963109; Leung KY, 2011, CURR OPIN MICROBIOL, V14, P9, DOI 10.1016/j.mib.2010.09.017; Liu AC, 2008, J APPL MICROBIOL, V105, P1372, DOI 10.1111/j.1365-2672.2008.03874.x; Lossi NS, 2013, J BIOL CHEM, V288, P7536, DOI 10.1074/jbc.M112.439273; Lossi NS, 2012, MOL MICROBIOL, V86, P437, DOI 10.1111/j.1365-2958.2012.08204.x; Lossi NS, 2011, MICROBIOL-SGM, V157, P3292, DOI 10.1099/mic.0.051987-0; Ludu JS, 2008, J BACTERIOL, V190, P4584, DOI 10.1128/JB.00198-08; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; Ma LS, 2012, J BIOL CHEM, V287, P15610, DOI 10.1074/jbc.M111.301630; Ma LS, 2009, J BACTERIOL, V191, P4316, DOI 10.1128/JB.00029-09; Miyata ST, 2011, INFECT IMMUN, V79, P2941, DOI 10.1128/IAI.01266-10; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Pietrosiuk A, 2011, J BIOL CHEM, V286, P30010, DOI 10.1074/jbc.M111.253377; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Records AR, 2011, MOL PLANT MICROBE IN, V24, P751, DOI 10.1094/MPMI-11-10-0262; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Shalom G, 2007, MICROBIOL-SGM, V153, P2689, DOI 10.1099/mic.0.2007/006585-0; Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619; Suarez G, 2010, J BACTERIOL, V192, P155, DOI 10.1128/JB.01260-09; Wu CF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002938; Wu HY, 2008, J BACTERIOL, V190, P2841, DOI 10.1128/JB.01775-07; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x; Zheng J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023876	63	61	62	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67647	10.1371/journal.pone.0067647	http://dx.doi.org/10.1371/journal.pone.0067647			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861778	Green Submitted, gold, Green Published			2022-12-27	WOS:000321425300021
J	Miao, GB; Chen, Z; Fang, XY; Liu, MB; Hao, G; An, HL; Zhang, ZY; Lu, LQ; Zhang, J; Zhang, L				Miao, Guobin; Chen, Zhe; Fang, Xiangyang; Liu, Miaobing; Hao, Gang; An, Huiling; Zhang, Zhiyong; Lu, Lingqiao; Zhang, Jian; Zhang, Lin			Relationship between the Autoantibody and Expression of beta(3)-Adrenoceptor in Lung and Heart	PLOS ONE			English	Article							ALVEOLAR FLUID CLEARANCE; CARDIOVASCULAR-SYSTEM; FAILURE; STIMULATION; RECEPTOR; CARDIOMYOPATHIES; AGONISTS	Background: Evidences suggest that beta(3)-adrenoceptor (beta(3)-AR) plays an important role in heart failure (HF), although no data is reported indicating how these effects may change with the increasing age. Pulmonary congestion and edema are the major life-threatening complications associated with HF. The purpose of this study is to explore the relationship between the anti-beta(3)-AR autoantibody and the expression of beta(3)-AR in the lungs and heart for both aged patients and rats with HF. Methods: Synthetic beta(3)-AR peptides served as the target antigens in ELISA were used to screen the anti-beta(3)-AR autoantibody in aged patients and rats. Two aged rat models were constructed based on aortic banding and sham-operation. The expression of beta(3)-AR mRNA and protein in the lung and heart was measured in intervention and non-intervention groups by Western blot analysis at the baseline, 5th, 7th, 9th and 11th week, respectively. Results: The frequency and titer of anti-beta(3)-AR autoantibody in aged patients and rats with HF were higher than those in the control group (p<0.05). The expression of beta(3)-AR mRNA and protein in pulmonary tissues decreased continually from the 7th week (p<0.05), followed by HF observed during the 9th week. The expression of beta(3)-AR in myocardial tissues continued to increase after the 9th week (p<0.05), and the expression of both beta(3)-AR mRNA and protein in the BRL group [HF group with BRL37344 (4-[-[2-hydroxy-(3-chlorophenyl)ethyl-amino] phenoxyacetic acid) (a beta(3)-AR agonist) injection] was positively correlated with BRL37344 when compared with non-BRL group (HF group without BRL37344 injection) (p<0.05). Conclusion: Anti-beta(3)-AR autoantibody was detected in aged patients and rats with HF. The expression of beta(3)-AR mRNA and protein in pulmonary tissues decreased continually, and began earlier than in the heart, but its expression in myocardial tissues increased continually and could be further promoted by beta(3)-AR agonist.	[Miao, Guobin; Chen, Zhe; Fang, Xiangyang; Liu, Miaobing; An, Huiling] Capital Med Univ, Beijing Chaoyang Hosp, Dept Internal Med, Beijing, Peoples R China; [Hao, Gang; Lu, Lingqiao] Capital Med Univ, Dept Pathophysiol, Beijing, Peoples R China; [Zhang, Zhiyong; Zhang, Lin] Capital Med Univ, Beijing Chaoyang Hosp, Dept Cardiol, Heart Failure Ctr, Beijing, Peoples R China; [Zhang, Jian] Capital Med Univ, Beijing Friendship Hosp, Med & Hlth Ctr, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; Capital Medical University	Zhang, J (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Med & Hlth Ctr, Beijing, Peoples R China.	zjian19@sina.com; linzhangpeking@hotmail.com			Beijing Natural Science Foundation [7122073]; Clinical-Basic Foundation of Capital Medical University [11JL-L06]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); Clinical-Basic Foundation of Capital Medical University	This work was supported by a grant from Beijing Natural Science Foundation (7122073) to GBM and a grant from the Clinical-Basic Foundation of Capital Medical University (Grant 11JL-L06) to ZC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birenbaum A, 2008, ANESTHESIOLOGY, V109, P1045, DOI 10.1097/ALN.0b013e31818d7e5a; Bossard F, 2011, AM J RESP CELL MOL, V44, P91, DOI 10.1165/rcmb.2009-0372OC; Brown RH, 1999, J APPL PHYSIOL, V87, P2362, DOI 10.1152/jappl.1999.87.6.2362; Dandel M, 2012, IMMUNOBIOLOGY, V217, P511, DOI 10.1016/j.imbio.2011.07.012; Du YH, 2012, J CELL BIOCHEM, V113, P3218, DOI 10.1002/jcb.24198; Evans BA, 1996, BRIT J PHARMACOL, V117, P210, DOI 10.1111/j.1476-5381.1996.tb15176.x; FU MLX, 1994, CLIN IMMUNOL IMMUNOP, V72, P15, DOI 10.1006/clin.1994.1101; Gauthier C, 1996, J CLIN INVEST, V98, P556, DOI 10.1172/JCI118823; Gauthier C, 1998, J CLIN INVEST, V102, P1377, DOI 10.1172/JCI2191; Gauthier C, 2007, CLIN HEMORHEOL MICRO, V37, P193; Germack R, 2006, J PHARMACOL EXP THER, V316, P392, DOI 10.1124/jpet.105.090597; Haberland A, 2011, CIRC RES, V109, P986, DOI 10.1161/CIRCRESAHA.111.253849; Herda LR, 2012, BRIT J PHARMACOL, V166, P847, DOI 10.1111/j.1476-5381.2012.01828.x; Li Mei-xia, 2005, Zhonghua Xinxueguanbing Zazhi, V33, P1114; Li NJ, 2010, CHINESE MED J-PEKING, V123, P1028, DOI 10.3760/cma.j.issn.0366-6999.2010.08.010; Maron MB, 2009, AM J PHYSIOL-LUNG C, V297, pL487, DOI 10.1152/ajplung.90629.2008; Moniotte S, 2001, CIRCULATION, V103, P1649, DOI 10.1161/01.CIR.103.12.1649; Ng TMH, 2002, J CARDIOVASC PHARM, V40, P140, DOI 10.1097/00005344-200207000-00017; Rasmussen HH, 2009, CURR OPIN INVEST DR, V10, P955; Rozec B, 2006, PHARMACOL THERAPEUT, V111, P652, DOI 10.1016/j.pharmthera.2005.12.002; Strosberg AD, 1997, ANNU REV PHARMACOL, V37, P421, DOI 10.1146/annurev.pharmtox.37.1.421; Wu Q, 2008, EXP PHYSIOL, V93, P1034, DOI 10.1113/expphysiol.2007.041939; Xiao RP, 1998, J CLIN INVEST, V101, P1273, DOI 10.1172/JCI1335; Zhang L, 2002, CHINESE MED J-PEKING, V115, P1127; Zhang ZS, 2005, J PHARMACOL EXP THER, V315, P1203, DOI 10.1124/jpet.105.089672; Zhao Q, 2007, CARDIOVASC DRUG THER, V21, P85, DOI 10.1007/s10557-007-6016-4	26	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68747	10.1371/journal.pone.0068747	http://dx.doi.org/10.1371/journal.pone.0068747			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861938	gold, Green Published, Green Submitted			2022-12-27	WOS:000321425300078
J	Yamashita, T; Rhoads, DD				Yamashita, Tsunemi; Rhoads, Douglas D.			Species Delimitation and Morphological Divergence in the Scorpion Centruroides vittatus (Say, 1821): Insights from Phylogeography	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; HISTORICAL DEMOGRAPHY; PLEISTOCENE REFUGIA; GENETIC DIVERSITY; PROGRAM PACKAGE; RANGE EXPANSION; DNA; RECOMBINATION; MIGRATION; EVOLUTION	Scorpion systematics and taxonomy have recently shown a need for revision, partially due to insights from molecular techniques. Scorpion taxonomy has been difficult with morphological characters as disagreement exists among researchers with character choice for adequate species delimitation in taxonomic studies. Within the family Buthidae, species identification and delimitation is particularly difficult due to the morphological similarity among species and extensive intraspecific morphological diversity. The genus Centruroides in the western hemisphere is a prime example of the difficulty in untangling the taxonomic complexity within buthid scorpions. In this paper, we present phylogeographic, Ecological Niche Modeling, and morphometric analyses to further understand how population diversification may have produced morphological diversity in Centruroides vittatus (Say, 1821). We show that C. vittatus populations in the Big Bend and Trans-Pecos region of Texas, USA are phylogeographically distinct and may predate the Last Glacial Maximum (LGM). In addition, we suggest the extended isolation of Big Bend region populations may have created the C. vittatus variant once known as C. pantheriensis.	[Yamashita, Tsunemi] Arkansas Tech Univ, Dept Biol Sci, Russellville, AR 72801 USA; [Rhoads, Douglas D.] Univ Arkansas, Dept Biol Sci, SCEN 601, Fayetteville, AR 72701 USA	Arkansas Tech University; University of Arkansas System; University of Arkansas Fayetteville	Yamashita, T (corresponding author), Arkansas Tech Univ, Dept Biol Sci, Russellville, AR 72801 USA.	tyamashita@atu.edu	Rhoads, Douglas/AAP-6270-2020		ATU Undergraduate Research Office, ATU Sponsored Programs, and National Institutes of Health [P20 RR-16460]; BRIN Program of the National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016460] Funding Source: NIH RePORTER	ATU Undergraduate Research Office, ATU Sponsored Programs, and National Institutes of Health; BRIN Program of the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by the ATU Undergraduate Research Office, ATU Sponsored Programs, and National Institutes of Health grant number P20 RR-16460 from the BRIN Program of the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff DM, 2002, EVOLUTION, V56, P1632, DOI 10.1111/j.0014-3820.2002.tb01475.x; Bond JE, 2008, SYST BIOL, V57, P628, DOI 10.1080/10635150802302443; Brandley MC, 2011, SYST BIOL, V60, P3, DOI 10.1093/sysbio/syq045; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; Carbone I, 2004, GENETICS, V166, P1611, DOI 10.1534/genetics.166.4.1611; Castoe TA, 2007, MOL PHYLOGENET EVOL, V42, P193, DOI 10.1016/j.ympev.2006.07.002; Cawthon D, 1996, THESIS U ARKANSAS; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Delcourt Paul A., 1993, P71; Drummond A. J., 2009, GENEIOUS V4 6; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fet V, 2000, CATALOG SCORPIONS WO; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontanella FM, 2008, MOL PHYLOGENET EVOL, V46, P1049, DOI 10.1016/j.ympev.2007.10.017; Fu YX, 1996, GENETICS, V143, P557; Gaffin Douglas D., 2011, Euscorpius, V122, P1; Gantenbein B, 2005, P ROY SOC B-BIOL SCI, V272, P697, DOI 10.1098/rspb.2004.3017; Gantenbein B, 2004, EVOLUTION, V58, P2486, DOI 10.1111/j.0014-3820.2004.tb00878.x; Gantenbein B, 2002, MOL ECOL, V11, P925, DOI 10.1046/j.1365-294X.2002.01494.x; Gantenbein Benjamin, 2001, P235; Gertsch W. J., 1939, Contributions from the Baylor University Museum Waco, V24, P17; Graham MR, 2012, ZOOL MIDDLE EAST, V55, P95, DOI 10.1080/09397140.2012.10648924; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Habel JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029403; Hamilton CA, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020156, 10.1371/journal.pone.0026207]; Hedgecock AA, 1993, THESIS APPALACHIAN S; Hey J, 2003, NAT REV GENET, V4, P535, DOI 10.1038/nrg1112; Hickerson MJ, 2005, EVOLUTION, V59, P344; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hintze J., 2007, NCSS 2007 NCSS LLC K; Hughes GB, 2011, J ARACHNOL, V39, P420, DOI 10.1636/Ha11-07.1; Hutchison DW, 1999, HERPETOL MONOGR, V13, P81, DOI 10.2307/1467061; Hutchison DW, 2003, AM MIDL NAT, V149, P148, DOI 10.1674/0003-0031(2003)149[0148:TTCPMA]2.0.CO;2; Jackson ND, 2010, EVOLUTION, V64, P409, DOI 10.1111/j.1558-5646.2009.00840.x; Jezkova T, 2009, J MAMMAL, V90, P306, DOI 10.1644/08-MAMM-A-243.1; Ji YJ, 2003, MOL ECOL NOTES, V3, P581, DOI 10.1046/j.1471-8286.2003.00519.x; Johnson JA, 2008, J HERED, V99, P165, DOI 10.1093/jhered/esn002; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; Luttikhuizen PC, 2003, MOL ECOL, V12, P2215, DOI 10.1046/j.1365-294X.2003.01872.x; Mirshamsi O, 2010, J NAT HIST, V44, P2851, DOI 10.1080/00222933.2010.512400; Mulcahy DG, 2008, MOL PHYLOGENET EVOL, V46, P1095, DOI 10.1016/j.ympev.2007.12.012; Murray EA, 2006, THESIS KANSAS STATE; Myers C, 2001, SCORPION BIOLOGY AND RESEARCH, P317; Nei M., 2000, MOL EVOLUTION PHYLOG; Nielsen R, 2001, GENETICS, V158, P885; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Page R.D.M., 1998, MOL EVOLUTION PHYLOG; Parmakelis A, 2006, MOL ECOL, V15, P2883, DOI 10.1111/j.1365-294X.2006.02982.x; Pfenninger M, 2002, EVOLUTION, V56, P1776, DOI 10.1111/j.0014-3820.2002.tb00191.x; Phillips CA, 2000, COPEIA, P542; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Polis G.A., 1990, P247; Polis GA, 2001, SCORPION BIOLOGY AND RESEARCH, P302; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; POSADA D, 2003, PHYLOGENETIC HDB PRA, P256; Possani LD, 2000, BIOCHIMIE, V82, P861, DOI 10.1016/S0300-9084(00)01167-6; Prendini Lorenzo, 2001, P113; Price EW, 2005, BIOINFORMATICS, V21, P402, DOI 10.1093/bioinformatics/bti003; Rebernig CA, 2010, MOL ECOL, V19, P3421, DOI 10.1111/j.1365-294X.2010.04754.x; Richards CL, 2007, J BIOGEOGR, V34, P1833, DOI 10.1111/j.1365-2699.2007.01814.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F., 2005, MRBAYES 3 1 MANUAL; Rosenblum EB, 2010, P NATL ACAD SCI USA, V107, P2113, DOI 10.1073/pnas.0911042107; Sambrook J., 2001, MOL CLONING LAB MANU; Sauquet H, 2012, SYST BIOL, V61, P289, DOI 10.1093/sysbio/syr116; SHELLEY RM, 1995, J ARACHNOL, V23, P100; Simard J.M., 1990, P414; Sissom W. David, 2005, P122; Smith CI, 2005, MOL ECOL, V14, P3049, DOI 10.1111/j.1365-294X.2005.02647.x; Smith CI, 2005, MOL ECOL, V14, P1025, DOI 10.1111/j.1365-294X.2005.02472.x; Sousa P, 2011, AFR INVERTEBR, V52, P135, DOI 10.5733/afin.052.0106; Sousa P, 2010, J ARACHNOL, V38, P206, DOI 10.1636/H08-98.1; STAHNKE H L, 1977, Entomological News, V88, P111; STAHNKE H. L., 1956, ENT NEWS, V67, P15; TAJIMA F, 1989, GENETICS, V123, P585; Templeton AR, 2001, MOL ECOL, V10, P779, DOI 10.1046/j.1365-294x.2001.01199.x; Teruel Rolando, 2006, Boletin de la SEA, V39, P219; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trauth S.E., 2004, AMPHIBIANS REPTILES; Valdez-Cruz NA, 2004, BIOCHIMIE, V86, P387, DOI 10.1016/j.biochi.2004.05.005; Von Haeseler A, 2003, PHYLOGENETIC HDB PRA, P137; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Williams S. C., 1980, OCCASIONAL PAPERS CA, V135, P1; Wilson JS, 2010, BIOL J LINN SOC, V101, P360, DOI 10.1111/j.1095-8312.2010.01526.x; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhang DX, 2003, MOL ECOL, V12, P563, DOI 10.1046/j.1365-294X.2003.01773.x	89	12	12	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68282	10.1371/journal.pone.0068282	http://dx.doi.org/10.1371/journal.pone.0068282			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861878	Green Published, Green Submitted, gold			2022-12-27	WOS:000321425300054
J	Al-abd, NM; Mahdy, MAK; Al-Mekhlafi, AMQ; Snounou, G; Abdul-Majid, NB; Al-Mekhlafi, HM; Fong, MY				Al-abd, Nazeh M.; Mahdy, Mohammed A. K.; Al-Mekhlafi, Abdulsalam M. Q.; Snounou, Georges; Abdul-Majid, Nazia B.; Al-Mekhlafi, Hesham M.; Fong, Mun Y.			The Suitability of P. falciparum Merozoite Surface Proteins 1 and 2 as Genetic Markers for In Vivo Drug Trials in Yemen	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; POPULATION-STRUCTURE; DIVERSITY; MALARIA; FREQUENCY; IDENTIFICATION; TRANSMISSION; GOVERNORATE; INFECTIONS; RESISTANCE	Background: The accuracy of the conclusions from in vivo efficacy anti-malarial drug trials depends on distinguishing between recrudescences and re-infections which is accomplished by genotyping genes coding P. falciparum merozoite surface 1 (MSP1) and MSP2. However, the reliability of the PCR analysis depends on the genetic markers' allelic diversity and variant frequency. In this study the genetic diversity of the genes coding for MSP1 and MSP2 was obtained for P. falciparum parasites circulating in Yemen. Methods: Blood samples were collected from 511 patients with fever and screened for malaria parasites using Giemsa-stained blood films. A total 74 samples were infected with P. falciparum, and the genetic diversity was assessed by nested PCR targeting Pfmsp1 (Block2) and Pfmsp2 (block 3). Results: Overall, 58%, 28% and 54% of the isolates harboured parasites of the Pfmsp1 K1, MAD20 and RO33 allelic families, and 55% and 89% harboured those of the Pfmsp2 FC27 and 3D7 allelic families, respectively. For both genetic makers, the multiplicity of the infection (MOI) was significantly higher in the isolates from the foothills/coastland areas as compared to those from the highland (P < 0.05). Pfmsp2 had higher number of distinct allelic variants than Pfmsp1 (20 vs 11). The expected heterozygosity (HE) for Pfmsp1 and Pfmsp2 were 0.82 and 0.94, respectively. Nonetheless, a bias in the frequency distribution of the Pfmsp1 allelic variants was noted from all areas, and of those of Pfmsp2 in the samples collected from the highland areas. Conclusions: Significant differences in the complexity and allelic diversity of Pfmsp1 and Pfmsp2 genes between areas probably reflect differences in the intensity of malaria transmission. The biased distribution of allelic variants suggests that in Yemen Pfmsp1 should not be used for PCR correction of in vivo clinical trials outcomes, and that caution should be exercised when employing Pfmsp2.	[Al-abd, Nazeh M.; Mahdy, Mohammed A. K.; Al-Mekhlafi, Hesham M.; Fong, Mun Y.] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia; [Al-abd, Nazeh M.; Abdul-Majid, Nazia B.] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia; [Mahdy, Mohammed A. K.; Al-Mekhlafi, Abdulsalam M. Q.; Al-Mekhlafi, Hesham M.] Sanaa Univ, Fac Med & Hlth Sci, Dept Parasitol, Sanaa, Yemen; [Snounou, Georges] INSERM, Unite Mixte Rech S 945, Paris, France; [Snounou, Georges] Univ Paris 06, Fac Med Pitie Salpetriere, Paris, France; [Mahdy, Mohammed A. K.] Univ Sci & Technol, Resarch Dept, Sanaa, Yemen	Universiti Malaya; Universiti Malaya; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Mahdy, MAK (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia.	alsharaby9@yahoo.com	MAJID, NAZIA ABDUL/B-9215-2010; Al-Mekhlafi, Hesham Mahyoub Sarhan/R-3568-2016; Mahdy, Mohammed A.K./C-1187-2010; FONG, MUN YIK/B-5443-2010; Snounou, Georges/F-3352-2011	MAJID, NAZIA ABDUL/0000-0002-6817-8046; Al-Mekhlafi, Hesham Mahyoub Sarhan/0000-0003-2582-7410; Mahdy, Mohammed A.K./0000-0002-8340-5219; Snounou, Georges/0000-0002-6133-6398; kamal, amera/0000-0002-9154-9415	University of Malaya, Kuala Lumpur, Malaysia (HIR-MOHE) [H-20001-00-E00051]	University of Malaya, Kuala Lumpur, Malaysia (HIR-MOHE)	This study was funded by research grants from the University of Malaya, Kuala Lumpur, Malaysia (HIR-MOHE (H-20001-00-E00051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Maktari Mohamed T., 2003, Journal of the Egyptian Society of Parasitology, V33, P361; Al-Mekhlafi AM, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-94; Al-Mekhlafi AMQ, 2010, TROP BIOMED, V27, P551; Alkadi HO, 2006, CHEMOTHERAPY, V52, P166, DOI 10.1159/000093592; [Anonymous], 2007, METHODS TECHNIQUES C; Ariey F, 1999, AM J TROP MED HYG, V61, P978, DOI 10.4269/ajtmh.1999.61.978; Babiker HA, 1997, PARASITOL TODAY, V13, P262, DOI 10.1016/S0169-4758(97)01075-2; Babiker HA, 1997, AM J TROP MED HYG, V56, P141, DOI 10.4269/ajtmh.1997.56.141; CONWAY DJ, 1991, PARASITOLOGY, V103, P1, DOI 10.1017/S0031182000059217; Daniels R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-223; Ghanchi NK, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-1; Greenhouse B, 2006, AM J TROP MED HYG, V75, P836, DOI 10.4269/ajtmh.2006.75.836; Haddad D, 1999, AM J TROP MED HYG, V60, P30, DOI 10.4269/ajtmh.1999.60.30; Joshi H, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-60; Kang JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-131; Ministry of planning and international cooperation Y, 2004, NAT CENS YEM; Mubjer RA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-245; Mwingira F, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-79; NMCP, 2002, MAL REP NMCP; Paul REL, 1998, AM J TROP MED HYG, V58, P195, DOI 10.4269/ajtmh.1998.58.195; Paul REL, 1998, PARASITOL TODAY, V14, P197, DOI 10.1016/S0169-4758(98)01226-5; Sakihama N, 2006, AM J TROP MED HYG, V74, P31, DOI 10.4269/ajtmh.2006.74.31; Schoepflin S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-250; Smith T, 1999, T ROY SOC TROP MED H, V93, pS15, DOI 10.1016/S0035-9203(99)90322-X; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; Soulama I, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-135; Takala S, 2002, MOL BIOCHEM PARASIT, V125, P163, DOI 10.1016/S0166-6851(02)00237-2; Vafa M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-17; WHO, 2010, WORLD MALARIA REPORT 2010, P1; World Health Organization, 2008, The global burden of disease: 2004 update; Zakeri S, 2005, TROP MED INT HEALTH, V10, P1060, DOI 10.1111/j.1365-3156.2005.01477.x; Zwetyenga J, 1998, AM J TROP MED HYG, V59, P726, DOI 10.4269/ajtmh.1998.59.726	32	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67853	10.1371/journal.pone.0067853	http://dx.doi.org/10.1371/journal.pone.0067853			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861823	gold, Green Published, Green Submitted			2022-12-27	WOS:000323350700051
J	Hoivik, EA; Witsoe, SL; Bergheim, IR; Xu, YJ; Jakobsson, I; Tengholm, A; Doskeland, SO; Bakke, M				Hoivik, Erling A.; Witsoe, Solveig L.; Bergheim, Inger R.; Xu, Yunjian; Jakobsson, Ida; Tengholm, Anders; Doskeland, Stein Ove; Bakke, Marit			DNA Methylation of Alternative Promoters Directs Tissue Specific Expression of Epac2 Isoforms	PLOS ONE			English	Article							EXCHANGE FACTOR; CYCLIC-AMP; SUBCELLULAR-LOCALIZATION; CAMP; GENOME; IDENTIFICATION; ACTIVATION; SECRETION; DYNAMICS; FEATURES	Epac 1 and Epac 2 (Epac1/2; exchange factors directly activated by cAMP) are multidomain proteins that mediate cellular responses upon activation by the signaling molecule cAMP. Epac1 is ubiquitously expressed, whereas Epac2 exhibits a restricted expression pattern. The gene encoding Epac2 gives rise to at least three protein isoforms (Epac2A, Epac2B and Epac2C) that exhibit confined tissue and cell specific expression profiles. Here, we describe alternative promoter usage for the different isoforms of Epac2, and demonstrate that the activity of these promoters depend on the DNA methylation status. Bisulfite sequencing demonstrated that the level of methylation of the promoters in different tissues correlates with Epac2 isoform expression. The presented data indicate that the tissue-specific expression of the Epac2 isoforms is epigenetically regulated, and identify tissue-specific differentially methylated promoter regions within the Epac2 locus that are essential for its transcriptional control.	[Hoivik, Erling A.; Witsoe, Solveig L.; Bergheim, Inger R.; Doskeland, Stein Ove; Bakke, Marit] Univ Bergen, Dept Biomed, Bergen, Norway; [Hoivik, Erling A.] Univ Bergen, Dept Clin Med, Sect Gynecol & Obstet, Bergen, Norway; [Xu, Yunjian; Jakobsson, Ida; Tengholm, Anders] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden	University of Bergen; University of Bergen; Uppsala University	Bakke, M (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	Marit.Bakke@biomed.uib.no		Doskeland, Stein Ove/0000-0002-4009-4756	National Program for Research in Functional Genomics in Norway (FUGE) in the Research Council of Norway; Meltzer Foundation; Swedish Diabetes Association; Family Ernfors' Foundation; Novo-Nordisk Foundation; Swedish Research Council	National Program for Research in Functional Genomics in Norway (FUGE) in the Research Council of Norway(Research Council of Norway); Meltzer Foundation; Swedish Diabetes Association; Family Ernfors' Foundation; Novo-Nordisk Foundation(Novo Nordisk Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the National Program for Research in Functional Genomics in Norway (FUGE) in the Research Council of Norway, the Meltzer Foundation (MB), the Swedish Diabetes Association, Family Ernfors' Foundation, Novo-Nordisk Foundation and the Swedish Research Council (AT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, PLOS BIOL, V9, DOI [10.1371/journal.pbio.1001046, DOI 10.1371/JOURNAL.PBIO.1001046]; Aumo L, 2010, ENDOCRINOLOGY, V151, P2151, DOI 10.1210/en.2009-1139; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; CROSBY SD, 1992, P NATL ACAD SCI USA, V89, P6663, DOI 10.1073/pnas.89.14.6663; Dao KK, 2006, J BIOL CHEM, V281, P21500, DOI 10.1074/jbc.M603116200; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Fu D, 2011, P NATL ACAD SCI USA, V108, P1403, DOI 10.1073/pnas.1018376108; Fukuda M, 2011, CELL METAB, V13, P331, DOI 10.1016/j.cmet.2011.01.016; Futscher BW, 2002, NAT GENET, V31, P175, DOI 10.1038/ng886; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gloerich M, 2011, J CELL BIOL, V193, P1009, DOI 10.1083/jcb.201011126; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Han H, 2011, HUM MOL GENET, V20, P4299, DOI 10.1093/hmg/ddr356; Hoivik EA, 2011, ENDOCRINOLOGY, V152, P2100, DOI 10.1210/en.2010-1305; Huston E, 2008, P NATL ACAD SCI USA, V105, P12791, DOI 10.1073/pnas.0805167105; Idevall-Hagren O, 2010, J BIOL CHEM, V285, P23005, DOI 10.1074/jbc.M109.095992; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Irizarry RA, 2009, MAMM GENOME, V20, P674, DOI 10.1007/s00335-009-9222-5; Islam D, 2009, AM J PHYSIOL-ENDOC M, V296, pE174, DOI 10.1152/ajpendo.90419.2008; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; Koga Y, 2009, GENOME RES, V19, P1462, DOI 10.1101/gr.091447.109; Kooistra MRH, 2005, FEBS LETT, V579, P4966, DOI 10.1016/j.febslet.2005.07.080; Landolin JM, 2010, GENOME RES, V20, P890, DOI 10.1101/gr.100370.109; Li Y, 2006, J BIOL CHEM, V281, P2506, DOI 10.1074/jbc.M508165200; Liu C, 2008, MOL CELL BIOL, V28, P7109, DOI 10.1128/MCB.01060-08; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Niimura M, 2009, J CELL PHYSIOL, V219, P652, DOI 10.1002/jcp.21709; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Peet DJ, 1998, CURR OPIN GENET DEV, V8, P571, DOI 10.1016/S0959-437X(98)80013-0; Ponsioen B, 2009, MOL CELL BIOL, V29, P2521, DOI 10.1128/MCB.01630-08; Qiao JB, 2002, J BIOL CHEM, V277, P26581, DOI 10.1074/jbc.M203571200; Rakyan VK, 2008, GENOME RES, V18, P1518, DOI 10.1101/gr.077479.108; Sehrawat S, 2008, MOL BIOL CELL, V19, P1261, DOI 10.1091/mbc.E06-10-0972; Shen L, 2007, PLOS GENET, V3, P2023, DOI 10.1371/journal.pgen.0030181; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Srivastava DP, 2012, J NEUROSCI, V32, P11864, DOI 10.1523/JNEUROSCI.1349-12.2012; Ueno H, 2001, GENOMICS, V78, P91, DOI 10.1006/geno.2001.6641; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Yang Y, 2012, NEURON, V73, P774, DOI 10.1016/j.neuron.2012.02.003	44	39	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67925	10.1371/journal.pone.0067925	http://dx.doi.org/10.1371/journal.pone.0067925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861833	Green Published, Green Submitted, gold			2022-12-27	WOS:000323350700061
J	Viel, T; Schelhaas, S; Wagner, S; Wachsmuth, L; Schwegmann, K; Kuhlmann, M; Faber, C; Kopka, K; Schafers, M; Jacobs, AH				Viel, Thomas; Schelhaas, Sonja; Wagner, Stefan; Wachsmuth, Lydia; Schwegmann, Katrin; Kuhlmann, Michael; Faber, Cornelius; Kopka, Klaus; Schaefers, Michael; Jacobs, Andreas H.			Early Assessment of the Efficacy of Temozolomide Chemotherapy in Experimental Glioblastoma Using [F-18]FLT-PET Imaging	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; PROLIFERATION IN-VIVO; SMALL-ANIMAL PET; MALIGNANT GLIOMAS; FLT-PET; THERAPY; BRAIN; METHYLTRANSFERASE	Addition of temozolomide (TMZ) to radiation therapy is the standard treatment for patients with glioblastoma (GBM). However, there is uncertainty regarding the effectiveness of TMZ. Considering the rapid evolution of the disease, methods to assess TMZ efficacy early during treatment would be of great benefit. Our aim was to monitor early effects of TMZ in a mouse model of GBM using positron emission tomography (PET) with 3'-deoxy-3'-[F-18]fluorothymidine ([F-18]FLT). Methods: Human glioma cells sensitive to TMZ (Gli36dEGFR-1) were treated with sub-lethal doses of TMZ to obtain cells with lower sensitivity to TMZ (Gli36dEGFR-2), as measured by growth and clonogenic assays. Gli36dEGFR-1 and Gli36dEGFR-2 cells were subcutaneously (s.c.) or intracranially (i.c.) xenografted into nude mice. Mice were treated for 7 days with daily injection of 25 or 50 mg/kg TMZ. Treatment efficacy was measured using [F-18]FLT-PET before treatment and after 2 days. Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) were used to determine tumor volumes before treatment and after 7 days. Results: A significant difference was observed between TMZ and DMSO treated tumors in terms of variations of [F-18]FLT T/B ratio as soon as day 2 in the i.c. as well as in the s.c. mouse model. Variations of [F-18]FLT T/B uptake ratio between days 0 and 2 correlated with variations of tumor size between days 0 and 7 (s.c. model: n(tumor) = 17 in n(mice) = 11, P<0.01; i.c. model: n(tumor/mice) = 9, P<0.01). Conclusions: Our results indicate that [F-18]FLT-PET may be useful for an early evaluation of the response of GBM to TMZ chemotherapy in patients with glioma.	[Viel, Thomas; Schelhaas, Sonja; Schwegmann, Katrin; Kuhlmann, Michael; Schaefers, Michael; Jacobs, Andreas H.] Univ Munster, EIMI, D-48149 Munster, Germany; [Wagner, Stefan; Schaefers, Michael] Univ Munster, Dept Nucl Med, Univ Hosp Munster, D-48149 Munster, Germany; [Wachsmuth, Lydia; Faber, Cornelius] Univ Munster, Dept Radiol, Univ Hosp Munster, D-48149 Munster, Germany; [Schaefers, Michael; Jacobs, Andreas H.] Univ Munster, Interdisciplinary Ctr Clin Res IZKF, D-48149 Munster, Germany; [Kopka, Klaus] German Canc Res Ctr, Heidelberg, Germany; [Jacobs, Andreas H.] Johanniter Krankenhaus, Dept Geriatr Med, Evangel Kliniken, Bonn, Germany	University of Munster; University of Munster; University of Munster; University of Munster; Helmholtz Association; German Cancer Research Center (DKFZ)	Jacobs, AH (corresponding author), Univ Munster, EIMI, D-48149 Munster, Germany.	ahjacobs@uni-muenster.de	Faber, Cornelius/Q-2689-2016; Kopka, Klaus/AAM-7233-2020; Viel, Thomas/K-4576-2013; Jacobs, Andreas H./AAA-6794-2020	Faber, Cornelius/0000-0001-7683-7710; Kopka, Klaus/0000-0003-4846-1271; Viel, Thomas/0000-0002-0756-9166; Schelhaas, Sonja/0000-0001-6928-4847	BMBF (Bundesministerium fur Bildung und Forschung) grant MoBiMed	BMBF (Bundesministerium fur Bildung und Forschung) grant MoBiMed	The authors thank the European Molecular Imaging Institute (EIMI Munster). This work was supported in part by BMBF (Bundesministerium fur Bildung und Forschung) grant MoBiMed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2002, CANCER GENE THER, V9, P228, DOI 10.1038/sj.cgt.7700437; Buck AK, 2006, CANCER RES, V66, P11055, DOI 10.1158/0008-5472.CAN-06-1955; Buckner JC, 2007, MAYO CLIN PROC, V82, P1271, DOI 10.4065/82.10.1271; Chen W, 2007, J CLIN ONCOL, V25, P4714, DOI 10.1200/JCO.2006.10.5825; Chen YL, 2010, J BIOL CHEM, V285, P27327, DOI 10.1074/jbc.M110.137042; de Wit MCY, 2004, NEUROLOGY, V63, P535, DOI 10.1212/01.WNL.0000133398.11870.9A; Galldiks N, 2010, MOL IMAGING, V9, P40, DOI 10.2310/7290.2010.00002; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hermisson M, 2006, J NEUROCHEM, V96, P766, DOI 10.1111/j.1471-4159.2005.03583.x; Jacobs AH, 2005, J NUCL MED, V46, P1948; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Katz SI, 2011, INT J ONCOL, V39, P91, DOI 10.3892/ijo.2011.1019; Kumar AJ, 2000, RADIOLOGY, V217, P377, DOI 10.1148/radiology.217.2.r00nv36377; Machulla HJ, 2000, J RADIOANAL NUCL CH, V243, P843, DOI 10.1023/A:1010684101509; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Rueger MA, 2011, MOL IMAGING BIOL, V13, P547, DOI 10.1007/s11307-010-0361-6; Schafers KP, 2005, J NUCL MED, V46, P996; Schwarzenberg J, 2012, J NUCL MED, V53, P29, DOI 10.2967/jnumed.111.092387; Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337; Silber JR, 2012, BBA-REV CANCER, V1826, P71, DOI 10.1016/j.bbcan.2011.12.004; Soloviev D, 2012, EUR J CANCER, V48, P416, DOI 10.1016/j.ejca.2011.11.035; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Ullrich R, 2008, CLIN CANCER RES, V14, P2049, DOI 10.1158/1078-0432.CCR-07-1553; Vesselle H, 2002, CLIN CANCER RES, V8, P3315; Viel T, 2012, J NUCL MED, V53, P1135, DOI 10.2967/jnumed.111.101659; Vollmar S., 2004, FORSCHUNG WISSENSCHA, P115; Waerzeggers Y, 2010, BBA-MOL BASIS DIS, V1802, P819, DOI 10.1016/j.bbadis.2010.04.009; Wei LH, 2008, CLIN CANCER RES, V14, P3416, DOI 10.1158/1078-0432.CCR-07-1824; Weller M., 2011, SWISS MED WEEKLY, V24, P141; Weller M, 2010, NAT REV NEUROL, V6, P39, DOI 10.1038/nrneurol.2009.197; Wells P, 2002, CANCER RES, V62, P5698; Zhang CC, 2012, CLIN CANCER RES, V18, P1303, DOI 10.1158/1078-0432.CCR-11-1433	32	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67911	10.1371/journal.pone.0067911	http://dx.doi.org/10.1371/journal.pone.0067911			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861829	gold, Green Published, Green Submitted			2022-12-27	WOS:000323350700057
J	Xiao, JY; Zhang, GX; Qiu, PX; Liu, XJ; Wu, YY; Du, BY; Li, JF; Zhou, J; Li, JJ; Tan, YH				Xiao, Jianyong; Zhang, Guangxian; Qiu, Pengxiang; Liu, Xijuan; Wu, Yingya; Du, Biaoyan; Li, Jiefen; Zhou, Jing; Li, Jingjing; Tan, Yuhui			Tanshinone IIA Increases the Bystander Effect of Herpes Simplex Virus Thymidine Kinase/Ganciclovir Gene Therapy via Enhanced Gap Junctional Intercellular Communication	PLOS ONE			English	Article							IN-VITRO; BREAST-TUMORS; CELLS; CANCER; EXPRESSION; DIFFERENTIATION; CYTOTOXICITY; CONNEXIN-26; INDUCTION; CARCINOGENESIS	The bystander effect is an intriguing phenomenon by which adjacent cells become sensitized to drug treatment during gene therapy with herpes simplex virus thymidine kinase/ganciclovir (HSV-tk/GCV). This effect is reported to be mediated by gap junctional intercellular communication (GJIC), and therefore, we postulated that upregulation of genes that facilitate GJIC may enhance the HSV-tk/GCV bystander effect. Previous findings have shown Tanshinone IIA (Tan IIA), a chemical substance derived from a Chinese medicine herb, promotes the upregulation of the connexins Cx26 and Cx43 in B16 cells. Because gap junctions are formed by connexins, we hypothesized that Tan IIA might increase GJIC. Our results show that Tan IIA increased GJIC in B16 melanoma cells, leading to more efficient GCV-induced bystander killing in cells stably expressing HSV-tk. Additionally, in vivo experiments demonstrated that tumors in mice with 10% HSV-tk positive B16 cells and 90% wild-type B16 cells became smaller following treatment with the combination of GCV and Tan IIA as compared to GCV or Tan IIA alone. These data demonstrate that Tan IIA can augment the bystander effect of HSV-tk/GCV system through increased gap junction coupling, which adds strength to the promising strategy that develops connexins inducer to potentiate the effects of suicide gene therapy.	[Xiao, Jianyong; Zhang, Guangxian; Qiu, Pengxiang; Liu, Xijuan; Wu, Yingya; Li, Jiefen; Zhou, Jing; Li, Jingjing; Tan, Yuhui] Guangzhou Univ Chinese Med, Dept Biochem, Guangzhou, Guangdong, Peoples R China; [Du, Biaoyan] Guangzhou Univ Chinese Med, Dept Pathol, Guangzhou, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Tan, YH (corresponding author), Guangzhou Univ Chinese Med, Dept Biochem, Guangzhou, Guangdong, Peoples R China.	yuhuitan@yeah.net	谭, 育慧/AAP-4868-2021; Qiu, Pengxiang/J-7535-2019		National Natural Science Foundation of China [30973811, 81274145]; Guangdong Natural Science Foundation [S2012040007005]; Guangdong Provincial Administration of Chinese Traditional Medicine [20121227]; Ministry of Education, Science Technology Development Center [20124425120012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangdong Provincial Administration of Chinese Traditional Medicine; Ministry of Education, Science Technology Development Center	This work was supported by grants from the National Natural Science Foundation of China (Nos. 30973811 and 81274145), Guangdong Natural Science Foundation (No. S2012040007005), Guangdong Provincial Administration of Chinese Traditional Medicine (No. 20121227) and Ministry of Education, Science Technology Development Center (No. 20124425120012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT MVL, 1991, NEURON, V6, P305, DOI 10.1016/0896-6273(91)90241-Q; Carystinos GD, 1999, CLIN CANCER RES, V5, P61; CULVER KW, 1992, SCIENCE, V256, P1550, DOI 10.1126/science.1317968; Elshami AA, 1996, GENE THER, V3, P85; FICK J, 1995, P NATL ACAD SCI USA, V92, P11071, DOI 10.1073/pnas.92.24.11071; Fish JM, 2006, CIRCULATION, V113, P1393, DOI 10.1161/CIRCULATIONAHA.105.601690; Garcia-Rodriguez L, 2011, MOL CANCER THER, V10, P505, DOI 10.1158/1535-7163.MCT-10-0693; GOLDBERG GS, 1995, BIOTECHNIQUES, V18, P490; Haass NK, 2006, J HISTOCHEM CYTOCHEM, V54, P171, DOI 10.1369/jhc.5A6719.2005; Haass NK, 2004, J MOL HISTOL, V35, P309; Holden PR, 1997, CARCINOGENESIS, V18, P15, DOI 10.1093/carcin/18.1.15; HOSSAIN MZ, 1994, CELL GROWTH DIFFER, V5, P1253; Jamieson S, 1998, J PATHOL, V184, P37, DOI 10.1002/(SICI)1096-9896(199801)184:1<37::AID-PATH966>3.0.CO;2-D; Jin ZJ, 2004, ACTA PHARMACOL SIN, V25, P146; KOZARSKY KF, 1993, CURR OPIN GENET DEV, V3, P499, DOI 10.1016/0959-437X(93)90126-A; Laird DW, 1999, CANCER RES, V59, P4104; Lawrence TS, 1998, CANCER RES, V58, P2588; Lin R, 2006, J ETHNOPHARMACOL, V108, P217, DOI 10.1016/j.jep.2006.05.004; Liu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042138; McLachlan E, 2006, CANCER RES, V66, P9886, DOI 10.1158/0008-5472.CAN-05-4302; MEHTA PP, 1991, J MEMBRANE BIOL, V124, P207, DOI 10.1007/BF01994355; Mesnil M, 2000, CANCER RES, V60, P3989; Mesnil M, 1997, CANCER RES, V57, P2929; Mesnil M, 1996, P NATL ACAD SCI USA, V93, P1831, DOI 10.1073/pnas.93.5.1831; MILLER AD, 1992, NATURE, V357, P455, DOI 10.1038/357455a0; MOOLTEN FL, 1994, CANCER GENE THER, V1, P279; MOOLTEN FL, 1986, CANCER RES, V46, P5276; Park JY, 1997, GENE THER, V4, P909, DOI 10.1038/sj.gt.3300477; Proulx AA, 1997, CELL GROWTH DIFFER, V8, P533; Putzer BM, 1998, HUM GENE THER, V9, P707, DOI 10.1089/hum.1998.9.5-707; Rezze GG, 2011, HUM PATHOL, V42, P409, DOI 10.1016/j.humpath.2010.09.004; Saito-Katsuragi M, 2007, CANCER, V110, P1162, DOI 10.1002/cncr.22894; Saitoh M, 1997, CARCINOGENESIS, V18, P1319, DOI 10.1093/carcin/18.7.1319; Trosko James E., 1998, Frontiers in Bioscience, V3, pD208; Wang J, 2007, J NEURO-ONCOL, V82, P11, DOI 10.1007/s11060-006-9242-x; Wygoda MR, 1997, CANCER RES, V57, P1699; Yang J, 2012, MOL VIS, V18, P2053; Yin X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0038381, 10.1371/journal.pone.0051853]; Zhai Y, 2002, AM J PATHOL, V160, P1229, DOI 10.1016/S0002-9440(10)62550-3; Zhang Y, 2010, CELL PHYSIOL BIOCHEM, V26, P991, DOI 10.1159/000324012	40	12	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67662	10.1371/journal.pone.0067662	http://dx.doi.org/10.1371/journal.pone.0067662			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861780	gold, Green Published, Green Submitted			2022-12-27	WOS:000323350700019
J	Auersperg, AMI; Kacelnik, A; von Bayern, AMP				Auersperg, Alice M. I.; Kacelnik, Alex; von Bayern, Auguste M. P.			Explorative Learning and Functional Inferences on a Five-Step Means-Means-End Problem in Goffin's Cockatoos (Cacatua goffini)	PLOS ONE			English	Article							TOOL; MANUFACTURE	To investigate cognitive operations underlying sequential problem solving, we confronted ten Goffin's cockatoos with a baited box locked by five different inter-locking devices. Subjects were either naive or had watched a conspecific demonstration, and either faced all devices at once or incrementally. One naive subject solved the problem without demonstration and with all locks present within the first five sessions (each consisting of one trial of up to 20 minutes), while five others did so after social demonstrations or incremental experience. Performance was aided by species-specific traits including neophilia, a haptic modality and persistence. Most birds showed a ratchet-like progress, rarely failing to solve a stage once they had done it once. In most transfer tests subjects reacted flexibly and sensitively to alterations of the locks' sequencing and functionality, as expected from the presence of predictive inferences about mechanical interactions between the locks.	[Auersperg, Alice M. I.] Univ Vienna, Dept Cognit Biol, Vienna, Austria; [Kacelnik, Alex; von Bayern, Auguste M. P.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Auersperg, Alice M. I.; von Bayern, Auguste M. P.] Max Planck Inst Ornithol, Seewiesen, Germany	University of Vienna; University of Oxford; Max Planck Society	Auersperg, AMI (corresponding author), Univ Vienna, Dept Cognit Biol, Vienna, Austria.	alice.auersperg@univie.ac.at; alex.kacelnik@zoo.ox.ac.uk		von Bayern, Auguste/0000-0002-0981-9456; Auersperg, Alice/0000-0001-7405-9791	Austria Science Fond (FWF) [J 3404-B19]; Austrian Science Fund (FWF) [J 3404] Funding Source: researchfish	Austria Science Fond (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This Project was supported by the Austria Science Fond (FWF) Project no. J 3404-B19 to Alice Auersperg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auersperg AMI, 2012, CURR BIOL, V22, pR903, DOI 10.1016/j.cub.2012.09.002; Auersperg AMI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020231; Auersperg AMI, 2010, ANIM BEHAV, V80, P783, DOI 10.1016/j.anbehav.2010.08.007; Auersperg AMI, 2013, J COMP PSYC IN PRESS; Bird CD, 2009, P NATL ACAD SCI USA, V106, P10370, DOI 10.1073/pnas.0901008106; Boesch C, 2009, J HUM EVOL, V56, P560, DOI 10.1016/j.jhevol.2009.04.001; Carvalho S, 2008, J HUM EVOL, V55, P148, DOI 10.1016/j.jhevol.2008.02.005; Carvalho S, 2009, ANIM COGN, V12, pS103, DOI 10.1007/s10071-009-0271-7; Chappell J, 2012, BEHAV PROCESS, V89, P179, DOI 10.1016/j.beproc.2011.10.001; Cheke LG, 2011, ANIM COGN, V14, P441, DOI 10.1007/s10071-011-0379-4; Diefenbach K, 1985, KAKADUS ENZYKLOPADIE; EPSTEIN R, 1984, NATURE, V308, P61, DOI 10.1038/308061a0; Epstein R, 1999, 2 ENCY CREATIVITY; Gallistel CR, 2004, P NATL ACAD SCI USA, V101, P13124, DOI 10.1073/pnas.0404965101; Higgins P. J., 1999, HDB AUSTR NZ ANTARCT, V4, P1049; Huber L, 2001, ANIM BEHAV, V62, P945, DOI 10.1006/anbe.2001.1822; Hunt GR, 1996, NATURE, V379, P249, DOI 10.1038/379249a0; Lefebvre L, 1997, ANIM BEHAV, V53, P549, DOI 10.1006/anbe.1996.0330; Martin-Ordas G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052074; McGrew W.C., 1992, CHIMPANZEE MAT CULTU; Mettke-Hofmann C, 2002, ETHOLOGY, V108, P249, DOI 10.1046/j.1439-0310.2002.00773.x; Miyata H, 2011, ANIM COGN, V14, P45, DOI 10.1007/s10071-010-0342-9; Overington SE, 2011, BEHAV PROCESS, V87, P274, DOI 10.1016/j.beproc.2011.06.002; Overington SE, 2009, ANIM BEHAV, V78, P1001, DOI 10.1016/j.anbehav.2009.06.033; Povinelli D.J., 2000, FOLK PHYS APES CHIMP; Power T. G., 2000, PLAY EXPLORATION CHI; Santos LR, 2005, ANIM COGN, V8, P236, DOI 10.1007/s10071-004-0246-7; Shettleworth S.J., 2009, COGNITION EVOLUTION; Shumaker R. W., 2011, ANIMAL TOOL BEHAV US; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Taylor AH, 2007, CURR BIOL, V17, P1504, DOI 10.1016/j.cub.2007.07.057; Tomasello M, 1997, PRIMATE COGNITION; Whiten A, 1996, J COMP PSYCHOL, V110, P3, DOI 10.1037/0735-7036.110.1.3; Wimpenny JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006471	34	34	34	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68979	10.1371/journal.pone.0068979	http://dx.doi.org/10.1371/journal.pone.0068979			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844247	Green Submitted, Green Published, gold			2022-12-27	WOS:000321733000031
J	Arevalo, H; Plank, G; Helm, P; Halperin, H; Trayanova, N				Arevalo, Hermenegild; Plank, Gernot; Helm, Patrick; Halperin, Henry; Trayanova, Natalia			Tachycardia in Post-Infarction Hearts: Insights from 3D Image-Based Ventricular Models	PLOS ONE			English	Article							EPICARDIAL BORDER ZONE; INFARCT TISSUE HETEROGENEITY; GAP-JUNCTION DISTRIBUTION; REENTRANT CIRCUITS; MYOCARDIAL INFARCTS; CONDUCTION-VELOCITY; IRREVERSIBLE INJURY; SUSCEPTIBILITY; ARRHYTHMIA; CURRENTS	Ventricular tachycardia, a life-threatening regular and repetitive fast heart rhythm, frequently occurs in the setting of myocardial infarction. Recently, the peri-infarct zones surrounding the necrotic scar (termed gray zones) have been shown to correlate with ventricular tachycardia inducibility. However, it remains unknown how the latter is determined by gray zone distribution and size. The goal of this study is to examine how tachycardia circuits are maintained in the infarcted heart and to explore the relationship between the tachycardia organizing centers and the infarct gray zone size and degree of heterogeneity. To achieve the goals of the study, we employ a sophisticated high-resolution electrophysiological model of the infarcted canine ventricles reconstructed from imaging data, representing both scar and gray zone. The baseline canine ventricular model was also used to generate additional ventricular models with different gray zone sizes, as well as models in which the gray zone was represented as different heterogeneous combinations of viable tissue and necrotic scar. The results of the tachycardia induction simulations with a number of high-resolution canine ventricular models (22 altogether) demonstrated that the gray zone was the critical factor resulting in arrhythmia induction and maintenance. In all models with inducible arrhythmia, the scroll-wave filaments were contained entirely within the gray zone, regardless of its size or the level of heterogeneity of its composition. The gray zone was thus found to be the arrhythmogenic substrate that promoted wavebreak and reentry formation. We found that the scroll-wave filament locations were insensitive to the structural composition of the gray zone and were determined predominantly by the gray zone morphology and size. The findings of this study have important implications for the advancement of improved criteria for stratifying arrhythmia risk in post-infarction patients and for the development of new approaches for determining the ablation targets of infarct-related tachycardia.	[Arevalo, Hermenegild; Trayanova, Natalia] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Plank, Gernot] Med Univ Graz, Inst Biophys, Graz, Austria; [Helm, Patrick] Medtronic Inc, Minneapolis, MN USA; [Halperin, Henry] Johns Hopkins Univ, Dept Med, Baltimore, MD USA	Johns Hopkins University; Medical University of Graz; Medtronic; Johns Hopkins University	Trayanova, N (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.	ntrayanova@jhu.edu	Plank, Gernot/O-3791-2019; Plank, Gernot/C-9498-2011	Plank, Gernot/0000-0002-7380-6908; Plank, Gernot/0000-0002-7380-6908; Trayanova, Natalia/0000-0002-8661-063X	National Intitutes of Health [R01-HL094610, R01-HL103428, R01-HL105216]; NIH [F31-HL099275]; Austrian Science Fund FWF [F3210-N18]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094610, R01HL103428, F31HL099275, R01HL105216] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [F 3201] Funding Source: researchfish	National Intitutes of Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund FWF(Austrian Science Fund (FWF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This project was supported by National Intitutes of Health grants R01-HL094610, R01-HL103428, R01-HL105216, NIH fellowship F31-HL099275, and Austrian Science Fund FWF grant F3210-N18. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo H, 2007, CHAOS, V17, DOI 10.1063/1.2430637; Arheden H, 2000, RADIOLOGY, V215, P520, DOI 10.1148/radiology.215.2.r00ma38520; Ashikaga H, 2007, CIRC RES, V101, P939, DOI 10.1161/CIRCRESAHA.107.158980; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bishop MJ, 2011, IEEE T BIO-MED ENG, V58, P1066, DOI 10.1109/TBME.2010.2096425; Brignole M, 2009, EUROPACE, V11, P1129, DOI 10.1093/europace/eup174; Cabo C, 2006, CARDIOVASC RES, V72, P241, DOI 10.1016/j.cardiores.2006.07.005; Curtis JP, 2009, JAMA-J AM MED ASSOC, V301, P1661, DOI 10.1001/jama.2009.547; de Bakker JMT, 2006, J CARDIOVASC ELECTR, V17, P567, DOI 10.1111/j.1540-8167.2006.00367.x; DEBAKKER JMT, 1993, CIRCULATION, V88, P915, DOI 10.1161/01.CIR.88.3.915; Decker KF, 2010, AM J PHYSIOL-HEART C, V299, pH1588, DOI 10.1152/ajpheart.00362.2010; Dun W, 2004, AM J PHYSIOL-HEART C, V287, pH1046, DOI 10.1152/ajpheart.00082.2004; Engelman ZJ, 2010, CIRC-ARRHYTHMIA ELEC, V3, P195, DOI 10.1161/CIRCEP.109.890459; Epstein AE, 2008, CIRCULATION, V117, pE350, DOI 10.1161/CIRCUALTIONAHA.108.189742; Estner HL, 2011, HEART RHYTHM, V8, P1942, DOI 10.1016/j.hrthm.2011.07.027; Fieno DS, 2000, J AM COLL CARDIOL, V36, P1985, DOI 10.1016/S0735-1097(00)00958-X; Gima K, 2002, CIRC RES, V90, P889, DOI 10.1161/01.RES.0000016960.61087.86; Greener ID, 2012, J AM COLL CARDIOL, V60, P1103, DOI 10.1016/j.jacc.2012.04.042; Gurev V, 2011, BIOMECH MODEL MECHAN, V10, P295, DOI 10.1007/s10237-010-0235-5; HARALICK RM, 1987, IEEE T PATTERN ANAL, V9, P532, DOI 10.1109/TPAMI.1987.4767941; Igarashi T, 2012, CIRCULATION, V125, P216, DOI 10.1161/CIRCULATIONAHA.111.053272; Jiang M, 2000, CARDIOVASC RES, V48, P34, DOI 10.1016/S0008-6363(00)00159-0; Kim RJ, 1999, CIRCULATION, V100, P1992, DOI 10.1161/01.CIR.100.19.1992; Kleber AG, 2004, PHYSIOL REV, V84, P431, DOI 10.1152/physrev.00025.2003; Larson C, 2003, ANN BIOMED ENG, V31, P768, DOI 10.1114/1.1581289; LIMA JAC, 1995, CIRCULATION, V92, P1117, DOI 10.1161/01.CIR.92.5.1117; LUO CH, 1994, CIRC RES, V74, P1097, DOI 10.1161/01.RES.74.6.1097; McDowell KS, 2011, BIOPHYS J, V101, P1307, DOI 10.1016/j.bpj.2011.08.009; Moreno JD, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002588; Ng J, 2012, J AM COLL CARDIOL, V60, P423, DOI 10.1016/j.jacc.2012.03.029; Peters NS, 1997, CIRCULATION, V95, P988; Plank G, 2008, PHILOS T R SOC A, V366, P3381, DOI 10.1098/rsta.2008.0112; Prassl AJ, 2009, IEEE T BIO-MED ENG, V56, P1318, DOI 10.1109/TBME.2009.2014243; Pu JL, 1997, CIRC RES, V81, P110, DOI 10.1161/01.RES.81.1.110; Qu ZL, 1999, AM J PHYSIOL-HEART C, V276, pH269, DOI 10.1152/ajpheart.1999.276.1.H269; ROBERTS DE, 1979, CIRC RES, V44, P701, DOI 10.1161/01.RES.44.5.701; Rocha BM, 2011, IEEE T BIO-MED ENG, V58, P1055, DOI 10.1109/TBME.2010.2064167; Rodriguez B, 2004, AM J PHYSIOL-HEART C, V286, pH2078, DOI 10.1152/ajpheart.01175.2003; Roes SD, 2009, CIRC-CARDIOVASC IMAG, V2, P183, DOI 10.1161/CIRCIMAGING.108.826529; Rutherford SL, 2012, CIRC RES, V111, P301, DOI 10.1161/CIRCRESAHA.111.260943; Sasano T, 2006, NAT MED, V12, P1256, DOI 10.1038/nm1503; Schmidt A, 2007, CIRCULATION, V115, P2006, DOI 10.1161/CIRCULATIONAHA.106.653568; Simonetti OP, 2001, RADIOLOGY, V218, P215, DOI 10.1148/radiology.218.1.r01ja50215; SMITH JH, 1991, AM J PATHOL, V139, P801; Strijkers GJ, 2009, NMR BIOMED, V22, P182, DOI 10.1002/nbm.1299; URSELL PC, 1985, CIRC RES, V56, P436, DOI 10.1161/01.RES.56.3.436; Vadakkumpadan F, 2010, WIRES SYST BIOL MED, V2, P489, DOI 10.1002/wsbm.76; Vigmond EJ, 2008, PROG BIOPHYS MOL BIO, V96, P3, DOI 10.1016/j.pbiomolbio.2007.07.012; Vigmond EJ, 2003, J ELECTROCARDIOL, V36, P69, DOI 10.1016/j.jelectrocard.2003.09.017; Winfree A.T., 1987, TIME BREAKS 3 DIMENS; Wu E, 2001, LANCET, V357, P21, DOI 10.1016/S0140-6736(00)03567-4; Yan AT, 2006, CIRCULATION, V114, P32, DOI 10.1161/CIRCULATIONAHA.106.613414; Yao JA, 2003, CIRC RES, V92, P437, DOI 10.1161/01.RES.0000059301.81035.06; Zipes DP, 2006, EUR HEART J, V27, P2099, DOI 10.1093/eurheartj/ehl199; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	55	62	62	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68872	10.1371/journal.pone.0068872	http://dx.doi.org/10.1371/journal.pone.0068872			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844245	Green Submitted, gold, Green Published			2022-12-27	WOS:000321341000182
J	Conza, L; Pagani, SC; Gaia, V				Conza, Lisa; Pagani, Simona Casati; Gaia, Valeria			Presence of Legionella and Free-Living Amoebae in Composts and Bioaerosols from Composting Facilities	PLOS ONE			English	Article							LEGIONNAIRES-DISEASE; POTTING SOILS; PNEUMOPHILA; COCULTURE; AEROSOLS; WATER; SURVIVAL; SAMPLES	Several species of Legionella cause Legionnaires' disease (LD). Infection may occur through inhalation of Legionella or amoebal vesicles. The reservoirs of Legionella are water, soil, potting soil and compost. Some species of free-living amoebae (FLA) that are naturally present in water and soil were described as hosts for Legionella. This study aimed to understand whether or not the composting facilities could be sources of community-acquired Legionella infections after development of bioaerosols containing Legionella or FLA. We looked for the presence of Legionella (by co-culture) and FLA (by culture) in composts and bioaerosols collected at four composting facilities located in southern Switzerland. We investigated the association between the presence of Legionella and compost and air parameters and presence of FLA. Legionella spp. (including L. pneumophila) were detected in 69.3% (61/88) of the composts and FLA (mainly Acanthamoeba, Vermamoeba, Naegleria and Stenamoeba) in 92.0% (81/88). L. pneumophila and L. bozemanii were most frequently isolated. FLA as potential host for Legionella spp. were isolated from 40.9% (36/88) of the composts in all facilities. In Legionella-positive samples the temperature of compost was significantly lower (P = 0.012) than in Legionella-negative samples. Of 47 bioaerosol samples, 19.1% (9/47) were positive for FLA and 10.6% (5/47) for L. pneumophila. Composts (62.8%) were positive for Legionella and FLA contemporaneously, but both microorganisms were never detected simultaneously in bioaerosols. Compost can release bioaerosol containing FLA or Legionella and could represent a source of infection of community-acquired Legionella infections for workers and nearby residents.	[Conza, Lisa; Pagani, Simona Casati; Gaia, Valeria] Swiss Natl Reference Ctr Legionella, Cantonal Inst Microbiol, Bellinzona, Switzerland		Conza, L (corresponding author), Swiss Natl Reference Ctr Legionella, Cantonal Inst Microbiol, Bellinzona, Switzerland.	lisaconza@gmail.com			Ticino Pulmonary League; Lung Leagues of the Canton Ticino; Dr. Pierluigi Crivelli Foundation	Ticino Pulmonary League; Lung Leagues of the Canton Ticino; Dr. Pierluigi Crivelli Foundation	The work has been partially supported by the Ticino Pulmonary League. A special thanks to Lung Leagues of the Canton Ticino and to the Dr. Pierluigi Crivelli Foundation for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	BERENDT RF, 1980, J INFECT DIS, V141, P689, DOI 10.1093/infdis/141.5.689; Blatny JM, 2008, ENVIRON SCI TECHNOL, V42, P7360, DOI 10.1021/es800306m; Carvalho E, 2008, AEROBIOLOGIA, V24, P191, DOI 10.1007/s10453-008-9098-y; Casati S, 2010, CLIN MICROBIOL INFEC, V16, P945, DOI 10.1111/j.1469-0691.2009.03009.x; Casati S, 2009, CLIN MICROBIOL INFEC, V15, P571, DOI 10.1111/j.1469-0691.2009.02742.x; Conza L, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-49; Danon M, 2008, FEMS MICROBIOL ECOL, V65, P133, DOI 10.1111/j.1574-6941.2008.00506.x; Declerck P, 2007, WATER RES, V41, P3159, DOI 10.1016/j.watres.2007.04.011; den Boer JW, 2007, CLIN MICROBIOL INFEC, V13, P88, DOI 10.1111/j.1469-0691.2006.01562.x; DENNIS PJ, 1988, J APPL BACTERIOL, V65, P135, DOI 10.1111/j.1365-2672.1988.tb01501.x; DENNIS PJL, 1984, J HYG-CAMBRIDGE, V93, P349, DOI 10.1017/S0022172400064901; Descours G, 2012, J CLIN MICROBIOL, V50, P1725, DOI 10.1128/JCM.06531-11; Dey R, 2009, FEMS MICROBIOL LETT, V290, P10, DOI 10.1111/j.1574-6968.2008.01387.x; FLIERMANS CB, 1981, APPL ENVIRON MICROB, V41, P9, DOI 10.1128/AEM.41.1.9-16.1981; Fracchia L, 2006, J APPL MICROBIOL, V100, P973, DOI 10.1111/j.1365-2672.2006.02846.x; Gaia V, 2011, SYST APPL MICROBIOL, V34, P40, DOI 10.1016/j.syapm.2010.11.007; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Helbig JH, 2002, EUR J CLIN MICROBIOL, V21, P710, DOI 10.1007/s10096-002-0820-3; Helbig JH, 1997, J CLIN MICROBIOL, V35, P2841, DOI 10.1128/JCM.35.11.2841-2845.1997; Hryhorczuk D, 2001, ANN AGR ENV MED, V8, P177; Joseph CA, 2010, EURO SURVEILL; La Scola B, 2001, J CLIN MICROBIOL, V39, P365, DOI 10.1128/JCM.39.1.365-366.2001; Lin H, 2009, J APPL MICROBIOL, V106, P606, DOI 10.1111/j.1365-2672.2008.04031.x; Nguyen TMN, 2006, J INFECT DIS, V193, P102, DOI 10.1086/498575; Ratcliff RM, 1998, J CLIN MICROBIOL, V36, P1560, DOI 10.1128/JCM.36.6.1560-1567.1998; RODRIGUEZZARAGOZA S, 1994, CRIT REV MICROBIOL, V20, P225, DOI 10.3109/10408419409114556; ROWBOTHAM TJ, 1983, J CLIN PATHOL, V36, P978, DOI 10.1136/jcp.36.9.978; Sanchez-Monedero MA, 2005, J AIR WASTE MANAGE, V55, P612, DOI 10.1080/10473289.2005.10464652; Schuster FL, 2002, CLIN MICROBIOL REV, V15, P342, DOI 10.1128/CMR.15.3.342-354.2002; STEELE TW, 1990, APPL ENVIRON MICROB, V56, P2984, DOI 10.1128/AEM.56.10.2984-2988.1990; Storey MV, 2004, SCAND J INFECT DIS, V36, P656, DOI 10.1080/00365540410020785; Taha MPM, 2005, WASTE MANAGE, V25, P445, DOI 10.1016/j.wasman.2005.02.013; Thomas V, 2006, APPL ENVIRON MICROB, V72, P2428, DOI 10.1128/AEM.72.4.2428-2438.2006	33	37	38	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68244	10.1371/journal.pone.0068244	http://dx.doi.org/10.1371/journal.pone.0068244			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844174	gold, Green Published, Green Submitted			2022-12-27	WOS:000321341000146
J	Hall, LK; Larsen, RT; Knight, RN; Bunnell, KD; McMillan, BR				Hall, Lucas K.; Larsen, Randy T.; Knight, Robert N.; Bunnell, Kevin D.; McMillan, Brock R.			Water Developments and Canids in Two North American Deserts: A Test of the Indirect Effect of Water Hypothesis	PLOS ONE			English	Article							JOAQUIN KIT FOXES; WESTERN UNITED-STATES; GREAT-BASIN DESERT; SOUTHWESTERN ARIZONA; DISPERSAL DISTANCE; LAKE BONNEVILLE; MULE DEER; WILDLIFE; COYOTES; PREDATION	Anthropogenic modifications to landscapes intended to benefit wildlife may negatively influence wildlife communities. Anthropogenic provisioning of free water (water developments) to enhance abundance and distribution of wildlife is a common management practice in arid regions where water is limiting. Despite the long-term and widespread use of water developments, little is known about how they influence native species. Water developments may negatively influence arid-adapted species (e. g., kit fox, Vulpes macrotis) by enabling water-dependent competitors (e.g., coyote, Canis latrans) to expand distribution in arid landscapes (i.e., indirect effect of water hypothesis). We tested the two predictions of the indirect effect of water hypothesis (i.e., coyotes will visit areas with free water more frequently and kit foxes will spatially and temporally avoid coyotes) and evaluated relative use of free water by canids in the Great Basin and Mojave Deserts from 2010 to 2012. We established scent stations in areas with (wet) and without (dry) free water and monitored visitation by canids to these sites and visitation to water sources using infrared-triggered cameras. There was no difference in the proportions of visits to scent stations in wet or dry areas by coyotes or kit foxes at either study area. We did not detect spatial (no negative correlation between visits to scent stations) or temporal (no difference between times when stations were visited) segregation between coyotes and kit foxes. Visitation to water sources was not different for coyotes between study areas, but kit foxes visited water sources more in Mojave than Great Basin. Our results did not support the indirect effect of water hypothesis in the Great Basin or Mojave Deserts for these two canids.	[Hall, Lucas K.; Larsen, Randy T.; McMillan, Brock R.] Brigham Young Univ, Dept Plant & Wildlife Sci, Provo, UT 84602 USA; [Larsen, Randy T.] Brigham Young Univ, Monte L Bean Life Sci Museum, Provo, UT 84602 USA; [Knight, Robert N.] United States Army Dugway Proving Ground, Environm Programs, Dugway, UT USA; [Bunnell, Kevin D.] Utah Div Wildlife Resources, Salt Lake City, UT USA	Brigham Young University; Brigham Young University	Hall, LK (corresponding author), Brigham Young Univ, Dept Plant & Wildlife Sci, Provo, UT 84602 USA.	lucashall4@gmail.com			United States Army Dugway Proving Ground; Utah Division of Wildlife Resources	United States Army Dugway Proving Ground; Utah Division of Wildlife Resources	Funding for this project was provided by the United States Army Dugway Proving Ground and the Utah Division of Wildlife Resources. RN Knight (US Army Dugway Proving Ground) and KD Bunnell (Utah Division of Wildlife Resources) were involved in the preparation of the manuscript. The funders had no role in study design, data collection and analysis, or decision to publish.	Arjo WM, 2007, WEST N AM NATURALIST, V67, P389, DOI 10.3398/1527-0904(2007)67[389:CIKFRI]2.0.CO;2; Atwood TC, 2011, J WILDLIFE MANAGE, V75, P1609, DOI 10.1002/jwmg.225; Atwood TC, 2010, J MAMMAL, V91, P490, DOI 10.1644/09-MAMM-A-078.1; Bleich VC, 2006, WILDLIFE SOC B, V34, P627, DOI 10.2193/0091-7648(2006)34[627:QOWATW]2.0.CO;2; Bowman J, 2003, CAN J ZOOL, V81, P195, DOI 10.1139/Z02-237; Bowman J, 2002, ECOLOGY, V83, P2049, DOI 10.2307/3071786; Brawata RL, 2011, WILDLIFE RES, V38, P426, DOI 10.1071/WR10169; BROECKER WS, 1965, GEOL SOC AM BULL, V76, P537, DOI 10.1130/0016-7606(1965)76[537:RCOLLA]2.0.CO;2; Broyles B, 1995, WILDLIFE SOC B, V23, P663; Cain JW, 2006, WILDLIFE SOC B, V34, P570, DOI 10.2193/0091-7648(2006)34[570:MOTAWB]2.0.CO;2; Cook ER, 2004, SCIENCE, V306, P1015, DOI 10.1126/science.1102586; Cooper SM, 2000, WILDLIFE SOC B, V28, P660; CURREY DR, 1990, PALAEOGEOGR PALAEOCL, V76, P189, DOI 10.1016/0031-0182(90)90113-L; Cutler TL, 1998, SOUTHWEST NAT, V43, P155; Cypher BL, 1998, J MAMMAL, V79, P204, DOI 10.2307/1382855; Cypher BL, 2000, WILDLIFE MONOGR, P1; Cypher Brian L., 1992, Proceedings of the Vertebrate Pest Conference, V15, P42; Dennis B, 2000, J WILDLIFE MANAGE, V64, P388, DOI 10.2307/3803237; EGOSCUE H. J., 1956, JOUR MAMMAL, V37, P351, DOI 10.2307/1376734; GOLIGHTLY RT, 1984, J MAMMAL, V65, P51, DOI 10.2307/1381199; GOLIGHTLY RT, 1983, J MAMMAL, V64, P624, DOI 10.2307/1380518; Hall LK, 2013, BEHAV PROCESS, V94, P76, DOI 10.1016/j.beproc.2012.12.007; Hamilton AM, 2002, AM MIDL NAT, V147, P123, DOI 10.1674/0003-0031(2002)147[0123:EODFHA]2.0.CO;2; HERVERT JJ, 1986, J WILDLIFE MANAGE, V50, P670, DOI 10.2307/3800979; Horn KJ, 2012, J ARID ENVIRON, V77, P54, DOI 10.1016/j.jaridenv.2011.10.003; Kendall M. G., 1962, RANK CORRELATION MET; Kozlowski AJ, 2008, AM MIDL NAT, V160, P191, DOI 10.1674/0003-0031(2008)160[191:NOARPB]2.0.CO;2; Krausman PR, 2006, WILDLIFE SOC B, V34, P563, DOI 10.2193/0091-7648(2006)34[563:DWFWSP]2.0.CO;2; Larsen RT, 2012, CALIF FISH GAME, V98, P148; Longshore KM, 2009, J ARID ENVIRON, V73, P280, DOI 10.1016/j.jaridenv.2008.09.021; Martinson TJ, 2003, WILDLIFE SOC B, V31, P510; McGrew JC, 1979, MAMM SPECIES, V123, P1; Michalski F, 2007, CONSERV BIOL, V21, P1626, DOI 10.1111/j.1523-1739.2007.00797.x; MILLS LS, 1991, CAN J ZOOL, V69, P1516, DOI 10.1139/z91-212; Moehrenschlager A, 2007, J MAMMAL, V88, P1029, DOI 10.1644/06-MAMM-A-159R.1; Morgart JR, 2005, WILDLIFE SOC B, V33, P51, DOI 10.2193/0091-7648(2005)33[51:SPUOAA]2.0.CO;2; Neale JCC, 2001, OIKOS, V94, P236, DOI 10.1034/j.1600-0706.2001.940204.x; Nelson JL, 2007, J WILDLIFE MANAGE, V71, P1467, DOI 10.2193/2006-234; O'Brien CS, 2006, WILDLIFE SOC B, V34, P582, DOI 10.2193/0091-7648(2006)34[582:WUOWCI]2.0.CO;2; O'Farrell T.P., 1999, WILD FURBEARER MANAG, P422; OwenSmith N, 1996, S AFR J WILDL RES, V26, P107; R Development Core Team, 2011, R LANG ENV STAT COMP; RAUTENSTRAUCH KR, 1989, J MAMMAL, V70, P197, DOI 10.2307/1381689; Rosenstock SS, 1999, J RANGE MANAGE, V52, P302, DOI 10.2307/4003538; Simpson NO, 2011, CALIF FISH GAME, V97, P190; VALLENTINE JF, 1980, RANGE DEV IMPROVEMEN; Warrick GD, 1999, SOUTHWEST NAT, V44, P367; Warrick GD, 1998, J WILDLIFE MANAGE, V62, P707, DOI 10.2307/3802347; WHITE PJ, 1994, CAN J ZOOL, V72, P1831, DOI 10.1139/z94-247; White PJ, 1996, J MAMMAL, V77, P370, DOI 10.2307/1382810; WHITE PJ, 1995, SOUTHWEST NAT, V40, P342; Zar JH, 1999, BIOSTATISTICAL ANAL	52	13	13	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67800	10.1371/journal.pone.0067800	http://dx.doi.org/10.1371/journal.pone.0067800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844097	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000100
J	Kim, JJ; Cho, HW; Park, HR; Jung, U; Jo, SK; Yee, ST				Kim, Jong-Jin; Cho, Hyun Wook; Park, Hae-Ran; Jung, Uhee; Jo, Sung-Kee; Yee, Sung-Tae			Preventative Effect of an Herbal Preparation (HemoHIM) on Development of Airway Inflammation in Mice via Modulation of Th1/2 Cells Differentiation	PLOS ONE			English	Article							ENDOCRINE DISRUPTORS; TH2 POLARIZATION; MOUSE MODEL; T-CELLS; ASTHMA; HYPERRESPONSIVENESS; SUPPRESSION; INHIBITION; RESPONSES; EXTRACT	HemoHIM, an herbal preparation of three edible herbs (Angelica gigas Nakai, Cnidium officinale Makino, Paeonia japonica Miyabe) is known to increase the Th1 immune response as well as reduce the allergic response in human mast cells. Here, our goal was to determine whether or not HemoHIM could induce Th1 cell differentiation as well as inhibit the development of airway inflammation. To study Th1/Th2 cell differentiation, naive CD4(+) T cells isolated from C57BL/6 mouse spleens were cultured with or without HemoHIM. To examine airway inflammation, C57BL/6 mice were fed HemoHIM for 4 weeks before sensitization and provocation with ovalbumin (OVA). In an in vitro experiment, naive CD4(+) T cells displayed increased Th1 (IFN-gamma(+) cell) as well as decreased Th2 (IL-4(+) cell) differentiation in a HemoHIM concentration-dependent manner. Furthermore, in an airway inflammation mice model, eosinophil numbers in BALF, serum levels of OVA-specific IgE and IgG1, and cytokine (IL-4, IL-5, and IL-13) levels in BALF and the supernatant of splenocytes all decreased upon HemoHIM (100 mg/kg body weight) pretreatment (4 weeks). These results show that HemoHIM attenuated allergic airway inflammation in the mouse model through regulation of the Th1/Th2 balance.	[Kim, Jong-Jin; Cho, Hyun Wook; Yee, Sung-Tae] Sunchon Natl Univ, Dept Biol, Sunchon, South Korea; [Park, Hae-Ran; Jung, Uhee; Jo, Sung-Kee] Korea Atom Energy Res Inst KAERI, Radiat Res Div Biotechnol, Adv Radiat Technol Inst, Jeongeup, South Korea; [Yee, Sung-Tae] Sunchon Natl Univ, Dept Pharm, Sunchon, South Korea	Sunchon National University; Korea Atomic Energy Research Institute (KAERI); Sunchon National University	Yee, ST (corresponding author), Sunchon Natl Univ, Dept Biol, Sunchon, South Korea.	sungtae@sunchon.ac.kr		Kim, Jong-Jin/0000-0002-1810-5383	creative research project; Korea Atomic Energy Research Institute, Korea [KAERI 527910-12]	creative research project; Korea Atomic Energy Research Institute, Korea	This work was supported by a creative research project funded from Korea Atomic Energy Research Institute, Korea (KAERI 527910-12)(http://www.kaeri.re.kr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandan C, 2010, ALLERGY, V65, P152, DOI 10.1111/j.1398-9995.2009.02244.x; Denes A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.86; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; HAN Rui, 2009, Zhejiang Da Xue Xue Bao Yi Xue Ban, V38, P352; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; Iwata M, 2004, IMMUNOL LETT, V94, P135, DOI 10.1016/j.imlet.2004.04.013; Jo SK, 2007, PHYTOTHER RES, V21, P625, DOI 10.1002/ptr.2068; Kato T, 2006, EUR J IMMUNOL, V36, P1199, DOI 10.1002/eji.200535140; Kato T, 2004, EUR J IMMUNOL, V34, P1312, DOI 10.1002/eji.200324667; Kim CK, 2010, RESP MED, V104, P1436, DOI 10.1016/j.rmed.2010.03.023; Kim JJ, 2009, J LIFE SCI, V12, P1808; Kim SH, 2009, J MED FOOD, V12, P1353, DOI 10.1089/jmf.2008.1322; Mahajan SG, 2011, EUR J PHARMACOL, V650, P458, DOI 10.1016/j.ejphar.2010.09.075; Meyts I, 2006, J IMMUNOL, V177, P6460, DOI 10.4049/jimmunol.177.9.6460; Miyaura H, 2002, J IMMUNOL, V168, P1087, DOI 10.4049/jimmunol.168.3.1087; Natarajan S, 2008, J IMMUNOL, V181, P8402, DOI 10.4049/jimmunol.181.12.8402; Nemzek JA, 2009, COMPARATIVE MED, V59, P321; Oh SW, 2011, J ETHNOPHARMACOL, V136, P414, DOI 10.1016/j.jep.2010.07.026; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; Palmqvist C, 2007, BRIT J PHARMACOL, V151, P725, DOI 10.1038/sj.bjp.0707263; Park HR, 2008, PHYTOTHER RES, V22, P36, DOI 10.1002/ptr.2255; Park HR, 2012, RADIAT RES, V177, P676, DOI 10.1667/RR2768.1; Park HR, 2010, J MED FOOD, V13, P47, DOI 10.1089/jmf.2009.1049; Park HR, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-85; Saito K, 2008, J IMMUNOL, V181, P6889, DOI 10.4049/jimmunol.181.10.6889; SNAPPER CM, 1993, IMMUNOL TODAY, V14, P15, DOI 10.1016/0167-5699(93)90318-F; Tada-Oikawa S, 2008, BIOCHEM PHARMACOL, V75, P552, DOI 10.1016/j.bcp.2007.09.011; Torii M, 2010, EUR J IMMUNOL, V40, P787, DOI 10.1002/eji.200939724; Yang EJ, 2011, J ETHNOPHARMACOL, V136, P422, DOI 10.1016/j.jep.2010.05.066; Yang EJ, 2011, PHYTOTHER RES, V25, P59, DOI 10.1002/ptr.3220; Yu J, 2010, ALLERGY ASTHMA IMMUN, V2, P199, DOI 10.4168/aair.2010.2.3.199	31	11	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68552	10.1371/journal.pone.0068552	http://dx.doi.org/10.1371/journal.pone.0068552			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844220	gold, Green Submitted, Green Published			2022-12-27	WOS:000321341000172
J	Montes, VN; Turner, MS; Subramanian, S; Ding, YL; Hayden-Ledbetter, M; Slater, S; Goodspeed, L; Wang, SR; Omer, M; Den Hartigh, LJ; Averill, MM; O'Brien, KD; Ledbetter, J; Chait, A				Montes, Vince N.; Turner, Michael S.; Subramanian, Savitha; Ding, Yilei; Hayden-Ledbetter, Martha; Slater, Sonya; Goodspeed, Leela; Wang, Shari; Omer, Mohamed; Den Hartigh, Laura J.; Averill, Michelle M.; O'Brien, Kevin D.; Ledbetter, Jeffrey; Chait, Alan			T Cell Activation Inhibitors Reduce CD8+T Cell and Pro-Inflammatory Macrophage Accumulation in Adipose Tissue of Obese Mice	PLOS ONE			English	Article							DIET-INDUCED OBESITY; SERUM AMYLOID A3; INSULIN-RESISTANCE; LDL RECEPTOR; ATHEROSCLEROSIS; PATHOPHYSIOLOGY; APOLIPOPROTEIN; IMMUNOGLOBULIN; COSTIMULATION; CHOLESTEROL	Adipose tissue inflammation and specifically, pro-inflammatory macrophages are believed to contribute to insulin resistance (IR) in obesity in humans and animal models. Recent studies have invoked T cells in the recruitment of pro-inflammatory macrophages and the development of IR. To test the role of the T cell response in adipose tissue of mice fed an obesogenic diet, we used two agents (CTLA-4 Ig and anti-CD40L antibody) that block co-stimulation, which is essential for full T cell activation. C57BL/6 mice were fed an obesogenic diet for 16 weeks, and concomitantly either treated with CTLA-4 Ig, anti-CD40L antibody or an IgG control (300 mu g/week). The treatments altered the immune cell composition of adipose tissue in obese mice. Treated mice demonstrated a marked reduction in pro-inflammatory adipose tissue macrophages and activated CD8+ T cells. Mice treated with anti-CD40L exhibited reduced weight gain, which was accompanied by a trend toward improved IR. CTLA-4 Ig treatment, however, was not associated with improved IR. These data suggest that the presence of pro-inflammatory T cells and macrophages can be altered with co-stimulatory inhibitors, but may not be a significant contributor to the whole body IR phenotype.	[Montes, Vince N.; Subramanian, Savitha; Ding, Yilei; Goodspeed, Leela; Wang, Shari; Omer, Mohamed; Den Hartigh, Laura J.; Averill, Michelle M.; Chait, Alan] Univ Washington, Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA; [Turner, Michael S.] Benaroya Res Inst, Seattle, WA USA; [Hayden-Ledbetter, Martha; Slater, Sonya; Ledbetter, Jeffrey] Univ Washington, Div Rheumatol, Seattle, WA 98195 USA; [O'Brien, Kevin D.] Univ Washington, Div Cardiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Benaroya Research Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Chait, A (corresponding author), Univ Washington, Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA.	achait@u.washington.edu	O'Brien, Kevin/CAH-4638-2022; O'Brien, Kevin Douglas/HDO-1461-2022	O'Brien, Kevin/0000-0002-2293-9196; O'Brien, Kevin Douglas/0000-0002-2293-9196; Subramanian, Savitha/0000-0002-4866-2009	NIH (NHLBI) [R01HL094352]; DPPG (NHLBI) [P01HL092969]; Nutrition, Obesity and Atherosclerosis (NHLBI) [T32 HL007028]; DRC (NIDDK) [P30DK017047]; NORC (NIDDK) [P30DK035816]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094352, P01HL092969, T32HL007028, K01HL118711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK035816, P30DK017047] Funding Source: NIH RePORTER	NIH (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DPPG (NHLBI); Nutrition, Obesity and Atherosclerosis (NHLBI); DRC (NIDDK); NORC (NIDDK); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NIH (NHLBI) R01HL094352; DPPG (NHLBI) P01HL092969; Nutrition, Obesity and Atherosclerosis (NHLBI) T32 HL007028 (www.nhlbi.nih.gov); DRC (NIDDK) P30DK017047; NORC (NIDDK) P30DK035816 (www.niddk.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EK, 2010, CURR OPIN LIPIDOL, V21, P172, DOI 10.1097/MOL.0b013e3283393867; Andersson J, 2010, CLIN IMMUNOL, V134, P33, DOI 10.1016/j.clim.2009.07.002; BEATTY PG, 1983, J IMMUNOL, V131, P2913; Chiba T, 2009, J LIPID RES, V50, P1353, DOI 10.1194/jlr.M900089-JLR200; Deiuliis J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016376; Ding Y, 2012, ARTERIOSCLER THROMB; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Gerdes N, 2011, THROMBOSIS HAEMOSTAS, P106; Han CY, 2007, DIABETES, V56, P2260, DOI 10.2337/db07-0218; HANSSON GK, 1989, AM J PATHOL, V135, P169; Harte RA, 1999, HORM METAB RES, V31, P570, DOI 10.1055/s-2007-978797; Hartvigsen K, 2009, J LIPID RES, V50, pS388, DOI 10.1194/jlr.R800100-JLR200; Hayden MS, 1996, TISSUE ANTIGENS, V48, P242, DOI 10.1111/j.1399-0039.1996.tb02642.x; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Ilan Y, 2010, P NATL ACAD SCI USA, V107, P9765, DOI 10.1073/pnas.0908771107; Jolles S, 2005, CLIN EXP IMMUNOL, V142, P1, DOI 10.1111/j.1365-2249.2005.02834.X; Lewis KE, 2004, CIRCULATION, V110, P540, DOI 10.1161/01.CIR.0000136819.93989.E1; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Lougaris V, 2005, IMMUNOL REV, V203, P48, DOI 10.1111/j.0105-2896.2005.00229.x; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2007, AM J PHYSIOL-ENDOC M, V292, pE166, DOI 10.1152/ajpendo.00284.2006; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MEEK RL, 1992, P NATL ACAD SCI USA, V89, P7949, DOI 10.1073/pnas.89.17.7949; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; O'Brien KD, 2005, ARTERIOSCL THROM VAS, V25, P785, DOI 10.1161/01.ATV.0000158383.65277.2b; Poggi M, 2011, ARTERIOSCL THROM VAS, V31, P2251, DOI 10.1161/ATVBAHA.111.231357; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Riella LV, 2012, AM J TRANSPLANT, V12, P846, DOI 10.1111/j.1600-6143.2011.03929.x; Robles-Carrillo L, 2010, J IMMUNOL, V185, P1577, DOI 10.4049/jimmunol.0903888; Schonbeck U, 2000, P NATL ACAD SCI USA, V97, P7458, DOI 10.1073/pnas.97.13.7458; Schreyer SA, 2002, AM J PHYSIOL-ENDOC M, V282, pE207, DOI 10.1152/ajpendo.2002.282.1.E207; Subramanian S, 2008, ARTERIOSCL THROM VAS, V28, P685, DOI 10.1161/ATVBAHA.107.157685; Verbinnen B, 2008, J IMMUNOL, V181, P1034, DOI 10.4049/jimmunol.181.2.1034; Watanabe Y, 2012, DIABETES, V61, P1199, DOI 10.2337/db11-1182; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001	35	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67709	10.1371/journal.pone.0067709	http://dx.doi.org/10.1371/journal.pone.0067709			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844072	Green Submitted, Green Published, gold			2022-12-27	WOS:000321341000081
J	Aihara, I; Fujioka, E; Hiryu, S				Aihara, Ikkyu; Fujioka, Emyo; Hiryu, Shizuko			Qualitative and Quantitative Analyses of the Echolocation Strategies of Bats on the Basis of Mathematical Modelling and Laboratory Experiments	PLOS ONE			English	Article							BIG BROWN BATS; PREY; PURSUIT; BEHAVIOR; INTERCEPTION; PROJECTIONS; HEARING	Prey pursuit by an echolocating bat was studied theoretically and experimentally. First, a mathematical model was proposed to describe the flight dynamics of a bat and a single prey. In this model, the flight angle of the bat was affected by 2 angles related to the flight path of the single moving prey, that is, the angle from the bat to the prey and the flight angle of the prey. Numerical simulation showed that the success rate of prey capture was high, when the bat mainly used the angle to the prey to minimize the distance to the prey, and also used the flight angle of the prey to minimize the difference in flight directions of itself and the prey. Second, parameters in the model were estimated according to experimental data obtained from video recordings taken while a Japanese horseshoe bat (Rhinolphus derrumequinum nippon) pursued a moving moth (Goniocraspidum pryeri) in a flight chamber. One of the estimated parameter values, which represents the ratio in the use of the 2 angles, was consistent with the optimal value of the numerical simulation. This agreement between the numerical simulation and parameter estimation suggests that a bat chooses an effective flight path for successful prey capture by using the 2 angles. Finally, the mathematical model was extended to include a bat and 2 prey. Parameter estimation of the extended model based on laboratory experiments revealed the existence of bat's dynamical attention towards 2 prey, that is, simultaneous pursuit of 2 prey and selective pursuit of respective prey. Thus, our mathematical model contributes not only to quantitative analysis of effective foraging, but also to qualitative evaluation of a bat's dynamical flight strategy during multiple prey pursuit.	[Aihara, Ikkyu] RIKEN, Brain Sci Inst, Wako, Saitama, Japan; [Fujioka, Emyo; Hiryu, Shizuko] Doshisha Univ, Fac Life & Med Sci, Kyotanabe, Kyoto, Japan	RIKEN; Doshisha University	Aihara, I (corresponding author), RIKEN, Brain Sci Inst, Wako, Saitama, Japan.	ikkyu@brain.riken.jp			Japan Society for the Promotion of Science (JSPS) [20200055, 21760318]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was partially supported by RIKEN's Special Postdoctoral Researcher Program, a Grant-in-Aid for Scientific Research on Innovative Areas (Grant No. 20200055), and a Grant-in-Aid for Young Scientists (B) (Grant No. 21760318) from the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett ATD, 1996, NATURE, V380, P433, DOI 10.1038/380433a0; CARR CE, 1990, J NEUROSCI, V10, P3227; Feng AS, 2006, NATURE, V440, P333, DOI 10.1038/nature04416; Fujioka E, 2011, J ACOUST SOC AM, V129, P1081, DOI 10.1121/1.3523300; Ghose K, 2006, J NEUROSCI, V26, P1704, DOI 10.1523/JNEUROSCI.4315-05.2006; Ghose K, 2003, J ACOUST SOC AM, V114, P1120, DOI 10.1121/1.1589754; Ghose K, 2006, PLOS BIOL, V4, P865, DOI 10.1371/journal.pbio.0040108; Griffin D.R., 1958, LISTENING DARK ACOUS; Johnson M, 2004, P ROY SOC B-BIOL SCI, V271, pS383, DOI 10.1098/rsbl.2004.0208; Kanzaki R, 2003, CHEM SENSES, V28, P113, DOI 10.1093/chemse/28.2.113; Kinoshita Y, 2013, P 21 INT C AC, V19; Kloeden P. E., 1992, APPL MATH NEW YORK, V23, DOI [10.1007/978-3-662-12616-5, DOI 10.1007/978-3-662-12616-5]; KOONTZ MA, 1987, CELL TISSUE RES, V249, P39, DOI 10.1007/BF00215416; LAND MF, 1974, J COMP PHYSIOL, V89, P331, DOI 10.1007/BF00695351; Mantani S, 2012, J COMP PHYSIOL A, V198, P741, DOI 10.1007/s00359-012-0744-z; Matsuta N, 2013, J EXP BIOL, V216, P1210, DOI 10.1242/jeb.081398; Miller LA, 2001, BIOSCIENCE, V51, P570, DOI 10.1641/0006-3568(2001)051[0570:HSIDAA]2.0.CO;2; Olberg RM, 2007, J COMP PHYSIOL A, V193, P685, DOI 10.1007/s00359-007-0223-0; Olberg RM, 2000, J COMP PHYSIOL A, V186, P155, DOI 10.1007/s003590050015; Romanczuk P, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.010602; Rydell J, 1997, P ROY SOC B-BIOL SCI, V264, P83, DOI 10.1098/rspb.1997.0012; Simmons JA, 2005, ACOUST RES LETT ONL, V6, P238, DOI 10.1121/1.1985957; SIMMONS JA, 1979, SCIENCE, V203, P16, DOI 10.1126/science.758674; Surlykke A, 2000, J ACOUST SOC AM, V108, P2419, DOI 10.1121/1.1315295; THOMAS JA, 2002, ECHOLOCATION BATS DO; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004	26	6	6	0	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68635	10.1371/journal.pone.0068635	http://dx.doi.org/10.1371/journal.pone.0068635			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861930	Green Published, gold, Green Submitted			2022-12-27	WOS:000321425300076
J	Montgomery, CP; Daniels, MD; Zhao, F; Spellberg, B; Chong, AS; Daum, RS				Montgomery, Christopher P.; Daniels, Melvin D.; Zhao, Fan; Spellberg, Brad; Chong, Anita S.; Daum, Robert S.			Local Inflammation Exacerbates the Severity of Staphylococcus aureus Skin Infection	PLOS ONE			English	Article							VIRULENCE DETERMINANTS; MICE; PATHOGENESIS; RESISTANCE; DISEASE; MRSA	Staphylococcus aureus is the leading cause of skin infections. In a mouse model of S. aureus skin infection, we found that lesion size did not correlate with bacterial burden. Athymic nude mice had smaller skin lesions that contained lower levels of myeloperoxidase, IL-17A, and CXCL1, compared with wild type mice, although there was no difference in bacterial burden. T cell deficiency did not explain the difference in lesion size, because TCR beta delta (-/-) mice did not have smaller lesions, and adoptive transfer of congenic T cells into athymic nude mice prior to infection did not alter lesion size. The differences observed were specific to the skin, because mortality in a pneumonia model was not different between wild type and athymic nude mice. Thus, the clinical severity of S. aureus skin infection is driven by the inflammatory response to the bacteria, rather than bacterial burden, in a T cell independent manner.	[Montgomery, Christopher P.; Zhao, Fan; Daum, Robert S.] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Daniels, Melvin D.; Chong, Anita S.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Spellberg, Brad] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Div Gen Internal Med, Torrance, CA 90509 USA	University of Chicago; University of Chicago; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute	Montgomery, CP (corresponding author), Univ Chicago, Dept Pediat, Chicago, IL 60637 USA.	cmontgomery@bsd.uchicago.edu		Montgomery, Christopher/0000-0001-7247-0683	National Institute of Child Health and Human Development [Pediatric Critical Care Scholar Development Program] [HD047349]; National Institute of Allergy and Infectious Diseases [AI076596, AI072630, AI081719, AI97113, AI040481]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR059414]; National Heart, Lung, and Blood Institute [T32 HL07605]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD047349] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081719, P01AI097113, R01AI072630, R01AI040481, R56AI040481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059414] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development [Pediatric Critical Care Scholar Development Program]; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institute of Child Health and Human Development [Pediatric Critical Care Scholar Development Program HD047349 to CPM]; the National Institute of Allergy and Infectious Diseases [AI076596 to CPM, AI072630 to MDD and ASC, AI081719 to BS, AI97113 to ASC, and AI040481 to RSD]; the National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR059414 to RSD]; and the National Heart, Lung, and Blood Institute [T32 HL07605 to MDD]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; Cheung GYC, 2011, INFECT IMMUN, V79, P1927, DOI 10.1128/IAI.00046-11; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Inoshima N, 2012, J INVEST DERMATOL, V132, P1513, DOI 10.1038/jid.2011.462; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kobayashi SD, 2011, J INFECT DIS, V204, P937, DOI 10.1093/infdis/jir441; Lin L, 2012, MBIO, P3; MACDONALD HR, 1986, J IMMUNOL, V136, P4337; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Molne L, 2000, INFECT IMMUN, V68, P6162, DOI 10.1128/IAI.68.11.6162-6167.2000; Montgomery CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015177; Montgomery CP, 2009, INFECT IMMUN, V77, P2650, DOI 10.1128/IAI.00256-09; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Nonaka S, 2005, J IMMUNOL, V174, P1906, DOI 10.4049/jimmunol.174.4.1906; Nygaard TK, 2010, J INFECT DIS, V201, P241, DOI 10.1086/649570; Pelleitier M, 1975, Methods Achiev Exp Pathol, V7, P149; Segal BH, 2000, MEDICINE, V79, P170, DOI 10.1097/00005792-200005000-00004; Shadyab AH, 2012, HIV MED, V13, P319, DOI 10.1111/j.1468-1293.2011.00978.x; Spellberg B, 2008, INFECT IMMUN, V76, P4574, DOI 10.1128/IAI.00700-08; Spellberg B, 2013, NEW ENGL J MED, V368, P299, DOI 10.1056/NEJMp1215093; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Watts CJ, 2009, J INFECT DIS, V199, P673, DOI 10.1086/596631	24	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e69508	10.1371/journal.pone.0069508	http://dx.doi.org/10.1371/journal.pone.0069508			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861974	Green Published, gold, Green Submitted			2022-12-27	WOS:000321425300088
J	Rundqvist, H; Augsten, M; Stromberg, A; Rullman, E; Mijwel, S; Kharaziha, P; Panaretakis, T; Gustafsson, T; Ostman, A				Rundqvist, Helene; Augsten, Martin; Stromberg, Anna; Rullman, Eric; Mijwel, Sara; Kharaziha, Pedram; Panaretakis, Theocharis; Gustafsson, Thomas; Ostman, Arne			Effect of Acute Exercise on Prostate Cancer Cell Growth	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; IGF-I; BINDING-PROTEINS; SERUM-INSULIN; RISK; DIET; HEALTHY; INTENSITY; MEDIATORS; APOPTOSIS	Physical activity is associated with reduced risk of several cancers, including aggressive prostate cancer. The mechanisms mediating the effects are not yet understood; among the candidates are modifications of endogenous hormone levels. Long-term exercise is known to reduce serum levels of growth stimulating hormones. In contrast, the endocrine effects of acute endurance exercise include increased levels of mitogenic factors such as GH and IGF-1. It can be speculated that the elevation of serum growth factors may be detrimental to prostate cancer progression into malignancy. The incentive of the current study is to evaluate the effect of acute exercise serum on prostate cancer cell growth. We designed an exercise intervention where 10 male individuals performed 60 minutes of bicycle exercise at increasing intensity. Serum samples were obtained before (rest serum) and after completed exercise (exercise serum). The established prostate cancer cell line LNCaP was exposed to exercise or rest serum. Exercise serum from 9 out of 10 individuals had a growth inhibitory effect on LNCaP cells. Incubation with pooled exercise serum resulted in a 31% inhibition of LNCaP growth and pre-incubation before subcutaneous injection into SCID mice caused a delay in tumor formation. Serum analyses indicated two possible candidates for the effect; increased levels of IGFBP-1 and reduced levels of EGF. In conclusion, despite the fear of possible detrimental effects of acute exercise serum on tumor cell growth, we show that even the short-term effects seem to add to the overall beneficial influence of exercise on neoplasia.	[Rundqvist, Helene; Augsten, Martin; Mijwel, Sara; Kharaziha, Pedram; Panaretakis, Theocharis; Ostman, Arne] Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden; [Stromberg, Anna; Rullman, Eric; Gustafsson, Thomas] Karolinska Inst, Dept Med Lab Sci & Technol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Rundqvist, H (corresponding author), Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden.	helene.rundqvist@ki.se	Kharaziha, Pedram/O-7584-2014; Gustafsson, Thomas/AAH-1056-2019; Rundqvist, Helene/AAE-7334-2020	Kharaziha, Pedram/0000-0002-3598-5271; Rundqvist, Helene/0000-0002-5617-9076; Rullman, Eric/0000-0003-2854-7262; Gustafsson, Thomas/0000-0002-1559-4206; Panaretakis, Theocharis/0000-0001-5754-6950; Mijwel, Sara/0000-0002-6718-5797	Swedish Research Council; Swedish National Centre for Research in Sports; Swedish Medical Association; KI Foundation; Wallenberg Foundation; Swedish Cancer Society; Swedish Society of Medical Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish National Centre for Research in Sports; Swedish Medical Association; KI Foundation; Wallenberg Foundation(European Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Society of Medical Research	The present study was supported by the funding of TG: the Swedish Research Council, the Swedish National Centre for Research in Sports, the Swedish Medical Association, the KI Foundation and the Wallenberg Foundation; AO: the Swedish Cancer Society and the Swedish Research Council including support for the Linne center and cancer research network "Starget." HR is supported by a Post Doc training grant from the Swedish Society of Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augsten M, 2009, P NATL ACAD SCI USA, V106, P3414, DOI 10.1073/pnas.0813144106; Barnard RJ, 2007, EUR J CANCER PREV, V16, P415, DOI 10.1097/01.cej.0000243851.66985.e4; Barnard RJ, 2003, PROSTATE, V56, P201, DOI 10.1002/pros.10251; Berg U, 2004, HORM RES, V62, P50, DOI 10.1159/000080759; Chan JM, 1998, SCIENCE, V279, P563, DOI 10.1126/science.279.5350.563; Galvao DA, 2008, PROSTATE CANCER P D, V11, P160, DOI 10.1038/sj.pcan.4500991; Giovannucci EL, 2005, ARCH INTERN MED, V165, P1005, DOI 10.1001/archinte.165.9.1005; HACKNEY AC, 1988, MED SCI SPORT EXER, V20, P60, DOI 10.1249/00005768-198802000-00009; HELLENIUS MLB, 1995, J INTERN MED, V238, P121, DOI 10.1111/j.1365-2796.1995.tb00909.x; Hsing AW, 2001, JNCI-J NATL CANCER I, V93, P783, DOI 10.1093/jnci/93.10.783; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Kushi LH, 2012, CA-CANCER J CLIN, V62, P30, DOI 10.3322/caac.20140; Lehrer S, 2002, PROSTATE, V50, P1, DOI 10.1002/pros.10026; Liu YP, 2011, EUR UROL, V60, P1029, DOI 10.1016/j.eururo.2011.07.007; Mantzoros CS, 1997, BRIT J CANCER, V76, P1115, DOI 10.1038/bjc.1997.520; McTiernan A, 2008, NAT REV CANCER, V8, P205, DOI 10.1038/nrc2325; Ngo TH, 2003, ENDOCRINOLOGY, V144, P2319, DOI 10.1210/en.2003-221028; Ngo TH, 2002, CANCER CAUSE CONTROL, V13, P929, DOI 10.1023/A:1021911517010; Nilsen TIL, 2006, INT J CANCER, V119, P2943, DOI 10.1002/ijc.22184; NORTHOFF H, 1991, INT J SPORTS MED, V12, pS9, DOI 10.1055/s-2007-1024743; Orsini N, 2009, BRIT J CANCER, V101, P1932, DOI 10.1038/sj.bjc.6605404; Ostrowski K, 1998, J PHYSIOL-LONDON, V513, P889, DOI 10.1111/j.1469-7793.1998.889ba.x; Pritzlaff CJ, 1999, J APPL PHYSIOL, V87, P498; Roddam AW, 2008, ANN INTERN MED, V149, P461, DOI 10.7326/0003-4819-149-7-200810070-00006; Rundqvist H, 2009, EUR J ENDOCRINOL, V161, P427, DOI 10.1530/EJE-09-0342; Schlomm T, 2007, CLIN CANCER RES, V13, P6579, DOI 10.1158/1078-0432.CCR-07-1257; SCHUURMANS ALG, 1991, J STEROID BIOCHEM, V40, P193, DOI 10.1016/0960-0760(91)90182-5; Schwarz AJ, 1996, J CLIN ENDOCR METAB, V81, P3492, DOI 10.1210/jc.81.10.3492; Sridhar SS, 2010, AM J CLIN ONCOL-CANC, V33, P609, DOI 10.1097/COC.0b013e3181beac33; Tuxhorn JA, 2002, CANCER RES, V62, P3298; Tymchuk CN, 2001, J UROLOGY, V166, P1185, DOI 10.1016/S0022-5347(05)65943-5; Ullen A, 2010, INT J ONCOL, V37, P15, DOI 10.3892/ijo_00000648; Weinstock C, 1997, MED SCI SPORT EXER, V29, P345, DOI 10.1097/00005768-199703000-00009	35	69	69	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67579	10.1371/journal.pone.0067579	http://dx.doi.org/10.1371/journal.pone.0067579			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861774	Green Published, Green Submitted, gold			2022-12-27	WOS:000321425300018
J	Eisenegger, C; Pedroni, A; Rieskamp, J; Zehnder, C; Ebstein, R; Fehr, E; Knoch, D				Eisenegger, Christoph; Pedroni, Andreas; Rieskamp, Joerg; Zehnder, Christian; Ebstein, Richard; Fehr, Ernst; Knoch, Daria			DAT1 Polymorphism Determines L-DOPA Effects on Learning about Others' Prosociality	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; TRANSPORTER GENE; SOCIAL-INTERACTION; NUCLEUS-ACCUMBENS; WORKING-MEMORY; HUMAN STRIATUM; REWARD; HUMANS; BRAIN; TRUST	Despite that a wealth of evidence links striatal dopamine to individuals reward learning performance in non-social environments, the neurochemical underpinnings of such learning during social interaction are unknown. Here, we show that the administration of 300 mg of the dopamine precursor L-DOPA to 200 healthy male subjects influences learning about a partners' prosocial preferences in a novel social interaction task, which is akin to a repeated trust game. We found learning to be modulated by a well-established genetic marker of striatal dopamine levels, the 40-bp variable number tandem repeats polymorphism of the dopamine transporter (DAT1 polymorphism). In particular, we found that L-DOPA improves learning in 10/10R genoype subjects, who are assumed to have lower endogenous striatal dopamine levels and impairs learning in 9/10R genotype subjects, who are assumed to have higher endogenous dopamine levels. These findings provide first evidence for a critical role of dopamine in learning whether an interaction partner has a prosocial or a selfish personality. The applied pharmacogenetic approach may open doors to new ways of studying psychiatric disorders such as psychosis, which is characterized by distorted perceptions of others' prosocial attitudes.	[Eisenegger, Christoph] Univ Cambridge, Dept Psychol, Behav & Clin Neurosci Inst, Cambridge, England; [Pedroni, Andreas; Knoch, Daria] Univ Basel, Div Social & Affect Neurosci, Dept Psychol, Basel, Switzerland; [Rieskamp, Joerg] Univ Basel, Ctr Econ Psychol, Dept Psychol, Basel, Switzerland; [Zehnder, Christian] Univ Lausanne, Fac Business & Econ, Quartier UNIL Dorigny, Lausanne, Switzerland; [Ebstein, Richard] Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore; [Fehr, Ernst] Univ Zurich, Lab Social & Neural Syst Res, Dept Econ, Zurich, Switzerland	University of Cambridge; University of Basel; University of Basel; University of Lausanne; National University of Singapore; University of Zurich	Eisenegger, C (corresponding author), Univ Cambridge, Dept Psychol, Behav & Clin Neurosci Inst, Cambridge, England.	christoph.eisenegger@gmail.com; andreas.pedroni@unibas.ch; daria.knoch@unibas.ch	Rieskamp, Joerg/D-4004-2013	Rieskamp, Joerg/0000-0003-2632-8015; Zehnder, Christian/0000-0001-6199-4975; Ebstein, Richard/0000-0002-3626-541X	Swiss National Science Foundation [PP00P1_123381, PA00P1_134135, 100014_130352]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This project was supported by a grant to DK by the Swiss National Science Foundation (PP00P1_123381). CE was supported by the Swiss National Science Foundation (PA00P1_134135). JR acknowledges the Swiss National Science Foundation (100014_130352). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts E, 2010, NEUROPSYCHOPHARMACOL, V35, P1943, DOI 10.1038/npp.2010.68; Beeler JA, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00170; BOND A, 1974, BRIT J MED PSYCHOL, V47, P211, DOI 10.1111/j.2044-8341.1974.tb02285.x; Brown M, 2004, ECONOMETRICA, V72, P747, DOI 10.1111/j.1468-0262.2004.00511.x; Chamberlain SR, 2006, SCIENCE, V311, P861, DOI 10.1126/science.1121218; Clatworthy PL, 2009, J NEUROSCI, V29, P4690, DOI 10.1523/JNEUROSCI.3266-08.2009; Cools R, 2007, NEUROPSYCHOPHARMACOL, V32, P180, DOI 10.1038/sj.npp.1301153; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Dreher JC, 2009, P NATL ACAD SCI USA, V106, P617, DOI 10.1073/pnas.0805517106; Eisenegger C, 2010, BIOL PSYCHIAT, V67, P702, DOI 10.1016/j.biopsych.2009.09.021; Fareri DS, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00148; Fett AKJ, 2012, BRAIN, V135, P976, DOI 10.1093/brain/awr359; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Fletcher PC, 2009, NAT REV NEUROSCI, V10, P48, DOI 10.1038/nrn2536; Forbes EE, 2009, MOL PSYCHIATR, V14, P60, DOI 10.1038/sj.mp.4002086; Frank MJ, 2011, NEUROPSYCHOPHARMACOL, V36, P133, DOI 10.1038/npp.2010.96; Fuke S., 2001, Pharmacogenomics Journal, V1, P152; Heinz A, 2000, NEUROPSYCHOPHARMACOL, V22, P133, DOI 10.1016/S0893-133X(99)00099-8; Hoffman E, 1998, ECON INQ, V36, P335, DOI 10.1111/j.1465-7295.1998.tb01719.x; Ito H, 2008, NEUROIMAGE, V39, P555, DOI 10.1016/j.neuroimage.2007.09.011; Ito H, 2007, ANN NUCL MED, V21, P355, DOI 10.1007/s12149-007-0033-z; Jones RM, 2011, J NEUROSCI, V31, P13039, DOI 10.1523/JNEUROSCI.2972-11.2011; Kaiser R, 2003, NEUROLOGY, V60, P1750, DOI 10.1212/01.WNL.0000068009.32067.A1; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Kishida KT, 2012, BIOL PSYCHIAT, V72, P93, DOI 10.1016/j.biopsych.2012.02.037; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; Krueger F, 2008, PHILOS T R SOC B, V363, P3859, DOI 10.1098/rstb.2008.0165; Krueger F, 2007, P NATL ACAD SCI USA, V104, P20084, DOI 10.1073/pnas.0710103104; Mata R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039135; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Mill J, 2002, AM J MED GENET, V114, P975, DOI 10.1002/ajmg.b.10948; Ostrom E., 2005, TRUST RECIPROCITY IN; Parush N, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00022; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Phan KL, 2010, P NATL ACAD SCI USA, V107, P13099, DOI 10.1073/pnas.1008137107; Rilling JK, 2008, CURR OPIN NEUROBIOL, V18, P159, DOI 10.1016/j.conb.2008.06.003; Rutledge RB, 2009, J NEUROSCI, V29, P15104, DOI 10.1523/JNEUROSCI.3524-09.2009; SALAMONE JD, 1994, BEHAV BRAIN RES, V61, P117, DOI 10.1016/0166-4328(94)90153-8; Schultz W, 1998, NEUROPHARMACOLOGY, V37, P421, DOI 10.1016/S0028-3908(98)00071-9; Shohamy D, 2011, CURR OPIN NEUROBIOL, V21, P408, DOI 10.1016/j.conb.2011.05.009; Sutton R.S., 1998, INTRO REINFORCEMENT, DOI [10.1109/TNN.1998.712192, DOI 10.1109/TNN.1998.712192]; VANDENBERGH DJ, 1992, GENOMICS, V14, P1104, DOI 10.1016/S0888-7543(05)80138-7; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Voon V, 2010, NEURON, V65, P135, DOI 10.1016/j.neuron.2009.12.027	46	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67820	10.1371/journal.pone.0067820	http://dx.doi.org/10.1371/journal.pone.0067820			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861813	Green Published, gold			2022-12-27	WOS:000323350700041
J	Shahi, SK; Singh, VK; Kumar, A				Shahi, Shailesh K.; Singh, Vinay K.; Kumar, Ashok			Detection of Escherichia coli and Associated beta-Lactamases Genes from Diabetic Foot Ulcers by Multiplex PCR and Molecular Modeling and Docking of SHV-1, TEM-1, and OXA-1 beta-Lactamases with Clindamycin and Piperacillin-Tazobactam	PLOS ONE			English	Article							CLASS-A; RESISTANCE; EPIDEMIOLOGY; INFECTION; FAMILY	Diabetic foot ulcer (DFU) is a common and devastating complication in diabetes. Antimicrobial resistance mediated by extended-spectrum beta-lactamases (ESBLs) production by bacteria is considered to be a major threat for foot amputation. The present study deals with the detection of Escherichia coli and the prevalence of bla(TEM), bla(SHV) and bla(OXA) genes directly from biopsy and swab of foot ulcers of diabetic patients. In total, 116 DFU patients were screened, of which 42 suffering with severe DFUs were selected for this study. Altogether 16 E. coli strains were successfully isolated from biopsy and/or swab samples of 15 (35.71%) patients. ESBL production was noted in 12 (75%) strains. Amplification of beta-lactamase genes by multiplex PCR showed the presence of bla(CTX-M) like genes in 10 strains, bla(TEM) and bla(OXA) in 9 strains each, and bla(SHV) in 8 of the total 16 strains of E. coli. Out of the ten antibiotics tested, E. coli strains were found to be resistant to ampicillin (75%), cefoxitin (56.25%), cefazolin (50%), meropenem (37.5%), cefoperazone (25%), cefepime (31.25%), ceftazidime (56.25%), and cefotaxime (68.75%) but all showed sensitivity (100%) to clindamycin and piperacillin-tazobactam. 3D models of the most prevalent variants of beta-lactamases namely TEM-1, SHV-1, OXA-1, and ESBL namely CTX-M-15 were predicted and docking was performed with clindamycin and piperacillin-tazobactam to reveal the molecular basis of drug sensitivity. Docking showed the best docking score with significant interactions, forming hydrogen bond, Van der Waals and polar level interaction with active site residues. Findings of the present study may provide useful insights for the development of new antibiotic drugs and may also prevent ESBLs-mediated resistance problem in DFU. The novel multiplex PCR assay designed in this study may be routinely used in clinical diagnostics of E. coli and associated bla(TEM), bla(SHV), and bla(OXA) like genes.	[Shahi, Shailesh K.; Singh, Vinay K.; Kumar, Ashok] Banaras Hindu Univ, Sch Biotechnol, Fac Sci, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Kumar, A (corresponding author), Banaras Hindu Univ, Sch Biotechnol, Fac Sci, Varanasi 221005, Uttar Pradesh, India.	kasokbt@rediffmail.com	Shahi, Shailesh/ABD-6388-2020	Shahi, Shailesh/0000-0002-8506-7655	ICMR, New Delhi (India) [80/622/2009-ECD-1]; Indian Agricultural Research Institute, New Delhi [NBAIM/AMAAS/MD (19)/AK/BG]	ICMR, New Delhi (India)(Indian Council of Medical Research (ICMR)); Indian Agricultural Research Institute, New Delhi(Indian Council of Agricultural Research (ICAR))	Shailesh K. Shahi is thankful to ICMR, New Delhi (India), for the award of Senior Research Fellowship (80/622/2009-ECD-1). This work is partially supported by a research grant sanctioned to Ashok Kumar by the Indian Agricultural Research Institute (No. NBAIM/AMAAS/MD (19)/AK/BG), New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AI, 1999, DIABETES CARE, V22, P1029, DOI 10.2337/diacare.22.7.1029; Alavi SM, 2008, INT J INFECT DIS, V12, pE209, DOI 10.1016/j.ijid.2008.05.519; AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; Arabaci F., 2009, Journal of Medical Sciences (Pakistan), V9, P103, DOI 10.3923/jms.2009.103.107; Armstrong DG, 2004, CLIN INFECT DIS, V39, pS92, DOI 10.1086/383269; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Baudry PJ, 2009, DIAGN MICR INFEC DIS, V63, P319, DOI 10.1016/j.diagmicrobio.2008.12.001; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Bos F, 2008, ANTIMICROB AGENTS CH, V52, P1072, DOI 10.1128/AAC.01035-07; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; BRUNBUISSON C, 1987, LANCET, V2, P302; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; Chaudhary U, 2004, Indian J Med Microbiol, V22, P75; *CLIN LAB STAND I, 2011, M100S21 CLSI; Coque T M, 2008, Euro Surveill, V13; Coudron PE, 1997, J CLIN MICROBIOL, V35, P2593, DOI 10.1128/JCM.35.10.2593-2597.1997; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; Gadepalli R, 2006, DIABETES CARE, V29, P1727, DOI 10.2337/dc06-0116; Gao Yue-Dong, 2011, Zoological Research, V32, P262, DOI 10.3724/SP.J.1141.2011.03262; Gupta V, 2008, J ASSOC PHYSICIAN I, P56; Icks A, 2009, EXP CLIN ENDOCR DIAB, V117, P500, DOI 10.1055/s-0029-1225333; Kiratisin P, 2008, ANTIMICROB AGENTS CH, V52, P2818, DOI 10.1128/AAC.00171-08; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pD266, DOI 10.1093/nar/gki001; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Majiduddin FK, 2002, INT J MED MICROBIOL, V292, P127, DOI 10.1078/1438-4221-00198; Mansouri M., 2009, Journal of Biological Sciences, V9, P362, DOI 10.3923/jbs.2009.362.366; MATAGNE A, 1990, BIOCHEM J, V265, P131, DOI 10.1042/bj2650131; Mathai D, 2002, DIAGN MICR INFEC DIS, V44, P367, DOI 10.1016/S0732-8893(02)00466-2; Mitsuhashi S, 1981, MECH RESISTANCE BETA; Motta RN, 2003, BRAZ J INFECT DIS, V2, P129; Murugan S, 2011, RES J MICROBIOL, DOI [10.3923/jm.2011: 1-9, DOI 10.3923/JM.2011:1-9]; Ness S, 2000, BIOCHEMISTRY-US, V39, P5312, DOI 10.1021/bi992505b; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pattanaik P, 2009, J BIOL CHEM, V284, P945, DOI 10.1074/jbc.M806833200; Poirel L, 2004, ANTIMICROB AGENTS CH, V48, P15, DOI 10.1128/AAC.48.1.15-22.2004; Sahu S, 2011, INDIAN MED GAZ, V12, P461; Sana T., 2011, IAJAA, V1; Schwaber MJ, 2005, ANTIMICROB AGENTS CH, V49, P2137, DOI 10.1128/AAC.49.5.2137-2139.2005; Selvakumar B. N., 2007, Journal of Medical Sciences (Pakistan), V7, P443; Shahi SK, 2013, J MOL MODEL, V19, P973, DOI 10.1007/s00894-012-1635-5; Shakil S, 2010, BIOINFORMATION, V4, P468, DOI 10.6026/97320630004468; Shanmugam P, 2013, J CLIN DIAGN RES, V7, P441, DOI 10.7860/JCDR/2013/5091.2794; Shobhana R, 2000, J Assoc Physicians India, V48, P1147; Solovyev V, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s10; Sun T, 2003, PROTEIN SCI, V12, P82, DOI 10.1110/ps.0224303; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tofteland S, 2007, J CLIN MICROBIOL, V45, P199, DOI 10.1128/JCM.01319-06; UrbancicRovan V, 1997, CLIN INFECT DIS, V25, pS184, DOI 10.1086/516184; Wagner F W Jr, 1981, Foot Ankle, V2, P64	52	17	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68234	10.1371/journal.pone.0068234	http://dx.doi.org/10.1371/journal.pone.0068234			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861873	Green Published, Green Submitted, gold			2022-12-27	WOS:000323350700075
J	Triboulet, S; Dubee, V; Lecoq, L; Bougault, C; Mainardi, JL; Rice, LB; Etheve-Quelquejeu, M; Gutmann, L; Marie, A; Dubost, L; Hugonnet, JE; Simorre, JP; Arthur, M				Triboulet, Sebastien; Dubee, Vincent; Lecoq, Lauriane; Bougault, Catherine; Mainardi, Jean-Luc; Rice, Louis B.; Etheve-Quelquejeu, Melanie; Gutmann, Laurent; Marie, Arul; Dubost, Lionel; Hugonnet, Jean-Emmanuel; Simorre, Jean-Pierre; Arthur, Michel			Kinetic Features of L,D-Transpeptidase Inactivation Critical for beta-Lactam Antibacterial Activity	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS L,D-TRANSPEPTIDASE; DD-CARBOXYPEPTIDASE-TRANSPEPTIDASE; PENICILLIN-BINDING PROTEINS; CRYSTAL-STRUCTURE; PEPTIDOGLYCAN; MECHANISM; INHIBITION; RESISTANCE; MEROPENEM; ANTIBIOTICS	Active-site serine D,D-transpeptidases belonging to the penicillin-binding protein family (PBPs) have been considered for a long time as essential for peptidoglycan cross-linking in all bacteria. However, bypass of the PBPs by an L,D-transpeptidase (Ldt(fm)) conveys high-level resistance to beta-lactams of the penam class in Enterococcus faecium with a minimal inhibitory concentration (MIC) of ampicillin > 2,000 mu g/ml. Unexpectedly, Ldt(fm) does not confer resistance to beta-lactams of the carbapenem class (imipenem MIC = 0.5 mu g/ml) whereas cephems display residual activity (ceftriaxone MIC = 128 mu g/ml). Mass spectrometry, fluorescence kinetics, and NMR chemical shift perturbation experiments were performed to explore the basis for this specificity and identify beta-lactam features that are critical for efficient L,D-transpeptidase inactivation. We show that imipenem, ceftriaxone, and ampicillin acylate Ldtfm by formation of a thioester bond between the active-site cysteine and the beta-lactam-ring carbonyl. However, slow acylation and slow acylenzyme hydrolysis resulted in partial Ldtfm inactivation by ampicillin and ceftriaxone. For ampicillin, Ldt(fm) acylation was followed by rupture of the C-5 - C-6 bond of the beta-lactam ring and formation of a secondary acylenzyme prone to hydrolysis. The saturable step of the catalytic cycle was the reversible formation of a tetrahedral intermediate (oxyanion) without significant accumulation of a non-covalent complex. In agreement, a derivative of Ldt(fm) blocked in acylation bound ertapenem (a carbapenem), ceftriaxone, and ampicillin with similar low affinities. Thus, oxyanion and acylenzyme stabilization are both critical for rapid L,D-transpeptidase inactivation and antibacterial activity. These results pave the way for optimization of the b-lactam scaffold for L,D-transpeptidase-inactivation.	[Triboulet, Sebastien; Dubee, Vincent; Mainardi, Jean-Luc; Gutmann, Laurent; Hugonnet, Jean-Emmanuel; Arthur, Michel] Univ Paris 06, Ctr Rech Cordeliers, Equipe 12, UMR S 872, Paris, France; [Triboulet, Sebastien; Dubee, Vincent; Mainardi, Jean-Luc; Gutmann, Laurent; Hugonnet, Jean-Emmanuel; Arthur, Michel] INSERM, U872, Paris, France; [Triboulet, Sebastien; Dubee, Vincent; Mainardi, Jean-Luc; Gutmann, Laurent; Hugonnet, Jean-Emmanuel; Arthur, Michel] Univ Paris 05, Sorbonne Paris Cite, UMR S 872, Paris, France; [Lecoq, Lauriane; Bougault, Catherine; Simorre, Jean-Pierre] CEA, DSV, IBS, Grenoble, France; [Lecoq, Lauriane; Bougault, Catherine; Simorre, Jean-Pierre] CNRS, UMR 5075, Grenoble, France; [Lecoq, Lauriane; Bougault, Catherine; Simorre, Jean-Pierre] Univ Grenoble 1, Grenoble 1, France; [Mainardi, Jean-Luc; Gutmann, Laurent] Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Paris, France; [Rice, Louis B.] Brown Univ, Rhode Isl Hosp, Providence, RI 02903 USA; [Etheve-Quelquejeu, Melanie] Univ Paris 05, Lab Chim & Biochim Pharmacol & Toxicol, UMR 8601, Paris, France; [Etheve-Quelquejeu, Melanie] CNRS, UMR 8601, Paris, France; [Marie, Arul; Dubost, Lionel] Museum Natl Hist Nat, USM0502, Plateforme Spectrometrie Masse & Prote Museum, F-75231 Paris, France; [Marie, Arul; Dubost, Lionel] CNRS, UMR8041, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS)	Simorre, JP (corresponding author), CEA, DSV, IBS, Grenoble, France.	jean-pierre.simorre@ibs.fr; michel.arthur@crc.jussieu.fr	Dubée, Vincent/F-8768-2018; HUGONNET, Jean-Emmanuel/ABC-7914-2021; Triboulet, Sebastien/AAI-8676-2020; Arthur, Michel/G-3680-2013; MAINARDI, Jean-Luc/E-2714-2014; HUGONNET, Jean-Emmanuel/H-3581-2014	Dubée, Vincent/0000-0002-9982-4741; HUGONNET, Jean-Emmanuel/0000-0003-4150-0944; Arthur, Michel/0000-0003-1007-636X; MAINARDI, Jean-Luc/0000-0002-4159-0129; HUGONNET, Jean-Emmanuel/0000-0003-4150-0944; Lecoq, Lauriane/0000-0002-5995-3733; MARIE, Arul/0000-0003-4104-140X; Bougault, Catherine/0000-0003-3358-5255; simorre, jean-pierre/0000-0002-7943-1342	National Institute of Allergy and Infectious Diseases [RO1 AI046626]; Project CARBATUB [ANR 2011 BSV5 024 01]; European Community [261378]; Poste d'Accueil, Institut National de la Sante et de la Recherche Medicale; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045626] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Project CARBATUB; European Community(European Commission); Poste d'Accueil, Institut National de la Sante et de la Recherche Medicale; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institute of Allergy and Infectious Diseases (Grants RO1 AI046626) Agence National de la Recherche and Project CARBATUB (No ANR 2011 BSV5 024 01). ST was supported by the seventh Framework Program of the European Community, Project ORCHID (261378). VD was supported by a Poste d'Accueil, Institut National de la Sante et de la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, TUBERCULOSIS 2011 WH; Biarrotte-Sorin S, 2006, J MOL BIOL, V359, P533, DOI 10.1016/j.jmb.2006.03.014; Dubee V, 2012, ANTIMICROB AGENTS CH, V56, P4189, DOI 10.1128/AAC.00665-12; Erdemli SB, 2012, STRUCTURE, V20, P2103, DOI 10.1016/j.str.2012.09.016; FRERE JM, 1976, NATURE, V260, P451, DOI 10.1038/260451a0; Gupta R, 2010, NAT MED, V16, P466, DOI 10.1038/nm.2120; Hugonnet JE, 2007, BIOCHEMISTRY-US, V46, P11998, DOI 10.1021/bi701506h; Hugonnet JE, 2009, SCIENCE, V323, P1215, DOI 10.1126/science.1167498; Kim HS, 2013, ACTA CRYSTALLOGR D, V69, P420, DOI 10.1107/S0907444912048998; Lavollay M, 2008, J BACTERIOL, V190, P4360, DOI 10.1128/JB.00239-08; Lavollay M, 2011, J BACTERIOL, V193, P778, DOI 10.1128/JB.00606-10; Lecoq L, 2013, ACS CHEM BI IN PRESS, DOI [10.1021/cb4001603, DOI 10.1021/CB4001603)]; Lecoq L, 2012, STRUCTURE, V20, P850, DOI 10.1016/j.str.2012.03.015; Li WJ, 2013, CELL RES, V23, P728, DOI 10.1038/cr.2013.53; Mainard JL, 2002, J BIOL CHEM, V277, P35801, DOI 10.1074/jbc.M204319200; Mainardi JL, 2011, CLIN MICROBIOL INFEC, V17, P1755, DOI 10.1111/j.1469-0691.2011.03699.x; Mainardi JL, 2008, FEMS MICROBIOL REV, V32, P386, DOI 10.1111/j.1574-6976.2007.00097.x; Mainardi JL, 2007, J BIOL CHEM, V282, P30414, DOI 10.1074/jbc.M704286200; Mainardi JL, 2005, J BIOL CHEM, V280, P38146, DOI 10.1074/jbc.M507384200; Mainardi JL, 2000, J BIOL CHEM, V275, P16490, DOI 10.1074/jbc.M909877199; MARQUET A, 1979, BIOCHEM J, V177, P909, DOI 10.1042/bj1770909; Peltier J, 2011, J BIOL CHEM, V286, P29053, DOI 10.1074/jbc.M111.259150; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; TIPPER DJ, 1965, P NATL ACAD SCI USA, V54, P1133, DOI 10.1073/pnas.54.4.1133; Triboulet S, 2011, J BIOL CHEM, V286, P22777, DOI 10.1074/jbc.M111.239988; Zapun A, 2008, FEMS MICROBIOL REV, V32, P361, DOI 10.1111/j.1574-6976.2007.00095.x	26	45	45	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67831	10.1371/journal.pone.0067831	http://dx.doi.org/10.1371/journal.pone.0067831			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861815	gold, Green Submitted, Green Published			2022-12-27	WOS:000323350700043
J	Jezberova, J; Jezbera, J; Hahn, MW				Jezberova, Jitka; Jezbera, Jan; Hahn, Martin W.			Insights into Variability of Actinorhodopsin Genes of the LG1 Cluster in Two Different Freshwater Habitats	PLOS ONE			English	Article							ACTINOBACTERIA; DIVERSITY; SEQUENCES; LAKES	Actinorhodopsins (ActRs) are recently discovered proteorhodopsins present in Actinobacteria, enabling them to adapt to a wider spectrum of environmental conditions. Frequently, a large fraction of freshwater bacterioplankton belongs to the acI lineage of Actinobacteria and codes the LG1 type of ActRs. In this paper we studied the genotype variability of the LG1 ActRs. We have constructed two clone libraries originating from two environmentally different habitats located in Central Europe; the large alkaline lake Mondsee (Austria) and the small humic reservoir Jiricka (the Czech Republic). The 75 yielded clones were phylogenetically analyzed together with all ActR sequences currently available in public databases. Altogether 156 sequences were analyzed and 13 clusters of ActRs were distinguished. Newly obtained clones are distributed over all three LG1 subgroups - LG1-A, B and C. Eighty percent of the sequences belonged to the acI lineage (LG1-A ActR gene bearers) further divided into LG1-A1 and LG1-A2 subgroups. Interestingly, the two habitats markedly differed in genotype composition with no identical sequence found in both samples of clones. Moreover, Jiricka reservoir contained three so far not reported clusters, one of them LG1-C related, presenting thus completely new, so far undescribed, genotypes of Actinobacteria in freshwaters.	[Jezberova, Jitka; Jezbera, Jan] ASCR, Ctr Biol, Inst Hydrobiol, Vvi, Ceske Budejovice, Czech Republic; [Hahn, Martin W.] Univ Innsbruck, Res Inst Limnol, Mondsee, Austria	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of Innsbruck	Jezbera, J (corresponding author), ASCR, Ctr Biol, Inst Hydrobiol, Vvi, Ceske Budejovice, Czech Republic.	jezbera@hbu.cas.cz	Hahn, Martin W./B-9998-2008; Jezbera, Jan/B-5657-2015; Jezberova, Jitka/G-1024-2014	Hahn, Martin W./0000-0003-0501-2556; Jezberova, Jitka/0000-0001-5000-9319	Czech Grant Agency [EEF/10/E011]	Czech Grant Agency(Grant Agency of the Czech Republic)	This study was financially supported by the Czech Grant Agency project EEF/10/E011 awarded to Jan Jezbera. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier M, 2006, APPL ENVIRON MICROB, V72, P3489, DOI 10.1128/AEM.72.5.3489-3497.2006; [Anonymous], ADV NEURAL INFORM PR; Atamna-Ismaeel N, 2008, ISME J, V2, P656, DOI 10.1038/ismej.2008.27; Debroas D, 2009, ENVIRON MICROBIOL, V11, P2412, DOI 10.1111/j.1462-2920.2009.01969.x; Garcia SL, 2013, ISME J, V7, P137, DOI 10.1038/ismej.2012.86; Glockner FO, 2000, APPL ENVIRON MICROB, V66, P5053, DOI 10.1128/AEM.66.11.5053-5065.2000; Gonzalez JM, 2008, P NATL ACAD SCI USA, V105, P8724, DOI 10.1073/pnas.0712027105; Hahn MW, 2009, INT J SYST EVOL MICR, V59, P112, DOI 10.1099/ijs.0.001743-0; Hahn MW, 2005, APPL ENVIRON MICROB, V71, P766, DOI 10.1128/AEM.71.2.766-773.2005; Hahn MW, 2003, APPL ENVIRON MICROB, V69, P1442, DOI 10.1128/AEM.69.3.1442-1451.2003; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jezbera J, 2011, ENVIRON MICROBIOL, V13, P922, DOI 10.1111/j.1462-2920.2010.02396.x; Jezbera J, 2009, INT J SYST EVOL MICR, V59, P2864, DOI 10.1099/ijs.0.010199-0; Martinez-Garcia M, 2012, ISME J, V6, P113, DOI 10.1038/ismej.2011.84; Newton RJ, 2007, APPL ENVIRON MICROB, V73, P7169, DOI 10.1128/AEM.00794-07; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Philosof A, 2009, ENVIRON MICROBIOL, V11, P3189, DOI 10.1111/j.1462-2920.2009.02024.x; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sekar R, 2003, APPL ENVIRON MICROB, V69, P2928, DOI 10.1128/AEm.69.5.2928-2935.2003; Sharma AK, 2008, ENVIRON MICROBIOL, V10, P1039, DOI 10.1111/j.1462-2920.2007.01525.x; Sharma AK, 2009, ISME J, V3, P726, DOI 10.1038/ismej.2009.13; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Zwart G, 2002, AQUAT MICROB ECOL, V28, P141, DOI 10.3354/ame028141; Zwickl DJ., 2006, THESIS	26	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68542	10.1371/journal.pone.0068542	http://dx.doi.org/10.1371/journal.pone.0068542			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844219	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000171
J	Lee, S; Lim, WA; Thorn, KS				Lee, Sidae; Lim, Wendell A.; Thorn, Kurt S.			Improved Blue, Green, and Red Fluorescent Protein Tagging Vectors for S. cerevisiae	PLOS ONE			English	Article							MONOMERIC RED; GENE-EXPRESSION; BRIGHT; VARIANTS; COLOR; CYAN; DETERMINANTS; SENSITIVITY; CASSETTES; ORANGE	Fluorescent protein fusions are a powerful tool to monitor the localization and trafficking of proteins. Such studies are particularly easy to carry out in the budding yeast Saccharomyces cerevisiae due to the ease with which tags can be introduced into the genome by homologous recombination. However, the available yeast tagging plasmids have not kept pace with the development of new and improved fluorescent proteins. Here, we have constructed yeast optimized versions of 19 different fluorescent proteins and tested them for use as fusion tags in yeast. These include two blue, seven green, and seven red fluorescent proteins, which we have assessed for brightness, photostability and perturbation of tagged proteins. We find that EGFP remains the best performing green fluorescent protein, that TagRFP-T and mRuby2 outperform mCherry as red fluorescent proteins, and that mTagBFP2 can be used as a blue fluorescent protein tag. Together, the new tagging vectors we have constructed provide improved blue and red fluorescent proteins for yeast tagging and three color imaging.	[Lee, Sidae; Lim, Wendell A.] Univ Calif San Francisco, UCSF Ctr Syst & Synthet Biol, San Francisco, CA 94143 USA; [Lee, Sidae; Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA; [Lim, Wendell A.] Calif Inst Quantitat Biomed Res, San Francisco, CA USA; [Thorn, Kurt S.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Thorn, KS (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	kurt.thorn@ucsf.edu		Thorn, Kurt/0000-0001-9310-288X	NIGMS Systems Biology Center [P50 GM081879]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081879] Funding Source: NIH RePORTER	NIGMS Systems Biology Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this project was provided by an NIGMS Systems Biology Center grant, number P50 GM081879. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-13; Bogdanov AM, 2009, NAT CHEM BIOL, V5, P459, DOI 10.1038/nchembio.174; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Cubitt AB, 1999, METHOD CELL BIOL, V58, P19; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Hailey DW, 2002, METHOD ENZYMOL, V351, P34; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kogure T, 2006, NAT BIOTECHNOL, V24, P577, DOI 10.1038/nbt1207; Kredel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004391; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Morozova KS, 2010, BIOPHYS J, V99, pL13, DOI 10.1016/j.bpj.2010.04.025; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Petracek ME, 2002, METHOD ENZYMOL, V350, P445, DOI 10.1016/S0076-6879(02)50978-2; Piatkevich KD, 2010, P NATL ACAD SCI USA, V107, P5369, DOI 10.1073/pnas.0914365107; Reid RJD, 2002, METHOD ENZYMOL, V350, P258; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/NMETH.2413, 10.1038/nmeth.2413]; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Slaughter BD, 2007, P NATL ACAD SCI USA, V104, P20320, DOI 10.1073/pnas.0710336105; Subach OM, 2008, CHEM BIOL, V15, P1116, DOI 10.1016/j.chembiol.2008.08.006; Subach OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028674; Vorvis C, 2008, YEAST, V25, P651, DOI 10.1002/yea.1611; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wach A, 1997, AID YEA159 3 0 CO 2; Welch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007002; Yang TT, 1996, NUCLEIC ACIDS RES, V24, P4592, DOI 10.1093/nar/24.22.4592; Young CL, 2012, YEAST, V29, P119, DOI 10.1002/yea.2895; Zapata-Hommer O, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-5; Zhang CD, 2010, EUKARYOT CELL, V9, P224, DOI 10.1128/EC.00327-09	38	96	96	9	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67902	10.1371/journal.pone.0067902	http://dx.doi.org/10.1371/journal.pone.0067902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844123	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000116
J	Tian, XS; Guo, JC; Zhu, M; Li, MW; Wu, GC; Xia, Y				Tian, Xuesong; Guo, Jingchun; Zhu, Min; Li, Minwei; Wu, Gencheng; Xia, Ying			delta-Opioid Receptor Activation Rescues the Functional TrkB Receptor and Protects the Brain from Ischemia-Reperfusion Injury in the Rat	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; CREB PHOSPHORYLATION; CORTICAL-NEURONS; K+ HOMEOSTASIS; TRUNCATED TRKB; MESSENGER-RNA; EXPRESSION; HYPOXIA; DEATH; MU	Objectives: delta-opioid receptor (DOR) activation reduced brain ischemic infarction and attenuated neurological deficits, while DOR inhibition aggravated the ischemic damage. The underlying mechanisms are, however, not well understood yet. In this work, we asked if DOR activation protects the brain against ischemic injury through a brain-derived neurotrophic factor (BDNF) -TrkB pathway. Methods: We exposed adult male Sprague-Dawley rats to focal cerebral ischemia, which was induced by middle cerebral artery occlusion (MCAO). DOR agonist TAN-67 (60 nmol), antagonist Naltrindole (100 nmol) or artificial cerebral spinal fluid was injected into the lateral cerebroventricle 30 min before MCAO. Besides the detection of ischemic injury, the expression of BDNF, full-length and truncated TrkB, total CREB, p-CREB, p-ATF and CD11b was detected by Western blot and fluorescence immunostaining. Results: DOR activation with TAN-67 significantly reduced the ischemic volume and largely reversed the decrease in full-length TrkB protein expression in the ischemic cortex and striatum without any appreciable change in cerebral blood flow, while the DOR antagonist Naltrindole aggregated the ischemic injury. However, the level of BDNF remained unchanged in the cortex, striatum and hippocampus at 24 hours after MCAO and did not change in response to DOR activation or inhibition. MCAO decreased both total CREB and pCREB in the striatum, but not in the cortex, while DOR inhibition promoted a further decrease in total and phosphorylated CREB in the striatum and decreased pATF-1 expression in the cortex. In addition, MCAO increased C11b expression in the cortex, striatum and hippocampus, and DOR activation specifically attenuated the ischemic increase in the cortex but not in the striatum and hippocampus. Conclusions: DOR activation rescues TrkB signaling by reversing ischemia/reperfusion induced decrease in the full-length TrkB receptor and reduces brain injury in ischemia/reperfusion	[Tian, Xuesong; Guo, Jingchun; Zhu, Min; Li, Minwei; Wu, Gencheng] Fudan Univ, Shanghai Med Coll, Dept Integrat Med & Neurobiol, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Tian, Xuesong; Xia, Ying] Univ Texas Houston, Sch Med, Dept Neurosurg, Houston, TX USA; [Guo, Jingchun] Shanghai Res Ctr Acupuncture & Meridians, Lab Mol Neurol, Shanghai, Peoples R China	Fudan University; University of Texas System; University of Texas Health Science Center Houston	Guo, JC (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Integrat Med & Neurobiol, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China.	jingchunguo@shmu.edu.cn; Ying.Xia@uth.tmc.edu		Tian, Xuesong/0000-0001-6162-2856	National Natural Science Foundation of China [30873318, 81072646]; Science and Technology Commission Program of Shanghai [06DZ19734]; National Basic Research Program of China [12CB518502]; National Institutes of Health [AT-004422, HD-034852]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD034852] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT004422] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission Program of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); National Basic Research Program of China(National Basic Research Program of China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported by National Natural Science Foundation of China (30873318 and 81072646), Science and Technology Commission Program of Shanghai (06DZ19734), National Basic Research Program of China (12CB518502) and National Institutes of Health (AT-004422 and HD-034852). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilecki W, 2000, EUR J PHARMACOL, V390, P1, DOI 10.1016/S0014-2999(00)00018-2; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Borlongan CV, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-31; Buchthal B, 2012, J BIOL CHEM, V287, P30967, DOI 10.1074/jbc.M112.382507; Chao DM, 2008, CEREB CORTEX, V18, P2217, DOI 10.1093/cercor/bhm247; Chao DM, 2007, J CELL PHYSIOL, V212, P60, DOI 10.1002/jcp.21000; Chao DM, 2007, J CEREBR BLOOD F MET, V27, P356, DOI 10.1038/sj.jcbfm.9600352; Chao DM, 2010, PROG NEUROBIOL, V90, P439, DOI 10.1016/j.pneurobio.2009.12.007; Choi Bo-Ryoung, 2011, Exp Neurobiol, V20, P92, DOI 10.5607/en.2011.20.2.92; Fan LW, 2006, EUR J NEUROSCI, V24, P341, DOI 10.1111/j.1460-9568.2006.04918.x; Fan XA, 2010, STROKE, V41, pS54, DOI 10.1161/STROKEAHA.110.596106; Fenner BM, 2012, CYTOKINE GROWTH F R, V23, P15, DOI 10.1016/j.cytogfr.2012.01.002; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Gomes JR, 2012, J NEUROSCI, V32, P4610, DOI 10.1523/JNEUROSCI.0374-12.2012; Govindaswami M, 2008, ACAD EMERG MED, V15, P250, DOI 10.1111/j.1553-2712.2008.00048.x; Hallenbeck JM, 2002, NAT MED, V8, P1363, DOI 10.1038/nm1202-1363; He XZ, 2013, CELL MOL LIFE SCI, V70, P2291, DOI 10.1007/s00018-012-1167-2; Hong SS, 2007, BRAIN RES, V1149, P76, DOI 10.1016/j.brainres.2007.02.062; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Iwata M, 2007, NEUROSCI LETT, V414, P242, DOI 10.1016/j.neulet.2006.12.021; Kang XZ, 2009, CELL MOL LIFE SCI, V66, P3505, DOI 10.1007/s00018-009-0136-x; Kaur C, 2013, J NEUROIMMUNE PHARM, V8, P66, DOI 10.1007/s11481-012-9347-2; Lim YJ, 2004, ANESTHESIOLOGY, V100, P562, DOI 10.1097/00000542-200403000-00015; Ma MC, 2005, J BIOL CHEM, V280, P16208, DOI 10.1074/jbc.M408055200; Narantuya D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011746; Narumiya S, 1998, BRAIN RES, V797, P278, DOI 10.1016/S0006-8993(98)00385-0; Noorian AR, 2011, J NEUROSURG SCI, V55, P127; Ooboshi H, 2011, CURR PHARM DESIGN, V17, P424, DOI 10.2174/138161211795164149; Pabello NG, 2005, BRAIN RES, V1038, P11, DOI 10.1016/j.brainres.2004.12.047; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Persson AI, 2005, NEUROSCI RES, V52, P1, DOI 10.1016/j.neures.2005.01.003; Roy AA, 2006, J BIOL CHEM, V281, P32684, DOI 10.1074/jbc.M604416200; Schabitz WR, 1997, J CEREBR BLOOD F MET, V17, P500, DOI 10.1097/00004647-199705000-00003; Schabitz WR, 2007, STROKE, V38, P2165, DOI 10.1161/STROKEAHA.106.477331; Su DS, 2007, NEUROSCI LETT, V423, P113, DOI 10.1016/j.neulet.2007.06.044; Tanaka K, 1999, NEUROREPORT, V10, P2245, DOI 10.1097/00001756-199908020-00004; Tanaka K, 1999, BRAIN RES, V818, P520, DOI 10.1016/S0006-8993(98)01263-3; Tian Xue-song, 2008, Zhong Xi Yi Jie He Xue Bao, V6, P632, DOI 10.3736/jcim20080617; Tian Xue-Song, 2008, Shengli Xuebao, V60, P475; Torregrossa MM, 2004, NEUROPSYCHOPHARMACOL, V29, P649, DOI 10.1038/sj.npp.1300345; Vidaurre OG, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.143; Warnick JE, 2005, BEHAV BRAIN RES, V160, P277, DOI 10.1016/j.bbr.2004.12.009; Wong J., 2011, SCHIZOPHR B, V39, P130; XIA Y, 1991, BRAIN RES, V549, P181, DOI 10.1016/0006-8993(91)90457-7; Xia Y, 2001, J COMP NEUROL, V436, P202; Yang YL, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-55; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765; Yu ZY, 2009, NEUROL RES, V31, P122, DOI 10.1179/174313209X389866; Zausinger S, 2000, BRAIN RES, V863, P94, DOI 10.1016/S0006-8993(00)02100-4; Zhang HN, 2006, EUR J NEUROSCI, V23, P984, DOI 10.1111/j.1460-9568.2006.04621.x; Zhang J.H., 1999, SOC NEUR ABSTR, V28, P736; Zhang JH, 2006, STROKE, V37, P1094, DOI 10.1161/01.STR.0000206444.29930.18; Zhang JH, 2002, AM J PHYSIOL-CELL PH, V282, pC1225, DOI 10.1152/ajpcell.00226.2001; Zhang JH, 2000, BRAIN RES, V885, P143, DOI 10.1016/S0006-8993(00)02906-1; Zhang R, 2006, NEUROBIOL DIS, V24, P345, DOI 10.1016/j.nbd.2006.07.012; Zhao P, 2000, ACUPUNCTURE ELECTRO, V25, P101, DOI 10.3727/036012900816356163; Zhao P., 2002, SOC NEUR ABSTR, V28, P736; Zhou F, 2013, EVID-BASED COMPL ALT, V2013; Zhou F., 2013, EVID-BASED COMPL ALT, V2013; Zhou F, 2011, J APPL PHYSIOL, V111, P1877, DOI 10.1152/japplphysiol.00313.2011; Zhu L, 2008, NEUROCHEM RES, V33, P784, DOI 10.1007/s11064-007-9495-6	61	26	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e69252	10.1371/journal.pone.0069252	http://dx.doi.org/10.1371/journal.pone.0069252			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844255	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000187
J	van Casteren, A; Sellers, WI; Thorpe, SKS; Coward, S; Crompton, RH; Ennos, AR				van Casteren, Adam; Sellers, William I.; Thorpe, Susannah K. S.; Coward, Sam; Crompton, Robin H.; Ennos, A. Roland			Factors Affecting the Compliance and Sway Properties of Tree Branches Used by the Sumatran Orangutan (Pongo abelii)	PLOS ONE			English	Article							WILD ORANGUTANS; LOCOMOTION; PRIMATES; MECHANICS; CHIMPANZEES; ADAPTATION; STRATEGIES; INDONESIA; EVOLUTION; PYGMAEUS	The tropical arboreal environment is a mechanically complex and varied habitat. Arboreal inhabitants must adapt to changes in the compliance and stability of supports when moving around trees. Because the orangutan is the largest habitual arboreal inhabitant, it is unusually susceptible to branch compliance and stability and therefore represents a unique animal model to help investigate how animals cope with the mechanical heterogeneity of the tropical canopy. The aim of this study was to investigate how changes in compliance and time of oscillation of branches are related to easily observable traits of arboreal supports. This should help predict how supports react mechanically to the weight and mass of a moving orangutan, and suggest how orangutans themselves predict branch properties. We measured the compliance and time of oscillation of branches from 11 tree species frequented by orangutans in the rainforest of Sumatra. Branches were pulled at several points along their length using a force balance at the end of a stiff rope, and the local diameter of the branch and the distance to its base and tip were measured. Compliance was negatively associated with both local diameter and length to the tip of the branch, and positively, if weakly, associated with length from the trunk. However, branch diameter not only predicted compliance best, but would also be easiest for an orangutan to observe. In contrast, oscillation times of branches were largely unaffected by local diameter, and only significantly increased at diameters below 2 cm. The results of this study validate previous field research, which related locomotory modes to local branch diameter, while suggesting how arboreal animals themselves sense their mechanical environment.	[van Casteren, Adam; Sellers, William I.; Ennos, A. Roland] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Thorpe, Susannah K. S.; Coward, Sam] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Crompton, Robin H.] Univ Liverpool, Inst Aging & Chron Dis, Dept Musculoskeletal Biol 2, Liverpool L69 3BX, Merseyside, England	University of Manchester; University of Birmingham; University of Liverpool	van Casteren, A (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	adam.vancasteren@gmail.com	van Casteren, Adam/AAS-9702-2020; Sellers, William Irvin/Q-3843-2019	van Casteren, Adam/0000-0002-2993-8874; Sellers, William Irvin/0000-0002-2913-5406; Thorpe, Susannah/0000-0002-6160-4452	Natural Environment Research Council [NE/F003730/1]; Sumatran Orangutan Conservation Project (SOCP); Natural Environment Research Council [NE/F003307/1] Funding Source: researchfish; NERC [NE/F003730/1, NE/F003307/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Sumatran Orangutan Conservation Project (SOCP); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by grants from the Natural Environment Research Council (NE/F003730/1) (http://www.nerc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Permission to carry out research at Ketambe Reseach Station in the Gunung Leuser National Park was kindly granted by RISTEK (Jakarta), BPKEL (Banda Aceh), PHKA (Jakarta) and TNGL (Medan and Kutacane). I would like to thank the Sumatran Orangutan Conservation Project (SOCP) for their help and support whilst researching at Ketambe. I would like to thank all the staff at Ketambe Research Centre for their support and guidance during my time there with particular thanks to Mahyudin whose tireless effort and support made the research possible.	ALEXANDER R M, 1991, Zeitschrift fuer Morphologie und Anthropologie, V78, P315; Beismann H, 2000, J EXP BOT, V51, P617, DOI 10.1093/jexbot/51.344.617; Bergman R, 2010, FPLGTR113; Biewener AA., 2003, ANIMAL LOCOMOTION; Bonser RHC, 1999, J EXP BIOL, V202, P1459; CANT JGH, 1992, AM J PHYS ANTHROPOL, V88, P273, DOI 10.1002/ajpa.1330880302; CANT JGH, 1987, AM J PHYS ANTHROPOL, V74, P143, DOI 10.1002/ajpa.1330740202; Channon AJ, 2011, J EXP BIOL, V214, P687, DOI 10.1242/jeb.046797; CROMPTON RH, 1993, P ROY SOC B-BIOL SCI, V254, P41, DOI 10.1098/rspb.1993.0124; DEMES B, 1995, AM J PHYS ANTHROPOL, V96, P419, DOI 10.1002/ajpa.1330960407; Ennos AR, 1997, TRENDS ECOL EVOL, V12, P108, DOI 10.1016/S0169-5347(96)10066-5; Farrar R. A., 1999, ENG DATA BOOK; Gilman CA, 2012, J EXP BIOL, V215, P220, DOI 10.1242/jeb.061838; Gordon J.E., 1978, STRUCTURES WHY THING; Houle A, 2004, INT J PRIMATOL, V25, P237, DOI 10.1023/B:IJOP.0000014652.83830.e4; HUNT KD, 1992, AM J PHYS ANTHROPOL, V87, P83, DOI 10.1002/ajpa.1330870108; Kerdok AE, 2002, J APPL PHYSIOL, V92, P469, DOI 10.1152/japplphysiol.01164.2000; MARKHAM R, 1990, AM J PHYS ANTHROPOL, V81, P1, DOI 10.1002/ajpa.1330810102; MCMAHON TA, 1976, J THEOR BIOL, V59, P443, DOI 10.1016/0022-5193(76)90182-X; MCMAHON TA, 1979, J BIOMECH, V12, P893, DOI 10.1016/0021-9290(79)90057-5; Niklas KJ, 1992, PLANT BIOMECHANICS; Pontzer H, 2004, J HUM EVOL, V46, P317, DOI 10.1016/j.jhevol.2003.12.006; Povinelli DJ, 1995, Q REV BIOL, V70, P393, DOI 10.1086/419170; Schmitt D, 1999, J ZOOL, V248, P149, DOI 10.1017/S0952836999006020; Spatz HC, 2007, AM J BOT, V94, P1603, DOI 10.3732/ajb.94.10.1603; Stewart FA, 2011, J HUM EVOL, V61, P388, DOI 10.1016/j.jhevol.2011.05.005; SUGARDJITO J, 1987, INT J PRIMATOL, V8, P17, DOI 10.1007/BF02737112; Thomas P, 2000, TREES THEIR NATURAL, P230; Thorpe SKS, 2007, SCIENCE, V316, P1328, DOI 10.1126/science.1140799; Thorpe SKS, 2007, BIOLOGY LETT, V3, P253, DOI 10.1098/rsbl.2007.0049; Thorpe SKS, 2005, AM J PHYS ANTHROPOL, V127, P58, DOI 10.1002/ajpa.20151; Thorpe SKS, 2009, P NATL ACAD SCI USA, V106, P12646, DOI 10.1073/pnas.0811537106; van Casteren A, 2012, P NATL ACAD SCI USA, V109, P6873, DOI 10.1073/pnas.1200902109; Vincent JFV, 1992, BIOMECHANICS MAT PRA	34	22	22	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67877	10.1371/journal.pone.0067877	http://dx.doi.org/10.1371/journal.pone.0067877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844116	Green Submitted, Green Published, gold			2022-12-27	WOS:000321341000112
J	Rommel, PC; Bosque, D; Gitlin, AD; Croft, GF; Heintz, N; Casellas, R; Nussenzweig, MC; Kriaucionis, S; Robbiani, DF				Rommel, Philipp C.; Bosque, David; Gitlin, Alexander D.; Croft, Gist F.; Heintz, Nathaniel; Casellas, Rafael; Nussenzweig, Michel C.; Kriaucionis, Skirmantas; Robbiani, Davide F.			Fate Mapping for Activation-Induced Cytidine Deaminase (AID) Marks Non-Lymphoid Cells During Mouse Development	PLOS ONE			English	Article							CLASS SWITCH RECOMBINATION; B-CELL; SOMATIC HYPERMUTATION; EMBRYONIC LETHALITY; DNA; TRANSLOCATIONS; DEFICIENCY; MICE; MEDULLOBLASTOMAS; INACTIVATION	The Aicda gene encodes Activation-Induced cytidine Deaminase (AID), an enzyme essential for remodeling antibody genes in mature B lymphocytes. AID is also responsible for DNA damage at oncogenes, leading to their mutation and cancer-associated chromosome translocation in lymphoma. We used fate mapping and AID(GFP) reporter mice to determine if AID expression in the mouse extends beyond lymphocytes. We discovered that AID(cre) tags a small fraction of non-lymphoid cells starting at 10.5 days post conception (dpc), and that AID(GFP+) cells are detectable at dpc 11.5 and 12.5. Embryonic cells are tagged by AID(cre) in the submandibular region, where conditional deletion of the tumor suppressor PTEN causes squamous papillomas. AID(cre) also tags non-lymphoid cells in the embryonic central nervous system. Finally, in the adult mouse brain, AID(cre) marks a small fraction of diverse neurons and distinct neuronal populations, including pyramidal cells in cortical layer IV.	[Rommel, Philipp C.; Bosque, David; Gitlin, Alexander D.; Nussenzweig, Michel C.; Robbiani, Davide F.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; [Croft, Gist F.] Rockefeller Univ, Lab Mol Vertebrate Embryol, New York, NY 10021 USA; [Heintz, Nathaniel; Kriaucionis, Skirmantas] Rockefeller Univ, Mol Biol Lab, New York, NY 10021 USA; [Heintz, Nathaniel; Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; [Casellas, Rafael] NIAMS, Bethesda, MD USA; [Casellas, Rafael] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Kriaucionis, Skirmantas] Ludwig Inst Canc Res, Oxford, England; [Kriaucionis, Skirmantas] Univ Oxford, Oxford, England	Rockefeller University; Rockefeller University; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Ludwig Institute for Cancer Research; University of Oxford	Robbiani, DF (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.	drobbiani@rockefeller.edu	Rommel, Philipp C/AAP-1813-2020; Kriaucionis, Skirmantas/A-2986-2015; Robbiani, Davide F./AAF-7662-2019; Nussenzweig, Michel/AAE-7292-2019	Rommel, Philipp C/0000-0002-9790-4086; Kriaucionis, Skirmantas/0000-0002-2273-5994; Robbiani, Davide F./0000-0001-7379-3484; Gitlin, Alexander/0000-0002-9229-0919; Croft, Gist/0000-0002-9721-0148	Ludwig Institute for Cancer Research; National Institutes of Health (NIH) [AI037526]; NIH Medical Scientist Training Program grant [GM007739]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037526, R37AI037526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	Ludwig Institute for Cancer Research; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Medical Scientist Training Program grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by institutional funds to DFR, the Ludwig Institute for Cancer Research to SK, and in part by National Institutes of Health (NIH) AI037526 to MCN. ADG was supported by NIH Medical Scientist Training Program grant GM007739. NH and MCN are HHMI Investigators. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Crouch EE, 2007, J EXP MED, V204, P1145, DOI 10.1084/jem.20061952; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Frank KM, 2000, MOL CELL, V5, P993, DOI 10.1016/S1097-2765(00)80264-6; Frappart PO, 2009, P NATL ACAD SCI USA, V106, P1880, DOI 10.1073/pnas.0806882106; Fritz EL, 2010, GENE DEV, V24, P2107, DOI 10.1101/gad.1963010; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Gostissa M, 2011, ANNU REV IMMUNOL, V29, P319, DOI 10.1146/annurev-immunol-031210-101329; Gourzi P, 2006, IMMUNITY, V24, P779, DOI 10.1016/j.immuni.2006.03.021; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Han JH, 2007, IMMUNITY, V27, P64, DOI 10.1016/j.immuni.2007.05.018; Hildenbrand C, 2001, DERMATOLOGY, V202, P362, DOI 10.1159/000051684; JASZCZUR M, 2012, AID APOBEC3G HAPHAZA; Kioussis D, 2009, IMMUNITY, V31, P705, DOI 10.1016/j.immuni.2009.09.009; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Kretzschmar K, 2012, CELL, V148, P33, DOI 10.1016/j.cell.2012.01.002; Lee Y, 2002, CANCER RES, V62, P6395; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Lubke J, 2000, J NEUROSCI, V20, P5300, DOI 10.1523/JNEUROSCI.20-14-05300.2000; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mao CC, 2004, IMMUNITY, V20, P133, DOI 10.1016/S1074-7613(04)00019-6; Marino S, 2000, GENE DEV, V14, P994; McKinnon PJ, 2009, NAT REV NEUROSCI, V10, P100, DOI 10.1038/nrn2559; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Okazaki Il-mi, 2007, Adv Immunol, V94, P245, DOI 10.1016/S0065-2776(06)94008-5; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Pham P, 2011, J BIOL CHEM, V286, P24931, DOI 10.1074/jbc.M111.241208; Qin HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029141; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Robbiani DF, 2013, ANNU REV PATHOL-MECH, V8, P79, DOI 10.1146/annurev-pathol-020712-164004; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; SHAFFER AL, 2011, ANN REV IMMUNOL; Shaffer AL, 2012, ANNU REV IMMUNOL, V30, P565, DOI 10.1146/annurev-immunol-020711-075027; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Stoller JZ, 2008, GENESIS, V46, P200, DOI 10.1002/dvg.20384; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Suzuki A, 2003, CANCER RES, V63, P674; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Yan CT, 2006, P NATL ACAD SCI USA, V103, P7378, DOI 10.1073/pnas.0601938103	48	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e69208	10.1371/journal.pone.0069208	http://dx.doi.org/10.1371/journal.pone.0069208			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861962	Green Published, Green Submitted, gold			2022-12-27	WOS:000321692000038
J	Shen, ZLL; Vince, DG; Li, ZM				Shen, Zhilei Liu; Vince, D. Geoffrey; Li, Zong-Ming			In Vivo Study of Transverse Carpal Ligament Stiffness Using Acoustic Radiation Force Impulse (ARFI) Imaging	PLOS ONE			English	Article							FATTY LIVER-DISEASE; WRIST POSTURE; TUNNEL; STABILITY; FIBROSIS; QUANTIFICATION; ELASTOGRAPHY; MUSCLES; THENAR; ARCH	The transverse carpal ligament (TCL) forms the volar boundary of the carpal tunnel and may provide mechanical constraint to the median nerve, leading to carpal tunnel syndrome. Therefore, the mechanical properties of the TCL are essential to better understand the etiology of carpal tunnel syndrome. The purpose of this study was to investigate the in vivo TCL stiffness using acoustic radiation force impulse (ARFI) imaging. The shear wave velocity (SWV) of the TCL was measured using Virtual Touch IQ (TM) software in 15 healthy, male subjects. The skin and the thenar muscles were also examined as reference tissues. In addition, the effects of measurement location and ultrasound transducer compression on the SWV were studied. The SWV of the TCL was dependent on the tissue location, with greater SWV values within the muscle-attached region than those outside of the muscle-attached region. The SWV of the TCL was significantly smaller without compression (5.21 +/- 1.08 m/s) than with compression (6.62 +/- 1.18 m/s). The SWV measurements of the skin and the thenar muscles were also affected by transducer compression, but to different extents than the SWV of the TCL. Therefore to standardize the ARFI imaging procedure, it is recommended that a layer of ultrasound gel be maintained to minimize the effects of tissue compression. This study demonstrated the feasibility of ARFI imaging for assessing the stiffness characteristics of the TCL in vivo, which has the potential to identify pathomechanical changes of the tissue.	[Shen, Zhilei Liu; Vince, D. Geoffrey; Li, Zong-Ming] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA; [Li, Zong-Ming] Cleveland Clin, Dept Orthopaed Surg, Cleveland, OH 44106 USA; [Li, Zong-Ming] Cleveland Clin, Dept Phys Med & Rehabil, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Li, ZM (corresponding author), Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA.	liz4@ccf.org			National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)/NIH [R21AR062753]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR062753] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The project described was supported by Grant Number R21AR062753 from The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)/NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG TJ, 1979, J BIOMECH, V12, P567, DOI 10.1016/0021-9290(79)90045-9; Bhatia KSS, 2012, ULTRASOUND MED BIOL, V38, P195, DOI 10.1016/j.ultrasmedbio.2011.10.024; Bota S, 2010, J MED ULTRASON, V12, P213; D'Anastasi M, 2011, CLIN HEMORHEOL MICRO, V49, P105, DOI 10.3233/CH-2011-1461; D'Onofrio M, 2009, J PANCREAS, V10, P543; Friedrich-Rust M, 2012, ULTRASONICS, V52, P69, DOI 10.1016/j.ultras.2011.06.012; Friedrich-Rust M, 2009, RADIOLOGY, V252, P595, DOI 10.1148/radiol.2523081928; GARCIAELIAS M, 1989, J HAND SURG-AM, V14, P277, DOI 10.1016/0363-5023(89)90021-X; GARCIAELIAS M, 1989, J ORTHOPAED RES, V7, P738, DOI 10.1002/jor.1100070516; Goss BC, 2010, J HAND SURG-AM, V35A, P197, DOI 10.1016/j.jhsa.2009.09.019; Holmes MWR, 2012, J ORTHOP RES, V30, P757, DOI 10.1002/jor.21583; Holmes MWR, 2011, J ORTHOP RES, V29, P1682, DOI 10.1002/jor.21442; Keir PJ, 1999, CLIN BIOMECH, V14, P635, DOI 10.1016/S0268-0033(99)00012-1; KLINE SC, 1992, J BONE JOINT SURG AM, V74A, P1478, DOI 10.2106/00004623-199274100-00006; Kot BCW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044348; Kung J, 2005, J HAND SURG-BRIT EUR, V30B, P475, DOI 10.1016/j.jhsb.2005.04.019; Li ZM, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3148469; Main EK, 2012, J BIOMECH, V45, P1180, DOI 10.1016/j.jbiomech.2012.01.048; Meng W, 2011, ULTRASOUND MED BIOL, V37, P1436, DOI 10.1016/j.ultrasmedbio.2011.05.022; MESGARZADEH M, 1989, RADIOLOGY, V171, P749, DOI 10.1148/radiology.171.3.2541464; Nightingale K, 2003, ULTRASOUND MED BIOL, V29, P1715, DOI 10.1016/j.ultrasmedbio.2003.08.008; Palmeri ML, 2008, ULTRASOUND MED BIOL, V34, P546, DOI 10.1016/j.ultrasmedbio.2007.10.009; Palmeri ML, 2011, J HEPATOL, V55, P666, DOI 10.1016/j.jhep.2010.12.019; Shen ZLL, 2013, J APPL PHYSIOL, V114, P225, DOI 10.1152/japplphysiol.01273.2012; Shen ZLL, 2012, ULTRASOUND MED BIOL, V38, P982, DOI 10.1016/j.ultrasmedbio.2012.02.021; Stock KF, 2010, CLIN HEMORHEOL MICRO, V46, P139, DOI 10.3233/CH-2010-1340; Syversveen T, 2012, EUR RADIOL, V22, P2130, DOI 10.1007/s00330-012-2476-4; Tengrootenhuysen M, 2009, ACTA ORTHOP BELG, V75, P467; Tozaki M, 2011, EUR J RADIOL, V80, pE182, DOI 10.1016/j.ejrad.2011.05.020; Xiu KH, 2010, CLIN BIOMECH, V25, P776, DOI 10.1016/j.clinbiomech.2010.05.011; Yoneda M, 2010, RADIOLOGY, V256, P640, DOI 10.1148/radiol.10091662; Zhai L, 2012, ULTRASOUND MED BIOL, V38, P50, DOI 10.1016/j.ultrasmedbio.2011.10.002; Zhao H, 2011, ULTRASOUND MED BIOL, V37, P1884, DOI 10.1016/j.ultrasmedbio.2011.07.012	33	20	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68569	10.1371/journal.pone.0068569	http://dx.doi.org/10.1371/journal.pone.0068569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861919	Green Published, Green Submitted, gold			2022-12-27	WOS:000321425300070
J	How, C; Hui, ABY; Alajez, NM; Shi, W; Boutros, PC; Clarke, BA; Yan, R; Pintilie, M; Fyles, A; Hedley, DW; Hill, RP; Milosevic, M; Liu, FF				How, Christine; Hui, Angela B. Y.; Alajez, Nehad M.; Shi, Wei; Boutros, Paul C.; Clarke, Blaise A.; Yan, Rui; Pintilie, Melania; Fyles, Anthony; Hedley, David W.; Hill, Richard P.; Milosevic, Michael; Liu, Fei-Fei			MicroRNA-196b Regulates the Homeobox B7-Vascular Endothelial Growth Factor Axis in Cervical Cancer	PLOS ONE			English	Article							GENE-EXPRESSION; HOX GENES; FACTOR RECEPTOR-1; IDENTIFICATION; PROFILES; MIR-196B; PROGRESSION; PREDICTION; INVASION; PCR	The down-regulation of microRNA-196b (miR-196b) has been reported, but its contribution to cervical cancer progression remains to be investigated. In this study, we first demonstrated that miR-196b down-regulation was significantly associated with worse disease-free survival (DFS) for cervical cancer patients treated with combined chemo-radiation. Secondly, using a tri-modal approach for target identification, we determined that homeobox-B7 (HOXB7) was a bona fide target for miR-196b, and in turn, vascular endothelial growth factor (VEGF) was a downstream transcript regulated by HOXB7. Reconstitution of miR-196b expression by transient transfection resulted in reduced cell growth, clonogenicity, migration and invasion in vitro, as well as reduced tumor angiogenesis and tumor cell proliferation in vivo. Concordantly, siRNA knockdown of HOXB7 or VEGF phenocopied the biological effects of miR-196b over-expression. Our findings have demonstrated that the miR-196b/HOXB7/VEGF pathway plays an important role in cervical cancer progression; hence targeting this pathway could be a promising therapeutic strategy for the future management of this disease.	[How, Christine; Hui, Angela B. Y.; Shi, Wei; Hedley, David W.; Hill, Richard P.; Liu, Fei-Fei] Princess Margaret Hosp, Ontario Canc Inst, Univ Hlth Network, Toronto, ON M4X 1K9, Canada; [How, Christine; Boutros, Paul C.; Hedley, David W.; Hill, Richard P.; Liu, Fei-Fei] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Alajez, Nehad M.] King Saud Univ, Coll Med, Dept Anat, Stem Cell Unit, Riyadh 11461, Saudi Arabia; [Boutros, Paul C.; Yan, Rui] Ontario Inst Canc Res, Toronto, ON, Canada; [Clarke, Blaise A.] Univ Hlth Network, Dept Pathol, Toronto, ON, Canada; [Pintilie, Melania] Princess Margaret Hosp, Div Biostat, Univ Hlth Network, Toronto, ON M4X 1K9, Canada; [Hedley, David W.] Princess Margaret Hosp, Div Med Oncol, Univ Hlth Network, Toronto, ON M4X 1K9, Canada; [Fyles, Anthony; Milosevic, Michael; Liu, Fei-Fei] Princess Margaret Hosp, Dept Radiat Oncol, Univ Hlth Network, Toronto, ON M4X 1K9, Canada; [Fyles, Anthony; Milosevic, Michael; Liu, Fei-Fei] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; King Saud University; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Liu, FF (corresponding author), Princess Margaret Hosp, Ontario Canc Inst, Univ Hlth Network, Toronto, ON M4X 1K9, Canada.	Fei-Fei.Liu@rmp.uhn.on.ca		Milosevic, Michael/0000-0002-9620-6876; Fyles, Anthony/0000-0002-3633-2483; Boutros, Paul/0000-0003-0553-7520; Spence, Tara/0000-0001-7098-4103; Hill, Richard Peter/0000-0001-5331-8045; Hedley, David/0000-0003-1323-2655; Clarke, Blaise/0000-0002-2585-8391; Liu, Fei-Fei/0000-0003-4344-6486; Alajez, Nehad/0000-0002-1546-1091	Ontario Institute for Cancer Research [10NOV-399]; Lawrence, Ila and William Gifford Scholarship Fund; Campbell Family Institute for Cancer Research; Ministry of Health and Long-term Planning; CIHR Strategic Training Fellow in the Excellence in Radiation Research for the 21st Century Program [EIRR21]	Ontario Institute for Cancer Research; Lawrence, Ila and William Gifford Scholarship Fund; Campbell Family Institute for Cancer Research; Ministry of Health and Long-term Planning; CIHR Strategic Training Fellow in the Excellence in Radiation Research for the 21st Century Program(Canadian Institutes of Health Research (CIHR))	This work was supported by funds from the Ontario Institute for Cancer Research (Grant Number: 10NOV-399). Christine How is a CIHR Strategic Training Fellow in the Excellence in Radiation Research for the 21st Century (EIRR21) Program, and is supported by the Lawrence, Ila and William Gifford Scholarship Fund. Support is also provided from the Campbell Family Institute for Cancer Research and the Ministry of Health and Long-term Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Alajez NM, 2011, CANCER RES, V71, P2381, DOI 10.1158/0008-5472.CAN-10-2754; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bachtiary B, 2002, CANCER LETT, V179, P197, DOI 10.1016/S0304-3835(01)00872-2; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, FEBS LETT, V579, P5904, DOI 10.1016/j.febslet.2005.09.040; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bhatia S, 2010, MOL CELL BIOCHEM, V340, P97, DOI 10.1007/s11010-010-0406-9; Buchler P, 2002, ANN SURG, V236, P738, DOI 10.1097/01.SLA.0000036262.67458.E7; Cancer Facts and Figures, 2012, CANC FACTS FIG 2012; Care A, 1996, MOL CELL BIOL, V16, P4842; Care A, 2001, CANCER RES, V61, P6532; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Choi YW, 2007, INT J GYNECOL CANCER, V17, P687, DOI 10.1111/j.1525-1438.2007.00834.x; Cillo C, 2011, INT J CANCER, V129, P2577, DOI 10.1002/ijc.25941; Dirix LY, 1997, BRIT J CANCER, V76, P238, DOI 10.1038/bjc.1997.368; Fan F, 2005, ONCOGENE, V24, P2647, DOI 10.1038/sj.onc.1208246; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hui ABY, 2011, CLIN CANCER RES, V17, P7539, DOI 10.1158/1078-0432.CCR-11-2102; Hui ABY, 2009, LAB INVEST, V89, P597, DOI 10.1038/labinvest.2009.12; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kelly ZL, 2011, J OVARIAN RES, V4, DOI 10.1186/1757-2215-4-16; Lakomy R, 2011, CANCER SCI, V102, P2186, DOI 10.1111/j.1349-7006.2011.02092.x; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liang YY, 2006, ENDOCR-RELAT CANCER, V13, P905, DOI 10.1677/erc.1.01221; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mallo M, 2010, DEV BIOL, V344, P7, DOI 10.1016/j.ydbio.2010.04.024; Perez-Plasencia Carlos, 2007, Infect Agent Cancer, V2, P16, DOI 10.1186/1750-9378-2-16; Rice KL, 2007, J CLIN INVEST, V117, P865, DOI 10.1172/JCI31861; Ries LAG EM, 2003, SEER CANC STAT REV, P1975; Rubin E, 2007, CANCER RES, V67, P1527, DOI 10.1158/0008-5472.CAN-06-4283; Schotte D, 2009, LEUKEMIA, V23, P313, DOI 10.1038/leu.2008.286; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Storti P, 2011, LEUKEMIA, V25, P527, DOI 10.1038/leu.2010.270; Teague EMCO, 2009, MOL ENDOCRINOL, V23, P265, DOI 10.1210/me.2008-0387; Tsai KW, 2010, GENE CHROMOSOME CANC, V49, P969, DOI 10.1002/gcc.20804; Wang YX, 2010, J DIGEST DIS, V11, P50, DOI 10.1111/j.1751-2980.2009.00413.x; Wey JS, 2005, CANCER-AM CANCER SOC, V104, P427, DOI 10.1002/cncr.21145; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zusterzeel PLM, 2009, J CANCER RES CLIN, V135, P283, DOI 10.1007/s00432-008-0442-y	46	56	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67846	10.1371/journal.pone.0067846	http://dx.doi.org/10.1371/journal.pone.0067846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861821	Green Published, Green Submitted, gold			2022-12-27	WOS:000323350700049
J	Huang, W; DiFranza, JR; Kennedy, DN; Zhang, NY; Ziedonis, D; Ursprung, S; King, JA				Huang, Wei; DiFranza, Joseph R.; Kennedy, David N.; Zhang, Nanyin; Ziedonis, Douglas; Ursprung, Sanouri; King, Jean A.			Progressive Levels of Physical Dependence to Tobacco Coincide with Changes in the Anterior Cingulum Bundle Microstructure	PLOS ONE			English	Article							SMOKING CUE REACTIVITY; NICOTINE DEPENDENCE; SPATIAL STATISTICS; FAGERSTROM TEST; WHITE-MATTER; SMOKERS; ACTIVATION; NONSMOKERS; ADDICTION; CHECKLIST	Background: The tobacco withdrawal syndrome indicates the development of neurophysiologic dependence. Clinical evidence indicates that neurophysiologic dependence develops through a set sequence of symptom presentation that can be assessed with a new 3-item survey measure of wanting, craving, and needing tobacco, the Level of Physical Dependence (PD). This study sought to determine if advancing neurophysiologic dependence as measured by the Level of PD correlates with characteristics of white matter structure measured by Fractional Anisotropy (FA). Methods: Diffusion-MRI based FA and diffusion tensor imaging probabilistic tractography were used to evaluate 11 smokers and 10 nonsmokers. FA was also examined in relation to two additional measures of dependence severity, the Hooked on Nicotine Checklist (HONC), and the Fagerstrom Test for Nicotine Dependence (FTND). Results: Among smokers, FA in the left anterior cingulate bundle (ACb) correlated negatively with the Level of PD (r = -0.68, p = 0.02) and HONC scores (r = -0.65, p = 0.03), but the correlation for the FTND did not reach statistical significance (r = -49, p = 0.12). With advancing Levels of PD, the density of streamlines between the ACb and precuneus increased (r = -0.67, p < 0.05) and those between the ACb and white matter projecting to the superior-frontal cortex (r = -0.86, p = 0.0006) decreased significantly. Conclusions: The correlations between neural structure and both the clinical Level of PD survey measure and the HONC suggest that the Level of PD and the HONC may reflect the microstructural integrity of white matter, as influenced by tobacco abuse. Given that the Level of PD is measuring a sequence of symptoms of neurophysiologic dependence that develops over time, the correlation between the Level of PD and neural structure suggests that these features might represent neuroplastic changes that develop over time to support the development of neurophysiologic dependence.	[Huang, Wei; Zhang, Nanyin; King, Jean A.] Univ Massachusetts, Sch Med, Dept Psychiat, Ctr Comparat NeuroImaging, Worcester, MA 01655 USA; [DiFranza, Joseph R.; Ursprung, Sanouri] Univ Massachusetts, Sch Med, Dept Family Med & Community Hlth, Worcester, MA USA; [Kennedy, David N.; Ziedonis, Douglas] Univ Massachusetts, Sch Med, Dept Psychiat, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	King, JA (corresponding author), Univ Massachusetts, Sch Med, Dept Psychiat, Ctr Comparat NeuroImaging, Worcester, MA 01655 USA.	Jean.King@umassmed.edu	Zhang, Nanyin/N-3457-2014	Zhang, Nanyin/0000-0002-5824-9058	National Institutes of Health grant [1 R03 DA024217]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD004147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA024217] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by National Institutes of Health grant 1 R03 DA024217. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brody A, 2006, NEURLA SUBSTRATES RE; Brody AL, 2004, PSYCHIAT RES-NEUROIM, V130, P269, DOI 10.1016/j.pscychresns.2003.12.006; Brody AL, 2004, BIOL PSYCHIAT, V55, P77, DOI 10.1016/S0006-3223(03)00610-3; Brody AL, 2002, ARCH GEN PSYCHIAT, V59, P1162, DOI 10.1001/archpsyc.59.12.1162; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; Daglish MRC, 2001, AM J PSYCHIAT, V158, P1680, DOI 10.1176/appi.ajp.158.10.1680; David SP, 2005, BIOL PSYCHIAT, V58, P488, DOI 10.1016/j.biopsych.2005.04.028; DiFranza J, 2013, ISRN ADDICT IN PRESS; DiFranza JR, 2007, ARCH PEDIAT ADOL MED, V161, P704, DOI 10.1001/archpedi.161.7.704; DiFranza JR, 2012, BRAIN SCI, V2, P523, DOI 10.3390/brainsci2040523; DiFranza JR, 2012, PSYCHOPHARMACOLOGY, V219, P815, DOI 10.1007/s00213-011-2411-4; DiFranza JR, 2012, PHARMACOL BIOCHEM BE, V100, P494, DOI 10.1016/j.pbb.2011.10.018; DiFranza JR, 2011, CURR PEDIATR REV, V7, P88, DOI 10.2174/157339611795735648; DiFranza JR, 2011, J PEDIATR-US, V159, P999, DOI 10.1016/j.jpeds.2011.05.037; DiFranza JR, 2010, J ADOLESCENCE, V33, P209, DOI 10.1016/j.adolescence.2009.03.009; Engelmann JM, 2012, NEUROIMAGE, V60, P252, DOI 10.1016/j.neuroimage.2011.12.024; Franklin T, 2006, BRAIN SIGNATURE CIGA; Froeliger B, 2010, PSYCHOPHARMACOLOGY, V210, P577, DOI 10.1007/s00213-010-1862-3; Gallinat J, 2006, EUR J NEUROSCI, V24, P1744, DOI 10.1111/j.1460-9568.2006.05050.x; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; Hartwell KJ, 2011, ADDICT BIOL, V16, P654, DOI 10.1111/j.1369-1600.2011.00340.x; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Heatherton TF, 2011, TRENDS COGN SCI, V15, P132, DOI 10.1016/j.tics.2010.12.005; Hong LE, 2010, P NATL ACAD SCI USA, V107, P13509, DOI 10.1073/pnas.1004745107; Hudkins M, 2012, PSYCHOPHARMACOLOGY; Jacobsen LK, 2007, J NEUROSCI, V27, P13491, DOI 10.1523/JNEUROSCI.2402-07.2007; Kilts CD, 2004, AM J PSYCHIAT, V161, P233, DOI 10.1176/appi.ajp.161.2.233; Liao YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026460; Lim HK, 2005, J PSYCHIATR RES, V39, P333, DOI 10.1016/j.jpsychires.2004.08.004; Lin FC, 2013, DRUG ALCOHOL DEPEN, V129, P82, DOI 10.1016/j.drugalcdep.2012.09.013; London E, 2004, SOC RES NIC TOB 10 A; Maas LC, 1998, AM J PSYCHIAT, V155, P124, DOI 10.1176/ajp.155.1.124; MacPherson L, 2008, ADDICT BEHAV, V33, P880, DOI 10.1016/j.addbeh.2008.02.007; Moolchan ET, 2002, ADDICT BEHAV, V27, P101, DOI 10.1016/S0306-4603(00)00171-4; Paul RH, 2008, NICOTINE TOB RES, V10, P137, DOI 10.1080/14622200701767829; Rubinstein ML, 2011, J ADOLESCENT HEALTH, V48, P7, DOI 10.1016/j.jadohealth.2010.09.016; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Wellman R, 2008, J AM COLL HEALTH, V56, P549, DOI 10.3200/JACH.56.5.549-554; Wexler BE, 2001, AM J PSYCHIAT, V158, P86, DOI 10.1176/appi.ajp.158.1.86; Wheeler KC, 2004, J ADOLESCENT HEALTH, V35, P225, DOI 10.1016/j.jadohealth.2003.10.004; Wilson SJ, 2005, NICOTINE TOB RES, V7, P637, DOI 10.1080/14622200500185520; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Zhang XC, 2011, NEUROIMAGE, V54, P42, DOI 10.1016/j.neuroimage.2010.08.008; Zhang XC, 2011, NEUROIMAGE, V54, P131, DOI 10.1016/j.neuroimage.2010.07.063; Zhang XC, 2010, BIOL PSYCHIAT, V68, P674, DOI 10.1016/j.biopsych.2010.06.018	46	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67837	10.1371/journal.pone.0067837	http://dx.doi.org/10.1371/journal.pone.0067837			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861816	Green Published, gold, Green Submitted			2022-12-27	WOS:000323350700044
J	Kvicerova, J; Hypsa, V				Kvicerova, Jana; Hypsa, Vaclav			Host-Parasite Incongruences in Rodent Eimeria Suggest Significant Role of Adaptation Rather than Cophylogeny in Maintenance of Host Specificity	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; DNA EVOLUTION; NUCLEAR 18S; APICOMPLEXA; COCCIDIA; ISOSPORA; OOCYSTS; COSPECIATION; GENUS; SPP.	The degree of host specificity, its phylogenetic conservativeness and origin are virtually unknown in Eimeria. This situation is largely due to the inadequate sample of eimerian molecular data available for reliable phylogenetic analyses. In this study, we extend the data set by adding 71 new sequences of coccidia infecting 16 small-mammal genera, mostly rodents. According to the respective feasibility of PCR gene amplification, the new samples are represented by one or more of the following genes: nuclear 18S rRNA, plastid ORF 470, and mitochondrial COI. Phylogenetic analyses of these sequences confirm the previous hypothesis that Eimeria, in its current morphology-based delimitation, is not a monophyletic group. Several samples of coccidia corresponding morphologically to other genera are scattered among the Eimeria lineages. More importantly, the distribution of eimerians from different hosts indicates that the clustering of eimerian species is influenced by their host specificity, but does not arise from a cophylogenetic/cospeciation process; while several clusters are specific to a particular host group, inner topologies within these clusters do not reflect host phylogeny. This observation suggests that the host specificity of Eimeria is caused by adaptive rather than cophylogenetic processes.	[Kvicerova, Jana; Hypsa, Vaclav] Univ South Bohemia, Dept Parasitol, Fac Sci, Ceske Budejovice, Czech Republic; [Kvicerova, Jana; Hypsa, Vaclav] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Kvicerova, J (corresponding author), Univ South Bohemia, Dept Parasitol, Fac Sci, Ceske Budejovice, Czech Republic.	janaq@centrum.cz	Kvičerová, Jana/Q-9577-2018; Hypša, Václav/ABA-1503-2021; Hypsa, Vaclav/G-9847-2014	Kvičerová, Jana/0000-0001-8370-3008; Hypša, Václav/0000-0001-5572-782X; 	Grant Agency of the Czech Republic [206/08/1019, 206/09/H026]; International Scientific and Technical Cooperation MOBILITY/KONTAKT [MEB 0810106]; Ministry of Education, Youth and Sports of the Czech Republic [LC06073, MSM 6007665801]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); International Scientific and Technical Cooperation MOBILITY/KONTAKT; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by the Grant Agency of the Czech Republic (grant numbers 206/08/1019, 206/09/H026); the International Scientific and Technical Cooperation MOBILITY/KONTAKT (number MEB 0810106); and the Ministry of Education, Youth and Sports of the Czech Republic (grant numbers LC06073, MSM 6007665801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barta JR, 1997, J PARASITOL, V83, P262, DOI 10.2307/3284453; Barta JR, 2005, J PARASITOL, V91, P726, DOI 10.1645/GE-3341.1; Brabec J, 2006, INT J PARASITOL, V36, P1535, DOI 10.1016/j.ijpara.2006.08.003; Brant SV, 2000, J PARASITOL, V86, P545, DOI 10.1645/0022-3395(2000)086[0545:POSOTG]2.0.CO;2; Brooks DR, 1993, PARASCRIPT PARASITES; Carreno RA, 1998, J EUKARYOT MICROBIOL, V45, P184, DOI 10.1111/j.1550-7408.1998.tb04523.x; Charleston MA, 1998, MATH BIOSCI, V149, P191, DOI 10.1016/S0025-5564(97)10012-8; Conow C, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-16; DEVOS A J, 1970, Onderstepoort Journal of Veterinary Research, V37, P29; Dolnik OV, 2009, J PARASITOL, V95, P169, DOI 10.1645/GE-1873.1; Duszynski DW, 1997, J PARASITOL, V83, P333, DOI 10.2307/3284470; Duszynski DW, 2000, SPECIAL PUBLICATION, P1; Duszynski DW, 2001, PARASITIC DIS WILD M; Fiala I, 2006, INT J PARASITOL, V36, P1521, DOI 10.1016/j.ijpara.2006.06.016; Franzen C, 2000, PARASITOL RES, V86, P669, DOI 10.1007/PL00008550; GARDNER SL, 1990, J PARASITOL, V76, P805, DOI 10.2307/3282798; Golemansky Vassil G., 2007, Acta Zoologica Bulgarica, V59, P81; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAFNER MS, 1988, NATURE, V332, P258, DOI 10.1038/332258a0; HAFNER MS, 1990, SYST ZOOL, V39, P192, DOI 10.2307/2992181; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HIGGS S, 1991, SYST PARASITOL, V20, P203, DOI 10.1007/BF00009784; Huelsenbeck JP, 2000, EVOLUTION, V54, P352, DOI 10.1111/j.0014-3820.2000.tb00039.x; Huelsenbeck JP, 1997, EVOLUTION, V51, P410, DOI [10.1111/j.1558-5646.1997.tb02428.x, 10.2307/2411113]; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hurkova L, 2005, PARASITOL RES, V97, P33, DOI 10.1007/s00436-005-1353-3; Jirku M, 2002, PROTIST, V153, P379, DOI 10.1078/14344610260450118; Jirku M, 2009, PROTIST, V160, P123, DOI 10.1016/j.protis.2008.08.003; Jirku M, 2009, J EUKARYOT MICROBIOL, V56, P39, DOI 10.1111/j.1550-7408.2008.00362.x; Jousson O, 2000, J EVOLUTION BIOL, V13, P778, DOI 10.1046/j.1420-9101.2000.00221.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; KOUDELA B, 1994, CAN J ZOOL, V72, P239, DOI 10.1139/z94-032; Kvicerova J, 2008, PARASITOLOGY, V135, P443, DOI 10.1017/S0031182007004106; Kvicerova J, 2011, PARASITOLOGY, V138, P1217, DOI 10.1017/S0031182011001107; Levine N. D., 1990, COCCIDIAN PARASITES; LEWIS DC, 1983, SYST PARASITOL, V5, P259, DOI 10.1007/BF00009160; LONG PL, 1984, J PROTOZOOL, V31, P535, DOI 10.1111/j.1550-7408.1984.tb05498.x; Lynch AJ, 2007, J PARASITOL, V93, P1230, DOI 10.1645/GE-1206R.1; Matsubayashi M, 2005, PARASITOL RES, V97, P80, DOI 10.1007/s00436-005-1404-9; Merkle D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S60; Morrison DA, 2004, INT J PARASITOL, V34, P501, DOI 10.1016/j.ijpara.2003.11.006; Nylander JAA., 2004, BIOINFORMATICS; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Page RDM, 1998, MOL PHYLOGENET EVOL, V9, P276, DOI 10.1006/mpev.1997.0458; Page RDM, 1996, SYST BIOL, V45, P151, DOI 10.2307/2413612; PARKER BB, 1986, J PARASITOL, V72, P602, DOI 10.2307/3281518; Paterson Adrian M., 1997, P236; Paterson AM, 2001, INT J PARASITOL, V31, P1012, DOI 10.1016/S0020-7519(01)00199-0; Pellerdy L. P., 1974, COCCIDIA COCCIDIOSIS, V2nd; Perlman SJ, 2003, MOL ECOL, V12, P237, DOI 10.1046/j.1365-294X.2003.01721.x; Pieniazek NJ, 1997, EMERG INFECT DIS, V3, P381, DOI 10.3201/eid0303.970319; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Posada D, 2009, METHODS MOL BIOL, V537, P93, DOI 10.1007/978-1-59745-251-9_5; Power ML, 2009, EXP PARASITOL, V122, P165, DOI 10.1016/j.exppara.2009.02.008; Relman DA, 1996, J INFECT DIS, V173, P440, DOI 10.1093/infdis/173.2.440; Ricklefs RE, 2004, SYST BIOL, V53, P111, DOI 10.1080/10635150490264987; Ricklefs RE, 2002, P ROY SOC B-BIOL SCI, V269, P885, DOI 10.1098/rspb.2001.1940; Samarasinghe B, 2008, EXP PARASITOL, V118, P592, DOI 10.1016/j.exppara.2007.10.015; Schwarz RS, 2009, J PARASITOL, V95, P871, DOI 10.1645/GE-1898.1; Seville RS, 2005, J PARASITOL, V91, P857, DOI 10.1645/GE-466R.1; Stefka J, 2008, INT J PARASITOL, V38, P731, DOI 10.1016/j.ijpara.2007.09.011; UPTON SJ, 1992, J PARASITOL, V78, P406, DOI 10.2307/3283636; Weckstein JD, 2004, SYST BIOL, V53, P154, DOI 10.1080/10635150490265085; Whiteman NK, 2004, INT J PARASITOL, V34, P1113, DOI 10.1016/j.ijpara.2004.06.003; Yabsley MJ, 2006, J PARASITOL, V92, P385, DOI 10.1645/GE-592R.1; Zhao X, 2001, PARASITOL RES, V87, P638, DOI 10.1007/s004360100393; Zhao XM, 2001, J PARASITOL, V87, P1120, DOI 10.1645/0022-3395(2001)087[1120:PPOEAA]2.0.CO;2; Zhao XM, 2001, INT J PARASITOL, V31, P715, DOI 10.1016/S0020-7519(01)00136-9	69	30	30	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e63601	10.1371/journal.pone.0063601	http://dx.doi.org/10.1371/journal.pone.0063601			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861732	gold, Green Submitted, Green Published			2022-12-27	WOS:000323350700001
J	Shnier, A; Lexchin, J; Mintzes, B; Jutel, A; Holloway, K				Shnier, Adrienne; Lexchin, Joel; Mintzes, Barbara; Jutel, Annemarie; Holloway, Kelly			Too Few, Too Weak: Conflict of Interest Policies at Canadian Medical Schools	PLOS ONE			English	Article							EXPOSURE; ATTITUDES; INDUSTRY	Introduction: The education of medical students should be based on the best clinical information available, rather than on commercial interests. Previous research looking at university-wide conflict of interest (COI) policies used in Canadian medical schools has shown very poor regulation. An analysis of COI policies was undertaken to document the current policy environment in all 17 Canadian medical schools. Methods: A web search was used to initially locate COI policies supplemented by additional information from the deans of each medical school. Strength of policies was rated on a scale of 0 to 2 in 12 categories and also on the presence of enforcement measures. For each school, we report scores for all 12 categories, enforcement measures, and summative scores. Results: COI policies received summative scores that ranged from 0 to 19, with 0 the lowest possible score obtainable and 24 the maximum. The highest mean scores per category were for disclosure and ghostwriting (0.9) and for gifts and scholarships (0.8). Discussion: This study provides the first comprehensive evaluation of all 17 Canadian medical school-specific COI policies. Our results suggest that the COI policy environment at Canadian medical schools is generally permissive. Policy development is a dynamic process. We therefore encourage all Canadian medical schools to develop restrictive COI policies to ensure that their medical students are educated based on the best clinical evidence available, free of industry biases and COI relationships that may influence the future medical thinking and prescribing practices of medical students in Canada once they graduate.	[Shnier, Adrienne; Lexchin, Joel] York Univ, Sch Hlth Policy & Management, Toronto, ON M3J 2R7, Canada; [Lexchin, Joel] Univ Hlth Network, Toronto, ON, Canada; [Lexchin, Joel] Univ Toronto, Fac Med, Dept Family & Community Med, Toronto, ON, Canada; [Mintzes, Barbara] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Jutel, Annemarie] Victoria Univ Wellington, Grad Sch Nursing Midwifery & Hlth, Wellington, New Zealand; [Holloway, Kelly] York Univ, Dept Sociol, Toronto, ON M3J 2R7, Canada	York University - Canada; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of British Columbia; Victoria University Wellington; York University - Canada	Lexchin, J (corresponding author), York Univ, Sch Hlth Policy & Management, Toronto, ON M3J 2R7, Canada.	jlexchin@yorku.ca	Mintzes, Barbara/AFK-6613-2022; Jutel, Annemarie/I-2616-2019	Mintzes, Barbara/0000-0002-8671-915X; Jutel, Annemarie/0000-0001-7131-3838				Adair RF, 2005, AM J MED, V118, P881, DOI 10.1016/j.amjmed.2005.02.031; AMSA: American Medical Student Association, 2012, AMSA PHARMFREE SCOR; Association of American Medical Colleges, 2008, IND FUND MED ED REP; Association of American Universities Task Force on Research Accountability, 2001, REP IND I FIN CONFL; Association of Faculties of Medicine of Canada, 2008, IND FUND MED ED ANT; Austad KE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001037; Busing N, 2008, CMAJ, V183, P463; Chimonas S, 2011, ACAD MED, V86, P293, DOI 10.1097/ACM.0b013e3182087156; Cho MK, 2000, JAMA-J AM MED ASSOC, V284, P2203, DOI 10.1001/jama.284.17.2203; Downie J., 2007, MCGILL J LAW HEALTH, V1, P23; Ehringhaus SH, 2008, JAMA-J AM MED ASSOC, V299, P665, DOI 10.1001/jama.299.6.665; Epstein AJ, 2013, MED CARE, V51, P199, DOI 10.1097/MLR.0b013e318277eb19; Grande D, 2011, J GEN INTERNAL MED, V27, P1760; Grande D, 2009, ARCH INTERN MED, V169, P887, DOI 10.1001/archinternmed.2009.64; Hebert PC, 2010, CAN MED ASSOC J, V182, P1279, DOI 10.1503/cmaj.100605; Industry funding working group, 2011, DEF REL EV BAS REV R; Institute of Medicine, 2009, CONFLICT INTEREST ME; King M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f264; Mason PR, 2011, MED J AUSTRALIA, V194, P121, DOI 10.5694/j.1326-5377.2011.tb04193.x; Mathieu G, 2012, BIOETHIQUE, P1; McCormick BB, 2001, JAMA-J AM MED ASSOC, V286, P1994, DOI 10.1001/jama.286.16.1994; Naylor CD, 2002, CAN MED ASSOC J, V166, P453; Rothman DJ, 2010, JAMA-J AM MED ASSOC, V304, P2294, DOI 10.1001/jama.2010.1714; SCCPD working group on industry relations, SSCPD POS PAP ROL IN; Sierles FS, 2005, JAMA-J AM MED ASSOC, V294, P1034, DOI 10.1001/jama.294.9.1034; Spurling GK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000352; Steinbrook R, 2009, NEW ENGL J MED, V360, P2160, DOI 10.1056/NEJMp0810200; Stern S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001070; Ubelacker S, 2010, MED SCH PAIN COURSE; World Health Organization Health Action International, 2010, UND RESP PHARM PROM; Zinner DE, 2009, HEALTH AFFAIR, V28, P1814, DOI 10.1377/hlthaff.28.6.1814	31	25	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68633	10.1371/journal.pone.0068633	http://dx.doi.org/10.1371/journal.pone.0068633			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861928	Green Submitted, gold, Green Published			2022-12-27	WOS:000323350700094
J	Shrivastava, S; Schneider, MF				Shrivastava, Shamit; Schneider, Matthias F.			Opto-Mechanical Coupling in Interfaces under Static and Propagative Conditions and Its Biological Implications	PLOS ONE			English	Article							EXTRINSIC FLUORESCENCE; LIPID MONOLAYERS; MEMBRANE; TRANSITIONS; PROBES	Fluorescent dyes are vital for studying static and dynamic patterns and pattern formation in cell biology. Emission properties of the dyes incorporated in a biological interface are known to be sensitive to their local environment. We report that the fluorescence intensity of dye molecules embedded in lipid interfaces is indeed a thermodynamic observable of the system. Opto-mechanical coupling of lipid-dye system was measured as a function of the thermodynamic state of the interface. The corresponding state diagrams quantify the thermodynamic coupling between intensity I and lateral pressure pi. We further demonstrate that the coupling is conserved upon varying the temperature T. Notably, the observed opto-mechanical coupling is not limited to equilibrium conditions, but also holds for propagating pressure pulses. The non-equilibrium data show, that fluorescence is especially sensitive to dynamic changes in state such as the LE-LC phase transition. We conclude that variations in the thermodynamic state (here pi and T, in general pH, membrane potential V, etc also) of lipid membranes are capable of controlling fluorescence intensity. Therefore, interfacial thermodynamic state diagrams of I should be obtained for a proper interpretation of intensity data.	[Shrivastava, Shamit; Schneider, Matthias F.] Boston Univ, Dept Mech & Biomed Engn, Boston, MA 02215 USA	Boston University	Schneider, MF (corresponding author), Boston Univ, Dept Mech & Biomed Engn, Boston, MA 02215 USA.	mfs@bu.edu	shrivastava, shamit/P-5093-2019	shrivastava, shamit/0000-0003-0916-7336; Shrivastava, Shamit/0000-0002-2244-3246	NIH through BU-XTNC; BU-ENG-ME; German Research Foundation (DFG); SHENC-research unit [FOR 1543]	NIH through BU-XTNC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BU-ENG-ME; German Research Foundation (DFG)(German Research Foundation (DFG)); SHENC-research unit	This study was funded by NIH through BU-XTNC (http://nano-cancer.bu.edu/), BU-ENG-ME and the German Research Foundation (DFG), SHENC-research unit FOR 1543. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SSL, 2009, PROG NEUROBIOL, V88, P104, DOI 10.1016/j.pneurobio.2009.03.002; Boldyrev IA, 2007, J LIPID RES, V48, P1518, DOI 10.1194/jlr.M600459-JLR200; BROWN RS, 1994, J CHEM PHYS, V100, P6019, DOI 10.1063/1.467112; Caseli L, 2005, LANGMUIR, V21, P4090, DOI 10.1021/la047292s; CONTI F, 1974, BIOPHYS STRUCT MECH, V1, P27, DOI 10.1007/BF01022558; CONTI F, 1975, ANNU REV BIOPHYS BIO, V4, P287, DOI 10.1146/annurev.bb.04.060175.001443; Day CA, 2009, BBA-BIOMEMBRANES, V1788, P245, DOI 10.1016/j.bbamem.2008.10.024; Einstein A, 1910, ANN PHYS-BERLIN, V33, P1275; Griesbauer J, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.061909; Griesbauer J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.198103; Griesbauer J, 2009, BIOPHYS J, V97, P2710, DOI 10.1016/j.bpj.2009.07.049; Groves JT, 1998, P NATL ACAD SCI USA, V95, P935, DOI 10.1073/pnas.95.3.935; Han JY, 2010, CHEM REV, V110, P2709, DOI 10.1021/cr900249z; Harris FM, 2002, BBA-BIOMEMBRANES, V1565, P123, DOI 10.1016/S0005-2736(02)00514-X; Heimburg T, 2005, P NATL ACAD SCI USA, V102, P9790, DOI 10.1073/pnas.0503823102; Heimburg T, 2012, BIOPHYS J, V103, P918, DOI 10.1016/j.bpj.2012.07.010; Honger T, 1996, BIOCHEMISTRY-US, V35, P9003, DOI 10.1021/bi960866a; Jin L, 2006, BIOPHYS J, V90, P2563, DOI 10.1529/biophysj.105.072884; Jin L, 2005, BIOPHYS J, DOI DOI 10.1529/BI0PHYSJ.105.064816.ACCESSED; Kaganer VM, 1999, REV MOD PHYS, V71, P779, DOI 10.1103/RevModPhys.71.779; Kaufmann KK, 1999, KAROLINSKA DOCUMENTS, P326; Kim GH, 2007, BIOPHYS J, V92, P3122, DOI 10.1529/biophysj.106.103754; Lenaz G, 1978, MOL CELL BIOCHEM, V22, DOI [10.1007/BF00241467, DOI 10.1007/BF00241467]; MCCONNELL HM, 1991, ANNU REV PHYS CHEM, V42, P171, DOI 10.1146/annurev.physchem.42.1.171; MCCONNELL HM, 1984, P NATL ACAD SCI USA, V81, P3249, DOI 10.1073/pnas.81.10.3249; MOY VT, 1988, J PHYS CHEM-US, V92, P5233, DOI 10.1021/j100329a033; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; OPDENKAMP JA, 1974, BIOCHIM BIOPHYS ACTA, V345, P253, DOI 10.1016/0005-2736(74)90263-6; OPDENKAMP JAF, 1975, BIOCHIM BIOPHYS ACTA, V406, P169, DOI 10.1016/0005-2736(75)90001-2; Sanden T, 2010, P NATL ACAD SCI USA, V107, P4129, DOI 10.1073/pnas.0908671107; SANDERMANN H, 1978, BIOCHIM BIOPHYS ACTA, V515, P209, DOI 10.1016/0304-4157(78)90015-1; Seeger HM, 2010, BIOPHYS J, V99, P3675, DOI 10.1016/j.bpj.2010.10.042; Soderlund T, 1999, MOL PHARMACOL, V55, P32; TASAKI I, 1969, P NATL ACAD SCI USA, V64, P1362, DOI 10.1073/pnas.64.4.1362; TASAKI I, 1971, P NATL ACAD SCI USA, V68, P938, DOI 10.1073/pnas.68.5.938; Tasaki I., 1982, PHYSL ELECTROCHEMIST; VERGER R, 1976, ANNU REV BIOPHYS BIO, V5, P77, DOI 10.1146/annurev.bb.05.060176.000453; VOGEL V, 1988, J COLLOID INTERF SCI, V126, P408, DOI 10.1016/0021-9797(88)90140-3; Wu YK, 1996, BIOPHYS J, V71, P91, DOI 10.1016/S0006-3495(96)79243-3; Zhang YL, 2006, BIOCHEM BIOPH RES CO, V347, P838, DOI 10.1016/j.bbrc.2006.06.152	40	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67524	10.1371/journal.pone.0067524	http://dx.doi.org/10.1371/journal.pone.0067524			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861769	Green Submitted, Green Published, gold			2022-12-27	WOS:000323350700016
J	Acimovic, J; Lovgren-Sandblom, A; Olin, M; Ali, Z; Heverin, M; Schule, R; Schols, L; Fischler, B; Fickert, P; Trauner, M; Bjorkhem, I				Acimovic, Jure; Lovgren-Sandblom, Anita; Olin, Maria; Ali, Zeina; Heverin, Maura; Schuele, Rebecca; Schoels, Ludger; Fischler, Bjorn; Fickert, Peter; Trauner, Michael; Bjorkhem, Ingemar			Sulphatation Does Not Appear to Be a Protective Mechanism to Prevent Oxysterol Accumulation in Humans and Mice	PLOS ONE			English	Article							BILE-ACID SYNTHESIS; RECEPTOR LXR-ALPHA; CHOLESTEROL HOMEOSTASIS; 7-ALPHA-HYDROXYLASE GENE; LIVER-DISEASE; HUMAN BRAIN; 24S-HYDROXYCHOLESTEROL; 27-HYDROXYCHOLESTEROL; IDENTIFICATION; METABOLISM	24S- and 27-hydroxycholesterol (24OHC and 27OHC) are potent regulators of different biochemical systems in vitro and are the major circulating oxysterols. A small fraction of these oxysterols has been reported to be sulphated but there are no detailed studies. We considered the possibility that sulphatation is a protective mechanism preventing accumulation of free oxysterols. Using an accurate assay we found the sulphated fraction of 24OHC and 27OHC in circulation of adults to be less than 15% of total. In two patients with a mutation in CYP7B1 and markedly increased levels of 27OHC the sulphated fraction was 8% and 10% respectively. Infants with severe neonatal cholestasis had however markedly increased sulphate fraction of the above oxysterols. In untreated mice the degree of sulphatation of 24OHC and 27OHC in serum varied between 0 and 16%. Similar degree of sulphatation was found in two mouse models with markedly increased levels of 27OHC and 24OHC respectively. Bile duct ligated mice had higher levels of oxysterols than sham-operated controls but the sulphate fraction was not increased. We conclude that a primary increase in the levels of the oxysterols due to increased synthesis or reduced metabolism in adults and mice does not induce increased sulphatation.	[Acimovic, Jure; Lovgren-Sandblom, Anita; Olin, Maria; Ali, Zeina; Heverin, Maura; Bjorkhem, Ingemar] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Div Clin Chem,Dept Lab Med, Stockholm, Sweden; [Acimovic, Jure] Univ Ljubljana, Fac Med, Inst Biochem, Ljubljana 61000, Slovenia; [Schuele, Rebecca; Schoels, Ludger] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany; [Schuele, Rebecca; Schoels, Ludger] Univ Tubingen, Ctr Neurol, Tubingen, Germany; [Fischler, Bjorn] Karolinska Inst, Div Pediat CLINTEC, Karolinska Univ Hosp, Stockholm, Sweden; [Fickert, Peter] Med Univ, Res Unit Expt & Mol Hepatol, Div Gastroenterol & Hepatol, Dept Med, Graz, Austria; [Trauner, Michael] Med Univ Vienna, Div Gastroenterol & Hepatol, Dept Internal Med 3, Vienna, Austria	Karolinska Institutet; Karolinska University Hospital; University of Ljubljana; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Karolinska Institutet; Karolinska University Hospital; Medical University of Graz; Medical University of Vienna	Acimovic, J (corresponding author), Karolinska Univ, Huddinge Hosp, Karolinska Inst, Div Clin Chem,Dept Lab Med, Stockholm, Sweden.	jure.acimovic@mf.uni-lj.si	Schöls, Ludger/ABB-2482-2021	Schöls, Ludger/0000-0001-7774-5025; Trauner, Michael/0000-0002-1275-6425; Fickert, Peter/0000-0003-0906-4636; Bjorkhem, Ingemar/0000-0002-0575-9425; Bjorkhem, Ingemar/0000-0001-6087-9190	FEBS short-term fellowship; Swedish Brain Power; Swedish Science Council	FEBS short-term fellowship; Swedish Brain Power; Swedish Science Council	This work was supported by FEBS short-term fellowship (JA). Support was also obtained from Swedish Brain Power and the Swedish Science Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorkhem I, 2002, ARTERIOSCL THROM VAS, V22, P734, DOI 10.1161/01.ATV.0000013312.32196.49; Bjorkhem I, 2001, J LIPID RES, V42, P366; Bjorkhem I, 1998, J LIPID RES, V39, P1594; Bjorkhem I, 2009, J LIPID RES, V50, pS213, DOI 10.1194/jlr.R800025-JLR200; Bretillon L, 2000, J LIPID RES, V41, P840; BURSTEIN S, 1958, J BIOL CHEM, V233, P331; DZELETOVIC S, 1995, ANAL BIOCHEM, V225, P73, DOI 10.1006/abio.1995.1110; Fakheri RJ, 2012, STEROIDS, V77, P575, DOI 10.1016/j.steroids.2012.02.006; Fickert P, 2002, GASTROENTEROLOGY, V123, P1238, DOI 10.1053/gast.2002.35948; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Javitt NB, 2001, ENDOCRINOLOGY, V142, P2978, DOI 10.1210/en.142.7.2978; KORNEL L, 1965, BIOCHEMISTRY-US, V4, P444, DOI 10.1021/bi00879a011; Li XB, 2007, J LIPID RES, V48, P2587, DOI 10.1194/jlr.M700301-JLR200; Li-Hawkins J, 2000, J BIOL CHEM, V275, P16536, DOI 10.1074/jbc.M001811200; Lund EG, 2003, J BIOL CHEM, V278, P22980, DOI 10.1074/jbc.M303415200; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Meir K, 2002, J BIOL CHEM, V277, P34036, DOI 10.1074/jbc.M201122200; Meng LJ, 1997, J LIPID RES, V38, P926; Meng LJ, 1996, J STEROID BIOCHEM, V58, P585, DOI 10.1016/0960-0760(96)00080-5; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Ren SL, 2007, BIOCHEM BIOPH RES CO, V360, P802, DOI 10.1016/j.bbrc.2007.06.143; Rosen H, 1998, J BIOL CHEM, V273, P14805, DOI 10.1074/jbc.273.24.14805; Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361; Schule R, 2010, J LIPID RES, V51, P819, DOI 10.1194/jlr.M002543; SEGAL L, 1960, J BIOL CHEM, V235, P3108; Setchell KDR, 1998, J CLIN INVEST, V102, P1690, DOI 10.1172/JCI2962; Shafaati M, 2011, J INTERN MED, V270, P377, DOI 10.1111/j.1365-2796.2011.02389.x; Vaya J, 2007, J NEUROCHEM, V102, P1727, DOI 10.1111/j.1471-4159.2007.04689.x	28	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68031	10.1371/journal.pone.0068031	http://dx.doi.org/10.1371/journal.pone.0068031			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844150	gold, Green Submitted, Green Published			2022-12-27	WOS:000321733000125
J	Symmonds, M; Wright, ND; Fagan, E; Dolan, RJ				Symmonds, Mkael; Wright, Nicholas D.; Fagan, Elizabeth; Dolan, Raymond J.			Assaying the Effect of Levodopa on the Evaluation of Risk in Healthy Humans	PLOS ONE			English	Article							DECISION-MAKING; PARKINSONS-DISEASE; REWARD PROBABILITY; RECEPTOR GENE; L-DOPA; SEROTONIN; PREDICTION; UNCERTAINTY; VARIANCE; BEHAVIOR	In humans, dopamine is implicated in reward and risk-based decision-making. However, the specific effects of dopamine augmentation on risk evaluation are unclear. Here we sought to measure the effect of 100 mg oral levodopa, which enhances synaptic release of dopamine, on choice behaviour in healthy humans. We use a paradigm without feedback or learning, which solely isolates effects on risk evaluation. We present two studies (n = 20; n = 20) employing a randomised, placebo-controlled, within-subjects design. We manipulated different dimensions of risk in a controlled economic paradigm. We test effects on risk-reward tradeoffs, assaying both aversion to variance (the spread of possible outcomes) and preference for relative losses and gains (asymmetry of outcomes - skewness), dissociating this from potential non-specific effects on choice randomness using behavioural modelling. There were no systematic effects of levodopa on risk attitudes, either for variance or skewness. However, there was a drift towards more risk-averse behaviour over time, indicating that this paradigm was sensitive to detect changes in risk-preferences. These findings suggest that levodopa administration does not change the evaluation of risk. One possible reason is that dopaminergic influences on decision making may be due to changing the response to reward feedback.	[Symmonds, Mkael; Wright, Nicholas D.; Fagan, Elizabeth; Dolan, Raymond J.] UCL, Wellcome Trust Ctr Neuroimaging, Inst Neurol, London, England; [Symmonds, Mkael] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England	University of London; University College London; University of Oxford	Symmonds, M (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, Inst Neurol, London, England.	mkael.symmonds@googlemail.com	Wright, Nicholas/HHY-7227-2022; Fagan, Elizabeth/F-7815-2014	Dolan, Ray/0000-0001-9356-761X	Wellcome Trust [098362/Z/12/Z, 091593/Z/10/Z]; Wellcome Trust Research Training Fellowship	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Research Training Fellowship(Wellcome Trust)	This work was supported by the Wellcome Trust (RJD Senior Investigator Award 098362/Z/12/Z). The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust (091593/Z/10/Z). NDW is in receipt of a Wellcome Trust Research Training Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler B, 2006, NEUROIMAGE, V31, P790, DOI 10.1016/j.neuroimage.2006.01.001; ALDERFER CP, 1970, J BUS, V43, P341, DOI 10.1086/295286; Angwin AJ, 2004, J INT NEUROPSYCH SOC, V10, P15, DOI 10.1017/S1355617704101033; Bach DR, 2012, NAT REV NEUROSCI, V13, P572, DOI 10.1038/nrn3289; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; Brand M, 2005, NEUROPSYCHOLOGY, V19, P267, DOI 10.1037/0894-4105.19.3.267; Breitenstein C, 2006, NEUROPSYCHOPHARMACOL, V31, P2552, DOI 10.1038/sj.npp.1301167; Buelow MT, 2009, NEUROPSYCHOL REV, V19, P102, DOI 10.1007/s11065-009-9083-4; Camara E, 2010, CEREB CORTEX, V20, P1985, DOI 10.1093/cercor/bhp263; Comings DE, 1997, MOL PSYCHIATR, V2, P44, DOI 10.1038/sj.mp.4000207; Comings DE, 2001, CLIN GENET, V60, P107, DOI 10.1034/j.1399-0004.2001.600204.x; Comings DE, 1996, PHARMACOGENETICS, V6, P223, DOI 10.1097/00008571-199606000-00004; Cools R, 2003, NEUROPSYCHOLOGIA, V41, P1431, DOI 10.1016/S0028-3932(03)00117-9; Cools R, 2009, J NEUROSCI, V29, P1538, DOI 10.1523/JNEUROSCI.4467-08.2009; COOMBS CH, 1960, J EXP PSYCHOL, V60, P265, DOI 10.1037/h0041444; Copland DA, 2009, CEREB CORTEX, V19, P2651, DOI 10.1093/cercor/bhp017; CREVOISIER C, 1987, European Neurology, V27, P36, DOI 10.1159/000116173; Czernecki V, 2002, NEUROPSYCHOLOGIA, V40, P2257, DOI 10.1016/S0028-3932(02)00108-2; d'Acremont M, 2008, COGN AFFECT BEHAV NE, V8, P363, DOI 10.3758/CABN.8.4.363; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; de Vries MH, 2010, NEUROPSYCHOLOGIA, V48, P3193, DOI 10.1016/j.neuropsychologia.2010.06.024; Delazer M, 2009, NEUROPSYCHOLOGIA, V47, P1901, DOI 10.1016/j.neuropsychologia.2009.02.034; Dethy S, 1997, CLIN CHEM, V43, P740; Dreber A, 2009, EVOL HUM BEHAV, V30, P85, DOI 10.1016/j.evolhumbehav.2008.11.001; Eisenegger C, 2010, BIOL PSYCHIAT, V67, P702, DOI 10.1016/j.biopsych.2009.09.021; ELLSBERG D, 1961, Q J ECON, V75, P643, DOI 10.2307/1884324; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Fiorillo CD, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-7; FISHBURN PC, 1984, MANAGE SCI, V30, P396, DOI 10.1287/mnsc.30.4.396; Floel A, 2005, NEUROLOGY, V65, P472, DOI 10.1212/01.wnl.0000172340.56307.5e; Forbes E.E., 2007, MOL PSYCHIATR, V14, P60, DOI DOI 10.1038/SJ.MP.4002086; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Gallagher DA, 2007, MOVEMENT DISORD, V22, P1757, DOI 10.1002/mds.21611; Golec J, 1998, J POLIT ECON, V106, P205, DOI 10.1086/250007; Grosset KA, 2006, MOVEMENT DISORD, V21, P2206, DOI 10.1002/mds.21110; Ha RY, 2009, PROG NEURO-PSYCHOPH, V33, P1217, DOI 10.1016/j.pnpbp.2009.07.009; Imamura A, 2006, PARKINSONISM RELAT D, V12, P506, DOI 10.1016/j.parkreldis.2006.02.004; Kacelnik A, 1996, AM ZOOL, V36, P402; Kagel JH, 1995, HDB EXPT EC; Kaminski BJ, 2001, J EXP ANAL BEHAV, V75, P275, DOI 10.1901/jeab.2001.75-275; Kischka U, 1996, NEUROPSYCHOLOGIA, V34, P1107, DOI 10.1016/0028-3932(96)00024-3; Knecht S, 2004, ANN NEUROL, V56, P20, DOI 10.1002/ana.20125; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Leibowitz SF, 1998, BIOL PSYCHIAT, V44, P851, DOI 10.1016/S0006-3223(98)00186-3; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Levin IP, 2007, JUDGM DECIS MAK, V2, P225; Lobo DSS, 2010, BIOL PSYCHOL, V85, P33, DOI 10.1016/j.biopsycho.2010.04.008; Long AB, 2009, SOC COGN AFFECT NEUR, V4, P346, DOI 10.1093/scan/nsp020; Lu C, 2006, ARCH NEUROL-CHICAGO, V63, P298, DOI 10.1001/archneur.63.2.298-a; Marco-Pallares J, 2009, BIOL PSYCHIAT, V66, P154, DOI 10.1016/j.biopsych.2009.01.006; McCabe C, 2010, BIOL PSYCHIAT, V67, P439, DOI 10.1016/j.biopsych.2009.11.001; Mihatsch O, 2002, MACH LEARN, V49, P267, DOI 10.1023/A:1017940631555; Molina JA, 2000, MOVEMENT DISORD, V15, P869, DOI 10.1002/1531-8257(200009)15:5<869::AID-MDS1016>3.0.CO;2-I; Moran RJ, 2011, CURR BIOL, V21, P1320, DOI 10.1016/j.cub.2011.06.053; Nakamura K, 2008, J NEUROSCI, V28, P5331, DOI 10.1523/JNEUROSCI.0021-08.2008; Niv Y, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-6; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; Niv Y, 2012, J NEUROSCI, V32, P551, DOI 10.1523/JNEUROSCI.5498-10.2012; Onur OA, 2011, J COGNITIVE NEUROSCI, V23, P2797, DOI 10.1162/jocn.2011.21603; Pelli DG, 2009, HDB OPTICS VISION VI; Penny WD, 2004, NEUROIMAGE, V22, P1157, DOI 10.1016/j.neuroimage.2004.03.026; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Pleger B, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000164; Pothos EN, 2002, BEHAV BRAIN RES, V130, P203, DOI 10.1016/S0166-4328(01)00419-3; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; Redish AD, 2004, SCIENCE, V306, P1944, DOI 10.1126/science.1102384; Rogers RD, 1999, J NEUROSCI, V19, P9029, DOI 10.1523/JNEUROSCI.19-20-09029.1999; Rogers RD, 2003, NEUROPSYCHOPHARMACOL, V28, P153, DOI 10.1038/sj.npp.1300001; ROTHSCHILD M, 1971, J ECON THEORY, V3, P66, DOI 10.1016/0022-0531(71)90034-2; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sevy S, 2006, PSYCHOPHARMACOLOGY, V188, P228, DOI 10.1007/s00213-006-0450-z; Sharot T, 2009, CURR BIOL, V19, P2077, DOI 10.1016/j.cub.2009.10.025; St Onge JR, 2009, NEUROPSYCHOPHARMACOL, V34, P681, DOI 10.1038/npp.2008.121; Symmonds M, 2011, NEUROIMAGE, V58, P1139, DOI 10.1016/j.neuroimage.2011.06.087; Symmonds M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011090; Takahashi H, 2010, J NEUROSCI, V30, P16567, DOI 10.1523/JNEUROSCI.3933-10.2010; Tanaka SC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001333; Tanaka SC, 2009, J NEUROSCI, V29, P15669, DOI 10.1523/JNEUROSCI.2799-09.2009; Tippmann-Peikert M, 2007, NEUROLOGY, V68, P301, DOI 10.1212/01.wnl.0000252368.25106.b6; Tobler PN, 2007, J NEUROPHYSIOL, V97, P1621, DOI 10.1152/jn.00745.2006; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Torta DME, 2009, BRAIN COGNITION, V71, P84, DOI 10.1016/j.bandc.2009.04.003; Wright ND, 2012, J NEUROSCI, V32, P7009, DOI 10.1523/JNEUROSCI.0049-12.2012	85	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68177	10.1371/journal.pone.0068177	http://dx.doi.org/10.1371/journal.pone.0068177			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844168	gold, Green Published, Green Submitted			2022-12-27	WOS:000321733000133
J	Lindberg, AS; Oksa, J; Gavhed, D; Malm, C				Lindberg, Ann-Sofie; Oksa, Juha; Gavhed, Desiree; Malm, Christer			Field Tests for Evaluating the Aerobic Work Capacity of Firefighters	PLOS ONE			English	Article							CONTAINED BREATHING APPARATUS; MAXIMAL OXYGEN-UPTAKE; PHYSIOLOGICAL DEMANDS; FIRE-FIGHTERS; PHYSICAL DEMANDS; ABILITY TEST; PERFORMANCE; RESPONSES; EXERCISE; TASKS	Working as a firefighter is physically strenuous, and a high level of physical fitness increases a firefighter's ability to cope with the physical stress of their profession. Direct measurements of aerobic capacity, however, are often complicated, time consuming, and expensive. The first aim of the present study was to evaluate the correlations between direct (laboratory) and indirect (field) aerobic capacity tests with common and physically demanding firefighting tasks. The second aim was to give recommendations as to which field tests may be the most useful for evaluating firefighters' aerobic work capacity. A total of 38 subjects (26 men and 12 women) were included. Two aerobic capacity tests, six field tests, and seven firefighting tasks were performed. Lactate threshold and onset of blood lactate accumulation were found to be correlated to the performance of one work task (r(s) = -0.65 and -0.63, p < 0.01, respectively). Absolute (mL.min(-1)) and relative (mL.kg(-1).min(-1)) maximal aerobic capacity was correlated to all but one of the work tasks (r(s) = -0.79 to 0.55 and -0.74 to 0.47, p < 0.01, respectively). Aerobic capacity is important for firefighters' work performance, and we have concluded that the time to row 500 m, the time to run 3000 m relative to body weight (s.kg(-1)), and the percent of maximal heart rate achieved during treadmill walking are the most valid field tests for evaluating a firefighter's aerobic work capacity.	[Lindberg, Ann-Sofie; Malm, Christer] Umea Univ, Sports Med Unit, S-90187 Umea, Sweden; [Lindberg, Ann-Sofie; Malm, Christer] Winternet, Boden, Sweden; [Oksa, Juha] Finnish Inst Occupat Hlth, Phys Work Capac Team, Oulu, Finland; [Gavhed, Desiree] Karolinska Inst, Dept Womens & Childrens Hlth, S-10401 Stockholm, Sweden	Umea University; Finnish Institute of Occupational Health; Karolinska Institutet	Lindberg, AS (corresponding author), Umea Univ, Sports Med Unit, S-90187 Umea, Sweden.	ann-sofie.lindberg@winter-net.se	Malm, Christer B/O-3458-2014	Malm, Christer B/0000-0002-8436-2476	Swedish Civil Contingencies Agency	Swedish Civil Contingencies Agency	The work was supported by funding from the Swedish Civil Contingencies Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GM, 2002, SCI UNITS MEASURE EX, P22; Arbetsmiljoverket, 2005, MED KONTROLLER ARBET, P18; Barr D, 2010, APPL ERGON, V41, P161, DOI 10.1016/j.apergo.2009.07.001; Bilzon JLJ, 2001, ERGONOMICS, V44, P766, DOI 10.1080/00140130118253; Borg G, 1998, BORGS PERCEIVED EXER, P9; Bos J, 2004, ERGONOMICS, V47, P446, DOI 10.1080/00140130310001643283; BRANSFORD DR, 1977, MED SCI SPORT EXER, V9, P41; CURETON K, 1986, EUR J APPL PHYSIOL O, V54, P656, DOI 10.1007/BF00943356; DAVIS PO, 1982, MED SCI SPORT EXER, V14, P65, DOI 10.1249/00005768-198201000-00013; Deakin J, 1996, DEV BONA FIDE PHYS M, P1; Dennison KJ, 2012, J STRENGTH COND RES, V26, P1101, DOI 10.1519/JSC.0b013e31822dd027; Dreger RW, 2007, APPL PHYSIOL NUTR ME, V32, P454, DOI 10.1139/H07-020; Dreger RW, 2006, ERGONOMICS, V49, P911, DOI 10.1080/00140130600667451; Eglin CM, 2004, ERGONOMICS, V47, P483, DOI 10.1080/0014013031000107568; Gavhed D, 2001, BRANDMANNENS FYSISKA; GAVHED DCE, 1989, EUR J APPL PHYSIOL O, V59, P115, DOI 10.1007/BF02396588; GLEDHILL N, 1992, CAN J SPORT SCI, V17, P207; GLEDHILL N, 1992, CAN J SPORT SCI, V17, P199; Harvey DG, 2008, EUR J APPL PHYSIOL, V103, P89, DOI 10.1007/s00421-008-0673-2; HAYMES EM, 1980, MED SCI SPORT EXER, V12, P153; Holmer I, 2007, APPL ERGON, V38, P45, DOI 10.1016/j.apergo.2006.01.004; Hooper AJ, 2001, APPL ERGON, V32, P399, DOI 10.1016/S0003-6870(01)00007-2; Huang CJ, 2010, INT J PSYCHOPHYSIOL, V75, P312, DOI 10.1016/j.ijpsycho.2009.12.013; Irving BA, 2006, MED SCI SPORT EXER, V38, P1348, DOI 10.1249/01.mss.0000227322.61964.d2; Lord C, 2012, APPL ERGON, V43, P191, DOI 10.1016/j.apergo.2011.05.003; LOUHEVAARA V, 1994, INT J IND ERGONOM, V13, P139, DOI 10.1016/0169-8141(94)90080-9; Lund A, 2013, TESTING NORMALITY LA; LUSA S, 1994, J OCCUP ENVIRON MED, V36, P70; Lusa S, 1992, AGING WORK, V28-30, P134; MCARDLE W, 2001, EXERCISE PHYSL ENERG, P1158; Michaelides MA, 2011, J STRENGTH COND RES, V25, P956, DOI 10.1519/JSC.0b013e3181cc23ea; Michaelides MA, 2008, RES Q EXERCISE SPORT, V79, P468, DOI 10.1080/02701367.2008.10599513; OCONNELL ER, 1986, J OCCUP ENVIRON MED, V28, P282; Phillips M, 2011, APPL ERGON, V42, P411, DOI 10.1016/j.apergo.2010.08.020; Rynders CA, 2011, EUR J APPL PHYSIOL, V111, P2063, DOI 10.1007/s00421-010-1821-z; Sawyer BJ, 2010, MED SCI SPORT EXER, V42, P2122, DOI 10.1249/MSS.0b013e3181de2da7; Sheaff AK, 2010, J STRENGTH COND RES, V24, P3112, DOI 10.1519/JSC.0b013e3181f0a8d5; SJODIN B, 1981, INT J SPORTS MED, V2, P166, DOI 10.1055/s-2008-1034605; Smith DL, 2011, CURR SPORT MED REP, V10, P167, DOI 10.1249/JSR.0b013e31821a9fec; Sothmann MS, 2004, ERGONOMICS, V47, P864, DOI 10.1080/00140130410001670372; Stoudemire NM, 1996, MED SCI SPORT EXER, V28, P490, DOI 10.1097/00005768-199604000-00014; Taylor NAS, 2012, EUR J APPL PHYSIOL, V112, P2913, DOI 10.1007/s00421-011-2267-7; Tokmakidis S, 1995, COACHING SPORT SCI J, V1, P19; von Heimburg ED, 2006, ERGONOMICS, V49, P111, DOI 10.1080/00140130500435793; Whitley E, 2002, CRIT CARE, V6, P66; Williams-Bell FM, 2009, MED SCI SPORT EXER, V41, P653, DOI 10.1249/MSS.0b013e31818ad117; Zylberstein M, 1973, FYSISK BELASTNING RO	47	23	26	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68047	10.1371/journal.pone.0068047	http://dx.doi.org/10.1371/journal.pone.0068047			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844153	gold, Green Published, Green Submitted			2022-12-27	WOS:000321341000133
J	Lu, X; Yang, XY; Li, X; Lu, Y; Ren, ZT; Zhao, LY; Hu, XX; Jiang, JD; You, XF				Lu, Xi; Yang, Xinyi; Li, Xue; Lu, Yun; Ren, Zhitao; Zhao, Longyin; Hu, Xinxin; Jiang, Jiandong; You, Xuefu			In Vitro Activity of Sodium New Houttuyfonate Alone and in Combination with Oxacillin or Netilmicin against Methicillin-Resistant Staphylococcus aureus	PLOS ONE			English	Article							HOUTTUYNIA-CORDATA; ANTIBACTERIAL ACTIVITIES; ARTESUNATE; HOMOLOGS; MALARIA; TRIAL; MRSA	Background: Staphylococcus aureus can cause severe infections, including bacteremia and sepsis. The spread of methicillin-resistant Staphylococcus aureus (MRSA) highlights the need for novel treatment options. Sodium new houttuyfonate (SNH) is an analogue of houttuynin, the main antibacterial ingredient of Houttuynia cordata Thunb. The aim of this study was to evaluate in vitro activity of SNH and its potential for synergy with antibiotics against hospital-associated MRSA. Methodology: A total of 103 MRSA clinical isolates recovered in two hospitals in Beijing were evaluated for susceptibility to SNH, oxacillin, cephalothin, meropenem, vancomycin, levofloxacin, minocycline, netilmicin, and trimethoprim/sulfamethoxazole by broth microdilution. Ten isolates were evaluated for potential for synergy between SNH and the antibiotics above by checkerboard assay. Time-kill analysis was performed in three isolates to characterize the kill kinetics of SNH alone and in combination with the antibiotics that engendered synergy in checkerboard assays. Besides, two reference strains were included in all assays. Principal Findings: SNH inhibited all test strains with minimum inhibitory concentrations (MICs) ranging from 16 to 64 mu g/mL in susceptibility tests, and displayed inhibition to bacterial growth in concentration-dependent manner in time-kill analysis. In synergy studies, the combinations of SNH-oxacillin, SNH-cephalothin, SNH-meropenem and SNH-netilmicin showed synergistic effects against 12 MRSA strains with median fractional inhibitory concentration (FIC) indices of 0.38, 0.38, 0.25 and 0.38 in checkerboard assays. In time-kill analysis, SNH at 1/2 MIC in combination with oxacillin at 1/128 to 1/64 MIC or netilmicin at 1/8 to 1/2 MIC decreased the viable colonies by >= 2log(10) CFU/mL. Conclusions/Significance: SNH demonstrated in vitro antibacterial activity against 103 hospital-associated MRSA isolates. Combinations of sub-MIC levels of SNH and oxacillin or netilmicin significantly improved the in vitro antibacterial activity against MRSA compared with either drug alone. The SNH-based combinations showed promise in combating MRSA.	[Lu, Xi; Yang, Xinyi; Li, Xue; Lu, Yun; Ren, Zhitao; Zhao, Longyin; Hu, Xinxin; Jiang, Jiandong; You, Xuefu] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China; [Lu, Xi; Yang, Xinyi; Li, Xue; Lu, Yun; Ren, Zhitao; Zhao, Longyin; Hu, Xinxin; Jiang, Jiandong; You, Xuefu] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhao, Longyin] Beijing Stand Herbs Med Sci & Technol Dev Co LTD, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Jiang, JD (corresponding author), Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China.	jiang.jdong@163.com; xuefuyou@imb.pumc.edu.cn			National Natural Science Foundation of China [30701062, 30672502, 81273427]; National Mega-project for Innovative Drugs, People's Republic of China [2012ZX09301002-001, 2012ZX09301002-005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Mega-project for Innovative Drugs, People's Republic of China	This work was supported by the National Natural Science Foundation of China (30701062, 30672502, and 81273427) and the National Mega-project for Innovative Drugs (2012ZX09301002-001, 2012ZX09301002-005), People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjuik M, 2004, LANCET, V363, P9, DOI 10.1016/S0140-6736(03)15162-8; Chinese Pharmacopoeia Commission, 2010, CHIN PHARM 1, P208; Chinese Pharmacopoeia Commission, 1995, PHARM PEOPL REP CHIN, P411; Clinical and Laboratory Standards Institute, 2012, M07A99 CLSI; Faiz MA, 2005, LANCET, V366, P717; Gould IM, 2012, INT J ANTIMICROB AG, V39, P96, DOI 10.1016/j.ijantimicag.2011.09.028; HAYASHI K, 1995, PLANTA MED, V61, P237, DOI 10.1055/s-2006-958063; Jenkins RE, 2012, J ANTIMICROB CHEMOTH, V67, P1405, DOI 10.1093/jac/dks071; Kim GS, 2008, BIOL PHARM BULL, V31, P2012, DOI 10.1248/bpb.31.2012; Li ZB, 2009, MED CHEM RES, V18, P362, DOI 10.1007/s00044-008-9133-0; Liang L., 2006, SHENZHEN J INTEGRATE, V16, P36; Liu GX, 2011, MOLECULES, V16, P8848, DOI 10.3390/molecules16108848; Liu YD, 2009, ANTIMICROB AGENTS CH, V53, P512, DOI 10.1128/AAC.00804-08; Lu HM, 2006, J ETHNOPHARMACOL, V104, P245, DOI 10.1016/j.jep.2005.09.012; Lu HM, 2006, CHEM PHARM BULL, V54, P936, DOI 10.1248/cpb.54.936; Maesaki S, 1994, Kansenshogaku Zasshi, V68, P1523; Moellering RC, 2012, J ANTIMICROB CHEMOTH, V67, P4, DOI 10.1093/jac/dkr437; Nasu Masaru, 1994, Japanese Journal of Antibiotics, V47, P1305; Patricia MJ, 1961, BRIT MED J, V14, P124; Performance Standards for Antimicrobial Susceptibility Testing, 2007, M100S17 CLSI; Pillai SK, 2005, ANTIBIOTICS LAB MED, P365; RABBANI GH, 1987, J INFECT DIS, V155, P979, DOI 10.1093/infdis/155.5.979; Savage PB, 2002, FEMS MICROBIOL LETT, V217, P1; Verma P., 2007, ANTIMICROBIAL SUSCEP, P275, DOI DOI 10.1201/9781420014495.CH12; Wang H, 2008, DIAGN MICR INFEC DIS, V62, P226, DOI 10.1016/j.diagmicrobio.2008.06.003; Ye XL, 2006, J ASIAN NAT PROD RES, V8, P327, DOI 10.1080/10286020500035243; Ye XL, 2007, COLLOID SURFACE A, V301, P412, DOI 10.1016/j.colsurfa.2007.01.012; Ye XL, 2009, COLLOID SURFACE A, V350, P130, DOI 10.1016/j.colsurfa.2009.09.017; Yu X, 2005, TIANJIN PHARM, V17, P39; Zhang Z, 1979, NEW MED, V10, P601	30	25	28	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68053	10.1371/journal.pone.0068053	http://dx.doi.org/10.1371/journal.pone.0068053			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844154	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000134
J	Tabassum, F; Batty, GD				Tabassum, Faiza; Batty, G. David			Are Current UK National Institute for Health and Clinical Excellence (NICE) Obesity Risk Guidelines Useful? Cross-Sectional Associations with Cardiovascular Disease Risk Factors in a Large, Representative English Population	PLOS ONE			English	Article							BODY-MASS INDEX; CORONARY-HEART-DISEASE; NUTRITION EXAMINATION SURVEY; CAUSE-SPECIFIC MORTALITY; WAIST CIRCUMFERENCE; ORIGINAL WHITEHALL; ABDOMINAL ADIPOSITY; US ADULTS; FOLLOW-UP; OVERWEIGHT	The National Institute for Health and Clinical Excellence (NICE) has recently released obesity guidelines for health risk. For the first time in the UK, we estimate the utility of these guidelines by relating them to the established cardiovascular disease (CVD) risk factors. Health Survey for England (HSE) 2006, a population-based cross-sectional study in England was used with a sample size of 7225 men and women aged >= 35 years (age range: 35-97 years). The following CVD risk factor outcomes were used: hypertension, diabetes, total and high density lipoprotein cholesterol, glycated haemoglobin, fibrinogen, C-reactive protein and Framingham risk score. Four NICE categories of obesity were created based on body mass index (BMI) and waist circumference (WC): no risk (up to normal BMI and low/high WC); increased risk (normal BMI & very high WC, or obese & low WC); high risk (overweight & very high WC, or obese & high WC); and very high risk (obese I & very high WC or obese II/III with any levels of WC. Men and women in the very high risk category had the highest odds ratios (OR) of having unfavourable CVD risk factors compared to those in the no risk category. For example, the OR of having hypertension for those in the very high risk category of the NICE obesity groupings was 2.57 (95% confidence interval 2.06 to 3.21) in men, and 2.15 (1.75 to 2.64) in women. Moreover, a dose-response association between the adiposity groups and most of the CVD risk factors was observed except total cholesterol in men and low HDL in women. Similar results were apparent when the Framingham risk score was the outcome of interest. In conclusion, the current NICE definitions of obesity show utility for a range of CVD risk factors and CVD risk in both men and women.	[Tabassum, Faiza] UCL, Dept Infect & Populat Hlth, London, England; [Batty, G. David] UCL, Dept Epidemiol & Publ Hlth, London, England	University of London; University College London; University of London; University College London	Tabassum, F (corresponding author), UCL, Dept Infect & Populat Hlth, London, England.	f.tabassum@ucl.ac.uk	Batty, GD/Y-4401-2018	Batty, GD/0000-0003-1822-5753				Ardern CI, 2004, OBES RES, V12, P1094, DOI 10.1038/oby.2004.137; Ardern CL, 2003, OBES RES, V11, P135, DOI 10.1038/oby.2003.22; Batty GD, 2006, HEART, V92, P886, DOI 10.1136/hrt.2005.072637; Batty GD, 2005, INT J OBESITY, V29, P1267, DOI 10.1038/sj.ijo.0803020; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Craig R, 2008, METHODOLOGY DOCUMENT; Czernichow S, 2011, OBES REV, V12, P680, DOI 10.1111/j.1467-789X.2011.00879.x; Czernichow S, 2011, EUR J CARDIOV PREV R, V18, P312, DOI 10.1097/HJR.0b013e32833c1aa3; Ferraro KF, 2002, AM J PUBLIC HEALTH, V92, P834, DOI 10.2105/AJPH.92.5.834; Han TS, 1996, BRIT MED J, V312, P1227; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Janssen I, 2005, PEDIATRICS, V115, P1623, DOI 10.1542/peds.2004-2588; Janssen I, 2002, ARCH INTERN MED, V162, P2074, DOI 10.1001/archinte.162.18.2074; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Jousilahti P, 1996, CIRCULATION, V93, P1372, DOI 10.1161/01.CIR.93.7.1372; Kivimaki M, 2008, OBESITY, V16, P1926, DOI 10.1038/oby.2008.322; Koster A, 2008, AM J EPIDEMIOL, V167, P1465, DOI 10.1093/aje/kwn079; Larrieu S, 2004, INT J OBESITY, V28, P1555, DOI 10.1038/sj.ijo.0802755; LAUNER LJ, 1994, JAMA-J AM MED ASSOC, V271, P1093, DOI 10.1001/jama.271.14.1093; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; Logue J, 2011, HEART, V97, P564, DOI 10.1136/hrt.2010.211201; McCrea R, 2012, INT J OBESITY, V36, P414, DOI 10.1038/ijo.2011.65; Nanchahal K, 2005, INT J OBESITY, V29, P317, DOI 10.1038/sj.ijo.0802877; National Institute for HealthandClinical Excellence, 2006, OB PREV ID ASS MAN O; National Institutes of Health, 2000, PRACT GUID ID EV TRE; Office for National Statistics, 2005, NATL STAT SOCIO EC C; Parr CL, 2010, LANCET ONCOL, V11, P741, DOI 10.1016/S1470-2045(10)70141-8; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Tabassum F, 2009, HLTH SURVEY ENGLAND, V1, P113; Tiffin Paul A, 2011, Child Adolesc Psychiatry Ment Health, V5, P31, DOI 10.1186/1753-2000-5-31; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Zhao GX, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-130; Zhu SK, 2004, OBES RES, V12, P633, DOI 10.1038/oby.2004.73; Zhu SK, 2002, AM J CLIN NUTR, V76, P743, DOI 10.1093/ajcn/76.4.743	36	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67764	10.1371/journal.pone.0067764	http://dx.doi.org/10.1371/journal.pone.0067764			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844088	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000094
J	Ye, Y; Wang, L; Xie, NG				Ye, Ye; Wang, Lu; Xie, Nenggang			Parrondo's Games Based on Complex Networks and the Paradoxical Effect	PLOS ONE			English	Article							STRATEGIES; SYSTEMS	Parrondo's games were first constructed using a simple tossing scenario, which demonstrates the following paradoxical situation: in sequences of games, a winning expectation may be obtained by playing the games in a random order, although each game (game A or game B) in the sequence may result in losing when played individually. The available Parrondo's games based on the spatial niche (the neighboring environment) are applied in the regular networks. The neighbors of each node are the same in the regular graphs, whereas they are different in the complex networks. Here, Parrondo's model based on complex networks is proposed, and a structure of game B applied in arbitrary topologies is constructed. The results confirm that Parrondo's paradox occurs. Moreover, the size of the region of the parameter space that elicits Parrondo's paradox depends on the heterogeneity of the degree distributions of the networks. The higher heterogeneity yields a larger region of the parameter space where the strong paradox occurs. In addition, we use scale-free networks to show that the network size has no significant influence on the region of the parameter space where the strong or weak Parrondo's paradox occurs. The region of the parameter space where the strong Parrondo's paradox occurs reduces slightly when the average degree of the network increases.				wanglu@ahut.edu.cn; xienenggang@aliyun.com			Ministry of Education, Humanities and Social Sciences research [11YJC630208, 13YJAZH106]; Natural Science Foundation of Anhui Province of China [11040606M119]	Ministry of Education, Humanities and Social Sciences research; Natural Science Foundation of Anhui Province of China(Natural Science Foundation of Anhui Province)	This project was supported by Ministry of Education, Humanities and Social Sciences research projects (11YJC630208 and 13YJAZH106), and the Natural Science Foundation of Anhui Province of China (Grant No. 11040606M119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott D, 2010, FLUCT NOISE LETT, V9, P129, DOI 10.1142/S0219477510000010; Allison A, 2005, ANN INT SOC DYN GAME, V7, P613, DOI 10.1007/0-8176-4429-6_32; Allison A, 2001, CHAOS, V11, P715, DOI 10.1063/1.1397769; Almberg WS, 2005, ARTIF INTELL COMPUT, P123; Almeida J, 2005, PHYSICA D, V200, P124, DOI 10.1016/j.physd.2004.10.003; Arena P, 2003, CHAOS SOLITON FRACT, V17, P545, DOI 10.1016/S0960-0779(02)00397-1; Atkinson D., 2007, REASONING RATIONALIT; Boman M., 2001, INTELLIGENT AGENT TE, P150; Cleuren B, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.030101; Di Crescenzo A., 2007, MATH SCI, V32, P17; Gomez-Gardenes J., 2006, PHYS REV E, V73, P1; Harmer GP, 2001, CHAOS, V11, P705, DOI 10.1063/1.1395623; Harmer GP, 1999, NATURE, V402, P864, DOI 10.1038/47220; Kestenbaum D, 1997, NEW SCI, V154, P24; Kocarev L, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.046215; Masuda N, 2004, EUR PHYS J B, V40, P313, DOI 10.1140/epjb/e2004-00279-5; Mihailovic Z, 2006, PHYSICA A, V365, P244, DOI 10.1016/j.physa.2006.01.032; Mihailovic Z, 2003, FLUCT NOISE LETT, V3, pL389, DOI 10.1142/S0219477503001464; Parrondo JMR, 2000, PHYS REV LETT, V85, P5226, DOI 10.1103/PhysRevLett.85.5226; PINSKY R, 1992, ANN I H POINCARE-PR, V28, P519; Reed FA, 2007, GENETICS, V176, P1923, DOI 10.1534/genetics.106.069997; ROSATO A, 1987, PHYS REV LETT, V58, P1038, DOI 10.1103/PhysRevLett.58.1038; Szabo G, 2004, J PHYS A-MATH GEN, V37, P2599, DOI 10.1088/0305-4470/37/7/006; Tang TW, 2004, FLUCT NOISE LETT, V4, pL585, DOI 10.1142/S021947750400221X; Toral R, 2001, FLUCT NOISE LETT, V1, pL7, DOI 10.1142/S021947750100007X; Toyota N, 2012, ARXIV12045249V1 PHYS; Wolf DM, 2005, J THEOR BIOL, V234, P227, DOI 10.1016/j.jtbi.2004.11.020	27	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67924	10.1371/journal.pone.0067924	http://dx.doi.org/10.1371/journal.pone.0067924			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844131	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000121
J	Bordelon, H; Russ, PK; Wright, DW; Haselton, FR				Bordelon, Hali; Russ, Patricia K.; Wright, David W.; Haselton, Frederick R.			A Magnetic Bead-Based Method for Concentrating DNA from Human Urine for Downstream Detection	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; CHLAMYDIA-TRACHOMATIS; SAMPLE PREPARATION; NUCLEIC-ACIDS; DIAGNOSIS; AMPLIFICATION; PURIFICATION	Due to the presence of PCR inhibitors, PCR cannot be used directly on most clinical samples, including human urine, without pre-treatment. A magnetic bead-based strategy is one potential method to collect biomarkers from urine samples and separate the biomarkers from PCR inhibitors. In this report, a 1 mL urine sample was mixed within the bulb of a transfer pipette containing lyophilized nucleic acid-silica adsorption buffer and silica-coated magnetic beads. After mixing, the sample was transferred from the pipette bulb to a small diameter tube, and captured biomarkers were concentrated using magnetic entrainment of beads through pre-arrayed wash solutions separated by small air gaps. Feasibility was tested using synthetic segments of the 140 bp tuberculosis IS6110 DNA sequence spiked into pooled human urine samples. DNA recovery was evaluated by qPCR. Despite the presence of spiked DNA, no DNA was detectable in unextracted urine samples, presumably due to the presence of PCR inhibitors. However, following extraction with the magnetic bead-based method, we found that similar to 50% of spiked TB DNA was recovered from human urine containing roughly 5x10(3) to 5x10(8) copies of IS6110 DNA. In addition, the DNA was concentrated approximately ten-fold into water. The final concentration of DNA in the eluate was 5x10(6), 14x10(6), and 8x10(6) copies/mu L for 1, 3, and 5 mL urine samples, respectively. Lyophilized and freshly prepared reagents within the transfer pipette produced similar results, suggesting that long-term storage without refrigeration is possible. DNA recovery increased with the length of the spiked DNA segments from 10+/-0.9% for a 75 bp DNA sequence to 42+/-4% for a 100 bp segment and 58+/-9% for a 140 bp segment. The estimated LOD was 77 copies of DNA/mu L of urine. The strategy presented here provides a simple means to achieve high nucleic acid recovery from easily obtained urine samples, which does not contain inhibitors of PCR.	[Bordelon, Hali; Russ, Patricia K.; Haselton, Frederick R.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Wright, David W.] Vanderbilt Univ, Dept Chem, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Haselton, FR (corresponding author), Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA.	rick.haselton@vanderbilt.edu			Bill and Melinda Gates Foundation through the Grand Challenges in Global Health Initiative in diagnostics	Bill and Melinda Gates Foundation through the Grand Challenges in Global Health Initiative in diagnostics	This work was supported in part by the Bill and Melinda Gates Foundation through the Grand Challenges in Global Health Initiative in diagnostics. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceti A, 1999, THORAX, V54, P145, DOI 10.1136/thx.54.2.145; Adams NM, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4788922; Berensmeier S, 2006, APPL MICROBIOL BIOT, V73, P495, DOI 10.1007/s00253-006-0675-0; Betsou F, 2003, J CLIN MICROBIOL, V41, P1274, DOI 10.1128/JCM.41.3.1274-1276.2003; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Bordelon H, 2011, ACS APPL MATER INTER, V3, P2161, DOI 10.1021/am2004009; Botezatu I, 2000, CLIN CHEM, V46, P1078; Cannas A, 2008, INT J TUBERC LUNG D, V12, P146; Davis KM, 2012, ANAL CHEM, V84, P6136, DOI 10.1021/ac301030m; Dineva MA, 2007, ANALYST, V132, P1193, DOI 10.1039/b705672a; Enk MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038947; Moreira VG, 2009, CLIN BIOCHEM, V42, P729, DOI 10.1016/j.clinbiochem.2008.12.021; Gopinath K, 2009, INT J INFECT DIS, V13, P374, DOI 10.1016/j.ijid.2008.07.022; Green C, 2009, LANCET INFECT DIS, V9, P505, DOI 10.1016/S1473-3099(09)70149-5; Hopkins MJ, 2010, SEX TRANSM INFECT, V86, P207, DOI 10.1136/sti.2009.040634; Huggett J, 2009, BIOCHEM SOC T, V37, P419, DOI 10.1042/BST0370419; Lichtenstein AV, 2001, ANN NY ACAD SCI, V945, P239; Mariella R, 2008, BIOMED MICRODEVICES, V10, P777, DOI 10.1007/s10544-008-9190-7; Truong M, 2013, J UROLOGY, V189, P422, DOI 10.1016/j.juro.2012.04.143; Melkonyan HS, 2008, ANN NY ACAD SCI, V1137, P73, DOI 10.1196/annals.1448.015; Minion J, 2011, EUR RESPIR J, V38, P1398, DOI 10.1183/09031936.00025711; Niemz A, 2011, TRENDS BIOTECHNOL, V29, P240, DOI 10.1016/j.tibtech.2011.01.007; Putaporntip C, 2011, CLIN MICROBIOL INFEC, V17, P1484, DOI 10.1111/j.1469-0691.2011.03507.x; Rebollo MJ, 2006, DIAGN MICR INFEC DIS, V56, P141, DOI 10.1016/j.diagmicrobio.2006.03.018; Ritzi-Lehnert M, 2012, EXPERT REV MOL DIAGN, V12, P189, DOI [10.1586/ERM.11.98, 10.1586/erm.11.98]; Sasso LA, 2012, MICROFLUID NANOFLUID, V13, P603, DOI 10.1007/s10404-012-0980-0; Sechi LA, 1997, MOL CELL PROBE, V11, P281, DOI 10.1006/mcpr.1997.0119; Shields MJ, 2012, J FOOD PROTECT, V75, P1243, DOI 10.4315/0362-028X.JFP-12-048; Su YH, 2004, J MOL DIAGN, V6, P101, DOI 10.1016/S1525-1578(10)60497-7; Umansky SR, 2006, EXPERT REV MOL DIAGN, V6, P153, DOI 10.1586/14737159.6.2.153; Wu HW, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3454767	31	36	38	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68369	10.1371/journal.pone.0068369	http://dx.doi.org/10.1371/journal.pone.0068369			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861895	Green Published, gold, Green Submitted			2022-12-27	WOS:000321692000025
J	Elliott, S; Swift, S; Busse, L; Scully, S; Van, G; Rossi, J; Johnson, C				Elliott, Steve; Swift, Susan; Busse, Leigh; Scully, Sheila; Van, Gwyneth; Rossi, John; Johnson, Carol			Epo Receptors Are Not Detectable in Primary Human Tumor Tissue Samples	PLOS ONE			English	Article							BREAST-CANCER CELLS; BONE-MARROW-CELLS; ERYTHROPOIETIN-RECEPTOR; SURFACE EXPRESSION; SIGNALING PATHWAYS; DEPENDENT PATHWAY; GROWTH; LINE; ACTIVATION; KINASE	Erythropoietin (Epo) is a cytokine that binds and activates an Epo receptor (EpoR) expressed on the surface of erythroid progenitor cells to promote erythropoiesis. While early studies suggested EpoR transcripts were expressed exclusively in the erythroid compartment, low-level EpoR transcripts were detected in nonhematopoietic tissues and tumor cell lines using sensitive RT-PCR methods. However due to the widespread use of nonspecific anti-EpoR antibodies there are conflicting data on EpoR protein expression. In tumor cell lines and normal human tissues examined with a specific and sensitive monoclonal antibody to human EpoR (A82), little/no EpoR protein was detected and it was not functional. In contrast, EpoR protein was reportedly detectable in a breast tumor cell line (MCF-7) and breast cancer tissues with an anti-EpoR polyclonal antibody (M-20), and functional responses to rHuEpo were reported with MCF-7 cells. In another study, a functional response was reported with the lung tumor cell line (NCI-H838) at physiological levels of rHuEpo. However, the specificity of M-20 is in question and the absence of appropriate negative controls raise questions about possible false-positive effects. Here we show that with A82, no EpoR protein was detectable in normal human and matching cancer tissues from breast, lung, colon, ovary and skin with little/no EpoR in MCF-7 and most other breast and lung tumor cell lines. We show further that M-20 provides false positive staining with tissues and it binds to a non-EpoR protein that migrates at the same size as EpoR with MCF-7 lysates. EpoR protein was detectable with NCI-H838 cells, but no rHuEpo-induced phosphorylation of AKT, STAT3, pS6RP or STAT5 was observed suggesting the EpoR was not functional. Taken together these results raise questions about the hypothesis that most tumors express high levels of functional EpoR protein.	[Elliott, Steve; Swift, Susan; Busse, Leigh; Scully, Sheila; Van, Gwyneth; Rossi, John; Johnson, Carol] Amgen Inc, Thousand Oaks, CA 91320 USA	Amgen	Elliott, S (corresponding author), Amgen Inc, Thousand Oaks, CA 91320 USA.	selliott@amgen.com						Ammarguellat F, 2001, BIOCHEM BIOPH RES CO, V284, P1031, DOI 10.1006/bbrc.2001.5085; Binder C, 2008, ASSAY DRUG DEV TECHN, V6, P27, DOI 10.1089/adt.2007.111; Bordeaux J, 2010, BIOTECHNIQUES, V48, P197, DOI 10.2144/000113382; BOSMAN FT, 1988, ACTA HISTOCHEM, P27; BROUDY VC, 1991, BLOOD, V77, P2583, DOI 10.1182/blood.V77.12.2583.2583; BROUDY VC, 1990, BLOOD, V75, P1622; BROUDY VC, 1988, P NATL ACAD SCI USA, V85, P6513, DOI 10.1073/pnas.85.17.6513; Brown WM, 2007, STEM CELLS, V25, P718, DOI 10.1634/stemcells.2006-0687; DANDREA AD, 1991, SEMIN HEMATOL, V28, P152; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Della Ragione F, 2007, J CLIN ONCOL, V25, P1812, DOI 10.1200/JCO.2006.09.7212; Divoky V, 2001, P NATL ACAD SCI USA, V98, P986, DOI 10.1073/pnas.98.3.986; Doan HQ, 2009, ANTICANCER RES, V29, P2473; Dunlop EA, 2006, NEURODEGENER DIS, V3, P94, DOI 10.1159/000092099; Ebong S, 2004, INVEST OPHTH VIS SCI, V45, P872, DOI 10.1167/iovs.03-0311; Elliott S, 2006, BLOOD, V107, P1892, DOI 10.1182/blood-2005-10-4066; Elliott S, 2012, BIOL-TARGETS THER, V6, P163, DOI 10.2147/BTT.S32281; Elliott S, 2012, NEPHROL DIAL TRANSPL, V27, P2733, DOI 10.1093/ndt/gfr698; Elliott S, 2010, J IMMUNOL METHODS, V352, P126, DOI 10.1016/j.jim.2009.10.006; ETHERTON TD, 1984, J ANIM SCI, V59, P366, DOI 10.2527/jas1984.592366x; FRASER JK, 1988, EXP HEMATOL, V16, P836; Fritschy JM, 2008, EUR J NEUROSCI, V28, P2365, DOI 10.1111/j.1460-9568.2008.06552.x; Fu P, 2009, BIOCHEM BIOPH RES CO, V379, P696, DOI 10.1016/j.bbrc.2008.12.146; Gaffen SL, 1999, BLOOD, V94, P74, DOI 10.1182/blood.V94.1.74.413k36_74_86; Gewirtz DA, 2006, CLIN CANCER RES, V12, pt; Hardee ME, 2006, MOL CANCER THER, V5, P356, DOI 10.1158/1535-7163.MCT-05-0196; Hardee ME, 2005, BRIT J CANCER, V93, P1350, DOI 10.1038/sj.bjc.6602846; HILTON DJ, 1995, P NATL ACAD SCI USA, V92, P190, DOI 10.1073/pnas.92.1.190; Hsi ED, 2001, ARCH PATHOL LAB MED, V125, P289; Hsu RYC, 2011, CANCER RES, V71, P1989, DOI 10.1158/0008-5472.CAN-10-2833; Inthal A, 2008, CLIN CANCER RES, V14, P7196, DOI 10.1158/1078-0432.CCR-07-5051; Jegalian AG, 2002, BLOOD, V99, P2603, DOI 10.1182/blood.V99.7.2603; Jelkmann W, 2008, CRIT REV ONCOL HEMAT, V67, P39, DOI 10.1016/j.critrevonc.2008.03.006; Jeong JY, 2008, INT J CANCER, V122, P274, DOI 10.1002/ijc.23068; Kang JK, 2011, CELL ONCOL, V34, P11, DOI 10.1007/s13402-010-0001-9; Keenan J, 1996, CYTOTECHNOLOGY, V24, P252; Kessler C, 2012, CYTOKINE, V57, P226, DOI 10.1016/j.cyto.2011.11.010; Kirkeby A, 2007, J NEUROSCI METH, V164, P50, DOI 10.1016/j.jneumeth.2007.03.026; KOMATSU N, 1993, BLOOD, V82, P456; KRANTZ SB, 1991, BLOOD, V77, P419; LaMontagne KR, 2006, MOL CANCER THER, V5, P347, DOI 10.1158/1535-7163.MCT-05-0203; Laugsch M, 2008, INT J CANCER, V122, P1005, DOI 10.1002/ijc.23201; Layon ME, 2007, J MOL BIOL, V366, P737, DOI 10.1016/j.jmb.2006.11.094; Leong ASY, 2004, ADV ANAT PATHOL, V11, P86, DOI 10.1097/00125480-200403000-00002; Lester RD, 2005, J BIOL CHEM, V280, P39273, DOI 10.1074/jbc.M509446200; Liang K, 2010, CANCER CELL, V18, P423, DOI 10.1016/j.ccr.2010.10.025; LONGMORE GD, 1991, CELL, V67, P1089, DOI 10.1016/0092-8674(91)90286-8; Lorincz A, 2008, J NEUROSCI, V28, P9083, DOI 10.1523/JNEUROSCI.2494-08.2008; MCARTHUR GA, 1995, EXP HEMATOL, V23, P645; MIGLIACCIO AR, 1991, P NATL ACAD SCI USA, V88, P11086, DOI 10.1073/pnas.88.24.11086; MINAMOTO S, 1995, BLOOD, V86, P2281, DOI 10.1182/blood.V86.6.2281.bloodjournal8662281; MITJAVILA MT, 1989, J CELL PHYSIOL, V138, P617, DOI 10.1002/jcp.1041380324; MIURA Y, 1994, J BIOL CHEM, V269, P29962; NEUMANN D, 1993, J BIOL CHEM, V268, P13639; Okazaki T, 2008, NEOPLASIA, V10, P932, DOI 10.1593/neo.08140; PAPAYANNOPOULOU T, 1988, BLOOD, V72, P1029; SANTUCCI MA, 1994, STEM CELLS, V12, P506, DOI 10.1002/stem.5530120506; Saper CB, 2009, J HISTOCHEM CYTOCHEM, V57, P1, DOI 10.1369/jhc.2008.952770; Sasaki Y, 2009, ACTA ONCOL, V48, P1062, DOI 10.1080/02841860902913553; Shannon AM, 2005, BRIT J CANCER, V93, P224, DOI 10.1038/sj.bjc.6602685; Shikama Y, 1996, BLOOD, V88, P455, DOI 10.1182/blood.V88.2.455.bloodjournal882455; Sinclair AM, 2008, BRIT J CANCER, V98, P1059, DOI 10.1038/sj.bjc.6604220; Sinclair AM, 2007, CANCER-AM CANCER SOC, V110, P477, DOI 10.1002/cncr.22832; Sinclair AM, 2010, BLOOD, V115, P4264, DOI 10.1182/blood-2009-10-248666; Slaaby R, 2008, GROWTH HORM IGF RES, V18, P267, DOI 10.1016/j.ghir.2007.09.003; Swift S, 2010, BLOOD, V115, P4254, DOI 10.1182/blood-2009-10-248674; Swift SE, 2010, MOL CANCER THER, V9, P1070, DOI 10.1158/1535-7163.MCT-09-0439; WAKAO H, 1995, EMBO J, V14, P2527, DOI 10.1002/j.1460-2075.1995.tb07250.x; Wenker SD, 2010, J CELL BIOCHEM, V110, P151, DOI 10.1002/jcb.22521; WICKREMA A, 1992, BLOOD, V80, P1940, DOI 10.1182/blood.V80.8.1940.1940; WOGNUM AW, 1990, BLOOD, V76, P697; WOGNUM AW, 1992, BLOOD, V79, P642; YAMAMURA Y, 1992, EMBO J, V11, P4909, DOI 10.1002/j.1460-2075.1992.tb05597.x; YAWATA H, 1993, EMBO J, V12, P1705, DOI 10.1002/j.1460-2075.1993.tb05815.x; Yin D, 2007, INT J ONCOL, V31, P1193; Yuan ZL, 2004, MOL CELL BIOL, V24, P9390, DOI 10.1128/MCB.24.21.9390-9400.2004; Zhang C, 2012, BREAST CANCER RES TR, V136, P739, DOI 10.1007/s10549-012-2316-x; Zou XM, 1999, J BIOL CHEM, V274, P18141, DOI 10.1074/jbc.274.26.18141	78	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68083	10.1371/journal.pone.0068083	http://dx.doi.org/10.1371/journal.pone.0068083			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861852	Green Published, Green Submitted, gold			2022-12-27	WOS:000323350700069
J	Johnston, K; Timney, B; Goodale, MA				Johnston, Kevin; Timney, Brian; Goodale, Melvyn A.			Acute Alcohol Consumption Impairs Controlled but Not Automatic Processes in a Psychophysical Pointing Paradigm	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; ARBITRARY VISUOMOTOR ASSOCIATIONS; REACHING MOVEMENTS; OPTIC ATAXIA; BEHAVIORAL-CONTROL; NEURONAL-ACTIVITY; MEMORY PROCESSES; VISUAL CONTROL; COMBINED TMS; HAND	Numerous studies have investigated the effects of alcohol consumption on controlled and automatic cognitive processes. Such studies have shown that alcohol impairs performance on tasks requiring conscious, intentional control, while leaving automatic performance relatively intact. Here, we sought to extend these findings to aspects of visuomotor control by investigating the effects of alcohol in a visuomotor pointing paradigm that allowed us to separate the influence of controlled and automatic processes. Six male participants were assigned to an experimental "correction" condition in which they were instructed to point at a visual target as quickly and accurately as possible. On a small percentage of trials, the target "jumped" to a new location. On these trials, the participants' task was to amend their movement such that they pointed to the new target location. A second group of 6 participants were assigned to a "countermanding" condition, in which they were instructed to terminate their movements upon detection of target "jumps". In both the correction and countermanding conditions, participants served as their own controls, taking part in alcohol and no-alcohol conditions on separate days. Alcohol had no effect on participants' ability to correct movements "in flight", but impaired the ability to withhold such automatic corrections. Our data support the notion that alcohol selectively impairs controlled processes in the visuomotor domain.	[Johnston, Kevin; Timney, Brian; Goodale, Melvyn A.] Brain & Mind Inst, London, ON, Canada; [Johnston, Kevin; Timney, Brian; Goodale, Melvyn A.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Johnston, Kevin; Timney, Brian; Goodale, Melvyn A.] Univ Western Ontario, Dept Psychol, London, ON, Canada; [Timney, Brian; Goodale, Melvyn A.] Univ Western Ontario, Grad Program Neurosci, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Johnston, K (corresponding author), Brain & Mind Inst, London, ON, Canada.	kjohnst9@uwo.ca	Everling, Stefan/K-5208-2013; Goodale, Melvyn A/M-5907-2013; Johnston, Kevin/U-4453-2018	Goodale, Melvyn A/0000-0001-6748-0561; Johnston, Kevin/0000-0001-9481-6251	AMBRF; NSERC	AMBRF; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by AMBRF and NSERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abroms BD, 2003, J STUD ALCOHOL, V64, P687, DOI 10.15288/jsa.2003.64.687; Abroms BD, 2006, PSYCHOPHARMACOLOGY, V188, P324, DOI 10.1007/s00213-006-0524-y; Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; CONNORS GJ, 1980, J STUD ALCOHOL, V41, P509, DOI 10.15288/jsa.1980.41.509; Desmurget M, 1999, NAT NEUROSCI, V2, P563, DOI 10.1038/9219; Desmurget M, 2001, J NEUROSCI, V21, P2919, DOI 10.1523/JNEUROSCI.21-08-02919.2001; Fillmore MT, 1999, EXP CLIN PSYCHOPHARM, V7, P372, DOI 10.1037/1064-1297.7.4.372; FILLMORE MT, 1995, J STUD ALCOHOL, V56, P90, DOI 10.15288/jsa.1995.56.90; Fillmore MT, 2000, J STUD ALCOHOL, V61, P239, DOI 10.15288/jsa.2000.61.239; Fogarty JN, 2002, J STUD ALCOHOL, V63, P404, DOI 10.15288/jsa.2002.63.404; Gomi H, 2008, CURR OPIN NEUROBIOL, V18, P558, DOI 10.1016/j.conb.2008.11.002; GOODALE MA, 1986, NATURE, V320, P748, DOI 10.1038/320748a0; Gorbet DJ, 2009, BRAIN RES, V1284, P77, DOI 10.1016/j.brainres.2009.05.057; Gorbet DJ, 2004, NEUROIMAGE, V23, P1100, DOI 10.1016/j.neuroimage.2004.07.043; Granek JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046619; Grea H, 2002, NEUROPSYCHOLOGIA, V40, P2471, DOI 10.1016/S0028-3932(02)00009-X; Grol MJ, 2006, J NEUROSCI, V26, P117, DOI 10.1523/JNEUROSCI.2786-05.2006; HYVARINEN J, 1979, ACTA PHYSIOL SCAND, V107, P219, DOI 10.1111/j.1748-1716.1979.tb06466.x; HYVARINEN J, 1978, BRAIN, V101, P701, DOI 10.1093/brain/101.4.701; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; Johnston KD, 2008, VISION RES, V48, P1539, DOI 10.1016/j.visres.2008.04.010; Kahkonen S, 2003, NEUROPSYCHOPHARMACOL, V28, P747, DOI 10.1038/sj.npp.1300099; Kahkonen S, 2001, NEUROIMAGE, V14, P322, DOI 10.1006/nimg.2001.0849; Kirchner TR, 2003, EXP CLIN PSYCHOPHARM, V11, P167, DOI 10.1037/1064-1297.11.2.167; LYVERS MF, 1991, BRIT J ADDICT, V86, P399; Marinkovic K, 2000, J STUD ALCOHOL, V61, P24, DOI 10.15288/jsa.2000.61.24; Mulvihill LE, 1997, J STUD ALCOHOL, V58, P600, DOI 10.15288/jsa.1997.58.600; PELISSON D, 1986, EXP BRAIN RES, V62, P303; Peterson B, 1990, J STUD ALCOHOL, V51, P114; Pisella L, 2000, NAT NEUROSCI, V3, P729, DOI 10.1038/76694; Pisella L, 2006, NEUROPSYCHOLOGIA, V44, P2734, DOI 10.1016/j.neuropsychologia.2006.03.027; PRABLANC C, 1986, EXP BRAIN RES, V62, P293; PRABLANC C, 1992, J NEUROPHYSIOL, V67, P455, DOI 10.1152/jn.1992.67.2.455; Rossetti Y, 2003, EXP BRAIN RES, V153, P171, DOI 10.1007/s00221-003-1590-6; ROSSETTI Y, 1994, EXP BRAIN RES, V101, P323, DOI 10.1007/BF00228753; Rossetti Y, 2003, BRADFORD BOOKS, P67; STEELE CM, 1990, AM PSYCHOL, V45, P921, DOI 10.1037/0003-066X.45.8.921; Toni I, 2002, CEREB CORTEX, V12, P1040, DOI 10.1093/cercor/12.10.1040; Toni I, 2001, NEUROIMAGE, V14, P1048, DOI 10.1006/nimg.2001.0894; Tracy JI, 1999, NEUROPSYCHOLOGY, V13, P282, DOI 10.1037/0894-4105.13.2.282; Tranel D, 2003, COGN NEUROPSYCHOL, V20, P409, DOI 10.1080/02643290244000248; Vogel-Sprott M, 2001, ALCOHOL CLIN EXP RES, V25, P117, DOI 10.1097/00000374-200101000-00017; Weissenborn R, 2003, PSYCHOPHARMACOLOGY, V165, P306, DOI 10.1007/s00213-002-1281-1; WESTHEIMER G, 1954, AMA ARCH OPHTHALMOL, V52, P932; Wise SP, 1996, CAN J PHYSIOL PHARM, V74, P469, DOI 10.1139/cjpp-74-4-469	46	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68682	10.1371/journal.pone.0068682	http://dx.doi.org/10.1371/journal.pone.0068682			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861934	gold, Green Published, Green Submitted			2022-12-27	WOS:000323350700099
J	Matsumiya, M; Stylianou, E; Griffiths, K; Lang, Z; Meyer, J; Harris, SA; Rowland, R; Minassian, AM; Pathan, AA; Fletcher, H; McShane, H				Matsumiya, Magali; Stylianou, Elena; Griffiths, Kristin; Lang, Zoe; Meyer, Joel; Harris, Stephanie A.; Rowland, Rosalind; Minassian, Angela M.; Pathan, Ansar A.; Fletcher, Helen; McShane, Helen			Roles for Treg Expansion and HMGB1 Signaling through the TLR1-2-6 Axis in Determining the Magnitude of the Antigen-Specific Immune Response to MVA85A	PLOS ONE			English	Article							VACCINIA VIRUS ANKARA; CALMETTE-GUERIN VACCINATION; LARGE GENE LISTS; TUBERCULOSIS VACCINE; DENDRITIC CELLS; RECOMBINANT VACCINIA; MICROARRAY DATA; HUMANS; BCG; IMMUNOGENICITY	A better understanding of the relationships between vaccine, immunogenicity and protection from disease would greatly facilitate vaccine development. Modified vaccinia virus Ankara expressing antigen 85A (MVA85A) is a novel tuberculosis vaccine candidate designed to enhance responses induced by BCG. Antigen-specific interferon-gamma (IFN-gamma) production is greatly enhanced by MVA85A, however the variability between healthy individuals is extensive. In this study we have sought to characterize the early changes in gene expression in humans following vaccination with MVA85A and relate these to long-term immunogenicity. Two days post-vaccination, MVA85A induces a strong interferon and inflammatory response. Separating volunteers into high and low responders on the basis of T cell responses to 85A peptides measured during the trial, an expansion of circulating CD4+ CD25+ Foxp3+ cells is seen in low but not high responders. Additionally, high levels of Toll-like Receptor (TLR) 1 on day of vaccination are associated with an increased response to antigen 85A. In a classification model, combined expression levels of TLR1, TICAM2 and CD14 on day of vaccination and CTLA4 and IL2R alpha two days post-vaccination can classify high and low responders with over 80% accuracy. Furthermore, administering MVA85A in mice with anti-TLR2 antibodies may abrogate high responses, and neutralising antibodies to TLRs 1, 2 or 6 or HMGB1 decrease CXCL2 production during in vitro stimulation with MVA85A. HMGB1 is released into the supernatant following atimulation with MVA85A and we propose this signal may be the trigger activating the TLR pathway. This study suggests an important role for an endogenous ligand in innate sensing of MVA and demonstrates the importance of pattern recognition receptors and regulatory T cell responses in determining the magnitude of the antigen specific immune response to vaccination with MVA85A in humans.	[Matsumiya, Magali; Stylianou, Elena; Griffiths, Kristin; Lang, Zoe; Meyer, Joel; Harris, Stephanie A.; Rowland, Rosalind; Minassian, Angela M.; Pathan, Ansar A.; Fletcher, Helen; McShane, Helen] Univ Oxford, Jenner Inst, Oxford, England	University of Oxford; Jenner Institute	Matsumiya, M (corresponding author), Univ Oxford, Jenner Inst, Oxford, England.	magali.matsumiya@msdtc.ox.ac.uk		Minassian, Angela/0000-0001-7832-9824; /0000-0002-6008-2955; Fletcher, Helen/0000-0002-0435-1006; McShane, Helen/0000-0002-2126-5142	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust. MM has a Wellcome Trust PhD studentship and HM is a Wellcome Trust Senior Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2009, IMMUNOL CELL BIOL, V87, P279, DOI 10.1038/icb.2009.14; Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732; Bell CW, 2006, AM J PHYSIOL-CELL PH, V291, pC1318, DOI 10.1152/ajpcell.00616.2005; Betts G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050447; Brennan MJ, 2012, INT J TUBERC LUNG D, V16, P1566, DOI 10.5588/ijtld.12.0569; COLDITZ GA, 1995, PEDIATRICS, V96, P29; Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480; Dye C, 2013, LANCET, V381, P972, DOI 10.1016/S0140-6736(13)60137-3; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Farhat K, 2008, J LEUKOCYTE BIOL, V83, P692, DOI 10.1189/jlb.0807586; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Fletcher HA, 2008, VACCINE, V26, P5269, DOI 10.1016/j.vaccine.2008.07.040; Goodman AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025938; Griffiths KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023463; Guerra S, 2010, J VIROL, V84, P8141, DOI 10.1128/JVI.00749-10; Guo YQ, 2007, BIOSTATISTICS, V8, P86, DOI 10.1093/biostatistics/kxj035; Guzman E, 2012, J VIROL, V86, P5452, DOI 10.1128/JVI.00264-12; Hanekom WA, 2008, PLOS MED, V5, P1033, DOI 10.1371/journal.pmed.0050145; Hoft DF, 2008, J INFECT DIS, V198, P1491, DOI 10.1086/592450; Huang B, 2011, GENE THER, V18, P164, DOI 10.1038/gt.2010.121; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Janssens S, 2003, CLIN MICROBIOL REV, V16, P637, DOI 10.1128/CMR.16.4.637-646.2003; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Kastenmuller W, 2006, VIROLOGY, V350, P276, DOI 10.1016/j.virol.2006.02.039; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; Kim JW, 2012, EXPERT OPIN BIOL TH, V12, P463, DOI 10.1517/14712598.2012.668516; Krupa M, 2011, VACCINE, V29, P1504, DOI 10.1016/j.vaccine.2010.12.016; Lousberg EL, 2011, EXPERT REV VACCINES, V10, P1435, DOI [10.1586/erv.11.121, 10.1586/ERV.11.121]; McFadden G, 2005, NAT REV MICROBIOL, V3, P201, DOI 10.1038/nrmicro1099; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Meyer J, 2013, VACCINE, V31, P1026, DOI 10.1016/j.vaccine.2012.12.042; Minassian AM, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000223; Mohamed MR, 2009, CELL CYCLE, V8, P3125, DOI 10.4161/cc.8.19.9683; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Najera JL, 2006, J VIROL, V80, P6033, DOI 10.1128/JVI.02108-05; Nakaya H, 2012, SYSTEMS VACCINOLOGY, P1, DOI [10.1002/wsbm.163.Systems, DOI 10.1002/WSBM.163.SYSTEMS]; Odunsi K, 2012, P NATL ACAD SCI USA, V109, P5797, DOI 10.1073/pnas.1117208109; Pascutti MF, 2011, J VIROL, V85, P5532, DOI 10.1128/JVI.02267-10; Pathan A a, 2012, VACCINE, V31, P1, DOI [10.1016/j.vaccine.2012.06.084, DOI 10.1016/J.VACCINE.2012.06.084.PUBMED:23142303]; Perdiguero B, 2012, DELETION VIRAL ANTIA, V7, DOI [10.1371/journal.pone.0048524, DOI 10.1371/J0URNAL.P0NE.0048524]; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ritchie ME, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-261; RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154; Sander CR, 2009, AM J RESP CRIT CARE, V179, P724, DOI 10.1164/rccm.200809-1486OC; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Scriba TJ, 2011, J INFECT DIS, V203, P1832, DOI 10.1093/infdis/jir195; Scriba TJ, 2010, EUR J IMMUNOL, V40, P279, DOI 10.1002/eji.200939754; Sheehy SH, 2012, MOL THER, V20, P2355, DOI 10.1038/mt.2012.223; Shi W, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq871; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tameris MD, 2013, LANCET, V6736, P1, DOI [10.1016/S0140-6736(13)60177-4, DOI 10.1016/S0140-6736(13)60177-4.PUBMED:23391465]; Urbonaviciute V, 2008, J EXP MED, V205, P3007, DOI 10.1084/jem.20081165; Von Eschen K, 2009, HUM VACCINES, V5, P475, DOI 10.4161/hv.8570; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Zhu JG, 2007, BLOOD, V109, P619, DOI 10.1182/blood-2006-06-027136	61	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67922	10.1371/journal.pone.0067922	http://dx.doi.org/10.1371/journal.pone.0067922			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844129	gold, Green Published, Green Accepted			2022-12-27	WOS:000321733000116
J	Arno, B; D'Annessa, I; Tesauro, C; Zuccaro, L; Ottaviani, A; Knudsen, B; Fiorani, P; Desideri, A				Arno, Barbara; D'Annessa, Ilda; Tesauro, Cinzia; Zuccaro, Laura; Ottaviani, Alessio; Knudsen, Birgitta; Fiorani, Paola; Desideri, Alessandro			Replacement of the Human Topoisomerase Linker Domain with the Plasmodial Counterpart Renders the Enzyme Camptothecin Resistant	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; SWISS-MODEL; DNA TOPOISOMERASES; FUNCTIONAL LINKER; SINGLE MUTATION; I INHIBITORS; SENSITIVITY; FLEXIBILITY; RELAXATION; COVALENT	A human/plasmodial hybrid enzyme, generated by swapping the human topoisomerase IB linker domain with the corresponding domain of the Plasmodium falciparum enzyme, has been produced and characterized. The hybrid enzyme displays a relaxation activity comparable to the human enzyme, but it is characterized by a much faster religation rate. The hybrid enzyme is also camptothecin resistant. A 3D structure of the hybrid enzyme has been built and its structural-dynamical properties have been analyzed by molecular dynamics simulation. The analysis indicates that the swapped plasmodial linker samples a conformational space much larger than the corresponding domain in the human enzyme. The large linker conformational variability is then linked to important functional properties such as an increased religation rate and a low drug reactivity, demonstrating that the linker domain has a crucial role in the modulation of the topoisomerase IB activity.	[Arno, Barbara; D'Annessa, Ilda; Tesauro, Cinzia; Zuccaro, Laura; Ottaviani, Alessio; Desideri, Alessandro] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Arno, Barbara; D'Annessa, Ilda; Tesauro, Cinzia; Zuccaro, Laura; Ottaviani, Alessio; Desideri, Alessandro] Univ Roma Tor Vergata, Interuniv Consortium, Natl Inst Biostruct & Biosyst INBB, I-00173 Rome, Italy; [Knudsen, Birgitta] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Fiorani, Paola] CNR, Inst Translat Pharmacol, Rome, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata; Aarhus University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR)	Desideri, A (corresponding author), Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy.	desideri@uniroma2.it	Ottaviani, Alessio/K-7240-2018	Ottaviani, Alessio/0000-0002-4796-3184; Tesauro, Cinzia/0000-0003-2986-9618; Knudsen, Birgitta Ruth/0000-0002-3484-3802; desideri, alessandro/0000-0003-1541-4217	AIRC [10121]	AIRC(Fondazione AIRC per la ricerca sul cancro)	This work has been supported by the AIRC project 10121 to A.D. and the Minister Erna Hamiltons Grant for Science and Art to B.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSEN AH, 1985, NUCLEIC ACIDS RES, V13, P1543, DOI 10.1093/nar/13.5.1543; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BJORNSTI MA, 1989, CANCER RES, V49, P6318; Castelli S, 2012, BIOL CHEM, V393, P1327, DOI 10.1515/hsz-2012-0240; Champoux JJ, 2000, METH MOL B, V95, P81; CHEATHAM TE, 1995, J AM CHEM SOC, V117, P4193, DOI 10.1021/ja00119a045; Chillemi G, 2005, NUCLEIC ACIDS RES, V33, P3339, DOI 10.1093/nar/gki642; Chillemi G, 2004, BIOPHYS J, V87, P4087, DOI 10.1529/biophysj.104.044925; Chillemi G, 2001, BIOPHYS J, V81, P490, DOI 10.1016/S0006-3495(01)75716-5; Chillemi G, 2008, NUCLEIC ACIDS RES, V36, P5645, DOI 10.1093/nar/gkn558; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Fiorani P, 2003, J BIOL CHEM, V278, P43268, DOI 10.1074/jbc.M303899200; Frohlich RF, 2008, BIOCHEMISTRY-US, V47, P7127, DOI 10.1021/bi800031k; Garcia-Estrada C, 2010, P ROY SOC B-BIOL SCI, V277, P1777, DOI 10.1098/rspb.2009.2176; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Juul S, 2012, ACS NANO; KAUH EA, 1995, P NATL ACAD SCI USA, V92, P6299, DOI 10.1073/pnas.92.14.6299; Kim N, 2011, SCIENCE, V332, P1561, DOI 10.1126/science.1205016; Koster DA, 2005, NATURE, V434, P671, DOI 10.1038/nature03395; Lisby M, 1998, BIOCHEMISTRY-US, V37, P10815, DOI 10.1021/bi980757r; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; Losasso C, 2008, NUCLEIC ACIDS RES, V36, P5635, DOI 10.1093/nar/gkn557; Losasso C, 2007, J BIOL CHEM, V282, P9855, DOI 10.1074/jbc.M608200200; Mancini G, 2012, PLOS ONE IN PRESS; Mancini G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010934; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Redinbo MR, 1999, J MOL BIOL, V292, P685, DOI 10.1006/jmbi.1999.3065; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sari L, 2005, NUCLEIC ACIDS RES, V33, P6621, DOI 10.1093/nar/gki935; Scaldaferro S, 2001, CHEM BIOL, V8, P871, DOI 10.1016/S1074-5521(01)00059-X; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; Staker BL, 2005, J MED CHEM, V48, P2336, DOI 10.1021/jm049146p; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Stewart L, 1999, J BIOL CHEM, V274, P32950, DOI 10.1074/jbc.274.46.32950; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; Stewart L, 1996, J BIOL CHEM, V271, P7593, DOI 10.1074/jbc.271.13.7593; Szklarczyk O, 2009, PROTEINS, V77, P420, DOI 10.1002/prot.22450; Tesauro C., 2012, J AMINO ACIDS, V2012; van der Merwe M, 2008, J BIOL CHEM, V283, P3305, DOI 10.1074/jbc.M705781200; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Yang Z, 2002, J BIOL CHEM, V277, P30815, DOI 10.1074/jbc.M205302200	53	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68404	10.1371/journal.pone.0068404	http://dx.doi.org/10.1371/journal.pone.0068404			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844196	gold, Green Published, Green Submitted			2022-12-27	WOS:000321341000160
J	Kancha, RK; Bartosch, N; Duyster, J				Kancha, Rama Krishna; Bartosch, Natalie; Duyster, Justus			Analysis of Conformational Determinants Underlying HSP90-Kinase Interaction	PLOS ONE			English	Article							KINASE DOMAIN MUTATION; LARGE-CELL LYMPHOMA; TYROSINE KINASE; NPM-ALK; HSP90 CHAPERONE; BCR-ABL; B-RAF; PROTEIN; INHIBITORS; ACTIVATION	The role of HSP90 in stabilization of oncogenic tyrosine kinases made it an attractive therapeutic target for treating cancer but the molecular basis underlying the interaction between the HSP90 chaperone and client kinases is not elucidated yet. Using kinase inhibitors we show that the inactive conformation of ERBB2 does not interact with HSP90 chaperone and is thus not amenable to degradation upon HSP90 inhibitor treatment, while active ERBB2 kinase conformation promotes interaction with the HSP90 machinery and thus is degraded upon HSP90 inhibitor treatment. Interestingly, the kinase-chaperone interaction is disrupted in case of BCR-ABL and FLT3-ITD when bound to inhibitors irrespective of whether they block the kinase in an active or inactive conformation and thus our results indicate that the stability of the active kinase conformation varies between different kinases.	[Kancha, Rama Krishna; Duyster, Justus] Univ Med Ctr Freiburg, Dept Med 1, Freiburg, Germany; [Bartosch, Natalie] Tech Univ Munich, Dept Internal Med 3, D-80290 Munich, Germany	University of Freiburg; Technical University of Munich; University of Munich	Duyster, J (corresponding author), Univ Med Ctr Freiburg, Dept Med 1, Freiburg, Germany.	direktion-med1@uniklinik-freiburg.de	Kancha, Rama Krishna/B-5992-2009	Kancha, Rama Krishna/0000-0001-8146-1551	Jose Carreras Leukamie-Stiftung	Jose Carreras Leukamie-Stiftung	JD is supported by a grant from the Jose Carreras Leukamie-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aertgeerts K, 2011, J BIOL CHEM, V286, P18756, DOI 10.1074/jbc.M110.206193; An WG, 2000, CELL GROWTH DIFFER, V11, P355; Bonvini P, 2002, CANCER RES, V62, P1559; Coutinho S, 2000, BLOOD, V96, P618; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Engelman JA, 2007, CANCER RES, V67, P11924, DOI 10.1158/0008-5472.CAN-07-1885; Falsone SF, 2004, J MOL BIOL, V344, P281, DOI 10.1016/j.jmb.2004.08.091; Giannini A, 2004, MOL CELL BIOL, V24, P5667, DOI 10.1128/MCB.24.13.5667-5676.2004; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; Guix M, 2008, J CLIN ONCOL, V26, P897, DOI 10.1200/JCO.2007.13.5939; HUANG SS, 1990, J BIOL CHEM, V265, P3340; Hubinger G, 2003, EXP HEMATOL, V31, P226, DOI 10.1016/S0301-472X(02)01084-6; Hubinger G, 1999, EXP HEMATOL, V27, P1796, DOI 10.1016/S0301-472X(99)00116-2; Kancha RK, 2007, EXP HEMATOL, V35, P1522, DOI 10.1016/j.exphem.2007.07.008; Kancha RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026760; Kancha RK, 2008, HAEMATOL-HEMATOL J, V93, P1718, DOI 10.3324/haematol.13207; pale M, 2010, NATURE REV, V11, P515; Salas A, 2011, BLOOD, V117, P5941, DOI 10.1182/blood-2010-08-300772; Schaefer G, 2007, CANCER RES, V67, P1228, DOI 10.1158/0008-5472.CAN-06-3493; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Vajpai N, 2008, J BIOL CHEM, V283, P18292, DOI 10.1074/jbc.M801337200; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; Weisberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025351; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Xu WP, 2005, NAT STRUCT MOL BIOL, V12, P120, DOI 10.1038/nsmb885; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200; Yao Q, 2003, CLIN CANCER RES, V9, P4483; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	28	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68394	10.1371/journal.pone.0068394	http://dx.doi.org/10.1371/journal.pone.0068394			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844194	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000158
J	Kopriva, SE; Chiasson, VL; Mitchell, BM; Chatterjee, P				Kopriva, Shelley E.; Chiasson, Valorie L.; Mitchell, Brett M.; Chatterjee, Piyali			TLR3-Induced Placental miR-210 Down-Regulates the STAT6/Interleukin-4 Pathway	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; GENE-EXPRESSION; INFLAMMATORY RESPONSE; MICRORNA EXPRESSION; CELL-LINES; TROPHOBLAST; PREECLAMPSIA; HYPOXIA; ACTIVATION; MECHANISMS	Several clinical studies have reported increased placental miR-210 expression in women with PE compared to normotensive women, but whether miR-210 plays a role in the etiology of PE is unknown. We reported that activation of TLR3 produces the PE-like symptoms of hypertension, endothelial dysfunction, and proteinuria in mice only when pregnant, but whether TLR3 activation in pregnant mice and human cytotrophoblasts (CTBs) increases miR-210 and modulates its targets related to inflammation are unknown. Placental miR-210 levels were increased significantly in pregnant mice treated with the TLR3 agonist poly I:C (P-PIC). Both HIF-1 alpha and NF-kappa Bp50, known to bind the miR-210 promoter and induce its expression, were also increased significantly in placentas of P-PIC mice. Target identification algorithms and gene ontology predicted STAT6 as an inflammation-related target of miR-210 and STAT6 was decreased significantly in placentas of P-PIC mice. IL-4, which is regulated by STAT6 and increases during normotensive pregnancy, failed to increase in serum of P-PIC mice. P-PIC TLR3 KO mice did not develop hypertension and placental HIF-1 alpha, NF-kappa Bp50, miR-210, STAT6, and IL-4 levels were unchanged. To determine the placental etiology, treatment of human CTBs with poly I:C significantly increased HIF-1 alpha, NF-kappa Bp50, and miR-210 levels and decreased STAT6 and IL-4 levels. Overexpression of miR-210 in CTBs decreased STAT6 and IL-4 while inhibition of miR-210 increased STAT6 and IL-4. These findings demonstrate that TLR3 activation induces placental miR-210 via HIF-1 alpha and NF-kappa Bp50 leading to decreased STAT6 and IL-4 levels and this may contribute to the development of PE.	[Kopriva, Shelley E.; Chiasson, Valorie L.; Mitchell, Brett M.; Chatterjee, Piyali] Scott & White Healthcare Texas A&M Hlth Sci Ctr, Dept Internal Med, Div Nephrol & Hypertens, Temple, TX USA		Chatterjee, P (corresponding author), Scott & White Healthcare Texas A&M Hlth Sci Ctr, Dept Internal Med, Div Nephrol & Hypertens, Temple, TX USA.	pchatterjee@sw.org		Chatterjee, Piyali/0000-0002-7655-0485	Scientist Development Grant from American Heart Association [13SDG14630018]; Scott and White Memorial Hospital Research Development Grant	Scientist Development Grant from American Heart Association(American Heart Association); Scott and White Memorial Hospital Research Development Grant	This was was supported by Scientist Development Grant (13SDG14630018) from American Heart Association to PC and Scott and White Memorial Hospital Research Development Grant to BMM and PC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams VM, 2005, J IMMUNOL, V175, P8096, DOI 10.4049/jimmunol.175.12.8096; Ardite E, 2012, J CELL BIOL, V196, P163, DOI 10.1083/jcb.201105013; Arechavaleta-Velasco F, 2006, AM J PATHOL, V168, P1951, DOI 10.2353/ajpath.2006.050781; Azizieh F, 2005, AM J REPROD IMMUNOL, V54, P30, DOI 10.1111/j.1600-0897.2005.00278.x; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Cartwright JE, 1999, BRIT J PHARMACOL, V128, P181, DOI 10.1038/sj.bjp.0702757; Carty DM, 2008, TRENDS CARDIOVAS MED, V18, P186, DOI 10.1016/j.tcm.2008.07.002; Chapoval S, 2010, J LEUKOCYTE BIOL, V87, P1011, DOI 10.1189/jlb.1209772; Chatterjee P, 2011, PLACENTA, V32, P201, DOI 10.1016/j.placenta.2010.12.026; Chatterjee P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041884; Chatterjee P, 2011, HYPERTENSION, V58, P489, DOI 10.1161/HYPERTENSIONAHA.111.172114; Crosby ME, 2009, CURR PHARM DESIGN, V15, P3861, DOI 10.2174/138161209789649367; Enquobahrie Daniel A, 2011, Am J Obstet Gynecol, V204, DOI 10.1016/j.ajog.2010.09.004; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gong AY, 2010, J INFECT DIS, V201, P160, DOI 10.1086/648589; Gonzalez JM, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.021; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gunel T, 2011, GENET MOL RES, V10, P4034, DOI 10.4238/2011.November.8.5; Hu GK, 2009, J IMMUNOL, V183, P1617, DOI 10.4049/jimmunol.0804362; Hu YL, 2009, CLIN CHEM LAB MED, V47, P923, DOI 10.1515/CCLM.2009.228; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Ishibashi O, 2012, HYPERTENSION, V59, P265, DOI 10.1161/HYPERTENSIONAHA.111.180232; Jonsson Y, 2006, J REPROD IMMUNOL, V70, P83, DOI 10.1016/j.jri.2005.10.007; Kanasaki K, 2009, KIDNEY INT, V76, P831, DOI 10.1038/ki.2009.284; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kim HW, 2009, J BIOL CHEM, V284, P33161, DOI 10.1074/jbc.M109.020925; Koga K, 2009, J OBSTET GYNAECOL RE, V35, P191, DOI 10.1111/j.1447-0756.2008.00963.x; Koga K, 2009, AM J REPROD IMMUNOL, V61, P196, DOI 10.1111/j.1600-0897.2008.00682.x; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee DC, 2011, AM J PATHOL, V179, P590, DOI 10.1016/j.ajpath.2011.04.035; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang H, 2007, RNA, V13, P1402, DOI 10.1261/rna.634607; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long C, 2007, HYPERTENSION, V49, P569, DOI 10.1161/01.HYP.0000257914.80918.72; Matthiesen L, 2005, CHEM IMMUNOL ALLERGY, V89, P49, DOI 10.1159/000087912; Mazouni C, 2008, J REPROD IMMUNOL, V78, P80, DOI 10.1016/j.jri.2007.10.002; Montgomery RL, 2011, CIRCULATION, V124, P1537, DOI 10.1161/CIRCULATIONAHA.111.030932; Muralimanoharan S, 2012, PLACENTA, V33, P816, DOI 10.1016/j.placenta.2012.07.002; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Paone A, 2010, NEOPLASIA, V12, P539, DOI 10.1593/neo.92106; Pineles BL, 2007, AM J OBSTET GYNECOL, V196, P261, DOI 10.1016/j.ajog.2007.01.008; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Vaughan JE, 2012, HYPERTENS PREGNANCY, V31, P243, DOI 10.3109/10641955.2011.642436; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zarjou A, 2011, AM J PHYSIOL-RENAL, V301, pF793, DOI 10.1152/ajprenal.00273.2011; Zhang Y, 2012, J CELL MOL MED, V16, P249, DOI 10.1111/j.1582-4934.2011.01291.x; Zhou R, 2011, CELL MOL IMMUNOL, V8, P371, DOI 10.1038/cmi.2011.19; Zhu XM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.045	55	46	51	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67760	10.1371/journal.pone.0067760	http://dx.doi.org/10.1371/journal.pone.0067760			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844087	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000093
J	Masello, JF; Wikelski, M; Voigt, CC; Quillfeldt, P				Masello, Juan F.; Wikelski, Martin; Voigt, Christian C.; Quillfeldt, Petra			Distribution Patterns Predict Individual Specialization in the Diet of Dolphin Gulls	PLOS ONE			English	Article							STABLE-ISOTOPES; FORAGING PATTERNS; LARUS-SCORESBII; CARBON ISOTOPES; HERRING-GULLS; GREAT SKUAS; PUNTA-TOMBO; HABITAT USE; SEA OTTERS; SEABIRDS	Many animals show some degree of individual specialization in foraging strategies and diet. This has profound ecological and evolutionary implications. For example, populations containing diverse individual foraging strategies will respond in different ways to changes in the environment, thus affecting the capacity of the populations to adapt to environmental changes and to diversify. However, patterns of individual specialization have been examined in few species. Likewise it is usually unknown whether specialization is maintained over time, because examining the temporal scale at which specialization occurs can prove difficult in the field. In the present study, we analyzed individual specialization in foraging in Dolphin Gulls Leucophaeus scoresbii, a scavenger endemic to the southernmost coasts of South America. We used GPS position logging and stable isotope analyses (SIA) to investigate individual specialization in feeding strategies and their persistence over time. The analysis of GPS data indicated two major foraging strategies in Dolphin Gulls from New I. (Falkland Is./Islas Malvinas). Tagged individuals repeatedly attended either a site with mussel beds or seabird and seal colonies during 5 to 7 days of tracking. Females foraging at mussel beds were heavier than those foraging at seabird colonies. Nitrogen isotope ratios (delta N-15) of Dolphin Gull blood cells clustered in two groups, showing that individuals were consistent in their preferred foraging strategies over a period of at least several weeks. The results of the SIA as well as the foraging patterns recorded revealed a high degree of specialization for particular feeding sites and diets by individual Dolphin Gulls. Individual differences in foraging behavior were not related to sex. Specialization in Dolphin Gulls may be favored by the advantages of learning and memorizing optimal feeding locations and behaviors. Specialized individuals may reduce search and handling time and thus, optimize their energy gain and/or minimize time spent foraging.	[Masello, Juan F.; Wikelski, Martin; Quillfeldt, Petra] Max Planck Inst Ornithol, Vogelwarte Radolfzell, Radolfzell, Germany; [Voigt, Christian C.] Leibniz Inst Zoo & Wildlife Res, Evolutionary Ecol Res Grp, Berlin, Germany	Max Planck Society; Leibniz Institut fur Zoo und Wildtierforschung	Masello, JF (corresponding author), Univ Giessen, Dept Anim Ecol & Systemat, D-35390 Giessen, Germany.	juan.f.masello@bio.uni-giessen.de	Quillfeldt, Petra/A-9549-2009; Masello, Juan/C-7133-2009	Quillfeldt, Petra/0000-0002-4450-8688; Masello, Juan/0000-0002-6826-4016	Deutsche Forschungsgemeinschaft [QU148/1ff]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study received financial support from the Deutsche Forschungsgemeinschaft (QU148/1ff). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew DJ, 2002, AQUAT CONSERV, V12, P39, DOI 10.1002/aqc.474; Annett CA, 1999, ECOLOGY, V80, P288, DOI 10.1890/0012-9658(1999)080[0288:LTROIW]2.0.CO;2; Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; Barlow KE, 2002, MAR BIOL, V140, P205, DOI 10.1007/s00227-001-0691-7; Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bugoni L, 2009, MAR ECOL PROG SER, V374, P273, DOI 10.3354/meps07750; Castellanos A., 1935, HORNERO, V6, P22; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; CAWKELL E. M., 1961, IBIS, V103a, P1, DOI 10.1111/j.1474-919X.1961.tb02417.x; Cook TR, 2006, POLAR BIOL, V29, P562, DOI 10.1007/s00300-005-0089-y; Dahl TM, 2003, MAR ECOL PROG SER, V256, P257, DOI 10.3354/meps256257; DAVIS JWF, 1975, J ANIM ECOL, V44, P795, DOI 10.2307/3719; Davoren GK, 2003, ECOL MONOGR, V73, P463, DOI 10.1890/02-0208; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DEVILLERS P, 1977, Gerfaut, V67, P254; DOHERTY S, 1994, ETHOLOGY, V97, P177; Estes JA, 2003, J ANIM ECOL, V72, P144, DOI 10.1046/j.1365-2656.2003.00690.x; Forero MG, 2004, J ANIM ECOL, V73, P789, DOI 10.1111/j.0021-8790.2004.00852.x; Forero MG, 2002, ECOLOGY, V83, P3466, DOI 10.1890/0012-9658(2002)083[3466:CFCEVI]2.0.CO;2; Forero MG, 2002, MAR ECOL PROG SER, V234, P289, DOI 10.3354/meps234289; Gandini PA, 2008, ORNITOL NEOTROP, V19, P109; Golet GH, 2000, AUK, V117, P82, DOI 10.1642/0004-8038(2000)117[0082:APCACG]2.0.CO;2; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hahn S, 2003, POLAR BIOL, V26, P552, DOI 10.1007/s00300-003-0522-z; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; HOBSON KA, 1993, AUK, V110, P638, DOI 10.2307/4088430; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Holland RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008264; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Irons DB, 1998, ECOLOGY, V79, P647, DOI 10.2307/176960; Jaeger A, 2010, MAR ECOL PROG SER, V401, P269, DOI 10.3354/meps08380; JEHL JR, 1973, AUK, V90, P114; Lewis S, 2002, P ROY SOC B-BIOL SCI, V269, P1687, DOI 10.1098/rspb.2002.2083; Masello JF, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00103.1; MCCLEERY RH, 1986, J ANIM ECOL, V55, P245, DOI 10.2307/4705; Michalik A, 2010, POLAR BIOL, V33, P1537, DOI 10.1007/s00300-010-0843-7; Michener R.H., 1994, P138; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Morrison RIG, 2004, AUK, V121, P333, DOI 10.1642/0004-8038(2004)121[0333:UOBSIS]2.0.CO;2; MURPHY R.C., 1936, OCEANIC BIRDS S AM, V2; Newsome SD, 2009, ECOLOGY, V90, P961, DOI 10.1890/07-1812.1; Nisbet ICT, 2002, MAR ECOL PROG SER, V242, P267, DOI 10.3354/meps242267; Olive PJW, 2003, J ANIM ECOL, V72, P608, DOI 10.1046/j.1365-2656.2003.00730.x; OWENS NJP, 1987, ADV MAR BIOL, V24, P389; PARMELEE DF, 1975, CONDOR, V77, P218, DOI 10.2307/1365800; PARNELL A, 2008, STABLE ISOTOPE ANAL; PIEROTTI R, 1991, ECOLOGY, V72, P319, DOI 10.2307/1938925; Quillfeldt P, 2006, AREA DESCRIPTION BRE, P78283; Quillfeldt P, 2008, MAR BIOL, V155, P593, DOI 10.1007/s00227-008-1048-2; Quillfeldt P, 2011, MAR ECOL PROG SER, V428, P271, DOI 10.3354/meps09058; Quillfeldt P, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-15; R Core Team, 2020, R LANG ENV STAT COMP; Rey AR, 2000, POLAR BIOL, V23, P338; Reynolds P. W., 1935, Ibis, V1935, P65; Ropert-Coudert Y, 2003, WATERBIRDS, V26, P403, DOI 10.1675/1524-4695(2003)026[0403:IDSITL]2.0.CO;2; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; SIBLY RM, 1983, J ANIM ECOL, V52, P35, DOI 10.2307/4586; SIBLY RM, 1983, J ANIM ECOL, V52, P51, DOI 10.2307/4587; Stephens D.W., 1986, pi; Stillman RA, 2002, J ANIM ECOL, V71, P874, DOI 10.1046/j.1365-2656.2002.00652.x; Strange G, 2010, BLACK BROWED ALBATRO, P1230; Strange I., 2007, NEW ISLAND FALKLAND; Strange IJ, 1992, FIELD GUIDE WILDLIFE; Suarez N, 2005, IBIS, V147, P544, DOI 10.1111/j.1474-919x.2005.00426.x; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Votier SC, 2004, J APPL ECOL, V41, P1117, DOI 10.1111/j.0021-8901.2004.00974.x; Votier SC, 2003, POLAR BIOL, V26, P20, DOI 10.1007/s00300-002-0446-z; Votier SC, 2010, J APPL ECOL, V47, P487, DOI 10.1111/j.1365-2664.2010.01790.x; Weaver D. K, 1970, Bird Banding, V41, P28, DOI 10.2307/4511621; Wilson RP, 1997, WILDLIFE SOC B, V25, P101; Woo KJ, 2008, J ANIM ECOL, V77, P1082, DOI 10.1111/j.1365-2656.2008.01429.x; Wood AG, 2000, J AVIAN BIOL, V31, P278, DOI 10.1034/j.1600-048X.2000.310302.x; Woods RW, 1975, BIRDS FALKLAND ISLAN; Yorio P, 2004, WATERBIRDS, V27, P193, DOI 10.1675/1524-4695(2004)027[0193:FPOBOG]2.0.CO;2; Yorio P, 1996, CONDOR, V98, P208, DOI 10.2307/1369138; Yorio P, 1999, BIRD CONSERV INT, V9, P299, DOI 10.1017/S0959270900003506; Yorio Pablo, 2005, Hornero, V20, P53	80	31	31	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67714	10.1371/journal.pone.0067714	http://dx.doi.org/10.1371/journal.pone.0067714			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844073	gold, Green Published, Green Submitted			2022-12-27	WOS:000321341000082
J	Pinloche, E; McEwan, N; Marden, JP; Bayourthe, C; Auclair, E; Newbold, CJ				Pinloche, Eric; McEwan, Neil; Marden, Jean-Philippe; Bayourthe, Corinne; Auclair, Eric; Newbold, C. Jamie			The Effects of a Probiotic Yeast on the Bacterial Diversity and Population Structure in the Rumen of Cattle	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; SACCHAROMYCES-CEREVISIAE CULTURE; FRAGMENT-LENGTH-POLYMORPHISMS; HIGH-GRAIN DIET; REAL-TIME PCR; RUMINAL FERMENTATION; DAIRY-COWS; IN-VITRO; MICROBIAL FERMENTATION; MEGASPHAERA-ELSDENII	It has been suggested that the ability of live yeast to improve milk yield and weight gain in cattle is because the yeast stimulates bacterial activity within the rumen. However it remains unclear if this is a general stimulation of all species or a specific stimulation of certain species. Here we characterised the change in the bacterial population within the rumen of cattle fed supplemental live yeast. Three cannulated lactating cows received a daily ration (24 kg/d) of corn silage (61% of DM), concentrates (30% of DM), dehydrated alfalfa (9% of DM) and a minerals and vitamins mix (1% of DM). The effect of yeast (BIOSAF SC 47, Lesaffre Feed Additives, France; 0.5 or 5 g/d) was compared to a control (no additive) in a 363 Latin square design. The variation in the rumen bacterial community between treatments was assessed using Serial Analysis of V1 Ribosomal Sequence Tag (SARST-V1) and 454 pyrosequencing based on analysis of the 16S rRNA gene. Compared to the control diet supplementation of probiotic yeast maintained a healthy fermentation in the rumen of lactating cattle (higher VFA concentration [high yeast dose only], higher rumen pH, and lower Eh and lactate). These improvements were accompanied with a shift in the main fibrolytic group (Fibrobacter and Ruminococcus) and lactate utilising bacteria (Megasphaera and Selenomonas). In addition we have shown that the analysis of short V1 region of 16s rRNA gene (50-60 bp) could give as much phylogenetic information as a longer read (454 pyrosequencing of 250 bp). This study also highlights the difficulty of drawing conclusions on composition and diversity of complex microbiota because of the variation caused by the use of different methods (sequencing technology and/or analysis).	[Pinloche, Eric; McEwan, Neil; Newbold, C. Jamie] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales; [Pinloche, Eric; Marden, Jean-Philippe; Auclair, Eric] Lesaffre Feed Addit, Marcq En Baroeul, France; [Bayourthe, Corinne] INRA, TANDEM UMR1289, F-31326 Castanet Tolosan, France; [Bayourthe, Corinne] Univ Toulouse, INPT ENSAT, INP ENVT, TANDEM UMR1289, Castanet Tolosan, France	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); INRAE; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse	Newbold, CJ (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales.	cjn@aber.ac.uk		McEwan, Neil/0000-0003-3839-9072	Lesaffre Feed Additives, Marquette-Lez-Lille, France	Lesaffre Feed Additives, Marquette-Lez-Lille, France	The authors acknowledge the generous financial support of Lesaffre Feed Additives, Marquette-Lez-Lille, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2006, ENVIRON MICROBIOL, V8, P929, DOI 10.1111/j.1462-2920.2005.00959.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; [Anonymous], 1997, RUMEN MICROBIAL ECOS; Boyd R.D., 1991, J ANIM SCI, V69, P56, DOI [10.2527/1991.69suppl_256x., DOI 10.2527/1991.69SUPPL_256X]; Busquet M, 2006, J DAIRY SCI, V89, P761, DOI 10.3168/jds.S0022-0302(06)72137-3; Callaway ES, 1997, J DAIRY SCI, V80, P2035, DOI 10.3168/jds.S0022-0302(97)76148-4; Cardozo PW, 2005, J ANIM SCI, V83, P2572; Chaucheyras F, 1996, CAN J MICROBIOL, V42, P927, DOI 10.1139/m96-119; Coolen MJL, 2005, APPL ENVIRON MICROB, V71, P8729, DOI 10.1128/AEM.71.12.8729-8737.2005; Dijkstra J, 2002, NUTR RES REV, V15, P67, DOI 10.1079/NRR200237; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Dowd S.E., 2008, BMC MICROBIOLOGY, V8; ERASMUS LJ, 1992, J DAIRY SCI, V75, P3056, DOI 10.3168/jds.S0022-0302(92)78069-2; ESDALE WJ, 1972, J DAIRY SCI, V55, P964, DOI 10.3168/jds.S0022-0302(72)85603-0; Fernando SC, 2010, APPL ENVIRON MICROB, V76, P7482, DOI 10.1128/AEM.00388-10; Goad DW, 1998, J ANIM SCI, V76, P234; HALL TA, 1999, BIOEDIT USER FRIENDL, V41, P95; HARRISON GA, 1988, J DAIRY SCI, V71, P2967, DOI 10.3168/jds.S0022-0302(88)79894-X; Hongoh Y, 2003, FEMS MICROBIOL LETT, V221, P299, DOI 10.1016/S0378-1097(03)00218-0; JOUANY JP, 1994, ARCH ANIM NUTR, V46, P133, DOI 10.1080/17450399409381766; Khafipour E, 2009, APPL ENVIRON MICROB, V75, P7115, DOI 10.1128/AEM.00739-09; Koike S, 2003, FEMS MICROBIOL LETT, V229, P23, DOI 10.1016/S0378-1097(03)00760-2; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Krause KM, 2005, J DAIRY SCI, V88, P3633, DOI 10.3168/jds.S0022-0302(05)73048-4; Lan GQ, 2002, INT J SYST EVOL MICR, V52, P713, DOI [10.1099/ijs.0.01930-0, 10.1099/00207713-52-3-713]; Larue R, 2005, ENVIRON MICROBIOL, V7, P530, DOI 10.1111/j.1462-2920.2005.00721.x; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Marden JP, 2008, J DAIRY SCI, V91, P3528, DOI 10.3168/jds.2007-0889; Marden JP, 2005, J DAIRY SCI, V88, P277, DOI 10.3168/jds.S0022-0302(05)72685-0; MARTIN SA, 1994, J ANIM SCI, V72, P3019, DOI 10.2527/1994.72113019x; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Middelbos IS, 2009, FASEB J, V23; Morgan JP, 1996, ANN STAT, V24, P1185; Mosoni P, 2007, J APPL MICROBIOL, V103, P2676, DOI 10.1111/j.1365-2672.2007.03517.x; Mwenya B, 2005, J DAIRY SCI, V88, P1404, DOI 10.3168/jds.S0022-0302(05)72808-3; Nagashima K, 2003, APPL ENVIRON MICROB, V69, P1251, DOI 10.1128/AEM.69.2.1251-1262.2003; Newbold CJ, 1996, BRIT J NUTR, V76, P249, DOI 10.1079/BJN19960029; Newbold CJ, 1998, CAN J ANIM SCI, V78, P241, DOI 10.4141/A97-086; Nocek JE, 1997, J DAIRY SCI, V80, P1005, DOI 10.3168/jds.S0022-0302(97)76026-0; Owens FN, 1998, J ANIM SCI, V76, P275; Pitta DW, 2010, MICROB ECOL, V59, P511, DOI 10.1007/s00248-009-9609-6; PIVA G, 1993, J DAIRY SCI, V76, P2717, DOI 10.3168/jds.S0022-0302(93)77608-0; PLATA F, 1994, ANIM FEED SCI TECH, V49, P203, DOI 10.1016/0377-8401(94)90046-9; PLAYNE MJ, 1983, BIOTECHNOL BIOENG, V25, P1251, DOI 10.1002/bit.260250508; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; ROGER V, 1990, APPL ENVIRON MICROB, V56, P3081, DOI 10.1128/AEM.56.10.3081-3087.1990; Rossi F, 2004, ANIM RES, V53, P177, DOI 10.1051/animres:2004009; Russell J. B., 2002, RUMEN MICROBIOLOGY I; RUSSELL JB, 1981, APPL ENVIRON MICROB, V41, P1394, DOI 10.1128/AEM.41.6.1394-1399.1981; SAUVANT D, 2004, ALLT 20 ANN S BIOT F, P221; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Soto-Cruz O, 2001, BRAZ ARCH BIOL TECHN, V44, P179, DOI 10.1590/S1516-89132001000200011; STREETER MN, 1990, J ANIM SCI, V68, P3429; Tajima K, 1999, FEMS MICROBIOL ECOL, V29, P159, DOI 10.1111/j.1574-6941.1999.tb00607.x; Tajima K, 2001, APPL ENVIRON MICROB, V67, P2766, DOI 10.1128/AEM.67.6.2766-2774.2001; Tajima K, 2000, ANAEROBE, V6, P273, DOI 10.1006/anae.2000.0353; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WALLACE RJ, 1992, FEMS MICROBIOL LETT, V100, P529, DOI 10.1111/j.1574-6968.1992.tb05751.x; Wallace RJ, 1993, BIOTECHNOLOGY FEED I; Weimer PJ, 1998, J ANIM SCI, V76, P3114; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; WILLIAMS PEV, 1991, J ANIM SCI, V69, P3016, DOI 10.2527/1991.6973016x; WOLDA H, 1981, OECOLOGIA, V50, P296, DOI 10.1007/BF00344966; Yu ZT, 2006, ENVIRON MICROBIOL, V8, P603, DOI 10.1111/j.1462-2920.2005.00933.x	68	108	122	0	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67824	10.1371/journal.pone.0067824	http://dx.doi.org/10.1371/journal.pone.0067824			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844101	Green Published, gold			2022-12-27	WOS:000321341000103
J	Westerholz, J; Schack, T; Koester, D				Westerholz, Jan; Schack, Thomas; Koester, Dirk			Event-Related Brain Potentials for Goal-Related Power Grips	PLOS ONE			English	Article							CORTICAL CONTROL; HAND MOVEMENTS; GO/NO-GO; MOTOR; ACTIVATION; COMPONENTS; HANDEDNESS; IMMEDIATE; OBJECT; TASKS	Recent research has shown that neurophysiological activation during action planning depends on the orientation to initial or final action goals for precision grips. However, the neural signature for a distinct class of grasping, power grips, is still unknown. The aim of the present study was to differentiate between cerebral activity, by means of event-related potentials (ERPs), and its temporal organization during power grips executed with an emphasis on either the initial or final parts of movement sequences. In a grasp and transportation task, visual cues emphasized either the grip (the immediate goal) or the target location (the final goal). ERPs differed between immediate and final goal-cued conditions, suggesting different means of operation dependent on goal-relatedness. Differences in mean amplitude occurred earlier for power grips than for recently reported precision grips time-locked to grasping over parieto-occipital areas. Time-locked to final object placement, differences occurred within a similar time window for power and precision grips over frontal areas. These results suggest that a parieto-frontal network of activation is of crucial importance for grasp planning and execution. Our results indicate that power grip preparation and execution for goal-related actions are controlled by similar neural mechanisms as have been observed during precision grips, but with a distinct temporal pattern.	[Westerholz, Jan; Schack, Thomas; Koester, Dirk] Ctr Excellence Cognit Interact Technol CITEC, Bielefeld, Germany; [Westerholz, Jan; Schack, Thomas; Koester, Dirk] Univ Bielefeld, Neurocognit & Action Res Grp, Fac Psychol & Sports Sci, D-33615 Bielefeld, Germany; [Schack, Thomas] Res Inst Cognit & Robot CoR Lab, Bielefeld, Germany	University of Bielefeld	Westerholz, J (corresponding author), Ctr Excellence Cognit Interact Technol CITEC, Bielefeld, Germany.	jan.westerholz@uni-bielefeld.de	Koester, Dirk/B-2438-2008	Koester, Dirk/0000-0003-3940-8559	German Research Foundation [DFG EXC 277]	German Research Foundation(German Research Foundation (DFG))	This research was supported by German Research Foundation Grant DFG EXC 277 "Cognitive Interaction Technology" (CITEC)(www.cit-ec.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansuini C, 2008, EXP BRAIN RES, V185, P111, DOI 10.1007/s00221-007-1136-4; Begliomini C, 2007, EUR J NEUROSCI, V25, P1245, DOI 10.1111/j.1460-9568.2007.05365.x; BOTWINICK J, 1966, J EXP PSYCHOL, V71, P9, DOI 10.1037/h0022634; Bozzacchi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047783; Bozzacchi C, 2012, BIOL PSYCHOL, V89, P503, DOI 10.1016/j.biopsycho.2011.12.020; CASTIELLO U, 1992, BEHAV BRAIN RES, V50, P7, DOI 10.1016/S0166-4328(05)80283-9; Castiello U, 2008, NEUROSCIENTIST, V14, P157, DOI 10.1177/1073858407312080; Danek RH, 2011, J EXP PSYCHOL HUMAN, V37, P1323, DOI 10.1037/a0023092; Elliott D, 2001, PSYCHOL BULL, V127, P342, DOI 10.1037//0033-2909.127.3.342; Elliott D, 2010, PSYCHOL BULL, V136, P1023, DOI 10.1037/a0020958; Filimon F, 2010, NEUROSCIENTIST, V16, P388, DOI 10.1177/1073858410375468; Ganushchak LY, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00208; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; GRATTON G, 1988, J EXP PSYCHOL HUMAN, V14, P331, DOI 10.1037/0096-1523.14.3.331; Hughes CML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043015; Hughes CML, 2012, EXP BRAIN RES, V219, P391, DOI 10.1007/s00221-012-3100-1; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Kirsch W, 2010, PSYCHOPHYSIOLOGY, V47, P486, DOI 10.1111/j.1469-8986.2009.00952.x; Koester D, 2008, NEUROIMAGE, V42, P1622, DOI 10.1016/j.neuroimage.2008.06.043; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; KUTAS M, 1974, SCIENCE, V186, P545, DOI 10.1126/science.186.4163.545; Lange JJ, 1999, BIOL PSYCHOL, V50, P203, DOI 10.1016/S0301-0511(99)00009-5; Lindemann O, 2006, J EXP PSYCHOL HUMAN, V32, P633, DOI 10.1037/0096-1523.32.3.633; Majdandzic J, 2007, NEUROIMAGE, V37, P589, DOI 10.1016/j.neuroimage.2007.04.071; MARTENIUK RG, 1987, CAN J PSYCHOL, V41, P365, DOI 10.1037/h0084157; Miller JO, 2001, J EXP PSYCHOL HUMAN, V27, P266, DOI 10.1037//0096-1523.27.2.266; Mordkoff JT, 1996, J EXP PSYCHOL HUMAN, V22, P25, DOI 10.1037/0096-1523.22.1.25; NAPIER JR, 1956, J BONE JOINT SURG BR, V38, P902, DOI 10.1302/0301-620X.38B4.902; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; ROSENBAUM DA, 1990, ATTENTION PERFORM, V8, P321; ROSENBAUM DA, 1992, HUM MOVEMENT SCI, V11, P61, DOI 10.1016/0167-9457(92)90050-L; Schack T, 2009, PROG BRAIN RES, V174, P231, DOI 10.1016/S0079-6123(09)01319-3; Schutz C, 2011, MOTOR CONTROL, V15, P321, DOI 10.1123/mcj.15.3.321; Shibasaki H, 2006, CLIN NEUROPHYSIOL, V117, P2341, DOI 10.1016/j.clinph.2006.04.025; Spiegel MA, 2012, NEUROSCI LETT, V509, P82, DOI 10.1016/j.neulet.2011.12.033; Uithol S, 2012, J COGNITIVE NEUROSCI, V24, P1077, DOI 10.1162/jocn_a_00204; van Elk M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036450; van Schie HT, 2007, BRAIN RES, V1148, P183, DOI 10.1016/j.brainres.2007.02.085; Woodworth RS, 1899, PSYCHOL REV-MONOGR S, V3, P1	40	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68501	10.1371/journal.pone.0068501	http://dx.doi.org/10.1371/journal.pone.0068501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844211	Green Submitted, Green Published, gold			2022-12-27	WOS:000321341000166
J	Catala-Lopez, F; Sanfelix-Gimeno, G; Ridao, M; Peiro, S				Catala-Lopez, Ferran; Sanfelix-Gimeno, Gabriel; Ridao, Manuel; Peiro, Salvador			When Are Statins Cost-Effective in Cardiovascular Prevention? A Systematic Review of Sponsorship Bias and Conclusions in Economic Evaluations of Statins	PLOS ONE			English	Article							PHARMACOECONOMIC ANALYSES; CLINICAL-EXCELLENCE; OF-INTEREST; LOW-RISK; ASSOCIATION; HEALTH; TRIALS; ORGANIZATIONS; TRANSPARENCY; SUBMISSIONS	Background: We examined sponsorship of published cost-effectiveness analyses of statin use for cardiovascular (CV) prevention, and determined whether the funding source is associated with study conclusions. Methods and Findings: We searched PubMed/MEDLINE (up to June 2011) to identify cost-effectiveness analyses of statin use for CV prevention reporting outcomes as incremental costs per quality-adjusted life years (QALY) and/or life years gained (LYG). We examined relationships between the funding source and the study conclusions by means of tests of differences between proportions. Seventy-five studies were included. Forty-eight studies (64.0%) were industry-sponsored. Fifty-two (69.3%) articles compared statins versus non-active alternatives. Secondary CV prevention represented 42.7% of articles, followed by primary CV prevention (38.7%) and both (18.7%). Overall, industry-sponsored studies were much less likely to report unfavourable or neutral conclusions (0% versus 37.1%; p<0.001). For primary CV prevention, the proportion with unfavourable or neutral conclusions was 0% for industry-sponsored studies versus 57.9% for non-sponsored studies (p<0.001). Conversely, no statistically significant differences were identified for studies evaluating secondary CV prevention (0% versus 12.5%; p=0.222). Incremental costs per QALY/LYG estimates reported in industry-sponsored studies were generally more likely to fall below a hypothetical willingness-to-pay threshold of US $50,000. Conclusions: Our systematic analysis suggests that pharmaceutical industry sponsored economic evaluations of statins have generally favored the cost-effectiveness profile of their products particularly in primary CV prevention.	[Catala-Lopez, Ferran; Sanfelix-Gimeno, Gabriel; Ridao, Manuel; Peiro, Salvador] Ctr Super Invest Salud Publ CSISP FISABIO, Red Invest Serv Salud Enfermedades Cron REDISSEC, Valencia, Spain; [Ridao, Manuel] Inst Aragones Ciencias Salud I CS, Red Invest Serv Salud Enfermedades Cron REDISSEC, Zaragoza, Spain		Catala-Lopez, F (corresponding author), Ctr Super Invest Salud Publ CSISP FISABIO, Red Invest Serv Salud Enfermedades Cron REDISSEC, Valencia, Spain.	ferran_catala@hotmail.com	Catalá-López, Ferrán/N-6018-2018; Sanfélix-Gimeno, Gabriel/E-9140-2012; Peiro, Salvador/H-5778-2017	Catalá-López, Ferrán/0000-0002-3833-9312; Sanfélix-Gimeno, Gabriel/0000-0001-7098-4576; Peiro, Salvador/0000-0002-3902-569X; Ridao Lopez, Manuel/0000-0001-7837-5759	Novartis	Novartis(Novartis)	SP is president of the Fundacion Instituto de Investigacion en Servicios de Salud, a non-profit organization promoting health services research that has received funding from both public and private third parties, including a non-conditioned funding/grant from Novartis for activities for research diffusion. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; Azimi NA, 1998, J GEN INTERN MED, V13, P664, DOI 10.1046/j.1525-1497.1998.00201.x; Baker CB, 2003, BRIT J PSYCHIAT, V183, P498, DOI 10.1192/bjp.183.6.498; Basu A, 2004, SCHIZOPHR RES, V71, P445, DOI 10.1016/j.schres.2004.02.012; Battaggia A, 2012, LANCET, V380, P1815, DOI 10.1016/S0140-6736(12)62022-4; Bell CM, 2006, BMJ-BRIT MED J, V332, P699, DOI 10.1136/bmj.38737.607558.80; Bero L, 2007, PLOS MED, V4, P1001, DOI 10.1371/journal.pmed.0040184; Beutels P, 2004, VACCINE, V22, P3312, DOI 10.1016/j.vaccine.2004.03.001; Bhandari M, 2004, CAN MED ASSOC J, V170, P477; Catala-Lopez F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038012; Chauhan D, 2007, INT J TECHNOL ASSESS, V23, P96, DOI 10.1017/S0266462307051628; Donzelli A, 2012, LANCET, V380, P1814, DOI 10.1016/S0140-6736(12)62021-2; Drummond M, 2005, MED CARE, V43, P5; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; EVANS RG, 1995, ANN INTERN MED, V123, P59, DOI 10.7326/0003-4819-123-1-199507010-00010; Ferner RE, 2006, BMJ-BRIT MED J, V332, P1268, DOI 10.1136/bmj.332.7552.1268; Fleurence RL, 2010, PHARMACOECONOMICS, V28, P295, DOI 10.2165/11530530-000000000-00000; Franco OH, 2005, J EPIDEMIOL COMMUN H, V59, P927, DOI 10.1136/jech.2005.034900; Friedberg M, 1999, JAMA-J AM MED ASSOC, V282, P1453, DOI 10.1001/jama.282.15.1453; Garattini L, 2003, INT J TECHNOL ASSESS, V19, P685, DOI 10.1017/S0266462303000643; Garattini L, 2010, INT J TECHNOL ASSESS, V26, P330, DOI 10.1017/S0266462310000322; Goodacre S, 2002, EMERG MED J, V19, P301, DOI 10.1136/emj.19.4.301; Greenberg D, 2010, MED DECIS MAKING, V30, P320, DOI 10.1177/0272989X09360066; Hartmann M, 2003, BRIT J CANCER, V89, P1405, DOI 10.1038/sj.bjc.6601308; Hill SR, 2000, JAMA-J AM MED ASSOC, V283, P2116, DOI 10.1001/jama.283.16.2116; HILLMAN AL, 1991, NEW ENGL J MED, V324, P1362, DOI 10.1056/NEJM199105093241911; Hutton J, 2006, INT J TECHNOL ASSESS, V22, P10, DOI 10.1017/S0266462306050781; Jang S, 2011, AM J CLIN ONCOL-CANC, V34, P524, DOI 10.1097/COC.0b013e3181f4799b; Jang S, 2010, BREAST CANCER RES TR, V121, P273, DOI 10.1007/s10549-010-0870-7; John-Baptiste AA, 2011, CAN MED ASSOC J, V183, pE307, DOI 10.1503/cmaj.110384; KASSIRER JP, 1994, NEW ENGL J MED, V331, P669, DOI 10.1056/NEJM199409083311009; Kjaergard LL, 2002, BMJ-BRIT MED J, V325, P249, DOI 10.1136/bmj.325.7358.249; Lazar LD, 2011, CIRCULATION, V124, P146, DOI 10.1161/CIRCULATIONAHA.110.986349; Ligthart S, 2007, CAN MED ASSOC J, V176, P199, DOI 10.1503/cmaj.061020; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Mascitelli L, 2012, LANCET, V380, P1816, DOI 10.1016/S0140-6736(12)62025-X; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Miners AH, 2005, BMJ-BRIT MED J, V330, P65, DOI 10.1136/bmj.38285.482350.82; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Neumann PJ, 1998, MED DECIS MAKING, V18, pS23, DOI 10.1177/0272989X98018002S05; Newman DH, 2012, LANCET, V380, P1814, DOI 10.1016/S0140-6736(12)62020-0; Peura PK, 2012, MED DECIS MAKING, V32, P237, DOI 10.1177/0272989X11403834; Polyzos NP, 2011, CAN MED ASSOC J, V183, pE337, DOI 10.1503/cmaj.101506; Ray KK, 2012, LANCET, V380, P1816, DOI 10.1016/S0140-6736(12)62024-8; Redberg RF, 2012, JAMA-J AM MED ASSOC, V307, P1491, DOI 10.1001/jama.2012.423; Rennie D, 2000, JAMA-J AM MED ASSOC, V283, P2158, DOI 10.1001/jama.283.16.2158; Ridker PM, 2006, JAMA-J AM MED ASSOC, V295, P2270, DOI 10.1001/jama.295.19.2270; Ross JS, 2012, AM J PUBLIC HEALTH, V102, P72, DOI 10.2105/AJPH.2011.300187; Rovira J, 2008, PHARMACOECONOMICS, V26, P181, DOI 10.2165/00019053-200826030-00002; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Simpson WG, 2012, LANCET, V380, P1815, DOI 10.1016/S0140-6736(12)62023-6; Sismondo S, 2007, PLOS MED, V4, P1429, DOI 10.1371/journal.pmed.0040286; TAYLOR F, 2011, COCHRANE DB SYST REV; Thirugnanam S, 2012, CRIT CARE, V16, DOI 10.1186/cc11241; Valachis A, 2012, J CLIN ONCOL, V30, P1316, DOI 10.1200/JCO.2011.38.6078; Wald N, 2012, LANCET, V380, P1818, DOI 10.1016/S0140-6736(12)62028-5; WEINSTEIN MC, 1977, NEW ENGL J MED, V296, P716, DOI 10.1056/NEJM197703312961304; Welsing PMJ, 2003, RHEUMATOLOGY, V42, P1574, DOI 10.1093/rheumatology/keg456; Zomer E, 2012, LANCET, V380, P1817, DOI 10.1016/S0140-6736(12)62026-1	59	22	22	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e69462	10.1371/journal.pone.0069462	http://dx.doi.org/10.1371/journal.pone.0069462			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	181TS	23861972	Green Published, Green Submitted, gold			2022-12-27	WOS:000321692000045
J	Petri, A; Pfeil, BE; Oxelman, B				Petri, Anna; Pfeil, Bernard E.; Oxelman, Bengt			Introgressive Hybridization between Anciently Diverged Lineages of Silene (Caryophyllaceae)	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; GENE; CHLOROPLAST; EVOLUTION; HYBRID; ORIGIN; RETICULATE; SPECIATION; HISTORY; POA	Hybridization has played a major role during the evolution of angiosperms, mediating both gene flow between already distinct species and the formation of new species. Newly formed hybrids between distantly related taxa are often sterile. For this reason, interspecific crosses resulting in fertile hybrids have rarely been described to take place after more than a few million years after divergence. We describe here the traces of a reproductively successful hybrid between two ancestral species of Silene, diverged for about six million years prior to hybridization. No extant hybrids between the two parental lineages are currently known, but introgression of the RNA polymerase gene NRPA2 provides clear evidence of a temporary and fertile hybrid. Parsimony reconciliation between gene trees and the species tree, as well as consideration of clade ages, help exclude gene paralogy and lineage sorting as alternative hypotheses. This may represent one of the most extreme cases of divergence between species prior to introgressive hybridization discovered yet, notably at a homoploid level. Although species boundaries are generally believed to be stable after millions of years of divergence, we believe that this finding may indicate that gene flow between distantly related species is merely largely undetected at present.	[Petri, Anna; Pfeil, Bernard E.; Oxelman, Bengt] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden	University of Gothenburg	Petri, A (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden.	anna.petri@bioenv.gu.se	Pfeil, Bernard E/C-1108-2008	Pfeil, Bernard E/0000-0001-8179-2270	Helge Ax:son Johnssons fund; Lundgrenska fund; Swedish Research Council [2006-3766, 2009-5202, 2009-5206]; Royal Swedish Academy of Sciences; Lars Hiertas Minne fund; Royal Physiographic Society in Lund; Helge Ax:son Johnsons fund	Helge Ax:son Johnssons fund; Lundgrenska fund; Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Swedish Academy of Sciences; Lars Hiertas Minne fund; Royal Physiographic Society in Lund; Helge Ax:son Johnsons fund	This work was supported by grants from Helge Ax:son Johnssons fund (http://www.haxsonj.se/) and the Lundgrenska fund (http://www.wmlundgren.se/) to AP, and from the Swedish Research Council (www.vr.se) to BO (2006-3766 and 2009-5202). BEP is supported by grants from the Swedish Research Council (2009-5206), the Royal Swedish Academy of Sciences (www.kva.se), Lars Hiertas Minne fund (http://www.larshiertasminne.se/), The Royal Physiographic Society in Lund (http://www.fysiografen.se/), Helge Ax:son Johnsons fund and the Lundgrenska fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson JO, 2005, CELL MOL LIFE SCI, V62, P1182, DOI 10.1007/s00018-005-4539-z; [Anonymous], 2002, SE AL SEQUENCE ALIGN; Bock R, 2010, TRENDS PLANT SCI, V15, P11, DOI 10.1016/j.tplants.2009.10.001; Buggs RJA, 2011, TAXON, V60, P324, DOI 10.1002/tax.602003; Cha R S, 1992, PCR Methods Appl, V2, P14; CRANG RE, 1971, B TORREY BOT CLUB, V98, P214, DOI 10.2307/2483687; Doyle JJ, 2010, NEW PHYTOL, V186, P73, DOI 10.1111/j.1469-8137.2009.03118.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edmands S, 2002, TRENDS ECOL EVOL, V17, P520, DOI 10.1016/S0169-5347(02)02585-5; Erixon P, 2008, MOL PHYLOGENET EVOL, V48, P313, DOI 10.1016/j.ympev.2008.04.015; Frajman B, 2009, TAXON, V58, P811, DOI 10.1002/tax.583010; Ghatnekar L, 2006, P ROY SOC B-BIOL SCI, V273, P395, DOI 10.1098/rspb.2005.3355; HOLMGREN PK, 1990, INDEX HERBARIORUM 1, V120; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jenkins C, 2011, BIOL INVASIONS, V13, P1471, DOI 10.1007/s10530-010-9907-4; Joly S, 2009, MOL PHYLOGENET EVOL, V51, P365, DOI 10.1016/j.ympev.2009.02.015; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Kronforst MR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-98; KRUCKEBERG AR, 1955, AM J BOT, V42, P373, DOI 10.2307/2438743; KRUCKEBERG ARTHUR. R., 1962, BRITTONIA, V14, P311, DOI 10.2307/2805248; Maureira-Butler IJ, 2008, SYST BIOL, V57, P466, DOI 10.1080/10635150802172168; Minder AM, 2007, MOL ECOL, V16, P2504, DOI 10.1111/j.1365-294X.2007.03292.x; Minin VN, 2005, BIOINFORMATICS, V21, P3034, DOI 10.1093/bioinformatics/bti459; Nylander J.A.A., 2004, MRMODELTEST 2 3 PROG; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Oxelman B, 2000, NORD J BOT, V20, P743, DOI 10.1111/j.1756-1051.2000.tb00760.x; Oxelman B, 2011, ONWARDS SILENEAE TAX; Page RDM, 1998, BIOINFORMATICS, V14, P819, DOI 10.1093/bioinformatics/14.9.819; Paun O, 2009, NEW PHYTOL, V182, P507, DOI 10.1111/j.1469-8137.2009.02767.x; Petri A, 2011, TAXON, V60, P953, DOI 10.1002/tax.604002; Popp M, 2005, SYST BOT, V30, P302, DOI 10.1600/0363644054223648; Popp M, 2004, SYST BIOL, V53, P914, DOI 10.1080/10635150490888840; Popp M, 2001, MOL PHYLOGENET EVOL, V20, P474, DOI 10.1006/mpev.2001.0977; Popp M, 2007, AM J BOT, V94, P330, DOI 10.3732/ajb.94.3.330; Rambaut A, 2009, TRACER V1 5 0; Rambaut A, 2001, PHYLOGENETIC TREE; Rautenberg A, 2012, SYST BOT, V37, P226, DOI 10.1600/036364412X616792; Rautenberg A, 2010, MOL PHYLOGENET EVOL, V57, P978, DOI 10.1016/j.ympev.2010.08.003; Rautenberg A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-299; Suchard MA, 2003, J AM STAT ASSOC, V98, P427, DOI 10.1198/016214503000215; Swofford D.L., 2002, PHYLOGENETIC ANAL US; Vallenback P, 2008, MOL PHYLOGENET EVOL, V46, P890, DOI 10.1016/j.ympev.2007.11.031; Vallenback P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013529	47	12	12	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e67729	10.1371/journal.pone.0067729	http://dx.doi.org/10.1371/journal.pone.0067729			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861793	Green Submitted, Green Published, gold			2022-12-27	WOS:000321692000012
J	Zhang, W; Li, R; Li, J; Wang, WQ; Tie, R; Tian, F; Liang, XY; Xing, WJ; He, Y; Yu, L; Xi, MM; Wang, SW; Zheng, QS; Zhang, HF				Zhang, Wei; Li, Rong; Li, Jia; Wang, Wenqing; Tie, Ru; Tian, Fei; Liang, Xiangyan; Xing, Wenjuan; He, Yong; Yu, Liang; Xi, Miaomiao; Wang, Siwang; Zheng, Qiangsun; Zhang, Haifeng			Alpha-Linolenic Acid Exerts an Endothelial Protective Effect against High Glucose Injury via PI3K/Akt Pathway	PLOS ONE			English	Article							INDUCED DIABETIC-RATS; POLYUNSATURATED FATTY-ACIDS; CARDIOVASCULAR RISK-FACTORS; ADHESION MOLECULES; MYOCARDIAL ISCHEMIA/REPERFUSION; INSULIN-RESISTANCE; INDUCED APOPTOSIS; CULTURED HUMAN; B PATHWAY; KAPPA-B	Mounting evidence has indicated that the cardiovascular protective effects of dietary alpha-linolenic acid (ALA), but whether ALA exerts an endothelial protective effect against high glucose injury and the underlying mechanisms remain largely unknown. Streptozocin-induced diabetic rats were randomized treated orally for 4 weeks with vehicle (0.01% alcohol) or ALA (500 mu g/kg per day by gavage). Human umbilical vein endothelial cells (HUVECs) were exposed to high glucose (28 mmol/L) stimulation for 48 hours. ALA significantly improved concentration-dependent vasorelaxation to ACh in diabetic aortic segments and inhibited endothelial inflammation as evidenced by decreased soluble P-selectin and intercellular adhesion molecule-1 (ICAM-1) in diabetic rats. Furthermore, both P-selectin and ICAM-1 expression were increased significantly in high glucose-induced HUVECs, resulting in enhanced neutrophils adhesion to HUVECs compared with normal glucose group. Treatment with ALA (50 mmol/L) increased Akt phosphorylation, attenuated P-selectin and ICAM-1 expressions and thus inhibited neutrophils adhesion in HUVECs exposed to high glucose, all of which was blocked by the PI3K inhibitors LY294002 and wortmannin. These data indicates that ALA inhibits endothelial inflammation and improved endothelial function in STZ-induced diabetic rats. The anti-adhesive effect of ALA against high glucose injury may partially be mediated by the PI3K/Akt pathway.	[Zhang, Wei; He, Yong; Yu, Liang; Zheng, Qiangsun] Fourth Mil Med Univ, Tangdu Hosp, Dept Cardiol, Xian 710032, Peoples R China; [Zhang, Wei; Tie, Ru; Tian, Fei; Liang, Xiangyan; Zhang, Haifeng] Fourth Mil Med Univ, Expt Teaching Ctr, Xian 710032, Peoples R China; [Li, Rong] Fourth Mil Med Univ, Xijing Hosp, Dept Geratol, Xian 710032, Peoples R China; [Li, Jia; Xing, Wenjuan] Fourth Mil Med Univ, Dept Physiol, Xian 710032, Peoples R China; [Wang, Wenqing] Fourth Mil Med Univ, Tangdu Hosp, Dept Hematol, Xian 710032, Peoples R China; [Xi, Miaomiao] Fourth Mil Med Univ, Xijing Hosp, Dept Pharm, Xian 710032, Peoples R China; [Wang, Siwang] Fourth Mil Med Univ, Pharmaceut Res Inst, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Zheng, QS (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Cardiol, Xian 710032, Peoples R China.	tdxznk01@hotmail.com; hfzhang@fmmu.edu.cn		Zhang, Haifeng/0000-0003-1938-3796; Wang, Siwang/0000-0003-1888-4716	National Natural Science Foundation of China (NSFC) [81100083, 81270330, 81270401]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by grants from National Natural Science Foundation of China (NSFC numbers 81100083, 81270330 and 81270401) (http://www.nsfc.gov.cn/Portal0/default166.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CM, 2005, CIRCULATION, V112, P3232, DOI 10.1161/CIRCULATIONAHA.105.572008; Blann AD, 2000, J CLIN ENDOCR METAB, V85, P1745, DOI 10.1210/jc.85.5.1745; CALVER A, 1992, J CLIN INVEST, V90, P2548, DOI 10.1172/JCI116149; Chen HJ, 2003, J MOL CELL CARDIOL, V35, P769, DOI 10.1016/S0022-2828(03)00120-2; Djousse L, 2005, CIRCULATION, V111, P2921, DOI 10.1161/CIRCULATIONAHA.104.489534; Finnegan YE, 2003, AM J CLIN NUTR, V77, P783, DOI 10.1093/ajcn/77.4.783; Fox CS, 2004, JAMA-J AM MED ASSOC, V292, P2495, DOI 10.1001/jama.292.20.2495; Grover-Paez F, 2009, DIABETES RES CLIN PR, V84, P1, DOI 10.1016/j.diabres.2008.12.013; Ho FM, 2006, CELL SIGNAL, V18, P391, DOI 10.1016/j.cellsig.2005.05.009; Hong HK, 2003, DIABETES RES CLIN PR, V62, P1, DOI 10.1016/S0168-8227(03)00142-6; Horani MH, 2006, NUTRITION, V22, P123, DOI 10.1016/j.nut.2005.05.012; JOHNSTONE MT, 1993, CIRCULATION, V88, P2510, DOI 10.1161/01.CIR.88.6.2510; Li J, 2009, J MOL CELL CARDIOL, V47, P512, DOI 10.1016/j.yjmcc.2009.07.010; Majithiya JB, 2005, CARDIOVASC RES, V66, P150, DOI 10.1016/j.cardiores.2004.12.025; Matsumoto K, 2002, DIABETES RES CLIN PR, V55, P131, DOI 10.1016/S0168-8227(01)00296-0; McEwen B, 2010, DIABETES EDUCATOR, V36, P565, DOI 10.1177/0145721710372675; Omi H, 2002, J DIABETES COMPLICAT, V16, P201, DOI 10.1016/S1056-8727(01)00163-5; Ottonello L, 2009, BRIT J PHARMACOL, V157, P294, DOI 10.1111/j.1476-5381.2009.00162.x; Rodriguez-Manas L, 1998, BRIT J PHARMACOL, V123, P1495, DOI 10.1038/sj.bjp.0701749; Schalkwijk CG, 2005, CLIN SCI, V109, P143, DOI 10.1042/CS20050025; Sekikawa A, 2008, J AM COLL CARDIOL, V52, P417, DOI 10.1016/j.jacc.2008.03.047; Song YQ, 2007, DIABETES, V56, P1898, DOI 10.2337/db07-0250; Toborek M, 2002, AM J CLIN NUTR, V75, P119, DOI 10.1093/ajcn/75.1.119; Vallejo S, 2000, J DIABETES COMPLICAT, V14, P224, DOI 10.1016/S1056-8727(00)00079-9; Xie NL, 2011, ARCH MED RES, V42, P171, DOI 10.1016/j.arcmed.2011.04.008; Xing WJ, 2013, HYPERTENSION, V61, P1028, DOI 10.1161/HYPERTENSIONAHA.111.00728; Zhang W, 2007, NUTRITION, V23, P762, DOI 10.1016/j.nut.2007.07.003; Zhang XH, 2010, BRIT J PHARMACOL, V159, P928, DOI 10.1111/j.1476-5381.2009.00594.x; Zhao GX, 2007, AM J CLIN NUTR, V85, P385, DOI 10.1093/ajcn/85.2.385; Zhao GX, 2004, J NUTR, V134, P2991, DOI 10.1093/jn/134.11.2991; Zhao GX, 2005, BIOCHEM BIOPH RES CO, V336, P909, DOI 10.1016/j.bbrc.2005.08.204	31	18	22	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68489	10.1371/journal.pone.0068489	http://dx.doi.org/10.1371/journal.pone.0068489			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861910	Green Submitted, Green Published, gold			2022-12-27	WOS:000321425300064
J	Bischof, J; Randoll, SJ; Sussner, N; Henne-Bruns, D; Pinna, LA; Knippschild, U				Bischof, Joachim; Randoll, Sven-Jannis; Suessner, Nadine; Henne-Bruns, Doris; Pinna, Lorenzo A.; Knippschild, Uwe			CK1 delta Kinase Activity Is Modulated by Chk1-Mediated Phosphorylation	PLOS ONE			English	Article							CASEIN-KINASE; PROTEIN-KINASE; I-EPSILON; BETA-CATENIN; ALZHEIMERS-DISEASE; CELL-CYCLE; DNA-DAMAGE; SCHIZOSACCHAROMYCES-POMBE; SUBSTRATE DETERMINANTS; PROTEOMICS ANALYSIS	CK1 delta, a member of the casein kinase 1 family, is involved in the regulation of various cellular processes and has been associated with the pathophysiology of neurodegenerative diseases and cancer. Therefore recently, interest in generating highly specific inhibitors for personalized therapy has increased enormously. However, the efficacy of newly developed inhibitors is affected by the phosphorylation state of CK1 delta. Cellular kinases phosphorylating CK1 delta within its C-terminal domain have been identified but still more information regarding the role of site-specific phosphorylation in modulating the activity of CK1 delta is required. Here we show that Chk1 phosphorylates rat CK1d at serine residues 328, 331, 370, and threonine residue 397 as well as the human CK1 delta transcription variants 1 and 2. CK1 delta mutant proteins bearing one, two or three mutations at these identified phosphorylation sites exhibited significant differences in their kinetic properties compared to wild-type CK1 delta. Additionally, CK1 delta co-precipitates with Chk1 from HT1080 cell extracts and activation of cellular Chk1 resulted in a significant decrease in cellular CK1 delta kinase activity. Taken together, these data point towards a possible regulatory relationship between Chk1 and CK1 delta.	[Bischof, Joachim; Randoll, Sven-Jannis; Suessner, Nadine; Henne-Bruns, Doris; Knippschild, Uwe] Ulm Univ Hosp, Dept Gen & Visceral Surg, Ulm, Germany; [Pinna, Lorenzo A.] Univ Padua, Dept Biol Sci, Padua, Italy; [Pinna, Lorenzo A.] Univ Padua, Consiglio Nazl Ric, Inst Neurosci, Padua, Italy	Ulm University; University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Padua	Knippschild, U (corresponding author), Ulm Univ Hosp, Dept Gen & Visceral Surg, Ulm, Germany.	uwe.knippschild@uniklinik-ulm.de		Pinna, Lorenzo A./0000-0002-8856-4956	Deutsche Krebshilfe, Dr. Mildred Scheel Stiftung [108489]; AIRC [IG 10312]	Deutsche Krebshilfe, Dr. Mildred Scheel Stiftung(Deutsche Krebshilfe); AIRC(Fondazione AIRC per la ricerca sul cancro)	Work in the lab of Uwe Knippschild is supported by a grant from the Deutsche Krebshilfe, Dr. Mildred Scheel Stiftung (108489). Work in the lab of Lorenzo Pinna is supported by the AIRC (Project IG 10312). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanchy Ramars, 2011, J Proteomics Bioinform, V4, P22; Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Arey R, 2012, BEHAV PHARMACOL, V23, P392, DOI 10.1097/FBP.0b013e32835651fd; Behrend L, 2000, ONCOGENE, V19, P5303, DOI 10.1038/sj.onc.1203939; Behrend L, 2000, EUR J CELL BIOL, V79, P240, DOI 10.1078/S0171-9335(04)70027-8; BEYAERT R, 1995, J BIOL CHEM, V270, P23293, DOI 10.1074/jbc.270.40.23293; BIANCHI V, 1986, J BIOL CHEM, V261, P6037; Bischof J, 2012, AMINO ACIDS; Borchert N, 2010, GENOME RES, V20, P837, DOI 10.1101/gr.103119.109; BROCKMAN JL, 1992, P NATL ACAD SCI USA, V89, P9454, DOI 10.1073/pnas.89.20.9454; Brockschmidt C, 2008, GUT, V57, P799, DOI 10.1136/gut.2007.123695; Brunati AM, 2001, BIOCHEM BIOPH RES CO, V284, P817, DOI 10.1006/bbrc.2001.5049; Burzio V, 2002, J CELL BIOCHEM, V86, P805, DOI 10.1002/jcb.10263; Bustos VH, 2005, BIOCHEM J, V391, P417, DOI 10.1042/BJ20050717; Bustos VH, 2006, P NATL ACAD SCI USA, V103, P19725, DOI 10.1073/pnas.0609424104; Camacho F, 2001, FEBS LETT, V489, P159, DOI 10.1016/S0014-5793(00)02434-0; CARMEL G, 1994, J BIOL CHEM, V269, P7304; Cegielska A, 1998, J BIOL CHEM, V273, P1357, DOI 10.1074/jbc.273.3.1357; COBB MH, 1983, J BIOL CHEM, V258, P2472; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Cruciat CM, 2013, SCIENCE; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Desagher S, 2001, MOL CELL, V8, P601, DOI 10.1016/S1097-2765(01)00335-5; DHILLON N, 1994, EMBO J, V13, P2777, DOI 10.1002/j.1460-2075.1994.tb06571.x; Dubois T, 2002, EUR J BIOCHEM, V269, P909, DOI 10.1046/j.0014-2956.2001.02725.x; Eide EJ, 2002, J BIOL CHEM, V277, P17248, DOI 10.1074/jbc.M111466200; ELIAS L, 1981, CANCER RES, V41, P2182; Faundez VV, 2000, MOL BIOL CELL, V11, P2591, DOI 10.1091/mbc.11.8.2591; Feijoo C, 2001, J CELL BIOL, V154, P913, DOI 10.1083/jcb.200104099; FLOTOW H, 1991, J BIOL CHEM, V266, P3724; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; Foldynova-Trantirkova S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2581; Frierson HF, 2002, AM J PATHOL, V161, P1315, DOI 10.1016/S0002-9440(10)64408-2; Fuja TJ, 2004, CANCER RES, V64, P942, DOI 10.1158/0008-5472.CAN-03-2100; Gault WJ, 2012, J CELL BIOL, V196, P605, DOI 10.1083/jcb.201107137; Giamas G, 2007, BIOCHEM J, V406, P389, DOI 10.1042/BJ20070091; GRAVES PR, 1995, J BIOL CHEM, V270, P21689, DOI 10.1074/jbc.270.37.21689; GRAVES PR, 1993, J BIOL CHEM, V268, P6394; Grietzen KF, 1999, J BIOL CHEM, V274, P32063, DOI 10.1074/jbc.274.45.32063; GROSS SD, 1995, J CELL BIOL, V130, P711, DOI 10.1083/jcb.130.3.711; Honaker Y, 2010, ONCOGENE, V29, P3324, DOI 10.1038/onc.2010.96; Hutchinson JA, 2011, J BIOL CHEM, V286, P8688, DOI 10.1074/jbc.M110.141754; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Izeradjene K, 2004, CANCER RES, V64, P8036, DOI 10.1158/0008-5472.CAN-04-0762; Jackson JR, 2000, CANCER RES, V60, P566; Kattapuram T, 2005, J BIOL CHEM, V280, P15340, DOI 10.1074/jbc.M500214200; Kawakami F, 2008, BIOL PHARM BULL, V31, P193, DOI 10.1248/bpb.31.193; Kim SY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008979; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Knippschild U, 1996, ONCOGENE, V13, P1387; Knippschild U, 1997, ONCOGENE, V15, P1727, DOI 10.1038/sj.onc.1201541; Koch A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001588; Kuret J, 1997, J NEUROCHEM, V69, P2506; Li GB, 2004, J BIOL CHEM, V279, P15938, DOI 10.1074/jbc.M314116200; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lolli G, 2012, BIOCHEMISTRY; Maritzen T, 2003, EUR J CELL BIOL, V82, P369, DOI 10.1078/0171-9335-00323; Masuda K, 2003, INT J CANCER, V105, P803, DOI 10.1002/ijc.11152; McKenzie JAG, 2006, FEBS LETT, V580, P2388, DOI 10.1016/j.febslet.2006.03.048; MEGGIO F, 1991, FEBS LETT, V283, P303, DOI 10.1016/0014-5793(91)80614-9; Meng Z, 2011, MOL BIOL CELL, V22, P2834, DOI 10.1091/mbc.E11-01-0048; Milne DM, 2001, EXP CELL RES, V263, P43, DOI 10.1006/excr.2000.5100; O'Neill T, 2002, J BIOL CHEM, V277, P16102, DOI 10.1074/jbc.M111705200; Olsen Jesper V., 2009, V492, P131, DOI 10.1007/978-1-59745-493-3_7; Oppermann FS, 2009, MOL CELL PROTEOMICS, V8, P1751, DOI 10.1074/mcp.M800588-MCP200; Peifer C, 2009, J MED CHEM, V52, P7618, DOI 10.1021/jm9005127; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Petronczki M, 2006, CELL, V126, P1049, DOI 10.1016/j.cell.2006.07.029; Piao S, 2011, CELL CYCLE, V10, P531, DOI 10.4161/cc.10.3.14757; Pyle RA, 2000, J BIOL CHEM, V275, P17195, DOI 10.1074/jbc.M000674200; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Rodriguez N, 2012, EMBO MOL MED; Rumpf C, 2010, CELL CYCLE, V9, P2657, DOI 10.4161/cc.9.13.12146; Santos JA, 1996, J CELL SCI, V109, P1847; Schwab C, 2000, NEUROBIOL AGING, V21, P503, DOI 10.1016/S0197-4580(00)00110-X; Shiromizu T, 2013, J PROTEOME RES; Sillibourne JE, 2002, J MOL BIOL, V322, P785, DOI 10.1016/S0022-2836(02)00857-4; SINGH TJ, 1995, J NEUROCHEM, V64, P1420; Swiatek W, 2006, J BIOL CHEM, V281, P12233, DOI 10.1074/jbc.M510580200; Swiatek W, 2004, J BIOL CHEM, V279, P13011, DOI 10.1074/jbc.M304682200; Takano A, 2004, NEUROREPORT, V15, P1461, DOI 10.1097/01.wnr.0000133297.77278.81; Takano A, 2004, NEUROPSYCHOPHARMACOL, V29, P1901, DOI 10.1038/sj.npp.1300503; Takenaka Y, 2004, MOL CELL BIOL, V24, P4395, DOI 10.1128/MCB.24.10.4395-4406.2004; Tapia-Alveal C, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-8; Thal DR, 2011, ACTA NEUROPATHOL, V122, P577, DOI 10.1007/s00401-011-0871-6; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; VANDERGEER P, 1994, ELECTROPHORESIS, V15, P544, DOI 10.1002/elps.1150150173; Vielhaber E, 2000, MOL CELL BIOL, V20, P4888, DOI 10.1128/MCB.20.13.4888-4899.2000; Walker AJ, 2010, CELL TISSUE RES, V341, P131, DOI 10.1007/s00441-010-0986-4; Walter J, 1998, BIOCHEMISTRY-US, V37, P5961, DOI 10.1021/bi971763a; Wang LZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054522, 10.1371/journal.pone.0081908]; Weber C, 2012, J PROTEOMICS, V75, P1343, DOI 10.1016/j.jprot.2011.11.004; Wissing J, 2007, MOL CELL PROTEOMICS, V6, P537, DOI 10.1074/mcp.T600062-MCP200; Wolff S, 2005, BBA-MOL CELL RES, V1745, P196, DOI 10.1016/j.bbamcr.2005.05.004; Wolff S, 2006, FEBS LETT, V580, P6477, DOI 10.1016/j.febslet.2006.10.068; Yin HS, 2006, BIOCHEMISTRY-US, V45, P5297, DOI 10.1021/bi052354e; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zanivan S, 2008, J PROTEOME RES, V7, P5314, DOI 10.1021/pr800599n; Zhang JR, 1996, BIOCHEMISTRY-US, V35, P16319, DOI 10.1021/bi9614444; Zhao Y, 2004, J BIOL CHEM, V279, P30844, DOI 10.1074/jbc.M404651200	104	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68803	10.1371/journal.pone.0068803	http://dx.doi.org/10.1371/journal.pone.0068803			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861943	gold, Green Submitted, Green Published			2022-12-27	WOS:000323350700103
J	Farar, V; Hrabovska, A; Krejci, E; Myslivecek, J				Farar, Vladimir; Hrabovska, Anna; Krejci, Eric; Myslivecek, Jaromir			Developmental Adaptation of Central Nervous System to Extremely High Acetylcholine Levels	PLOS ONE			English	Article							CHOLINE-ACETYLTRANSFERASE; POSTNATAL-DEVELOPMENT; BUTYRYLCHOLINESTERASE ACTIVITY; MUSCARINIC RECEPTORS; MEMBRANE ANCHOR; DEFICIENT MICE; MOUSE-BRAIN; RAT-BRAIN; IN-VIVO; PROTEIN	Acetylcholinesterase (AChE) is a key enzyme in termination of fast cholinergic transmission. In brain, acetylcholine (ACh) is produced by cholinergic neurons and released in extracellular space where it is cleaved by AChE anchored by protein PRiMA. Recently, we showed that the lack of AChE in brain of PRiMA knock-out (KO) mouse increased ACh levels 200-300 times. The PRiMA KO mice adapt nearly completely by the reduction of muscarinic receptor (MR) density. Here we investigated changes in MR density, AChE, butyrylcholinesterase (BChE) activity in brain in order to determine developmental period responsible for such adaptation. Brains were studied at embryonal day 18.5 and postnatal days (pd) 0, 9, 30, 120, and 425. We found that the AChE activity in PRiMA KO mice remained very low at all studied ages while in wild type (WT) mice it gradually increased till pd120. BChE activity in WT mice gradually decreased until pd9 and then increased by pd120, it continually decreased in KO mice till pd30 and remained unchanged thereafter. MR number increased in WT mice till pd120 and then became stable. Similarly, MR increased in PRiMA KO mice till pd30 and then remained stable, but the maximal level reached is approximately 50% of WT mice. Therefore, we provide the evidence that adaptive changes in MR happen up to pd30. This is new phenomenon that could contribute to the explanation of survival and nearly unchanged phenotype of PRiMA KO mice.	[Farar, Vladimir; Myslivecek, Jaromir] Charles Univ Prague, Inst Physiol, Fac Med 1, Prague, Czech Republic; [Farar, Vladimir; Krejci, Eric] Univ Paris 05, Ctr Etud Sensorimotricite, CNRS, UMR 8194, Paris, France; [Hrabovska, Anna] Comenius Univ, Fac Pharm, Dept Pharmacol & Toxicol, Bratislava, Slovakia	Charles University Prague; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Comenius University Bratislava	Myslivecek, J (corresponding author), Charles Univ Prague, Inst Physiol, Fac Med 1, Prague, Czech Republic.	jmys@lf1.cuni.cz	Myslivecek, Jaromir/A-1078-2008; Hrabovska, Anna/ABE-8931-2020; Farar, Vladimir/J-1581-2017	Myslivecek, Jaromir/0000-0002-4275-4607; Farar, Vladimir/0000-0003-0158-4645; Krejci, Eric/0000-0001-8564-0290	Grant Agency of Charles University [GAUK480613]	Grant Agency of Charles University	This work was supported by Grant GAUK480613 from Grant Agency of Charles University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Villaca Y, 2011, BEHAV BRAIN RES, V221, P367, DOI 10.1016/j.bbr.2009.12.049; Alexander SPH, 2011, BRIT J PHARMACOL, V164, pS1, DOI 10.1111/j.1476-5381.2011.01649_1.x; Aosaki T, 2010, GERIATR GERONTOL INT, V10, pS148, DOI 10.1111/j.1447-0594.2010.00588.x; Aznavour N, 2005, J COMP NEUROL, V486, P61, DOI 10.1002/cne.20501; Bajgar J, 2008, CHEM-BIOL INTERACT, V175, P281, DOI 10.1016/j.cbi.2008.05.015; Bazalakova MH, 2006, HANDB EXP PHARM, V175, P525; Bernard W, 2006, TRENDS NEUROSCI, V29, P140, DOI 10.1016/j.tins.2006.01.006; Brandon EP, 2003, J NEUROSCI, V23, P539, DOI 10.1523/JNEUROSCI.23-02-00539.2003; Bullock R, 2007, CURR ALZHEIMER RES, V4, P277; de Castro BM, 2009, MOL CELL BIOL, V29, P5238, DOI 10.1128/MCB.00245-09; Dobbertin A, 2009, J NEUROSCI, V29, P4519, DOI 10.1523/JNEUROSCI.3863-08.2009; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Farar V, 2012, J NEUROCHEM, V122, P1065, DOI 10.1111/j.1471-4159.2012.07856.x; FIEDLER EP, 1987, J NEUROCHEM, V49, P983, DOI 10.1111/j.1471-4159.1987.tb00990.x; Geula C, 2007, EXP NEUROL, V204, P640, DOI 10.1016/j.expneurol.2006.12.015; Guzman MS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001194; Holler T, 1996, NEUROSCI LETT, V212, P107, DOI 10.1016/0304-3940(96)12808-1; Hut RA, 2011, BEHAV BRAIN RES, V221, P466, DOI 10.1016/j.bbr.2010.11.039; Jositsch G, 2009, N-S ARCH PHARMACOL, V379, P389, DOI 10.1007/s00210-008-0365-9; LAMMERDINGKOPPEL M, 1995, HISTOCHEM CELL BIOL, V103, P301, DOI 10.1007/BF01457415; Lassiter TL, 1998, DEV BRAIN RES, V105, P109, DOI 10.1016/S0165-3806(97)00177-6; Le Novere N, 2002, J NEUROBIOL, V53, P447, DOI 10.1002/neu.10153; Marks MJ, 2010, J MOL NEUROSCI, V40, P96, DOI 10.1007/s12031-009-9264-x; Massoulie J, 2002, NEUROSIGNALS, V11, P130, DOI 10.1159/000065054; Massoulie J, 2008, CHEM-BIOL INTERACT, V175, P30, DOI 10.1016/j.cbi.2008.04.039; Maxwell DM, 2006, ARCH TOXICOL, V80, P756, DOI 10.1007/s00204-006-0120-2; Mechawar N, 2001, NEUROSCIENCE, V108, P555, DOI 10.1016/S0306-4522(01)00389-X; Mesulam MM, 2002, NEUROSCIENCE, V110, P627, DOI 10.1016/S0306-4522(01)00613-3; Michel MC, 2009, N-S ARCH PHARMACOL, V379, P385, DOI 10.1007/s00210-009-0395-y; Moreno RD, 1998, INT J DEV NEUROSCI, V16, P123, DOI 10.1016/S0736-5748(98)00008-2; Mrvova K, 2012, CHEMICOBIOLOGICAL IN, V203, P348; Myslivecek J, 2007, N-S ARCH PHARMACOL, V376, P83, DOI 10.1007/s00210-007-0184-4; Oda Y, 1999, PATHOL INT, V49, P921, DOI 10.1046/j.1440-1827.1999.00977.x; Pepeu G, 2010, CHEM-BIOL INTERACT, V187, P403, DOI 10.1016/j.cbi.2009.11.018; Perrier AL, 2002, NEURON, V33, P275, DOI 10.1016/S0896-6273(01)00584-0; SAWYER TW, 1993, DEV BRAIN RES, V71, P147, DOI 10.1016/0165-3806(93)90115-Q; Svedberg MM, 2003, NEUROSCI LETT, V340, P148, DOI 10.1016/S0304-3940(03)00092-2; Wess J, 2008, TRENDS PHARMACOL SCI, V29, P616, DOI 10.1016/j.tips.2008.08.006; Williams MJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1779, DOI 10.1038/sj.npp.1301585; Xie HDQ, 2010, CHEM-BIOL INTERACT, V187, P78, DOI 10.1016/j.cbi.2010.02.018; Xie WH, 2000, J PHARMACOL EXP THER, V293, P896; Yamada N, 2011, J APPL TOXICOLOGY; Zheng Q, 2000, TOXICOL SCI, V55, P124, DOI 10.1093/toxsci/55.1.124	43	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68265	10.1371/journal.pone.0068265	http://dx.doi.org/10.1371/journal.pone.0068265			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861875	Green Published, gold, Green Submitted			2022-12-27	WOS:000323350700076
J	Intawicha, P; Wang, SH; Hsieh, YC; Lo, NW; Lee, KH; Huang, SY; Ju, JC				Intawicha, Payungsuk; Wang, Shih-Han; Hsieh, Ya-Chen; Lo, Neng-Wen; Lee, Kun-Hsiung; Huang, San-Yuan; Ju, Jyh-Cherng			Proteomic Profiling of Rabbit Embryonic Stem Cells Derived from Parthenotes and Fertilized Embryos	PLOS ONE			English	Article							EARLY-STAGE DIFFERENTIATION; LEUKEMIA INHIBITORY FACTOR; CYTOPLASMIC CHAPERONIN; IN-VITRO; MOUSE; PROTEINS; TUBULIN; IDENTIFICATION; PEROXIREDOXIN; EXPRESSION	Rabbit embryonic stem (rES) cells can be derived from various sources of embryos. However, understanding of the gene expression profile, which distincts embryonic stem (ES) cells from other cell types, is still extremely limited. In this study, we compared the protein profiles of three independent lines of rabbit cells, i.e., fibroblasts, fertilized embryo-derived stem (f-rES) cells, and parthenote-derived ES (p-rES) cells. Proteomic analyses were performed using two-dimensional gel electrophoresis (2-DE) and mass spectrometry. Collectively, the expression levels of 100 out of 284 protein spots differed significantly among these three cell types (p < 0.05). Of those differentially expressed spots, 91% were identified in the protein database and represented 63 distinct proteins. Proteins with known identities are mainly localized in the cytoplasmic compartments (48%), nucleus (14%), and cytoskeletal machineries (13%). These proteins were majorly involved in biological functions of energy and metabolic pathways (25%), cell growth and maintenance (25%), signal transduction (14%), and protein metabolisms (10%). When protein expression levels among cell types were compared, six proteins associated with a variety of cellular activities, including structural constituents of the cytoskeleton (tubulins), structural molecule (KRT8), catalytic molecules (alpha-enolase), receptor complex scaffold (14-3-3 protein sigma), microfilament motor proteins (Myosin-9), and heat shock protein (HSP60), were found highly expressed in p-rES cells. Two proteins related to HSP activity and structural constituent of cytoskeleton in f-rES cells, and one structural molecule activity protein in fibroblasts showed significantly higher expression levels (p < 0.05). Marker protein expressions in f-rES and p-rES cells were further confirmed by Western blotting and immunocytochemical staining. This study demonstrated unique proteomic profiles of the three rabbit cell types and revealed some novel proteins differentially expressed between f-rES and p-rES cells. These analyses provide insights into rES cell biology and would invite more in-depth studies toward rES cell applications.	[Intawicha, Payungsuk; Wang, Shih-Han; Hsieh, Ya-Chen; Huang, San-Yuan; Ju, Jyh-Cherng] Natl Chung Hsing Univ, Dept Anim Sci, Taichung 40227, Taiwan; [Lo, Neng-Wen] Tunghai Univ, Dept Anim Sci & Biotechnol, Taichung 40704, Taiwan; [Lee, Kun-Hsiung; Huang, San-Yuan] Anim Technol Inst Taiwan, Div Biotechnol, Miaoli, Taiwan; [Huang, San-Yuan; Ju, Jyh-Cherng] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan; [Huang, San-Yuan] Natl Chung Hsing Univ, Ctr Nanosci & Nanotechnol, Taichung 40227, Taiwan	National Chung Hsing University; Tunghai University; National Chung Hsing University; National Chung Hsing University	Huang, SY (corresponding author), Natl Chung Hsing Univ, Dept Anim Sci, Taichung 40227, Taiwan.	syhuang@dragon.nchu.edu.tw; jcju@dragon.nchu.edu.tw	Wang, Shih-Han/HGA-7092-2022		National Science Council (NSC) [96-2313-B-005-013, 98-2628-B005-019-MY3, 101-2313-B-005 -013 -MY3]; Executive Yuan; Ministry of Education, Taiwan, Republic of China, under the ATU plan	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); Executive Yuan; Ministry of Education, Taiwan, Republic of China, under the ATU plan	This study was supported in part by grants from National Science Council (NSC# 96-2313-B-005-013, NSC# 98-2628-B005-019-MY3, and NSC# 101-2313-B-005 -013 -MY3), Executive Yuan and the Ministry of Education, Taiwan, Republic of China, under the ATU plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akama K, 2008, BBA-PROTEINS PROTEOM, V1784, P773, DOI 10.1016/j.bbapap.2008.02.001; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Catunda AP, 2008, CLONING STEM CELLS, V10, P523, DOI 10.1089/clo.2008.0023; Andre N, 2006, CANCER TREAT REV, V32, P65, DOI 10.1016/j.ctrv.2005.12.010; Arner A, 2003, J MUSCLE RES CELL M, V24, P165, DOI 10.1023/A:1026001513928; Arrigo AP, 1998, BIOL CHEM, V379, P19; Attard G, 2006, PATHOL BIOL, V54, P72, DOI 10.1016/j.patbio.2005.03.003; Baharvand H, 2008, J PROTEOME RES, V7, P412, DOI 10.1021/pr700560t; Bouwens L, 1998, J PATHOL, V184, P234; Chae HZ, 1999, DIABETES RES CLIN PR, V45, P101, DOI 10.1016/S0168-8227(99)00037-6; Chiang SK, 2008, REPROD DOMEST ANIM, V43, P181, DOI 10.1111/j.1439-0531.2007.00875.x; Di Quinzio MKW, 2007, AUST NZ J OBSTET GYN, V47, P9, DOI 10.1111/j.1479-828X.2006.00671.x; Fang ZF, 2006, EXP CELL RES, V312, P3669, DOI 10.1016/j.yexcr.2006.08.013; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; FUNDELE RH, 1990, DEVELOPMENT, V108, P203; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; Gong SP, 2008, STEM CELLS DEV, V17, P695, DOI 10.1089/scd.2007.0168; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; GRAVES KH, 1993, MOL REPROD DEV, V36, P424, DOI 10.1002/mrd.1080360404; Guo XX, 2001, ELECTROPHORESIS, V22, P3067, DOI 10.1002/1522-2683(200108)22:14<3067::AID-ELPS3067>3.0.CO;2-V; Gupta MK, 2009, PROTEOMICS, V9, P2846, DOI 10.1002/pmic.200800700; Hansen JM, 2007, FREE RADICAL BIO MED, V43, P282, DOI 10.1016/j.freeradbiomed.2007.04.029; Havlis J, 2003, ANAL CHEM, V75, P1300, DOI 10.1021/ac026136s; Hernebring M, 2006, P NATL ACAD SCI USA, V103, P7700, DOI 10.1073/pnas.0510944103; Honda A, 2008, REPROD BIOMED ONLINE, V17, P706, DOI 10.1016/S1472-6483(10)60320-3; Hsieh YC, 2011, CELL REPROGRAM, V13, P241, DOI 10.1089/cell.2010.0097; Huang SY, 2006, PROTEOMICS, V6, P5815, DOI 10.1002/pmic.200600054; Huang SY, 2005, PROTEOMICS, V5, P4205, DOI 10.1002/pmic.200401284; Intawicha P, 2009, CLONING STEM CELLS, V11, P27, DOI 10.1089/clo.2008.0040; Jadaliha M, 2012, PLOS ONE, DOI DOI 10.1371/J0URNAL.P0NE.0038532.ACCESSED; Jang JH, 2012, ANTIOXID REDOX SIGN, V16, P383, DOI 10.1089/ars.2011.4134; KAUFMAN MH, 1977, NATURE, V265, P53, DOI 10.1038/265053a0; Kim SH, 2001, J NEURAL TRANSM-SUPP, P223; Kono T, 2004, NATURE, V428, P860, DOI 10.1038/nature02402; Kubo E, 2009, LIFE SCI, V84, P857, DOI 10.1016/j.lfs.2009.03.019; Lee Yu-Il, 2011, Clin Exp Reprod Med, V38, P18, DOI 10.5653/cerm.2011.38.1.18; Leyens G, 2003, COMP BIOCHEM PHYS B, V136, P943, DOI 10.1016/S1096-4959(03)00290-2; Li JY, 2003, CELL RES, V13, P219, DOI 10.1038/sj.cr.7290167; Li Y, 2009, ELECTROPHORESIS, V30, P1431, DOI 10.1002/elps.200800836; Longshaw VM, 2009, EUR J CELL BIOL, V88, P153, DOI 10.1016/j.ejcb.2008.09.003; Munoz IG, 2011, NAT STRUCT MOL BIOL, V18, P14, DOI 10.1038/nsmb.1971; Nasrabadi D, 2009, J PROTEOME RES, V8, P1527, DOI 10.1021/pr800880v; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Nogales E, 2001, ANNU REV BIOPH BIOM, V30, P397, DOI 10.1146/annurev.biophys.30.1.397; O'Flaherty C, 2011, BIOL REPROD, V84, P238, DOI 10.1095/biolreprod.110.085712; Odunuga OO, 2004, BIOESSAYS, V26, P1058, DOI 10.1002/bies.20107; Pasquier E, 2008, IUBMB LIFE, V60, P165, DOI 10.1002/iub.25; Perez EA, 2009, MOL CANCER THER, V8, P2086, DOI 10.1158/1535-7163.MCT-09-0366; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Prescott J, 2006, CANCER LETT, V231, P12, DOI 10.1016/j.canlet.2004.12.037; Prudhomme W, 2004, P NATL ACAD SCI USA, V101, P2900, DOI 10.1073/pnas.0308768101; ROOBOL A, 1995, J CELL SCI, V108, P1477; SAS Institute Statistical Analysis System (SAS), 2002, US GUID STAT REL; Sato N, 2003, BIOCHEM BIOPH RES CO, V300, P847, DOI 10.1016/S0006-291X(02)02941-8; Schoonjans L, 1996, MOL REPROD DEV, V45, P439, DOI 10.1002/(SICI)1098-2795(199612)45:4&lt;439::AID-MRD5&gt;3.0.CO;2-S; Setati MM, 2010, IUBMB LIFE, V62, P61, DOI 10.1002/iub.283; Shah M, 2002, J BIOL CHEM, V277, P45662, DOI 10.1074/jbc.M205935200; Stephanou A, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/238601; STERNLICHT H, 1993, P NATL ACAD SCI USA, V90, P9422, DOI 10.1073/pnas.90.20.9422; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; Swindell WR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-125; Wang DJ, 2005, PROTEOMICS, V5, P4414, DOI 10.1002/pmic.200401304; Wang SE, 2010, ANAT REC, V293, P291, DOI 10.1002/ar.21031; Wang SF, 2007, STEM CELLS, V25, P481, DOI 10.1634/stemcells.2006-0226; Wen JY, 2007, J CELL BIOCHEM, V102, P149, DOI 10.1002/jcb.21285; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Williamson AJK, 2008, MOL CELL PROTEOMICS, V7, P459, DOI 10.1074/mcp.M700370-MCP200; Xue F, 2012, CELL REPROGRAM, V14, P364, DOI 10.1089/cell.2012.0001; YAFFE MB, 1992, NATURE, V358, P245, DOI 10.1038/358245a0; Yokota S, 1999, J BIOL CHEM, V274, P37070, DOI 10.1074/jbc.274.52.37070	70	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67772	10.1371/journal.pone.0067772	http://dx.doi.org/10.1371/journal.pone.0067772			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861804	Green Published, Green Submitted, gold			2022-12-27	WOS:000323350700035
J	Pereira, CAP; Marra, AR; Camargo, LFA; Pignatari, ACC; Sukiennik, T; Behar, PRP; Medeiros, EAS; Ribeiro, J; Girao, E; Correa, L; Guerra, C; Carneiro, I; Brites, C; Reis, M; de Souza, MA; Tranchesi, R; Barata, CU; Edmond, MB				Pires Pereira, Carlos Alberto; Marra, Alexandre R.; Aranha Camargo, Luis Fernando; Campos Pignatari, Antonio Carlos; Sukiennik, Teresa; Petersen Behar, Paulo Renato; Servolo Medeiros, Eduardo Alexandrino; Ribeiro, Julival; Girao, Evelyne; Correa, Luci; Guerra, Carla; Carneiro, Irna; Brites, Carlos; Reis, Marise; de Souza, Marta Antunes; Tranchesi, Regina; Barata, Cristina U.; Edmond, Michael B.		Brazilian SCOPE Study Grp	Nosocomial Bloodstream Infections in Brazilian Pediatric Patients: Microbiology, Epidemiology, and Clinical Features	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; PCR ASSAY; HOSPITALS; SURVEILLANCE; COLISTIN; UPDATE	Background: Nosocomial bloodstream infections (nBSIs) are an important cause of morbidity and mortality and are the most frequent type of nosocomial infection in pediatric patients. Methods: We identified the predominant pathogens and antimicrobial susceptibilities of nosocomial bloodstream isolates in pediatric patients (<= 16 years of age) in the Brazilian Prospective Surveillance for nBSIs at 16 hospitals from 12 June 2007 to 31 March 2010 (Br SCOPE project). Results: In our study a total of 2,563 cases of nBSI were reported by hospitals participating in the Br SCOPE project. Among these, 342 clinically significant episodes of BSI were identified in pediatric patients (<= 16 years of age). Ninety-six percent of BSIs were monomicrobial. Gram-negative organisms caused 49.0% of these BSIs, Gram-positive organisms caused 42.6%, and fungi caused 8.4%. The most common pathogens were Coagulase-negative staphylococci (CoNS) (21.3%), Klebsiella spp. (15.7%), Staphylococcus aureus (10.6%), and Acinetobacter spp. (9.2%). The crude mortality was 21.6% (74 of 342). Forty-five percent of nBSIs occurred in a pediatric or neonatal intensive-care unit (ICU). The most frequent underlying conditions were malignancy, in 95 patients (27.8%). Among the potential factors predisposing patients to BSI, central venous catheters were the most frequent (66.4%). Methicillin resistance was detected in 37 S. aureus isolates (27.1%). Of the Klebsiella spp. isolates, 43.2% were resistant to ceftriaxone. Of the Acinetobacter spp. and Pseudomonas aeruginosa isolates, 42.9% and 21.4%, respectively, were resistant to imipenem. Conclusions: In our multicenter study, we found a high mortality and a large proportion of gram-negative bacilli with elevated levels of resistance in pediatric patients.	[Pires Pereira, Carlos Alberto] Inst Oncol Pediat IOP GRAAC, Sao Paulo, Brazil; [Marra, Alexandre R.; Aranha Camargo, Luis Fernando; Correa, Luci] Hosp Israelita Albert Einstein, Sao Paulo, Brazil; [Marra, Alexandre R.; Aranha Camargo, Luis Fernando; Campos Pignatari, Antonio Carlos; Servolo Medeiros, Eduardo Alexandrino] Univ Fed Sao Paulo UNIFESP, Sao Paulo, Brazil; [Campos Pignatari, Antonio Carlos; Tranchesi, Regina] Hosp 9 Julho, Sao Paulo, Brazil; [Sukiennik, Teresa] Santa Casa Porto Alegre, Porto Alegre, RS, Brazil; [Petersen Behar, Paulo Renato] Hosp Conceicao, Porto Alegre, RS, Brazil; [Ribeiro, Julival] Hosp Base, Brasilia, DF, Brazil; [Girao, Evelyne] Hosp Walter Cantidio, Fortaleza, Ceara, Brazil; [Guerra, Carla] Hosp Diadema, Sao Paulo, Brazil; [Brites, Carlos] Hosp Espanhol, Salvador, BA, Brazil; [Reis, Marise] Hosp Coracao, Natal, RN, Brazil; [Reis, Marise] Hosp UNIMED, Natal, RN, Brazil; [de Souza, Marta Antunes] Hosp Clin Goiania, Goiania, Go, Brazil; [Correa, Luci] Hosp Rim & Hipertensao, Sao Paulo, Brazil; [Barata, Cristina U.] Univ Fed Triangulo Mineiro, Uberaba, MG, Brazil; [Edmond, Michael B.] Virginia Commonwealth Univ, Richmond, VA USA	Hospital Israelita Albert Einstein; Universidade Federal de Sao Paulo (UNIFESP); Hospital do Coracao - HCor; Universidade Federal do Triangulo Mineiro; Virginia Commonwealth University	Marra, AR (corresponding author), Hosp Israelita Albert Einstein, Sao Paulo, Brazil.	alexandre.marra@einstein.br	Brites, Carlos/D-1353-2013; Faria, Carolina Pereira de Morais/HHT-0142-2022; Pignatari, Antonio CC/C-8427-2012; Medeiros, Eduardo Alexandrino/B-9825-2012	Brites, Carlos/0000-0002-4673-6991; Medeiros, Eduardo Alexandrino/0000-0002-6205-259X; Edmond, Michael/0000-0002-4144-8974; Camargo, Luis Fernando Aranha/0000-0002-3888-8661; Pignatari, Antonio/0000-0002-2146-8476	Pfizer, Inc.; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brasil [2006/57700-0]	Pfizer, Inc.(Pfizer); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brasil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The study was funded in part by an independent medical grant provided by Pfizer, Inc. We also thank the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brasil (grant 2006/57700-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariffin N, 2012, AM J INFECT CONTROL, V40, P572, DOI 10.1016/j.ajic.2012.02.032; Becerra MR, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-66; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI; Deshpande LM, 2006, MICROB DRUG RESIST, V12, P223, DOI 10.1089/mdr.2006.12.223; Elward AM, 2005, PEDIATRICS, V115, P868, DOI 10.1542/peds.2004-0256; Grisaru-Soen G, 2007, MED SCI MONITOR, V13, pCR251; Isaacs D, 2003, ARCH DIS CHILD-FETAL, V88, pF89, DOI 10.1136/fn.88.2.F89; Jean-Baptiste N, 2011, INFECT CONT HOSP EP, V32, P679, DOI 10.1086/660361; Joram N, 2012, EUR J CLIN MICROBIOL; Levin AS, 1999, CLIN INFECT DIS, V28, P1008, DOI 10.1086/514732; Marra AR, 2011, J CLIN MICROBIOL, V49, P1866, DOI 10.1128/JCM.00376-11; Mendes RE, 2007, J CLIN MICROBIOL, V45, P544, DOI 10.1128/JCM.01728-06; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Monteiro J, 2009, ANTIMICROB AGENTS CH, V53, P333, DOI 10.1128/AAC.00736-08; Paul M, 2010, J ANTIMICROB CHEMOTH, V65, P1019, DOI 10.1093/jac/dkq069; Slonim Anthony D., 2001, Pediatr Crit Care Med, V2, P170, DOI 10.1097/00130478-200104000-00012; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Wisplinghoff H, 2003, PEDIATR INFECT DIS J, V22, P686, DOI 10.1097/01.inf.0000078159.53132.40; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	21	34	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68144	10.1371/journal.pone.0068144	http://dx.doi.org/10.1371/journal.pone.0068144			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861860	Green Published, gold, Green Submitted			2022-12-27	WOS:000323350700072
J	Yin, H; Liu, J; Xu, YX; Liu, X; Zhang, SL; Ma, JX; Du, JC				Yin, Hao; Liu, Jing; Xu, Yingxiu; Liu, Xing; Zhang, Shaoling; Ma, Jianxin; Du, Jianchang			TARE1, a Mutated Copia-Like LTR Retrotransposon Followed by Recent Massive Amplification in Tomato	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; RICE; DIVERGENCE; DIVERSITY; RECOMBINATION; PALEONTOLOGY; EVOLUTION; EXPANSION; EFFICIENT; LINEAGES	Long terminal repeat retrotransposons (LTR-RTs) are the major DNA components in flowering plants. Most LTR-RTs contain dinucleotides 'TG' and 'CA' at the ends of the two LTRs. Here we report the structure, evolution, and propensity of a tomato atypical retrotransposon element (TARE1) with both LTRs starting as 'TA'. This family is also characterized by high copy numbers (354 copies), short LTR size (194 bp), extremely low ratio of solo LTRs to intact elements (0.05: 1), recent insertion (most within 0.75 similar to 1.75 million years, Mys), and enrichment in pericentromeric region. The majority (83%) of the TARE1 elements are shared between S. lycopersicum and its wild relative S. pimpinellifolium, but none of them are found in potato. In the present study, we used shared LTR-RTs as molecular markers and estimated the divergence time between S. lycopersicum and S. pimpinellifolium to be <0.5 Mys. Phylogenetic analysis showed that the TARE1 elements, together with two closely related families, TARE2 and TGRE1, have formed a sub-lineage belonging to a Copia-like Ale lineage. Although TARE1 and TARE2 shared similar structural characteristics, the timing, scale, and activity of their amplification were found to be substantially different. We further propose a model wherein a single mutation from 'G' to 'A' in 39 LTR followed by amplification is responsible for the origin of TARE1, thus providing evidence that the proliferation of a spontaneous mutation can be mediated by the amplification of LTR-RTs at the level of RNA.	[Yin, Hao; Liu, Jing; Xu, Yingxiu; Liu, Xing; Du, Jianchang] Jiangsu Acad Agr Sci, Bioinformat Grp, Inst Ind Crops, Nanjing, Jiangsu, Peoples R China; [Yin, Hao; Liu, Xing; Zhang, Shaoling] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Ctr Pear Engn Technol Res, Nanjing, Jiangsu, Peoples R China; [Ma, Jianxin] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA	Jiangsu Academy of Agricultural Sciences; Nanjing Agricultural University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Du, JC (corresponding author), Jiangsu Acad Agr Sci, Bioinformat Grp, Inst Ind Crops, Nanjing, Jiangsu, Peoples R China.	changzi75@hotmail.com		zhang, shaoling/0000-0002-1835-1824	Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Human Resources and Social Security (SRF for ROCS, MOHRSS); Jiangsu Province Six Funding Plans of Peak of Talents [2011NY030]; Jiangsu Academy of Agricultural Sciences Startup Funds; Jiangsu Agricultural Science and Technology Innovation Funds [CX(11)4007]	Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Human Resources and Social Security (SRF for ROCS, MOHRSS)(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Jiangsu Province Six Funding Plans of Peak of Talents; Jiangsu Academy of Agricultural Sciences Startup Funds; Jiangsu Agricultural Science and Technology Innovation Funds	This study was partially supported by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Human Resources and Social Security (SRF for ROCS, MOHRSS) to JD, Jiangsu Province Six Funding Plans of Peak of Talents to JD (2011NY030), Jiangsu Academy of Agricultural Sciences Startup Funds to JD, and Jiangsu Agricultural Science and Technology Innovation Funds to JD (CX(11)4007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng XD, 2009, GENETICS, V181, P1183, DOI 10.1534/genetics.108.099150; Costas J, 2000, MOL BIOL EVOL, V17, P320, DOI 10.1093/oxfordjournals.molbev.a026312; Devos KM, 2002, GENOME RES, V12, P1075, DOI 10.1101/gr.132102; Du JC, 2012, PLANT CELL, V24, P21, DOI [10.1105/tpc.111.092759, 10.1105/tpc.112.103630]; Du JC, 2010, PLANT J, V63, P584, DOI 10.1111/j.1365-313X.2010.04263.x; Du JC, 2010, PLANT CELL, V22, P48, DOI 10.1105/tpc.109.068775; Du JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellinghaus D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-18; Gao DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032010; Gaut BS, 1998, EVOL BIOL, V30, P93; Gill N, 2009, PLANT PHYSIOL, V151, P1167, DOI 10.1104/pp.109.137935; Hirochika H, 1996, P NATL ACAD SCI USA, V93, P7783, DOI 10.1073/pnas.93.15.7783; Hirochika H, 2001, CURR OPIN PLANT BIOL, V4, P118, DOI 10.1016/S1369-5266(00)00146-1; Huang XH, 2008, PLANT PHYSIOL, V148, P25, DOI 10.1104/pp.108.121491; Jiang N, 2002, PLANT PHYSIOL, V130, P1697, DOI 10.1104/pp.015412; Jiang N, 2009, PLANT J, V60, P181, DOI 10.1111/j.1365-313X.2009.03946.x; Kamenetzky L, 2010, PLANT PHYSIOL, V152, P1772, DOI 10.1104/pp.109.150532; Kapitonov V, 1996, J MOL EVOL, V42, P59, DOI 10.1007/BF00163212; Kim MY, 2010, P NATL ACAD SCI USA, V107, P22032, DOI 10.1073/pnas.1009526107; KIMURA M, 1972, J MOL EVOL, V2, P87, DOI 10.1007/BF01653945; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Ma JX, 2006, P NATL ACAD SCI USA, V103, P383, DOI 10.1073/pnas.0509810102; Ma JX, 2006, GENOME RES, V16, P251, DOI [10.1101/gr4583106, 10.1101/gr.4583106]; Ma JX, 2004, P NATL ACAD SCI USA, V101, P12404, DOI 10.1073/pnas.0403715101; McCarthy EM, 2003, BIOINFORMATICS, V19, P362, DOI 10.1093/bioinformatics/btf878; Molina J, 2011, P NATL ACAD SCI USA, V108, P8351, DOI 10.1073/pnas.1104686108; Nagaki K, 2005, PLANT CELL, V17, P1886, DOI 10.1105/tpc.105.032961; Nesbitt TC, 2002, GENETICS, V162, P365; Neumann P, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-4; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Presting GG, 1998, PLANT J, V16, P721, DOI 10.1046/j.1365-313x.1998.00341.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sharma A, 2008, MOL GENET GENOMICS, V279, P133, DOI 10.1007/s00438-007-0302-5; Steinbauerova V, 2011, GENETICA, V139, P1543, DOI 10.1007/s10709-012-9654-9; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tian ZX, 2012, PLANT CELL, V24, P4422, DOI 10.1105/tpc.112.103630; Tian ZX, 2009, GENOME RES, V19, P2221, DOI 10.1101/gr.083899.108; Vitte C, 2004, MOL GENET GENOMICS, V272, P504, DOI 10.1007/s00438-004-1069-6; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; Wang Y, 2006, GENETICS, V172, P2529, DOI 10.1534/genetics.106.055772; Wicker T, 2007, GENOME RES, V17, P1072, DOI 10.1101/gr.6214107; Xiao H, 2008, SCIENCE, V319, P1527, DOI 10.1126/science.1153040; XIONG Y, 1990, EMBO J, V9, P3353, DOI 10.1002/j.1460-2075.1990.tb07536.x; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286	49	17	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68587	10.1371/journal.pone.0068587	http://dx.doi.org/10.1371/journal.pone.0068587			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861922	gold, Green Published, Green Submitted			2022-12-27	WOS:000323350700091
J	Cardoso, S; Valverde, L; Alfonso-Sanchez, MA; Palencia-Madrid, L; Elcoroaristizabal, X; Algorta, J; Catarino, S; Arteta, D; Herrera, RJ; Zarrabeitia, MT; Pena, JA; de Pancorbo, MM				Cardoso, Sergio; Valverde, Laura; Alfonso-Sanchez, Miguel A.; Palencia-Madrid, Leire; Elcoroaristizabal, Xabier; Algorta, Jaime; Catarino, Susana; Arteta, David; Herrera, Rene J.; Teresa Zarrabeitia, Maria; Pena, Jose A.; de Pancorbo, Marian M.			The Expanded mtDNA Phylogeny of the Franco-Cantabrian Region Upholds the Pre-Neolithic Genetic Substrate of Basques	PLOS ONE			English	Article							MITOCHONDRIAL-DNA VARIATION; Y-CHROMOSOME; POPULATION EXPANSION; HUMAN ISOLATE; EUROPE; DIVERSITY; COUNTRY; SPAIN; RECOLONIZATION; CONSANGUINITY	The European genetic landscape has been shaped by several human migrations occurred since Paleolithic times. The accumulation of archaeological records and the concordance of different lines of genetic evidence during the last two decades have triggered an interesting debate concerning the role of ancient settlers from the Franco-Cantabrian region in the postglacial resettlement of Europe. Among the Franco-Cantabrian populations, Basques are regarded as one of the oldest and more intriguing human groups of Europe. Recent data on complete mitochondrial DNA genomes focused on macrohaplogroup R0 revealed that Basques harbor some autochthonous lineages, suggesting a genetic continuity since pre-Neolithic times. However, excluding haplogroup H, the most representative lineage of macrohaplogroup R0, the majority of maternal lineages of this area remains virtually unexplored, so that further refinement of the mtDNA phylogeny based on analyses at the highest level of resolution is crucial for a better understanding of the European prehistory. We thus explored the maternal ancestry of 548 autochthonous individuals from various Franco-Cantabrian populations and sequenced 76 mitogenomes of the most representative lineages. Interestingly, we identified three mtDNA haplogroups, U5b1f, J1c5c1 and V22, that proved to be representative of Franco-Cantabria, notably of the Basque population. The seclusion and diversity of these female genetic lineages support a local origin in the Franco-Cantabrian area during the Mesolithic of southwestern Europe, similar to 10,000 years before present (YBP), with signals of expansions at similar to 3,500 YBP. These findings provide robust evidence of a partial genetic continuity between contemporary autochthonous populations from the Franco-Cantabrian region, specifically the Basques, and Paleolithic/Mesolithic hunter-gatherer groups. Furthermore, our results raise the current proportion (approximate to 15%) of the Franco-Cantabrian maternal gene pool with a putative pre-Neolithic origin to approximate to 35%, further supporting the notion of a predominant Paleolithic genetic substrate in extant European populations.	[Cardoso, Sergio; Valverde, Laura; Alfonso-Sanchez, Miguel A.; Palencia-Madrid, Leire; Elcoroaristizabal, Xabier; de Pancorbo, Marian M.] Univ Pais Vasco UPV EHU, Ctr Invest Lascaray Ikergunea, BIOMICs Res Grp, Vitoria, Spain; [Algorta, Jaime] Univ Pais Vasco UPV EHU, Fac Ciencia & Tecnol, Dept Bioquim & Biol Mol, Vitoria, Spain; [Algorta, Jaime; Catarino, Susana; Arteta, David] Parque Tecnol Bizkaia, Progenika Biopharma, Derio Bizkaia, Spain; [Herrera, Rene J.] Florida Int Univ, Coll Med, Dept Mol & Human Genet, Miami, FL 33199 USA; [Teresa Zarrabeitia, Maria] Univ Cantabria, Unidad Med Legal, E-39005 Santander, Spain; [Pena, Jose A.] Univ Pais Vasco UPV EHU, Dept Genet Antropol Fis & Fisiol Anim, Fac Ciencia & Tecnol, Vitoria, Spain	University of Basque Country; University of Basque Country; State University System of Florida; Florida International University; Universidad de Cantabria; University of Basque Country	de Pancorbo, MM (corresponding author), Univ Pais Vasco UPV EHU, Ctr Invest Lascaray Ikergunea, BIOMICs Res Grp, Vitoria, Spain.	marian.mdepancorbo@ehu.es	Peña, Jose A/L-5855-2014; Algorta, Jaime/CAF-7793-2022; Algorta, Jaime/K-9002-2012; Palencia-Madrid, Leire/AAW-8145-2020; Alfonso-Sanchez, Miguel A./P-3388-2019	Peña, Jose A/0000-0002-2952-8461; Algorta, Jaime/0000-0002-7042-5675; Algorta, Jaime/0000-0002-7042-5675; Palencia-Madrid, Leire/0000-0002-4351-3450; Alfonso-Sanchez, Miguel A./0000-0002-1261-2624; M. de Pancorbo, Marian/0000-0002-8081-0702; Zarrabeitia, Maria T./0000-0002-2836-7766; MARTINEZ DE PANCORBO, MARIA DE LOS ANGELES/0000-0002-7408-6068	Basque Government [Grupo Consolidado IT-424-07]; University of the Basque Country UPV/EHU [ELDUNANOTEK UFI11/32]; Basque Government (Dpto. de Educacion, Universidades e Investigacion)	Basque Government(Basque Government); University of the Basque Country UPV/EHU; Basque Government (Dpto. de Educacion, Universidades e Investigacion)(Basque Government)	Funds were provided by the Basque Government (Grupo Consolidado IT-424-07) and a grant from the University of the Basque Country UPV/EHU (ELDUNANOTEK UFI11/32). Leire Palencia is a PhD student granted by the Basque Government (Dpto. de Educacion, Universidades e Investigacion). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; Alfonso-Sanchez MA, 2008, AM J HUM BIOL, V20, P154, DOI 10.1002/ajhb.20706; Alfonso-Sanchez MA, 2005, AM J PHYS ANTHROPOL, V127, P240, DOI 10.1002/ajpa.20172; Alfonso-Sanchez MA, 2001, ANN HUM BIOL, V28, P505, DOI 10.1080/03014460010025158; Alonso S, 2005, EUR J HUM GENET, V13, P1293, DOI 10.1038/sj.ejhg.5201482; Altuna J, 1994, RIEV REV INT ESTUDIO, VXXXIX, P13; Alvarez-Iglesias V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005112; Alzualde A, 2005, ANN HUM GENET, V69, P665, DOI 10.1046/j.1529-8817.2005.00170.x; Balaresque P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000285; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BARBUJANI G, 1990, P NATL ACAD SCI USA, V87, P1816, DOI 10.1073/pnas.87.5.1816; Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; Behar DM, 2006, AM J HUM GENET, V78, P487, DOI 10.1086/500307; Behar DM, 2012, AM J HUM GENET, V90, P486, DOI 10.1016/j.ajhg.2012.01.002; Cardoso S, 2012, HEREDITY, V108, P609, DOI 10.1038/hdy.2011.131; Cardoso S, 2012, FORENSIC SCI INT-GEN, V6, pE106, DOI 10.1016/j.fsigen.2011.12.007; Cardoso S, 2011, AM J PHYS ANTHROPOL, V145, P480, DOI 10.1002/ajpa.21532; Cardoso S, 2010, J FORENSIC SCI, V55, P1196, DOI 10.1111/j.1556-4029.2010.01440.x; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Cavalli-Sforza LL, 1988, MUNIBE S, V6, P129; de Pancorbo MM, 2001, HUM GENET, V109, P224, DOI 10.1007/s004390100544; Deguilloux MF, 2011, AM J PHYS ANTHROPOL, V144, P108, DOI 10.1002/ajpa.21376; EuskoJaurlaritza, 2008, 4 SOC SURV 2006 VIT; Flores C, 2004, EUR J HUM GENET, V12, P855, DOI 10.1038/sj.ejhg.5201225; Forster P, 1996, AM J HUM GENET, V59, P935; Frank RM, 2008, INSULA QUADERNO CULT; Friedrich WL, 2006, SCIENCE, V312, P548, DOI 10.1126/science.1125087; Garcia O, 2011, HEREDITY, V106, P37, DOI 10.1038/hdy.2010.47; Gomez-Carballa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032851; Gonzalez AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-124; Gonzalez-Sainz C., 1989, MAGDALENIENSE SUPERI; Harding A.F., 2000, EUROPEAN SOC BRONZE; Izagirre N, 1999, AM J HUM GENET, V65, P199, DOI 10.1086/302442; Laayouni H, 2010, HUM GENET, V127, P455, DOI 10.1007/s00439-010-0798-3; Lopez-Parra AM, 2009, ANN HUM GENET, V73, P42, DOI 10.1111/j.1469-1809.2008.00478.x; Maca-Meyer N, 2003, ANN HUM GENET, V67, P329, DOI 10.1046/j.1469-1809.2003.00045.x; Meyer S, 1999, GENETICS, V152, P1103; Michelena L, 1977, LIBRO BLANCO LENGUA; Michelena L, 1988, SEM FIL VASC JUL URQ; Pala M, 2012, AM J HUM GENET, V90, P915, DOI 10.1016/j.ajhg.2012.04.003; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Parson W, 2007, FORENSIC SCI INT-GEN, V1, P88, DOI 10.1016/j.fsigen.2007.01.018; Pereira L, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-390; Prieto L, 2011, FORENSIC SCI INT-GEN, V5, P146, DOI 10.1016/j.fsigen.2010.10.013; Renfrew C, 1991, CAMB ARCHAEOL J, V1, P3, DOI DOI 10.1017/S0959774300000238; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 2003, ANNU REV ANTHROPOL, V32, P135, DOI 10.1146/annurev.anthro.32.061002.093207; Rodriguez-Ezpeleta N, 2010, HUM GENET, V128, P113, DOI 10.1007/s00439-010-0833-4; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Seoane M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023327; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Tambets K, 2004, AM J HUM GENET, V74, P661, DOI 10.1086/383203; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; VOGEL JS, 1990, NATURE, V344, P534, DOI 10.1038/344534a0	58	18	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67835	10.1371/journal.pone.0067835	http://dx.doi.org/10.1371/journal.pone.0067835			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844106	Green Published, gold, Green Submitted			2022-12-27	WOS:000321733000106
J	Guo, Y; Duan, ZJ; Qian, Y				Guo, Ying; Duan, Zhaojun; Qian, Yuan			Changes in Human Parechovirus Profiles in Hospitalized Children with Acute Gastroenteritis after a Three-Year Interval in Lanzhou, China	PLOS ONE			English	Article							REVERSE TRANSCRIPTION-PCR; CLINICAL STOOL SAMPLES; RT-MULTIPLEX PCR; HPEV GENOTYPES; INFECTIONS; PREVALENCE; EPIDEMIOLOGY; ENTEROVIRUS; INFANTS; ASSOCIATION	The changing profile of infection over time for Human Parechoviruses (HPeVs) is not well known and no detailed study has been reported to date in China. This investigation on HPeV infection in hospitalized children in Lanzhou, China revealed variations in epidemiological characteristics after a three-year interval. To assess the changes that had occurred, epidemiological and clinical characteristics of HPeVs were characterized and compared with previously reported data by our group. A comparable positivity rate (25.3%, 73/289) was revealed after the three-year interval with the majority of the infected children (95.9%, 70/73) being younger than two years of age. While a temporal change in the seasonal distribution was noted in the current study, HPeVs were more frequently detected during July to November compared to September to December in the previous study. Changes in HPeV genotypes patterns, a temporal change in the prevalence of HPeV1, a younger susceptible age to HPeV3 compared with HPeV1 and a tendency of older children to be infected with HPeV4 are in contrast to our previous report. HPeV2, a rarely reported genotype, was identified for the first time in China. In addition, an exclusive trinucleotide (GAT) insertion in the HPeV4 nucleotide sequence was identified. However, the profiles of co-infection with other enteric related viruses were similar to our previous findings. In summary, these data suggest temporal variation in the seasonal distribution of HPeV and changing patterns of HPeV genotypes over time in the study region.	[Guo, Ying; Qian, Yuan] Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China; [Guo, Ying; Qian, Yuan] Capital Inst Pediat, Virol Lab, Beijing, Peoples R China; [Duan, Zhaojun] China Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Institute of Pediatrics (CIP); Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Duan, ZJ (corresponding author), China Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	zhaojund@126.com; yqianbjc@263.net						Abed Y, 2006, EMERG INFECT DIS, V12, P969, DOI 10.3201/eid1206.051675; Baumgarte S, 2008, J CLIN MICROBIOL, V46, P242, DOI 10.1128/JCM.01468-07; Bennett S, 2011, J CLIN MICROBIOL, V49, P2620, DOI 10.1128/JCM.02445-10; Benschop K, 2008, J CLIN MICROBIOL, V46, P3965, DOI 10.1128/JCM.01379-08; Benschop KSM, 2010, J GEN VIROL, V91, P145, DOI 10.1099/vir.0.014670-0; Benschop K, 2010, DIAGN MICR INFEC DIS, V68, P166, DOI 10.1016/j.diagmicrobio.2010.05.016; Benschop KSM, 2006, CLIN INFECT DIS, V42, P204, DOI 10.1086/498905; Boivin G, 2005, EMERG INFECT DIS, V11, P103, DOI 10.3201/eid1101.040606; Boros A, 2010, J CLIN VIROL, V47, P379, DOI 10.1016/j.jcv.2010.01.012; Calvert J, 2010, J GEN VIROL, V91, P1229, DOI 10.1099/vir.0.018747-0; Cashman O, 2010, VET MICROBIOL, V146, P238, DOI 10.1016/j.vetmic.2010.05.012; Chakravarti A, 2012, INDIAN J MED MICROBI, V30, P222, DOI 10.4103/0255-0857.96699; Chieochansin T, 2011, VIROLOGY, V421, P159, DOI 10.1016/j.virol.2011.09.021; Eis-Hubinger AM, 2013, J CLIN MICROBIOL, V51, P715, DOI 10.1128/JCM.02731-12; Ghazi F, 1998, J GEN VIROL, V79, P2641, DOI 10.1099/0022-1317-79-11-2641; Ghazi F, 2012, INT J INFECT DIS, V16, pE673, DOI 10.1016/j.ijid.2012.05.1020; Gupta S, 2010, EUR J PAEDIATR NEURO, V14, P531, DOI 10.1016/j.ejpn.2009.12.007; Han TH, 2011, ARCH VIROL, V156, P1471, DOI 10.1007/s00705-011-0995-y; Harvala H, 2008, J CLIN MICROBIOL, V46, P3446, DOI 10.1128/JCM.01207-08; Harvala H, 2009, J INFECT DIS, V199, P1753, DOI 10.1086/599094; Harvala H, 2011, J MED VIROL, V83, P889, DOI 10.1002/jmv.22023; Harvala H, 2010, CURR OPIN INFECT DIS, V23, P224, DOI 10.1097/QCO.0b013e32833890ca; Ito M, 2004, J GEN VIROL, V85, P391, DOI 10.1099/vir.0.19456-0; Ito M, 2010, J CLIN MICROBIOL, V48, P2683, DOI 10.1128/JCM.00086-10; Jokela P, 2005, J CLIN MICROBIOL, V43, P1239, DOI 10.1128/JCM.43.3.1239-1245.2005; Joki-Korpela P, 1998, CLIN INFECT DIS, V27, P129, DOI 10.1086/514615; Katano H, 2011, J MED VIROL, V83, P322, DOI 10.1002/jmv.21962; Khamrin P, 2011, J VIROL METHODS, V173, P390, DOI 10.1016/j.jviromet.2011.02.012; King A.M.Q., 2000, VIRUS TAXONOMY, P657; Kolehmainen P, 2012, J CLIN VIROL, V54, P156, DOI 10.1016/j.jcv.2012.02.006; Kurugol Z, 2011, VACCINE, V29, P6259, DOI 10.1016/j.vaccine.2011.06.069; Landry ML, 2010, CLIN INFECT DIS, V50, P362, DOI 10.1086/649864; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Legay V, 2002, J CLIN VIROL, V25, P193, DOI 10.1016/S1386-6532(02)00009-4; Lequin M, 2009, BMJ CASE REP, V2009, P2009; Levorson RE, 2009, PEDIATR INFECT DIS J, V28, P545, DOI 10.1097/INF.0b013e318194596a; Li LL, 2009, EMERG INFECT DIS, V15, P288, DOI 10.3201/eid1502.080341; Ljubin-Sternak S, 2011, J MED VIROL, V83, P137, DOI 10.1002/jmv.21848; Ngan TKP, 2011, J CLIN MICROBIOL, V49, P364, DOI 10.1128/JCM.02151-10; Ngan TKP, 2011, J MED VIROL, V83, P331, DOI 10.1002/jmv.21740; Noordhoek GT, 2008, J CLIN VIROL, V41, P75, DOI 10.1016/j.jcv.2007.09.011; Pajkrt D, 2009, PEDIATR INFECT DIS J, V28, P1008, DOI 10.1097/INF.0b013e3181a7ab5f; Pham NTK, 2010, J VIROL METHODS, V169, P193, DOI 10.1016/j.jviromet.2010.07.038; Pham NTK, 2010, J CLIN MICROBIOL, V48, P115, DOI 10.1128/JCM.01015-09; Phan TG, 2005, CLIN LAB, V51, P429; Piralla A, 2012, J MED VIROL, V84, P686, DOI 10.1002/jmv.23197; Renaud C, 2011, J CLIN VIROL, V51, P50, DOI 10.1016/j.jcv.2011.02.010; Sedmak G, 2010, CLIN INFECT DIS, V50, P357, DOI 10.1086/649863; Selvarangan R, 2011, PEDIATR INFECT DIS J, V30, P238, DOI 10.1097/INF.0b013e3181fbefc8; Shan TL, 2010, EMERG INFECT DIS, V16, P1168, DOI [10.3201/eid1607.091103, 10.3201/1607.091103]; Shan TL, 2009, J CLIN VIROL, V45, P371, DOI 10.1016/j.jcv.2009.05.033; Sharp J, 2013, PEDIATR INFECT DIS J, V32, P213, DOI 10.1097/INF.0b013e318276b328; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tapia G, 2008, J MED VIROL, V80, P1835, DOI 10.1002/jmv.21283; Tapia G, 2011, PEDIATR DIABETES, V12, P58, DOI 10.1111/j.1399-5448.2010.00658.x; Tauriainen S, 2007, J MED VIROL, V79, P457, DOI 10.1002/jmv.20831; van der Sanden S, 2008, J CLIN MICROBIOL, V46, P2884, DOI 10.1128/JCM.00168-08; Verboon-Maciolek MA, 2008, ANN NEUROL, V64, P266, DOI 10.1002/ana.21445; Verboon-Maciolek MA, 2008, PEDIATR INFECT DIS J, V27, P241, DOI 10.1097/INF.0b013e31815c1b07; Wang YH, 2011, ARCH VIROL, V156, P2221, DOI 10.1007/s00705-011-1122-9; Watanabe K, 2007, EMERG INFECT DIS, V13, P889, DOI 10.3201/eid1306.060896; Williams CH, 2009, J GEN VIROL, V90, P1702, DOI 10.1099/vir.0.008813-0; Wolthers KC, 2008, CLIN INFECT DIS, V47, P358, DOI 10.1086/589752; Yamamoto M, 2009, JPN J INFECT DIS, V62, P244; Zhang DL, 2011, CLIN MICROBIOL INFEC, V17, P1563, DOI 10.1111/j.1469-0691.2010.03390.x; Zhong HQ, 2013, J MED VIROL, V85, P320, DOI 10.1002/jmv.23449; Zhong HQ, 2011, J MED VIROL, V83, P1428, DOI 10.1002/jmv.22114	67	18	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68321	10.1371/journal.pone.0068321	http://dx.doi.org/10.1371/journal.pone.0068321			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844186	Green Submitted, Green Published, gold			2022-12-27	WOS:000321733000139
J	Pontes, B; Ayala, Y; Fonseca, ACC; Romao, LF; Amaral, RF; Salgado, LT; Lima, FR; Farina, M; Viana, NB; Moura-Neto, V; Nussenzveig, HM				Pontes, Bruno; Ayala, Yareni; Fonseca, Anna Carolina C.; Romao, Luciana F.; Amaral, Rackele F.; Salgado, Leonardo T.; Lima, Flavia R.; Farina, Marcos; Viana, Nathan B.; Moura-Neto, Vivaldo; Nussenzveig, H. Moyses			Membrane Elastic Properties and Cell Function	PLOS ONE			English	Article							TETHER FORMATION; DEVELOPING CNS; IN-VIVO; MICROGLIA; TENSION; BRAIN; PHAGOCYTOSIS; CYTOSKELETON; ACTIN; CURVATURE	Recent studies indicate that the cell membrane, interacting with its attached cytoskeleton, is an important regulator of cell function, exerting and responding to forces. We investigate this relationship by looking for connections between cell membrane elastic properties, especially surface tension and bending modulus, and cell function. Those properties are measured by pulling tethers from the cell membrane with optical tweezers. Their values are determined for all major cell types of the central nervous system, as well as for macrophage. Astrocytes and glioblastoma cells, which are considerably more dynamic than neurons, have substantially larger surface tensions. Resting microglia, which continually scan their environment through motility and protrusions, have the highest elastic constants, with values similar to those for resting macrophage. For both microglia and macrophage, we find a sharp softening of bending modulus between their resting and activated forms, which is very advantageous for their acquisition of phagocytic functions upon activation. We also determine the elastic constants of pure cell membrane, with no attached cytoskeleton. For all cell types, the presence of F-actin within tethers, contrary to conventional wisdom, is confirmed. Our findings suggest the existence of a close connection between membrane elastic constants and cell function.	[Pontes, Bruno; Ayala, Yareni; Fonseca, Anna Carolina C.; Amaral, Rackele F.; Lima, Flavia R.; Farina, Marcos; Viana, Nathan B.; Moura-Neto, Vivaldo; Nussenzveig, H. Moyses] Univ Fed Rio de Janeiro, LPO COPEA, Inst Ciencias Biomed, Rio De Janeiro, Brazil; [Ayala, Yareni; Viana, Nathan B.; Nussenzveig, H. Moyses] Univ Fed Rio de Janeiro, Inst Fis, Rio De Janeiro, Brazil; [Romao, Luciana F.] Univ Fed Rio de Janeiro Macae, Rio De Janeiro, Brazil; [Salgado, Leonardo T.] Inst Pesquisas Jardim Bot Rio de Janeiro, Diretoria Pesquisas, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Jardim Botanico do Rio de Janeiro	Nussenzveig, HM (corresponding author), Univ Fed Rio de Janeiro, LPO COPEA, Inst Ciencias Biomed, Rio De Janeiro, Brazil.	hmoyses@globo.com	Viana, Nathan/AAH-5868-2021; Farina, Marcos/I-3744-2014; Pontes, Bruno/L-5121-2015; da Fonseca, Anna Carolina Carvalho/C-5825-2015; Romao, Luciana/I-4291-2015; Salgado, Leonardo T/F-1123-2013; da Fonseca, Anna Carolina Carvalho/AAQ-7440-2020; Moura-Neto, VIVALDO/V-9913-2019	Viana, Nathan/0000-0002-2528-0876; da Fonseca, Anna Carolina Carvalho/0000-0002-8366-3146; da Fonseca, Anna Carolina Carvalho/0000-0002-8366-3146; Moura-Neto, VIVALDO/0000-0002-6266-043X; Souza Lima, Flavia Regina/0000-0003-0799-9235	Brazilian Agencies National Council for Scientific and Technological Development; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	Brazilian Agencies National Council for Scientific and Technological Development; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Funded by grants from Brazilian Agencies National Council for Scientific and Technological Development, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo. The funders had no role in study design, data collection and analysis, decision to publish or preparation of this manuscript.	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Anitei M, 2012, NAT CELL BIOL, V14, P11, DOI 10.1038/ncb2409; Antonny B, 2011, ANNU REV BIOCHEM, V80, P101, DOI 10.1146/annurev-biochem-052809-155121; Bauer B, 2009, ANGEW CHEM, V121, P1684; Bauer B, 2006, LANGMUIR, V22, P9329, DOI 10.1021/la060828k; Belien ATJ, 1999, J CELL BIOL, V144, P373, DOI 10.1083/jcb.144.2.373; BO L, 1989, BIOPHYS J, V55, P509, DOI 10.1016/S0006-3495(89)82844-9; Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011; Botelho RJ, 2011, CURR BIOL, V21, pR533, DOI 10.1016/j.cub.2011.05.053; Boulbitch A, 2000, PHYS REV E, V62, P3974, DOI 10.1103/PhysRevE.62.3974; Brenner MD, 2011, BIOPOLYMERS, V95, P332, DOI 10.1002/bip.21587; Brodal P, 2010, CENTRAL NERVOUS SYST; Campillo C, 2013, BIOPHYS J, V104, P1248, DOI 10.1016/j.bpj.2013.01.051; Cayre M, 2009, PROG NEUROBIOL, V88, P41, DOI 10.1016/j.pneurobio.2009.02.001; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; da Fonseca ACC, 2012, NEUROSCIENCE, V200, P130, DOI 10.1016/j.neuroscience.2011.10.025; Dai JW, 1999, BIOPHYS J, V77, P3363, DOI 10.1016/S0006-3495(99)77168-7; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Derenyi I, 2007, LECT NOTES PHYS, V711, P141; Derenyi I, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.238101; Diz-Munoz A, 2013, TRENDS CELL BIOL, V23, P47, DOI 10.1016/j.tcb.2012.09.006; Faria J, 2006, DIFFERENTIATION, V74, P562, DOI 10.1111/j.1432-0436.2006.00090.x; Farrell B, 2013, INTEGR BIOL-UK, V5, P204, DOI 10.1039/c2ib20097j; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; GARCIAABREU J, 1995, J NEUROSCI RES, V40, P471, DOI 10.1002/jnr.490400406; Gauthier NC, 2012, TRENDS CELL BIOL, V22, P527, DOI 10.1016/j.tcb.2012.07.005; Gauthier NC, 2011, P NATL ACAD SCI USA, V108, P14467, DOI 10.1073/pnas.1105845108; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Gomes FCA, 1999, GLIA, V26, P97; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hayakawa K, 2011, J CELL BIOL, V195, P721, DOI 10.1083/jcb.201102039; Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927; Jung S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00089; Keren K, 2011, P NATL ACAD SCI USA, V108, P14379, DOI 10.1073/pnas.1111671108; Keren K, 2011, EUR BIOPHYS J BIOPHY, V40, P1013, DOI 10.1007/s00249-011-0741-0; Koster G, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.068101; Koster G, 2005, THESIS LEIDEN U; Leporatti S, 2006, FEBS LETT, V580, P450, DOI 10.1016/j.febslet.2005.12.037; Lima FRS, 2007, J NEUROCHEM, V103, P2164, DOI 10.1111/j.1471-4159.2007.04904.x; Lima FRS, 2012, BBA-REV CANCER, V1826, P338, DOI 10.1016/j.bbcan.2012.05.004; Lima FRS, 2001, J NEUROSCI, V21, P2028, DOI 10.1523/JNEUROSCI.21-06-02028.2001; Mallat M, 2005, CURR OPIN NEUROBIOL, V15, P101, DOI 10.1016/j.conb.2005.01.006; May RC, 2001, J CELL SCI, V114, P1061; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; NETO VM, 1983, EMBO J, V2, P1243, DOI 10.1002/j.1460-2075.1983.tb01576.x; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Pontes B, 2011, BIOPHYS J, V101, P43, DOI 10.1016/j.bpj.2011.05.044; Powers TR, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041901; Raivich G, 2005, TRENDS NEUROSCI, V28, P571, DOI 10.1016/j.tins.2005.09.001; SCOTT RE, 1976, SCIENCE, V194, P743, DOI 10.1126/science.982043; SCOTT RE, 1979, J CELL SCI, V35, P229; Sheetz MP, 2001, NAT REV MOL CELL BIO, V2, P392, DOI 10.1038/35073095; Shen HY, 2012, CELL, V150, P1300, DOI 10.1016/j.cell.2012.08.017; Streit WJ, 2001, NEUROTOXICOLOGY, V22, P619, DOI 10.1016/S0161-813X(01)00033-X; Theodosis DT, 2008, PHYSIOL REV, V88, P983, DOI 10.1152/physrev.00036.2007; Vilhardt F, 2005, INT J BIOCHEM CELL B, V37, P17, DOI 10.1016/j.biocel.2004.06.010; Wirtz D, 2013, BIOPHYS J, V104, P1217, DOI 10.1016/j.bpj.2013.02.003; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251	58	79	80	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67708	10.1371/journal.pone.0067708	http://dx.doi.org/10.1371/journal.pone.0067708			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844071	gold, Green Submitted, Green Published			2022-12-27	WOS:000321733000097
J	Norman, JF; Kappers, AML; Cheeseman, JR; Ronning, C; Thomason, KE; Baxter, MW; Calloway, AB; Lamirande, DN				Norman, J. Farley; Kappers, Astrid M. L.; Cheeseman, Jacob R.; Ronning, Cecilia; Thomason, Kelsey E.; Baxter, Michael W.; Calloway, Autum B.; Lamirande, Davora N.			Aging and Curvature Discrimination from Static and Dynamic Touch	PLOS ONE			English	Article							ADAPTING MECHANORECEPTIVE AFFERENTS; TACTILE SPATIAL-RESOLUTION; MONKEY FINGERPAD; OBJECT SHAPE; HUMANS; SKIN; RECOGNITION; RESPONSES; ACUITY; INFORMATION	Two experiments evaluated the ability of 30 older and younger adults to discriminate the curvature of simple object surfaces from static and dynamic touch. The ages of the older adults ranged from 66 to 85 years, while those of the younger adults ranged from 20 to 29 years. For each participant in both experiments, the minimum curvature magnitude needed to reliably discriminate between convex and concave surfaces was determined. In Experiment 1, participants used static touch to make their judgments of curvature, while dynamic touch was used in Experiment 2. When static touch was used to discriminate curvature, a large effect of age occurred (the thresholds were 0.67 & 1.11/m for the younger and older participants, respectively). However, when participants used dynamic touch, there was no significant difference between the ability of younger and older participants to discriminate curvature (the thresholds were 0.58 & 0.59/m for the younger and older participants, respectively). The results of the current study demonstrate that while older adults can accurately discriminate surface curvature from dynamic touch, they possess significant impairments for static touch.	[Norman, J. Farley; Cheeseman, Jacob R.; Ronning, Cecilia; Thomason, Kelsey E.; Baxter, Michael W.; Calloway, Autum B.; Lamirande, Davora N.] Western Kentucky Univ, Dept Psychol, Bowling Green, KY 42101 USA; [Norman, J. Farley] Western Kentucky Univ, Ctr Study Lifespan Dev, Bowling Green, KY 42101 USA; [Kappers, Astrid M. L.] Vrije Univ Amsterdam, Fac Human Movement Sci, Amsterdam, Netherlands	Western Kentucky University; Western Kentucky University; Vrije Universiteit Amsterdam	Norman, JF (corresponding author), Western Kentucky Univ, Dept Psychol, Bowling Green, KY 42101 USA.	Farley.Norman@wku.edu	Norman, Farley/A-7169-2012	Norman, Farley/0000-0001-5877-1914				Bleyenheuft Y, 2007, SOMATOSENS MOT RES, V24, P111, DOI 10.1080/08990220701496639; Bodegard A, 2001, NEURON, V31, P317, DOI 10.1016/S0896-6273(01)00362-2; Clark F.J., 1986, HDB PERCEPTION PERFO, V1, P1; GIBSON JJ, 1962, PSYCHOL REV, V69, P477, DOI 10.1037/h0046962; GOODWIN AW, 1991, EXP BRAIN RES, V86, P663; HELLER MA, 1984, J GEN PSYCHOL, V110, P243, DOI 10.1080/00221309.1984.9709968; HELLER MA, 1983, J GEN PSYCHOL, V108, P225, DOI 10.1080/00221309.1983.9711496; JONES MB, 1973, AM J PSYCHOL, V86, P49, DOI 10.2307/1421847; Kappers AML, 1996, PERCEPTION, V25, P739, DOI 10.1068/p250739; Klatzky R.L., 2003, HDB PSYCHOL, P147, DOI DOI 10.1002/0471264385.WEI0406; LAMOTTE RH, 1987, J NEUROSCI, V7, P1672; LAMOTTE RH, 1987, J NEUROSCI, V7, P1655; Lederman S.J., 1986, HDB PERCEPTION HUMAN, V2, P1, DOI 10.1167/9.8.1126; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; LOO CKC, 1983, BEHAV BRAIN RES, V7, P383, DOI 10.1016/0166-4328(83)90029-3; MAGEE LE, 1980, NATURE, V283, P287, DOI 10.1038/283287a0; Norman JF, 2006, PERCEPTION, V35, P1383, DOI 10.1068/p5504; Norman JF, 2012, EXP BRAIN RES, V222, P321, DOI 10.1007/s00221-012-3220-7; Norman JF, 2011, ATTEN PERCEPT PSYCHO, V73, P2323, DOI 10.3758/s13414-011-0160-4; Norman JF, 2011, ATTEN PERCEPT PSYCHO, V73, P908, DOI 10.3758/s13414-010-0053-y; Pont SC, 1997, PERCEPT PSYCHOPHYS, V59, P1225, DOI 10.3758/BF03214210; Pont SC, 1999, PERCEPT PSYCHOPHYS, V61, P874, DOI 10.3758/BF03206903; Shimansky Y, 1997, LEARN MEMORY, V4, P36, DOI 10.1101/lm.4.1.36; SRINIVASAN MA, 1987, J NEUROSCI, V7, P1682; STEVENS JC, 1992, J GERONTOL, V47, pP35, DOI 10.1093/geronj/47.1.P35; Symmons MA, 2008, PERCEPTION, V37, P1596, DOI 10.1068/p5855; Van Doorn GH, 2012, ATTEN PERCEPT PSYCHO, V74, P1539, DOI 10.3758/s13414-012-0327-7; VANBOVEN RW, 1994, NEUROLOGY, V44, P2361, DOI 10.1212/WNL.44.12.2361; Vega-Bermudez F, 2004, PERCEPT PSYCHOPHYS, V66, P60, DOI 10.3758/BF03194861; Vega-Bermudez F, 2002, BRAIN, V125, P1256, DOI 10.1093/brain/awf129; Voisin J, 2002, EXP BRAIN RES, V145, P251, DOI 10.1007/s00221-002-1118-5; WOODWARD KL, 1993, SOMATOSENS MOT RES, V10, P63, DOI 10.3109/08990229309028824	32	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68577	10.1371/journal.pone.0068577	http://dx.doi.org/10.1371/journal.pone.0068577			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844224	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000174
J	Tzeng, HE; Lin, CL; Tsai, CH; Tang, CH; Hwang, WL; Cheng, YW; Sung, FC; Chung, CJ				Tzeng, Huey-En; Lin, Cheng-Li; Tsai, Chun-Hao; Tang, Chih-Hsin; Hwang, Wen-Li; Cheng, Ya-Wen; Sung, Fung-Chang; Chung, Chi-Jung			Time Trend of Multiple Myeloma and Associated Secondary Primary Malignancies in Asian Patients: A Taiwan Population-Based Study	PLOS ONE			English	Article							INCREASED RISK; MYELODYSPLASTIC SYNDROMES; BREAST-CANCER; UNITED-STATES; 2ND CANCER; LEUKEMIA; EPIDEMIOLOGY; CHEMOTHERAPY; NEOPLASMS; MELPHALAN	Studies involving second malignancies in patients with multiple myeloma are limited for the Asian population. Using data from population-based insurance claims, we assessed the risk of developing secondary malignancies after multiple myeloma, in particular hematologic malignancies. A retrospective cohort study was conducted in 3970 patients with newly diagnosed multiple myeloma from the registry of catastrophic illnesses between 1997 and 2009. A total of 15880 subjects without multiple myeloma were randomly selected as comparisons from the insured population, frequency-matched based on gender, age, and the date of diagnosis. The incidence of secondary malignancies was ascertained through cross-referencing with the National Cancer Registry System. The Cox proportional hazards model was used for analyses. The incidence of multiple myeloma in the insured population increased annually. The overall incidence of secondary malignancy was lower in the multiple myeloma cohort than in the comparison cohort (93.6 vs. 104.5 per 10,000 person-years, IRR = 0.90, 95% CI = 0.78-1.04). The incidence of hematologic malignancies was 11-fold greater for multiple myeloma patients (47.2 vs. 4.09 per 10,000 person-years) with an adjusted HR of 13.0 (95% CI = 7.79-21.6) compared with the comparison cohort. The relative risk of secondary malignancy was also strong for myeloid leukemia (21.2 vs. 1.36 per 10,000 person-years). Gender-and age-specific analysis for secondary hematologic malignancies showed that males and patients with multiple myeloma < 60 years of age had a higher risk of secondary malignancy than females and patients with multiple myeloma > 60 years of age. In conclusion, patients with multiple myeloma, especially younger patients, are at a high risk of hematologic malignancies.	[Tzeng, Huey-En; Tsai, Chun-Hao; Tang, Chih-Hsin] China Med Univ, Grad Inst Med, Taichung, Taiwan; [Tzeng, Huey-En; Hwang, Wen-Li] Taichung Vet Gen Hosp, Div Hematol Oncol, Taichung, Taiwan; [Lin, Cheng-Li; Sung, Fung-Chang] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Cheng-Li; Sung, Fung-Chang] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Tsai, Chun-Hao] China Med Univ Hosp, Dept Orthopaed, Taichung, Taiwan; [Tang, Chih-Hsin] China Med Univ & Hosp, Sch Med, Dept Pharmacol, Taichung, Taiwan; [Cheng, Ya-Wen] Taipei Med Univ, Coll Med Sci & Technol, Inst Canc Biol & Drug Discovery, Taipei, Taiwan; [Chung, Chi-Jung] China Med Univ, Dept Hlth Risk Management, Taichung, Taiwan; [Chung, Chi-Jung] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan	China Medical University Taiwan; Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Taipei Medical University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Tang, CH (corresponding author), China Med Univ, Grad Inst Med, Taichung, Taiwan.	chtang@mail.cmu.edu.tw; cjchung@mail.cmu.edu.tw	Tang, Chih Hsin/O-5212-2015; Chung, Chi-Jung/G-4755-2013; Tsai, Chun-Hao/H-3140-2013	Tang, Chih Hsin/0000-0002-7113-8352; Tsai, Chun-Hao/0000-0002-4428-3132	Executive Yuan National Science Council [NSC 100-2621-M-039-001]; Department of Health [DOH100-TD-B-111-004, DOH100-TD-C-111-005]; China Medical University Hospital [1MS1]	Executive Yuan National Science Council; Department of Health; China Medical University Hospital	This study was supported in part by the Executive Yuan National Science Council (Grant No. NSC 100-2621-M-039-001), the Department of Health (Grant Nos. DOH100-TD-B-111-004 and DOH100-TD-C-111-005), and the China Medical University Hospital (Grant No. 1MS1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts SR, 1997, CANCER EPIDEM BIOMAR, V6, p[857, 49]; Allan JM, 2005, NAT REV CANCER, V5, P943, DOI 10.1038/nrc1749; Barlogie B, 2008, BLOOD, V111, P94, DOI 10.1182/blood-2007-06-097444; Becker N, 2011, RECENT RESULTS CANC, V183, P25, DOI 10.1007/978-3-540-85772-3_2; BERGSAGEL DE, 1979, NEW ENGL J MED, V301, P743, DOI 10.1056/NEJM197910043011402; Bird JM, 2011, BRIT J HAEMATOL, V154, P32, DOI 10.1111/j.1365-2141.2011.08573.x; Bouchardy C, 2008, GYNECOL ONCOL, V109, P210, DOI 10.1016/j.ygyno.2008.01.032; Chen HL, 2005, SCI TOTAL ENVIRON, V337, P31, DOI 10.1016/j.scitotenv.2004.06.021; CUZICK J, 1987, BRIT J CANCER, V55, P523, DOI 10.1038/bjc.1987.107; Dores GM, 2009, BRIT J HAEMATOL, V144, P86, DOI 10.1111/j.1365-2141.2008.07421.x; Fayers PM, 2011, BLOOD, V118, P1239, DOI 10.1182/blood-2011-03-341669; Fenk R, 2012, BRIT J HAEMATOL, V156, P683, DOI 10.1111/j.1365-2141.2011.08905.x; George ED, 1999, AM FAM PHYSICIAN, V59, P1885; Gold LS, 2009, CANCER EPIDEMIOL, V33, P276, DOI 10.1016/j.canep.2009.08.005; Govindarajan R, 1996, BRIT J HAEMATOL, V95, P349, DOI 10.1046/j.1365-2141.1996.d01-1891.x; Hasskarl J, 2011, LEUKEMIA LYMPHOMA, V52, P247, DOI 10.3109/10428194.2010.529207; Hirabayashi Y, 2008, JPN J CLIN ONCOL, V38, P720, DOI 10.1093/jjco/hyn113; Hsu JF, 2010, CHEMOSPHERE, V81, P469, DOI 10.1016/j.chemosphere.2010.07.044; Huang SY, 2007, CANCER-AM CANCER SOC, V110, P896, DOI 10.1002/cncr.22850; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; KYLE RA, 1970, NEW ENGL J MED, V283, P1121, DOI 10.1056/NEJM197011192832101; Landgren O, 2012, LEUKEMIA, V26, P844, DOI 10.1038/leu.2011.262; Landgren O, 2009, LEUKEMIA, V23, P1691, DOI 10.1038/leu.2009.134; Landgren O, 2011, NEW ENGL J MED, V365, P2241, DOI 10.1056/NEJMc1111010; LAW IP, 1977, ONCOLOGY-BASEL, V34, P20, DOI 10.1159/000225175; Lee KD, 2008, CANCER EPIDEM BIOMAR, V17, P2647, DOI 10.1158/1055-9965.EPI-08-0109; Mailankody S, 2011, BLOOD, V118, P4086, DOI 10.1182/blood-2011-05-355743; Moller H, 2007, BRIT J CANCER, V96, P1484, DOI 10.1038/sj.bjc.6603746; Moser EC, 2006, HAEMATOLOGICA, V91, P1481; Oivanen T, 2000, EUR J HAEMATOL, V65, P123; RAO JNK, 1992, BIOMETRICS, V48, P577, DOI 10.2307/2532311; ROSNER F, 1977, JAMA-J AM MED ASSOC, V237, P120, DOI 10.1001/jama.1977.03270290020015; Rubino C, 2000, BREAST CANCER RES TR, V61, P183, DOI 10.1023/A:1006489918700; Schwartz GG, 1997, CANCER EPIDEM BIOMAR, V6, P49; Soong G, 2011, CHINA POST TAIPEI; 't Mannetje A, 2005, OCCUP ENVIRON MED, V62, P34, DOI 10.1136/oem.2004.015776; Tsung-Mei C, 2009, TAIWANS NATL HLTH IN; Turesson I, 2010, J CLIN ONCOL, V28, P830, DOI 10.1200/JCO.2009.25.4177	38	25	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68041	10.1371/journal.pone.0068041	http://dx.doi.org/10.1371/journal.pone.0068041			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844152	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000132
J	Lee, CC; Carette, JE; Brummelkamp, TR; Ploegh, HL				Lee, Clarissa C.; Carette, Jan E.; Brummelkamp, Thijn R.; Ploegh, Hidde L.			A Reporter Screen in a Human Haploid Cell Line Identifies CYLD as a Constitutive Inhibitor of NF-kappa B	PLOS ONE			English	Article							DEUBIQUITINATING ENZYME; TRANSCRIPTION FACTORS; GENE DISRUPTION; ACTIVATION; REQUIRES	The development of forward genetic screens in human haploid cells has the potential to transform our understanding of the genetic basis of cellular processes unique to man. So far, this approach has been limited mostly to the identification of genes that mediate cell death in response to a lethal agent, likely due to the ease with which this phenotype can be observed. Here, we perform the first reporter screen in the near-haploid KBM7 cell line to identify constitutive inhibitors of NF-kappa B. CYLD was the only currently known negative regulator of NF-kappa B to be identified, thus uniquely distinguishing this gene. Also identified were three genes with no previous known connection to NF-kappa B. Our results demonstrate that reporter screens in haploid human cells can be applied to investigate the many complex signaling pathways that converge upon transcription factors.	[Lee, Clarissa C.; Carette, Jan E.; Brummelkamp, Thijn R.; Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Lee, Clarissa C.; Ploegh, Hidde L.] MIT, Dept Biol, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Ploegh, HL (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	ploegh@wi.mit.edu		Carette, Jan/0000-0002-5187-8070	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abascal F, 2012, BIOESSAYS, V34, P551, DOI 10.1002/bies.201100173; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Duncan LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039651; Guimaraes CP, 2011, J CELL BIOL, V195, P751, DOI 10.1083/jcb.201108103; Hayashi T, 2011, BIOL PHARM BULL, V34, P1257, DOI 10.1248/bpb.34.1257; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hovelmeyer N, 2007, J EXP MED, V204, P2615, DOI 10.1084/jem.20070318; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Jin W, 2007, J BIOL CHEM, V282, P15884, DOI 10.1074/jbc.M609952200; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Kotecki M, 1999, EXP CELL RES, V252, P273, DOI 10.1006/excr.1999.4656; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; Papatheodorou P, 2011, P NATL ACAD SCI USA, V108, P16422, DOI 10.1073/pnas.1109772108; Rosmarin DM, 2012, P NATL ACAD SCI USA, V109, P10059, DOI 10.1073/pnas.1120244109; Sawada A, 2003, J CLIN INVEST, V112, P1707, DOI 10.1172/JCI18937; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; Tominaga K, 2004, J BIOL CHEM, V279, P34840, DOI 10.1074/jbc.M312927200; Tornatore L, 2012, TRENDS CELL BIOL, V22, P557, DOI 10.1016/j.tcb.2012.08.001; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538	26	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e70339	10.1371/journal.pone.0070339	http://dx.doi.org/10.1371/journal.pone.0070339			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861985	Green Published, gold, Green Submitted			2022-12-27	WOS:000321692000053
J	Lee, YT; Kim, KS; Byrnes, C; de Vasconcellos, JF; Noh, SJ; Rabel, A; Meier, ER; Miller, JL				Lee, Y. Terry; Kim, Ki Soon; Byrnes, Colleen; de Vasconcellos, Jaira F.; Noh, Seung-Jae; Rabel, Antoinette; Meier, Emily R.; Miller, Jeffery L.			A Synthetic Model of Human Beta-Thalassemia Erythropoiesis Using CD34+Cells from Healthy Adult Donors	PLOS ONE			English	Article							INEFFECTIVE ERYTHROPOIESIS; ERYTHROID-CELLS; MOUSE MODEL; HEMOGLOBIN; EXPRESSION; MURINE; GLOBIN; APOPTOSIS; BLOOD	Based upon the lack of clinical samples available for research in many laboratories worldwide, a significant gap exists between basic and clinical studies of beta-thalassemia major. To bridge this gap, we developed an artificially engineered model for human beta thalassemia by knocking down beta-globin gene and protein expression in cultured CD34+ cells obtained from healthy adults. Lentiviral-mediated transduction of beta-globin shRNA (beta-KD) caused imbalanced globin chain production. Beta-globin mRNA was reduced by 90% compared to controls, while alpha-globin mRNA levels were maintained. HPLC analyses revealed a 96% reduction in HbA with only a minor increase in HbF. During the terminal phases of differentiation (culture days 14-21), beta-KD cells demonstrated increased levels of insoluble alpha-globin, as well as activated caspase-3. The majority of the beta-KD cells underwent apoptosis around the polychromatophilic stage of maturation. GDF15, a marker of ineffective erythropoiesis in humans with thalassemia, was significantly increased in the culture supernatants from the beta-KD cells. Knockdown of beta-globin expression in cultured primary human erythroblasts provides a robust ex vivo model for beta-thalassemia.	[Lee, Y. Terry; Kim, Ki Soon; Byrnes, Colleen; de Vasconcellos, Jaira F.; Noh, Seung-Jae; Rabel, Antoinette; Meier, Emily R.; Miller, Jeffery L.] NIDDK, Mol Genom & Therapeut Sect, Mol Med Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Miller, JL (corresponding author), NIDDK, Mol Genom & Therapeut Sect, Mol Med Branch, NIH, Bethesda, MD 20892 USA.	jm7f@nih.gov		Ferreira de Vasconcellos, Jaira/0000-0001-5011-4493	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (Bethesda, MD); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK025094, ZIADK025101, ZIADK025098] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (Bethesda, MD); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (Bethesda, MD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADVANI R, 1992, BLOOD, V79, P1058; Bhanu NV, 2005, BLOOD, V105, P387, DOI 10.1182/blood-2004-04-1599; Centis F, 2000, BLOOD, V96, P3624; Franceschi LD, 2006, HAEMATOLOGICA, V91, P1336; Franceschi LD, 2007, HAEMATOLOGICA, V92, P1319; Ginzburg Y, 2011, BLOOD, V118, P4321, DOI 10.1182/blood-2011-03-283614; Ginzburg YZ, 2009, EXP HEMATOL, V37, P172, DOI 10.1016/j.exphem.2008.10.004; Khandros E, 2012, BLOOD, V119, P5265, DOI 10.1182/blood-2011-12-397729; Kong Y, 2004, J CLIN INVEST, V114, P1457, DOI 10.1172/JCI200421982; Kuypers FA, 1998, BLOOD, V91, P3044, DOI 10.1182/blood.V91.8.3044.3044_3044_3051; Li HH, 2010, NAT MED, V16, P177, DOI 10.1038/nm.2073; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; Libani IV, 2008, BLOOD, V112, P875, DOI 10.1182/blood-2007-12-126938; Mathias LA, 2000, EXP HEMATOL, V28, P1343, DOI 10.1016/S0301-472X(00)00555-5; Mendel A, 2009, MSURJ, V4, P20; Migliaccio G, 2002, BLOOD CELL MOL DIS, V28, P169, DOI 10.1006/bcmd.2002.0502; Olivieri NF, 1999, NEW ENGL J MED, V341, P99, DOI 10.1056/NEJM199907083410207; Patrinos GP, 2004, NUCLEIC ACIDS RES, V32, pD537, DOI 10.1093/nar/gkh006; Ribeil JA, 2007, NATURE, V445, P102, DOI 10.1038/nature05378; Rivella S, 2003, BLOOD, V101, P2932, DOI 10.1182/blood-2002-10-3305; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Sankaran VG, 2010, HEMATOL ONCOL CLIN N, V24, P1005, DOI 10.1016/j.hoc.2010.08.009; Schrier SL, 2002, CURR OPIN HEMATOL, V9, P123, DOI 10.1097/00062752-200203000-00007; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; SKOW LC, 1983, CELL, V34, P1043, DOI 10.1016/0092-8674(83)90562-7; Sripichai O, 2009, BLOOD, V114, P2299, DOI 10.1182/blood-2009-05-219386; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Tanno T, 2009, BLOOD, V114, P181, DOI 10.1182/blood-2008-12-195503; Tavazzi D, 1998, HEMOGLOBIN, V22, P483, DOI 10.3109/03630269809071545; Weatherall D.J., 2001, THALASSAEMIA SYNDROM, Vfourth; WICKRAMASINGHE SN, 1975, BRIT J HAEMATOL, V30, P395, DOI 10.1111/j.1365-2141.1975.tb01853.x; Wojda U, 2002, BLOOD, V99, P3005, DOI 10.1182/blood.V99.8.3005.h8003005_3005_3013; YANG BL, 1995, P NATL ACAD SCI USA, V92, P11608, DOI 10.1073/pnas.92.25.11608	33	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68307	10.1371/journal.pone.0068307	http://dx.doi.org/10.1371/journal.pone.0068307			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861885	Green Submitted, Green Published, gold			2022-12-27	WOS:000321692000021
J	Leepiyasakulchai, C; Taher, C; Chuquimia, OD; Mazurek, J; Soderberg-Naucler, C; Fernandez, C; Skold, M				Leepiyasakulchai, Chaniya; Taher, Chato; Chuquimia, Olga D.; Mazurek, Jolanta; Soderberg-Naucler, Cecilia; Fernandez, Carmen; Skold, Markus			Infection Rate and Tissue Localization of Murine IL-12p40-Producing Monocyte-Derived CD103(+) Lung Dendritic Cells during Pulmonary Tuberculosis	PLOS ONE			English	Article							HOUSE-DUST MITE; ALVEOLAR EPITHELIAL-CELLS; MOUSE BONE-MARROW; MYCOBACTERIUM-TUBERCULOSIS; IN-VIVO; INTERFERON-GAMMA; MICE; MACROPHAGES; IMMUNITY; DIFFERENTIATION	Non-hematopoietic cells, including lung epithelial cells, influence host immune responses. By co-culturing primary alveolar epithelial cells and monocytes from naive donor mice, we show that alveolar epithelial cells support monocyte survival and differentiation in vitro, suggesting a role for non-hematopoietic cells in monocyte differentiation during the steady state in vivo. CD103(+) dendritic cells (alpha E-DC) are present at mucosal surfaces. Using a murine primary monocyte adoptive transfer model, we demonstrate that alpha E-DC in the lungs and pulmonary lymph nodes are monocyte-derived during pulmonary tuberculosis. The tissue localization may influence the functional potential of alpha E-DC that accumulate in Mycobacterium tuberculosis-infected lungs. Here, we confirm the localization of alpha E-DC in uninfected mice beneath the bronchial epithelial cell layer and near the vascular wall, and show that alpha E-DC have a similar distribution in the lungs during pulmonary tuberculosis and are detected in the bronchoalveolar lavage fluid from infected mice. Lung DC can be targeted by M. tuberculosis in vivo and play a role in bacterial dissemination to the draining lymph node. In contrast to other DC subsets, only a fraction of lung alpha E-DC are infected with the bacterium. We also show that virulent M. tuberculosis does not significantly alter cell surface expression levels of MHC class II on infected cells in vivo and that alpha E-DC contain the highest frequency of IL-12p40(+) cells among the myeloid cell subsets in infected lungs. Our results support a model in which inflammatory monocytes are recruited into the M. tuberculosis-infected lung tissue and, depending on which non-hematopoietic cells they interact with, differentiate along different paths to give rise to multiple monocyte-derived cells, including DC with a distinctive alpha E-DC phenotype.	[Leepiyasakulchai, Chaniya; Mazurek, Jolanta; Skold, Markus] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Taher, Chato; Soderberg-Naucler, Cecilia] Karolinska Inst, Dept Med, Ctr Mol Med, Stockholm, Sweden; [Chuquimia, Olga D.; Fernandez, Carmen] Stockholm Univ, Wenner Gren Inst, Dept Immunol, S-10691 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Stockholm University	Skold, M (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	markus.skold@ki.se		Mazurek, Jolanta/0000-0001-5023-0398	Swedish Research Council [K2007-57X-20360-01-4]; Swedish Heart-Lung Foundation; Konung Oscar II:s jubileumsfond; Stiftelsen Clas Groschinskys Minnesfond; Karolinska Institutet (ki.se); Royal Thai Government; Stiftelsen Sigurd och Elsa Goljes Minne	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Konung Oscar II:s jubileumsfond; Stiftelsen Clas Groschinskys Minnesfond; Karolinska Institutet (ki.se); Royal Thai Government; Stiftelsen Sigurd och Elsa Goljes Minne	This work was supported by grants from The Swedish Research Council (grant no. K2007-57X-20360-01-4, www.vr.se), The Swedish Heart-Lung Foundation and Konung Oscar II:s jubileumsfond (www.hjart-lungfonden.se), Stiftelsen Clas Groschinskys Minnesfond (www.groschinsky.org) and Karolinska Institutet (ki.se) to MS. CL was supported by a scholarship from the Royal Thai Government and a grant from Stiftelsen Sigurd och Elsa Goljes Minne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Chackerian AA, 2002, INFECT IMMUN, V70, P4501, DOI 10.1128/IAI.70.8.4501-4509.2002; Chuquimia OD, 2013, INFECT IMMUN, V81, P381, DOI 10.1128/IAI.00950-12; Chuquimia OD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032125; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Cooper AM, 1997, J EXP MED, V186, P39, DOI 10.1084/jem.186.1.39; DEBRUIJN MFTR, 1994, EUR J IMMUNOL, V24, P2279, DOI 10.1002/eji.1830241003; del Rio ML, 2008, J IMMUNOL, V181, P6178, DOI 10.4049/jimmunol.181.9.6178; del Rio ML, 2010, IMMUNOL REV, V234, P268, DOI 10.1111/j.0105-2896.2009.00874.x; Demoor T, 2011, J IMMUNOL, V186, P5457, DOI 10.4049/jimmunol.1003862; Desch AN, 2011, J EXP MED, V208, P1789, DOI 10.1084/jem.20110538; Desvignes L, 2009, IMMUNITY, V31, P974, DOI 10.1016/j.immuni.2009.10.007; Edelson BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025660; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gonzalez-Juarrero M, 2003, J IMMUNOL, V171, P3128, DOI 10.4049/jimmunol.171.6.3128; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hoshino K, 1999, J IMMUNOL, V162, P3749; Humphreys IR, 2006, MICROBES INFECT, V8, P1339, DOI 10.1016/j.micinf.2005.12.023; Iliev ID, 2009, GUT, V58, P1481, DOI 10.1136/gut.2008.175166; Jakubzick C, 2008, J IMMUNOL, V180, P3019, DOI 10.4049/jimmunol.180.5.3019; Khader SA, 2006, J EXP MED, V203, P1805, DOI 10.1084/jem.20052545; Kiers A, 1997, INT J TUBERC LUNG D, V1, P239; Kincaid EZ, 2007, J IMMUNOL, V179, P3187, DOI 10.4049/jimmunol.179.5.3187; Leepiyasakulchai C, 2012, INFECT IMMUN, V80, P1128, DOI 10.1128/IAI.05552-11; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Marquis JF, 2009, J IMMUNOL, V182, P3008, DOI 10.4049/jimmunol.0800680; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; Nathan AT, 2009, J ALLERGY CLIN IMMUN, V123, P612, DOI 10.1016/j.jaci.2008.12.006; Nikolic T, 2003, INT IMMUNOL, V15, P515, DOI 10.1093/intimm/dxg050; Osterlund C, 2009, CLIN EXP ALLERGY, V39, P1199, DOI 10.1111/j.1365-2222.2009.03284.x; Pecora ND, 2009, CELL IMMUNOL, V254, P94, DOI 10.1016/j.cellimm.2008.07.002; Peters W, 2001, P NATL ACAD SCI USA, V98, P7958, DOI 10.1073/pnas.131207398; Pichavant M, 2005, J ALLERGY CLIN IMMUN, V115, P771, DOI 10.1016/j.jaci.2004.11.043; Skold M, 2008, J IMMUNOL, V181, P6349, DOI 10.4049/jimmunol.181.9.6349; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; Svensson M, 2004, IMMUNITY, V21, P805, DOI 10.1016/j.immuni.2004.10.012; Teitelbaum R, 1999, IMMUNITY, V10, P641, DOI 10.1016/S1074-7613(00)80063-1; Tian T, 2005, J IMMUNOL, V175, P3268, DOI 10.4049/jimmunol.175.5.3268; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Unkel B, 2012, J CLIN INVEST, V122, P3652, DOI 10.1172/JCI62139; Valdivia RH, 1996, GENE, V173, P47, DOI 10.1016/0378-1119(95)00706-7; WALKER L, 1981, NATURE, V293, P69, DOI 10.1038/293069a0; Welin A, 2011, J INNATE IMMUN, V3, P508, DOI 10.1159/000325297; WHO, 2010, 201020107 WHOHTMTB; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509	52	13	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e69287	10.1371/journal.pone.0069287	http://dx.doi.org/10.1371/journal.pone.0069287			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861965	gold, Green Published, Green Submitted			2022-12-27	WOS:000321692000041
J	Wang, ZY; Wang, N; Han, SW; Wang, DM; Mo, SL; Yu, LZ; Huang, H; Tsui, K; Shen, JG; Chen, JP				Wang, Zhiyu; Wang, Neng; Han, Shouwei; Wang, Dongmei; Mo, Suilin; Yu, Linzhong; Huang, Hui; Tsui, Kamchuen; Shen, Jiangang; Chen, Jianping			Dietary Compound Isoliquiritigenin Inhibits Breast Cancer Neoangiogenesis via VEGF/VEGFR-2 Signaling Pathway	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; IN-VIVO; INDUCED ANGIOGENESIS; THERAPEUTIC TARGET; MESSENGER-RNA; LICORICE ROOT; TUMOR-GROWTH; KINASE; VEGF; MMP-2	Angiogenesis is crucial for cancer initiation, development and metastasis. Identifying natural botanicals targeting angiogenesis has been paid much attention for drug discovery in recent years, with the advantage of increased safety. Isoliquiritigenin (ISL) is a dietary chalcone-type flavonoid with various anti-cancer activities. However, little is known about the anti-angiogenic activity of isoliquiritigenin and its underlying mechanisms. Herein, we found that ISL significantly inhibited the VEGF-induced proliferation of human umbilical vein endothelial cells (HUVECs) at non-toxic concentration. A series of angiogenesis processes including tube formation, invasion and migration abilities of HUVECs were also interrupted by ISL in vitro. Furthermore, ISL suppressed sprout formation from VEGF-treated aortic rings in an ex-vivo model. Molecular mechanisms study demonstrated that ISL could significantly inhibit VEGF expression in breast cancer cells via promoting HIF-1 alpha (Hypoxia inducible factor-1 alpha) proteasome degradation and directly interacted with VEGFR-2 to block its kinase activity. In vivo studies further showed that ISL administration could inhibit breast cancer growth and neoangiogenesis accompanying with suppressed VEGF/VEGFR-2 signaling, elevated apoptosis ratio and little toxicity effects. Molecular docking simulation indicated that ISL could stably form hydrogen bonds and aromatic interactions within the ATP-binding region of VEGFR-2. Taken together, our study shed light on the potential application of ISL as a novel natural inhibitor for cancer angiogenesis via the VEGF/VEGFR-2 pathway. Future studies of ISL for chemoprevention or chemosensitization against breast cancer are thus warranted.	[Wang, Zhiyu; Wang, Neng; Shen, Jiangang; Chen, Jianping] Univ Hong Kong, Sch Chinese Med, Pokfulam, Hong Kong, Peoples R China; [Han, Shouwei] Univ Guangzhou Tradit Chinese Med, Clin Med Collage 2, Guangdong Prov Hosp Chinese Med, Guangzhou, Guangdong, Peoples R China; [Wang, Dongmei] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China; [Mo, Suilin] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Yu, Linzhong] South Med Univ, Sch Chinese Med, Guangzhou, Guangdong, Peoples R China; [Huang, Hui] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Tsui, Kamchuen] Hong Kong Associate Chinese Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Guangzhou University of Chinese Medicine; Sun Yat Sen University; Sun Yat Sen University; Southern Medical University - China; Sun Yat Sen University	Chen, JP (corresponding author), Univ Hong Kong, Sch Chinese Med, Pokfulam, Hong Kong, Peoples R China.	jpjpchen@yahoo.com	wang, zhiyu/K-5255-2016	wang, zhiyu/0000-0002-5299-8410	Hong Kong Innovation and Technology Support Programme ITF [ITS/073/11FP]	Hong Kong Innovation and Technology Support Programme ITF	This work was supported by the Hong Kong Innovation and Technology Support Programme ITF funding (ITS/073/11FP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo AG, 2007, CURR PHARM DESIGN, V13, P1787, DOI 10.2174/138161207780831284; Bagri A, 2010, TRENDS MOL MED, V16, P122, DOI 10.1016/j.molmed.2010.01.004; Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Cuendet M, 2010, CANCER PREV RES, V3, P221, DOI 10.1158/1940-6207.CAPR-09-0049; Fang J, 2007, CELL SIGNAL, V19, P2487, DOI 10.1016/j.cellsig.2007.07.025; Faria A, 2006, J AGR FOOD CHEM, V54, P2392, DOI 10.1021/jf0526487; Fisher JF, 2010, METHODS MOL BIOL, V622, P471, DOI 10.1007/978-1-60327-299-5_27; Giraudo E, 2004, J CLIN INVEST, V114, P623, DOI 10.1172/JCI200422087; Goh PP, 2007, CURR CANCER DRUG TAR, V7, P743, DOI 10.2174/156800907783220462; Grothey A, 2009, NAT REV CLIN ONCOL, V6, P507, DOI 10.1038/nrclinonc.2009.110; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Ispanovic E, 2006, AM J PHYSIOL-CELL PH, V291, pC579, DOI 10.1152/ajpcell.00300.2005; Jhanji V, 2011, BRIT J OPHTHALMOL, V95, P1309, DOI 10.1136/bjophthalmol-2011-300110; Jiang BH, 2008, CURR CANCER DRUG TAR, V8, P19, DOI 10.2174/156800908783497122; Kang SW, 2010, J NUTR BIOCHEM, V21, P55, DOI 10.1016/j.jnutbio.2008.10.004; Kargiotis O, 2008, ONCOGENE, V27, P4830, DOI 10.1038/onc.2008.122; Kiselyov A, 2007, EXPERT OPIN INV DRUG, V16, P83, DOI 10.1517/13543784.16.1.83; KOBAYASHI S, 1995, BIOL PHARM BULL, V18, P1382, DOI 10.1248/bpb.18.1382; Kumaran G, 2008, CLIN MED, V8, P455, DOI 10.7861/clinmedicine.8-4-455; Lam W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001270; Lee YM, 2009, J MED FOOD, V12, P8, DOI 10.1089/jmf.2008.0039; Lee YJ, 2010, CANCER RES, V70, P8357, DOI 10.1158/0008-5472.CAN-10-1138; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Li DF, 2009, FREE RADICAL BIO MED, V46, P731, DOI 10.1016/j.freeradbiomed.2008.11.011; Limer JL, 2004, BREAST CANCER RES, V6, P119, DOI 10.1186/bcr781; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; McTigue MA, 1999, STRUCT FOLD DES, V7, P319, DOI 10.1016/S0969-2126(99)80042-2; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Oguro Y, 2010, BIOORGAN MED CHEM, V18, P7260, DOI 10.1016/j.bmc.2010.08.017; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Park I, 2009, CANCER LETT, V277, P174, DOI 10.1016/j.canlet.2008.12.005; Poveshchenko A. F., 2010, Uspekhi Fiziologicheskikh Nauk, V41, P68; Rahimi N, 2006, FRONT BIOSCI-LANDMRK, V11, P818; Randall LM, 2010, GYNECOL ONCOL, V117, P497, DOI 10.1016/j.ygyno.2010.02.021; Ruf W, 2010, THROMB RES, V125, pS36, DOI 10.1016/S0049-3848(10)70010-4; Scott A, 2009, BIOCHEM SOC T, V37, P1184, DOI 10.1042/BST0371184; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Takahashi T, 2004, CANCER SCI, V95, P448, DOI 10.1111/j.1349-7006.2004.tb03230.x; Wang N, 2012, BREAST CANCER RES TR, V134, P943, DOI 10.1007/s10549-012-1977-9; Wang ZY, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/873175; Wu GF, 2006, CARDIOVASC RES, V69, P512, DOI 10.1016/j.cardiores.2005.09.019; YAMAMOTO S, 1991, CARCINOGENESIS, V12, P317, DOI 10.1093/carcin/12.2.317; Ye L, 2009, INT J CANCER, V124, P1028, DOI 10.1002/ijc.24046; Yilmaz A, 2003, BIOCHEM BIOPH RES CO, V306, P730, DOI 10.1016/S0006-291X(03)01064-7; Zhang LQ, 2010, CELL RES, V20, P1319, DOI 10.1038/cr.2010.116; Zheng HC, 2006, ANTICANCER RES, V26, P3579	48	42	47	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68566	10.1371/journal.pone.0068566	http://dx.doi.org/10.1371/journal.pone.0068566			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861918	Green Submitted, Green Published, gold			2022-12-27	WOS:000321425300069
J	Feyrer, F; Portz, D; Odum, D; Newman, KB; Sommer, T; Contreras, D; Baxter, R; Slater, SB; Sereno, D; Van Nieuwenhuyse, E				Feyrer, Frederick; Portz, Donald; Odum, Darren; Newman, Ken B.; Sommer, Ted; Contreras, Dave; Baxter, Randall; Slater, Steven B.; Sereno, Deanna; Van Nieuwenhuyse, Erwin			SmeltCam: Underwater Video Codend for Trawled Nets with an Application to the Distribution of the Imperiled Delta Smelt	PLOS ONE			English	Article							SAN-FRANCISCO ESTUARY; WELL-MIXED ESTUARY; TIDAL TRANSPORT; OSMERUS-MORDAX; LONGITUDINAL DISTRIBUTION; SILHOUETTE PHOTOGRAPHY; REEF FISH; IN-SITU; LARVAL; ABUNDANCE	Studying rare and sensitive species is a challenge in conservation biology. The problem is exemplified by the case of the imperiled delta smelt Hypomesus transpacificus, a small delicate fish species endemic to the San Francisco Estuary, California. Persistent record-low levels of abundance and relatively high sensitivity to handling stress pose considerable challenges to studying delta smelt in the wild. To attempt to overcome these and other challenges we have developed the SmeltCam, an underwater video camera codend for trawled nets. The SmeltCam functions as an open-ended codend that automatically collects information on the number and species of fishes that pass freely through a trawled net without handling. We applied the SmeltCam to study the fine-scale distribution of juvenile delta smelt in the water column in the upper San Francisco Estuary. We learned that during flood tides delta smelt were relatively abundant throughout the water column and that during ebb tides delta smelt were significantly less abundant and occurred only in the lower half and sides of the water column. The results suggest that delta smelt manipulate their position in the water column to facilitate retention in favorable habitats. With the application of the SmeltCam we increased the survival of individual delta smelt by 72% compared to using a traditional codend, where all of the fish would have likely died due to handling stress. The SmeltCam improves upon similar previously developed silhouette photography or video recording devices and demonstrates how new technology can be developed to address important questions in conservation biology as well as lessen the negative effects associated with traditional sampling methods on imperiled species.	[Feyrer, Frederick; Van Nieuwenhuyse, Erwin] US Bur Reclamat, Bay Delta Off, Sacramento, CA USA; [Portz, Donald] US Bur Reclamat, Tech Serv Ctr, Denver, CO 80225 USA; [Odum, Darren] SureWorks LLC, Longmont, CO USA; [Newman, Ken B.] US Fish & Wildlife Serv, Lodi, CA USA; [Sommer, Ted] Calif Dept Water Resources, West Sacramento, CA USA; [Contreras, Dave; Baxter, Randall; Slater, Steven B.] Calif Dept Fish & Wildlife, Stockton, CA USA; [Sereno, Deanna] Costa Water Dist, Concord, CA USA	United States Department of the Interior; US Fish & Wildlife Service	Feyrer, F (corresponding author), US Bur Reclamat, Bay Delta Off, Sacramento, CA USA.	ffeyrer@usbr.gov	Newman, Ken/AAH-5654-2020	Newman, Kenneth/0000-0003-1734-5833	Bureau of Reclamation; California Department of Water Resources; California Department of Fish and Wildlife; State and Federal Contractors Water Agency (SFWCA)	Bureau of Reclamation; California Department of Water Resources; California Department of Fish and Wildlife; State and Federal Contractors Water Agency (SFWCA)	Funding for the research and development of the SmeltCam has been provided by the Bureau of Reclamation and the California Department of Water Resources. The California Department of Fish and Wildlife provided funding in the form of in-kind services. The State and Federal Contractors Water Agency (SFWCA) provided some additional funding to conduct the field study. SFWCA had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker A, 2010, J EXP MAR BIOL ECOL, V391, P161, DOI 10.1016/j.jembe.2010.06.028; Bennett W. A, 2005, SAN FRANCISCO ESTUAR, V3; Bennett WA, 2002, LIMNOL OCEANOGR, V47, P1496, DOI 10.4319/lo.2002.47.5.1496; Bos AR, 1999, ARCH FISH MAR RES, V47, P47; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Castillo Gonzalo, 2012, San Francisco Estuary & Watershed Science, V10, P1; Culverhouse PF, 2006, MAR ECOL PROG SER, V312, P297, DOI 10.3354/meps312297; Cutler TL, 1999, WILDLIFE SOC B, V27, P571; Daum DW, 2005, N AM J FISH MANAGE, V25, P322, DOI 10.1577/M04-086.1; DAUVIN JC, 1990, MAR ECOL PROG SER, V60, P1, DOI 10.3354/meps060001; Dege M, 2004, AM FISH S S, V39, P49; DODSON JJ, 1989, ESTUARIES, V12, P66, DOI 10.2307/1351498; Draper AJ, 2004, J WATER RES PLAN MAN, V130, P480, DOI 10.1061/(ASCE)0733-9496(2004)130:6(480); Ellender BR, 2012, AQUAT CONSERV, V22, P58, DOI 10.1002/aqc.1236; Feyrer F, 2007, CAN J FISH AQUAT SCI, V64, P723, DOI 10.1139/F07-048; Feyrer F, 2011, ESTUAR COAST, V34, P120, DOI 10.1007/s12237-010-9343-9; Frezza TL, 2003, J FRESHWATER ECOL, V18, P269, DOI 10.1080/02705060.2003.9664493; Gibson RN, 2003, HYDROBIOLOGIA, V503, P153, DOI 10.1023/B:HYDR.0000008488.33614.62; Graham DL, 2003, MARINE ECOLOGY PROGR, V254, P129; Grimaldo LF, 2009, N AM J FISH MANAGE, V29, P1253, DOI 10.1577/M08-062.1; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; HUGHES DA, 1969, BIOL BULL, V136, P43, DOI 10.2307/1539667; Jackman S., 2012, PSCL CLASSES METHODS; Jordan F, 2008, ENVIRON BIOL FISH, V81, P313, DOI 10.1007/s10641-007-9202-0; Krumme U, 2004, FISH RES, V70, P1, DOI 10.1016/j.fishres.2004.07.004; LAPRISE R, 1989, J FISH BIOL, V35, P39; LAPRISE R, 1989, MAR ECOL PROG SER, V55, P101, DOI 10.3354/meps055101; LENZ J, 1995, ICES J MAR SCI, V52, P409, DOI 10.1016/1054-3139(95)80056-5; Mac Nally R, 2010, ECOL APPL, V20, P1417, DOI 10.1890/09-1724.1; MacKenzie DI, 2005, ECOLOGY, V86, P1101, DOI 10.1890/04-1060; Martin TG, 2005, ECOL LETT, V8, P1235, DOI 10.1111/j.1461-0248.2005.00826.x; Morrison M, 2006, FISH RES, V82, P150, DOI 10.1016/j.fishres.2006.06.024; MOYLE PB, 1992, T AM FISH SOC, V121, P67, DOI 10.1577/1548-8659(1992)121<0067:LHASOD>2.3.CO;2; Newman K, 2008, SAN FRANCISCO ESTUAR; NORCROSS BL, 1984, T AM FISH SOC, V113, P153, DOI 10.1577/1548-8659(1984)113<153:OAETOF>2.0.CO;2; OLNEY JE, 1993, B MAR SCI, V52, P845; ORTNER PB, 1981, DEEP-SEA RES, V28, P1569, DOI 10.1016/0198-0149(81)90098-4; R Development Core Team, 2008, R LANG ENV STAT COMP; RIJNSDORP AD, 1985, T AM FISH SOC, V114, P461, DOI 10.1577/1548-8659(1985)114<461:STTONS>2.0.CO;2; Rockriver AK, 2004, AM FISH S S, V39, P97; Sommer T., 2011, SAN FRANC ESTUARY WA, V9, DOI 10.15447/sfews.2014v9iss2art2; Sommer T, 2007, FISHERIES, V32, P270, DOI 10.1577/1548-8446(2007)32[270:TCOPFI]2.0.CO;2; Stevens DE, 1983, T AM FISH SOC, V3, P425, DOI DOI 10.1577/1548-8659(1983)3<425:E0RF0A>2.0.00;2; Swann DE, 2004, WILDLIFE SOC B, V32, P357, DOI 10.2193/0091-7648(2004)32[357:ICFDWA]2.0.CO;2; Swanson C, 1996, T AM FISH SOC, V125, P326, DOI 10.1577/1548-8659(1996)125&lt;0326:UOSAAP&gt;2.3.CO;2; Thompson WL, 2004, SAMPLING RARE ELUSIV; Thomson J, 2009, ECOLOGICAL APPL, V20, P1431; Watson DL, 2005, MAR BIOL, V148, P415, DOI 10.1007/s00227-005-0090-6; Willis TJ, 2000, MAR FRESHWATER RES, V51, P755, DOI 10.1071/MF00010; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08	50	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67829	10.1371/journal.pone.0067829	http://dx.doi.org/10.1371/journal.pone.0067829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861814	Green Submitted, Green Published, gold			2022-12-27	WOS:000323350700042
J	Kvarnhammar, AM; Tengroth, L; Adner, M; Cardell, LO				Kvarnhammar, Anne Mansson; Tengroth, Lotta; Adner, Mikael; Cardell, Lars-Olaf			Innate Immune Receptors in Human Airway Smooth Muscle Cells: Activation by TLR1/2, TLR3, TLR4, TLR7 and NOD1 Agonists	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; TRANSLATIONAL MINIREVIEW SERIES; RECOGNITION; ACID; INFLAMMATION; EXPRESSION; PATHWAY; ASTHMA; RNA; TOLL-LIKE-RECEPTOR-2	Background: Pattern-recognition receptors (PRRs), including Toll-like receptors (TLRs), NOD-like receptors (NLRs) and RIG-I-like receptors (RLRs), recognize microbial components and trigger a host defense response. Respiratory tract infections are common causes of asthma exacerbations, suggesting a role for PRRs in this process. The present study aimed to examine the expression and function of PRRs on human airway smooth muscle cells (HASMCs). Methods: Expression of TLR, NLR and RLR mRNA and proteins was determined using real-time RT-PCR, flow cytometry and immunocytochemistry. The functional responses to ligand stimulation were investigated in terms of cytokine and chemokine release, cell surface marker expression, proliferation and proteins regulating the contractile state. Results: HASMCs expressed functional TLR2, TLR3, TLR4, TLR7 and NOD1. Stimulation with the corresponding agonists Pam(3)CSK(4), poly(I:C), LPS, R-837 and iE-DAP, respectively, induced IL-6, IL-8 and GM-CSF release and up-regulation of ICAM-1 and HLA-DR, while poly(I:C) also affected the release of eotaxin and RANTES. The proliferative response was slightly increased by LPS. Stimulation, most prominently with poly(I:C), down-regulated myosin light chain kinase and cysteinyl leukotriene 1 receptor expression and up-regulated beta(2)-adrenoceptor expression. No effects were seen for agonist to TLR2/6, TLR5, TLR8, TLR9, NOD2 or RIG-I/MDA-5. Conclusion: Activation of TLR2, TLR3, TLR4, TLR7 and NOD1 favors a synthetic phenotype, characterized by an increased ability to release inflammatory mediators, acquire immunomodulatory properties by recruiting and interacting with other cells, and reduce the contractile state. The PRRs might therefore be of therapeutic use in the management of asthma and infection-induced disease exacerbations.	[Kvarnhammar, Anne Mansson; Tengroth, Lotta; Cardell, Lars-Olaf] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div ENT Dis, Stockholm, Sweden; [Adner, Mikael] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Cardell, LO (corresponding author), Karolinska Inst, Dept Clin Sci Intervent & Technol, Div ENT Dis, Stockholm, Sweden.	lars-olaf.cardell@ki.se						Absher M, 1994, AM J PHYSIOL, V267, pL101; Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; [Anonymous], SCIENCE, V300, P1584; Bachar O, 2004, EUR J IMMUNOL, V34, P1196, DOI 10.1002/eji.200324569; Bachar O, 2006, AM J PHYSIOL-LUNG C, V291, pL322, DOI 10.1152/ajplung.00141.2006; Bogefors J, 2010, ALLERGY, V65, P1222, DOI 10.1111/j.1398-9995.2009.02315.x; Bowie AG, 2007, CLIN EXP IMMUNOL, V147, P217, DOI 10.1111/j.1365-2249.2006.03301.x; Carneiro LAM, 2008, J PATHOL, V214, P136, DOI 10.1002/path.2271; Cartwright N, 2007, AM J RESP CRIT CARE, V175, P595, DOI 10.1164/rccm.200608-1103OC; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chung KF, 2000, EUR RESPIR J, V15, P961, DOI 10.1034/j.1399-3003.2000.15e26.x; Cooper PR, 2009, AM J PHYSIOL-LUNG C, V297, pL530, DOI 10.1152/ajplung.00133.2009; Ekman AK, 2011, EUR J PHARMACOL, V652, P145, DOI 10.1016/j.ejphar.2010.11.009; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Halayko AJ, 1996, AM J PHYSIOL-LUNG C, V270, pL1040, DOI 10.1152/ajplung.1996.270.6.L1040; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kaparakis M, 2007, IMMUNOL CELL BIOL, V85, P495, DOI 10.1038/sj.icb.7100105; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kaufman EH, 2011, J ALLERGY CLIN IMMUN, V127, P462, DOI 10.1016/j.jaci.2010.10.029; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kumagai Y, 2010, J ALLERGY CLIN IMMUN, V125, P985, DOI 10.1016/j.jaci.2010.01.058; Kuo C, 2011, AM J PHYSIOL-LUNG C, V300, pL951, DOI 10.1152/ajplung.00411.2010; Lee CW, 2004, AM J PHYSIOL-LUNG C, V286, pL921, DOI 10.1152/ajplung.00124.2003; Lee IT, 2008, J IMMUNOL, V181, P5098, DOI 10.4049/jimmunol.181.7.5098; Lee IT, 2010, AM J PATHOL, V176, P1671, DOI 10.2353/ajpath.2010.090714; Lee KY, 2006, AM J RESP CELL MOL, V35, P407, DOI 10.1165/rcmb.2006-0012OC; Luo SF, 2000, BRIT J PHARMACOL, V130, P1799, DOI 10.1038/sj.bjp.0703489; Mansson A, 2006, IMMUNOLOGY, V118, P539, DOI 10.1111/j.1365-2567.2006.02392.x; Mansson Kvarnhammar A, 2011, IMMUNOLOGY, V134, P314; Moller-Larsen S, 2008, THORAX, V63, P1064, DOI 10.1136/thx.2007.094128; Moreno L, 2010, BRIT J PHARMACOL, V160, P1997, DOI 10.1111/j.1476-5381.2010.00814.x; Morishima H, 2008, INT ARCH ALLERGY IMM, V145, P163, DOI 10.1159/000108141; Morris GE, 2006, FASEB J, V20, P2153, DOI 10.1096/fj.06-5910fje; Morris GE, 2005, AM J RESP CRIT CARE, V171, P814, DOI 10.1164/rccm.200403-406OC; Niimi K, 2007, J IMMUNOL, V178, P489, DOI 10.4049/jimmunol.178.1.489; Niimi K, 2012, AM J PHYSIOL-LUNG C, V302, pL334, DOI 10.1152/ajplung.00163.2011; Parker LC, 2007, CLIN EXP IMMUNOL, V147, P199, DOI 10.1111/j.1365-2249.2006.03203.x; Patel M, 2005, J IMMUNOL, V174, P7558, DOI 10.4049/jimmunol.174.12.7558; Petterson T, 2011, IMMUNOLOGY, V133, P84, DOI 10.1111/j.1365-2567.2011.03414.x; Petterson T, 2011, J LEUKOCYTE BIOL, V89, P177, DOI 10.1189/jlb.0210061; Shan XY, 2006, AM J PHYSIOL-LUNG C, V291, pL324, DOI 10.1152/ajplung.00056.2006; Sukkar MB, 2006, J ALLERGY CLIN IMMUN, V118, P641, DOI 10.1016/j.jaci.2006.05.013; Szefler SJ, 2010, J ALLERGY CLIN IMMUN, V125, P285, DOI 10.1016/j.jaci.2009.10.026; Takahashi K, 2010, P NATL ACAD SCI USA, V107, P7431, DOI 10.1073/pnas.1002301107; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Trian T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020000; Vignola AM, 1997, AM J RESP CRIT CARE, V156, P591, DOI 10.1164/ajrccm.156.2.9609066; Zuyderduyn S, 2008, EUR RESPIR J, V32, P265, DOI 10.1183/09031936.00051407	54	41	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68701	10.1371/journal.pone.0068701	http://dx.doi.org/10.1371/journal.pone.0068701			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861935	Green Published, Green Submitted, gold			2022-12-27	WOS:000323350700100
J	Smelt, MJ; de Haan, BJ; Bron, PA; van Swam, I; Meijerink, M; Wells, JM; Faas, MM; de Vos, P				Smelt, Maaike J.; de Haan, Bart J.; Bron, Peter A.; van Swam, Iris; Meijerink, Marjolein; Wells, Jerry M.; Faas, Marijke M.; de Vos, Paul			Probiotics Can Generate FoxP3 T-Cell Responses in the Small Intestine and Simultaneously Inducing CD4 and CD8 T Cell Activation in the Large Intestine	PLOS ONE			English	Article							CD103(+) DENDRITIC CELLS; IRRITABLE-BOWEL-SYNDROME; COMPLETE GENOME SEQUENCE; LACTOBACILLUS-PLANTARUM; DOUBLE-BLIND; IN-VITRO; MAINTAINING REMISSION; ULCERATIVE-COLITIS; INFLAMMATION; IMMUNITY	Most studies on probiotics aim to restore intestinal homeostasis to reduce immune-pathology in disease. Of equal importance are studies on how probiotics might prevent or delay disease in healthy individuals. However, knowledge on mechanisms of probiotic actions in healthy individuals is scarce. To gain more insight in how different bacterial strains may modulate the healthy intestinal immune system, we investigated the effect of the food derived bacterial strains L. plantarum WCFS1, L. salivarius UCC118, and L. lactis MG1363, on the intestinal regulatory immune phenotype in healthy mice. All three bacterial strains induced an upregulation of activity and numbers of CD11c+ MHCII+ DCs in the immune-sampling Peyer's Patches. Only L. salivarius UCC118 skewed towards an immune regulatory phenotype in the small intestinal lamina propria (SILP). The effects were different in the large intestine lamina propria. L. salivarius UCC118 induced activation in both CD4 and CD8 positive T-cells while L. plantarum WCFS1 induced a more regulatory phenotype. Moreover, L. plantarum WCFS1 decreased the Th1/ Th2 ratio in the SILP. Also L. lactis MG1363 had immunomodulatory effects. L. lactis MG1363 decreased the expression of the GATA-3 and T-bet in the SILP. As our data show that contradictory effects may occur in different parts of the gut, it is recommended to study effects of probiotic in different sites in the intestine. Our strain-specific results suggest that unspecified application of probiotics may not be very effective. Our data also indicate that selection of specific probiotic strain activities on the basis of responses in healthy mice may be a promising strategy to specifically stimulate or suppress immunity in specific parts of the intestine.	[Smelt, Maaike J.; Bron, Peter A.; van Swam, Iris; Meijerink, Marjolein; Wells, Jerry M.; de Vos, Paul] Top Inst Food & Nutr, Wageningen, Netherlands; [Smelt, Maaike J.; de Haan, Bart J.; Faas, Marijke M.; de Vos, Paul] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Sect Immunoendocrinol, Groningen, Netherlands; [Bron, Peter A.; van Swam, Iris] NIZO Food Res, Ede, Netherlands; [Meijerink, Marjolein; Wells, Jerry M.] Wageningen Univ, NL-6700 AP Wageningen, Netherlands	Top Institute Food & Nutrition; University of Groningen; NIZO Food Research; Wageningen University & Research	de Vos, P (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.	p.de.vos@umcg.nl	Meijerink, Marjolein/B-9258-2014; de Vos, Paul/A-3170-2013	Meijerink, Marjolein/0000-0003-3994-9785; de vos, paul/0000-0001-9618-2408	Top Institute Food and Nutrition, Wageningen, The Netherlands	Top Institute Food and Nutrition, Wageningen, The Netherlands(Netherlands Government)	This work was supported by a project from the Top Institute Food and Nutrition, Wageningen, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooks-Worrell B, 2012, TRENDS IMMUNOL, V33, P546, DOI 10.1016/j.it.2012.07.002; CHANDRA RK, 1994, NUTRITION, V10, P207; Davidson LE, 2011, EUR J CLIN NUTR, V65, P501, DOI 10.1038/ejcn.2010.289; Dicksved J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046399; Dunne C, 1999, ANTON LEEUW INT J G, V76, P279, DOI 10.1023/A:1002065931997; Fang F, 2008, APPL ENVIRON MICROB, V74, P3216, DOI 10.1128/AEM.02631-07; Feighery LM, 2008, DIGEST DIS SCI, V53, P2495, DOI 10.1007/s10620-007-0157-y; Foligne B, 2006, DIGEST DIS SCI, V51, P390, DOI 10.1007/s10620-006-3143-x; Foligne B, 2007, GASTROENTEROLOGY, V133, P862, DOI 10.1053/j.gastro.2007.06.018; Foligne B, 2007, WORLD J GASTROENTERO, V13, P236, DOI 10.3748/wjg.v13.i2.236; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Gosselink MP, 2004, DIS COLON RECTUM, V47, P876, DOI 10.1007/s10350-004-0525-z; Grangette C, 2005, P NATL ACAD SCI USA, V102, P10321, DOI 10.1073/pnas.0504084102; Guandalini S, 2002, DIGEST LIVER DIS, V34, pS63, DOI 10.1016/S1590-8658(02)80167-0; Guandalini S, 2010, J PEDIATR GASTR NUTR, V51, P24, DOI 10.1097/MPG.0b013e3181ca4d95; Hansson GC, 2010, GUT MICROBES, V1, P51, DOI 10.4161/gmic.1.1.10470; Hatakka K, 2001, BMJ-BRIT MED J, V322, P1327, DOI 10.1136/bmj.322.7298.1327; Hojsak I, 2010, PEDIATRICS, V125, pE1171, DOI 10.1542/peds.2009-2568; Iijima H, 2001, REV MED VIROL, V11, P117, DOI 10.1002/rmv.307; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Johansson MEV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012238; Johansson ME, 2013, GUT; KAPLAN HB, 1991, SOC SCI MED, V33, P909, DOI 10.1016/0277-9536(91)90262-B; Kawase M, 2010, LETT APPL MICROBIOL, V51, P6, DOI 10.1111/j.1472-765X.2010.02849.x; Kinoshita M, 2012, J IMMUNOL, V189, P2869, DOI 10.4049/jimmunol.1200420; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Kwon HK, 2010, P NATL ACAD SCI USA, V107, P2159, DOI 10.1073/pnas.0904055107; Lemon KP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004183; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Meijerink M, 2012, FEMS IMMUNOL MED MIC, V65, P488, DOI 10.1111/j.1574-695X.2012.00981.x; Meijerink M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010632; Mimura T, 2004, GUT, V53, P108, DOI 10.1136/gut.53.1.108; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; O'Mahony L, 2005, GASTROENTEROLOGY, V128, P541, DOI 10.1053/j.gastro.2004.11.050; Osman N, 2004, DIGEST DIS SCI, V49, P320, DOI 10.1023/B:DDAS.0000017459.59088.43; Ottman N, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00104; Pathmakanthan S, 2004, J GASTROEN HEPATOL, V19, P166, DOI 10.1111/j.1440-1746.2004.03181.x; Perez-Machado MA, 2003, EUR J IMMUNOL, V33, P2307, DOI 10.1002/eji.200323308; Sartor RB, 1997, ALIMENT PHARM THERAP, V11, P17; Schultz M, 2002, INFLAMM BOWEL DIS, V8, P71, DOI 10.1097/00054725-200203000-00001; Shida K, 2008, TRENDS IMMUNOL, V29, P565, DOI 10.1016/j.it.2008.07.011; Sipos F, 2010, PATHOL ONCOL RES, V16, P11, DOI 10.1007/s12253-009-9181-x; Smelt MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063099; Smelt MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047244; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Tamboli CP, 2004, GUT, V53, P1057; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; van Baarlen P, 2009, P NATL ACAD SCI USA, V106, P2371, DOI 10.1073/pnas.0809919106; VanHemert S, LAB920080831; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; Wells JM, 2011, P NATL ACAD SCI USA, V108, P4607, DOI 10.1073/pnas.1000092107; Won TJ, 2011, CAN J PHYSIOL PHARM, V89, P429, DOI [10.1139/Y11-047, 10.1139/y11-047]; Xia Y, 2011, J GASTROEN HEPATOL, V26, P405, DOI 10.1111/j.1440-1746.2010.06498.x; Yang HY, 2009, NUTR RES, V29, P281, DOI 10.1016/j.nutres.2009.03.010; Yasui H, 2004, CLIN DIAGN LAB IMMUN, V11, P675, DOI 10.1128/CDLI.11.4.675-679.2004	59	32	36	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68952	10.1371/journal.pone.0068952	http://dx.doi.org/10.1371/journal.pone.0068952			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861953	Green Published, gold, Green Submitted			2022-12-27	WOS:000323350700109
J	Nov, Y				Nov, Yuval			Fitness Loss and Library Size Determination in Saturation Mutagenesis	PLOS ONE			English	Article							DIRECTED EVOLUTION; TARGETED LIBRARIES; PROTEIN EVOLUTION; LANDSCAPES; DESIGN; CONSTRUCTION; IMPROVEMENT; ALGORITHMS; MATURATION; ADDITIVITY	Saturation mutagenesis is a widely used directed evolution technique, in which a large number of protein variants, each having random amino acids in certain predetermined positions, are screened in order to discover high-fitness variants among them. Several metrics for determining the library size (the number of variants screened) have been suggested in the literature, but none of them incorporates the actual fitness of the variants discovered in the experiment. We present the results of an extensive simulation study, which is based on probabilistic models for protein fitness landscape, and which investigates how the result of a saturation mutagenesis experiment - the fitness of the best variant discovered - varies as a function of the library size. In particular, we study the loss of fitness in the experiment: the difference between the fitness of the best variant discovered, and the fitness of the best variant in variant space. Our results are that the existing criteria for determining the library size are conservative, so smaller libraries are often satisfactory. Reducing the library size can save labor, time, and expenses in the laboratory.	Univ Haifa, Dept Stat, IL-31999 Haifa, Israel	University of Haifa	Nov, Y (corresponding author), Univ Haifa, Dept Stat, IL-31999 Haifa, Israel.	yuval@stat.haifa.ac.il						Aita T, 2000, J MATH BIOL, V41, P207, DOI 10.1007/s002850000046; Alcolombri U, 2011, J MOL BIOL, V411, P837, DOI 10.1016/j.jmb.2011.06.037; Arnold FH, 1996, CHEM ENG SCI, V51, P5091, DOI 10.1016/S0009-2509(96)00288-6; Barak Y, 2008, ISME J, V2, P171, DOI 10.1038/ismej.2007.100; Benos PV, 2002, NUCLEIC ACIDS RES, V30, P4442, DOI 10.1093/nar/gkf578; Boersma YL, 2008, CHEM BIOL, V15, P782, DOI 10.1016/j.chembiol.2008.06.009; Bosley AD, 2005, BIOMOL ENG, V22, P57, DOI 10.1016/j.bioeng.2004.11.002; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Brouk M, 2010, APPL ENVIRON MICROB, V76, P6397, DOI 10.1128/AEM.00878-10; Carneiro M, 2010, P NATL ACAD SCI USA, V107, P1747, DOI 10.1073/pnas.0906192106; Champion E, 2010, CHEMCATCHEM, V2, P969, DOI 10.1002/cctc.201000111; DANDEKAR T, 1992, PROTEIN ENG, V5, P637, DOI 10.1093/protein/5.7.637; Drummond DA, 2005, J MOL BIOL, V350, P806, DOI 10.1016/j.jmb.2005.05.023; Feingersch R, 2008, APPL ENVIRON MICROB, V74, P1555, DOI 10.1128/AEM.01849-07; Firth AE, 2008, NUCLEIC ACIDS RES, V36, pW281, DOI 10.1093/nar/gkn226; Fox RJ, 2007, NAT BIOTECHNOL, V25, P338, DOI 10.1038/nbt1286; Goldsmith M, 2013, METHOD ENZYMOL, V523, P257, DOI 10.1016/B978-0-12-394292-0.00012-6; Herman A, 2007, PROTEIN ENG DES SEL, V20, P219, DOI 10.1093/protein/gzm014; Hughes MD, 2003, J MOL BIOL, V331, P973, DOI 10.1016/S0022-2836(03)00833-7; KAUFFMAN SA, 1989, J THEOR BIOL, V141, P211, DOI 10.1016/S0022-5193(89)80019-0; Kille S, 2013, ACS SYNTH BIOL, V2, P83, DOI 10.1021/sb300037w; Koga N, 2012, NATURE, V491, P222, DOI 10.1038/nature11600; Lutz S, 2010, CURR OPIN BIOTECH, V21, P734, DOI 10.1016/j.copbio.2010.08.011; Maeda T, 2008, APPL MICROBIOL BIOT, V79, P77, DOI 10.1007/s00253-008-1416-3; Nov Y, 2005, J COMPUT BIOL, V12, P247, DOI 10.1089/cmb.2005.12.247; Nov Y, 2012, APPL ENVIRON MICROB, V78, P258, DOI 10.1128/AEM.06265-11; Patrick WM, 2005, BIOMOL ENG, V22, P105, DOI 10.1016/j.bioeng.2005.06.001; Patrick WM, 2003, PROTEIN ENG, V16, P451, DOI 10.1093/protein/gzg057; Pavelka A, 2009, NUCLEIC ACIDS RES, V37, pW376, DOI 10.1093/nar/gkp410; Prasad S, 2011, CHEMPHYSCHEM, V12, P1550, DOI 10.1002/cphc.201100031; Reetz MT, 2008, CHEM COMMUN, P5499, DOI 10.1039/b813388c; Reetz MT, 2008, CHEMBIOCHEM, V9, P1797, DOI 10.1002/cbic.200800298; Reetz MT, 2007, NAT PROTOC, V2, P891, DOI 10.1038/nprot.2007.72; Reetz MT, 2013, ANGEW CHEM INT EDIT, V52, P2658, DOI 10.1002/anie.201207842; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Skinner MM, 1996, P NATL ACAD SCI USA, V93, P10753, DOI 10.1073/pnas.93.20.10753; SLEPIAN D, 1962, BELL SYST TECH J, V41, P463, DOI 10.1002/j.1538-7305.1962.tb02419.x; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Tang LX, 2012, BIOTECHNIQUES, V52, P149, DOI 10.2144/000113820; Voigt CA, 2001, ADV PROTEIN CHEM, V55, P79; Williams GJ, 2008, CHEM BIOL, V15, P393, DOI 10.1016/j.chembiol.2008.02.017; Wu HR, 1998, P NATL ACAD SCI USA, V95, P6037, DOI 10.1073/pnas.95.11.6037; Yeung YA, 2009, J IMMUNOL, V182, P7663, DOI 10.4049/jimmunol.0804182	45	7	7	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68069	10.1371/journal.pone.0068069	http://dx.doi.org/10.1371/journal.pone.0068069			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844158	Green Published, gold			2022-12-27	WOS:000321733000127
J	Shionome, T; Endo, S; Omagari, D; Asano, M; Toyoma, H; Ishigami, T; Komiyama, K				Shionome, Takashi; Endo, Shigeki; Omagari, Daisuke; Asano, Masatake; Toyoma, Hitoshi; Ishigami, Tomohiko; Komiyama, Kazuo			Nickel Ion Inhibits Nuclear Factor-Kappa B Activity in Human Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; HUMAN HEAD; SIGNALING PATHWAYS; GENE-EXPRESSION; TUMOR-GROWTH; ENDOTHELIAL-CELLS; ESCHERICHIA-COLI; METAL-IONS; RECEPTOR 4; IN-VIVO	Background: The spontaneous IL-8 secretion observed in OSCC is partially dependent on the disregulated activity of transcription factor NF-kappa B. Nickel compounds are well established human carcinogens, however, little is known about the influence of nickel on the spontaneous secretion of IL-8 in oral squamous cell carcinoma (OSCC) cells. The aim of the present study was to investigate whether Ni2+ ions can influence on IL-8 secretion by OSCC. Methods and Results: The IL-8 secretion was measured by ELISA. The expression of IL-8 mRNA was examined by real-time PCR. The NF-kappa B activity was measured by luciferase assay. The phosphorylation status and nuclear localization of NF-kappa B subunits were examined by Western blotting or Transfactor kit and immunofluorescence staining, respectively. The interaction of NF-kappa B p50 subunit and Ni2+ ions was examined by Ni2+-column pull down assay. The site-directed mutagenesis was used to generate a series of p50 mutants. Scratch motility assay was used to monitor the cell mobility. Our results demonstrated that, on the contrary to our expectations, Ni2+ ions inhibited the spontaneous secretion of IL-8. As IL-8 reduction was observed in a transcriptional level, we performed the luciferase assay and the data indicated that Ni2+ ions reduced the NF-kappa B activity. Measurement of p50 subunit in the nucleus and the immunofluorescence staining revealed that the inhibitory effect of Ni2+ ions was attributed to the prevention of p50 subunit accumulation to the nucleus. By Ni2+-column pull down assay, Ni2+ ions were shown to interact directly with His cluster in the N-terminus of p50 subunit. The inhibitory effect of Ni2+ ions was reverted in the transfectant expressing the His cluster-deleted p50 mutant. Moreover, Ni2+ ions inhibited the OSCC mobility in a dose dependent fashion. Conclusions: Taken together, inhibition of NF-kappa B activity by Ni2+ ion might be a novel therapeutic strategy for the treatment of oral cancer.	[Shionome, Takashi; Endo, Shigeki; Toyoma, Hitoshi; Ishigami, Tomohiko] Nihon Univ, Sch Dent, Dept Partial Denture Prosthodont, Tokyo 101, Japan; [Omagari, Daisuke; Asano, Masatake; Komiyama, Kazuo] Nihon Univ, Sch Dent, Dept Pathol, Tokyo 101, Japan	Nihon University; Nihon University	Asano, M (corresponding author), Nihon Univ, Sch Dent, Dept Pathol, Tokyo 101, Japan.	asano.masatake@nihon-u.ac.jp	Asano, Masatake/ABH-5102-2020		Nihon University Joint Research Grant; Strategic Research Base Development Program for Private Universities from Ministry of Education, Culture, Sports, Science, and Technology, JAPAN (MEXT) [S1001024, 23592778]; Health and Labour Sciences Research Grants and Research on international cooperation in medical science; Promotion and Mutual Aid Corporation for Private Schools of Japan	Nihon University Joint Research Grant; Strategic Research Base Development Program for Private Universities from Ministry of Education, Culture, Sports, Science, and Technology, JAPAN (MEXT); Health and Labour Sciences Research Grants and Research on international cooperation in medical science; Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan)	This work was supported by Nihon University Joint Research Grant for 2010-2012 (to Dr. Okayama and Dr. Imamura); a grant of Strategic Research Base Development Program for Private Universities from Ministry of Education, Culture, Sports, Science, and Technology, JAPAN (MEXT), 2010-2014 (S1001024) and 2011-2013 (23592778); Health and Labour Sciences Research Grants and Research on international cooperation in medical science; The Promotion and Mutual Aid Corporation for Private Schools of Japan (2011); and Grant-in-aid for Scientific Research (C) (2011-2013). The funders had no role in study design, deta collection and analysis, decision to publish, or preparation of the manuscript.	Allen CT, 2007, HEAD NECK-J SCI SPEC, V29, P959, DOI 10.1002/hed.20615; Antonios D, 2010, J IMMUNOL, V185, P89, DOI 10.4049/jimmunol.0901992; Asano M, 1998, J IMMUNOL METHODS, V214, P131, DOI 10.1016/S0022-1759(98)00052-0; Asano M, 2004, DNA CELL BIOL, V23, P403, DOI 10.1089/1044549041474779; Bancroft CC, 2002, INT J CANCER, V99, P538, DOI 10.1002/ijc.10398; Bindhu OS, 2006, HEAD NECK-J SCI SPEC, V28, P916, DOI 10.1002/hed.20437; BRUNE D, 1986, BIOMATERIALS, V7, P163, DOI 10.1016/0142-9612(86)90097-9; Caamano JH, 1996, MOL CELL BIOL, V16, P1342; Cangul H, 2002, TOXICOL LETT, V127, P69, DOI 10.1016/S0378-4274(01)00485-4; Costa M, 2005, MUTAT RES-FUND MOL M, V592, P79, DOI 10.1016/j.mrfmmm.2005.06.008; Cruz MT, 2004, EXP DERMATOL, V13, P18, DOI 10.1111/j.0906-6705.2004.00105.x; Duffey DC, 1999, CANCER RES, V59, P3468; GOEBELER M, 1995, J IMMUNOL, V155, P2459; GUENICHE A, 1994, ARCH DERMATOL RES, V286, P466, DOI 10.1007/BF00371573; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Gursoy UK, 2007, EUR J ORTHODONT, V29, P555, DOI 10.1093/ejo/cjm074; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; He D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-343; Hirose K, 1996, ORAL MICROBIOL IMMUN, V11, P402, DOI 10.1111/j.1399-302X.1996.tb00202.x; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hosoki M, 2009, BIO-MED MATER ENG, V19, P53, DOI 10.3233/BME-2009-0563; Hsieh PC, 2010, J CLIN PERIODONTOL, V37, P705, DOI 10.1111/j.1600-051X.2010.01542.x; Jamaluddin M, 2005, J VIROL, V79, P15302, DOI 10.1128/JVI.79.24.15302-15313.2005; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Lewis JB, 2005, J BIOMED MATER RES A, V74A, P474, DOI 10.1002/jbm.a.30383; Lewis JB, 2003, J BIOMED MATER RES A, V67A, P868, DOI 10.1002/jbm.a.10169; Lin L, 1996, MOL CELL BIOL, V16, P2248; Loercher A, 2004, CANCER RES, V64, P6511, DOI 10.1158/0008-5472.CAN-04-0852; Mishra A, 2006, INT J CANCER, V119, P2840, DOI 10.1002/ijc.22262; Molinolo AA, 2009, ORAL ONCOL, V45, P324, DOI 10.1016/j.oraloncology.2008.07.011; MOMOSE F, 1989, J ORAL PATHOL MED, V18, P391, DOI 10.1111/j.1600-0714.1989.tb01570.x; NAVARRO C, 1993, MOL MICROBIOL, V9, P1181, DOI 10.1111/j.1365-2958.1993.tb01247.x; Omagari D, 2009, CLIN EXP IMMUNOL, V156, P294, DOI 10.1111/j.1365-2249.2009.03892.x; Ondrey FG, 1999, MOL CARCINOGEN, V26, P119, DOI 10.1002/(SICI)1098-2744(199910)26:2<119::AID-MC6>3.0.CO;2-N; Pereira SG, 2008, INT J BIOCHEM CELL B, V40, P1425, DOI 10.1016/j.biocel.2007.05.004; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Richmond A, 2002, NAT REV IMMUNOL, V2, P664, DOI 10.1038/nri887; ROBERTS RS, 1989, TOXICOL IND HEALTH, V5, P975; Rowe JL, 2005, J BACTERIOL, V187, P6317, DOI 10.1128/JB.187.18.6317-6323.2005; SALNIKOW K, 1994, CANCER RES, V54, P6407; Sawhney M, 2007, INT J CANCER, V120, P2545, DOI 10.1002/ijc.22657; Scardina GA, 2009, MED ORAL PATOL ORAL, V14, pE558, DOI 10.4317/medoral.14.e558; Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919; Schulz GE, 1993, CURR OPIN CELL BIOL, V5, P701, DOI 10.1016/0955-0674(93)90143-E; SHEN HM, 1994, ENVIRON HEALTH PERSP, V102, P275, DOI 10.1289/ehp.94102s1275; Squarize CH, 2006, NEOPLASIA, V8, P733, DOI 10.1593/neo.06274; Sunwoo JB, 2001, CLIN CANCER RES, V7, P1419; Szczepanski MJ, 2009, CANCER RES, V69, P3105, DOI 10.1158/0008-5472.CAN-08-3838; Wagner M, 1998, J BIOMED MATER RES, V42, P443, DOI 10.1002/(SICI)1097-4636(19981205)42:3<443::AID-JBM14>3.0.CO;2-H; Wataha JC, 1999, J BIOMED MATER RES, V45, P251, DOI 10.1002/(SICI)1097-4636(19990605)45:3<251::AID-JBM13>3.0.CO;2-5	50	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68257	10.1371/journal.pone.0068257	http://dx.doi.org/10.1371/journal.pone.0068257			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844176	Green Published, Green Submitted, gold			2022-12-27	WOS:000321733000135
J	Hurtado, LA; Lee, EJ; Mateos, M				Hurtado, Luis A.; Lee, Eun Jung; Mateos, Mariana			Contrasting Phylogeography of Sandy vs. Rocky Supralittoral Isopods in the Megadiverse and Geologically Dynamic Gulf of California and Adjacent Areas	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; BAYESIAN PHYLOGENETIC INFERENCE; BAJA-CALIFORNIA; BEACH ISOPOD; POPULATION DIFFERENTIATION; CRUSTACEA ONISCIDEA; SOUTHERN-CALIFORNIA; CRYPTIC VICARIANCE; HISTORY; EVOLUTION	Phylogeographic studies of animals with low vagility and restricted to patchy habitats of the supralittoral zone, can uncover unknown diversity and shed light on processes that shaped evolution along a continent's edge. The Pacific coast between southern California and central Mexico, including the megadiverse Gulf of California, offers a remarkable setting to study biological diversification in the supralittoral. A complex geological history coupled with cyclical fluctuations in temperature and sea level provided ample opportunities for diversification of supralittoral organisms. Indeed, a previous phylogeographic study of Ligia, a supralittoral isopod that has limited dispersal abilities and is restricted to rocky patches, revealed high levels of morphologically cryptic diversity. Herein, we examined phylogeographic patterns of Tylos, another supralittoral isopod with limited dispersal potential, but whose habitat (i.e., sandy shores) appears to be more extensive and connected than that of Ligia. We conducted Maximum Likelihood and Bayesian phylogenetic analyses on mitochondrial and nuclear DNA sequences. These analyses revealed multiple highly divergent lineages with discrete regional distributions, despite the recognition of a single valid species for this region. A traditional species-diagnostic morphological trait distinguished several of these lineages. The phylogeographic patterns of Tylos inside the Gulf of California show a deep and complex history. In contrast, patterns along the Pacific region between southern California and the Baja Peninsula indicate a recent range expansion, probably postglacial and related to changes in sea surface temperature (SST). In general, the phylogeographic patterns of Tylos differed from those of Ligia. Differences in the extension and connectivity of the habitats occupied by Tylos and Ligia may account for the different degrees of population isolation experienced by these two isopods and their contrasting phylogeographic patterns. Identification of divergent lineages of Tylos in the study area is important for conservation, as some populations are threatened by human activities.	[Hurtado, Luis A.; Lee, Eun Jung; Mateos, Mariana] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Hurtado, LA (corresponding author), Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA.	lhurtado@tamu.edu	Hurtado, Luis A/B-5953-2008; Mateos, Mariana/B-5235-2008	Hurtado, Luis A/0000-0002-9773-4996; Mateos, Mariana/0000-0001-5738-0145	NSF [DEB 0743782]; TAMU-CONACyT; Division Of Environmental Biology [0743782] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); TAMU-CONACyT; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by NSF grant DEB 0743782 to LAH and MM, and by TAMU-CONACyT grants to LAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATWATER T, 1989, E PACIFIC OCEAN HAWA, P21, DOI DOI 10.1130/DNAG-GNA-N.21; Audouin V., 1826, DESCRIPTION EGYPTE H, P77; Briggs J.C., 1974, CIMAC C SHANGH CHIN, DOI 10.2307/1442613; BROWN AC, 1994, ADV MAR BIOL, V30, P89, DOI 10.1016/S0065-2881(08)60062-0; Brown AC, 2001, ENCY OCEAN SCI, V5, P2496; Brusca RC, 1980, COMMON INTERTIDAL IN, P220; Brusca Richard C., 2010, P72; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Burton RS, 1998, EVOLUTION, V52, P734, DOI 10.1111/j.1558-5646.1998.tb03698.x; Camacho-Ibar VF, 2003, ORG GEOCHEM, V34, P425, DOI 10.1016/S0146-6380(02)00211-5; Carefoot Thomas H., 1995, Crustacean Issues, V9, P47; Carreno AL, 2002, NEW ISLAND BIOGEOGRA; Carvajal Maria de los Angeles, 2010, P219; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Dorsey RJ, 1997, PLIOCENE CARBONATES, P83; Eberl R, J BIOGEOGR IN PRESS; Edmands S, 2001, MOL ECOL, V10, P1743, DOI 10.1046/j.0962-1083.2001.01306.x; Escalona-Alcazar F.J., 2001, REV MEX CIENC GEOL, V18, P111; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fallaci M, 1996, MAR BIOL, V125, P751, DOI 10.1007/BF00349258; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Giribet G, 1996, MOL BIOL EVOL, V13, P76, DOI 10.1093/oxfordjournals.molbev.a025573; Graham MH, 2003, TRENDS ECOL EVOL, V18, P33, DOI 10.1016/S0169-5347(02)00006-X; Grantham BA, 2003, ECOL APPL, V13, pS108; Grismer L., 1994, HERPETOLOGICAL NATUR, V2, P51; HAMNER WM, 1969, ECOLOGY, V50, P442, DOI 10.2307/1933895; HARPENDING HC, 1994, HUM BIOL, V66, P591; HAYES WB, 1970, ECOLOGY, V51, P721, DOI 10.2307/1934054; HAYES WB, 1977, PAC SCI, V31, P165; Held C, 2001, POLAR BIOL, V24, P497, DOI 10.1007/s003000100245; Helenes J, 2009, MAR MICROPALEONTOL, V72, P10, DOI 10.1016/j.marmicro.2009.02.003; Helenes J, 1999, J S AM EARTH SCI, V12, P589, DOI 10.1016/S0895-9811(99)00042-5; Hellberg ME, 2001, SCIENCE, V292, P1707, DOI 10.1126/science.1060102; HOLANOV SH, 1980, J EXP MAR BIOL ECOL, V46, P81, DOI 10.1016/0022-0981(80)90093-3; Holt JW, 2000, GEOL SOC AM BULL, V112, P540, DOI 10.1130/0016-7606(2000)112<540:AACOGO>2.0.CO;2; Hubbard DM, ESTUAR COAS IN PRESS; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hurtado LA, 2007, MAR BIOL, V151, P1863, DOI 10.1007/s00227-007-0620-5; Hurtado LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011633; Inman D.L, 1983, QUATERNARY COASTLINE, P1; Johnson ME, 2009, ATLAS COASTAL ECOSYS, P28; KARIG DE, 1972, EARTH PLANET SC LETT, V17, P169, DOI 10.1016/0012-821X(72)90272-5; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Kawai Y, 2007, J OCEANOGR, V63, P721, DOI 10.1007/s10872-007-0063-0; KENSLEY B, 1974, Annals of the South African Museum, V65, P401; Ketmaier V, 2003, MOL ECOL, V12, P547, DOI 10.1046/j.1365-294X.2003.01734.x; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; LARSON RL, 1972, GEOL SOC AM BULL, V83, P3345, DOI 10.1130/0016-7606(1972)83[3345:BMAAPT]2.0.CO;2; Ledesma-Vasquez J, 2010, GULF CALIFORNIA BIOD, P7; Ledesma-Vasquez J, 2002, REV MEXICANA CIENCIA, V19, P145; Ledesma-Vazquez J., 2009, ATLAS COASTAL ECOSYS; Lee EJ, 2012, THESIS TEXAS A M U C; Lewis PO, 2005, SYST BIOL, V54, P241, DOI 10.1080/10635150590924208; Leyva C, 2006, NAT AREA J, V26, P117, DOI 10.3375/0885-8608(2006)26[117:CLFBTD]2.0.CO;2; Lindell J, 2005, MOL PHYLOGENET EVOL, V36, P682, DOI 10.1016/j.ympev.2005.04.031; Maddison D. R., 2003, MACCLADE 4 ANAL PHYL; Marko PB, 1998, EVOLUTION, V52, P757, DOI 10.1111/j.1558-5646.1998.tb03700.x; Masselink G., 2003, INTRO COASTAL PROCES; McLachlan A, 2006, ECOLOGY SANDY SHORES, P91, DOI [10.1016/B978-012372569-1/50006-9, DOI 10.1016/B978-012372569-1/50006-9]; Meldahl Keith H., 1997, Geological Society of America Special Paper, V318, P39; Merritt TJS, 1998, MOL MAR BIOL BIOTECH, V7, P7; Mortyn PG, 1996, PALEOCEANOGRAPHY, V11, P415, DOI 10.1029/96PA01236; MULAIK S. B., 1960, REV SOC MEX HIST NAT, V21, P79; Murphy Robert W., 2002, P181; Ochoa-Landin L., 2000, REV MEXICANA CIENCIA, V17, P83; Oskin M, 2003, GEOLOGY, V31, P23, DOI 10.1130/0091-7613(2003)031<0023:MISWPB>2.0.CO;2; Pagel M, 2004, SYST BIOL, V53, P571, DOI 10.1080/10635150490468675; Palumbi Stephen R., 1996, P205; Peterson CH, 2005, BIOSCIENCE, V55, P887, DOI 10.1641/0006-3568(2005)055[0887:ATEIOB]2.0.CO;2; Podsiadlowski L, 2005, MAR BIOTECHNOL, V7, P618, DOI 10.1007/s10126-005-0017-8; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2009, TRACER V1 5 MCMC TRA; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Riddle BR, 2000, P NATL ACAD SCI USA, V97, P14438, DOI 10.1073/pnas.250413397; Riginos C, 2005, EVOLUTION, V59, P2678; Roehrdanz RL, 2002, MOL BIOL EVOL, V19, P841, DOI 10.1093/oxfordjournals.molbev.a004141; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schmalfuss Helmut, 2000, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), V612, P1; Schmalfuss Helmut, 2003, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), V654, P1; Schneider S, 1999, GENETICS, V152, P1079; SCHOENHERR AA, 1999, NATURAL HIST ISLANDS; SCHULTZ G A, 1970, Crustaceana (Leiden), V19, P297, DOI 10.1163/156854070X00383; SCHULTZ GA, 1984, J CRUSTACEAN BIOL, V4, P154, DOI 10.2307/1547904; Seapy R. R., 1980, CALIFORNIA ISLANDS, P307; Silvestro D., 2011, ORG DIVERS EVOL, V12, P335, DOI [10.1007/sI3127-011-0056-0, DOI 10.1007/S13127-011-0056-0]; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stock J. M., 2000, GEOLOGICAL SOC AM SP, V334, P143, DOI DOI 10.1130/0-8137-2334-5.143; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Suzuki Y, 2002, P NATL ACAD SCI USA, V99, P16138, DOI 10.1073/pnas.212646199; Taiti Stefano, 2004, V20, P211; Taiti Stefano, 1996, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V18, P459; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang YM, 2012, J APPL METEOROL CLIM, V51, P986, DOI 10.1175/JAMC-D-11-0253.1; Van Name W. C., 1924, Zoologica New York, V5, P181; Van Name WG, 1936, B AM MUS NAT HIST, V71, P1; VANDEL ALBERT, 1960, FAUNE DE FRANCE, V64, P1; VANDENDOOL HM, 1985, MON WEATHER REV, V113, P878, DOI 10.1175/1520-0493(1985)113<0878:SALRAT>2.0.CO;2; Waters JM, 2011, MOL ECOL, V20, P4388, DOI 10.1111/j.1365-294X.2011.05286.x; Wetzer R, 2001, CONTRIB ZOOL, V70, P23, DOI 10.1163/18759866-07001002; Wildish DJ, 2012, J NAT HIST, V46, P2329, DOI 10.1080/00222933.2012.708458; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Zwickl DJ., 2006, THESIS	105	29	29	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67827	10.1371/journal.pone.0067827	http://dx.doi.org/10.1371/journal.pone.0067827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844103	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000105
J	Wang, F; Wang, PX; Wu, XL; Dang, SY; Chen, Y; Ni, YY; Gao, LH; Lu, SY; Kuang, Y; Huang, L; Fei, J; Wang, ZG; Pang, XF				Wang, Fang; Wang, Pei-xia; Wu, Xiao-lin; Dang, Su-ying; Chen, Yan; Ni, Ying-yin; Gao, Li-hong; Lu, Shun-yuan; Kuang, Ying; Huang, Lei; Fei, Jian; Wang, Zhu-gang; Pang, Xiao-fen			Deficiency of Adiponectin Protects against Ovariectomy-Induced Osteoporosis in Mice	PLOS ONE			English	Article							BONE-MINERAL DENSITY; MESENCHYMAL STEM-CELLS; MAPK SIGNALING PATHWAY; BODY-COMPOSITION; POSTMENOPAUSAL WOMEN; PREMENOPAUSAL WOMEN; SERUM ADIPONECTIN; HUMAN OSTEOBLASTS; IN-VITRO; DIFFERENTIATION	Adipokine adiponectin (APN) has been recently reported to play a role in regulating bone mineral density (BMD). To explore the mechanism by which APN affects BMD, we investigated BMD and biomechanical strength properties of the femur and vertebra in sham-operated (Sham) and ovariectomized (OVX) APN knockout (KO) mice as compared to their operated wildtype (WT) littermates. The results show that APN deficiency has no effect on BMD but induces increased ALP activity and osteoclast cell number. While OVX indeed leads to significant bone loss in both femora and vertebras of WT mice with comparable osteogenic activity and a significant increase in osteoclast cell number when compared to that of sham control. However, no differences in BMD, ALP activity and osteoclast cell number were found between Sham and OVX mice deficient for APN. Further studies using bone marrow derived mesenchymal stem cells (MSCs) demonstrate an enhanced osteogenic differentiation and extracellular matrix calcification in APN KO mice. The possible mechanism for APN deletion induced acceleration of osteogenesis could involve increased proliferation of MSCs and higher expression of Runx2 and Osterix genes. These findings indicate that APN deficiency can protect against OVX-induced osteoporosis in mice, suggesting a potential role of APN in regulating the balance of bone formation and bone resorption, especially in the development of post-menopausal osteoporosis.	[Wang, Fang; Wu, Xiao-lin; Dang, Su-ying; Chen, Yan; Ni, Ying-yin; Huang, Lei; Wang, Zhu-gang] Shanghai Jiao Tong Univ, Dept Med Genet, E Inst Shanghai Univ, Sch Med SJTUSM, Shanghai 200030, Peoples R China; [Wang, Pei-xia; Gao, Li-hong; Pang, Xiao-fen] SJTUSM, Ruijin Hosp, Dept Geriatr, Shanghai, Peoples R China; [Lu, Shun-yuan; Kuang, Ying; Fei, Jian; Wang, Zhu-gang] Shanghai Res Ctr Model Organisms, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Pang, XF (corresponding author), SJTUSM, Ruijin Hosp, Dept Geriatr, Shanghai, Peoples R China.	xiaofenpang@yeah.net		Chen, Yan/0000-0001-5325-1151; Huang, Lei/0000-0002-4851-4807	National Natural Science Foundation of China [31000986, 30900156, 81071444]; Shanghai Science and Technology Commission [09JC1410300]; Health Bureau of Shanghai [2008053]; National Natural Science Foundation of Shanghai [10ZR1417400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); Health Bureau of Shanghai; National Natural Science Foundation of Shanghai	This work is partially supported by the grants from the National Natural Science Foundation of China (31000986, 30900156, 81071444, URL: http://www.nsfc.gov. cn/Portal0/default152.htm), Shanghai Science and Technology Commission (09JC1410300, URL: http://www.stcsm.gov.cn/structure/index.htm), the Health Bureau of Shanghai (2008053, URL: http://wsj.sh.gov.cn/), and by grants from the National Natural Science Foundation of Shanghai (10ZR1417400, URL: http://www.stcsm.gov.cn/structure/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacchetta J, 2009, NEPHROL DIAL TRANSPL, V24, P3120, DOI 10.1093/ndt/gfp262; Berner HS, 2004, BONE, V35, P842, DOI 10.1016/j.bone.2004.06.008; Buckwalter J A, 1987, Instr Course Lect, V36, P27; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0; Chao D, 2000, J AM GERIATR SOC, V48, P753, DOI 10.1111/j.1532-5415.2000.tb04749.x; Crepaldi G, 2007, J ENDOCRINOL INVEST, V30, P610, DOI 10.1007/BF03346357; Douchi T, 2000, OBSTET GYNECOL, V96, P13, DOI 10.1016/S0029-7844(00)00814-0; Ealey KN, 2008, EXP BIOL MED, V233, P1546, DOI 10.3181/0806-RM-192; Frost M, 2007, CALCIFIED TISSUE INT, V87, P36; Hankenson KD, 2000, J BONE MINER RES, V15, P851, DOI 10.1359/jbmr.2000.15.5.851; Ijuin M, 2002, MATURITAS, V43, P239, DOI 10.1016/S0378-5122(02)00273-6; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Jurimae J, 2007, OSTEOPOROSIS INT, V18, P1253, DOI 10.1007/s00198-007-0365-5; Jun AY, 2012, FITOTERAPIA, V83, P1523, DOI 10.1016/j.fitote.2012.08.020; Jurimae J, 2005, HORM METAB RES, V37, P297, DOI 10.1055/s-861483; Jurimae J, 2007, AM J PHYSIOL-ENDOC M, V293, pE42, DOI 10.1152/ajpendo.00610.2006; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Katagiri T, 2002, ORAL DIS, V8, P147, DOI 10.1034/j.1601-0825.2002.01829.x; Khan SN, 2005, J AM ACAD ORTHOP SUR, V13, P77, DOI 10.5435/00124635-200501000-00010; Lei Xianyang, 2009, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V34, P559; Lenchik L, 2003, BONE, V33, P646, DOI 10.1016/S8756-3282(03)00237-0; Luo XH, 2005, EXP CELL RES, V309, P99, DOI 10.1016/j.yexcr.2005.05.021; Luo XH, 2006, J BONE MINER RES, V21, P1648, DOI 10.1359/JBMR.060707; Luo XH, 2009, J BONE MINER RES, V24, P1461, DOI [10.1359/JBMR.090227, 10.1359/jbmr.090227]; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Magni P, 2010, CURR MOL MED, V10, P522; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Oshima K, 2005, BIOCHEM BIOPH RES CO, V331, P520, DOI 10.1016/j.bbrc.2005.03.210; Park HA, 2007, J CLIN ENDOCR METAB, V92, P3809, DOI 10.1210/jc.2007-1040; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Radak TL, 2004, NUTR REV, V62, P468, DOI 10.1111/j.1753-4887.2004.tb00019.x; Ren WH, 2006, PROG BIOCHEM BIOPHYS, V33, P846; Rendina E, 2012, J NUTR BIOCHEM, V23, P60, DOI 10.1016/j.jnutbio.2010.10.010; Richards JB, 2007, J CLIN ENDOCR METAB, V92, P1517, DOI 10.1210/jc.2006-2097; Riedt CS, 2005, J BONE MINER RES, V20, P455, DOI 10.1359/JBMR.041132; Ruscica M, 2012, VITAM HORM, V90, P321, DOI 10.1016/B978-0-12-398313-8.00012-9; Shinoda Y, 2006, J CELL BIOCHEM, V99, P196, DOI 10.1002/jcb.20890; Shu RZ, 2009, LAB INVEST, V89, P1043, DOI 10.1038/labinvest.2009.63; Taaffe DR, 2001, J BONE MINER RES, V16, P1343, DOI 10.1359/jbmr.2001.16.7.1343; Tu QS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.152405; Williams GA, 2009, ENDOCRINOLOGY, V150, P3603, DOI 10.1210/en.2008-1639; Yamaguchi N, 2008, FEBS LETT, V582, P451, DOI 10.1016/j.febslet.2007.12.037; Yamaguchi N, 2007, FEMS IMMUNOL MED MIC, V49, P28, DOI 10.1111/j.1574-695X.2006.00164.x; Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z; Zhang H, 2010, J ENDOCRINOL INVEST, V33, P707, DOI [10.1007/BF03346674, 10.3275/6886]	46	10	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68497	10.1371/journal.pone.0068497	http://dx.doi.org/10.1371/journal.pone.0068497			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844209	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000165
J	Zhan, WH; Shaboltas, AV; Skochilov, RV; Krasnoselskikh, TV; Abdala, N				Zhan, Weihai; Shaboltas, Alla V.; Skochilov, Roman V.; Krasnoselskikh, Tatiana V.; Abdala, Nadia			History of Childhood Abuse, Sensation Seeking, and Intimate Partner Violence under/Not under the Influence of a Substance: A Cross-Sectional Study in Russia	PLOS ONE			English	Article							ST-PETERSBURG; HISPANIC COUPLES; PHYSICAL ABUSE; ALCOHOL-USE; DRUG-USE; RISK; WOMEN; PERPETRATION; EXPERIENCES; BEHAVIORS	Objectives: To examine correlates of perpetration and victimization of intimate partner violence (IPV) under and not under the influence of a substance, we conducted a study among women in Russia. Methods: In 2011, a cross-sectional survey was conducted among patients receiving services at a clinic for sexually transmitted infections in St. Petersburg, Russia. Multinomial logistic regression was used for analysis. Results: Of 299 women, 104 (34.8%) and 113 (37.8%) reported a history of IPV perpetration and victimization, respectively. Nearly half (47.1%) of perpetrators and 61.1% of victims reported that the latest IPV event (perpetration and victimization, respectively) was experienced under the influence of a substance. Factors independently associated with IPV victimization under the influence of a substance were alcohol misuse and a higher number of lifetime sex partners, whereas only experience of childhood abuse (emotional and physical abuse) was independently associated with IPV victimization that did not occur under the influence of a substance. Childhood physical abuse, lower age of first sex, sensation seeking, and alcohol misuse were independently associated with IPV perpetration under the influence of a substance, while only childhood abuse (emotional and physical abuse) was independently associated with IPV perpetration that did not occur under the influence of a substance. Conclusions: IPV under and not under the influence of a substance had different correlates (e. g., alcohol misuse and sensation seeking). Despite the strong association between substance use and IPV, experience of childhood abuse is an important predictor of IPV perpetration and victimization in Russia, above and beyond substance use.	[Zhan, Weihai; Abdala, Nadia] Yale Univ, Sch Publ Hlth, Ctr Interdisciplinary Res AIDS, New Haven, CT 06520 USA; [Shaboltas, Alla V.; Skochilov, Roman V.] St Petersburg State Univ, Dept Psychol, St Petersburg 199034, Russia; [Krasnoselskikh, Tatiana V.] St Petersburg Pavlov State Med Univ, Dept Dermatol & Venereal Dis, St Petersburg, Russia	Yale University; Saint Petersburg State University; Pavlov First Saint Petersburg State Medical University	Abdala, N (corresponding author), Yale Univ, Sch Publ Hlth, Ctr Interdisciplinary Res AIDS, New Haven, CT 06520 USA.	nadia.abdala@yale.edu	Krasnoselskikh, Tatiana V/T-5370-2018; Shaboltas, Alla/AAP-7007-2020; Skochilov, Roman V/H-6541-2013; Shaboltas, Alla/AAP-7050-2020	Krasnoselskikh, Tatiana V/0000-0002-2278-5393; Skochilov, Roman V/0000-0001-6046-7655; Shaboltas, Alla/0000-0002-1966-6924	National Institute on Alcohol Abuse and Alcoholism [R01AA017389]; National Institute of Mental Health [T32MH020031]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062294, T32MH020031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017389] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was funded by grant number R01AA017389 (PI: N. Abdala) from the National Institute on Alcohol Abuse and Alcoholism (http://www.nih.gov/icd/). This study was supported by the award number T32MH020031 from the National Institute of Mental Health (http://www.nih.gov/icd/). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Health. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-676; Babor TF, 2001, CH1211 WHO DEP MENT; Bell KM, 2008, CLIN PSYCHOL REV, V28, P1096, DOI 10.1016/j.cpr.2008.03.003; Berzenski S.R., 2010, J AGGRESS MALTREAT T, V19, P180, DOI [https://doi.org/10.1080/10926770903539474, DOI 10.1080/10926770903539474]; Caetano R, 2001, ALCOHOL RES HEALTH, V25, P58; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Castro R, 2003, AM J PUBLIC HEALTH, V93, P1110, DOI 10.2105/AJPH.93.7.1110; CHERMACK ST, 1995, J STUD ALCOHOL, V56, P449, DOI 10.15288/jsa.1995.56.449; Coid J, 2001, LANCET, V358, P450, DOI 10.1016/S0140-6736(01)05622-7; Coker AL, 2000, AM J PUBLIC HEALTH, V90, P553, DOI 10.2105/AJPH.90.4.553; Coleman S, 2012, AIDS CARE; Cunradi CB, 1999, ALCOHOL CLIN EXP RES, V23, P1492, DOI 10.1111/j.1530-0277.1999.tb04672.x; Derefinko K, 2011, AGGRESSIVE BEHAV, V37, P223, DOI 10.1002/ab.20387; Dixon L, 2011, CLIN PSYCHOL REV, V31, P1145, DOI 10.1016/j.cpr.2011.07.001; Donohew RL, 1999, J STUD ALCOHOL, V60, P622, DOI 10.15288/jsa.1999.60.622; Ehrensaft MK, 2003, J CONSULT CLIN PSYCH, V71, P741, DOI 10.1037/0022-006X.71.4.741; Fals-Stewart W, 2003, ADDICT BEHAV, V28, P1555, DOI 10.1016/j.addbeh.2003.08.035; Fang XM, 2007, AM J PREV MED, V33, P281, DOI 10.1016/j.amepre.2007.06.003; Foran HM, 2008, CLIN PSYCHOL REV, V28, P1222, DOI 10.1016/j.cpr.2008.05.001; Gil-Gonzalez D, 2008, J PUBLIC HEALTH-UK, V30, P14, DOI 10.1093/pubmed/fdm071; Herrenkohl Todd I, 2004, Violence Vict, V19, P123, DOI 10.1891/088667004780927954; Hoyle RH, 2002, PERS INDIV DIFFER, V32, P401, DOI 10.1016/S0191-8869(01)00032-0; Jewkes R, 2002, LANCET, V359, P1423, DOI 10.1016/S0140-6736(02)08357-5; Kalichman SC, 2006, PSYCHOL ADDICT BEHAV, V20, P298, DOI 10.1037/0893-164X.20.3.298; LEONARD KE, 1993, J STUD ALCOHOL, P96, DOI 10.15288/jsas.1993.s11.96; Lokhmatkina NV, 2010, FAM PRACT, V27, P625, DOI 10.1093/fampra/cmq044; Lysova AV, 2008, J INTERPERS VIOLENCE, V23, P1579, DOI 10.1177/0886260508314320; Marcus RF, 2012, VIOLENCE VICTIMS, V27, P299, DOI 10.1891/0886-6708.27.3.299; Ross JM, 2011, BEHAV SCI LAW, V29, P711, DOI 10.1002/bsl.1004; Saewyc EM, 2009, J ADOLESCENT HEALTH, V45, P587, DOI 10.1016/j.jadohealth.2009.03.024; Schafer J, 2004, J INTERPERS VIOLENCE, V19, P127, DOI 10.1177/0886260503260244; STRAUS MA, 1979, J MARRIAGE FAM, V41, P75, DOI 10.2307/351733; Swogger MT, 2012, CRIM JUSTICE BEHAV, V39, P910, DOI 10.1177/0093854812438160; Temple JR, 2008, ADDICT BEHAV, V33, P1244, DOI 10.1016/j.addbeh.2008.05.005; Tjaden P, 2000, EXTENT NATURE CONSEQ; Whitfield CL, 2003, J INTERPERS VIOLENCE, V18, P166, DOI 10.1177/0886260502238733; Zhan WH, 2012, J TRAUMA STRESS, V25, P86, DOI 10.1002/jts.21658; Zhan WH, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-629	38	4	4	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68027	10.1371/journal.pone.0068027	http://dx.doi.org/10.1371/journal.pone.0068027			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	176XV	23844148	Green Submitted, gold, Green Published			2022-12-27	WOS:000321341000130
J	Hartmann, W; Brenz, Y; Kingsley, MT; Ajonina-Ekoti, I; Brattig, NW; Liebau, E; Breloer, M				Hartmann, Wiebke; Brenz, Yannick; Kingsley, Manchang Tanyi; Ajonina-Ekoti, Irene; Brattig, Norbert W.; Liebau, Eva; Breloer, Minka			Nematode-Derived Proteins Suppress Proliferation and Cytokine Production of Antigen-Specific T Cells via Induction of Cell Death	PLOS ONE			English	Article							EXCRETORY-SECRETORY PRODUCTS; HUMAN ONCHOCERCIASIS; TETANUS VACCINATION; HUMORAL RESPONSES; FASCIOLA-HEPATICA; EOSINOPHIL APOPTOSIS; LYMPHATIC FILARIASIS; ALLERGIC RESPONSES; HELMINTH; INFECTION	In order to establish long-lasting infections in their mammalian host, filarial nematodes have developed sophisticated strategies to dampen their host's immune response. Proteins that are actively secreted by the parasites have been shown to induce the expansion of regulatory T cells and to directly interfere with effector T cell function. Here, we analyze the suppressive capacity of Onchocerca volvulus-derived excreted/secreted proteins. Addition of two recombinant O. volvulus proteins, abundant larval transcript-2 (OvALT-2) and novel larval transcript-1 (OvNLT-1) to cell cultures of T cell receptor transgenic CD4(+) and CD8(+) T cells suppressed antigen-specific stimulation in vitro. Ovalbumin-specific CD4(+) DO11.10 and OT-II T cells that had been stimulated with their cognate antigen in the presence of OvALT-2 or OvNLT-1 displayed reduced DNA synthesis quantified by H-3-thymidine incorporation and reduced cell division quantified by CFSE dilution. Furthermore, the IL-2 and IFN-gamma response of ovalbumin-specific CD8(+) OT-I T cells was suppressed by OvALT-2 and OvNLT-1. In contrast, another recombinant O. volvulus protein, microfilariae surface-associated antigen (Ov103), did not modulate T cell activation, thus serving as internal control for non-ESP-mediated artifacts. Suppressive capacity of the identified ESP was associated with induction of apoptosis in T cells demonstrated by increased exposure of phosphatidylserine on the plasma membrane. Of note, the digestion of recombinant proteins with proteinase K did not abolish the suppression of antigen-specific proliferation although the suppressive capacity of the identified excreted/secreted products was not mediated by low molecular weight contaminants in the undigested preparations. In summary, we identified two suppressive excreted/secreted products from O. volvulus, which interfere with the function of antigen-specific T cells in vitro.	[Hartmann, Wiebke; Brenz, Yannick; Kingsley, Manchang Tanyi; Brattig, Norbert W.; Breloer, Minka] Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany; [Kingsley, Manchang Tanyi] Wakwa Reg Ctr, Vet Res Lab, Inst Agr Res Dev, Ngaoundere, Cameroon; [Ajonina-Ekoti, Irene; Liebau, Eva] Univ Munster, Inst Anim Physiol, D-48149 Munster, Germany	Bernhard Nocht Institut fur Tropenmedizin; University of Munster	Breloer, M (corresponding author), Bernhard Nocht Inst Trop Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	breloer@bnitm.de	Breloer, Minka/F-3999-2018	Breloer, Minka/0000-0001-6199-4908	Deutsche Forschungsgemeinschaft [PAK 296 BR 1020/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft grant number PAK 296 BR 1020/4-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham D, 2001, INFECT IMMUN, V69, P262, DOI 10.1128/IAI.69.1.262-270.2001; Bennett SRM, 1998, J EXP MED, V188, P1977, DOI 10.1084/jem.188.11.1977; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUTTNER DW, 1988, TROP MED PARASITOL, V39, P73; Chu BK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000708; CLOS J, 1994, PROTEIN EXPRES PURIF, V5, P133, DOI 10.1006/prep.1994.1020; Cooper PJ, 1999, INFECT IMMUN, V67, P5951, DOI 10.1128/IAI.67.11.5951-5957.1999; Cooper PJ, 1998, J INFECT DIS, V178, P1133, DOI 10.1086/515661; Danilowicz-Luebert E, 2013, INT J PARASITOL, V43, P201, DOI 10.1016/j.ijpara.2012.10.014; Elliott DE, 2012, ANN NY ACAD SCI, V1247, P83, DOI 10.1111/j.1749-6632.2011.06292.x; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Guasconi L, 2012, VET IMMUNOL IMMUNOP, V148, P359, DOI 10.1016/j.vetimm.2012.06.022; Harnett W, 2008, PARASITE IMMUNOL, V30, P447, DOI 10.1111/j.1365-3024.2008.01045.x; Hartmann W, 2012, EXP PARASITOL, V132, P69, DOI 10.1016/j.exppara.2011.06.001; Hartmann W, 2011, J IMMUNOL, V187, P4088, DOI 10.4049/jimmunol.1004136; Helmby H, 2009, PARASITOL INT, V58, P121, DOI 10.1016/j.parint.2009.02.001; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Hoerauf A, 2003, MICROBES INFECT, V5, P261, DOI 10.1016/S1286-4579(03)00026-1; Kolbaum J, 2011, EUR J IMMUNOL; Lizotte-Waniewski M, 2000, INFECT IMMUN, V68, P3491, DOI 10.1128/IAI.68.6.3491-3501.2000; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; Maizels RM, 2001, PARASITE IMMUNOL, V23, P327, DOI 10.1046/j.1365-3024.2001.00397.x; McSorley HJ, 2012, EUR J IMMUNOL, V42, P2667, DOI 10.1002/eji.201142161; McSorley HJ, 2012, CLIN MICROBIOL REV, V25, P585, DOI 10.1128/CMR.05040-11; Nono JK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001516; Nookala S, 2004, INFECT IMMUN, V72, P2598, DOI 10.1128/IAI.72.5.2598-2604.2004; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; Sartono E, 1995, PARASITE IMMUNOL, V17, P587, DOI 10.1111/j.1365-3024.1995.tb01002.x; Schnoeller C, 2008, J IMMUNOL, V180, P4265, DOI 10.4049/jimmunol.180.6.4265; Schonemeyer A, 2001, J IMMUNOL, V167, P3207, DOI 10.4049/jimmunol.167.6.3207; Serradell MC, 2007, VET IMMUNOL IMMUNOP, V117, P197, DOI 10.1016/j.vetimm.2007.03.007; Serradell MC, 2009, MOL BIOCHEM PARASIT, V163, P95, DOI 10.1016/j.molbiopara.2008.10.005; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Subramanian S, 2004, PARASITOLOGY, V128, P467, DOI 10.1017/S0031182004004822; Taylor MD, 2012, TRENDS IMMUNOL, V33, P181, DOI 10.1016/j.it.2012.01.001; Trujillo-Vargas CM, 2007, AM J RESP CRIT CARE, V175, P336, DOI 10.1164/rccm.200601-054OC	36	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e68380	10.1371/journal.pone.0068380	http://dx.doi.org/10.1371/journal.pone.0068380			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23861729	gold, Green Published, Green Submitted			2022-12-27	WOS:000320846500160
J	Bohl, CR; Abrahamyan, LG; Wood, C				Bohl, Christopher R.; Abrahamyan, Levon G.; Wood, Charles			Human Ubc9 Is Involved in Intracellular HIV-1 Env Stability after Trafficking out of the Trans-Golgi Network in a Gag Dependent Manner	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CONJUGATING ENZYME UBC9; GP41 CYTOPLASMIC TAIL; TYROSINE-BASED SIGNAL; ENVELOPE GLYCOPROTEIN; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; FUNCTIONAL INTERACTION; VIRION INCORPORATION; MUTATIONAL ANALYSIS	The cellular E2 Sumo conjugase, Ubc9 interacts with HIV-1 Gag, and is important for the assembly of infectious HIV-1 virions. In the previous study we demonstrated that in the absence of Ubc9, a defect in virion assembly was associated with decreased levels of mature intracellular Envelope (Env) that affected Env incorporation into virions and virion infectivity. We have further characterized the effect of Ubc9 knockdown on HIV Env processing and assembly. We found that gp160 stability in the endoplasmic reticulum (ER) and its trafficking to the trans-Golgi network (TGN) were unaffected, indicating that the decreased intracellular mature Env levels in Ubc9-depleted cells were due to a selective degradation of mature Env gp120 after cleavage from gp160 and trafficked out of the TGN. Decreased levels of Gag and mature Env were found to be associated with the plasma membrane and lipid rafts, which suggest that these viral proteins were not trafficked correctly to the assembly site. Intracellular gp120 were partially rescued when treated with a combination of lysosome inhibitors. Taken together our results suggest that in the absence of Ubc9, gp120 is preferentially degraded in the lysosomes likely before trafficking to assembly sites leading to the production of defective virions. This study provides further insight in the processing and packaging of the HIV-1 gp120 into mature HIV-1 virions.	[Wood, Charles] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68508 USA; Univ Nebraska, Sch Biol Sci, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Wood, C (corresponding author), Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68508 USA.	cwood1@unl.edu	Abrahamyan, Levon/E-1982-2013; Wood, Charles/AAH-4536-2021	Abrahamyan, Levon/0000-0002-0849-0134; Wood, Charles/0000-0002-4256-1530; Bohl, Christopher/0000-0003-4312-5172	PHS [P30 GM103509, T32 AI060547]; NATIONAL CANCER INSTITUTE [R01CA075903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103509] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by PHS grants P30 GM103509 and T32 AI060547 to CW. CRB is a NIH Ruth L. Kirschstein Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamyan LG, 2005, J VIROL, V79, P106, DOI 10.1128/JVI.79.1.106-115.2005; ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Alroy I, 2005, P NATL ACAD SCI USA, V102, P1478, DOI 10.1073/pnas.0408717102; AOYAGI T, 1969, J ANTIBIOT, V22, P283, DOI 10.7164/antibiotics.22.283; Argasinska J, 2004, J MOL BIOL, V341, P15, DOI 10.1016/j.jmb.2004.06.004; Azevedo C, 2009, P NATL ACAD SCI USA, V106, P21161, DOI 10.1073/pnas.0909176106; Batonick M, 2005, VIROLOGY, V342, P190, DOI 10.1016/j.virol.2005.08.001; Bauby H, 2010, TRAFFIC, V11, P455, DOI 10.1111/j.1600-0854.2010.01036.x; Berlioz-Torrent C, 1999, J VIROL, V73, P1350, DOI 10.1128/JVI.73.2.1350-1361.1999; BERNSTEIN HB, 1994, J VIROL, V68, P463, DOI 10.1128/JVI.68.1.463-468.1994; Bhattacharya J, 2004, J VIROL, V78, P5500, DOI 10.1128/JVI.78.10.5500-5506.2004; Bhattacharya J, 2006, J VIROL, V80, P5292, DOI 10.1128/JVI.01469-05; Blot G, 2003, J VIROL, V77, P6931, DOI 10.1128/JVI.77.12.6931-6945.2003; Boge M, 1998, J BIOL CHEM, V273, P15773, DOI 10.1074/jbc.273.25.15773; Boggio R, 2005, CELL CYCLE, V4, P533, DOI 10.4161/cc.4.4.1605; Boggio R, 2006, CURR OPIN MICROBIOL, V9, P430, DOI 10.1016/j.mib.2006.06.008; BOSCH V, 1990, J VIROL, V64, P2337, DOI 10.1128/JVI.64.5.2337-2344.1990; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Bultmann A, 2000, J VIROL, V74, P5373, DOI 10.1128/JVI.74.11.5373-5376.2000; Byland R, 2007, MOL BIOL CELL, V18, P414, DOI 10.1091/mbc.E06-06-0535; Camus G, 2007, MOL BIOL CELL, V18, P3193, DOI 10.1091/mbc.E06-12-1147; Chang YL, 2007, INT J BIOCHEM CELL B, V39, P1035, DOI 10.1016/j.biocel.2007.02.002; Chatel-Chaix L, 2004, MOL CELL BIOL, V24, P2637, DOI 10.1128/MCB.24.7.2637-2648.2004; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Christoffersen NR, 2007, RNA, V13, P1172, DOI 10.1261/rna.586807; Coffin John M., 1997; Courageot J, 1999, EUR J BIOCHEM, V260, P482, DOI 10.1046/j.1432-1327.1999.00193.x; Davis MR, 2006, J VIROL, V80, P2405, DOI 10.1128/JVI.80.5.2405-2417.2006; Deschambeault J, 1999, J VIROL, V73, P5010, DOI 10.1128/JVI.73.6.5010-5017.1999; Deyrieux AF, 2009, SUMO REGULATION OF CELLULAR PROCESSES, P315, DOI 10.1007/978-90-481-2649-1_18; Dong XH, 2005, CELL, V120, P663, DOI 10.1016/j.cell.2004.12.023; DUBAY JW, 1995, J VIROL, V69, P4675, DOI 10.1128/JVI.69.8.4675-4682.1995; EARL PL, 1991, J VIROL, V65, P2047, DOI 10.1128/JVI.65.4.2047-2055.1991; Egan MA, 1996, J VIROL, V70, P6547, DOI 10.1128/JVI.70.10.6547-6556.1996; ELDER JH, 1982, P NATL ACAD SCI-BIOL, V79, P4540, DOI 10.1073/pnas.79.15.4540; FREED EO, 1995, J VIROL, V69, P1984, DOI 10.1128/JVI.69.3.1984-1989.1995; FREED EO, 1989, J VIROL, V63, P4670, DOI 10.1128/JVI.63.11.4670-4675.1989; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; Freed EO, 1996, J VIROL, V70, P341, DOI 10.1128/JVI.70.1.341-351.1996; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Grigorov B, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-28; Guo YG, 2008, BIOCHEM BIOPH RES CO, V374, P570, DOI 10.1016/j.bbrc.2008.07.064; Gurer C, 2005, J VIROL, V79, P910, DOI 10.1128/JVI.79.2.910-917.2005; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; Hermida-Matsumoto L, 2000, J VIROL, V74, P8670, DOI 10.1128/JVI.74.18.8670-8679.2000; Ivanchenko S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000652; Jaber T, 2009, J VIROL, V83, P10448, DOI 10.1128/JVI.00237-09; Jejcic A, 2009, J VIROL, V83, P10075, DOI 10.1128/JVI.01700-08; Jiang JY, 2007, J VIROL, V81, P9999, DOI 10.1128/JVI.00592-07; Johnson MC, 2011, AIDS RES HUM RETROV, V27, P239, DOI 10.1089/AID.2010.0350; Jorgenson RL, 2009, J VIROL, V83, P4060, DOI 10.1128/JVI.02425-08; JOSHI A, J BIOL CHEM; Joshi A, 2008, MOL CELL, V30, P227, DOI 10.1016/j.molcel.2008.03.015; Jouvenet N, 2008, NATURE, V454, P236, DOI 10.1038/nature06998; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kurtzman AL, 2001, P NATL ACAD SCI USA, V98, P5602, DOI 10.1073/pnas.101129698; Lambele M, 2007, J VIROL, V81, P125, DOI 10.1128/JVI.01659-06; Lee YM, 1997, J VIROL, V71, P1443, DOI 10.1128/JVI.71.2.1443-1452.1997; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Lingappa JR, 2006, J BIOL CHEM, V281, P3773, DOI 10.1074/jbc.M507255200; Liu LB, 2007, DIABETES, V56, P1977, DOI 10.2337/db06-1100; Lodge R, 1997, EMBO J, V16, P695, DOI 10.1093/emboj/16.4.695; LODGE R, 1994, J VIROL, V68, P4857, DOI 10.1128/JVI.68.8.4857-4861.1994; Lopez-Verges S, 2006, P NATL ACAD SCI USA, V103, P14947, DOI 10.1073/pnas.0602941103; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Martinez NW, 2008, J VIROL, V82, P9937, DOI 10.1128/JVI.00819-08; MCGOWAN EB, 1989, BIOCHEM BIOPH RES CO, V158, P432, DOI 10.1016/S0006-291X(89)80065-8; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mishra RK, 2004, J BIOL CHEM, V279, P31445, DOI 10.1074/jbc.M402911200; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Murakami T, 2000, J VIROL, V74, P3548, DOI 10.1128/JVI.74.8.3548-3554.2000; Murakami T, 2000, P NATL ACAD SCI USA, V97, P343, DOI 10.1073/pnas.97.1.343; MURAKAMI T, MOL BIOL INT, V2012; Murray JL, 2005, J VIROL, V79, P11742, DOI 10.1128/JVI.79.18.11742-11751.2005; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ohno H, 1997, VIROLOGY, V238, P305, DOI 10.1006/viro.1997.8839; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ono A, 2001, P NATL ACAD SCI USA, V98, P13925, DOI 10.1073/pnas.241320298; Ono A, 2010, BIOL CELL, V102, P335, DOI 10.1042/BC20090165; OWENS RJ, 1991, P NATL ACAD SCI USA, V88, P3987, DOI 10.1073/pnas.88.9.3987; Pan X, 2006, BIOCHEM BIOPH RES CO, V344, P727, DOI 10.1016/j.bbrc.2006.03.194; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Patil A, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-3; Popov S, 2011, J VIROL, V85, P3792, DOI 10.1128/JVI.02329-10; Postler TS, 2013, J VIROL, V87, P2, DOI 10.1128/JVI.02053-12; RICH DH, 1985, BIOCHEMISTRY-US, V24, P3165, DOI 10.1021/bi00334a014; Rizos H, 2005, CELL CYCLE, V4, P597, DOI 10.4161/cc.4.4.1588; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Ryo A, 2008, P NATL ACAD SCI USA, V105, P294, DOI 10.1073/pnas.0704831105; Saltzman A, 1998, FEBS LETT, V425, P431, DOI 10.1016/S0014-5793(98)00287-7; SALZWEDEL K, 1993, J VIROL, V67, P5279, DOI 10.1128/JVI.67.9.5279-5288.1993; Salzwedel K, 1998, J VIROL, V72, P7523, DOI 10.1128/JVI.72.9.7523-7531.1998; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Sandrin V, 2004, J VIROL, V78, P7153, DOI 10.1128/JVI.78.13.7153-7164.2004; Sato K, 2011, MOL BIOL CELL, V22, P3103, DOI 10.1091/mbc.E11-03-0274; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Schubert U, 2000, P NATL ACAD SCI USA, V97, P13057, DOI 10.1073/pnas.97.24.13057; STEIN BS, 1990, J BIOL CHEM, V265, P2640; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Swanstrom R, 1997, RETROVIRUSES; Tomoiu A, 2006, J VIROL, V80, P10218, DOI 10.1128/JVI.00375-06; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Waheed AA, 2010, VIRUSES-BASEL, V2, P1146, DOI 10.3390/v2051146; Weclewicz K, 1998, J VIROL, V72, P2832, DOI 10.1128/JVI.72.4.2832-2845.1998; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WILLEY RL, 1991, VIROLOGY, V184, P319, DOI 10.1016/0042-6822(91)90848-6; WILLS JW, 1991, AIDS, V5, P639, DOI 10.1097/00002030-199106000-00002; Wyatt D, 2011, J BIOL CHEM, V286, P3884, DOI 10.1074/jbc.M110.152116; Zamborlini A, 2011, J BIOL CHEM, V286, P21013, DOI 10.1074/jbc.M110.189274; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4; Zhu S, 2010, ONCOGENE, V29, P1763, DOI 10.1038/onc.2009.459	117	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e69359	10.1371/journal.pone.0069359	http://dx.doi.org/10.1371/journal.pone.0069359			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861967	Green Published, gold			2022-12-27	WOS:000321692000043
J	Matsudaira, T; Uchida, Y; Tanabe, K; Kon, S; Watanabe, T; Taguchi, T; Arai, H				Matsudaira, Tatsuyuki; Uchida, Yasunori; Tanabe, Kenji; Kon, Shunsuke; Watanabe, Toshio; Taguchi, Tomohiko; Arai, Hiroyuki			SMAP2 Regulates Retrograde Transport from Recycling Endosomes to the Golgi	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; SHIGA TOXIN; ARF FAMILY; TRAFFICKING; COMPARTMENT; INTERACTS; CLATHRIN; DOMAIN; ROUTE; ROLES	Retrograde transport is where proteins and lipids are transported back from the plasma membrane (PM) and endosomes to the Golgi, and crucial for a diverse range of cellular functions. Recycling endosomes (REs) serve as a sorting station for the retrograde transport and we recently identified evection-2, an RE protein with a pleckstrin homology (PH) domain, as an essential factor of this pathway. How evection-2 regulates retrograde transport from REs to the Golgi is not well understood. Here, we report that evection-2 binds to SMAP2, an Arf GTPase-activating protein. Endogenous SMAP2 localized mostly in REs and to a lesser extent, the trans-Golgi network (TGN). SMAP2 binds evection-2, and the RE localization of SMAP2 was abolished in cells depleted of evection-2. Knockdown of SMAP2, like that of evection-2, impaired the retrograde transport of cholera toxin B subunit (CTxB) from REs. These findings suggest that evection-2 recruits SMAP2 to REs, thereby regulating the retrograde transport of CTxB from REs to the Golgi.	[Matsudaira, Tatsuyuki; Uchida, Yasunori; Taguchi, Tomohiko; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Hlth Chem, Tokyo, Japan; [Tanabe, Kenji] Tokyo Womens Med Univ, Med Res Inst, Tokyo, Japan; [Kon, Shunsuke] Tohoku Univ, Inst Dev Aging & Canc, Dept Mol Immunol, Sendai, Miyagi 980, Japan; [Watanabe, Toshio] Nara Womens Univ, Grad Sch Humanities & Sci, Dept Biol Sci, Nara 630, Japan; [Taguchi, Tomohiko; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Pathol Cell Biol Lab, Tokyo, Japan	University of Tokyo; Tokyo Women's Medical University; Tohoku University; Nara Womens University; University of Tokyo	Taguchi, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Hlth Chem, Tokyo, Japan.	tom_taguchi@mol.f.u-tokyo.ac.jp; harai@mol.f.u-tokyo.ac.jp	Taguchi, Tomohiko/I-5014-2019	Taguchi, Tomohiko/0000-0003-0464-6370; Tanabe, Kenji/0000-0003-2645-9429	Core Research for Evolutional Science and Technology, Japan Science and Technology Agency; Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Japanese Ministry of Education, Culture, Sports, Science, and Technology [20370045]; Grants-in-Aid for Scientific Research [23770148, 23227004] Funding Source: KAKEN	Core Research for Evolutional Science and Technology, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Core Research for Evolutional Science and Technology, Japan Science and Technology Agency (to HA), the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (to HA), and Grants-in-aid from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (20370045 to HA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dai J, 2004, DEV CELL, V7, P771, DOI 10.1016/j.devcel.2004.10.002; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Ghosh RN, 1998, J CELL BIOL, V142, P923, DOI 10.1083/jcb.142.4.923; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Kobayashi H, 2012, J CELL SCI, V125, P2235, DOI 10.1242/jcs.098657; Lencer WI, 2003, TRENDS BIOCHEM SCI, V28, P639, DOI 10.1016/j.tibs.2003.10.002; Lin SX, 2004, MOL BIOL CELL, V15, P721, DOI 10.1091/mbc.E03-07-0497; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; McKenzie J, 2009, FEBS J, V276, P1581, DOI 10.1111/j.1742-4658.2009.06890.x; McKenzie JE, 2012, TRAFFIC, V13, P1140, DOI 10.1111/j.1600-0854.2012.01374.x; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Misaki R, 2007, BIOCHEM BIOPH RES CO, V360, P580, DOI 10.1016/j.bbrc.2007.06.101; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; Natsume W, 2006, MOL BIOL CELL, V17, P2592, DOI 10.1091/mbc.E05-10-0909; Okazaki S, 2012, ACTA CRYSTALLOGR D, V68, P117, DOI 10.1107/S0907444911051626; Puri S, 2002, TRAFFIC, V3, P641, DOI 10.1034/j.1600-0854.2002.30906.x; SANDVIG K, 1992, NATURE, V358, P510, DOI 10.1038/358510a0; Shiba Y, 2010, J CELL SCI, V123, P2381, DOI 10.1242/jcs.057778; Stanley Keith K., 1993, Trends in Cell Biology, V3, P252, DOI 10.1016/0962-8924(93)90046-4; Tanabe K, 2005, MOL BIOL CELL, V16, P1617, DOI 10.1091/mbc.E04-08-0683; Thompson A, 2007, MOL BIOL CELL, V18, P2687, DOI 10.1091/mbc.E05-09-0873; Uchida Y, 2011, P NATL ACAD SCI USA, V108, P15846, DOI 10.1073/pnas.1109101108	31	6	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e69145	10.1371/journal.pone.0069145	http://dx.doi.org/10.1371/journal.pone.0069145			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861959	Green Published, Green Submitted, gold			2022-12-27	WOS:000321692000035
J	den Haan, J; Huisman, J; Dekker, F; ten Brinke, JL; Ford, AK; van Ooijen, J; van Duyl, FC; Vermeij, MJA; Visser, PM				den Haan, Joost; Huisman, Jef; Dekker, Friso; ten Brinke, Jacomina L.; Ford, Amanda K.; van Ooijen, Jan; van Duyl, Fleur C.; Vermeij, Mark J. A.; Visser, Petra M.			Fast Detection of Nutrient Limitation in Macroalgae and Seagrass with Nutrient-Induced Fluorescence	PLOS ONE			English	Article							CORAL-REEF MACROALGAE; COMMUNITY STRUCTURE; LIMITED GROWTH; FRESH-WATER; NITROGEN; PHYTOPLANKTON; PHOSPHORUS; EUTROPHICATION; TRANSIENTS; MARINE	Background: Rapid determination of which nutrients limit the primary production of macroalgae and seagrasses is vital for understanding the impacts of eutrophication on marine and freshwater ecosystems. However, current methods to assess nutrient limitation are often cumbersome and time consuming. For phytoplankton, a rapid method has been described based on short-term changes in chlorophyll fluorescence upon nutrient addition, also known as Nutrient-Induced Fluorescence Transients (NIFTs). Thus far, though, the NIFT technique was not well suited for macroalgae and seagrasses. Methodology & Principal Findings: We developed a new experimental setup so that the NIFT technique can be used to assess nutrient limitation of benthic macroalgae and seagrasses. We first tested the applicability of the technique on sea lettuce (Ulva lactuca) cultured in the laboratory on nutrient-enriched medium without either nitrogen or phosphorus. Addition of the limiting nutrient resulted in a characteristic change in the fluorescence signal, whereas addition of non-limiting nutrients did not yield a response. Next, we applied the NIFT technique to field samples of the encrusting fan-leaf alga Lobophora variegata, one of the key algal species often involved in the degradation of coral reef ecosystems. The results pointed at co-limitation of L. variegata by phosphorus and nitrogen, although it responded more strongly to phosphate than to nitrate and ammonium addition. For turtle grass (Thalassia testudinum) we found the opposite result, with a stronger NIFT response to nitrate and ammonium than to phosphate. Conclusions & Significance: Our extension of the NIFT technique offers an easy and fast method (30-60 min per sample) to determine nutrient limitation of macroalgae and seagrasses. We successfully applied this technique to macroalgae on coral reef ecosystems and to seagrass in a tropical inner bay, and foresee wider application to other aquatic plants, and to other marine and freshwater ecosystems.	[den Haan, Joost; Huisman, Jef; Dekker, Friso; Ford, Amanda K.; Vermeij, Mark J. A.; Visser, Petra M.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [ten Brinke, Jacomina L.] Wageningen Univ, Aquaculture & Fisheries Grp, NL-6700 AP Wageningen, Netherlands; [van Ooijen, Jan; van Duyl, Fleur C.] Royal Netherlands Inst Sea Res NIOZ, Den Burg, Texel, Netherlands; [Vermeij, Mark J. A.] CARMABI Fdn, Willemstad, Curacao, Netherlands	University of Amsterdam; Wageningen University & Research; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Visser, PM (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands.	p.m.visser@uva.nl	Vermeij, Mark/B-2752-2013; Vermeij, Mark/AAR-6757-2020; van Duyl, Fleur C./P-9711-2016; Ford, Amanda K/J-9774-2019; Huisman, Jef/A-1089-2013	Vermeij, Mark/0000-0001-9612-9527; Vermeij, Mark/0000-0001-9612-9527; van Duyl, Fleur C./0000-0002-8410-4151; Ford, Amanda K/0000-0002-4971-048X; Huisman, Jef/0000-0001-9598-3211; Visser, Petra/0000-0003-3294-1908; den Haan, Joost/0000-0002-5397-9027	European Union [244161]; Schure-Beijerinck-Popping Fund (The Netherlands) [SBP/JK/2011-31 KNAW]	European Union(European Commission); Schure-Beijerinck-Popping Fund (The Netherlands)(Netherlands Government)	This research was funded by the European Union Seventh Framework Programme (P7/2007-2013) under grant agreement no. 244161 (Future of Reefs in a Changing Environment), and by the Schure-Beijerinck-Popping Fund (SBP/JK/2011-31 KNAW, The Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage AR, 2005, ESTUARIES, V28, P422, DOI 10.1007/BF02693924; Beardall J, 2001, AQUAT SCI, V63, P44, DOI 10.1007/PL00001344; Beardall J, 2001, AQUAT SCI, V63, P107, DOI 10.1007/PL00001342; BELL PRF, 1992, WATER RES, V26, P553, DOI 10.1016/0043-1354(92)90228-V; Brauer VS, 2012, AM NAT, V179, P721, DOI 10.1086/665650; Burkepile DE, 2009, MAR ECOL PROG SER, V389, P71, DOI 10.3354/meps08142; Cheal AJ, 2010, CORAL REEFS, V29, P1005, DOI 10.1007/s00338-010-0661-y; Diaz-Pulido G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005239; Enriquez S, 2010, DEVEL APPL PHYCOL, V4, P187, DOI 10.1007/978-90-481-9268-7_9; FONG P, 1994, MAR ECOL PROG SER, V106, P273, DOI 10.3354/meps106273; FUJITA RM, 1985, J EXP MAR BIOL ECOL, V92, P283, DOI 10.1016/0022-0981(85)90100-5; GEIDER RJ, 1993, J PHYCOL, V29, P755, DOI 10.1111/j.0022-3646.1993.00755.x; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Grasshoff K., 1999, METHODS SEAWATER ANA, V3rd; HELDER W, 1979, NETH J SEA RES, V13, P154, DOI 10.1016/0077-7579(79)90038-3; Holland D, 2004, ECOL INDIC, V4, P149, DOI 10.1016/j.ecolind.2004.04.001; Howarth R, 2011, FRONT ECOL ENVIRON, V9, P18, DOI 10.1890/100008; Huot Y, 2010, DEVEL APPL PHYCOL, V4, P31, DOI 10.1007/978-90-481-9268-7_3; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kromkamp J, 1998, MAR ECOL PROG SER, V162, P45, DOI 10.3354/meps162045; Lapointe BE, 1997, LIMNOL OCEANOGR, V42, P1119, DOI 10.4319/lo.1997.42.5_part_2.1119; Larned ST, 1998, MAR BIOL, V132, P409, DOI 10.1007/s002270050407; Lippemeier S, 2001, EUR J PHYCOL, V36, P89, DOI 10.1017/S0967026201003031; Luo MB, 2012, AQUAT BOT, V100, P18, DOI 10.1016/j.aquabot.2012.03.006; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Mumby PJ, 2005, CORAL REEFS, V24, P681, DOI 10.1007/s00338-005-0058-5; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Nugues MM, 2008, CORAL REEFS, V27, P389, DOI 10.1007/s00338-007-0346-3; PAERL HW, 1988, LIMNOL OCEANOGR, V33, P823, DOI 10.4319/lo.1988.33.4_part_2.0823; PATRIQUIN DG, 1972, MAR BIOL, V15, P35, DOI 10.1007/BF00347435; Petrou K, 2008, J PHYCOL, V44, P1204, DOI 10.1111/j.1529-8817.2008.00585.x; Schaffelke B, 1998, MAR ECOL PROG SER, V164, P199, DOI 10.3354/meps164199; Schaffelke B, 1998, MAR ECOL PROG SER, V170, P95, DOI 10.3354/meps170095; Schaffelke B, 1999, MAR ECOL PROG SER, V182, P305, DOI 10.3354/meps182305; Shelly K, 2007, PHYCOLOGIA, V46, P503, DOI 10.2216/06-55.1; Shelly K, 2010, DEVEL APPL PHYCOL, V4, P223, DOI 10.1007/978-90-481-9268-7_11; Smith VH, 2006, LIMNOL OCEANOGR, V51, P351, DOI 10.4319/lo.2006.51.1_part_2.0351; Smith VH, 1999, ENVIRON POLLUT, V100, P179, DOI 10.1016/S0269-7491(99)00091-3; Teichberg M, 2008, MAR ECOL PROG SER, V368, P117, DOI 10.3354/meps07564; Touchette BW, 2000, J EXP MAR BIOL ECOL, V250, P133, DOI 10.1016/S0022-0981(00)00195-7; Townsend SA, 2008, FRESHWATER BIOL, V53, P509, DOI 10.1111/j.1365-2427.2007.01916.x; TURPIN DH, 1988, PLANT PHYSIOL, V88, P97, DOI 10.1104/pp.88.1.97; WOOD MD, 1995, AUST J PLANT PHYSIOL, V22, P331, DOI 10.1071/PP9950331; Young EB, 2003, J PHYCOL, V39, P332, DOI 10.1046/j.1529-8817.2003.02109.x	44	12	12	3	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68834	10.1371/journal.pone.0068834	http://dx.doi.org/10.1371/journal.pone.0068834			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861947	Green Submitted, Green Published, gold			2022-12-27	WOS:000321425300081
J	Matsubara, K; Fujino, M; Takeuchi, K; Iwata, S; Nakayama, T				Matsubara, Keita; Fujino, Motoko; Takeuchi, Kaoru; Iwata, Satoshi; Nakayama, Tetsuo			A New Method for the Detection of Neutralizing Antibodies against Mumps Virus	PLOS ONE			English	Article							COMPLEMENT-MEDIATED NEUTRALIZATION; VESICULAR STOMATITIS-VIRUS; REINFECTION; IMMUNITY; PROPOSAL; VSV	Neutralization test is the most reliable method of evaluating immunity against viral diseases but there is no standard procedure for mumps virus, with tests differing in the infectivity of the challenge virus, 50% plaque reduction or complete inhibition of cytopathic effects (CPE), and usage of complement. A reliable, easy, and simple neutralization test for mumps virus was developed in this study. A recombinant mumps virus expressing GFP was generated as a challenge virus. Complement was added to the neutralizing mixture at 1:200 when stocked serum samples were used. Neutralizing antibody titers were expressed as the reciprocal of the highest dilution that did not exceed two-fold of FU values (GFP expression) of the cell control wells. A total of 1,452 serum samples were assayed by inhibition of GFP expression in comparison with those examined by conventional 100% inhibition of CPE. 1,367 (94.1%) showed similar neutralizing antibody titers when examined by both methods. The GFP expression inhibition assay, using a recombinant mumps virus expressing GFP, is a simple and time-saving method.	[Matsubara, Keita] Hiroshima Prefectural Hosp, Dept Pediat, Minami Ku, Hiroshima, Japan; [Fujino, Motoko] Saiseikai Cent Hosp, Dept Pediat, Minato Ku, Tokyo, Japan; [Takeuchi, Kaoru] Univ Tsukuba, Fac Med, Div Biomed Sci, Dept Infect Biol, Tsukuba, Ibaraki, Japan; [Iwata, Satoshi] Keio Univ, Sch Med, Ctr Infect Dis & Infect Control, Shinjuku Ku, Tokyo, Japan; [Nakayama, Tetsuo] Kitasato Inst Life Sci, Lab Viral Infect, Minato Ku, Tokyo, Japan	Tokyo Saiseikai Central Hospital; University of Tsukuba; Keio University	Nakayama, T (corresponding author), Kitasato Inst Life Sci, Lab Viral Infect, Minato Ku, Tokyo, Japan.	tetsuo-n@lisci.kitasato-u.ac.jp	Iwata, Satoshi/L-9942-2013					[Anonymous], 2012, Wkly Epidemiol Rec, V87, P217; BEEBE DP, 1981, J IMMUNOL, V126, P1562; Carbone KM, 2007, FIELDS VIROLOGY, P1527; COOPER NR, 1984, J INVEST DERMATOL, V83, pS121, DOI 10.1111/1523-1747.ep12281847; Cusi MG, 2001, VIRUS RES, V74, P133, DOI 10.1016/S0168-1702(00)00254-9; Friedman HM, 2000, J IMMUNOL, V165, P4528, DOI 10.4049/jimmunol.165.8.4528; Fujino M, 2007, J VIROL METHODS, V142, P15, DOI 10.1016/j.jviromet.2007.01.001; Gershman K., 2006, Morbidity and Mortality Weekly Report, V55, P559; HISHIYAMA M, 1988, VACCINE, V6, P423, DOI 10.1016/0264-410X(88)90143-0; Hook LM, 2006, J VIROL, V80, P4038, DOI 10.1128/JVI.80.8.4038-4046.2006; Inou Y, 2004, J MED VIROL, V73, P97, DOI 10.1002/jmv.20065; Jin L, 2005, ARCH VIROL, V150, P1903, DOI 10.1007/s00705-005-0563-4; Johnson JB, 2008, VIROLOGY, V376, P112, DOI 10.1016/j.virol.2008.03.022; Lachmann PJ, 1997, IMMUNOL REV, V159, P69, DOI 10.1111/j.1600-065X.1997.tb01007.x; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; Matsubara K, 2012, J INFECT CHEMOTHER, V18, P466, DOI 10.1007/s10156-011-0358-3; Mehlhop E, 2006, J EXP MED, V203, P1371, DOI 10.1084/jem.20052388; MILLS BJ, 1979, J IMMUNOL, V123, P2518; Nagai T, 2007, VACCINE, V25, P2742, DOI 10.1016/j.vaccine.2005.11.068; Ninomiya K, 2009, VACCINE, V27, P6160, DOI 10.1016/j.vaccine.2009.08.020; Nojd J, 2001, VACCINE, V19, P1727, DOI 10.1016/S0264-410X(00)00392-3; OKUNO Y, 1985, MICROBIOL IMMUNOL, V29, P327, DOI 10.1111/j.1348-0421.1985.tb00831.x; Orvell C, 2002, J GEN VIROL, V83, P2489, DOI 10.1099/0022-1317-83-10-2489; Pipkin PA, 1999, J VIROL METHODS, V79, P219, DOI 10.1016/S0166-0934(99)00019-1; SASAKI K, 1976, Kitasato Archives of Experimental Medicine, V49, P43; Usonis V, 2001, INFECTION, V29, P159, DOI 10.1007/s15010-001-1098-7; Yoshida N, 2008, J MED VIROL, V80, P517, DOI 10.1002/jmv.21106	27	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e65281	10.1371/journal.pone.0065281	http://dx.doi.org/10.1371/journal.pone.0065281			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861738	gold, Green Published			2022-12-27	WOS:000321425300004
J	Gingell-Littlejohn, M; McGuinness, D; McGlynn, LM; Kingsmore, D; Stevenson, KS; Koppelstaetter, C; Clancy, MJ; Shiels, PG				Gingell-Littlejohn, Marc; McGuinness, Dagmara; McGlynn, Liane M.; Kingsmore, David; Stevenson, Karen S.; Koppelstaetter, Christian; Clancy, Marc J.; Shiels, Paul G.			Pre-Transplant CDKN2A Expression in Kidney Biopsies Predicts Renal Function and Is a Future Component of Donor Scoring Criteria	PLOS ONE			English	Article							DELAYED GRAFT FUNCTION; CELLULAR SENESCENCE; TRANSPLANTATION; P16(INK4A); TIME	CDKN2A is a proven and validated biomarker of ageing which acts as an off switch for cell proliferation. We have demonstrated previously that CDKN2A is the most robust and the strongest pre-transplant predictor of post-transplant serum creatinine when compared to "Gold Standard'' clinical factors, such as cold ischaemic time and donor chronological age. This report shows that CDKN2A is better than telomere length, the most celebrated biomarker of ageing, as a predictor of post-transplant renal function. It also shows that CDKN2A is as strong a determinant of post-transplant organ function when compared to extended criteria (ECD) kidneys. A multivariate analysis model was able to predict up to 27.1% of eGFR at one year post-transplant (p = 0.008). Significantly, CDKN2A was also able to strongly predict delayed graft function. A pre-transplant donor risk classification system based on CDKN2A and ECD criteria is shown to be feasible and commendable for implementation in the near future.	[Gingell-Littlejohn, Marc; McGuinness, Dagmara; McGlynn, Liane M.; Kingsmore, David; Stevenson, Karen S.; Clancy, Marc J.; Shiels, Paul G.] Univ Glasgow, Inst Canc Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Gingell-Littlejohn, Marc; Kingsmore, David; Stevenson, Karen S.; Clancy, Marc J.] Univ Glasgow, Western Infirm, Transplant Unit, Glasgow G11 6NT, Lanark, Scotland; [Koppelstaetter, Christian] Med Univ Innsbruck, Dept Internal Med, Div Nephrol, A-6020 Innsbruck, Austria	University of Glasgow; University of Glasgow; Medical University of Innsbruck	Shiels, PG (corresponding author), Univ Glasgow, Inst Canc Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	paul.shiels@glasgow.ac.uk		Shiels, Paul/0000-0002-7577-9843; Stevenson, Karen/0000-0002-2170-511X; Clancy, Marc/0000-0002-1709-9743; Kingsmore, David/0000-0002-0401-2178; McGuinness, Dagmara/0000-0001-9057-3504	Darlinda's Charity for Renal Research	Darlinda's Charity for Renal Research	This work was supported by Darlinda's Charity for Renal Research (http://www.darlindascharity.co.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], AM J KIDNEY DIS, V39, pS1; BAKER GT, 1988, EXP GERONTOL, V23, P223, DOI 10.1016/0531-5565(88)90025-3; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Halloran PF, 1999, J AM SOC NEPHROL, V10, P167; Koning OHJ, 1997, TRANSPLANTATION, V63, P1620, DOI 10.1097/00007890-199706150-00015; Koppelstaetter C, 2008, AGING CELL, V7, P491, DOI 10.1111/j.1474-9726.2008.00398.x; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Lamb K, 2006, NEPHROL DIAL TRANSPL, V21, P259; Lamb Kelly J, 2009, SEB Exp Biol Ser, V62, P117; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mayer G, 2006, NEPHROL DIAL TRANSPL, V21, P2, DOI 10.1093/ndt/gfi269; McGlynn LM, 2009, AGING CELL, V8, P45, DOI 10.1111/j.1474-9726.2008.00447.x; Melk A, 2005, AM J TRANSPLANT, V5, P1375, DOI 10.1111/j.1600-6143.2005.00846.x; Melk A, 2004, KIDNEY INT, V65, P510, DOI 10.1111/j.1523-1755.2004.00438.x; Melk A, 2001, J AM SOC NEPHROL, V12, P385, DOI 10.1681/ASN.V122385; Metzger RA, 2003, AM J TRANSPLANT, V3, P114, DOI 10.1034/j.1600-6143.3.s4.11.x; Morris PJ, 1999, LANCET, V354, P1147, DOI 10.1016/S0140-6736(99)01104-6; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Ornish D, 2008, LANCET ONCOL, V9, P1048, DOI 10.1016/S1470-2045(08)70234-1; Rao PS, 2009, TRANSPLANTATION, V88, P231, DOI 10.1097/TP.0b013e3181ac620b; SANFILIPPO F, 1984, TRANSPLANTATION, V38, P643, DOI 10.1097/00007890-198412000-00019; Shay JW, 2000, NAT REV MOL CELL BIO, V1, P72, DOI 10.1038/35036093; Shiels PG, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1415; Shiels PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022521; Shiels PG, 2010, J GERONTOL A-BIOL, V65, P789, DOI 10.1093/gerona/glq095; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; von Zglinicki T, 2005, CURR MOL MED, V5, P197; Yarlagadda G, 2008, NEPHROL DIAL TRANSPL, V23, P2995, DOI 10.1093/ndt/gfn158	30	39	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68133	10.1371/journal.pone.0068133	http://dx.doi.org/10.1371/journal.pone.0068133			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861858	gold, Green Published, Green Submitted			2022-12-27	WOS:000323350700070
J	Parigi, P; State, B; Dakhlallah, D; Corten, R; Cook, K				Parigi, Paolo; State, Bogdan; Dakhlallah, Diana; Corten, Rense; Cook, Karen			A Community of Strangers: The Dis-Embedding of Social Ties	PLOS ONE			English	Article								In this paper we explore two contrasting perspectives on individuals' participation in associations. On the one hand, some have considered participation the byproduct of pre-existing friendship ties - the more friends one already has in the association, the more likely he or she is to participate. On the other hand, some have considered participation to be driven by the association's capacity to form new identities - the more new friends one meets in the association, the more likely he or she is to participate. We use detailed temporal data from an online association to adjudicate between these two mechanisms and explore their interplay. Our results show a significant impact of new friendship ties on participation, compared to a negligible impact of pre-existing friends, defined here as ties to other members formed outside of the organization's context. We relate this finding to the sociological literature on participation and we explore its implications in the discussion.	[Parigi, Paolo; State, Bogdan; Dakhlallah, Diana; Cook, Karen] Stanford Univ, Dept Sociol, Stanford, CA 94305 USA; [Corten, Rense] Tilburg Univ, Dept Sociol, NL-5000 LE Tilburg, Netherlands	Stanford University; Tilburg University	Parigi, P (corresponding author), Stanford Univ, Dept Sociol, Stanford, CA 94305 USA.	pparigi@stanford.edu			Netherlands Organization for Scientific Research (NWO) [446-09-023]; Institute for Research in the Social Sciences (IRiSS) at Stanford University	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Institute for Research in the Social Sciences (IRiSS) at Stanford University	Corten's contribution was supported by a Rubicon grant from the Netherlands Organization for Scientific Research (NWO) under grant number 446-09-023. Parigi's contribution was supported by a fellowship at the Institute for Research in the Social Sciences (IRiSS) at Stanford University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almond G, 1963, CIVIC CULTURE; Baldassarri D, 2007, AM J SOCIOL, V113, P735, DOI 10.1086/521839; BEARMAN PS, 1991, SOC FORCES, V70, P321, DOI 10.2307/2580242; Boyd DM, 2007, J COMPUT-MEDIAT COMM, V13, P210, DOI 10.1111/j.1083-6101.2007.00393.x; Centola D, 2007, AM J SOCIOL, V113, P702, DOI 10.1086/521848; Dahl R. A., 1989, WHO GOVERNS DEMOCRAC; De Toqueville A, 2007, DEMOCRACY AM; Della Porta D, 1999, SOCIAL MOVEMENTS INT; Ellison NB, 2007, J COMPUT-MEDIAT COMM, V12, P1143, DOI 10.1111/j.1083-6101.2007.00367.x; FERNANDEZ RM, 1988, SOCIOL FORUM, V3, P357, DOI 10.1007/BF01116431; Gould R, 1991, AM SOCIOL REV, V56; Green Penelop, 2012, NY TIMES; Hampton K., 2003, CITY COMMUNITY, V2, P277, DOI DOI 10.1046/J.1535-6841.2003.00057.X; Howard P.N., 2010, DIGITAL ORIGINS DICT; Kairam S., 2012, ADM INT C WEB SEARCH; Lauterbach D., 2009, SURFING WEB TRUST RE; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Love I, 2006, Q REV ECON FINANC, V46, P190, DOI 10.1016/j.qref.2005.11.007; Marx P, 2012, NEW YORKER; McAdam D, 1999, POLITICAL PROCESS DE; McAdam Doug., 1988, FREEDOM SUMMER; Minkoff D, 1995, ASA ROSE BOOK SERIES, P1955; Nie NH, 2001, AM BEHAV SCI, V45, P420, DOI 10.1177/00027640121957277; Polletta F, 2001, ANNU REV SOCIOL, V27, P283, DOI 10.1146/annurev.soc.27.1.283; Putnam R.D., 1994, MAKING DEMOCRACY WOR, DOI DOI 10.2307/206637; Sampson RJ, 2005, AM J SOCIOL, V111, P673, DOI 10.1086/497351; Tarrow S, 1996, AM POLIT SCI REV, V90, P874, DOI 10.2307/2945851; Van de Donk W, 2004, CYBERPROTEST NEW MED; Weber E., 1976, PEASANTS FRENCHMEN; Wellman B., 2002, IT SOC, V1, P151	30	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67388	10.1371/journal.pone.0067388	http://dx.doi.org/10.1371/journal.pone.0067388			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	204FO	23861761	Green Submitted, Green Published, gold			2022-12-27	WOS:000323350700012
J	Ramachandran, R; Jha, V				Ramachandran, Raja; Jha, Vivekanand			Kidney Transplantation Is Associated with Catastrophic Out of Pocket Expenditure in India	PLOS ONE			English	Article							STAGE RENAL-DISEASE; HEALTH-CARE; DIALYSIS; COST; HEMODIALYSIS; COUNTRIES; IMPACT	Kidney transplantation (KT) is only viable renal replacement option for most patients in India. Most patients do not have health insurance and meet treatment expenditure from their own resources. We prospectively evaluated the expenses associated with KT and its impact on the socioeconomic status of families in a public hospital. All direct and indirect expenses incurred by the patients from the time of diagnosis of chronic kidney disease to KT were recorded. Direct expenses included physician fees, cost of drugs and disposables, dialysis, and expenses on investigations and hospitalization. Indirect expenses included travel, food, stay, and loss of income suffered by the family. Educational dropout and financial loss were also recorded. There were 43 males and 7 females between the ages of 12 and 57 years. Direct expenses ranged from US$ 2,151-23,792 and accounted for two-thirds of the total expenses. Pre-referral hospitalization, dialysis and medication accounted for majority of direct expense. Indirect expenses ranged from US$ 226-15,283. Travel expenses and loss of income accounted for most of indirect expense. About 54%, 8%, and 10% of families suffered from severe, moderate, and some financial crisis respectively. A total of 38 families had job losses, and 1 patient and 12 caregivers dropped out of studies. To conclude, KT is associated with catastrophic out-of-pocket expenditure and pushes a majority of the patients who come for treatment to public hospitals into severe financial crisis. Educational dropout and loss of jobs are other major concerns. Systematic efforts are required to address these issues.	[Ramachandran, Raja; Jha, Vivekanand] Postgrad Inst Med Educ & Res, Dept Nephrol, Chandigarh 160012, India; [Jha, Vivekanand] George Inst Global Hlth, New Delhi, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Jha, V (corresponding author), Postgrad Inst Med Educ & Res, Dept Nephrol, Chandigarh 160012, India.	vjha@pginephro.org		Ramachandran, Raja/0000-0002-1273-9107; Jha, Vivekanand/0000-0002-8015-9470				Abraham G, 2012, TRANSPLANTATION, V93, P757, DOI 10.1097/TP.0b013e3182469b91; [Anonymous], ANAL CATASTROPHIC OO; Chaib-Eddour D, 2005, TRANSPLANT P, V37, P2819, DOI 10.1016/j.transproceed.2005.05.035; Chandel N, 2009, PHARMACOGENET GENOM, V19, P458, DOI 10.1097/FPC.0b013e32832bd085; CHUGH KS, 1995, KIDNEY INT, V48, pS7; Chugh KS, 1999, TRANSPLANT P, V31, P3275, DOI 10.1016/S0041-1345(99)00722-8; Clarke KS, 2006, NEPHROL DIAL TRANSPL, V21, P1952, DOI 10.1093/ndt/gfl069; Cusumano AM, 2010, CLIN NEPHROL, V74, pS3; Flores G, 2008, HEALTH ECON, V17, P1393, DOI 10.1002/hec.1338; Jha V, 2004, RENAL FAILURE, V26, P201, DOI 10.1081/JDI-120039516; Knauf F, 2009, J AM SOC NEPHROL, V20, P2093, DOI 10.1681/ASN.2009070715; Lee H, 2002, AM J KIDNEY DIS, V40, P611, DOI 10.1053/ajkd.2002.34924; Modi GK, 2006, KIDNEY INT, V70, P2131; National Institute of Diabetes and Digestive and Kidney Diseases, 2012, US REN DAT SYST USRD; Parameswaran S, 2011, NATL MED J INDIA, V24, P208; Perovic S, 2009, VOJNOSANIT PREGL, V66, P639, DOI 10.2298/VSP0908639P; Pradhan M, 2002, HEALTH ECON, V11, P431, DOI 10.1002/hec.689; Rajapurkar MM, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-10; Ranson MK, 2002, B WORLD HEALTH ORGAN, V80, P613; Rao M, 1998, NEPHROL DIAL TRANSPL, V13, P2494, DOI 10.1093/ndt/13.10.2494; Sinha K., 2011, INDIANS PAY 78 MED E; Starzomski R, 2000, Nephrol Nurs J, V27, P17; Tantivess S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f462; University of Maryland, 2013, UOMM REC CONTR KIDN; van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; World Bank, 2013, GNI PER CAP PPP CURR; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5	28	67	71	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67812	10.1371/journal.pone.0067812	http://dx.doi.org/10.1371/journal.pone.0067812			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861812	Green Published, gold, Green Submitted			2022-12-27	WOS:000323350700040
J	Mohanty, SK; Donnelly, B; Bondoc, A; Jafri, M; Walther, A; Coots, A; McNeal, M; Witte, D; Tiao, GM				Mohanty, Sujit K.; Donnelly, Bryan; Bondoc, Alexander; Jafri, Mubeen; Walther, Ashley; Coots, Abigail; McNeal, Monica; Witte, David; Tiao, Gregory M.			Rotavirus Replication in the Cholangiocyte Mediates the Temporal Dependence of Murine Biliary Atresia	PLOS ONE			English	Article							REGULATORY T-CELLS; AUTOIMMUNE HEPATITIS; EPITHELIAL INJURY; OBSTRUCTION; MODEL; LYMPHOCYTES; ACTIVATION; INFECTION; NEWBORN	Biliary atresia (BA) is a neonatal disease that results in obliteration of the biliary tree. The murine model of BA, which mirrors the human disease, is based upon infection of newborn mice with rhesus rotavirus (RRV), leading to an obstructive cholangiopathy. The purpose of this study was to characterize the temporal relationship between viral infection and the induction of this model. BALB/c mice were infected with RRV on day of life (DOL) 0, 3, 5, and 7. Groups were characterized as early-infection (infection by DOL 3) or late-infection (infection after DOL 5). Early RRV infection induced symptoms in 95% of pups with a mortality rate of 80%. In contrast, late infection caused symptoms in only 50% of mice, and 100% of pups survived. The clinical findings correlated with histological analysis of extrahepatic biliary trees, cytokine expression, and viral titers. Primary murine cholangiocytes isolated, cultured, and infected with RRV yielded higher titers of infectious virus in those harvested from DOL 2 versus DOL 9 mice. Less interferon alpha and beta was produced in DOL 2 versus DOL 9 RRV infected primary cholangiocytes. Injection of BALB/c interferon alpha/beta receptor knockout (IFN-alpha beta R-/-) pups at DOL 7 showed increased symptoms (79%) and mortality (46%) when compared to late infected wild type mice. In conclusion, the degree of injury sustained by relatively immature cholangiocytes due to more robust RRV replication correlated with more severe clinical manifestations of cholangiopathy and higher mortality. Interferon alpha production by cholangiocytes appears to play a regulatory role. These findings confirm a temporal dependence of RRV infection in murine BA and begin to define a pathophysiologic role of the maturing cholangiocyte.	[Mohanty, Sujit K.; Donnelly, Bryan; Bondoc, Alexander; Jafri, Mubeen; Walther, Ashley; Coots, Abigail; Tiao, Gregory M.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat & Thorac Surg, Cincinnati, OH 45229 USA; [McNeal, Monica] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA; [Witte, David] Cincinnati Childrens Hosp Med Ctr, Dept Pathol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Tiao, GM (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat & Thorac Surg, Cincinnati, OH 45229 USA.	greg.tiao@cchmc.org		McNeal, Monica/0000-0002-3784-9062; Mohanty, Sujit/0000-0001-9559-4638	National Institutes of Health (NIH) [R01 DK-091566]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091566] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by National Institutes of Health (NIH) R01 DK-091566. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SR, 2007, J VIROL, V81, P1671, DOI 10.1128/JVI.02094-06; BANGARU B, 1980, LAB INVEST, V43, P456; Barnes BH, 2009, LIVER INT, V29, P1253, DOI 10.1111/j.1478-3231.2008.01921.x; Coots A, 2012, J SURG RES, V177, P275, DOI 10.1016/j.jss.2012.05.082; Czech-Schmidt G, 2001, J SURG RES, V101, P62, DOI 10.1006/jsre.2001.6234; Danis B, 2008, EUR J IMMUNOL, V38, P507, DOI 10.1002/eji.200737760; Erickson N, 2008, HEPATOLOGY, V47, P1567, DOI 10.1002/hep.22229; Glaser S, 2006, WORLD J GASTROENTERO, V12, P3523, DOI 10.3748/wjg.v12.i22.3523; Graham KL, 2005, J GEN VIROL, V86, P3397, DOI 10.1099/vir.0.81102-0; Guerrero CA, 2000, P NATL ACAD SCI USA, V97, P14644, DOI 10.1073/pnas.250299897; Hernandez HM, 2001, J PEDIATR GASTR NUTR, V32, P131, DOI 10.1097/00005176-200102000-00007; Jafri M, 2008, AM J PHYSL GASTROINT; Jafri M, 2008, AM J PHYSIOL-GASTR L, V295, pG16, DOI 10.1152/ajpgi.00442.2007; Jafri M, 2007, SURGERY, V142, P192, DOI 10.1016/j.surg.2007.03.008; Jafri M, 2009, J PEDIATR SURG, V44, P500, DOI 10.1016/j.jpedsurg.2008.07.007; Kerkar N, 1998, LANCET, V351, P409, DOI 10.1016/S0140-6736(97)06478-7; Lages CS, 2012, HEPATOLOGY, V56, P219, DOI 10.1002/hep.25662; Lopez S, 2006, CURR TOP MICROBIOL, V309, P39; Mack CL, 2007, SEMIN LIVER DIS, V27, P233, DOI 10.1055/s-2007-985068; Mack CL, 2004, PEDIATR RES, V56, P79, DOI 10.1203/01.PDR.0000130480.51066.FB; MCNEAL MM, 1994, VIROLOGY, V204, P642, DOI 10.1006/viro.1994.1579; Miethke AG, 2010, J HEPATOL, V52, P718, DOI 10.1016/j.jhep.2009.12.027; MORECKI R, 1984, HEPATOLOGY, V4, P1137, DOI 10.1002/hep.1840040608; Narayanaswamy B, 2007, HEPATOLOGY, V46, P180, DOI 10.1002/hep.21701; Petersen C, 1998, J HEPATOL, V28, P603, DOI 10.1016/S0168-8278(98)80283-3; RIEPENHOFFTALTY M, 1993, PEDIATR RES, V33, P394; RiepenhoffTalty M, 1996, J INFECT DIS, V174, P8, DOI 10.1093/infdis/174.1.8; Seo NS, 2008, P NATL ACAD SCI USA, V105, P8811, DOI 10.1073/pnas.0803934105; Shivakumar P, 2004, J CLIN INVEST, V114, P322, DOI 10.1172/jci200421153; Shivakumar P, 2007, GASTROENTEROLOGY, V133, P268, DOI 10.1053/j.gastro.2007.04.031; Shivakumar P, 2009, J CLIN INVEST, V119, P2281, DOI 10.1172/JCI38879; Sokol RJ, 2007, HEPATOLOGY, V46, P566, DOI 10.1002/hep.21790	32	19	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e69069	10.1371/journal.pone.0069069	http://dx.doi.org/10.1371/journal.pone.0069069			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844248	Green Submitted, Green Published, gold			2022-12-27	WOS:000321733000032
J	Oh, Y; Jang, D; Sonn, JY; Choe, J				Oh, Yangkyun; Jang, Donghoon; Sonn, Jun Young; Choe, Joonho			Histamine-HisCl1 Receptor Axis Regulates Wake-Promoting Signals in Drosophila melanogaster	PLOS ONE			English	Article							GATED CHLORIDE CHANNEL; H-3 RECEPTOR; HYPOTHALAMIC REGULATION; PHOTORECEPTOR SYNAPSE; CIRCADIAN-RHYTHMS; SLEEP REGULATION; MUSHROOM BODIES; NERVOUS-SYSTEM; NEURAL CIRCUIT; KNOCKOUT MICE	Histamine and its two receptors, histamine-gated chloride channel subunit 1 (HisCl1) and ora transientless (Ort), are known to control photoreception and temperature sensing in Drosophila. However, histamine signaling in the context of neural circuitry for sleep-wake behaviors has not yet been examined in detail. Here, we obtained mutant flies with compromised or enhanced histamine signaling and tested their baseline sleep. Hypomorphic mutations in histidine decarboxylase (HDC), an enzyme catalyzing the conversion from histidine to histamine, caused an increase in sleep duration. Interestingly, hisCl1 mutants but not ort mutants showed long-sleep phenotypes similar to those in hdc mutants. Increased sleep duration in hisCl1 mutants was rescued by overexpressing hisCl1 in circadian pacemaker neurons expressing a neuropeptide pigment dispersing factor (PDF). Consistently, RNA interference (RNAi)-mediated depletion of hisCl1 in PDF neurons was sufficient to mimic hisCl1 mutant phenotypes, suggesting that PDF neurons are crucial for sleep regulation by the histamine-HisCl1 signaling. Finally, either hisCl1 mutation or genetic ablation of PDF neurons dampened wake-promoting effects of elevated histamine signaling via direct histamine administration. Taken together, these data clearly demonstrate that the histamine-HisCl1 receptor axis can activate and maintain the wake state in Drosophila and that wake-activating signals may travel via the PDF neurons.	[Oh, Yangkyun; Jang, Donghoon; Sonn, Jun Young; Choe, Joonho] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Choe, J (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.	jchoe@kaist.ac.kr	Choe, Joonho/F-3066-2011	Sonn, Jun Young/0000-0002-5114-8983; Oh, Yangkyun/0000-0003-4070-7601	Brain Research Center of the 21st Century Frontier Research Program through the National Research Foundation of Korea; Ministry of Education, Science and Technology (MEST), the Republic of Korea; National Research Foundation of Korea; MEST [20110015442]	Brain Research Center of the 21st Century Frontier Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST), the Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by grants from the Brain Research Center of the 21st Century Frontier Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (MEST), the Republic of Korea, and from the National Research Foundation of Korea grant funded by MEST (No. 20110015442). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beersma D G, 1998, Sleep Med Rev, V2, P31, DOI 10.1016/S1087-0792(98)90052-1; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BRAND AH, 1993, DEVELOPMENT, V118, P401; BURG MG, 1993, EMBO J, V12, P911, DOI 10.1002/j.1460-2075.1993.tb05732.x; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; Cirelli C, 2003, BIOESSAYS, V25, P940, DOI 10.1002/bies.10333; Crocker A, 2008, J NEUROSCI, V28, P9377, DOI 10.1523/JNEUROSCI.3072-08a.2008; Crocker A, 2010, NEURON, V65, P670, DOI 10.1016/j.neuron.2010.01.032; Dai HM, 2007, NEUROSCI RES, V57, P306, DOI 10.1016/j.neures.2006.10.020; de Esch IJP, 2005, TRENDS PHARMACOL SCI, V26, P462, DOI 10.1016/j.tips.2005.07.002; de Lecea L, 2005, FEBS J, V272, P5675, DOI 10.1111/j.1742-4658.2005.04981.x; Donlea JM, 2011, SCIENCE, V332, P1571, DOI 10.1126/science.1202249; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Esbenshade TA, 2008, BRIT J PHARMACOL, V154, P1166, DOI 10.1038/bjp.2008.147; Foltenyi K, 2007, NAT NEUROSCI, V10, P1160, DOI 10.1038/nn1957; Gengs CX, 2002, J BIOL CHEM, V277, P42113, DOI 10.1074/jbc.M207133200; Gisselmann G, 2002, NAT NEUROSCI, V5, P11, DOI 10.1038/nn787; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Hamasaka Y, 2006, J COMP NEUROL, V494, P314, DOI 10.1002/cne.20807; Hamblen MJ, 1998, GENETICS, V149, P165; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hendricks JC, 2001, NAT NEUROSCI, V4, P1108, DOI 10.1038/nn743; Hendricks JC, 2000, PROG NEUROBIOL, V61, P339, DOI 10.1016/S0301-0082(99)00048-9; Hong ST, 2006, J NEUROSCI, V26, P7245, DOI 10.1523/JNEUROSCI.5426-05.2006; Huang ZL, 2006, P NATL ACAD SCI USA, V103, P4687, DOI 10.1073/pnas.0600451103; Huang ZL, 2001, P NATL ACAD SCI USA, V98, P9965, DOI 10.1073/pnas.181330998; Iovchev M, 2002, J NEUROGENET, V16, P249, DOI 10.1080/01677060216293; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; KOSAKA T, 1983, J NEUROBIOL, V14, P207, DOI 10.1002/neu.480140305; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; LEURS R, 1994, J NEUROCHEM, V62, P519; Leurs R, 2005, NAT REV DRUG DISCOV, V4, P107, DOI 10.1038/nrd1631; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Liu QL, 2012, CURR BIOL, V22, P2114, DOI 10.1016/j.cub.2012.09.008; McNabb SL, 1997, NEURON, V19, P813, DOI 10.1016/S0896-6273(00)80963-0; Mignot E, 2002, NAT NEUROSCI, V5, P1071, DOI 10.1038/nn944; MONTI JM, 1990, BRAIN RES BULL, V25, P229, DOI 10.1016/0361-9230(90)90065-8; Nassel DR, 1999, MICROSC RES TECHNIQ, V44, P121, DOI 10.1002/(SICI)1097-0029(19990115/01)44:2/3<121::AID-JEMT6>3.0.CO;2-F; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Pantazis A, 2008, J NEUROSCI, V28, P7250, DOI 10.1523/JNEUROSCI.1654-08.2008; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Parmentier R, 2002, J NEUROSCI, V22, P7695; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Roeder T, 2003, EUR J PHARMACOL, V466, P85, DOI 10.1016/S0014-2999(03)01553-X; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; SCHWARTZ JC, 1991, PHYSIOL REV, V71, P1, DOI 10.1152/physrev.1991.71.1.1; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Siegel JM, 1999, CELL, V98, P409, DOI 10.1016/S0092-8674(00)81969-8; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; Stuart AE, 2007, PROG NEUROBIOL, V82, P202, DOI 10.1016/j.pneurobio.2007.03.006; Szymusiak R, 2008, ANN NY ACAD SCI, V1129, P275, DOI 10.1196/annals.1417.027; Thakkar MM, 2011, SLEEP MED REV, V15, P65, DOI 10.1016/j.smrv.2010.06.004; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Toyota H, 2002, MOL PHARMACOL, V62, P389, DOI 10.1124/mol.62.2.389; Ueno T, 2012, NAT NEUROSCI, V15, P1516, DOI 10.1038/nn.3238; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Yuan Q, 2006, CURR BIOL, V16, P1051, DOI 10.1016/j.cub.2006.04.032; Yusein Shazie, 2008, Invertebrate Neuroscience, V8, P211, DOI 10.1007/s10158-008-0078-2; Zhou L, 1997, P NATL ACAD SCI USA, V94, P5131, DOI 10.1073/pnas.94.10.5131	68	25	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68269	10.1371/journal.pone.0068269	http://dx.doi.org/10.1371/journal.pone.0068269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844178	Green Published, Green Submitted, gold			2022-12-27	WOS:000321733000136
J	Wang, J; Xu, L; Yun, X; Yang, K; Liao, DJ; Tian, LC; Jiang, HY; Lu, WJ				Wang, Jian; Xu, Lei; Yun, Xin; Yang, Kai; Liao, Dongjiang; Tian, Lichun; Jiang, Haiyang; Lu, Wenju			Proteomic Analysis Reveals that Proteasome Subunit Beta 6 Is Involved in Hypoxia-Induced Pulmonary Vascular Remodeling in Rats	PLOS ONE			English	Article							ARTERIAL SMOOTH-MUSCLE; RECEPTOR POTENTIAL EXPRESSION; CELL-GROWTH; PRESSURE-OVERLOAD; LUNG-CANCER; INHIBITION; THERAPY; SYSTEM; MG132; CA2+	Background: Chronic hypoxia (CH) is known to be one of the major causes of pulmonary hypertension (PH), which is characterized by sustained elevation of pulmonary vascular resistance resulting from vascular remodeling. In this study, we investigated whether the ubiquitin proteasome system (UPS) was involved in the mechanism of hypoxia-induced pulmonary vascular remodeling. We isolated the distal pulmonary artery (PA) from a previously defined chronic hypoxic pulmonary hypertension (CHPH) rat model, performed proteomic analyses in search of differentially expressed proteins belonging to the UPS, and subsequently identified their roles in arterial remodeling. Results: Twenty-two proteins were differently expressed between the CH and normoxic group. Among them, the expression of proteasome subunit beta (PSMB) 1 and PSMB6 increased after CH exposure. Given that PSMB1 is a well-known structural subunit and PSMB6 is a functional subunit, we sought to assess whether PSMB6 could be related to the multiple functional changes during the CHPH process. We confirmed the proteomic results by real-time PCR and Western blot. With the increase in quantity of the active subunit, proteasome activity in both cultured pulmonary artery smooth muscle cells (PASMCs) and isolated PA from the hypoxic group increased. An MTT assay revealed that the proteasome inhibitor MG132 was able to attenuate the hypoxia-induced proliferation of PASMC in a dose-dependent manner. Knockdown of PSMB6 using siRNA also prevented hypoxia-induced proliferation. Conclusion: The present study revealed the association between increased PSMB6 and CHPH. CH up-regulated proteasome activity and the proliferation of PASMCs, which may have been related to increased PSMB6 expression and the subsequently enhanced functional catalytic sites of the proteasome. These results suggested an essential role of the proteasome during CHPH development, a novel finding requiring further study.	[Wang, Jian; Xu, Lei; Yun, Xin; Yang, Kai; Liao, Dongjiang; Tian, Lichun; Lu, Wenju] Guangzhou Med Univ, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Wang, Jian; Xu, Lei; Yun, Xin; Yang, Kai; Jiang, Haiyang] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD USA; [Lu, Wenju] Guangzhou Med Univ, Dept Lab Med, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Johns Hopkins University; Guangzhou Medical University	Wang, J (corresponding author), Guangzhou Med Univ, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	jwang31@jhmi.edu; wlu92@yahoo.com	Yang, Kai/I-6524-2019; Yun, Xin/AHB-7710-2022	Yang, Kai/0000-0003-3044-2240; Yun, Xin/0000-0001-9624-1439	Hational Institutes of Health (NIH) research grants [R01HL093020]; National Natural Science Foundation of China [81070043, 81071917, 81173112, 81170052, 81220108001]; Chinese Central Government Key Research Projects of the 973 grants [2009CB522107]; Changjiang Scholars and Innovative Research Team in University grant [IRT0961]; Guangdong Department of Science and Technology of China [2009B050700041, 2010B03160030]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme China; Guangdong Department of Education research grant [cxzd1025]; Guangdong Natural Science Foundation team grant; Guangzhou Department of Education Yangcheng Scholarship [10A058S, 12A001S]; Guangzhou Elite Scholarship Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093020] Funding Source: NIH RePORTER	Hational Institutes of Health (NIH) research grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Central Government Key Research Projects of the 973 grants(National Basic Research Program of China); Changjiang Scholars and Innovative Research Team in University grant(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Guangdong Department of Science and Technology of China; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme China; Guangdong Department of Education research grant; Guangdong Natural Science Foundation team grant; Guangzhou Department of Education Yangcheng Scholarship; Guangzhou Elite Scholarship Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Hational Institutes of Health (NIH) research grants (R01HL093020), National Natural Science Foundation of China (81070043, 81071917, 81173112, 81170052, 81220108001), Chinese Central Government Key Research Projects of the 973 grants (2009CB522107), Changjiang Scholars and Innovative Research Team in University grant (IRT0961), Guangdong Department of Science and Technology of China (2009B050700041, 2010B03160030), Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2008) China, Guangdong Department of Education research grant (cxzd1025), Guangdong Natural Science Foundation team grant (2010), Guangzhou Department of Education Yangcheng Scholarship (10A058S, 12A001S). Lei Xu was supported by the Guangzhou Elite Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beranova-Giorgianni S, 2003, TRAC-TREND ANAL CHEM, V22, P273, DOI 10.1016/S0165-9936(03)00508-9; Bulteau AL, 2001, J BIOL CHEM, V276, P30057, DOI 10.1074/jbc.M100142200; Chauhan D, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S1; Crnkovic S, 2011, RESP PHYSIOL NEUROBI, V179, P342, DOI 10.1016/j.resp.2011.09.016; D'Arcy P, 2011, NAT MED, V17, P1636, DOI 10.1038/nm.2536; de Wilt LHAM, 2012, BIOCHEM PHARMACOL, V83, P207, DOI 10.1016/j.bcp.2011.10.009; Depre C, 2006, CIRCULATION, V114, P1821, DOI 10.1161/CIRCULATIONAHA.106.637827; Divald A, 2010, CIRC RES, V106, P1829, DOI 10.1161/CIRCRESAHA.110.219485; Eba S, 2013, AM J RESP CELL MOL B; Friehs I, 2008, AM J PHYSIOL-HEART C, V295, pH1373, DOI 10.1152/ajpheart.00886.2008; Groll M, 2003, INT J BIOCHEM CELL B, V35, P606, DOI 10.1016/S1357-2725(02)00390-4; Han YH, 2010, HUM EXP TOXICOL, V29, P607, DOI 10.1177/0960327109358733; Hedhli N, 2008, AM J PHYSIOL-HEART C, V295, pH1385, DOI 10.1152/ajpheart.00532.2008; Hedhli N, 2010, CARDIOVASC RES, V85, P321, DOI 10.1093/cvr/cvp226; Huang HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052576; Kim SY, 2012, AM J RESP CELL MOL, V47, P698, DOI 10.1165/rcmb.2011-0331OC; Koch A, 2011, CELL CYCLE, V10, P1200, DOI 10.4161/cc.10.8.15327; Li HH, 2011, AM J PATHOL, V178, P1043, DOI 10.1016/j.ajpath.2010.11.049; Lu WJ, 2010, AM J PHYSIOL-CELL PH, V298, pC114, DOI 10.1152/ajpcell.00629.2008; Luo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056774; LUPAS A, 1993, ENZYME PROTEIN, V47, P252, DOI 10.1159/000468684; Ma Y, 2011, BIOCHEM PHARMACOL, V81, P1228, DOI 10.1016/j.bcp.2011.03.009; Malhotra D, 2009, AM J RESP CRIT CARE, V180, P1196, DOI 10.1164/rccm.200903-0324OC; Mato AR, 2012, ONCOLOGIST, V17, P694, DOI 10.1634/theoncologist.2011-0341; Nandi D, 2006, J BIOSCIENCES, V31, P137, DOI 10.1007/BF02705243; Pan J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013298; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Powell SR, 2012, PROG MOL BIOL TRANSL, V109, P295, DOI 10.1016/B978-0-12-397863-9.00009-2; Saeki Y, 2012, METHODS MOL BIOL, V832, P315, DOI 10.1007/978-1-61779-474-2_22; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shimoda LA, 2006, MICROCIRCULATION, V13, P657, DOI 10.1080/10739680600930305; Slingerland J, 1998, Results Probl Cell Differ, V22, P133; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009; Tanaka K, 1998, J BIOCHEM-TOKYO, V123, P195; Tashkin DP, 2009, RESP MED, V103, P963, DOI 10.1016/j.rmed.2009.02.013; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Wang C, 2008, J PHARMACOL SCI, V108, P71, DOI 10.1254/jphs.08069FP; Wang J, 2004, AM J PHYSIOL-LUNG C, V286, pL848, DOI 10.1152/ajplung.00319.2003; Wang J, 2006, CIRC RES, V98, P1528, DOI 10.1161/01.RES.0000227551.68124.98; Wang J, 2013, AM J RESP CELL MOL, V48, P125, DOI 10.1165/rcmb.2012-0071OC; Weiss Curtis H, 2010, Proc Am Thorac Soc, V7, P77, DOI 10.1513/pats.200906-055JS; You BR, 2011, DRUG CHEM TOXICOL, V34, P45, DOI 10.3109/01480545.2010.494663; Zwickl P, 1999, PHILOS T R SOC B, V354, P1501, DOI 10.1098/rstb.1999.0494	44	19	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67942	10.1371/journal.pone.0067942	http://dx.doi.org/10.1371/journal.pone.0067942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844134	Green Published, gold, Green Submitted			2022-12-27	WOS:000321733000117
J	Frank, DU; Emechebe, U; Thomas, KR; Moon, AM				Frank, Deborah U.; Emechebe, Uchenna; Thomas, Kirk R.; Moon, Anne M.			Mouse Tbx3 Mutants Suggest Novel Molecular Mechanisms for Ulnar-Mammary Syndrome	PLOS ONE			English	Article							GENOTYPE-PHENOTYPE RELATIONSHIP; EXPRESSION; MUTATIONS; GENE; LIMB; DEFECTS; FAMILY; DOMAIN	The transcription factor TBX3 plays critical roles in development and TBX3 mutations in humans cause Ulnar-mammary syndrome. Efforts to understand how altered TBX3 dosage and function disrupt the development of numerous structures have been hampered by embryonic lethality of mice bearing presumed null alleles. We generated a novel conditional null allele of Tbx3: after Cre-mediated recombination, no mRNA or protein is detectable. In contrast, a putative null allele in which exons 1-3 are deleted produces a truncated protein that is abnormally located in the cytoplasm. Heterozygotes and homozygotes for this allele have different phenotypes than their counterparts bearing a true null allele. Our observations with these alleles in mice, and the different types of TBX3 mutations observed in human ulnar-mammary syndrome, suggest that not all mutations observed in humans generate functionally null alleles. The possibility that mechanisms in addition to TBX3 haploinsufficiency may cause UMS or other malformations merits investigation in the human UMS population.	[Frank, Deborah U.; Moon, Anne M.] Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA; [Emechebe, Uchenna; Moon, Anne M.] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT USA; [Moon, Anne M.] Univ Utah, Dept Human Genet, Salt Lake City, UT USA; [Moon, Anne M.] Univ Utah, Program Mol Med, Salt Lake City, UT USA; [Thomas, Kirk R.; Moon, Anne M.] Weis Ctr Res, Danville, PA USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Moon, AM (corresponding author), Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA.	anne.moon@genetics.utah.edu	Frank, Deborah/K-7111-2019	Frank, Deborah/0000-0003-0901-5420; moon, anne/0000-0002-9090-1093	Primary Children's Medical Center Foundation Awards; March of Dimes Basil O'Connor Award; Pediatric Critical Care Scientist Development Program National Institutes of Health [K12HD047349]; National Institutes of Health [R01HD046767]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD046767] Funding Source: NIH RePORTER	Primary Children's Medical Center Foundation Awards; March of Dimes Basil O'Connor Award(March of Dimes); Pediatric Critical Care Scientist Development Program National Institutes of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by: Primary Children's Medical Center Foundation Awards (DUF, AMM); March of Dimes Basil O'Connor Award (DUF, AMM); Pediatric Critical Care Scientist Development Program National Institutes of Health [grant number K12HD047349] (DUF); and National Institutes of Health [grant number R01HD046767] (AMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Bamshad M, 1999, AM J HUM GENET, V64, P1550, DOI 10.1086/302417; Bimber B, 2007, DEV BIOL, V302, P230, DOI 10.1016/j.ydbio.2006.09.023; Carlson H, 2001, HUM MOL GENET, V10, P2403, DOI 10.1093/hmg/10.21.2403; Davenport TG, 2003, DEVELOPMENT, V130, P2263, DOI 10.1242/dev.00431; Fan C, 2009, J BIOL CHEM, V284, P25653, DOI 10.1074/jbc.M109.041368; Frank DU, 2012, P NATL ACAD SCI US; HERRMANN BG, 1991, DEVELOPMENT, V113, P913; Hoogaars WMH, 2007, GENE DEV, V21, P1098, DOI 10.1101/gad.416007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Lu JA, 2010, BBA-REV CANCER, V1806, P268, DOI 10.1016/j.bbcan.2010.07.001; MACMURRAY A, 1988, GENETICS, V120, P545; Meneghini V, 2006, EUR J MED GENET, V49, P151, DOI 10.1016/j.ejmg.2005.04.021; Mesbah K, 2008, CIRC RES, V103, P743, DOI 10.1161/CIRCRESAHA.108.172858; Moskowitz IPG, 2004, DEVELOPMENT, V131, P4107, DOI 10.1242/dev.01265; Ribeiro I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000398; Sasaki G, 2002, AM J MED GENET, V110, P365, DOI 10.1002/ajmg.10447; Wollnik B, 2002, ANN GENET-PARIS, V45, P213, DOI 10.1016/S0003-3995(02)01144-9; Zhang Z, 2008, HUM MOL GENET, V17, P150, DOI 10.1093/hmg/ddm291	20	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67841	10.1371/journal.pone.0067841	http://dx.doi.org/10.1371/journal.pone.0067841			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844108	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000108
J	Kerschbaum, J; Vychytil, A; Lhotta, K; Prischl, FC; Wiesholzer, M; Machhold-Fabrizii, V; Kopriva-Altfahrt, G; Schwarz, C; Balcke, P; Oberbauer, R; Kramar, R; Konig, P; Rudnicki, M				Kerschbaum, Julia; Vychytil, Andreas; Lhotta, Karl; Prischl, Friedrich C.; Wiesholzer, Martin; Machhold-Fabrizii, Veronika; Kopriva-Altfahrt, Gertrude; Schwarz, Christoph; Balcke, Peter; Oberbauer, Rainer; Kramar, Reinhard; Koenig, Paul; Rudnicki, Michael			Treatment with Oral Active Vitamin D Is Associated with Decreased Risk of Peritonitis and Improved Survival in Patients on Peritoneal Dialysis	PLOS ONE			English	Article							CALCIFICATION; FAILURE; D-3	Peritonitis is a major complication of peritoneal dialysis (PD) being associated with hospitalization, catheter loss, technique failure, and increased mortality. Data on incidence rates and risk factors for peritonitis episodes vary between centers. In seven Austrian PD units clinical and laboratory data on each peritonitis episode were collected from all patients (n = 726) who performed PD between January 2000 and December 2009. The peritonitis incidence rate was 0.32 episodes/patient-year. In a multivariate analysis the risk of peritonitis was decreased by 57% in patients treated with oral active vitamin D (HR 0.43; 95% CI 0.28-0.64). Renal disease classified as "other or unknown" (HR 1.65; 95% CI 1.08-2.53) and serum albumin,3500 mg/dl (HR 1.49; 95% CI 1.04-2.15) were also associated with an increased risk of peritonitis. Albumin levels,3500 mg/dl (HR 1.89; 95% CI 1.13-3.17), age (HR 1.06 per year; 95% CI 1.03-1.09), and cardiomyopathy (HR 3.01; 95% CI 1.62-5.59) were associated with increased mortality, whereas treatment with oral active vitamin D was associated with a significantly lower risk of death (HR 0.46; 95% CI 0.27-0.81). In this retrospective multi-center study we identified several factors being related to increased risk of peritonitis in PD patients. Treatment with oral active vitamin D was identified as being independently associated with decreased risk of peritonitis, and decreased all-cause mortality in PD patients.	[Kerschbaum, Julia; Koenig, Paul; Rudnicki, Michael] Med Univ Innsbruck, Dept Internal Med Nephrol & Hypertens 4, A-6020 Innsbruck, Austria; [Vychytil, Andreas; Oberbauer, Rainer] Med Univ Vienna, Dept Med 3, Div Nephrol, Vienna, Austria; [Lhotta, Karl] Acad Teaching Hosp Feldkirch, Dept Nephrol & Dialysis, Feldkirch, Austria; [Prischl, Friedrich C.] Klinikum Wels Grieskirchen, Dept Med 4, Clin Div Nephrol, Wels, Austria; [Wiesholzer, Martin; Balcke, Peter] Ao Krankenhaus St Polten, Dept Med 1, Div Nephrol & Dialysis, St Polten, Austria; [Machhold-Fabrizii, Veronika; Kopriva-Altfahrt, Gertrude] Wilhelminenspital Stadt Wien, Dept Med 6, Div Nephrol & Dialysis, Vienna, Austria; [Schwarz, Christoph; Oberbauer, Rainer] Krankenhaus Elisabethinen, Dept Nephrol, Linz, Austria; [Oberbauer, Rainer; Kramar, Reinhard] Austrian Dialysis & Transplant Registry, Linz, Austria	Medical University of Innsbruck; Medical University of Vienna; Wilhelminenspital; Ordensklinikum Linz Elisabethinen	Rudnicki, M (corresponding author), Med Univ Innsbruck, Dept Internal Med Nephrol & Hypertens 4, A-6020 Innsbruck, Austria.	michael.rudnicki@i-med.ac.at		Prischl, Friedrich/0000-0002-6187-9827	Fresenius Medical Care; Baxter Healthcare	Fresenius Medical Care; Baxter Healthcare	MR received an unrestricted research grant from Fresenius Medical Care and Baxter Healthcare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Fresenius Medical Care and Baxter Healthcare provided funding for this study. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.	Andrews PA, 1996, NEPHROL DIAL TRANSPL, V11, P1104; Biggar PH, 2011, PEDIATR NEPHROL, V26, P7, DOI 10.1007/s00467-010-1526-x; Chow KM, 2005, PERITON DIALYSIS INT, V25, P374; Chung SH, 2005, NEPHROL DIAL TRANSPL, V20, P1207, DOI 10.1093/ndt/gfh772; Churchill DN, 1996, J AM SOC NEPHROL, V7, P198; Cohen ML, 2001, KIDNEY INT, V59, P69, DOI 10.1046/j.1523-1755.2001.00467.x; Goldsmith DJA, 1997, NEPHRON, V77, P37, DOI 10.1159/000190244; Henley C, 2005, NEPHROL DIAL TRANSPL, V20, P1370, DOI 10.1093/ndt/gfh834; Kerschbaum J, 2011, WIEN KLIN WOCHENSCHR, V123, P204, DOI 10.1007/s00508-011-1551-1; Kopriva-Altfahrt G, 2009, PERITON DIALYSIS INT, V29, P330; Li PKT, 2010, PERITON DIALYSIS INT, V30, P393, DOI 10.3747/pdi.2010.00049; Lim WH, 2005, NEPHROLOGY, V10, P192, DOI 10.1111/j.1440-1797.2005.00374.x; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Lopez I, 2006, J AM SOC NEPHROL, V17, P795, DOI 10.1681/ASN.2005040342; Martineau AR, 2007, AM J RESP CRIT CARE, V176, P208, DOI 10.1164/rccm.200701-007OC; McDonald SR, 2004, PERITON DIALYSIS INT, V24, P340; Naves-Diaz M, 2008, KIDNEY INT, V74, P1070, DOI 10.1038/ki.2008.343; Rudnicki M, PERIT DIAL INT; Schaubel DE, 2001, PERITON DIALYSIS INT, V21, P365; Shoji T, 2004, NEPHROL DIAL TRANSPL, V19, P179, DOI 10.1093/ndt/gfg513; Sirivongs Dhavee, 2006, J Med Assoc Thai, V89 Suppl 2, pS138; Strippoli GFM, 2004, J AM SOC NEPHROL, V15, P2735, DOI 10.1097/01.ASN.0000141463.95561.79; Teng M, 2005, J AM SOC NEPHROL, V16, P1115, DOI 10.1681/ASN.2004070573	23	23	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67836	10.1371/journal.pone.0067836	http://dx.doi.org/10.1371/journal.pone.0067836			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844107	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000107
J	Soma, S; Shimegi, S; Suematsu, N; Tamura, H; Sato, H				Soma, Shogo; Shimegi, Satoshi; Suematsu, Naofumi; Tamura, Hiroshi; Sato, Hiromichi			Modulation-Specific and Laminar-Dependent Effects of Acetylcholine on Visual Responses in the Rat Primary Visual Cortex	PLOS ONE			English	Article							NUCLEUS BASALIS-MAGNOCELLULARIS; CHOLINERGIC MODULATION; COMPLEX CELLS; BARREL CORTEX; INNERVATION; ORGANIZATION; MECHANISMS; EXCITATION; RECEPTORS; NICOTINE	Acetylcholine (ACh) is secreted from cholinergic neurons in the basal forebrain to regions throughout the cerebral cortex, including the primary visual cortex (V1), and influences neuronal activities across all six layers via a form of diffuse extrasynaptic modulation termed volume transmission. To understand this effect in V1, we performed extracellular multi-point recordings of neuronal responses to drifting sinusoidal grating stimuli from the cortical layers of V1 in anesthetized rats and examined the modulatory effects of topically administered ACh. ACh facilitated or suppressed the visual responses of individual cells with a laminar bias: response suppression prevailed in layers 2/3, whereas response facilitation prevailed in layer 5. ACh effects on the stimulus contrast-response function showed that ACh changes the response gain upward or downward in facilitated or suppressed cells, respectively. Next, ACh effects on the signal-to-noise (S/N) ratio and the grating-phase information were tested. The grating-phase information was calculated as the F1/F0 ratio, which represents the amount of temporal response modulation at the fundamental frequency (F1) of a drifting grating relative to the mean evoked response (F0). In facilitated cells, ACh improved the S/N ratio, while in suppressed cells it enhanced the F1/F0 ratio without any concurrent reduction in the S/N ratio. These effects were predominantly observed in regular-spiking cells, but not in fast-spiking cells. Electrophysiological and histological findings suggest that ACh promotes the signaling of grating-phase information to higher-order areas by a suppressive effect on supragranular layers and enhances feedback signals with a high S/N ratio to subcortical areas by a facilitatory effect on infragranular layers. Thus, ACh distinctly and finely controls visual information processing in a manner that is specific for the modulation and cell type and is also laminar dependent.	[Soma, Shogo; Shimegi, Satoshi; Suematsu, Naofumi; Tamura, Hiroshi; Sato, Hiromichi] Osaka Univ, Grad Sch Frontier Biosci, Toyonaka, Osaka 560, Japan; [Shimegi, Satoshi; Sato, Hiromichi] Osaka Univ, Grad Sch Med, Toyonaka, Osaka 560, Japan	Osaka University; Osaka University	Shimegi, S (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Toyonaka, Osaka 560, Japan.	shimegi@vision.hss.osaka-u.ac.jp		Soma, Shogo/0000-0002-7381-9477; Suematsu, Naofumi/0000-0002-5431-1723	KAKENHI [21500369, 22500573, 17021026, 20500285, 23135521]; Japan Society for the Promotion of Science Research Fellowships	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science Research Fellowships(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by KAKENHI, 21500369 to H. Sato, 22500573 to S. Shimegi, and 17021026, 20500285, 23135521 to H. Tamura. S. Soma was supported by the Japan Society for the Promotion of Science Research Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitto HJ, 2013, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00079; Arroyo S, 2012, J NEUROSCI, V32, P3859, DOI 10.1523/JNEUROSCI.0115-12.2012; Bardy C, 2006, J PHYSIOL-LONDON, V574, P731, DOI 10.1113/jphysiol.2006.110320; BEAULIEU C, 1985, J COMP NEUROL, V231, P180, DOI 10.1002/cne.902310206; Bereshpolova Y, 2006, J NEUROSCI, V26, P2250, DOI 10.1523/JNEUROSCI.4402-05.2006; Bhattacharyya A, 2012, EUR J NEUROSCI, V35, P1270, DOI 10.1111/j.1460-9568.2012.08052.x; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; CANDY JM, 1974, NEUROPHARMACOLOGY, V13, P423, DOI 10.1016/0028-3908(74)90130-0; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; CLARKE PBS, 1984, BRAIN RES, V323, P390, DOI 10.1016/0006-8993(84)90320-2; Descarries L, 1997, PROG NEUROBIOL, V53, P603, DOI 10.1016/S0301-0082(97)00050-6; Disney AA, 2007, NEURON, V56, P701, DOI 10.1016/j.neuron.2007.09.034; Disney AA, 2006, J COMP NEUROL, V499, P49, DOI 10.1002/cne.21096; Disney AA, 2012, J NEUROPHYSIOL, V108, P1907, DOI 10.1152/jn.00188.2012; ECKENSTEIN FP, 1988, NEUROSCIENCE, V25, P457, DOI 10.1016/0306-4522(88)90251-5; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; Gulledge AT, 2007, J NEUROPHYSIOL, V97, P2215, DOI 10.1152/jn.00493.2006; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; HASSELMO ME, 1994, J NEUROSCI, V14, P3898; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; JOHNSTON MV, 1981, EXP BRAIN RES, V43, P159; Jones BE, 2008, ANN NY ACAD SCI, V1129, P26, DOI 10.1196/annals.1417.026; KENANVAKNIN G, 1992, BRAIN RES, V574, P147, DOI 10.1016/0006-8993(92)90811-M; Kimura F, 1999, EUR J NEUROSCI, V11, P3597, DOI 10.1046/j.1460-9568.1999.00779.x; LEHMANN J, 1980, NEUROSCIENCE, V5, P1161, DOI 10.1016/0306-4522(80)90195-5; LEVEY AI, 1991, J NEUROSCI, V11, P3218; Lucas-Meunier E, 2003, PFLUG ARCH EUR J PHY, V446, P17, DOI 10.1007/s00424-002-0999-2; Lucas-Meunier E, 2009, CEREB CORTEX, V19, P2411, DOI 10.1093/cercor/bhn258; MALCOLM J. L., 1967, INT J NEUROPHARMACOL, V6, P509; Maskos U, 2005, NATURE, V436, P103, DOI 10.1038/nature03694; MAYO W, 1993, BRAIN RES, V607, P324, DOI 10.1016/0006-8993(93)91524-V; MONTERO VM, 1968, J NEUROPHYSIOL, V31, P221, DOI 10.1152/jn.1968.31.2.221; MURPHY PC, 1991, NEUROSCIENCE, V40, P13, DOI 10.1016/0306-4522(91)90170-S; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P587, DOI 10.1113/jphysiol.1966.sp008003; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Parikh V, 2007, NEURON, V56, P141, DOI 10.1016/j.neuron.2007.08.025; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pepeu G, 2010, CHEM-BIOL INTERACT, V187, P403, DOI 10.1016/j.cbi.2009.11.018; Roberts MJ, 2005, J NEUROPHYSIOL, V93, P2062, DOI 10.1152/jn.00911.2004; SAPER CB, 1984, J COMP NEUROL, V222, P313, DOI 10.1002/cne.902220302; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; SATO H, 1987, J NEUROPHYSIOL, V58, P765, DOI 10.1152/jn.1987.58.4.765; Schiller PH, 2005, PROG BRAIN RES, V149, P157, DOI 10.1016/S0079-6123(05)49012-3; Sengpiel F, 1998, VISION RES, V38, P2067, DOI 10.1016/S0042-6989(97)00413-6; Shimegi S, 1999, J NEUROSCI, V19, P10164; Shimegi S, 2000, J NEUROSCI, V20, P6241, DOI 10.1523/JNEUROSCI.20-16-06241.2000; SILLITO AM, 1983, BRAIN RES, V289, P143, DOI 10.1016/0006-8993(83)90015-X; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; Soma S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01138; Soma S, 2012, J NEUROPHYSIOL, V107, P283, DOI 10.1152/jn.00330.2011; St Peters M, 2011, J NEUROSCI, V31, P9760, DOI 10.1523/JNEUROSCI.1902-11.2011; STONE TW, 1972, J PHYSIOL-LONDON, V225, P485, DOI 10.1113/jphysiol.1972.sp009951; Tehovnik EJ, 2003, EUR J NEUROSCI, V17, P870, DOI 10.1046/j.1460-9568.2003.02489.x; UMBRIACO D, 1994, J COMP NEUROL, V348, P351, DOI 10.1002/cne.903480304; Williford T, 2006, J NEUROPHYSIOL, V96, P40, DOI 10.1152/jn.01207.2005; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; Zinke W, 2006, EUR J NEUROSCI, V24, P314, DOI 10.1111/j.1460-9568.2006.04882.x	58	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68430	10.1371/journal.pone.0068430	http://dx.doi.org/10.1371/journal.pone.0068430			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844199	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000161
J	Chen, J; Wang, JM; Yang, JM; Zhang, WP; Song, XM; Chen, L				Chen, Jie; Wang, Jianmin; Yang, Jianmin; Zhang, Weiping; Song, Xianmin; Chen, Li			Concurrent Infection of Hepatitis B Virus Negatively Affects the Clinical Outcome and Prognosis of Patients with Non-Hodgkin's Lymphoma after Chemotherapy	PLOS ONE			English	Article							MALIGNANT-LYMPHOMA; HBV REACTIVATION; HIGH PREVALENCE; RITUXIMAB; EPIDEMIOLOGY; REPLICATION; LAMIVUDINE; CARRIERS; THERAPY; IMPACT	Hepatitis B virus (HBV) is hepatotropic and lymphotropic. HBV-infected individuals have an increased risk of developing malignant lymphoma, and the HBV infection rate in lymphoma patients is significantly higher than that in the general population. However, the exact mechanism and correlation between HBV infection and lymphoma onset and progression currently remain unclear. We retrospectively analyzed clinical data from non-Hodgkin's lymphoma (NHL) patients with different HBV infection statuses. The results showed that the HBV infection rate was significantly higher in patients with B-cell type and late stage of NHL. The chemotherapy efficacy for NHL patients with chronic active HBV infection was significantly lower than that for the patients with chronic inactive HBV infection, the patients with HBV carriers and the patients without HBV infection. In addition, the NHL chemotherapy activated HBV replication and caused significant liver dysfunction, which could further reduce the chemotherapy efficacy. Through Kaplan-Meier survival curve and log-rank analysis, we found that the HBV infection status in NHL patients was significantly correlated with the patients' progression-free survival (PFS) and overall survival (OS). Compared with the patients without HBV infection (PFS: 95% CI 47.915 to 55.640; OS: 95% CI 81.324 to 86.858), the PFS and OS of the patients with chronic active HBV infection were significantly shorter (PFS: 95% CI 9.424 to 42.589, P < 0.001; OS: 95% CI 42.840 to 82.259, P = 0.006). The study demonstrated that the sustained HBV replication in patients with chronic active HBV infection could be a key factor that influences the prognosis of NHL patients after chemotherapy, and thus may provide information for designing rational clinical treatments for NHL patients with different HBV infection statuses and improve the treatment efficacy and prognosis.	[Chen, Jie; Wang, Jianmin; Yang, Jianmin; Zhang, Weiping; Song, Xianmin; Chen, Li] Second Mil Med Univ, Changhai Hosp, Dept Hematol, Shanghai, Peoples R China	Naval Medical University	Wang, JM (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Hematol, Shanghai, Peoples R China.	jmwangch@139.com	wang, jian/GVS-0711-2022		National Natural Science Foundation of China [81170499]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by a grant from the National Natural Science Foundation of China (No. 81170499). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assogba BD, 2004, DNA CELL BIOL, V23, P141, DOI 10.1089/104454904322964733; Chan HLY, 2011, J GASTROEN HEPATOL, V26, P131, DOI 10.1111/j.1440-1746.2010.06544.x; Chen MH, 2008, ANN HEMATOL, V87, P475, DOI 10.1007/s00277-008-0469-9; Cheng AL, 2003, HEPATOLOGY, V37, P1320, DOI 10.1053/jhep.2003.50220; Cucuianu A, 1999, BRIT J HAEMATOL, V107, P353, DOI 10.1046/j.1365-2141.1999.01692.x; Engels EA, 2010, LANCET ONCOL, V11, P827, DOI 10.1016/S1470-2045(10)70167-4; Francisci D, 2012, TUMORI J, V98, P220, DOI 10.1700/1088.11933; Fukushima N, 2009, ANN ONCOL, V20, P2013, DOI 10.1093/annonc/mdp230; Fwu CW, 2011, HEPATOLOGY, V53, P1217, DOI 10.1002/hep.24150; He YF, 2008, ANN HEMATOL, V87, P481, DOI 10.1007/s00277-008-0454-3; Huang CF, 2006, CELL MOL IMMUNOL, V3, P97; Kim YM, 2011, J CLIN VIROL, V51, P237, DOI 10.1016/j.jcv.2011.05.004; Kusumoto S, 2009, INT J HEMATOL, V90, P13, DOI 10.1007/s12185-009-0359-5; Lim ST, 2007, EUR J HAEMATOL, V79, P132, DOI 10.1111/j.1600-0609.2007.00878.x; Ma RP, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-486; Ma Z, 2008, WORLD J GASTROENTERO, V14, P5412, DOI 10.3748/wjg.14.5412; Marcucci F, 2006, HAEMATOLOGICA, V91, P554; Marcucci F, 2012, AM J BLOOD RES, V2, P18; Marcucci F, 2011, BLOOD, V117, P1792, DOI 10.1182/blood-2010-06-275818; Matsue K, 2010, CANCER-AM CANCER SOC, V116, P4769, DOI 10.1002/cncr.25253; Murakami Y, 2004, J MED VIROL, V72, P203, DOI 10.1002/jmv.10547; Nakamura Y, 1996, CANCER-AM CANCER SOC, V78, P2210, DOI 10.1002/(SICI)1097-0142(19961115)78:10<2210::AID-CNCR24>3.0.CO;2-0; Ohishi W, 2011, CLIN EXP NEPHROL, V15, P634, DOI 10.1007/s10157-011-0464-7; Park SC, 2008, J MED VIROL, V80, P960, DOI 10.1002/jmv.21168; Pei SN, 2010, ANN HEMATOL, V89, P255, DOI 10.1007/s00277-009-0806-7; Pontisso P, 2008, AUTOIMMUN REV, V8, P13, DOI 10.1016/j.autrev.2008.07.016; Qiu Miao-Zhen, 2010, Chin J Cancer, V29, P735; Takai S, 2005, EUR J HAEMATOL, V74, P158, DOI 10.1111/j.1600-0609.2004.00376.x; Tanaka M, 2011, J EPIDEMIOL, V21, P401, DOI 10.2188/jea.JE20100190; Thompson PA, 2010, LEUKEMIA LYMPHOMA, V51, P1592, DOI 10.3109/10428194.2010.509456; Tonziello G, 2013, INFECTION, V41, P225, DOI 10.1007/s15010-012-0305-y; Tsutsumi Y, 2012, INT J HEMATOL, V95, P588, DOI 10.1007/s12185-012-1050-9; Wang F, 2007, CANCER-AM CANCER SOC, V109, P1360, DOI 10.1002/cncr.22549; Wang F, 2012, EUR J CANCER PREV, V21, P261, DOI 10.1097/CEJ.0b013e3283498e87; Wang F, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-115; Yeo W, 2000, J MED VIROL, V62, P299, DOI 10.1002/1096-9071(200011)62:3&lt;299::AID-JMV1&gt;3.0.CO;2-0; Zhang BB, 2010, ONKOLOGIE, V33, P537, DOI 10.1159/000319696; Ziakas PD, 2009, HAEMATOL-HEMATOL J, V94, P998, DOI 10.3324/haematol.2009.005819	38	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e69400	10.1371/journal.pone.0069400	http://dx.doi.org/10.1371/journal.pone.0069400			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861969	Green Published, Green Submitted, gold			2022-12-27	WOS:000321692000044
J	Herbomel, G; Kloster-Landsberg, M; Folco, EG; Col, E; Usson, Y; Vourc'h, C; Delon, A; Souchier, C				Herbomel, Gaetan; Kloster-Landsberg, Meike; Folco, Eric G.; Col, Edwige; Usson, Yves; Vourc'h, Claire; Delon, Antoine; Souchier, Catherine			Dynamics of the Full Length and Mutated Heat Shock Factor 1 in Human Cells	PLOS ONE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; NUCLEAR STRESS GRANULES; DNA-BINDING ACTIVITY; LIVING CELLS; LIVE CELLS; GENOME FUNCTION; IN-VIVO; TRANSCRIPTION; PROTEIN; GENE	Heat shock factor 1 is the key transcription factor of the heat shock response. Its function is to protect the cell against the deleterious effects of stress. Upon stress, HSF1 binds to and transcribes hsp genes and repeated satellite III (sat III) sequences present at the 9q12 locus. HSF1 binding to pericentric sat III sequences forms structures known as nuclear stress bodies (nSBs). nSBs represent a natural amplification of RNA pol II dependent transcription sites. Dynamics of HSF1 and of deletion mutants were studied in living cells using multi-confocal Fluorescence Correlation Spectroscopy (mFCS) and Fluorescence Recovery After Photobleaching (FRAP). In this paper, we show that HSF1 dynamics modifications upon heat shock result from both formation of high molecular weight complexes and increased HSF1 interactions with chromatin. These interactions involve both DNA binding with Heat Shock Element (HSE) and sat III sequences and a more transient sequence-independent binding likely corresponding to a search for more specific targets. We find that the trimerization domain is required for low affinity interactions with chromatin while the DNA binding domain is required for site-specific interactions of HSF1 with DNA.	[Herbomel, Gaetan; Folco, Eric G.; Col, Edwige; Vourc'h, Claire; Souchier, Catherine] Univ Grenoble 1, INSERM, IAB CRI U823, Team 10, La Tronche, France; [Kloster-Landsberg, Meike; Delon, Antoine] Univ Grenoble 1, CNRS, LIPhy UMR 5588, F-38402 St Martin Dheres, France; [Usson, Yves] Univ Grenoble 1, CNRS, TIMC IMAG UMR5525, La Tronche, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Souchier, C (corresponding author), Univ Grenoble 1, INSERM, IAB CRI U823, Team 10, La Tronche, France.	Catherine.Souchier@ujf-grenoble.fr	Souchier, Catherine/M-2747-2013; Vourc'h, Claire/AAE-3119-2022; VOURC'H, Claire/AAG-8576-2021; USSON, Yves/B-2002-2014; Folco, Eric/M-2665-2013; VOURC'H, Claire/L-9319-2013	VOURC'H, Claire/0000-0002-7276-9359; USSON, Yves/0000-0003-0242-191X; VOURC'H, Claire/0000-0002-7276-9359	French "Agence Nationale de la Recherche'' [ANR-08-PCVI-0004-01]; "Region Rhone-Alpes", CIBLE; French Cancer Research Association "ARC''	French "Agence Nationale de la Recherche''(French National Research Agency (ANR)); "Region Rhone-Alpes", CIBLE(Region Auvergne-Rhone-Alpes); French Cancer Research Association "ARC''(Fondation ARC pour la Recherche sur le Cancer)	This project was funded by the French "Agence Nationale de la Recherche'' (http://www.agence-nationale-recherche.fr/) under contract ANR-08-PCVI-0004-01, by the "Region Rhone-Alpes'', CIBLE 2009 (http://www.rhonealpes.fr/), and by the French Cancer Research Association "ARC'' (http://www.arc-cancer.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Alastalo TP, 2003, J CELL SCI, V116, P3557, DOI 10.1242/jcs.00671; Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Biamonti G, 2011, COLD SPRING HARB PER, V2; Christians E, 1997, MOL CELL BIOL, V17, P778, DOI 10.1128/MCB.17.2.778; Darzacq X, 2009, ANNU REV BIOPHYS, V38, P173, DOI 10.1146/annurev.biophys.050708.133728; de Graaf P, 2010, J CELL SCI, V123, P2663, DOI 10.1242/jcs.064097; Delon A, 2006, BIOPHYS J, V90, P2548, DOI 10.1529/biophysj.105.069815; Elson EL, 2011, BIOPHYS J, V101, P2855, DOI 10.1016/j.bpj.2011.11.012; Hemmerich P, 2011, CHROMOSOME RES, V19, P131, DOI 10.1007/s10577-010-9161-8; Hensen S.M., 2013, CELL STRESS CHAPERON; Hinow P, 2006, BIOPHYS J, V91, P330, DOI 10.1529/biophysj.105.078303; Hu YZ, 2003, J BIOL CHEM, V278, P17299, DOI 10.1074/jbc.M300788200; Jolly C, 1999, P NATL ACAD SCI USA, V96, P6769, DOI 10.1073/pnas.96.12.6769; Jolly C, 2004, J CELL BIOL, V164, P25, DOI 10.1083/jcb.200306104; Jolly C, 2002, J CELL BIOL, V156, P775, DOI 10.1083/jcb.200109018; Kang M, 2012, SIMPLIFIED EQUATION, P9999; Kim SA, 2005, FEBS LETT, V579, P6559, DOI 10.1016/j.febslet.2005.10.043; Kloster-Landsberg M, 2012, BIOPHYS J, V103, P1110, DOI 10.1016/j.bpj.2012.07.041; Mazza D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks701; Michelman-Ribeiro A, 2009, BIOPHYS J, V97, P337, DOI 10.1016/j.bpj.2009.04.027; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Muller CB, 2008, J PHYS CHEM B, V112, P8236, DOI 10.1021/jp802280u; Mueller F, 2010, CURR OPIN CELL BIOL, V22, P403, DOI 10.1016/j.ceb.2010.03.002; Rafalska-Metcalf IU, 2007, J CELL SCI, V120, P2301, DOI 10.1242/jcs.008664; Ries J, 2012, BIOESSAYS, V34, P361, DOI 10.1002/bies.201100111; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Schaaf MJM, 2003, MOL CELL BIOL, V23, P1922, DOI 10.1128/MCB.23.6.1922-1934.2003; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Sharp ZD, 2006, J CELL SCI, V119, P4101, DOI 10.1242/jcs.03161; Sheval EV, 2006, CELL BIOL INT, V30, P1028, DOI 10.1016/j.cellbi.2006.07.009; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Stasevich TJ, 2010, EMBO J, V29, P1225, DOI 10.1038/emboj.2010.24; Voellmy R, 2004, CELL STRESS CHAPERON, V9, P122, DOI 10.1379/CSC-14R.1; Westerheide SD, 2012, CURR PROTEIN PEPT SC, V13, P86; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Xu YM, 2012, J PROTEOME RES, V11, P2625, DOI 10.1021/pr201151a; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025	38	10	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e67566	10.1371/journal.pone.0067566	http://dx.doi.org/10.1371/journal.pone.0067566			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861773	Green Published, gold			2022-12-27	WOS:000321692000010
J	Ternhag, A; Cederstrom, A; Torner, A; Westling, K				Ternhag, Anders; Cederstrom, Agneta; Torner, Anna; Westling, Katarina			A Nationwide Cohort Study of Mortality Risk and Long-Term Prognosis in Infective Endocarditis in Sweden	PLOS ONE			English	Article							NATIVE VALVE ENDOCARDITIS; INTRAVENOUS-DRUG-USERS; STAPHYLOCOCCUS-AUREUS; POPULATION; SURGERY; TRENDS; IMPACT; BIAS	Objectives: Infective endocarditis (IE) remains a serious disease with substantial mortality. In this study we investigated the incidence of IE, as well as its associated short and long term mortality rates. Methods: The IE cases were identified in the Swedish national inpatient register using ICD-10 codes, and then linked to the population register in order to identify deaths in the cohort. Crude mortality rates among IE patients were obtained for different time intervals. These rates were directly standardized using sex-and age-matched mortality in the general population. Results: The cohort consisted of 7603 individuals and 7817 episodes of IE during 1997-2007. The 30 days all-cause crude mortality rate was 10.4% and the standardized mortality ratio (SMR) was 33.7 (95% confidence interval [CI]: 31.0-36.6). Excluding the first year of follow-up, the long term mortality (1-5 years) showed an increased SMR of 2.2 (95% CI: 2.0-2.3) compared to the general population. Significantly higher SMR was found for cases of IE younger than 65 years of age with a 1-5 year SMR of 6.3, and intravenous drug-users with a SMR of 19.1. Native valve IE cases, in which surgery was performed had lower crude mortality rates and Mantel-Haenzel odds ratios of less than one compared to those with medical therapy alone during 30-day and 5-years follow-up. Conclusions: The 30-days crude mortality rate for IE was 10.4% and long-term relative mortality risk remains increased even up to 5 years of follow-up, therefore a close monitoring of these patients would be of value.	[Ternhag, Anders; Cederstrom, Agneta; Westling, Katarina] Karolinska Inst, Dept Med, Div Infect Dis, Stockholm, Sweden; [Torner, Anna] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Ternhag, A (corresponding author), Karolinska Inst, Dept Med, Div Infect Dis, Stockholm, Sweden.	anders.ternhag@karolinska.se		Ternhag, Anders/0000-0003-4968-8945; Westling, Katarina/0000-0002-8755-1037	Karolinska Institutet	Karolinska Institutet(Karolinska Institutet)	This work was supported in part by grants from Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cabell CH, 2002, ARCH INTERN MED, V162, P90, DOI 10.1001/archinte.162.1.90; Chu VH, 2004, CIRCULATION, V109, P1745, DOI 10.1161/01.CIR.0000124719.61827.7F; DELAHAYE F, 1995, EUR HEART J, V16, P48, DOI 10.1093/eurheartj/16.suppl_B.48; DURACK DT, 1994, AM J MED, V96, P200, DOI 10.1016/0002-9343(94)90143-0; Duval X, 2012, J AM COLL CARDIOL, V59, P1968, DOI 10.1016/j.jacc.2012.02.029; Fedeli U, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-48; Federspiel JJ, 2012, ARCH INTERN MED, V172, P363, DOI 10.1001/archinternmed.2011.1027; Fernandez-Hidalgo N, 2012, CLIN MICROBIOL INFEC, V18, pE522, DOI 10.1111/1469-0691.12033; Hill EE, 2008, AM J CARDIOL, V101, P1174, DOI 10.1016/j.amjcard.2007.12.015; Hoen B, 2002, JAMA-J AM MED ASSOC, V288, P75, DOI 10.1001/jama.288.1.75; HOGEVIK H, 1995, MEDICINE, V74, P324, DOI 10.1097/00005792-199511000-00003; Lalani T, 2010, CIRCULATION, V121, P1005, DOI 10.1161/CIRCULATIONAHA.109.864488; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Martinez-Selles M, 2008, MAYO CLIN PROC, V83, P1213, DOI 10.4065/83.11.1213; MATHEW J, 1995, ARCH INTERN MED, V155, P1641, DOI 10.1001/archinte.155.15.1641; Mokhles MM, 2011, ANN THORAC SURG, V91, P1407, DOI 10.1016/j.athoracsur.2011.02.007; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; Que YA, 2011, NAT REV CARDIOL, V8, P322, DOI 10.1038/nrcardio.2011.43; Selton-Suty C, 2012, CLIN INFECT DIS, V54, P1230, DOI 10.1093/cid/cis199; Thuny F, 2012, AM HEART J, V164, P94, DOI 10.1016/j.ahj.2012.04.003; Tleyjeh IM, 2010, J CLIN EPIDEMIOL, V63, P130, DOI 10.1016/j.jclinepi.2008.06.022; Tleyjeh Imad M, 2006, Curr Infect Dis Rep, V8, P265, DOI 10.1007/s11908-006-0070-0; Vikram HR, 2003, JAMA-J AM MED ASSOC, V290, P3207, DOI 10.1001/jama.290.24.3207; Yiu KH, 2007, INT J CARDIOL, V121, P119, DOI 10.1016/j.ijcard.2006.08.053	25	67	67	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e67519	10.1371/journal.pone.0067519	http://dx.doi.org/10.1371/journal.pone.0067519			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861768	Green Submitted, gold, Green Published			2022-12-27	WOS:000321692000009
J	Boyd, JC; Simpson, CA; Jung, ME; Gurd, BJ				Boyd, J. Colin; Simpson, Craig A.; Jung, Mary E.; Gurd, Brendon J.			Reducing the Intensity and Volume of Interval Training Diminishes Cardiovascular Adaptation but Not Mitochondrial Biogenesis in Overweight/Obese Men	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; EXERCISE INTENSITY; METABOLIC ADAPTATIONS; SPRINT INTERVAL; SIRT1 ACTIVITY; STROKE VOLUME; OXYGEN PULSE; IN-VITRO; PERFORMANCE; HUMANS	Objective: The purpose of this research was to determine if the adaptations to high intensity interval training (HIT) are mitigated when both intensity and training volume (i.e. exercise energy expenditure) are reduced. Methods: 19 overweight/obese, sedentary males (Age: 22.7 +/- 3.9 yrs, Body Mass Index: 31.4 +/- 2.6 kg/m(2), Waist Circumference: 106.5 +/- 6.6 cm) performed 9 sessions of interval training using a 1-min on, 1-min off protocol on a cycle ergometer over three weeks at either 70% (LO) or 100% (HI) peak work rate. Results: Cytochrome oxidase I protein content, cytochrome oxidase IV protein content, and citrate synthase maximal activity all demonstrated similar increases between groups with a significant effect of training for each. beta-hydroxyacyl-CoA dehydrogenase maximal activity tended to increase with training but did not reach statistical significance (p = 0.07). Peroxisome proliferator-activated receptor gamma coactivator-1 alpha and silent mating type information regulator 2 homolog 1 protein contents also increased significantly (p = 0.047), while AMP-activated protein kinase protein content decreased following the intervention (p = 0.019). VO(2)peak increased by 11.0 +/- 7.4% and 27.7 +/- 4.4% in the LO and HI groups respectively with significant effects of both training (p < 0.001) and interaction (p = 0.027). Exercise performance improved by 8.6 +/- 7.6% in the LO group and 14.1 +/- 4.3% in the HI group with a significant effect of training and a significant difference in the improvement between groups. There were no differences in perceived enjoyment or self-efficacy between groups despite significantly lower affect scores during training in the HI group. Conclusions: While improvements in aerobic capacity and exercise performance were different between groups, changes in oxidative capacity were similar despite reductions in both training intensity and volume.	[Boyd, J. Colin; Gurd, Brendon J.] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada; [Simpson, Craig A.] Queens Univ, Dept Emergency Med, Kingston, ON, Canada; [Jung, Mary E.] Univ British Columbia Okanagan, Fac Hlth & Social Dev, Kelowna, BC, Canada	Queens University - Canada; Queens University - Canada; University of British Columbia; University of British Columbia Okanagan	Gurd, BJ (corresponding author), Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada.	gurdb@queensu.ca			Canadian Foundation for Innovation [25476]; National Sciences and Engineering Research Council of Canada [402635-2011]	Canadian Foundation for Innovation(Canada Foundation for Innovation); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported with funding from the Canadian Foundation for Innovation (IOF#25476), and the National Sciences and Engineering Research Council of Canada (402635-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balducci S, 2010, NUTR METAB CARDIOVAS, V20, P608, DOI 10.1016/j.numecd.2009.04.015; Bartlett JD, 2011, J SPORT SCI, V29, P547, DOI 10.1080/02640414.2010.545427; BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787; BHAMBHANI Y, 1994, CAN J APPL PHYSIOL, V19, P49, DOI 10.1139/h94-003; Bruun JM, 2003, AM J PHYSIOL-ENDOC M, V285, pE527, DOI 10.1152/ajpendo.00110.2003; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; Coyle EF, 2005, J APPL PHYSIOL, V98, P1983, DOI 10.1152/japplphysiol.00215.2005; Dalleck L, 2010, INT J SPORTS MED, V31, P567, DOI 10.1055/s-0030-1254136; Daussin FN, 2007, EUR J APPL PHYSIOL, V101, P377, DOI 10.1007/s00421-007-0499-3; DUDLEY GA, 1982, J APPL PHYSIOL, V53, P844, DOI 10.1152/jappl.1982.53.4.844; Egan B, 2010, J PHYSIOL-LONDON, V588, P1779, DOI 10.1113/jphysiol.2010.188011; Ekkekakis P, 2008, ANN BEHAV MED, V35, P136, DOI 10.1007/s12160-008-9025-z; Ekkekakis P, 2010, OBESITY, V18, P79, DOI 10.1038/oby.2009.204; Gaesser GA, 2011, J APPL PHYSIOL, V111, P1540, DOI 10.1152/japplphysiol.01237.2011; Gibala MJ, 2008, EXERC SPORT SCI REV, V36, P58, DOI 10.1097/JES.0b013e318168ec1f; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; Gibala MJ, 2012, J PHYSIOL-LONDON, V590, P1077, DOI 10.1113/jphysiol.2011.224725; Guiraud T, 2011, MED SCI SPORT EXER, V43, P211, DOI 10.1249/MSS.0b013e3181ebc5de; Gurd BJ, 2012, J APPL PHYSIOL, V112, P926, DOI 10.1152/japplphysiol.01262.2011; Gurd BJ, 2011, APPL PHYSIOL NUTR ME, V36, P589, DOI [10.1139/h11-070, 10.1139/H11-070]; Gurd BJ, 2011, AM J PHYSIOL-REG I, V301, pR67, DOI 10.1152/ajpregu.00417.2010; Gurd BJ, 2010, APPL PHYSIOL NUTR ME, V35, P350, DOI 10.1139/H10-030; Hazell TJ, 2010, EUR J APPL PHYSIOL, V110, P153, DOI 10.1007/s00421-010-1474-y; Helgerud J, 2007, MED SCI SPORT EXER, V39, P665, DOI 10.1249/mss.0b013e3180304570; Hood MS, 2011, MED SCI SPORT EXER, V43, P1849, DOI 10.1249/MSS.0b013e3182199834; Jeukendrup A, 1996, MED SCI SPORT EXER, V28, P266, DOI 10.1097/00005768-199602000-00017; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; Little JP, 2010, J PHYSIOL-LONDON, V588, P1011, DOI 10.1113/jphysiol.2009.181743; MathieuCostello O, 1996, J APPL PHYSIOL, V80, P904, DOI 10.1152/jappl.1996.80.3.904; McKay BR, 2009, J APPL PHYSIOL, V107, P128, DOI 10.1152/japplphysiol.90828.2008; Metcalfe RS, 2012, EUR J APPL PHYSIOL, V112, P2767, DOI 10.1007/s00421-011-2254-z; Meyer P, 2012, J CARD FAIL, V18, P126, DOI 10.1016/j.cardfail.2011.10.010; Moran CN, 2011, METABOLISM, V60, P206, DOI 10.1016/j.metabol.2009.12.026; Munk PS, 2011, EUR J CARDIOV PREV R, V18, P850, DOI 10.1177/1741826710397600; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Nordsborg NB, 2010, MED SCI SPORT EXER, V42, P1477, DOI 10.1249/MSS.0b013e3181d2d21c; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Richardson RS, 2000, MED SCI SPORT EXER, V32, P89; Stensvold D, 2012, METAB SYNDR RELAT D, V10, P267, DOI 10.1089/met.2011.0140; Tjonna AE, 2009, CLIN SCI, V116, P317, DOI 10.1042/CS20080249; WENGER HA, 1986, SPORTS MED, V3, P346, DOI 10.2165/00007256-198603050-00004; Whipp BJ, 1996, J APPL PHYSIOL, V81, P2674, DOI 10.1152/jappl.1996.81.6.2674; Williams DM, 2008, PSYCHOL SPORT EXERC, V9, P231, DOI 10.1016/j.psychsport.2007.04.002	43	69	71	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68091	10.1371/journal.pone.0068091	http://dx.doi.org/10.1371/journal.pone.0068091			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861854	Green Published, Green Submitted, gold			2022-12-27	WOS:000321425300042
J	Challand, MR; Salvadori, E; Driesener, RC; Kay, CWM; Roach, PL; Spencer, J				Challand, Martin R.; Salvadori, Enrico; Driesener, Rebecca C.; Kay, Christopher W. M.; Roach, Peter L.; Spencer, James			Cysteine Methylation Controls Radical Generation in the Cfr Radical AdoMet rRNA Methyltransferase	PLOS ONE			English	Article							LYASE-ACTIVATING ENZYME; IRON-SULFUR CLUSTER; ADENOSYL-L-METHIONINE; S-ADENOSYLMETHIONINE; BIOTIN SYNTHASE; ESCHERICHIA-COLI; LYSINE 2,3-AMINOMUTASE; CRYSTAL-STRUCTURE; SAM ENZYMES; ENTEROCOCCUS-FAECALIS	The 'radical S-adenosyl-L-methionine (AdoMet)' enzyme Cfr methylates adenosine 2503 of the 23S rRNA in the peptidyltransferase centre (P-site) of the bacterial ribosome. This modification protects host bacteria, notably methicillin-resistant Staphylococcus aureus (MRSA), from numerous antibiotics, including agents (e.g. linezolid, retapamulin) that were developed to treat such organisms. Cfr contains a single [4Fe-4S] cluster that binds two separate molecules of AdoMet during the reaction cycle. These are used sequentially to first methylate a cysteine residue, Cys338; and subsequently generate an oxidative radical intermediate that facilitates methyl transfer to the unreactive C8 (and/or C2) carbon centres of adenosine 2503. How the Cfr active site, with its single [4Fe-4S] cluster, catalyses these two distinct activities that each utilise AdoMet as a substrate remains to be established. Here, we use absorbance and electron paramagnetic resonance (EPR) spectroscopy to investigate the interactions of AdoMet with the [4Fe-4S] clusters of wild-type Cfr and a Cys338 Ala mutant, which is unable to accept a methyl group. Cfr binds AdoMet with high (similar to 10 mu M) affinity notwithstanding the absence of the RNA cosubstrate. In wild-type Cfr, where Cys338 is methylated, AdoMet binding leads to rapid oxidation of the [4Fe-4S] cluster and production of 5'-deoxyadenosine (DOA). In contrast, while Cys338 Ala Cfr binds AdoMet with equivalent affinity, oxidation of the [4Fe-4S] cluster is not observed. Our results indicate that the presence of a methyl group on Cfr Cys338 is a key determinant of the activity of the enzyme towards AdoMet, thus enabling a single active site to support two distinct modes of AdoMet cleavage.	[Challand, Martin R.; Spencer, James] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England; [Salvadori, Enrico; Kay, Christopher W. M.] UCL, Inst Struct & Mol Biol, London, England; [Salvadori, Enrico; Kay, Christopher W. M.] UCL, London Ctr Nanotechnol, London, England; [Driesener, Rebecca C.; Roach, Peter L.] Univ Southampton, Southampton, Hants, England; [Roach, Peter L.] Univ Southampton, Inst Life Sci, Southampton, Hants, England	University of Bristol; University of London; Birkbeck University London; University College London; University of London; University College London; University of Southampton; University of Southampton	Kay, CWM (corresponding author), UCL, Inst Struct & Mol Biol, London, England.	c.kay@ucl.ac.uk; p.l.roach@soton.ac.uk; Jim.Spencer@bristol.ac.uk	Roach, Peter/AAW-7071-2021; Kay, Christopher William Michael/C-2467-2008; Challand, Martin/C-6395-2015	Kay, Christopher William Michael/0000-0002-5200-6004; Challand, Martin/0000-0002-9685-3504; Salvadori, Enrico/0000-0003-4394-9438	Leverhulme Trust [F/00 182/CO]; United Kingdom Biotechnology and Biological Sciences Research Council [BB/J017906/1]; BBSRC [BB/J017906/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J017906/1] Funding Source: researchfish	Leverhulme Trust(Leverhulme Trust); United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Leverhulme Trust (www.leverhulme.ac.uk; award ref. F/00 182/CO to JS, PLR and RC) and the United Kingdom Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk; award ref. BB/J017906/1 to JS, PLR and MRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atta M, 2010, CURR OPIN STRUC BIOL, V20, P684, DOI 10.1016/j.sbi.2010.09.009; Benjdia A, 2012, NUCLEIC ACIDS RES, V40, P9308, DOI 10.1093/nar/gks603; Benjdia A, 2010, FEBS J, V277, P1906, DOI 10.1111/j.1742-4658.2010.07613.x; Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493; Boal AK, 2011, SCIENCE, V332, P1089, DOI 10.1126/science.1205358; Booth MPS, 2010, PROTEIN EXPRES PURIF, V74, P204, DOI 10.1016/j.pep.2010.07.010; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brickner SJ, 2008, J MED CHEM, V51, P1981, DOI 10.1021/jm800038g; BRUSCHI M, 1976, BIOCHIM BIOPHYS ACTA, V449, P275, DOI 10.1016/0005-2728(76)90139-0; Bui BTS, 2004, BIOCHEMISTRY-US, V43, P16432, DOI 10.1021/bi048040t; Challand MR, 2011, NAT PROD REP, V28, P1696, DOI 10.1039/c1np00036e; Challand MR, 2010, J BIOL CHEM, V285, P5240, DOI 10.1074/jbc.M109.056606; Chandramouli K, 2007, BIOCHEMISTRY-US, V46, P6804, DOI 10.1021/bi6026659; Diaz L, 2012, ANTIMICROB AGENTS CH, V56, P3917, DOI 10.1128/AAC.00419-12; Dos Santos PC, 2007, J BACTERIOL, V189, P2854, DOI 10.1128/JB.01734-06; Driesener RC, 2010, ANGEW CHEM INT EDIT, V49, P1687, DOI 10.1002/anie.200907047; Duschene KS, 2010, FEBS LETT, V584, P1263, DOI 10.1016/j.febslet.2010.02.041; Farrar CE, 2010, BIOCHEMISTRY-US, V49, P9985, DOI 10.1021/bi101023c; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Giessing AMB, 2009, RNA, V15, P327, DOI 10.1261/rna.1371409; Grove TL, 2011, J AM CHEM SOC, V133, P19586, DOI 10.1021/ja207327v; Grove TL, 2011, SCIENCE, V332, P604, DOI 10.1126/science.1200877; HAGEN KS, 1983, J AM CHEM SOC, V105, P3905, DOI 10.1021/ja00350a028; Hanzelmann P, 2004, P NATL ACAD SCI USA, V101, P12870, DOI 10.1073/pnas.0404624101; Hinckley GT, 2006, BIOCHEMISTRY-US, V45, P3219, DOI 10.1021/bi0519497; Hioe J, 2012, CHEM-EUR J, V18, P16463, DOI 10.1002/chem.201202869; Iwig DF, 2004, BIOCHEMISTRY-US, V43, P13496, DOI 10.1021/bi048693+; Kehrenberg C, 2005, MOL MICROBIOL, V57, P1064, DOI 10.1111/j.1365-2958.2005.04754.x; Kriek M, 2007, J BIOL CHEM, V282, P17413, DOI 10.1074/jbc.M700782200; Kulzer R, 1998, J BIOL CHEM, V273, P4897, DOI 10.1074/jbc.273.9.4897; Layer G, 2003, EMBO J, V22, P6214, DOI 10.1093/emboj/cdg598; Lepore BW, 2005, P NATL ACAD SCI USA, V102, P13819, DOI 10.1073/pnas.0505726102; Lieder KW, 1998, BIOCHEMISTRY-US, V37, P2578, DOI 10.1021/bi972417w; Lippard S. J., 1994, PRINCIPLES BIOINORGA, pXVII; Liu Y, 2012, ANTIMICROB AGENTS CH, V56, P1650, DOI 10.1128/AAC.06091-11; Long KS, 2006, ANTIMICROB AGENTS CH, V50, P2500, DOI 10.1128/AAC.00131-06; MOSS ML, 1990, J BIOL CHEM, V265, P18112; MULLER B, 1991, BIOCHEMISTRY-US, V30, P3709, DOI 10.1021/bi00229a017; Nicolet Y, 2008, J BIOL CHEM, V283, P18861, DOI 10.1074/jbc.M801161200; Ollagnier S, 1997, J BIOL CHEM, V272, P24216, DOI 10.1074/jbc.272.39.24216; Ollagnier-de Choudens S, 2002, J BIOL CHEM, V277, P13449, DOI 10.1074/jbc.M111324200; Roach PL, 2011, CURR OPIN CHEM BIOL, V15, P267, DOI 10.1016/j.cbpa.2010.11.015; RUPP H, 1978, BIOCHIM BIOPHYS ACTA, V537, P255, DOI 10.1016/0005-2795(78)90509-3; Schluckebier G, 1997, J MOL BIOL, V265, P56, DOI 10.1006/jmbi.1996.0711; Selmer T, 2005, BIOL CHEM, V386, P981, DOI 10.1515/BC.2005.114; SHAPIRO SK, 1966, ANAL BIOCHEM, V15, P323, DOI 10.1016/0003-2697(66)90038-8; Shepard EM, 2010, J AM CHEM SOC, V132, P9247, DOI 10.1021/ja1012273; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; STOLOWITZ ML, 1981, J AM CHEM SOC, V103, P6015, DOI 10.1021/ja00410a004; Toh SM, 2007, MOL MICROBIOL, V64, P1506, DOI 10.1111/j.1365-2958.2007.05744.x; Toh SM, 2008, RNA, V14, P98, DOI 10.1261/rna.814408; Ugulava NB, 2003, BIOCHEMISTRY-US, V42, P2708, DOI 10.1021/bi0261084; Ugulava NB, 2001, BIOCHEMISTRY-US, V40, P8343, DOI 10.1021/bi0104625; Vey JL, 2008, P NATL ACAD SCI USA, V105, P16137, DOI 10.1073/pnas.0806640105; Vey JL, 2011, CHEM REV, V111, P2487, DOI 10.1021/cr9002616; Walsby CJ, 2002, J AM CHEM SOC, V124, P3143, DOI 10.1021/ja012034s; Wang SC, 2007, BIOCHEMISTRY-US, V46, P12889, DOI 10.1021/bi701745h; Wang SC, 2007, TRENDS BIOCHEM SCI, V32, P101, DOI 10.1016/j.tibs.2007.01.002; Wang Y, 2012, J ANTIMICROB CHEMOTH, V67, P1094, DOI 10.1093/jac/dks020; Yan F, 2011, P NATL ACAD SCI USA, V108, P3930, DOI 10.1073/pnas.1017781108; Yan F, 2010, J AM CHEM SOC, V132, P3953, DOI 10.1021/ja910850y; Yeeles JTP, 2009, J BIOL CHEM, V284, P7746, DOI 10.1074/jbc.M808526200; Zhang Q, 2012, ACCOUNTS CHEM RES, V45, P555, DOI 10.1021/ar200202c; Zhang Q, 2011, J BIOL CHEM, V286, P21287, DOI 10.1074/jbc.M111.224832; Zhang Q, 2011, NAT CHEM BIOL, V7, P154, DOI [10.1038/nchembio.512, 10.1038/NCHEMBIO.512]	65	9	10	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67979	10.1371/journal.pone.0067979	http://dx.doi.org/10.1371/journal.pone.0067979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861844	Green Published, Green Submitted, gold			2022-12-27	WOS:000321425300034
J	Nicholas, J; Charlton, J; Dregan, A; Gulliford, MC				Nicholas, Jennifer; Charlton, Judith; Dregan, Alex; Gulliford, Martin C.			Recent HbA1c Values and Mortality Risk in Type 2 Diabetes. Population-Based Case-Control Study	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; GLUCOSE CONTROL; VASCULAR COMPLICATIONS; CARDIOVASCULAR DEATH; SULFONYLUREA DRUGS; GLYCEMIC CONTROL; HEMOGLOBIN A1C; FOLLOW-UP; METAANALYSIS; MELLITUS	This study aimed to evaluate mortality within 365 days of HbA1c values of <6.5% or >9.0% in participants with clinical type 2 diabetes mellitus. A matched nested case-control study was implemented, within a cohort of participants with type 2 diabetes from 2000 to 2008. Conditional logistic regression was used to model the odds ratio for mortality adjusting for comorbidity and drug utilisation. There were 97,450 participants with type 2 diabetes; 16,585 cases that died during follow up were matched to 16,585 controls. The most recent HbA1c value was <6.5% (48 mmol/mol) for 22.2% of cases and 24.2% of controls, the HbA1c was >9.0% for 9.0% of cases and 7.7% of controls. In a complete case analysis, the adjusted odds ratio (AOR) for mortality associated with most recent HbA1c <6.5% was 1.31 (95% confidence interval (CI): 1.21,1.42). After multiple imputation of missing HbA1c values the AOR was 1.20 (CI: 1.12,1.28). The complete case analysis gave an AOR for HbA1c >9.0% of 1.51 (CI: 1.33, 1.70), in the multiple imputation analysis this was 1.29 (1.17,1.41). The risk associated with HbA1c <6.5% was age dependent. In the multiple imputation analysis the AOR was 1.53 (CI: 0.84 to 2.79) at age<55 years but 1.04 (CI: 0.92, 1.17) at age 85 years and over. In non-randomised data, values of HbA1c that are either <6.5% or >9.0% may be associated with increased mortality within one year in clinical type 2 diabetes. Relative risks may be higher at younger ages.	[Nicholas, Jennifer] London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England; [Charlton, Judith; Dregan, Alex; Gulliford, Martin C.] Kings Coll London, NIHR Biomed Res Ctr, Guys & St Thomas NHS Fdn Trust, London WC2R 2LS, England; [Charlton, Judith; Dregan, Alex; Gulliford, Martin C.] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London WC2R 2LS, England	University of London; London School of Hygiene & Tropical Medicine; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London	Dregan, A (corresponding author), Kings Coll London, NIHR Biomed Res Ctr, Guys & St Thomas NHS Fdn Trust, London WC2R 2LS, England.	alexandru.dregan@kcl.ac.uk	Gulliford, Martin C/I-8606-2018	Gulliford, Martin C/0000-0003-1898-9075; Dregan, Alex/0000-0002-7620-4902	National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; Medical Research Council; MHRA; National Institute for Health Research (NIHR) Biomedical Research Centre at King's College London	National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MHRA; National Institute for Health Research (NIHR) Biomedical Research Centre at King's College London(National Institute for Health Research (NIHR))	This research was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. Access to the GPRD database was funded through the Medical Research Council's license agreement with MHRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2011, Diabetes Care, V34 Suppl 1, pS3, DOI 10.2337/dc11-S003; BLAND JM, 1994, BRIT MED J, V309, P1128, DOI 10.1136/bmj.309.6962.1128; Boussageon R, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4169; Carson AP, 2010, CIRC-CARDIOVASC QUAL, V3, P661, DOI 10.1161/CIRCOUTCOMES.110.957936; Christman AL, 2011, J INVEST DERMATOL, V131, P2121, DOI 10.1038/jid.2011.176; Currie CJ, 2013, J CLIN ENDOCR METAB, V98, P668, DOI 10.1210/jc.2012-3042; Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Forst T, 2013, DIABETES VASC DIS RE; Garratt KN, 1999, J AM COLL CARDIOL, V33, P119, DOI 10.1016/S0735-1097(98)00557-9; Gerstein HC, 2008, ARCH INTERN MED, V168, P1699, DOI 10.1001/archinte.168.15.1699; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Grimes DA, 2005, LANCET, V365, P1429, DOI 10.1016/S0140-6736(05)66379-9; He YL, 2010, CIRC-CARDIOVASC QUAL, V3, P98, DOI 10.1161/CIRCOUTCOMES.109.875658; Hemmingsen B, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6898; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; International Diabetes Federation, 2013, GLOB GUID TYOE 2 DIA; Iqbal N, 2008, ANN CLIN BIOCHEM, V45, P504, DOI 10.1258/acb.2008.008034; Kelly TN, 2009, ANN INTERN MED, V151, P394, DOI 10.7326/0003-4819-151-6-200909150-00137; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Khaw KT, 2004, CANCER EPIDEM BIOMAR, V13, P915; Kowall B, 2011, EUR J EPIDEMIOL, V26, P637, DOI 10.1007/s10654-011-9609-y; Monami M, 2012, ADV THER, V29, P14, DOI 10.1007/s12325-011-0088-z; National Institute for Health and Clinical Excellence, 2008, TYP 2 DIAB MAN TYP 2; Pani LN, 2008, DIABETES CARE, V31, P1991, DOI 10.2337/dc08-0577; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Riddle MC, 2010, DIABETES CARE, V33, P983, DOI 10.2337/dc09-1278; Riveline JP, 2010, LANCET, V375, P1433, DOI 10.1016/S0140-6736(10)60612-5; Rubin DB, 2004, MULTIPLE IMPUTATION; Simpson SH, 2006, CAN MED ASSOC J, V174, P169, DOI 10.1503/cmaj.050748; Sterne JA, 2009, BMJ-BRIT MED J, V338, pb2392; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Zoungas S, 2012, DIABETOLOGIA, V55, P636, DOI 10.1007/s00125-011-2404-1; Zoungas S, 2012, NEW ENGL J MED, V363, P1410; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	37	46	46	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68008	10.1371/journal.pone.0068008	http://dx.doi.org/10.1371/journal.pone.0068008			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861845	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000321425300035
J	Rumple, A; McMurray, M; Johns, J; Lauder, J; Makam, P; Radcliffe, M; Oguz, I				Rumple, Ashley; McMurray, Matthew; Johns, Josephine; Lauder, Jean; Makam, Pooja; Radcliffe, Marlana; Oguz, Ipek			3-Dimensional Diffusion Tensor Imaging (DTI) Atlas of the Rat Brain	PLOS ONE			English	Article							MAGNETIC-RESONANCE HISTOLOGY; DEVELOPING MOUSE-BRAIN; VARIABILITY; DATABASE; SPACE; ECHO	Anatomical atlases play an important role in the analysis of neuroimaging data in rodent neuroimaging studies. Having a high resolution, detailed atlas not only can expand understanding of rodent brain anatomy, but also enables automatic segmentation of new images, thus greatly increasing the efficiency of future analysis when applied to new data. These atlases can be used to analyze new scans of individual cases using a variety of automated segmentation methods. This project seeks to develop a set of detailed 3D anatomical atlases of the brain at postnatal day 5 (P5), 14 (P14), and adults (P72) in Sprague-Dawley rats. Our methods consisted of first creating a template image based on fixed scans of control rats, then manually segmenting various individual brain regions on the template. Using itk-SNAP software, subcortical and cortical regions, including both white matter and gray matter structures, were manually segmented in the axial, sagittal, and coronal planes. The P5, P14, and P72 atlases had 39, 45, and 29 regions segmented, respectively. These atlases have been made available to the broader research community.	[Rumple, Ashley; Johns, Josephine; Lauder, Jean; Makam, Pooja; Radcliffe, Marlana] Univ N Carolina, Chapel Hill, NC 27515 USA; [McMurray, Matthew] UIC, Chicago, IL USA; [Oguz, Ipek] UI, Iowa City, IA USA	University of North Carolina; University of North Carolina Chapel Hill; University of Illinois System; University of Illinois Chicago	Rumple, A (corresponding author), Univ N Carolina, Chapel Hill, NC 27515 USA.	rumple@ad.unc.edu	McMurray, Matthew/AAO-5310-2021	McMurray, Matthew/0000-0002-1898-2933	UNC Neurodevelopment Disorders Research Center [HD 03110]; National Institutes of Health (NIH) STTR [R41 NS059095]; NIH [P01 DA022446, F31DA026251]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R41NS059095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA022446, F31DA026251] Funding Source: NIH RePORTER	UNC Neurodevelopment Disorders Research Center; National Institutes of Health (NIH) STTR; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by the UNC Neurodevelopment Disorders Research Center HD 03110, the National Institutes of Health (NIH) STTR grant R41 NS059095, the NIH Program Project P01 DA022446, and F31DA026251. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal M, 2009, NEUROSCIENCE, V162, P1339, DOI 10.1016/j.neuroscience.2009.05.070; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Cai Yu, 2011, Front Psychiatry, V2, P54, DOI 10.3389/fpsyt.2011.00054; Calabrese E, 2013, NEUROIMAGE, V71, P196, DOI 10.1016/j.neuroimage.2013.01.017; Chuang N, 2011, NEUROIMAGE, V54, P80, DOI 10.1016/j.neuroimage.2010.07.043; Ehlers C., 2011, PROC SOC PHOTOOPT IN, V7962; Johnson GA, 2007, NEUROIMAGE, V37, P82, DOI 10.1016/j.neuroimage.2007.05.013; Johnson GA, 2010, NEUROIMAGE, V53, P365, DOI 10.1016/j.neuroimage.2010.06.067; Joshi S, 2004, NEUROIMAGE, V23, pS151, DOI 10.1016/j.neuroimage.2004.07.068; Kovacevic N, 2005, CEREB CORTEX, V15, P639, DOI 10.1093/cercor/bhh165; Lee J, 2009, P SOC PHOTO-OPT INS, DOI [10.1117/12.812762, DOI 10.1117/12.812762]; Ma Y, 2005, NEUROSCIENCE, V135, P1203, DOI 10.1016/j.neuroscience.2005.07.014; MacKenzie-Graham A, 2006, NEUROIMAGE, V32, P1016, DOI 10.1016/j.neuroimage.2006.05.006; Mayer AD, 1998, DEV PSYCHOBIOL, V32, P131; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Mori S, 1998, MAGNET RESON MED, V40, P511, DOI 10.1002/mrm.1910400403; Nie B, 2013, HUM BRAIN MAPP, V34, P1306, DOI 10.1002/hbm.21511; Oguz I, 2012, DEV NEUROSCI-BASEL, V34, P5, DOI 10.1159/000336825; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Veraart J, 2011, NEUROIMAGE, V58, P975, DOI 10.1016/j.neuroimage.2011.06.063; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zhang J, 2006, EMBS 06 28 ANN INT C, DOI [10.1109/IEMBS.2006.259388, DOI 10.1109/IEMBS.2006.259388]; Zhang JY, 2003, NEUROIMAGE, V20, P1639, DOI 10.1016/S1053-8119(03)00410-5	24	34	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67334	10.1371/journal.pone.0067334	http://dx.doi.org/10.1371/journal.pone.0067334			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861758	Green Published, Green Submitted, gold			2022-12-27	WOS:000321425300011
J	Ambrosini, E; Reddy, V; de Looper, A; Costantini, M; Lopez, B; Sinigaglia, C				Ambrosini, Ettore; Reddy, Vasudevi; de Looper, Annette; Costantini, Marcello; Lopez, Beatriz; Sinigaglia, C.			Looking Ahead: Anticipatory Gaze and Motor Ability in Infancy	PLOS ONE			English	Article							OTHERS ACTIONS; EYE TRACKING; GOAL OBJECT; PERCEPTION; HANDS; EXPERIENCE; SHIFTS; GRASP; REACH; AGE	The present study asks when infants are able to selectively anticipate the goals of observed actions, and how this ability relates to infants' own abilities to produce those specific actions. Using eye-tracking technology to measure on-line anticipation, 6-, 8- and 10-month-old infants and a control group of adults were tested while observing an adult reach with a whole hand grasp, a precision grasp or a closed fist towards one of two different sized objects. The same infants were also given a comparable action production task. All infants showed proactive gaze to the whole hand grasps, with increased degrees of proactivity in the older groups. Gaze proactivity to the precision grasps, however, was present from 8 months of age. Moreover, the infants' ability in performing precision grasping strongly predicted their ability in using the actor's hand shape cues to differentially anticipate the goal of the observed action, even when age was partialled out. The results are discussed in terms of the specificity of action anticipation, and the fine-grained relationship between action production and action perception.	[Ambrosini, Ettore; Costantini, Marcello] Univ G DAnnunzio, Dept Neurosci & Imaging, Lab Neuropsychol & Cognit Neurosci, Chieti, Italy; [Ambrosini, Ettore; Costantini, Marcello] Fdn Univ G dAnnunzio, Inst Adv Biomed Technol ITAB, Chieti, Italy; [Reddy, Vasudevi; de Looper, Annette; Lopez, Beatriz] Univ Portsmouth, Dept Psychol, Ctr Situated Act & Commun, Portsmouth, Hants, England; [Sinigaglia, C.] Univ Milan, Dept Philosophy, Milan, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of Portsmouth; University of Milan	Ambrosini, E (corresponding author), Univ G DAnnunzio, Dept Neurosci & Imaging, Lab Neuropsychol & Cognit Neurosci, Chieti, Italy.	e.ambrosini@unich.it	Ambrosini, Ettore/K-5882-2016; Costantini, Marcello/F-7083-2011; SINIGAGLIA, CORRADO/AGY-7196-2022; Ambrosini, Ettore/AAH-5525-2019; sinigaglia, corrado/AAI-2220-2021	Ambrosini, Ettore/0000-0002-1439-5491; SINIGAGLIA, CORRADO/0000-0002-3365-7522; Ambrosini, Ettore/0000-0002-1439-5491; Lopez, Beatriz/0000-0001-5621-6044; Costantini, Marcello/0000-0002-0504-1296	Abruzzo region (Progetto Speciale Multiasse "Reti per l'alta formazione'')	Abruzzo region (Progetto Speciale Multiasse "Reti per l'alta formazione'')	The work was supported by funding to EA from the Abruzzo region (Progetto Speciale Multiasse "Reti per l'alta formazione'' - P.O. F.S.E. 2007-2013, Piano Operativo 2009-2010-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Ambrosini E, 2012, J EXP PSYCHOL HUMAN, V38, P263, DOI 10.1037/a0026570; Ambrosini E, 2011, J NEUROPHYSIOL, V106, P1437, DOI 10.1152/jn.00118.2011; Baldwin DA, 2001, CHILD DEV, V72, P708, DOI 10.1111/1467-8624.00310; Baldwin D, 2008, COGNITION, V106, P1382, DOI 10.1016/j.cognition.2007.07.005; Barrett TM, 2008, INFANT BEHAV DEV, V31, P1, DOI 10.1016/j.infbeh.2007.05.004; BRESSON F, 1977, NEUROPSYCHOLOGIA, V15, P311, DOI 10.1016/0028-3932(77)90040-9; Butterworth G, 1997, BRIT J DEV PSYCHOL, V15, P223, DOI 10.1111/j.2044-835X.1997.tb00736.x; Butterworth G, 1990, JOINT VISUAL ATTENTI; Cannon EN, 2012, DEVELOPMENTAL SCI, V15, P292, DOI 10.1111/j.1467-7687.2011.01127.x; Cannon EN, 2012, DEVELOPMENTAL SCI, V15, P35, DOI 10.1111/j.1467-7687.2011.01095.x; Corbetta D, 2002, J MOTOR BEHAV, V34, P83, DOI 10.1080/00222890209601933; Corbetta D, 2000, MOTOR CONSTRAINTS DE; Costantini M, 2012, ACTA PSYCHOL, V141, P199, DOI 10.1016/j.actpsy.2012.07.012; Costantini M, 2012, Q J EXP PSYCHOL, V65, P848, DOI 10.1080/17470218.2012.679945; Daum MM, 2011, EXP BRAIN RES, V208, P297, DOI 10.1007/s00221-010-2479-9; Daum MM, 2011, J EXP CHILD PSYCHOL, V108, P810, DOI 10.1016/j.jecp.2010.10.003; Daum MM, 2009, DEVELOPMENTAL SCI, V12, P854, DOI 10.1111/j.1467-7687.2009.00831.x; Eshuis R, 2009, PSYCHOL SCI, V20, P438, DOI 10.1111/j.1467-9280.2009.02317.x; Fagard J, 2000, DEVELOPMENTAL SCI, V3, P137, DOI 10.1111/1467-7687.00107; Falck-Ytter T, 2006, NAT NEUROSCI, V9, P878, DOI 10.1038/nn1729; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Flanagan JR, 2003, NATURE, V424, P769, DOI 10.1038/nature01861; Gibson E. J., 2000, ECOLOGICAL APPROACH; Gibson J.J., 1986, ECOLOGICAL APPROACH; Gredeback G, 2010, EXP BRAIN RES, V202, P493, DOI 10.1007/s00221-009-2138-1; Gredeback G, 2010, DEV NEUROPSYCHOL, V35, P1, DOI 10.1080/87565640903325758; Gredeback G, 2009, DEV PSYCHOL, V45, P1190, DOI 10.1037/a0015667; Henrichs I, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00391; HOFSTEN CV, 1979, J EXP CHILD PSYCHOL, V28, P158, DOI 10.1016/0022-0965(79)90109-7; Hunnius S, 2010, DEV PSYCHOL, V46, P446, DOI 10.1037/a0016543; Kanakogi Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1342; Kochukhova O, 2010, CHILD DEV, V81, P1729, DOI 10.1111/j.1467-8624.2010.01506.x; Loucks J, 2012, CHILD DEV, V83, P801, DOI 10.1111/j.1467-8624.2012.01735.x; Marshall PJ, 2011, DEV COGN NEUROS-NETH, V1, P110, DOI 10.1016/j.dcn.2010.09.001; Meltzoff AN, 2013, ACTION SCIENCE: FOUNDATIONS OF AN EMERGING DISCIPLINE, P281; Melzer A, 2012, INFANT BEHAV DEV, V35, P570, DOI 10.1016/j.infbeh.2012.05.003; Paulus M, 2011, VISION RES, V51, P955, DOI 10.1016/j.visres.2010.12.012; REDDY V., 2008, INFANTS KNOW MINDS; Rosander K, 2011, NEUROPSYCHOLOGIA, V49, P2911, DOI 10.1016/j.neuropsychologia.2011.06.018; SALOMAO SR, 1995, INVEST OPHTH VIS SCI, V36, P657; Sommerville JA, 2005, COGNITION, V96, pB1, DOI 10.1016/j.cognition.2004.07.004; van Hof P, 2002, CHILD DEV, V73, P1353, DOI 10.1111/1467-8624.00476; VonHofsten C, 1996, VISION RES, V36, P81, DOI 10.1016/0042-6989(95)00054-4; Woodward AL, 1998, COGNITION, V69, P1, DOI 10.1016/S0010-0277(98)00058-4; Woodward AL, 1999, INFANT BEHAV DEV, V22, P145, DOI 10.1016/S0163-6383(99)00007-7	46	80	81	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67916	10.1371/journal.pone.0067916	http://dx.doi.org/10.1371/journal.pone.0067916			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	204FO	23861832	Green Published, Green Submitted, gold			2022-12-27	WOS:000323350700060
J	Forget, KJ; Tremblay, G; Roucou, X				Forget, Karolyn J.; Tremblay, Guillaume; Roucou, Xavier			p53 Aggregates Penetrate Cells and Induce the Co-Aggregation of Intracellular p53	PLOS ONE			English	Article							MUTANT P53; TETRAMERIZATION DOMAIN; WILD-TYPE; AMYLOID FORMATION; DNA-BINDING; PRION; PROTEIN; PROPAGATION; STABILITY; INSIGHTS	Prion diseases are unique pathologies in which the infectious particles are prions, a protein aggregate. The prion protein has many particular features, such as spontaneous aggregation, conformation transmission to other native PrP proteins and transmission from an individual to another. Protein aggregation is now frequently associated to many human diseases, for example Alzheimer's disease, Parkinson's disease or type 2 diabetes. A few proteins associated to these conformational diseases are part of a new category of proteins, called prionoids: proteins that share some, but not all, of the characteristics associated with prions. The p53 protein, a transcription factor that plays a major role in cancer, has recently been suggested to be a possible prionoid. The protein has been shown to accumulate in multiple cancer cell types, and its aggregation has also been reproduced in vitro by many independent groups. These observations suggest a role for p53 aggregates in cancer development. This study aims to test the "prion-like" features of p53. Our results show in vitro aggregation of the full length and N-terminally truncated protein (p53C), and penetration of these aggregates into cells. According to our findings, the aggregates enter cells using macropinocytosis, a non-specific pathway of entry. Lastly, we also show that once internalized by the cell, p53C aggregates can co-aggregate with endogenous p53 protein. Together, these findings suggest prion-like characteristics for p53 protein, based on the fact that p53 can spontaneously aggregate, these aggregates can penetrate cells and co-aggregate with cellular p53.	[Forget, Karolyn J.; Tremblay, Guillaume; Roucou, Xavier] Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Roucou, X (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ J1K 2R1, Canada.	xavier.roucou@usherbrooke.ca			Canadian Institutes for Health Research [MOP -89881]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This research was funded by the Canadian Institutes for Health Research to Xavier Roucou (MOP -89881). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Aguzzi A, 2009, NATURE, V459, P924, DOI 10.1038/459924a; Ang HC, 2006, J BIOL CHEM, V281, P21934, DOI 10.1074/jbc.M604209200; Bell S, 2002, J MOL BIOL, V322, P917, DOI 10.1016/S0022-2836(02)00848-3; Bom APDA, 2012, J BIOL CHEM, V287, P28152, DOI 10.1074/jbc.M112.340638; Bosch B, 2008, ANTIVIR RES, V80, P185, DOI 10.1016/j.antiviral.2008.06.004; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; Bussell R, 2001, J BIOL CHEM, V276, P45996, DOI 10.1074/jbc.M106777200; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Furukawa Y, 2011, J BIOL CHEM, V286, P18664, DOI 10.1074/jbc.M111.231209; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Guest WC, 2011, J TOXICOL ENV HEAL A, V74, P1433, DOI 10.1080/15287394.2011.618967; Higashimoto Y, 2006, BIOCHEMISTRY-US, V45, P1608, DOI 10.1021/bi051192j; Ishimaru D, 2003, BIOCHEMISTRY-US, V42, P9022, DOI 10.1021/bi034218k; Iversen TG, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-33; Lee AS, 2003, J MOL BIOL, V327, P699, DOI 10.1016/S0022-2836(03)00175-X; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Magalhaes AC, 2002, J BIOL CHEM, V277, P33311, DOI 10.1074/jbc.M203661200; Moll UM, 1996, MOL CELL BIOL, V16, P1126; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; Ostermeyer AG, 1996, P NATL ACAD SCI USA, V93, P15190, DOI 10.1073/pnas.93.26.15190; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Rigacci S, 2008, BIOPHYS J, V94, P3635, DOI 10.1529/biophysj.107.122283; Roostaee A, 2009, J BIOL CHEM, V284, P30907, DOI 10.1074/jbc.M109.057950; Roucou X, 2005, CELL DEATH DIFFER, V12, P783, DOI 10.1038/sj.cdd.4401629; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Sandgren KJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000866; Silva JL, 2010, ACCOUNTS CHEM RES, V43, P271, DOI 10.1021/ar900179t; Soto C, 2012, CELL, V149, P968, DOI 10.1016/j.cell.2012.05.007; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Viegas MS, 2007, EUR J HISTOCHEM, V51, P59; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Weinberg R.A., 2006, BIOL CANC, P864; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546; Xu X, 2012, J STRUCT BIOL, V177, P358, DOI 10.1016/j.jsb.2011.12.008; YOSHIMURA T, 1993, METHOD ENZYMOL, V221, P72, DOI 10.1016/0076-6879(93)21008-V	43	44	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e69242	10.1371/journal.pone.0069242	http://dx.doi.org/10.1371/journal.pone.0069242			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844254	Green Submitted, Green Published, gold			2022-12-27	WOS:000321733000034
J	Zhang, JH; Jiang, YY; Lin, Y; Sun, YF; Zheng, SP; Han, SY				Zhang, Jun-Hui; Jiang, Yu-Yan; Lin, Ying; Sun, Yu-Fei; Zheng, Sui-Ping; Han, Shuang-Yan			Structure-Guided Modification of Rhizomucor miehei Lipase for Production of Structured Lipids	PLOS ONE			English	Article							MILK FAT SUBSTITUTES; SITE-DIRECTED MUTAGENESIS; ENZYMATIC INTERESTERIFICATION; IMMOBILIZED LIPASE; ORGANIC-SOLVENT; CANDIDA-RUGOSA; PALMITIC ACID; SN-2 POSITION; EVOLUTION; PROTEIN	To improve the performance of yeast surface-displayed Rhizomucor miehei lipase (RML) in the production of human milk fat substitute (HMFS), we mutated amino acids in the lipase substrate-binding pocket based on protein hydrophobicity, to improve esterification activity. Five mutants: Asn87Ile, Asn87Ile/Asp91Val, His108Leu/Lys109Ile, Asp256Ile/His257Leu, and His108Leu/Lys109Ile/Asp256Ile/His257Leu were obtained and their hydrolytic and esterification activities were assayed. Using Discovery Studio 3.1 to build models and calculate the binding energy between lipase and substrates, compared to wild-type, the mutant Asp256Ile/His257Leu was found to have significantly lower energy when oleic acid (3.97 KJ/mol decrease) and tripalmitin (7.55 KJ/mol decrease) were substrates. This result was in accordance with the esterification activity of Asp256Ile/His257Leu (2.37-fold of wild-type). The four mutants were also evaluated for the production of HMFS in organic solvent and in a solvent-free system. Asp256Ile/His257Leu had an oleic acid incorporation of 28.27% for catalyzing tripalmitin and oleic acid, and 53.18% for the reaction of palm oil with oleic acid. The efficiency of Asp256Ile/His257Leu was 1.82-fold and 1.65-fold that of the wild-type enzyme for the two reactions. The oleic acid incorporation of Asp256Ile/His257Leu was similar to commercial Lipozyme RM IM for palm oil acidolysis with oleic acid. Yeast surface-displayed RML mutant Asp256Ile/His257Leu is a potential, economically feasible catalyst for the production of structured lipids.	[Zhang, Jun-Hui; Jiang, Yu-Yan; Lin, Ying; Sun, Yu-Fei; Zheng, Sui-Ping; Han, Shuang-Yan] S China Univ Technol, Guangdong Key Lab Fermentat & Enzyme Engn, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China	South China University of Technology	Han, SY (corresponding author), S China Univ Technol, Guangdong Key Lab Fermentat & Enzyme Engn, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China.	syhan@scut.edu.cn	jiang, yu/HGU-0029-2022		National High-tech R&D Program of China [2012AA022205]; Guangdong Key Technology RD Program [2012B010300008]; Fundamental Research Funds for the Central Universities [2012ZZ0092]	National High-tech R&D Program of China; Guangdong Key Technology RD Program; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was funded by National High-tech R&D Program of China (2012AA022205), Guangdong Key Technology R&D Program (No. 2012B010300008), the Fundamental Research Funds for the Central Universities (No. 2012ZZ0092). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASRI M, 1995, J AM OIL CHEM SOC, V72, P407, DOI 10.1007/BF02636079; Chen ML, 2004, J AM OIL CHEM SOC, V81, P525, DOI 10.1007/s11746-006-0935-2; CHO SW, 1993, BIOTECHNOL BIOENG, V41, P204, DOI 10.1002/bit.260410206; DEREWENDA U, 1992, BIOCHEMISTRY-US, V31, P1532, DOI 10.1021/bi00120a034; Esteban L, 2011, BIOCHEM ENG J, V54, P62, DOI 10.1016/j.bej.2011.01.009; Gao B, 2011, J MOL CATAL B-ENZYM, V68, P286, DOI 10.1016/j.molcatb.2010.12.001; Garcia-Galan C, 2011, ADV SYNTH CATAL, V353, P2885, DOI 10.1002/adsc.201100534; Han ZL, 2009, APPL MICROBIOL BIOT, V85, P117, DOI 10.1007/s00253-009-2067-8; Hernandez K, 2011, ENZYME MICROB TECH, V48, P107, DOI 10.1016/j.enzmictec.2010.10.003; Huang DF, 2012, BIOCHEM ENG J, V63, P10, DOI 10.1016/j.bej.2010.08.009; HUGEJENSEN B, 1988, J AM OIL CHEM SOC, V65, P905, DOI 10.1007/BF02544508; Ibrahim NA, 2008, J AM OIL CHEM SOC, V85, P37, DOI 10.1007/s11746-007-1157-y; KOBORI H, 1992, PROTOPLASMA, V167, P193, DOI 10.1007/BF01403383; Kourist R, 2010, EUR J LIPID SCI TECH, V112, P64, DOI 10.1002/ejlt.200900143; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Liang XX, 2013, BIOTECHNOL LETT, V35, P367, DOI 10.1007/s10529-012-1085-2; LIE E, 1991, J CHEM TECHNOL BIOT, V50, P549; Lutz S, 2010, CURR OPIN BIOTECH, V21, P734, DOI 10.1016/j.copbio.2010.08.011; OTERO C, 1995, FEBS LETT, V360, P202, DOI 10.1016/0014-5793(95)00104-H; Palomo JM, 2002, J MOL CATAL B-ENZYM, V19, P279, DOI 10.1016/S1381-1177(02)00178-9; Pleiss J, 1998, CHEM PHYS LIPIDS, V93, P67, DOI 10.1016/S0009-3084(98)00030-9; Reetz MT, 2010, J AM CHEM SOC, V132, P9144, DOI 10.1021/ja1030479; Reetz MT, 1999, TOP CURR CHEM, V200, P31; Reetz MT, 1997, ADV MATER, V9, P943, DOI 10.1002/adma.19970091203; Rodrigues RC, 2013, CHEM SOC REV, V42, P6290, DOI 10.1039/c2cs35231a; Rodrigues RC, 2010, J MOL CATAL B-ENZYM, V64, P1, DOI 10.1016/j.molcatb.2010.02.003; RUCKENSTEIN E, 1993, BIOTECHNOL BIOENG, V42, P821, DOI 10.1002/bit.260420706; Sahin N, 2006, J AGR FOOD CHEM, V54, P3717, DOI 10.1021/jf053103f; Santarossa G, 2005, FEBS LETT, V579, P2383, DOI 10.1016/j.febslet.2005.03.037; Sorensen ADM, 2010, J AM OIL CHEM SOC, V87, P185, DOI 10.1007/s11746-009-1479-z; Srivastava A, 2006, J AGR FOOD CHEM, V54, P5175, DOI 10.1021/jf060623h; Tecelao C, 2012, EUR J LIPID SCI TECH, V114, P266, DOI 10.1002/ejlt.201100226; Teichert SA, 2011, J AGR FOOD CHEM, V59, P5692, DOI 10.1021/jf200336t; Thomas A, 2005, J BIOL CHEM, V280, P40074, DOI 10.1074/jbc.M502123200; Turner NJ, 2009, NAT CHEM BIOL, V5, P568, DOI 10.1038/nchembio.203; Xu T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-257; YOKOZEKI K, 1982, EUR J APPL MICROBIOL, V14, P1, DOI 10.1007/BF00507995; Zou XQ, 2013, J AGR FOOD CHEM, V61, P167, DOI 10.1021/jf304094p	38	7	11	0	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67892	10.1371/journal.pone.0067892	http://dx.doi.org/10.1371/journal.pone.0067892			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844120	gold, Green Published, Green Submitted			2022-12-27	WOS:000321733000112
J	Bivalacqua, TJ; Musicki, B; Hsu, LL; Berkowitz, DE; Champion, HC; Burnett, AL				Bivalacqua, Trinity J.; Musicki, Biljana; Hsu, Lewis L.; Berkowitz, Dan E.; Champion, Hunter C.; Burnett, Arthur L.			Sildenafil Citrate-Restored eNOS and PDE5 Regulation in Sickle Cell Mouse Penis Prevents Priapism Via Control of Oxidative/Nitrosative Stress	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ENDOTHELIAL DYSFUNCTION; PULMONARY-HYPERTENSION; RECURRENT PRIAPISM; OXIDATIVE STRESS; ANIMAL-MODEL; MICE; ERECTION; REVERSES; THERAPY	Sildenafil citrate revolutionized the practice of sexual medicine upon its federal regulatory agency approval approximately 15 years ago as the prototypical phosphodiesterase type 5 inhibitor indicated for the treatment of male erectile dysfunction. We now provide scientific support for its alternative use in the management of priapism, a clinical disorder of prolonged and uncontrolled penile erection. Sildenafil administered continuously to sickle cell mice, which show a priapism phenotype, reverses oxidative/nitrosative stress effects in the penis, mainly via reversion of uncoupled endothelial nitric oxide synthase to the functional coupled state of the enzyme, which in turn corrects aberrant signaling and function of the nitric oxide/cyclic GMP/protein kinase G/phosphodiesterase type 5 cascade. Priapism tendencies in these mice are reverted partially toward normal neurostimulated erection frequencies and durations after sildenafil treatment in association with normalized cyclic GMP concentration, protein kinase G activity and phosphodiesterase type 5 activity in the penis. Thus, sildenafil exerts pleiotropic effects in the penis that extend to diverse erection disorders.	[Bivalacqua, Trinity J.; Musicki, Biljana; Burnett, Arthur L.] Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA; [Hsu, Lewis L.] NHLBI, Vasc Med Branch, NIH, Bethesda, MD 20892 USA; [Hsu, Lewis L.] Univ Illinois, Dept Pediat, Chicago, IL USA; [Berkowitz, Dan E.] Johns Hopkins Med Inst, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Berkowitz, Dan E.] Johns Hopkins Med Inst, Baltimore, MD 21205 USA; [Champion, Hunter C.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA	Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Burnett, AL (corresponding author), Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA.	aburnet1@jhmi.edu	Hsu, Lewis L/H-8001-2019	Hsu, Lewis L/0000-0002-3156-2378	US Public Service Grants [HL090515, RO1DK067223]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL090515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067223, K08DK090370] Funding Source: NIH RePORTER	US Public Service Grants; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by US Public Service Grants HL090515 and RO1DK067223 (to ALB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behr-Roussel D, 2008, EUR UROL, V53, P1272, DOI 10.1016/j.eururo.2007.11.018; Bivalacqua TJ, 2007, EUR UROL, V51, P1732, DOI 10.1016/j.eururo.2006.10.061; Bivalacqua TJ, 2010, UROLOGY, V76, DOI 10.1016/j.urology.2010.02.050; Bivalacqua TJ, 2009, J SEX MED, V6, P2494, DOI 10.1111/j.1743-6109.2009.01359.x; Bivalacqua TJ, 2009, J UROLOGY, V181, P899, DOI 10.1016/j.juro.2008.10.062; Broderick GA, 2012, J SEX MED, V9, P88, DOI 10.1111/j.1743-6109.2011.02317.x; Burnett AL, 2006, UROLOGY, V67, P1043, DOI 10.1016/j.urology.2005.11.045; Burnett AL, 2002, J ANDROL, V23, P92, DOI 10.1002/j.1939-4640.2002.tb02601.x; Burnett AL, 2006, J SEX MED, V3, P1077, DOI 10.1111/j.1743-6109.2006.00333.x; Burnett Arthur L, 2006, J Clin Hypertens (Greenwich), V8, P53; Champion HC, 2005, P NATL ACAD SCI USA, V102, P1661, DOI 10.1073/pnas.0407183102; Claudino MA, 2009, J SEX MED, V6, P2187, DOI 10.1111/j.1743-6109.2009.01337.x; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Hemnes AR, 2008, AM J PHYSIOL-LUNG C, V294, pL24, DOI 10.1152/ajplung.00245.2007; Hotston M, 2008, ASIAN J ANDROL, V10, P905, DOI 10.1111/j.1745-7262.2008.00380.x; Hsu LL, 2007, BLOOD, V109, P3088, DOI 10.1182/blood-2006-08-039438; Kanika ND, 2010, INT J IMPOT RES, V22, P363, DOI 10.1038/ijir.2010.27; Kanika ND, 2009, AM J PHYSIOL-CELL PH, V297, pC916, DOI 10.1152/ajpcell.00656.2008; Kietadisorn R, 2012, AM J PHYSIOL-ENDOC M, V302, pE481, DOI 10.1152/ajpendo.00540.2011; Lin GT, 2003, J UROLOGY, V170, pS15, DOI 10.1097/01.ju.0000075500.11519.e8; Mi T, 2008, J CLIN INVEST, V118, P1491, DOI 10.1172/JCI33467; Munarriz R, 2003, UROLOGY, V62, P760, DOI 10.1016/S0090-4295(03)00484-9; Musicki B, 2005, MOL PHARMACOL, V68, P226, DOI 10.1124/mol.104.010678; Musicki B, 2012, J SEX MED, V9, P1980, DOI 10.1111/j.1743-6109.2012.02798.x; Musicki B, 2011, J SEX MED, V8, P419, DOI 10.1111/j.1743-6109.2010.02123.x; Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876; Schafer A, 2008, BRIT J PHARMACOL, V153, P886, DOI 10.1038/sj.bjp.0707459; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Vicari E, 2010, J SEX MED, V7, P1247, DOI 10.1111/j.1743-6109.2009.01420.x; Vignozzi L, 2006, J SEX MED, V3, P419, DOI 10.1111/j.1743-6109.2006.00208.x; Wen J, 2010, J SEX MED, V7, P3011, DOI 10.1111/j.1743-6109.2009.01552.x; Wood KC, 2006, FREE RADICAL BIO MED, V40, P1443, DOI 10.1016/j.freeradbiomed.2005.12.015; Yamagishi S, 2011, PHARMACOL RES, V64, P187, DOI 10.1016/j.phrs.2011.05.009	33	41	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68028	10.1371/journal.pone.0068028	http://dx.doi.org/10.1371/journal.pone.0068028			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844149	Green Published, gold, Green Accepted			2022-12-27	WOS:000321341000131
J	Brede, M				Brede, Markus			Costly Advertising and the Evolution of Cooperation	PLOS ONE			English	Article							PRISONERS-DILEMMA GAME; NETWORKS	In this paper, I investigate the co-evolution of fast and slow strategy spread and game strategies in populations of spatially distributed agents engaged in a one off evolutionary dilemma game. Agents are characterized by a pair of traits, a game strategy (cooperate or defect) and a binary 'advertising' strategy (advertise or don't advertise). Advertising, which comes at a cost a, allows investment into faster propagation of the agents' traits to adjacent individuals. Importantly, game strategy and advertising strategy are subject to the same evolutionary mechanism. Via analytical reasoning and numerical simulations I demonstrate that a range of advertising costs exists, such that the prevalence of cooperation is significantly enhanced through co-evolution. Linking costly replication to the success of cooperators exposes a novel co-evolutionary mechanism that might contribute towards a better understanding of the origins of cooperation-supporting heterogeneity in agent populations.	Univ Southampton, Dept Elect & Comp Sci, Southampton SO9 5NH, Hants, England	University of Southampton	Brede, M (corresponding author), Univ Southampton, Dept Elect & Comp Sci, Southampton SO9 5NH, Hants, England.	Brede.Markus@gmail.com						Abramson G, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.030901; Beinhocker E., 2007, ORIGIN WEALTH; Brede M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056016; Brede M, 2011, ARTIF LIFE, V17, P365, DOI 10.1162/artl_a_00044; Cao L, 2011, J THEOR BIOL, V272, P8, DOI 10.1016/j.jtbi.2010.12.008; Chen X, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051120; Hauert C, 2005, AM J PHYS, V73, P405, DOI 10.1119/1.1848514; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hebb Donald O., 1949, ORG BEHAV; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; HUBERMAN BA, 1993, P NATL ACAD SCI USA, V90, P7716, DOI 10.1073/pnas.90.16.7716; Jansen VAA, 2006, NATURE, V440, P663, DOI 10.1038/nature04387; Masuda N, 2007, P R SOC B, V274, P1815, DOI 10.1098/rspb.2007.0294; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Penn AS, 2012, FEMS IMMUNOL MED MIC, V65, P226, DOI 10.1111/j.1574-695X.2012.00970.x; Perc M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/2/022; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Riolo RL, 2001, NATURE, V414, P441, DOI 10.1038/35106555; Santos FC, 2006, P ROY SOC B-BIOL SCI, V273, P51, DOI 10.1098/rspb.2005.3272; Santos FC, 2006, PLOS COMPUT BIOL, V2, P1284, DOI 10.1371/journal.pcbi.0020140; Santos FC, 2011, J THEOR BIOL, V274, P30, DOI 10.1016/j.jtbi.2011.01.004; Szabo G, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.062903; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2004, PHYS REV LETT, V89; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/30004; Szolnoki A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.037102; Szolnoki A, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/9/093016; Szolnoki A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00576; Szolnoki A, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036110; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056112; Szolnoki A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/043036; Tanimoto J, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.032101; Tanimoto J, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.041130; Van Segbroeck S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.058105; Wang Z, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.011149; Weibull Jorgen W., EVOLUTIONARY GAME TH; Zhang HF, 2010, PHYSICA A, V389, P4734, DOI 10.1016/j.physa.2010.06.023; Zimmermann MG, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056118	42	5	5	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e67056	10.1371/journal.pone.0067056	http://dx.doi.org/10.1371/journal.pone.0067056			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861752	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000321692000006
J	Oluwagbemi, OO; Fornadel, CM; Adebiyi, EF; Norris, DE; Rasgon, JL				Oluwagbemi, Olugbenga O.; Fornadel, Christen M.; Adebiyi, Ezekiel F.; Norris, Douglas E.; Rasgon, Jason L.			ANOSPEX: A Stochastic, Spatially Explicit Model for Studying Anopheles Metapopulation Dynamics	PLOS ONE			English	Article							MOSQUITO-BORNE DISEASES; AEDES-AEGYPTI DIPTERA; LIFE TABLE MODEL; MALARIA TRANSMISSION; DESICCATION RESISTANCE; GAMBIAE POPULATION; WESTERN KENYA; LARVAE; CULICIDAE; TEMPERATURE	Anopheles mosquitoes transmit malaria, a major public health problem among many African countries. One of the most effective methods to control malaria is by controlling the Anopheles mosquito vectors that transmit the parasites. Mathematical models have both predictive and explorative utility to investigate the pros and cons of different malaria control strategies. We have developed a C++ based, stochastic spatially explicit model (ANOSPEX; Anopheles Spatially-Explicit) to simulate Anopheles metapopulation dynamics. The model is biologically rich, parameterized by field data, and driven by field-collected weather data from Macha, Zambia. To preliminarily validate ANOSPEX, simulation results were compared to field mosquito collection data from Macha; simulated and observed dynamics were similar. The ANOSPEX model will be useful in a predictive and exploratory manner to develop, evaluate and implement traditional and novel strategies to control malaria, and for understanding the environmental forces driving Anopheles population dynamics.	[Rasgon, Jason L.] Penn State Univ, Dept Entomol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Rasgon, Jason L.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Oluwagbemi, Olugbenga O.; Fornadel, Christen M.; Norris, Douglas E.] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Oluwagbemi, Olugbenga O.; Fornadel, Christen M.; Norris, Douglas E.] Johns Hopkins Bloomberg Sch Publ Hlth, Johns Hopkins Malaria Res Inst, Baltimore, MD USA; [Oluwagbemi, Olugbenga O.; Adebiyi, Ezekiel F.] Covenant Univ, Dept Comp & Informat Sci, Coll Sci & Technol, Sch Nat & Appl Sci, Ota, Ogun State, Nigeria	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Covenant University	Rasgon, JL (corresponding author), Penn State Univ, Dept Entomol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.	jlr54@psu.edu	Norris, Doug/GXV-3397-2022; Fornadel, Christen/AAF-3555-2020	Oluwagbemi, Olugbenga/0000-0001-9085-3370; Rasgon, Jason/0000-0002-4050-8429; Norris, Douglas/0000-0002-4631-2777; Fornadel, Christen/0000-0002-2498-8979	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIAID)(NIH/NIAID) [R21AI088311]; Bill and Melinda Gates Foundation through the Grand Challenges Explorations Initiative; Fulbright Foundation Fellowship; Covenant University Staff Development Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088311, T32AI007417] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIAID)(NIH/NIAID); Bill and Melinda Gates Foundation through the Grand Challenges Explorations Initiative; Fulbright Foundation Fellowship; Covenant University Staff Development Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIAID)(NIH/NIAID) grant R21AI088311 and a grant from the Bill and Melinda Gates Foundation through the Grand Challenges Explorations Initiative to JLR. OOO was partially supported by a Fulbright Foundation Fellowship and the Covenant University Staff Development Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboagye-Antwi F, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-225; Alphey L, 2008, ADV EXP MED BIOL, V627, P93, DOI 10.1007/978-0-387-78225-6_8; Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014; ALY C, 1986, ENTOMOL EXP APPL, V42, P83, DOI 10.1007/BF00186162; Amalraj DD, 2005, MEM I OSWALDO CRUZ, V100, P893, DOI 10.1590/S0074-02762005000800012; [Anonymous], 1987, WILEY SERIES PROBABI; Arifin SMN, 2011, INT J AGENT TECHNOLO, V3, P1; Asidi AN, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-25; Axtell R., 1996, COMPUT MATH ORGAN TH, V2, P123, DOI DOI 10.1007/BF01299065; Baber I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010270; Bauschke H.H., 1993, SET-VALUED ANAL, V1, P185, DOI DOI 10.1007/BF01027691; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Becker N, 2008, PARASITOL RES, V103, pS19, DOI 10.1007/s00436-008-1210-2; BEHRISCH HW, 1969, BIOCHEM J, V115, P687, DOI 10.1042/bj1150687; Benedict MQ, 2010, J VECTOR ECOL, V35, P116, DOI 10.1111/j.1948-7134.2010.00037.x; Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192; Bond JG, 2004, P ROY SOC B-BIOL SCI, V271, P2161, DOI 10.1098/rspb.2004.2826; Cloern JE, 1995, LIMNOL OCEANOGR, V40, P1313, DOI 10.4319/lo.1995.40.7.1313; Coutinho-Abreu IV, 2010, PARASITOL INT, V59, P1, DOI 10.1016/j.parint.2009.10.002; CUELLAR CB, 1969, B WORLD HEALTH ORGAN, V40, P205; CURTIS CF, 1985, B ENTOMOL RES, V75, P259, DOI 10.1017/S0007485300014346; Curtis CF, 2007, BRIDGING LAB FIELD R, P33; Depinay JMO, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-29; Dhiman R. C., 2008, Regional Health Forum, V12, P27; Diabate A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-5; DIETZ K, 1974, B WORLD HEALTH ORGAN, V50, P347; Eckhoff PA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-303; Ermert V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-62; Ermert V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-35; FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003; FOCKS DA, 1993, J MED ENTOMOL, V30, P1018, DOI 10.1093/jmedent/30.6.1018; Fornadel CM, 2010, AM J TROP MED HYG, V83, P838, DOI 10.4269/ajtmh.2010.10-0088; FRANCHETTI C, 1986, J MATH ANAL APPL, V114, P305, DOI 10.1016/0022-247X(86)90085-5; GAHAN JB, 1964, B WORLD HEALTH ORGAN, V31, P445; GARRETTJ.C, 1964, B WORLD HEALTH ORGAN, V31, P71; GILLIES M. T., 1961, BULL ENT RES, V52, P99, DOI 10.1017/S0007485300055309; GILPIN ME, 1979, FORTS ZOOL, V25, P355; Gimnig JE, 2001, J MED ENTOMOL, V38, P282, DOI 10.1603/0022-2585-38.2.282; Goltsev Y, 2009, DEV BIOL, V330, P462, DOI 10.1016/j.ydbio.2009.02.038; Greenwood B, 2002, NATURE, V415, P670, DOI 10.1038/415670a; GREENWOOD BM, 1993, T ROY SOC TROP MED H, V87, P3, DOI 10.1016/0035-9203(93)90169-Q; Gu JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021329; Gu WD, 2008, AM J TROP MED HYG, V78, P2, DOI 10.4269/ajtmh.2008.78.2; Hoshen MB, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-32; Howard SC, 2000, T ROY SOC TROP MED H, V94, P357, DOI 10.1016/S0035-9203(00)90103-2; Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043; Impoinvil DE, 2007, J AM MOSQUITO CONTR, V23, P124, DOI 10.2987/8756-971X(2007)23[124:CTATPE]2.0.CO;2; Irlich UM, 2009, AM NAT, V174, P819, DOI 10.1086/647904; JEPSON WF, 1947, B ENTOMOL RES, V38, P177, DOI 10.1017/S0007485300030273; Kaufman MG, 2006, J MED ENTOMOL, V43, P669, DOI 10.1603/0022-2585(2006)43[669:IOABTG]2.0.CO;2; KAVANAU JL, 1950, J GEN PHYSIOL, V34, P193, DOI 10.1085/jgp.34.2.193; Kessler S, 2008, J VECTOR ECOL, V33, P145, DOI 10.3376/1081-1710(2008)33[145:ROAGAS]2.0.CO;2; Kirby MJ, 2009, ACTA TROP, V109, P118, DOI 10.1016/j.actatropica.2008.09.025; Knols Bart G.J., 2002, Malaria Journal, V1, pUnpaginated, DOI 10.1186/1475-2875-1-19; Lee Y, 2009, J MED ENTOMOL, V46, P316, DOI 10.1603/033.046.0216; Louca V, 2009, J MED ENTOMOL, V46, P546, DOI 10.1603/033.046.0320; MACAN TT, 1961, BIOL REV, V36, P151, DOI 10.1111/j.1469-185X.1961.tb01582.x; MACDONALD G, 1952, Trop Dis Bull, V49, P813; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508; McKenzie FE, 2000, PARASITOL TODAY, V16, P511, DOI 10.1016/S0169-4758(00)01789-0; Mogi M, 2007, J AM MOSQUITO CONTR, V23, P93, DOI 10.2987/8756-971X(2007)23[93:IAOIP]2.0.CO;2; Molineaux L, 1980, THE GARKI PROJECT; Mugittu K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-126; Munga S, 2006, J MED ENTOMOL, V43, P221, DOI 10.1603/0022-2585(2006)043[0221:EOLCAP]2.0.CO;2; Munga S, 2005, J MED ENTOMOL, V42, P993, DOI 10.1603/0022-2585(2005)042[0993:OSPAEH]2.0.CO;2; Mwangangi JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-228; Olayemi IK, 2009, J VECTOR DIS, V46, P295; Omlin FX, 2007, AM J TROP MED HYG, V77, P264, DOI 10.4269/ajtmh.2007.77.264; Paaijmans KP, 2009, ACTA TROP, V109, P124, DOI 10.1016/j.actatropica.2008.07.010; Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11; Purchase S, 2008, IMP C P UPPS; Ren XX, 2010, J VIROL, V84, P7726, DOI 10.1128/JVI.00631-10; Richards A. G., 1964, Physiological Zoology Chicago, V37, P199; Roper C, 2004, LANCET, V305, P1123; Ross R., 1911, PREVENTION MALARIA; Ross Ronald, 1928, STUDIES MALARIA; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Sattler MA, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-4; Schneider P, 2000, MED VET ENTOMOL, V14, P165, DOI 10.1046/j.1365-2915.2000.00204.x; SCHOOLFIELD RM, 1981, J THEOR BIOL, V88, P719, DOI 10.1016/0022-5193(81)90246-0; Scolari F, 2011, GENETICA, V139, P41, DOI 10.1007/s10709-010-9483-7; SEAWRIGHT JA, 1979, AM J TROP MED HYG, V28, P155, DOI 10.4269/ajtmh.1979.28.155; SERVICE MW, 1973, B ENTOMOL RES, V62, P359, DOI 10.1017/S0007485300003862; SHARPE PJH, 1977, J THEOR BIOL, V64, P649, DOI 10.1016/0022-5193(77)90265-X; Silver JB, 2008, MOSQUITO ECOLOGY FIE; Tuno N, 2005, J MED ENTOMOL, V42, P270, DOI 10.1603/0022-2585(2005)042[0270:SOAGSS]2.0.CO;2; von Neumman J., 1950, ANN MATH STUD, V22; WARD JV, 1982, ANNU REV ENTOMOL, V27, P97, DOI 10.1146/annurev.en.27.010182.000525; White MT, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-153; Wilensky U, 2007, JASSS-J ARTIF SOC S, V10, P1; Wilke AB, 2009, ASIA PACIFIC J MOL B, V17, P65; Williams CR, 2008, J MED ENTOMOL, V45, P1173, DOI 10.1603/0022-2585(2008)45[1173:REOAAP]2.0.CO;2; Windbichler N, 2011, NATURE, V473, P212, DOI 10.1038/nature09937; Yaro AS, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-19; Yurista PM, 1999, J PLANKTON RES, V21, P721, DOI 10.1093/plankt/21.4.721	96	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68040	10.1371/journal.pone.0068040	http://dx.doi.org/10.1371/journal.pone.0068040			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861847	Green Published, Green Submitted, gold			2022-12-27	WOS:000321692000014
J	Steen, RG; Casadevall, A; Fang, FC				Steen, R. Grant; Casadevall, Arturo; Fang, Ferric C.			Why Has the Number of Scientific Retractions Increased?	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; TEST DATA INTEGRITY; MEDICAL-RESEARCH; FRAUD; MISCONDUCT; SCIENCE; FALSIFY	Background: The number of retracted scientific publications has risen sharply, but it is unclear whether this reflects an increase in publication of flawed articles or an increase in the rate at which flawed articles are withdrawn. Methods and Findings: We examined the interval between publication and retraction for 2,047 retracted articles indexed in PubMed. Time-to-retraction (from publication of article to publication of retraction) averaged 32.91 months. Among 714 retracted articles published in or before 2002, retraction required 49.82 months; among 1,333 retracted articles published after 2002, retraction required 23.82 months (p<0.0001). This suggests that journals are retracting papers more quickly than in the past, although recent articles requiring retraction may not have been recognized yet. To test the hypothesis that time-to-retraction is shorter for articles that receive careful scrutiny, time-to-retraction was correlated with journal impact factor (IF). Time-to-retraction was significantly shorter for high-IF journals, but only similar to 1% of the variance in time-to-retraction was explained by increased scrutiny. The first article retracted for plagiarism was published in 1979 and the first for duplicate publication in 1990, showing that articles are now retracted for reasons not cited in the past. The proportional impact of authors with multiple retractions was greater in 1972-1992 than in the current era (p<0.001). From 1972-1992, 46.0% of retracted papers were written by authors with a single retraction; from 1993 to 2012, 63.1% of retracted papers were written by single-retraction authors (p<0.001). Conclusions: The increase in retracted articles appears to reflect changes in the behavior of both authors and institutions. Lower barriers to publication of flawed articles are seen in the increase in number and proportion of retractions by authors with a single retraction. Lower barriers to retraction are apparent in an increase in retraction for "new" offenses such as plagiarism and a decrease in the time-to-retraction of flawed work.	[Steen, R. Grant] Med Commun Consultants LLC, MediCC, Chapel Hill, NC USA; [Casadevall, Arturo] Yeshiva Univ Albert Einstein Coll Med, Bronx, NY 10461 USA; [Fang, Ferric C.] Univ Washington, Sch Med, Seattle, WA USA	Yeshiva University; Albert Einstein College of Medicine; University of Washington; University of Washington Seattle	Steen, RG (corresponding author), Med Commun Consultants LLC, MediCC, Chapel Hill, NC USA.	G_Steen_MediCC@yahoo.com		Steen, R. Grant/0000-0003-3386-6575; Fang, Ferric/0000-0002-3243-110X				Agres T, 2011, ANESTHES NEWS, V37; Baerlocher MO, 2010, EUR J INTERN MED, V21, P40, DOI 10.1016/j.ejim.2009.11.002; Carlisle JB, 2012, ANAESTHESIA, V67, P521, DOI 10.1111/j.1365-2044.2012.07128.x; Casadevall A, 2012, INFECT IMMUN, V80, P891, DOI 10.1128/IAI.06183-11; Cokol M, 2008, EMBO REP, V9, DOI 10.1038/sj.embor.7401143; Cokol M, 2007, EMBO REP, V8, P422, DOI 10.1038/sj.embor.7400970; DARSEE J, 1983, NEW ENGL J MED, V308, P1419; ENGLER RL, 1987, NEW ENGL J MED, V317, P1383, DOI 10.1056/NEJM198711263172205; Fanelli D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005738; Fang FC, 2013, MBIO, V4, DOI 10.1128/mBio.00640-12; Fang FC, 2012, P NATL ACAD SCI USA, V109, P17028, DOI 10.1073/pnas.1212247109; Fisher R. A., 1936, Ann Sci London, V1, P115, DOI 10.1080/00033793600200111; Fujii Y, 2012, ANAESTHESIA, V67, P669, DOI 10.1111/j.1365-2044.2012.07189.x; Furman JL, 2012, RES POLICY, V41, P276, DOI 10.1016/j.respol.2011.11.001; Galton DJ, 2012, QJM-INT J MED, V105, P215, DOI 10.1093/qjmed/hcr195; Gauchat G, 2012, AM SOCIOL REV, V77, P167, DOI 10.1177/0003122412438225; Grieneisen ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044118; GULLIS RJ, 1977, NATURE, V265, P764, DOI 10.1038/265764b0; HAWKES N, 1979, SCIENCE, V205, P673, DOI 10.1126/science.205.4407.673; John LK, 2012, PSYCHOL SCI, V23, P524, DOI 10.1177/0956797611430953; Kakuk P, 2009, SCI ENG ETHICS, V15, P545, DOI 10.1007/s11948-009-9121-x; Kennedy D, 2002, SCIENCE, V298, P495, DOI 10.1126/science.298.5593.495; Korpela KM, 2010, CURR MED RES OPIN, V26, P843, DOI 10.1185/03007991003603804; Kranke P, 2000, ANESTH ANALG, V90, P1004, DOI 10.1213/00000539-200004000-00053; Marret E, 2009, ANESTHESIOLOGY, V111, P1279, DOI 10.1097/ALN.0b013e3181c14c3d; Martinson BC, 2005, NATURE, V435, P737, DOI 10.1038/435737a; Miller DR, 2011, CAN J ANESTH, V58, P777, DOI 10.1007/s12630-011-9558-7; Miller DR, 2012, CAN J ANAESTH; Normile D., 2011, SCIENCEINSIDER; Ranstam J, 2000, CONTROL CLIN TRIALS, V21, P415, DOI 10.1016/S0197-2456(00)00069-6; Shafer SL, 2011, ANESTH ANALG, V112, P1; Shen Z, 2010, J CELL MOL MED, V14, P226, DOI 10.1111/j.1582-4934.2008.00370.x; Shen ZK, 2011, ACS NANO, V5, P6855, DOI 10.1021/nn202932z; Shen ZK, 2011, LANGMUIR, V27, P5167, DOI 10.1021/la200377b; Smith R, 2005, BMJ, V331; Sovacool BK, 2005, AM J BIOETHICS, V5, pW1, DOI 10.1080/15265160500313242; Steen R., 2011, AMWA J, P2; Steen RG, 2011, J MED ETHICS, V37, P249, DOI 10.1136/jme.2010.040923; Steen RG, 2011, J MED ETHICS, V37, P113, DOI 10.1136/jme.2010.038125; Titus SL, 2008, NATURE, V453, P980, DOI 10.1038/453980a; Van Noorden R, 2011, NATURE, V478, P26, DOI 10.1038/478026a; Weissmann G, 2006, FASEB J, V20, P587, DOI 10.1096/fj.06-0401ufm; Weissmann G, 2010, FASEB J, V24, P2591, DOI 10.1096/fj.10-0801ufm	43	219	223	7	135	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68397	10.1371/journal.pone.0068397	http://dx.doi.org/10.1371/journal.pone.0068397			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	181TS	23861902	gold, Green Published, Green Submitted			2022-12-27	WOS:000321692000027
J	Lessler, J; Metcalf, CJE				Lessler, Justin; Metcalf, C. Jessica E.			Balancing Evidence and Uncertainty when Considering Rubella Vaccine Introduction	PLOS ONE			English	Article							IMMUNIZATION; EPIDEMIOLOGY; MEASLES; MUMPS	Background: Despite a safe and effective vaccine, rubella vaccination programs with inadequate coverage can raise the average age of rubella infection; thereby increasing rubella cases among pregnant women and the resulting congenital rubella syndrome (CRS) in their newborns. The vaccination coverage necessary to reduce CRS depends on the birthrate in a country and the reproductive number, R-0, a measure of how efficiently a disease transmits. While the birthrate within a country can be known with some accuracy, R-0 varies between settings and can be difficult to measure. Here we aim to provide guidance on the safe introduction of rubella vaccine into countries in the face of substantial uncertainty in R-0. Methods: We estimated the distribution of R-0 in African countries based on the age distribution of rubella infection using Bayesian hierarchical models. We developed an age specific model of rubella transmission to predict the level of R-0 that would result in an increase in CRS burden for specific birth rates and coverage levels. Combining these results, we summarize the safety of introducing rubella vaccine across demographic and coverage contexts. Findings: The median R-0 of rubella in the African region is 5.2, with 90% of countries expected to have an R-0 between 4.0 and 6.7. Overall, we predict that countries maintaining routine vaccination coverage of 80% or higher are can be confident in seeing a reduction in CRS over a 30 year time horizon. Conclusions: Under realistic assumptions about human contact, our results suggest that even in low birth rate settings high vaccine coverage must be maintained to avoid an increase in CRS. These results lend further support to the WHO recommendation that countries reach 80% coverage for measles vaccine before introducing rubella vaccination, and highlight the importance of maintaining high levels of vaccination coverage once the vaccine is introduced.	[Lessler, Justin] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Metcalf, C. Jessica E.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Oxford	Lessler, J (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.	jlessler@jhsph.edu		Lessler, Justin/0000-0002-9741-8109	Bill and Melinda Gates Foundation (Vaccine Modeling Initiative) [705580-3]; National Institute of Allergy and Infectious Disease [K22AI092150]; Royal Society; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD047879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI092150] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation (Vaccine Modeling Initiative); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Royal Society(Royal Society of London); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work of JL and CJEM was funded by a grant from the Bill and Melinda Gates Foundation (Vaccine Modeling Initiative, 705580-3). JL is the recipient of a Research Scholar Development Award from the National Institute of Allergy and Infectious Disease (K22AI092150). CJEM was supported by the Royal Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; ANDERSON RM, 1986, J HYG-CAMBRIDGE, V96, P305, DOI 10.1017/S0022172400066079; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P301; BOULIANNE N, 1995, VACCINE, V13, P1611, DOI 10.1016/0264-410X(95)00098-L; Cormen TH, 2000, INTRO ALGORITHMS; Cutts FT, 2012, LANCET, V380, P217, DOI 10.1016/S0140-6736(12)61215-X; Cutts FT, 2000, EPIDEMIOL INFECT, V124, P467, DOI 10.1017/S0950268899003532; DeStefano F, 2011, EPIDEMIOL INFECT, V139, P1181, DOI 10.1017/S095026881000230X; Edmunds WJ, 2000, EPIDEMIOL INFECT, V125, P635, DOI 10.1017/S0950268800004672; Fu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045113; GAVI Alliance, MEASL RUB VACC SUPP; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Goodson JL, 2011, J INFECT DIS, V204, pS215, DOI 10.1093/infdis/jir108; Horby P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016965; Jimenez G, 2007, PEDIATR INFECT DIS J, V26, P382, DOI 10.1097/01.inf.0000260000.84792.9e; Lessler J, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001110; Metcalf CJE, 2012, THEOR POPUL BIOL, V82, P275, DOI 10.1016/j.tpb.2011.12.001; Metcalf CJE, 2012, EPIDEMIOL INFECT, V140, P2290, DOI 10.1017/S0950268812000131; Metcalf CJE, 2011, J R SOC INTERFACE, V8, P369, DOI 10.1098/rsif.2010.0320; Metcalf CJE, 2012, J ROYAL SOC INTERFAC, V10; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Omer SB, 2008, AM J EPIDEMIOL, V168, P1389, DOI 10.1093/aje/kwn263; Panagiotopoulos T, 1999, BRIT MED J, V319, P1462, DOI 10.1136/bmj.319.7223.1462; US Census Bureau, INT PROGR INF GAT; van der Heijden OG, 1998, EPIDEMIOL INFECT, V121, P653, DOI 10.1017/S0950268898001472; van der Veen Y, 2005, EUROSURVEILLANCE, V10, P2839; World Bank, BIRTH RAT CRUD; World Health Organization, WHO UNICEF EST MCV C; World Health Organization, 2012, IMM PROF CAP VERD	29	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67639	10.1371/journal.pone.0067639	http://dx.doi.org/10.1371/journal.pone.0067639			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861777	Green Published, gold, Green Submitted			2022-12-27	WOS:000321425300020
J	Li, MJ; Yang, YH; Chen, XJ; Wang, FQ; Lin, WX; Yi, YJ; Zeng, L; Yang, SY; Zhang, ZY				Li, Ming Jie; Yang, Yan Hui; Chen, Xin Jian; Wang, Feng Qing; Lin, Wen Xiong; Yi, Yan Jie; Zeng, Lei; Yang, Shuo Ye; Zhang, Zhong Yi			Transcriptome/Degradome-Wide Identification of R. glutinosa miRNAs and Their Targets: The Role of miRNA Activity in the Replanting Disease	PLOS ONE			English	Article							AUXIN-RESPONSE-FACTOR; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; TRANSCRIPTION FACTORS; ROOT-FORMATION; SMALL RNA; MICRORNAS; PROTEIN; BIOGENESIS; PLANTS	Rehmannia glutinosa, a traditional Chinese medicine herb, is unable to grow normally in a soil where the same species has recently been cultivated. The biological basis of this so called "replanting disease" is unknown, but it may involve the action of microRNAs (miRNAs), which are known to be important regulators of plant growth and development. High throughput Solexa/Illumina sequencing was used to generate a transcript library of the R. glutinosa transcriptome and degradome in order to identify possible miRNAs and their targets implicated in the replanting disease. A total of 87,665 unigenes and 589 miRNA families (17 of which have not been identified in plants to date) was identified from the libraries made from a first year (FP) and a second year (SP) crop. A comparison between the FP and SP miRNAs showed that the abundance of eight of the novel and 295 of the known miRNA families differed between the FP and SP plants. Sequencing of the degradome sampled from FP and SP plants led to the identification of 165 transcript targets of 85 of the differentially abundant miRNA families. The interaction of some of these miRNAs with their target(s) is likely to form an important part of the molecular basis of the replanting disease of R. glutinosa.	[Li, Ming Jie; Yang, Yan Hui; Chen, Xin Jian; Wang, Feng Qing; Zhang, Zhong Yi] Henan Agr Univ, Coll Life Sci, Zhengzhou, Peoples R China; [Yang, Yan Hui; Yi, Yan Jie; Zeng, Lei; Yang, Shuo Ye] Henan Univ Technol, Coll Bioengn, Zhengzhou 450000, Peoples R China; [Lin, Wen Xiong; Zhang, Zhong Yi] Fujian Agr & Forestry Univ, Coll Crop Sci, Fuzhou, Peoples R China	Henan Agricultural University; Henan University of Technology; Fujian Agriculture & Forestry University	Chen, XJ (corresponding author), Henan Agr Univ, Coll Life Sci, Zhengzhou, Peoples R China.	xinjian1@yahoo.com; hauzzy@163.com			National Natural Science Foundation of China [30772729, 81072983, 31271674, 81274022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China ( Nos. 30772729, 81072983, 31271674 and 81274022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; Ashley MK, 2006, J EXP BOT, V57, P425, DOI 10.1093/jxb/erj034; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bilwes AM, 2001, NAT STRUCT BIOL, V8, P353, DOI 10.1038/86243; Bortiri E, 2006, PLANT CELL, V18, P574, DOI 10.1105/tpc.105.039032; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Bruhn L, 2012, GENE DEV, V11, P640; Cao ZY, 2011, J EXP BOT, V62, P4675, DOI 10.1093/jxb/err190; Chagne D, 2012, PLANT PHYSIOL, DOI [http://dx.doi.org/10.1104/pp.112, DOI 10.1104/PP.112]; Du Jia-fang, 2009, Shengtaixue Zazhi, V28, P445; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Gazzani S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-62; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Grabov A, 2007, ANN BOT-LONDON, V99, P1035, DOI 10.1093/aob/mcm066; Gutierrez L, 2009, PLANT CELL, V21, P3119, DOI 10.1105/tpc.108.064758; Inukai Y, 2005, PLANT CELL, V17, P1387, DOI 10.1105/tpc.105.030981; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kawashima CG, 2009, PLANT J, V57, P313, DOI 10.1111/j.1365-313X.2008.03690.x; Kim J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-657; Kwak PB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-457; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li ZF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0028806, 10.1371/journal.pone.0052388]; Liu SP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-148; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Miyashima S, 2011, DEVELOPMENT, V138, P2303, DOI 10.1242/dev.060491; Nagatoshi Y, 2009, J BIOL CHEM, V284, P19301, DOI 10.1074/jbc.M109.001032; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Pavlova S. V., 2003, Genetika, V39, P1301; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Ruan MB, 2009, GENOMICS, V94, P263, DOI 10.1016/j.ygeno.2009.07.002; Shi DQ, 2005, PLANT CELL, V17, P2340, DOI 10.1105/tpc.105.033563; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Tang XR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003091; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wang Z, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-650; [温学森 Wen Xuesen], 2002, [中草药, Chinese Traditional and Herbal Drugs], V33, P946; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; Xie FL, 2011, GENE, V473, P8, DOI 10.1016/j.gene.2010.09.007; Xie KB, 2006, PLANT PHYSIOL, V142, P280, DOI 10.1104/pp.106.084475; Xu DL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-133; Xu Q, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-246; Yang YH, 2013, ACTA PHYSIOL PLANT, V35, P645, DOI 10.1007/s11738-012-1105-9; Yang YH, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-53; Yang YH, 2011, PLANT MOL BIOL REP, V29, P986, DOI 10.1007/s11105-011-0293-6; YU FP, 1994, ACTA PHYTOPATHOLOGIC, V24, P310; Zhan XQ, 2012, P NATL ACAD SCI USA, V109, P18198, DOI 10.1073/pnas.1216199109; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3; ZHAO YJ, 1991, J CHIN MED MAT, V14, P3; Zhou ZS, 2012, PLANT CELL ENVIRON, V35, P86, DOI 10.1111/j.1365-3040.2011.02418.x; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; 李先恩, 2006, [中国中药杂志, China Journal of Chinese Materia Medica], V31, P344	59	19	47	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68531	10.1371/journal.pone.0068531	http://dx.doi.org/10.1371/journal.pone.0068531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861915	Green Published, gold, Green Submitted			2022-12-27	WOS:000321425300067
J	Stephens, M				Stephens, Matthew			A Unified Framework for Association Analysis with Multiple Related Phenotypes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BAYESIAN VARIABLE SELECTION; FUNCTIONAL ANNOTATION; SCAVENGER RECEPTOR; RISK; LOCI; VARIANTS; VEGFA; GENE; POLYMORPHISMS	We consider the problem of assessing associations between multiple related outcome variables, and a single explanatory variable of interest. This problem arises in many settings, including genetic association studies, where the explanatory variable is genotype at a genetic variant. We outline a framework for conducting this type of analysis, based on Bayesian model comparison and model averaging for multivariate regressions. This framework unifies several common approaches to this problem, and includes both standard univariate and standard multivariate association tests as special cases. The framework also unifies the problems of testing for associations and explaining associations - that is, identifying which outcome variables are associated with genotype. This provides an alternative to the usual, but conceptually unsatisfying, approach of resorting to univariate tests when explaining and interpreting significant multivariate findings. The method is computationally tractable genome-wide for modest numbers of phenotypes (e. g. 5-10), and can be applied to summary data, without access to raw genotype and phenotype data. We illustrate the methods on both simulated examples, and to a genome-wide association study of blood lipid traits where we identify 18 potential novel genetic associations that were not identified by univariate analyses of the same data.	[Stephens, Matthew] Univ Chicago, Dept Stat, Chicago, IL 60637 USA; [Stephens, Matthew] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Stephens, M (corresponding author), Univ Chicago, Dept Stat, Chicago, IL 60637 USA.	mstephens@uchicago.edu			National Institutes of Health grant [HG02585]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002585] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by National Institutes of Health grant HG02585 to MS (http://www.genome.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhary S, 2009, INVEST OPHTH VIS SCI, V50, P5552, DOI 10.1167/iovs.09-3694; Adachi H, 2002, J BIOL CHEM, V277, P34264, DOI 10.1074/jbc.M204277200; Al-Kateb H, 2007, DIABETES, V56, P2161, DOI 10.2337/db07-0376; Anderson TW, 1984, INTRO MULTIVARIATE S; Baker Allison R, 2009, BMC Proc, V3 Suppl 7, pS42; Banerjee S, 2008, GENETICS, V179, P2275, DOI 10.1534/genetics.108.088427; Box G, 1973, APPL MULTIVARIATE AN; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; Brown PJ, 1998, J R STAT SOC B, V60, P627, DOI 10.1111/1467-9868.00144; Chelala C, 2009, BIOINFORMATICS, V25, P655, DOI 10.1093/bioinformatics/btn653; DAWID AP, 1981, BIOMETRIKA, V68, P265, DOI 10.1093/biomet/68.1.265; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; DICKEY JM, 1967, ANN MATH STAT, V38, P511, DOI 10.1214/aoms/1177698967; Engelhardt BE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001117; Ferreira MAR, 2009, BIOINFORMATICS, V25, P132, DOI 10.1093/bioinformatics/btn563; Finegold M, 2011, ANN APPL STAT, V5, P1057, DOI 10.1214/10-AOAS410; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Ganji SH, 2004, J LIPID RES, V45, P1835, DOI 10.1194/jlr.M300403-JLR200; Geiger D, 2002, ANN STAT, V30, P1412; Guan YT, 2011, ANN APPL STAT, V5, P1780, DOI 10.1214/11-AOAS455; Hoggart CJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000130; Holmes CC, 2002, J COMPUT GRAPH STAT, V11, P533, DOI 10.1198/106186002475; Hu M, 2012, J LIPID RES, V53, P802, DOI 10.1194/jlr.P023614; Huang JS, 2007, HEPATOLOGY, V46, P147, DOI 10.1002/hep.21632; Huberty C, 1989, J COUNS PSYCHOL, V33, P15; Kachigan, 1982, MULTIVARIATE STAT AN; Kim S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000587; Kim S, 2009, BIOINFORMATICS, V25, pI204, DOI 10.1093/bioinformatics/btp218; KSHIRSAGAR AM, 1960, BIOMETRIKA, V47, P480, DOI 10.2307/2333324; Kzhyshkowska J, 2006, J CELL MOL MED, V10, P635, DOI 10.1111/j.1582-4934.2006.tb00425.x; Lauritzen Steffen L., 1996, OXFORD STAT SCI SERI, V17; Li RM, 2011, AM J PHYSIOL-GASTR L, V300, pG71, DOI 10.1152/ajpgi.00215.2010; Maranville JC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002162; Martinez-Royo A, 2010, RES VET SCI, V88, P452, DOI 10.1016/j.rvsc.2009.12.009; Minka T, 1999, BAYESIAN LINEA UNPUB; Neyman J, 1933, PHILOS T R SOC LOND, V231, P289, DOI 10.1098/rsta.1933.0009; O'Reilly PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034861; Pe'er Dana, 2005, Sci STKE, V2005, ppl4, DOI 10.1126/stke.2812005pl4; Petretto E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000737; Yang Q, 2012, J PROBAB STAT, V2012, DOI 10.1155/2012/652569; R Core Team, 2012, R LANG ENV STAT COMP; Rothenberg T, 1963, 6315 EC I; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; SARRIA AJ, 1992, J BIOL CHEM, V267, P19455; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Smith M, 2000, J ECONOMETRICS, V98, P257, DOI 10.1016/S0304-4076(00)00018-X; Spirtes P., 2000, CAUSATION PREDICTION, V81; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; TIAO GC, 1964, J ROY STAT SOC B, V26, P277; Ullah AZD, 2012, NUCLEIC ACIDS RES, V40, pW65, DOI 10.1093/nar/gks364; Verzilli CJ, 2005, GENET EPIDEMIOL, V28, P313, DOI 10.1002/gepi.20072; Vogel D, 2011, BIOMETRIKA, V98, P935, DOI 10.1093/biomet/asr037; Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yang XF, 2011, MOL VIS, V17, P3088; Yu Y, 2011, HUM MOL GENET, V20, P3699, DOI 10.1093/hmg/ddr270; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012; Zhang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006502	61	140	142	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e65245	10.1371/journal.pone.0065245	http://dx.doi.org/10.1371/journal.pone.0065245			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861737	Green Submitted, Green Published, gold			2022-12-27	WOS:000321425300003
J	Vogt, L; Ramasamy, U; Meyer, D; Pullens, G; Venema, K; Faas, MM; Schols, HA; de Vos, P				Vogt, Leonie; Ramasamy, Uttara; Meyer, Diederick; Pullens, Gerdie; Venema, Koen; Faas, Marijke M.; Schols, Henk A.; de Vos, Paul			Immune Modulation by Different Types of beta 2 -> 1-Fructans Is Toll-Like Receptor Dependent	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; NF-KAPPA-B; DENDRITIC CELLS; LACTOBACILLUS-RHAMNOSUS; INNATE IMMUNITY; DIETARY FIBER; PROBIOTICS; INULIN; FRUCTOOLIGOSACCHARIDES; ACTIVATION	Introduction: beta 2 -> 1-fructans are dietary fibers. Main objectives of this study were 1) to demonstrate direct signalling of beta 2 -> 1-fructans on immune cells, 2) to study whether this is mediated by the pattern recognition receptors Toll-like receptors (TLRs) and nucleotide-binding oligomerisation domain-containing proteins (NODs), and 3) to relate the observed effects to the chain length differences in beta 2 -> 1-fructans. Methods: Four different beta 2 -> 1-fructan formulations were characterised for their chain length profile. Human peripheral blood mononuclear cells (PBMCs) were stimulated in vitro with beta 2 -> 1-fructans, and production of IL-1Ra, IL-1 beta, IL-6, IL-10, IL-12p70, and TNF-alpha was analysed. Reporter cells for TLRs and NODs were incubated with beta 2 -> 1-fructans and analysed for NF-kappa B/AP-1 activation. Results: Cytokine production in human PBMCs was dose-and chain length-dependent. Strikingly, short chain enriched beta 2 -> 1-fructans induced a regulatory cytokine balance compared to long chain enriched beta 2 -> 1-fructans as measured by IL10/ IL-12 ratios. Activation of reporter cells showed that signalling was highly dependent on TLRs and their adapter, myeloid differentiation primary response protein 88 (MyD88). In human embryonic kidney reporter cells, TLR2 was prominently activated, while TLR4, 5, 7, 8, and NOD2 were mildly activated. Conclusions: beta 2 -> 1-fructans possess direct signalling capacity on human immune cells. By activating primarily TLR2, and to a lesser extent TLR4, 5, 7, 8, and NOD2, beta 2 -> 1-fructan stimulation results in NF-kappa B/AP-1 activation. Chain length of beta 2 -> 1fructans is important for the induced activation pattern and IL-10/IL-12 ratios.	[Vogt, Leonie; Faas, Marijke M.; de Vos, Paul] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Ramasamy, Uttara; Schols, Henk A.] Wageningen Univ, Food Chem Lab, NL-6700 AP Wageningen, Netherlands; [Meyer, Diederick] Sensus BV, Sci & Regulatory Affairs, Roosendaal, Netherlands; [Pullens, Gerdie] Cosun Food Technol Ctr, Prod Dev, Roosendaal, Netherlands; [Venema, Koen] TNO, Dept Biosci, NL-3700 AJ Zeist, Netherlands	University of Groningen; Wageningen University & Research; Netherlands Organization Applied Science Research	Vogt, L (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.	L.M.Vogt@umcg.nl	de Vos, Paul/A-3170-2013	de vos, paul/0000-0001-9618-2408	European Union; The Northern Netherlands Provinces; KOERS NOORD	European Union(European Commission); The Northern Netherlands Provinces; KOERS NOORD	Within the framework of the Carbohydrate Competence Center, this research has been financially supported by the European Union, the European Regional Development Fund, and The Northern Netherlands Provinces (Samenwerkingsverband Noord-Nederland), KOERS NOORD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2012, SEMIN IMMUNOPATHOL, V34, P551, DOI 10.1007/s00281-012-0316-x; Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Benyacoub J, 2008, J NUTR, V138, P123, DOI 10.1093/jn/138.1.123; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Bruns AM, 2012, CRIT REV BIOCHEM MOL, V47, P194, DOI 10.3109/10409238.2011.630974; Cambi A, 2003, CURR OPIN CELL BIOL, V15, P539, DOI 10.1016/j.ceb.2003.08.004; Chen Z, 2008, CLIN IMMUNOL, V128, P400, DOI 10.1016/j.clim.2008.04.006; Chuang SC, 2012, AM J CLIN NUTR, V96, P164, DOI 10.3945/ajcn.111.028415; de Kivit S, 2011, EUR J PHARM; Delgado MA, 2009, CELL DEATH DIFFER, V16, P976, DOI 10.1038/cdd.2009.40; Eiwegger T, 2010, PEDIAT ALLERG IMM-UK, V21, P1179, DOI 10.1111/j.1399-3038.2010.01062.x; Fardet A, 2010, NUTR RES REV, V23, P65, DOI 10.1017/S0954422410000041; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Hamer HM, 2010, CLIN NUTR, V29, P738, DOI 10.1016/j.clnu.2010.04.002; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hosono A, 2003, BIOSCI BIOTECH BIOCH, V67, P758, DOI 10.1271/bbb.67.758; Ito H, 2011, J AGR FOOD CHEM, V59, P5771, DOI 10.1021/jf200859z; Jacobs DR, 2007, AM J CLIN NUTR, V85, P1606, DOI 10.1093/ajcn/85.6.1606; Janardhana V, 2009, J NUTR, V139, P1404, DOI 10.3945/jn.109.105007; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Joosten LAB, 2008, P NATL ACAD SCI USA, V105, P9017, DOI 10.1073/pnas.0710445105; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kelly G, 2008, ALTERN MED REV, V13, P315; Kerrigan AM, 2010, IMMUNOL REV, V234, P335, DOI 10.1111/j.0105-2896.2009.00882.x; Kwon HK, 2010, P NATL ACAD SCI USA, V107, P2159, DOI 10.1073/pnas.0904055107; Landberg R, 2012, AM J CLIN NUTR, V96, P3, DOI 10.3945/ajcn.112.040808; Lelouard H, 2012, GASTROENTEROLOGY, V142, P592, DOI 10.1053/j.gastro.2011.11.039; Lindsay JO, 2006, GUT, V55, P348, DOI 10.1136/gut.2005.074971; Lomax AR, 2009, CURR PHARM DESIGN, V15, P1428, DOI 10.2174/138161209788168155; Manhart N, 2003, NUTRITION, V19, P657, DOI 10.1016/S0899-9007(03)00059-5; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Meijer K, 2010, CURR OPIN CLIN NUTR, V13, P715, DOI 10.1097/MCO.0b013e32833eebe5; Meijerink M, 2012, FEMS IMMUNOL MED MIC, V65, P488, DOI 10.1111/j.1574-695X.2012.00981.x; Meijerink M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010632; Nakamura Y, 2004, CLIN EXP IMMUNOL, V137, P52, DOI 10.1111/j.1365-2249.2004.02487.x; Niness KR, 1999, J NUTR, V129, p1402S, DOI 10.1093/jn/129.7.1402S; Oliveira-Nascimento L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00079; Park JS, 2007, INT IMMUNOPHARMACOL, V7, P70, DOI 10.1016/j.intimp.2006.08.015; Park Y, 2011, ARCH INTERN MED, V171, P1061, DOI 10.1001/archinternmed.2011.18; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; Roller M, 2004, BRIT J NUTR, V92, P931, DOI 10.1079/BJN20041289; Roller M, 2004, J NUTR, V134, P153, DOI 10.1093/jn/134.1.153; Saavedra JM, 2002, BRIT J NUTR, V87, pS241, DOI 10.1079/BJN/2002543; Sato M, 2003, J IMMUNOL, V171, P417, DOI 10.4049/jimmunol.171.1.417; Seifert S, 2007, J NUTR, V137, p2563S, DOI 10.1093/jn/137.11.2563S; Shalhoub J, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-9; Siednienko Jakub, 2009, V517, P3, DOI 10.1007/978-1-59745-541-1_1; Starkie R, 2003, FASEB J, V17, P884, DOI 10.1096/fj.02-0670fje; Swanson KS, 2002, ARCH ANIM NUTR, V56, P309, DOI 10.1080/00039420214344; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; van Hemert S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-293; van Hoffen E, 2009, ALLERGY, V64, P484, DOI 10.1111/j.1398-9995.2008.01765.x; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Vinolo MAR, 2011, J NUTR BIOCHEM, V22, P849, DOI 10.1016/j.jnutbio.2010.07.009; Vinolo MAR, 2009, CLIN SCI, V117, P331, DOI 10.1042/CS20080642; Visintin A, 2003, J BIOL CHEM, V278, P48313, DOI 10.1074/jbc.M306802200; Vogt L, 2015, CRIT REV FOOD SCI, V55, P414, DOI 10.1080/10408398.2012.656772; Vos AP, 2007, CRIT REV IMMUNOL, V27, P97, DOI 10.1615/CritRevImmunol.v27.i2.10; Wells JM, 2011, P NATL ACAD SCI USA, V108, P4607, DOI 10.1073/pnas.1000092107; Zheng H, 2012, VET MICROBIOL, V156, P147, DOI 10.1016/j.vetmic.2011.10.014	63	130	133	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68367	10.1371/journal.pone.0068367	http://dx.doi.org/10.1371/journal.pone.0068367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861894	Green Submitted, Green Published, gold			2022-12-27	WOS:000321425300060
J	Garcia, AE; Rico, MC; Liverani, E; DeLa Cadena, RA; Bray, PF; Kunapuli, SP				Garcia, Analia E.; Rico, Mario C.; Liverani, Elisabetta; DeLa Cadena, Raul A.; Bray, Paul F.; Kunapuli, Satya P.			Erosive Arthritis and Hepatic Granuloma Formation Induced by Peptidoglycan Polysaccharide in Rats Is Aggravated by Prasugrel Treatment	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; CLOPIDOGREL; MICROPARTICLES; P2Y(12); INFLAMMATION; SYNOVITIS; MODEL	Administration of the thienopyridine P2Y12 receptor antagonist, clopidogrel, increased the erosive arthritis induced by peptidoglycan polysaccharide (PG-PS) in rats or by injection of the arthritogenic K/BxN serum in mice. To determine if the detrimental effects are caused exclusively by clopidogrel, we evaluated prasugrel, a third-generation thienopyridine prodrug, that contrary to clopidogrel is mostly metabolized into its active metabolite in the intestine. Prasugrel effects were examined on the PG-PS-induced arthritis rat model. Erosive arthritis was induced in Lewis rats followed by treatment with prasugrel for 21 days. Prasugrel treated arthritic animals showed a significant increase in the inflammatory response, compared with untreated arthritic rats, in terms of augmented macroscopic joint diameter associated with significant signs of inflammation, histomorphometric measurements of the hind joints and elevated platelet number. Moreover, fibrosis at the pannus, assessed by immunofluorescence of connective tissue growth factor, was increased in arthritic rats treated with prasugrel. In addition to the arthritic manifestations, hepatomegaly, liver granulomas and giant cell formation were observed after PG-PS induction and even more after prasugrel exposure. Cytokine plasma levels of IL-1 beta, IL-6, MIP1 alpha, MCP1, IL-17 and RANTES were increased in arthritis-induced animals. IL-10 plasma levels were significantly decreased in animals treated with prasugrel. Overall, prasugrel enhances inflammation in joints and liver of this animal model. Since prasugrel metabolites inhibit neutrophil function ex-vivo and the effects of both clopidogrel and prasugrel metabolites on platelets are identical, we conclude that the thienopyridines metabolites might exert non-platelet effects on other immune cells to aggravate inflammation.	[Garcia, Analia E.; Rico, Mario C.; Liverani, Elisabetta; DeLa Cadena, Raul A.; Kunapuli, Satya P.] Temple Univ, Temple Univ Hosp, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19122 USA; [Garcia, Analia E.; DeLa Cadena, Raul A.; Kunapuli, Satya P.] Temple Univ, Temple Univ Hosp, Sch Med, Dept Physiol, Philadelphia, PA 19122 USA; [Kunapuli, Satya P.] Temple Univ, Temple Univ Hosp, Sch Med, Dept Pharmacol, Philadelphia, PA 19122 USA; [Bray, Paul F.] Philadelphia Temple Univ, Thomas Jefferson Univ, Cardeza Fdn Hematol Res, Sch Med,Temple Univ Hosp, Philadelphia, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Jefferson University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Garcia, AE (corresponding author), Temple Univ, Temple Univ Hosp, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19122 USA.	agarcia@temple.edu	Liverani, Elisabetta/AAR-4132-2021	Liverani, Elisabetta/0000-0001-5540-0456; Rico, Mario/0000-0002-1356-0416	 [K01 HL092586];  [T32 HL07777];  [K01 HL103197];  [R25 HL096331];  [R01 HL60683]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060683, T32HL007777, R25HL096331, K01HL103197, K01HL092586] Funding Source: NIH RePORTER	; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by research grants K01 HL092586 (AG), T32 HL07777 (MR), K01 HL103197 (MR), R25 HL096331 (RADC) and R01 HL60683 (SPK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos D, 2011, JACC-CARDIOVASC INTE, V4, P403, DOI 10.1016/j.jcin.2010.12.011; Algaier I, 2008, J THROMB HAEMOST, V6, P1908, DOI 10.1111/j.1538-7836.2008.03136.x; Barry OP, 1998, J CLIN INVEST, V102, P136, DOI 10.1172/JCI2592; Becker RC, 2010, THROMB HAEMOSTASIS, V103, P535, DOI 10.1160/TH09-07-0491; Berckmans RJ, 2002, ARTHRITIS RHEUM-US, V46, P2857, DOI 10.1002/art.10587; Blauwet L, 2003, JCR-J CLIN RHEUMATOL, V9, P128, DOI 10.1097/01.RHU.0000062515.74319.4b; Boilard E, 2011, J IMMUNOL, V186, P4361, DOI 10.4049/jimmunol.1002857; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Boulman N, 2005, ISR MED ASSOC J, V7, P670; Chen KK, 2003, INTERN MED J, V33, P618, DOI 10.1111/j.1445-5994.2003.00496.x; DELACADENA RA, 1991, AM J PHYSIOL, V260, pG213, DOI 10.1152/ajpgi.1991.260.2.G213; EISMAN R, 1990, BLOOD, V76, P336; Espinola RG, 2004, AM J PATHOL, V165, P969, DOI 10.1016/S0002-9440(10)63358-5; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Garcia AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026035; Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83; Hsu J, 2013, IMMUNOL LETT, V150, P97, DOI 10.1016/j.imlet.2012.12.007; Kahner BN, 2008, FRONT BIOSCI-LANDMRK, V13, P433, DOI 10.2741/2690; Kanadiya Mehulkumar K, 2011, J Invasive Cardiol, V23, pE137; Kawashiri SY, 2009, RHEUMATOL INT; Khan EAR, 2009, J RHEUMATOL, V36, P855, DOI 10.3899/jrheum.081131; Knijff-Dutmer EAJ, 2002, ARTHRITIS RHEUM-US, V46, P1498, DOI 10.1002/art.10312; Kochetkova I, 2011, J IMMUNOL, V187, P4654, DOI 10.4049/jimmunol.1100530; Koizumi F, 1999, PATHOL INT, V49, P298, DOI 10.1046/j.1440-1827.1999.00863.x; Liverani E, 2013, J PHARMACOL EXP THER, V344, P231, DOI 10.1124/jpet.112.195883; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121; MOSMANN TR, 1994, ADV IMMUNOL, V56, P1, DOI 10.1016/S0065-2776(08)60449-6; Muthusamy ASR, 2006, INT J IMMUNOPATH PH, V19, P443, DOI 10.1177/039463200601900221; Niitsu Y, 2005, SEMIN THROMB HEMOST, V31, P184, DOI 10.1055/s-2005-869524; Rico MC, 2007, J CELL PHYSIOL, V211, P504, DOI 10.1002/jcp.20958; ROONEY M, 1988, ARTHRITIS RHEUM, V31, P956, DOI 10.1002/art.1780310803; Sellam J, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2833; Spinler SA, 2009, J MANAGE CARE PHARM, V15, P383, DOI 10.18553/jmcp.2009.15.5.383; Tayyareci Y, 2008, JCR-J CLIN RHEUMATOL, V14, P254, DOI 10.1097/RHU.0b013e31818272a6; Umekita K, 2009, MOD RHEUMATOL, V19, P265, DOI 10.1007/s10165-009-0164-2; Wang L, 2004, J THROMB HAEMOST, V2, P1436, DOI 10.1111/j.1538-7836.2004.00854.x; Wang Lingwei, 2004, BMC Immunol, V5, P16, DOI 10.1186/1471-2172-5-16	37	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e69093	10.1371/journal.pone.0069093	http://dx.doi.org/10.1371/journal.pone.0069093			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861957	Green Published, Green Submitted, gold			2022-12-27	WOS:000323350700110
J	Nie, HR; Shu, HY; Vartak, R; Milstein, AC; Mo, YL; Hu, XQ; Fang, HZ; Shen, LJ; Ding, ZN; Lu, JX; Bai, YD				Nie, Hezhongrong; Shu, Hongying; Vartak, Rasika; Milstein, Amanda Claire; Mo, Yalin; Hu, Xiaoqin; Fang, Hezhi; Shen, Lijun; Ding, Zhinan; Lu, Jianxin; Bai, Yidong			Mitochondrial Common Deletion, a Potential Biomarker for Cancer Occurrence, Is Selected against in Cancer Background: A Meta-Analysis of 38 Studies	PLOS ONE			English	Article							OXYGEN SPECIES GENERATION; SQUAMOUS-CELL CARCINOMA; DNA 4977-BP DELETION; D-LOOP MUTATIONS; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; BP DELETION; ESOPHAGEAL CANCER; SOMATIC MUTATIONS; GASTRIC-CANCER	Mitochondrial dysfunction has been long proposed to play a major role in tumorigenesis. Mitochondrial DNA (mtDNA) mutations, especially the mtDNA 4,977 bp deletion has been found in patients of various types of cancer. In order to comprehend the mtDNA 4,977 bp deletion status in various cancer types, we performed a meta-analysis composed of 33 publications, in which a total of 1613 cancer cases, 1516 adjacent normals and 638 healthy controls were included. When all studies were pooled, we found that cancerous tissue carried a lower mtDNA 4,977 bp deletion frequency than adjacent non-cancerous tissue (OR = 0.43, 95% CI = 0.20-0.92, P = 0.03 for heterogeneity test, I-2 = 91.5%) among various types of cancer. In the stratified analysis by cancer type the deletion frequency was even lower in tumor tissue than in adjacent normal tissue of breast cancer (OR = 0.19, 95% CI = 0.06-0.61, P = 0.005 for heterogeneity test, I-2 = 82.7%). Interestingly, this observation became more significant in the stratified studies with larger sample sizes (OR = 0.70, 95% CI = 0.58-0.86, P = 0.0005 for heterogeneity test, I-2 = 95.1%). Furthermore, when compared with the normal tissue from the matched healthy controls, increased deletion frequencies were observed in both adjacent non-cancerous tissue (OR = 3.02, 95% CI = 2.13-4.28, P<0.00001 for heterogeneity test, I-2 = 53.7%), and cancerous tissue (OR = 1.36, 95% CI = 1.04-1.77, P = 0.02 for heterogeneity test, I-2 = 83.5%). This meta-analysis suggests that the mtDNA 4,977 bp deletion is often found in cancerous tissue and thus has the potential to be a biomarker for cancer occurrence in the tissue, but at the same time being selected against in various types of carcinoma tissues. Larger and better-designed studies are still warranted to confirm these findings.	[Nie, Hezhongrong; Shu, Hongying; Mo, Yalin; Hu, Xiaoqin; Fang, Hezhi; Shen, Lijun; Ding, Zhinan; Lu, Jianxin; Bai, Yidong] Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Key Lab Med Genet, Wenzhou, Zhejiang, Peoples R China; [Vartak, Rasika; Milstein, Amanda Claire; Bai, Yidong] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	Wenzhou Medical University; University of Texas System; University of Texas Health San Antonio	Lu, JX (corresponding author), Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Key Lab Med Genet, Wenzhou, Zhejiang, Peoples R China.	jxlu313@163.com; baiy@uthscsa.edu	Vartak, Rasika/X-3012-2019; Bai, Yidong/A-4959-2012		NIH [1R21NS072777]; Chinese National Science Foundation [31070765/C050605, 81000879/H1602, 81101506/H1602]; Zhejiang Provincial Natural Science Foundation of China [LZ12H12001, Y2110605/C0605]; Program of 'Xinmiao' (Potential) Talents in Zhejiang Province [2011R413048]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS072777] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Program of 'Xinmiao' (Potential) Talents in Zhejiang Province; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by NIH 1R21NS072777, Chinese National Science Foundation (Grant No. 31070765/C050605, 81000879/H1602 and 81101506/H1602), Zhejiang Provincial Natural Science Foundation of China (Grant No. LZ12H12001 and Y2110605/C0605) and Program of 'Xinmiao' (Potential) Talents in Zhejiang Province (Grant No. 2011R413048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-30; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Aral C, 2010, GENET MOL BIOL, V33, P1, DOI 10.1590/S1415-47572009005000102; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; Berneburg M, 1999, J BIOL CHEM, V274, P15345, DOI 10.1074/jbc.274.22.15345; Berneburg M, 1997, PHOTOCHEM PHOTOBIOL, V66, P271, DOI 10.1111/j.1751-1097.1997.tb08654.x; BIANCHI MS, 1995, CYTOGENET CELL GENET, V71, P99, DOI 10.1159/000134072; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Chen T, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-8; CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525; CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927; Czarnecka AM, 2006, J APPL GENET, V47, P67, DOI 10.1007/BF03194602; Dai Ji Gang, 2006, Indian J Cancer, V43, P20; Dani Maria Angela C, 2004, Genet Mol Res, V3, P395; Dani SU, 2003, MED HYPOTHESES, V61, P60, DOI 10.1016/S0306-9877(03)00105-1; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017; Frenny V J, 2003, Indian J Cancer, V40, P135; FUKUSHIMA S, 1995, HEPATOLOGY, V21, P1547; Futyma K, 2008, ONCOL REP, V20, P683, DOI 10.3892/or_00000060; Gwak GY, 2011, HEPATO-GASTROENTEROL, V58, P522; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603; Howell N, 1996, AM J HUM GENET, V59, P501; Kamalidehghan B, 2006, ARCH MED RES, V37, P730, DOI 10.1016/j.arcmed.2006.02.005; Kamenisch Y, 2007, J INVEST DERMATOL, V127, P486, DOI 10.1038/sj.jid.5700552; KAO SH, 1995, BIOL REPROD, V52, P729, DOI 10.1095/biolreprod52.4.729; Kara M, 2012, BALK J MED GENET, V15, P25, DOI 10.2478/v10034-012-0004-0; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lee HC, 2001, MUTAT RES-GEN TOX EN, V493, P67, DOI 10.1016/S1383-5718(01)00160-7; Lee HC, 2007, MITOCHONDRION, V7, P157, DOI 10.1016/j.mito.2006.11.016; Lee HC, 2009, INT J MOL SCI, V10, P674, DOI 10.3390/ijms10020674; Lewis PD, 2000, J PATHOL, V191, P274; Lu JX, 2009, CELL RES, V19, P802, DOI 10.1038/cr.2009.69; Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504; MANTEL N, 1959, J NATL CANCER I, V22, P719; Maximo V, 2002, AM J PATHOL, V160, P1857, DOI 10.1016/S0002-9440(10)61132-7; Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004; Park JS, 2009, HUM MOL GENET, V18, P1578, DOI 10.1093/hmg/ddp069; Pavicic WH, 2009, MUTAT RES-FUND MOL M, V670, P99, DOI 10.1016/j.mrfmmm.2009.07.009; Peng TI, 2006, BBA-MOL BASIS DIS, V1762, P241, DOI 10.1016/j.bbadis.2005.10.008; Rahul Pandey DM CC, 2012, J ORAL BIOL CRANIOFA, V2, P4; Rogounovitch TI, 2002, CANCER RES, V62, P7031; Shao JY, 2004, WORLD J GASTROENTERO, V10, P1560, DOI 10.3748/wjg.v10.i11.1560; Shen LJ, 2010, ANN NY ACAD SCI, V1201, P26, DOI 10.1111/j.1749-6632.2010.05635.x; Shenkar R, 1996, AM J HUM GENET, V59, P772; Tan BHL, 2009, EUR J CANCER, V45, P736, DOI 10.1016/j.ejca.2009.01.013; Tan DJ, 2003, GENE CHROMOSOME CANC, V37, P186, DOI 10.1002/gcc.10217; Tan DJ, 2002, CANCER RES, V62, P972; Tan DJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-93; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Thayer RE, 2003, EXP GERONTOL, V38, P567, DOI 10.1016/S0531-5565(03)00033-0; Tseng LM, 2009, ONCOL REP, V21, P1169, DOI 10.3892/or_00000337; Tseng LM, 2006, GENE CHROMOSOME CANC, V45, P629, DOI 10.1002/gcc.20326; Upadhyay R, 2009, CANCER GENET CYTOGEN, V195, P175, DOI 10.1016/j.cancergencyto.2009.06.017; WALLACE DC, 1995, BBA-MOL BASIS DIS, V1271, P141, DOI 10.1016/0925-4439(95)00021-U; Wang ED, 1997, MUTAT RES-FUND MOL M, V377, P157, DOI 10.1016/S0027-5107(97)00091-2; Wang J, 2009, CHINESE MED J-PEKING, V122, P431, DOI 10.3760/cma.j.issn.0366-6999.2009.04.0014; WARBURG O, 1956, SCIENCE, V124, P269; Wen Q, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-133; Wheelhouse NM, 2005, BRIT J CANCER, V92, P1268, DOI 10.1038/sj.bjc.6602496; Wu CW, 2005, GENE CHROMOSOME CANC, V44, P19, DOI 10.1002/gcc.20213; Yang JH, 2004, ANTICANCER RES, V24, P1753; Ye CZ, 2008, BREAST CANCER RES TR, V108, P427, DOI 10.1007/s10549-007-9613-9; Yin PH, 2004, BRIT J CANCER, V90, P2390, DOI 10.1038/sj.bjc.6601838; Yu JJ, 2010, AGING MALE, V13, P159, DOI 10.3109/13685530903536668; Zhu WZ, 2004, CANCER DETECT PREV, V28, P119, DOI 10.1016/j.cdp.2003.11.008	70	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67953	10.1371/journal.pone.0067953	http://dx.doi.org/10.1371/journal.pone.0067953			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861839	gold, Green Submitted, Green Published			2022-12-27	WOS:000323350700065
J	Sacolo, HN; Chung, MH; Chu, H; Liao, YM; Chen, CH; Ou, KL; Chang, LI; Chou, KR				Sacolo, Hlengiwe Nokuthula; Chung, Min-Huey; Chu, Hsin; Liao, Yuan-Mei; Chen, Chiung-Hua; Ou, Keng-Liang; Chang, Lu-I; Chou, Kuei-Ru			High Risk Sexual Behaviors for HIV among the In-School Youth in Swaziland: A Structural Equation Modeling Approach	PLOS ONE			English	Article							CONDOM USE; PLANNED BEHAVIOR; ADOLESCENTS; PREDICTORS; INTENTION; SAMPLE; DETERMINANTS; BELIEFS; ENGAGE	Background: Global efforts in response to the increased prevalence of the human immunodeficiency virus (HIV) are mainly aimed at reducing high risk sexual behaviors among young people. However, knowledge regarding intentions of young people to engage in protective sexual behaviors is still lacking in many countries around the world, especially in Sub-Saharan Africa where prevalence of human immunodeficiency virus is the highest. The objective of this study was to test the theory of planned behavior (TPB) for predicting factors associated with protective sexual behaviors, including sexual abstinence and condom use, among in-school youths aged between 15 and 19 years in Swaziland. Methods: This cross-sectional survey was conducted using a anonymous questionnaire. A two-stage stratified and cluster random sampling method was used. Approximately one hundred pupils from each of four schools agreed to participate in the study, providing a total sample size of 403 pupils of which 369 were ultimately included for data analysis. The response rate was 98%. Structural equation modeling was used to analyse hypothesized paths. Results: The TPB model used in this study was effective in predicting protective sexual behavior among Swazi in-school youths, as shown by model fit indices. All hypothesized constructs significantly predicted intentions for abstinence and condom use, except perceived abstinence controls. Subjective norms were the strongest predictors of intention for premarital sexual abstinence; however, perceived controls for condom use were the strongest predictors of intention for condom use. Conclusions: Our findings support application of the model in predicting determinants of condom use and abstinence intentions among Swazi in-school youths.	[Sacolo, Hlengiwe Nokuthula; Chung, Min-Huey; Liao, Yuan-Mei; Chang, Lu-I; Chou, Kuei-Ru] Taipei Med Univ, Grad Inst Nursing, Coll Nursing, Taipei, Taiwan; [Chu, Hsin] Natl Def Med Ctr, Inst Aerosp & Undersea Med, Sch Med, Taipei, Taiwan; [Chu, Hsin] Natl Def Med Ctr, Dept Neurol, Triserv Gen Hosp, Taipei, Taiwan; [Chen, Chiung-Hua] Mei Ho Univ, Sch Nursing, Pingtung, Taiwan; [Ou, Keng-Liang] Taipei Med Univ, Graduat Inst Biomed Mat & Tissue Engn, Coll Oral Med, Taipei, Taiwan; [Ou, Keng-Liang] Taipei Med Univ, Res Ctr Biomed Devices & Prototyping Prod, Taipei, Taiwan; [Ou, Keng-Liang] Taipei Med Univ, Res Ctr Biomed Implants & Microsurg Devices, Taipei, Taiwan; [Ou, Keng-Liang] Taipei Med Univ, Dept Dent, Shuang Ho Hosp, Taipei, Taiwan	Taipei Medical University; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital	Chou, KR (corresponding author), Taipei Med Univ, Grad Inst Nursing, Coll Nursing, Taipei, Taiwan.	kueiru@tmu.edu.tw		chou, kueiru/0000-0002-4882-3503	Cheng Hsin General Hospital [CHGH 101-57]; Taipei Medical University Hospital [102TMU-TMUH-20]	Cheng Hsin General Hospital; Taipei Medical University Hospital	This manuscript was supported by Cheng Hsin General Hospital (project no. CHGH 101-57) and the Taipei Medical University Hospital (Project Number 102TMU-TMUH-20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez C, 2010, RES THEOR NURS PRACT, V24, P187, DOI 10.1891/1541-6577.24.3.187; Bailey JA, 2008, J ADOLESCENT HEALTH, V42, P573, DOI 10.1016/j.jadohealth.2007.11.138; Basen-Engquist K, 1999, HEALTH EDUC RES, V14, P25, DOI 10.1093/her/14.1.25; Baumgartner SE, 2010, J YOUTH ADOLESCENCE, V39, P1226, DOI 10.1007/s10964-010-9512-y; Bleakley A, 2009, AM J HEALTH BEHAV, V33, P37; Brauner-Otto SR, 2010, SOC SCI RES, V39, P875, DOI 10.1016/j.ssresearch.2010.06.015; Busse P, 2010, COMMUN RES, V37, P239, DOI 10.1177/0093650209356393; Carmack CC, 2009, J PRIM PREV, V30, P659, DOI 10.1007/s10935-009-0199-3; Cha ES, 2007, INT J NURS STUD, V44, P1147, DOI 10.1016/j.ijnurstu.2006.04.015; Cha ES, 2008, ARCH SEX BEHAV, V37, P641, DOI 10.1007/s10508-007-9187-y; De La Rosa M, 2010, ARCH SEX BEHAV, V39, P1305, DOI 10.1007/s10508-009-9498-2; Doswell Willa M, 2011, J Pediatr Nurs, V26, pe45, DOI 10.1016/j.pedn.2011.03.007; Doswell WM, 2002, J THEORY CONSTRUCTIO, V7, P56; Fatusi AO, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-136; Gardner M, 2012, J RES ADOLESCENCE, V22, P135, DOI 10.1111/j.1532-7795.2011.00752.x; Hanna K M, 1999, J Pediatr Nurs, V14, P59, DOI 10.1016/S0882-5963(99)80061-X; Henderson M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-53; Hendriksen ES, 2007, AM J PUBLIC HEALTH, V97, P1241, DOI 10.2105/AJPH.2006.086009; Hutchinson MK, 2012, J NURS SCHOLARSHIP, V44, P27, DOI 10.1111/j.1547-5069.2011.01431.x; Joint United Programme on HIV/AIDS, 2007, SWAZ HIV AIDS PROJ; Kline RB., 2015, METHODOLOGY SOCIAL S, V4th ed; Lee YH, 2009, INT J NURS STUD, V46, P653, DOI 10.1016/j.ijnurstu.2008.11.007; MacCallum RC, 1999, PSYCHOL METHODS, V4, P84, DOI 10.1037/1082-989x.4.1.84; Makiwane M, 2012, AFRICAN J AIDS RES, V9, P17; Mathunjwa Tengetile R, 2006, J Natl Black Nurses Assoc, V17, P39; Molla M, 2007, AIDS CARE, V19, P425, DOI 10.1080/09540120600722692; Monahan KC, 2009, DEV PSYCHOL, V45, P1520, DOI 10.1037/a0017417; Myklestad I, 2007, HEALTH EDUC BEHAV, V34, P686, DOI 10.1177/1090198106289571; National Emergency Council on HIV and AIDS, 2009, SEAZ HIV PREV RESP M; Norris Anne E, 2003, J Pediatr Health Care, V17, P140, DOI 10.1016/S0891-5245(02)88312-2; Patrick ME, 2010, J RES ADOLESCENCE, V20, P456, DOI 10.1111/j.1532-7795.2010.00649.x; Philippa C, 1996, YOUTH STUDIES AUSTR, V3, P60; Potard C, 2012, EUR J CONTRACEP REPR, V17, P55, DOI 10.3109/13625187.2011.634455; Sayles JN, 2006, JAIDS-J ACQ IMM DEF, V43, P226, DOI 10.1097/01.qai.0000230527.17459.5c; Schumacher R.E., 2010, BEGINNERS GUIDE STRU; Selikow TA, 2009, SCAND J PUBLIC HEALT, V37, P107, DOI 10.1177/1403494809103903; Stevensons J, 1996, APPL MULTIVARIATE ST; Swazi Government Report, 2011, SCH LISTS; Swaziland Behavioral Surveillance Survey, 2002, SWAZ BEH SURV SURV; Swaziland National Network of People Living with HIV and AIDS, 2011, BEST PRACT CHALL GEN; Swaziland Second Behavioral Surveillance Survey, 2010, REP 2 BEH SURV SURV; Tobias BQ, 2001, INT J ADV COUNS, V23, P99, DOI DOI 10.1023/A:1010614313756; UNAIDS, 2009, SWAZ COUNTR REP MON; UNAIDS, 2012, SWAZ COUNTR REP MON; Uwah C., 2012, WORLD J AIDS, V2, P17, DOI https://doi.org/10.4236/wja.2012.21003; Van Rossem R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-632; Villarruel AM, 2004, NURS RES, V53, P172, DOI 10.1097/00006199-200405000-00004; Wand Handan, 2012, BMJ Open, V2, pe000285, DOI 10.1136/bmjopen-2011-000285; Warner TD, 2011, SOC SCI RES, V40, P1676, DOI 10.1016/j.ssresearch.2011.06.009; World AIDS Day Report, 2011, GET ZERO FASTER SMAR; Zwane I T, 2004, Int Nurs Rev, V51, P15, DOI 10.1111/j.1466-7657.2003.00214.x	51	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67289	10.1371/journal.pone.0067289	http://dx.doi.org/10.1371/journal.pone.0067289			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	204FO	23861756	Green Submitted, Green Published, gold			2022-12-27	WOS:000323350700011
J	Burkart, JM; Rueth, K				Burkart, Judith Maria; Rueth, Katja			Preschool Children Fail Primate Prosocial Game Because of Attentional Task Demands	PLOS ONE			English	Article							THEORY-OF-MIND; CHIMPANZEES PAN-TROGLODYTES; TAMARINS SAGUINUS-OEDIPUS; CAPUCHIN MONKEYS; CONTINGENT RECIPROCITY; SELF-RECOGNITION; COMMON MARMOSETS; FALSE BELIEF; CEBUS-APELLA; BEHAVIOR	Various nonhuman primate species have been tested with prosocial games (i.e. derivates from dictator games) in order to better understand the evolutionary origin of proactive prosociality in humans. Results of these efforts are mixed, and it is difficult to disentangle true species differences from methodological artifacts. We tested 2- to 5-year-old children with a costly and a cost-free version of a prosocial game that differ with regard to the payoff distribution and are widely used with nonhuman primates. Simultaneously, we assessed the subjects' level of Theory of Mind understanding. Prosocial behavior was demonstrated with the prosocial game, and did not increase with more advanced Theory of Mind understanding. However, prosocial behavior could only be detected with the costly version of the game, whereas the children failed the cost-free version that is most commonly used with nonhuman primates. A detailed comparison of the children's behavior in the two versions of the game indicates that the failure was due to higher attentional demands of the cost-free version, rather than to a lack of prosociality per se. Our results thus show (i) that subtle differences in prosociality tasks can substantially bias the outcome and thus prevent meaningful species comparisons, and (ii) that like in nonhuman primates, prosocial behavior in human children does not require advanced Theory of Mind understanding in the present context. However, both developmental and comparative psychology accumulate increasing evidence for the multidimensionality of prosocial behaviors, suggesting that different forms of prosociality are also regulated differentially. For future efforts to understand the evolutionary origin of prosociality it is thus crucial to take this heterogeneity into account.	[Burkart, Judith Maria; Rueth, Katja] Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland	University of Zurich	Burkart, JM (corresponding author), Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland.	Judith.Burkart@aim.uzh.ch	Burkart, Judith M./P-6357-2014	Burkart, Judith M./0000-0002-6229-525X				ANDERSON JR, 1989, PRIMATES, V30, P581, DOI 10.1007/BF02380884; Ashley J, 1998, SOC DEV, V7, P143, DOI 10.1111/1467-9507.00059; Barnes JL, 2008, BIOL LETTERS, V4, P638, DOI 10.1098/rsbl.2008.0410; Bischof-Ku┬hler D., 1989, SPIEGELBILD EMPATHIE; BISCHOFKOHLER D, 1994, Z PSYCHOL, V202, P349; Brauer J, 2007, ANIM COGN, V10, P439, DOI 10.1007/s10071-007-0088-1; Brosnan SF, 2009, ANIM COGN, V12, P587, DOI 10.1007/s10071-009-0218-z; Brownell CA, 2013, INFANCY, V18, P1, DOI 10.1111/infa.12004; Brownell CA, 2009, INFANCY, V14, P117, DOI 10.1080/15250000802569868; Burkart JM, 2009, EVOL ANTHROPOL, V18, P175, DOI 10.1002/evan.20222; Burkart J. M., 2012, J COMP PSYCHOL; Burkart J, 2012, J COMP PSYCHOL, V126, P129, DOI 10.1037/a0026025; Burkart JM, 2007, P NATL ACAD SCI USA, V104, P19762, DOI 10.1073/pnas.0710310104; Burkart JM, 2007, ANIM BEHAV, V73, P457, DOI 10.1016/j.anbehav.2006.05.019; Burkart JM, 2010, ANIM COGN, V13, P1, DOI 10.1007/s10071-009-0263-7; CALL J, 2007, HDB EVOLUTIONARY PSY, P71; Camerer C.F., 2011, BEHAV GAME THEORY EX; Cassidy KW, 2003, SOC DEV, V12, P198, DOI 10.1111/1467-9507.00229; Charman T, 2002, SOC DEV, V11, P1, DOI 10.1111/1467-9507.00183; Cronin KA, 2012, ANIMAL BEHAV; Cronin KA, 2010, P ROY SOC B-BIOL SCI, V277, P3845, DOI 10.1098/rspb.2010.0879; Cronin KA, 2009, J COMP PSYCHOL, V123, P231, DOI 10.1037/a0015094; de Waal FBM, 2008, P NATL ACAD SCI USA, V105, P13685, DOI 10.1073/pnas.0807060105; Dunfield KA, 2013, CHILD DEV; Dunfield K, 2011, INFANCY, V16, P227, DOI 10.1111/j.1532-7078.2010.00041.x; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Gallup GG, 2002, COGNITIVE ANIMAL, P325; Hare B, 2000, ANIM BEHAV, V59, P771, DOI 10.1006/anbe.1999.1377; Hare B, 2003, ANIM BEHAV, V65, P131, DOI 10.1006/anbe.2002.2017; Hauser MD, 2001, AM J PRIMATOL, V53, P131; Hepach R, 2012, INFANCY; Heschl A, 2006, PRIMATES, V47, P187, DOI 10.1007/s10329-005-0170-8; Hofer T., 2007, THEORY MIND SKALA 3; Horner V, 2011, P NATL ACAD SCI USA, V108, P13847, DOI 10.1073/pnas.1111088108; House B, 2013, EVOL HUM BEHAV, V34, P86, DOI 10.1016/j.evolhumbehav.2012.10.001; House BR, 2012, EVOLUTION HUMAN BEHA; Hrdy SarahBlaffer., 2009, MOTHERS OTHERS EVOLU; Jaeggi AV, 2010, PHILOS T R SOC B, V365, P2723, DOI 10.1098/rstb.2010.0118; JOHNSON DB, 1982, MERRILL PALMER QUART, V28, P379; KARINDARCY RM, 2002, INT J COMP PSYCHOL, V15, P853; Kristen S, 2006, Z ENTWICKL PADAGOGIS, V38, P190, DOI 10.1026/0049-8637.38.4.186; Kupferberg A, 2013, BEHAV BRAIN RES; Largo RH, 2001, DEV MED CHILD NEUROL, V43, P436, DOI 10.1017/S0012162201000810; Li YL, 2006, BEHAV RES METHODS, V38, P532, DOI 10.3758/BF03192809; LIMONGELLI L, 1995, J COMP PSYCHOL, V109, P18, DOI 10.1037/0735-7036.109.1.18; Lukas D, 2012, P ROY SOC B-BIOL SCI, V279, P2151, DOI 10.1098/rspb.2011.2468; Moore C, 1998, SOC DEV, V7, P198, DOI 10.1111/1467-9507.00062; Mulcahy NJ, 2006, ANIM COGN, V9, P193, DOI 10.1007/s10071-006-0019-6; Mulcahy NJ, 2012, ANIM BEHAV, V83, P313, DOI 10.1016/j.anbehav.2011.11.019; Paulus M, 2012, NEUROIMAGE; Ramseyer A, 2006, P ROY SOC B-BIOL SCI, V273, P179, DOI 10.1098/rspb.2005.3300; Sally D, 2006, J ECON PSYCHOL, V27, P73, DOI 10.1016/j.joep.2005.06.015; Silk JB, 2005, NATURE, V437, P1357, DOI 10.1038/nature04243; Silk JB, 2011, P NATL ACAD SCI USA, V108, P10910, DOI 10.1073/pnas.1100305108; Skerry AE, 2011, ANIM COGN, V14, P647, DOI 10.1007/s10071-011-0399-0; Stevens Jeffrey R., 2005, P159; Suchak M, 2012, P NATL ACAD SCI USA, V109, P15191, DOI 10.1073/pnas.1213173109; TAKIMOTO A, 2009, ANIMAL COGNITION, V13, P249; Tebbich S, 2004, ANIM BEHAV, V67, P689, DOI 10.1016/j.anbehav.2003.08.003; Thoermer C, 2012, BRIT J DEV PSYCHOL, V30, P172, DOI 10.1111/j.2044-835X.2011.02067.x; Thompson RA, 2013, INFANCY, V18, P120, DOI 10.1111/j.1532-7078.2012.00139.x; Tomasello M, 2009, WHY WE COOPERATE, P1; Trivers R, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P67; Vaish A, 2012, SO NEUROSCI SER, P131; van Schaik CP, 2011, PHILOS T R SOC B, V366, P1008, DOI 10.1098/rstb.2010.0304; VISALBERGHI E, 1994, J COMP PSYCHOL, V108, P15, DOI 10.1037/0735-7036.108.1.15; Vonk J, 2008, ANIM BEHAV, V75, P1757, DOI 10.1016/j.anbehav.2007.09.036; Walker S, 2005, J GENET PSYCHOL, V166, P297, DOI 10.3200/GNTP.166.3.297-312; Wellman HM, 2009, CURR OPIN NEUROBIOL, V19, P57, DOI 10.1016/j.conb.2009.02.004; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; Wellman HM, 2004, CHILD DEV, V75, P523, DOI 10.1111/j.1467-8624.2004.00691.x; Wright BD, 1982, RATING SCALE ANAL RA; Yamamoto S, 2012, P NATL ACAD SCI USA, V109, P3588, DOI 10.1073/pnas.1108517109; Yamamoto S, 2010, ANIM BEHAV, V79, P595, DOI 10.1016/j.anbehav.2009.11.034; Yamamoto S, 2009, J COMP PSYCHOL, V123, P242, DOI 10.1037/a0015838; ZAHNWAXLER C, 1992, DEV PSYCHOL, V28, P126, DOI 10.1037/0012-1649.28.1.126	76	29	29	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68440	10.1371/journal.pone.0068440	http://dx.doi.org/10.1371/journal.pone.0068440			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182HT	23844201	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000321733000006
J	Carvalho, AL; Turner, DL; Fonseca, LL; Solopova, A; Catarino, T; Kuipers, OP; Voit, EO; Neves, AR; Santos, H				Carvalho, Ana Lucia; Turner, David L.; Fonseca, Luis L.; Solopova, Ana; Catarino, Teresa; Kuipers, Oscar P.; Voit, Eberhard O.; Neves, Ana Rute; Santos, Helena			Metabolic and Transcriptional Analysis of Acid Stress in Lactococcus lactis, with a Focus on the Kinetics of Lactic Acid Pools	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; STREPTOCOCCUS-LACTIS; ESCHERICHIA-COLI; IN-VIVO; PROTONMOTIVE FORCE; SUBSP LACTIS; LOW PH; CREMORIS; TRANSPORT; SYSTEM	The effect of pH on the glucose metabolism of non-growing cells of L. lactis MG1363 was studied by in vivo NMR in the range 4.8 to 6.5. Immediate pH effects on glucose transporters and/or enzyme activities were distinguished from transcriptional/translational effects by using cells grown at the optimal pH of 6.5 or pre-adjusted to low pH by growth at 5.1. In cells grown at pH 5.1, glucose metabolism proceeds at a rate 35% higher than in non-adjusted cells at the same pH. Besides the upregulation of stress-related genes (such as dnaK and groEL), cells adjusted to low pH overexpressed H+-ATPase subunits as well as glycolytic genes. At sub-optimal pHs, the total intracellular pool of lactic acid reached approximately 500 mM in cells grown at optimal pH and about 700 mM in cells grown at pH 5.1. These high levels, together with good pH homeostasis (internal pH always above 6), imply intracellular accumulation of the ionized form of lactic acid (lactate anion), and the concomitant export of the equivalent protons. The average number, n, of protons exported with each lactate anion was determined directly from the kinetics of accumulation of intra-and extracellular lactic acid as monitored online by C-13-NMR. In cells non-adjusted to low pH, n varies between 2 and 1 during glucose consumption, suggesting an inhibitory effect of intracellular lactate on proton export. We confirmed that extracellular lactate did not affect the lactate: proton stoichiometry. In adjusted cells, n was lower and varied less, indicating a different mix of lactic acid exporters less affected by the high level of intracellular lactate. A qualitative model for pH effects and acid stress adaptation is proposed on the basis of these results.	[Carvalho, Ana Lucia; Turner, David L.; Fonseca, Luis L.; Catarino, Teresa; Neves, Ana Rute; Santos, Helena] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Solopova, Ana; Kuipers, Oscar P.] Univ Groningen, Dept Mol Genet, Groningen Biomol Sci & Biotechnol Inst, Haren, Netherlands; [Fonseca, Luis L.; Voit, Eberhard O.] Georgia Inst Technol, Integrat BioSyst Inst, Atlanta, GA 30332 USA; [Fonseca, Luis L.; Voit, Eberhard O.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Fonseca, Luis L.; Voit, Eberhard O.] Emory Univ, Atlanta, GA 30322 USA; [Catarino, Teresa] Univ Nova Lisboa, Dept Quim, Fac Ciencias & Tecnol, P-2780156 Oeiras, Portugal	Universidade Nova de Lisboa; University of Groningen; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Emory University; Universidade Nova de Lisboa	Santos, H (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal.	santos@itqb.unl.pt	Fonseca, Luis L/B-2265-2009; Santos, Helena/B-9141-2011; Catarino, Teresa/A-9267-2012; Turner, David L/B-9061-2011; Kuipers, Oscar/B-6752-2009	Fonseca, Luis L/0000-0002-7902-742X; Santos, Helena/0000-0002-8050-9485; Catarino, Teresa/0000-0003-3782-4014; Turner, David L/0000-0002-3754-6459; Kuipers, Oscar/0000-0001-5596-7735; Serafim de Carvalho Kok, Ana Lucia/0000-0002-3401-2240	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/30419/2006, SFRH//BPD/26902/2006]; Programa Operacional Ciencia e Inovacao (POCTI) [REDE/1517/RMN/2005]; U.S. National Science Foundation [MCB- 0946595]; FCT Project [PTDC/EBB-EBI/113727/2009]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa Operacional Ciencia e Inovacao (POCTI); U.S. National Science Foundation(National Science Foundation (NSF)); FCT Project(Portuguese Foundation for Science and Technology)	AL Carvalho and LL Fonseca were supported by fellowships (SFRH/BD/30419/2006 and SFRH//BPD/26902/2006) from Fundacao para a Ciencia e a Tecnologia (FCT). The NMR spectrometers are part of the National NMR Network (REDE/1517/RMN/2005), supported by "Programa Operacional Ciencia e Inovacao (POCTI) 2010" and FCT. This work was funded in part by the U.S. National Science Foundation Project MCB- 0946595, Principal Investigator EO Voit, and by FCT Project PTDC/EBB- EBI/113727/2009 (to AR Neves). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amachi S, 1998, BIOSCI BIOTECH BIOCH, V62, P1574, DOI 10.1271/bbb.62.1574; Andersson U, 2001, J BIOL CHEM, V276, P42707, DOI 10.1074/jbc.M108279200; BAKKER EP, 1980, J BIOL CHEM, V255, P433; Bandell M, 1998, APPL ENVIRON MICROB, V64, P1594; BRINK BT, 1985, J BACTERIOL, V162, P383, DOI 10.1128/JB.162.1.383-390.1985; Budin-Verneuil A, 2005, PROTEOMICS, V5, P4794, DOI 10.1002/pmic.200401327; Casal M, 1999, J BACTERIOL, V181, P2620, DOI 10.1128/JB.181.8.2620-2623.1999; Castro R, 2009, MOL MICROBIOL, V71, P795, DOI 10.1111/j.1365-2958.2008.06564.x; Cho SL, 2008, INT J SYST EVOL MICR, V58, P1844, DOI 10.1099/ijs.0.65527-0; Cotter PD, 2003, APPL ENVIRON MICROB, V69, P702, DOI 10.1128/AEM.69.1.702-706.2003; CROW VL, 1977, J BACTERIOL, V131, P82, DOI 10.1128/JB.131.1.82-91.1977; DONG JM, 1993, J BACTERIOL, V175, P6671, DOI 10.1128/jb.175.20.6671-6678.1993; FORDYCE AM, 1982, METHOD ENZYMOL, V90, P77, DOI 10.1016/S0076-6879(82)90109-4; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Frees D, 2003, INT J FOOD MICROBIOL, V87, P293, DOI 10.1016/S0168-1605(03)00104-1; Gaspar P, 2007, FEBS J, V274, P5924, DOI 10.1111/j.1742-4658.2007.06115.x; GASSON MJ, 1983, J BACTERIOL, V154, P1; GATJE G, 1991, APPL MICROBIOL BIOT, V34, P778, DOI 10.1007/BF00169349; Goel A, 2012, APPL ENVIRON MICROB, V78, P134, DOI 10.1128/AEM.05276-11; Hartke A, 1996, CURR MICROBIOL, V33, P194, DOI 10.1007/s002849900099; Hirshfield Irvin N., 2003, Science Progress, V86, P245, DOI 10.3184/003685003783238626; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Kuipers OP, 2002, ANTON LEEUW INT J G, V82, P113, DOI 10.1023/A:1020691801251; Linares DM, 2010, J BACTERIOL, V192, P5806, DOI 10.1128/JB.00533-10; MARQUIS RE, 1987, APPL ENVIRON MICROB, V53, P198, DOI 10.1128/AEM.53.1.198-200.1987; Martinez AR, 2010, MOL ORAL MICROBIOL, V25, P331, DOI 10.1111/j.2041-1014.2010.00580.x; Mercade M, 2006, J APPL MICROBIOL, V100, P1364, DOI 10.1111/j.1365-2672.2006.02867.x; Mercade M, 2000, INT J FOOD MICROBIOL, V55, P161, DOI 10.1016/S0168-1605(00)00190-2; Neves AR, 1999, BIOTECHNOL BIOENG, V64, P200, DOI 10.1002/(SICI)1097-0290(19990720)64:2&lt;200::AID-BIT9&gt;3.0.CO;2-K; Neves AR, 2002, J BIOL CHEM, V277, P28088, DOI 10.1074/jbc.M202573200; Neves AR, 2002, APPL ENVIRON MICROB, V68, P6332, DOI 10.1128/AEM.68.12.6332-6342.2002; OTTO R, 1980, P NATL ACAD SCI-BIOL, V77, P5502, DOI 10.1073/pnas.77.9.5502; Pool WA, 2006, METAB ENG, V8, P456, DOI 10.1016/j.ymben.2006.05.003; POOLMAN B, 1988, J BACTERIOL, V170, P700, DOI 10.1128/jb.170.2.700-707.1988; Rallu F, 1996, ANTON LEEUW INT J G, V70, P243, DOI 10.1007/BF00395935; THOMPSON J, 1976, J BACTERIOL, V127, P719, DOI 10.1128/JB.127.2.719-730.1976; VADEBONCOEUR C, 1991, INFECT IMMUN, V59, P900, DOI 10.1128/IAI.59.3.900-906.1991; van de Guchte M, 2002, ANTON LEEUW INT J G, V82, P187, DOI 10.1023/A:1020631532202; van Hijum SAFT, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-77; van Maris AJA, 2004, METAB ENG, V6, P245, DOI 10.1016/j.ymben.2004.05.001; Wei Y, 2000, J BIOL CHEM, V275, P30287, DOI 10.1074/jbc.M001112200; Xie Y, 2004, APPL ENVIRON MICROB, V70, P6738, DOI 10.1128/AEM.70.11.6738-6747.2004	42	29	30	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68470	10.1371/journal.pone.0068470	http://dx.doi.org/10.1371/journal.pone.0068470			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844205	gold, Green Published, Green Submitted			2022-12-27	WOS:000321733000009
J	Liquete, C; Piroddi, C; Drakou, EG; Gurney, L; Katsanevakis, S; Charef, A; Egoh, B				Liquete, Camino; Piroddi, Chiara; Drakou, Evangelia G.; Gurney, Leigh; Katsanevakis, Stelios; Charef, Aymen; Egoh, Benis			Current Status and Future Prospects for the Assessment of Marine and Coastal Ecosystem Services: A Systematic Review	PLOS ONE			English	Review							GREAT-BARRIER-REEF; DECISION-MAKING; ECONOMIC VALUE; CONSERVATION; BIODIVERSITY; INDICATORS; VALUATION; FRAMEWORK; GOODS; CLASSIFICATION	Background: Research on ecosystem services has grown exponentially during the last decade. Most of the studies have focused on assessing and mapping terrestrial ecosystem services highlighting a knowledge gap on marine and coastal ecosystem services (MCES) and an urgent need to assess them. Methodology/Principal Findings: We reviewed and summarized existing scientific literature related to MCES with the aim of extracting and classifying indicators used to assess and map them. We found 145 papers that specifically assessed marine and coastal ecosystem services from which we extracted 476 indicators. Food provision, in particular fisheries, was the most extensively analyzed MCES while water purification and coastal protection were the most frequently studied regulating and maintenance services. Also recreation and tourism under the cultural services was relatively well assessed. We highlight knowledge gaps regarding the availability of indicators that measure the capacity, flow or benefit derived from each ecosystem service. The majority of the case studies was found in mangroves and coastal wetlands and was mainly concentrated in Europe and North America. Our systematic review highlighted the need of an improved ecosystem service classification for marine and coastal systems, which is herein proposed with definitions and links to previous classifications. Conclusions/Significance: This review summarizes the state of available information related to ecosystem services associated with marine and coastal ecosystems. The cataloging of MCES indicators and the integrated classification of MCES provided in this paper establish a background that can facilitate the planning and integration of future assessments. The final goal is to establish a consistent structure and populate it with information able to support the implementation of biodiversity conservation policies.	[Liquete, Camino; Piroddi, Chiara; Gurney, Leigh; Katsanevakis, Stelios; Egoh, Benis] Commiss European Communities, Joint Res Ctr, Water Resources Unit, Inst Environm & Sustainabil, I-21020 Ispra, Italy; [Drakou, Evangelia G.] Commiss European Communities, Joint Res Ctr, Land Resource Management Unit, Inst Environm & Sustainabil, I-21020 Ispra, Italy; [Charef, Aymen] Commiss European Communities, Joint Res Ctr, Maritime Affairs Unit, Inst Protect & Secur Citizen, I-21020 Ispra, Italy	European Commission Joint Research Centre; EC JRC ISPRA Site; European Commission Joint Research Centre; EC JRC ISPRA Site; European Commission Joint Research Centre; EC JRC ISPRA Site	Liquete, C (corresponding author), Commiss European Communities, Joint Res Ctr, Water Resources Unit, Inst Environm & Sustainabil, I-21020 Ispra, Italy.	camino.liquete@gmail.com	Drakou, Evangelia/S-9511-2019; Piroddi, Chiara/AAD-8895-2019; Katsanevakis, Stelios/AAD-8289-2020; Katsanevakis, Stelios/AGR-7012-2022	Drakou, Evangelia/0000-0003-4404-629X; Katsanevakis, Stelios/0000-0002-5137-7540; Egoh, Benis/0000-0002-9126-7784; Piroddi, Chiara/0000-0003-2168-5830				Alcamo J, 2005, ECOL SOC, V10; Anton A, 2011, ECOL APPL, V21, P991, DOI 10.1890/09-0841.1; Barbier EB, 2012, REV ENV ECON POLICY, V6, P1, DOI 10.1093/reep/rer017; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Barr RF, 2009, OCEAN COAST MANAGE, V52, P568, DOI 10.1016/j.ocecoaman.2009.08.010; Beaudoin Y., 2012, WHY VALUE OCEANS DIS; Beaumont NJ, 2007, MAR POLLUT BULL, V54, P253, DOI 10.1016/j.marpolbul.2006.12.003; Bos AR, 2007, ESTUAR COAST SHELF S, V74, P344, DOI 10.1016/j.ecss.2007.04.006; Brenner J, 2010, OCEAN COAST MANAGE, V53, P27, DOI 10.1016/j.ocecoaman.2009.10.008; Chan Kai Ma, 2010, F1000 Biol Rep, V2, P54, DOI 10.3410/B2-54; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Costanza R, 1999, ECOL ECON, V31, P199, DOI 10.1016/S0921-8009(99)00079-8; Costanza R, 2007, BIOL CONSERV, V1, P8; Costanza R, 2008, AMBIO, V37, P241, DOI 10.1579/0044-7447(2008)37[241:TVOCWF]2.0.CO;2; Costanza R, 2008, BIOL CONSERV, V141, P350, DOI 10.1016/j.biocon.2007.12.020; Costanza R, 2012, ECOSYST SERV, V1, P16, DOI 10.1016/j.ecoser.2012.06.002; Cowling RM, 2008, P NATL ACAD SCI USA, V105, P9483, DOI 10.1073/pnas.0706559105; Daily G. C., 1997, Nature's services: societal dependence on natural ecosystems., P113; Daily GC, 2009, FRONT ECOL ENVIRON, V7, P21, DOI 10.1890/080025; de Groot RS, 2010, ECOL COMPLEX, V7, P260, DOI 10.1016/j.ecocom.2009.10.006; de Groot RS, 2002, ECOL ECON, V41, P393, DOI 10.1016/S0921-8009(02)00089-7; Dobson A, 2006, ECOLOGY, V87, P1915, DOI 10.1890/0012-9658(2006)87[1915:HLTCAT]2.0.CO;2; Dolan MFJ, 2009, NORW J GEOL, V89, P17; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; Douvere F, 2008, MAR POLICY, V32, P762, DOI 10.1016/j.marpol.2008.03.021; Duarte CM, 1996, LIMNOL OCEANOGR, V41, P1758, DOI 10.4319/lo.1996.41.8.1758; Edwards HJ, 2010, BIOL CONSERV, V143, P457, DOI 10.1016/j.biocon.2009.11.013; Egoh B, 2012, PUBLICATIONS OFFICE; Everard M, 2010, AQUAT CONSERV, V20, P476, DOI 10.1002/aqc.1114; Farber S, 2006, BIOSCIENCE, V56, P121, DOI 10.1641/0006-3568(2006)056[0121:LEAEFE]2.0.CO;2; Feagin RA, 2010, ECOL SOC, V15; Feld CK, 2010, BIODIVERS CONSERV, V19, P2895, DOI 10.1007/s10531-010-9875-0; Feld CK, 2009, OIKOS, V118, P1862, DOI 10.1111/j.1600-0706.2009.17860.x; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Fisher B, 2009, ECOL ECON, V68, P643, DOI 10.1016/j.ecolecon.2008.09.014; Fletcher S, 2011, J COASTAL RES, P378; Gomez-Baggethun E, 2010, ECOL ECON, V69, P1209, DOI 10.1016/j.ecolecon.2009.11.007; Haines-Young R., 2010, ECOSYSTEM ECOLOGY NE, DOI DOI 10.1017/CBO9780511750458.007; Haines-Young R, 2012, ECOL INDIC, V21, P39, DOI 10.1016/j.ecolind.2011.09.004; HainesYoung R, 2013, COMMON INT CLASSIFIC; Harris Alasdair, 2010, Atoll Research Bulletin, P1; Hicks CC, 2011, COAST MANAGE, V39, P358, DOI 10.1080/08920753.2011.589219; Hussain SA, 2010, WETL ECOL MANAG, V18, P321, DOI 10.1007/s11273-009-9173-3; Hyytiainen K, 2009, AGR FOOD SCI, V18, P440, DOI 10.23986/afsci.5951; Kandziora M, 2012, ECOLOGICAL IN PRESS; Katsanevakis S, 2011, OCEAN COAST MANAGE, V54, P807, DOI 10.1016/j.ocecoaman.2011.09.002; Kauffman JB, 2011, WETLANDS, V31, P343, DOI 10.1007/s13157-011-0148-9; Koch EW, 2009, FRONT ECOL ENVIRON, V7, P29, DOI 10.1890/080126; Kremen C, 2005, FRONT ECOL ENVIRON, V3, P540, DOI 10.1890/1540-9295(2005)003[0540:ACTEMA]2.0.CO;2; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; Lange GM, 2009, OCEAN COAST MANAGE, V52, P521, DOI 10.1016/j.ocecoaman.2009.08.005; Layke C, 2012, ECOL INDIC, V17, P77, DOI 10.1016/j.ecolind.2011.04.025; Liquete C., 2011, Ecohydrology and Hydrobiology, V11, P247; Liquete C, 2013, ECOL INDIC, V30, P205, DOI 10.1016/j.ecolind.2013.02.013; Luisetti T, 2008, 25 CTR SOC EC RES GL, V25; Machado Antonio, 2004, Journal for Nature Conservation (Jena), V12, P95, DOI 10.1016/j.jnc.2003.12.002; Maes J, 2012, BIOL CONSERV, V155, P1, DOI 10.1016/j.biocon.2012.06.016; Maes J, 2013, PUBLICATIONS OFFICE; Maes J, 2012, ECOSYST SERV, V1, P31, DOI 10.1016/j.ecoser.2012.06.004; Mangi SC, 2011, ENVIRONMETRICS, V22, P686, DOI 10.1002/env.1095; Markandya A, 2008, EC ECOSYSTEMS BIODIV; Martinez ML, 2007, ECOL ECON, V63, P254, DOI 10.1016/j.ecolecon.2006.10.022; McGlashan DJ, 2003, SCOT GEOGR J, V119, P103, DOI 10.1080/00369220318737166; McGlathery KJ, 2012, MAR ECOL PROG SER, V448, P209, DOI 10.3354/meps09574; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Lozoya JP, 2011, ENVIRON SCI POLICY, V14, P685, DOI 10.1016/j.envsci.2011.05.002; Papanicolopulu I, 2007, OCEAN DEV INT LAW, V38, P381, DOI 10.1080/00908320701641636; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Perez-Maqueo O, 2007, ECOL ECON, V63, P273, DOI 10.1016/j.ecolecon.2006.11.011; Plummer ML, 2009, FRONT ECOL ENVIRON, V7, P38, DOI 10.1890/080091; Plutchak R, 2010, ESTUAR COAST, V33, P1355, DOI 10.1007/s12237-010-9327-9; Roncin N, 2008, J NAT CONSERV, V16, P256, DOI 10.1016/j.jnc.2008.09.006; Ronnback P, 2003, ENVIRON CONSERV, V30, P344, DOI 10.1017/S0376892903000365; Ruiz-Frau A, 2011, MAR ECOL PROG SER, V434, P239, DOI 10.3354/meps09136; Sagoff M, 2008, ENVIRON VALUE, V17, P239, DOI 10.3197/096327108X303873; Salomidi M, 2012, MEDITERR MAR SCI, V13, P49, DOI 10.12681/mms.23; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Somerfield PJ, 2008, ICES J MAR SCI, V65, P1462, DOI 10.1093/icesjms/fsn118; Souza FES, 2011, J COAST CONSERV, V15, P195, DOI 10.1007/s11852-010-0133-0; Steinhardt U., 1999, ENVIRONMENTALS INDIC, P237; Stentford, 2011, UK NATL ECOSYSTEM AS, P459; Stoeckl N, 2011, ANN NY ACAD SCI, V1219, P113, DOI 10.1111/j.1749-6632.2010.05892.x; Tallis H, 2012, MAR POLICY, V36, P303, DOI 10.1016/j.marpol.2011.03.013; The Economics of Ecosystems and Biodiversity (TEEB), 2010, EC EC BIOD EC EC FDN; Tomlinson B, 2011, ECOL SOC, V16, DOI 10.5751/ES-04484-160428; Troell M, 2005, ECOL SOC, V10; Turner RK, 2003, ECOL ECON, V46, P493, DOI 10.1016/S0921-8009(03)00189-7; UNEP-WCMC, 2011, MONTR CAN SECR CONV; VALIELA I, 2001, BIOSCIENCE, V51, P807, DOI DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2; Van den Hove S, 2007, CAMBR UNEP WORLD CON; van Oudenhoven APE, 2012, ECOL INDIC, V21, P110, DOI 10.1016/j.ecolind.2012.01.012; Viehman S, 2009, OCEAN COAST MANAGE, V52, P181, DOI 10.1016/j.ocecoaman.2008.12.004; Wabnitz CC, 2008, REMOTE SENS ENVIRON, V112, P3455, DOI 10.1016/j.rse.2008.01.020; Zhao B, 2004, LAND USE POLICY, V21, P139, DOI 10.1016/j.landusepol.2003.10.003	95	337	352	42	441	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67737	10.1371/journal.pone.0067737	http://dx.doi.org/10.1371/journal.pone.0067737			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844080	Green Published, gold			2022-12-27	WOS:000321733000098
J	Ochoa, E; Iriondo, M; Bielsa, A; Ruiz-Irastorza, G; Estonba, A; Zubiaga, AM				Ochoa, Eguzkine; Iriondo, Mikel; Bielsa, Ana; Ruiz-Irastorza, Guillermo; Estonba, Andone; Zubiaga, Ana M.			Thrombotic Antiphospholipid Syndrome Shows Strong Haplotypic Association with SH2B3-ATXN2 Locus	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; 3,000 SHARED CONTROLS; GENE-EXPRESSION; COPY NUMBER; MEDIATED THROMBOSIS; IMMUNE-RESPONSE; ISCHEMIC-STROKE; ADAPTER PROTEIN; COMMON DISEASES	Background: Thrombotic antiphospholipid syndrome is defined as a complex form of thrombophilia that is developed by a fraction of antiphospholipid antibody (aPLA) carriers. Little is known about the genetic risk factors involved in thrombosis development among aPLA carriers. Methods: To identify new loci conferring susceptibility to thrombotic antiphospholipid syndrome, a two-stage genotyping strategy was performed. In stage one, 19,000 CNV loci were genotyped in 14 thrombotic aPLA+ patients and 14 healthy controls by array-CGH. In stage two, significant CNV loci were fine-mapped in a larger cohort (85 thrombotic aPLA+, 100 non-thrombotic aPLA+ and 569 healthy controls). Results: Array-CGH and fine-mapping analysis led to the identification of 12q24.12 locus as a new susceptibility locus for thrombotic APS. Within this region, a TAC risk haplotype comprising one SNP in SH2B3 gene (rs3184504) and two SNPs in ATXN2 gene (rs10774625 and rs653178) exhibited the strongest association with thrombotic antiphospholipid syndrome (p-value = 5,9 x 10(-4) OR 95% CI 1.84 (1.32-2.55)). Conclusion: The presence of a TAC risk haplotype in ATXN2-SH2B3 locus may contribute to increased thrombotic risk in aPLA carriers.	[Ochoa, Eguzkine; Iriondo, Mikel; Estonba, Andone; Zubiaga, Ana M.] Univ Basque Country UPV EHU, Sch Sci & Technol, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain; [Bielsa, Ana; Ruiz-Irastorza, Guillermo] Univ Basque Country UPV EHU, Autoimmune Dis Res Unit, Serv Internal Med, Hosp Cruces, Leioa, Spain	University of Basque Country; Hospital Universitario Cruces; University of Basque Country	Zubiaga, AM (corresponding author), Univ Basque Country UPV EHU, Sch Sci & Technol, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain.	ana.zubiaga@ehu.es	Iriondo, Mikel/AAA-7997-2019; Ochoa, Eguzkine/AAO-5639-2020; zubiaga, ana/S-3457-2019; Ruiz-Irastorza, Guillermo/P-7058-2014	Iriondo, Mikel/0000-0001-7835-0041; zubiaga, ana/0000-0002-2132-9708; Ruiz-Irastorza, Guillermo/0000-0001-7788-1043; Estonba, Andone/0000-0003-2851-5201; Ochoa, Eguzkine/0000-0002-1506-9065	Basque Government [Etortek IE09-256, Saiotek S-PE10UN82, Plan +Euskadi 09UE09+/57, Saiotek- PE08UN73, Saiotek- PE09UN64]; UPV/EHU [UFI 11/20]; Department of Education, Universities and Research of the Basque Government	Basque Government(Basque Government); UPV/EHU; Department of Education, Universities and Research of the Basque Government	This work was supported by the Basque Government (Etortek IE09-256, Saiotek S-PE10UN82 and Plan +Euskadi 09UE09+/57 to AMZ and Saiotek- PE08UN73 and Saiotek- PE09UN64 to AE) and by the UPV/EHU (UFI 11/20 to AMZ). Dr. Ruiz-Irastorza is supported by the Department of Education, Universities and Research of the Basque Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Alcina A, 2010, GENES IMMUN, V11, P439, DOI 10.1038/gene.2010.30; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bernales I, 2008, GENES IMMUN, V9, P38, DOI 10.1038/sj.gene.6364443; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; de la Red G, 2009, THROMB HAEMOSTASIS, V101, P312, DOI 10.1160/TH08-06-0347; Devalliere J, 2011, BIOCHEM PHARMACOL, V82, P1391, DOI 10.1016/j.bcp.2011.06.023; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Fitau J, 2006, J BIOL CHEM, V281, P20148, DOI 10.1074/jbc.M510997200; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Galli M, 2000, BRIT J HAEMATOL, V108, P865, DOI 10.1046/j.1365-2141.2000.01964.x; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Hamid C, 2007, ANN RHEUM DIS, V66, P1000, DOI 10.1136/ard.2006.063909; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Ikram MK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001184; Kenet G, 2000, STROKE, V31, P1283, DOI 10.1161/01.STR.31.6.1283; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Lavrikova EY, 2011, PEDIATR DIABETES, V12, P127, DOI 10.1111/j.1399-5448.2010.00656.x; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Li YJ, 2000, J IMMUNOL, V164, P5199, DOI 10.4049/jimmunol.164.10.5199; Lipson D, 2006, J COMPUT BIOL, V13, P215, DOI 10.1089/cmb.2006.13.215; Lopez-Pedrera C, 2008, ARTHRITIS RHEUM-US, V58, P2835, DOI 10.1002/art.23756; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Matarin M, 2007, LANCET NEUROL, V6, P414, DOI 10.1016/S1474-4422(07)70081-9; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Meroni PL, 2011, NAT REV RHEUMATOL, V7, P330, DOI 10.1038/nrrheum.2011.52; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Pielberg G, 2003, GENOME RES, V13, P2171, DOI 10.1101/gr.1188203; Pierangeli SS, 2007, ANN RHEUM DIS, V66, P1327, DOI 10.1136/ard.2006.065037; Plagnol V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002216; Potti A, 2006, BLOOD, V107, P1391, DOI 10.1182/blood-2005-07-2669; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Ruiz-Irastorza G, 2011, LUPUS, V20, P206, DOI 10.1177/0961203310395803; Ruiz-Irastorza G, 2010, LANCET, V376, P1498, DOI 10.1016/S0140-6736(10)60709-X; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Sivapalaratnam S, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-64; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Takaki S, 2002, J EXP MED, V195, P151, DOI 10.1084/jem.20011170; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Vega-Ostertag Mariano E, 2007, Curr Rheumatol Rep, V9, P190, DOI 10.1007/s11926-007-0031-0; Velazquez L, 2002, J EXP MED, V195, P1599, DOI 10.1084/jem.20011883; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Wild PS, 2011, CIRC-CARDIOVASC GENE, V4, P403, DOI 10.1161/CIRCGENETICS.110.958728; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004; Zhernakova A, 2010, AM J HUM GENET, V86, P970, DOI 10.1016/j.ajhg.2010.05.004; Zhou H, 2004, BLOOD, V104, P2353, DOI 10.1182/blood-2004-01-0145	54	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67897	10.1371/journal.pone.0067897	http://dx.doi.org/10.1371/journal.pone.0067897			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844121	Green Submitted, Green Published, gold			2022-12-27	WOS:000321733000113
J	Turke, M; Weisser, WW				Tuerke, Manfred; Weisser, Wolfgang W.			Species, Diaspore Volume and Body Mass Matter in Gastropod Seed Feeding Behavior	PLOS ONE			English	Article							ARIOLIMAX-COLUMBIANUS; BANANA SLUG; ANT; DISPERSAL; MYRMECOCHORY; MUTUALISM; FORESTS; SIZE; ELAIOSOMES; EARTHWORMS	Background: Seed dispersal of ant-dispersed plants (myrmecochores) is a well studied ecosystem function. Recently, slugs have been found to act as seed dispersers of myrmecochores. The aim of our study was to (1) further generalize the finding that gastropods feed on seeds of myrmecochores and hence may act as seed dispersers, (2) to test whether gastropod body mass and the volume of diaspores have an influence on the seed dispersal potential. Methodology and Principal Findings: We assessed the seed dispersal potential of four slug and snail species with a set of seven myrmecochorous plant species from seven different plant families common to Central European beech forests. Diaspores differed in shape and size. Gastropods differed in their readiness to feed on diaspores and in the proportion of seeds that were swallowed as a whole, and this readiness generally decreased with increasing diaspore size. Smaller Arionid slugs (58 mm body length; mean) mostly fed on the elaiosome but also swallowed small diaspores and therefore not only act as elaiosome consumers, a nutrient rich appendage on myrmecochorous diaspores, but may also disperse seeds. Large Arionid slugs (>100 mm body length) swallowed diaspores of all sizes. Diaspores swallowed by gastropods were defecated without damage. Within-species variability in body size also affect seed dispersal potential, as larger individuals of the red slug (Arion rufus) swallowed more diaspores of wood anemone (Anemone nemorosa) than smaller ones. Conclusions and Significance: Our results help to generalize the finding that gastropods consume and potentially disperse seeds of myrmecochores. The dispersal potential of gastropods is strongly influenced by diaspore size in relation to gastropod size.	[Tuerke, Manfred; Weisser, Wolfgang W.] Univ Jena, Inst Ecol, Jena, Germany	Friedrich Schiller University of Jena	Turke, M (corresponding author), Tech Univ Munich, Chair Terr Ecol, Res Dept Ecol & Ecosyst Management, Freising Weihenstephan, Germany.	manfred.tuerke@gmx.net	Weisser, Wolfgang W/B-9718-2014	Weisser, Wolfgang W/0000-0002-2757-8959; Turke, Manfred/0000-0002-8957-5454	German Research Foundation; Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" [WE 3018/9-1]	German Research Foundation(German Research Foundation (DFG)); Priority Program 1374 "Infrastructure-Biodiversity-Exploratories"	The work has been funded by the German Research Foundation (http://www.dfg.de) Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" (WE 3018/9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, BIOL TERRESTRIAL MOL; Beattie A. J., 1985, EVOLUTIONARY ECOLOGY; Bogon K, 1990, LANDSCHNECKEN BIOL B; Bojnansky V, 2007, ATLAS SEEDS FRUITS C; BOND W, 1984, ECOLOGY, V65, P1031, DOI 10.2307/1938311; Boyd RS, 2001, AM J BOT, V88, P234, DOI 10.2307/2657014; Bronstein JL, 1997, OECOLOGIA, V112, P379, DOI 10.1007/s004420050323; Bronstein JL, 2001, ECOL LETT, V4, P277, DOI 10.1046/j.1461-0248.2001.00218.x; Calvino-Cancela M, 2012, PLANT ECOL, V213, P663, DOI 10.1007/s11258-012-0030-8; CANULLO R, 1985, Giornale Botanico Italiano, V119, P261; Eisenhauer N, 2010, SOIL BIOL BIOCHEM, V42, P1245, DOI 10.1016/j.soilbio.2010.04.012; Eisenhauer N, 2009, PEDOBIOLOGIA, V52, P151, DOI 10.1016/j.pedobi.2008.07.002; Fischer RC, 2008, OECOLOGIA, V155, P539, DOI 10.1007/s00442-007-0931-8; Fischer W, 1998, BODENKULTUR, V49, P281; Gervais JA, 1998, AM MIDL NAT, V140, P103, DOI 10.1674/0003-0031(1998)140[0103:TPFSDB]2.0.CO;2; Giladi I, 2006, OIKOS, V112, P481, DOI 10.1111/j.0030-1299.2006.14258.x; Gorb, 2003, SEED DISPERSAL ANTS; Honek A, 2009, AGR ECOSYST ENVIRON, V134, P126, DOI 10.1016/j.agee.2009.06.001; HUGHES L, 1994, FUNCT ECOL, V8, P358, DOI 10.2307/2389829; Kappes H, 2006, FOREST ECOL MANAG, V237, P450, DOI 10.1016/j.foreco.2006.09.067; Kappes H, 2009, LANDSCAPE ECOL, V24, P685, DOI 10.1007/s10980-009-9342-z; Kollmann J, 2001, AGR ECOSYST ENVIRON, V83, P285, DOI 10.1016/S0167-8809(00)00202-4; Lengyel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005480; Manzaneda AJ, 2012, ECOGRAPHY, V35, P322, DOI 10.1111/j.1600-0587.2011.06923.x; Manzaneda AJ, 2009, ECOLOGY, V90, P3009, DOI 10.1890/08-2274.1; Mark S, 1996, OECOLOGIA, V107, P95, DOI 10.1007/BF00582239; MESLER MR, 1983, AM J BOT, V70, P1460, DOI 10.2307/2443344; Muller J, 2005, EUR J FOREST RES, V124, P233, DOI 10.1007/s10342-005-0071-9; MULLER P., 1934, BER SCHWEIZ BOT GES, V43, P241; MULLER-SCHNEIDER P., 1967, VEGETATIO, V15, P27; Ness JH, 2004, ECOLOGY, V85, P1244, DOI 10.1890/03-0364; Pearson AK, 2006, VELIGER, V48, P143; PRIOR DJ, 1983, J EXP ZOOL, V225, P321, DOI 10.1002/jez.1402250215; Reifenrath K, 2012, J CHEM ECOL, V38, P1093, DOI 10.1007/s10886-012-0174-y; Sernander R., 1906, ENTWURF MONOGRAPHIE; Servigne P, 2008, INSECT SOC, V55, P220, DOI 10.1007/s00040-008-0991-8; Servigne P, 2008, THESIS U LIBRE BRUXE, P125; Shumway DL, 1994, APPL SOIL ECOL, V1, P11, DOI 10.1016/0929-1393(94)90019-1; Turke M, 2012, AM NAT, V179, P124, DOI 10.1086/663195; Turke M, 2010, OECOLOGIA, V163, P681, DOI 10.1007/s00442-010-1612-6; Ulbrich E, 1919, DTSCH MYRMEKOCHOREN, V117, P1; Weidema I, 2006, INVASIVE ALIEN ASPEC	42	9	9	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68788	10.1371/journal.pone.0068788	http://dx.doi.org/10.1371/journal.pone.0068788			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844239	Green Published, gold, Green Submitted			2022-12-27	WOS:000321733000026
J	Chen, HL; Yi, MH; Sheng, Y; Cheng, HH; Zhou, RJ				Chen, Hengling; Yi, Minhan; Sheng, Yue; Cheng, Hanhua; Zhou, Rongjia			A Novel Testis-Enriched Gene Spata33 Is Expressed during Spermatogenesis	PLOS ONE			English	Article							COFILIN PHOSPHORYLATION; ACTIN REORGANIZATION; DEFICIENT MICE; Y-CHROMOSOME; PROTEIN; MOUSE; CELLS; MEIOSIS; INFERTILITY; DIFFERENTIATION	With an increasing incidence of male idiopathic infertility, identification of novel genes involved in spermatogenesis is an important aspect for the understanding of human testicular failure. In the present study, we have identified a novel gene Spata33, also called as 4732415M23Rik or C16orf55, which is conserved in mammalian species. Spata33 was predominantly expressed in the postpartum and adult mouse testes at mRNA and protein levels. Its expression was increased during the first wave of the spermatogenesis, indicating that Spata33 may be associated with the meiotic process. Further immunohistochemistry analysis revealed that Spata33 was mainly expressed in the spermatocytes, spermatogonia and round spermatids. Its expression was uniformly distributed in the nucleus and cytosol in these germ cells, which was further confirmed by Spata33-tagged with GFP staining in the GC-1 and TM4 cells. These results indicated that Spata33 was predominantly expressed in the mouse testis and associated with spermatogenesis. Identification and characterization of the novel testis-enriched gene Spata33 may provide a new route for understanding of spermatogenesis failure.	[Chen, Hengling; Yi, Minhan; Sheng, Yue; Cheng, Hanhua; Zhou, Rongjia] Wuhan Univ, Coll Life Sci, Dept Genet, Wuhan 430072, Peoples R China	Wuhan University	Cheng, HH (corresponding author), Wuhan Univ, Coll Life Sci, Dept Genet, Wuhan 430072, Peoples R China.	hhcheng@whu.edu.cn; rjzhou@whu.edu.cn	Zhou, Rongjia/G-4660-2013; Zhou, Rongjia/N-9739-2019	Zhou, Rongjia/0000-0002-9701-8009; Zhou, Rongjia/0000-0002-9701-8009	National Natural Science Foundation of China; National Key Basic Research project; National Key Technologies RD Program; Chinese 111 project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research project(National Basic Research Program of China); National Key Technologies RD Program(National Key Technology R&D Program); Chinese 111 project(Ministry of Education, China - 111 Project)	This work was supported by the National Natural Science Foundation of China, the National Key Basic Research project, National Key Technologies R&D Program and the Chinese 111 project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; CALENDA A, 1994, EMBO J, V13, P100, DOI 10.1002/j.1460-2075.1994.tb06239.x; Danshina PV, 2010, BIOL REPROD, V82, P136, DOI 10.1095/biolreprod.109.079699; De Kretser DM, 1999, J CLIN ENDOCR METAB, V84, P3443, DOI 10.1210/jc.84.10.3443; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; Eddy EM, 1999, REV REPROD, V4, P23, DOI 10.1530/revreprod/4.1.23; Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075; Escalier D, 2001, HUM REPROD UPDATE, V7, P191, DOI 10.1093/humupd/7.2.191; Furuchi T, 1996, DEVELOPMENT, V122, P1703; GOETZ P, 1984, J CELL SCI, V65, P249; Hackstein JHP, 2000, TRENDS GENET, V16, P565, DOI 10.1016/S0168-9525(00)02140-5; He C, 2007, CARCINOGENESIS, V28, P2484, DOI 10.1093/carcin/bgm194; HILL CS, 1990, EMBO J, V9, P805, DOI 10.1002/j.1460-2075.1990.tb08177.x; HILL CS, 1991, EMBO J, V10, P1939, DOI 10.1002/j.1460-2075.1991.tb07720.x; Iyer AK, 2004, MOL GENET METAB, V83, P60, DOI 10.1016/j.ymgme.2004.07.018; Jangravi Z, 2013, J PROTEOME RES, V12, P6, DOI 10.1021/pr300864k; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Kneitz B, 2000, GENE DEV, V14, P1085; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Matson CK, 2010, DEV CELL, V19, P612, DOI 10.1016/j.devcel.2010.09.010; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; Nishimune Y, 2006, J ANDROL, V27, P326, DOI 10.2164/jandrol.05162; OAKBERG EF, 1956, AM J ANAT, V99, P507, DOI 10.1002/aja.1000990307; Raymond CS, 2000, GENE DEV, V14, P2587, DOI 10.1101/gad.834100; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Sha JH, 2002, MOL HUM REPROD, V8, P511, DOI 10.1093/molehr/8.6.511; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Toshima J, 2001, J BIOL CHEM, V276, P31449, DOI 10.1074/jbc.M102988200; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Vogt PH, 2005, REPROD BIOMED ONLINE, V10, P81, DOI 10.1016/S1472-6483(10)60807-3; Wain HM, 2002, GENOMICS, V79, P464, DOI 10.1006/geno.2002.6748; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; White-Cooper H, 2010, PHILOS T R SOC B, V365, P1465, DOI 10.1098/rstb.2009.0323; Wilkins MR, 1999, METH MOL B, V112, P531; Yu YE, 2000, P NATL ACAD SCI USA, V97, P4683, DOI 10.1073/pnas.97.9.4683; Yu ZR, 2003, BIOL REPROD, V69, P37, DOI 10.1095/biolreprod.102.012609	37	12	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67882	10.1371/journal.pone.0067882	http://dx.doi.org/10.1371/journal.pone.0067882			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844118	gold, Green Submitted, Green Published			2022-12-27	WOS:000321341000114
J	de Wit, E; Prescott, J; Baseler, L; Bushmaker, T; Thomas, T; Lackemeyer, MG; Martellaro, C; Milne-Price, S; Haddock, E; Haagmans, BL; Feldmann, H; Munster, VJ				de Wit, Emmie; Prescott, Joseph; Baseler, Laura; Bushmaker, Trenton; Thomas, Tina; Lackemeyer, Matthew G.; Martellaro, Cynthia; Milne-Price, Shauna; Haddock, Elaine; Haagmans, Bart L.; Feldmann, Heinz; Munster, Vincent J.			The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Does Not Replicate in Syrian Hamsters	PLOS ONE			English	Article								In 2012 a novel coronavirus, MERS-CoV, associated with severe respiratory disease emerged in the Arabian Peninsula. To date, 55 human cases have been reported, including 31 fatal cases. Several of the cases were likely a result of human-to-human transmission. The emergence of this novel coronavirus prompts the need for a small animal model to study the pathogenesis of this virus and to test the efficacy of potential intervention strategies. In this study we explored the use of Syrian hamsters as a small animal disease model, using intratracheal inoculation and inoculation via aerosol. Clinical signs of disease, virus replication, histological lesions, cytokine upregulation nor seroconversion were observed in any of the inoculated animals, indicating that MERS-CoV does not replicate in Syrian hamsters.	[de Wit, Emmie; Prescott, Joseph; Baseler, Laura; Bushmaker, Trenton; Thomas, Tina; Martellaro, Cynthia; Milne-Price, Shauna; Haddock, Elaine; Feldmann, Heinz; Munster, Vincent J.] NIAID, Virol Lab, Div Intramural Res, NIH, Hamilton, MT USA; [Lackemeyer, Matthew G.] NIAID, Div Clin Res, Div Intramural Res, NIH, Frederick, MD USA; [Haagmans, Bart L.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Feldmann, Heinz] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Erasmus University Rotterdam; Erasmus MC; University of Manitoba	de Wit, E (corresponding author), NIAID, Virol Lab, Div Intramural Res, NIH, Hamilton, MT USA.	emmie.dewit@nih.gov	Haagmans, Bart/E-9791-2015; Munster, Vincent/I-7607-2018; de Wit, Emmie/A-1549-2019	Haagmans, Bart/0000-0001-6221-2015; Munster, Vincent/0000-0002-2288-3196; de Wit, Emmie/0000-0002-9763-7758; Prescott, Joseph/0000-0001-5718-5155; Lackemeyer, Matthew/0000-0002-2174-9630	National Institute of Allergy and Infectious Diseases, National Institutes of Health; European Union [223498]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001088, ZIAAI001179] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); European Union(European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. BLH was financed by the European Union FP7 project EMPERIE (contract number 223498). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2008, INHAL TOXICOL, V20, P1179, DOI [10.1080/08958370802207318, 10.1080/08958370802207318 ]; Annan A, 2013, EMERG INFECT DIS, V19, P456, DOI 10.3201/eid1903.121503; Anthony SJ, 2013, J GEN VIROL, V94, P1028, DOI 10.1099/vir.0.049759-0; Corman V. M., 2012, EURO SURVEILL, V17; de Groot RJ, 2013, J VIROL, DOI 10.1128/JVI.01244-13; Haller O, 2007, MICROBES INFECT, V9, P1636, DOI 10.1016/j.micinf.2007.09.010; Hartings Justin M., 2004, Journal of Pharmacological and Toxicological Methods, V49, P39, DOI 10.1016/j.vascn.2003.07.001; Muller MA, 2012, MBIO, V3, DOI 10.1128/mBio.00515-12; Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Roberts A, 2005, J VIROL, V79, P503, DOI 10.1128/JVI.79.1.503-511.2005; Roberts A, 2008, VIRUS RES, V133, P20, DOI 10.1016/j.virusres.2007.03.025; van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12; WHO, 2013, COR INF; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zivcec M, 2011, J IMMUNOL METHODS, V368, P24, DOI 10.1016/j.jim.2011.02.004	16	96	98	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e69127	10.1371/journal.pone.0069127	http://dx.doi.org/10.1371/journal.pone.0069127			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844250	Green Published, gold			2022-12-27	WOS:000321341000183
J	Merabishvili, M; Vervaet, C; Pirnay, JP; De Vos, D; Verbeken, G; Mast, J; Chanishvili, N; Vaneechoutte, M				Merabishvili, Maia; Vervaet, Chris; Pirnay, Jean-Paul; De Vos, Daniel; Verbeken, Gilbert; Mast, Jan; Chanishvili, Nino; Vaneechoutte, Mario			Stability of Staphylococcus aureus Phage ISP after Freeze-Drying (Lyophilization)	PLOS ONE			English	Article							BACTERIOPHAGE; VIABILITY; PRESERVATION; COMPLEX; OXYGEN	Staphylococcus aureus phage ISP was lyophilized, using an Amsco-Finn Aqua GT4 freeze dryer, in the presence of six different stabilizers at different concentrations. Stability of the lyophilized phage at 4 degrees C was monitored up to 37 months and compared to stability in Luria Bertani broth and physiological saline at 4 degrees C. Sucrose and trehalose were shown to be the best stabilizing additives, causing a decrease of only 1 log immediately after the lyophilization procedure and showing high stability during a 27 month storage period.	[Merabishvili, Maia; Pirnay, Jean-Paul; De Vos, Daniel; Verbeken, Gilbert] Queen Astrid Mil Hosp, Lab Mol & Cellular Technol, Brussels, Belgium; [Merabishvili, Maia; Vaneechoutte, Mario] Univ Ghent, Fac Med & Hlth Sci, Dept Clin Chem Microbiol & Immunol, Lab Bacteriol Res, B-9000 Ghent, Belgium; [Merabishvili, Maia; Chanishvili, Nino] Eliava Inst Bacteriophage Microbiol & Virol, R&D Dept, Tbilisi, Georgia; [Vervaet, Chris] Univ Ghent, Fac Pharmaceut Sci, Lab Pharmaceut Technol, B-9000 Ghent, Belgium; [Mast, Jan] Vet & Agrochem Res Ctr, Electron Microscopy Unit, Brussels, Belgium	Queen Astrid Military Hospital; Ghent University; Ghent University	Merabishvili, M (corresponding author), Queen Astrid Mil Hosp, Lab Mol & Cellular Technol, Brussels, Belgium.	maia.merabishvili@mil.be	Vaneechoutte, Mario/A-6189-2009; Chanishvili, Nina/CAG-5114-2022; Merabishvili, Maia/GLU-4387-2022	Vaneechoutte, Mario/0000-0002-4586-203X; Chanishvili, Nina/0000-0002-7859-3032; Merabishvili, Maia/0000-0002-2566-0772; Mast, Jan/0000-0002-4879-3367; Pirnay, Jean-Paul/0000-0002-6863-5219	Royal Higher Institute for Defense [MED 12]	Royal Higher Institute for Defense	MM and JPP were financially supported by grant MED 12 of the Royal Higher Institute for Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahed W, 2006, ADV DRUG DELIVER REV, V58, P1688, DOI 10.1016/j.addr.2006.09.017; Abedon Stephen T, 2011, Bacteriophage, V1, P66; Ackermann H.-W., 2004, WFCC NEWSLETTER, V38, P35; Alfadhel M, 2011, INT J PHARMACEUT, V416, P280, DOI 10.1016/j.ijpharm.2011.07.006; Anany H, 2011, APPL ENVIRON MICROB, V77, P6379, DOI 10.1128/AEM.05493-11; Burrowes B, 2011, EXPERT REV ANTI-INFE, V9, P775, DOI [10.1586/ERI.11.90, 10.1586/eri.11.90]; CARNE HR, 1974, J HYG-CAMBRIDGE, V72, P467, DOI 10.1017/S0022172400023706; CLARK WA, 1962, APPL MICROBIOL, V10, P466, DOI 10.1128/AEM.10.5.466-471.1962; COX CS, 1973, CAN J MICROBIOL, V19, P189, DOI 10.1139/m73-029; COX CS, 1974, J GEN MICROBIOL, V81, P207, DOI 10.1099/00221287-81-1-207; DAVIES JD, 1969, J HYG-CAMB, V67, P573, DOI 10.1017/S0022172400042030; Golshahi L, 2011, J APPL MICROBIOL, V110, P106, DOI 10.1111/j.1365-2672.2010.04863.x; GREAVES RIN, 1965, ANN NY ACAD SCI, V125, P548, DOI 10.1111/j.1749-6632.1965.tb45413.x; Haq IU, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-9; Jikia D, 2005, CLIN EXP DERMATOL, V30, P23, DOI 10.1111/j.1365-2230.2004.01600.x; Kvachadze L, 2011, MICROB BIOTECHNOL, V4, P643, DOI 10.1111/j.1751-7915.2011.00259.x; Kwan T, 2005, P NATL ACAD SCI USA, V102, P5174, DOI 10.1073/pnas.0501140102; LION MB, 1961, J GEN MICROBIOL, V24, P191, DOI 10.1099/00221287-24-2-191; Lu TK, 2011, CURR OPIN MICROBIOL, V14, P524, DOI 10.1016/j.mib.2011.07.028; Matinkhoo S, 2011, J PHARM SCI-US, V100, P5197, DOI 10.1002/jps.22715; Merabishvili M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004944; Puapermpoonsiri U, 2010, INT J PHARMACEUT, V389, P168, DOI 10.1016/j.ijpharm.2010.01.034; Puapermpoonsiri U, 2009, EUR J PHARM BIOPHARM, V72, P26, DOI 10.1016/j.ejpb.2008.12.001; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; SHAPIRA A, 1974, CRYOBIOLOGY, V11, P452, DOI 10.1016/0011-2240(74)90113-8; STEELE PRM, 1969, J HYG-CAMB, V67, P107, DOI 10.1017/S0022172400041486; Vandersteegen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024418; Wang W, 2000, INT J PHARMACEUT, V203, P1, DOI 10.1016/S0378-5173(00)00423-3; Weiss FA, 1957, SOCIETY AMERICAN BAC, P99; ZIERDT CH, 1959, AM J CLIN PATHOL, V31, P326; ZIERDT CH, 1988, APPL ENVIRON MICROB, V54, P2590, DOI 10.1128/AEM.54.10.2590-.1988	31	78	80	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68797	10.1371/journal.pone.0068797	http://dx.doi.org/10.1371/journal.pone.0068797			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844241	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000181
J	Smolskaya, S; Zhang, ZJ; Alfonta, L				Smolskaya, Sviatlana; Zhang, Zhiwen Jonathan; Alfonta, Lital			Enhanced Yield of Recombinant Proteins with Site-Specifically Incorporated Unnatural Amino Acids Using a Cell-Free Expression System	PLOS ONE			English	Article							ELONGATION-FACTOR TU; TRANSFER-RNA SYNTHETASE; EXPANDED GENETIC-CODE; ESCHERICHIA-COLI; TRANSLATIONAL TERMINATION; RELEASE FACTOR-1; EFFICIENCY; SUPPRESSION; MUTAGENESIS; EVOLUTION	Using a commercial protein expression system, we sought the crucial elements and conditions for the expression of proteins with genetically encoded unnatural amino acids. By identifying the most important translational components, we were able to increase suppression efficiency to 55% and to increase mutant protein yields to levels higher than achieved with wild type expression (120%), reaching over 500 mu g/mL of translated protein (comprising 25 mu g in 50 mL of reaction mixture). To our knowledge, these results are the highest obtained for both in vivo and in vitro systems. We also demonstrated that efficiency of nonsense suppression depends greatly on the nucleotide following the stop codon. Insights gained in this thorough analysis could prove useful for augmenting in vivo expression levels as well.	[Smolskaya, Sviatlana; Alfonta, Lital] Ben Gurion Univ Negev, Avram & Stella Goldstein Goren Dept Biotechnol En, IL-84105 Beer Sheva, Israel; [Smolskaya, Sviatlana; Alfonta, Lital] Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, IL-84105 Beer Sheva, Israel; [Zhang, Zhiwen Jonathan] Santa Clara Univ, Sch Engn, Dept Bioengn, Santa Clara, CA 95053 USA	Ben Gurion University; Ben Gurion University; Santa Clara University	Zhang, ZJ (corresponding author), Santa Clara Univ, Sch Engn, Dept Bioengn, Santa Clara, CA 95053 USA.	zzhang@scu.edu; alfontal@bgu.ac.il	Alfonta, Lital/AAB-9689-2022; Alfonta, Lital/B-6101-2012	Alfonta, Lital/0000-0002-3805-8625; Alfonta, Lital/0000-0002-3805-8625; Smolskaya, Sviatlana/0000-0003-3734-8644	European Research Council under the European Union's Seventh Framework Programme [260647]; Edmond J. Safra Center for the Design and Engineering of Functional Biopolymers	European Research Council under the European Union's Seventh Framework Programme(European Research Council (ERC)); Edmond J. Safra Center for the Design and Engineering of Functional Biopolymers	The research leading to these results received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 260647 and from the Edmond J. Safra Center for the Design and Engineering of Functional Biopolymers. LA holds the Elaine S. and Alvin W. Wene Career Development Chair in Biotechnology Engineering. SS acknowledges the Harbour Foundation for a Fay and Bert Harbour Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Agafonov DE, 2005, FEBS LETT, V579, P2156, DOI 10.1016/j.febslet.2005.03.004; BAIN JD, 1989, J AM CHEM SOC, V111, P8013, DOI 10.1021/ja00202a052; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Eargle J, 2008, J MOL BIOL, V377, P1382, DOI 10.1016/j.jmb.2008.01.073; Goerke AR, 2009, BIOTECHNOL BIOENG, V102, P400, DOI 10.1002/bit.22070; Guo JT, 2009, ANGEW CHEM INT EDIT, V48, P9148, DOI 10.1002/anie.200904035; Hohsaka T, 2001, NUCLEIC ACIDS RES, V29, P3646, DOI 10.1093/nar/29.17.3646; Hohsaka T, 1996, J AM CHEM SOC, V118, P9778, DOI 10.1021/ja9614225; Jewett MC, 2004, BIOTECHNOL PROGR, V20, P102, DOI 10.1021/bp0341693; Johnson DBF, 2011, NAT CHEM BIOL, V7, P779, DOI 10.1038/nchembio.657; Kiga D, 2002, P NATL ACAD SCI USA, V99, P9715, DOI 10.1073/pnas.142220099; LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Liu DR, 1999, P NATL ACAD SCI USA, V96, P4780, DOI 10.1073/pnas.96.9.4780; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; Pape T, 2000, NAT STRUCT BIOL, V7, P104; Park HS, 2011, SCIENCE, V333, P1151, DOI 10.1126/science.1207203; Poole ES, 1998, NUCLEIC ACIDS RES, V26, P954, DOI 10.1093/nar/26.4.954; POOLE ES, 1995, EMBO J, V14, P151, DOI 10.1002/j.1460-2075.1995.tb06985.x; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Sando S, 2007, BIOORG MED CHEM LETT, V17, P1216, DOI 10.1016/j.bmcl.2006.12.013; Schrader JM, 2009, J MOL BIOL, V386, P1255, DOI 10.1016/j.jmb.2009.01.021; Short GF, 1999, BIOCHEMISTRY-US, V38, P8808, DOI 10.1021/bi990281r; Sisido M, 2001, APPL MICROBIOL BIOT, V57, P274; Wang KH, 2007, NAT BIOTECHNOL, V25, P770, DOI 10.1038/nbt1314; Wang L, 2003, P NATL ACAD SCI USA, V100, P56, DOI 10.1073/pnas.0234824100; Wang L, 2000, J AM CHEM SOC, V122, P5010, DOI 10.1021/ja000595y; Wang Q, 2009, CHEM BIOL, V16, P323, DOI 10.1016/j.chembiol.2009.03.001; Xie JM, 2006, NAT REV MOL CELL BIO, V7, P775, DOI 10.1038/nrm2005; Xie JM, 2004, NAT BIOTECHNOL, V22, P1297, DOI 10.1038/nbt1013; Ye SX, 2008, J BIOL CHEM, V283, P1525, DOI 10.1074/jbc.M707355200; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030	32	11	11	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68363	10.1371/journal.pone.0068363	http://dx.doi.org/10.1371/journal.pone.0068363			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844190	gold, Green Submitted, Green Published			2022-12-27	WOS:000321341000155
J	Yan, T; Chopp, M; Ning, RZ; Zacharek, A; Roberts, C; Chen, JL				Yan, Tao; Chopp, Michael; Ning, Ruizhuo; Zacharek, Alex; Roberts, Cynthia; Chen, Jieli			Intracranial Aneurysm Formation in Type-One Diabetes Rats	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; GLYCOSYLATION END-PRODUCTS; INDUCED CEREBRAL ANEURYSMS; ABDOMINAL AORTIC-ANEURYSM; RISK-FACTORS; MATRIX METALLOPROTEINASES; CLINICAL CONSEQUENCES; VASCULAR-DISEASE; MEDICAL THERAPY; RECEPTOR 4	Background & Objective: Diabetes mellitus (DM) plays an important role in the pathogenesis of vascular complications including arteriosclerosis and ischemic stroke. Whether DM impacts intracranial aneurysm (IA) formation has not been extensively investigated. In this study, we tested the underlying mechanism of type one DM (T1DM) induced IA formation in rats. Experimental Approaches: T1DM was induced by streptozotocin injection. Rats were euthanized at 0, 4 and 10 weeks after T1DM induction. To evaluate cerebral vascular perfusion, Fluorescein isothiocyanate - dye was injected at 5 min prior to euthanasia. Vascular perfusion was measured by laser scanning confocal microscopy. Trichrome, Elastica van Gieson, alpha-smooth muscle actin (a-SMA) and receptor of advanced glycation end-products (RAGE), toll-like receptor 4 (TLR4) and matrix metalloproteinase 9 (MMP9) immunostaining were performed. The IA formation was classified by 0-3 stages: 0: Normal; 1: Endothelial damage; 2: Moderate protrusion; and 3: Saccular aneurysm formation. Results: T1DM significantly increased IA formation identified by the classification of aneurysmal changes compared with non-DM rats (p < 0.05). However, T1DM induced IA formations were classified as stage 1 and stage 2, but not stage 3. Cerebral vascular perfusion was significantly decreased in T1DM rats compared to non-DM rats (p < 0.01). DM10W rats exhibited a significant decrease of cerebral vascular perfusion compared to DM4W rats (p < 0.05). T1DM rats also significantly increased the internal carotid artery (ICA) intimae and media thickness, and decreased the internal carotid artery diameter compared to non-DM rats. RAGE, MMP9 and TLR4 expression were significantly increased in T1DM rats compared to non-DM rats. The increased RAGE, TLR4 and MMP9 significantly correlated with IA formation (p < 0.05). Conclusion: T1DM increases IA formation. The increased RAGE, MMP9 and TLR4 expressions might contribute to IA formation in T1DM rats.	[Yan, Tao; Chen, Jieli] Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurol, Tianjin, Peoples R China; [Yan, Tao; Chopp, Michael; Ning, Ruizhuo; Zacharek, Alex; Roberts, Cynthia; Chen, Jieli] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA	Tianjin Medical University; Henry Ford Health System; Henry Ford Hospital; Oakland University	Chen, JL (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurol, Tianjin, Peoples R China.	jieli@neuro.hfh.edu	Yan, Tao/B-2930-2012	Yan, Tao/0000-0003-3138-4468	National Institute on Aging [RO1 AG031811]; National Institute of Neurological Disorders and Stroke [PO1 NS23393, 1R41NS064708]; American Heart Association [09GRNT2300151]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R41NS064708, P01NS023393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031811, R01AG037506] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institute on Aging RO1 AG031811 (JC) (http://www.nia.nih.gov/), National Institute of Neurological Disorders and Stroke PO1 NS23393 (MC) and 1R41NS064708 (JC) (http://www.ninds.nih.gov/), and American Heart Association grant 09GRNT2300151 (JC) (http://www.heart.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1984, ARCH NEUROL-CHICAGO, V41, P1033, DOI 10.1001/archneur.1984.04050210031009; Aoki T, 2008, STROKE, V39, P1276, DOI 10.1161/STROKEAHA.107.503086; Aoki T, 2011, LAB INVEST, V91, P619, DOI 10.1038/labinvest.2010.204; Aoki T, 2010, J NEUROSURG, V113, P851, DOI 10.3171/2009.9.JNS09329; ASARI S, 1993, CLIN NEUROL NEUROSUR, V95, P205, DOI 10.1016/0303-8467(93)90125-Z; Astrand H, 2007, EUR J VASC ENDOVASC, V33, P592, DOI 10.1016/j.ejvs.2006.11.011; Calza L, 2001, P NATL ACAD SCI USA, V98, P4160, DOI 10.1073/pnas.051626998; Chen JL, 2003, ANN NEUROL, V53, P743, DOI 10.1002/ana.10555; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Creager MA, 2003, CIRCULATION, V108, P1527, DOI 10.1161/01.CIR.0000091257.27563.32; DOLLERY CM, 1995, CIRC RES, V77, P863, DOI 10.1161/01.RES.77.5.863; Dua MM, 2010, SURGERY, V148, P429, DOI 10.1016/j.surg.2010.05.014; EPSTEIN M, 1992, HYPERTENSION, V19, P403, DOI 10.1161/01.HYP.19.5.403; Fan X, 2013, STROKE, V44, P745, DOI 10.1161/STROKEAHA.111.000309; Feigin VL, 2005, STROKE, V36, P2773, DOI 10.1161/01.STR.0000190838.02954.e8; Festa A, 1999, ARTERIOSCL THROM VAS, V19, P562, DOI 10.1161/01.ATV.19.3.562; Fox CS, 2004, JAMA-J AM MED ASSOC, V292, P2495, DOI 10.1001/jama.292.20.2495; Fujita T, 2010, ANN SURG, V252, P203, DOI 10.1097/SLA.0b013e3181e495e6; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Golledge J, 2006, ARTERIOSCL THROM VAS, V26, P2605, DOI 10.1161/01.ATV.0000245819.32762.cb; GREENHALGH RM, 1980, J CARDIOVASC SURG, V21, P559; Grenier D, 2006, ORAL MICROBIOL IMMUN, V21, P190, DOI 10.1111/j.1399-302X.2006.00278.x; Guerreiro NE, 2004, SURG NEUROL, V62, P406, DOI 10.1016/j.surneu.2004.01.023; Haley AP, 2012, METAB BRAIN DIS; Hodgkinson CR, 2008, THROMB HAEMOSTASIS, V100, P301, DOI 10.1160/TH08-03-0179; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Inagawa T, 2010, WORLD NEUROSURG, V73, P155, DOI 10.1016/j.surneu.2009.03.007; Juvela S, 2001, STROKE, V32, P485, DOI 10.1161/01.STR.32.2.485; Kanematsu Y, 2011, STROKE, V42, P173, DOI 10.1161/STROKEAHA.110.590976; Kittaka M, 1996, STROKE, V27, P712, DOI 10.1161/01.STR.27.4.712; Kuzuya Masafumi, 2003, J Atheroscler Thromb, V10, P275; KWAK R, 1979, TOHOKU J EXP MED, V128, P267, DOI 10.1620/tjem.128.267; Lagares A, 1999, SURG NEUROL, V52, P623, DOI 10.1016/S0090-3019(99)00147-0; Lederle FA, 1997, ANN INTERN MED, V126, P441, DOI 10.7326/0003-4819-126-6-199703150-00004; Lee AJ, 1997, EUR HEART J, V18, P671; Li HL, 2007, J CELL MOL MED, V11, P88, DOI 10.1111/j.1582-4934.2007.00011.x; Li WG, 2010, DIABETES, V59, P228, DOI 10.2337/db09-0902; Lindeman JHN, 2009, CIRCULATION, V119, P2209, DOI 10.1161/CIRCULATIONAHA.108.806505; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Luscher TF, 2003, CIRCULATION, V108, P1655, DOI 10.1161/01.CIR.0000089189.70578.E2; McMillan WD, 1997, CIRCULATION, V96, P2228; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Naduk-Kik J, 2008, POSTEP HIG MED DOSW, V62, P442; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Ning R, 2012, NEUROSCIENCE, V222, P326, DOI 10.1016/j.neuroscience.2012.07.018; Onda Hideaki, 2008, Brain and Nerve (Tokyo), V60, P1245; Prall AK, 2002, J VASC SURG, V35, P923, DOI 10.1067/mva.2002.123757; Qiu JH, 2010, STROKE, V41, P2077, DOI 10.1161/STROKEAHA.110.590463; Schmidt AM, 2000, TRENDS ENDOCRIN MET, V11, P368, DOI 10.1016/S1043-2760(00)00311-8; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Tada Y, 2011, STROKE, V42, P2286, DOI 10.1161/STROKEAHA.110.608034; Tada Y, 2010, J HYPERTENS, V28, P1883, DOI 10.1097/HJH;0b013e32833c2273; Takeshita H, 1999, J VIROL, V73, P5548, DOI 10.1128/JVI.73.7.5548-5555.1999; Tamura T, 2009, J HYPERTENS, V27, P1284, DOI 10.1097/HJH.0b013e328329d1a7; TAYLOR CL, 1995, J NEUROSURG, V83, P812, DOI 10.3171/jns.1995.83.5.0812; Thompson RW, 2002, CURR PROB SURG, V39, P98; WINN HR, 1983, J NEUROSURG, V59, P642, DOI 10.3171/jns.1983.59.4.0642; Yamagishi S, 2005, CURR DIABETES REV, V1, P93, DOI 10.2174/1573399052952631; Ye X, 2011, NEUROSCIENCE, V190, P339, DOI 10.1016/j.neuroscience.2011.06.004; Ye XC, 2011, EXP NEUROL, V232, P299, DOI 10.1016/j.expneurol.2011.09.022; Zhang F, 2009, ANN SURG, V250, P416, DOI [10.1097/SLA.0b013e3e181b41a18, 10.1097/SLA.0b013e3181b41a18]	63	11	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67949	10.1371/journal.pone.0067949	http://dx.doi.org/10.1371/journal.pone.0067949			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844137	Green Submitted, Green Published, gold			2022-12-27	WOS:000321341000124
J	Guescini, M; Sisti, D; Rocchi, MBL; Panebianco, R; Tibollo, P; Stocchi, V				Guescini, Michele; Sisti, Davide; Rocchi, Marco B. L.; Panebianco, Renato; Tibollo, Pasquale; Stocchi, Vilberto			Accurate and Precise DNA Quantification in the Presence of Different Amplification Efficiencies Using an Improved Cy0 Method	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; QUANTITATIVE PCR; RELATIVE QUANTIFICATION; MESSENGER-RNA; INHIBITION; VALIDATION; ASSAYS; BIAS	Quantitative real-time PCR represents a highly sensitive and powerful technology for the quantification of DNA. Although real-time PCR is well accepted as the gold standard in nucleic acid quantification, there is a largely unexplored area of experimental conditions that limit the application of the Ct method. As an alternative, our research team has recently proposed the Cy0 method, which can compensate for small amplification variations among the samples being compared. However, when there is a marked decrease in amplification efficiency, the Cy0 is impaired, hence determining reaction efficiency is essential to achieve a reliable quantification. The proposed improvement in Cy0 is based on the use of the kinetic parameters calculated in the curve inflection point to compensate for efficiency variations. Three experimental models were used: inhibition of primer extension, non-optimal primer annealing and a very small biological sample. In all these models, the improved Cy0 method increased quantification accuracy up to about 500% without affecting precision. Furthermore, the stability of this procedure was enhanced integrating it with the SOD method. In short, the improved Cy0 method represents a simple yet powerful approach for reliable DNA quantification even in the presence of marked efficiency variations.	[Guescini, Michele; Sisti, Davide; Rocchi, Marco B. L.; Panebianco, Renato; Tibollo, Pasquale; Stocchi, Vilberto] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy	University of Urbino	Guescini, M (corresponding author), Univ Urbino Carlo Bo, Dept Biomol Sci, Via I Maggetti, Urbino, Italy.	michele.guescini@uniurb.it	Rocchi, Marco BL/AAK-5926-2021; Guescini, Michele/L-1297-2019	Guescini, Michele/0000-0001-9372-7038; davide, sisti/0000-0002-7925-7495; Rocchi, marco/0000-0002-0056-5795				AKANE A, 1994, J FORENSIC SCI, V39, P362; Annibalini G, 2012, BMB REP, V45, P32, DOI 10.5483/BMBRep.2012.45.1.32; Bar T, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng106; Bar T, 2012, NUCLEIC ACIDS RES, V40, P1395, DOI 10.1093/nar/gkr778; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chervoneva I, 2007, STAT MED, V26, P5596, DOI 10.1002/sim.3127; Cikos S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-113; Gingeras TR, 2005, CLIN CHEM, V51, P661, DOI 10.1373/clinchem.2004.045336; Goll R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-107; Guescini M, 2007, NUTR METAB CARDIOVAS, V17, P383, DOI 10.1016/j.numecd.2007.01.012; Guescini M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-326; Kainz P, 2000, BBA-GENE STRUCT EXPR, V1494, P23, DOI 10.1016/S0167-4781(00)00200-1; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Liu WH, 2002, ANAL BIOCHEM, V302, P52, DOI 10.1006/abio.2001.5530; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; Nolan T, 2006, ANAL BIOCHEM, V351, P308, DOI 10.1016/j.ab.2006.01.051; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; ROSSEN L, 1992, INT J FOOD MICROBIOL, V17, P37, DOI 10.1016/0168-1605(92)90017-W; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Ruijter JM, 2013, METHODS, V59, P32, DOI 10.1016/j.ymeth.2012.08.011; Rutledge RG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh177; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; Rutledge RG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009731; Rutledge RG, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-96; Rutledge RG, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-47; Shain EB, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn408; Sisti D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-186; Spiess AN, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-221; Tichopad A, 2004, MOL CELL PROBE, V18, P45, DOI 10.1016/j.mcp.2003.09.001; Tichopad A, 2010, METHODS, V50, P308, DOI 10.1016/j.ymeth.2010.01.028; Tichopad A, 2009, CLIN CHEM, V55, P1816, DOI 10.1373/clinchem.2009.126201; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Wang YL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-59; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997	37	9	10	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68481	10.1371/journal.pone.0068481	http://dx.doi.org/10.1371/journal.pone.0068481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861909	Green Published, gold, Green Submitted			2022-12-27	WOS:000321692000029
J	Ichikawa, T; Nakazato, K; Keller, PJ; Kajiura-Kobayashi, H; Stelzer, EHK; Mochizuki, A; Nonaka, S				Ichikawa, Takehiko; Nakazato, Kenichi; Keller, Philipp J.; Kajiura-Kobayashi, Hiroko; Stelzer, Ernst H. K.; Mochizuki, Atsushi; Nonaka, Shigenori			Live Imaging of Whole Mouse Embryos during Gastrulation: Migration Analyses of Epiblast and Mesodermal Cells	PLOS ONE			English	Article							INTERKINETIC NUCLEAR MIGRATION; LIGHT SHEET MICROSCOPY; NEURAL PROGENITORS; MOVEMENT; NEUROGENESIS; POLARITY; NEUROEPITHELIUM; ESTABLISHMENT; MECHANISMS; BLASTOCYST	During gastrulation in the mouse embryo, dynamic cell movements including epiblast invagination and mesodermal layer expansion lead to the establishment of the three-layered body plan. The precise details of these movements, however, are sometimes elusive, because of the limitations in live imaging. To overcome this problem, we developed techniques to enable observation of living mouse embryos with digital scanned light sheet microscope (DSLM). The achieved deep and high time-resolution images of GFP-expressing nuclei and following 3D tracking analysis revealed the following findings: (i) Interkinetic nuclear migration (INM) occurs in the epiblast at embryonic day (E) 6 and 6.5. (ii) INM-like migration occurs in the E5.5 embryo, when the epiblast is a monolayer and not yet pseudostratified. (iii) Primary driving force for INM at E6.5 is not pressure from neighboring nuclei. (iv) Mesodermal cells migrate not as a sheet but as individual cells without coordination.	[Ichikawa, Takehiko; Kajiura-Kobayashi, Hiroko; Nonaka, Shigenori] Natl Inst Basic Biol, Lab Spatiotemporal Regulat, Okazaki, Aichi 444, Japan; [Nakazato, Kenichi; Mochizuki, Atsushi] RIKEN, Theoret Biol Lab, Adv Sci Inst, Wako, Saitama, Japan; [Keller, Philipp J.] Howard Hughes Med Inst, Ashburn, VA USA; [Stelzer, Ernst H. K.] Goethe Univ Frankfurt, Phys Biol FB IZN 15, Buchmann Inst Mol Life Sci BMLS, CEF MC, D-60054 Frankfurt, Germany; [Nonaka, Shigenori] Grad Univ Adv Studies SOKENDAI, Dept Basic Biol, Sch Life Sci, Hayama, Kanagawa, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); RIKEN; Howard Hughes Medical Institute; Goethe University Frankfurt; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB)	Nonaka, S (corresponding author), Natl Inst Basic Biol, Lab Spatiotemporal Regulat, Okazaki, Aichi 444, Japan.	snonaka@nibb.ac.jp	Stelzer, Ernst H K/A-7648-2011; Mochizuki, Atsushi/A-7917-2015; Nonaka, Shigenori/I-2132-2013	Stelzer, Ernst H K/0000-0003-1545-0736; Mochizuki, Atsushi/0000-0002-7714-1755; Nonaka, Shigenori/0000-0002-8093-0325; Ichikawa, Takehiko/0000-0002-2438-5502; Keller, Philipp/0000-0003-2896-4920	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [18687902, 10J00353]; Japan Society for the Promotion of Science (JSPS); Human Frontier Science Program (HFSP); CREST	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Human Frontier Science Program (HFSP)(Human Frontier Science Program); CREST(Core Research for Evolutional Science and Technology (CREST))	This work was supported by Grant-in-Aid for Scientific Research 18687902 and 10J00353 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT, http://www.mext.go.jp/english/); the Japan Society for the Promotion of Science (JSPS, http://www.jsps.go.jp/english/index.html); the Human Frontier Science Program (HFSP, http://www.hfsp.org/), and CREST (http://www.jst.go.jp/kisoken/crest/en/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2011, GENESIS, V49, P579, DOI 10.1002/dvg.20753; Agathocleous M, 2009, ANNU REV CELL DEV BI, V25, P45, DOI 10.1146/annurev.cellbio.042308.113259; Arboleda-Estudillo Y, 2010, CURR BIOL, V20, P161, DOI 10.1016/j.cub.2009.11.036; Baye LM, 2008, BRAIN RES, V1192, P29, DOI 10.1016/j.brainres.2007.05.021; Davidson BP, 2000, CURR BIOL, V10, pR617, DOI 10.1016/S0960-9822(00)00675-8; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; FUJITA S, 1960, NATURE, V185, P702, DOI 10.1038/185702a0; Guerrier S, 2007, NEURON, V56, P1, DOI 10.1016/j.neuron.2007.09.019; Huisken J, 2007, OPT LETT, V32, P2608, DOI 10.1364/OL.32.002608; Huisken J, 2009, DEVELOPMENT, V136, P1963, DOI 10.1242/dev.022426; Latasa MJ, 2009, INT J DEV BIOL, V53, P895, DOI 10.1387/ijdb.082721ml; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Keller PJ, 2008, CURR OPIN NEUROBIOL, V18, P624, DOI 10.1016/j.conb.2009.03.008; Keller R, 2005, CURR OPIN CELL BIOL, V17, P533, DOI 10.1016/j.ceb.2005.08.006; Khairy K, 2010, RECONSTRUCTING EMBRY; Kim SK, 2010, SCIENCE, V329, P1337, DOI 10.1126/science.1191184; Kinder SJ, 2001, DEVELOPMENT, V128, P3623; Kosodo Y, 2011, EMBO J, V30, P1690, DOI 10.1038/emboj.2011.81; Kurotaki Y, 2007, SCIENCE, V316, P719, DOI 10.1126/science.1138591; Kwon GS, 2008, DEV CELL, V15, P509, DOI 10.1016/j.devcel.2008.07.017; Lewis SL, 2006, DEV DYNAM, V235, P2315, DOI 10.1002/dvdy.20846; Meyer EJ, 2011, CURR BIOL, V21, P485, DOI 10.1016/j.cub.2011.02.002; Minobe S, 2009, NEUROSCI RES, V63, P294, DOI 10.1016/j.neures.2009.01.006; Miyata T, 2008, DEV GROWTH DIFFER, V50, pS105, DOI 10.1111/j.1440-169x.2007.00980.x; NAKATSUJI N, 1986, J EMBRYOL EXP MORPH, V96, P99; Norden C, 2009, CELL, V138, P1195, DOI 10.1016/j.cell.2009.06.032; Nowotschin S, 2010, CURR OPIN GENET DEV, V20, P420, DOI 10.1016/j.gde.2010.05.008; Robb L, 2004, SEMIN CELL DEV BIOL, V15, P543, DOI 10.1016/j.semcdb.2004.04.005; Sauer FC, 1936, J MORPHOL, V37, P1; Schenk J, 2009, P NATL ACAD SCI USA, V106, P16487, DOI 10.1073/pnas.0908928106; Stern CD, 2004, GASTRULATION CELLS E, Vxvi; Tam PPL, 2001, BIOESSAYS, V23, P508, DOI 10.1002/bies.1070; Tamai H, 2007, GENES CELLS, V12, P983, DOI 10.1111/j.1365-2443.2007.01113.x; Tao H, 2009, P NATL ACAD SCI USA, V106, P14426, DOI 10.1073/pnas.0901332106; Theveneau E, 2010, DEV CELL, V19, P39, DOI 10.1016/j.devcel.2010.06.012; Tomer R, 2011, CURR OPIN GENET DEV, V21, P558, DOI 10.1016/j.gde.2011.07.003; Tsai JW, 2010, NAT NEUROSCI, V13, P1463, DOI 10.1038/nn.2665; Weber GF, 2012, DEV CELL, V22, P104, DOI 10.1016/j.devcel.2011.10.013; Yamanaka Y, 2007, DEV CELL, V13, P884, DOI 10.1016/j.devcel.2007.10.016; Zernicka-Goetz M, 2002, DEVELOPMENT, V129, P815; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018	41	47	47	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e64506	10.1371/journal.pone.0064506	http://dx.doi.org/10.1371/journal.pone.0064506			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861733	Green Published, Green Submitted, gold			2022-12-27	WOS:000321692000001
J	Watari, K; Nakaya, M; Nishida, M; Kim, KM; Kurose, H				Watari, Kenji; Nakaya, Michio; Nishida, Motohiro; Kim, Kyeong-Man; Kurose, Hitoshi			beta-arrestin2 in Infiltrated Macrophages Inhibits Excessive Inflammation after Myocardial Infarction	PLOS ONE			English	Article							BETA-ARRESTIN; NITRIC-OXIDE; RECEPTOR; PATHWAYS; CELL; HYPERTROPHY; CHEMOTAXIS; APOPTOSIS; IMPROVES; ALPHA	Beta-arrestins (beta-arrestin1 and beta-arrestin2) are known as cytosolic proteins that mediate desensitization and internalization of activated G protein-coupled receptors. In addition to these functions, beta-arrestins have been found to work as adaptor proteins for intracellular signaling pathways. beta-arrestin1 and beta-arrestin2 are expressed in the heart and are reported to participate in normal cardiac function. However, the physiological and pathological roles of beta-arrestin1/2 in myocardial infarction (MI) have not been examined. Here, we demonstrate that beta-arrestin2 negatively regulates inflammatory responses of macrophages recruited to the infarct area. beta-arrestin2 knockout (KO) mice have higher mortality than wild-type (WT) mice after MI. In infarcted hearts, beta-arrestin2 was strongly expressed in infiltrated macrophages. The production of inflammatory cytokines was enhanced in beta-arrestin2 KO mice. In addition, p65 phosphorylation in the macrophages from the infarcted hearts of beta-arrestin2 KO mice was increased in comparison to that of WT mice. These results suggest that the infiltrated macrophages of beta-arrestin2 KO mice induce excessive inflammation at the infarct area. Furthermore, the inflammation in WT mice transplanted with bone marrow cells of beta-arrestin2 KO mice is enhanced by MI, which is similar to that in beta-arrestin2 KO mice. In contrast, the inflammation after MI in beta-arrestin2 KO mice transplanted with bone marrow cells of WT mice is comparable to that in WT mice transplanted with bone marrow cells of WT mice. In summary, our present study demonstrates that beta-arrestin2 of infiltrated macrophages negatively regulates inflammation in infarcted hearts, thereby enhancing inflammation when the beta-arrestin2 gene is knocked out. beta-arrestin2 plays a protective role in MI-induced inflammation.	[Watari, Kenji; Nakaya, Michio; Nishida, Motohiro; Kurose, Hitoshi] Kyushu Univ, Dept Pharmacol & Toxicol, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan; [Kim, Kyeong-Man] Chonnam Natl Univ, Pharmacol Lab, Coll Pharm, Kwangju, South Korea	Kyushu University; Chonnam National University	Kurose, H (corresponding author), Kyushu Univ, Dept Pharmacol & Toxicol, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan.	kurose@phar.kyushu-u.ac.jp	Kim, Kyeong-Man/AAA-9847-2020	Nishida, Motohiro/0000-0002-2587-5458	Ministry of Education, Culture, Sports, Science, and Technology of Japan; SENSHIN Medical Research Foundation; JSPS; Grants-in-Aid for Scientific Research [22136008] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. Nakaya, M. Nishida, and H. Kurose); from Grant-in-Aid for Scientific Research on Innovative Areas (M. Nakaya); from The SENSHIN Medical Research Foundation (M. Na.); from Bilateral Joint Research Project of JSPS (H. Kurose); and from Grant-in-Aid for JSPS Fellows (K. Watari). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2009, J BIOL CHEM, V284, P8846, DOI 10.1074/jbc.M808463200; Anzai A, 2012, CIRCULATION, V125, P1234, DOI 10.1161/CIRCULATIONAHA.111.052126; DeFea KA, 2007, ANNU REV PHYSIOL, V69, P535, DOI 10.1146/annurev.physiol.69.022405.154804; Esposito G, 2011, BASIC RES CARDIOL, V106, P577, DOI 10.1007/s00395-011-0163-2; Fan HK, 2010, IMMUNOLOGY, V130, P344, DOI 10.1111/j.1365-2567.2009.03185.x; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Frangogiannis NG, 2008, PHARMACOL RES, V58, P88, DOI 10.1016/j.phrs.2008.06.007; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hu YL, 2011, BASIC RES CARDIOL, V106, P1311, DOI 10.1007/s00395-011-0204-x; Ibrahim IAAEH, 2012, J PHARMACOL SCI, V118, P408, DOI 10.1254/jphs.11R10CP; Ing DJ, 1999, CIRC RES, V84, P21; Jones SP, 1999, AM J PHYSIOL-HEART C, V276, pH1567, DOI 10.1152/ajpheart.1999.276.5.H1567; Kobara M, 2010, CARDIOVASC RES, V87, P424, DOI 10.1093/cvr/cvq078; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Li HL, 2007, CIRCULATION, V115, P1885, DOI 10.1161/CIRCULATIONAHA.106.656835; Maekawa Y, 2009, CIRCULATION, V120, P1401, DOI 10.1161/CIRCULATIONAHA.109.865956; Mangmool S, 2010, J CELL BIOL, V189, P573, DOI 10.1083/jcb.200911047; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409; Nishida M, 2008, EMBO J, V27, P3104, DOI 10.1038/emboj.2008.237; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Noor N, 2011, J MOL CELL CARDIOL, V51, P534, DOI 10.1016/j.yjmcc.2010.11.005; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Rajagopal K, 2006, P NATL ACAD SCI USA, V103, P16284, DOI 10.1073/pnas.0607583103; Reilkoff RA, 2011, NAT REV IMMUNOL, V11, P427, DOI 10.1038/nri2990; Singh MV, 2012, J MOL CELL CARDIOL, V52, P1135, DOI 10.1016/j.yjmcc.2012.01.021; Tilley DG, 2011, CIRC RES, V109, P217, DOI 10.1161/CIRCRESAHA.110.231225; Troidl C, 2009, J CELL MOL MED, V13, P3485, DOI 10.1111/j.1582-4934.2009.00707.x; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; WINSTON BW, 1995, P NATL ACAD SCI USA, V92, P1614, DOI 10.1073/pnas.92.5.1614; Witherow DS, 2004, P NATL ACAD SCI USA, V101, P8603, DOI 10.1073/pnas.0402851101; Yang XH, 2012, APOPTOSIS, V17, P1019, DOI 10.1007/s10495-012-0741-2	34	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68351	10.1371/journal.pone.0068351	http://dx.doi.org/10.1371/journal.pone.0068351			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861891	Green Submitted, gold, Green Published			2022-12-27	WOS:000321692000023
J	Dugassa, S; Lindh, JM; Oyieke, F; Mukabana, WR; Lindsay, SW; Fillinger, U				Dugassa, Sisay; Lindh, Jenny M.; Oyieke, Florence; Mukabana, Wolfgang R.; Lindsay, Steven W.; Fillinger, Ulrike			Development of a Gravid Trap for Collecting Live Malaria Vectors Anopheles gambiae s.l.	PLOS ONE			English	Article							CULEX-QUINQUEFASCIATUS DIPTERA; MOSQUITOS DIPTERA; OVIPOSITION BEHAVIOR; SITE SELECTION; ARID AREA; CLAY POTS; CULICIDAE; OUTDOOR; NETS; SURVEILLANCE	Background: Effective malaria vector control targeting indoor host-seeking mosquitoes has resulted in fewer vectors entering houses in many areas of sub-Saharan Africa, with the proportion of vectors outdoors becoming more important in the transmission of this disease. This study aimed to develop a gravid trap for the outdoor collection of the malaria vector Anopheles gambiae s.l. based on evaluation and modification of commercially available gravid traps. Methods: Experiments were implemented in an 80 m(2) semi-field system where 200 gravid Anopheles gambiae s.s. were released nightly. The efficacy of the Box, CDC and Frommer updraft gravid traps was compared. The Box gravid trap was tested to determine if the presence of the trap over water and the trap's sound affected catch size. Mosquitoes approaching the treatment were evaluated using electrocuting nets or detergents added to the water in the trap. Based on the results, a new gravid trap (OviART trap) that provided an open, unobstructed oviposition site was developed and evaluated. Results: Box and CDC gravid traps collected similar numbers (relative rate (RR) 0.8, 95% confidence interval (CI) 0.6-1.2; p = 0.284), whereas the Frommer trap caught 70% fewer mosquitoes (RR 0.3, 95% CI 0.2-0.5; p < 0.001). The number of mosquitoes approaching the Box trap was significantly reduced when the trap was positioned over a water-filled basin compared to an open pond (RR 0.7 95% CI 0.6-0.7; p < 0.001). This effect was not due to the sound of the trap. Catch size increased by 60% (RR 1.6, 1.2-2.2; p = 0.001) with the new OviART trap. Conclusion: Gravid An. Gambiae s.s. females were visually deterred by the presence of the trapping device directly over the oviposition medium. Based on these investigations, an effective gravid trap was developed that provides open landing space for egg-laying Anopheles.	[Dugassa, Sisay; Mukabana, Wolfgang R.; Fillinger, Ulrike] Int Ctr Insect Physiol & Ecol, Mbita, Kenya; [Dugassa, Sisay; Oyieke, Florence; Mukabana, Wolfgang R.] Univ Nairobi, Sch Biol Sci, Nairobi, Kenya; [Lindh, Jenny M.] Royal Inst Technol, Stockholm, Sweden; [Lindsay, Steven W.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Fillinger, Ulrike] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England	International Centre of Insect Physiology & Ecology (ICIPE); University of Nairobi; Royal Institute of Technology; Durham University; University of London; London School of Hygiene & Tropical Medicine	Fillinger, U (corresponding author), Int Ctr Insect Physiol & Ecol, Thomas Odhiambo Campus, Mbita, Kenya.	ufillinger@mbita.icipe.org	Dugassa, Sisay/AAY-3749-2020	Dugassa, Sisay/0000-0002-6951-3299; Lindsay, Steve/0000-0002-3461-9050; Fillinger, Ulrike/0000-0002-4037-431X	African Regional Postgraduate Programme in Insect Sciences, International Centre of Insect Physiology and Ecology, Kenya (ARPPIS/icipe); National Institute of Health (NIH) [R01AI082537]; Research and Policy for Infectious Disease Dynamics (RAPIDD) Program of the Science and Technology Directory; Department of Homeland Security; Fogarty International Center, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082537] Funding Source: NIH RePORTER	African Regional Postgraduate Programme in Insect Sciences, International Centre of Insect Physiology and Ecology, Kenya (ARPPIS/icipe); National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research and Policy for Infectious Disease Dynamics (RAPIDD) Program of the Science and Technology Directory; Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SD was funded by the African Regional Postgraduate Programme in Insect Sciences, International Centre of Insect Physiology and Ecology, Kenya (ARPPIS/icipe). Research funds were provided through a National Institute of Health (NIH) grant no. R01AI082537 supporting the OviART project (Oviposition of Anopheles gambiae: Attractants, Residual Larvicides and Traps). SWL received support from the Research and Policy for Infectious Disease Dynamics (RAPIDD) Program of the Science and Technology Directory, Department of Homeland Security, and Fogarty International Center, National Institutes of Health. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	ALLAN SA, 1987, ANNU REV ENTOMOL, V32, P297, DOI 10.1146/annurev.en.32.010187.001501; Allan SA, 2004, J VECTOR ECOL, V29, P285; Andrianaivolambo L, 2010, ACTA TROP, V116, P240, DOI 10.1016/j.actatropica.2010.08.017; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Beier JC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S4; BENTLEY MD, 1989, ANNU REV ENTOMOL, V34, P401, DOI 10.1146/annurev.en.34.010189.002153; Bernath B, 2004, J EXP BIOL, V207, P755, DOI 10.1242/jeb.00810; Bernath B, 2008, VISION RES, V48, P1449, DOI 10.1016/j.visres.2008.04.007; Bernath B, 2012, J INSECT PHYSIOL, V58, P1000, DOI 10.1016/j.jinsphys.2012.05.004; BIDLINGMAYER WL, 1975, ANN ENTOMOL SOC AM, V68, P51, DOI 10.1093/aesa/68.1.51; Braks MAH, 2007, J VECTOR ECOL, V32, P83, DOI 10.3376/1081-1710(2007)32[83:IEOBGT]2.0.CO;2; BROWNE SM, 1981, J MED ENTOMOL, V18, P505, DOI 10.1093/jmedent/18.6.505; Collins LE, 2000, J VECTOR ECOL, V25, P127; Dennett JA, 2007, J AM MOSQUITO CONTR, V23, P359, DOI 10.2987/8756-971X(2007)23[359:DAUOTH]2.0.CO;2; Derua YA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-188; Dia I, 2005, J MED ENTOMOL, V42, P104, DOI 10.1603/0022-2585(2005)042[0104:COHCAO]2.0.CO;2; Dugassa S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-374; Duo-quan W, 2012, PLOS ONE, V7, DOI DOI 10.1371/J0URNAL.P0NE.0028988.PUBMED:22235256; Eguchi E., 1999, ATLAS ARTHROPOD RECE; Enayati A, 2009, SHRINKING MALARIA MA, P140; Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303; Ferguson HM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-158; Fillinger U, 2003, TROP MED INT HEALTH, V8, P37, DOI 10.1046/j.1365-3156.2003.00979.x; Fillinger U, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-20; Fillinger U, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-62; Gillies M. T., 1968, S A Inst med Res Johannesburg Publ, VNo. 54, P1; GILLIES M. T., 1958, ANN TROP MED AND PARASITOL, V52, P261; GILLIES MT, 1982, J MED ENTOMOL, V19, P68, DOI 10.1093/jmedent/19.1.68; Gimnig JE, 2001, J MED ENTOMOL, V38, P282, DOI 10.1603/0022-2585-38.2.282; Greenwood BM, 2008, TRENDS PARASITOL, V24, P449, DOI 10.1016/j.pt.2008.07.002; Harris C, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-125; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Hoel DF, 2011, J AM MOSQUITO CONTR, V27, P245, DOI 10.2987/11-6121.1; Huang J, 2005, MED VET ENTOMOL, V19, P442, DOI 10.1111/j.1365-2915.2005.00588.x; Huang J, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-88; Irish SR, 2013, T ROY SOC TROP MED H, V107, P15, DOI 10.1093/trstmh/trs001; Jarju LBS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-170; Kennedy JS, 1942, B ENTOMOL RES, V32, P271; Killeen GF, 2004, AM J TROP MED HYG, V71, P87, DOI 10.4269/ajtmh.2004.71.2_suppl.0700087; Knols BGJ, 2009, ACTA TROP, V112, P88, DOI 10.1016/j.actatropica.2009.06.010; Kweka EJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-82; LYIMO EO, 1993, MED VET ENTOMOL, V7, P328, DOI 10.1111/j.1365-2915.1993.tb00700.x; Mahande A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-100; Majambere S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-76; Malima RC, 2009, MED VET ENTOMOL, V23, P317, DOI 10.1111/j.1365-2915.2009.00837.x; Mboera LEG, 2000, J MED ENTOMOL, V37, P172, DOI 10.1603/0022-2585-37.1.172; MCCRAE AWR, 1984, ANN TROP MED PARASIT, V78, P307, DOI 10.1080/00034983.1984.11811821; Mendis K, 2009, TROP MED INT HEALTH, V14, P802, DOI 10.1111/j.1365-3156.2009.02287.x; Michaelakis A, 2007, PEST MANAG SCI, V63, P954, DOI 10.1002/ps.1418; Minakawa N, 2002, AM J TROP MED HYG, V67, P32, DOI 10.4269/ajtmh.2002.67.32; Minakawa N, 1999, AM J TROP MED HYG, V61, P1010, DOI 10.4269/ajtmh.1999.61.1010; Muirhead-Thomson R. C., 1958, Bulletin of the World Health Organization, V19, P1116; Mukabana WR, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-202; Munga S, 2005, J MED ENTOMOL, V42, P993, DOI 10.1603/0022-2585(2005)042[0993:OSPAEH]2.0.CO;2; Mutero CM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-21; Mutuku FM, 2006, AM J TROP MED HYG, V74, P54, DOI 10.4269/ajtmh.2006.74.54; Muturi EJ, 2007, J MED ENTOMOL, V44, P503, DOI 10.1603/0022-2585(2007)44[503:EOFSTF]2.0.CO;2; Ndiath MO, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-270; Odiere M, 2007, J MED ENTOMOL, V44, P14, DOI 10.1603/0022-2585(2007)44[14:SORAGA]2.0.CO;2; Oyewole I. O., 2007, Journal of Vector Borne Diseases, V44, P56; Qiu YT, 2007, J MED ENTOMOL, V44, P970, DOI 10.1603/0022-2585(2007)44[970:AOMTBW]2.0.CO;2; Reddy MR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-184; REITER P, 1983, MOSQ NEWS, V43, P496; REITER P, 1987, J AM MOSQUITO CONTR, V3, P325; REITER P, 1986, J AM MOSQUITO CONTR, V2, P209; Ritchie SA, 1984, MOSQ NEWS, P44; Russell CB, 2010, J AM MOSQUITO CONTR, V26, P119, DOI 10.2987/09-5905.1; Russell TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-80; Scott JJ, 2001, J AM MOSQUITO CONTR, V17, P142; Seavy Nathaniel E., 2005, U S Forest Service General Technical Report PSW, V191, P744; SERVICE MW, 1977, B ENTOMOL RES, V67, P343, DOI 10.1017/S0007485300011184; Stevenson J, 2012, EMERG INFECT DIS, V18, P1547, DOI 10.3201/eid1809.120283; Sumba, 2004, J CIRC RYTHMS, V2, P7; Sumba LA, 2008, J CHEM ECOL, V34, P1430, DOI 10.1007/s10886-008-9549-5; Takken W, 2002, TROP MED INT HEALTH, V7, P1022, DOI 10.1046/j.1365-3156.2002.00983.x; Team RDC, 2021, R LANG ENV STAT COMP; THOMSON RCM, 1945, B ENTOMOL RES, V36, P185, DOI 10.1017/S0007485300024020; Tirados I, 2006, MED VET ENTOMOL, V20, P425, DOI 10.1111/j.1365-2915.2006.652.x; van den Bijllaardt W, 2009, ACTA TROP, V111, P197, DOI 10.1016/j.actatropica.2009.04.003; Wachira SW, 2010, MED VET ENTOMOL, V24, P369, DOI 10.1111/j.1365-2915.2010.00913.x; Warburg A, 2011, J VECTOR ECOL, V36, P421, DOI 10.1111/j.1948-7134.2011.00183.x; WHO, 2006, WHO TECH REP SER, V936, P1; WHO, 2009, WHO TECH REP SER, V958, P1; WHO, 2012, WHOHTMNTDVEM20122; Williams GM, 2007, J VECTOR ECOL, V32, P285, DOI 10.3376/1081-1710(2007)32[285:COLTGT]2.0.CO;2; World Health Organization, 2004, WHOCDSCPEPVC200410	86	12	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68948	10.1371/journal.pone.0068948	http://dx.doi.org/10.1371/journal.pone.0068948			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861952	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000321425300082
J	Hamby, KA; Kwok, RS; Zalom, FG; Chiu, JC				Hamby, Kelly A.; Kwok, Rosanna S.; Zalom, Frank G.; Chiu, Joanna C.			Integrating Circadian Activity and Gene Expression Profiles to Predict Chronotoxicity of Drosophila suzukii Response to Insecticides	PLOS ONE			English	Article							SPOTTED-WING DROSOPHILA; DIPTERA DROSOPHILIDAE; DARK CYCLES; CLOCK GENE; LIGHT; RHYTHMS; ENTRAINMENT; TEMPERATURE; RESISTANCE; SUSCEPTIBILITY	Native to Southeast Asia, Drosophila suzukii (Matsumura) is a recent invader that infests intact ripe and ripening fruit, leading to significant crop losses in the U.S., Canada, and Europe. Since current D. suzukii management strategies rely heavily on insecticide usage and insecticide detoxification gene expression is under circadian regulation in the closely related Drosophila melanogaster, we set out to determine if integrative analysis of daily activity patterns and detoxification gene expression can predict chronotoxicity of D. suzukii to insecticides. Locomotor assays were performed under conditions that approximate a typical summer or winter day in Watsonville, California, where D. suzukii was first detected in North America. As expected, daily activity patterns of D. suzukii appeared quite different between 'summer' and 'winter' conditions due to differences in photoperiod and temperature. In the 'summer', D. suzukii assumed a more bimodal activity pattern, with maximum activity occurring at dawn and dusk. In the 'winter', activity was unimodal and restricted to the warmest part of the circadian cycle. Expression analysis of six detoxification genes and acute contact bioassays were performed at multiple circadian times, but only in conditions approximating Watsonville summer, the cropping season, when most insecticide applications occur. Five of the genes tested exhibited rhythmic expression, with the majority showing peak expression at dawn (ZT0, 6am). We observed significant differences in the chronotoxicity of D. suzukii towards malathion, with highest susceptibility at ZT0 (6am), corresponding to peak expression of cytochrome P450s that may be involved in bioactivation of malathion. High activity levels were not found to correlate with high insecticide susceptibility as initially hypothesized. Chronobiology and chronotoxicity of D. suzukii provide valuable insights for monitoring and control efforts, because insect activity as well as insecticide timing and efficacy are crucial considerations for pest management. However, field research is necessary for extrapolation to agricultural settings.	[Hamby, Kelly A.; Kwok, Rosanna S.; Zalom, Frank G.; Chiu, Joanna C.] Univ Calif Davis, Coll Agr & Environm Sci, Dept Entomol & Nematol, Davis, CA 95616 USA	University of California System; University of California Davis	Chiu, JC (corresponding author), Univ Calif Davis, Coll Agr & Environm Sci, Dept Entomol & Nematol, Davis, CA 95616 USA.	jcchiu@ucdavis.edu		Chiu, Joanna/0000-0001-7613-8127	CA Strawberry Commission [ST12-20]; NIH [R00 NS069542]; Clarence and Estelle Albaugh Endowment; NSF GRFP [2011129573]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS061952] Funding Source: NIH RePORTER	CA Strawberry Commission; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clarence and Estelle Albaugh Endowment; NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by CA Strawberry Commission grant ST12-20 to JCC and FGZ; NIH R00 NS069542 and Clarence and Estelle Albaugh Endowment to JCC. KAH is supported by NSF GRFP ID# 2011129573. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, AM ENTOMOL; Arthurs SP, 2007, BIOL CONTROL, V41, P99, DOI 10.1016/j.biocontrol.2007.01.001; Barrozo RB, 2004, BIOL RHYTHM RES, V35, P79, DOI 10.1080/09291010412331313250; Beaver LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050454; Beaver LM, 2010, TOXICOL SCI, V115, P513, DOI 10.1093/toxsci/kfq083; BECK STANLEY D., 1963, BULL ENTOMOL SOC AMER, V9, P8; Beers EH, 2011, PEST MANAG SCI, V67, P1386, DOI 10.1002/ps.2279; Bruck DJ, 2011, PEST MANAG SCI, V67, P1375, DOI 10.1002/ps.2242; Burrack HJ, 2013, PEST MANAG SCI, V69, P1173, DOI 10.1002/ps.3489; Calabria G, 2012, J APPL ENTOMOL, V136, P139, DOI 10.1111/j.1439-0418.2010.01583.x; California Department of Pesticide Regulation, 2011, SUMM PEST US REP DAT; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Chen WF, 2007, COLD SPRING HARB SYM, V72, P599, DOI 10.1101/sqb.2007.72.021; Chen WF, 2006, J BIOL RHYTHM, V21, P256, DOI 10.1177/0748730406289306; Chiu Joanna C, 2010, J Vis Exp, DOI 10.3791/2157; Cini A, 2012, B INSECTOL, V65, P149; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; COLE CL, 1964, SCIENCE, V144, P1148, DOI 10.1126/science.144.3622.1148; Collins BH, 2004, P NATL ACAD SCI USA, V101, P1945, DOI 10.1073/pnas.0308240100; Costa LG., 2008, CASARETT DOULLS TOXI, P883; Crosby DG, 2008, ENVIRON TOXICOL CHEM, P95; Currie J, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-49; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Daborn PJ, 2007, INSECT BIOCHEM MOLEC, V37, P512, DOI 10.1016/j.ibmb.2007.02.008; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Dalton DT, 2011, PEST MANAG SCI, V67, P1368, DOI 10.1002/ps.2280; Dubruille R, 2008, MOL NEUROBIOL, V38, P129, DOI 10.1007/s12035-008-8035-y; Eesa N. M., 1995, J ISLAMIC ACAD SCI, V8, P21; Feyereisen R, 2005, COMPREHENSEIVE MOL I, V4; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Gerghiou GP, 1983, PEST RESISTANCE PEST; Glaser FT, 2007, COLD SH Q B, V72, P233, DOI 10.1101/sqb.2007.72.046; Glossop NRJ, 2003, NEURON, V37, P249, DOI 10.1016/S0896-6273(03)00002-3; Goodhue RE, 2011, PEST MANAG SCI, V67, P1396, DOI 10.1002/ps.2259; HAMBLENCOYLE MJ, 1992, J INSECT BEHAV, V5, P417, DOI 10.1007/BF01058189; Hardin PE, 2005, CURR BIOL, V15, pR714, DOI 10.1016/j.cub.2005.08.019; Hauser M, 2011, PEST MANAG SCI, V67, P1352, DOI 10.1002/ps.2265; Haviland DR, 2012, J INTEGR PEST MANAG, V3, DOI 10.1603/IPM11034; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hooven LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006469; Hughes ME, 2012, GENOME RES, V22, P1266, DOI 10.1101/gr.128876.111; KANZAWA T., 1936, Journal of Plant Protection, V23, P66; Kanzawa T, 1936, J PLANT PROTECTION, V23, P127; Kanzawa T, 1939, ABSTR REV APPL ENT; Kanzawa T, 1936, J PLANT PROTECTION, V23, P183; Kanzawa T, 1936, REV APPL ENTOMOL, V24, P315; Kaushik R, 2007, PLOS BIOL, V5, P1257, DOI 10.1371/journal.pbio.0050146; Keegan KP, 2007, PLOS COMPUT BIOL, V3, P2087, DOI 10.1371/journal.pcbi.0030208; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; Lacey LA, 2008, ANNU REV ENTOMOL, V53, P121, DOI 10.1146/annurev.ento.53.103106.093419; Lavery DJ, 1999, MOL CELL BIOL, V19, P6488; Lee JC, 2012, J ECON ENTOMOL, V105, P1350, DOI 10.1603/EC12132; Lee JC, 2011, PEST MANAG SCI, V67, P1349, DOI 10.1002/ps.2271; Lee JC, 2011, PEST MANAG SCI, V67, P1358, DOI 10.1002/ps.2225; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Lin Y, 2002, P NATL ACAD SCI USA, V99, P9562, DOI 10.1073/pnas.132269699; Lorenzo MG, 1998, ACTA TROP, V70, P163, DOI 10.1016/S0001-706X(98)00025-4; Low KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049536; Low KH, 2008, NEURON, V60, P1054, DOI 10.1016/j.neuron.2008.10.048; Majercak J, 1999, NEURON, V24, P219, DOI 10.1016/S0896-6273(00)80834-X; Majercak J, 2004, MOL CELL BIOL, V24, P3359, DOI 10.1128/MCB.24.8.3359-3372.2004; McCart C, 2008, PEST MANAG SCI, V64, P639, DOI 10.1002/ps.1567; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Merlin C, 2009, SCIENCE, V325, P1700, DOI 10.1126/science.1176221; Misra JR, 2011, GENE DEV, V25, P1796, DOI 10.1101/gad.17280911; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Pedigo LP., 2009, ENTOMOLOGY PEST MANA; Perry T, 2011, INSECT BIOCHEM MOLEC, V41, P411, DOI 10.1016/j.ibmb.2011.03.003; Peschel N, 2009, CURR BIOL, V19, P241, DOI 10.1016/j.cub.2008.12.042; PICKEL C, 1994, J ECON ENTOMOL, V87, P1636, DOI 10.1093/jee/87.6.1636; Piechowicz Bartosz, 2012, Journal of Plant Protection Research, V52, P286, DOI 10.2478/v10045-012-0046-z; PITTENDRIGH CS, 1964, AM NAT, V98, P261, DOI 10.1086/282327; Rancourt B, 2000, J ECON ENTOMOL, V93, P1160, DOI 10.1603/0022-0493-93.4.1160; Rensing L, 2002, CHRONOBIOL INT, V19, P807, DOI 10.1081/CBI-120014569; Roberts T.R., 1998, METABOLIC PATHWAYS A, P360; Rodriguez J, 2013, P NATL ACAD SCI USA, V110, pE275, DOI 10.1073/pnas.1219969110; Russell TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-80; Scott JG, 1999, INSECT BIOCHEM MOLEC, V29, P757, DOI 10.1016/S0965-1748(99)00038-7; Sehadova H, 2009, NEURON, V64, P251, DOI 10.1016/j.neuron.2009.08.026; SHIPP E, 1976, ENTOMOL EXP APPL, V19, P163, DOI 10.1007/BF00345778; Smith S. C., 1994, Tropical Science, V34, P391; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Ueda HR, 2002, J BIOL CHEM, V277, P14048, DOI 10.1074/jbc.C100765200; US Department of Agriculture, 2009, NONC FRUITS NUTS 200; Vanin S, 2012, NATURE, V484, P371, DOI 10.1038/nature10991; Vincent C, 2000, ENTOMOL EXP APPL, V97, P347, DOI 10.1023/A:1004141002662; Walsh DB, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10010; WARE GW, 1980, J ECON ENTOMOL, V73, P15, DOI 10.1093/jee/73.1.15; WHEELER DA, 1993, J BIOL RHYTHM, V8, P67, DOI 10.1177/074873049300800106; Wijnen H, 2006, PLOS GENET, V2, P326, DOI 10.1371/journal.pgen.0020039; Willoughby L, 2006, INSECT BIOCHEM MOLEC, V36, P934, DOI 10.1016/j.ibmb.2006.09.004; Yoshii T, 2009, J BIOL RHYTHM, V24, P452, DOI 10.1177/0748730409348551; Zalom FG, 2006, ENCY PEST MANAGEMENT, V1, P1; Zhang EE, 2010, NAT REV MOL CELL BIO, V11, P764, DOI 10.1038/nrm2995; Zhu HS, 2008, PLOS BIOL, V6, P138, DOI 10.1371/journal.pbio.0060004	96	61	61	1	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68472	10.1371/journal.pone.0068472	http://dx.doi.org/10.1371/journal.pone.0068472			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861907	Green Published, gold, Green Submitted			2022-12-27	WOS:000321425300063
J	Hernandez-Rodriguez, CS; Hernandez-Martinez, P; Van Rie, J; Escriche, B; Ferre, J				Sara Hernandez-Rodriguez, Carmen; Hernandez-Martinez, Patricia; Van Rie, Jeroen; Escriche, Baltasar; Ferre, Juan			Shared Midgut Binding Sites for Cry1A. 105, Cry1Aa, Cry1Ab, Cry1Ac and Cry1Fa Proteins from Bacillus thuringiensis in Two Important Corn Pests, Ostrinia nubilalis and Spodoptera frugiperda	PLOS ONE			English	Article							BRUSH-BORDER MEMBRANE; INSECT RESISTANCE MANAGEMENT; DOMAIN-III; DELTA-ENDOTOXINS; CROSS-RESISTANCE; PLUTELLA-XYLOSTELLA; CRYSTAL PROTEINS; LEPIDOPTERA CRAMBIDAE; SUSCEPTIBLE STRAINS; HUBNER LEPIDOPTERA	First generation of insect-protected transgenic corn (Bt-corn) was based on the expression of Cry1Ab or Cry1Fa proteins. Currently, the trend is the combination of two or more genes expressing proteins that bind to different targets. In addition to broadening the spectrum of action, this strategy helps to delay the evolution of resistance in exposed insect populations. One of such examples is the combination of Cry1A. 105 with Cry1Fa and Cry2Ab to control O. nubilalis and S. frugiperda. Cry1A. 105 is a chimeric protein with domains I and II and the C-terminal half of the protein from Cry1Ac, and domain III almost identical to Cry1Fa. The aim of the present study was to determine whether the chimeric Cry1A. 105 has shared binding sites either with Cry1A proteins, with Cry1Fa, or with both, in O. nubilalis and in S. frugiperda. Brush-border membrane vesicles (BBMV) from last instar larval midguts were used in competition binding assays with I-125-labeled Cry1A. 105, Cry1Ab, and Cry1Fa, and unlabeled Cry1A. 105, Cry1Aa, Cry1Ab, Cry1Ac, Cry1Fa, Cry2Ab and Cry2Ae. The results showed that Cry1A. 105, Cry1Ab, Cry1Ac and Cry1Fa competed with high affinity for the same binding sites in both insect species. However, Cry2Ab and Cry2Ae did not compete for the binding sites of Cry1 proteins. Therefore, according to our results, the development of cross-resistance among Cry1Ab/Ac, Cry1A. 105, and Cry1Fa proteins is possible in these two insect species if the alteration of shared binding sites occurs. Conversely, cross-resistance between these proteins and Cry2A proteins is very unlikely in such case.	[Sara Hernandez-Rodriguez, Carmen; Hernandez-Martinez, Patricia; Escriche, Baltasar; Ferre, Juan] Univ Valencia, Dept Genet, E-46100 Burjassot, Spain; [Van Rie, Jeroen] Bayer CropSci NV, Ghent, Belgium	University of Valencia; Bayer AG; Bayer CropScience	Ferre, J (corresponding author), Univ Valencia, Dept Genet, E-46100 Burjassot, Spain.	Juan.Ferre@uv.es	Ferré, Juan/L-9426-2014; Patricia, Hernandez-Martinez/Q-3082-2019; Hernandez Rodriguez, C Sara Hernández-Rodríguez/J-6739-2012; Escriche, Baltasar/N-5136-2014	Ferré, Juan/0000-0001-5535-0612; Patricia, Hernandez-Martinez/0000-0002-3263-5786; Hernandez Rodriguez, C Sara Hernández-Rodríguez/0000-0002-1234-1190; Escriche, Baltasar/0000-0003-4889-793X	Bayer CropScience	Bayer CropScience(Bayer AG)	Funding for this study was provided by Bayer CropScience. JVR is employed by Bayer CropScience and JF provides consultancy services to this company. Bayer Cropscience provided plasmids for this study. Bayer may hold patents covering some of the material described herein or their uses. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ballester V, 1999, APPL ENVIRON MICROB, V65, P1413; Bates SL, 2005, NAT BIOTECHNOL, V23, P57, DOI 10.1038/nbt1056; BELL RA, 1976, ANN ENTOMOL SOC AM, V69, P365, DOI 10.1093/aesa/69.2.365; BOSCH D, 1994, BIO-TECHNOL, V12, P915, DOI 10.1038/nbt0994-915; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bravo A, 1997, J BACTERIOL, V179, P2793, DOI 10.1128/jb.179.9.2793-2801.1997; Caccia S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009975; Coates BS, 2011, GENETICA, V139, P961, DOI 10.1007/s10709-011-9590-0; Crespo ALB, 2011, J INVERTEBR PATHOL, V107, P185, DOI 10.1016/j.jip.2011.04.007; de Maagd RA, 2001, TRENDS GENET, V17, P193, DOI 10.1016/S0168-9525(01)02237-5; de Maagd RA, 1999, MOL MICROBIOL, V31, P463, DOI 10.1046/j.1365-2958.1999.01188.x; deMaagd RA, 1996, APPL ENVIRON MICROB, V62, P1537, DOI 10.1128/AEM.62.5.1537-1543.1996; DENOLF P, 1993, APPL ENVIRON MICROB, V59, P1828, DOI 10.1128/AEM.59.6.1828-1837.1993; Environmental Protection Agency, 2010, BACILLUS THURINGIENS; Environmental Protection Agency, 2009, MON 89034 X TC1507 X; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; FERRE J, 1991, P NATL ACAD SCI USA, V88, P5119, DOI 10.1073/pnas.88.12.5119; Ferre Juan, 2008, V5, P41; Finney D.J., 1971, PROBIT ANAL; Gomez I, 2006, J BIOL CHEM, V281, P34032, DOI 10.1074/jbc.M604721200; Gonzalez-Cabrera J, 2003, INSECT BIOCHEM MOLEC, V33, P929, DOI 10.1016/S0965-1748(03)00099-7; Gonzalez-Cabrera J., 2006, APPL ENVIRON MICROB, V59, P1828; Gouffon C, 2011, APPL ENVIRON MICROB, V77, P3182, DOI 10.1128/AEM.02791-10; GOULD F, 1995, J ECON ENTOMOL, V88, P1545, DOI 10.1093/jee/88.6.1545; Granero F, 1996, BIOCHEM BIOPH RES CO, V224, P779, DOI 10.1006/bbrc.1996.1099; Hernandez CS, 2005, APPL ENVIRON MICROB, V71, P5627, DOI 10.1128/AEM.71.9.5627-5629.2005; Hernandez-Martinez P, 2012, APPL ENVIRON MICROB, V78, P6759, DOI 10.1128/AEM.01689-12; Hernandez-Rodriguez CS, 2012, APPL ENVIRON MICROB, V78, P4048, DOI 10.1128/AEM.07591-11; Herrero S, 2004, BIOCHEM J, V384, P507, DOI 10.1042/BJ20041094; Herrero S, 2002, APPL ENVIRON MICROB, V68, P4090, DOI 10.1128/AEM.68.8.4090-4094.2002; Hua G, 2001, APPL ENVIRON MICROB, V67, P872, DOI 10.1128/AEM.67.2.872-879.2001; Jakka SRK, 2011, P 2011 INT C INV PAT; Jurat-Fuentes JL, 2002, APPL ENVIRON MICROB, V68, P5711, DOI 10.1128/AEM.68.11.5711-5717.2002; Jurat-Fuentes JL, 2001, APPL ENVIRON MICROB, V67, P323, DOI 10.1128/AEM.67.1.323-329.2001; LEE MK, 1995, APPL ENVIRON MICROB, V61, P3836, DOI 10.1128/AEM.61.11.3836-3842.1995; LEE MK, 1995, BIOCHEM BIOPH RES CO, V216, P306, DOI 10.1006/bbrc.1995.2625; Li HR, 2004, BIOCHEM BIOPH RES CO, V323, P52, DOI 10.1016/j.bbrc.2004.08.054; Luo K, 1999, APPL ENVIRON MICROB, V65, P457; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Oppert B, 2010, J STORED PROD RES, V46, P143, DOI 10.1016/j.jspr.2010.01.003; Pereira EJG, 2008, ENTOMOL EXP APPL, V126, P115, DOI 10.1111/j.1570-7458.2007.00642.x; Pereira EJG, 2010, J INVERTEBR PATHOL, V103, P1, DOI 10.1016/j.jip.2009.08.014; Rang C, 2004, CURR MICROBIOL, V49, P22, DOI 10.1007/s00284-003-4258-3; Roush RT, 1998, PHILOS T R SOC B, V353, P1777, DOI 10.1098/rstb.1998.0330; Hernandez-Rodriguez CS, 2008, APPL ENVIRON MICROB, V74, P7654, DOI 10.1128/AEM.01373-08; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Sena JAD, 2009, APPL ENVIRON MICROB, V75, P2236, DOI 10.1128/AEM.02342-08; Shelton AM, 2002, ANNU REV ENTOMOL, V47, P845, DOI 10.1146/annurev.ento.47.091201.145309; Siqueira HAA, 2004, J ECON ENTOMOL, V97, P1049, DOI 10.1603/0022-0493(2004)097[1049:COCONL]2.0.CO;2; Siqueira HAA, 2006, APPL ENVIRON MICROB, V72, P5318, DOI 10.1128/AEM.00219-06; Storer Nicholas P, 2012, GM Crops Food, V3, P154, DOI 10.4161/gmcr.20945; Storer NP, 2012, J INVERTEBR PATHOL, V110, P294, DOI 10.1016/j.jip.2012.04.007; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Tabashnik BE, 1997, P NATL ACAD SCI USA, V94, P1640, DOI 10.1073/pnas.94.5.1640; Tabashnik BE, 1997, P NATL ACAD SCI USA, V94, P12780, DOI 10.1073/pnas.94.24.12780; TABASHNIK BE, 1994, APPL ENVIRON MICROB, V60, P4627, DOI 10.1128/AEM.60.12.4627-4629.1994; Thompson M A, 1995, Genet Eng (N Y), V17, P99; Vachon V, 2012, J INVERTEBR PATHOL, V111, P1, DOI 10.1016/j.jip.2012.05.001; VAECK M, 1987, NATURE, V328, P33, DOI 10.1038/328033a0; VANRIE J, 1989, EUR J BIOCHEM, V186, P239, DOI 10.1111/j.1432-1033.1989.tb15201.x; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; Wu XY, 2009, J INVERTEBR PATHOL, V100, P29, DOI 10.1016/j.jip.2008.10.003; Wyniger R, 1974, INSEKTENZUCHT METHOD; Zhao JZ, 2003, NAT BIOTECHNOL, V21, P1493, DOI 10.1038/nbt907	64	96	102	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68164	10.1371/journal.pone.0068164	http://dx.doi.org/10.1371/journal.pone.0068164			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861865	Green Submitted, Green Published, gold			2022-12-27	WOS:000321425300046
J	Seymour, RS				Seymour, Roger S.			Maximal Aerobic and Anaerobic Power Generation in Large Crocodiles versus Mammals: Implications for Dinosaur Gigantothermy	PLOS ONE			English	Article							STANDARD METABOLIC-RATE; TERRESTRIAL LOCOMOTION; AMERICAN ALLIGATOR; BODY TEMPERATURES; CROCODYLUS; GLYCOLYSIS; MASS; THERMOREGULATION; ENDOTHERMY; DEPENDENCE	Inertial homeothermy, the maintenance of a relatively constant body temperature that occurs simply because of large size, is often applied to large dinosaurs. Moreover, biophysical modelling and actual measurements show that large crocodiles can behaviourally achieve body temperatures above 30 degrees C. Therefore it is possible that some dinosaurs could achieve high and stable body temperatures without the high energy cost of typical endotherms. However it is not known whether an ectothermic dinosaur could produce the equivalent amount of muscular power as an endothermic one. To address this question, this study analyses maximal power output from measured aerobic and anaerobic metabolism in burst exercising estuarine crocodiles, Crocodylus porosus, weighing up to 200 kg. These results are compared with similar data from endothermic mammals. A 1 kg crocodile at 30 degrees C produces about 16 watts from aerobic and anaerobic energy sources during the first 10% of exhaustive activity, which is 57% of that expected for a similarly sized mammal. A 200 kg crocodile produces about 400 watts, or only 14% of that for a mammal. Phosphocreatine is a minor energy source, used only in the first seconds of exercise and of similar concentrations in reptiles and mammals. Ectothermic crocodiles lack not only the absolute power for exercise, but also the endurance, that are evident in endothermic mammals. Despite the ability to achieve high and fairly constant body temperatures, therefore, large, ectothermic, crocodile-like dinosaurs would have been competitively inferior to endothermic, mammal-like dinosaurs with high aerobic power. Endothermy in dinosaurs is likely to explain their dominance over mammals in terrestrial ecosystems throughout the Mesozoic.	Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia	University of Adelaide	Seymour, RS (corresponding author), Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia.	roger.seymour@adelaide.edu.au			Australian Research Council [LP0882478]	Australian Research Council(Australian Research Council)	Supported by the Australian Research Council grant LP0882478. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RM, 1998, PALAEONTOLOGY, V41, P1231; BALDWIN J, 1995, COMP BIOCHEM PHYS A, V112, P285, DOI 10.1016/0300-9629(95)00100-X; Barbosa LA, 2006, PHYSICA A, V359, P547, DOI 10.1016/j.physa.2005.06.050; Bennett A.F., 1982, Biology of Reptilia, V13, P155; BENNETT AF, 1972, J COMP PHYSIOL, V81, P277, DOI 10.1007/BF00693632; BENNETT AF, 1985, J EXP BIOL, V118, P161; BENNETT AF, 1979, SCIENCE, V206, P649, DOI 10.1126/science.493968; Benton MJ, 2009, CURR BIOL, V19, pR318, DOI 10.1016/j.cub.2009.02.003; Brazaitis P, 2011, HIST BIOL, V23, P73, DOI 10.1080/08912963.2011.560723; Brusatte S.L., 2012, DINOSAUR PALEOBIOLOG; Coulson R.A., 1974, P217; COULSON RA, 1986, COMP BIOCHEM PHYS A, V84, P673, DOI 10.1016/0300-9629(86)90385-3; di Prampero PE, 1999, RESP PHYSIOL, V118, P103, DOI 10.1016/S0034-5687(99)00083-3; Dodson P, 2003, ANAT REC PART A, V274A, P887, DOI 10.1002/ar.a.10098; Donovan ER, 2001, J EXP BIOL, V204, P4099; ELSE PL, 1985, J COMP PHYSIOL B, V156, P3, DOI 10.1007/BF00692920; Eme J, 2009, J COMP PHYSIOL B, V179, P921, DOI 10.1007/s00360-009-0374-0; Emshwiller MG, 1997, J HERPETOL, V31, P142, DOI 10.2307/1565346; FARLOW JO, 1995, ANNU REV ECOL SYST, V26, P445, DOI 10.1146/annurev.es.26.110195.002305; Farmer CG, 2010, SCIENCE, V327, P338, DOI 10.1126/science.1180219; Farmer CG, 2000, J EXP BIOL, V203, P1671; Farmer CG, 2000, RESP PHYSL, V120, P67; Garland Jr T, 1983, AM J PHYSIOL-REG I, V247, pR806; GARLAND T, 1983, J ZOOL, V199, P157, DOI 10.1111/j.1469-7998.1983.tb02087.x; GATTEN RE, 1991, J HERPETOL, V25, P406, DOI 10.2307/1564761; GATTEN RE, 1981, J EXP ZOOL, V216, P377, DOI 10.1002/jez.1402160305; Gillooly JF, 2006, PLOS BIOL, V4, P1467, DOI 10.1371/journal.pbio.0040248; Grigg GC, 1998, P ROY SOC B-BIOL SCI, V265, P1793, DOI 10.1098/rspb.1998.0504; HERNANDEZ T, 1980, COMP BIOCHEM PHYS A, V67, P283, DOI 10.1016/0300-9629(80)90278-9; HIRVONEN J, 1987, EUR J APPL PHYSIOL O, V56, P253, DOI 10.1007/BF00690889; Horner JR, 2001, PALEOBIOLOGY, V27, P39, DOI 10.1666/0094-8373(2001)027<0039:COOSEA>2.0.CO;2; Hulbert AJ, 2000, ANNU REV PHYSIOL, V62, P207, DOI 10.1146/annurev.physiol.62.1.207; Janke A, 2001, P ROY SOC B-BIOL SCI, V268, P623, DOI 10.1098/rspb.2000.1402; KUSHMERICK MJ, 1992, P NATL ACAD SCI USA, V89, P7521, DOI 10.1073/pnas.89.16.7521; Lang J.W., 1987, P273; Lee MSY, 2001, CONTRIB ZOOL, V70, P1; McNab BK, 2009, P NATL ACAD SCI USA, V106, P12184, DOI 10.1073/pnas.0904000106; Moxnes JF, 2012, THEOR BIOL MED MODEL, V9, DOI 10.1186/1742-4682-9-7; Munns SL, 2005, J EXP BIOL, V208, P3331, DOI 10.1242/jeb.01758; O'Connor MP, 1999, PALEOBIOLOGY, V25, P341, DOI 10.1017/S0094837300021321; O'Connor MP, 1999, J THERM BIOL, V24, P113, DOI 10.1016/S0306-4565(98)00046-1; Owerkowicz T, 2008, COMP BIOCHEM PHYS A, V150, P211, DOI 10.1016/j.cbpa.2008.04.594; PALADINO FV, 1990, NATURE, V344, P858, DOI 10.1038/344858a0; Reid R.E.H., 1997, P449; Rich PR, 2003, BIOCHEM SOC T, V31, P1095; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Ruben JA, 2012, COMPLETE DINOSAUR, P785; Seebacher F, 1999, J EXP BIOL, V202, P77; Seebacher F, 2003, PALEOBIOLOGY, V29, P105, DOI 10.1666/0094-8373(2003)029<0105:DBTTOO>2.0.CO;2; Seymour RS, 2013, J COMP PHYSIOL B, V183, P491, DOI 10.1007/s00360-012-0732-1; Seymour RS, 2012, P ROY SOC B-BIOL SCI, V279, P451, DOI 10.1098/rspb.2011.0968; Seymour RS, 2004, PHYSIOL BIOCHEM ZOOL, V77, P1051, DOI 10.1086/422766; Spotila J.R., 1991, Modern Geology, V16, P203; SPOTILA JR, 1973, AM NAT, V107, P391, DOI 10.1086/282842; TAYLOR CR, 1981, RESP PHYSIOL, V44, P25, DOI 10.1016/0034-5687(81)90075-X; VALBERG S, 1989, EQUINE VET J, V21, P91, DOI 10.1111/j.2042-3306.1989.tb02102.x; WEBB G J W, 1982, Records of the Australian Museum, V34, P607; Webb G.J.W., 1987, P107; Weibel ER, 2004, RESP PHYSIOL NEUROBI, V140, P115, DOI 10.1016/j.resp.2004.01.006; White CR, 2006, BIOL LETTERS, V2, P125, DOI 10.1098/rsbl.2005.0378; WITHERS PC, 1992, COMP ANIMAL PHYSL; WRIGHT JC, 1986, PHYSIOL ZOOL, V59, P505, DOI 10.1086/physzool.59.5.30156114	62	23	23	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e69361	10.1371/journal.pone.0069361	http://dx.doi.org/10.1371/journal.pone.0069361			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861968	Green Published, Green Submitted, gold			2022-12-27	WOS:000321425300085
J	Anandakrishnan, R; Baker, C; Izadi, S; Onufriev, AV				Anandakrishnan, Ramu; Baker, Charles; Izadi, Saeed; Onufriev, Alexey V.			Point Charges Optimally Placed to Represent the Multipole Expansion of Charge Distributions	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; DERIVING ATOMIC CHARGES; GAUSSIAN-BASIS SETS; ELECTROSTATIC POTENTIALS; WATER; ALGORITHM; DENSITY; BORON; AMBER	We propose an approach for approximating electrostatic charge distributions with a small number of point charges to optimally represent the original charge distribution. By construction, the proposed optimal point charge approximation (OPCA) retains many of the useful properties of point multipole expansion, including the same far-field asymptotic behavior of the approximate potential. A general framework for numerically computing OPCA, for any given number of approximating charges, is described. We then derive a 2-charge practical point charge approximation, PPCA, which approximates the 2-charge OPCA via closed form analytical expressions, and test the PPCA on a set of charge distributions relevant to biomolecular modeling. We measure the accuracy of the new approximations as the RMS error in the electrostatic potential relative to that produced by the original charge distribution, at a distance (2) over tilde x the extent of the charge distribution-the mid-field. The error for the 2-charge PPCA is found to be on average 23% smaller than that of optimally placed point dipole approximation, and comparable to that of the point quadrupole approximation. The standard deviation in RMS error for the 2-charge PPCA is 53% lower than that of the optimal point dipole approximation, and comparable to that of the point quadrupole approximation. We also calculate the 3-charge OPCA for representing the gas phase quantum mechanical charge distribution of a water molecule. The electrostatic potential calculated by the 3-charge OPCA for water, in the mid-field (2.8 angstrom from the oxygen atom), is on average 33.3% more accurate than the potential due to the point multipole expansion up to the octupole order. Compared to a 3 point charge approximation in which the charges are placed on the atom centers, the 3-charge OPCA is seven times more accurate, by RMS error. The maximum error at the oxygen-Na distance (2.23 angstrom) is half that of the point multipole expansion up to the octupole order.	[Anandakrishnan, Ramu; Onufriev, Alexey V.] Virginia Tech, Dept Comp Sci, Blacksburg, VA 24061 USA; [Baker, Charles] Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; [Izadi, Saeed] Virginia Tech, Dept Engn Sci & Mech, Blacksburg, VA USA; [Onufriev, Alexey V.] Virginia Tech, Dept Phys, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Harvard University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Onufriev, AV (corresponding author), Virginia Tech, Dept Comp Sci, Blacksburg, VA 24061 USA.	alexey@cs.vt.edu	Anandakrishnan, Ramu/AAB-9040-2020	Anandakrishnan, Ramu/0000-0003-0422-3984; Onufriev, Alexey/0000-0002-4930-6612	National Institute of Health [GM076121]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076121] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of Health (grant number GM076121 to AO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandakrishnan R, 2011, J CHEM THEORY COMPUT, V7, P544, DOI 10.1021/ct100390b; Anandakrishnan R, 2010, J COMPUT CHEM, V31, P691, DOI 10.1002/jcc.21357; Ball P., 1999, LIFES MATRIX BIOGRAP; Basdevant N, 2007, J PHYS CHEM B, V111, P9390, DOI 10.1021/jp0727190; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Bishop TC, 1997, J COMPUT CHEM, V18, P1785, DOI 10.1002/(SICI)1096-987X(19971115)18:14<1785::AID-JCC7>3.0.CO;2-G; BRENEMAN CM, 1990, J COMPUT CHEM, V11, P361, DOI 10.1002/jcc.540110311; Cai W, 2007, J COMPUT PHYS, V223, P846, DOI 10.1016/j.jcp.2006.10.019; CARRIER J, 1988, SIAM J SCI STAT COMP, V9, P669, DOI 10.1137/0909044; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen JH, 2008, CURR OPIN STRUC BIOL, V18, P140, DOI 10.1016/j.sbi.2008.01.003; Cheng H, 1999, J COMPUT PHYS, V155, P468, DOI 10.1006/jcph.1999.6355; CHIRLIAN LE, 1987, J COMPUT CHEM, V8, P894, DOI 10.1002/jcc.540080616; CLOUGH SA, 1973, J CHEM PHYS, V59, P2254, DOI 10.1063/1.1680328; COLONNA F, 1992, J COMPUT CHEM, V13, P1234, DOI 10.1002/jcc.540131007; Cruz FA, 2009, INT J NUMER METH ENG, V79, P1577, DOI 10.1002/nme.2611; Dill KA, 2005, ANNU REV BIOPH BIOM, V34, P173, DOI 10.1146/annurev.biophys.34.040204.144517; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; Franks F., 2000, WATER MATRIX LIFE; Freddolino PL, 2006, STRUCTURE, V14, P437, DOI 10.1016/j.str.2005.11.014; Gordon JC, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2956499; Gramada A, 2011, COMPUT PHYS COMMUN, V182, P1455, DOI 10.1016/j.cpc.2011.03.014; Gramada A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.066601; GREENGARD L, 1987, J COMPUT PHYS, V73, P325, DOI 10.1016/0021-9991(87)90140-9; Greengard L., 1997, Acta Numerica, V6, P229, DOI 10.1017/S0962492900002725; Guillot B, 2002, J MOL LIQ, V101, P219, DOI 10.1016/S0167-7322(02)00094-6; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ichiye T, 2006, J CHEM PHYS, V124; Izvekov S, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2038787; Izvekov S, 2005, J PHYS CHEM B, V109, P2469, DOI 10.1021/jp044629q; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Kale S, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3688228; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; KELL GS, 1975, J CHEM ENG DATA, V20, P97, DOI 10.1021/je60064a005; KENDALL RA, 1992, J CHEM PHYS, V96, P6796, DOI 10.1063/1.462569; Koumoutsakos P, 1995, 96N25344 NASA AM RES; Lambert CG, 1996, J COMPUT PHYS, V126, P274, DOI 10.1006/jcph.1996.0137; LEE FS, 1992, J CHEM PHYS, V97, P3100, DOI 10.1063/1.462997; Mark P, 2001, J PHYS CHEM A, V105, P9954, DOI 10.1021/jp003020w; Mukhopadhyay A, 2012, J PHYS CHEM B, V116, P9776, DOI 10.1021/jp305226j; Niu SQ, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3569563; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Platt DE, 1996, J COMPUT CHEM, V17, P358, DOI 10.1002/(SICI)1096-987X(199602)17:3<358::AID-JCC10>3.0.CO;2-G; Pollock EL, 1995, COMMENTS PPPM FMM EW; Salsbury FR, 2010, CURR OPIN PHARMACOL, V10, P738, DOI 10.1016/j.coph.2010.09.016; Schlick T., 2010, MOL MODELING SIMULAT, V2nd ed.; SCHMIDT KE, 1991, J STAT PHYS, V63, P1223, DOI 10.1007/BF01030008; Sigfridsson E, 1998, J COMPUT CHEM, V19, P377, DOI 10.1002/(SICI)1096-987X(199803)19:4<377::AID-JCC1>3.0.CO;2-P; STONE AJ, 1985, MOL PHYS, V56, P1047, DOI 10.1080/00268978500102891; STONE AJ, 1981, CHEM PHYS LETT, V83, P233, DOI 10.1016/0009-2614(81)85452-8; Swart M, 2001, J COMPUT CHEM, V22, P79, DOI 10.1002/1096-987X(20010115)22:1<79::AID-JCC8>3.0.CO;2-B; TAIT MJ, 1971, NATURE, V230, P91, DOI 10.1038/230091a0; Te JA, 2010, CHEM PHYS LETT, V499, P219, DOI 10.1016/j.cplett.2010.09.043; Tu YQ, 2000, CHEM PHYS LETT, V329, P283, DOI 10.1016/S0009-2614(00)01026-5; Walsh TR, 2009, J COMPUT CHEM, V30, P893, DOI 10.1002/jcc.21111; WOON DE, 1995, J CHEM PHYS, V103, P4572, DOI 10.1063/1.470645; Wu YJ, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2136877; Ying LX, 2006, J COMPUT PHYS, V213, P451, DOI 10.1016/j.jcp.2005.09.010	58	21	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67715	10.1371/journal.pone.0067715	http://dx.doi.org/10.1371/journal.pone.0067715			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861790	gold, Green Published, Green Submitted			2022-12-27	WOS:000323350700028
J	Figarska, SM; Vonk, JM; van Diemen, CC; Postma, DS; Boezen, HM				Figarska, Sylwia M.; Vonk, Judith M.; van Diemen, Cleo C.; Postma, Dirkje S.; Boezen, H. Marike			ADAM33 Gene Polymorphisms and Mortality. A Prospective Cohort Study	PLOS ONE			English	Article							LUNG-FUNCTION; ASTHMA; SUSCEPTIBILITY; ASSOCIATION; DISEASE; DISINTEGRIN; POPULATION; AIRWAYS	The ADAM33 gene is associated with the pathophysiology of Chronic Obstructive Pulmonary Disease (COPD) and atherosclerosis. In this study we investigated all-cause, COPD and cardiovascular mortality, in relation to single nucleotide polymorphisms (SNPs) in ADAM33 (Q_1, S_1, S_2, T_1 and T_2) that were genotyped in 1,390 subjects from the Vlagtwedde/Vlaardingen cohort. Participants were examined at entry in 1989/1990 and followed up till evaluation of the vital status on December 31st, 2008. Using Cox proportional hazards regression we estimated the risk of the SNPs in relation to mortality, adjusting for gender, age, FEV1, height, place of residence and packyears of smoking. Additionally, we performed stratified analyses according to gender and smoking habits. After 18 years, 284 (20.4%) subjects had died (107 due to cardiovascular disease and 20 due to COPD). Individuals homozygous for the minor allele of SNP T_2 had an increased risk of all-cause and cardiovascular mortality compared to wild types: hazard ratio 3.6 (95% confidence interval 2.0 to 6.7) and 3.4 (1.2 to 9.5) respectively. Individuals homozygous for the minor allele of S_1, S_2, T_2 or Q_1 had a significantly increased risk of COPD mortality. In stratified analyses the risk of all-cause mortality associated with SNP T_2 did not change: females 3.5 (1.5 to 8.3), males 3.1 (1.2 to 7.6), never smokers 3.8 (0.9 to 16.3), ever smokers 3.6 (1.8 to 7.2). This study shows for the first time that ADAM33 is a pleiotropic gene that is associated with all-cause, COPD and cardiovascular mortality, independent of potential confounders.	[Figarska, Sylwia M.; Vonk, Judith M.; Boezen, H. Marike] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [van Diemen, Cleo C.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands; [Figarska, Sylwia M.; Vonk, Judith M.; Postma, Dirkje S.; Boezen, H. Marike] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma & COPD, NL-9713 AV Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Boezen, HM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.	h.m.boezen@umcg.nl	Vonk, Judith M/ABA-3009-2020; Vonk, Judith/K-8477-2019	Vonk, Judith M/0000-0001-7531-4547; Vonk, Judith/0000-0001-7531-4547; van Diemen, Cleo/0000-0001-9283-2207; Figarska, Sylwia/0000-0003-3601-1548	Graduate School for Drug Exploration (GUIDE), University Medical Center Groningen, University of Groningen, The Netherlands; Netherlands Asthma Foundation [3.2.02.51]; Stichting Astma Bestrijding [2005/020]	Graduate School for Drug Exploration (GUIDE), University Medical Center Groningen, University of Groningen, The Netherlands; Netherlands Asthma Foundation; Stichting Astma Bestrijding	This work was supported by the Graduate School for Drug Exploration (GUIDE), University Medical Center Groningen, University of Groningen, The Netherlands. The Vlagtwedde\Vlaardingen study was supported by unrestricted grants of the Netherlands Asthma Foundation (grant number 3.2.02.51) and Stichting Astma Bestrijding (grant number 2005/020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Blagosklonny MV, 2010, AGING-US, V2, P177, DOI 10.18632/aging.100139; Blakey JD, 2009, THORAX, V64, P381, DOI 10.1136/thx.2008.102053; Butcher SK, 2004, AGING CELL, V3, P151, DOI 10.1111/j.1474-9728.2004.00103.x; Chen C, 2006, MOL CELL BIOL, V26, P6950, DOI 10.1128/MCB.00646-06; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Gosman MME, 2007, THORAX, V62, P242, DOI 10.1136/thx.2006.060988; Haitchi HM, 2005, AM J RESP CRIT CARE, V171, P958, DOI 10.1164/rccm.200409-1251OC; Holgate ST, 2010, DRUG NEWS PERSPECT, V23, P381, DOI 10.1358/dnp.2010.23.6.1437242; Holloway JW, 2010, ATHEROSCLEROSIS, V211, P224, DOI 10.1016/j.atherosclerosis.2010.02.023; Korytina G F, 2012, Mol Biol (Mosk), V46, P487; Lao JI, 2005, ANN NY ACAD SCI, V1057, P50, DOI 10.1196/annals.1356.003; Lee YH, 2012, INFLAMM RES, V61, P1355, DOI 10.1007/s00011-012-0536-5; Naumova E, 2004, EXP GERONTOL, V39, P637, DOI 10.1016/j.exger.2003.08.014; Puxeddu I, 2008, J ALLERGY CLIN IMMUN, V121, P1400, DOI 10.1016/j.jaci.2008.03.003; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Sadeghnejad A, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-21; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Simpson A, 2005, AM J RESP CRIT CARE, V172, P55, DOI 10.1164/rccm.200412-1708OC; Streiner DL, 2011, CHEST, V140, P16, DOI 10.1378/chest.11-0523; Swindell WR, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-55; Tripathi P, 2012, ANN HUM BIOL, V39, P479, DOI 10.3109/03014460.2012.716451; van Diemen CC, 2005, AM J RESP CRIT CARE, V172, P329, DOI 10.1164/rccm.200411-1486OC; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878	24	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67768	10.1371/journal.pone.0067768	http://dx.doi.org/10.1371/journal.pone.0067768			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861802	Green Published, Green Submitted, gold			2022-12-27	WOS:000323350700033
J	Palavesam, A; Esnault, C; O'Brochta, DA				Palavesam, Azhahianambi; Esnault, Caroline; O'Brochta, David A.			Post-Integration Silencing of piggyBac Transposable Elements in Aedes aegypti	PLOS ONE			English	Article							INSERTIONAL MUTAGENESIS; TRIBOLIUM-CASTANEUM; ANOPHELES-GAMBIAE; DNA TRANSPOSONS; GENE-TRANSFER; VECTOR; EXPRESSION; TRANSFORMATION; EVOLUTION; GENOME	The piggyBac transposon, originating in the genome of the Lepidoptera Trichoplusia ni, has a broad host range, making it useful for the development of a number of transposon-based functional genomic technologies including gene vectors, enhancer-, gene- and protein-traps. While capable of being used as a vector for the creation of transgenic insects and insect cell lines, piggyBac has very limited mobility once integrated into the genome of the yellow fever mosquito, Aedes aegypti. A transgenic Aedes aegypti cell line (AagPB8) was created containing three integrated piggyBac elements and the remobilization potential of the elements was tested. The integrated piggyBac elements in AagPB8 were transpositionally silent in the presence of functional transposase, which was shown to be capable of catalyzing the movement of plasmid-borne piggyBac elements in the same cells. The structural integrity of one of the integrated elements along with the quality of element-flanking DNA, which is known to influence transposition rates, were tested in D. melanogaster. The element was found to be structurally intact, capable of transposition and excision in the soma and germ-line of Drosophila melanogaster, and in a DNA sequence context highly conducive to element movement in Drosophila melanogaster. These data show that transpositional silencing of integrated piggyBac elements in the genome of Aedes aegypti appears to be a function of higher scale genome organization or perhaps epigenetic factors, and not due to structural defects or suboptimal integration sites.	[Palavesam, Azhahianambi; Esnault, Caroline; O'Brochta, David A.] Univ Maryland, Dept Entomol, Inst Biosci & Biotechnol Res, College Pk, MD 20742 USA; [O'Brochta, David A.] Inst Biosci & Biotechnol Res, Rockville, MD USA	University System of Maryland; University of Maryland College Park	O'Brochta, DA (corresponding author), Univ Maryland, Dept Entomol, Inst Biosci & Biotechnol Res, College Pk, MD 20742 USA.	dobrocht@umd.edu	Palavesam, Azhahianambi/H-3307-2019; Esnault, Caroline/C-7221-2015; Palavesam, Azhahianambi/K-7606-2015	Palavesam, Azhahianambi/0000-0002-7108-6767; Palavesam, Azhahianambi/0000-0002-7108-6767	National Institute of Allergy and Infectious diseases [R01AI070812]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070812] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the National Institute of Allergy and Infectious diseases, grant number R01AI070812. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arensburger P, 2011, BMC GENOMICS, P12; Balu B, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-83; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bonin CP, 2004, GENETICS, V167, P1801, DOI 10.1534/genetics.104.027557; Bonizzoni M, 2007, INSECT MOL BIOL, V16, P645, DOI 10.1111/j.1365-2583.2007.00756.x; Castaneda J, 2011, MUTAT RES-FUND MOL M, V714, P95, DOI 10.1016/j.mrfmmm.2011.05.002; Castillo DM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-258; Elick TA, 1996, GENETICA, V98, P33, DOI 10.1007/BF00120216; Esnault C, 2011, GENETICS, V187, P319, DOI 10.1534/genetics.110.122168; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Fraser MJ, 2012, ANNU REV ENTOMOL, V57, P267, DOI 10.1146/annurev.ento.54.110807.090545; Grossman GL, 2001, INSECT MOL BIOL, V10, P597, DOI 10.1046/j.0962-1075.2001.00299.x; Guimond N, 2003, MOL GENET GENOMICS, V268, P779, DOI 10.1007/s00438-002-0800-4; Handler AM, 1999, INSECT MOL BIOL, V8, P449, DOI 10.1046/j.1365-2583.1999.00139.x; Handler AM, 2004, NAT BIOTECHNOL, V22, P1150, DOI 10.1038/nbt1002; Hikosaka A, 2007, MOL BIOL EVOL, V24, P2648, DOI 10.1093/molbev/msm191; Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110; Ivics Z, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-25; Kang Y, 2009, CELL BIOL INT, V33, P509, DOI 10.1016/j.cellbi.2009.01.017; LAN Q, 1990, AM J TROP MED HYG, V43, P669, DOI 10.4269/ajtmh.1990.43.669; LEVIS R, 1985, SCIENCE, V229, P558, DOI 10.1126/science.2992080; Lorenzen MD, 2007, INSECT MOL BIOL, V16, P265, DOI 10.1111/j.1365-2583.2007.00727.x; Munoz-Lopez M, 2010, CURR GENOMICS, V11, P115, DOI 10.2174/138920210790886871; O'Brochta DA, 2011, P NATL ACAD SCI USA, V108, P16339, DOI 10.1073/pnas.1110628108; Pagan HJT, 2010, GENOME BIOL EVOL, V2, P293, DOI 10.1093/gbe/evq021; Peleg J, 1968, AM J TROPICAL MED HY, V17, P219; Rad R, 2010, SCIENCE, V330, P1104, DOI 10.1126/science.1193004; Sarkar A, 2003, MOL GENET GENOMICS, V270, P173, DOI 10.1007/s00438-003-0909-0; Schetelig MF, 2009, P NATL ACAD SCI USA, V106, P18171, DOI 10.1073/pnas.0907264106; Sethuraman N, 2007, INSECT BIOCHEM MOLEC, V37, P941, DOI 10.1016/j.ibmb.2007.05.004; Sun ZC, 2008, INSECT MOL BIOL, V17, P9, DOI 10.1111/j.1365-2583.2008.00780.x; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Trauner J, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-73; Uchino K, 2008, INSECT BIOCHEM MOLEC, V38, P1165, DOI 10.1016/j.ibmb.2008.09.009; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Wilson R, 2003, INSECT BIOCHEM MOLEC, V33, P853, DOI 10.1016/S0965-1748(03)00044-4; Wu M, 2008, INSECT SCI, V15, P521, DOI 10.1111/j.1744-7917.2008.00241.x; Zhao YG, 1998, INSECT BIOCHEM MOLEC, V28, P213, DOI 10.1016/S0965-1748(98)00020-4; Zimowska GJ, 2006, INSECT BIOCHEM MOLEC, V36, P421, DOI 10.1016/j.ibmb.2006.03.001	39	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68454	10.1371/journal.pone.0068454	http://dx.doi.org/10.1371/journal.pone.0068454			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861905	Green Submitted, gold, Green Published			2022-12-27	WOS:000323350700086
J	Su, MY; Kuo, CI; Chang, CF; Chang, CI				Su, Ming-Yuan; Kuo, Chiao-I; Chang, Chi-Fon; Chang, Chung-I			Three-Dimensional Structure of Human NLRP10/PYNOD Pyrin Domain Reveals a Homotypic Interaction Site Distinct from Its Mouse Homologue	PLOS ONE			English	Article							NOD-LIKE RECEPTORS; NMR STRUCTURE; PROTEIN; DYNAMICS; ASC; INFLAMMASOME; FOLD; LCA	NLRPs (Nucleotide-binding domain, leucine-rich repeat and pyrin domain containing proteins) are a family of patternrecognition receptors (PRRs) that sense intracellular microbial components and endogenous stress signals. NLRP10 (also known as PYNOD) is a unique NLRP member characterized by a lack of the putative ligand-binding leucine-rich repeat domain. Recently, human NLRP10 has been shown to inhibit the self-association of ASC into aggregates and ASC-mediated procaspase-1 processing. However, such activities are not found in mouse NLRP10. Here we report the solution structure and dynamics of human NLRP10 pyrin domain (PYD), whose helix H3 and loop H2-H3 adopt a conformation distinct from those of mouse NLRP10. Docking studies show that human and mouse NLRP10 PYDs may interact differently with ASC PYD. These results provide a possible structural explanation for the contrasting effect of NLRP10 on ASC aggregation in human cells versus mouse models. Finally, we also provide evidence that in human NLRP10 the PYD domain may not interact with the NOD domain to regulate its intrinsic nucleotide hydrolysis activity.	[Su, Ming-Yuan; Kuo, Chiao-I; Chang, Chung-I] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Su, Ming-Yuan; Chang, Chung-I] Natl Taiwan Univ, Inst Biochem Sci, Coll Life Sci, Taipei, Taiwan; [Chang, Chi-Fon] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan	Academia Sinica - Taiwan; National Taiwan University; Academia Sinica - Taiwan	Chang, CF (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.	chifon@gate.sinica.edu.tw; chungi@gate.sinica.edu.tw		Chang, Chi-Fon/0000-0002-2961-0748; Chang, Chung-I/0000-0003-0989-1228; Su, Ming-Yuan/0000-0003-1581-0914	National Science Council of Taiwan [NSC99-2320-B-001-MY2, NSC 101-2811-M-001-164]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported in part by the National Science Council of Taiwan (http://web1.nsc.gov.tw) under grant nos. NSC99-2320-B-001-MY2 and NSC 101-2811-M-001-164. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bae JY, 2011, J BIOL CHEM, V286, P39528, DOI 10.1074/jbc.M111.278812; Chang CI, 2007, CELL MOL LIFE SCI, V64, P1395, DOI 10.1007/s00018-007-6567-3; Chang CI, 2006, SCIENCE, V311, P1761, DOI 10.1126/science.1123056; Chang CI, 2005, P NATL ACAD SCI USA, V102, P10279, DOI 10.1073/pnas.0504547102; Cogan EB, 1999, ANAL BIOCHEM, V271, P29, DOI 10.1006/abio.1999.4100; Cordier F, 1999, J BIOMOL NMR, V13, P175, DOI 10.1023/A:1008301415843; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; de Alba E, 2009, J BIOL CHEM, V284, P32932, DOI 10.1074/jbc.M109.024273; Eibl C, 2012, BIOCHEMISTRY-US, V51, P7330, DOI 10.1021/bi3007059; Eisenbarth SC, 2012, NATURE, V484, P510, DOI 10.1038/nature11012; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hiller S, 2003, STRUCTURE, V11, P1199, DOI 10.1016/j.str.2003.08.009; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Imamura R, 2010, J IMMUNOL, V184, P5874, DOI 10.4049/jimmunol.0900779; Kersse K, 2011, CYTOKINE GROWTH F R, V22, P257, DOI 10.1016/j.cytogfr.2011.09.003; Kersse K, 2011, TRENDS BIOCHEM SCI, V36, P541, DOI 10.1016/j.tibs.2011.06.006; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liepinsh E, 2003, J MOL BIOL, V332, P1155, DOI 10.1016/j.jmb.2003.07.007; Markley JL, 1998, J BIOMOL NMR, V12, P1, DOI 10.1023/A:1008290618449; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Natarajan A, 2006, J BIOL CHEM, V281, P31863, DOI 10.1074/jbc.M605458200; Pinheiro AS, 2011, J MOL BIOL, V413, P790, DOI 10.1016/j.jmb.2011.09.024; Pinheiro AS, 2010, J BIOL CHEM, V285, P27402, DOI 10.1074/jbc.M110.113191; Saito K, SOLUTION STRUC UNPUB; Shaw MH, 2008, CURR OPIN IMMUNOL, V20, P377, DOI 10.1016/j.coi.2008.06.001; Srimathi T, 2008, J BIOL CHEM, V283, P15390, DOI 10.1074/jbc.M801589200; Su MY, 2012, BIOMOLECULAR NMR ASS; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Vajjhala PR, 2012, J BIOL CHEM, V287, P41732, DOI 10.1074/jbc.M112.381228; Wang YT, 2004, INT IMMUNOL, V16, P777, DOI 10.1093/intimm/dxh081	34	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67843	10.1371/journal.pone.0067843	http://dx.doi.org/10.1371/journal.pone.0067843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861819	Green Published, Green Submitted, gold			2022-12-27	WOS:000323350700047
J	Coertjens, L; Donche, V; De Maeyer, S; Vanthournout, G; Van Petegem, P				Coertjens, Liesje; Donche, Vincent; De Maeyer, Sven; Vanthournout, Gert; Van Petegem, Peter			Modeling Change in Learning Strategies throughout Higher Education: A Multi-Indicator Latent Growth Perspective	PLOS ONE			English	Article							CONFIRMATORY FACTOR-ANALYSIS; STUDENTS; SECONDARY; PATTERNS; QUESTIONNAIRE; PERCEPTIONS; PERFORMANCE; MOTIVATION; STABILITY; STYLES	The change in learning strategies during higher education is an important topic of research in the Student Approaches to Learning field. Although the studies on this topic are increasingly longitudinal, analyses have continued to rely primarily on traditional statistical methods. The present research is innovative in the way it uses a multi-indicator latent growth analysis in order to more accurately estimate the general and differential development in learning strategy scales. Moreover, the predictive strength of the latent growth models are estimated. The sample consists of one cohort of Flemish University College students, 245 of whom participated in the three measurement waves by filling out the processing and regulation strategies scales of the Inventory of Learning Styles - Short Versions. Independent-samples t-tests revealed that the longitudinal group is a non-random subset of students starting University College. For each scale, a multi-indicator latent growth model is estimated using Mplus 6.1. Results suggest that, on average, during higher education, students persisting in their studies in a non-delayed manner seem to shift towards high-quality learning and away from undirected and surface-oriented learning. Moreover, students from the longitudinal group are found to vary in their initial levels, while, unexpectedly, not in their change over time. Although the growth models fit the data well, significant residual variances in the latent factors remain.	[Coertjens, Liesje; Donche, Vincent; De Maeyer, Sven; Vanthournout, Gert; Van Petegem, Peter] Univ Antwerp, Inst Educ & Informat Sci, B-2020 Antwerp, Belgium; [De Maeyer, Sven] Univ Antwerp, Ctr Stat, Univ Antwerp StatUA, B-2020 Antwerp, Belgium	University of Antwerp; University of Antwerp	Coertjens, L (corresponding author), Univ Antwerp, Inst Educ & Informat Sci, B-2020 Antwerp, Belgium.	liesje.coertjens@ua.ac.be	Donche, Vincent/R-5757-2016; De Maeyer, Sven/K-7446-2015; Van Petegem, Peter/R-5494-2016	Donche, Vincent/0000-0002-9405-3896; De Maeyer, Sven/0000-0003-2888-1631; Van Petegem, Peter/0000-0002-4078-7800	Research Board of the University of Antwerp	Research Board of the University of Antwerp	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The research reported in this article was supported by a grant from the "Special Research Fund: New Research Initiatives" from the Research Board of the University of Antwerp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, ACT LEARN HIGH EDUC, DOI DOI 10.1177/1469787410365650; Baeten M, 2010, EDUC RES REV-NETH, V5, P243, DOI 10.1016/j.edurev.2010.06.001; Beauducel A, 2006, STRUCT EQU MODELING, V13, P186, DOI 10.1207/s15328007sem1302_2; Biggs J, 2001, BRIT J EDUC PSYCHOL, V71, P133, DOI 10.1348/000709901158433; Biggs J. B, 1987, STUDENT APPROACHES L; Bijleveld C, 1998, LONGITUDINAL DATA AN; Boyle EA, 2003, BRIT J EDUC PSYCHOL, V73, P267, DOI 10.1348/00070990360626976; BRIGGS SR, 1986, J PERS, V54, P106, DOI 10.1111/j.1467-6494.1986.tb00391.x; Busato VV, 1998, BRIT J EDUC PSYCHOL, V68, P427, DOI 10.1111/j.2044-8279.1998.tb01302.x; Coertjens L, 2012, J PSYCHOEDUC ASSESS, V30, P577, DOI 10.1177/0734282912438844; Coffield F., 2004, LEARNING STYLES PEDA; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; DART BC, 1991, HIGH EDUC, V22, P317, DOI 10.1007/BF00132294; DeRoche K.K., 2009, FUNCTIONING GLOBAL F; Diseth A, 2007, STUD HIGH EDUC, V32, P373, DOI 10.1080/03075070701346949; DiStefano C, 2005, J PSYCHOEDUC ASSESS, V23, P225, DOI 10.1177/073428290502300303; Donche V., 2008, STYLE CULTURAL DIFFE, P49; Donche V., 2011, HIGHER ED TEACHING I, P277; Donche V, 2010, LEARN INDIVID DIFFER, V20, P256, DOI 10.1016/j.lindif.2010.02.002; Duncan T, 2006, INTRO LATENT VARIABL; Entwistle N.J., 2003, UNRAVELLING BASIC CO, P89; Entwistle Noel., 1983, UNDERSTANDING STUDEN, V1st ed., DOI [10.4324/9781315718637/UNDERSTANDING-STUDENT-LEARNING-ROUTLEDGE-REVIVALS-NOEL-ENTWISTLE-PAUL-RAMSDEN, DOI 10.4324/9781315718637/UNDERSTANDING-STUDENT-LEARNING-ROUTLEDGE-REVIVALS-NOEL-ENTWISTLE-PAUL-RAMSDEN]; Fleming CB, 2008, J EARLY ADOLESCENCE, V28, P277, DOI 10.1177/0272431607313589; Flora DB, 2004, PSYCHOL METHODS, V9, P466, DOI 10.1037/1082-989X.9.4.466; Gijbels D, 2010, VOCATIONS LEARNING, V3, P329; Gijbels D, 2009, EDUC STUD-UK, V35, P503, DOI 10.1080/03055690902879184; Gordon C, 2002, BRIT J EDUC PSYCHOL, V72, P483, DOI 10.1348/00070990260377488; GOW L, 1990, HIGH EDUC, V19, P307, DOI 10.1007/BF00133895; Hoeksema L., 1997, INT J HUM RESOUR MAN, V8, P307, DOI DOI 10.1080/095851997341667; Jackling B., 2005, ACCOUNT FINANC, V45, P597, DOI DOI 10.1111/J.1467-629X.2005.00142.X; Kyndt E, 2011, HIGH EDUC RES DEV, V30, P135, DOI 10.1080/07294360.2010.501329; Marsh HW, 1994, STRUCT EQU MODELING, V1, P317, DOI 10.1080/10705519409539984; MARTON F, 1976, BRIT J EDUC PSYCHOL, V46, P4, DOI 10.1111/j.2044-8279.1976.tb02980.x; Mayer RE, 2011, LEARN INDIVID DIFFER, V21, P319, DOI 10.1016/j.lindif.2010.11.016; Mehta PD, 2004, PSYCHOL METHODS, V9, P301, DOI 10.1037/1082-989X.9.3.301; Messick S, 1996, INT ENCY DEV INSTRUC, P638; Muthen B., 1997, ROBUST INFERENCE USI; Muthen B., 2006, MPLUS WEB NOTES NO 1, V10; Muthen BO, 2007, NONPOSITIVE DEFINITE; Muthen L.K., 2010, MPLUS SHORT COURSES; Muthen L.K., 2009, MPLUS USERS GUIDE; Nieminen J, 2004, INSTR SCI, V32, P387, DOI 10.1023/B:TRUC.0000044642.35553.e5; Palant J., 2007, SPSS SURVIVAL MANUAL; Phan HP, 2011, J EDUC RES, V104, P283, DOI 10.1080/00220671003739382; Provost SC, 1997, HIGHER ED RES DEV, V16, P309; Reid WA, 2005, MED TEACH, V27, P401, DOI 10.1080/01421590500136410; Richardson JTE, 2011, LEARN INDIVID DIFFER, V21, P288, DOI 10.1016/j.lindif.2010.11.015; Richardson JTE, 2006, EUR J ENG EDUC, V31, P421, DOI 10.1080/03043790600676307; Richardson JTE, 2004, EDUC PSYCHOL REV, V16, P347, DOI 10.1007/s10648-004-0004-z; Richardson M, 2012, PSYCHOL BULL, V138, P353, DOI 10.1037/a0026838; Rozendaal JS, 2001, LEARN INDIVID DIFFER, V13, P273, DOI 10.1016/S1041-6080(03)00016-5; Sadler-Smith E, 1998, BRIT J EDUC PSYCHOL, V68, P81, DOI 10.1111/j.2044-8279.1998.tb01276.x; SadlerSmith E, 1996, EDUC STUD, V22, P367, DOI 10.1080/0305569960220306; Severiens S, 2001, HIGH EDUC, V42, P437, DOI 10.1023/A:1012227619770; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Stoel RD, 2006, LEARN INDIVID DIFFER, V16, P159, DOI 10.1016/j.lindif.2005.07.006; Tait H., 1998, IMPROVING STUDENTS L, P262, DOI DOI 10.3109/0142159X.2011.610843; Trigwell K, 1999, HIGH EDUC, V37, P57, DOI 10.1023/A:1003548313194; Van Bragt CAC, 2007, LEARN INDIVID DIFFER, V17, P83, DOI 10.1016/j.lindif.2007.02.003; van der Veen I, 2009, LEARN INDIVID DIFFER, V19, P34, DOI 10.1016/j.lindif.2008.03.001; Van der Veken J, 2009, MED TEACH, V31, P433, DOI 10.1080/01421590802141159; Vanthoumout G., 2011, STYLE DIFFERENCES CO, P78; Vanthournout G, 2012, STUDENTS PERSISTENCE; Vanthournout G., 2011, PATTERNS STUDENT LEA; Vermetten YJ, 1999, HIGH EDUC, V37, P1, DOI 10.1023/A:1003573727713; Vermetten YJ, 1999, BRIT J EDUC PSYCHOL, V69, P221, DOI 10.1348/000709999157699; Vermunt J. D., 2013, LEARNING PATTERNS HI; Vermunt JD, 2005, HIGH EDUC, V49, P205, DOI 10.1007/s10734-004-6664-2; Vermunt JD, 2004, EDUC PSYCHOL REV, V16, P359, DOI 10.1007/s10648-004-0005-y; Vermunt JD, 1998, BRIT J EDUC PSYCHOL, V68, P149, DOI 10.1111/j.2044-8279.1998.tb01281.x; Voelkle MC, 2006, LEARN INDIVID DIFFER, V16, P303, DOI 10.1016/j.lindif.2006.01.001; VOLET SE, 1994, BRIT J EDUC PSYCHOL, V64, P301, DOI 10.1111/j.2044-8279.1994.tb01104.x; WATKINS D, 1985, HUM LEARN, V4, P127; Wilson K., 2005, ASSESS EVAL HIGH EDU, V30, P37; Wu AD, 2010, SOC INDIC RES, V97, P123, DOI 10.1007/s11205-009-9496-8; Wu M.L, 2010, STRUCTURAL EQUATION; Zeegers P, 2001, BRIT J EDUC PSYCHOL, V71, P115, DOI 10.1348/000709901158424	78	26	26	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67854	10.1371/journal.pone.0067854	http://dx.doi.org/10.1371/journal.pone.0067854			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182HT	23844112	Green Submitted, Green Published, gold			2022-12-27	WOS:000321733000108
J	Gysels, M; Evans, N; Menaca, A; Higginson, IJ; Harding, R; Pool, R				Gysels, Marjolein; Evans, Natalie; Menaca, Arantza; Higginson, Irene J.; Harding, Richard; Pool, Robert		Project PRISMA	Diversity in Defining End of Life Care: An Obstacle or the Way Forward?	PLOS ONE			English	Article							PALLIATIVE-CARE; DEFINITIONS; PERSPECTIVE; ADVANCE	Aim: The terms used to describe care at the end of life (EoL), and its definitions, have evolved over time and reflect the changes in meaning the concept has undergone as the field develops. We explore the remit of EoL care as defined by experts in EoL care, from across Europe and beyond, to understand its current usage and meanings. Method: A qualitative survey attached to a call for expertise on cultural issues in EoL care was sent to experts in the field identified through the literature, European EoL care associations, and conferences targeted at EoL care professionals. Respondents were asked to identify further contacts for snowball recruitment. The responses were analysed using content and discourse analysis. Results: Responses were received from 167 individuals (33% response rate), mainly from academics (39%) and clinical practitioners working in an academic context (23%) from 19 countries in Europe and beyond. 29% of respondents said explicitly that there was no agreed definition of EoL care in practice and only 14% offered a standard definition (WHO, or local institution). 2% said that the concept of EoL care was not used in their country, and 5% said that there was opposition to the concept for religious or cultural reasons. Two approaches were identified to arrive at an understanding of EoL care: exclusively by drawing boundaries through setting time frames, and inclusively by approaching its scope in an integrative way. This led to reflections about terminology and whether defining EoL care is desirable. Conclusion: The global expansion of EoL care contributes to the variety of interpretations of what it means. This complicates the endeavour of defining the field. However, when diversity is taken seriously it can open up new perspectives to underpin the ethical framework of EoL care.	[Gysels, Marjolein; Pool, Robert] Univ Amsterdam, Ctr Social Sci & Global Hlth, Amsterdam, Netherlands; [Gysels, Marjolein; Higginson, Irene J.; Harding, Richard] Kings Coll London, Dept Palliat Care Policy & Rehabil, London WC2R 2LS, England; [Gysels, Marjolein; Menaca, Arantza; Pool, Robert] Univ Barcelona, Barcelona Ctr Int Hlth Res, Barcelona, Spain; [Evans, Natalie] Vrije Univ Amsterdam, Dept Publ & Occupat Hlth, Emgo Inst Hlth & Care Res, Expertise Ctr Palliat Care,Med Ctr, Amsterdam, Netherlands	University of Amsterdam; University of London; King's College London; ISGlobal; CRESIB; University of Barcelona; Vrije Universiteit Amsterdam	Gysels, M (corresponding author), Univ Amsterdam, Ctr Social Sci & Global Hlth, Amsterdam, Netherlands.	mhgysels@gmail.com	Evans, Natalie/M-1631-2013; Daveson, Barbara A/G-3122-2012; Murtagh, Fliss/C-3216-2009; Higginson, Irene Julie/C-7309-2012	Evans, Natalie/0000-0001-7124-9282; Deliens, Luc/0000-0002-8158-2422; Haugen, Dagny Faksvag/0000-0002-8592-4995; Koffman, Jonathan/0000-0001-8513-5681; Harding, Richard/0000-0001-9653-8689; Murtagh, Fliss/0000-0003-1289-3726; Higginson, Irene Julie/0000-0002-3687-1313; Daveson, Barbara/0000-0001-8039-8749	European Commission FP7 [Health-F2-2008-201655]	European Commission FP7(European CommissionEuropean Commission Joint Research Centre)	Funding provided by European Commission FP7(contract number: Health-F2-2008-201655). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew EVW, 2013, PALLIATIVE MED, V27, P131, DOI 10.1177/0269216311429619; Bernheim JL, 2008, BRIT MED J, V336, P864, DOI 10.1136/bmj.39497.397257.AD; Boldt AM, 2006, J PALLIAT MED, V9, P1128, DOI 10.1089/jpm.2006.9.1128; Borry P, 2005, BIOETHICS, V19, P49, DOI 10.1111/j.1467-8519.2005.00424.x; Chapple A, 2006, INT J NURS STUD, V43, P1011, DOI 10.1016/j.ijnurstu.2005.11.007; Cherny NI, 2009, CANCER-AM CANCER SOC, V115, P1808, DOI 10.1002/cncr.24212; Clark D, 2000, PALLIATIVE MED, V14, P479, DOI 10.1191/026921600701536408; CLARK D, 1999, REFLECTIONS PALLIATI; Coventry PA, 2005, AGE AGEING, V34, P218, DOI 10.1093/ageing/afi054; Department of Health, 2008, END LIF CAR STRAT AD; Evans N, 2012, J PALLIAT MED, V15, P812, DOI 10.1089/jpm.2011.0526; Evans N, 2012, PATIENT EDUC COUNS, V87, P277, DOI 10.1016/j.pec.2011.10.004; Evans N, 2012, J PAIN SYMPTOM MANAG, V43, P261, DOI 10.1016/j.jpainsymman.2011.04.012; Evans N, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-141; Fadul N, 2009, CANCER-AM CANCER SOC, V115, P2013, DOI 10.1002/cncr.24206; Gott M, 2012, PALLIATIVE MED, V26, P232, DOI 10.1177/0269216311408993; Griffiths J., 1998, EUTHANASIA LAW NETHE; Gysels M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034188; HAMILTON J, 1995, CAN MED ASSOC J, V153, P334; Harding R, 2010, EUR J CANCER, V46, P1493, DOI 10.1016/j.ejca.2010.01.035; Hermsen MA, 2001, PALLIATIVE MED, V15, P425, DOI 10.1191/026921601680419483; Hui D, 2012, J PAIN SYMPTOM MANAG, V43, P582, DOI 10.1016/j.jpainsymman.2011.04.016; Kleinman A, 2009, LANCET, V373, P292, DOI 10.1016/S0140-6736(09)60087-8; Larkin PJ, 2008, NURS ETHICS, V15, P234, DOI 10.1177/0969733007086021; Lorenz K, 2004, END OF LIFE CARE OUT; Lynn J, 2003, LIVING WELL END LIFE; Menaca A, 2011, CRITICAL REV ONCOLOG, DOI [10.1177/0269216311429619, DOI 10.1177/0269216311429619]; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; Pastrana T, 2008, PALLIATIVE MED, V22, P222, DOI 10.1177/0269216308089803; Putnam RD, 1998, HOUS POLICY DEBATE, V9, pV; Saunders, 1964, NEED I CARE PATIENT, P1; Sepulveda C, 2002, J PAIN SYMPTOM MANAG, V24, P91, DOI 10.1016/S0885-3924(02)00440-2; Shipman C, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1720; St John of God Health Care, 2019, OUR VIS; The A-M, 2010, VERLOSSERS NAAST GOD; Walshe C, 2011, DIET AND NUTRITION IN PALLIATIVE CARE, P17; World Health Organisation, WHO DEF PALL CAR	37	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68002	10.1371/journal.pone.0068002	http://dx.doi.org/10.1371/journal.pone.0068002			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182HT	23844145	Green Published, Green Submitted, gold			2022-12-27	WOS:000321733000124
J	Lai, HS; Lin, WH; Lai, SL; Lin, HY; Hsu, WM; Chou, CH; Lee, PH				Lai, Hong-Shiee; Lin, Wen-Hsi; Lai, Shuo-Lun; Lin, Hao-Yu; Hsu, Wen-Ming; Chou, Chia-Hung; Lee, Po-Huang			Interleukin-6 Mediates Angiotensinogen Gene Expression during Liver Regeneration	PLOS ONE			English	Article							PARTIAL-HEPATECTOMY; ANGIOGENESIS; APOPTOSIS; PROLIFERATION; HEPATOCYTES; ACTIVATION; SYSTEM; CELLS	Background: Angiotensinogen is the precursor of angiotensin II, which is associated with ischemia-reperfusion injury. Angiotensin II reduces liver regeneration after hepatectomy and causes dysfunction and failure of reduced-size liver transplants. However, the regulation of angiotensinogen during liver regeneration is still unclear. Aims: To investigate the regulation of angiotensinogen during liver regeneration for preventing angiotensin II-related ischemia-reperfusion injury during liver regeneration. Methods: A mouse in vitro partial hepatectomy animal model was used to evaluate the expression of interleukin-6 (IL-6) and angiotensinogen during liver regeneration. Serum IL-6 and angiotensinogen were detected by enzyme immunoassay (EIA). Angiotensinogen mRNA was detected by RT-PCR. Tissue levels of angiotensinogen protein were detected by Western blot analysis. Primary cultures of mouse hepatocytes were used to investigate IL-6-induced angiotensinogen. Chemical inhibitors were used to perturb signal transduction pathways. Synthetic double-stranded oligodeoxynucleotides (ODNs) were used as 'decoy' cis-elements to investigate transcription. Ki 67 staining and quantification were used to verify liver regeneration. Results: In the in vivo model, the levels of serum IL-6 and angiotensinogen correlated. In the in vitro model, IL-6 transcriptionally regulated angiotensinogen expression. Additionally, IL-6 mediated angiotensinogen expression through the Janus kinase (JAK)/signal transducer and activator of transcription 3 (STAT3) and JAK/p38 signaling. Decoy ODN analyses revealed that STAT3 and nuclear factor-kB (NF-kB) also played critical roles in the transcriptional regulation of angiotensinogen by IL-6. IL-6-mediated signaling, JAK2, STAT3 and p38 inhibitors reduced angiotensinogen expression in the partially hepatectomized mice. Conclusion: During liver regeneration, IL-6-enhanced angiotensinogen expression is dependent on the JAK/STAT3 and JAK/p38/NF-kB signaling pathways. Interruption of the molecular mechanisms of angiotensinogen regulation may be applied as the basis of therapeutic strategies for preventing angiotensin II-related ischemia-reperfusion injury during liver regeneration.	[Lai, Hong-Shiee] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University	Lai, HS (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan.	hslai@ntu.edu.tw		Lai, Shuo-Lun/0000-0002-2480-4252; LIN, HAO-YU/0000-0001-5611-7003; HSU, WEN-MING/0000-0002-5145-9538; Lai, Hong-Shiee/0000-0002-7958-2183; LEE, PO-HUANG/0000-0001-5831-035X	Taiwan National Science Council [NSC 96-2314-B-002-079-MY3, NSC 100-2314-B-002-019-MY3]; National Taiwan University Hospital [NTUH 97-S883, NTUH 100-S1491]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	This study was supported by Taiwan National Science Council grants NSC 96-2314-B-002-079-MY3 and NSC 100-2314-B-002-019-MY3, and National Taiwan University Hospital grants NTUH 97-S883 and NTUH 100-S1491. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldeguer X, 2002, HEPATOLOGY, V35, P40, DOI 10.1053/jhep.2002.30081; Brand M, 2007, J MOL MED-JMM, V85, P451, DOI 10.1007/s00109-006-0141-6; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; CRESSMAN DE, 1994, J BIOL CHEM, V269, P30429; Drixler TA, 2003, BRIT J SURG, V90, P1384, DOI 10.1002/bjs.4275; Drixler TA, 2002, ANN SURG, V236, P703, DOI 10.1097/00000658-200212000-00002; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Fernandez-Real JM, 2001, J CLIN ENDOCR METAB, V86, P1154, DOI 10.1210/jc.86.3.1154; FUKAMIZU A, 1990, J BIOL CHEM, V265, P7576; Fyhrquist F, 2008, J INTERN MED, V264, P224, DOI 10.1111/j.1365-2796.2008.01981.x; Gewiese-Rabsch J, 2010, BBA-MOL BASIS DIS, V1802, P1054, DOI 10.1016/j.bbadis.2010.07.023; Gilgenkrantz H, 2011, CLIN RES HEPATOL GAS, V35, P623, DOI 10.1016/j.clinre.2011.04.002; Greene AK, 2003, ANN SURG, V237, P530, DOI 10.1097/00000658-200304000-00015; Guo LP, 2004, HEPATOLOGY, V40, P583, DOI 10.1002/hep.20369; Higgins GM, 1931, ARCH PATHOL, V12, P186; Kawasaki T, 2010, J HEPATOL, V53, P648, DOI 10.1016/j.jhep.2010.04.021; KUMA S, 1990, IMMUNOBIOLOGY, V180, P235, DOI 10.1016/S0171-2985(11)80331-1; Lai HS, 2009, AM SURGEON, V75, P49; Lai HS, 2005, SURG TODAY, V35, P396, DOI 10.1007/s00595-004-2962-7; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; Lee DL, 2006, AM J PHYSIOL-HEART C, V290, pH935, DOI 10.1152/ajpheart.00708.2005; Liu F, 2008, J AM SOC NEPHROL, V19, P269, DOI 10.1681/ASN.2007010074; Matsusaka T, 2012, J AM SOC NEPHROL, V23, P1181, DOI 10.1681/ASN.2011121159; Miura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037974; Padrissa-Altes S, 2009, LIVER TRANSPLANT, V15, P313, DOI 10.1002/lt.21693; Peng JF, 2002, REGUL PEPTIDES, V110, P25, DOI 10.1016/S0167-0115(02)00156-8; Ray S, 2005, GASTROENTEROLOGY, V129, P1616, DOI 10.1053/j.gastro.2005.07.055; Shanmukhappa K, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-40; Singh VP, 2008, DIABETES, V57, P3297, DOI 10.2337/db08-0805; Sookoian S, 2005, AM J GASTROENTEROL, V100, P636, DOI 10.1111/j.1572-0241.2005.41168.x; Sun ZJ, 2003, HYPERTENSION, V41, P322, DOI 10.1161/01.HYP.0000050964.96018.FA; Togo S, 2004, J HEPATOL, V40, P464, DOI 10.1016/j.jhep.2003.11.005; Wang RQ, 2000, J CELL PHYSIOL, V185, P253; Weber A, 2010, HEPATOLOGY, V51, P1226, DOI 10.1002/hep.23479; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Xu CS, 2009, SCAND J GASTROENTERO, V44, P462, DOI 10.1080/00365520802495560	36	24	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67868	10.1371/journal.pone.0067868	http://dx.doi.org/10.1371/journal.pone.0067868			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844114	gold, Green Published, Green Submitted			2022-12-27	WOS:000321733000109
J	Van Kaer, L; Rabacal, WAS; Algood, HMS; Parekh, VV; Olivares-Villagomez, D				Van Kaer, Luc; Rabacal, Whitney A. S.; Algood, Holly M. Scott; Parekh, Vrajesh V.; Olivares-Villagomez, Danyvid			In Vitro Induction of Regulatory CD4(+)CD8 alpha(+) T Cells by TGF-beta, IL-7 and IFN-gamma	PLOS ONE			English	Article							INTESTINAL INTRAEPITHELIAL LYMPHOCYTES; INFLAMMATORY-BOWEL-DISEASE; THYMUS LEUKEMIA ANTIGEN; EPITHELIAL-CELLS; LAMINA PROPRIA; MOUSE MODEL; CD8; MICE; EXPRESSION; PROLIFERATION	In vitro CD4(+) T cell differentiation systems have made important contributions to understanding the mechanisms underlying the differentiation of naive CD4(+) T cells into effector cells with distinct biological functions. Mature CD4(+) T cells expressing CD8 alpha alpha homodimers are primarily found in the intestinal mucosa of men and mice, and to a lesser extent in other tissues such as peripheral blood. Although CD4(+)CD8 alpha(+) T cells are easily identified, very little is known about their development and immunological functions. It has been reported, however, that CD4(+)CD8 alpha(+) T cells possess regulatory properties. In this report, we present a novel in vitro differentiation system where CD4(+) T cells are stimulated to become CD4(+)CD8 alpha(+) T cells in the presence of TGF-beta, IL-7 and IFN-gamma, resulting in cells with very similar features as CD4(+)CD8 alpha(+) intraepithelial lymphocytes. This novel in vitro differentiation culture should provide a powerful and tractable tool for dissecting the differentiation and biological functions of CD4(+)CD8 alpha(+) T cells.	[Van Kaer, Luc; Rabacal, Whitney A. S.; Algood, Holly M. Scott; Parekh, Vrajesh V.; Olivares-Villagomez, Danyvid] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Algood, Holly M. Scott] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA; [Algood, Holly M. Scott] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University	Van Kaer, L (corresponding author), Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA.	luc.van.kaer@vanderbilt.edu; danyvid.olivares-villagomez@vanderbilt.edu	Van Kaer, Luc/H-1033-2015	Van Kaer, Luc/0000-0001-5275-2309	Digestive Disease Research Center (DDRC) at Vanderbilt University School of Medicine; National Institutes of Health (NIH) [P30DK058404, AI072471, AI070305, HL089667, DK081536]; Office of Medical Research, Department of Veterans Affairs; National Multiple Sclerosis Society of America; NATIONAL CANCER INSTITUTE [P01CA116087] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404, R01DK081536] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000915] Funding Source: NIH RePORTER	Digestive Disease Research Center (DDRC) at Vanderbilt University School of Medicine; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Medical Research, Department of Veterans Affairs(US Department of Veterans Affairs); National Multiple Sclerosis Society of America(National Multiple Sclerosis Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by a pilot grant from the Digestive Disease Research Center (DDRC) at Vanderbilt University School of Medicine, funded by National Institutes of Health (NIH) grant P30DK058404 (DOV), NIH grants AI072471, AI070305, HL089667, DK081536 (LVK), Merit Review Grants from the Office of Medical Research, Department of Veterans Affairs (HMSA), and a postdoctoral fellowship from the National Multiple Sclerosis Society of America (VVP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuzakouk M, 1998, EUR J GASTROEN HEPAT, V10, P325, DOI 10.1097/00042737-199804000-00009; Aranda R, 1997, J IMMUNOL, V158, P3464; Bernardo SR, 2013, NATURE IMMUNOLOGY, V14, P271; Carton J, 2004, EUR J GASTROEN HEPAT, V16, P961, DOI 10.1097/00042737-200410000-00003; Das G, 2003, P NATL ACAD SCI USA, V100, P5324, DOI 10.1073/pnas.0831037100; DEMARIA A, 1987, EUR J IMMUNOL, V17, P1815, DOI 10.1002/eji.1830171221; Denning TL, 2007, J IMMUNOL, V178, P4230, DOI 10.4049/jimmunol.178.7.4230; Desfrancois J, 2009, INT J CANCER, V125, P374, DOI 10.1002/ijc.24366; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Fahrer AM, 2001, P NATL ACAD SCI USA, V98, P10261, DOI 10.1073/pnas.171320798; FUJIHASHI K, 1993, J IMMUNOL, V151, P6681; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Hassan H, 2011, P NATL ACAD SCI USA, V108, P18330, DOI 10.1073/pnas.1105835108; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Konkel JE, 2011, NAT IMMUNOL, V12, P312, DOI 10.1038/ni.1997; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Maki K, 1996, P NATL ACAD SCI USA, V93, P7172, DOI 10.1073/pnas.93.14.7172; Montufar-Solis D, 2007, IMMUNOL REV, V215, P189, DOI 10.1111/j.1600-065X.2006.00471.x; MORRISSEY PJ, 1995, J IMMUNOL, V154, P2678; MOSLEY RL, 1990, INT IMMUNOL, V2, P361, DOI 10.1093/intimm/2.4.361; Olivares-Villagomez D, 2011, J IMMUNOL, V187, P4051, DOI 10.4049/jimmunol.1101052; Olivares-Villagomez D, 2008, P NATL ACAD SCI USA, V105, P17931, DOI 10.1073/pnas.0808242105; Ostanin DV, 2010, INT IMMUNOL, V22, P927, DOI 10.1093/intimm/dxq447; OTTENHOFF THM, 1986, NATURE, V322, P462, DOI 10.1038/322462a0; PALIARD X, 1988, NATURE, V335, P642, DOI 10.1038/335642a0; SENJU M, 1991, GUT, V32, P918, DOI 10.1136/gut.32.8.918; Suni MA, 2001, EUR J IMMUNOL, V31, P2512, DOI 10.1002/1521-4141(200108)31:8<2512::AID-IMMU2512>3.0.CO;2-M; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Urry Z, 2012, EUR J IMMUNOL, V42, P2697, DOI 10.1002/eji.201242370; WATANABE M, 1995, J CLIN INVEST, V95, P2945, DOI 10.1172/JCI118002; Yang H, 2008, AM J PHYSIOL-GASTR L, V294, pG1421, DOI 10.1152/ajpgi.00060.2008; Yang H, 2007, AM J PHYSIOL-GASTR L, V292, pG84, DOI 10.1152/ajpgi.00192.2006; Yu SH, 2008, P NATL ACAD SCI USA, V105, P20834, DOI 10.1073/pnas.0808700106; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	38	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67821	10.1371/journal.pone.0067821	http://dx.doi.org/10.1371/journal.pone.0067821			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844100	Green Published, Green Submitted, gold			2022-12-27	WOS:000321733000104
J	Derecka, K; Blythe, MJ; Malla, S; Genereux, DP; Guffanti, A; Pavan, P; Moles, A; Snart, C; Ryder, T; Ortori, CA; Barrett, DA; Schuster, E; Stoger, R				Derecka, Kamila; Blythe, Martin J.; Malla, Sunir; Genereux, Diane P.; Guffanti, Alessandro; Pavan, Paolo; Moles, Anna; Snart, Charles; Ryder, Thomas; Ortori, Catharine A.; Barrett, David A.; Schuster, Eugene; Stoeger, Reinhard			Transient Exposure to Low Levels of Insecticide Affects Metabolic Networks of Honeybee Larvae	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; GENE-EXPRESSION; NUTRITIONAL CONTROL; DROSOPHILA; HSP90; GROWTH; MYC; DETOXIFICATION; ENZYMES; INSULIN	The survival of a species depends on its capacity to adjust to changing environmental conditions, and new stressors. Such new, anthropogenic stressors include the neonicotinoid class of crop-protecting agents, which have been implicated in the population declines of pollinating insects, including honeybees (Apis mellifera). The low-dose effects of these compounds on larval development and physiological responses have remained largely unknown. Over a period of 15 days, we provided syrup tainted with low levels (2 mu g/L-1) of the neonicotinoid insecticide imidacloprid to beehives located in the field. We measured transcript levels by RNA sequencing and established lipid profiles using liquid chromatography coupled with mass spectrometry from worker-bee larvae of imidacloprid-exposed (IE) and unexposed, control (C) hives. Within a catalogue of 300 differentially expressed transcripts in larvae from IE hives, we detect significant enrichment of genes functioning in lipid-carbohydrate-mitochondrial metabolic networks. Myc-involved transcriptional response to exposure of this neonicotinoid is indicated by overrepresentation of E-box elements in the promoter regions of genes with altered expression. RNA levels for a cluster of genes encoding detoxifying P450 enzymes are elevated, with coordinated downregulation of genes in glycolytic and sugar-metabolising pathways. Expression of the environmentally responsive Hsp90 gene is also reduced, suggesting diminished buffering and stability of the developmental program. The multifaceted, physiological response described here may be of importance to our general understanding of pollinator health. Muscles, for instance, work at high glycolytic rates and flight performance could be impacted should low levels of this evolutionarily novel stressor likewise induce downregulation of energy metabolising genes in adult pollinators.	[Derecka, Kamila; Snart, Charles; Stoeger, Reinhard] Univ Nottingham, Sch Biosci, Nottingham, Leics, England; [Blythe, Martin J.; Malla, Sunir] Univ Nottingham, Ctr Genet & Genom, Deep Seq, Nottingham NG7 2RD, England; [Genereux, Diane P.] Westfield State Univ, Dept Biol, Westfield, MA USA; [Guffanti, Alessandro; Pavan, Paolo; Moles, Anna] Genomnia Srl, Milan, Italy; [Ryder, Thomas] Pk Apiaries, Nottingham, England; [Ortori, Catharine A.; Barrett, David A.] Univ Nottingham, Sch Pharm, Ctr Analyt Biosci, Nottingham NG7 2RD, England; [Schuster, Eugene] UCL, Dept Genet Evolut & Environm, Inst Hlth Ageing, London, England	University of Nottingham; University of Nottingham; Massachusetts System of Public Higher Education; Westfield State University; University of Nottingham; University of London; University College London	Stoger, R (corresponding author), Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Nottingham, Leics, England.	reinhard.stoger@nottingham.ac.uk	Serrano, Jose/A-2854-2009; Barrett, David A/C-9922-2011	Serrano, Jose/0000-0002-1565-5216; Barrett, David A/0000-0001-6900-9474; Genereux, Diane/0000-0001-5770-0989; Moles, Anna/0000-0002-5805-5763; Stoger, Reinhard/0000-0002-2301-0805; Snart, Charles/0000-0003-3164-3271; Schuster, Eugene/0000-0001-5076-2810	Co-operative Group, UK	Co-operative Group, UK	This project was supported by The Co-operative Group, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo S. A., 2012, HORM BEHAV; Alic N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.36; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baenziger JE, 2008, MOL PHARMACOL, V73, P880, DOI 10.1124/mol.107.039008; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonferroni C.E, 1936, PUBBL R 1 SUPER SCI, V8, P3; Bujold M, 2010, MOL CELL BIOL, V30, P793, DOI 10.1128/MCB.01327-09; Chen B, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-25; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Cresswell JE, 2012, PEST MANAG SCI, V68, P819, DOI 10.1002/ps.3290; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Daran-Lapujade P, 2007, P NATL ACAD SCI USA, V104, P15753, DOI 10.1073/pnas.0707476104; Delanoue R, 2010, DEV CELL, V18, P1012, DOI 10.1016/j.devcel.2010.05.007; Dionne MS, 2006, CURR BIOL, V16, P1977, DOI 10.1016/j.cub.2006.08.052; Eanes WF, 2006, P NATL ACAD SCI USA, V103, P19413, DOI 10.1073/pnas.0607095104; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Frei C, 2005, EMBO J, V24, P623, DOI 10.1038/sj.emboj.7600523; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Giraudo M, 2010, PESTIC BIOCHEM PHYS, V97, P115, DOI 10.1016/j.pestbp.2009.06.009; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Guertin DA, 2006, CURR BIOL, V16, P958, DOI 10.1016/j.cub.2006.03.084; Henry M, 2012, SCIENCE, V337, DOI 10.1126/science.1224930; Hilgers V, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000396; Horner MA, 2009, GENE DEV, V23, P2711, DOI 10.1101/gad.1833609; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Jarosz DF, 2010, SCIENCE, V330, P1820, DOI 10.1126/science.1195487; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kersey PJ, 2012, NUCLEIC ACIDS RES, V40, pD91, DOI 10.1093/nar/gkr895; King-Jones K, 2006, CELL METAB, V4, P37, DOI 10.1016/j.cmet.2006.06.006; Kunieda T, 2006, INSECT MOL BIOL, V15, P563, DOI 10.1111/j.1365-2583.2006.00677.x; Laycock I, 2012, ECOTOXICOLOGY, V21, P1937, DOI 10.1007/s10646-012-0927-y; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Li L, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-7; Li TR, 2003, DEV CELL, V5, P59, DOI 10.1016/S1534-5807(03)00192-8; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Matsuda K, 2009, MOL PHARMACOL, V76, P1, DOI 10.1124/mol.109.055186; Misra JR, 2011, GENE DEV, V25, P1796, DOI 10.1101/gad.17280911; Palanker L, 2009, CELL METAB, V9, P228, DOI 10.1016/j.cmet.2009.01.009; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sangster TA, 2004, BIOESSAYS, V26, P348, DOI 10.1002/bies.20020; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Shah S, 2012, PEST MANAG SCI, V68, P38, DOI 10.1002/ps.2218; Shomron N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000397; Sieber MH, 2009, CELL METAB, V10, P481, DOI 10.1016/j.cmet.2009.10.010; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Specchia V, 2010, NATURE, V463, P662, DOI 10.1038/nature08739; Staples JF, 1997, J EXP BIOL, V200, P1247; Tang HY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002373; Team RDC, R LANG ENV STAT COMP; Teleman AA, 2008, CELL METAB, V7, P21, DOI 10.1016/j.cmet.2007.11.010; Tennessen JM, 2011, CELL METAB, V13, P139, DOI 10.1016/j.cmet.2011.01.005; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Toth AL, 2005, J EXP BIOL, V208, P4641, DOI 10.1242/jeb.01956; Vansant G, 2006, INT J TOXICOL, V25, P85, DOI 10.1080/10915810600605690; Varghese J, 2010, GENE DEV, V24, P2748, DOI 10.1101/gad.1995910; Voellenkle C, 2012, RNA, V18, P472, DOI 10.1261/rna.027615.111; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wang B, 2011, CELL, V145, P596, DOI 10.1016/j.cell.2011.04.013; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002779; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Whitehorn PR, 2012, SCIENCE; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Yang EC, 2008, J ECON ENTOMOL, V101, P1743, DOI 10.1603/0022-0493-101.6.1743; Yang EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049472; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	72	85	88	5	156	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68191	10.1371/journal.pone.0068191	http://dx.doi.org/10.1371/journal.pone.0068191			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844170	Green Submitted, Green Published, gold			2022-12-27	WOS:000321341000143
J	Kantor, ED; Lampe, JW; Kratz, M; White, E				Kantor, Elizabeth D.; Lampe, Johanna W.; Kratz, Mario; White, Emily			Lifestyle Factors and Inflammation: Associations by Body Mass Index	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CANCER-RISK; PHYSICAL-ACTIVITY; FATTY-ACIDS; ALCOHOL INTAKE; DIETARY FIBER; MARKERS; OBESITY; INTERLEUKIN-6; SEX	Chronic inflammation, which is associated with obesity, may play a role in the etiology of several diseases. Thus, reducing inflammation may offer a disease-prevention strategy, particularly among the obese. Several modifiable factors have been associated with inflammation, including: dietary fiber intake, saturated fat intake, physical activity, smoking, alcohol, and use of certain supplements and medications (glucosamine, chondroitin, fish oil, vitamin E, statins and aspirin). To study whether these associations differ by body mass index (BMI), we used data on 9,895 adults included in the 1999-2004 cycles of the National Health and Nutrition Examination Survey (NHANES). Survey-weighted linear regression was used to evaluate the associations between modifiable factors and serum high-sensitivity C-reactive protein (hsCRP) concentrations across the following groups: underweight/normal weight (BMI<25 kg/m(2)), overweight (25-<30 kg/m(2)) and obese (30+ kg/m(2)). While several factors were significantly associated with decreased hsCRP among the normal weight or overweight groups (increased fiber intake, lower saturated fat intake, physical activity, not smoking, and use of chondroitin, fish oil and statins), only increasing dietary fiber intake and moderate alcohol consumption were associated with reduced hsCRP among the obese. Effect modification by BMI was statistically significant for the saturated fat-hsCRP and smoking-hsCRP associations. These results suggest that posited anti-inflammatory drugs and behaviors may be less strongly associated with inflammation among the obese than among lower weight persons.	[Kantor, Elizabeth D.; Lampe, Johanna W.; Kratz, Mario; White, Emily] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Kantor, Elizabeth D.; Lampe, Johanna W.; Kratz, Mario; White, Emily] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Kantor, ED (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.	ekantor@fhcrc.org		Kantor, Elizabeth/0000-0002-9124-5323	National Cancer Institute (NCI) [K05CA154337]; Office of Dietary Supplements from NCI [R01CA142545, R25CA094880]; NATIONAL CANCER INSTITUTE [K05CA154337, R25CA094880, R01CA142545] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Office of Dietary Supplements from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant K05CA154337 from the National Cancer Institute (NCI) and Office of Dietary Supplements and grants R01CA142545 and R25CA094880 from NCI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani UA, 2004, J NUTR, V134, P1181, DOI 10.1093/jn/134.5.1181; [Anonymous], 2013, FOOD LAB GUID GUID I; Arikawa AY, 2011, MED SCI SPORT EXER, V43, P1002, DOI 10.1249/MSS.0b013e3182059eda; Arya S, 2006, NUTRITION, V22, P865, DOI 10.1016/j.nut.2006.05.002; Cai QY, 2006, J CLIN ONCOL, V24, P5010, DOI 10.1200/JCO.2006.06.4931; Campbell PT, 2009, MED SCI SPORT EXER, V41, P1533, DOI 10.1249/MSS.0b013e31819c7feb; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Chan DC, 2002, CLIN CHEM, V48, P877; Chaturvedi AK, 2013, AM J EPIDEMIOL, V177, P14, DOI 10.1093/aje/kws357; Devaraj S, 2007, AM J CLIN NUTR, V86, P1392; Erridge C, 2007, AM J CLIN NUTR, V86, P1286, DOI 10.1093/ajcn/86.5.1286; Ferrante AW, 2007, J INTERN MED, V262, P408, DOI 10.1111/j.1365-2796.2007.01852.x; Gao XR, 2009, J PHARM PHARMACOL, V61, P1505, DOI 10.1211/jpp/61.11.0010; Goris AHC, 2001, BRIT J NUTR, V85, P629, DOI 10.1079/BJN2001322; Grammer TB, 2011, ATHEROSCLEROSIS, V215, P487, DOI 10.1016/j.atherosclerosis.2011.01.005; Harte AL, 2012, DIABETES CARE, V35, P375, DOI 10.2337/dc11-1593; Heikkila K, 2009, CANCER CAUSE CONTROL, V20, P15, DOI 10.1007/s10552-008-9212-z; HEITMANN BL, 1995, BRIT MED J, V311, P986; Hill RJ, 2001, BRIT J NUTR, V85, P415, DOI 10.1079/BJN2000281; Hullar MAJ, NESTLE NUTR WORKSHOP, V73, P67; Kantor ED, 2012, AM J EPIDEMIOL, V176, P1002, DOI 10.1093/aje/kws186; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kasapis C, 2005, J AM COLL CARDIOL, V45, P1563, DOI 10.1016/j.jacc.2004.12.077; Kennedy A, 2009, J NUTR, V139, P1, DOI 10.3945/jn.108.098269; Klein-Platat C, 2005, AM J CLIN NUTR, V82, P1178, DOI 10.1093/ajcn/82.6.1178; Lam YY, 2011, OBESITY, V19, P2113, DOI 10.1038/oby.2011.68; Lovu M, 2008, OSTEOARTHR CARTILAGE, V16, pS14, DOI 10.1016/j.joca.2008.06.008; Makhoul Z, 2011, EUR J CLIN NUTR, V65, P808, DOI 10.1038/ejcn.2011.39; Mariadason JM, 1999, GUT, V44, P394, DOI 10.1136/gut.44.3.394; McCarty MF, 1999, MED HYPOTHESES, V52, P465, DOI 10.1054/mehy.1997.0684; Micallef MA, 2009, EUR J CLIN NUTR, V63, P1154, DOI 10.1038/ejcn.2009.20; Milani RV, 2004, J AM COLL CARDIOL, V43, P1056, DOI 10.1016/j.jacc.2003.10.041; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; MOSHAGE HJ, 1988, BIOCHEM BIOPH RES CO, V155, P112, DOI 10.1016/S0006-291X(88)81056-8; Nakamura H, 2002, J RHEUMATISM JOINT S, V21, P175; National Center for Health Statistics, 2006, NAT HLTH NUTR EX SUR; National Center for Health Statistics, 2005, NHANES 2003 2004 PUB; Neilson HK, 2008, AM J CLIN NUTR, V87, P279, DOI 10.1093/ajcn/87.2.279; Nicholls SJ, 2006, AM J CARDIOL, V97, P1553, DOI 10.1016/j.amjcard.2005.12.042; Oliveira A, 2009, EUR J CLIN NUTR, V63, P1345, DOI 10.1038/ejcn.2009.61; Oliveira A, 2010, ALCOHOL ALCOHOLISM, V45, P119, DOI 10.1093/alcalc/agp092; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Plenge JK, 2002, CIRCULATION, V106, P1447, DOI 10.1161/01.CIR.0000029743.68247.31; Schottenfeld D, 2006, CA-CANCER J CLIN, V56, P69, DOI 10.3322/canjclin.56.2.69; Touvier M, 2013, AM J EPIDEMIOL, V177, P3, DOI 10.1093/aje/kws359; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tsilidis KK, 2008, INT J CANCER, V123, P1133, DOI 10.1002/ijc.23606; US Department of Agriculture and US Department of Health and Human Services, 2010, DIET GUID AM 2010; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Volpato S, 2004, CIRCULATION, V109, P607, DOI 10.1161/01.CIR.0000109503.13955.00; Wall R, 2010, NUTR REV, V68, P280, DOI 10.1111/j.1753-4887.2010.00287.x; Wang ZX, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/535918; Wener MH, 2000, J RHEUMATOL, V27, P2351; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179; Zelvyte I, 2002, PHARMACOL RES, V45, P147, DOI 10.1006/phrs.2001.0922	55	47	49	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67833	10.1371/journal.pone.0067833	http://dx.doi.org/10.1371/journal.pone.0067833			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844105	gold, Green Published, Green Submitted			2022-12-27	WOS:000321341000106
J	Milburn, JA; Ford, I; Mutch, NJ; Fluck, N; Brittenden, J				Milburn, James A.; Ford, Isobel; Mutch, Nicola J.; Fluck, Nicholas; Brittenden, Julie			Thrombin-Anti-Thrombin Levels and Patency of Arterio-Venous Fistula in Patients Undergoing Haemodialysis Compared to Healthy Volunteers: A Prospective Analysis	PLOS ONE			English	Article							C-REACTIVE PROTEIN; PLASMINOGEN-ACTIVATOR; VASCULAR ACCESS; RISK-FACTORS; COAGULATION-FACTORS; PLATELET-FUNCTION; TISSUE FACTOR; PLASMA; ATHEROSCLEROSIS; ANTICOAGULATION	Background: Patients on haemodialysis (HD) are at an increased risk of sustaining thrombotic events especially to their vascular access which is essential for maintenance of HD. Objectives: To assess whether 1) markers of coagulation, fibrinolysis or endothelial activation are increased in patients on HD compared to controls and 2) if measurement of any of these factors could help to identify patients at increased risk of arteriovenous (AVF) access occlusion. Patients/Methods: Venous blood samples were taken from 70 patients immediately before a session of HD and from 78 resting healthy volunteers. Thrombin-antithrombin (TAT), D-dimer, von Willebrand factor (vWF), plasminogen activator inhibitor-1 antigen (PAI-1) and soluble p-selectin were measured by ELISA. C-reactive protein (hsCRP) was measured by an immunonephelometric kinetic assay. Determination of the patency of the AVF was based upon international standards and was prospectively followed up for a minimum of four years or until the AVF was non-functioning. Results: A total of 70 patients were studied with a median follow-up of 740 days (range 72-1788 days). TAT, D-dimer, vWF, p-selectin and hsCRP were elevated in patients on HD compared with controls. At one year follow-up, primary patency was 66% (46 patients). In multivariate analysis TAT was inversely associated with primary assisted patency (r=-0.250, p=0.044) and secondary patency (r=-0.267, p=0.031). Conclusions: The novel finding of this study is that in patients on haemodialysis, TAT levels were increased and inversely correlated with primary assisted patency and secondary patency. Further evaluation is required into the possible role of TAT as a biomarker of AVF occlusion.	[Milburn, James A.] Aberdeen Royal Infirm, Dept Vasc Surg, Aberdeen, Scotland; [Ford, Isobel; Mutch, Nicola J.; Brittenden, Julie] Univ Aberdeen, Div Appl Med, Aberdeen, Scotland; [Fluck, Nicholas] Aberdeen Royal Infirm, Aberdeen, Scotland	University of Aberdeen; University of Aberdeen; University of Aberdeen	Milburn, JA (corresponding author), Aberdeen Royal Infirm, Dept Vasc Surg, Aberdeen, Scotland.	j.milburn@nhs.net		Mutch, Nicola/0000-0002-7452-0813	Grampian Renal Research Fund; British Heart Foundation [FS/11/02/28579]; British Heart Foundation [FS/11/2/28579] Funding Source: researchfish	Grampian Renal Research Fund; British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This project was funded by the Grampian Renal Research Fund. N.J.M. was supported by the British Heart Foundation (FS/11/02/28579). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saady NM, 1999, HEART, V81, P134, DOI 10.1136/hrt.81.2.134; Bartels PCM, 2000, SCAND J CLIN LAB INV, V60, P283, DOI 10.1080/003655100750046440; Bisoendial RJ, 2010, EUR HEART J, V31, P2087, DOI 10.1093/eurheartj/ehq238; BOOTH NA, 1988, BRIT J HAEMATOL, V70, P327, DOI 10.1111/j.1365-2141.1988.tb02490.x; Borawski J, 2001, NEPHROL DIAL TRANSPL, V16, P1442, DOI 10.1093/ndt/16.7.1442; Casonato A, 2001, CLIN APPL THROMB-HEM, V7, P81, DOI 10.1177/107602960100700201; Casserly LF, 2003, SEMIN DIALYSIS, V16, P245, DOI 10.1046/j.1525-139X.2003.16048.x; Chou CY, 2006, BLOOD PURIFICAT, V24, P342, DOI 10.1159/000092558; Covic A, 2003, J NEPHROL, V16, P476; D'Elia JA, 2005, INT J CARDIOL, V101, P19, DOI 10.1016/j.ijcard.2004.03.007; Da Silva A, 2008, COCHRANE DB SYST REV, V4; Darlington A, 2011, THROMB HAEMOSTASIS, V106, P67, DOI 10.1160/TH10-12-0785; DeMarchi S, 1996, J AM SOC NEPHROL, V7, P1169; Erdem Y, 1996, NEPHROL DIAL TRANSPL, V11, P1299; Feldman HI, 1996, J AM SOC NEPHROL, V7, P523; GREAVES M, 1987, DIABETOLOGIA, V30, P160, DOI 10.1007/BF00274221; Gyongyosi M, 2004, AM HEART J, V147, P158, DOI 10.1016/j.ahj.2003.07.015; Hakim R, 1998, KIDNEY INT, V54, P1029, DOI 10.1046/j.1523-1755.1998.00122.x; Haznedaroglu IC, 1996, BLOOD PURIFICAT, V14, P227, DOI 10.1159/000170265; Huijbregts HJT, 2008, CLIN J AM SOC NEPHRO, V3, P714, DOI 10.2215/CJN.02950707; Hutchinson WL, 2000, CLIN CHEM, V46, P934; Inoue A, 2000, CLIN APPL THROMB-HEM, V6, P100, DOI 10.1177/107602960000600210; Kadir RA, 1999, THROMB HAEMOSTASIS, V82, P1456; Kirmizis D, 2006, MED SCI MONITOR, V12, pCR55; Malyszko J, 1996, THROMB RES, V83, P351, DOI 10.1016/0049-3848(96)00145-4; Milburn JA, 2012, INT J LAB HEMATOL, V34, P52, DOI 10.1111/j.1751-553X.2011.01356.x; Milburn JA, 2011, INT J ARTIF ORGANS, V34, P280, DOI 10.5301/IJAO.2011.6469; Muller I, 2002, PATHOPHYSIOL HAEMO T, V32, P16, DOI 10.1159/000057284; Oda H, 2000, Adv Perit Dial, V16, P152; Paffen E, 2006, CARDIOVASC RES, V71, P30, DOI 10.1016/j.cardiores.2006.03.004; Pawlak K, 2007, THROMB RES, V119, P475, DOI 10.1016/j.thromres.2006.03.011; Rao AK, 2006, THROMB HAEMOSTASIS, V96, P738, DOI 10.1160/TH06-08-0451; Sadosty AT, 2001, J EMERG MED, V21, P423, DOI 10.1016/S0736-4679(01)00408-5; Sagedal S, 2001, NEPHROL DIAL TRANSPL, V16, P987, DOI 10.1093/ndt/16.5.987; Salobir B, 2008, THER APHER DIAL, V12, P133, DOI 10.1111/j.1744-9987.2008.00558.x; Segarra A, 2001, J AM SOC NEPHROL, V12, P1255, DOI 10.1681/ASN.V1261255; Sidawy AN, 2002, J VASC SURG, V35, P603, DOI 10.1067/mva.2002.122025; Sioulis A, 2009, HIPPOKRATIA, V13, P237; Stolic RV, 2008, INT UROL NEPHROL, V40, P503, DOI 10.1007/s11255-007-9321-8; Trimarchi H, 2008, J VASC ACCESS, V9, P142, DOI 10.1177/112972980800900212	40	14	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67799	10.1371/journal.pone.0067799	http://dx.doi.org/10.1371/journal.pone.0067799			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844096	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000099
J	Shadrach, KG; Rayborn, ME; Hollyfield, JG; Bonilha, VL				Shadrach, Karen G.; Rayborn, Mary E.; Hollyfield, Joe G.; Bonilha, Vera L.			DJ-1-Dependent Regulation of Oxidative Stress in the Retinal Pigment Epithelium (RPE)	PLOS ONE			English	Article							MITOCHONDRIAL-DNA DAMAGE; PARKINSONISM PROTEIN DJ-1; MACULAR DEGENERATION AMD; EARLY-ONSET PARKINSONISM; AGE-RELATED MACULOPATHY; CYSTEINE-SULFINIC ACID; CELL-DEATH; ALPHA-SYNUCLEIN; ANTIOXIDATIVE STRESS; CEREBROSPINAL-FLUID	Background: DJ-1 is found in many tissues, including the brain, where it has been extensively studied due to its association with Parkinson's disease. DJ-1 functions as a redox-sensitive molecular chaperone and transcription regulator that robustly protects cells from oxidative stress. Methodology: Retinal pigment epithelial (RPE) cultures were treated with H2O2 for various times followed by biochemical and immunohistological analysis. Cells were transfected with adenoviruses carrying the full-length human DJ-1 cDNA and a mutant construct, which has the cysteine residues at amino acid 46, 53 and 106 mutated to serine (C to S) prior to stress experiments. DJ-1 localization, levels of expression and reactive oxygen species (ROS) generation were also analyzed in cells expressing exogenous DJ-1 under baseline and oxidative stress conditions. The presence of DJ-1 and oxidized DJ-1 was evaluated in human RPE total lysates. The distribution of DJ-1 was assessed in AMD and non-AMD cryosectionss and in isolated human Bruch's membrane (BM)/choroid from AMD eyes. Principal Findings: DJ-1 in RPE cells under baseline conditions, displays a diffuse cytoplasmic and nuclear staining. After oxidative challenge, more DJ-1 was associated with mitochondria. Increasing concentrations of H2O2 resulted in a dose-dependent increase in DJ-1. Overexpression of DJ-1 but not the C to S mutant prior to exposure to oxidative stress led to significant decrease in the generation of ROS. DJ-1 and oxDJ-1 intensity of immunoreactivity was significantly higher in the RPE lysates from AMD eyes. More DJ-1 was localized to RPE cells from AMD donors with geographic atrophy and DJ-1 was also present in isolated human BM/choroid from AMD eyes. Conclusions/Significance: DJ-1 regulates RPE responses to oxidative stress. Most importantly, increased DJ-1 expression prior to oxidative stress leads to decreased generation of ROS, which will be relevant for future studies of AMD since oxidative stress is a known factor affecting this disease.	[Shadrach, Karen G.; Rayborn, Mary E.; Hollyfield, Joe G.; Bonilha, Vera L.] Cleveland Clin, Lerner Coll Med, Cole Eye Inst, Dept Ophthalm Res, Cleveland, OH 44106 USA	Case Western Reserve University; Cleveland Clinic Foundation	Bonilha, VL (corresponding author), Cleveland Clin, Lerner Coll Med, Cole Eye Inst, Dept Ophthalm Res, Cleveland, OH 44106 USA.	bonilhav@ccf.org	Bonilha, Vera/AAS-8566-2020	Bonilha, Vera/0000-0002-6166-5124	NIH [EY014240]; The Foundation Fighting Blindness and Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY014240, R56EY014240] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Foundation Fighting Blindness and Research to Prevent Blindness; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by NIH grants EY014240, Research Center Grants from The Foundation Fighting Blindness and Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla MA, 2012, J CANCER, V3, P390, DOI 10.7150/jca.4280; Akazawa YO, 2010, NEUROSCI LETT, V483, P201, DOI 10.1016/j.neulet.2010.08.007; Anderson DH, 2001, AM J OPHTHALMOL, V131, P767, DOI 10.1016/S0002-9394(00)00961-2; Bando H, 2007, EXP EYE RES, V84, P135, DOI 10.1016/j.exer.2006.09.008; Bandopadhyay R, 2004, BRAIN, V127, P420, DOI 10.1093/brain/awh054; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Bitar MS, 2012, INVEST OPHTH VIS SCI, V53, P5806, DOI 10.1167/iovs.12-10119; Blackinton J, 2005, MOL BRAIN RES, V134, P76, DOI 10.1016/j.molbrainres.2004.09.004; Blackinton J, 2009, J BIOL CHEM, V284, P6476, DOI 10.1074/jbc.M806599200; Blasiak J, 2013, INT J MOL SCI, V14, P2996, DOI 10.3390/ijms14022996; BOK D, 1993, J CELL SCI, P189; Bonifati V, 2003, NEUROL SCI, V24, P159, DOI 10.1007/s10072-003-0108-0; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bonilha VL, 2013, EXP EYE RES, V111, P71, DOI 10.1016/j.exer.2013.03.017; Bonilha VL, 1999, J CELL BIOL, V147, P1533, DOI 10.1083/jcb.147.7.1533; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Cao GF, 2011, BIOCHEM BIOPH RES CO, V414, P499, DOI 10.1016/j.bbrc.2011.09.094; Chan CM, 2008, MOL VIS, V14, P2528; Chen M, 2008, INVEST OPHTH VIS SCI, V49, P3699, DOI 10.1167/iovs.07-1522; Chen Y, 2012, J CANCER RES CLIN, V138, P1463, DOI 10.1007/s00432-012-1205-3; Choi J, 2006, J BIOL CHEM, V281, P10816, DOI 10.1074/jbc.M509079200; Chong EWT, 2007, BMJ-BRIT MED J, V335, P755, DOI 10.1136/bmj.39350.500428.47; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; DAVIS AA, 1995, INVEST OPHTH VIS SCI, V36, P955; Ding XY, 2009, PROG RETIN EYE RES, V28, P1, DOI 10.1016/j.preteyeres.2008.10.001; Drobek-Slowik Monika, 2007, Postepy Hig Med Dosw (Online), V61, P28; Feher J, 2006, NEUROBIOL AGING, V27, P983, DOI 10.1016/j.neurobiolaging.2005.05.012; Gao X, 2011, DRUG TODAY, V47, P215, DOI 10.1358/dot.2011.47.3.1519657; George S, 2010, J MOL NEUROSCI, V42, P243, DOI 10.1007/s12031-010-9378-1; Gorner K, 2007, J BIOL CHEM, V282, P13680, DOI 10.1074/jbc.M609821200; Gonzalez-Polo RA, 2009, J NEUROCHEM, V109, P889, DOI 10.1111/j.1471-4159.2009.06020.x; Gu XR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038673; Hageman GS, 1999, FASEB J, V13, P477, DOI 10.1096/fasebj.13.3.477; Hod Y, 2004, J CELL BIOCHEM, V92, P1221, DOI 10.1002/jcb.20159; Hod Y, 1999, J CELL BIOCHEM, V72, P435, DOI 10.1002/(SICI)1097-4644(19990301)72:3<435::AID-JCB12>3.3.CO;2-8; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; Huang XS, 2013, CELL BIOCH FUNCT; Hulleman JD, 2007, BIOCHEMISTRY-US, V46, P5776, DOI 10.1021/bi7001778; Inberg A, 2010, J BIOL CHEM, V285, P25686, DOI 10.1074/jbc.M110.109751; Jarrett SG, 2008, PROG RETIN EYE RES, V27, P596, DOI 10.1016/j.preteyeres.2008.09.001; Jeong HJ, 2012, EXP MOL MED, V44, P586, DOI 10.3858/emm.2012.44.10.067; Joselin AP, 2012, HUM MOL GENET, V21, P4888, DOI 10.1093/hmg/dds325; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Kahle PJ, 2009, FREE RADICAL BIO MED, V47, P1354, DOI 10.1016/j.freeradbiomed.2009.08.003; Kenney MC, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-4; Kenney MC, 2010, INVEST OPHTH VIS SCI, V51, P4289, DOI 10.1167/iovs.09-4778; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kim SJ, 2012, BIOCHEM BIOPH RES CO, V422, P8, DOI 10.1016/j.bbrc.2012.04.063; Kinnunen K, 2012, ACTA OPHTHALMOL, V90, P299, DOI 10.1111/j.1755-3768.2011.02179.x; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Kitamura Y, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-48; Knobbe CB, 2011, J PROTEOME RES, V10, P4388, DOI 10.1021/pr200225c; Larsen NJ, 2011, NEUROSCIENCE, V196, P251, DOI 10.1016/j.neuroscience.2011.08.016; Lev N, 2008, NEUROTOXICOLOGY, V29, P397, DOI 10.1016/j.neuro.2008.01.007; Lev N, 2009, J NEURAL TRANSM, V116, P151, DOI 10.1007/s00702-008-0134-4; Liang FQ, 2003, EXP EYE RES, V76, P397, DOI 10.1016/S0014-4835(03)00023-X; Lin JS, 2012, BIOCHEMISTRY-US, V51, P3799, DOI 10.1021/bi3003296; Lisitskaya K. V., 2011, Biomeditsinskaya Khimiya, V57, P392; Malek G, 2003, AM J PATHOL, V162, P413, DOI 10.1016/S0002-9440(10)63836-9; Malhotra D, 2008, AM J RESP CRIT CARE, V178, P592, DOI 10.1164/rccm.200803-380OC; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; Meulener MC, 2006, P NATL ACAD SCI USA, V103, P12517, DOI 10.1073/pnas.0601891103; MICELI MV, 1994, EXP CELL RES, V214, P242, DOI 10.1006/excr.1994.1254; Mitsumoto A, 2001, FREE RADICAL RES, V35, P885, DOI 10.1080/10715760100301381; Mitsumoto A, 2001, FREE RADICAL RES, V35, P301, DOI 10.1080/10715760100300831; Mohan R, 2000, J BIOL CHEM, V275, P10405, DOI 10.1074/jbc.275.14.10405; Mueller EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030874; Mullett SJ, 2011, J NEUROCHEM, V117, P375, DOI 10.1111/j.1471-4159.2011.07175.x; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Nandrot EE, 2004, J EXP MED, V200, P1539, DOI 10.1084/jem.20041447; Nordgaard CL, 2006, INVEST OPHTH VIS SCI, V47, P815, DOI 10.1167/iovs.05-0976; Nordgaard CL, 2008, INVEST OPHTH VIS SCI, V49, P2848, DOI 10.1167/iovs.07-1352; Nowak JZ, 2006, PHARMACOL REP, V58, P353; Oda M, 2012, CANCER SCI, V103, P1172, DOI 10.1111/j.1349-7006.2012.02267.x; Ooe H, 2005, TOXICOL SCI, V88, P114, DOI 10.1093/toxsci/kfi278; Ooe H, 2006, NEUROSCI LETT, V404, P166, DOI 10.1016/j.neulet.2006.05.031; Ottolini D, 2013, HUM MOL GENET; Pardo M, 2006, INT J CANCER, V119, P1014, DOI 10.1002/ijc.21942; Parisi V, 2008, OPHTHALMOLOGY, V115, P324, DOI 10.1016/j.ophtha.2007.05.029; Park J, 2005, GENE, V361, P133, DOI 10.1016/j.gene.2005.06.040; Robert G, 2012, CELL DEATH DIFFER, V19, P1769, DOI 10.1038/cdd.2012.55; Saito Y, 2009, NEUROSCI LETT, V465, P1, DOI 10.1016/j.neulet.2009.08.074; Salvesen L, 2012, PARKINSONISM RELAT D, V18, P899, DOI 10.1016/j.parkreldis.2012.03.013; SanGiovanni JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005508; Santos JH, 2003, J BIOL CHEM, V278, P1728, DOI 10.1074/jbc.M208752200; Schutt F, 2007, KLIN MONATSBL AUGENH, V224, P580, DOI 10.1055/s-2007-963339; Shabalina IG, 2011, BIOCHEM SOC T, V39, P1305, DOI 10.1042/BST0391305; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Shi M, 2012, NEUROBIOL AGING, V33; Shimwell NJ, 2012, BRIT J CANCER, V107, P1595, DOI 10.1038/bjc.2012.405; Shinbo YM, 2005, INT J ONCOL, V26, P641; Stenirri S, 2012, CLIN CHEM LAB MED, V50, P1021, DOI 10.1515/cclm-2011-0854; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Takahashi-Niki K, 2004, BIOCHEM BIOPH RES CO, V320, P389, DOI 10.1016/j.bbrc.2004.05.187; Tanito M, 2009, J LIPID RES, V50, P807, DOI 10.1194/jlr.M800170-JLR200; TATE DJ, 1995, INVEST OPHTH VIS SCI, V36, P1271; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; van der Brug MP, 2008, P NATL ACAD SCI USA, V105, P10244, DOI 10.1073/pnas.0708518105; Wilson MA, 2011, ANTIOXID REDOX SIGN, V15, P111, DOI 10.1089/ars.2010.3481; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Yamashita S, 2010, J NEUROCHEM, V113, P860, DOI 10.1111/j.1471-4159.2010.06658.x; Yokota T, 2003, BIOCHEM BIOPH RES CO, V312, P1342, DOI 10.1016/j.bbrc.2003.11.056; Yoshida K, 2003, MOL REPROD DEV, V66, P391, DOI 10.1002/mrd.10360; Zeng HZ, 2011, INT J MOL SCI, V12, P3489, DOI 10.3390/ijms12063489; Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211; Zhong N, 2006, J BIOL CHEM, V281, P20940, DOI 10.1074/jbc.M601935200; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030; Zhou WB, 2005, J BIOL CHEM, V280, P43150, DOI 10.1074/jbc.M507124200	111	36	38	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67983	10.1371/journal.pone.0067983	http://dx.doi.org/10.1371/journal.pone.0067983			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844142	Green Published, gold			2022-12-27	WOS:000321341000126
J	Shaffer, TL; Balder, R; Buskirk, SW; Hogan, RJ; Lafontaine, ER				Shaffer, Teresa L.; Balder, Rachel; Buskirk, Sean W.; Hogan, Robert J.; Lafontaine, Eric R.			Use of the Chinchilla Model to Evaluate the Vaccinogenic Potential of the Moraxella catarrhalis Filamentous Hemagglutinin-like Proteins MhaB1 and MhaB2	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; NONTYPABLE HAEMOPHILUS-INFLUENZAE; PNEUMOCOCCAL CONJUGATE VACCINE; OBSTRUCTIVE PULMONARY-DISEASE; BRO BETA-LACTAMASE; ACUTE MAXILLARY SINUSITIS; HUMAN EPITHELIAL-CELLS; HUMAN IMMUNE-RESPONSE; ACUTE OTITIS-MEDIA; BRANHAMELLA-CATARRHALIS	Moraxella catarrhalis causes significant health problems, including 15-20% of otitis media cases in children and,10% of respiratory infections in adults with chronic obstructive pulmonary disease. The lack of an efficacious vaccine, the rapid emergence of antibiotic resistance in clinical isolates, and high carriage rates reported in children are cause for concern. In addition, the effectiveness of conjugate vaccines at reducing the incidence of otitis media caused by Streptococcus pneumoniae and nontypeable Haemophilus influenzae suggest that M. catarrhalis infections may become even more prevalent. Hence, M. catarrhalis is an important and emerging cause of infectious disease for which the development of a vaccine is highly desirable. Studying the pathogenesis of M. catarrhalis and the testing of vaccine candidates have both been hindered by the lack of an animal model that mimics human colonization and infection. To address this, we intranasally infected chinchilla with M. catarrhalis to investigate colonization and examine the efficacy of a protein-based vaccine. The data reveal that infected chinchillas produce antibodies against antigens known to be major targets of the immune response in humans, thus establishing immune parallels between chinchillas and humans during M. catarrhalis infection. Our data also demonstrate that a mutant lacking expression of the adherence proteins MhaB1 and MhaB2 is impaired in its ability to colonize the chinchilla nasopharynx, and that immunization with a polypeptide shared by MhaB1 and MhaB2 elicits antibodies interfering with colonization. These findings underscore the importance of adherence proteins in colonization and emphasize the relevance of the chinchilla model to study M. catarrhalis-host interactions.	[Shaffer, Teresa L.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Balder, Rachel; Buskirk, Sean W.; Hogan, Robert J.; Lafontaine, Eric R.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA; [Hogan, Robert J.] Univ Georgia, Dept Vet Biosci & Diagnost Imaging, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Lafontaine, ER (corresponding author), Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA.	elafon10@uga.edu	Buskirk, Sean/AAM-1228-2021	Buskirk, Sean/0000-0003-1213-8130	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) [AI051477]; University of Georgia's College of Veterinary Medicine and Office of the Vice President for Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI051477, R01AI051477] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Georgia's College of Veterinary Medicine and Office of the Vice President for Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a grant from National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) (AI051477) and start-up funds from the University of Georgia's College of Veterinary Medicine and Office of the Vice President for Research to ERL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi C, 1998, INFECT IMMUN, V66, P3113, DOI 10.1128/IAI.66.7.3113-3119.1998; Ahmed A, 2008, PEDIATR INFECT DIS J, V27, P459, DOI 10.1097/INF.0b013e3181646d82; Akimana C, 2007, FEMS MICROBIOL LETT, V271, P12, DOI 10.1111/j.1574-6968.2007.00693.x; Arguedas A, 2010, INT J PEDIATR OTORHI, V74, P1419, DOI 10.1016/j.ijporl.2010.09.022; Armbruster CE, 2010, MBIO, V1, DOI 10.1128/mBio.00102-10; Bakaletz LO, 2009, EXPERT REV VACCINES, V8, P1063, DOI 10.1586/ERV.09.63; Bakaletz Lauren O., 1995, Trends in Microbiology, V3, P110, DOI 10.1016/S0966-842X(00)88892-7; BAKALETZ LO, 1993, J INFECT DIS, V168, P865, DOI 10.1093/infdis/168.4.865; Bakaletz LO, 1999, INFECT IMMUN, V67, P2746, DOI 10.1128/IAI.67.6.2746-2762.1999; BAKALETZ LO, 1995, INFECT IMMUN, V63, P4188, DOI 10.1128/IAI.63.10.4188-4190.1995; Balder R, 2007, INFECT IMMUN, V75, P2765, DOI 10.1128/IAI.00079-07; Balder R, 2009, INFECT IMMUN, V77, P4597, DOI 10.1128/IAI.00212-09; BEACHEY EH, 1981, J INFECT DIS, V143, P325, DOI 10.1093/infdis/143.3.325; Becker PD, 2007, INFECT IMMUN, V75, P1778, DOI 10.1128/IAI.01081-06; BERMAN S, 1995, PEDIATRICS, V96, P126; Berner R, 1996, EUR J CLIN MICROBIOL, V15, P506, DOI 10.1007/BF01691320; Bingen E, 2005, PEDIATR INFECT DIS J, V24, P731, DOI 10.1097/01.inf.0000172939.13159.3b; Bookwalter JE, 2008, INFECT IMMUN, V76, P48, DOI 10.1128/IAI.00980-07; Bootsma HJ, 1999, J BACTERIOL, V181, P5090, DOI 10.1128/JB.181.16.5090-5093.1999; Bootsma HJ, 2000, MOL MICROBIOL, V36, P93, DOI 10.1046/j.1365-2958.2000.01828.x; Boyle EC, 2003, CURR OPIN CELL BIOL, V15, P633, DOI 10.1016/S0955-0674(03)00099-1; Brockson ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040088; Brook I, 2005, OTOLARYNG CLIN N AM, V38, P1171, DOI 10.1016/j.otc.2005.08.007; Brook I, 2005, ANN OTO RHINOL LARYN, V114, P573, DOI 10.1177/000348940511400714; Brook I, 2005, J LARYNGOL OTOL, V119, P251, DOI 10.1258/0022215054020304; Brook I, 2007, INT J PEDIATR OTORHI, V71, P575, DOI 10.1016/j.ijporl.2006.10.025; Brook I, 2006, J MED MICROBIOL, V55, P943, DOI 10.1099/jmm.0.46346-0; Brooks MJ, 2008, INFECT IMMUN, V76, P5322, DOI 10.1128/IAI.00572-08; Bullard B, 2005, INFECT IMMUN, V73, P5127, DOI 10.1128/IAI.73.8.5127-5136.2005; Buznach N, 2005, PEDIATR INFECT DIS J, V24, P823, DOI 10.1097/01.inf.0000178066.24569.98; CATLIN BW, 1990, CLIN MICROBIOL REV, V3, P293, DOI 10.1128/CMR.3.4.293-320.1990; Chen DX, 1999, INFECT IMMUN, V67, P1310, DOI 10.1128/IAI.67.3.1310-1316.1999; Christensen J J, 1999, APMIS Suppl, V88, P1; Cope LD, 1999, J BACTERIOL, V181, P4026, DOI 10.1128/JB.181.13.4026-4034.1999; Cripps AW, 2005, VACCINE, V23, P2304, DOI 10.1016/j.vaccine.2005.01.023; DELBECCARO MA, 1992, J PEDIATR-US, V120, P81, DOI 10.1016/S0022-3476(05)80605-5; Enright MC, 1997, J MED MICROBIOL, V46, P360, DOI 10.1099/00222615-46-5-360; Esel D, 2007, CLIN MICROBIOL INFEC, V13, P1023, DOI 10.1111/j.1469-0691.2007.01776.x; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Faden H, 1997, J INFECT DIS, V175, P1440, DOI 10.1086/516477; FADEN H, 1990, PEDIATR INFECT DIS J, V9, P623; FADEN H, 1994, J INFECT DIS, V169, P1312, DOI 10.1093/infdis/169.6.1312; Faden H, 2001, EUR J PEDIATR, V160, P407, DOI 10.1007/s004310100754; Forsgren A, 2008, CLIN INFECT DIS, V46, P726, DOI 10.1086/527396; Garcia-Rodriguez JA, 2002, J ANTIMICROB CHEMOTH, V50, P59, DOI 10.1093/jac/dkf506; Gerlach RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/j.ijmm.2007.03.017; Giebink GS, 1999, MICROB DRUG RESIST, V5, P57, DOI 10.1089/mdr.1999.5.57; Giebink GS, 2005, ANN OTO RHINOL LARYN, V114, P86, DOI 10.1177/00034894051140S110; Giebink GS, 1997, ANN NY ACAD SCI, V830, P330, DOI 10.1111/j.1749-6632.1997.tb51906.x; Harris RH, 2004, J BIOL CHEM, V279, P20250, DOI 10.1074/jbc.M400499200; Hauck CR, 2002, MED MICROBIOL IMMUN, V191, P55, DOI 10.1007/s00430-002-0119-0; HELMINEN ME, 1993, INFECT IMMUN, V61, P2003, DOI 10.1128/IAI.61.5.2003-2010.1993; Hill DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045452; Hill DJ, 2003, MOL MICROBIOL, V48, P117, DOI 10.1046/j.1365-2958.2003.03433.x; Holm MM, 2004, INFECT IMMUN, V72, P1906, DOI 10.1128/IAI.72.4.1906-1913.2004; Holm MM, 2003, INFECT IMMUN, V71, P4977, DOI 10.1128/IAI.71.9.4977-4984.2003; Hoopman TC, 2012, INFECT IMMUN, V80, P982, DOI 10.1128/IAI.05918-11; Hunter MH, 2001, AM FAM PHYSICIAN, V64, P603; Hurd S, 2000, CHEST, V117, P1; Jacob-Dubuisson F, 2001, MOL MICROBIOL, V40, P306, DOI 10.1046/j.1365-2958.2001.02278.x; Jacobs MR, 2004, CLIN LAB MED, V24, P503, DOI 10.1016/j.cll.2004.03.008; Johnson DM, 2003, DIAGN MICR INFEC DIS, V47, P373, DOI 10.1016/S0732-8893(03)00089-0; Kadry AA, 2003, INT J ANTIMICROB AG, V22, P532, DOI 10.1016/S0924-8579(03)00158-4; Karalus R, 2000, MICROBES INFECT, V2, P547, DOI 10.1016/S1286-4579(00)00314-2; Kennedy BJ, 2000, INFECT IMMUN, V68, P2756, DOI 10.1128/IAI.68.5.2756-2765.2000; Kerschner JE, 2010, INT J PEDIATR OTORHI, V74, P980, DOI 10.1016/j.ijporl.2010.05.009; Kerschner JE, 2010, ANN OTO RHINOL LARYN, V119, P270, DOI 10.1177/000348941011900411; Kerschner JE, 2009, ARCH OTOLARYNGOL, V135, P33, DOI 10.1001/archoto.2008.513; Klein J O, 1992, Adv Pediatr, V39, P127; KLEIN JO, 1994, CLIN INFECT DIS, V19, P823, DOI 10.1093/clinids/19.5.823; Klein JO, 2000, VACCINE, V19, pS2, DOI 10.1016/S0264-410X(00)00271-1; Klugman KP, 1996, J ANTIMICROB CHEMOTH, V38, P133, DOI 10.1093/jac/38.suppl_A.133; Kyd JM, 1998, J MED MICROBIOL, V47, P159, DOI 10.1099/00222615-47-2-159; Lafontaine ER, 2000, J BACTERIOL, V182, P1364, DOI 10.1128/JB.182.5.1364-1373.2000; LaFontaine ER, 2009, CLIN VACCINE IMMUNOL, V16, P653, DOI 10.1128/CVI.00460-08; Lieberthal AS, 2004, PEDIATRICS, V113, P1451, DOI 10.1542/peds.113.5.1451; Lipski SL, 2007, INFECT IMMUN, V75, P314, DOI 10.1128/IAI.01330-06; Liu DF, 2007, INFECT IMMUN, V75, P2818, DOI 10.1128/IAI.00074-07; Luke NR, 2007, INFECT IMMUN, V75, P5559, DOI 10.1128/IAI.00946-07; MACIVER I, 1993, J INFECT DIS, V168, P469, DOI 10.1093/infdis/168.2.469; Manninen R, 1997, J ANTIMICROB CHEMOTH, V40, P387, DOI 10.1093/jac/40.3.387; Mathers K, 1999, PEDIATR INFECT DIS J, V18, P982, DOI 10.1097/00006454-199911000-00010; McGillivary G, 2007, MOL IMMUNOL, V44, P2446, DOI 10.1016/j.molimm.2006.10.008; McGillivary G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013224; McGillivary G, 2009, CELL MICROBIOL, V11, P1399, DOI 10.1111/j.1462-5822.2009.01339.x; Meier PS, 2006, FEMS MICROBIOL LETT, V262, P72, DOI 10.1111/j.1574-6968.2006.00365.x; Meier PS, 2003, PEDIATR INFECT DIS J, V22, P256, DOI 10.1097/00006454-200303000-00011; Meier PS, 2003, INFECT IMMUN, V71, P6793, DOI 10.1128/IAI.71.12.6793-6798.2003; Miyamoto N, 1997, MICROB PATHOGENESIS, V23, P119, DOI 10.1006/mpat.1997.0140; MURPHY TF, 1989, MICROB PATHOGENESIS, V6, P159, DOI 10.1016/0882-4010(89)90066-1; Murphy TF, 2005, INFECT IMMUN, V73, P8161, DOI 10.1128/IAI.73.12.8161-8166.2005; Murphy TF, 2005, AM J RESP CRIT CARE, V172, P195, DOI 10.1164/rccm.200412-1747OC; Murphy TF, 2005, INFECT IMMUN, V73, P3471, DOI 10.1128/IAI.73.6.3471-3478.2005; Murphy TF, 1999, INFECT IMMUN, V67, P4578, DOI 10.1128/IAI.67.9.4578-4585.1999; Murphy TF, 2003, INFECT IMMUN, V71, P1288, DOI 10.1128/IAI.71.3.1288-1294.2003; Murphy TF, 1996, MICROBIOL REV, V60, P267, DOI 10.1128/MMBR.60.2.267-279.1996; Murphy TF, 1998, J INFECT DIS, V178, P1667, DOI 10.1086/314501; Murphy TF, 2005, EXPERT REV VACCINES, V4, P843, DOI 10.1586/14760584.4.6.843; Neumayer U, 1999, J HEART VALVE DIS, V8, P114; Niemann HH, 2004, MICROBES INFECT, V6, P101, DOI 10.1016/j.micinf.2003.11.001; Nigrovic LE, 2008, ACAD EMERG MED, V15, P522, DOI 10.1111/j.1553-2712.2008.00117.x; NIH-NHLBI website, MORB MORT 2009 CHART; Novotny LA, 2000, INFECT IMMUN, V68, P2119, DOI 10.1128/IAI.68.4.2119-2128.2000; PATRICK CC, 1987, INFECT IMMUN, V55, P2902, DOI 10.1128/IAI.55.12.2902-2911.1987; Pearson MM, 2002, INFECT IMMUN, V70, P4523, DOI 10.1128/IAI.70.8.4523-4533.2002; Peng DX, 2005, INFECT IMMUN, V73, P4222, DOI 10.1128/IAI.73.7.4222-4230.2005; Pichichero Michael E, 2002, Expert Opin Pharmacother, V3, P1073; Plamondon P, 2007, INFECT IMMUN, V75, P2929, DOI 10.1128/IAI.00396-07; Prymula R, 2006, LANCET, V367, P740, DOI 10.1016/S0140-6736(06)68304-9; Revai K, 2006, PEDIATRICS, V117, P1823, DOI 10.1542/peds.2005-1983; Richter SS, 2000, ANTIMICROB AGENTS CH, V44, P444, DOI 10.1128/AAC.44.2.444-446.2000; RUUSKANEN O, 1994, PEDIATR INFECT DIS J, V13, pS23, DOI 10.1097/00006454-199401001-00006; Sambrook J., 2001, MOL CLONING LAB MANU; Schmitz FJ, 2002, J CLIN MICROBIOL, V40, P1546, DOI 10.1128/JCM.40.4.1546-1548.2002; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Sethi S, 2001, CLIN MICROBIOL REV, V14, P336, DOI 10.1128/CMR.14.2.336-363.2001; Song JM, 2010, VIROLOGY, V405, P165, DOI 10.1016/j.virol.2010.05.034; St Geme J W 3rd, 1997, Adv Pediatr, V44, P43; Stefanou J, 2000, SCAND J INFECT DIS, V32, P217, DOI 10.1080/003655400750045394; STOOL SE, 1989, PEDIATR INFECT DIS J, V8, pS11; Strassels SA, 2001, CHEST, V119, P344, DOI 10.1378/chest.119.2.344; Sullivan SD, 2000, CHEST, V117, P5; SUZUKI K, 1994, INFECT IMMUN, V62, P1710, DOI 10.1128/IAI.62.5.1710-1718.1994; Thorsson B, 1998, SCAND J INFECT DIS, V30, P105, DOI 10.1080/003655498750003447; Timpe JM, 2003, INFECT IMMUN, V71, P4341, DOI 10.1128/IAI.71.8.4341-4350.2003; TURNER HR, 1985, SOUTHERN MED J, V78, P1021, DOI 10.1097/00007611-198508000-00041; UNHANAND M, 1992, J INFECT DIS, V165, P644, DOI 10.1093/infdis/165.4.644; Utsunomiya T, 1984, Nihon Naika Gakkai Zasshi, V73, P1506; Verduin CM, 2002, CLIN MICROBIOL REV, V15, P125, DOI 10.1128/CMR.15.1.125-144.2002; World Health Organization, 2004, CHRON SUPP OT MED CS; World Health Organization website, 2008, FACT SHEET TOP 10 CA; World Health Organization website, WORLD HLTH STAT 2008	132	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67881	10.1371/journal.pone.0067881	http://dx.doi.org/10.1371/journal.pone.0067881			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844117	Green Submitted, gold, Green Published			2022-12-27	WOS:000321341000113
J	Proenca, CC; Stoehr, N; Bernhard, M; Seger, S; Genoud, C; Roscic, A; Paganetti, P; Liu, SM; Murphy, LO; Kuhn, R; Bouwmeester, T; Galimberti, I				Proenca, Catia C.; Stoehr, Natacha; Bernhard, Mario; Seger, Shanon; Genoud, Christel; Roscic, Ana; Paganetti, Paolo; Liu, Shanming; Murphy, Leon O.; Kuhn, Rainer; Bouwmeester, Tewis; Galimberti, Ivan			Atg4b-Dependent Autophagic Flux Alleviates Huntington's Disease Progression	PLOS ONE			English	Article							HIPPOCAMPAL SLICE CULTURES; AGGREGATE-PRONE PROTEINS; NEURODEGENERATIVE DISEASES; MUTANT HUNTINGTIN; MTOR INHIBITORS; MOUSE MODELS; CLEARANCE; POLYGLUTAMINE; DISORDERS; INDUCTION	The accumulation of aggregated mutant huntingtin (mHtt) inclusion bodies is involved in Huntigton's disease (HD) progression. Medium sized-spiny neurons (MSNs) in the corpus striatum are highly vulnerable to mHtt aggregate accumulation and degeneration, but the mechanisms and pathways involved remain elusive. Here we have developed a new model to study MSNs degeneration in the context of HD. We produced organotypic cortico-striatal slice cultures (CStS) from HD transgenic mice mimicking specific features of HD progression. We then show that induction of autophagy using catalytic inhibitors of mTOR prevents MSNs degeneration in HD CStS. Furthermore, disrupting autophagic flux by overexpressing Atg4b in neurons and slice cultures, accelerated mHtt aggregation and neuronal death, suggesting that Atg4b-dependent autophagic flux influences HD progression. Under these circumstances induction of autophagy using catalytic inhibitors of mTOR was inefficient and did not affect mHtt aggregate accumulation and toxicity, indicating that mTOR inhibition alleviates HD progression by inducing Atg4b-dependent autophagic flux. These results establish modulators of Atg4b-dependent autophagic flux as new potential targets in the treatment of HD.	[Proenca, Catia C.; Stoehr, Natacha; Bernhard, Mario; Liu, Shanming; Murphy, Leon O.; Bouwmeester, Tewis; Galimberti, Ivan] Novartis Inst Biomed Res, Dev & Mol Pathways, Basel, Switzerland; [Seger, Shanon; Roscic, Ana; Paganetti, Paolo; Kuhn, Rainer] Novartis Pharma AG Basel, Basel, Switzerland; [Genoud, Christel] Friedrich Miescher Inst Basel, Basel, Switzerland	Novartis; Novartis; Friedrich Miescher Institute for Biomedical Research	Galimberti, I (corresponding author), Novartis Inst Biomed Res, Dev & Mol Pathways, Basel, Switzerland.	ivan.galimberti@novartis.com	Paganetti, Paolo/AAF-8039-2020	genoud, christel/0000-0002-0933-9911; Paganetti, Paolo/0000-0003-1896-6324	Novartis	Novartis(Novartis)	All the work was funded by Novartis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 2010, TRENDS NEUROSCI, V33, P541, DOI 10.1016/j.tins.2010.09.001; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Codogno P, 2012, NAT REV MOL CELL BIO, V13, P7, DOI 10.1038/nrm3249; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; de Almeida LP, 2002, J NEUROSCI, V22, P3473; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; Fox JH, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-26; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Fujita N, 2009, AUTOPHAGY, V5, P88, DOI 10.4161/auto.5.1.7183; Galimberti I, 2006, NEURON, V50, P749, DOI 10.1016/j.neuron.2006.04.026; Galimberti I, 2010, NEURON, V65, P627, DOI 10.1016/j.neuron.2010.02.016; Ginovart N, 1997, BRAIN, V120, P503, DOI 10.1093/brain/120.3.503; Gogolla N, 2006, NAT PROTOC, V1, P1165, DOI 10.1038/nprot.2006.168; Gogolla N, 2006, NAT PROTOC, V1, P2452, DOI 10.1038/nprot.2006.180; Heng MY, 2008, NEUROBIOL DIS, V32, P1, DOI 10.1016/j.nbd.2008.06.005; Horne EA, 2013, EUR J NEUROSCI, V37, P429, DOI 10.1111/ejn.12045; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Klapstein GJ, 2001, J NEUROPHYSIOL, V86, P2667, DOI 10.1152/jn.2001.86.6.2667; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nakamura K, 2007, DRUG TODAY, V43, P97, DOI 10.1358/dot.2007.43.2.1050788; Nyfeler B, 2012, METHODS MOL BIOL, V821, P239, DOI 10.1007/978-1-61779-430-8_14; Nyfeler B, 2011, MOL CELL BIOL, V31, P2867, DOI 10.1128/MCB.05430-11; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Ravikumar Brinda, 2006, Molecular Aspects of Medicine, V27, P520, DOI 10.1016/j.mam.2006.08.008; Regulier Etienne, 2004, V277, P199; Renna M, 2010, J BIOL CHEM, V285, P11061, DOI 10.1074/jbc.R109.072181; Roscic A, 2011, J NEUROCHEM, V119, P398, DOI 10.1111/j.1471-4159.2011.07435.x; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Sarkar S, 2009, METHOD ENZYMOL, V453, P83, DOI 10.1016/S0076-6879(08)04005-6; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tabrizi SJ, 2012, LANCET NEUROL, V11, P42, DOI 10.1016/S1474-4422(11)70263-0; TELLEZNAGEL I, 1974, J NEUROPATH EXP NEUR, V33, P308, DOI 10.1097/00005072-197404000-00008; Turmaine M, 2000, P NATL ACAD SCI USA, V97, P8093, DOI 10.1073/pnas.110078997; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Weiss A, 2008, J NEUROCHEM, V104, P846, DOI 10.1111/j.1471-4159.2007.05032.x; Wiltfang J, 1997, ELECTROPHORESIS, V18, P527, DOI 10.1002/elps.1150180332; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x	45	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68357	10.1371/journal.pone.0068357	http://dx.doi.org/10.1371/journal.pone.0068357			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861892	Green Submitted, gold, Green Published			2022-12-27	WOS:000321692000024
J	Monette, A; Valiente-Echeverria, F; Rivero, M; Cohen, EA; Lopez-Lastra, M; Mouland, AJ				Monette, Anne; Valiente-Echeverria, Fernando; Rivero, Matias; Cohen, Eric A.; Lopez-Lastra, Marcelo; Mouland, Andrew J.			Dual Mechanisms of Translation Initiation of the Full-Length HIV-1 mRNA Contribute to Gag Synthesis	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CAP-INDEPENDENT TRANSLATION; RIBOSOME ENTRY SITE; HOST PROTEIN-SYNTHESIS; EUKARYOTIC TRANSLATION; POLY(A)-BINDING PROTEIN; GENOMIC RNA; 5-UNTRANSLATED REGION; MEDIATED TRANSLATION; EFFICIENT CLEAVAGE	The precursor group-specific antigen (wpr55(Gag)) is central to HIV-1 assembly. Its expression alone is sufficient to assemble into virus-like particles. It also selects the genomic RNA for encapsidation and is involved in several important virus-host interactions for viral assembly and restriction, making its synthesis essential for aspects of viral replication. Here, we show that the initiation of translation of the HIV-1 genomic RNA is mediated through both a cap-dependent and an internal ribosome entry site (IRES)-mediated mechanisms. In support of this notion, pr55(Gag) synthesis was maintained at 70% when cap-dependent translation initiation was blocked by the expression of elF4G- and PABP targeting viral proteases in two in vitro systems and in HIV-1-expressing cells directly infected with poliovirus. While our data reveal that IRES-dependent translation of the viral genomic RNA ensures pr55(Gag) expression, the synthesis of other HIV-1 proteins, including that of pr160(Gag/Pol), Vpr and Tat is suppressed early during progressive poliovirus infection. The data presented herein implies that the unspliced HIV-1 genomic RNA utilizes both cap-dependent and IRES-dependent translation initiation to supply pr55(Gag) for virus assembly and production.	[Monette, Anne; Valiente-Echeverria, Fernando; Mouland, Andrew J.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, HIV Trafficking Lab 1, Montreal, PQ H3T 1E2, Canada; [Monette, Anne; Valiente-Echeverria, Fernando; Mouland, Andrew J.] McGill Univ, Dept Med, Div Expt Med, Montreal, PQ, Canada; [Rivero, Matias; Lopez-Lastra, Marcelo] Pontificia Univ Catolica Chile, Escuela Med, Ctr Invest Med, Inst Milenio Inmunol & Inmunoterapia,Lab Virol Mo, Santiago, Chile; [Cohen, Eric A.] Inst Rech Clin Montreal, Lab Human Retrovirol, Montreal, PQ, Canada; [Mouland, Andrew J.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University; Pontificia Universidad Catolica de Chile; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University	Lopez-Lastra, M (corresponding author), Pontificia Univ Catolica Chile, Escuela Med, Ctr Invest Med, Inst Milenio Inmunol & Inmunoterapia,Lab Virol Mo, Alameda 340, Santiago, Chile.	malopez@med.puc.cl; andrew.mouland@mcgill.ca	Valiente-Echeverria, Fernando/I-6881-2018; Lopez-Lastra, Marcelo/HHM-9832-2022	Valiente-Echeverria, Fernando/0000-0001-9156-2516; Lopez-Lastra, Marcelo/0000-0002-7936-8478	Canadian Institutes of Health Research (CIHR) Doctoral Award; Becas Chile-Conicyt; Canada Research Chair in Human Retrovirology; McGill Fraser; Monat and MacPherson career award; Fondo Nacional de Ciencia y Tecnologia, Gobierno de Chile (FONDECYT) [1090318, 1130270]; Programa ICM through Proyecto Instituto Milenio [P09/016-F]; CIHR [HET-85519, MOP-56974]	Canadian Institutes of Health Research (CIHR) Doctoral Award(Canadian Institutes of Health Research (CIHR)); Becas Chile-Conicyt; Canada Research Chair in Human Retrovirology; McGill Fraser; Monat and MacPherson career award; Fondo Nacional de Ciencia y Tecnologia, Gobierno de Chile (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Programa ICM through Proyecto Instituto Milenio; CIHR(Canadian Institutes of Health Research (CIHR))	AM is a recipient of a Canadian Institutes of Health Research (CIHR) Doctoral Award; FVE is supported by a Postdoctoral Fellowship award from Becas Chile-Conicyt; EAC is a Canada Research Chair in Human Retrovirology and AJM is the recipient of a McGill Fraser, Monat and MacPherson career award. This work is supported by grant Fondo Nacional de Ciencia y Tecnologia, Gobierno de Chile (FONDECYT) Nos 1090318 and 1130270 to MLL, the Programa ICM through Proyecto Instituto Milenio P09/016-F IMII to MLL, and grants from the CIHR to EAC (#HET-85519) and to AJM (#MOP-56974). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDABE R, 1995, BIOCHEM BIOPH RES CO, V215, P928, DOI 10.1006/bbrc.1995.2553; Alvarez E, 2006, BIOCHEM J, V396, P219, DOI 10.1042/BJ20060108; Alvarez E, 2003, J VIROL, V77, P12392, DOI 10.1128/JVI.77.23.12392-12400.2003; Balvay L, 2007, NAT REV MICROBIOL, V5, P128, DOI 10.1038/nrmicro1599; Batonick M, 2005, VIROLOGY, V342, P190, DOI 10.1016/j.virol.2005.08.001; Bellodi C, 2010, EMBO J, V29, P1865, DOI 10.1038/emboj.2010.83; Berkhout B, 2011, NUCLEIC ACIDS RES, V39, P5232, DOI 10.1093/nar/gkr113; Bonderoff JM, 2008, J VIROL, V82, P9389, DOI 10.1128/JVI.00006-08; Brasey A, 2003, J VIROL, V77, P3939, DOI 10.1128/JVI.77.7.3939-3949.2003; Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; Buck CB, 2001, J VIROL, V75, P181, DOI 10.1128/JVI.75.1.181-191.2001; Camus G, 2007, MOL BIOL CELL, V18, P3193, DOI 10.1091/mbc.E06-12-1147; Castello A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/369648; Castello A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007997; Charnay N, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-74; COHEN EA, 1990, J ACQ IMMUN DEF SYND, V3, P601; de Breyne S, 2013, VIRUS RES; Dong XH, 2005, CELL, V120, P663, DOI 10.1016/j.cell.2004.12.023; Foeger N, 2005, FEBS J, V272, P2602, DOI 10.1111/j.1742-4658.2005.04689.x; FUERST TR, 1989, J MOL BIOL, V206, P333, DOI 10.1016/0022-2836(89)90483-X; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Gaudin R, 2012, J CELL BIOL, V199, P467, DOI 10.1083/jcb.201201144; Gendron K, 2011, NUCLEIC ACIDS RES, V39, P902, DOI 10.1093/nar/gkq885; Gilbert WV, 2007, SCIENCE, V317, P1224, DOI 10.1126/science.1144467; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Gottlinger HG, 2001, AIDS, V15, pS13; Gradi A, 2004, J VIROL, V78, P3271, DOI 10.1128/JVI.78.7.3271-3278.2004; Gradi A, 1998, P NATL ACAD SCI USA, V95, P11089, DOI 10.1073/pnas.95.19.11089; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Houck-Loomis B, 2011, NATURE, V480, P561, DOI 10.1038/nature10657; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jackson RJ, 1995, CURR TOP MICROBIOL, V203, P1; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Kemler I, 2010, J VIROL, V84, P6352, DOI 10.1128/JVI.00363-10; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Kuyumcu-Martinez NM, 2002, J VIROL, V76, P2062, DOI 10.1128/JVI.76.5.2062-2074.2002; Lehmann M, 2009, J BIOL CHEM, V284, P14572, DOI 10.1074/jbc.M808531200; Levesque K, 2006, TRAFFIC, V7, P1177, DOI 10.1111/j.1600-0854.2006.00461.x; Lopez-Lastra M, 2010, REV MED VIROL, V20, P177, DOI 10.1002/rmv.649; Lu K, 2011, SCIENCE, V334, P242, DOI 10.1126/science.1210460; MEDINA M, 1993, VIROLOGY, V194, P355, DOI 10.1006/viro.1993.1267; Miele G, 1996, J VIROL, V70, P944, DOI 10.1128/JVI.70.2.944-951.1996; Molle D, 2009, J BIOL CHEM, V284, P19727, DOI 10.1074/jbc.M109.019844; Monette A, 2009, J BIOL CHEM, V284, P31350, DOI 10.1074/jbc.M109.048736; Mouland AJ, 2002, VIROLOGY, V292, P321, DOI 10.1006/viro.2001.1261; MOULAND AJ, 1992, MOL ENDOCRINOL, V6, P1781, DOI 10.1210/me.6.11.1781; Ohlmann T, 2002, J MOL BIOL, V318, P9, DOI 10.1016/S0022-2836(02)00070-0; OHLMANN T, 1995, NUCLEIC ACIDS RES, V23, P334; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Perales C, 2003, FEBS LETT, V533, P89, DOI 10.1016/S0014-5793(02)03764-X; Plank TD, 2013, NUCL ACIDS IN PRESS; Poole E, 2005, TRAFFIC, V6, P741, DOI 10.1111/j.1600-0854.2005.00312.x; Prevot D, 2003, BIOL CELL, V95, P141, DOI 10.1016/S0248-4900(03)00031-5; Ricci EP, 2008, BIOCHEM SOC T, V36, P690, DOI 10.1042/BST0360690; Rivas-Aravena A, 2009, VIROLOGY, V392, P178, DOI 10.1016/j.virol.2009.06.050; Scarlata S, 2003, BBA-BIOMEMBRANES, V1614, P62, DOI 10.1016/S0005-2736(03)00163-9; SCHWARTZ S, 1992, MOL CELL BIOL, V12, P207, DOI 10.1128/MCB.12.1.207; Smith RWP, 2010, BIOCHEM J, V426, P1, DOI 10.1042/BJ20091571; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Strong R, 2004, J GEN VIROL, V85, P2953, DOI 10.1099/vir.0.80254-0; Svitkin YV, 2005, MOL CELL BIOL, V25, P10556, DOI 10.1128/MCB.25.23.10556-10565.2005; Valiente-Echeverria F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056962; Vallejos M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035031; Vallejos M, 2011, NUCLEIC ACIDS RES, V39, P6186, DOI 10.1093/nar/gkr189; Vallejos M, 2010, NUCLEIC ACIDS RES, V38, P618, DOI 10.1093/nar/gkp890; Walsh D, 2011, NAT REV MICROBIOL, V9, P860, DOI 10.1038/nrmicro2655; Weill L, 2010, NUCLEIC ACIDS RES, V38, P1367, DOI 10.1093/nar/gkp1109; Wilker EW, 2007, NATURE, V446, P329, DOI 10.1038/nature05584; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; Yao XJ, 1998, J VIROL, V72, P4686, DOI 10.1128/JVI.72.6.4686-4693.1998	70	37	37	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68108	10.1371/journal.pone.0068108	http://dx.doi.org/10.1371/journal.pone.0068108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861855	Green Submitted, gold, Green Published			2022-12-27	WOS:000321425300043
J	Verliin, A; Ojaveer, H; Kaju, K; Tammiksaar, E				Verliin, Aare; Ojaveer, Henn; Kaju, Katre; Tammiksaar, Erki			Quantification of the Early Small-Scale Fishery in the North-Eastern Baltic Sea in the Late 17th Century	PLOS ONE			English	Article							VARIABILITY; ECOLOGY; EUROPE; GULF; 1ST	Historical perspectives on fisheries and related human behaviour provide valuable information on fishery resources and their exploitation, helping to more appropriately set management targets and determine relevant reference levels. In this study we analyse historical fisheries and fish trade at the north-eastern Baltic Sea coast in the late 17th century. Local consumption and export together amounted to the annual removal of about 200 tonnes of fish from the nearby sea and freshwater bodies. The fishery was very diverse and exploited altogether one cyclostome and 17 fish species with over 90% of the catch being consumed locally. The exported fish consisted almost entirely of high-valued species with Stockholm (Sweden) being the most important export destination. Due to rich political history and natural features of the region, we suggest that the documented evidence of this small-scale fishery should be considered as the first quantitative summary of exploitation of aquatic living resources in the region and can provide a background for future analyses.	[Verliin, Aare] Univ Tartu, Estonian Marine Inst, EE-50090 Tartu, Estonia; [Ojaveer, Henn] Univ Tartu, Estonian Marine Inst, Parnu, Estonia; [Kaju, Katre] Estonian Natl Arch, Tartu, Estonia; [Tammiksaar, Erki] Univ Tartu, Dept Geog, EE-50090 Tartu, Estonia; [Tammiksaar, Erki] Estonian Univ Life Sci, Ctr Sci Studies, Tartu, Estonia	University of Tartu; Estonian Marine Institute; University of Tartu; Estonian Marine Institute; University of Tartu; Estonian University of Life Sciences	Verliin, A (corresponding author), Univ Tartu, Estonian Marine Inst, Ulikooli 18, EE-50090 Tartu, Estonia.	aare.verliin@ut.ee	Ojaveer, Henn/K-2160-2016; Tammiksaar, Erki/H-3465-2016; Verliin, Aare/AAN-7986-2021	Ojaveer, Henn/0000-0003-2742-6063; Tammiksaar, Erki/0000-0003-4293-0890; 	Estonian Ministry of Education and Research [SF0180049s09, SF0180005s10]; Estonian Science Foundation [8747]; Sloan Foundation through the History of Marine Animal Populations (HMAP) project; project "The status of marine biodiversity and its potential futures in the Estonian coastal sea" of Environmental Protection and Technology program of the European Regional Fund [3.2.0802.11-0029]	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Estonian Science Foundation; Sloan Foundation through the History of Marine Animal Populations (HMAP) project; project "The status of marine biodiversity and its potential futures in the Estonian coastal sea" of Environmental Protection and Technology program of the European Regional Fund	This work was partially financed by the Estonian Ministry of Education and Research (grants SF0180049s09 and SF0180005s10), the Estonian Science Foundation (grant 8747), the Sloan Foundation through the History of Marine Animal Populations (HMAP) project. The study has been partially supported by the project "The status of marine biodiversity and its potential futures in the Estonian coastal sea" 3.2.0802.11-0029 of Environmental Protection and Technology program of the European Regional Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baer KE, 1860, ISSLEDOVANIYA SOSTOY, V1, P1; BARANNIKOVA I. A., 1962, UCH ZAP LENINGRADSK GOS UNIV, V311, P109; Barrett J, 2008, J ARCHAEOL SCI, V35, P850, DOI 10.1016/j.jas.2007.06.004; Barrett JH, 2011, J ARCHAEOL SCI, V38, P1516, DOI 10.1016/j.jas.2011.02.017; Barrett JH, 2004, P ROY SOC B-BIOL SCI, V271, P2417, DOI 10.1098/rspb.2004.2885; Benecke N., 1986, BAR International Series, P9; Bolster WJ, 2008, AM HIST REV, V113, P19, DOI 10.1086/ahr.113.1.19; Bolster WJ, 2006, ENVIRON HIST-US, V11, P567; Efimova AI, 1966, GIDROBIOLOGICHESKIYE, V4, P228; Fortibuoni T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015502; Fuller BT, 2012, J ANAL ATOM SPECTROM, V27, P807, DOI 10.1039/c2ja10366d; Gaumiga R, 2007, FISH RES, V87, P120, DOI 10.1016/j.fishres.2007.04.003; Hansen HJ, 1858, GESCH STADT NARVA; HELCOM, 2012, BALTIC SEA ENV P, V131, P1; Hoffmann RC, 2005, HELGOLAND MAR RES, V59, P22, DOI 10.1007/s10152-004-0203-5; Hoffmann RC, 1996, AM HIST REV, V101, P631, DOI 10.2307/2169418; Hoffmann RC, 2010, INTERAZIONI EC AMBIE, P495; Holm P, 1996, N ATLANTIC FISHERIES, P177; Holm Poul, 2010, P3; Hornborg E, 1965, SUOMEN HIST; Indreko R., 1948, MITTLERE STEINZEIT E; Indreko R, 1932, EESTI RAHVA MUUSEUMI, V8, P48; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jahnke Carsten, 2009, CATCH FISHERIES N AT, P157; Jones E.T., 2000, ENGLANDS SEA FISHERI, P105; Kraikovski A, 2008, LEVA VID OSTERSJONSK, P217; Kraikovski A, 2008, LEVA VID OSTERSJONSK, P217; Kucina ES, 1939, IZVESTIYA VNIORH, V21, P157; Kung E., 1997, EESTI AJALOOARHIIVI, V2, P39; Liiv O, 1937, EESTI MAJANDUSAJALUG, P153; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lotze HK, 2009, TRENDS ECOL EVOL, V24, P254, DOI 10.1016/j.tree.2008.12.004; Lougas Lembi, 1999, P185; Ludwig A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-221; Lundberg S, 2010, ARCH NAT HIST, V37, P150, DOI 10.3366/E0260954109001703; Luts A, 1969, EESTI LOODUS, V12, P213; MacKenzie BR, 2007, FISH RES, V87, P106, DOI 10.1016/j.fishres.2007.07.003; MacKenzie BR, 2011, MAR POLICY, V35, P266, DOI 10.1016/j.marpol.2010.10.004; Makowiecki D., 2001, ANIMALS MAN, P236; Mihin VS, 1932, IZVESTIYA VNIORH, V15, P1; Mikelsaar N, 1984, EESTI NSV KALAD; Moora A, 1964, PEOPSIMAA ETNILISEST; Nyenstadt F, 1838, MONUMENTA LIVONIAE A, V2, P1; Ojaveer E., 2003, FISHES ESTONIA, P58; Ojaveer H, 2007, FISH RES, V87, P137, DOI 10.1016/j.fishres.2007.07.010; Ojaveer H, 2007, FISH RES, V87, P102, DOI 10.1016/j.fishres.2007.08.011; Orton DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027568; Palli Heldur, 1993, STOCKH STUD ENGL, V11, P195; Petrov AV, 1901, GOROD NARVA; Pinnegar JK, 2008, REV FISH BIOL FISHER, V18, P1, DOI 10.1007/s11160-007-9058-6; Poulsen B, 2007, FISH RES, V87, P181, DOI 10.1016/j.fishres.2007.07.014; Poulsen Bo, 2008, DUTCH HERRING ENV HI; Pullat R, 1992, EESTI LINNARAHVASTIK; Rannak L, 1983, LOHE JA MERIFORELL; Roberts C., 2007, UNNATURAL HIST SEA; Saarse, 1996, RECENT ADV ENV CULTU, P359; Sabaneyev LP, 1992, RYBY ROSSII TOM VTOR; Saenz-Arroyo A, 2006, FISH FISH, V7, P128, DOI 10.1111/j.1467-2979.2006.00214.x; Sainas A, 1939, EESTI KALANDUS, V7, P49; Sbornik MAMJ, 1913, SBORNIK MOSKOVSKOGO; Tarasov II, 2009, STAROLADOZHSKII SBOR, V7, P177; Titov S., 2008, ATLANTIC SALMON RUSS; Tuvikene L, 2003, FISHES ESTONIA, P114; Van Dam PJEM, 2009, CATCH FISHERIES N AT, P309; Van Neer W, 2010, ECOLOGIES EC MEDIEVA, P193; von Baer KE, 1854, MAT GESCH FISCHFANGE; Wolf T, 1986, TRAGFAHIGKEITEN LADU	67	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68513	10.1371/journal.pone.0068513	http://dx.doi.org/10.1371/journal.pone.0068513			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	178DW	23861914	Green Published, Green Submitted, gold			2022-12-27	WOS:000321425300066
J	Zhong, DB; Lo, E; Hu, RJ; Metzger, ME; Cummings, R; Bonizzoni, M; Fujioka, KK; Sorvillo, TE; Kluh, S; Healy, SP; Fredregill, C; Kramer, VL; Chen, XG; Yan, GY				Zhong, Daibin; Lo, Eugenia; Hu, Renjie; Metzger, Marco E.; Cummings, Robert; Bonizzoni, Mariangela; Fujioka, Kenn K.; Sorvillo, Teresa E.; Kluh, Susanne; Healy, Sean P.; Fredregill, Chris; Kramer, Vicki L.; Chen, Xiaoguang; Yan, Guiyun			Genetic Analysis of Invasive Aedes albopictus Populations in Los Angeles County, California and Its Potential Public Health Impact	PLOS ONE			English	Article							UNITED-STATES; MOLECULAR-IDENTIFICATION; MULTIPLE INTRODUCTIONS; STATISTICAL TESTS; DNA POLYMORPHISM; NORTH-AMERICA; CULICIDAE; DIPTERA; MOSQUITOS; ESTABLISHMENT	The Asian tiger mosquito, Aedes albopictus, is an anthropophilic aggressive daytime-biting nuisance and an efficient vector of certain arboviruses and filarial nematodes. Over the last 30 years, this species has spread rapidly through human travel and commerce from its native tropical forests of Asia to every continent except Antarctica. In 2011, a population of Asian tiger mosquito (Aedes albopictus) was discovered in Los Angeles (LA) County, California. To determine the probable origin of this invasive species, the genetic structure of the population was compared against 11 populations from the United States and abroad, as well as preserved specimens from a 2001 introduction into California using the mitochondrial cytochrome c oxidase 1 (CO1) gene. A total of 66 haplotypes were detected among samples and were divided into three main groups. Aedes albopictus collected in 2001 and 2011 from LA County were genetically related and similar to those from Asia but distinct from those collected in the eastern and southeastern United States. In view of the high genetic similarities between the 2001 and 2011 LA samples, it is possible that the 2011 population represents in part the descendants of the 2001 introduction. There remains an imperative need for improved surveillance and control strategies for this species.	[Zhong, Daibin; Lo, Eugenia; Bonizzoni, Mariangela; Yan, Guiyun] Univ Calif Irvine, Coll Hlth Sci, Program Publ Hlth, Irvine, CA 92717 USA; [Hu, Renjie; Metzger, Marco E.; Kramer, Vicki L.] Calif Dept Publ Hlth, Vector Borne Dis Sect, Ontario, CA USA; [Cummings, Robert] Orange Cty Vector Control Dist, Orange, CA USA; [Fujioka, Kenn K.; Sorvillo, Teresa E.] San Gabriel Valley Mosquito & Vector Control Dist, West Covina, CA USA; [Kluh, Susanne] Greater Los Angeles Cty Vector Control Dist, Santa Fe Springs, CA USA; [Healy, Sean P.] Monmouth Cty Mosquito Exterminat Commiss, Tinton Falls, NJ USA; [Fredregill, Chris] Harris Cty Publ Hlth & Environm Serv, Mosquito Control Div, Houston, TX USA; [Chen, Xiaoguang] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Parasitol, Guangzhou, Guangdong, Peoples R China	University of California System; University of California Irvine; California Department of Public Health; Southern Medical University - China	Yan, GY (corresponding author), Univ Calif Irvine, Coll Hlth Sci, Program Publ Hlth, Irvine, CA 92717 USA.	guiyuny@uci.edu	bonizzoni, mariangela/AAM-9035-2021; Zhong, Daibin/GRF-0564-2022	bonizzoni, mariangela/0000-0003-0568-8564; Fredregill, Chris/0000-0002-2200-6169	National Institutes of Health (NIH) [R01 AI083202]; NIH Pacific-Southwest Regional Center of Excellence (RCE) for Biodefense and Emerging Infectious Disease Research [U54 AI065359]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083202, U54AI065359] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Pacific-Southwest Regional Center of Excellence (RCE) for Biodefense and Emerging Infectious Disease Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by grants from the National Institutes of Health (NIH) (R01 AI083202) and NIH Pacific-Southwest Regional Center of Excellence (RCE) for Biodefense and Emerging Infectious Disease Research (U54 AI065359). The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Avise John C., 1994, pi; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Birungi J, 2002, ANN ENTOMOL SOC AM, V95, P125, DOI 10.1603/0013-8746(2002)095[0125:GSOAAD]2.0.CO;2; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cook S, 2005, J MED ENTOMOL, V42, P19, DOI 10.1603/0022-2585(2005)042[0019:MMFMIO]2.0.CO;2; Durka W, 2005, MOL ECOL, V14, P1697, DOI 10.1111/j.1365-294X.2005.02521.x; Enserink M, 2008, SCIENCE, V320, P864, DOI 10.1126/science.320.5878.864; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fu YX, 1997, GENETICS, V147, P915; Fujioka K., 2012, PROC PAP MOSQ VECT C, V80, P27; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; GUBLER DJ, 1987, EPIDEMIOLOGY ARTHROP, P223; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; Higa Y, 2010, JPN J INFECT DIS, V63, P312; KAMBHAMPATI S, 1991, HEREDITY, V67, P85, DOI 10.1038/hdy.1991.67; Kamgang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020257; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Linthicum KJ, 2003, J AM MOSQUITO CONTR, V19, P301; Loaiza JR, 2012, INFECT GENET EVOL, V12, P1, DOI 10.1016/j.meegid.2011.08.004; Madon MB, 2003, J AM MOSQUITO CONTR, V19, P297; Madon MB, 2002, J VECTOR ECOL, V27, P149; Metzger ME, 2012, P PAP ANN C MOSQ VEC, V80, P25; Middleton K., 2012, P PAP ANN C MOSQ VEC, V80, P30; Moore CG, 1999, J AM MOSQUITO CONTR, V15, P221; Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627; NAWROCKI SJ, 1987, J AM MOSQUITO CONTR, V3, P314; Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A, 2002, SE AL V 2 0A11 SEQ A; REITER P, 1984, MOSQ NEWS, V44, P396; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Rezza G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-72; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Spanos L, 2000, INSECT MOL BIOL, V9, P139, DOI 10.1046/j.1365-2583.2000.00165.x; SPRENGER D, 1986, J AM MOSQUITO CONTR, V2, P217; TAJIMA F, 1989, GENETICS, V123, P585; Urbanski JM, 2010, P ROY SOC B-BIOL SCI, V277, P2683, DOI 10.1098/rspb.2010.0362; Walton C, 2000, MOL BIOL EVOL, V17, P962, DOI 10.1093/oxfordjournals.molbev.a026377; WASHBURN JO, 1992, J MED ENTOMOL, V29, P995, DOI 10.1093/jmedent/29.6.995; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WHO/EMCA, 2011, WHO EMCA C VECT REL; Zalewski A, 2010, BIOL CONSERV, V143, P1355, DOI 10.1016/j.biocon.2010.03.009; Zhong DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055475	49	49	56	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68586	10.1371/journal.pone.0068586	http://dx.doi.org/10.1371/journal.pone.0068586			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861921	Green Published, gold, Green Submitted			2022-12-27	WOS:000321425300072
J	Arribat, Y; Bonneaud, N; Talmat-Amar, Y; Layalle, S; Parmentier, ML; Maschat, F				Arribat, Yoan; Bonneaud, Nathalie; Talmat-Amar, Yasmina; Layalle, Sophie; Parmentier, Marie-Laure; Maschat, Florence			A Huntingtin Peptide Inhibits PolyQ-Huntingtin Associated Defects	PLOS ONE			English	Article							YAC128 MOUSE MODEL; MUTANT HUNTINGTIN; AXONAL-TRANSPORT; INTRANUCLEAR INCLUSIONS; MOTOR DYSFUNCTION; DROSOPHILA MODEL; REDUCES TOXICITY; IN-VIVO; NEURODEGENERATION; EXPRESSION	Background: Huntington's disease (HD) is caused by the abnormal expansion of the polyglutamine tract in the human Huntingtin protein (polyQ-hHtt). Although this mutation behaves dominantly, huntingtin loss of function also contributes to HD pathogenesis. Indeed, wild-type Huntingtin plays a protective role with respect to polyQ-hHtt induced defects. Methodology/Principal Findings: The question that we addressed here is what part of the wild-type Huntingtin is responsible for these protective properties. We first screened peptides from the Huntingtin protein in HeLa cells and identified a 23 aa peptide (P42) that inhibits polyQ-hHtt aggregation. P42 is part of the endogenous Huntingtin protein and lies within a region rich in proteolytic sites that plays a critical role in the pathogenesis process. Using a Drosophila model of HD, we tested the protective properties of this peptide on aggregation, as well as on different polyQ-hHtt induced neuronal phenotypes: eye degeneration (an indicator of cell death), impairment of vesicular axonal trafficking, and physiological behaviors such as larval locomotion and adult survival. Together, our results demonstrate high protective properties for P42 in vivo, in whole animals. These data also demonstrate a specific role of P42 on Huntington's disease model, since it has no effect on other models of polyQ-induced diseases, such as spinocerebellar ataxias. Conclusions/Significance: Altogether our data show that P42, a 23 aa-long hHtt peptide, plays a protective role with respect to polyQ-hHtt aggregation as well as cellular and behavioral dysfunctions induced by polyQ-hHtt in vivo. Our study also confirms the correlation between polyQ-hHtt aggregation and neuronal defects. Finally, these results strongly suggest a therapeutic potential for P42, specific of Huntington's disease.	[Arribat, Yoan; Bonneaud, Nathalie; Talmat-Amar, Yasmina; Layalle, Sophie; Parmentier, Marie-Laure; Maschat, Florence] Univ Montpellier, CNRS, UMR5203, IGF,INSERM,U661, F-34059 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Parmentier, ML (corresponding author), Univ Montpellier, CNRS, UMR5203, IGF,INSERM,U661, F-34059 Montpellier, France.	Marie-Laure.Parmentier@igf.cnrs.fr; florence.maschat@igf.cnrs.fr	Layalle, Sophie/N-3815-2017; Parmentier, Marie-Laure/N-9915-2017	Layalle, Sophie/0000-0002-3650-0598; Parmentier, Marie-Laure/0000-0001-6133-3413; ARRIBAT, Yoan/0000-0003-0952-5279	CNRS (French National center of scientific research); soutien au transfert; ANR Emergence (Agence Nationale pour la Recherche)	CNRS (French National center of scientific research); soutien au transfert; ANR Emergence (Agence Nationale pour la Recherche)(French National Research Agency (ANR))	CNRS (French National center of scientific research), "soutien au transfert" and ANR Emergence (Agence Nationale pour la Recherche). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bauer PO, 2010, NAT BIOTECHNOL, V28, P256, DOI 10.1038/nbt.1608; Bogdanik L, 2004, J NEUROSCI, V24, P9105, DOI 10.1523/JNEUROSCI.2724-04.2004; BRAND AH, 1993, DEVELOPMENT, V118, P401; Butler DC, 2012, PROG NEUROBIOL, V97, P190, DOI 10.1016/j.pneurobio.2011.11.004; Butler DC, 2011, PROG NEUROBIOL; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Cowin RM, 2012, BEHAV BRAIN RES, V229, P308, DOI 10.1016/j.bbr.2011.12.045; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dlugosz M, 2011, J PHYS CHEM B, V115, P11597, DOI 10.1021/jp206373g; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Ehrnhoefer DE, 2006, HUM MOL GENET, V15, P2743, DOI 10.1093/hmg/ddl210; Ehrnhoefer DE, 2011, NEUROSCIENTIST; Feany MB, 2003, NEURON, V40, P1, DOI 10.1016/S0896-6273(03)00600-7; Fecke W, 2009, DRUG DISCOV TODAY, V14, P453, DOI 10.1016/j.drudis.2009.02.006; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Franco B, 2004, J NEUROSCI, V24, P6573, DOI 10.1523/JNEUROSCI.1580-04.2004; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Gafni J, 2002, J NEUROSCI, V22, P4842, DOI 10.1523/JNEUROSCI.22-12-04842.2002; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; GUTEKUNST CA, 1995, P NATL ACAD SCI USA, V92, P8710, DOI 10.1073/pnas.92.19.8710; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Khoshnan A, 2002, P NATL ACAD SCI USA, V99, P1002, DOI 10.1073/pnas.022631799; Lee WCM, 2004, P NATL ACAD SCI USA, V101, P3224, DOI 10.1073/pnas.0400243101; Li Z, 1999, HUM MOL GENET, V8, P1807, DOI 10.1093/hmg/8.9.1807; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; McLear JA, 2008, FASEB J, V22, P2003, DOI 10.1096/fj.07-099689; Milan M, 2000, DEVELOPMENT, V127, P3069; Miller JP, 2010, NEURON, V67, P199, DOI 10.1016/j.neuron.2010.06.021; Morfini GA, 2009, NAT NEUROSCI, V12, P864, DOI 10.1038/nn.2346; Mugat B, 2008, HUM MOL GENET, V17, P3601, DOI 10.1093/hmg/ddn255; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; Popiel HA, 2007, MOL THER, V15, P303, DOI 10.1038/sj.mt.6300045; Romero E, 2008, NEURON, V57, P27, DOI 10.1016/j.neuron.2007.11.025; Sanyal S, 2009, GENE EXPR PATTERNS, V9, P371, DOI 10.1016/j.gep.2009.01.002; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Sinadinos C, 2009, NEUROBIOL DIS, V34, P389, DOI 10.1016/j.nbd.2009.02.012; Slow EJ, 2005, P NATL ACAD SCI USA, V102, P11402, DOI 10.1073/pnas.0503634102; Snyder-Keller A, 2010, J NEUROPATH EXP NEUR, V69, P1078, DOI 10.1097/NEN.0b013e3181f530ec; Southwell AL, 2008, J NEUROSCI, V28, P9013, DOI 10.1523/JNEUROSCI.2747-08.2008; Southwell AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016676; Southwell AL, 2009, J NEUROSCI, V29, P13589, DOI 10.1523/JNEUROSCI.4286-09.2009; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Takano H, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-15; Talmat-Amar Y, 2011, HUM MOL GENET, V20, P3738, DOI 10.1093/hmg/ddr290; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Tanaka Y, 2006, NEUROBIOL DIS, V21, P381, DOI 10.1016/j.nbd.2005.07.014; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Van Raamsdonk JM, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-80; Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P1379, DOI 10.1093/hmg/ddi147; Warby SC, 2009, MOL CELL NEUROSCI, V40, P121, DOI 10.1016/j.mcn.2008.09.007; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Weiss KR, 2012, GENETICS, V190, P581, DOI 10.1534/genetics.111.133710; Wellington CL, 2002, J NEUROSCI, V22, P7862; Wolfgang WJ, 2005, P NATL ACAD SCI USA, V102, P11563, DOI 10.1073/pnas.0505321102; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Zala D, 2008, HUM MOL GENET, V17, P3837, DOI 10.1093/hmg/ddn281; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	63	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68775	10.1371/journal.pone.0068775	http://dx.doi.org/10.1371/journal.pone.0068775			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861941	Green Published, Green Submitted, gold			2022-12-27	WOS:000323350700102
J	Carnevali, L; Trombini, M; Porta, A; Montano, N; de Boer, SF; Sgoifo, A				Carnevali, Luca; Trombini, Mimosa; Porta, Alberto; Montano, Nicola; de Boer, Sietse F.; Sgoifo, Andrea			Vagal Withdrawal and Susceptibility to Cardiac Arrhythmias in Rats with High Trait Aggressiveness	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; SOCIAL STRESS; INDIVIDUAL-DIFFERENCES; FREQUENCY-DOMAIN; BEHAVIOR PATTERN; A BEHAVIOR; PERSONALITY; MORTALITY; HOSTILITY; RESPONSES	Personality characteristics, e. g. aggressiveness, have long been associated with an increased risk of cardiac disease. However, the underlying mechanisms remain unclear. In this study we used a rodent model for characterizing cardiac autonomic modulation in rats that differ widely in their level of aggressive behavior. To reach this goal, high-aggressive (HA, n = 10) and non-aggressive (NA, n = 10) rats were selected from a population (n = 121) of adult male Wild-type Groningen rats on the basis of their latency time to attack (ALT, s) a male intruder in a resident-intruder test lasting 600 s. In order to obtain information on their cardiac autonomic modulation, ECG recordings were subsequently obtained via radiotelemetry at rest, during stressful stimuli and under autonomic pharmacological manipulations, and analyzed by means of time- and frequency-domain indexes of heart rate variability. During resting conditions, HA rats (ALT<90 s) displayed reduced heart rate variability, mostly in terms of lower vagal modulation compared to NA rats (ALT>600 s). Exposure to stressful stimuli (i.e. restraint and psychosocial stress) provoked similar tachycardic responses between the two groups. However, under stress conditions HA rats displayed a reduced vagal antagonism and an increased incidence of tachyarrhythmias compared to NA rats. In addition, beta-adrenergic pharmacological stimulation induced a much larger incidence of ventricular tachyarrhythmias in HA rats compared to NA counterparts. These findings are consistent with the view that high levels of aggressive behavior in rats are associated to signs of cardiac autonomic impairment and increased arrhythmogenic susceptibility that may predict vulnerability to cardiac morbidity and mortality.	[Carnevali, Luca; Trombini, Mimosa; Sgoifo, Andrea] Univ Parma, Dept Neurosci, Stress Physiol Lab, I-43100 Parma, Italy; [Porta, Alberto] Univ Milan, Ist Ortoped Galeazzi, Dept Biomed Sci Hlth, Milan, Italy; [Montano, Nicola] Univ Milan, Luigi Sacco Hosp, Dept Biomed & Clin Sci, Milan, Italy; [Montano, Nicola] St Annes Univ Hosp, ICRC Dept Cardiovasc Dis, Brno, Czech Republic; [de Boer, Sietse F.] Univ Groningen, Dept Behav Physiol, Ctr Behav & Neurosci, Groningen, Netherlands	University of Parma; IRCCS Istituto Ortopedico Galeazzi; University of Milan; University of Milan; Luigi Sacco Hospital; St Anne's University Hospital Brno (FNUSA-ICRC); University of Groningen	Sgoifo, A (corresponding author), Univ Parma, Dept Neurosci, Stress Physiol Lab, I-43100 Parma, Italy.	andrea.sgoifo@unipr.it	Sgoifo, Andrea/AAC-6278-2022; Porta, Alberto/K-4390-2016; Carnevali, Luca/P-9508-2019; Carnevali, Luca/E-5322-2017	Sgoifo, Andrea/0000-0002-9428-6198; Porta, Alberto/0000-0002-6720-9824; Carnevali, Luca/0000-0001-9053-7976; Carnevali, Luca/0000-0001-9053-7976; Montano, Nicola/0000-0001-9206-0075	University of Parma (FIL)	University of Parma (FIL)	This study was supported by a grant from the University of Parma (FIL 2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERMAN EL, 1971, P SOC EXP BIOL MED, V136, P268; Bell AM, 2007, ECOL LETT, V10, P828, DOI 10.1111/j.1461-0248.2007.01081.x; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Betensky JD, 2010, ANN BEHAV MED, V39, P184, DOI 10.1007/s12160-010-9176-6; BIGGER JT, 1992, CIRCULATION, V85, P164, DOI 10.1161/01.CIR.85.1.164; Camm AJ, 1996, CIRCULATION, V93, P1043; Carnevali L, 2013, PSYCHOSOM MED, V75, P42, DOI 10.1097/PSY.0b013e318276cb0d; CASE RB, 1985, NEW ENGL J MED, V312, P737, DOI 10.1056/NEJM198503213121201; de Boer SF, 2003, BEHAV GENET, V33, P485, DOI 10.1023/A:1025766415159; Eckberg DL, 1997, CIRCULATION, V96, P3224, DOI 10.1161/01.CIR.96.9.3224; FRIEDMAN M, 1959, JAMA-J AM MED ASSOC, V169, P1286, DOI 10.1001/jama.1959.03000290012005; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P137, DOI 10.1016/j.neubiorev.2004.06.010; HALLER J, 1995, PSYCHONEUROENDOCRINO, V20, P65, DOI 10.1016/0306-4530(94)E0042-8; Huikuri HV, 1999, ARTERIOSCL THROM VAS, V19, P1979, DOI 10.1161/01.ATV.19.8.1979; Koolhaas JM, 2008, BRAIN BEHAV IMMUN, V22, P662, DOI 10.1016/j.bbi.2007.11.006; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; KOOLHAAS JM, 1980, PROG NEUROBIOL, V15, P247, DOI 10.1016/0301-0082(80)90024-6; Kop WJ, 1999, PSYCHOSOM MED, V61, P476, DOI 10.1097/00006842-199907000-00012; La Rovere MT, 2003, CIRCULATION, V107, P565, DOI 10.1161/01.CIR.0000047275.25795.17; La Rovere MT, 1998, LANCET, V351, P478; Liao DP, 1997, AM J EPIDEMIOL, V145, P696, DOI 10.1093/aje/145.8.696; LORE R, 1977, SCI AM, V236, P106, DOI 10.1038/scientificamerican0577-106; Magagnin V, 2011, PHYSIOL MEAS, V32, P1775, DOI 10.1088/0967-3334/32/11/S05; Montano N, 2009, NEUROSCI BIOBEHAV R, V33, P71, DOI 10.1016/j.neubiorev.2008.07.006; PORGES SW, 1995, NEUROSCI BIOBEHAV R, V19, P225, DOI 10.1016/0149-7634(94)00066-A; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; del Paso GAR, 2013, PSYCHOPHYSIOLOGY, V50, P477, DOI 10.1111/psyp.12027; Safa-Tisseront V, 1998, J HYPERTENS, V16, P1989, DOI 10.1097/00004872-199816121-00020; Sgoifo A, 2005, NEUROSCI BIOBEHAV R, V29, P59, DOI 10.1016/j.neubiorev.2004.07.001; Sgoifo A, 1996, PHYSIOL BEHAV, V60, P1397, DOI 10.1016/S0031-9384(96)00228-4; Sgoifo A, 1999, NEUROSCI BIOBEHAV R, V23, P915, DOI 10.1016/S0149-7634(99)00025-1; Sgoifo A, 1998, AGGRESSIVE BEHAV, V24, P287, DOI 10.1002/(SICI)1098-2337(1998)24:4<287::AID-AB4>3.0.CO;2-G; Sgoifo A, 1996, PHYSIOL BEHAV, V60, P1403, DOI 10.1016/S0031-9384(96)00229-6; SHEKELLE RB, 1985, AM J EPIDEMIOL, V122, P559, DOI 10.1093/oxfordjournals.aje.a114135; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Smith TW, 2004, J PERS, V72, P1217, DOI 10.1111/j.1467-6494.2004.00296.x; SMITH TW, 1992, HEALTH PSYCHOL, V11, P139, DOI 10.1037/0278-6133.11.3.139; Souza HCD, 2009, AUTON NEUROSCI-BASIC, V150, P38, DOI 10.1016/j.autneu.2009.04.007; STEIN PK, 1994, AM HEART J, V127, P1376, DOI 10.1016/0002-8703(94)90059-0; Trombini M, 2012, STRESS, V15, P457, DOI 10.3109/10253890.2011.639414; Tsuji H, 1996, CIRCULATION, V94, P2850, DOI 10.1161/01.CIR.94.11.2850; Verrier RL, 2004, CURR OPIN CARDIOL, V19, P2, DOI 10.1097/00001573-200401000-00003; WALKER MJA, 1988, CARDIOVASC RES, V22, P447, DOI 10.1093/cvr/22.7.447	43	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68316	10.1371/journal.pone.0068316	http://dx.doi.org/10.1371/journal.pone.0068316			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861886	gold, Green Published			2022-12-27	WOS:000323350700079
J	Kochupurakkal, BS; Iglehart, JD				Kochupurakkal, Bose S.; Iglehart, J. Dirk			Nourseothricin N-Acetyl Transferase: A Positive Selection Marker for Mammalian Cells	PLOS ONE			English	Article							TRANSFORMATION	Development of Nourseothricin N-acetyl transferase (NAT) as a selection marker for mammalian cells is described. Mammalian cells are acutely susceptible to Nourseothricin, similar to the widely used drug Puromycin, and NAT allows for quick and robust selection of transfected/transduced cells in the presence of Nourseothricin. NAT is compatible with other selection markers puromycin, hygromycin, neomycin, blasticidin, and is a valuable addition to the repertoire of mammalian selection markers.	[Kochupurakkal, Bose S.; Iglehart, J. Dirk] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Iglehart, J. Dirk] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital	Iglehart, JD (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	JIGLEHART@partners.org			Teri Brodeur Fellowship; Hale Fellowship; Women's Cancer Program at Dana-Farber Cancer Institute; National Cancer Institute Specialized Program in Research Excellence in Breast Cancer at Dana-Farber/Harvard Cancer Center [CA89393]; NATIONAL CANCER INSTITUTE [P50CA089393] Funding Source: NIH RePORTER	Teri Brodeur Fellowship; Hale Fellowship; Women's Cancer Program at Dana-Farber Cancer Institute; National Cancer Institute Specialized Program in Research Excellence in Breast Cancer at Dana-Farber/Harvard Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	KSB is a recipient of the Teri Brodeur Fellowship and the Hale Fellowship. The work was supported by the Women's Cancer Program at Dana-Farber Cancer Institute and National Cancer Institute Specialized Program in Research Excellence in Breast Cancer at Dana-Farber/Harvard Cancer Center (CA89393). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; KRUGEL H, 1993, GENE, V127, P127, DOI 10.1016/0378-1119(93)90627-F; Mortensen RM, 2009, CURR PROTOC MOL BIOL, V9; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; van Peer AF, 2009, APPL ENVIRON MICROB, V75, P1243, DOI 10.1128/AEM.02162-08; Van TT, 2006, J PARASITOL, V92, P668, DOI 10.1645/GE-706R.1; Wilson DN, 2009, CRIT REV BIOCHEM MOL, V44, P393, DOI 10.3109/10409230903307311; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6	10	10	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68509	10.1371/journal.pone.0068509	http://dx.doi.org/10.1371/journal.pone.0068509			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861913	Green Published, gold			2022-12-27	WOS:000323350700090
J	Nielsen, SB; Macchi, F; Raccosta, S; Langkilde, AE; Giehm, L; Kyrsting, A; Svane, ASP; Manno, M; Christiansen, G; Nielsen, NC; Oddershede, L; Vestergaard, B; Otzen, DE				Nielsen, Soren Bang; Macchi, Francesca; Raccosta, Samuele; Langkilde, Annette Eva; Giehm, Lise; Kyrsting, Anders; Svane, Anna Sigrid Pii; Manno, Mauro; Christiansen, Gunna; Nielsen, Niels Christian; Oddershede, Lene; Vestergaard, Bente; Otzen, Daniel Erik			Wildtype and A30P Mutant Alpha-Synuclein Form Different Fibril Structures	PLOS ONE			English	Article							SMALL-ANGLE-SCATTERING; POINT MUTATIONS A30P; FIBER DIFFRACTION; DISEASE; FIBRILLIZATION; NEUROTOXICITY; PATHOGENESIS; POLYMORPHISM; AGGREGATION; FILAMENTS	Parkinson's Disease (PD) is a neurodegenerative movement disorder affecting millions of people worldwide. One of the key players in the development of the disease is the protein alpha-synuclein (aSN), which aggregates in the brain of PD patients. The aSN mutant A30P has been reported to cause early-onset familial PD and shows different aggregation behavior compared to wt aSN. Here we use a multidisciplinary approach to compare the aggregation process of wt and A30P aSN. In agreement with previous studies, we observe an initial lag phase followed by a continuous structural development of fibrils until reaching an apparent monomer-aggregate equilibrium state and a plateau in Thioflavin T (ThT) fluorescence intensity. However, at later timepoints A30P shows greater propensity than alpha SN wt to form dense bundled fibril networks. Combining small angle x-ray scattering, x-ray fibre diffraction and linear dichroism, we demonstrate that while the microscopic structure of the individual fibril essentially remains constant throughout the experiment, the formation of dense A30P fibril networks occur through a continuous assembly pathway while the formation of less dense wt fibril networks with fewer contact points follows a continuous path during the elongation phase and a second rearrangement phase after reaching the ThT fluorescence plateau. Our work thus highlights that structural rearrangements proceed beyond the plateau in ThT-based monitoring of the fibrillation process, and the density and morphology of the resulting fibril networks is highly dependent on the aSN form studied.	[Nielsen, Soren Bang; Macchi, Francesca; Giehm, Lise; Svane, Anna Sigrid Pii; Nielsen, Niels Christian; Otzen, Daniel Erik] Aarhus Univ, Ctr Insoluble Prot Struct inSPIN, Interdisciplinary Nanosci Ctr iNANO, Aarhus, Denmark; [Nielsen, Soren Bang; Macchi, Francesca; Giehm, Lise; Otzen, Daniel Erik] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Raccosta, Samuele; Langkilde, Annette Eva; Vestergaard, Bente] Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Raccosta, Samuele; Manno, Mauro] Natl Res Council Italy, Inst Biophys, Palermo, Italy; [Kyrsting, Anders; Oddershede, Lene] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Svane, Anna Sigrid Pii; Nielsen, Niels Christian] Aarhus Univ, Dept Chem, DK-8000 Aarhus, Denmark; [Christiansen, Gunna] Univ Aarhus, Dept Biomed, Aarhus, Denmark	Aarhus University; Aarhus University; University of Copenhagen; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Copenhagen; Niels Bohr Institute; Aarhus University; Aarhus University	Vestergaard, B (corresponding author), Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark.	bv@farma.ku.dk; dao@inano.au.dk	Nielsen, Søren B/D-5936-2011; Raccosta, Samuele/P-3682-2018; Manno, Mauro/F-1385-2010	Raccosta, Samuele/0000-0001-7775-5928; Manno, Mauro/0000-0001-9843-0428; Langkilde, Annette Eva/0000-0003-2467-4205; Nielsen, Niels Chr./0000-0003-2978-4366; Kyrsting, Anders/0000-0003-2845-1287; Vestergaard, Bente/0000-0001-8011-6414; Otzen, Daniel/0000-0002-2918-8989; Christiansen, Gunna/0000-0003-0540-1367	Lundbeck Foundation (BioNET 2); Danish Councils for Independent Research in Natural Sciences (FNU) [11-113326]; Medical Sciences (FSS); innovation consortium CureND and Aalborg University; Novo Nordisk A/S; Research Training Council; Aarhus University; Danish National Research Foundation (inSPIN) [DNRF59]	Lundbeck Foundation (BioNET 2); Danish Councils for Independent Research in Natural Sciences (FNU); Medical Sciences (FSS)(Danish Medical Research Council); innovation consortium CureND and Aalborg University; Novo Nordisk A/S(Novo Nordisk); Research Training Council; Aarhus University; Danish National Research Foundation (inSPIN)(Danmarks Grundforskningsfond)	S.B.N. was supported by the Lundbeck Foundation (BioNET 2) and by grant 11-113326 from the Danish Councils for Independent Research in Natural Sciences (FNU) and Medical Sciences (FSS). L.G. was supported by a predoctoral grant from the innovation consortium CureND and Aalborg University. F.M. was supported by a predoctoral grant from Novo Nordisk A/S, the Research Training Council and Aarhus University. S.R. was supported by the Doctoral School in Physics at the University of Palermo. A.E.L. was also supported by the Lundbeck Foundation. B.V. was supported by the Danish Council for Independent Research Medical Sciences (Sapere Aude). D.E.O., A.P.S.S., and N.C.N. are supported by the Danish National Research Foundation (inSPIN) grant number DNRF59. The authors are grateful to DANSCATT for economical support during data collection (A.E.L., B.V., L.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi R, 2007, J BIOL CHEM, V282, P8978, DOI 10.1074/jbc.M611738200; Bertoncini CW, 2005, J BIOL CHEM, V280, P30649, DOI 10.1074/jbc.C500288200; BROWNSTEIN KR, 1977, J MAGN RESON, V26, P17, DOI 10.1016/0022-2364(77)90230-X; Celej MS, 2009, BIOCHEMISTRY-US, V48, P7465, DOI 10.1021/bi9003843; Cho MK, 2011, PROTEIN SCI, V20, P387, DOI 10.1002/pro.570; Clark GNI, 2010, P NATL ACAD SCI USA, V107, P14003, DOI 10.1073/pnas.1006599107; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Conway KA, 2000, ANN NY ACAD SCI, V920, P42; Dafforn TR, 2004, BIOPHYS J, V86, P404, DOI 10.1016/S0006-3495(04)74116-8; Dueholm MS, 2011, BIOCHEMISTRY-US, V50, P8281, DOI 10.1021/bi200967c; EANES ED, 1968, J HISTOCHEM CYTOCHEM, V16, P673, DOI 10.1177/16.11.673; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; Giehm L, 2011, P NATL ACAD SCI USA, V108, P3246, DOI 10.1073/pnas.1013225108; Giehm L, 2010, ANAL BIOCHEM, V400, P270, DOI 10.1016/j.ab.2010.02.001; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Halliday G, 2012, EXPERT REV NEUROTHER, V12, P673, DOI [10.1586/ern.12.47, 10.1586/ERN.12.47]; Harada R, 2009, BBA-MOL BASIS DIS, V1792, P998, DOI 10.1016/j.bbadis.2009.06.010; Hazy E, 2011, BIOPHYS J, V101, P2260, DOI 10.1016/j.bpj.2011.08.052; Huang C, 2009, P NATL ACAD SCI USA, V106, P15214, DOI 10.1073/pnas.0904743106; Huang CJ, 2005, PROTEIN EXPRES PURIF, V42, P173, DOI 10.1016/j.pep.2005.02.014; Kamiyoshihara T, 2007, BIOCHEM BIOPH RES CO, V355, P398, DOI 10.1016/j.bbrc.2007.01.162; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kuffel A, 2012, J PHYS CHEM B, V116, P12113, DOI 10.1021/jp305172t; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Li J, 2002, NEUROTOXICOLOGY, V23, P553, DOI 10.1016/S0161-813X(02)00066-9; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Makin OS, 2007, J APPL CRYSTALLOGR, V40, P966, DOI 10.1107/S0021889807034681; Marshall KE, 2010, BIOPHYS J, V98, P330, DOI 10.1016/j.bpj.2009.10.020; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Pedersen JS, 2006, J MOL BIOL, V355, P501, DOI 10.1016/j.jmb.2005.09.100; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rodger A., 2006, ENCY ANAL CHEM; Segers-Nolten I, 2007, P ANN INT IEEE EMBS, P6609; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; SVERGUN DI, 1988, ACTA CRYSTALLOGR A, V44, P244, DOI 10.1107/S0108767387011255; van Raaij ME, 2006, BIOPHYS J, V91, pL96, DOI 10.1529/biophysj.106.090449; Volles MJ, 2003, BIOCHEMISTRY-US, V42, P7871, DOI 10.1021/bi030086j; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509	43	47	47	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67713	10.1371/journal.pone.0067713	http://dx.doi.org/10.1371/journal.pone.0067713			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861789	gold, Green Published			2022-12-27	WOS:000323350700027
J	Shi, ST; Cai, J; de Gorter, DJJ; Sanchez-Duffhues, G; Kemaladewi, DU; Hoogaars, WMH; Aartsma-Rus, A; 't Hoen, PAC; ten Dijke, P				Shi, SongTing; Cai, Jie; de Gorter, David J. J.; Sanchez-Duffhues, Gonzalo; Kemaladewi, Dwi U.; Hoogaars, Willem M. H.; Aartsma-Rus, Annemieke; 't Hoen, Peter A. C.; ten Dijke, Peter			Antisense-Oligonucleotide Mediated Exon Skipping in Activin-Receptor-Like Kinase 2: Inhibiting the Receptor That Is Overactive in Fibrodysplasia Ossificans Progressiva	PLOS ONE			English	Article							I RECEPTOR; PROGENITOR CELLS; DIFFERENTIATION; MUTATION; R206H; RESTORATION; MOUSE; LINES; BETA; BMP2	Fibrodysplasia ossificans progressiva (FOP) is a rare heritable disease characterized by progressive heterotopic ossification of connective tissues, for which there is presently no definite treatment. A recurrent activating mutation (c. 617GRA; R206H) of activin receptor- like kinase 2 (ACVR1/ALK2), a BMP type I receptor, has been shown as the main cause of FOP. This mutation constitutively activates the BMP signaling pathway and initiates the formation of heterotopic bone. In this study, we have designed antisense oligonucleotides (AONs) to knockdown mouse ALK2 expression by means of exon skipping. The ALK2 AON could induce exon skipping in cells, which was accompanied by decreased ALK2 mRNA levels and impaired BMP signaling. In addition, the ALK2 AON potentiated muscle differentiation and repressed BMP6- induced osteoblast differentiation. Our results therefore provide a potential therapeutic approach for the treatment of FOP disease by reducing the excessive ALK2 activity in FOP patients.	[Shi, SongTing; Cai, Jie; de Gorter, David J. J.; Sanchez-Duffhues, Gonzalo; ten Dijke, Peter] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Canc Genom Ctr Netherlands, Leiden, Netherlands; [Shi, SongTing; Cai, Jie; de Gorter, David J. J.; Sanchez-Duffhues, Gonzalo; ten Dijke, Peter] Leiden Univ, Med Ctr, Ctr Biomed Genet, Leiden, Netherlands; [de Gorter, David J. J.] Univ Munster, Inst Mol Cell Biol, D-48149 Munster, Germany; [Kemaladewi, Dwi U.; Hoogaars, Willem M. H.; Aartsma-Rus, Annemieke; 't Hoen, Peter A. C.] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Munster; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	ten Dijke, P (corresponding author), Leiden Univ, Med Ctr, Dept Mol Cell Biol, Canc Genom Ctr Netherlands, Leiden, Netherlands.	P.ten_Dijke@lumc.nl	Sanchez-Duffhues, Gonzalo/AAH-1152-2020; Hoogaars, Willem/AAL-1657-2021; Dijke, Peter ten/AAG-4660-2021; Hoen, Peter A 't/D-3950-2018; Duffhues, Gonzalo Sanchez/D-2201-2017	Sanchez-Duffhues, Gonzalo/0000-0002-3205-0710; Dijke, Peter ten/0000-0002-7234-342X; Hoen, Peter A 't/0000-0003-4450-3112; Duffhues, Gonzalo Sanchez/0000-0002-3205-0710; Hoogaars, Willem/0000-0001-6061-2576; Kemaladewi, Dwi/0000-0002-0747-4589	Dutch Ministry for Economic Affairs [IGE7001]; Netherlands Research Council (NWO-MW); Cancer Genomics Centre Netherlands; Centre for Biomedical Genetics; LeDucq foundation; Targeting Endothelial-to-Mesenchymal transition in Fibrodysplasia Ossificans Progressiva [S-12-27S]	Dutch Ministry for Economic Affairs; Netherlands Research Council (NWO-MW); Cancer Genomics Centre Netherlands; Centre for Biomedical Genetics; LeDucq foundation(Leducq Foundation); Targeting Endothelial-to-Mesenchymal transition in Fibrodysplasia Ossificans Progressiva	This study was supported by Dutch Ministry for Economic Affairs (IOP Genomics grant IGE7001) "Towards broad clinical and technological application of gene expression engineering by exon skipping", Netherlands Research Council (NWO-MW), Cancer Genomics Centre Netherlands and Centre for Biomedical Genetics; and by funds from LeDucq foundation and AO Start-up Grant S-12-27S: Targeting Endothelial-to-Mesenchymal transition in Fibrodysplasia Ossificans Progressiva. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2002, NEUROMUSCULAR DISORD, V12, pS71, DOI 10.1016/S0960-8966(02)00086-X; Aartsma-Rus A, 2004, GENE THER, V11, P1391, DOI 10.1038/sj.gt.3302313; Aartsma-Rus A, 2007, RNA, V13, P1609, DOI 10.1261/rna.653607; Aartsma-Rus A, 2010, OLIGONUCLEOTIDES, V20, P69, DOI 10.1089/oli.2009.0215; Aartsma-Rus A, 2009, MOL THER, V17, P548, DOI 10.1038/mt.2008.205; Cai J, 2012, FEBS LETT, V586, P1993, DOI 10.1016/j.febslet.2012.04.030; Chakkalakal SA, 2012, J BONE MINER RES, V27, P1746, DOI 10.1002/jbmr.1637; Dang ZC, 2002, J BONE MINER RES, V17, P394, DOI 10.1359/jbmr.2002.17.3.394; de Gorter DJJ, 2012, CURR PHARM DESIGN, V18, P4087; de Gorter DJJ, 2011, J BONE MINER RES, V26, P1178, DOI 10.1002/jbmr.313; Ebisawa T, 1999, J CELL SCI, V112, P3519; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Groppe JC, 2011, CELLS TISSUES ORGANS, V194, P291, DOI 10.1159/000324230; Kaplan FS, 2008, BEST PRACT RES CL RH, V22, P191, DOI 10.1016/j.berh.2007.11.007; Kaplan Frederick S, 2009, Hum Mutat, V30, P379, DOI 10.1002/humu.20868; Kaplan J, 2012, GENE THER, V19, P786, DOI 10.1038/gt.2011.152; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Larsson J, 2001, EMBO J, V20, P1663, DOI 10.1093/emboj/20.7.1663; Lavery K, 2008, J BIOL CHEM, V283, P20948, DOI 10.1074/jbc.M800850200; Leblanc E, 2011, J BONE MINER RES, V26, P1166, DOI 10.1002/jbmr.311; Lounev VY, 2009, J BONE JOINT SURG AM, V91A, P652, DOI 10.2106/JBJS.H.01177; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; OBERBAUER R, 1995, KIDNEY INT, V48, P1226, DOI 10.1038/ki.1995.406; Schlange T, 2000, MECH DEVELOP, V91, P259, DOI 10.1016/S0925-4773(99)00311-1; Shi S, 2012, CELL MOL LIFE SCI; Shi S, 2011, NEUROBIOL DIS, V41, P353, DOI 10.1016/j.nbd.2010.10.003; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Song GA, 2010, J BIOL CHEM, V285, P22542, DOI 10.1074/jbc.M109.094557; Spitali P, 2012, CELL, V148, P1085, DOI 10.1016/j.cell.2012.02.014; Takahashi M, 2012, GENE THER, V19, P781, DOI 10.1038/gt.2011.193; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; van Dinther M, 2010, J BONE MINER RES, V25, P1208, DOI [10.1002/jbmr.091110, 10.1359/jbmr.091110]; Walter-Yohrling J, 2004, CLIN CANCER RES, V10, P2179, DOI 10.1158/1078-0432.CCR-03-1013; Yamashita T, 1996, BONE, V19, P429, DOI 10.1016/S8756-3282(96)00255-4; Yu PB, 2008, J BIOL CHEM, V283, P3877, DOI 10.1074/jbc.M706797200; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	39	29	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e69096	10.1371/journal.pone.0069096	http://dx.doi.org/10.1371/journal.pone.0069096			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861958	Green Published, gold, Green Submitted			2022-12-27	WOS:000323350700111
J	Zhu, L; Zhu, QQ; Zhang, XL; Wang, HW				Zhu, Li; Zhu, Qingqing; Zhang, Xinlin; Wang, Hongwei			The Correlation Analysis of Two Common Polymorphisms in STAT6 Gene and the Risk of Asthma: A Meta-Analysis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SIGNAL TRANSDUCER; SUSCEPTIBILITY LOCI; CHILDHOOD ASTHMA; TRANSCRIPTION 6; 1ST EXON; HAPLOTYPE; ACTIVATOR; SEARCH	Background: Several studies have reported that the GT dinucleotide repeat length polymorphism and the G2964A polymorphism in signal transducer and activator of transcriptional factor 6 gene are associated with asthma susceptibility, but others have conflicting results. Our meta-analysis aimed to elucidate the emerging paradigms. Methods: We searched PUBMED, EMBASE, ISI web of knowledge, Chinese National Knowledge Infrastructure, and Wanfang databases. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were used to evaluate the strength of association. We applied Bonferroni step-down and Benjamini-Hochberg step-up methods to adjust the values for multiple comparisons. Results: A total of 12 individual studies in 11 articles were included in the meta-analysis. For GT repeat polymorphism, the S allele had approximately 45% increased risk of asthma (S vs. L: OR = 1.45, 95% CI = 1.22-1.71, P-UNCORRECTED < 0.001, P-Bon < 0.001, P-FDR < 0.001). Further analysis indicated that GT(13) and GT(14) contributed to asthma risk, whereas GT(15) and GT(16) were protective (GT(13) vs. GT(15): OR = 1.38, 95% CI = 1.16-1.65, P-UNCORRECTED = 0.001, P-Bon = 0.005, P-FDR = 0.002). Similar results were obtained in the subgroup analysis of Asian population. G2964A polymorphism analysis showed that the AA genotype moderately increased the risk of asthma by 47% compared with the GG genotype (OR = 1.47, p = 0.068) in Chinese population, whereas the 2964A allele moderately increased the risk of asthma in Chinese population by 18% (2964A vs. 2964G: OR = 1.18, p = 0.08). However, none of the associations reached statistically significant levels particularly after correction for multiple testing. Conclusions: This meta-analysis suggests that S allele (GT(13) and GT(14)) of the GT repeat polymorphism confers significant risks to asthma. However, the G2964A polymorphism does not have an association with the susceptibility to asthma.	[Zhu, Li; Zhu, Qingqing; Zhang, Xinlin; Wang, Hongwei] Nanjing Univ, Ctr Translat Med, Nanjing 210008, Jiangsu, Peoples R China; [Zhu, Li; Zhu, Qingqing; Zhang, Xinlin; Wang, Hongwei] Nanjing Univ, Jiangsu Key Lab Mol Med, Sch Med, Nanjing 210008, Jiangsu, Peoples R China; [Zhu, Li; Zhang, Xinlin] Nanjing Univ, Dept Cardiol, Drum Tower Hosp, Sch Med, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University	Zhang, XL (corresponding author), Nanjing Univ, Ctr Translat Med, Nanjing 210008, Jiangsu, Peoples R China.	xinlzhang0807@gmail.com; hwang@nju.edu.cn	祝, 清清/AHD-0460-2022	Zhu, Qingqing/0000-0001-5211-6337	Natural Science Foundation of Jiangsu Province China [BK2010245]; National Natural Science Foundation of China [81030013]; National Basic Research Program of China [2009CB918704]	Natural Science Foundation of Jiangsu Province China(Natural Science Foundation of Jiangsu Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This study was supported by the grants from the Natural Science Foundation of Jiangsu Province China (No. BK2010245), the National Natural Science Foundation of China (81030013), and the grant from National Basic Research Program of China (Grant No. 2009CB918704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Caraballo L., 2004, Journal of Allergy and Clinical Immunology, V113, pS327, DOI 10.1016/j.jaci.2004.01.684; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; [丁毅鹏 Ding Yipeng], 2010, [中国全科医学, Chinese General Practice], V13, P1765; Duetsch G, 2002, HUM MOL GENET, V11, P613, DOI 10.1093/hmg/11.6.613; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elias JA, 2003, J CLIN INVEST, V111, P291, DOI 10.1172/JCI200317748; Gao PS, 2000, J MED GENET, V37, P380; Gao PS, 2004, J MED GENET, V41, P535, DOI 10.1136/jmg.2003.015842; Hershey GKK, 2003, J ALLERGY CLIN IMMUN, V111, P677, DOI 10.1067/mai.2003.1333; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hirota T, 2011, NAT GENET, V43, P893, DOI 10.1038/ng.887; [胡俊华 Hu Junhua], 2005, [中华微生物学和免疫学杂志, Chinese Journal of Microbiology and Immunology], V25, P243; [胡俊华 Hu Shunhua], 2005, [临床检验杂志, Chinese Journal of Clinical Laboratory Science], V23, P9; Li W, 2007, CHIN J PRIM MED PHAR, V14, P764; Li YF, 2007, RESP MED, V101, P1977, DOI 10.1016/j.rmed.2007.04.006; [林荣军 Lin Rongjun], 2012, [实用儿科临床杂志, Journal of Applied Clinical Pediatrics], V27, P1258; Los H, 2001, Twin Res, V4, P81, DOI 10.1375/1369052012191; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marsh DG, 1997, NAT GENET, V15, P389; Mathew A, 2001, J EXP MED, V193, P1087, DOI 10.1084/jem.193.9.1087; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Patel BKR, 1998, GENOMICS, V52, P192, DOI 10.1006/geno.1998.5436; Schedel M, 2004, J ALLERGY CLIN IMMUN, V114, P1100, DOI 10.1016/j.jaci.2004.07.048; Shao CC, 2004, J HUM GENET, V49, P115, DOI 10.1007/s10038-003-0118-z; Spycher BD, 2012, J ALLERGY CLIN IMMUN, V130, P503, DOI 10.1016/j.jaci.2012.06.002; Suzuki Michiko, 2004, Allergology International, V53, P241, DOI 10.1111/j.1440-1592.2004.00340.x; Takeda K, 1997, J MOL MED-JMM, V75, P317, DOI 10.1007/s001090050117; Tamura K, 2003, INT ARCH ALLERGY IMM, V131, P33, DOI 10.1159/000070432; Tamura K, 2001, CLIN EXP ALLERGY, V31, P1509, DOI 10.1046/j.1365-2222.2001.01191.x; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; Wang Q, 2011, BIOMED ENVIRON SCI, V24, P670, DOI 10.3967/0895-3988.2011.06.012; Weidinger S, 2004, J MED GENET, V41, P658, DOI 10.1136/jmg.2004.020263	35	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67657	10.1371/journal.pone.0067657	http://dx.doi.org/10.1371/journal.pone.0067657			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861779	Green Published, gold, Green Submitted			2022-12-27	WOS:000323350700018
J	Carvalho, SM; Andisi, VF; Gradstedt, H; Neef, J; Kuipers, OP; Neves, AR; Bijlsma, JJE				Carvalho, Sandra M.; Andisi, Vahid Farshchi; Gradstedt, Henrik; Neef, Jolanda; Kuipers, Oscar P.; Neves, Ana R.; Bijlsma, Jetta J. E.			Pyruvate Oxidase Influences the Sugar Utilization Pattern and Capsule Production in Streptococcus pneumoniae	PLOS ONE			English	Article							HYDROGEN-PEROXIDE PRODUCTION; IN-VIVO; LACTOBACILLUS-PLANTARUM; LACTOCOCCUS-LACTIS; CELLULAR PHOSPHOGLUCOMUTASE; POLYSACCHARIDE BIOSYNTHESIS; PHENOTYPIC VARIANTS; RESPIRATORY-TRACT; EPITHELIAL-CELLS; GENOME SEQUENCE	Pyruvate oxidase is a key function in the metabolism and lifestyle of many lactic acid bacteria and its activity depends on the presence of environmental oxygen. In Streptococcus pneumoniae the protein has been suggested to play a major role in metabolism and has been implicated in virulence, oxidative stress survival and death in stationary phase. Under semi-aerobic conditions, transcriptomic and metabolite profiling analysis of a spxB mutant grown on glucose showed minor changes compared to the wild type, apart from the significant induction of two operons involved in carbohydrate uptake and processing. This induction leads to a change in the sugar utilization capabilities of the bacterium, as indicated by the analysis of the growth profiles of the D39 parent and spxB mutant on alternative carbohydrates. Metabolic analysis and growth experiments showed that inactivation of SpxB has no effect on the glucose fermentation pattern, except under aerobic conditions. More importantly, we show that mutation of spxB results in the production of increased amounts of capsule, the major virulence factor of S. pneumoniae. Part of this increase can be attributed to induction of capsule operon (cps) transcription. Therefore, we propose that S. pneumoniae utilizes pyruvate oxidase as an indirect sensor of the oxygenation of the environment, resulting in the adaption of its nutritional capability and the amount of capsule to survive in the host.	[Carvalho, Sandra M.; Neves, Ana R.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Andisi, Vahid Farshchi; Gradstedt, Henrik; Neef, Jolanda] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [Kuipers, Oscar P.] Univ Groningen, Dept Mol Genet, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands	Universidade Nova de Lisboa; University of Groningen; University of Groningen	Bijlsma, JJE (corresponding author), Univ Groningen, Dept Med Microbiol, Univ Med Ctr Groningen, Groningen, Netherlands.	j.j.e.bijlsma@umcg.nl	Kuipers, Oscar/B-6752-2009	Kuipers, Oscar/0000-0001-5596-7735; Carvalho, Sandra/0000-0002-3144-411X; Neef, Jolanda/0000-0002-4898-4948	Fundacao para a Ciencia e a Tecnologia (FCT) Ph.D. grant [SFRH/BD/35947/2007]; Fundacao para a Ciencia e a Tecnologia, Portugal (FCT); FEDER [PTDC/BIA-MIC/099963/2008, PEst-OE/EQB/LA0004/2011]; Programa Operacional Ciencia e Inovacao (POCTI); FCT; Rosalind Franklin Fellow of the UMCG; NWO [40-00506-98-9021, 175-010-2009-023]	Fundacao para a Ciencia e a Tecnologia (FCT) Ph.D. grant; Fundacao para a Ciencia e a Tecnologia, Portugal (FCT)(Portuguese Foundation for Science and Technology); FEDER(European Commission); Programa Operacional Ciencia e Inovacao (POCTI); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Rosalind Franklin Fellow of the UMCG; NWO(Netherlands Organization for Scientific Research (NWO))	S. M. Carvalho was supported by Fundacao para a Ciencia e a Tecnologia (FCT) Ph.D. grant (SFRH/BD/35947/2007). The Portuguese team work was supported by Fundacao para a Ciencia e a Tecnologia, Portugal (FCT) and FEDER, project PTDC/BIA-MIC/099963/2008 and through grant PEst-OE/EQB/LA0004/2011. The NMR spectrometers are part of The National NMR Network (REDE/1517/RMN/2005), supported by "Programa Operacional Ciencia e Inovacao (POCTI) 2010" and FCT. JJE Bijlsma and H. Gradstedt were funded by a Rosalind Franklin Fellow of the UMCG. Part of this work has been performed at the UMCG Microscopy and Imaging center (UMIC), which is sponsored by NWO-grants 40-00506-98-9021, and 175-010-2009-023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegrucci M, 2008, J BACTERIOL, V190, P6330, DOI 10.1128/JB.00707-08; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; AVERY OSWALD T., 1931, JOUR EXP MED, V54, P73, DOI 10.1084/jem.54.1.73; Belanger AE, 2004, J BACTERIOL, V186, P8164, DOI 10.1128/JB.186.24.8164-8171.2004; Benisty R, 2010, BBA-MOL CELL BIOL L, V1801, P1098, DOI 10.1016/j.bbalip.2010.06.004; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Bidossi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033320; Bijlsma JJE, 2007, APPL ENVIRON MICROB, V73, P1514, DOI 10.1128/AEM.01900-06; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; Braun JS, 2002, J CLIN INVEST, V109, P19; Burnaugh AM, 2008, J BACTERIOL, V190, P221, DOI 10.1128/JB.01251-07; Carvalho SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058492; Carvalho SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026707; DUANE PG, 1993, INFECT IMMUN, V61, P4392, DOI 10.1128/IAI.61.10.4392-4397.1993; Goffin P, 2006, APPL ENVIRON MICROB, V72, P7933, DOI 10.1128/AEM.00659-06; Gualdi L, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-200; Hammerschmidt S, 2005, INFECT IMMUN, V73, P4653, DOI 10.1128/IAI.73.8.4653-4667.2005; Hardy GG, 2000, J BACTERIOL, V182, P1854, DOI 10.1128/JB.182.7.1854-1863.2000; Hardy GG, 2001, INFECT IMMUN, V69, P2309, DOI 10.1128/IAI.69.4.2309-2317.2001; Hirst RA, 2000, INFECT IMMUN, V68, P1557, DOI 10.1128/IAI.68.3.1557-1562.2000; Iannelli F, 1999, J BACTERIOL, V181, P2652, DOI 10.1128/JB.181.8.2652-2654.1999; Iyer R, 2005, J BACTERIOL, V187, P8340, DOI 10.1128/JB.187.24.8340-8349.2005; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Karlyshev AV, 2000, BIOTECHNIQUES, V28, P1078, DOI 10.2144/00286bm05; Kim JO, 1999, INFECT IMMUN, V67, P2327, DOI 10.1128/IAI.67.5.2327-2333.1999; Kim JO, 1998, J INFECT DIS, V177, P368, DOI 10.1086/514205; Kloosterman TG, 2006, MICROBIOL-SGM, V152, P351, DOI 10.1099/mic.0.28521-0; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; LeMessurier KS, 2006, MICROBIOL-SGM, V152, P305, DOI 10.1099/mic.0.28438-0; Li-Korotky HS, 2009, INT J PEDIATR OTORHI, V73, P1417, DOI 10.1016/j.ijporl.2009.07.007; Lorquet F, 2004, J BACTERIOL, V186, P3749, DOI 10.1128/JB.186.12.3749-3759.2004; Magee AD, 2001, INFECT IMMUN, V69, P3755, DOI 10.1128/IAI.69.6.3755-3761.2001; Maguin E, 1996, J BACTERIOL, V178, P931, DOI 10.1128/jb.178.3.931-935.1996; Marion C, 2012, INFECT IMMUN, V80, P1390, DOI 10.1128/IAI.05756-11; Maruyama Y, 2009, J BIOL CHEM, V284, P18059, DOI 10.1074/jbc.M109.005660; Meiattini F, 1988, METHOD ENZYMAT AN, P566; Morona JK, 2004, J INFECT DIS, V189, P1905, DOI 10.1086/383352; Morona JK, 2006, P NATL ACAD SCI USA, V103, P8505, DOI 10.1073/pnas.0602148103; Neef J, 2011, INFECT IMMUN, V79, P2314, DOI 10.1128/IAI.00677-10; Nelson AL, 2007, INFECT IMMUN, V75, P83, DOI 10.1128/IAI.01475-06; Neves AR, 2005, FEMS MICROBIOL REV, V29, P531, DOI 10.1016/j.femsre.2005.04.005; Obaro S, 2002, J MED MICROBIOL, V51, P98, DOI 10.1099/0022-1317-51-2-98; Ogunniyi AD, 2002, MICROBIOL-SGM, V148, P2045, DOI 10.1099/00221287-148-7-2045; Orihuela CJ, 2003, SCAND J INFECT DIS, V35, P647, DOI 10.1080/00365540310015854; Overweg K, 2000, INFECT IMMUN, V68, P4604, DOI 10.1128/IAI.68.8.4604-4610.2000; Pericone CD, 2000, INFECT IMMUN, V68, P3990, DOI 10.1128/IAI.68.7.3990-3997.2000; Pericone CD, 2002, J BACTERIOL, V184, P4392, DOI 10.1128/JB.184.16.4392-4399.2002; Pericone CD, 2003, J BACTERIOL, V185, P6815, DOI 10.1128/JB.185.23.6815-6825.2003; Pesakhov S, 2007, BBA-BIOMEMBRANES, V1768, P590, DOI 10.1016/j.bbamem.2006.12.016; Philips BJ, 2003, INTENS CARE MED, V29, P2204, DOI 10.1007/s00134-003-1961-2; Price CE, 2011, FEMS MICROBIOL REV; Ramos A, 2001, APPL ENVIRON MICROB, V67, P33, DOI 10.1128/AEM.67.1.33-41.2001; Ramos-Montanez S, 2008, MOL MICROBIOL, V67, P729, DOI 10.1111/j.1365-2958.2007.06082.x; Ramos-Montanez S, 2010, J BACTERIOL, V192, P6390, DOI 10.1128/JB.00995-10; Regev-Yochay G, 2007, J BACTERIOL, V189, P6532, DOI 10.1128/JB.00813-07; Sanders JW, 1998, MOL GEN GENET, V257, P681, DOI 10.1007/s004380050697; SEDEWITZ B, 1984, J BACTERIOL, V160, P462, DOI 10.1128/JB.160.1.462-465.1984; Seki M, 2004, J BACTERIOL, V186, P2046, DOI 10.1128/JB.186.7.2046-2051.2004; Song JH, 2012, VACCINE, V30, P2728, DOI 10.1016/j.vaccine.2012.01.091; Spellerberg B, 1996, MOL MICROBIOL, V19, P803, DOI 10.1046/j.1365-2958.1996.425954.x; Taniai H, 2008, J BACTERIOL, V190, P3572, DOI 10.1128/JB.01882-07; Terra VS, 2010, INFECT IMMUN, V78, P348, DOI 10.1128/IAI.00721-09; TERZAGHI BE, 1975, APPL MICROBIOL, V29, P807, DOI 10.1128/AEM.29.6.807-813.1975; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Weiser JN, 2001, INFECT IMMUN, V69, P5430, DOI 10.1128/IAI.69.9.5430-5439.2001; Wolfe AJ, 2010, CURR OPIN MICROBIOL, V13, P204, DOI 10.1016/j.mib.2010.01.002; Yother J, 2011, ANNU REV MICROBIOL, V65, P563, DOI 10.1146/annurev.micro.62.081307.162944; Yum DY, 1999, APPL ENVIRON MICROB, V65, P3341; Zheng LY, 2011, APPL ENVIRON MICROB, V77, P4318, DOI 10.1128/AEM.00309-11; Zheng LY, 2011, J BACTERIOL, V193, P516, DOI 10.1128/JB.01131-10	70	31	32	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68277	10.1371/journal.pone.0068277	http://dx.doi.org/10.1371/journal.pone.0068277			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844180	gold, Green Submitted, Green Published			2022-12-27	WOS:000321733000137
J	Tear, MJ; Nielsen, M				Tear, Morgan J.; Nielsen, Mark			Failure to Demonstrate That Playing Violent Video Games Diminishes Prosocial Behavior	PLOS ONE			English	Article							ET-AL. 2010; AGGRESSION; LIFE; FEELINGS; EASTERN; FALSE; MODEL	Background: Past research has found that playing a classic prosocial video game resulted in heightened prosocial behavior when compared to a control group, whereas playing a classic violent video game had no effect. Given purported links between violent video games and poor social behavior, this result is surprising. Here our aim was to assess whether this finding may be due to the specific games used. That is, modern games are experienced differently from classic games (more immersion in virtual environments, more connection with characters, etc.) and it may be that playing violent video games impacts prosocial behavior only when contemporary versions are used. Methods and Findings: Experiments 1 and 2 explored the effects of playing contemporary violent, non-violent, and prosocial video games on prosocial behavior, as measured by the pen-drop task. We found that slight contextual changes in the delivery of the pen-drop task led to different rates of helping but that the type of game played had little effect. Experiment 3 explored this further by using classic games. Again, we found no effect. Conclusions: We failed to find evidence that playing video games affects prosocial behavior. Research on the effects of video game play is of significant public interest. It is therefore important that speculation be rigorously tested and findings replicated. Here we fail to substantiate conjecture that playing contemporary violent video games will lead to diminished prosocial behavior.	[Tear, Morgan J.; Nielsen, Mark] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia	University of Queensland	Tear, MJ (corresponding author), Univ Queensland, Sch Psychol, St Lucia, Qld, Australia.	m.tear@uq.edu.au	Nielsen, Mark/A-6792-2013	Nielsen, Mark/0000-0002-0402-8372				Adachi PJC, 2011, AGGRESS VIOLENT BEH, V16, P55, DOI 10.1016/j.avb.2010.12.002; Anderson CA, 2000, J PERS SOC PSYCHOL, V78, P772, DOI 10.1037//0022-3514.78.4.772; Anderson CA, 2010, PSYCHOL BULL, V136, P151, DOI 10.1037/a0018251; Australian Government Attorney-General's Department, 2010, LIT REV IMP PLAYING; Ballard ME, 1999, SEX ROLES, V41, P541, DOI 10.1023/A:1018843304606; Baron R., 1994, HUMAN AGGRESSION, DOI 10.1002/1098-2337(1994)20:63.0.CO;2-O; Bennerstedt U, 2012, INT J COMP-SUPP COLL, V7, P43, DOI 10.1007/s11412-011-9136-6; Bensley L, 2001, J ADOLESCENT HEALTH, V29, P244, DOI 10.1016/S1054-139X(01)00239-7; Bowen HJ, 2011, APPL COGNITIVE PSYCH, V25, P906, DOI 10.1002/acp.1767; Bushman BJ, 2002, PERS SOC PSYCHOL B, V28, P1679, DOI 10.1177/014616702237649; Carnagey NL, 2007, J EXP SOC PSYCHOL, V43, P489, DOI 10.1016/j.jesp.2006.05.003; Chong YMG, 2012, J SOC CLIN PSYCHOL, V31, P952; Coburn N., 2012, PLOS ONE, V7, P1, DOI [10.1371/journal.pone.0042510, DOI 10.1371/J0URNAL.P0NE.0042510]; Colwell J, 2003, ASIAN J SOC PSYCHOL, V6, P149, DOI 10.1111/1467-839X.t01-1-00017; Doyen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029081; Ferguson CJ, 2013, AM PSYCHOL, V68, P57, DOI 10.1037/a0030597; Ferguson CJ, 2012, PERSPECT PSYCHOL SCI, V7, P555, DOI 10.1177/1745691612459059; Ferguson CJ, 2011, COMPUT HUM BEHAV, V27, P770, DOI 10.1016/j.chb.2010.10.026; Ferguson CJ, 2010, EUR PSYCHOL, V15, P99, DOI 10.1027/1016-9040/a000010; Ferguson CJ, 2010, PSYCHOL BULL, V136, P174, DOI 10.1037/a0018566; Fraser AM, 2012, J YOUTH ADOLESCENCE, V41, P636, DOI 10.1007/s10964-012-9742-2; Greitemeyer T, 2011, CURR DIR PSYCHOL SCI, V20, P251, DOI 10.1177/0963721411415229; Greitemeyer T, 2010, J PERS SOC PSYCHOL, V98, P211, DOI 10.1037/a0016997; Greitemeyer T, 2009, J EXP SOC PSYCHOL, V45, P896, DOI 10.1016/j.jesp.2009.04.005; Huesmann LR, 2010, PSYCHOL BULL, V136, P179, DOI 10.1037/a0018567; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Macrae CN, 1998, SOC COGNITION, V16, P400, DOI 10.1521/soco.1998.16.4.400; Nosek BA, 2012, PSYCHOL INQ, V23, P217, DOI 10.1080/1047840X.2012.692215; Przybylski AK, 2010, REV GEN PSYCHOL, V14, P154, DOI 10.1037/a0019440; Schneider EF, 2004, HUM COMMUN RES, V30, P361, DOI 10.1093/hcr/30.3.361; Sestir MA, 2010, J EXP SOC PSYCHOL, V46, P934, DOI 10.1016/j.jesp.2010.06.005; Shanks DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056515; Sheese BE, 2005, PSYCHOL SCI, V16, P354, DOI 10.1111/j.0956-7976.2005.01539.x; Sherry JL, 2001, HUM COMMUN RES, V27, P409, DOI 10.1093/hcr/27.3.409; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Tedeschi JT, 1996, AGGRESS VIOLENT BEH, V1, P163, DOI 10.1016/1359-1789(95)00014-3; van Baaren RB, 2004, PSYCHOL SCI, V15, P71, DOI 10.1111/j.0963-7214.2004.01501012.x; Yam M, 2007, NO VIDEO GAMES FOUND	38	51	54	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68382	10.1371/journal.pone.0068382	http://dx.doi.org/10.1371/journal.pone.0068382			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182HT	23844191	gold, Green Published, Green Accepted			2022-12-27	WOS:000321733000001
J	Deng, N; Sanchez, CG; Lasky, JA; Zhu, DX				Deng, Nan; Sanchez, Cecilia G.; Lasky, Joseph A.; Zhu, Dongxiao			Detecting Splicing Variants in Idiopathic Pulmonary Fibrosis from Non-Differentially Expressed Genes	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; RNA-SEQ EXPERIMENTS; MESSENGER-RNA; PEROXISOME PROLIFERATION; CHROMATIN ORGANIZATION; DNA METHYLATION; TENASCIN-C; EXON ARRAY; LUNG; PROTEIN	Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease of unknown cause that lacks a proven therapy for altering its high mortality rate. Microarrays have been employed to investigate the pathogenesis of IPF, but are presented mostly at the gene-expression level due to technologic limitations. In as much as, alternative RNA splicing isoforms are increasingly identified as potential regulators of human diseases, including IPF, we propose a new approach with the capacity to detect splicing variants using RNA-seq data. We conducted a joint analysis of differential expression and differential splicing on annotated human genes and isoforms, and identified 122 non-differentially expressed genes with a high degree of "switch'' between major and minor isoforms. Three cases with variant mechanisms for alternative splicing were validated using qRT-PCR, among the group of genes in which expression was not significantly changed at the gene level. We also identified 35 novel transcripts that were unique to the fibrotic lungs using exon-exon junction evidence, and selected a representative for qRT-PCR validation. The results of our study are likely to provide new insight into the pathogenesis of pulmonary fibrosis and may eventuate in new treatment targets.	[Deng, Nan; Zhu, Dongxiao] Wayne State Univ, Dept Comp Sci, Detroit, MI 48202 USA; [Sanchez, Cecilia G.; Lasky, Joseph A.] Tulane Univ, Sch Med, Tulane Canc Ctr, New Orleans, LA 70112 USA	Wayne State University; Tulane University	Lasky, JA (corresponding author), Tulane Univ, Sch Med, Tulane Canc Ctr, 1430 Tulane Ave, New Orleans, LA 70112 USA.	jlasky@tulane.edu; dzhu@wayne.edu	Zhu, Dongxiao/G-4049-2010		Tulane health sciences center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103629] Funding Source: NIH RePORTER	Tulane health sciences center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research is supported a pilot grant from Tulane health sciences center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasiadou C, 2011, DNA CELL BIOL, V30, P267, DOI 10.1089/dna.2010.1094; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Baumgart E, 2001, AM J PATHOL, V159, P1477, DOI 10.1016/S0002-9440(10)62534-5; Beane J, 2011, CANCER PREV RES, V4, P803, DOI 10.1158/1940-6207.CAPR-11-0212; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; Bocchino M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014003; Bonekamp NA, 2009, BIOFACTORS, V35, P346, DOI 10.1002/biof.48; Boon K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005134; Brinkman BMN, 2004, CLIN BIOCHEM, V37, P584, DOI 10.1016/j.clinbiochem.2004.05.015; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; Cao WH, 1997, RNA, V3, P1456; Chen W, 2010, NUCLEIC ACIDS RES, V38, P2788, DOI 10.1093/nar/gkq007; Cho JH, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-8; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Choi JK, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r70; Coward William R, 2010, Ther Adv Respir Dis, V4, P367, DOI 10.1177/1753465810379801; Deng N, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr042; El-Karef A, 2007, J HEPATOL, V46, P664, DOI 10.1016/j.jhep.2006.10.011; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; GE H, 1990, CELL, V62, P25, DOI 10.1016/0092-8674(90)90236-8; Glare EM, 2002, THORAX, V57, P765, DOI 10.1136/thorax.57.9.765; Han JH, 2011, MOL CELL BIOL, V31, P793, DOI 10.1128/MCB.01117-10; Hon G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000566; Hu Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1026; Huber W, 2006, BIOINFORMATICS, V22, P1963, DOI 10.1093/bioinformatics/btl289; Karnati S, 2008, HISTOCHEM CELL BIOL, V130, P719, DOI 10.1007/s00418-008-0462-3; Karnati S, 2009, HISTOCHEM CELL BIOL, V131, P447, DOI 10.1007/s00418-009-0566-4; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Kliment CR, 2010, FREE RADICAL BIO MED, V49, P707, DOI 10.1016/j.freeradbiomed.2010.04.036; Koch J, 2010, J CELL SCI, V123, P3389, DOI 10.1242/jcs.064907; Laajala E, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r77; Lasky JA, 2000, ENVIRON HEALTH PERSP, V108, P751, DOI 10.2307/3454412; Li XL, 2005, CELL CYCLE, V4, P1706, DOI 10.4161/cc.4.12.2210; Liu NS, 2009, EMBO J, V28, P3485, DOI 10.1038/emboj.2009.282; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch DA, 2005, AM J RESP CRIT CARE, V172, P488, DOI 10.1164/rccm.200412-1756OC; Minagawa S, 2011, AM J PHYSIOL-LUNG C, V300, pL391, DOI 10.1152/ajplung.00097.2010; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muro AF, 2008, AM J RESP CRIT CARE, V177, P638, DOI 10.1164/rccm.200708-1291OC; Navaratnam V, 2011, THORAX, V66, P462, DOI 10.1136/thx.2010.148031; Neverov AD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-266; Nicolas P, 2009, BIOINFORMATICS, V25, P2341, DOI 10.1093/bioinformatics/btp395; Plate M, 2010, MOL CELLS, V29, P355, DOI 10.1007/s10059-010-0038-7; Rabinovich EI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033770; Ramani AK, 2011, GENOME RES, V21, P342, DOI 10.1101/gr.114645.110; Richard H, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq041; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roser-Page S, 2011, AM J MED SCI; Sammeth M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000147; Schrader M, 1998, J BIOL CHEM, V273, P29607, DOI 10.1074/jbc.273.45.29607; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Serini G, 1998, J CELL BIOL, V142, P873, DOI 10.1083/jcb.142.3.873; Shen SH, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1291; Shen SH, 2010, BIOINFORMATICS, V26, P268, DOI 10.1093/bioinformatics/btp643; Sorek R, 2004, GENOME RES, V14, P1617, DOI 10.1101/gr.2572604; Spies N, 2009, MOL CELL, V36, P245, DOI 10.1016/j.molcel.2009.10.008; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Tanaka H, 2006, LIVER INT, V26, P311, DOI 10.1111/j.1478-3231.2005.01229.x; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Titorenko VI, 2011, TRAFFIC, V12, P252, DOI 10.1111/j.1600-0854.2010.01144.x; Torres-Gonzalez E, 2012, AM J RESP CELL MOL, V46, P748, DOI 10.1165/rcmb.2011-0224OC; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; White ES, 2010, EXP CELL RES, V316, P2644, DOI 10.1016/j.yexcr.2010.06.028; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Xiao SH, 1997, GENE DEV, V11, P334, DOI 10.1101/gad.11.3.334; ZHAO Y, 1995, AM J PHYSIOL-LUNG C, V268, pL173, DOI 10.1152/ajplung.1995.268.2.L173	72	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68352	10.1371/journal.pone.0068352	http://dx.doi.org/10.1371/journal.pone.0068352			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844188	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000154
J	Palmer, AL; Dolan, BP				Palmer, Amy L.; Dolan, Brian P.			MHC Class I Antigen Presentation of DRiP-Derived Peptides from a Model Antigen Is Not Dependent on the AAA ATPase p97	PLOS ONE			English	Article							DEFECTIVE RIBOSOMAL PRODUCTS; CROSS-PRESENTATION; ENDOPLASMIC-RETICULUM; DENDRITIC CELLS; PROTEIN-SYNTHESIS; VIRAL PROTEIN; MAJOR SOURCE; DEGRADATION; VCP/P97; PHAGOCYTOSIS	CD8(+) T cells are responsible for killing cells of the body that have become infected or oncogenically transformed. In order to do so, effector CD8(+) T cells must recognize their cognate antigenic peptide bound to a MHC class I molecule that has been directly presented by the target cell. Due to the rapid nature of antigen presentation, it is believed that antigenic peptides are derived from a subset of newly synthesized proteins which are degraded almost immediately following synthesis and termed Defective Ribosomal Products or DRiPs. We have recently reported on a bioassay which can distinguish antigen presentation of DRiP substrates from other forms of rapidly degraded proteins and found that poly-ubiquitin chain disassembly may be necessary for efficient DRiP presentation. The AAA ATPase p97 protein is necessary for efficient crosspresentation of antigens on MHC class I molecules and plays an important role in extracting mis-folded proteins from the endoplasmic reticulum. Here, we find that genetic ablation or chemical inhibition of p97 does not diminish DRiP antigen presentation to any great extent nor does it alter the levels of MHC class I molecules on the cell surface, despite our observations that p97 inhibition increased the levels of poly-ubiquitinated proteins in the cell. These data demonstrate that inhibiting poly-ubiquitin chain disassembly alone is insufficient to abolish DRiP presentation.	[Palmer, Amy L.; Dolan, Brian P.] Oregon State Univ, Dept Biomed Sci, Corvallis, OR 97331 USA	Oregon State University	Dolan, BP (corresponding author), Oregon State Univ, Dept Biomed Sci, Corvallis, OR 97331 USA.	Brian.Dolan@oregonstate.edu			NIH [1K22AI089861 - 01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI089861] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by NIH grant 1K22AI089861 - 01A1 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Besche HC, 2009, BIOCHEMISTRY-US, V48, P2538, DOI 10.1021/bi802198q; Bug M, 2012, J STRUCT BIOL, V179, P78, DOI 10.1016/j.jsb.2012.03.003; Burgdorf S, 2008, CURR OPIN IMMUNOL, V20, P89, DOI 10.1016/j.coi.2007.12.002; Cardinaud S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008692; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; Dalal S, 2004, MOL BIOL CELL, V15, P637, DOI 10.1091/mbc.E03-02-0097; Dolan BP, 2011, CELL MOL LIFE SCI, V68, P1481, DOI 10.1007/s00018-011-0656-z; Dolan BP, 2011, J IMMUNOL, V186, P2065, DOI 10.4049/jimmunol.1003096; Dolan BP, 2010, J IMMUNOL, V185, P6728, DOI 10.4049/jimmunol.1002543; Dolan BP, 2010, J IMMUNOL, V184, P1419, DOI 10.4049/jimmunol.0901907; ESQUIVEL F, 1992, J EXP MED, V175, P163, DOI 10.1084/jem.175.1.163; Giodini A, 2009, P NATL ACAD SCI USA, V106, P3324, DOI 10.1073/pnas.0813305106; Groothuis TAM, 2005, J EXP MED, V202, P1313, DOI 10.1084/jem.20051379; Imai J, 2005, INT IMMUNOL, V17, P45, DOI 10.1093/intimm/dxh184; Isakov E, 2011, J BIOL CHEM, V286, P30274, DOI 10.1074/jbc.M111.240309; Jutras I, 2005, ANNU REV CELL DEV BI, V21, P511, DOI 10.1146/annurev.cellbio.20.010403.102755; Khan S, 2001, J IMMUNOL, V167, P4801, DOI 10.4049/jimmunol.167.9.4801; KORMAN AJ, 1980, J EXP MED, V152, pS65; Larsson M, 2001, EUR J IMMUNOL, V31, P3432, DOI 10.1002/1521-4141(200112)31:12<3432::AID-IMMU3432>3.0.CO;2-R; Lev A, 2010, P NATL ACAD SCI USA, V107, P6964, DOI 10.1073/pnas.0910997107; Li M, 2001, J IMMUNOL, V166, P6099, DOI 10.4049/jimmunol.166.10.6099; Lu XJ, 2012, P NATL ACAD SCI USA, V109, P15407, DOI 10.1073/pnas.1208696109; Mackay LK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000699; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Reid DW, 2012, J BIOL CHEM, V287, P5518, DOI 10.1074/jbc.M111.312280; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Soetandyo N, 2010, J CELL SCI, V123, P1031, DOI 10.1242/jcs.059758; Stephens SB, 2008, MOL BIOL CELL, V19, P623, DOI 10.1091/mbc.E07-07-0677; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Wang QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015479; Wojcik C, 2004, J CELL SCI, V117, P281, DOI 10.1242/jcs.00841; Yamanaka K, 2012, BBA-MOL CELL RES, V1823, P130, DOI 10.1016/j.bbamcr.2011.07.001; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yewdell JW, 1996, J IMMUNOL, V157, P1823; Zehner M, 2011, P NATL ACAD SCI USA, V108, P9933, DOI 10.1073/pnas.1102397108	38	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67796	10.1371/journal.pone.0067796	http://dx.doi.org/10.1371/journal.pone.0067796			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844095	gold, Green Published, Green Submitted			2022-12-27	WOS:000321341000098
J	Williams, JAE; Greenwood, J; Moss, SE				Williams, Jennifer A. E.; Greenwood, John; Moss, Stephen E.			Retinal Changes Precede Visual Dysfunction in the Complement Factor H Knockout Mouse	PLOS ONE			English	Article							MACULAR DEGENERATION; REGULATORY PROTEINS; PIGMENT EPITHELIUM; AGED MICE; GENE; POLYMORPHISM; DEFICIENCY; ACTIVATION; EXPRESSION; MEMBRANE	We previously reported that aged mice lacking complement factor H (CFH) exhibit visual defects and structural changes in the retina. However, it is not known whether this phenotype is age-related or is the consequence of disturbed development. To address this question we investigated the effect of Cfh gene deletion on the retinal phenotype of young and mid-age mice. Cfh(-/-) mouse eyes exhibited thickening of the retina and reduced nuclear density, but relatively normal scotopic and photopic electroretinograms. At 12 months there was evidence of subtle astroglial activation in the Cfh(-/-) eyes, and significant elevation of the complement regulator, decay-accelerating factor (DAF) in Muller cells. In the retinal pigment epithelium (RPE) of young control and Cfh(-/-) animals mitochondria and melanosomes were oriented basally and apically respectively, whereas the apical positioning of melanosomes was significantly perturbed in the mid-age Cfh(-/-) RPE. We conclude that deletion of Cfh in the mouse leads to defects in the retina that precede any marked loss of visual function, but which become progressively more marked as the animals age. These observations are consistent with a lifelong role for CFH in retinal homeostasis.	[Williams, Jennifer A. E.; Greenwood, John; Moss, Stephen E.] UCL Inst Ophthalmol, Dept Cell Biol, London, England	University of London; University College London	Moss, SE (corresponding author), UCL Inst Ophthalmol, Dept Cell Biol, London, England.	s.moss@ucl.ac.uk		Greenwood, John/0000-0003-4496-2984	Medical Research Council; Wellcome Trust [090669]	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)	The work was funded by the Medical Research Council and the Wellcome Trust (grant reference 090669). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Chang B, 2008, HUM MOL GENET, V17, P3929, DOI 10.1093/hmg/ddn295; Chen M, 2010, INVEST OPHTH VIS SCI, V51, P5888, DOI 10.1167/iovs.09-5103; Coffey PJ, 2007, P NATL ACAD SCI USA, V104, P16651, DOI 10.1073/pnas.0705079104; Coleman HR, 2008, LANCET, V372, P1835, DOI 10.1016/S0140-6736(08)61759-6; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Faber C, 2012, INVEST OPHTH VIS SCI, V53, P6324, DOI 10.1167/iovs.12-10385; Fett AL, 2012, HISTOL HISTOPATHOL, V27, P357, DOI 10.14670/HH-27.357; Gouras P, 2010, GRAEF ARCH CLIN EXP, V248, P973, DOI 10.1007/s00417-010-1325-x; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Khandhadia S, 2012, IMMUNOBIOLOGY, V217, P127, DOI 10.1016/j.imbio.2011.07.019; Kim YH, 2009, GRAEF ARCH CLIN EXP, V247, P651, DOI 10.1007/s00417-009-1049-y; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Longbottom R, 2009, P NATL ACAD SCI USA, V106, P18728, DOI 10.1073/pnas.0902593106; Lyzogubov VV, 2010, AM J PATHOL, V177, P1870, DOI 10.2353/ajpath.2010.091168; Mandal NA, 2006, INVEST OPHTH VIS SCI, V47, P4091, DOI 10.1167/iovs.05-1655; MISHIMA H, 1981, EXP EYE RES, V33, P75, DOI 10.1016/S0014-4835(81)80083-8; Miwa T, 2001, INT IMMUNOPHARMACOL, V1, P445, DOI 10.1016/S1567-5769(00)00043-6; Pickering MC, 2002, NAT GENET, V31, P424, DOI 10.1038/ng912; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shaw PX, 2012, P NATL ACAD SCI USA, V109, P13757, DOI 10.1073/pnas.1121309109; Sohn JH, 2000, INVEST OPHTH VIS SCI, V41, P4195; Ufret-Vincenty RL, 2010, INVEST OPHTH VIS SCI, V51, P5878, DOI 10.1167/iovs.09-4457; von Leithner PL, 2009, AM J PATHOL, V175, P412, DOI 10.2353/ajpath.2009.080927; Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449; WING GL, 1978, INVEST OPHTH VIS SCI, V17, P601	27	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68616	10.1371/journal.pone.0068616	http://dx.doi.org/10.1371/journal.pone.0068616			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844226	gold, Green Published, Green Submitted			2022-12-27	WOS:000321341000175
J	Rockhill, AP; DePerno, CS; Powell, RA				Rockhill, Aimee P.; DePerno, Christopher S.; Powell, Roger A.			The Effect of Illumination and Time of Day on Movements of Bobcats (Lynx rufus)	PLOS ONE			English	Article							PREDATION RISK; FORAGING BEHAVIOR; MICROHABITAT USE; HUNTING SUCCESS; DESERT RODENT; OWL PREDATION; MOONLIGHT; COMPETITION; SELECTION; PATTERNS	Understanding behavioral changes of prey and predators based on lunar illumination provides insight into important life history, behavioral ecology, and survival information. The objectives of this research were to determine if bobcat movement rates differed by period of day (dark, moon, crepuscular, day), lunar illumination (<10%, 10 - <50%, 50 - <90%, >90%), and moon phase (new, full). Bobcats had high movement rates during crepuscular and day periods and low movement rates during dark periods with highest nighttime rates at 10-<50% lunar illumination. Bobcats had highest movement rates during daytime when nighttime illumination was low (new moon) and higher movement rates during nighttime when lunar illumination was high (full moon). The behaviors we observed are consistent with prey availability being affected by light level and by limited vision by bobcats during darkness.	[Rockhill, Aimee P.; DePerno, Christopher S.] N Carolina State Univ, Raleigh, NC 27695 USA; [Powell, Roger A.] N Carolina State Univ, Dept Biol & Fisheries Wildlife & Conservat Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Rockhill, AP (corresponding author), N Carolina State Univ, Raleigh, NC 27695 USA.	aimee_rockhill@ncsu.edu			Bull Neck Swamp Research Fund; Fisheries, Wildlife, and Conservation Biology Program; Department of Forestry and Environmental Resources at North Carolina State University	Bull Neck Swamp Research Fund; Fisheries, Wildlife, and Conservation Biology Program; Department of Forestry and Environmental Resources at North Carolina State University	This project was funded from the Bull Neck Swamp Research Fund, Fisheries, Wildlife, and Conservation Biology Program, and the Department of Forestry and Environmental Resources at North Carolina State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EM, 2003, WILD MAMMALS N AM BI, P759; Baker LA, 2001, AM MIDL NAT, V145, P80, DOI 10.1674/0003-0031(2001)145[0080:PSBRBL]2.0.CO;2; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Blair WF, 1943, ACTIVITIES CHIHUAHUA, V7, P92; BOUSKILA A, 1995, ECOLOGY, V76, P165, DOI 10.2307/1940639; BROWN JS, 1988, OECOLOGIA, V76, P408, DOI 10.1007/BF00377036; Buie DE, 1979, BOBC RES C P CURR RE, P42; CLARKE JA, 1983, BEHAV ECOL SOCIOBIOL, V13, P205, DOI 10.1007/BF00299924; DALY M, 1992, ANIM BEHAV, V44, P1, DOI 10.1016/S0003-3472(05)80748-1; Fernandez-Duque E, 2003, BEHAV ECOL SOCIOBIOL, V54, P431, DOI 10.1007/s00265-003-0637-9; Funston PJ, 2001, J ZOOL, V253, P419, DOI 10.1017/S0952836901000395; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Griffin PC, 2005, BEHAV ECOL, V16, P938, DOI 10.1093/beheco/ari074; HAHN CJ, 1995, J CLIMATE, V8, P1429, DOI 10.1175/1520-0442(1995)008<1429:TEOMOO>2.0.CO;2; Hall H. T., 1976, P ANN C SE ASS FISH, V30, P422; HANSEN K., 2007, BOBCAT MASTER SURVIV; Harmsen BJ, 2010, MAMM BIOL, P5, DOI DOI 10.1016/J.MAMBI0.2010.08.007.ACCESSED; HUGHES JJ, 1993, ANIM BEHAV, V46, P1243, DOI 10.1006/anbe.1993.1320; HUGHES JJ, 1994, ECOLOGY, V75, P1397, DOI 10.2307/1937463; Kappeler PM, 2003, BEHAV ECOL SOCIOBIOL, V54, P359, DOI 10.1007/s00265-003-0652-x; KAUFMAN DW, 1982, J MAMMAL, V63, P309, DOI 10.2307/1380644; KAVANAU JL, 1971, J MAMMAL, V52, P386, DOI 10.2307/1378681; KING A M, 1983, Brimleyana, P111; KITCHENER A., 1991, NATURAL HIST WILD CA; KOTLER BP, 1988, OIKOS, V53, P145, DOI 10.2307/3566056; KOTLER BP, 1994, OECOLOGIA, V100, P391, DOI 10.1007/BF00317860; KOTLER BP, 1991, ECOLOGY, V72, P2249, DOI 10.2307/1941575; KOTLER BP, 1984, ECOLOGY, V65, P689, DOI 10.2307/1938041; Kyba CCM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017307; LONGLAND WS, 1991, ECOLOGY, V72, P2261, DOI 10.2307/1941576; Lovallo MJ, 1996, AM MIDL NAT, V135, P241, DOI 10.2307/2426706; Marshall AD, 1966, P SE ASS GAME FISH C, V20, P206; Mason JR, 2002, INT BIODETER BIODEGR, V49, P189, DOI 10.1016/S0964-8305(01)00122-6; McCord C.M., 1982, P728; Milne DJ, 2005, J MAMMAL, V86, P909, DOI 10.1644/1545-1542(2005)86[909:TPOBIT]2.0.CO;2; Mitchell MS, 2012, TECH ECOL CONSERVAT, P218; Molsher RL, 2000, WILDLIFE RES, V27, P593, DOI 10.1071/WR99015; PALOMARES F, 1991, J WILDLIFE MANAGE, V55, P698, DOI 10.2307/3809521; Powell RA, 2000, METH C CONS, P65; Powell RA, 2012, J MAMMAL, V93, P948, DOI 10.1644/11-MAMM-S-177.1; Powell RA, 2012, TECH ECOL CONSERVAT, P188; PRICE MV, 1984, J MAMMAL, V65, P353, DOI 10.2307/1381183; Rockhill AP, 2011, J ZOO WILDLIFE MED, V42, P580, DOI 10.1638/2010-0152.1; Sunquist ME, 2002, WILD CATS WORLD; VANORSDOL KG, 1984, AFR J ECOL, V22, P79; VASQUEZ RA, 1994, BEHAV ECOL SOCIOBIOL, V34, P375, DOI 10.1007/BF00197008; VICKERY WL, 1981, J MAMMAL, V62, P140, DOI 10.2307/1380484; WILSON DE, 1999, SMITHSONIAN BOOK N A; Wolfe L, 1989, INFLUENCE LUNAR LIGH, P410; Zezulak D. S., 1980, BOBCAT BIOL MOJAVE D; Zezulak DS, 1981, NE CALIFORNIA BOBCAT; ZIELINSKI WJ, 1986, PHYSIOL BEHAV, V38, P613, DOI 10.1016/0031-9384(86)90254-4; ZIELINSKI WJ, 1988, ANIM BEHAV, V36, P239, DOI 10.1016/S0003-3472(88)80267-7	53	25	25	2	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e69213	10.1371/journal.pone.0069213	http://dx.doi.org/10.1371/journal.pone.0069213			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861963	gold, Green Submitted, Green Published			2022-12-27	WOS:000321692000039
J	Gao, Y; Liu, Y; Zhou, L; Guo, ZH; Rong, MD; Liu, XN; Lai, CH; Ding, XL				Gao, Yan; Liu, Ying; Zhou, Lei; Guo, Zehong; Rong, Mingdeng; Liu, Xiangning; Lai, Chunhua; Ding, Xianglong			The Effects of Different Wavelength UV Photofunctionalization on Micro-Arc Oxidized Titanium	PLOS ONE			English	Article							APATITE-FORMING ABILITY; SURFACE MODIFICATION; PROTEIN ADSORPTION; CELL RESPONSE; BONE RESPONSE; TIO2; INTEGRATION; IMPLANTS; OSSEOINTEGRATION; DEGRADATION	Many challenges exist in improving early osseointegration, one of the most critical factors in the long-term clinical success of dental implants. Recently, ultraviolet (UV) light-mediated photofunctionalization of titanium as a new potential surface treatment has aroused great interest. This study examines the bioactivity of titanium surfaces treated with UV light of different wavelengths and the underlying associated mechanism. Micro-arc oxidation (MAO) titanium samples were pretreated with UVA light (peak wavelength of 360 nm) or UVC light (peak wavelength of 250 nm) for up to 24 h. UVC treatment promoted the attachment, spread, proliferation and differentiation of MG-63 osteoblast-like cells on the titanium surface, as well as the capacity for apatite formation in simulated body fluid (SBF). These biological influences were not observed after UVA treatment, apart from a weaker effect on apatite formation. The enhanced bioactivity was substantially correlated with the amount of Ti-OH groups, which play an important role in improving the hydrophilicity, along with the removal of hydrocarbons on the titanium surface. Our results showed that both UVA and UVC irradiation altered the chemical properties of the titanium surface without sacrificing its excellent physical characteristics, suggesting that this technology has extensive potential applications and merits further investigation.	[Gao, Yan; Liu, Ying; Zhou, Lei; Lai, Chunhua; Ding, Xianglong] Southern Med Univ, Guangdong Prov Stomatol Hosp, Ctr Oral Implantol, Guangzhou, Guangdong, Peoples R China; [Liu, Ying] Southern Med Univ, Dept Stomatol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Liu, Ying] Southern Med Univ, Coll Stomatol, Guangzhou, Guangdong, Peoples R China; [Guo, Zehong; Rong, Mingdeng] Southern Med Univ, Guangdong Prov Stomatol Hosp, Dept Oral & Maxillofacial Surg, Guangzhou, Guangdong, Peoples R China; [Liu, Xiangning] Jinan Univ, Guangzhou Overseas Chinese Hosp, Dept Prosthodont, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Jinan University	Zhou, L (corresponding author), Southern Med Univ, Guangdong Prov Stomatol Hosp, Ctr Oral Implantol, Guangzhou, Guangdong, Peoples R China.	zho668@263.net	rong, mingdeng/GRJ-8507-2022		National Natural Science Foundation of China [81170998]; Medical Science Research Foundation of Guangdong Province [C2012034]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Science Research Foundation of Guangdong Province	The study was supported by the National Natural Science Foundation of China (http://nsfc.pubmed.cn/)(No. 81170998) and Medical Science Research Foundation of Guangdong Province (http://www.gdwst.gov.cn/) (C2012034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aita H, 2009, ACTA BIOMATER, V5, P3247, DOI 10.1016/j.actbio.2009.04.022; Aita H, 2009, BIOMATERIALS, V30, P1015, DOI 10.1016/j.biomaterials.2008.11.004; Alborzi A, 1996, J CRAN GENET DEV BIO, V16, P94; Att W, 2009, BIOMATERIALS, V30, P4268, DOI 10.1016/j.biomaterials.2009.04.048; Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016; Chen XB, 2008, BIOTECHNOL BIOENG, V101, P378, DOI 10.1002/bit.21900; Colombo JS, 2012, J DENT, V40, P338, DOI 10.1016/j.jdent.2012.01.010; Cooper LF, 1998, J PROSTHET DENT, V80, P439, DOI 10.1016/S0022-3913(98)70009-5; Davies JE, 1998, INT J PROSTHODONT, V11, P391; Davies John E, 2003, J Dent Educ, V67, P932; Davies JE, 2007, BIOMATERIALS, V28, P5058, DOI 10.1016/j.biomaterials.2007.07.049; De Maeztu MA, 2008, INT J ORAL MAX SURG, V37, P441, DOI 10.1016/j.ijom.2008.01.010; Di Veroli GY, 2013, AM J PHYSIOL-HEART C, V304, pH104, DOI 10.1152/ajpheart.00511.2012; Doi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049051; Guo ZH, 2010, INT J ORAL MAX IMPL, V25, P130; Han Y, 2008, ACTA BIOMATER, V4, P1518, DOI 10.1016/j.actbio.2008.03.005; Hori N, 2010, INT J ORAL MAX IMPL, V25, P49; Iwasa F, 2011, INT J NANOMED, V6, P1327, DOI 10.2147/IJN.S22099; Jager M, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/69036; Jansen EJP, 2005, BIOMATERIALS, V26, P4423, DOI 10.1016/j.biomaterials.2004.11.011; Kandori K, 2009, J PHYS CHEM B, V113, P11016, DOI 10.1021/jp904481z; Kasuga T, 2002, J CRYST GROWTH, V235, P235, DOI 10.1016/S0022-0248(01)01782-1; Lee YJ, 2012, J PERIODONTAL IMPLAN, V42, P81, DOI 10.5051/jpis.2012.42.3.81; Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048; Lim YW, 2009, CLIN ORTHOP RELAT R, V467, P2251, DOI 10.1007/s11999-009-0879-6; Linderback P, 2010, BIOMATERIALS, V31, P4795, DOI 10.1016/j.biomaterials.2010.02.060; Mata A, 2003, IEEE T NANOBIOSCI, V2, P287, DOI 10.1109/TNB.2003.820268; Miyauchi T, 2010, BIOMATERIALS, V31, P3827, DOI 10.1016/j.biomaterials.2010.01.133; Ogawa T, 2003, INT J ORAL MAX IMPL, V18, P200; Ohno H, 1998, Dent Mater J, V17, P285; Price NJ, 1999, J ELECTRON SPECTROSC, V98, P257, DOI 10.1016/S0368-2048(98)00291-6; Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X; Raghavendra S, 2005, INT J ORAL MAX IMPL, V20, P425; Rupp F, 2011, INT J ORAL MAX IMPL, V26, P1256; Sawase T, 2007, CLIN ORAL IMPLAN RES, V18, P680, DOI 10.1111/j.1600-0501.2007.01404.x; Son HS, 2009, J HAZARD MATER, V166, P954, DOI 10.1016/j.jhazmat.2008.11.107; Sul Young-Taeg, 2002, Clin Implant Dent Relat Res, V4, P78, DOI 10.1111/j.1708-8208.2002.tb00156.x; Sul YT, 2003, BIOMATERIALS, V24, P3893, DOI 10.1016/S0142-9612(03)00261-8; Tsukimura N, 2011, BIOMATERIALS, V32, P4358, DOI 10.1016/j.biomaterials.2011.03.001; Uchida M, 2003, J BIOMED MATER RES A, V64A, P164, DOI 10.1002/jbm.a.10414; Ueno T, 2011, BIOMATERIALS, V32, P7297, DOI 10.1016/j.biomaterials.2011.06.033; Viornery C, 2002, LANGMUIR, V18, P2582, DOI 10.1021/la010908i; Wang R, 1997, NATURE, V388, P431, DOI 10.1038/41233; Wong CC, 2003, CHEMOSPHERE, V50, P981, DOI 10.1016/S0045-6535(02)00640-9; Yada M, 2010, COLLOID SURFACE B, V80, P116, DOI 10.1016/j.colsurfb.2010.05.032; Yan SF, 2011, COLLOID SURFACE B, V86, P218, DOI 10.1016/j.colsurfb.2011.04.004; Yang ZP, 2008, ACTA BIOMATER, V4, P560, DOI 10.1016/j.actbio.2007.10.003; Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320; Zhao XY, 2011, COLLOID SURFACE B, V86, P260, DOI 10.1016/j.colsurfb.2011.03.044	49	32	33	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68086	10.1371/journal.pone.0068086	http://dx.doi.org/10.1371/journal.pone.0068086			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861853	Green Published, gold, Green Submitted			2022-12-27	WOS:000321425300041
J	Majek, O; Gondos, A; Jansen, L; Emrich, K; Holleczek, B; Katalinic, A; Nennecke, A; Eberle, A; Brenner, H				Majek, Ondrej; Gondos, Adam; Jansen, Lina; Emrich, Katharina; Holleczek, Bernd; Katalinic, Alexander; Nennecke, Alice; Eberle, Andrea; Brenner, Hermann		GEKID Canc Survival Working Grp	Sex Differences in Colorectal Cancer Survival: Population-Based Analysis of 164,996 Colorectal Cancer Patients in Germany	PLOS ONE			English	Article							HORMONE REPLACEMENT THERAPY; LONG-TERM SURVIVAL; UP-TO-DATE; GENDER INFLUENCES TREATMENT; EUROCARE HIGH-RESOLUTION; PERIOD ANALYSIS; RELATIVE SURVIVAL; POSTMENOPAUSAL WOMEN; EARLY 21ST-CENTURY; COLON-CANCER	Risk of colorectal cancer (CRC) is considerably higher in men compared to women; however, there is inconclusive evidence of sex differences in CRC prognosis. We aimed to assess and explain sex differences in 5-year relative survival using standard and model-based period analysis among 164,996 patients diagnosed with CRC from 1997 to 2006 and reported to 11 German cancer registries covering a population of 33 million inhabitants. Age-adjusted 5-year relative survival was higher in women (64.5% vs. 61.9%, P < 0.0001). A substantial survival advantage of women was confirmed in multivariate analysis after adjusting for CRC stage and subsite in subjects under 65 years of age (relative excess risk, RER 0.86, 95% CI 0.82-0.90), but not in older subjects (RER 1.01, 95% CI 0.98-1.04); this pattern was similar in the 1st and in the 2nd to 5th year after diagnosis. The survival advantage of women varied by CRC stage and age and was most pronounced for localized disease (RERs 0.59-0.88 in various age subgroups) and in patients under 45 years of age (RERs 0.59, 0.72 and 0.76 in patients with localized, regional or advanced disease, respectively). On the contrary, sex differences in survival did not vary by location of CRC. In conclusion, our large population-based study confirmed a survival advantage of female compared to male CRC patients, most notably in young and middle aged patients and patients with localized disease. The effect of sex hormones, either endogenous or through hormonal replacement therapy, might be the most plausible explanation for the observed patterns.	[Majek, Ondrej; Gondos, Adam; Jansen, Lina] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Majek, Ondrej] Masaryk Univ, Inst Biostat & Anal, Brno, Czech Republic; [Emrich, Katharina] Johannes Gutenberg Univ Mainz, Canc Registry Rhineland Palatinate, Inst Med Biostat Epidemiol & Informat, Univ Med Ctr, D-55122 Mainz, Germany; [Holleczek, Bernd] Saarland Canc Registry, Saarbrucken, Germany; [Katalinic, Alexander] Med Univ Lubeck, Inst Canc Epidemiol, Canc Registry Schleswig Holstein, D-23538 Lubeck, Germany; [Nennecke, Alice] Minist Hlth & Consumer Protect, Hamburg Canc Registry, Hamburg, Germany; [Eberle, Andrea] Leibniz Inst Prevent Res & Epidemiol BIPS, Canc Registry Bremen, Bremen, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Institute of Biostatistics & Analyses; Masaryk University Brno; Johannes Gutenberg University of Mainz; University of Lubeck; Leibniz Institute for Prevention Research & Epidemiology (BIPS)	Brenner, H (corresponding author), German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany.	h.brenner@dkfz.de	Katalinic, Alexander/D-2512-2010; Jansen, Lina/D-7255-2016; Brenner, Hermann/ABE-6383-2020; Majek, Ondrej/E-4521-2011; Brenner, Hermann/B-4627-2017	Katalinic, Alexander/0000-0003-0490-1554; Jansen, Lina/0000-0001-8004-4940; Brenner, Hermann/0000-0002-6129-1572; Majek, Ondrej/0000-0002-0034-3084; Brenner, Hermann/0000-0002-6129-1572	German Cancer Aid (Deutsche Krebshilfe) [108257]; Masaryk University [MUNI/A/0828/2011]	German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe); Masaryk University	This work was supported by the German Cancer Aid (Deutsche Krebshilfe, www.krebshilfe.de, grant number 108257) and Masaryk University (www.muni.cz, grant number MUNI/A/0828/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berrino F, 2002, ENCR RECOMMENDATION; Brenner H, 2007, BRIT J CANCER, V96, P828, DOI 10.1038/sj.bjc.6603628; Brenner H, 2002, INT J EPIDEMIOL, V31, P456, DOI 10.1093/ije/31.2.456; Brenner H, 2002, J CLIN ONCOL, V20, P826, DOI 10.1200/JCO.20.3.826; Brenner H, 2002, EUR J CANCER, V38, P690, DOI 10.1016/S0959-8049(02)00003-5; Brenner H, 2006, AM J EPIDEMIOL, V164, P689, DOI 10.1093/aje/kwj243; Chan JA, 2006, J CLIN ONCOL, V24, P5680, DOI 10.1200/JCO.2006.08.0580; Chlebowski RT, 2004, NEW ENGL J MED, V350, P991, DOI 10.1056/NEJMoa032071; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Corazziari I, 2004, EUR J CANCER, V40, P2307, DOI 10.1016/j.ejca.2004.07.002; Cosper PF, 2011, CANCER RES, V71, P1710, DOI 10.1158/0008-5472.CAN-10-3145; Dent OF, 2009, ANN SURG, V249, P402, DOI 10.1097/SLA.0b013e31819a0469; Dickman PW, 2004, STAT MED, V23, P51, DOI 10.1002/sim.1597; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fernandez E, 2001, BRIT J CANCER, V84, P722, DOI 10.1054/bjoc.2000.1622; Finlayson E, 2009, DIS COLON RECTUM, V52, P1991, DOI 10.1097/01.dcr.0000364983.74288.29; Franceschi S, 2000, BRIT J CANCER, V82, P1860, DOI 10.1054/bjoc.1999.1084; Fritz AG., 2000, INT CLASSIFICATION D, Vvii, P240; Gatta G, 2000, GUT, V47, P533, DOI 10.1136/gut.47.4.533; Gatta G, 2010, ACTA ONCOL, V49, P776, DOI 10.3109/02841861003782009; Gonzalez EC, 2001, DIS COLON RECTUM, V44, P251, DOI 10.1007/BF02234301; Grodstein F, 1999, AM J MED, V106, P574, DOI 10.1016/S0002-9343(99)00063-7; Heier M, 2009, MATURITAS, V62, P9, DOI 10.1016/j.maturitas.2008.10.002; Heitmann C, 2005, MENOPAUSE, V12, P405, DOI 10.1097/01.GME.0000153890.77135.00; Hendifar A, 2009, CLIN CANCER RES, V15, P6391, DOI 10.1158/1078-0432.CCR-09-0877; HENSON DE, 1995, CANCER-AM CANCER SOC, V76, P1687, DOI 10.1002/1097-0142(19951115)76:10<1687::AID-CNCR2820761002>3.0.CO;2-I; Hiripi E, 2012, ANN ONCOL, V23, P472, DOI 10.1093/annonc/mdr131; Koo JH, 2008, AM J GASTROENTEROL, V103, P1488, DOI 10.1111/j.1572-0241.2007.01779.x; Koo JH, 2010, J GASTROEN HEPATOL, V25, P33, DOI 10.1111/j.1440-1746.2009.05992.x; Majek O, 2012, BRIT J CANCER, V106, P1875, DOI 10.1038/bjc.2012.189; Mandelson MT, 2003, CANCER CAUSE CONTROL, V14, P979, DOI 10.1023/B:CACO.0000007970.04094.76; McArdle CS, 2003, BRIT J SURG, V90, P711, DOI 10.1002/bjs.4098; Meguid RA, 2008, ANN SURG ONCOL, V15, P2388, DOI 10.1245/s10434-008-0015-y; Micheli A, 2009, EUR J CANCER, V45, P1017, DOI 10.1016/j.ejca.2008.11.008; Paulson EC, 2009, DIS COLON RECTUM, V52, P1982, DOI 10.1007/DCR.0b013e3181beb42a; Pox CP, 2012, GASTROENTEROLOGY, V142, P1460, DOI 10.1053/j.gastro.2012.03.022; Slattery ML, 1999, CANCER CAUSE CONTROL, V10, P467, DOI 10.1023/A:1008974215622; Stock C, 2010, ENDOSCOPY, V42, P546, DOI 10.1055/s-0029-1244127; Swaminathan R, 2011, IARC Sci Publ, P7; Verdecchia A, 2007, LANCET ONCOL, V8, P784, DOI 10.1016/S1470-2045(07)70246-2; Wichmann MW, 2001, BRIT J SURG, V88, P1092, DOI 10.1046/j.0007-1323.2001.01819.x; Wong N D, 2001, Prev Cardiol, V4, P109, DOI 10.1111/j.1520-037X.2001.00570.x	42	99	104	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68077	10.1371/journal.pone.0068077	http://dx.doi.org/10.1371/journal.pone.0068077			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861851	Green Published, gold			2022-12-27	WOS:000321425300040
J	Pulli, B; Ali, M; Forghani, R; Schob, S; Hsieh, KLC; Wojtkiewicz, G; Linnoila, JJ; Chen, JW				Pulli, Benjamin; Ali, Muhammad; Forghani, Reza; Schob, Stefan; Hsieh, Kevin L. C.; Wojtkiewicz, Gregory; Linnoila, Jenny J.; Chen, John W.			Measuring Myeloperoxidase Activity in Biological Samples	PLOS ONE			English	Article							IN-VIVO; INHIBITION; ASSAY; MICE; POLYMORPHISM; LEUKOCYTE; BIOMARKER; OXIDANTS; DAMAGE	Background: Enzymatic activity measurements of the highly oxidative enzyme myeloperoxidase (MPO), which is implicated in many diseases, are widely used in the literature, but often suffer from nonspecificity and lack of uniformity. Thus, validation and standardization are needed to establish a robust method that is highly specific, sensitive, and reproducible for assaying MPO activity in biological samples. Principal findings: We found conflicting results between in vivo molecular MR imaging of MPO, which measures extracellular activity, and commonly used in vitro MPO activity assays. Thus, we established and validated a protocol to obtain extra- and intracellular MPO from murine organs. To validate the MPO activity assays, three different classes of MPO activity assays were used in spike and recovery experiments. However, these assay methods yielded inconsistent results, likely because of interfering substances and other peroxidases present in tissue extracts. To circumvent this, we first captured MPO with an antibody. The MPO activity of the resultant samples was assessed by ADHP and validated against samples from MPO-knockout mice in murine disease models of multiple sclerosis, steatohepatitis, and myocardial infarction. We found the measurements performed using this protocol to be highly specific and reproducible, and when performed using ADHP, to be highly sensitive over a broad range. In addition, we found that intracellular MPO activity correlated well with tissue neutrophil content, and can be used as a marker to assess neutrophil infiltration in the tissue. Conclusion: We validated a highly specific and sensitive assay protocol that should be used as the standard method for all MPO activity assays in biological samples. We also established a method to obtain extra- and intracellular MPO from murine organs. Extracellular MPO activity gives an estimate of the oxidative stress in inflammatory diseases, while intracellular MPO activity correlates well with tissue neutrophil content. A detailed step-by-step protocol is provided.	[Pulli, Benjamin; Ali, Muhammad; Schob, Stefan; Hsieh, Kevin L. C.; Wojtkiewicz, Gregory; Linnoila, Jenny J.; Chen, John W.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Pulli, Benjamin; Ali, Muhammad; Schob, Stefan; Hsieh, Kevin L. C.; Wojtkiewicz, Gregory; Linnoila, Jenny J.; Chen, John W.] Harvard Univ, Sch Med, Boston, MA USA; [Pulli, Benjamin; Chen, John W.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Forghani, Reza] McGill Univ, Jewish Gen Hosp, Dept Radiol, Montreal, PQ H3T 1E2, Canada; [Forghani, Reza] McGill Univ, Montreal, PQ, Canada; [Hsieh, Kevin L. C.] Far Eastern Mem Hosp, Dept Med Imaging, Taipei, Taiwan	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; McGill University; McGill University; Far Eastern Memorial Hospital	Chen, JW (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA.	jwchen@mgh.harvard.edu	; Wojtkiewicz, Gregory/L-3660-2018	Ali, Muhammad/0000-0001-8964-4416; schob, stefan/0000-0003-2846-5443; Pulli, Benjamin/0000-0002-1795-9897; Wojtkiewicz, Gregory/0000-0002-3148-8411; Forghani, Reza/0000-0002-8572-1864	NIH [R01-NS070835, R01-NS072167]; Ernst Schering Foundation in Berlin, Germany; National Natural Science Foundation, Beijing, China; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072167, R01NS070835] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ernst Schering Foundation in Berlin, Germany; National Natural Science Foundation, Beijing, China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported in part by the NIH (R01-NS070835 and R01-NS072167 to JWC). Additional funds have come from a fellowship from the Ernst Schering Foundation in Berlin, Germany, and a grant from the National Natural Science Foundation, Beijing, China, awarded to BP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADLEY PP, 1982, BLOOD, V60, P618; Breckwoldt MO, 2008, P NATL ACAD SCI USA, V105, P18584, DOI 10.1073/pnas.0803945105; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; Chapman AL, 2013, J BIOL CHEM; Chen JW, 2008, BRAIN, V131, P1123, DOI 10.1093/brain/awn004; Chen JW, 2006, RADIOLOGY, V240, P473, DOI 10.1148/radiol.2402050994; Chevrier I, 2006, ATHEROSCLEROSIS, V188, P150, DOI 10.1016/j.atherosclerosis.2005.10.012; Feyler A, 2002, CANCER EPIDEM BIOMAR, V11, P1550; Forghani R, 2012, RADIOLOGY, V263, P451, DOI 10.1148/radiol.12111593; Franck T, 2009, TALANTA, V80, P723, DOI 10.1016/j.talanta.2009.07.052; Gray E, 2008, NEUROSCI LETT, V444, P195, DOI 10.1016/j.neulet.2008.08.035; Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886; Haqqani AS, 1999, ANAL BIOCHEM, V273, P126, DOI 10.1006/abio.1999.4206; Heinecke JW, 1999, J LAB CLIN MED, V133, P321, DOI 10.1016/S0022-2143(99)90061-6; HOFSTEIN R, 1983, J NEUROCHEM, V40, P1448, DOI 10.1111/j.1471-4159.1983.tb13589.x; Holzer M, 2012, ANTIOXID REDOX SIGN, V17, P1043, DOI 10.1089/ars.2011.4403; Jahng A, 2004, J EXP MED, V199, P947, DOI 10.1084/jem.20031389; Kapralov A, 2009, J BIOL CHEM, V284, P30395, DOI 10.1074/jbc.M109.045567; KETTLE AJ, 1995, BIOCHEM J, V308, P559, DOI 10.1042/bj3080559; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Lefkowitz Doris L., 2010, Current Immunology Reviews, V6, P123; Meng Y, 2005, ANAL BIOCHEM, V345, P227, DOI 10.1016/j.ab.2005.07.026; Metzler KD, 2011, BLOOD, V117, P953, DOI 10.1182/blood-2010-06-290171; Miller S. D., 2010, CURR PROTOC IMMUNOL; Nahrendorf M, 2008, CIRCULATION, V117, P1153, DOI 10.1161/CIRCULATIONAHA.107.756510; O'Driscoll S, 2008, BRIT J HAEMATOL, V140, P206, DOI 10.1111/j.1365-2141.2007.06894.x; ORMROD DJ, 1987, J PHARMACOL METHOD, V18, P137, DOI 10.1016/0160-5402(87)90006-4; Parker H, 2012, J LEUKOCYTE BIOL, V91, P369, DOI 10.1189/jlb.0711387; Piedrafita FJ, 1996, J BIOL CHEM, V271, P14412, DOI 10.1074/jbc.271.24.14412; Pino PA, 2011, JOVE-J VIS EXP, DOI 10.3791/2348; Reynolds WF, 1999, EXP NEUROL, V155, P31, DOI 10.1006/exnr.1998.6977; Rudolph V, 2010, NAT MED, V16, P470, DOI 10.1038/nm.2124; Sahai A, 2004, AM J PHYSIOL-GASTR L, V287, pG1035, DOI 10.1152/ajpgi.00199.2004; SCHULTZ J, 1962, ARCH BIOCHEM BIOPHYS, V96, P465, DOI 10.1016/0003-9861(62)90321-1; Segelmark M, 1997, CLIN EXP IMMUNOL, V108, P167, DOI 10.1046/j.1365-2249.1997.d01-992.x; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; SUZUKI K, 1983, ANAL BIOCHEM, V132, P345, DOI 10.1016/0003-2697(83)90019-2; Swirski FK, 2010, J CLIN INVEST, V120, P2627, DOI 10.1172/JCI42304; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Talib J, 2012, FREE RADICAL BIO MED, V53, P20, DOI 10.1016/j.freeradbiomed.2012.04.018; Whiteman M, 2008, BIOCHEM BIOPH RES CO, V371, P50, DOI 10.1016/j.bbrc.2008.03.153; Wingfield P. T., 2001, CURR PROTOC PROTEIN; Wu WJ, 2000, J CLIN INVEST, V105, P1455, DOI 10.1172/JCI9702; Xia Y, 1997, ANAL BIOCHEM, V245, P93, DOI 10.1006/abio.1996.9940; Zhang ZL, 2001, JAMA-J AM MED ASSOC, V286, P2136, DOI 10.1001/jama.286.17.2136; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	47	210	211	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67976	10.1371/journal.pone.0067976	http://dx.doi.org/10.1371/journal.pone.0067976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861842	Green Submitted, gold, Green Published			2022-12-27	WOS:000321425300033
J	Yen, LF; Wei, VC; Kuo, EY; Lai, TW				Yen, Lola Fenghuei; Wei, Vivi Chiali; Kuo, Eva Yuhua; Lai, Ted Weita			Distinct Patterns of Cerebral Extravasation by Evans Blue and Sodium Fluorescein in Rats	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; VASCULAR-PERMEABILITY; ACTIVATION; INCREASE; DYE; LOCALIZATION; CHEMOTHERAPY; PEROXIDASE; DISORDERS; TRACERS	The Evans blue dye (EBD; 961 Da) and the sodium fluorescein dye (NaF; 376 Da) are commonly used inert tracers in blood-brain barrier (BBB) research. They are both highly charged low molecular weight (LMW) tracers with similar lipophobic profiles. Nevertheless, the EBD binds to serum albumin (69,000 Da) to become a high molecular weight (HMW) protein tracer when injected into the circulation, whereas the NaF remains an unbound small molecule in the circulation. In this study, rats were injected with equal doses of either EBD or NaF to monitor their blood and tissue distribution. The EBD was largely confined to the circulation with little accumulation in the peripheral organ and even less accumulation in the central tissue, whereas the NaF distributed more evenly between the blood and the peripheral organ but was also largely excluded from the central tissue. Importantly, the EBD crossed the BBB most effectively at the prefrontal cortex and the cerebellum, and most poorly at the striatum. In marked contrast, the NaF was evenly distributed throughout the brain. Finally, the EBD exhibited this same peculiar tissue distribution profile when administered by either bolus injection or slow infusion. Our study suggests that different regions of the brain are equally permeable to LMW inert dyes like the NaF, but are markedly different in permeability to HMW proteins such as EBD-labelled serum albumin.	[Yen, Lola Fenghuei; Wei, Vivi Chiali; Kuo, Eva Yuhua; Lai, Ted Weita] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Lai, Ted Weita] China Med Univ Hosp, Translat Med Res Ctr, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Lai, TW (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan.	ted.weita@me.com	Lai, Ted Weita/E-9392-2016; Kuo, Eva Yuhua/AAZ-2501-2021	Lai, Ted Weita/0000-0002-6229-4134; Kuo, Eva YuHua/0000-0003-0445-570X	China Medical University Hospital [DMR-101-120]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH102-TD-B-111-004]; National Research Council of Taiwan [NSC100-2632-B-039-001-MY3, NSC101-2321-B-039-008]	China Medical University Hospital; Taiwan Department of Health Clinical Trial and Research Center of Excellence; National Research Council of Taiwan	This work was supported by research grants from the China Medical University Hospital (DMR-101-120), the Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH102-TD-B-111-004), and the National Research Council of Taiwan (NSC100-2632-B-039-001-MY3; NSC101-2321-B-039-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelov L, 2009, J CLIN ONCOL, V27, P3503, DOI 10.1200/JCO.2008.19.3789; Arima Y, 2012, CELL, V148, P447, DOI 10.1016/j.cell.2012.01.022; Banks WA, 2012, ANN NY ACAD SCI, V1264, P13, DOI 10.1111/j.1749-6632.2012.06568.x; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; BELOVA TI, 1982, ACTA PHYSIOL SCAND, V116, P21, DOI 10.1111/j.1748-1716.1982.tb10594.x; BRIGHTMA.MW, 1969, J CELL BIOL, V40, P648, DOI 10.1083/jcb.40.3.648; Carman AJ, 2011, J NEUROSCI, V31, P13272, DOI 10.1523/JNEUROSCI.3337-11.2011; Castellano JM, 2012, P NATL ACAD SCI US; Chen KB, 2013, NEUROREPORT, V24, P303, DOI 10.1097/WNR.0b013e32835f8acb; Chen KB, 2012, NEUROREPORT, V23, P699, DOI 10.1097/WNR.0b013e3283556dcc; Doolittle ND, 2000, CANCER, V88, P637, DOI 10.1002/(SICI)1097-0142(20000201)88:3<637::AID-CNCR22>3.0.CO;2-Y; Elali A, 2011, STROKE, V42, P3238, DOI 10.1161/STROKEAHA.111.615559; Esposito P, 2001, BRAIN RES, V888, P117, DOI 10.1016/S0006-8993(00)03026-2; Gorantla S, 2012, TRENDS NEUROSCI, V35, P197, DOI 10.1016/j.tins.2011.12.006; Hjouj M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042817; Joshi S, 2011, J NEURO-ONCOL, V104, P11, DOI 10.1007/s11060-010-0466-4; Kaya M, 2011, METHODS MOL BIOL, V763, P369, DOI 10.1007/978-1-61779-191-8_25; Kozler P, 2003, PHYSIOL RES, V52, P607; Librizzi L, 2012, ANN NEUROL, V72, P82, DOI 10.1002/ana.23567; Malpass Katy, 2011, Nat Rev Neurol, V7, P597, DOI 10.1038/nrneurol.2011.161; Manaenko A, 2011, J NEUROSCI METH, V195, P206, DOI 10.1016/j.jneumeth.2010.12.013; Marchi N, 2004, CLIN CHIM ACTA, V342, P1, DOI 10.1016/j.cccn.2003.12.008; Marquet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022598; PATTERSON CE, 1992, J APPL PHYSIOL, V72, P865, DOI 10.1152/jappl.1992.72.3.865; Pisani V, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-188; Rapoport SI, 2001, EXPERT OPIN INV DRUG, V10, P1809, DOI 10.1517/13543784.10.10.1809; REESE TS, 1967, J CELL BIOL, V34, P207, DOI 10.1083/jcb.34.1.207; SARIA A, 1983, J NEUROSCI METH, V8, P41, DOI 10.1016/0165-0270(83)90050-X; Skultetyova I, 1998, BRAIN RES BULL, V45, P175, DOI 10.1016/S0361-9230(97)00335-3; Tung YS, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3580763; UYAMA O, 1988, J CEREBR BLOOD F MET, V8, P282, DOI 10.1038/jcbfm.1988.59; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; WOLMAN M, 1981, ACTA NEUROPATHOL, V54, P55, DOI 10.1007/BF00691332; Zhong Y, 2012, J NEUROSCI, V32, P143, DOI 10.1523/JNEUROSCI.4266-11.2012; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	35	61	61	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68595	10.1371/journal.pone.0068595	http://dx.doi.org/10.1371/journal.pone.0068595			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861924	Green Published, Green Submitted, gold			2022-12-27	WOS:000321425300073
J	Baptista, C; Barreto, HC; Sao-Jose, C				Baptista, Catarina; Barreto, Hugo Condessa; Sao-Jose, Carlos			High Levels of DegU-P Activate an Esat-6-Like Secretion System in Bacillus subtilis	PLOS ONE			English	Article							RESPONSE REGULATOR DEGU; PROTEIN SECRETION; VII SECRETION; CRYSTAL-STRUCTURE; GEL-FILTRATION; VIRULENCE; EXPRESSION; ESX-1; GENE; PATHOGENESIS	The recently discovered Type VII/Esat-6 secretion systems seem to be widespread among bacteria of the phyla Actinobacteria and Firmicutes. In some species they play an important role in pathogenic interactions with eukaryotic hosts. Several studies have predicted that the locus yukEDCByueBC of the non-pathogenic, Gram-positive bacterium Bacillus subtilis would encode an Esat-6-like secretion system (Ess). We provide here for the first time evidences for the functioning of this secretion pathway in an undomesticated B. subtilis strain. We show that YukE, a small protein with the typical features of the secretion substrates from the WXG100 superfamily is actively secreted to culture media. YukE secretion depends on intact yukDCByueBC genes, whose products share sequence or structural homology with known components of the S. aureus Ess. Biochemical characterization of YukE indicates that it exists as a dimer both in vitro and in vivo. We also show that the B. subtilis Ess essentially operates in late stationary growth phase in absolute dependence of phosphorylated DegU, the response regulator of the two-component system DegS-DegU. We present possible reasons that eventually have precluded the study of this secretion system in the B. subtilis laboratory strain 168.	[Baptista, Catarina; Barreto, Hugo Condessa; Sao-Jose, Carlos] Univ Lisbon, CPM URIA, Fac Farm, P-1699 Lisbon, Portugal	Universidade de Lisboa	Sao-Jose, C (corresponding author), Univ Lisbon, CPM URIA, Fac Farm, P-1699 Lisbon, Portugal.	csaojose@ff.ul.pt	Baptista, Catarina/U-8910-2017; Baptista, Catarina/O-9660-2019; iMed.ULisboa, M2B/B-5277-2014; Barreto, Hugo C./AAQ-1945-2020; Sao-Jose, Carlos Jorge/J-6703-2012	Baptista, Catarina/0000-0002-1263-7880; Baptista, Catarina/0000-0002-1263-7880; iMed.ULisboa, M2B/0000-0002-1245-3715; Barreto, Hugo C./0000-0002-6980-1047; Sao-Jose, Carlos Jorge/0000-0002-4890-9446	Fundacao para a Ciencia e a Tecnologia (FCT, MCTES, Portugal) [SFRH/BPD/63392/2009]	Fundacao para a Ciencia e a Tecnologia (FCT, MCTES, Portugal)(Portuguese Foundation for Science and Technology)	C. Baptista's work has been supported through post-doc fellowship SFRH/BPD/63392/2009 from Fundacao para a Ciencia e a Tecnologia (FCT, MCTES, Portugal). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson M, 2011, J BACTERIOL, V193, P1583, DOI 10.1128/JB.01096-10; Bitter W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000507; Bottai D, 2012, MOL MICROBIOL, V83, P1195, DOI 10.1111/j.1365-2958.2012.08001.x; Burroughs AM, 2011, MOL BIOSYST, V7, P2261, DOI 10.1039/c1mb05061c; Burts ML, 2005, P NATL ACAD SCI USA, V102, P1169, DOI 10.1073/pnas.0405620102; Burts ML, 2008, MOL MICROBIOL, V69, P736, DOI 10.1111/j.1365-2958.2008.06324.x; CABRE F, 1989, J CHROMATOGR, V472, P347, DOI 10.1016/S0021-9673(00)94133-5; Caldwell RB, 2004, APPL ENVIRON MICROB, V70, P610, DOI 10.1128/AEM.70.1.610-612.2004; Carlsson F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000285; Chen YH, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-219; Coros A, 2008, MOL MICROBIOL, V69, P794, DOI 10.1111/j.1365-2958.2008.06299.x; DAHL MK, 1992, J BIOL CHEM, V267, P14509; De Hoon M J L, 2004, Pac Symp Biocomput, P276; Desvaux M, 2006, FEMS MICROBIOL REV, V30, P774, DOI 10.1111/j.1574-6976.2006.00035.x; Desvaux M, 2009, TRENDS MICROBIOL, V17, P139, DOI 10.1016/j.tim.2009.01.004; Dubois JYF, 2009, ANTIMICROB AGENTS CH, V53, P651, DOI 10.1128/AAC.01189-08; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Errington J, 2001, NAT REV MOL CELL BIO, V2, P538, DOI 10.1038/35080005; Fyans JK, 2013, MOL PLANT PATHOL, V14, P119, DOI 10.1111/j.1364-3703.2012.00835.x; Garufi G, 2008, J BACTERIOL, V190, P7004, DOI 10.1128/JB.00458-08; Houben D, 2012, CELL MICROBIOL, V14, P1287, DOI 10.1111/j.1462-5822.2012.01799.x; Houben ENG, 2012, MOL MICROBIOL, V86, P472, DOI 10.1111/j.1365-2958.2012.08206.x; Hsueh YH, 2011, MOL MICROBIOL, V81, P1092, DOI 10.1111/j.1365-2958.2011.07755.x; Iyer LM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r60; Jakutyte L, 2011, J BACTERIOL, V193, P4893, DOI 10.1128/JB.05104-11; Kabisch J, 2013, J BIOTECHNOL, V163, P97, DOI 10.1016/j.jbiotec.2012.06.034; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kobayashi K, 2007, MOL MICROBIOL, V66, P395, DOI 10.1111/j.1365-2958.2007.05923.x; Kobayashi K, 2007, J BACTERIOL, V189, P4920, DOI 10.1128/JB.00157-07; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lopez D, 2010, FEMS MICROBIOL REV, V34, P134, DOI 10.1111/j.1574-6976.2009.00199.x; Mader U, 2002, MOL GENET GENOMICS, V268, P455, DOI 10.1007/s00438-002-0774-2; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Margot P, 1996, MICROBIOL-UK, V142, P3437, DOI 10.1099/13500872-142-12-3437; McLoon AL, 2011, J BACTERIOL, V193, P2027, DOI 10.1128/JB.01542-10; Murray EJ, 2009, MICROBIOL-SGM, V155, P1, DOI 10.1099/mic.0.023903-0; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Ogura M, 2001, NUCLEIC ACIDS RES, V29, P3804, DOI 10.1093/nar/29.18.3804; Ogura M, 2012, J BIOCHEM, V151, P643, DOI 10.1093/jb/mvs036; Ohol YM, 2010, CELL HOST MICROBE, V7, P210, DOI 10.1016/j.chom.2010.02.006; Otto A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1137; Pallen MJ, 2002, TRENDS MICROBIOL, V10, P209, DOI 10.1016/S0966-842X(02)02345-4; Patrick JE, 2009, J BACTERIOL, V191, P7129, DOI 10.1128/JB.00905-09; Renshaw PS, 2002, J BIOL CHEM, V277, P21598, DOI 10.1074/jbc.M201625200; Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732; Sambrook J., 2001, MOL CLONING LAB MANU; Sao-Jose C, 2006, J BIOL CHEM, V281, P11464, DOI 10.1074/jbc.M513625200; Sao-Jose C, 2004, J BACTERIOL, V186, P8337, DOI 10.1128/JB.186.24.8337-8346.2004; Sao-Jose C, 2000, J BACTERIOL, V182, P5823, DOI 10.1128/JB.182.20.5823-5831.2000; Shukla A, 2010, ACTA CRYSTALLOGR F, V66, P1421, DOI 10.1107/S1744309110036286; Simeone R, 2009, CURR OPIN MICROBIOL, V12, P4, DOI 10.1016/j.mib.2008.11.003; Sundaramoorthy R, 2008, J MOL BIOL, V383, P603, DOI 10.1016/j.jmb.2008.08.047; Sutcliffe IC, 2011, ANTON LEEUW INT J G, V99, P127, DOI 10.1007/s10482-010-9507-4; Tekaia F., 1999, Tubercle and Lung Disease, V79, P329, DOI 10.1054/tuld.1999.0220; Tjalsma H, 2004, MICROBIOL MOL BIOL R, V68, P207, DOI 10.1128/MMBR.68.2.207-233.2004; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; van den Ent F, 2005, FEBS LETT, V579, P3837, DOI 10.1016/j.febslet.2005.06.002; VANPITTIUS NCG, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-10-RESEARCH0044; Verhamme DT, 2007, MOL MICROBIOL, V65, P554, DOI 10.1111/j.1365-2958.2007.05810.x; Watson RO, 2012, CELL, V150, P803, DOI 10.1016/j.cell.2012.06.040; Way SS, 2005, INFECT IMMUN, V73, P6151, DOI 10.1128/IAI.73.9.6151-6153.2005; Wirth SE, 2012, MOL MICROBIOL, V83, P654, DOI 10.1111/j.1365-2958.2011.07958.x; YASBIN RE, 1975, J BACTERIOL, V121, P296, DOI 10.1128/JB.121.1.296-304.1975; Yu XW, 2012, CELL SIGNAL, V24, P1841, DOI 10.1016/j.cellsig.2012.05.014; Zeigler DR, 2008, J BACTERIOL, V190, P6983, DOI 10.1128/JB.00722-08; Zoltner M, 2013, BIOCHEM J, V449, P469, DOI 10.1042/BJ20121209	69	36	38	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67840	10.1371/journal.pone.0067840	http://dx.doi.org/10.1371/journal.pone.0067840			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861817	gold, Green Submitted, Green Published			2022-12-27	WOS:000323350700045
J	Queiroz, DMM; Harris, PR; Sanderson, IR; Windle, HJ; Walker, MM; Rocha, AMC; Rocha, GA; Carvalho, SD; Bittencourt, PFS; de Castro, LPF; Villagran, A; Serrano, C; Kelleher, D; Crabtree, JE				Magalhaes Queiroz, Dulciene Maria; Harris, Paul R.; Sanderson, Ian R.; Windle, Henry J.; Walker, Marjorie M.; Camargos Rocha, Andreia Maria; Rocha, Gifone Aguiar; Carvalho, Simone Diniz; Souto Bittencourt, Paulo Fernando; Fonseca de Castro, Lucia Porto; Villagran, Andrea; Serrano, Carolina; Kelleher, Dermot; Crabtree, Jean E.			Iron Status and Helicobacter pylori Infection in Symptomatic Children: An International Multi-Centered Study	PLOS ONE			English	Article							DEFICIENCY ANEMIA; IMMUNE-RESPONSE; ERADICATION; GASTRITIS; FAILURE	Objective: Iron deficiency (ID) and iron deficiency anaemia (IDA) are global major public health problems, particularly in developing countries. Whilst an association between H. pylori infection and ID/IDA has been proposed in the literature, currently there is no consensus. We studied the effects of H. pylori infection on ID/IDA in a cohort of children undergoing upper gastrointestinal endoscopy for upper abdominal pain in two developing and one developed country. Methods: In total 311 children (mean age 10.7 +/- 3.2 years) from Latin America -Belo Horizonte/Brazil (n = 125), Santiago/Chile (n = 105) - and London/UK (n = 81), were studied. Gastric and duodenal biopsies were obtained for evaluation of histology and H. pylori status and blood samples for parameters of ID/IDA. Results: The prevalence of H. pylori infection was 27.7% being significantly higher (p<0.001) in Latin America (35%) than in UK (7%). Multiple linear regression models revealed H. pylori infection as a significant predictor of low ferritin and haemoglobin concentrations in children from Latin-America. A negative correlation was observed between MCV (r = -0.26; p = 0.01) and MCH (r = -0.27; p = 0.01) values and the degree of antral chronic inflammation, and between MCH and the degree of corpus chronic (r = -0.29, p = 0.008) and active (r = -0.27, p = 0.002) inflammation. Conclusions: This study demonstrates that H. pylori infection in children influences the serum ferritin and haemoglobin concentrations, markers of early depletion of iron stores and anaemia respectively.	[Magalhaes Queiroz, Dulciene Maria; Camargos Rocha, Andreia Maria; Rocha, Gifone Aguiar] Univ Fed Minas Gerais, Fac Med, Lab Res Bacteriol, Belo Horizonte, MG, Brazil; [Harris, Paul R.; Villagran, Andrea; Serrano, Carolina] Pontificia Univ Catolica Chile, Sch Med, Div Pediat, Unit Gastroenterol & Nutr, Santiago, Chile; [Sanderson, Ian R.] Barts & London Queen Marys Sch Med & Dent, Blizard Inst, Queen Mary, England; [Windle, Henry J.] St James Hosp, Trinity Ctr Hlth Sci, Inst Mol Med, Dublin, Ireland; [Walker, Marjorie M.] Univ London Imperial Coll Sci Technol & Med, Div Med, Ctr Pathol, London, England; [Carvalho, Simone Diniz; Souto Bittencourt, Paulo Fernando] Univ Fed Minas Gerais, Univ Hosp, Endoscopy Serv, Belo Horizonte, MG, Brazil; [Fonseca de Castro, Lucia Porto] Univ Fed Minas Gerais, Fac Med, Dept Pathol, Belo Horizonte, MG, Brazil; [Kelleher, Dermot] Trinity Coll Dublin, Dept Clin Med, Dublin, Ireland; [Crabtree, Jean E.] Univ Leeds, St Jamess Univ Hosp, Leeds Inst Mol Med, Leeds, W Yorkshire, England	Universidade Federal de Minas Gerais; Pontificia Universidad Catolica de Chile; University of London; Queen Mary University London; Trinity College Dublin; Imperial College London; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Trinity College Dublin; Saint James's University Hospital; University of Leeds	Queiroz, DMM (corresponding author), Univ Fed Minas Gerais, Fac Med, Lab Res Bacteriol, Belo Horizonte, MG, Brazil.	dqueiroz@medicina.ufmg.br	Rocha, Gifone A/N-6913-2018; Queiroz, Dulciene/AAU-9386-2020	Rocha, Gifone A/0000-0002-1858-3166; Queiroz, Dulciene/0000-0003-1334-9423; Sanderson, Ian/0000-0002-9814-0161	European Union [INCO-CT-2006-032136]; Conselho Nacional de Desenvolvimento Cientifico e Tecnolologico (CNPq), Brazil; CONICYT/BM RUE [29]; FONDECYT, Chile [1100654]; Instituto Nacional de Ciencia e Tecnologia/CNPq/Brazil; Instituto de Biomedicina do Semi-Arido Brasileiro	European Union(European Commission); Conselho Nacional de Desenvolvimento Cientifico e Tecnolologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CONICYT/BM RUE; FONDECYT, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Instituto Nacional de Ciencia e Tecnologia/CNPq/Brazil; Instituto de Biomedicina do Semi-Arido Brasileiro	This work was mainly funded by the Sixth Framework Program of the European Union, Project CONTENT (INCO-CT-2006-032136). Funds were also provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnolologico (CNPq), Brazil and by CONICYT/BM RUE # 29 and FONDECYT # 1100654, Chile. DMMQ is funded under the Sixth Framework Program of the European Union, Project CONTENT (INCO-CT-2006-032136) and the Instituto Nacional de Ciencia e Tecnologia/CNPq/Brazil, Instituto de Biomedicina do Semi-Arido Brasileiro. JEC is funded under the Sixth Framework Program of the European Union, Project CONTENT (INCO-CT-2006-032136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annibale B, 2003, GUT, V52, P496, DOI 10.1136/gut.52.4.496; [Anonymous], 2001, IRON DEFICIENCY ANAE; Ashorn M, 2001, SCAND J GASTROENTERO, V36, P701, DOI 10.1080/003655201300191950; Baggett HC, 2006, PEDIATRICS, V117, pE396, DOI 10.1542/peds.2005-1129; Cardenas VM, 2011, J PEDIATR GASTR NUTR, V52, P326, DOI 10.1097/MPG.0b013e3182054123; Cardenas VM, 2006, AM J EPIDEMIOL, V163, P127, DOI 10.1093/aje/kwj018; Choe YH, 2000, ACTA PAEDIATR, V89, P154, DOI 10.1080/080352500750028753; Choi JW, 2003, ACTA PAEDIATR, V92, P970, DOI 10.1080/08035250310004225; CRUZCOKE R, 1994, J MED GENET, V31, P702, DOI 10.1136/jmg.31.9.702; de Oliveira AMR, 1999, J PEDIATR GASTR NUTR, V28, P157, DOI 10.1097/00005176-199902000-00012; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Fagan RP, 2009, J INFECT DIS, V199, P652, DOI 10.1086/596659; Harris PR, 2013, J CLIN PATHOL, V66, P343, DOI 10.1136/jclinpath-2012-201243; Janjetic MA, 2010, J PEDIATR GASTR NUTR, V51, P85, DOI 10.1097/MPG.0b013e3181c2c2cd; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100; Queiroz D. M. M., 2013, PLoS ONE, V8, pe57420, DOI 10.1371/journal.pone.0057420; Queiroz DMM, 2004, GASTROENTEROLOGY, V127, P73, DOI 10.1053/j.gastro.2004.03.069; Santos IS, 2009, PUBLIC HEALTH NUTR, V12, P1862, DOI 10.1017/S1368980009004789; Sarker SA, 2004, AM J CLIN NUTR, V80, P149; Sarker SA, 2008, GASTROENTEROLOGY, V135, P1534, DOI 10.1053/j.gastro.2008.07.030; SOBALA GM, 1991, GUT, V32, P1415, DOI 10.1136/gut.32.11.1415; Stoltzfus RJ, 2001, J NUTR, V131, p697S, DOI 10.1093/jn/131.2.697S; Suoglu OD, 2007, PEDIATR INT, V49, P858, DOI 10.1111/j.1442-200X.2007.02444.x; Thomson MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050194; Tsai CJ, 2005, AM J EPIDEMIOL, V162, P351, DOI 10.1093/aje/kwi207; Vannella L, 2008, ALIMENT PHARM THER, V28, P422, DOI 10.1111/j.1365-2036.2008.03741.x; Wilson KT, 2007, GASTROENTEROLOGY, V133, P288, DOI 10.1053/j.gastro.2007.05.008; Windle HJ, 2007, PEDIATRICS, V119, pE754, DOI 10.1542/peds.2006-2196; Yip R, 1997, JAMA-J AM MED ASSOC, V277, P1135, DOI 10.1001/jama.277.14.1135; Yokota S, 2008, CLIN INFECT DIS, V46, pE31, DOI 10.1086/526784; Zimmermann MB, 2007, LANCET, V370, P511, DOI 10.1016/S0140-6736(07)61235-5	32	47	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68833	10.1371/journal.pone.0068833	http://dx.doi.org/10.1371/journal.pone.0068833			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861946	Green Published, gold			2022-12-27	WOS:000323350700104
J	Boyer, DM; Seiffert, ER; Gladman, JT; Bloch, JI				Boyer, Doug M.; Seiffert, Erik R.; Gladman, Justin T.; Bloch, Jonathan I.			Evolution and Allometry of Calcaneal Elongation in Living and Extinct Primates	PLOS ONE			English	Article							EARLIEST LATE EOCENE; MIDDLE EOCENE; POSITIONAL BEHAVIOR; FOOT MORPHOLOGY; PHYLOGENETIC-RELATIONSHIPS; FUNCTIONAL-MORPHOLOGY; LOCOMOTOR BEHAVIOR; SKELETAL REMAINS; OMOMYIDAE; ORIGINS	Specialized acrobatic leaping has been recognized as a key adaptive trait tied to the origin and subsequent radiation of euprimates based on its observed frequency in extant primates and inferred frequency in extinct early euprimates. Hypothesized skeletal correlates include elongated tarsal elements, which would be expected to aid leaping by allowing for increased rates and durations of propulsive acceleration at takeoff. Alternatively, authors of a recent study argued that pronounced distal calcaneal elongation of euprimates (compared to other mammalian taxa) was related primarily to specialized pedal grasping. Testing for correlations between calcaneal elongation and leaping versus grasping is complicated by body size differences and associated allometric affects. We re-assess allometric constraints on, and the functional significance of, calcaneal elongation using phylogenetic comparative methods, and present an evolutionary hypothesis for the evolution of calcaneal elongation in primates using a Bayesian approach to ancestral state reconstruction (ASR). Results show that among all primates, logged ratios of distal calcaneal length to total calcaneal length are inversely correlated with logged body mass proxies derived from the area of the calcaneal facet for the cuboid. Results from phylogenetic ANOVA on residuals from this allometric line suggest that deviations are explained by degree of leaping specialization in prosimians, but not anthropoids. Results from ASR suggest that non-allometric increases in calcaneal elongation began in the primate stem lineage and continued independently in haplorhines and strepsirrhines. Anthropoid and lorisid lineages show stasis and decreasing elongation, respectively. Initial increases in calcaneal elongation in primate evolution may be related to either development of hallucal-grasping or a combination of grasping and more specialized leaping behaviors. As has been previously suggested, subsequent increases in calcaneal elongation are likely adaptations for more effective acrobatic leaping, highlighting the importance of this behavior in early euprimate evolution.	[Boyer, Doug M.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Boyer, Doug M.; Gladman, Justin T.] CUNY, Grad Ctr, Dept Anthropol, New York, NY USA; [Boyer, Doug M.; Gladman, Justin T.] New York Consortium Evolutionary Primatol, New York, NY USA; [Seiffert, Erik R.] SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; [Bloch, Jonathan I.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA	Duke University; City University of New York (CUNY) System; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University System of Florida; University of Florida	Boyer, DM (corresponding author), Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA.	doug.boyer@duke.edu		Boyer, Douglas/0000-0002-8697-2999; Bloch, Jonathan/0000-0003-1484-6931	National Science Foundation (NSF) [BCS 1317525, BCS 1231288, EAR-0640076, EAR-0719941]; American Association of Physical Anthropologists Professional Development Grant; NSF DDIG [SBE 1028505]; NYCEP IGERT [NSF DGE-0991660]; CUNY Graduate Center Provost's Digital Innovations Grant; CUNY Graduate Center Doctoral Student Research Grant; Yale Institute for Biospheric Studies (YIBS); Division Of Behavioral and Cognitive Sci [1317525, 1231288, 1028505] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); American Association of Physical Anthropologists Professional Development Grant; NSF DDIG(National Science Foundation (NSF)); NYCEP IGERT; CUNY Graduate Center Provost's Digital Innovations Grant; CUNY Graduate Center Doctoral Student Research Grant; Yale Institute for Biospheric Studies (YIBS); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	Major funding for this project was provided by National Science Foundation (NSF) grants to D. Boyer and E. Seiffert including BCS 1317525 (formerly BCS 1125507) and BCS 1231288, an American Association of Physical Anthropologists Professional Development Grant in 2009 to D. Boyer, and an NSF DDIG to S. Chester and E.J. Sargis SBE 1028505. A NSF grant to J.I. Bloch, J. Krigbaum and R. Secord (EAR-0640076) and one to J. I. Bloch (EAR-0719941) also provided support. J. Gladman and D. Boyer were also supported by a NYCEP IGERT (NSF DGE-0991660). J. Gladman was additionally supported by a CUNY Graduate Center Provost's Digital Innovations Grant and the CUNY Graduate Center Doctoral Student Research Grant. A portion of this manuscript was written while J. I. Bloch was supported by an Edward P. Bass Distinguished Visiting Environmental Scholarship from the Yale Institute for Biospheric Studies (YIBS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anemone RL, 2000, J HUM EVOL, V38, P607, DOI 10.1006/jhev.1999.0371; BEARD KC, 1993, MAMMAL PHYLOGENY : PLACENTALS, P129; BEARD KC, 1994, NATURE, V368, P604, DOI 10.1038/368604a0; Berge C., 1986, P146; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; Bloch JI, 2002, SCIENCE, V298, P1606, DOI 10.1126/science.1078249; Bloch Jonathan I., 2007, P535, DOI 10.1007/978-0-387-33507-0_16; Bloch JI, 2007, P NATL ACAD SCI USA, V104, P1159, DOI 10.1073/pnas.0610579104; BOCK WJ, 1965, EVOLUTION, V19, P269, DOI 10.2307/2406439; Boyer DM, 2009, NEW CRANIAL POSTCRAN; Boyer DM, 2010, AM J PHYS ANTHROPOL, V143, P383, DOI 10.1002/ajpa.21328; Campbell CJ, 2011, PRIMATES PERSPECTIVE; CARTMILL M, 1974, SCIENCE, V184, P436, DOI 10.1126/science.184.4135.436; Cartmill M., 1972, FUNCTIONAL EVOLUTION, P97, DOI DOI 10.4324/9781315132129; Cartmill M, 2012, EVOL ANTHROPOL, V21, P208, DOI 10.1002/evan.21324; Cartmill Matt, 1992, Evolutionary Anthropology, V1, P105, DOI 10.1002/evan.1360010308; Charles-Dominic P., 1974, P131; Charles-Dominique P, 1977, LOCOMOTION DEFENSIVE, P53; Charles-Dominique P., 1977, ECOLOGY BEHAV NOCTUR; Chester SGB, 2010, J MAMM EVOL, V17, P227, DOI 10.1007/s10914-010-9141-y; COVERT HH, 1993, J HUM EVOL, V25, P351, DOI 10.1006/jhev.1993.1054; COVERT HH, 1988, J HUM EVOL, V17, P57, DOI 10.1016/0047-2484(88)90049-8; CROMPTON RH, 1993, P ROY SOC B-BIOL SCI, V254, P41, DOI 10.1098/rspb.1993.0124; Crompton RH, 1995, CREATURES OF THE DARK, P11; Crompton RH, 2007, DEV PRIMATOL-PROG PR, P127, DOI 10.1007/978-0-387-34810-0_6; CROVELLA S, 1994, PRIMATES, V35, P519, DOI 10.1007/BF02381961; Dagosto M, 1999, ANN CARNEGIE MUS, V68, P175; DAGOSTO M, 1983, FOLIA PRIMATOL, V41, P49, DOI 10.1159/000156119; Dagosto Marian, 2007, P489, DOI 10.1007/978-0-387-33507-0_15; Delson Eric, 2000, Anthropological Papers of the American Museum of Natural History, V83, P1; DEMES B, 1989, FOLIA PRIMATOL, V53, P125, DOI 10.1159/000156412; Demes B, 1996, J HUM EVOL, V31, P367, DOI 10.1006/jhev.1996.0066; Demes B, 2005, AM J PHYS ANTHROPOL, V128, P348, DOI 10.1002/ajpa.20043; Fabre PH, 2009, MOL PHYLOGENET EVOL, V53, P808, DOI 10.1016/j.ympev.2009.08.004; Fleagle J.G., 1985, P1; FLEAGLE JG, 1992, J HUM EVOL, V22, P285, DOI 10.1016/0047-2484(92)90060-M; FLEAGLE JG, 1999, PRIMATE ADAPTATION E; Franzen JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005723; Gebo DL, 2004, YEARB PHYS ANTHROPOL, V47, P40, DOI 10.1002/ajpa.20154; Gebo DL, 2012, J HUM EVOL, V63, P205, DOI 10.1016/j.jhevol.2012.03.010; GEBO DL, 1988, J HUM EVOL, V17, P135, DOI 10.1016/0047-2484(88)90052-8; GEBO DL, 1987, AM J PRIMATOL, V13, P271, DOI 10.1002/ajp.1350130305; GEBO DL, 1988, FOLIA PRIMATOL, V50, P3, DOI 10.1159/000156332; GEBO DL, 1995, AM J PHYS ANTHROPOL, V97, P49, DOI 10.1002/ajpa.1330970105; GEBO DL, 1991, AM J PHYS ANTHROPOL, V86, P51, DOI 10.1002/ajpa.1330860105; GINGERICH PD, 1981, J HUM EVOL, V10, P345, DOI 10.1016/S0047-2484(81)80057-7; Gingerich Philip D., 2012, Palaeobiodiversity Palaeoenvironments, V92, P649, DOI 10.1007/s12549-012-0093-5; Gladman JT, AM J PHYS A IN PRESS; Godfrey L., 1986, Primate Conservation, P92; GODFREY LR, 1988, J HUM EVOL, V17, P93, DOI 10.1016/0047-2484(88)90051-6; Groves C.P., 2001, PRIMATE TAXONOMY; Gunnell GF, 2002, J HUM EVOL, V43, P353, DOI 10.1006/jhev.2002.0582; HALL-CRAGGS E. C. B., 1965, J ZOOL PROC ZOOL SOC LONDON, V147, P20; HALLCRAGGS EC, 1965, J ANAT, V99, P119; Hamrick MW, 1996, AM J PHYS ANTHROPOL, V99, P319, DOI 10.1002/(SICI)1096-8644(199602)99:2<319::AID-AJPA8>3.0.CO;2-T; Hartwig WC, 2002, PRIMATE FOSSIL RECOR; HOFFSTETTER R, 1977, B MEM SOC ANTHRO PAR, V4, P327, DOI 10.3406/bmsap.1977.1886; Janecka JE, 2007, SCIENCE, V318, P792, DOI 10.1126/science.1147555; Jungers WL, 1997, P NATL ACAD SCI USA, V94, P11998, DOI 10.1073/pnas.94.22.11998; Kay RF, 1997, SCIENCE, V275, P797, DOI 10.1126/science.275.5301.797; KAY RF, 1990, NATURE, V345, P342, DOI 10.1038/345342a0; Kay Richard F., 2004, P91; Le Gros Clark W. E., 1959, ANTECEDENTS MAN; Lemelin P, 1999, J ZOOL, V247, P165, DOI 10.1017/S0952836999002046; Lemelin Pierre, 2007, P329, DOI 10.1007/978-0-387-33507-0_10; Losos JB, 1999, ANIM BEHAV, V58, P1319, DOI 10.1006/anbe.1999.1261; Maiolino G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048171; Martins EP, 1999, SYST BIOL, V48, P642, DOI 10.1080/106351599260210; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; MASTERS JC, 1994, PRIMATES, V35, P177, DOI 10.1007/BF02382053; Masters JC, 2002, AM J PHYS ANTHROPOL, V117, P79, DOI 10.1002/ajpa.10001; Masters JC, 2007, AM J PRIMATOL, V69, P6, DOI 10.1002/ajp.20322; Menegaz RA, 2009, J HUM EVOL, V57, P672, DOI 10.1016/j.jhevol.2009.04.010; Morton DJ, 1924, AM J PHYS ANTHROPOL, V7, P1, DOI 10.1002/ajpa.1330070114; Moya-Sola Salvador, 2012, Swiss Journal of Palaeontology, V131, P147, DOI 10.1007/s13358-011-0032-5; NAPIER JR, 1967, FOLIA PRIMATOL, V6, P204, DOI 10.1159/000155079; NASH LT, 1989, INT J PRIMATOL, V10, P57, DOI 10.1007/BF02735704; Ni XJ, 2013, NATURE, V498, P60, DOI 10.1038/nature12200; Ni XJ, 2004, NATURE, V427, P65, DOI 10.1038/nature02126; Nunn C. L., 2011, COMP APPROACH EVOLUT; Orlando L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-121; Orme C.D.L., 2011, CAPER COMP ANAL PHYL; Oxnard C.E., 1990, ANIMAL LIFESTYLES AN; OXNARD CE, 1981, AM J PHYS ANTHROPOL, V54, P421, DOI 10.1002/ajpa.1330540316; Pagel M, 2011, BAYES TRAITS; Pages E., 1980, P97; Patel BA, 2012, J HUM EVOL, V63, P99, DOI 10.1016/j.jhevol.2012.05.002; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Polly PD, 2001, AM NAT, V157, P596, DOI 10.1086/320622; Rambaut A, 2009, TRACER V1 5; Ravosa MJ, 2004, J HUM EVOL, V46, P357, DOI 10.1016/j.jhevol.2003.12.002; Roberts TE, 2011, MOL PHYLOGENET EVOL, V60, P358, DOI 10.1016/j.ympev.2011.04.021; Roig Imma, 2009, Paleolusitana, V1, P419; ROSE KD, 1985, AM J PHYS ANTHROPOL, V66, P73, DOI 10.1002/ajpa.1330660107; Rose KD, 2011, AM J PHYS ANTHROPOL, V146, P281, DOI 10.1002/ajpa.21579; Rose KD, 2009, J HUM EVOL, V56, P366, DOI 10.1016/j.jhevol.2009.01.008; Rose Kenneth D., 1994, Evolutionary Anthropology, V3, P159, DOI 10.1002/evan.1360030505; SAVAGE DE, 1978, FOLIA PRIMATOL, V30, P1, DOI 10.1159/000155853; Schmitt D, 1996, FOLIA PRIMATOL, V67, P137, DOI 10.1159/000157215; Secord R, 2012, SCIENCE, V335, P959, DOI 10.1126/science.1213859; Seiffert ER, 2005, P NATL ACAD SCI USA, V102, P11396, DOI 10.1073/pnas.0505310102; Seiffert Erik R., 2004, P157; Seiffert ER, 2010, P NATL ACAD SCI USA, V107, P9712, DOI 10.1073/pnas.1001393107; Seiffert ER, 2009, NATURE, V461, P1118, DOI 10.1038/nature08429; Seligsohn D., 1974, P543; Silcox MT, 2009, J HUM EVOL, V56, P315, DOI 10.1016/j.jhevol.2008.10.007; Smith RJ, 2009, AM J PHYS ANTHROPOL, V140, P476, DOI 10.1002/ajpa.21090; Smith RJ, 1997, J HUM EVOL, V32, P523, DOI 10.1006/jhev.1996.0122; Smith T, 2006, P NATL ACAD SCI USA, V103, P11223, DOI 10.1073/pnas.0511296103; Soligo C, 2006, J HUM EVOL, V50, P414, DOI 10.1016/j.jhevol.2005.11.001; Springer MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049521; Steiper ME, 2012, P NATL ACAD SCI USA, V109, P6006, DOI 10.1073/pnas.1119506109; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; SZALAY F S, 1976, Bulletin of the American Museum of Natural History, V156, P157; Szalay F.S., 1979, EVOLUTIONARY HIST PR; Szalay Frederick S., 2007, P457, DOI 10.1007/978-0-387-33507-0_14; SZALAY FS, 1980, FOLIA PRIMATOL, V34, P1, DOI 10.1159/000155946; TATTERSALL I, 1974, ANTHROPOL PAP AM MUS, V52, P137; Tattersall I, 1982, SUBFOSSIL LEMURS PRI, P206; Tornow Matthew A., 2008, Bulletin of the Peabody Museum of Natural History, V49, P43, DOI 10.3374/0079-032X(2008)49[43:SAOTEP]2.0.CO;2; Wing SL, 2005, SCIENCE, V310, P993, DOI 10.1126/science.1116913	121	50	51	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67792	10.1371/journal.pone.0067792	http://dx.doi.org/10.1371/journal.pone.0067792			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844094	Green Published, gold, Green Submitted			2022-12-27	WOS:000321733000103
J	Dhainaut, A; Hoff, M; Syversen, U; Haugeberg, G				Dhainaut, Alvilde; Hoff, Mari; Syversen, Unni; Haugeberg, Glenn			Cortical Hand Bone Porosity and Its Association with Distal Radius Fracture in Middle Aged and Elderly Women	PLOS ONE			English	Article							X-RAY RADIOGRAMMETRY; MINERAL DENSITY; INTRACORTICAL POROSITY; POSTMENOPAUSAL WOMEN; HR-PQCT; OSTEOPOROSIS; MICROSTRUCTURE; EPIDEMIOLOGY; WRIST; TIBIA	Objective: Reduced bone mineral density (BMD), assessed by Dual Energy X-ray absorptiometry (DXA), is a well-known risk factor for fragility fracture. A large proportion of patients with fracture have only slightly reduced BMD. Assessment of other bone structure features than BMD may improve identification of individuals at increased fracture risk. Digital X-ray radiogrammetry (DXR), which is a feasible tool for measurement of metacarpal cortical bone density, also gives an estimate of cortical bone porosity. Our primary aim was to explore the association between cortical porosity in the hand assessed by DXR and distal radius fracture. Methods: This case-control study included 123 women > 50 years with distal radius fracture, and 170 controls. DXR was used to measure metacarpal BMD (DXR-BMD), cortical porosity (DXR-porosity), thickness (DXR-CT) and bone width (DXR-W) of the hand. Femoral neck BMD was measured by DXA. Results: The fracture group had a statistically significant lower DXR-BMD (0.492 vs. 0.524 g/cm(2) p < 0.001), higher cortical DXR-porosity (0.01256 vs. 0.01093, p < 0.001), less DXR-CT (0.148 vs. 0.161cm, p < 0.001) and lower femoral neck DXA-BMD (0.789 vs. 0.844 g/cm(2), p = 0.001) than the controls. In logistic regression analysis adjusted for age, a significant association with distal radius fracture (OR, 95% CI) was found for body mass index (0.930, 0.880-0.983), DXA-BMD (0.996, 0.995-0.999), DXR-BMD (0.990, 0.985-0.998), DXR-porosity (1.468, 1.278-1.687) and DXR-CT (0.997, 0.996-0.999). In an adjusted model, DXR-porosity remained the only variable associated with distal radius fracture (1.415, 1.194-1.677). Conclusion: DXR derived porosity is associated with fracture at distal radius and might be a sensitive marker for skeletal fragility.	[Dhainaut, Alvilde; Hoff, Mari; Haugeberg, Glenn] Norwegian Univ Sci & Technol, Dept Neurosci, Div Rheumatol, N-7034 Trondheim, Norway; [Hoff, Mari] St Olavs Hosp, Dept Rheumatol, Trondheim, Norway; [Syversen, Unni] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Syversen, Unni] St Olavs Hosp, Dept Endocrinol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Dhainaut, A (corresponding author), Norwegian Univ Sci & Technol, Dept Neurosci, Div Rheumatol, N-7034 Trondheim, Norway.	alvilde.dhainaut@ntnu.no	Hoff, Mari/AAZ-7302-2021	Hoff, Mari/0000-0002-9992-8663	Competence Development Fund of Southern Norway; Hospital of Southern Norway; Samarbeidsorganet; SECTRA	Competence Development Fund of Southern Norway; Hospital of Southern Norway; Samarbeidsorganet; SECTRA	This work has been supported and funded by the Competence Development Fund of Southern Norway and the Hospital of Southern Norway. PhD Fellow AD has been funded by Samarbeidsorganet (the liaison body operating between the NTNU University and the Central Regional Health Authority). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MH, AD and GH have presented lectures and open seminars for medical professionals in Scandinavia, where SECTRA has been a part sponsor. All authors state that they have no further conflicts of interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], 1994, ASS FRACT RISK ITS A; Augat P, 2006, AGE AGEING, V35, P27, DOI 10.1093/ageing/afl081; Bonnick SL, 2010, CURR CLIN PRACT, P1, DOI 10.1007/978-1-60327-499-9; Bouxsein Mary L, 2006, Curr Osteoporos Rep, V4, P49, DOI 10.1007/s11914-006-0002-9; Bouxsein ML, 2002, OSTEOPOROSIS INT, V13, P358, DOI 10.1007/s001980200040; Burghardt AJ, 2010, J BONE MINER RES, V25, P983, DOI 10.1359/jbmr.091104; Dhainaut A, 2010, J CLIN DENSITOM, V13, P418, DOI 10.1016/j.jocd.2010.07.005; Diamantopoulos AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043367; Granke M, 2011, BONE, V49, P1020, DOI 10.1016/j.bone.2011.08.002; Hoff M, 2009, J CLIN DENSITOM, V12, P17, DOI 10.1016/j.jocd.2008.10.005; Holroyd C, 2008, BEST PRACT RES CL EN, V22, P671, DOI 10.1016/j.beem.2008.06.001; Hyldstrup L, 2001, CALCIFIED TISSUE INT, V68, P135, DOI 10.1007/s002230001204; Kanis JA, 2008, BONE, V42, P467, DOI 10.1016/j.bone.2007.11.001; Kazakia GJ, 2011, J BIOMECH, V44, P257, DOI 10.1016/j.jbiomech.2010.10.010; Lofthus CM, 2008, OSTEOPOROSIS INT, V19, P781, DOI 10.1007/s00198-007-0499-5; Macdonald HM, 2011, J BONE MINER RES, V26, P50, DOI 10.1002/jbmr.171; Nicks KM, 2012, J BONE MINER RES, V27, P637, DOI 10.1002/jbmr.1468; Nishiyama KK, 2010, J BONE MINER RES, V25, P882, DOI 10.1359/jbmr.091020; Oyen J, 2010, OSTEOPOROSIS INT, V21, P1247, DOI 10.1007/s00198-009-1065-0; Oyen J, 2009, OSTEOPOROSINT; Oyen J, 2011, J BONE JOINT SURG AM, V93A, P348, DOI 10.2106/JBJS.J.00303; Patsch JM, 2012, JBONE MINERRES, V10; Rohde G, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-90; Rosholm A, 2001, OSTEOPOROSIS INT, V12, P961, DOI 10.1007/s001980170026; Siris ES, 2004, ARCH INTERN MED, V164, P1108, DOI 10.1001/archinte.164.10.1108; Sornay-Rendu E, 2009, OSTEOPOROSIS INT, V20, P1291, DOI 10.1007/s00198-009-1008-9; Ural A, 2007, J BIOMECH ENG-T ASME, V129, P625, DOI 10.1115/1.2768377; Vergara IA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-265; Walker MD, 2011, J BONE MINER RES, V26, P1392, DOI 10.1002/jbmr.352; Wang XF, 2012, OSTEOPOROSIS INT, V23, P411, DOI 10.1007/s00198-011-1739-2; Zebaze RMD, 2010, LANCET, V375, P1729, DOI 10.1016/S0140-6736(10)60320-0	31	11	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68405	10.1371/journal.pone.0068405	http://dx.doi.org/10.1371/journal.pone.0068405			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844197	Green Submitted, Green Published, gold			2022-12-27	WOS:000321733000003
J	Sandera, M; Albrecht, T; Stopka, P				Sandera, Martin; Albrecht, Tomas; Stopka, Pavel			Variation in Apical Hook Length Reflects the Intensity of Sperm Competition in Murine Rodents	PLOS ONE			English	Article							POSTCOPULATORY SEXUAL SELECTION; FEMALE PROMISCUITY; ACROSOME REACTION; GENUS APODEMUS; CYTOCHROME-B; TESTES SIZE; EVOLUTION; COOPERATION; SPERMATOZOON; MORPHOMETRY	Background: Post-copulatory sexual selection has been shown to shape morphology of male gametes. Both directional and stabilizing selection on sperm phenotype have been documented in vertebrates in response to sexual promiscuity. Methodology: Here we investigated the degree of variance in apical hook length and tail length in six taxa of murine rodents. Conclusions: Tail sperm length and apical hook length were positively associated with relative testis mass, our proxy for levels of sperm competition, thus indicating directional post-copulatory selection on sperm phenotypes. Moreover, our study shows that increased levels of sperm competition lead to the reduction of variance in the hook length, indicating stabilizing selection. Hence, the higher risk of sperm competition affects increasing hook length together with decreasing variance in the hook length. Species-specific post-copulatory sexual selection likely optimizes sperm morphology.	[Sandera, Martin; Albrecht, Tomas; Stopka, Pavel] Charles Univ Prague, Biocev Grp, Dept Zool, Fac Sci, Prague, Czech Republic; [Albrecht, Tomas] Acad Sci Czech Republ, Inst Vertebrate Biol, Brno, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences	Stopka, P (corresponding author), Charles Univ Prague, Biocev Grp, Dept Zool, Fac Sci, Prague, Czech Republic.	pstopka@natur.cuni.cz	Albrecht, Tomas/A-1130-2011; Stopka, Pavel/A-6193-2008	Stopka, Pavel/0000-0002-1104-1655; Albrecht, Tomas/0000-0002-9213-0034	Academy of Sciences of the Czech Republic [IAA601110908]; BIOCEV	Academy of Sciences of the Czech Republic(Czech Academy of Sciences); BIOCEV	This work was supported by the Academy of Sciences of the Czech Republic grant no. IAA601110908 (http://www.isvav.cz/projectDetail.do? rowId = IAA601110908). Institutional funding from BIOCEV covers the salary of the corresponding author (http://www.biocev.eu/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2434; [Anonymous], 2010, R LANG ENV STAT COMP; Baskevich MI, 2004, ZOOL ZH, V83, P725; Birkhead TR, 2010, J ZOOL, V281, P78, DOI 10.1111/j.1469-7998.2010.00701.x; Birkhead TR, 2005, NATURE, V434, P383, DOI 10.1038/nature03374; Breed WG, 2007, J ZOOL, V272, P299, DOI 10.1111/j.1469-7998.2006.00269.x; Breed WG, 2005, J MORPHOL, V265, P271, DOI 10.1002/jmor.10357; Breed WG, 2004, J MORPHOL, V261, P52, DOI 10.1002/jmor.10228; Breed WG, 2000, J MAMMAL, V81, P758, DOI 10.1644/1545-1542(2000)081&lt;0758:BMTMAS&gt;2.3.CO;2; Bryja J, 2005, ACTA THERIOL, V50, P189, DOI 10.1007/BF03194482; Bryja J, 2008, BEHAV ECOL SOCIOBIOL, V63, P251, DOI 10.1007/s00265-008-0656-7; Calhim S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000413; Clift LE, 2009, J REPROD IMMUNOL, V81, P62, DOI 10.1016/j.jri.2009.02.006; Clift LE, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-29; Dean MD, 2006, MOL ECOL, V15, P4141, DOI 10.1111/j.1365-294X.2006.03068.x; delBarco-Trillo J, 2004, NATURE, V431, P446, DOI 10.1038/nature02845; Firman RC, 2008, J EVOLUTION BIOL, V21, P1524, DOI 10.1111/j.1420-9101.2008.01612.x; Fisher HS, 2010, NATURE, V463, P801, DOI 10.1038/nature08736; Fitzpatrick JL, 2011, EVOLUTION, V65, P3006, DOI 10.1111/j.1558-5646.2011.01343.x; Fitzpatrick JL, 2009, P NATL ACAD SCI USA, V106, P1128, DOI 10.1073/pnas.0809990106; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Gage MJG, 2003, P ROY SOC B-BIOL SCI, V270, P625, DOI 10.1098/rspb.2002.2258; Montoto LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018173; Immler S, 2008, EVOLUTION, V62, P1538, DOI 10.1111/j.1558-5646.2008.00393.x; Immler S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000170; Immler S, 2007, P ROY SOC B-BIOL SCI, V274, P561, DOI 10.1098/rspb.2006.3752; Johnson PM, 2007, REPRODUCTION, V134, P739, DOI 10.1530/REP-07-0363; Kleven O, 2008, EVOLUTION, V62, P494, DOI 10.1111/j.1558-5646.2007.00287.x; KRZANOWSKA H, 1981, J REPROD FERTIL, V62, P385, DOI 10.1530/jrf.0.0620385; Laskemoen T, 2013, BEHAV ECOL SOCIOBIOL, V67, P301, DOI 10.1007/s00265-012-1450-0; Lifjeld JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013456; Lupold S, 2011, REPRODUCTION, V141, P595, DOI 10.1530/REP-10-0501; Martin Y, 2000, MOL PHYLOGENET EVOL, V16, P37, DOI 10.1006/mpev.1999.0760; Michaux JR, 2002, MOL PHYLOGENET EVOL, V23, P123, DOI 10.1016/S1055-7903(02)00007-6; Moore H, 2002, NATURE, V418, P174, DOI 10.1038/nature00832; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parker GA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0335; Pitcher TE, 2005, J EVOLUTION BIOL, V18, P557, DOI 10.1111/j.1420-9101.2004.00874.x; ROLDAN ERS, 1992, BIOL REV, V67, P551, DOI 10.1111/j.1469-185X.1992.tb01193.x; Sandera M, 2011, BIOLOGIA, V66, P916, DOI 10.2478/s11756-011-0095-1; Sebek Z., 1962, Symposium Theriologicum (Proc Int Symp Meth Mamm Invest Brno 1960) Praha, P318; Sokal R. R, 1981, BIOMETRY; Suzuki H, 2008, BIOCHEM GENET, V46, P329, DOI 10.1007/s10528-008-9149-7	44	18	18	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68427	10.1371/journal.pone.0068427	http://dx.doi.org/10.1371/journal.pone.0068427			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844198	Green Published, gold			2022-12-27	WOS:000321733000004
J	Sandlund, OT; Gjelland, KO; Bohn, T; Knudsen, R; Amundsen, PA				Sandlund, Odd Terje; Gjelland, Karl Oystein; Bohn, Thomas; Knudsen, Rune; Amundsen, Per-Arne			Contrasting Population and Life History Responses of a Young Morph-Pair of European Whitefish to the Invasion of a Specialised Coregonid Competitor, Vendace	PLOS ONE			English	Article							CHARR SALVELINUS-ALPINUS; HABITAT USE; GROWTH; FISH; LAVARETUS; NORWAY; ALBULA; DIVERSIFICATION; ZOOPLANKTON; COEXISTENCE	Invasions of non-native species represent a global problem of great scientific interest. Here we study in detail the response in population and life history characteristics of closely related native species, with divergent habitat preferences, that are impacted by an invading species over a sufficient time period to allow a new stable state to become established. A time series of 20 years starting at the first occurrence of the invader (vendace Coregonus albula (L.)) allows exploration of the long term population and life history response of two ecologically, morphologically, and genetically different native sympatric morphs (DR- and SR-) of congeneric whitefish C. lavaretus (L.). The whitefish morphs are taxonomically equally related to the invading vendace, but only the planktivorous DR-whitefish share its pelagic niche. We would expect that the ecological differences between the whitefish morphs may be used as a predictor of competitive effects. Vendace exhibited an initial boom-and-bust development, and has continued to fluctuate in density. The responses of the pelagic DR- whitefish were: i) an immediate habitat shift, ii) a subsequent population decline caused by increased annual mortality, and iii) a new stable state at a lower density and apparently relaxed competition. The ecologically more distant benthivorous SR-whitefish also showed significant, but a much more limited response during this process, indicating damped indirect interactions through the food-web. This long-term case-study found that in two native eco-species equally related to the invader, only one of the eco-species was highly affected. Direct competition for resources is obviously important for species interactions, whereas the taxonomic relatedness per se seems to offer little predictive power for invasion effects.	[Sandlund, Odd Terje; Gjelland, Karl Oystein] Norwegian Inst Nat Res, N-7004 Trondheim, Norway; [Gjelland, Karl Oystein; Knudsen, Rune; Amundsen, Per-Arne] Univ Tromso, Dept Arctic & Marine Biol, Fac Biosci Fisheries & Econ, Tromso, Norway; [Bohn, Thomas] GenOk Ctr Biosafety, Tromso, Norway; [Bohn, Thomas] Univ Tromso, Inst Pharm, Fac Hlth Sci, Tromso, Norway	Norwegian Institute Nature Research; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso	Sandlund, OT (corresponding author), Norwegian Inst Nat Res, Tungasletta 2, N-7004 Trondheim, Norway.	odd.t.sandlund@nina.no	Gjelland, Karl/I-7023-2012	Gjelland, Karl/0000-0003-4036-4207; Bohn, Thomas/0000-0002-3851-9313; Amundsen, Per-Arne/0000-0002-2203-8216	Norwegian Research Council [NFR 183984/S30, 186320/V40]; Directorate for Nature Management; Governor of Finnmark County	Norwegian Research Council(Research Council of NorwayEuropean Commission); Directorate for Nature Management; Governor of Finnmark County	Financial support was given by the Norwegian Research Council (NFR 183984/S30 and 186320/V40), the Directorate for Nature Management, and the Governor of Finnmark County. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; AMUNDSEN P-A, 1988, Finnish Fisheries Research, V9, P425; Amundsen PA, 2004, ANN ZOOL FENN, V41, P291; Amundsen PA, 2002, ERGEB LIMNOL, V57, P577; Amundsen PA, 1997, SCI TOTAL ENVIRON, V201, P211, DOI 10.1016/S0048-9697(97)84058-2; Amundsen PA, 1999, BIOL CONSERV, V88, P405, DOI 10.1016/S0006-3207(98)00110-4; Amundsen PA, 2011, ENVIRON MONIT ASSESS, V182, P301, DOI 10.1007/s10661-011-1877-1; Amundsen PA, 2009, FRESHWATER BIOL, V54, P24, DOI 10.1111/j.1365-2427.2008.02088.x; Baxter CV, 2007, OECOLOGIA, V153, P461, DOI 10.1007/s00442-007-0743-x; Berg MP, 2010, EVOL ECOL, V24, P617, DOI 10.1007/s10682-009-9347-8; Beyers DW, 1998, J N AM BENTHOL SOC, V17, P367, DOI 10.2307/1468339; Bohn T, 2004, ANN ZOOL FENN, V41, P125; Bohn T, 2004, OIKOS, V106, P138, DOI 10.1111/j.0030-1299.2004.13022.x; Bohn T, 2002, ERGEB LIMNOL, V57, P183; Bohn T, 2001, ECOLOGY, V82, P2150, DOI 10.1890/0012-9658(2001)082[2150:TCEOAI]2.0.CO;2; Bohn T, 2008, BIOL INVASIONS, V10, P359, DOI 10.1007/s10530-007-9135-8; Cailliet GM, 2006, ENVIRON BIOL FISH, V77, P211, DOI 10.1007/s10641-006-9105-5; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Darwin C, 1859, ORIGIN SPECIES MEANS; Dauvalter V, 2011, J ENVIRON SCI HEAL A, V46, P1020, DOI 10.1080/10934529.2011.584503; Davis M. A., 2009, INVASION BIOL; Dostal P, 2011, AM NAT, V177, P655, DOI 10.1086/659060; Falk-Petersen J, 2006, BIOL INVASIONS, V8, P1409, DOI 10.1007/s10530-005-0710-6; GALLUCCI VF, 1979, T AM FISH SOC, V108, P14, DOI 10.1577/1548-8659(1979)108<14:RFATAS>2.0.CO;2; Gjelland KO, 2007, J FISH BIOL, V71, P196, DOI 10.1111/j.1095-8649.2007.01678.x; Holmes E.E., 2012, ANAL MULTIVARIATE TI; Holmes EE, 2012, R J, V4, P11; Humbert JY, 2009, OIKOS, V118, P1940, DOI 10.1111/j.1600-0706.2009.17839.x; Kahilainen KK, 2011, EVOL ECOL, V25, P573, DOI 10.1007/s10682-010-9411-4; Karjalainen J, 2000, J FISH BIOL, V56, P837, DOI 10.1111/j.1095-8649.2000.tb00876.x; Kristoffersen K, 1984, 5 FYLK FINNM; Liso S, 2011, J FISH BIOL, V78, P332, DOI 10.1111/j.1095-8649.2010.02831.x; Lockwood BL, 2011, J EXP MAR BIOL ECOL, V400, P167, DOI 10.1016/j.jembe.2011.02.022; Mayer-Pinto M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047871; Mooij WM, 1999, T AM FISH SOC, V128, P483, DOI 10.1577/1548-8659(1999)128<0483:AACOFG>2.0.CO;2; Moyle Peter B., 1999, Population and Community Biology Series, V24, P177; Museth J, 2007, ADV LIMNOL, V60, P343; MUTENIA A, 1994, REHABILITATION OF FRESHWATER FISHERIES, P280; Mutenia Ahti, 1992, Polskie Archiwum Hydrobiologii, V39, P797; NAESJE TF, 1986, ENVIRON BIOL FISH, V15, P309; Ostbye K, 2006, MOL ECOL, V15, P3983, DOI 10.1111/j.1365-294X.2006.03062.x; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; Pinheiro J., 2019, NLME LINEAR NONLINEA; RICKER W E, 1975, P382; Roy ED, 2010, ECOL SOC, V15; Salonen E, 2007, ADV LIMNOL, V60, P331; Sandlund OT, 2013, ADV LIMNOL, V64, P345, DOI 10.1127/1612-166X/2013/0064-0013; Sandlund OT, 2010, HYDROBIOLOGIA, V650, P27, DOI 10.1007/s10750-009-0075-4; SANDLUND OT, 1991, J FISH BIOL, V38, P873, DOI 10.1111/j.1095-8649.1991.tb03627.x; Sarvala J, 1995, ERGEB LIMNOL, V46, P187; Simberloff D, 2004, BIOL INVASIONS, V6, P161, DOI 10.1023/B:BINV.0000022133.49752.46; Siwertsson A, 2012, ADV LIMNOL, V63, P229; Siwertsson A, 2010, EVOL ECOL RES, V12, P929; Smith E. P., 2013, ENCY ENV, V1, P141, DOI DOI 10.1002/9780470057339.VAB001.PUB2; SMITH EP, 1993, CAN J FISH AQUAT SCI, V50, P627, DOI 10.1139/f93-072; STEWARTOATEN A, 1992, ECOLOGY, V73, P1396, DOI 10.2307/1940685; SVARDSON G, 1976, Institute of Freshwater Research Drottningholm Report, P144; Violle C, 2011, ECOL LETT, V14, P782, DOI 10.1111/j.1461-0248.2011.01644.x; WELKER MT, 1994, T AM FISH SOC, V123, P703, DOI 10.1577/1548-8659(1994)123<0703:GASOLF>2.3.CO;2; Williamson M., 1996, BIOL INVASIONS; WINEMILLER KO, 1992, CAN J FISH AQUAT SCI, V49, P2196, DOI 10.1139/f92-242; Wootton R.J., 1998, ECOLOGY TELEOST FISH	63	10	11	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68156	10.1371/journal.pone.0068156	http://dx.doi.org/10.1371/journal.pone.0068156			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844164	Green Published, gold			2022-12-27	WOS:000321733000131
J	Turner, P; Turner, C; Jankhot, A; Phakaudom, K; Nosten, F; Goldblatt, D				Turner, Paul; Turner, Claudia; Jankhot, Auscharee; Phakaudom, Kawalee; Nosten, Francois; Goldblatt, David			Field Evaluation of Culture plus Latex Sweep Serotyping for Detection of Multiple Pneumococcal Serotype Colonisation in Infants and Young Children	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; NASOPHARYNGEAL COLONIZATION; COCOLONIZATION; AGGLUTINATION; CARRIAGE; DYNAMICS; DISEASE; IMPACT; 6D	Background: Nasopharyngeal swab (NPS) culture by World Health Organisation (WHO) methodology underestimates multiple pneumococcal serotype colonisation compared to a simple culture and latex sweep method. The impacts of this on descriptions of pneumococcal serotype distributions and colonisation dynamics in infancy are not clear. Methods: 8,736 NPS collected from infants enrolled into a longitudinal study were processed to evaluate the field utility of the latex sweep method. 1,107 had previously been cultured by WHO methodology. Additionally, colonisation results were compared in 100 matched pairs of infants, where swabs from an individual were cultured either by WHO or latex sweep method. Results: In 1,107 swabs cultured by both methods, the latex sweep method was three times more likely to detect colonisation with multiple pneumococcal serotypes than the WHO method (p < 0.001). At least one common serotype was identified in 91.2% of swabs from which typeable pneumococci were detected by both methods. Agreement improved with increasing colonisation density (p = 0.03). Estimates of age at first pneumococcal acquisition and colonisation duration were not affected by culture/serotyping method. However, a greater number of serotype carriage episodes were detected in infants cultured by latex sweep (p = 0.03). The overall rate of non-vaccine type pneumococcal acquisition was also greater in infants cultured by latex sweep (p = 0.04). Conclusions: Latex sweep serotyping was feasible to perform on a large specimen collection. Multiple serotype colonisation detection was significantly improved compared with WHO methodology. However, use of the latex sweep method is unlikely to significantly alter colonisation study serotype distribution or colonisation dynamics results.	[Turner, Paul; Turner, Claudia; Jankhot, Auscharee; Phakaudom, Kawalee; Nosten, Francois] Shoklo Malaria Res Unit, Mae Sot, Thailand; [Turner, Paul; Turner, Claudia; Nosten, Francois] Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Turner, Paul; Turner, Claudia; Nosten, Francois] Univ Oxford, Ctr Trop Med, Oxford, England; [Goldblatt, David] UCL, Inst Child Hlth, Immunobiol Unit, London, England	Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); University of Oxford; University of London; University College London	Turner, P (corresponding author), Angkor Hosp Children, Cambodia Oxford Med Res Unit, Siem Reap, Cambodia.	pault@tropmedres.ac	Goldblatt, David/C-5972-2008; Nosten, Francois/AAC-5509-2019	Goldblatt, David/0000-0002-0769-5242; Nosten, Francois/0000-0002-7951-0745; Turner, Paul/0000-0002-1013-7815	Wellcome Trust of Great Britain [083735/Z/07/Z]; Li Ka Shing Foundation - University of Oxford Global Health Programme [LKS-SM09]; National Institute for Health Research [NF-SI-0611-10066] Funding Source: researchfish	Wellcome Trust of Great Britain(Wellcome Trust); Li Ka Shing Foundation - University of Oxford Global Health Programme; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the Wellcome Trust of Great Britain (Grant No. 083735/Z/07/Z to PT) and the Li Ka Shing Foundation - University of Oxford Global Health Programme (Grant No. LKS-SM09 to AJ and PT). SMRU is part of the Mahidol Oxford University Research Unit and is supported by the Wellcome Trust of Great Britain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi O, 2007, J CLIN MICROBIOL, V45, P3408, DOI 10.1128/JCM.01393-07; Adegbola RA, 2006, TROP MED INT HEALTH, V11, P1128, DOI 10.1111/j.1365-3156.2006.01652.x; Antonio M, 2009, J MED MICROBIOL, V58, P296, DOI 10.1099/jmm.0.006031-0; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bronsdon MA, 2004, J CLIN MICROBIOL, V42, P1596, DOI 10.1128/JCM.42.4.1596-1600.2004; Brugger SD, 2009, J CLIN MICROBIOL, V47, P1750, DOI 10.1128/JCM.01877-08; Carvalho MD, 2012, J CLIN MICROBIOL, V50, P3146, DOI 10.1128/JCM.01505-12; Charalambous BM, 2008, J CLIN MICROBIOL, V46, P2467, DOI 10.1128/JCM.00838-08; Ghaffar F, 1999, PEDIATR INFECT DIS J, V18, P638, DOI 10.1097/00006454-199907000-00016; GRATTEN M, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P501; Hare KM, 2008, PEDIATR INFECT DIS J, V27, P178, DOI 10.1097/INF.0b013e31815bb6c5; Ip M, 2013, DIAGN MICROBIOL INFE; Jin P, 2009, J INFECT DIS, V200, P1375, DOI 10.1086/606118; LAFONG AC, 1988, J CLIN PATHOL, V41, P230, DOI 10.1136/jcp.41.2.230; Marsh R, 2010, J CLIN MICROBIOL, V48, P831, DOI 10.1128/JCM.01701-09; Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009; O'Brien KL, 2007, J INFECT DIS, V196, P1211, DOI 10.1086/521833; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Oftadeh S, 2010, J CLIN MICROBIOL, V48, P3378, DOI 10.1128/JCM.00675-10; Porat N, 2013, J CLIN MICROBIOL, V51, P1580, DOI 10.1128/JCM.03320-12; Roca A, 2012, CLIN INFECT DIS, V55, P816, DOI 10.1093/cid/cis554; Scott JR, 2012, J INFECT DIS, V205, P280, DOI 10.1093/infdis/jir730; Spellerberg B, 2007, MANUAL CLIN MICROBIO, P423; SSI Diagnostica, 2012, PNEUM ANT KIT INS; Turner C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054026; Turner P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038271; Turner P, 2011, J CLIN MICROBIOL, V49, P1784, DOI 10.1128/JCM.00157-11; VENKATESWARAN PS, 1983, J INFECT DIS, V147, P1041, DOI 10.1093/infdis/147.6.1041; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8	29	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67933	10.1371/journal.pone.0067933	http://dx.doi.org/10.1371/journal.pone.0067933			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844133	Green Published, gold			2022-12-27	WOS:000321341000123
J	Ratnasingham, S; Hebert, PDN				Ratnasingham, Sujeevan; Hebert, Paul D. N.			A DNA-Based Registry for All Animal Species: The Barcode Index Number (BIN) System	PLOS ONE			English	Article							OPERATIONAL TAXONOMIC UNITS; 16S RIBOSOMAL-RNA; DIVERSITY; SEQUENCE; PROGRAM; PROTEIN; MODELS	Because many animal species are undescribed, and because the identification of known species is often difficult, interim taxonomic nomenclature has often been used in biodiversity analysis. By assigning individuals to presumptive species, called operational taxonomic units (OTUs), these systems speed investigations into the patterning of biodiversity and enable studies that would otherwise be impossible. Although OTUs have conventionally been separated through their morphological divergence, DNA-based delineations are not only feasible, but have important advantages. OTU designation can be automated, data can be readily archived, and results can be easily compared among investigations. This study exploits these attributes to develop a persistent, species-level taxonomic registry for the animal kingdom based on the analysis of patterns of nucleotide variation in the barcode region of the cytochrome c oxidase I (COI) gene. It begins by examining the correspondence between groups of specimens identified to a species through prior taxonomic work and those inferred from the analysis of COI sequence variation using one new (RESL) and four established (ABGD, CROP, GMYC, jMOTU) algorithms. It subsequently describes the implementation, and structural attributes of the Barcode Index Number (BIN) system. Aside from a pragmatic role in biodiversity assessments, BINs will aid revisionary taxonomy by flagging possible cases of synonymy, and by collating geographical information, descriptive metadata, and images for specimens that are likely to belong to the same species, even if it is undescribed. More than 274,000 BIN web pages are now available, creating a biodiversity resource that is positioned for rapid growth.	[Ratnasingham, Sujeevan; Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Hebert, Paul D. N.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	University of Guelph; University of Guelph	Ratnasingham, S (corresponding author), Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada.	sratnasi@uoguelph.ca	Hebert, Paul DN/C-4161-2013; Ratnasingham, Sujeevan/G-9103-2014	Hebert, Paul DN/0000-0002-3081-6700; 	Ontario Ministry of Economic Development and Innovation; government of Canada through the Ontario Genomics Institute	Ontario Ministry of Economic Development and Innovation; government of Canada through the Ontario Genomics Institute	This work was enabled by a grant from the Ontario Ministry of Economic Development and Innovation and by an award from the government of Canada to Genome Canada through the Ontario Genomics Institute in support of the International Barcode of Life project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	April J, 2013, MOL ECOL, V22, P409, DOI 10.1111/mec.12116; AUGUSTSO.JG, 1970, J ACM, V17, P571, DOI 10.1145/321607.321608; Avise JC, 2000, PHYLOGEOGRAPHY HIST, DOI 10.2307/j.ctv1nzfgj7; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berners-Lee T, 2005, RFP3986 IETF; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Blaxter M, 2004, P ROY SOC B-BIOL SCI, V271, pS189, DOI 10.1098/rsbl.2003.0130; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Burns John M., 2007, Journal of the Lepidopterists' Society, V61, P138; Carbayo F, 2011, TRENDS ECOL EVOL, V26, P154, DOI 10.1016/j.tree.2011.01.004; Carr CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022232; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hao XL, 2011, BIOINFORMATICS, V27, P611, DOI 10.1093/bioinformatics/btq725; HARRISON RG, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P3; Hausmann Axel, 2011, Mitteilungen Muenchener Entomologischen Gesellschaft, V101, P73; Hausmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017134; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HILL RS, 1980, BOT GAZ, V141, P321, DOI 10.1086/337163; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Jones M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019259; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kauserud H, 2008, BOTANY, V86, P1326, DOI 10.1139/B08-102; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Kerr KCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004379; Kumar S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-182; Larsen B, 1999, P 5 ACM SIGKDD INT C, P16, DOI DOI 10.1145/312129.312186; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lovasz L, 1993, BOLYAI MATH STUD, V1, P9; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Magnacca KN, 2012, MOL ECOL RESOUR, V12, P990, DOI 10.1111/1755-0998.12001; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; MURTAGH F, 1983, COMPUT J, V26, P354, DOI 10.1093/comjnl/26.4.354; Mutanen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047214; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Page R., 2011, DARK TAXA GENBANK PO; Papadopoulou A, 2011, AM NAT, V178, P241, DOI 10.1086/660828; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paskin N, 2005, DATA SCI J, V4, P12, DOI DOI 10.2481/DSJ.4.12; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Pons J, 2011, MOL PHYLOGENET EVOL, V59, P251, DOI 10.1016/j.ympev.2011.02.013; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Robeson MS, 2011, P NATL ACAD SCI USA, V108, P4406, DOI 10.1073/pnas.1012678108; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schindel David E., 2010, P109, DOI 10.1201/EBK1420095012-c10; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Tauro CJM, 2012, INT J COMPUTER APPL, V48, P1, DOI DOI 10.5120/7461-0336; Trontelj P, 2009, SYST BIODIVERS, V7, P1, DOI 10.1017/S1477200008002909; Van Dongen S, 2008, SIAM J MATRIX ANAL A, V30, P121, DOI 10.1137/040608635; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Waugh J, 2007, BIOESSAYS, V29, P188, DOI 10.1002/bies.20529; Young MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048755	66	1338	1401	5	162	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e66213	10.1371/journal.pone.0066213	http://dx.doi.org/10.1371/journal.pone.0066213			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861743	Green Published, gold			2022-12-27	WOS:000321692000004
J	Dmytrenko, L; Cicanic, M; Anderova, M; Vorisek, I; Ottersen, OP; Sykova, E; Vargova, L				Dmytrenko, Lesia; Cicanic, Michal; Anderova, Miroslava; Vorisek, Ivan; Ottersen, Ole Petter; Sykova, Eva; Vargova, Lydia			The Impact of Alpha-Syntrophin Deletion on the Changes in Tissue Structure and Extracellular Diffusion Associated with Cell Swelling under Physiological and Pathological Conditions	PLOS ONE			English	Article							AQUAPORIN-4 WATER CHANNELS; RAT SPINAL-CORD; CEREBRAL-ISCHEMIA; POTASSIUM CHANNEL; VOLUME CHANGES; GLIAL-CELLS; BRAIN; MICE; K+; SPACE	Aquaporin-4 (AQP4) is the primary cellular water channel in the brain and is abundantly expressed by astrocytes along the blood-brain barrier and brain-cerebrospinal fluid interfaces. Water transport via AQP4 contributes to the activity-dependent volume changes of the extracellular space (ECS), which affect extracellular solute concentrations and neuronal excitability. AQP4 is anchored by alpha-syntrophin (alpha-syn), the deletion of which leads to reduced AQP4 levels in perivascular and subpial membranes. We used the real-time iontophoretic method and/or diffusion-weighted magnetic resonance imaging to clarify the impact of alpha-syn deletion on astrocyte morphology and changes in extracellular diffusion associated with cell swelling in vitro and in vivo. In mice lacking alpha-syn, we found higher resting values of the apparent diffusion coefficient of water (ADC(W)) and the extracellular volume fraction (alpha). No significant differences in tortuosity (lambda) or non-specific uptake (k'), were found between alpha-syn-negative (alpha-syn -/-) and alpha-syn-positive (alpha-syn +/+) mice. The deletion of alpha-syn resulted in a significantly smaller relative decrease in alpha observed during elevated K+ (10 mM) and severe hypotonic stress (-100 mOsmol/l), but not during mild hypotonic stress (-50 mOsmol/l). After the induction of terminal ischemia/anoxia, the final values of ADC(W) as well as of the ECS volume fraction alpha indicate milder cell swelling in alpha-syn -/- in comparison with alpha-syn +/+ mice. Shortly after terminal ischemia/anoxia induction, the onset of a steep rise in the extracellular potassium concentration and an increase in lambda was faster in alpha-syn -/- mice, but the final values did not differ between alpha-syn -/- and alpha-syn +/+ mice. This study reveals that water transport through AQP4 channels enhances and accelerates astrocyte swelling. The substantially altered ECS diffusion parameters will likely affect the movement of neuroactive substances and/or trophic factors, which in turn may modulate the extent of tissue damage and/or drug distribution.	[Dmytrenko, Lesia; Cicanic, Michal; Anderova, Miroslava; Vorisek, Ivan; Sykova, Eva; Vargova, Lydia] Inst Expt Med AS CR, Vvi, Prague, Czech Republic; [Cicanic, Michal; Anderova, Miroslava; Vorisek, Ivan; Sykova, Eva; Vargova, Lydia] Charles Univ Prague, Fac Med 2, Prague, Czech Republic; [Ottersen, Ole Petter] Univ Oslo, Ctr Mol Biol & Neurosci, Oslo, Norway; [Ottersen, Ole Petter] Univ Oslo, Dept Anat, Oslo, Norway	Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Charles University Prague; University of Oslo; University of Oslo	Vargova, L (corresponding author), Inst Expt Med AS CR, Vvi, Prague, Czech Republic.	lydie.vargova@lfmotol.cuni.cz	Anderova, Miroslava/H-2249-2014; Sykova, Eva/H-2659-2014; Vargova, Lydia/H-2568-2014	Anderova, Miroslava/0000-0002-9030-4571; 	Grant Agency of the Czech Republic [309/09/1597, P303/11/2378, P304/12/G069]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	This study was supported by the grants 309/09/1597, P303/11/2378 and P304/12/G069 from the Grant Agency of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P13615, DOI 10.1073/pnas.2336064100; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100; Amiry-Moghaddam M, 2004, NEUROSCIENCE, V129, P999, DOI 10.1016/j.neuroscience.2004.08.049; Benesova J, 2009, J NEUROSCI RES, V87, P96, DOI 10.1002/jnr.21828; Binder DK, 2012, GLIA, V60, P1203, DOI 10.1002/glia.22317; Binder DK, 2006, GLIA, V53, P631, DOI 10.1002/glia.20318; Binder DK, 2004, NEUROREPORT, V15, P259, DOI 10.1097/00001756-200402090-00009; Bloch O, 2005, J NEUROCHEM, V95, P254, DOI 10.1111/j.1471-4159.2005.03362.x; Bloch O, 2006, J CEREBR BLOOD F MET, V26, P1527, DOI 10.1038/sj.jcbfm.9600306; Connors NC, 2004, J BIOL CHEM, V279, P28387, DOI 10.1074/jbc.M402604200; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Fryclenlund DS, 2006, P NATL ACAD SCI USA, V103, P13532, DOI 10.1073/pnas.0605796103; Guadagno E, 2004, GLIA, V47, P138, DOI 10.1002/glia.20039; Haj-Yasein NN, 2011, P NATL ACAD SCI USA, V108, P17815, DOI 10.1073/pnas.1110655108; Haj-Yasein NN, 2011, GLIA, V59, P1635, DOI 10.1002/glia.21205; Ke CS, 2001, NEUROSCI LETT, V301, P21, DOI 10.1016/S0304-3940(01)01589-0; KIMELBERG HK, 1995, J CEREBR BLOOD F MET, V15, P409, DOI 10.1038/jcbfm.1995.51; Magistretti PJ, 2000, PROG BRAIN RES, V125, P229; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Nagelhus EA, 2004, NEUROSCIENCE, V129, P905, DOI 10.1016/j.neuroscience.2004.08.053; Nagelhus EA, 1999, GLIA, V26, P47, DOI 10.1002/(SICI)1098-1136(199903)26:1<47::AID-GLIA5>3.0.CO;2-5; Neely JD, 2001, P NATL ACAD SCI USA, V98, P14108, DOI 10.1073/pnas.241508198; Neprasova H, 2007, PFLUG ARCH EUR J PHY, V453, P839, DOI 10.1007/s00424-006-0151-9; Nicholson C, 1998, TRENDS NEUROSCI, V21, P207, DOI 10.1016/S0166-2236(98)01261-2; NICHOLSON C, 1981, J PHYSIOL-LONDON, V321, P225, DOI 10.1113/jphysiol.1981.sp013981; Papadopoulos MC, 2004, FASEB J, V18, P425, DOI 10.1096/fj.04-2834fje; Papadopoulos MC, 2005, J BIOL CHEM, V280, P13906, DOI 10.1074/jbc.M413627200; Pivonkova H, 2010, NEUROCHEM INT, V57, P783, DOI 10.1016/j.neuint.2010.08.016; Solenov E, 2004, AM J PHYSIOL-CELL PH, V286, pC426, DOI 10.1152/ajpcell.00298.2003; Strohschein S, 2011, GLIA, V59, P973, DOI 10.1002/glia.21169; Su G, 2002, AM J PHYSIOL-CELL PH, V282, pC1136, DOI 10.1152/ajpcell.00478.2001; SVOBODA J, 1991, BRAIN RES, V560, P216, DOI 10.1016/0006-8993(91)91235-S; Sykova E, 1997, NEUROSCIENTIST, V3, P28, DOI 10.1177/107385849700300113; Sykova E, 1999, GLIA, V25, P56, DOI 10.1002/(SICI)1098-1136(19990101)25:1<56::AID-GLIA6>3.0.CO;2-4; SYKOVA E, 1992, MONITORING NEURONAL, P261; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Taniguchi M, 2000, MOL BRAIN RES, V78, P131, DOI 10.1016/S0169-328X(00)00084-X; Vajda Z, 2000, BIOCHEM BIOPH RES CO, V270, P495, DOI 10.1006/bbrc.2000.2472; Verkman AS, 2012, ANNU REV MED, V63, P303, DOI 10.1146/annurev-med-043010-193843; Vorisek I, 2009, ACTA PHYSIOL, V195, P101, DOI 10.1111/j.1748-1716.2008.01924.x; Vorisek I, 1997, J CEREBR BLOOD F MET, V17, P191; Xiao F, 2009, NEUROSCIENCE, V161, P39, DOI 10.1016/j.neuroscience.2009.03.017; Yao XM, 2008, J NEUROSCI, V28, P5460, DOI 10.1523/JNEUROSCI.0257-08.2008; Zador Z, 2008, FASEB J, V22, P870, DOI 10.1096/fj.07-9468com; Zeynalov E, 2008, CRIT CARE MED, V36, P2634, DOI 10.1097/CCM.0b013e3181847853; Zhang H, 2008, MOL CELL NEUROSCI, V37, P1, DOI 10.1016/j.mcn.2007.08.007	46	17	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68044	10.1371/journal.pone.0068044	http://dx.doi.org/10.1371/journal.pone.0068044			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861848	Green Submitted, Green Published, gold			2022-12-27	WOS:000321425300037
J	Song, EL; Ma, X; Li, HZ; Zhang, P; Ni, D; Chen, WH; Gao, Y; Fan, Y; Pang, HG; Shi, TP; Ding, Q; Wang, BJ; Zhang, Y; Zhang, X				Song, Erlin; Ma, Xin; Li, Hongzhao; Zhang, Peng; Ni, Dong; Chen, Weihao; Gao, Yu; Fan, Yang; Pang, Haigang; Shi, Taoping; Ding, Qiang; Wang, Baojun; Zhang, Yu; Zhang, Xu			Attenuation of Kruppel-Like Factor 4 Facilitates Carcinogenesis by Inducing G1/S Phase Arrest in Clear Cell Renal Cell Carcinoma	PLOS ONE			English	Article							GASTRIC-CANCER DEVELOPMENT; TUMOR-SUPPRESSOR GENE; PROGNOSTIC-FACTORS; CYCLE PROGRESSION; EXPRESSION; KLF4; P21; KRUPPEL-LIKE-FACTOR-4; GROWTH; DIFFERENTIATION	Kruppel-like factor 4 (KLF4) is a transcription factor with diverse functions in various cancer types; however, the function of KLF4 in clear cell renal cell carcinoma (ccRCC) carcinogenesis remains unknown. In this study, we initially examined KLF4 expression by using a cohort of surgically removed ccRCC specimens and cell lines. Results indicated that the transcription and translation of KLF4 were lower in ccRCC tissues than in patient-matched normal tissues. Furthermore, the KLF4 expression was significantly downregulated in the five ccRCC cell lines at protein and mRNA levels compared with that in normal renal proximal tubular epithelial cell lines (HKC). KLF4 downregulation was significantly correlated with tumor stage and tumor diameter. Promoter hypermethylation may contribute to its low expression. In addition, in vitro studies indicated that the KLF4 overexpression significantly inhibited proliferation in human ccRCC cell lines 786-O and ACHN. Moreover, the KLF4 overexpression arrested the cell cycle progress at the G1/S phase transition by upregulating p21(WAF1/CIP1) expression and downregulating cyclin D1 expression, KLF4 knockdown in HKC cells did the opposite. In vivo studies confirmed the anti-proliferative effect of KLF4. Our results suggested that KLF4 had an important function in suppressing the growth of ccRCC.	[Song, Erlin; Ma, Xin; Li, Hongzhao; Zhang, Peng; Ni, Dong; Chen, Weihao; Gao, Yu; Fan, Yang; Pang, Haigang; Shi, Taoping; Ding, Qiang; Wang, Baojun; Zhang, Yu; Zhang, Xu] Chinese Peoples Liberat Army Gen Hosp, Dept Urol, State Key Lab Kidney Dis, Med Sch Chinese PLA, Beijing, Peoples R China; [Song, Erlin] Chinese PLA 211 Hosp, Dept Urol, Harbin, Peoples R China	Chinese People's Liberation Army General Hospital	Zhang, X (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Urol, State Key Lab Kidney Dis, Med Sch Chinese PLA, Beijing, Peoples R China.	xzhang@foxmail.com	zhang, xu/GYE-3558-2022		National Natural Science Foundation of China [81100483]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by National Natural Science Foundation of China (No. 81100483). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035022; Allory Y, 2011, PATHOBIOLOGY, V78, P90, DOI 10.1159/000315543; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Barroca H, 2009, PATHOL RES PRACT, V205, P466, DOI 10.1016/j.prp.2009.01.005; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Chen XM, 2001, J BIOL CHEM, V276, P30423, DOI 10.1074/jbc.M101194200; Chen YJ, 2008, CANCER BIOL THER, V7, P777, DOI 10.4161/cbt.7.5.5768; Coppin C, 2011, BJU INT, V108, P1556, DOI 10.1111/j.1464-410X.2011.10629.x; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Dang DT, 2000, INT J BIOCHEM CELL B, V32, P1103, DOI 10.1016/S1357-2725(00)00059-5; Delahunt B, 2007, PATHOLOGY, V39, P459, DOI 10.1080/00313020701570061; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; Evans PM, 2008, ACTA BIOCH BIOPH SIN, V40, P554, DOI 10.1111/j.1745-7270.2008.00439.x; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Foster KW, 2000, CANCER RES, V60, P6488; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Ghaleb AM, 2007, CANCER RES, V67, P7147, DOI 10.1158/0008-5472.CAN-07-1302; Gossage L, 2010, NAT REV CLIN ONCOL, V7, P277, DOI 10.1038/nrclinonc.2010.42; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hu WX, 2009, CLIN CANCER RES, V15, P5688, DOI 10.1158/1078-0432.CCR-09-0310; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; JIANG HP, 1994, ONCOGENE, V9, P3397; Kanai M, 2006, CLIN CANCER RES, V12, P6395, DOI 10.1158/1078-0432.CCR-06-1034; Le Magnen C, 2013, EUR J CANCER, V49, P955, DOI 10.1016/j.ejca.2012.09.023; Leng ZW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056082; Li J, 2012, CARCINOGENESIS, V33, P1239, DOI 10.1093/carcin/bgs143; Li Q, 2012, GASTROENTEROLOGY, V143, P799, DOI 10.1053/j.gastro.2012.05.043; Lian X, 2012, UROLOGY, V80, DOI 10.1016/j.urology.2012.02.024; Lin ZS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043593; Liu S, 2011, UROL ONCOL; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Miura K, 1996, CANCER RES, V56, P1629; Lopez CM, 2012, CLIN GENITOURIN CANC, V10, P262, DOI 10.1016/j.clgc.2012.06.005; Pandya AY, 2004, CLIN CANCER RES, V10, P2709, DOI 10.1158/1078-0432.CCR-03-0484; Park SH, 2008, CANCER BIOL THER, V7, P2015, DOI 10.4161/cbt.7.12.7069; Patel NV, 2010, CANCER EPIDEM BIOMAR, V19, P2631, DOI 10.1158/1055-9965.EPI-10-0677; Roth MJ, 2001, CANCER RES, V61, P4098; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Shie JL, 2000, NUCLEIC ACIDS RES, V28, P2969, DOI 10.1093/nar/28.15.2969; Tai SK, 2011, CANCER SCI, V102, P895, DOI 10.1111/j.1349-7006.2011.01859.x; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Villarreal G, 2010, BIOCHEM BIOPH RES CO, V391, P984, DOI 10.1016/j.bbrc.2009.12.002; Wang J, 2010, CANCER RES, V70, P10182, DOI 10.1158/0008-5472.CAN-10-2414; Wang JY, 2012, J NEURO-ONCOL, V106, P473, DOI 10.1007/s11060-011-0692-4; Wei DY, 2008, CANCER RES, V68, P4631, DOI 10.1158/0008-5472.CAN-07-5953; Wei DY, 2010, GASTROENTEROLOGY, V139, P2135, DOI 10.1053/j.gastro.2010.08.022; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; Wei DY, 2005, CANCER RES, V65, P2746, DOI 10.1158/0008-5472.CAN-04-3619; Wei S, 2012, CARCINOGENESIS, V33, P538, DOI 10.1093/carcin/bgr319; Weiss RH, 2007, J UROLOGY, V177, P63, DOI 10.1016/j.juro.2006.08.073; Yang WT, 2012, CANCER-AM CANCER SOC, V118, P3691, DOI 10.1002/cncr.26698; Yoon HS, 2004, J BIOL CHEM, V279, P5035, DOI 10.1074/jbc.M307631200; Yori JL, 2010, J BIOL CHEM, V285, P16854, DOI 10.1074/jbc.M110.114546; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Yuen JSP, 2009, MOL CANCER THER, V8, P1448, DOI 10.1158/1535-7163.MCT-09-0101; Zbar B, 2003, ANNU REV MED, V54, P217, DOI 10.1146/annurev.med.54.101601.152514; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zhao WD, 2004, ONCOGENE, V23, P395, DOI 10.1038/sj.onc.1207067	59	28	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67758	10.1371/journal.pone.0067758	http://dx.doi.org/10.1371/journal.pone.0067758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861801	gold, Green Submitted, Green Published			2022-12-27	WOS:000321425300028
J	Braun, K; Larcombe, L; Orr, P; Nickerson, P; Wolfe, J; Sharma, M				Braun, Kali; Larcombe, Linda; Orr, Pamela; Nickerson, Peter; Wolfe, Joyce; Sharma, Meenu			Killer Immunoglobulin-Like Receptor (KIR) Centromeric-AA Haplotype Is Associated with Ethnicity and Tuberculosis Disease in a Canadian First Nations Cohort	PLOS ONE			English	Article							VARIANT KIR1D; GENE; POPULATIONS; KIR2DS4; POLYMORPHISMS; INFECTION; STRAIN	Killer immunoglobulin-like receptors (KIR) on natural killer (NK) cells interact with other immune cells to monitor the immune system and combat infectious diseases, such as tuberculosis (TB). The balance of activating and inhibiting KIR interactions helps determine the NK cell response. In order to examine the enrichment or depletion of KIRs as well as to explore the association between TB status and inhibitory/stimulatory KIR haplotypes, we performed KIR genotyping on samples from 93 Canadian First Nations (Dene, Cree, and Ojibwa) individuals from Manitoba with active, latent, or no TB infection, and 75 uninfected Caucasian controls. There were significant differences in KIR genes between Caucasians and First Nations samples and also between the First Nations ethnocultural groups (Dene, Cree, and Ojibwa). When analyzing ethnicity and tuberculosis status in the study population, it appears that the KIR profile and centromeric haplotype are more predictive than the presence or absence of individual genes. Specifically, the decreased presence of haplotype B centromeric genes and increased presence of centromeric-AA haplotypes in First Nations may contribute to an inhibitory immune profile, explaining the high rates of TB in this population.	[Braun, Kali; Sharma, Meenu] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Larcombe, Linda; Orr, Pamela; Nickerson, Peter] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada; [Wolfe, Joyce; Sharma, Meenu] Publ Hlth Agcy Canada, Natl Reference Ctr Mycobacteriol, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; Public Health Agency of Canada	Sharma, M (corresponding author), Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada.	meenu.sharma@phac-aspc.gc.ca	Sharma, Meenu/AAE-2536-2022; Sharma, Meenu/GWM-5030-2022	Sharma, Meenu/0000-0002-6020-9995; Nickerson, Peter/0000-0002-7393-7799; Larcombe, Linda/0000-0002-7828-1290	University of Manitoba	University of Manitoba	No specific funding was sought for this project. Kali Braun is Dr. Sharma's graduate student and was funded by a graduate student stipend from the University of Manitoba. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GLOB TUB CONTR 2011; Arvanitakis Z, 1998, NEUROLOGY, V50, P1827, DOI 10.1212/WNL.50.6.1827; Carrington M, 2003, THE KIR GENE CLUSTER; Clifford H.T., 1975, INTRO NUMERICAL CLAS; Delgado JC, 2002, J INFECT DIS, V186, P1463, DOI 10.1086/344891; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Giebel S, 2008, LEUKEMIA, V22, P2129, DOI 10.1038/leu.2008.108; Gutierrez-Rodriguez ME, 2006, HUM IMMUNOL, V67, P85, DOI 10.1016/j.humimm.2005.11.007; Hsu KC, 2002, J IMMUNOL, V169, P5118, DOI 10.4049/jimmunol.169.9.5118; Kelley J, 2005, PLOS GENET, V1, P129, DOI 10.1371/journal.pgen.0010027; Khakoo SI, 2006, IMMUNOL REV, V214, P186, DOI 10.1111/j.1600-065X.2006.00459.x; La D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029200; Larcombe L, 2005, GENES IMMUN, V6, P140, DOI 10.1038/sj.gene.6364157; Larcombe L, 2011, INT J CIRCUMPOL HEAL, V70, P141, DOI 10.3402/ijch.v70i2.17806; Larcombe LA, 2008, J INFECT DIS, V198, P1175, DOI 10.1086/592049; Mahfouz R, 2011, INT J TUBERC LUNG D, V15, P1688, DOI 10.5588/ijtld.11.0138; Martin Maureen P., 2008, V415, P49, DOI 10.1007/978-1-59745-570-1_3; Mendez A, 2006, TISSUE ANTIGENS, V68, P386, DOI 10.1111/j.1399-0039.2006.00685.x; Middleton D, 2007, HUM IMMUNOL, V68, P128, DOI 10.1016/j.humimm.2006.12.007; Middleton D, 2010, IMMUNOLOGY, V129, P8, DOI 10.1111/j.1365-2567.2009.03208.x; Morris GAJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016656; Petrelli D, 2004, TUBERCULOSIS, V84, P317, DOI 10.1016/j.tube.2004.01.001; Public Health Agency of Canada, 2007, CANADIAN TUBERCULOSI; Reid JK, 2007, CHEST, V131, P1806, DOI 10.1378/chest.06-1133; Rempel JD, 2011, EUR J HUM GENET, V19, P1276, DOI 10.1038/ejhg.2011.114; Shahsavar F, 2012, IRAN J IMMUNOL, V9, P39, DOI IJIv9i1A3; Sharma MK, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-3; Trajman A, 2013, PULM MED, V2013, DOI 10.1155/2013/601737; Vernon A, 2013, SEMIN RESP CRIT CARE, V34, P67, DOI 10.1055/s-0032-1333544; Versalovic J, MANUAL CLIN MICROBIO; Wilson S., 2008, RES IS CEREMONY INDI; Zhang Y, 2010, LEUKEMIA RES, V34, P55, DOI 10.1016/j.leukres.2009.04.022; Zhuang YL, 2012, INT J IMMUNOGENET, V39, P114, DOI 10.1111/j.1744-313X.2011.01063.x	33	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67842	10.1371/journal.pone.0067842	http://dx.doi.org/10.1371/journal.pone.0067842			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861818	Green Published, gold, Green Submitted			2022-12-27	WOS:000323350700046
J	Brown, T; Bourne, D; Rodriguez-Lanetty, M				Brown, Tanya; Bourne, David; Rodriguez-Lanetty, Mauricio			Transcriptional Activation of c3 and hsp70 as Part of the Immune Response of Acropora millepora to Bacterial Challenges	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; CORAL POCILLOPORA-DAMICORNIS; ANEMONE ANEMONIA-VIRIDIS; SEA-ANEMONE; ARTEMIA-FRANCISCANA; MONTASTRAEA-FAVEOLATA; SCLERACTINIAN CORALS; INNATE IMMUNITY; CLIMATE-CHANGE; COMPLEMENT	The impact of disease outbreaks on coral physiology represents an increasing concern for the fitness and resilience of reef ecosystems. Predicting the tolerance of corals to disease relies on an understanding of the coral immune response to pathogenic interactions. This study explored the transcriptional response of two putative immune genes (c3 and c-type lectin) and one stress response gene (hsp70) in the reef building coral, Acropora millepora challenged for 48 hours with bacterial strains, Vibrio coralliilyticus and Alteromonas sp. at concentrations of 10(6) cells ml(-1). Coral fragments challenged with V. coralliilyticus appeared healthy while fragments challenged with Alteromonas sp. showed signs of tissue lesions after 48 hr. Coral-associated bacterial community profiles assessed using denaturing gradient gel electrophoresis changed after challenge by both bacterial strains with the Alteromonas sp. treatment demonstrating the greatest community shift. Transcriptional profiles of c3 and hsp70 increased at 24 hours and correlated with disease signs in the Alteromonas sp. treatment. The expression of hsp70 also showed a significant increase in V. coralliilyticus inoculated corals at 24 h suggesting that even in the absence of disease signs, the microbial inoculum activated a stress response in the coral. C-type lectin did not show a response to any of the bacterial treatments. Increase in gene expression of c3 and hsp70 in corals showing signs of disease indicates their potential involvement in immune and stress response to microbial challenges.	[Brown, Tanya; Rodriguez-Lanetty, Mauricio] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Bourne, David] Australia Inst Marine Sci, Townsville, Qld, Australia	State University System of Florida; Florida International University	Rodriguez-Lanetty, M (corresponding author), Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA.	rodmauri@fiu.edu	Bourne, David G/B-5073-2008	Bourne, David G/0000-0002-1492-8710; Brown, Tanya/0000-0003-0103-7510	NSF-OCE grant [0851123]	NSF-OCE grant	This research was funded by NSF-OCE grant (0851123) awarded to MRL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers E, 2008, APPL ENVIRON MICROB, V74, P3274, DOI 10.1128/AEM.01870-07; Altincicek B, 2006, DEV COMP IMMUNOL, V30, P1108, DOI 10.1016/j.dci.2006.03.002; Antonius A, 1982, P 4 INT COR REEF S M, V2, P7; Baruah K, 2011, FISH SHELLFISH IMMUN, V31, P134, DOI 10.1016/j.fsi.2011.04.008; Baruah K, 2010, FISH SHELLFISH IMMUN, V29, P733, DOI 10.1016/j.fsi.2010.07.011; Baugh LR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018086; Bellantuono AJ, 2012, P ROY SOC B-BIOL SCI, V279, P1100, DOI 10.1098/rspb.2011.1780; Ben-Haim Y, 2003, APPL ENVIRON MICROB, V69, P4236, DOI 10.1128/AEM.69.7.4236-4242.2003; Ben-Haim Y, 2003, INT J SYST EVOL MICR, V53, P309, DOI 10.1099/ijs.0.02402-0; BIGGER CH, 1982, J IMMUNOL, V129, P1570; BLACK NA, 1995, BIOL BULL, V188, P234, DOI 10.2307/1542301; Bosch TCG, 2009, DEV COMP IMMUNOL, V33, P559, DOI 10.1016/j.dci.2008.10.004; Bourne D, 2008, ISME J, V2, P350, DOI 10.1038/ismej.2007.112; Bourne DG, 2009, TRENDS MICROBIOL, V17, P554, DOI 10.1016/j.tim.2009.09.004; Brown BE, 2002, MAR ECOL PROG SER, V242, P119, DOI 10.3354/meps242119; Carroll MC, 1998, CURR OPIN IMMUNOL, V10, P36; Carroll MC, 1998, ANNU REV IMMUNOL, V16, P545, DOI 10.1146/annurev.immunol.16.1.545; Choresh O, 2001, MAR BIOTECHNOL, V3, P501, DOI 10.1007/s10126-001-0007-4; Choresh O, 2007, J THERM BIOL, V32, P367, DOI 10.1016/j.jtherbio.2007.04.006; Core RD, 2011, R LANG ENV STAT COMP; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dishaw LJ, 2005, IMMUNOGENETICS, V57, P535, DOI 10.1007/s00251-005-0005-1; Downs CA, 2005, MAR POLLUT BULL, V51, P558, DOI 10.1016/j.marpolbul.2005.04.017; Downs CA, 2000, MAR BIOTECHNOL, V2, P533, DOI 10.1007/s101260000038; Dunn SR, 2009, ISJ-INVERT SURVIV J, V6, P7; Fang LS, 1997, CORAL REEFS, V16, P127, DOI 10.1007/s003380050066; Feder ME, 1999, AM ZOOL, V39, P857; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; GARLAND CD, 1983, AUST J MAR FRESH RES, V34, P483; Gates RD, 1999, AM ZOOL, V39, P30; Geffen Y, 2005, MAR BIOL, V146, P931, DOI 10.1007/s00227-004-1505-5; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell D, 2004, FRONT ECOL ENVIRON, V2, P375, DOI 10.1890/1540-9295(2004)002[0375:TRTOOD]2.0.CO;2; Harvell D, 2001, HYDROBIOLOGIA, V460, P97, DOI 10.1023/A:1013169331913; Hashimoto K, 2004, CORAL REEFS, V23, P485, DOI 10.1007/s00338-004-0410-1; Hayes Raymond L., 1995, Molecular Marine Biology and Biotechnology, V4, P36; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Ibrahaim Abdelnasser S.S., 2008, Research Journal of Microbiology, V3, P614; Kim K, 2009, DIS AQUAT ORGAN, V87, P1, DOI 10.3354/dao02177; Kimura A, 2009, IMMUNOBIOLOGY, V214, P165, DOI 10.1016/j.imbio.2009.01.003; Klein J, 1997, SCAND J IMMUNOL, V46, P558, DOI 10.1046/j.1365-3083.1997.d01-164.x; Koh EGL, 1997, J CHEM ECOL, V23, P379, DOI 10.1023/B:JOEC.0000006366.58633.f4; Kooperman N, 2007, FEMS MICROBIOL LETT, V276, P106, DOI 10.1111/j.1574-6968.2007.00921.x; Kvennefors ECE, 2008, DEV COMP IMMUNOL, V32, P1582, DOI 10.1016/j.dci.2008.05.010; Kvennefors ECE, 2010, DEV COMP IMMUNOL, V34, P1219, DOI 10.1016/j.dci.2010.06.016; LECAMPIONALSUMARD T, 1995, MAR ECOL PROG SER, V117, P149, DOI 10.3354/meps117149; Littman RA, 2009, MAR ECOL PROG SER, V389, P45, DOI 10.3354/meps08180; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Miller DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r59; Mullen KM, 2004, CORAL RESISTANCE DIS; Mydlarz LD, 2006, ANNU REV ECOL EVOL S, V37, P251, DOI 10.1146/annurev.ecolsys.37.091305.110103; Mydlarz LD, 2010, J EXP BIOL, V213, P934, DOI 10.1242/jeb.037580; Mydlarz LD, 2009, DIS AQUAT ORGAN, V87, P67, DOI 10.3354/dao02088; Norland S, 2004, GEL 2K 1 2; Oksanen SF, 2011, VEGAN COMMUNITY ECOL, V1; Palmer CV, 2008, P ROY SOC B-BIOL SCI, V275, P2687, DOI 10.1098/rspb.2008.0335; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; PAUL JH, 1986, MAR ECOL PROG SER, V33, P29, DOI 10.3354/meps033029; Prohaszka Z, 2002, CELL STRESS CHAPERON, V7, P17, DOI 10.1379/1466-1268(2002)007<0017:HSPIAP>2.0.CO;2; Prohaszka Z, 2004, TISSUE ANTIGENS, V64, P334; Raina JB, 2009, APPL ENVIRON MICROB, V75, P3492, DOI 10.1128/AEM.02567-08; Richardson LL, 1998, TRENDS ECOL EVOL, V13, P438, DOI 10.1016/S0169-5347(98)01460-8; Rinkevich B, 2011, VISIONS PERSPECTIVES; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rodriguez-Lanetty M, 2008, J BIOCHEM BIOPH METH, V70, P985, DOI 10.1016/j.jbbm.2007.08.005; Rodriguez-Lanetty M, 2009, MOL ECOL, V18, P5101, DOI 10.1111/j.1365-294X.2009.04419.x; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; SHARP VA, 1994, J EXP MAR BIOL ECOL, V179, P179, DOI 10.1016/0022-0981(94)90113-9; Sharp VA, 1997, J THERM BIOL, V22, P11, DOI 10.1016/S0306-4565(96)00029-0; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Sunagawa S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-258; Sung YY, 2008, CELL STRESS CHAPERON, V13, P59, DOI 10.1007/s12192-008-0011-y; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sussman M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004511; Tom M, 1999, BIOCHEM BIOPH RES CO, V262, P103, DOI 10.1006/bbrc.1999.1165; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vidal-Dupiol J, 2011, J EXP BIOL, V214, P1533, DOI 10.1242/jeb.053165; Wang KJ, 2008, DEV COMP IMMUNOL, V32, P1326, DOI 10.1016/j.dci.2008.04.007; Werner T, 2003, J BIOL CHEM, V278, P26319, DOI 10.1074/jbc.C300184200; Wood-Charlson EM, 2009, DEV COMP IMMUNOL, V33, P881, DOI 10.1016/j.dci.2009.01.008; Work TM, 2006, DIS AQUAT ORGAN, V70, P155, DOI 10.3354/dao070155; Zhu Y, 2005, EMBO J, V24, P382, DOI 10.1038/sj.emboj.7600533	84	36	37	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67246	10.1371/journal.pone.0067246	http://dx.doi.org/10.1371/journal.pone.0067246			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861754	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000323350700010
J	Peredo, EL; King, UM; Les, DH				Peredo, Elena L.; King, Ursula M.; Les, Donald H.			The Plastid Genome of Najas flexilis: Adaptation to Submersed Environments Is Accompanied by the Complete Loss of the NDH Complex in an Aquatic Angiosperm	PLOS ONE			English	Article							COMPLETE CHLOROPLAST GENOME; SEQUENCE; GENES; EVOLUTION; IDENTIFICATION; ANNOTATION; SITE	The re-colonization of aquatic habitats by angiosperms has presented a difficult challenge to plants whose long evolutionary history primarily reflects adaptations to terrestrial conditions. Many aquatics must complete vital stages of their life cycle on the water surface by means of floating or emergent leaves and flowers. Only a few species, mainly within the order Alismatales, are able to complete all aspects of their life cycle including pollination, entirely underwater. Water-pollinated Alismatales include seagrasses and water nymphs (Najas), the latter being the only freshwater genus in the family Hydrocharitaceae with subsurface water-pollination. We have determined the complete nucleotide sequence of the plastid genome of Najas flexilis. The plastid genome of N. flexilis is a circular AT-rich DNA molecule of 156 kb, which displays a quadripartite structure with two inverted repeats (IR) separating the large single copy (LSC) from the small single copy (SSC) regions. In N. flexilis, as in other Alismatales, the rps19 and trnH genes are localized in the LSC region instead of within the IR regions as in other monocots. However, the N. flexilis plastid genome presents some anomalous modifications. The size of the SSC region is only one third of that reported for closely related species. The number of genes in the plastid is considerably less. Both features are due to loss of the eleven ndh genes in the Najas flexilis plastid. In angiosperms, the absence of ndh genes has been related mainly to the loss of photosynthetic function in parasitic plants. The ndh genes encode the NAD(P) H dehydrogenase complex, believed essential in terrestrial environments, where it increases photosynthetic efficiency in variable light intensities. The modified structure of the N. flexilis plastid genome suggests that adaptation to submersed environments, where light is scarce, has involved the loss of the NDH complex in at least some photosynthetic angiosperms.	[Peredo, Elena L.; King, Ursula M.; Les, Donald H.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT USA	University of Connecticut	Peredo, EL (corresponding author), Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT USA.	elperedo@outlook.com	Peredo, Elena L/N-8688-2013	Peredo, Elena L/0000-0001-9691-4189	National Science Foundation (NSF) [DEB-0841658]; Fulbright Foundation; Spanish MEC; Irish Research Council for Science, Engineering and Technology (IRCSET); University of Connecticut CLAS; University of Connecticut Open Access Author Fund	National Science Foundation (NSF)(National Science Foundation (NSF)); Fulbright Foundation; Spanish MEC(Spanish Government); Irish Research Council for Science, Engineering and Technology (IRCSET)(Irish Research Council for Science, Engineering and Technology); University of Connecticut CLAS; University of Connecticut Open Access Author Fund	Portions of this research were funded by grants from the National Science Foundation (NSF DEB-0841658), Fulbright Foundation and Spanish MEC, Irish Research Council for Science, Engineering and Technology (IRCSET) and University of Connecticut CLAS. Publication costs were provided by the University of Connecticut Open Access Author Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONEN L, 1975, P NATL ACAD SCI USA, V72, P2310, DOI 10.1073/pnas.72.6.2310; Boussardon C, 2012, PLANT CELL, V24, P3684, DOI 10.1105/tpc.112.099507; Braukmann TWA, 2009, CURR GENET, V55, P323, DOI 10.1007/s00294-009-0249-7; Cameron DD, 2006, NEW PHYTOL, V171, P405, DOI 10.1111/j.1469-8137.2006.01767.x; Chang CC, 2006, MOL BIOL EVOL, V23, P279, DOI 10.1093/molbev/msj029; Blazier J, 2011, PLANT MOL BIOL, V76, P263, DOI 10.1007/s11103-011-9753-5; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Funk HT, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-45; Goremykin VV, 2005, MOL BIOL EVOL, V22, P1813, DOI 10.1093/molbev/msi173; Goremykin VV, 2004, MOL BIOL EVOL, V21, P1445, DOI 10.1093/molbev/msh147; Goremykin VV, 2003, MOL BIOL EVOL, V20, P1499, DOI 10.1093/molbev/msg159; Grant JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-202; Green BR, 2011, PLANT J, V66, P34, DOI 10.1111/j.1365-313X.2011.04541.x; Grosche C, 2012, GENOME BIOL EVOL, V4, P1349, DOI 10.1093/gbe/evs114; HABERHAUSEN G, 1994, PLANT MOL BIOL, V24, P217, DOI 10.1007/BF00040588; Hammani K, 2009, PLANT CELL, V21, P3686, DOI 10.1105/tpc.109.071472; Huotari T, 2012, GENE, V508, P96, DOI 10.1016/j.gene.2012.07.020; Iles WJD, 2013, SYST ASSOC SPEC VOL, V83, P1; Kleine T, 2009, ANNU REV PLANT BIOL, V60, P115, DOI 10.1146/annurev.arplant.043008.092119; Les DH, 1997, SYST BOT, V22, P443, DOI 10.2307/2419820; Les DH, 2010, SYST BOT, V35, P736, DOI 10.1600/036364410X539826; Liu J, 2012, MOL PHYLOGENET EVOL, V64, P545, DOI 10.1016/j.ympev.2012.05.010; Logacheva MD, 2011, GENOME BIOL EVOL, V3, P1296, DOI 10.1093/gbe/evr102; Mardanov AV, 2008, J MOL EVOL, V66, P555, DOI 10.1007/s00239-008-9091-7; Martin M, 2010, PLANT PHYSIOL BIOCH, V48, P636, DOI 10.1016/j.plaphy.2010.04.009; Martin M, 2009, BBA-BIOENERGETICS, V1787, P920, DOI 10.1016/j.bbabio.2009.03.001; Neyland R, 1996, PLANTA, V200, P273, DOI 10.1007/BF00208318; Pan IC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034738; Peredo EL, 2012, J MOL EVOL, V75, P184, DOI 10.1007/s00239-012-9526-z; Ravi V, 2008, PLANT SYST EVOL, V271, P101, DOI 10.1007/s00606-007-0608-0; ROGSTAD SH, 1992, TAXON, V41, P701, DOI 10.2307/1222395; Rozen S, 2000, Methods Mol Biol, V132, P365; Saski C, 2007, THEOR APPL GENET, V115, P571, DOI 10.1007/s00122-007-0595-0; Sculthorpe CD., 1967, BIOL AQUATIC VASCULA; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Stern DB, 2010, ANNU REV PLANT BIOL, V61, P125, DOI 10.1146/annurev-arplant-042809-112242; WAKASUGI T, 1994, P NATL ACAD SCI USA, V91, P9794, DOI 10.1073/pnas.91.21.9794; Wang RJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-36; Wang WQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024670; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Wickett NJ, 2008, MOL BIOL EVOL, V25, P393, DOI 10.1093/molbev/msm267; WOLFE KH, 1992, P NATL ACAD SCI USA, V89, P10648, DOI 10.1073/pnas.89.22.10648; Wu FH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-68; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762	48	56	59	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68591	10.1371/journal.pone.0068591	http://dx.doi.org/10.1371/journal.pone.0068591			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861923	gold, Green Published, Green Submitted			2022-12-27	WOS:000323350700092
J	Tian, W; Ding, WP; Kim, S; Zheng, LZ; Zhang, L; Li, XP; Gu, JC; Zhang, L; Pan, MG; Chen, SY				Tian, Wei; Ding, Wenping; Kim, Sungkyoung; Zheng, Leizhen; Zhang, Li; Li, Xiaoping; Gu, Jianchun; Zhang, Lian; Pan, Minggui; Chen, Siyu			Efficacy and Safety Profile of Combining Vandetanib with Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer: A Meta-Analysis	PLOS ONE			English	Article							1ST-LINE TREATMENT; PLUS DOCETAXEL; TUMOR-GROWTH; PHASE-II; INHIBITOR; ERLOTINIB; ZD6474	Objective: To evaluate the efficacy and safety profile of combining vandetanib with chemotherapy in patients with advanced non-small cell lung cancer (NSCLC). Methods: MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials (CENTRAL), ASCO Abstracts, ESMO Abstracts, Wanfang Database, CNKI were searched. Eligible studies were the randomized clinical trials (RCTs) that compared the efficacy and safety profile of adding vandetanib to chemotherapy with single chemotherapy in patients with advanced NSCLC. The outcomes included overall survival (OS), progression-free survival (PFS), overall response rate (ORR) and toxicities. All meta-analysis were performed using Review Manager 5.1. The fixed-effect model weighted by the Mantel-Haenszel method was used. When considerable heterogeneity was found (p<0.1, or I-2>50%), further analysis (subgroup analysis, sensitivity analysis or random-effect model) was performed to identify potential cause. Results: Results reported from 5 RCTs involving 2284 patients were included in the analysis. Compared to chemotherapy alone, the addition of vandetanib resulted in a significant longer PFS (HR 0.79 [0.72-0.87], p<0.00001) and a higher ORR (RR 1.75 [1.43-2.15], p<0.00001), but failed to show advantage on OS (HR 0.96 [0.87-1.06], p = 0.44). Conclusion: Vandetanib has activity in NSCLC. Identification of predictive biomarkers is warranted in future trials to select a subset of patients with advanced NSCLC who may benefit from vandetanib.	[Tian, Wei; Ding, Wenping; Kim, Sungkyoung; Zheng, Leizhen; Zhang, Li; Li, Xiaoping; Gu, Jianchun; Zhang, Lian; Chen, Siyu] Shanghai Jiao Tong Univ, Dept Oncol, Sch Med, Xinhua Hosp, Shanghai 200030, Peoples R China; [Pan, Minggui] Kaiser Permanente Med Ctr, Dept Med Oncol & Hematol, Santa Clara, CA USA	Shanghai Jiao Tong University; Kaiser Permanente	Chen, SY (corresponding author), Shanghai Jiao Tong Univ, Dept Oncol, Sch Med, Xinhua Hosp, Shanghai 200030, Peoples R China.	siyu.chen@shsmu.edu.cn	CHEN, SI/GZL-4800-2022; Pan, Minggui/AAB-7371-2020		National Natural Science Foundation of China [81274142, 30300139]; Key Project of Shanghai Municipal Education Commission [07zz43]; Natural Science Foundation of Science and Technology Commission of Shanghai Municipality [11ZR1423400]; Jiayan Foundation; Kaiser Foundation Community Benefit Research Grant	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Shanghai Municipal Education Commission(Science & Technology Commission of Shanghai Municipality (STCSM)); Natural Science Foundation of Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Jiayan Foundation; Kaiser Foundation Community Benefit Research Grant	This work was supported in part by the National Natural Science Foundation of China (81274142, 30300139), the Key Project of Shanghai Municipal Education Commission (07zz43), the Natural Science Foundation of Science and Technology Commission of Shanghai Municipality (11ZR1423400). M.P. was partly supported by the Jiayan Foundation and the Kaiser Foundation Community Benefit Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carlomagno F, 2002, CANCER RES, V62, P7284; Ciardiello F, 2006, ANN ONCOL, V17, pVII109, DOI 10.1093/annonc/mdl962; Lima ABC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022681; de Boer RH, 2011, J CLIN ONCOL, V29, P1067, DOI 10.1200/JCO.2010.29.5717; Fischer C, 2006, NAT MED, V12, P732, DOI 10.1038/nm0706-732; Gridelli C, 2012, J CLIN ONCOL S, V30; Guan JL, 2013, ANN SURG ONCOL, V20, P1381, DOI 10.1245/s10434-012-2754-z; Hanrahan EO, 2009, CLIN CANCER RES, V15, P3600, DOI 10.1158/1078-0432.CCR-08-2568; Herbst RS, 2010, LANCET ONCOL, V11, P619, DOI 10.1016/S1470-2045(10)70132-7; Heymach JV, 2007, J CLIN ONCOL, V25, P4270, DOI 10.1200/JCO.2006.10.5122; Heymach JV, 2008, J CLIN ONCOL, V26, P5407, DOI 10.1200/JCO.2008.17.3138; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mao C, 2010, LUNG CANCER, V69, P272, DOI 10.1016/j.lungcan.2009.11.020; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Naumov GN, 2009, CLIN CANCER RES, V15, P3484, DOI 10.1158/1078-0432.CCR-08-2904; Riely Gregory J, 2009, Proc Am Thorac Soc, V6, P201, DOI 10.1513/pats.200809-107LC; Rosen AC, 2012, J CLIN ENDOCR METAB, V97, P1125, DOI 10.1210/jc.2011-2677; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Wedge SR, 2002, CANCER RES, V62, P4645; Xiao YY, 2013, CLIN ONCOL-UK, V25, pE7, DOI 10.1016/j.clon.2012.09.005; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	26	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67929	10.1371/journal.pone.0067929	http://dx.doi.org/10.1371/journal.pone.0067929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861835	Green Published, Green Submitted, gold			2022-12-27	WOS:000323350700063
J	Alonso, A; Marsal, S; Tortosa, R; Canela-Xandri, O; Julia, A				Alonso, Arnald; Marsal, Sara; Tortosa, Rauel; Canela-Xandri, Oriol; Julia, Antonio			GStream: Improving SNP and CNV Coverage on Genome-Wide Association Studies	PLOS ONE			English	Article							COPY NUMBER VARIATION; 3,000 SHARED CONTROLS; HIDDEN-MARKOV MODEL; RHEUMATOID-ARTHRITIS; MACULAR DEGENERATION; STRUCTURAL VARIATION; JAPANESE POPULATION; COMMON VARIANTS; GENOTYPING DATA; DISEASE	We present GStream, a method that combines genome-wide SNP and CNV genotyping in the Illumina microarray platform with unprecedented accuracy. This new method outperforms previous well-established SNP genotyping software. More importantly, the CNV calling algorithm of GStream dramatically improves the results obtained by previous state-of-the-art methods and yields an accuracy that is close to that obtained by purely CNV-oriented technologies like Comparative Genomic Hybridization (CGH). We demonstrate the superior performance of GStream using microarray data generated from HapMap samples. Using the reference CNV calls generated by the 1000 Genomes Project (1KGP) and well-known studies on whole genome CNV characterization based either on CGH or genotyping microarray technologies, we show that GStream can increase the number of reliably detected variants up to 25% compared to previously developed methods. Furthermore, the increased genome coverage provided by GStream allows the discovery of CNVs in close linkage disequilibrium with SNPs, previously associated with disease risk in published Genome-Wide Association Studies (GWAS). These results could provide important insights into the biological mechanism underlying the detected disease risk association. With GStream, large-scale GWAS will not only benefit from the combined genotyping of SNPs and CNVs at an unprecedented accuracy, but will also take advantage of the computational efficiency of the method.	[Alonso, Arnald; Marsal, Sara; Tortosa, Rauel; Canela-Xandri, Oriol; Julia, Antonio] Vall dHebron Hosp Res Inst, Rheumatol Res Grp, Barcelona, Spain; [Alonso, Arnald] Univ Politecn Cataluna, Dept ESAII, Barcelona, Spain	Hospital Universitari Vall d'Hebron; Universitat Politecnica de Catalunya	Julia, A (corresponding author), Vall dHebron Hosp Res Inst, Rheumatol Res Grp, Barcelona, Spain.	toni.julia@vhir.org		Julia Cano, Antonio/0000-0001-6064-3620; marsal, sara/0000-0001-5515-3854	Spanish Ministry of Economy and Competitiveness Strategic Project grants [PSE-010000-2006-6, IPT-010000-2010-36]	Spanish Ministry of Economy and Competitiveness Strategic Project grants	This work was supported by the Spanish Ministry of Economy and Competitiveness Strategic Project grants [PSE-010000-2006-6, IPT-010000-2010-36]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetunji OR, 2010, CLIN ENDOCRINOL, V72, P422, DOI 10.1111/j.1365-2265.2009.03638.x; Alonso A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-264; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Beckmann JS, 2007, NAT REV GENET, V8, P639, DOI 10.1038/nrg2149; Bergmann C, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.032318; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell CD, 2011, AM J HUM GENET, V88, P317, DOI 10.1016/j.ajhg.2011.02.004; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Colobran R, 2010, CLIN EXP IMMUNOL, V162, P41, DOI 10.1111/j.1365-2249.2010.04224.x; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Day N, 2007, BIOINFORMATICS, V23, P1424, DOI 10.1093/bioinformatics/btm096; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Dorfman R, 2008, J CLIN INVEST, V118, P1040, DOI [10.1172/JCI337S4, 10.1172/JCI33754]; Elia J, 2012, NAT GENET, V44, P78, DOI 10.1038/ng.1013; Estivill X, 2007, PLOS GENET, V3, P1787, DOI 10.1371/journal.pgen.0030190; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fujita PA, 2011, NUCL ACIDS RES; Gamazon ER, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001292; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Giannoulatou E, 2008, BIOINFORMATICS, V24, P2209, DOI 10.1093/bioinformatics/btn386; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Girirajan S, 2011, ANNU REV GENET, V45, P203, DOI 10.1146/annurev-genet-102209-163544; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Halper-Stromberg E, 2011, BIOINFORMATICS, V27, P1052, DOI 10.1093/bioinformatics/btr106; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirschhorn JN, 2011, ANNU REV MED, V62, P11, DOI 10.1146/annurev.med.091708.162036; Huang L, 2009, AM J HUM GENET, V84, P235, DOI 10.1016/j.ajhg.2009.01.013; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Illumina, 2010, GEN WID DNA AN BEADC; Illumina, 2005, ILL GENCALL DAT AN S; Jiang YA, 2011, GENET EPIDEMIOL, V35, P125, DOI 10.1002/gepi.20558; Jin Y, 2010, NEW ENGL J MED, V362, P1686, DOI 10.1056/NEJMoa0908547; Julia A, 2008, ARTHRITIS RHEUM-US, V58, P2275, DOI 10.1002/art.23623; Li GX, 2012, BIOINFORMATICS, V28, P358, DOI 10.1093/bioinformatics/btr673; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Matsuo H, 2008, AM J HUM GENET, V83, P744, DOI 10.1016/j.ajhg.2008.11.001; Mbarek H, 2011, HUM MOL GENET, V20, P3884, DOI 10.1093/hmg/ddr301; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Mefford HC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000962; Moskvina V, 2006, HUM HERED, V61, P55, DOI 10.1159/000092553; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Nothnagel M, 2009, HUM GENET, V125, P163, DOI 10.1007/s00439-008-0606-5; Pankratz N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020988; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Ragoussis J, 2009, ANNU REV GENOM HUM G, V10, P117, DOI 10.1146/annurev-genom-082908-150116; Ritchie ME, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-68; RODRIGUES NR, 1995, HUM MOL GENET, V4, P631, DOI 10.1093/hmg/4.4.631; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Tang ChengCai, 2012, Journal of Resources and Ecology, V3, P8; Teng YN, 2002, J CLIN ENDOCR METAB, V87, P5258, DOI 10.1210/jc.2002-020016; Terao C, 2011, HUM MOL GENET, V20, P2680, DOI 10.1093/hmg/ddr161; Thio CL, 2005, J VIROL, V79, P9192, DOI 10.1128/JVI.79.14.9192-9196.2005; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang LL, 2002, AM J HUM GENET, V71, P165, DOI 10.1086/341234; Yu Y, 2011, HUM MOL GENET, V20, P3699, DOI 10.1093/hmg/ddr270; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhao J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002079	72	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68822	10.1371/journal.pone.0068822	http://dx.doi.org/10.1371/journal.pone.0068822			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844243	gold, Green Published, Green Submitted			2022-12-27	WOS:000321733000028
J	Chatterjee, B; Lee, CY; Lin, C; Chen, EHL; Huang, CL; Yang, CC; Chen, RPY				Chatterjee, Biswanath; Lee, Chung-Yu; Lin, Chen; Chen, Eric H. -L.; Huang, Chao-Li; Yang, Chien-Chih; Chen, Rita P-Y.			Amyloid Core Formed of Full-Length Recombinant Mouse Prion Protein Involves Sequence 127-143 but Not Sequence 107-126	PLOS ONE			English	Article							IN-VITRO; SCRAPIE PRION; CONFORMATIONAL TRANSITIONS; MOLECULAR-STRUCTURE; SECONDARY STRUCTURE; SYNTHETIC PEPTIDES; ALPHA-HELICES; FIBRILS; CONVERSION; RESIDUES	The principal event underlying the development of prion disease is the conversion of soluble cellular prion protein (PrPC) into its disease-causing isoform, PrPSc. This conversion is associated with a marked change in secondary structure from predominantly alpha-helical to a high beta-sheet content, ultimately leading to the formation of aggregates consisting of ordered fibrillar assemblies referred to as amyloid. In vitro, recombinant prion proteins and short prion peptides from various species have been shown to form amyloid under various conditions and it has been proposed that, theoretically, any protein and peptide could form amyloid under appropriate conditions. To identify the peptide segment involved in the amyloid core formed from recombinant full-length mouse prion protein mPrP(23-230), we carried out seed-induced amyloid formation from recombinant prion protein in the presence of seeds generated from the short prion peptides mPrP(107-143), mPrP(107-126), and mPrP(127-143). Our results showed that the amyloid fibrils formed from mPrP(107-143) and mPrP(127-143), but not those formed from mPrP(107-126), were able to seed the amyloidogenesis of mPrP(23-230), showing that the segment residing in sequence 127-143 was used to form the amyloid core in the fibrillization of mPrP(23-230).	[Chatterjee, Biswanath; Lee, Chung-Yu; Lin, Chen; Chen, Eric H. -L.; Chen, Rita P-Y.] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Lee, Chung-Yu; Chen, Rita P-Y.] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan; [Huang, Chao-Li; Yang, Chien-Chih] Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10764, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National Taiwan University	Chen, RPY (corresponding author), Acad Sinica, Inst Biol Chem, Taipei, Taiwan.	pyc@gate.sinica.edu.tw	Chen, Rita P/M-8397-2013; Chattopadhyay, Biswanath Chatterjee/AAF-9104-2021	Chen, Rita P/0000-0003-3987-033X; YANG, CHIEN-CHIH/0000-0002-6238-2871; Chen, Eric H.-L./0000-0003-1641-5086	Academia Sinica; National Science Council, Taiwan, R. O. C. [NSC 97-2321-B-001-032, NSC 98-2311-B-001-019, NSC 99-2321-B-001-038, NSC 100-2321-B-001-026]; National Science Council	Academia Sinica(Academia Sinica - Taiwan); National Science Council, Taiwan, R. O. C.(Ministry of Science and Technology, Taiwan); National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by the Academia Sinica and the National Science Council, Taiwan, R. O. C. (grant nos. NSC 97-2321-B-001-032, NSC 98-2311-B-001-019, NSC 99-2321-B-001-038, and NSC 100-2321-B-001-026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Ilia Baskakov for kindly providing the plasmid containing the mouse PrP gene. The ESI-TOF mass identification of proteins was performed by the Core Facilities at the Institute of Biological Chemistry, Academia Sinica, supported by the National Science Council and the Academia Sinica. We thank Mr. Tai-Lang Lin and the Core Facility of the Institute of Cellular and Organismic Biology, Academia Sinica, Taiwan for assistance in transmission electron microscopy.	Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Alvarez-Martinez MT, 2011, BBA-PROTEINS PROTEOM, V1814, P1305, DOI 10.1016/j.bbapap.2011.05.016; Baskakov IV, 2000, BIOCHEMISTRY-US, V39, P2792, DOI 10.1021/bi9923353; Blake C, 1996, STRUCTURE, V4, P989, DOI 10.1016/S0969-2126(96)00104-9; Bocharova OV, 2005, PROTEIN SCI, V14, P1222, DOI 10.1110/ps.041186605; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Chabry J, 1998, J BIOL CHEM, V273, P13203, DOI 10.1074/jbc.273.21.13203; Chesebro B, 2003, BRIT MED BULL, V66, P1, DOI 10.1093/bmb/66.1.1; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; de la Paz ML, 2002, P NATL ACAD SCI USA, V99, P16052, DOI 10.1073/pnas.252340199; DeMarco ML, 2006, BIOCHEMISTRY-US, V45, P15573, DOI 10.1021/bi0612723; DeMarco ML, 2004, P NATL ACAD SCI USA, V101, P2293, DOI 10.1073/pnas.0307178101; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Dupiereux I, 2005, BIOCHEM BIOPH RES CO, V331, P894, DOI 10.1016/j.bbrc.2005.04.012; Ettaiche M, 2000, J BIOL CHEM, V275, P36487, DOI 10.1074/jbc.C000579200; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; Garbuzynskiy SO, 2010, BIOINFORMATICS, V26, P326, DOI 10.1093/bioinformatics/btp691; GASSET M, 1993, P NATL ACAD SCI USA, V90, P1, DOI 10.1073/pnas.90.1.1; GASSET M, 1992, P NATL ACAD SCI USA, V89, P10940, DOI 10.1073/pnas.89.22.10940; Hafner-Bratkovic I, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.213926; Haire LF, 2004, J MOL BIOL, V336, P1175, DOI 10.1016/j.jmb.2003.12.059; Hsu RL, 2009, J AGR FOOD CHEM, V57, P503, DOI 10.1021/jf803072r; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Kourie JI, 2000, J NEUROSCI RES, V62, P120, DOI 10.1002/1097-4547(20001001)62:1<120::AID-JNR13>3.0.CO;2-2; Kundu B, 2003, P NATL ACAD SCI USA, V100, P12069, DOI 10.1073/pnas.2033281100; Lee LYL, 2007, J AM CHEM SOC, V129, P1644, DOI 10.1021/ja0667413; Lee SW, 2008, J MOL BIOL, V378, P1142, DOI 10.1016/j.jmb.2008.03.035; Liao TY, 2011, FEBS J, V278, P4351, DOI 10.1111/j.1742-4658.2011.08353.x; Lin MX, 1997, J BIOL CHEM, V272, P44; Lin NS, 2010, CHEM-EUR J, V16, P5492, DOI 10.1002/chem.200903290; Makarava Natallia, 2008, V459, P131, DOI 10.1007/978-1-59745-234-2_10; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Riesner D, 2003, BRIT MED BULL, V66, P21, DOI 10.1093/bmb/66.1.21; SAFAR J, 1993, J BIOL CHEM, V268, P20276; Serpell LC, 2000, BIOCHEMISTRY-US, V39, P13269, DOI 10.1021/bi000637v; Serpell LC, 1997, CELL MOL LIFE SCI, V53, P871, DOI 10.1007/s000180050107; Singh J, 2012, J MOL BIOL, V423, P217, DOI 10.1016/j.jmb.2012.06.040; Supattapone S, 2001, MOL CELL BIOL, V21, P2608, DOI 10.1128/MCB.21.7.2608-2616.2001; TAGLIAVINI F, 1993, P NATL ACAD SCI USA, V90, P9678, DOI 10.1073/pnas.90.20.9678; Thellung S, 2000, INT J DEV NEUROSCI, V18, P481, DOI 10.1016/S0736-5748(00)00005-8; Walsh P, 2009, STRUCTURE, V17, P417, DOI 10.1016/j.str.2008.12.018; Yamaguchi KI, 2008, BIOCHEMISTRY-US, V47, P13242, DOI 10.1021/bi801562w; ZHANG H, 1995, J MOL BIOL, V250, P514, DOI 10.1006/jmbi.1995.0395	50	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67967	10.1371/journal.pone.0067967	http://dx.doi.org/10.1371/journal.pone.0067967			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844138	Green Submitted, Green Published, gold			2022-12-27	WOS:000321733000120
J	Fan, HQ; Tang, W; Wang, ZX; Wang, SJ; Qin, YH; Fu, Q; Gao, Y; Sun, M; Zhang, M; Zhou, HW; Yang, T				Fan, Hong-Qi; Tang, Wei; Wang, Zhi-Xiao; Wang, Su-Juan; Qin, Yue-Hua; Fu, Qi; Gao, Yuan; Sun, Min; Zhang, Mei; Zhou, Hong-Wen; Yang, Tao			Association of Serum Uric Acid with 2-Hour Postload Glucose in Chinese with Impaired Fasting Plasma Glucose and/or HbA1c	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; 20-YEAR FOLLOW-UP; CARDIOVASCULAR-DISEASE; RISK-FACTOR; DIABETES-MELLITUS; ENDOTHELIAL DYSFUNCTION; CELL-PROLIFERATION; METABOLIC SYNDROME; MORTALITY; MEN	Objective: To examine whether serum uric acid (SUA) is associated with 2-hour postload glucose (2-h PG) in Chinese with impaired fasting plasma glucose (IFG) and/or HbA1c (IA1C). Research Design and Methods: Anthropometric and biochemical examinations, such as SUA concentration, were performed in 3763 individuals from all the villages in Baqiao County, China. A 75-g oral glucose tolerance test (OGTT) was conducted in 1197 Chinese with prediabetes as having IFG (110 <= fasting plasma glucose [FPG] < 126 mg/dl and HbA1c < 6.5%), IA1C (5.7% <= HbA1c < 6.5% and FPG < 126 mg/dl), or both. Results: The present study included 1197 participants with IFG and/or IA1C (mean age 56.5 +/- 10.3 years; 50.6% men). In multivariate linear regression, after adjustment for gender, age, smoking and drinking, body mass index (BMI), systolic and diastolic blood pressure (SBP, DBP), lipid profiles, logarithmic transformed C-reactive protein (log-CRP), estimated glomerular filtration rate (e-GFR), FPG and HbA1c, with a 1-mg/dl increment of SUA, 2-h PG increased by 5.04 +/- 0.72 (P < 0.001), 3.06 +/- 1.08 (P = 0.001), 5.40 +/- 1.26 (P < 0.001), and 2.34 +/- 2.16 mg/dl (P = 0.056) in all participants, in participants with normal glucose tolerance (NGT), with impaired glucose tolerance (IGT), and with 2-h newly diagnosed diabetes (2-h NDM, with 2-h PG >= 200 mg/dl), respectively. In both men and women, 2-h PG increased progressively and significantly from the lower to the upper SUA tertiles (P < 0.001). Moreover, in multivariate logistic regression, 1-standard deviation (SD; 1.53 mg/dl) increment of SUA was significantly associated with a 36% higher risk for 2-h NDM (Odds ratio [CI 95%]: 1.36 [1.09-1.99]; P = 0.03). Conclusion: SUA is significantly associated with 2-h PG in Chinese with IFG and/or IA1C.	[Fan, Hong-Qi; Wang, Zhi-Xiao; Wang, Su-Juan; Qin, Yue-Hua; Fu, Qi; Gao, Yuan; Sun, Min; Zhang, Mei; Zhou, Hong-Wen; Yang, Tao] Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China; [Tang, Wei] Southeast Univ, Coll Med, Affiliated Jiangyin Hosp, Dept Endocrinol, Jiangyin, Jiangsu, Peoples R China	Nanjing Medical University; Southeast University - China	Yang, T (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China.	yangt@njmu.edu.cn			National Natural Science Foundation of China [81100578]; National Key Technologies R&D Program of China [2007BAI07A10]; Jiangsu Province Science and Technology Support Program [BE2009613]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies R&D Program of China(National Key Technology R&D Program); Jiangsu Province Science and Technology Support Program	This study was supported by grants from the National Natural Science Foundation of China (81100578), the National Key Technologies R&D Program of China, during the 11th Five-Year Plan Period (2007BAI07A10) and the Jiangsu Province Science and Technology Support Program (BE2009613).	Abdul-Ghani MA, 2008, DIABETES CARE, V31, P1650, DOI 10.2337/dc08-0225; Abdul-Ghani MA, 2007, DIABETES CARE, V30, P89, DOI 10.2337/dc06-1519; Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; [Anonymous], 1995, DIABETES, V44, P968; Baker JF, 2005, AM J MED, V118, P816, DOI 10.1016/j.amjmed.2005.03.043; Balkau B, 1998, DIABETES CARE, V21, P360, DOI 10.2337/diacare.21.3.360; Barrett-Connor E, 1998, DIABETES CARE, V21, P1236, DOI 10.2337/diacare.21.8.1236; Borch-Johnsen K, 1999, LANCET, V354, P617; Bos MJ, 2006, STROKE, V37, P1503, DOI 10.1161/01.STR.0000221716.55088.d4; Corry DB, 2008, J HYPERTENS, V26, P269, DOI 10.1097/HJH.0b013e3282f240bf; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Dehghan A, 2008, DIABETES CARE, V31, P361, DOI 10.2337/dc07-1276; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Gao W, 2008, DIABETES RES CLIN PR, V79, P151, DOI 10.1016/j.diabres.2007.07.018; Groeneveld Y, 1999, DIABETIC MED, V16, P2, DOI 10.1046/j.1464-5491.1999.00003.x; Gu D, 2003, DIABETOLOGIA, V46, P1190, DOI 10.1007/s00125-003-1167-8; Haffner SM, 2000, NEW ENGL J MED, V342, P1040, DOI 10.1056/NEJM200004063421408; HERMAN JB, 1976, DIABETOLOGIA, V12, P47, DOI 10.1007/BF01221964; Hodge AM, 2001, INT J OBESITY, V25, P126, DOI 10.1038/sj.ijo.0801522; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Jansson SPO, 2010, DIABETES CARE, V33, P551, DOI 10.2337/dc09-0680; Jia WP, 2007, DIABETOLOGIA, V50, P286, DOI 10.1007/s00125-006-0503-1; Johnson RJ, 2005, HYPERTENSION, V45, P18, DOI 10.1161/01.HYP.0000150785.39055.e8; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; KANNEL WB, 1974, AM J CARDIOL, V34, P29, DOI 10.1016/0002-9149(74)90089-7; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Mercuro G, 2004, AM J CARDIOL, V94, P932, DOI 10.1016/j.amjcard.2004.06.032; Nan HR, 2007, DIABETES RES CLIN PR, V76, P68, DOI 10.1016/j.diabres.2006.07.022; Perticone F, 2012, DIABETES CARE, V35, P153, DOI 10.2337/dc11-1727; PETRIE JC, 1986, BRIT MED J, V293, P611, DOI 10.1136/bmj.293.6547.611; Pour OR, 2011, CLIN CHEM, V57, P215, DOI 10.1373/clinchem.2010.149096; Qiao Q, 2000, DIABETOLOGIA, V43, P1470, DOI 10.1007/s001250051557; Roy D, 1998, AM J PHYSIOL-ENDOC M, V274, pE692, DOI 10.1152/ajpendo.1998.274.4.E692; So A, 2010, J CLIN INVEST, V120, P1791, DOI 10.1172/JCI42344; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Temelkova-Kurktschiev TS, 2000, DIABETES CARE, V23, P1830, DOI 10.2337/diacare.23.12.1830; TUOMILEHTO J, 1988, AM J EPIDEMIOL, V127, P321, DOI 10.1093/oxfordjournals.aje.a114807; Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x; Verdecchia P, 2000, HYPERTENSION, V36, P1072, DOI 10.1161/01.HYP.36.6.1072; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zoccali C, 2006, J AM SOC NEPHROL, V17, P1466, DOI 10.1681/ASN.2005090949; Zoccali C, 2006, J AM SOC NEPHROL, V17, pS64, DOI 10.1681/ASN.2005121345	45	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67759	10.1371/journal.pone.0067759	http://dx.doi.org/10.1371/journal.pone.0067759			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844086	Green Submitted, gold, Green Published			2022-12-27	WOS:000321733000100
J	Kung, LH; Gong, KR; Adedoyin, M; Ng, J; Bhargava, A; Ohara, PT; Jasmin, L				Kung, Ling-Hsuan; Gong, Kerui; Adedoyin, Mary; Ng, Johnson; Bhargava, Aditi; Ohara, Peter T.; Jasmin, Luc			Evidence for Glutamate as a Neuroglial Transmitter within Sensory Ganglia	PLOS ONE			English	Article							DORSAL-ROOT GANGLION; SATELLITE GLIAL-CELLS; CHRONIC CONSTRICTION INJURY; PERIPHERAL NERVOUS-SYSTEM; MOUSE TRIGEMINAL GANGLIA; PRIMARY AFFERENT NEURONS; EXCITATORY AMINO-ACIDS; RAT DRG NEURONS; SPINAL-CORD; SUBSTANCE-P	This study examines key elements of glutamatergic transmission within sensory ganglia of the rat. We show that the soma of primary sensory neurons release glutamate when depolarized. Using acute dissociated mixed neuronal/glia cultures of dorsal root ganglia (DRG) or trigeminal ganglia and a colorimetric assay, we show that when glutamate uptake by satellite glial cells (SGCs) is inhibited, KCl stimulation leads to simultaneous increase of glutamate in the culture medium. With calcium imaging we see that the soma of primary sensory neurons and SGCs respond to AMPA, NMDA, kainate and mGluR agonists, and selective antagonists block this response. Using whole cell patch-clamp technique, inward currents were recorded from small diameter (<30 mu m) DRG neurons from intact DRGs (ex-vivo whole ganglion preparation) in response to local application of the above glutamate receptor agonists. Following a chronic constriction injury (CCI) of either the inferior orbital nerve or the sciatic nerve, glutamate expression increases in the trigeminal ganglia and DRG respectively. This increase occurs in neurons of all diameters and is present in the somata of neurons with injured axons as well as in somata of neighboring uninjured neurons. These data provides additional evidence that glutamate can be released within the sensory ganglion, and that the somata of primary sensory neurons as well as SGCs express functional glutamate receptors at their surface. These findings, together with our previous gene knockdown data, suggest that glutamatergic transmission within the ganglion could impact nociceptive threshold.	[Kung, Ling-Hsuan; Gong, Kerui; Adedoyin, Mary; Ohara, Peter T.; Jasmin, Luc] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Ng, Johnson] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Bhargava, Aditi] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Chinese University of Hong Kong; University of California System; University of California San Francisco	Ohara, PT (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	peter.ohara@ucsf.edu			NIH [NS061241, NS051336]; Painless Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051336, R21NS079897, R01NS061241] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Painless Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by NIH NS061241, NS051336 and the Painless Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRAWAL SG, 1986, BRIT J PHARMACOL, V87, P345, DOI 10.1111/j.1476-5381.1986.tb10823.x; Akagi Y, 2003, J BIOCHEM, V134, P353, DOI 10.1093/jb/mvg152; Anderson CM, 2001, J NEUROCHEM, V79, P1207; AZERAD J, 1992, CR ACAD SCI III-VIE, V314, P469; Barreto-Chang Odmara L, 2009, J Vis Exp, DOI 10.3791/1067; BASBAUM AI, 1991, PAIN, V47, P359, DOI 10.1016/0304-3959(91)90229-Q; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; BATTAGLIA G, 1988, J COMP NEUROL, V277, P302, DOI 10.1002/cne.902770210; Beart PM, 2007, BRIT J PHARMACOL, V150, P5, DOI 10.1038/sj.bjp.0706949; Benarroch EE, 2010, NEUROLOGY, V74, P259, DOI 10.1212/WNL.0b013e3181cc89e3; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Berger UV, 2000, J COMP NEUROL, V421, P385, DOI 10.1002/(SICI)1096-9861(20000605)421:3<385::AID-CNE7>3.0.CO;2-S; Bernabucci M, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-77; Berta T, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-18; Broman J, 2000, HAND CHEM N, V18, P1; Brumovsky P, 2007, NEUROSCIENCE, V147, P469, DOI 10.1016/j.neuroscience.2007.02.068; CANGRO CB, 1985, BRAIN RES, V336, P158, DOI 10.1016/0006-8993(85)90428-7; Carlton SM, 2007, J COMP NEUROL, V501, P780, DOI 10.1002/cne.21285; Carlton SM, 2011, J NEUROSCI, V31, P12727, DOI 10.1523/JNEUROSCI.6558-10.2011; Carozzi V, 2008, CNS NEUROL DISORD-DR, V7, P348, DOI 10.2174/187152708786441876; Carozzi VA, 2008, J ANAT, V213, P539, DOI 10.1111/j.1469-7580.2008.00984.x; Castillo C, 2011, NEUROSCIENCE, V177, P308, DOI 10.1016/j.neuroscience.2010.12.040; Ceruti S, 2011, J NEUROSCI, V31, P3638, DOI 10.1523/JNEUROSCI.6440-10.2011; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Crawford JH, 1997, J NEUROPHYSIOL, V77, P2573, DOI 10.1152/jn.1997.77.5.2573; Crawford JH, 2000, NEUROPHARMACOLOGY, V39, P621, DOI 10.1016/S0028-3908(99)00167-7; de Groot J, 2000, NEUROREPORT, V11, P497, DOI 10.1097/00001756-200002280-00014; DEBIASI S, 1988, P NATL ACAD SCI USA, V85, P7820; DEVOR M, 1985, SOMATOSENS MOT RES, V3, P139, DOI 10.3109/07367228509144581; Duan SM, 2003, J NEUROSCI, V23, P1320, DOI 10.1523/JNEUROSCI.23-04-01320.2003; FONNUM F, 1984, J NEUROCHEM, V42, P1, DOI 10.1111/j.1471-4159.1984.tb09689.x; Gu JGG, 1997, NATURE, V389, P749, DOI 10.1038/39639; Gu YP, 2010, NEURON GLIA BIOL, V6, P53, DOI 10.1017/S1740925X10000116; Guo H, 2001, J PHYSIOL-LONDON, V537, P115, DOI 10.1111/j.1469-7793.2001.0115k.x; Hai T, 1999, GENE EXPRESSION, V7, P321; Hertz L, 2004, TRENDS NEUROSCI, V27, P735, DOI 10.1016/j.tins.2004.10.008; HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A; Inquimbert P, 2012, PAIN, V153, P2422, DOI 10.1016/j.pain.2012.08.011; Ivanusic JJ, 2009, J COMP NEUROL, V517, P276, DOI 10.1002/cne.22160; Jasmin L, 2010, NEURON GLIA BIOL, V6, P63, DOI 10.1017/S1740925X10000098; JEFTINIJA S, 1991, NEUROSCI LETT, V125, P191, DOI 10.1016/0304-3940(91)90025-O; Jung H, 2008, J NEUROCHEM, V104, P254, DOI 10.1111/j.1471-4159.2007.04969.x; KAIKAI MA, 1991, HISTOCHEM J, V23, P171, DOI 10.1007/BF01046588; KANEKO T, 1988, BRAIN RES, V457, P160, DOI 10.1016/0006-8993(88)90069-8; Keast JR, 2000, J COMP NEUROL, V424, P577; Kernisant M, 2008, J NEUROSCI METH, V172, P43, DOI 10.1016/j.jneumeth.2008.04.013; Kuo LT, 2011, J MOL NEUROSCI, V43, P503, DOI 10.1007/s12031-010-9473-3; Li JY, 2012, NEUROSCI LETT, V531, P52, DOI 10.1016/j.neulet.2012.10.014; Liu Y, 2010, NEURON, V68, P543, DOI 10.1016/j.neuron.2010.09.008; LOVINGER DM, 1988, NEUROSCI LETT, V94, P314, DOI 10.1016/0304-3940(88)90037-7; Marsala M, 1995, J NEUROSCI METH, V62, P43, DOI 10.1016/0165-0270(95)00053-4; MCMAHON HT, 1991, J NEUROCHEM, V56, P86, DOI 10.1111/j.1471-4159.1991.tb02566.x; McRoberts JA, 2011, NEUROSCIENCE, V172, P474, DOI 10.1016/j.neuroscience.2010.10.045; Miller KE, 2002, BRAIN RES, V945, P202, DOI 10.1016/S0006-8993(02)02802-0; Miller KE, 2011, PHARMACOL THERAPEUT, V130, P283, DOI 10.1016/j.pharmthera.2011.01.005; Moller KA, 1998, J NEUROSCI METH, V84, P41, DOI 10.1016/S0165-0270(98)00083-1; Napier IA, 2012, J NEUROPHYSIOL, V107, P649, DOI 10.1152/jn.00763.2011; Neugebauer V, 2007, Handb Exp Pharmacol, P217; Nguyen D, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-6; Niederberger E, 2006, BIOCHEM BIOPH RES CO, V346, P393, DOI 10.1016/j.bbrc.2006.05.163; Ohara PT, 2009, NEUROSCIENTIST, V15, P450, DOI 10.1177/1073858409336094; Oliveira ALR, 2003, SYNAPSE, V50, P117, DOI 10.1002/syn.10249; Purkiss J, 2000, BIOCHEM PHARMACOL, V59, P1403, DOI 10.1016/S0006-2952(00)00260-4; Purkiss John R., 1998, Biochemical Society Transactions, V26, pS108; SATO K, 1993, NEUROREPORT, V4, P1263, DOI 10.1097/00001756-199309000-00013; Schaeffer V, 2010, PROG NEUROBIOL, V92, P33, DOI 10.1016/j.pneurobio.2010.04.009; Shoji Y, 2010, HISTOCHEM CELL BIOL, V134, P13, DOI 10.1007/s00418-010-0711-0; SKILLING SR, 1990, J NEUROSCI, V10, P1309; Suadicani SO, 2010, NEURON GLIA BIOL, V6, P43, DOI 10.1017/S1740925X09990408; SWETT JE, 1991, EXP NEUROL, V114, P82, DOI 10.1016/0014-4886(91)90087-S; TACHIBANA M, 1994, J COMP NEUROL, V344, P431, DOI 10.1002/cne.903440307; Takeda M, 2012, BRAIN BEHAV IMMUNITY; THIO LL, 1991, J NEUROSCI, V11, P3430; Van Steenwinckel J, 2009, NEUROSCIENCE, V161, P838, DOI 10.1016/j.neuroscience.2009.03.087; Vikelis Michail, 2007, CNS & Neurological Disorders-Drug Targets, V6, P251; VOS BP, 1994, J NEUROSCI, V14, P2708; WANAKA A, 1987, EXP BRAIN RES, V65, P691; Weng HR, 2006, NEUROSCIENCE, V138, P1351, DOI 10.1016/j.neuroscience.2005.11.061; WESTLUND KN, 1992, BRAIN RES REV, V17, P15, DOI 10.1016/0165-0173(92)90003-5; WHEELER DD, 1966, J CELL PHYSIOL, V67, P141, DOI 10.1002/jcp.1040670116; Willcockson H, 2008, CELL TISSUE RES, V334, P17, DOI 10.1007/s00441-008-0662-0; Xiao Y, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-12; Xin WJ, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-15; Yang CQ, 2012, DIGEST DIS SCI, V57, P865, DOI 10.1007/s10620-011-1970-x; YU YB, 1987, EUR J PHARMACOL, V141, P371, DOI 10.1016/0014-2999(87)90554-1; Zhang Q, 2004, J BIOL CHEM, V279, P12724, DOI 10.1074/jbc.M312845200; Zhang X, 2007, P NATL ACAD SCI USA, V104, P9864, DOI 10.1073/pnas.0611048104	87	74	77	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68312	10.1371/journal.pone.0068312	http://dx.doi.org/10.1371/journal.pone.0068312			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844184	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000152
J	Sun, ZF; Smyth, K; Garcia, K; Mattson, E; Li, L; Xiao, ZG				Sun, Zhifeng; Smyth, Kendra; Garcia, Karla; Mattson, Elliot; Li, Lei; Xiao, Zhengguo			Nicotine Inhibits Memory CTL Programming	PLOS ONE			English	Article							CD8 T-CELLS; OBSTRUCTIVE PULMONARY-DISEASE; IFN-GAMMA PRODUCTION; ACETYLCHOLINE-RECEPTORS; CLONAL EXPANSION; EFFECTOR FUNCTION; CUTTING EDGE; I IFN; ANTIINFLAMMATORY PATHWAY; SIGNALING MECHANISMS	Nicotine is the main tobacco component responsible for tobacco addiction and is used extensively in smoking and smoking cessation therapies. However, little is known about its effects on the immune system. We confirmed that multiple nicotinic receptors are expressed on mouse and human cytotoxic T lymphocytes (CTLs) and demonstrated that nicotinic receptors on mouse CTLs are regulated during activation. Acute nicotine presence during activation increases primary CTL expansion in vitro, but impairs in vivo expansion after transfer and subsequent memory CTL differentiation, which reduces protection against subsequent pathogen challenges. Furthermore, nicotine abolishes the regulatory effect of rapamycin on memory CTL programming, which can be attributed to the fact that rapamycin enhances expression of nicotinic receptors. Interestingly, naive CTLs from chronic nicotine-treated mice have normal memory programming, which is impaired by nicotine during activation in vitro. In conclusion, simultaneous exposure to nicotine and antigen during CTL activation negatively affects memory development.	[Sun, Zhifeng; Smyth, Kendra; Garcia, Karla; Mattson, Elliot; Li, Lei; Xiao, Zhengguo] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Xiao, ZG (corresponding author), Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.	xiao0028@umd.edu		Xiao, Zhengguo/0000-0002-3359-6491	National Institutes of Health [R21AI095715A]; University of Maryland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI095715] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institutes of Health Grants R21AI095715A (to XZ) and Startup from the University of Maryland (to XZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2009, J IMMUNOL, V183, P1695, DOI 10.4049/jimmunol.0900592; Ahmed R, 2009, NAT REV IMMUNOL, V9, P662, DOI 10.1038/nri2619; Aichele P, 2006, J IMMUNOL, V176, P4525, DOI 10.4049/jimmunol.176.8.4525; Al-Wadei HAN, 2009, CARCINOGENESIS, V30, P506, DOI 10.1093/carcin/bgp010; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Balendran A, 1999, J BIOL CHEM, V274, P37400, DOI 10.1074/jbc.274.52.37400; Benowitz NL, 2011, CLIN PHARMACOL THER, V90, P491, DOI 10.1038/clpt.2011.191; Buckingham SD, 2009, PHARMACOL REV, V61, P39, DOI 10.1124/pr.108.000562; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Cannarile MA, 2006, NAT IMMUNOL, V7, P1317, DOI 10.1038/ni1403; Cui WG, 2011, IMMUNITY, V35, P792, DOI 10.1016/j.immuni.2011.09.017; Curtsinger JM, 1998, J IMMUNOL, V160, P3236; Curtsinger JM, 1999, J IMMUNOL, V162, P3256; Curtsinger JM, 2005, J IMMUNOL, V174, P4465, DOI 10.4049/jimmunol.174.8.4465; Curtsinger JM, 2003, J IMMUNOL, V171, P5165, DOI 10.4049/jimmunol.171.10.5165; Curtsinger JM, 2003, J EXP MED, V197, P1141, DOI 10.1084/jem.20021910; Dajas-Bailador F, 2004, TRENDS PHARMACOL SCI, V25, P317, DOI 10.1016/j.tips.2004.04.006; De Biasi M, 2011, ANNU REV NEUROSCI, V34, P105, DOI 10.1146/annurev-neuro-061010-113734; De Rosa MJ, 2005, J NEUROIMMUNOL, V160, P154, DOI 10.1016/j.jneuroim.2004.11.010; Djordjevic Mirjana V, 2009, Handb Exp Pharmacol, P61, DOI 10.1007/978-3-540-69248-5_3; Gahring LC, 2008, J BIOL CHEM, V283, P693, DOI 10.1074/jbc.M707330200; Gentry CL, 2002, CNS NEUROL DISORD-DR, V1, P359, DOI 10.2174/1568007023339184; Glantz SA, 2011, BMJ, V343; Govind AP, 2009, BIOCHEM PHARMACOL, V78, P756, DOI 10.1016/j.bcp.2009.06.011; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Ichii H, 2002, NAT IMMUNOL, V3, P558, DOI 10.1038/ni802; Ilhan SO, 2008, EUR J PHARMACOL, V587, P267, DOI 10.1016/j.ejphar.2008.03.029; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kavoussi B, 2007, INTEGR CANCER THER, V6, P251, DOI 10.1177/1534735407305892; Kawashima K, 2003, LIFE SCI, V72, P2101, DOI 10.1016/S0024-3205(03)00068-7; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Lawson GM, 1998, J CLIN PHARMACOL, V38, P502, DOI 10.1002/j.1552-4604.1998.tb05787.x; Levite M, 2000, ANN NY ACAD SCI, V917, P307; Levite M, 2008, CURR OPIN PHARMACOL, V8, P460, DOI 10.1016/j.coph.2008.05.001; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Li QS, 2006, J IMMUNOL, V177, P7618, DOI 10.4049/jimmunol.177.11.7618; Li XD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025177; Manicassamy S, 2006, CELL MOL IMMUNOL, V3, P263; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Miwa JM, 2011, NEURON, V70, P20, DOI 10.1016/j.neuron.2011.03.014; Peng HS, 2004, LIFE SCI, V76, P263, DOI 10.1016/j.lfs.2004.05.031; Powell JD, 2010, IMMUNITY, V33, P301, DOI 10.1016/j.immuni.2010.09.002; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Qian J, 2011, GENES IMMUN, V12, P222, DOI 10.1038/gene.2010.72; Rao RR, 2012, IMMUNITY, V36, P374, DOI 10.1016/j.immuni.2012.01.015; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Rodu B, 2011, HARM REDUCT J, V8, DOI 10.1186/1477-7517-8-19; Rutishauser RL, 2010, IMMUNOL REV, V235, P219, DOI 10.1111/j.0105-2896.2010.00901.x; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Saeta M, 1999, AM J RESP CRIT CARE, V160, P711, DOI 10.1164/ajrccm.160.2.9812020; Saetta M, 1998, AM J RESP CRIT CARE, V157, P822, DOI 10.1164/ajrccm.157.3.9709027; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Sato KZ, 1999, NEUROSCI LETT, V266, P17, DOI 10.1016/S0304-3940(99)00259-1; Schmidt CS, 1999, J IMMUNOL, V163, P2561; Scott DA, 2006, WORLD J GASTROENTERO, V12, P7451, DOI 10.3748/wjg.v12.i46.7451; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Song JX, 2007, NAT IMMUNOL, V8, P64, DOI 10.1038/ni1413; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Sopori ML, 1998, J NEUROIMMUNOL, V83, P148, DOI 10.1016/S0165-5728(97)00231-2; Staempfli MR, 2009, NAT REV IMMUNOL, V9, P377, DOI 10.1038/nri2530; Sullivan JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002533; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; Tammimaki A, 2011, BIOCHEM PHARMACOL, V82, P808, DOI 10.1016/j.bcp.2011.06.014; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Tournier JM, 2011, CURR OPIN ONCOL, V23, P83, DOI 10.1097/CCO.0b013e3283412ea1; Traves SL, 2004, J LEUKOCYTE BIOL, V76, P441, DOI 10.1189/jlb.1003495; Tuesta LM, 2011, BIOCHEM PHARMACOL, V82, P984, DOI 10.1016/j.bcp.2011.06.026; Ulloa L, 2005, NAT REV DRUG DISCOV, V4, P673, DOI 10.1038/nrd1797; Wakim LM, 2010, CURR OPIN IMMUNOL, V22, P274, DOI 10.1016/j.coi.2010.03.003; Wang DW, 2010, J PHARMACOL EXP THER, V335, P553, DOI 10.1124/jpet.110.169961; Way SS, 2007, J IMMUNOL, V178, P4498, DOI 10.4049/jimmunol.178.7.4498; Wirth TC, 2010, IMMUNITY, V33, P128, DOI 10.1016/j.immuni.2010.06.014; Xiao C, 2009, J NEUROSCI, V29, P12428, DOI 10.1523/JNEUROSCI.2939-09.2009; Xiao ZG, 2007, J EXP MED, V204, P2667, DOI 10.1084/jem.20062376; Xiao ZG, 2007, INT IMMUNOL, V19, P733, DOI 10.1093/intimm/dxm039; Xiao ZG, 2009, J IMMUNOL, V182, P2786, DOI 10.4049/jimmunol.0803484	83	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68183	10.1371/journal.pone.0068183	http://dx.doi.org/10.1371/journal.pone.0068183			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844169	gold, Green Published, Green Submitted			2022-12-27	WOS:000321341000142
J	Wu, J; Cai, GQ; Tu, JY; Li, LX; Liu, S; Luo, XP; Zhou, LP; Fan, CC; Zhou, YM				Wu, Jian; Cai, Guangqin; Tu, Jiangying; Li, Lixia; Liu, Sheng; Luo, Xinping; Zhou, Lipeng; Fan, Chuchuan; Zhou, Yongming			Identification of QTLs for Resistance to Sclerotinia Stem Rot and BnaC.IGMT5.a as a Candidate Gene of the Major Resistant QTL SRC6 in Brassica napus	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; WHITE MOLD; OILSEED RAPE; LINKAGE MAP; ARABIDOPSIS; CANOLA; EXPRESSION; AVOIDANCE; CULTIVARS; GENOMES	Stem rot caused by Sclerotinia sclerotiorum in many important dicotyledonous crops, including oilseed rape (Brassica napus), is one of the most devastating fungal diseases and imposes huge yield loss each year worldwide. Currently, breeding for Sclerotinia resistance in B. napus, as in other crops, can only rely on germplasms with quantitative resistance genes. Thus, the identification of quantitative trait locus (QTL) for S. sclerotiorum resistance/tolerance in this crop holds immediate promise for the genetic improvement of the disease resistance. In this study, ten QTLs for stem resistance (SR) at the mature plant stage and three QTLs for leaf resistance (LR) at the seedling stage in multiple environments were mapped on nine linkage groups (LGs) of a whole genome map for B. napus constructed with SSR markers. Two major QTLs, LRA9 on LG A9 and SRC6 on LG C6, were repeatedly detected across all environments and explained 8.54-15.86% and 29.01%-32.61% of the phenotypic variations, respectively. Genotypes containing resistant SRC6 or LRA9 allele showed a significant reduction in disease lesion after pathogen infection. Comparative mapping with Arabidopsis and data mining from previous gene profiling experiments identified that the Arabidopsis homologous gene of IGMT5 (At1g76790) was related to the SRC6 locus. Four copies of the IGMT5 gene in B. napus were isolated through homologous cloning, among which, only BnaC.IGMT5.a showed a polymorphism between parental lines and can be associated with the SRC6. Furthermore, two parental lines exhibited a differential expression pattern of the BnaC.IGMT5.a gene in responding to pathogen inoculation. Thus, our data suggested that BnaC.IGMT5.a was very likely a candidate gene of this major resistance QTL.	[Wu, Jian; Cai, Guangqin; Tu, Jiangying; Li, Lixia; Liu, Sheng; Luo, Xinping; Zhou, Lipeng; Fan, Chuchuan; Zhou, Yongming] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China	Huazhong Agricultural University	Zhou, YM (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	ymzhou@mail.hzau.edu.cn		Wu, Jian/0000-0002-5350-8938; Fan, Chuchuan/0000-0001-8443-7194	Ministry of Science and Technology of China [2006CB101604, 2011AA10A104, 2012AA101107]; Ministry of Agriculture of China [nycytx-00503]; Huazhong Agricultural University [STSIF 2012YB14]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); Huazhong Agricultural University	The work was supported by the funding from Ministry of Science and Technology of China (Grant nos. 2006CB101604, 2011AA10A104, and 2012AA101107), Ministry of Agriculture of China (nycytx-00503), and Huazhong Agricultural University (STSIF 2012YB14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arahana VS, 2001, CROP SCI, V41, P180, DOI 10.2135/cropsci2001.411180x; Bert PF, 2002, THEOR APPL GENET, V105, P985, DOI 10.1007/s00122-002-1004-3; BOLAND GJ, 1994, CAN J PLANT PATHOL, V16, P93, DOI 10.1080/07060669409500766; Bradley CA, 2006, PLANT DIS, V90, P215, DOI 10.1094/PD-90-0215; Cai GQ, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-105; Cheng XM, 2009, THEOR APPL GENET, V118, P1121, DOI 10.1007/s00122-009-0967-8; CHURCHILL GA, 1994, GENETICS, V138, P963; Ender M, 2005, CROP SCI, V45, P2482, DOI 10.2135/cropsci2005.0064; Eynck C, 2012, MOL PLANT PATHOL, V13, P887, DOI 10.1111/j.1364-3703.2012.00798.x; Fan CC, 2010, THEOR APPL GENET, V121, P1289, DOI 10.1007/s00122-010-1388-4; GODOY G, 1990, PHYSIOL MOL PLANT P, V37, P179, DOI 10.1016/0885-5765(90)90010-U; Hegedus DD, 2005, FEMS MICROBIOL LETT, V251, P177, DOI 10.1016/j.femsle.2005.07.040; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Huang YongJu, 2000, Chinese Journal of Oil Crop Sciences, V22, P1; Kolkman JM, 2003, CROP SCI, V43, P539, DOI 10.2135/cropsci2003.0539; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Li D, 2001, ACTA BOT BOREALI-OCC, V21, P451; Li Y., 1999, P 10 INT RAP C CANB; LIU C, 1991, Scientia Agricultura Sinica, V24, P43; Liu ShengYi, 2003, Chinese Journal of Oil Crop Sciences, V25, P54; Lowe AJ, 2004, THEOR APPL GENET, V108, P1103, DOI 10.1007/s00122-003-1522-7; McCartney H., 1999, P 10 INT RAP C CANB; Mei J, 2011, EUPHYTICA, V177, P393, DOI 10.1007/s10681-010-0274-0; Mei JQ, 2013, THEOR APPL GENET, V126, P549, DOI 10.1007/s00122-012-2000-x; Mestries E, 1998, MOL BREEDING, V4, P215, DOI 10.1023/A:1009694626992; Miklas PN, 2001, CROP SCI, V41, P309, DOI 10.2135/cropsci2001.412309x; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Oilcrop Research Institute Chinese Academy of Sciences, 1975, SCLER DIS OILS CROPS; Ostergaard L, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-10; Panjabi P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-113; Parkin IAP, 2005, GENETICS, V171, P765, DOI 10.1534/genetics.105.042093; Parkin IAP, 1995, GENOME, V38, P1122, DOI 10.1139/g95-149; PHILLIPS D V, 1990, Phytopathology, V80, P1039; Piquemal J, 2005, THEOR APPL GENET, V111, P1514, DOI 10.1007/s00122-005-0080-6; PURDY LH, 1979, PHYTOPATHOLOGY, V69, P875, DOI 10.1094/Phyto-69-875; Qiu D, 2006, THEOR APPL GENET, V114, P67, DOI 10.1007/s00122-006-0411-2; Raes J, 2003, PLANT PHYSIOL, V133, P1051, DOI 10.1104/pp.103.026484; Rogers LA, 2005, J EXP BOT, V56, P1651, DOI 10.1093/jxb/eri162; Ronicke S, 2005, PHYTOPATHOLOGY, V95, P834, DOI 10.1094/PHYTO-95-0834; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; TURKINGTON TK, 1993, PHYTOPATHOLOGY, V83, P682, DOI 10.1094/Phyto-83-682; Wang HanZhong, 2004, Scientia Agricultura Sinica, V37, P23; Xie WB, 2010, P NATL ACAD SCI USA, V107, P10578, DOI 10.1073/pnas.1005931107; Xu L, 2011, J EXP BOT, V62, P5607, DOI 10.1093/jxb/err245; Yang B, 2007, PLANT SCI, V173, P156, DOI 10.1016/j.plantsci.2007.04.012; Yang J, 2007, BIOINFORMATICS, V23, P1527, DOI 10.1093/bioinformatics/btm143; Yin XR, 2010, EUPHYTICA, V173, P25, DOI 10.1007/s10681-009-0095-1; Yu B, 2010, PLANT BREEDING, V129, P39, DOI 10.1111/j.1439-0523.2009.01662.x; Yu HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017595; Yue B, 2008, PHYTOPATHOLOGY, V98, P926, DOI 10.1094/PHYTO-98-8-0926; ZENG ZB, 1994, GENETICS, V136, P1457; Zhao JW, 2007, PLANTA, V227, P13, DOI 10.1007/s00425-007-0586-z; Zhao JW, 2009, MOL PLANT PATHOL, V10, P635, DOI [10.1111/J.1364-3703.2009.00558.X, 10.1111/j.1364-3703.2009.00558.x]; Zhao JW, 2003, THEOR APPL GENET, V106, P759, DOI 10.1007/s00122-002-1171-2; Zhao JW, 2006, THEOR APPL GENET, V112, P509, DOI 10.1007/s00122-005-0154-5	57	66	76	7	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67740	10.1371/journal.pone.0067740	http://dx.doi.org/10.1371/journal.pone.0067740			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844081	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000089
J	Xiu, FM; Stanojcic, M; Jeschke, MG				Xiu, Fangming; Stanojcic, Mile; Jeschke, Marc G.			Norepinephrine Inhibits Macrophage Migration by Decreasing CCR2 Expression	PLOS ONE			English	Article							THERMAL-INJURY; BONE-MARROW; HEMATOPOIETIC STEM; COLD STRESS; BURN INJURY; SEPSIS; PHAGOCYTOSIS; MONOCYTES; CELLS; INFILTRATION	Increased incidences of infectious and septic complications during post-burn courses represent the main contributor to burn injury mortality. Sustained increases in catecholamine levels, especially norepinephrine (NE), contribute to immune disturbances in severely burned patients. The precise mechanisms underlying NE-mediated immunoregulation are not fully understood. Here we hypothesize that persistently elevated NE levels are associated with immunodysfunctions. We examined the effects of NE on the phenotype and functions of bone marrow-derived macrophages (BMMs). Whole mouse bone marrow cells were treated in vitro with 40 ng/mL of M-CSF and with 1 x 10(-6) M or 1 x 10(-8) M of NE or without NE for 7 days; cells were collected and stained with antibodies for CD11b, F4/80, MHC II and the inflammatory CC chemokine receptor 2 (CCR2). We found 1 x 10(-6) M of NE inhibited MHC II and CCR2 expression on CD11b(+)/F4/80(+) BMM cells. It also inhibited BMM proliferation by inhibiting CSF-1R expression. On the contrary, 1 x 10(-8) M of NE slightly increased both MHC II and CCR2 expression on CD11b(+)/F4/80(+) BMM cells but inhibited CD11b(+)/F4/80(+) BMM proliferation. MCP-1 based migration assay showed that the migration of 1 x 10(-6) M of NE-treated BMM toward MCP-1 was significantly decreased compared to BMM without NE treatment. Both 1 x 10(-8) M and 1 x 10(-6) M of NE enhanced TNF-alpha production and phagocytosis of FITC-Dextran. Intracellular staining of transcriptional factor MafB showed that 1 x 10(-6) M of NE treatment enhanced its expression, whereas 1 x 10(-8) M of NE decreased expression. Stimulation with LPS in the last 24-hours of BMM culture further decreased CCR2 and MHC II expression of these BMM, suggesting the synergistic effect of LPS and NE on macrophage. Our results demonstrate that NE regulates macrophage differentiation, proliferation and function, and may play a critical role in the dysfunctional immune response post-burn.	[Xiu, Fangming; Stanojcic, Mile; Jeschke, Marc G.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst,Dept Immunol, Ross Tilley Burn Ctr,Div Plast Surg,Dept Surg, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Jeschke, MG (corresponding author), Univ Toronto, Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst,Dept Immunol, Ross Tilley Burn Ctr,Div Plast Surg,Dept Surg, Toronto, ON, Canada.	marc.jeschke@sunnybrook.ca			Canadian Institutes of Health Research [123336]; CFI Leader's Opportunity Fund [25407]; NIH [RO1 GM087285-01]; Physicians' Services Incorporated Foundation - Health Research Grant Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087285] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CFI Leader's Opportunity Fund(Canada Foundation for Innovation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Physicians' Services Incorporated Foundation - Health Research Grant Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following grant funding sources: Canadian Institutes of Health Research # 123336; CFI Leader's Opportunity Fund: Project # 25407. NIH RO1 GM087285-01; and Physicians' Services Incorporated Foundation - Health Research Grant Program. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Baccan GC, 2010, NEUROIMMUNOMODULAT, V17, P379, DOI 10.1159/000292058; Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006; Clover AJP, 2011, BURNS, V37, P1386, DOI 10.1016/j.burns.2011.08.001; Cohen MJ, 2004, ANN SURG, V240, P132, DOI 10.1097/01.sla.0000130724.84914.d6; Deng JP, 2004, AM J PHYSIOL-CELL PH, V287, pC730, DOI 10.1152/ajpcell.00562.2003; Engel DR, 2008, J IMMUNOL, V181, P5579, DOI 10.4049/jimmunol.181.8.5579; Enomoto N, 2004, J GASTROENTEROL, V39, P1175, DOI 10.1007/s00535-004-1468-9; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gosain A, 2007, SURGERY, V142, P170, DOI 10.1016/j.surg.2007.04.015; Gosain A, 2009, J SURG RES, V152, P311, DOI 10.1016/j.jss.2008.05.001; Howell K, 2012, J LEUKOCYTE BIOL, V91, P69, DOI 10.1189/jlb.0711338; HU XX, 1991, J NEUROIMMUNOL, V31, P35, DOI 10.1016/0165-5728(91)90084-K; Jeschke MG, 2007, CRIT CARE, V11, DOI 10.1186/cc6102; Jeschke MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021245; Kapoor A, 2011, AM J RESP CRIT CARE, V183, P150, DOI 10.1164/rccm.201009-1403ED; Kelly JL, 1997, ANN SURG, V225, P530, DOI 10.1097/00000658-199705000-00010; Kelly LM, 2000, EMBO J, V19, P1987, DOI 10.1093/emboj/19.9.1987; King KY, 2011, NAT REV IMMUNOL, V11, P685, DOI 10.1038/nri3062; Koo DJ, 2000, INT J MOL MED, V5, P457; Kraft R, 2012, LANCET, V379, P1013, DOI 10.1016/S0140-6736(11)61345-7; Kulp GA, 2010, SHOCK, V33, P369, DOI 10.1097/SHK.0b013e3181b92340; MAEJIMA K, 1984, INFECT IMMUN, V43, P6, DOI 10.1128/IAI.43.1.6-10.1984; Muthu K, 2008, J BURN CARE RES, V29, P12, DOI 10.1097/BCR.0b013e31815fa499; Muthu K, 2010, J LEUKOCYTE BIOL, V88, P715, DOI 10.1189/jlb.0410186; Rodriguez S, 2009, BLOOD, V114, P4064, DOI 10.1182/blood-2009-04-214916; Santangelo S, 2001, ANN SURG, V233, P97, DOI 10.1097/00000658-200101000-00015; Sarrazin S, 2009, CELL, V138, P300, DOI 10.1016/j.cell.2009.04.057; Schwacha MG, 2003, BURNS, V29, P1, DOI 10.1016/S0305-4179(02)00187-0; Scumpia PO, 2010, J IMMUNOL, V184, P2247, DOI 10.4049/jimmunol.0903652; Sesti-Costa R, 2010, NEUROIMMUNOMODULAT, V17, P79, DOI 10.1159/000258690; Sica A, 1997, J EXP MED, V185, P969, DOI 10.1084/jem.185.5.969; Souto FO, 2011, AM J RESP CRIT CARE, V183, P234, DOI 10.1164/rccm.201003-0416OC; SPENGLER RN, 1990, J IMMUNOL, V145, P1430; Szelenyi J, 2000, J NEUROIMMUNOL, V103, P34, DOI 10.1016/S0165-5728(99)00234-9; Tang YM, 2001, ANN SURG, V233, P266, DOI 10.1097/00000658-200102000-00017; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Weischenfeldt J, 2008, CSH PROTOC, V2008; Williams John G., 1994, Journal of Burn Care and Rehabilitation, V15, P493, DOI 10.1097/00004630-199411000-00006; Yi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030404; Zhou YH, 1999, J LEUKOCYTE BIOL, V65, P265, DOI 10.1002/jlb.65.2.265	40	29	32	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e69167	10.1371/journal.pone.0069167	http://dx.doi.org/10.1371/journal.pone.0069167			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844252	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000185
J	Bauer, JW; Brandl, C; Haubenreisser, O; Wimmer, B; Weber, M; Karl, T; Klausegger, A; Breitenbach, M; Hintner, H; von der Haar, T; Tuite, MF; Breitenbach-Koller, L				Bauer, Johann W.; Brandl, Clemens; Haubenreisser, Olaf; Wimmer, Bjoern; Weber, Manuela; Karl, Thomas; Klausegger, Alfred; Breitenbach, Michael; Hintner, Helmut; von der Haar, Tobias; Tuite, Mick F.; Breitenbach-Koller, Lore			Specialized Yeast Ribosomes: A Customized Tool for Selective mRNA Translation	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; 80S RIBOSOME; EXPRESSION; PROTEINS; GENES; PHOSPHORYLATION; IDENTIFICATION; DUPLICATION; SPECIFICITY	Evidence is now accumulating that sub-populations of ribosomes-so-called specialized ribosomes-can favour the translation of subsets of mRNAs. Here we use a large collection of diploid yeast strains, each deficient in one or other copy of the set of ribosomal protein (RP) genes, to generate eukaryotic cells carrying distinct populations of altered 'specialized' ribosomes. We show by comparative protein synthesis assays that different heterologous mRNA reporters based on luciferase are preferentially translated by distinct populations of specialized ribosomes. These mRNAs include reporters carrying premature termination codons (PTC) thus allowing us to identify specialized ribosomes that alter the efficiency of translation termination leading to enhanced synthesis of the wild-type protein. This finding suggests that these strains can be used to identify novel therapeutic targets in the ribosome. To explore this further we examined the translation of the mRNA encoding the extracellular matrix protein laminin beta 3 (LAMB3) since a LAMB3-PTC mutant is implicated in the blistering skin disease Epidermolysis bullosa (EB). This screen identified specialized ribosomes with reduced levels of RP L35B as showing enhanced synthesis of full-length LAMB3 in cells expressing the LAMB3-PTC mutant. Importantly, the RPL35B sub-population of specialized ribosomes leave both translation of a reporter luciferase carrying a different PTC and bulk mRNA translation largely unaltered.	[Bauer, Johann W.; Brandl, Clemens; Haubenreisser, Olaf; Wimmer, Bjoern; Weber, Manuela; Karl, Thomas; Breitenbach, Michael; Hintner, Helmut; Breitenbach-Koller, Lore] Salzburg Univ, Dept Cell Biol, A-5020 Salzburg, Austria; [Bauer, Johann W.; Klausegger, Alfred; Hintner, Helmut] Gen Hosp Salzburg PMU, Dept Dermatol, Salzburg, Austria; [von der Haar, Tobias; Tuite, Mick F.] Univ Kent, Kent Fungal Grp, Sch Biosci, Canterbury, Kent, England	Salzburg University; University of Kent	Tuite, MF (corresponding author), Univ Kent, Kent Fungal Grp, Sch Biosci, Canterbury, Kent, England.	M.F.Tuite@kent.ac.uk; Hannelore.koller@sbg.ac.at	Tuite, Mick/ABC-7909-2020; Klausegger, Alfred/R-2078-2019; Klausegger, Alfred/G-8001-2018	Tuite, Mick/0000-0002-5214-540X; Klausegger, Alfred/0000-0001-6160-9934; von der Haar, Tobias/0000-0002-6031-9254; Breitenbach-Koller, Hannelore/0000-0002-8387-6408; Hintner, Helmut/0000-0001-9199-0991	Epidermolysis bullosa Society DEBRA [Austria P_147200_09]	Epidermolysis bullosa Society DEBRA	This work was funded by a grant from the Epidermolysis bullosa Society DEBRA (Austria P_147200_09) to JWB and LBK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOVICH N, 1984, MOL CELL BIOL, V4, P1871, DOI 10.1128/MCB.4.9.1871; Angov E, 2011, BIOTECHNOL J, V6, P650, DOI 10.1002/biot.201000332; Angov E, 2011, METHODS MOL BIOL, V705, P1, DOI 10.1007/978-1-61737-967-3_1; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; Barrett LW, 2012, CELL MOL LIFE SCI; Bhushan S, 2010, MOL CELL, V40, P138, DOI 10.1016/j.molcel.2010.09.009; Chen Q, 2011, MOL BIOL CELL, V22, P2646, DOI 10.1091/mbc.E11-03-0239; Connolly K, 2009, TRENDS BIOCHEM SCI, V34, P256, DOI 10.1016/j.tibs.2009.01.011; Dean EJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000113; Filipovska A, 2013, FEBS LETT, V587, P1189, DOI 10.1016/j.febslet.2013.02.032; Finkbeiner E, 2011, NUCLEUS-PHILA, V2, P527, DOI 10.4161/nucl.2.6.17604; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gilbert WV, 2011, TRENDS BIOCHEM SCI, V36, P127, DOI 10.1016/j.tibs.2010.12.002; Jenner L, 2012, CURR OPIN STRUC BIOL, V22, P759, DOI 10.1016/j.sbi.2012.07.013; Kaberdina AC, 2009, MOL CELL, V33, P227, DOI 10.1016/j.molcel.2008.12.014; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kelly DE, 2001, COMPAR FUNCT GENOM, V2, P236, DOI 10.1002/cfg.95; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; Laimer M, 2010, DERMATOL CLIN, V28, P55, DOI 10.1016/j.det.2009.10.006; Lee K, 1996, RNA, V2, P1270; Malik Vinod, 2010, Ther Adv Neurol Disord, V3, P379, DOI 10.1177/1756285610388693; Maya D, 2008, BIOTECHNOL LETT, V30, P979, DOI 10.1007/s10529-008-9647-z; Moll I, 2004, NUCLEIC ACIDS RES, V32, P3354, DOI 10.1093/nar/gkh663; Namy O, 2003, NUCLEIC ACIDS RES, V31, P2289, DOI 10.1093/nar/gkg330; Neumann H, 2010, NATURE, V464, P441, DOI 10.1038/nature08817; Nilsson J, 2007, J MOL BIOL, V369, P429, DOI 10.1016/j.jmb.2007.03.035; Nudelman I, 2010, BIOORGAN MED CHEM, V18, P3735, DOI 10.1016/j.bmc.2010.03.060; Nusspaumer G, 2000, EMBO J, V19, P6075, DOI 10.1093/emboj/19.22.6075; Oender K, 2003, YEAST, V20, P281, DOI 10.1002/yea.963; Peltz SW, 2009, RNA BIOL, V6, P329, DOI 10.4161/rna.6.3.8953; Reid DW, 2012, J BIOL CHEM, V287, P5518, DOI 10.1074/jbc.M111.312280; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Simoff I, 2009, CURR GENET, V55, P111, DOI 10.1007/s00294-009-0228-z; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Steffen KK, 2012, GENETICS, V191, P107, DOI 10.1534/genetics.111.136549; Steitz TA, 2008, NAT REV MOL CELL BIO, V9, P242, DOI 10.1038/nrm2352; Takacs JE, 2011, RNA, V17, P439, DOI 10.1261/rna.2475211; Taylor DJ, 2009, STRUCTURE, V17, P1591, DOI 10.1016/j.str.2009.09.015; Thyer R, 2013, J AM CHEM SOC, V135, P2, DOI 10.1021/ja3069177; Vesper O, 2011, CELL, V147, P147, DOI 10.1016/j.cell.2011.07.047; von der Haar T, 2007, TRENDS MICROBIOL, V15, P78, DOI 10.1016/j.tim.2006.12.002; Wang KH, 2007, NAT BIOTECHNOL, V25, P770, DOI 10.1038/nbt1314; Wilson DN, 2011, CURR OPIN STRUC BIOL, V21, P274, DOI 10.1016/j.sbi.2011.01.007; Wilson DN, 2009, CRIT REV BIOCHEM MOL, V44, P393, DOI 10.3109/10409230903307311; Wilson DN, 2005, CRIT REV BIOCHEM MOL, V40, P243, DOI 10.1080/10409230500256523; Wilson DN, 2012, COLD SPRING HARB PER, V4; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; WOOD TK, 1991, BIOTECHNOL BIOENG, V38, P891, DOI 10.1002/bit.260380811; Xue SF, 2012, NAT REV MOL CELL BIO, V13, P355, DOI 10.1038/nrm3359; You T, 2010, YEAST, V27, P785, DOI 10.1002/yea.1770; Young BD, 2012, BIOCHEMISTRY-US, V51, P5091, DOI 10.1021/bi300186g	53	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e67609	10.1371/journal.pone.0067609	http://dx.doi.org/10.1371/journal.pone.0067609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861776	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000321692000011
J	Aube, M; Roby, J; Kocifaj, M				Aube, Martin; Roby, Johanne; Kocifaj, Miroslav			Evaluating Potential Spectral Impacts of Various Artificial Lights on Melatonin Suppression, Photosynthesis, and Star Visibility	PLOS ONE			English	Article							CO-DISTRIBUTES; NIGHT LAN; AT-NIGHT; BREAST; CANCER; POLLUTION; HUMANS; PHOTORECEPTOR; PERFORMANCE; MODEL	Artificial light at night can be harmful to the environment, and interferes with fauna and flora, star visibility, and human health. To estimate the relative impact of a lighting device, its radiant power, angular photometry and detailed spectral power distribution have to be considered. In this paper we focus on the spectral power distribution. While specific spectral characteristics can be considered harmful during the night, they can be considered advantageous during the day. As an example, while blue-rich Metal Halide lamps can be problematic for human health, star visibility and vegetation photosynthesis during the night, they can be highly appropriate during the day for plant growth and light therapy. In this paper we propose three new indices to characterize lamp spectra. These indices have been designed to allow a quick estimation of the potential impact of a lamp spectrum on melatonin suppression, photosynthesis, and star visibility. We used these new indices to compare various lighting technologies objectively. We also considered the transformation of such indices according to the propagation of light into the atmosphere as a function of distance to the observer. Among other results, we found that low pressure sodium, phosphor-converted amber light emitting diodes (LED) and LED 2700 K lamps filtered with the new Ledtech's Equilib filter showed a lower or equivalent potential impact on melatonin suppression and star visibility in comparison to high pressure sodium lamps. Low pressure sodium, LED 5000 K-filtered and LED 2700 K-filtered lamps had a lower impact on photosynthesis than did high pressure sodium lamps. Finally, we propose these indices as new standards for the lighting industry to be used in characterizing their lighting technologies. We hope that their use will favor the design of new environmentally and health-friendly lighting technologies.	[Aube, Martin] Cegep Sherbrooke, Dept Phys, Sherbrooke, PQ, Canada; [Roby, Johanne] Cegep Sherbrooke, Dept Chim, Sherbrooke, PQ, Canada; [Kocifaj, Miroslav] Slovak Acad Sci, Astron Inst, Bratislava, Slovakia	Slovak Academy of Sciences; Astronomical Institute, SAS	Aube, M (corresponding author), Cegep Sherbrooke, Dept Phys, Sherbrooke, PQ, Canada.	martin.aube@cegepsherbrooke.qc.ca	Kocifaj, Miroslav/AFT-6322-2022	Kocifaj, Miroslav/0000-0001-9277-4692	Fond de recherche du Quebec - Nature et Technologie (FRQNT); Cegep de Sherbrooke - CERTEE; Slovak National Grant Agency VEGA [2/0002/12]; Programme de soutien aux chercheurs et aux chercheuses du collegial from ministere de l'Enseignement superieur, de la Recherche, de la Science et de la Technologie, Quebec	Fond de recherche du Quebec - Nature et Technologie (FRQNT); Cegep de Sherbrooke - CERTEE; Slovak National Grant Agency VEGA(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)); Programme de soutien aux chercheurs et aux chercheuses du collegial from ministere de l'Enseignement superieur, de la Recherche, de la Science et de la Technologie, Quebec	This work was supported by Fond de recherche du Quebec - Nature et Technologie (FRQNT) Programme pour le degagement d'enseignement des chercheurs de college Regroupements strategiques (http://www.fqrnt.gouv.qc.ca/) and Cegep de Sherbrooke - CERTEE (http://cegepsherbrooke.qc.ca). This work was partially supported by the Slovak National Grant Agency VEGA (grant No. 2/0002/12). This work was also partially supported by the Programme de soutien aux chercheurs et aux chercheuses du collegial from ministere de l'Enseignement superieur, de la Recherche, de la Science et de la Technologie, Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedrosian TA, 2011, PSYCHONEUROENDOCRINO, V36, P1062, DOI 10.1016/j.psyneuen.2011.01.004; Bisketzis N., 2004, WSEAS Transactions on Circuits and Systems, V3, P1380; Blask DE, 2005, CANCER RES, V65, P11174, DOI 10.1158/0008-5472.CAN-05-1945; Braak CJ, 2001, J QUANT SPECTROSC RA, V69, P585, DOI 10.1016/S0022-4073(00)00103-5; Brainard GC, 2001, J NEUROSCI, V21, P6405; Briggs W. R., 2006, ECOLOGICAL CONSEQUEN, P389; Bruce-White C., 2011, REV IMPACT ARTIFICIA; Buchanan Bryant W., 2006, P192; Cajochen C, 2011, J APPL PHYSIOL, V110, P1432, DOI 10.1152/japplphysiol.00165.2011; Calo F, 2011, TORTUES MARINES POLL; Chellappa SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016429; CIE, 1932, 1931 COMM INT ECL P 1931 COMM INT ECL P, P19; Cinzano P, 2001, MON NOT R ASTRON SOC, V328, P689, DOI 10.1046/j.1365-8711.2001.04882.x; CLARK JB, 1975, PLANT PHYSIOL, V55, P401, DOI 10.1104/pp.55.2.401; Commission International de l'Eclairage (CIE), 1995, 133 CIE; [DIN] Deutsches Institut fur Normung, 2000, 503110DIN; Falchi F, 2011, J ENVIRON MANAGE, V92, P2714, DOI 10.1016/j.jenvman.2011.06.029; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; Fritsches KA, 2012, MAR FRESHW BEHAV PHY, V45, P79, DOI 10.1080/10236244.2012.690576; Gall D, 2004, P 2004 CIE S LIGHT H, P129; Gauthreaux Sidney A. Jr., 2006, P67; Geisler-Moroder D, 2010, 5 EUR C COLOUR GRAPH, P346; Green RN, 1997, CLOUDS EARTHS RADIAN; Gushchin G. P, 1988, METHODS INSTRUMENTAT; Haim A., 2010, SLEEP SCI, V3, P32; Hansen J, 2001, JNCI-J NATL CANCER I, V93, P1513, DOI 10.1093/jnci/93.20.1513; Horvath H, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001472; Judd D. B., 1951, P 12 SESS CIE STOCKH, V1, P11; Kloog I, 2009, CHRONOBIOL INT, V26, P108, DOI 10.1080/07420520802694020; Kloog I, 2008, CHRONOBIOL INT, V25, P65, DOI 10.1080/07420520801921572; Kloog I, 2010, CANCER CAUSE CONTROL, V21, P2059, DOI 10.1007/s10552-010-9624-4; Kocifaj M, 2007, APPL OPTICS, V46, P3013, DOI 10.1364/AO.46.003013; Kokhanovsky A., 2004, LIGHT SCATTERING MED; Kuijper Dries P. J., 2008, Lutra, V51, P37; Lamphar HAS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056563; LECKNER B, 1978, SOL ENERGY, V20, P143, DOI 10.1016/0038-092X(78)90187-1; Lockley SW, 2003, J CLIN ENDOCR METAB, V88, P4502, DOI 10.1210/jc.2003-030570; Longcore T, 2004, FRONT ECOL ENVIRON, V2, P191, DOI 10.2307/3868314; MCCAMY CS, 1992, COLOR RES APPL, V17, P142, DOI 10.1002/col.5080170211; Mishchenko M.I., 2002, SCATTERING ABSORPTIO; Navara KJ, 2007, J PINEAL RES, V43, P215, DOI 10.1111/j.1600-079X.2007.00473.x; Nightingale Barbara, 2006, P257; Perry Gad, 2006, P169; Pesava P, 2001, J AEROSOL SCI, V32, P1249, DOI 10.1016/S0021-8502(01)00053-2; Rea M. S., 2004, Lighting Research & Technology, V36, P85, DOI 10.1191/13657828041i114oa; Rea MS, 2009, OUTDOOR LIGHTING VIS, V6; Rich C., 2006, ECOLOGICAL CONSEQUEN; ROSENTHAL NE, 1989, SEASONAL AFFECTIVE D; Salmon Michael, 2003, Biologist (London), V50, P163; Spiegel K, 2005, J APPL PHYSIOL, V99, P2008, DOI 10.1152/japplphysiol.00660.2005; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Stevens RG, 2011, CHRONOBIOL INT, V28, P653, DOI 10.3109/07420528.2011.606945; Stevens RG, 2009, INT J EPIDEMIOL, V38, P963, DOI 10.1093/ije/dyp178; Thapan K, 2001, J PHYSIOL-LONDON, V535, P261, DOI 10.1111/j.1469-7793.2001.t01-1-00261.x; Thomas GE., 2002, RAD TRANSFER ATMOSPH; Toublanc D, 1996, APPL OPTICS, V35, P3270, DOI 10.1364/AO.35.003270; Viola AU, 2008, SCAND J WORK ENV HEA, V34, P297, DOI 10.5271/sjweh.1268; Vos J., 1978, COLOR RES APPL, V3, P125, DOI DOI 10.1002/COL.5080030309; Wright KP, 2001, P NATL ACAD SCI USA, V98, P14027, DOI 10.1073/pnas.201530198; Wyszecki G., 2000, COLOR SCI CONCEPTS M, V2nd ed., P117; Zeitzer JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022078	61	107	109	3	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67798	10.1371/journal.pone.0067798	http://dx.doi.org/10.1371/journal.pone.0067798			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861808	Green Published, gold			2022-12-27	WOS:000321425300030
J	Lv, ML; Zhang, XP; Li, MQ; Chen, QC; Ye, M; Liang, WQ; Ding, LB; Cai, HD; Fu, D; Lv, ZW				Lv, Mingli; Zhang, Xiaoping; Li, Maoquan; Chen, Quanchi; Ye, Meng; Liang, Wenqing; Ding, Lanbao; Cai, Haidong; Fu, Da; Lv, Zhongwei			miR-26a and its Target CKS2 Modulate Cell Growth and Tumorigenesis of Papillary Thyroid Carcinoma	PLOS ONE			English	Article							MICRORNA EXPRESSION; DEREGULATION; REPRESSION; PROTEIN; EZH2; CDC2	Background: While many studies have shown that levels of miR-26a are lower in papillary thyroid carcinoma (PTC), the role and mechanism of miR-26a in PTC are unclear. Method: We used database searches to select potential mRNA targets of miR-26a. Anti-miR-26a, miR-26a mimic, siRNA for CKS2 and their effects on cell growth, cell-cycle distribution and colony formation were evaluated. We also evaluate the over-expressed miR-26a in TPC-1 cells in severe combined immune-deficient mice. We used luciferase reporter assays, real-time PCR and western blot analysis to measure the expression and activity of miR-26a, CKS2, and related factors such as cyclin B1, cyclin A, cdk1, bcl-xl and Akt. Finally, we measured the relationship between the levels of miR-26a and CKS2 in PTC and normal thyroid tissues. Results: Relative to normal thyroid tissues, miR-26a is consistently down-regulated in TPC specimens, and CKS2 was identified as a potential target. Up-regulated miR-26a expression or down-regulated CKS2 expression in TPC-1 and CGTH W3 cells lines caused G2 phase-arrest. Decreased miR-26a expression or increased CKS2 expression could have inverse function on PTC cell lines. CyclinB1, cyclinA, bcl-xl and AKt are indirectly regulated by miR-26a in a CKS2-dependent manner. Finally, CKS2 is overexpressed in PTC specimens relative to normal thyroid tissue, and a significant inverse correlation exists between miR-26a and CKS2 expression in clinical PTC specimens. Conclusion: Our data indicate that miR-26a functions as a growth-suppressive miRNA in PTC, and that its suppressive effects are mediated mainly by repressing CKS2 expression.	[Lv, Mingli; Zhang, Xiaoping; Chen, Quanchi; Ye, Meng; Ding, Lanbao; Cai, Haidong; Fu, Da; Lv, Zhongwei] Tongji Univ, Dept Nucl Med, Shanghai Peoples Hosp 10, Sch Med, Shanghai 200092, Peoples R China; [Li, Maoquan] Tongji Univ, Shanghai Peoples Hosp 10, Dept Intervent Therapy, Shanghai 200092, Peoples R China; [Liang, Wenqing] Shaoxing Peoples Hosp, Dept Orthopaed, Shaoxing, Peoples R China	Tongji University; Tongji University	Lv, ZW (corresponding author), Tongji Univ, Dept Nucl Med, Shanghai Peoples Hosp 10, Sch Med, Shanghai 200092, Peoples R China.	lvzhongweikxy@163.com	lyu, Minfli/GVU-4023-2022		Shanghai Municipal Science and Technology commission [10JC1412700]; Natural Science Foundation of China [30901770, 81150110493]; General Research Plan B of Zhejiang province [2012KYB213]	Shanghai Municipal Science and Technology commission(Science & Technology Commission of Shanghai Municipality (STCSM)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); General Research Plan B of Zhejiang province	The study was funded by Shanghai Municipal Science and Technology commission (NO. 10JC1412700), the Natural Science Foundation of China (NO. 30901770 and NO. 81150110493) and General Research Plan B of Zhejiang province (2012KYB213). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban Y, 2012, J THROID RES, V2012, DOI 10.1155/2012/815079; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Chen HC, 2009, BRIT J CANCER, V100, P1002, DOI 10.1038/sj.bjc.6604948; Dang XM, 2012, CANCER GENET-NY, V205, P113, DOI 10.1016/j.cancergen.2012.01.002; Doree M, 2002, J CELL SCI, V115, P2461; Gonzalez-Gonzalez R., 2011, ISRN ONCOL, V2011, DOI DOI 10.5402/2011/915925; HAYLES J, 1986, MOL GEN GENET, V202, P291, DOI 10.1007/BF00331653; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Lan YS, 2008, INT J CANCER, V123, P543, DOI 10.1002/ijc.23548; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Mitomo S, 2008, CANCER SCI, V99, P280, DOI 10.1111/j.1349-7006.2007.00666.x; Pallante P, 2010, ENDOCR-RELAT CANCER, V17, pF91, DOI 10.1677/ERC-09-0217; RICHARDSON HE, 1990, GENE DEV, V4, P1332, DOI 10.1101/gad.4.8.1332; Sander S, 2008, BLOOD, V112, P4202, DOI 10.1182/blood-2008-03-147645; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Slaby O, 2012, GENE CHROMOSOME CANC, V51, P707, DOI 10.1002/gcc.21957; Tetzlaff MT, 2007, ENDOCR PATHOL, V18, P163, DOI 10.1007/s12022-007-0023-7; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Zhang JQ, 2012, GASTROENTEROLOGY, V143, P246, DOI 10.1053/j.gastro.2012.03.045	22	35	39	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67591	10.1371/journal.pone.0067591	http://dx.doi.org/10.1371/journal.pone.0067591			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861775	Green Published, gold, Green Submitted			2022-12-27	WOS:000321425300019
J	Nair, VS; Keu, KV; Luttgen, MS; Kolatkar, A; Vasanawala, M; Kuschner, W; Bethel, K; Iagaru, AH; Hoh, C; Shrager, JB; Loo, BW; Bazhenova, L; Nieva, J; Gambhir, SS; Kuhn, P				Nair, Viswam S.; Keu, Khun Visith; Luttgen, Madelyn S.; Kolatkar, Anand; Vasanawala, Minal; Kuschner, Ware; Bethel, Kelly; Iagaru, Andrei H.; Hoh, Carl; Shrager, Joseph B.; Loo, Billy W., Jr.; Bazhenova, Lyudmila; Nieva, Jorge; Gambhir, Sanjiv S.; Kuhn, Peter			An Observational Study of Circulating Tumor Cells and F-18-FDG PET Uptake in Patients with Treatment-Naive Non-Small Cell Lung Cancer	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; PROGNOSTIC VALUE; METASTASES; SURVIVAL; VOLUME	Introduction: We investigated the relationship of circulating tumor cells (CTCs) in non-small cell lung cancer (NSCLC) with tumor glucose metabolism as defined by F-18-fluorodeoxyglucose (FDG) uptake since both have been associated with patient prognosis. Materials & Methods: We performed a retrospective screen of patients at four medical centers who underwent FDG PET-CT imaging and phlebotomy prior to a therapeutic intervention for NSCLC. We used an Epithelial Cell Adhesion Molecule (EpCAM) independent fluid biopsy based on cell morphology for CTC detection and enumeration (defined here as High Definition CTCs or "HD-CTCs"). We then correlated HD-CTCs with quantitative FDG uptake image data calibrated across centers in a cross-sectional analysis. Results: We assessed seventy-one NSCLC patients whose median tumor size was 2.8 cm (interquartile range, IQR, 2.0-3.6) and median maximum standardized uptake value (SUVmax) was 7.2 (IQR 3.7-15.5). More than 2 HD-CTCs were detected in 63% of patients, whether across all stages (45 of 71) or in stage I disease (27 of 43). HD-CTCs were weakly correlated with partial volume corrected tumor SUVmax (r = 0.27, p-value = 0.03) and not correlated with tumor diameter (r = 0.07; p-value = 0.60). For a given partial volume corrected SUVmax or tumor diameter there was a wide range of detected HD-CTCs in circulation for both early and late stage disease. Conclusions: CTCs are detected frequently in early-stage NSCLC using a non-EpCAM mediated approach with a wide range noted for a given level of FDG uptake or tumor size. Integrating potentially complementary biomarkers like these with traditional patient data may eventually enhance our understanding of clinical, in vivo tumor biology in the early stages of this deadly disease.	[Nair, Viswam S.; Kuschner, Ware] Stanford Univ, Div Pulm & Crit Care Med, Sch Med, Stanford, CA 94305 USA; [Keu, Khun Visith; Iagaru, Andrei H.] Stanford Univ, Sch Med, Div Nucl Med & Mol Imaging, Stanford, CA 94305 USA; [Luttgen, Madelyn S.; Kolatkar, Anand; Kuhn, Peter] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Vasanawala, Minal] Vet Affairs Palo Alto Hlth Care Syst, Div Nucl Med, Palo Alto, CA USA; [Kuschner, Ware] Vet Affairs Palo Alto Hlth Care Syst, Pulm & Crit Care Med Sect, Palo Alto, CA USA; [Bethel, Kelly] Scripps Clin, Dept Pathol, La Jolla, CA 92037 USA; [Hoh, Carl] Univ Calif San Diego, Med Ctr, Dept Radiol, La Jolla, CA 92093 USA; [Shrager, Joseph B.] Vet Affairs Palo Alto Hlth Care Syst, Div Thorac Surg, Palo Alto, CA USA; [Shrager, Joseph B.] Stanford Univ, Sch Med, Div Thorac Surg, Stanford, CA 94305 USA; [Loo, Billy W., Jr.] Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA; [Bazhenova, Lyudmila] Univ Calif San Diego, Med Ctr, Moores Canc Ctr, La Jolla, CA 92093 USA; [Nieva, Jorge] Billings Clin, Dept Hematol & Oncol, Billings, MT USA; [Gambhir, Sanjiv S.] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA; [Gambhir, Sanjiv S.] Stanford Univ, Mol Imaging Program Stanford, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Scripps Research Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Scripps Research Institute; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University; University of California System; University of California San Diego; Stanford University; Stanford University	Nair, VS (corresponding author), Stanford Univ, Div Pulm & Crit Care Med, Sch Med, Stanford, CA 94305 USA.	viswamnair@stanford.edu	Nieva, Jorge/AAE-3634-2022	Nieva, Jorge/0000-0003-1605-4719; Bethel, Kelly/0000-0002-7005-8641; Kuschner, Ware/0000-0002-9732-1366; Bazhenova, Lyudmila/0000-0001-8764-4359	National Institutes of Health (NIH) NHLBI [HL007948]; Lung Cancer Research Foundation; LUNGevity Foundation; Faculte de Medecine et des Sciences de la Sante de l'Universite de Sherbrooke & SMUS Research Fellow Scholarship; National Cancer Institute [U54CA143906]; NCI [ICMIC P50CA114747, NCI CCNE-TR U54 CA119367, CCNE-T U54 CA151459]; Doris Duke Foundation; Canary Foundation; Stanford Center for Clinical and Translational Education and Research through NIH/NCRR [UL1 RR025744]; NATIONAL CANCER INSTITUTE [U54CA119367, U54CA151459, U54CA143906, P50CA114747, R33CA173373] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001085] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025744] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007948] Funding Source: NIH RePORTER	National Institutes of Health (NIH) NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Lung Cancer Research Foundation; LUNGevity Foundation; Faculte de Medecine et des Sciences de la Sante de l'Universite de Sherbrooke & SMUS Research Fellow Scholarship; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF)); Canary Foundation; Stanford Center for Clinical and Translational Education and Research through NIH/NCRR; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	VSN was funded by the National Institutes of Health (NIH) T32 NHLBI training grant (HL007948), the Lung Cancer Research Foundation and the LUNGevity Foundation. KVK was supported by a Faculte de Medecine et des Sciences de la Sante de l'Universite de Sherbrooke & SMUS Research Fellow Scholarship. This manuscript was supported by Award Number U54CA143906 from the National Cancer Institute. Funding for Dr. Gambhir pertaining to this project was supplied through the NCI ICMIC P50CA114747, NCI CCNE-TR U54 CA119367, CCNE-T U54 CA151459, Doris Duke Foundation, and the Canary Foundation. Database support for this project was provided by The Stanford Center for Clinical and Translational Education and Research through NIH/NCRR grant UL1 RR025744. The content published here is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berezovskaya O, 2005, CANCER RES, V65, P2378, DOI 10.1158/0008-5472.CAN-04-2649; Cho EH, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016001; Coleman RE, 1999, J NUCL MED, V40, P814; Dang CV, 2010, CANCER RES, V70, P859, DOI 10.1158/0008-5472.CAN-09-3556; De Giorgi U, 2010, J NUCL MED, V51, P1213, DOI 10.2967/jnumed.110.076455; De Giorgi U, 2009, J CLIN ONCOL, V27, P3303, DOI 10.1200/JCO.2008.19.4423; Glinsky VV, 2003, CANCER RES, V63, P3805; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Gould MK, 2001, JAMA-J AM MED ASSOC, V285, P914, DOI 10.1001/jama.285.7.914; Gulec SA, 2011, EUR J NUCL MED MOL I, V38, P1289, DOI 10.1007/s00259-011-1758-4; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hofman V, 2011, CLIN CANCER RES, V17, P827, DOI 10.1158/1078-0432.CCR-10-0445; Hou JM, 2011, AM J PATHOL, V178, P989, DOI 10.1016/j.ajpath.2010.12.003; Jadvar H, 2009, J NUCL MED, V50, P1820, DOI 10.2967/jnumed.108.054098; James ML, 2012, PHYSIOL REV, V92, P897, DOI 10.1152/physrev.00049.2010; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Krebs Matthew G, 2010, Ther Adv Med Oncol, V2, P351, DOI 10.1177/1758834010378414; Krivacic RT, 2004, P NATL ACAD SCI USA, V101, P10501, DOI 10.1073/pnas.0404036101; Lee P, 2012, CLIN LUNG CANCER, V13, P52, DOI 10.1016/j.cllc.2011.05.001; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; Marrinucci D, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016003; Nieva J, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016004; Paesmans M, 2010, J THORAC ONCOL, V5, P612, DOI 10.1097/JTO.0b013e3181d0a4f5; Palaskas NJ, 2011, CANCER RES, V5164-5174, P1; Paterlini-Brechot P, 2007, CANCER LETT, V253, P180, DOI 10.1016/j.canlet.2006.12.014; Punnoose EA, 2012, CLIN CANCER RES, V18, P2391, DOI 10.1158/1078-0432.CCR-11-3148; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Tanaka F, 2010, LUNG CANCER-TARGETS, V1, P77; Tanaka F, 2009, CLIN CANCER RES, V15, P6980, DOI 10.1158/1078-0432.CCR-09-1095; van Tinteren H, 2002, LANCET, V359, P1388, DOI 10.1016/S0140-6736(02)08352-6; Velasquez LM, 2009, J NUCL MED, V50, P1646, DOI 10.2967/jnumed.109.063347; Vesselle H, 2008, J THORAC ONCOL, V3, P971, DOI 10.1097/JTO.0b013e31818307a7; Vesselle H, 2007, CLIN CANCER RES, V13, P3255, DOI 10.1158/1078-0432.CCR-06-1128; WARBURG O, 1956, SCIENCE, V124, P269; Wendel M, 2012, PHYS BIOL, V9, DOI [10.1088/1478-3967/9/1/016005, 10.1088/1478-3975/9/1/016005]; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522	37	30	41	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67733	10.1371/journal.pone.0067733	http://dx.doi.org/10.1371/journal.pone.0067733			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861795	Green Published, Green Submitted, gold			2022-12-27	WOS:000321425300025
J	Song, HD; Zhu, FQ				Song, Hyun Deok; Zhu, Fangqiang			Conformational Dynamics of a Ligand-Free Adenylate Kinase	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; ESCHERICHIA-COLI; FREE-ENERGY; STRUCTURAL-CHARACTERIZATION; TRANSITIONS; DEFICIENCY; CATALYSIS; COMMUNICATION; MOTIONS; ROLES	Adenylate kinase (AdK) is a phosphoryl-transfer enzyme with important physiological functions. Based on a ligand-free open structure and a ligand-bound closed structure solved by crystallography, here we use molecular dynamics simulations to examine the stability and dynamics of AdK conformations in the absence of ligands. We first perform multiple simulations starting from the open or the closed structure, and observe their free evolutions during a simulation time of 100 or 200 nanoseconds. In all seven simulations starting from the open structure, AdK remained stable near the initial conformation. The eight simulations initiated from the closed structure, in contrast, exhibited large variation in the subsequent evolutions, with most (seven) undergoing large-scale spontaneous conformational changes and approaching or reaching the open state. To characterize the thermodynamics of the transition, we propose and apply a new sampling method that employs a series of restrained simulations to calculate a one-dimensional free energy along a curved pathway in the high-dimensional conformational space. Our calculated free energy profile features a single minimum at the open conformation, and indicates that the closed state, with a high (similar to 13 kcal/mol) free energy, is not metastable, consistent with the observed behaviors of the unrestrained simulations. Collectively, our simulations suggest that it is energetically unfavorable for the ligand-free AdK to access the closed conformation, and imply that ligand binding may precede the closure of the enzyme.	[Song, Hyun Deok; Zhu, Fangqiang] Indiana Univ Purdue Univ, Dept Phys, Indianapolis, IN 46205 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Zhu, FQ (corresponding author), Indiana Univ Purdue Univ, Dept Phys, Indianapolis, IN 46205 USA.	fzhu0@iupui.edu			Enhance Interdisciplinary Research and Education, Institute of Mathematical Modeling and Computational Science, School of Science, IUPUI	Enhance Interdisciplinary Research and Education, Institute of Mathematical Modeling and Computational Science, School of Science, IUPUI	Grants to Enhance Interdisciplinary Research and Education, Institute of Mathematical Modeling and Computational Science, School of Science, IUPUI. Release Time for Research, IUPUI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora K, 2007, P NATL ACAD SCI USA, V104, P18496, DOI 10.1073/pnas.0706443104; Beckstein O, 2009, J MOL BIOL, V394, P160, DOI 10.1016/j.jmb.2009.09.009; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Brokaw JB, 2010, BIOPHYS J, V99, P3420, DOI 10.1016/j.bpj.2010.09.040; Carrasco AJ, 2001, P NATL ACAD SCI USA, V98, P7623, DOI 10.1073/pnas.121038198; Cukier RI, 2009, J PHYS CHEM B, V113, P1662, DOI 10.1021/jp8053795; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dzeja P, 2009, INT J MOL SCI, V10, P1729, DOI 10.3390/ijms10041729; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fukunishi H, 2002, J CHEM PHYS, V116, P9058, DOI 10.1063/1.1472510; Hanson JA, 2007, P NATL ACAD SCI USA, V104, P18055, DOI 10.1073/pnas.0708600104; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Khavrutskii IV, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2363379; Kubitzki MB, 2008, STRUCTURE, V16, P1175, DOI 10.1016/j.str.2008.04.013; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lagresle-Peyrou C, 2009, NAT GENET, V41, P106, DOI 10.1038/ng.278; Lin Y, 2000, BIOCHEMISTRY-US, V39, P3636, DOI 10.1021/bi991921t; Lin Y, 2000, BIOCHEMISTRY-US, V39, P3647, DOI 10.1021/bi992460e; Lu Q, 1996, P NATL ACAD SCI USA, V93, P5720, DOI 10.1073/pnas.93.12.5720; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maragliano L, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2212942; Matsunaga Y, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002555; MATSUURA S, 1989, J BIOL CHEM, V264, P10148; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; MULLER CW, 1992, J MOL BIOL, V224, P159, DOI 10.1016/0022-2836(92)90582-5; Muller CW, 1996, STRUCTURE, V4, P147, DOI 10.1016/S0969-2126(96)00018-4; Ovchinnikov V, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3544209; Peng C, 2010, BIOPHYS J, V98, P2356, DOI 10.1016/j.bpj.2010.01.044; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Potoyan DA, 2012, J PHYS CHEM B, V116, P1709, DOI 10.1021/jp209980b; Ramanathan A, 2012, PROTEINS, V80, P2536, DOI 10.1002/prot.24135; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shapiro YE, 2006, J PHYS CHEM B, V110, P11519, DOI 10.1021/jp060282a; Snow C, 2007, PROTEINS, V67, P325, DOI 10.1002/prot.21280; Vanden-Eijnden E, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3130083; Weinan E, 2005, J PHYS CHEM B, V109, P6688, DOI 10.1021/jp0455430; Whitford PC, 2008, J BIOL CHEM, V283, P2042, DOI 10.1074/jbc.M707632200; Whitford PC, 2007, J MOL BIOL, V366, P1661, DOI 10.1016/j.jmb.2006.11.085; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821; Zhu FQ, 2012, J COMPUT CHEM, V33, P453, DOI 10.1002/jcc.21989; Zhu FQ, 2010, P NATL ACAD SCI USA, V107, P19814, DOI 10.1073/pnas.1009313107	45	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68023	10.1371/journal.pone.0068023	http://dx.doi.org/10.1371/journal.pone.0068023			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861846	Green Published, Green Submitted, gold			2022-12-27	WOS:000321425300036
J	Belatik, A; Hotchandani, S; Carpentier, R				Belatik, Ahmed; Hotchandani, Surat; Carpentier, Robert			Inhibition of the Water Oxidizing Complex of Photosystem II and the Reoxidation of the Quinone Acceptor Q(A)(-) by Pb2+	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE RISE; OXYGEN-EVOLVING COMPLEX; MOLECULAR-MECHANISM; THERMO-LUMINESCENCE; ELECTRON-ACCEPTOR; THERMOLUMINESCENCE; BICARBONATE; KINETICS; REDUCTION; SYSTEM	The action of the environmental toxic Pb2+ on photosynthetic electron transport was studied in thylakoid membranes isolated from spinach leaves. Fluorescence and thermoluminescence techniques were performed in order to determine the mode of Pb2+ action in photosystem II (PSII). The invariance of fluorescence characteristics of chlorophyll a (Chl a) and magnesium tetraphenylporphyrin (MgTPP), a molecule structurally analogous to Chl a, in the presence of Pb2+ confirms that Pb cation does not interact directly with chlorophyll molecules in PSII. The results show that Pb interacts with the water oxidation complex thus perturbing charge recombination between the quinone acceptors of PSII and the S-2 state of the Mn4Ca cluster. Electron transfer between the quinone acceptors Q(A) and Q(B) is also greatly retarded in the presence of Pb2+. This is proposed to be owing to a transmembrane modification of the acceptor side of the photosystem.	[Belatik, Ahmed; Hotchandani, Surat; Carpentier, Robert] Univ Quebec Trois Rivieres, Grp Rech Biol Vegetale, Trois Rivieres, PQ, Canada	University of Quebec; University of Quebec Trois Rivieres	Carpentier, R (corresponding author), Univ Quebec Trois Rivieres, Grp Rech Biol Vegetale, Trois Rivieres, PQ, Canada.	Robert.Carpentier@uqtr.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work is supported by a grant from Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 1998, PHOTOSYNTH RES, V56, P1, DOI 10.1023/A:1005946808488; Babani F, 1996, J PLANT PHYSIOL, V148, P555, DOI 10.1016/S0176-1617(96)80075-7; BABICH H, 1980, CRC CR REV MICROBIOL, V8, P99, DOI 10.3109/10408418009081123; Baker AJM, 1990, EVOLUTIONARY ASPECTS, P155; Barazzouk S, 2005, J PHYS CHEM B, V109, P716, DOI 10.1021/jp046474s; Beauchemkin R, 2007, BBA-BIOENERGETICS, V1767, P905, DOI 10.1016/j.bbabio.2007.04.001; Belatik A, 2013, J PHOTOCH B IN PRESS; Belatik A, 2012, PHOTOCHEM PHOTOBIOL, V88, P67, DOI 10.1111/j.1751-1097.2011.01016.x; Boisvert S, 2007, BIOMETALS, V20, P879, DOI 10.1007/s10534-007-9081-z; Boisvert S, 2006, FEBS J, V273, P4770, DOI 10.1111/j.1742-4658.2006.05475.x; Boucher N, 1999, PHOTOSYNTH RES, V59, P167, DOI 10.1023/A:1006194621553; Bukhov NG, 2004, BBA-BIOENERGETICS, V1657, P121, DOI 10.1016/j.bbabio.2004.04.008; Callender E., 2004, TREATISE GEOCHEMISTR, V9, P67, DOI DOI 10.1016/B0-08-043751-6/09161-1; Chugh LK, 1999, PLANT PHYSIOL BIOCH, V37, P297, DOI 10.1016/S0981-9428(99)80028-X; DEMETER S, 1984, BIOCHIM BIOPHYS ACTA, V764, P24, DOI 10.1016/0005-2728(84)90136-1; Ducruet JM, 2005, PHOTOSYNTH RES, V84, P161, DOI 10.1007/s11120-004-6433-1; Ducruet JM, 2003, J EXP BOT, V54, P2419, DOI 10.1093/jxb/erg268; EATONRYE JJ, 1988, BIOCHIM BIOPHYS ACTA, V935, P248, DOI 10.1016/0005-2728(88)90221-6; Farineau J, 1983, OXYGEN EVOLVING SYST, P317; Gauthier A, 2006, BBA-BIOENERGETICS, V1757, P1547, DOI 10.1016/j.bbabio.2006.09.005; Gauthier A, 2010, PHOTOCHEM PHOTOBIOL, V86, P1064, DOI 10.1111/j.1751-1097.2010.00765.x; Giardi MT, 1997, PHYSIOL PLANTARUM, V101, P635, DOI 10.1111/j.1399-3054.1997.tb01048.x; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; HOMANN PH, 1993, PHOTOSYNTH RES, V35, P29, DOI 10.1007/BF02185409; Joly D, 2005, PHOTOSYNTH RES, V84, P107, DOI 10.1007/s11120-004-7763-8; Joly D, 2007, J PHOTOCH PHOTOBIO B, V88, P43, DOI 10.1016/j.jphotobiol.2007.04.014; JURSINIC P, 1976, BIOCHIM BIOPHYS ACTA, V440, P322, DOI 10.1016/0005-2728(76)90066-9; KRIEGER A, 1993, BIOCHIM BIOPHYS ACTA, V1144, P411, DOI 10.1016/0005-2728(93)90128-3; Kruger GHJ, 1997, PHYSIOL PLANTARUM, V101, P265, DOI 10.1034/j.1399-3054.1997.1010203.x; Lazar D, 2006, FUNCT PLANT BIOL, V33, P9, DOI 10.1071/FP05095; Ling QF, 2009, BIOL TRACE ELEM RES, V129, P251, DOI 10.1007/s12011-008-8283-8; Mamedov F, 2000, BIOCHEMISTRY-US, V39, P10478, DOI 10.1021/bi992877k; Mamedov F, 2002, PHOTOSYNTH RES, V74, P61, DOI 10.1023/A:1020835822266; MOHANTY N, 1989, PHYSIOL PLANTARUM, V76, P386, DOI 10.1111/j.1399-3054.1989.tb06208.x; Morlot M, 1996, ASPECTS ANAL PLOMB E; ONO TA, 1995, BBA-BIOENERGETICS, V1229, P239, DOI 10.1016/0005-2728(95)00010-G; Petrouleas V, 2005, ADV PHOTO RESPIRAT, V22, P177; Pospisil P, 2002, BBA-BIOENERGETICS, V1554, P94, DOI 10.1016/S0005-2728(02)00216-5; Pospisil P, 1999, PHOTOSYNTH RES, V62, P55, DOI 10.1023/A:1006369009170; Prasad M. N. V., 1999, HEAVY METAL STRESS P; Putrenko II, 1999, BIOCHEMISTRY-US, V38, P10632, DOI 10.1021/bi990518j; Rajagopal S, 2003, BBA-BIOENERGETICS, V1606, P147, DOI 10.1016/S0005-2728(03)00111-7; RASHID A, 1990, FEBS LETT, V271, P181, DOI 10.1016/0014-5793(90)80401-4; RASHID A, 1994, FEBS LETT, V350, P296, DOI 10.1016/0014-5793(94)00789-6; Raskin I., 2000, PHYTOREMEDIATION TOX; REBEIZ CA, 1973, ANNU REV PLANT PHYS, V24, P129, DOI 10.1146/annurev.pp.24.060173.001021; Renger G, 2011, J PHOTOCH PHOTOBIO B, V104, P35, DOI 10.1016/j.jphotobiol.2011.01.023; ROBINSON HH, 1984, Z NATURFORSCH C, V39, P382; RUTHERFORD AW, 1982, BIOCHIM BIOPHYS ACTA, V682, P457, DOI 10.1016/0005-2728(82)90061-5; Sane PV, 2004, METH MOL B, V274, P229; SCHMIDT W, 1990, PHOTOSYNTH RES, V25, P241, DOI 10.1007/BF00033165; Shaffer M, 2001, WASTE LANDS THREAT T; Sigfridsson KGV, 2004, BBA-BIOENERGETICS, V1659, P19, DOI 10.1016/j.bbabio.2004.07.003; Sterckeman T, 2000, ENVIRON POLLUT, V107, P377, DOI 10.1016/S0269-7491(99)00165-7; STRASSER RJ, 1995, PHOTOCHEM PHOTOBIOL, V61, P32, DOI 10.1111/j.1751-1097.1995.tb09240.x; Strasser RJ, 1992, RES PHOTOSYNTHESIS, P23; VANASSCHE F, 1990, PLANT CELL ENVIRON, V13, P195, DOI 10.1111/j.1365-3040.1990.tb01304.x; VANRENSEN JJS, 1988, FEBS LETT, V226, P347, DOI 10.1016/0014-5793(88)81452-2; Vass I, 1996, PHOTOSYNTH RES, V48, P117, DOI 10.1007/BF00041002; VASS I, 1987, BIOCHIM BIOPHYS ACTA, V892, P224, DOI 10.1016/0005-2728(87)90178-2; Wani PA, 2007, CURR MICROBIOL, V54, P237, DOI 10.1007/s00284-006-0451-5; WU JT, 1984, BOT BULL ACAD SINICA, V25, P125; Xiao W, 2008, BIOL TRACE ELEM RES, V126, P269, DOI 10.1007/s12011-008-8196-6; Yruela I, 1996, BIOCHEMISTRY-US, V35, P9469, DOI 10.1021/bi951667e	64	14	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68142	10.1371/journal.pone.0068142	http://dx.doi.org/10.1371/journal.pone.0068142			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861859	Green Published, gold, Green Submitted			2022-12-27	WOS:000323350700071
J	Loupakis, F; Cremolini, C; Yang, DY; Salvatore, L; Zhang, W; Wakatsuki, T; Bohanes, P; Schirripa, M; Benhaim, L; Lonardi, S; Antoniotti, C; Aprile, G; Graziano, F; Ruzzo, A; Lucchesi, S; Ronzoni, M; De Vita, F; Tonini, G; Falcone, A; Lenz, HJ				Loupakis, Fotios; Cremolini, Chiara; Yang, Dongyun; Salvatore, Lisa; Zhang, Wu; Wakatsuki, Takeru; Bohanes, Pierre; Schirripa, Marta; Benhaim, Leonor; Lonardi, Sara; Antoniotti, Carlotta; Aprile, Giuseppe; Graziano, Francesco; Ruzzo, Annamaria; Lucchesi, Sara; Ronzoni, Monica; De Vita, Ferdinando; Tonini, Giuseppe; Falcone, Alfredo; Lenz, Heinz-Josef			Prospective Validation of Candidate SNPs of VEGF/VEGFR Pathway in Metastatic Colorectal Cancer Patients Treated with First-Line FOLFIRI Plus Bevacizumab	PLOS ONE			English	Article							CLINICAL-TRIAL DESIGNS; CHINESE POPULATION; GENETIC-VARIATIONS; PHASE-3 TRIAL; POLYMORPHISMS; FLUOROURACIL; OXALIPLATIN; LEUCOVORIN; BIOMARKERS; RESISTANCE	Purpose: The potential impact of different SNPs of VEGF/VEGFR pathway on the clinical outcome of mCRC patients receiving bev-containing regimens has been investigated in retrospective experiences with contrasting results. We previously reported the association of VEGFA rs833061 C/T variants with PFS in metastatic colorectal cancer patients treated with first-line FOLFIRI plus bevacizumab. The primary objective of this work was to prospectively validate that retrospective finding. A confirmatory analysis of other SNPs of VEGF/VEGFR pathway genes was included. Experimental design: To detect a HR for PFS of 1.7 for VEGFA rs833061 T/T compared to C-variants in metastatic colorectal cancer patients treated with first-line FOLFIRI plus bevacizumab, setting two-sided alpha = 0.05 and beta = 0.20, 199 events were required. VEGFA rs699946 A/G, rs699947 A/C, VEGFR1 rs9582036 A/C and rs7993418 A/G, VEGFR2 rs11133360 C/T, rs12505758 C/T and rs2305948 C/T and EPAS1 rs4145836 A/G were also tested. Germ-line DNA was extracted from peripheral blood. SNPs were analyzed by PCR and sequencing. Results: Four-hundred-twenty-four pts were included. At the univariate analysis, no differences according to VEGFA rs833061 C/T variants were observed in PFS (p = 0.38) or OS (p = 0.95). Among analyzed SNPs, only VEGFR2 rs12505758 C-variants, compared to T/T, were associated to shorter PFS (HR: 1.36 [1.05-1.75], p = 0.015, dominant genetic model) and OS, with a trend toward significance (HR: 1.34 [0.95-1.88], p = 0.088). In the multivariate model, this association retained significance (HR: 1.405 [1.082-1.825], p = 0.012) in PFS, that was lost by applying multiple testing correction (p = 0.14). Conclusion: This prospective experience failed to validate the hypothesized predictive impact of VEGFA rs833061 variants. Retrospective findings on different candidate SNPs were not confirmed. Only VEGFR2 rs12505758 variants, whose prognostic and not predictive impact was previously reported, correlated with PFS. Given the complexity of angiogenesis, it is rather unlike that a single germ-line SNP might be a good predictor of benefit from bevacizumab.	[Loupakis, Fotios; Yang, Dongyun; Zhang, Wu; Wakatsuki, Takeru; Bohanes, Pierre; Benhaim, Leonor; Lenz, Heinz-Josef] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Loupakis, Fotios; Cremolini, Chiara; Salvatore, Lisa; Schirripa, Marta; Antoniotti, Carlotta; Falcone, Alfredo] Azienda Osped Univ Pisana, Ist Toscano Tumori, Pisa, Italy; [Lonardi, Sara] Oncol Inst Veneto, Unit Med Oncol 1, Padua, Italy; [Aprile, Giuseppe] Azienda Osped Univ Udine, Udine, Italy; [Graziano, Francesco] Azienda Osped Osped San Salvatore, Med Oncol Unit, Pesaro, Italy; [Ruzzo, Annamaria] Univ Urbino, Sect Biochem & Mol Biol G Fornaini, Dept Biomol Sci, I-61029 Urbino, Italy; [Lucchesi, Sara] Ist Toscano Tumori, Med Oncol Unit, Azienda Pontedera USL5, Pisa, Italy; [Ronzoni, Monica] Ist Sci San Raffaele, Unit Oncol, Milan, Italy; [De Vita, Ferdinando] Univ Naples 2, Med Oncol Unit, Naples, Italy; [Tonini, Giuseppe] Univ Campus Biomed, Med Oncol Unit, Rome, Italy	University of Southern California; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Pisa; Azienda Ospedaliero Universitaria Pisana; IRCCS Istituto Oncologico Veneto (IOV); University of Udine; University Hospital of Udine; University of Urbino; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Universita della Campania Vanvitelli; University Campus Bio-Medico - Rome Italy	Loupakis, F (corresponding author), Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA.	fotiosloupakis@gmail.com	Salvatore, Lisa/L-7746-2019; Ruzzo, Annamaria/Q-2155-2016; Schirripa, Marta/F-3688-2017; Cremolini, Chiara/AAC-1889-2019; Falcone, Alfredo/G-5217-2013; Lonardi, Sara/F-4228-2014; Loupakis, Fotios/I-7243-2012; Yang, Dongyun/M-2579-2019	Ruzzo, Annamaria/0000-0003-2815-1890; Schirripa, Marta/0000-0001-8316-4411; Lonardi, Sara/0000-0002-7593-8138; Loupakis, Fotios/0000-0001-9651-0395; Yang, Dongyun/0000-0003-0736-4977; Tonini, Giuseppe/0000-0003-4442-8677; CREMOLINI, CHIARA/0000-0002-0520-4841; Salvatore, Lisa/0000-0003-3864-0719; Ronzoni, Monica/0000-0002-2845-275X; Falcone, Alfredo/0000-0001-5840-2529				Bennouna J, 2013, LANCET ONCOL, V14, P29, DOI 10.1016/S1470-2045(12)70477-1; Bocci G, 2011, PHARMACOGENOMICS, V12, P1077, DOI [10.2217/PGS.11.75, 10.2217/pgs.11.75]; Bottsford-Miller JN, 2012, J CLIN ONCOL, V30, P4026, DOI 10.1200/JCO.2012.41.9242; Buyse M, 2010, NAT REV CLIN ONCOL, V7, P309, DOI 10.1038/nrclinonc.2010.43; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Gerger A, 2011, CLIN CANCER RES, V17, P5783, DOI 10.1158/1078-0432.CCR-11-1115; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Grothey A, 2008, J CLIN ONCOL, V26, P183, DOI 10.1200/JCO.2007.13.8099; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jain RK, 2009, NAT REV CLIN ONCOL, V6, P327, DOI 10.1038/nrclinonc.2009.63; Lambrechts D, 2011, EUR J CANCER, V47, pS173, DOI 10.1016/S0959-8049(11)70907-8; Lambrechts D, 2012, LANCET ONCOL, V13, P724, DOI 10.1016/S1470-2045(12)70231-0; Liu L, 2011, CARCINOGENESIS, V32, P336, DOI 10.1093/carcin/bgq264; Loupakis F, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-247; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Mandrekar SJ, 2009, J CLIN ONCOL, V27, P4027, DOI 10.1200/JCO.2009.22.3701; Pander J, 2011, ANN ONCOL, V22, P1147, DOI 10.1093/annonc/mdq572; Sargent DJ, 2005, J CLIN ONCOL, V23, P2020, DOI 10.1200/JCO.2005.01.112; Schneider BP, 2008, J CLIN ONCOL, V26, P4672, DOI 10.1200/JCO.2008.16.1612; Schultheis AM, 2008, CLIN CANCER RES, V14, P7554, DOI 10.1158/1078-0432.CCR-08-0351; Tejpar S, 2012, ONCOLOGIST, V17, P1039, DOI 10.1634/theoncologist.2012-0068; Van Cutsem E, 2012, J CLIN ONCOL, V30, P3499, DOI 10.1200/JCO.2012.42.8201; Zhong R, 2013, CARCINOGENESIS, V34, P936, DOI 10.1093/carcin/bgs395	24	53	56	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e66774	10.1371/journal.pone.0066774	http://dx.doi.org/10.1371/journal.pone.0066774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861747	Green Published, gold, Green Submitted			2022-12-27	WOS:000323350700007
J	Kezic, JM; McMenamin, PG				Kezic, Jelena M.; McMenamin, Paul G.			The Effects of CX(3)CR1 Deficiency and Irradiation on the Homing of Monocyte-Derived Cell Populations in the Mouse Eye	PLOS ONE			English	Article							FRACTALKINE RECEPTOR CX(3)CR1; RETINAL MICROGLIA; RESIDENT-MICROGLIA; DENDRITIC CELLS; CHEMOKINE; CX3CR1; MIGRATION; RADIATION; TURNOVER; RECRUITMENT	This study examined whether CX(3)CR1 deficiency altered monocytic cell replenishment dynamics in ocular tissues in the context of radiation chimeras. Long-term effects of irradiation and effects of sublethal irradiation on ocular macrophages were also assessed. Bone marrow from BALB/c Cx(3)cr1(+/gfp) or Cx(3)cr1(gfp/gfp) mice was used to reconstitute full body irradiated WT mice and donor cell densities in the uveal tract were compared at 4 and 8 weeks post-transplantation. BALB/c and C57BL/6J chimeric mice were examined at 6 months of age to determine strain-related differences in microglial replenishment and radiation sensitivity. A separate cohort of mice were sublethally irradiated (5.5 Gy) and retinal tissue assessed 8 and 12 weeks later. CX(3)CR1 deficiency altered the early replenishment of monocytes in the posterior iris but not in the iris stroma, choroid or retina. In six month old chimeric mice, there were significantly higher GFP(+) cell densities in the uveal tract when compared to non-irradiated 8-12 week old Cx(3)cr1(+/gfp) mice. Additionally, MHC Class II expression was upregulated on hyalocytes and GFP(+) cells in the peripheral retina and the repopulation of microglia appeared to be more rapid in C57BL/6J mice compared to BALB/c mice. Transient expression of MHC Class II was observed on retinal vasculature in sublethally irradiated mice. These data indicate CX(3)CR1-deficiency only slightly alters monocyte-derived cell replenishment in the murine uveal tract. Lethal irradiation leads to long-term increase in monocytic cell density in the uveal tract and retinal microglial activation, possibly as a sequelae to local irradiation induced injury. Microglial replenishment in this model appears to be strain dependent.	[Kezic, Jelena M.; McMenamin, Paul G.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Kezic, Jelena M.] Univ Melbourne, Ctr Eye Res Australia, Dept Ophthalmol, Royal Victorian Eye & Ear Hosp, East Melbourne, Vic, Australia	Monash University; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne	Kezic, JM (corresponding author), Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia.	Jelena.Kezic@monash.edu		McMenamin, Paul/0000-0002-7141-1283				Agarwal RK, 2004, METH MOLEC MED, V102, P395; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Albini TA, 2005, BRIT J OPHTHALMOL, V89, P901, DOI 10.1136/bjo.2004.060293; Anderson MG, 2005, P NATL ACAD SCI USA, V102, P4566, DOI 10.1073/pnas.0407357102; Bhogal N, 2010, RADIAT RES, V173, P1, DOI 10.1667/RR1851.1; Blomster LV, 2011, MOL CELL NEUROSCI, V48, P236, DOI 10.1016/j.mcn.2011.08.004; Bosco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043602; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chen M, 2012, GLIA, V60, P833, DOI 10.1002/glia.22315; Chinnery HR, 2008, IMMUNOLOGY, V125, P541, DOI 10.1111/j.1365-2567.2008.02868.x; Chinnery HR, 2007, INVEST OPHTH VIS SCI, V48, P1568, DOI 10.1167/iovs.06-0746; Chinnery HR, 2012, NEUROBIOL AGING, V33, P1769, DOI 10.1016/j.neurobiolaging.2011.03.010; Clover AJP, 2011, BURNS, V37, P1386, DOI 10.1016/j.burns.2011.08.001; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Dagkalis A, 2009, IMMUNOLOGY, V128, P25, DOI 10.1111/j.1365-2567.2009.03046.x; Echigo T, 2004, J ALLERGY CLIN IMMUN, V113, P940, DOI 10.1016/S0091-6749(04)01061-9; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Haston CK, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00094; Haston CK, 1997, CANCER RES, V57, P5286; Howell GR, 2012, J CLIN INVEST, V122, P1246, DOI 10.1172/JCI61135; Huang D, 2006, FASEB J, V20, P896, DOI 10.1096/fj.05-5465com; Hughes PM, 2002, GLIA, V37, P314, DOI 10.1002/glia.10037; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Joly S, 2009, AM J PATHOL, V174, P2310, DOI 10.2353/ajpath.2009.090023; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kezic J, 2008, J LEUKOCYTE BIOL, V84, P721, DOI 10.1189/jlb.0308166; Kezic J, 2008, INVEST OPHTH VIS SCI, V49, P1599, DOI 10.1167/iovs.07-0953; Kezic J, 2010, INVEST OPHTH VIS SCI, V51, P5121, DOI 10.1167/iovs.10-5325; Kipnis J, 2004, EUR J NEUROSCI, V19, P1191, DOI 10.1111/j.1460-9568.2004.03207.x; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2; Liang KJ, 2009, REGULATION DYNAMIC B, P4444; Lindsay KJ, 2007, BRIT J RADIOL, V80, pS2, DOI 10.1259/bjr/60507340; London A, 2011, J EXP MED, V208, P23, DOI 10.1084/jem.20101202; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Lyszkiewicz M, 2011, EUR J IMMUNOL, V41, P1256, DOI 10.1002/eji.201040977; McMenamin PG, 2000, INVEST OPHTH VIS SCI, V41, P3043; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Muther PS, 2010, INVEST OPHTH VIS SCI, V51, P4831, DOI 10.1167/iovs.09-4923; Nanki T, 2004, J IMMUNOL, V173, P7010, DOI 10.4049/jimmunol.173.11.7010; Ng TF, 2001, INVEST OPHTH VIS SCI, V42, P3301; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Papadopoulos EJ, 1999, EUR J IMMUNOL, V29, P2551, DOI 10.1002/(SICI)1521-4141(199908)29:08<2551::AID-IMMU2551>3.0.CO;2-T; Raoul W, 2008, OPHTHAL RES, V40, P115, DOI 10.1159/000119860; Ruitenberg MJ, 2008, J NEUROIMMUNOL, V205, P80, DOI 10.1016/j.jneuroim.2008.09.010; Shiose S, 2011, J BIOL CHEM, V286, P15543, DOI 10.1074/jbc.M111.228551; Su SB, 2007, INVEST OPHTH VIS SCI, V48, P4616, DOI 10.1167/iovs.07-0233; Sun B, 1997, J IMMUNOL, V159, P1004; Sunnemark D, 2003, BRAIN PATHOL, V13, P617; Suzuki F, 2005, J IMMUNOL, V175, P6987, DOI 10.4049/jimmunol.175.10.6987; Tanaka R, 2003, NEUROSCIENCE, V117, P531, DOI 10.1016/S0306-4522(02)00954-5; Vagaja NN, 2012, INVEST OPHTH VIS SCI, V53, P1445, DOI 10.1167/iovs.11-8601; Xu HP, 2007, GLIA, V55, P1189, DOI 10.1002/glia.20535; Xu HP, 2007, INVEST OPHTH VIS SCI, V48, P1701, DOI 10.1167/iovs.06-0697; Zhao L, 2009, EXP EYE RES, V88, P1004, DOI 10.1016/j.exer.2008.12.013; Zujovic V, 2000, GLIA, V29, P305, DOI 10.1002/(SICI)1098-1136(20000215)29:4<305::AID-GLIA2>3.0.CO;2-V	55	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68570	10.1371/journal.pone.0068570	http://dx.doi.org/10.1371/journal.pone.0068570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844223	gold, Green Published			2022-12-27	WOS:000321733000016
J	Bagoly, Z; Sarkady, F; Magyar, T; Kappelmayer, J; Pongracz, E; Csiba, L; Muszbek, L				Bagoly, Zsuzsa; Sarkady, Ferenc; Magyar, Tuende; Kappelmayer, Janos; Pongracz, Endre; Csiba, Laszlo; Muszbek, Laszlo			Comparison of a New P2Y12 Receptor Specific Platelet Aggregation Test with Other Laboratory Methods in Stroke Patients on Clopidogrel Monotherapy	PLOS ONE			English	Article							RESPONSE VARIABILITY; ANTIPLATELET THERAPY; VASP-PHOSPHORYLATION; STENT IMPLANTATION; REACTIVITY; RESISTANCE; RESPONSIVENESS; INHIBITION; PREVALENCE	Background: Clinical studies suggest that 10-50% of patients are resistant to clopidogrel therapy. ADP induced platelet aggregation, a widely used test to monitor clopidogrel therapy, is affected by aspirin and is not specific for the P2Y12 receptor inhibited by clopidogrel. Objectives: To develop a P2Y12-specific platelet aggregation test and to compare it with other methods used for monitoring clopidogrel therapy. Patients/Methods: Study population included 111 patients with the history of ischemic stroke being on clopidogrel monotherapy and 140 controls. The effect of clopidogrel was tested by a newly developed ADP(PGE1) aggregation test in which prostaglandin E1 treated platelets are used. Results of conventional ADP induced platelet aggregation, VerifyNow P2Y12 assay and ADP(PGE1) aggregation were compared to those obtained by flow cytometric analysis of vasodilator stimulated phosphoprotein (VASP) phosphorylation. Reference intervals for all assays were determined according to the guidelines of Clinical Laboratory Standards Institute. Results: The P2Y12-specificity of ADP(PGE1) test was proven by comparing it with ADP aggregation in the presence of P2Y1 antagonist, adenosine 3',5'-diphosphate. The method was not influenced by aspirin treatment. Approximately 50% of patients were clopidogrel resistant by conventional ADP aggregation and VerifyNow tests. The ADP(PGE1) method and the VASP phosphorylation assay identified 25.9% and 11.7% of patients as non-responders, respectively. ADP(PGE1) aggregation showed good correlation with VASP phosphorylation and had high diagnostic efficiency. Conclusion: The new ADP(PGE1) method is a reliable test for monitoring P2Y12 receptor inhibition by platelet aggregation. As a subset of patients are non-responders, monitoring clopidogrel therapy by adequate methods is essential.	[Bagoly, Zsuzsa; Sarkady, Ferenc; Muszbek, Laszlo] Univ Debrecen, Med & Hlth Sci Ctr, Clin Res Ctr, H-4012 Debrecen, Hungary; [Magyar, Tuende; Csiba, Laszlo] Univ Debrecen, Med & Hlth Sci Ctr, Dept Neurol, H-4012 Debrecen, Hungary; [Kappelmayer, Janos] Univ Debrecen, Med & Hlth Sci Ctr, Inst Lab Med, H-4012 Debrecen, Hungary; [Pongracz, Endre] Szent Imre Hosp, Budapest, Hungary; [Muszbek, Laszlo] Hungarian Acad Sci, Thrombosis & Haemostasis Res Grp, Debrecen, Hungary	University of Debrecen; University of Debrecen; University of Debrecen; Hungarian Academy of Sciences	Muszbek, L (corresponding author), Univ Debrecen, Med & Hlth Sci Ctr, Clin Res Ctr, H-4012 Debrecen, Hungary.	muszbek@med.unideb.hu	Bagoly, Zsuzsa/AAB-3553-2020		National Office for Research and Technology; DE-LABDIA; National Research Fund [OTKA K78386]; Hungarian Academy of Science [MTA11003, TKI227]; National Development Agency (TAMOP) [4.2.2.B-10/1-2010-0024, 4.2.2.A-11/1/KONV-2012-0045]; University of Debrecen, Medical and Health Science Center [MEC1/2011]; Janos Bolyai fellowship	National Office for Research and Technology(National Office for Research and TechnologyTurkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); DE-LABDIA; National Research Fund(Luxembourg National Research Fund); Hungarian Academy of Science(Hungarian Academy of Sciences); National Development Agency (TAMOP); University of Debrecen, Medical and Health Science Center; Janos Bolyai fellowship(Hungarian Academy of Sciences)	This work was supported by the National Office for Research and Technology (http://www.nfu.gov.hu) Jedlik Anyos program, DE-LABDIA, by the National Research Fund (www.otka.hu) (OTKA K78386), by the Hungarian Academy of Science (MTA11003, TKI227), by the National Development Agency (http://www.nfu.gov.hu) (TAMOP projects 4.2.2.B-10/1-2010-0024, 4.2.2.A-11/1/KONV-2012-0045) and by the University of Debrecen, Medical and Health Science Center (http://www.med.unideb.hu) (MEC1/2011). Z. Bagoly is the recipient of Janos Bolyai fellowship and Lajos Szodoray Prize. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Mokhtar O, 2012, HEART LUNG CIRC, V21, P12, DOI 10.1016/j.hlc.2011.08.069; Aleil B, 2005, J THROMB HAEMOST, V3, P85, DOI 10.1111/j.1538-7836.2004.01063.x; Aradi D, 2010, PLATELETS, V21, P563, DOI 10.3109/09537104.2010.494742; Aw D, 2012, POSTGRAD MED J, V88, P34, DOI 10.1136/postgradmedj-2011-130100; Bonello L, 2010, J AM COLL CARDIOL, V56, P919, DOI 10.1016/j.jacc.2010.04.047; Bouman HJ, 2011, J THROMB HAEMOST, V9, P909, DOI 10.1111/j.1538-7836.2011.04255.x; Bouman HJ, 2010, J THROMB HAEMOST, V8, P482, DOI 10.1111/j.1538-7836.2009.03733.x; Breet NJ, 2010, JAMA-J AM MED ASSOC, V303, P754, DOI 10.1001/jama.2010.181; Cattaneo M, 2012, J THROMB HAEMOST, V10, P327, DOI 10.1111/j.1538-7836.2011.04602.x; Cattaneo M, 2011, HEMATOL-AM SOC HEMAT, P70, DOI 10.1182/asheducation-2011.1.70; Ceriotti F, 2008, C28A3 CLIN LAB STAND; Damman P, 2012, J THROMB THROMBOLYS, V33, P143, DOI 10.1007/s11239-011-0667-5; Fabre JE, 1999, NAT MED, V5, P1199, DOI 10.1038/13522; Gremmel T, 2009, THROMB HAEMOSTASIS, V101, P333, DOI 10.1160/TH08-09-0577; Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83; Gurbel PA, 2011, THROMB HAEMOSTASIS, V106, P265, DOI 10.1160/TH11-03-0167; Huang BT, 2012, ARCH MED RES, V43, P212, DOI 10.1016/j.arcmed.2012.04.004; Jakubowski JA, 2008, THROMB HAEMOSTASIS, V99, P215, DOI 10.1160/TH07-09-0555; Jarvis GE, 2000, BRIT J PHARMACOL, V129, P275, DOI 10.1038/sj.bjp.0703046; Komocsi A, 2012, INT J CARDIOL; Kubica A, 2011, J THROMB THROMBOLYS, V32, P459, DOI 10.1007/s11239-011-0611-8; Mallouk N, 2012, THROMB HAEMOSTASIS, V107, P494, DOI 10.1160/TH11-03-0202; Muller I, 2003, THROMB HAEMOSTASIS, V89, P783, DOI 10.1055/s-0037-1613462; Nguyen TA, 2005, J AM COLL CARDIOL, V45, P1157, DOI 10.1016/j.jacc.2005.01.034; Shiraga M, 2005, J THROMB HAEMOST, V3, P2315, DOI 10.1111/j.1538-7836.2005.01554.x; Shulga Olga, 2011, Front Neurol, V2, P36, DOI 10.3389/fneur.2011.00036; Smock KJ, 2011, AM J HEMATOL, V86, P1032, DOI 10.1002/ajh.22112; Sollier CBD, 2010, THROMB HAEMOSTASIS, V104, P571, DOI 10.1160/TH09-11-0803; Sollier CBD, 2009, THROMB HAEMOSTASIS, V101, P116, DOI 10.1160/TH08-07-0481; Tentzeris I, 2011, THROMB HAEMOSTASIS, V105, pS60, DOI 10.1160/THS11-01-0025; Tobin WO, 2013, EUR J NEUROL, V20, P344, DOI 10.1111/j.1468-1331.2012.03861.x; Topcuoglu MA, 2011, EXPERT REV NEUROTHER, V11, P251, DOI 10.1586/ERN.10.203; van Werkum JW, 2008, PLATELETS, V19, P479, DOI 10.1080/09537100802317918	33	18	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e69417	10.1371/journal.pone.0069417	http://dx.doi.org/10.1371/journal.pone.0069417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844259	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000321341000191
J	Dong, BC; Wang, JZ; Liu, RH; Zhang, MX; Yu, FH				Dong, Bi-Cheng; Wang, Jiu-Zhong; Liu, Rui-Hua; Zhang, Ming-Xiang; Yu, Fei-Hai			Effects of Heterogeneous Competitor Distribution and Ramet Aggregation on the Growth and Size Structure of a Clonal Plant	PLOS ONE			English	Article							SOIL NUTRIENT HETEROGENEITY; ENVIRONMENTAL HETEROGENEITY; TEMPORAL HETEROGENEITY; FORAGING BEHAVIOR; SPATIAL-PATTERNS; MODULAR CONCEPT; PLASTICITY; POPULATIONS; RESPONSES; LIGHT	Spatially heterogeneous distribution of interspecific competitors and intraspecific aggregation of offspring ramets may affect the growth and size structure of clonal plant populations, but these have been rarely studied. We conducted a greenhouse experiment in which we grew a population of eight offspring ramets (plants) of the stoloniferous clonal plant Hydrocotyle vulgaris aggregately or segregately in two homogeneous treatments with or without a competing grass Festuca elata and a heterogeneous treatment with a patchy distribution of the grass. In patchy grass treatments, H. vulgaris produced markedly more biomass, ramets and stolons in open patches (without grasses) than in grass patches, but displayed lower size variations as measured by coefficient of variation of biomass, ramets and stolons among the eight plants. In open areas, H. vulgaris produced statistically the same amounts of biomass and even more stolons and showed higher size variations in patchy grass treatments than in open (no grass) treatments. In grass areas, H. vulgaris grew much worse and displayed higher size variations in patchy grass treatments than in full grass treatments. Ramet aggregation decreased the growth of H. vulgaris in open treatments and in both open and grass patches in patchy grass treatments, but had little effect in full grass treatments. Ramet aggregation had little effect on size variations. Therefore, heterogeneous distribution of competitors can affect the growth and size structure of clonal plant populations, and ramet aggregation may decrease population growth when they grow in open environments or heterogeneous environments with a patchy distribution of interspecific competitors.	[Dong, Bi-Cheng; Liu, Rui-Hua; Zhang, Ming-Xiang; Yu, Fei-Hai] Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China; [Wang, Jiu-Zhong] Beijing Forestry Univ, Sch Forestry, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University	Yu, FH (corresponding author), Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China.	feihaiyu@bjfu.edu.cn	Yu, Fei-Hai/O-9395-2016	Yu, Fei-Hai/0000-0001-5007-1745; Dong, Bi-Cheng/0000-0002-9658-9969	Beijing Forestry University [BLYJ201104]; Fundamental Research Funds for the Central Universities [TD-JC-2013-1]; Program for New Century Excellent Talents in University [NECT-10-0234]	Beijing Forestry University; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This research was supported by the Specific Programs in Graduate Science and Technology Innovation of Beijing Forestry University (BLYJ201104), the Fundamental Research Funds for the Central Universities (TD-JC-2013-1) and the Program for New Century Excellent Talents in University (NECT-10-0234). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert P, 1996, VEGETATIO, V122, P83, DOI 10.1007/BF00052818; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Begon M., 2009, ECOLOGY INDIVIDUALS; BIRCH CPD, 1994, J ECOL, V82, P653, DOI 10.2307/2261272; Bolker BM, 2003, AM NAT, V162, P135, DOI 10.1086/376575; Bolker BM, 1999, AM NAT, V153, P575, DOI 10.1086/303199; Cahill JF, 2011, ANNU REV ECOL EVOL S, V42, P289, DOI 10.1146/annurev-ecolsys-102710-145006; Caldwell M.M., 1994, EXPLOITATION ENV HET; Casper BB, 1998, AM J BOT, V85, P1680, DOI 10.2307/2446501; Casper BB, 1996, AM J BOT, V83, P333, DOI 10.2307/2446168; Chen JS, 2010, ACTA OECOL, V36, P23, DOI 10.1016/j.actao.2009.09.006; Chu Y, 2006, J INTEGR PLANT BIOL, V48, P400, DOI 10.1111/j.1744-7909.2006.00237.x; Day KJ, 2003, J ECOL, V91, P541, DOI 10.1046/j.1365-2745.2003.00799.x; Day KJ, 2003, J ECOL, V91, P305, DOI 10.1046/j.1365-2745.2003.00763.x; de Kroon H, 2005, NEW PHYTOL, V166, P73, DOI 10.1111/j.1469-8137.2004.01310.x; De Kroon H, 2009, PLANT CELL ENVIRON, V32, P704, DOI 10.1111/j.1365-3040.2009.01936.x; DEKROON H, 1995, J ECOL, V83, P143, DOI 10.2307/2261158; DEKROON H, 2003, ROOT ECOLOGY; Dimitrakopoulos PG, 2004, ECOL LETT, V7, P574, DOI 10.1111/j.1461-0248.2004.00607.x; DONG M, 1995, OECOLOGIA, V101, P282, DOI 10.1007/BF00328813; EVANS JP, 1995, ECOLOGY, V76, P1147, DOI 10.2307/1940922; Facelli E, 2002, OECOLOGIA, V133, P54, DOI 10.1007/s00442-002-1022-5; Fransen B, 2001, ECOLOGY, V82, P2534, DOI 10.1890/0012-9658(2001)082[2534:SNHACB]2.0.CO;2; GIBSON DJ, 1988, J ECOL, V76, P233, DOI 10.2307/2260466; Gough L, 2001, EVOL ECOL, V15, P547, DOI 10.1023/A:1016061604630; Guo W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027998; Hagiwara Y, 2012, ECOL RES, V27, P1079, DOI 10.1007/s11284-012-0989-6; Hagiwara Y, 2010, ANN BOT-LONDON, V106, P173, DOI 10.1093/aob/mcq096; He WM, 2011, J ECOL, V99, P1202, DOI 10.1111/j.1365-2745.2011.01848.x; Huber-Sannwald E, 1998, ECOLOGY, V79, P2267, DOI 10.1890/0012-9658(1998)079[2267:EONPAR]2.0.CO;2; Huber-Sannwald E, 2001, PROG BOT, V62, P451; Hutchings MJ, 2008, EVOL ECOL, V22, P313, DOI 10.1007/s10682-007-9178-4; Hutchings MJ, 2004, ANN BOT-LONDON, V94, P1, DOI 10.1093/aob/mch111; Hutchings MJ, 2003, ECOLOGY, V84, P2322, DOI 10.1890/02-0290; Leeflang L, 1998, OECOLOGIA, V117, P235, DOI 10.1007/s004420050653; Lenssen JPM, 2005, ECOLOGY, V86, P1358, DOI 10.1890/04-0939; Li PX, 2008, J ARID ENVIRON, V72, P953, DOI 10.1016/j.jaridenv.2007.11.004; Liu HD, 2009, FLORA, V204, P298, DOI 10.1016/j.flora.2008.03.003; MAHALL BE, 1991, P NATL ACAD SCI USA, V88, P874, DOI 10.1073/pnas.88.3.874; MCCONNAUGHAY KDM, 1991, ECOLOGY, V72, P94, DOI 10.2307/1938905; Miao LiHua, 2011, Journal of Zhejiang University (Agriculture and Life Sciences), V37, P425; Monzeglio U, 2005, OECOLOGIA, V145, P619, DOI 10.1007/s00442-005-0168-3; NOVOPLANSKY A, 1990, OECOLOGIA, V82, P490, DOI 10.1007/BF00319791; Novoplansky A, 2009, PLANT CELL ENVIRON, V32, P726, DOI 10.1111/j.1365-3040.2009.01979.x; Price EAC, 1996, OIKOS, V75, P279, DOI 10.2307/3546251; QUINN GP, 2002, EXPT DESIGN DATA ANA, P443; Richards CL, 2008, AM J BOT, V95, P931, DOI 10.3732/ajb.2007364; Roiloa SR, 2007, J ECOL, V95, P397, DOI 10.1111/j.1365-2745.2007.01216.x; ROSS MA, 1972, J ECOL, V60, P77, DOI 10.2307/2258041; Stark JM, 1994, EXPLOITATION ENV HET, P255; Stoll P, 2001, ECOLOGY, V82, P319, DOI 10.1890/0012-9658(2001)082[0319:IAACII]2.0.CO;2; STUEFER JF, 1994, OECOLOGIA, V100, P302, DOI 10.1007/BF00316958; Tilman D, 1997, SPATIAL ECOLOGY ROLE; Von Ende CN., 2001, DESIGN ANAL ECOLOGIC, P134; von Felten S, 2008, J PLANT ECOL, V1, P33, DOI 10.1093/jpe/rtm006; Wang P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039105; WEINER J, 1985, ECOLOGY, V66, P743, DOI 10.2307/1940535; WEINER J, 1986, OIKOS, V47, P211, DOI 10.2307/3566048; Winkler E, 2001, EVOL ECOL, V15, P281, DOI 10.1023/A:1016080714200; Xu CY, 2010, J ECOL, V98, P833, DOI 10.1111/j.1365-2745.2010.01668.x; Zhou J, 2012, ANN BOT-LONDON, V109, P813, DOI 10.1093/aob/mcr314; Zobel M, 2010, OIKOS, V119, P802, DOI 10.1111/j.1600-0706.2010.18296.x	62	3	7	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68557	10.1371/journal.pone.0068557	http://dx.doi.org/10.1371/journal.pone.0068557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844221	gold, Green Published			2022-12-27	WOS:000321341000173
J	Grasmeijer, F; Hagedoorn, P; Frijlink, HW; de Boer, HA				Grasmeijer, Floris; Hagedoorn, Paul; Frijlink, Henderik W.; de Boer, H. Anne			Mixing Time Effects on the Dispersion Performance of Adhesive Mixtures for Inhalation	PLOS ONE			English	Article							POWDER INHALER FORMULATIONS; DRUG PARTICLE DETACHMENT; CLASSIFIER TECHNOLOGY ACT; AIR CLASSIFIER; APPARENT SOLUBILITY; CARRIER CRYSTALS; SURFACE; MODE	This paper deals with the effects of mixing time on the homogeneity and dispersion performance of adhesive mixtures for inhalation. Interactions between these effects and the carrier size fraction, the type of drug and the inhalation flow rate were studied. Furthermore, it was examined whether or not changes in the dispersion performance as a result of prolonged mixing can be explained with a balance of three processes that occur during mixing, knowing drug redistribution over the lactose carrier; (de-) agglomeration of the drug (and fine lactose) particles; and compression of the drug particles onto the carrier surface. For this purpose, mixtures containing salmeterol xinafoate or fluticasone propionate were mixed for different periods of time with a fine or coarse crystalline lactose carrier in a Turbula mixer. Drug detachment experiments were performed using a classifier based inhaler at different flow rates. Scanning electron microscopy and laser diffraction techniques were used to measure drug distribution and agglomeration, whereas changes in the apparent solubility were measured as a means to monitor the degree of mechanical stress imparted on the drug particles. No clear trend between mixing time and content uniformity was observed. Quantitative and qualitative interactions between the effect of mixing time on drug detachment and the type of drug, the carrier size fraction and the flow rate were measured, which could be explained with the three processes mentioned. Generally, prolonged mixing caused drug detachment to decrease, with the strongest decline occurring in the first 120 minutes of mixing. For the most cohesive drug (salmeterol) and the coarse carrier, agglomerate formation seemed to dominate the overall effect of mixing time at a low inhalation flow rate, causing drug detachment to increase with prolonged mixing. The optimal mixing time will thus depend on the formulation purpose and the choice for other, interacting variables.	[Grasmeijer, Floris; Hagedoorn, Paul; Frijlink, Henderik W.; de Boer, H. Anne] Univ Groningen, Dept Pharmaceut Technol & Biopharm, Groningen, Netherlands	University of Groningen	Grasmeijer, F (corresponding author), Univ Groningen, Dept Pharmaceut Technol & Biopharm, Groningen, Netherlands.	F.Grasmeijer@rug.nl	Frijlink, Henderik Willem/AAD-7382-2020	Frijlink, Henderik Willem/0000-0001-7901-8198	Department of Pharmaceutical Technology and Biopharmacy of the University of Groningen	Department of Pharmaceutical Technology and Biopharmacy of the University of Groningen	The work was funded by the Department of Pharmaceutical Technology and Biopharmacy of the University of Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begat P, 2004, PHARM RES-DORDR, V21, P1826, DOI 10.1023/B:PHAM.0000045236.60029.cb; Bridson RH, 2007, INT J PHARM, V339, P84, DOI 10.1016/j.ijpharm.2007.02.022; Cordts E, 2012, DRUGS DELIV LUNGS, V23, P146; de Boer AH, 2004, PHARM RES-DORDR, V21, P2167, DOI 10.1007/s11095-004-5171-6; de Boer AH, 2003, INT J PHARMACEUT, V260, P187, DOI 10.1016/S0378-5173(03)00250-3; de Boer AH, 2003, INT J PHARM, V260, P201, DOI 10.1016/S0378-5173(03)00264-3; de Boer AH, 2005, INT J PHARMACEUT, V294, P173, DOI 10.1016/j.ijpharm.2005.01.035; DEVILLIERS MM, 1993, POWDER TECHNOL, V75, P159, DOI 10.1016/0032-5910(93)80077-N; Dickhoff BHJ, 2002, EUR J PHARM BIOPHARM, V54, P245, DOI 10.1016/S0939-6411(02)00082-6; Dickhoff BHJ, 2003, EUR J PHARM BIOPHARM, V56, P291, DOI 10.1016/S0939-6411(03)00109-7; ELAMIN AA, 1994, INT J PHARMACEUT, V111, P159, DOI 10.1016/0378-5173(94)00132-4; HERSEY JA, 1975, POWDER TECHNOL, V11, P41, DOI 10.1016/0032-5910(75)80021-0; HUTTENRAUCH R, 1985, PHARM RES-DORDR, P302, DOI 10.1023/A:1016397719020; Jones MD, 2008, PHARM RES-DORDR, V25, P337, DOI 10.1007/s11095-007-9467-1; Kale K, 2009, EUR J PHARM BIOPHARM, V72, P156, DOI 10.1016/j.ejpb.2008.12.015; KULVANICH P, 1987, J PHARM PHARMACOL, V39, P732, DOI 10.1111/j.2042-7158.1987.tb06978.x; Lacey PMC, 1997, CHEM ENG RES DES, V75, pS49, DOI 10.1016/S0263-8762(97)80004-4; LAM KK, 1991, POWDER TECHNOL, V65, P167, DOI 10.1016/0032-5910(91)80179-M; Le VNP, 2012, EUR J PHARM BIOPHARM, V80, P596, DOI 10.1016/j.ejpb.2011.12.004; Mosharraf M, 2003, DRUG DEV IND PHARM, V29, P603, DOI 10.1081/DDC-120021310; Mosharraf M, 1999, EUR J PHARM SCI, V9, P145, DOI 10.1016/S0928-0987(99)00043-3; Podczeck F, 1996, INT J PHARM, V145, P65, DOI 10.1016/S0378-5173(96)04718-7; Price R, 2010, C LACT CARR INH PROD; Shur J, 2008, PHARM RES-DORDR, V25, P1931, DOI 10.1007/s11095-008-9538-y; STANIFORTH JN, 1987, J PHARM PHARMACOL, V39, P329, DOI 10.1111/j.2042-7158.1987.tb03393.x; Staniforth JN., 1981, INT J PHARM TECH PRO, V2, P7; TRAVERS DN, 1975, POWDER TECHNOL, V12, P189, DOI 10.1016/0032-5910(75)80011-8	27	20	20	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e69263	10.1371/journal.pone.0069263	http://dx.doi.org/10.1371/journal.pone.0069263			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844256	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000188
J	Lavigne, JP; Cuzon, G; Combescure, C; Bourg, G; Sotto, A; Nordmann, P				Lavigne, Jean-Philippe; Cuzon, Gaelle; Combescure, Christophe; Bourg, Gisele; Sotto, Albert; Nordmann, Patrice			Virulence of Klebsiella pneumoniae Isolates Harboring bla(KPC-2) Carbapenemase Gene in a Caenorhabditis elegans Model	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; KPC; PLASMID; EPIDEMIOLOGY; EFFLUX; SPP.	Klebsiella pneumoniae carbapenemase (KPC) is a carbapenemase increasingly reported worldwide in Enterobacteriaceae. The aim of this study was to analyze the virulence of several KPC-2-producing K. pneumoniae isolates. The studied strains were (i) five KPC-2 clinical strains from different geographical origins, belonging to different ST-types and possessing plasmids of different incompatibility groups; (ii) seven transformants obtained after electroporation of either these natural KPC plasmids or a recombinant plasmid harboring only the bla(KPC-2) gene into reference strains K. pneumoniae ATCC10031/CIP53153; and (iii) five clinical strains cured of plasmids. The virulence of K. pneumoniae isolates was evaluated in the Caenorhabditis elegans model. The clinical KPC producers and transformants were significantly less virulent (LT50: 5.5 days) than K. pneumoniae reference strain (LT50: 4.3 days) (p<0.01). However, the worldwide spread KPC-2 positive K. pneumoniae ST258 strains and reference strains containing plasmids extracted from K. pneumoniae ST258 strains had a higher virulence than KPC-2 strains belonging to other ST types (LT50: 5 days vs. 6 days, p<0.01). The increased virulence observed in cured strains confirmed this trend. The bla(KPC-2) gene itself was not associated to increased virulence.	[Lavigne, Jean-Philippe; Bourg, Gisele; Sotto, Albert] Univ Montpellier I, INSERM, U1047, UFR Med, Nimes, France; [Lavigne, Jean-Philippe] CHU Caremeau, Bacteriol Lab, Nimes, France; [Cuzon, Gaelle; Nordmann, Patrice] Univ Paris 11, AP HP Bicetre, INSERM, Serv Bacteriol Virol Hyg,U914, Le Kremlin Bicetre, France; [Combescure, Christophe] Univ Geneva, Div Clin Epidemiol, Geneva, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Nimes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Geneva	Lavigne, JP (corresponding author), Univ Montpellier I, INSERM, U1047, UFR Med, Nimes, France.	jean.philippe.lavigne@chu-nimes.fr	Sotto, Albert/AFJ-9023-2022; Lavigne, Jean-Philippe/E-1756-2014	Lavigne, Jean-Philippe/0000-0002-9484-0304; Sotto, Albert/0000-0002-6463-9386	INSERM, France, Universite de Montpellier 1, La Ville de Nimes; La Region Languedoc Roussillon (Grant "Chercheur d'Avenir"); INSERM; NIH National Center for Research Resources (NCRR)	INSERM, France, Universite de Montpellier 1, La Ville de Nimes; La Region Languedoc Roussillon (Grant "Chercheur d'Avenir")(Region Occitanie); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	INSERM U1047 is supported by INSERM, France, Universite de Montpellier 1, La Ville de Nimes and La Region Languedoc Roussillon (Grant "Chercheur d'Avenir"). INSERM U914 is supported by INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Fer-15 was provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR).	Bialek S, 2010, ANTIMICROB AGENTS CH, V54, P4373, DOI 10.1128/AAC.01607-09; Bratu S, 2005, ARCH INTERN MED, V165, P1430, DOI 10.1001/archinte.165.12.1430; Chmelnitsky I, 2009, J ANTIMICROB CHEMOTH, V64, P718, DOI 10.1093/jac/dkp272; Coudeyras S, 2008, INFECT IMMUN, V76, P4633, DOI 10.1128/IAI.00356-08; DiMartino P, 1997, J CLIN MICROBIOL, V35, P1499, DOI 10.1128/JCM.35.6.1499-1503.1997; El Fertas-Aissani R, 2012, PATHOL BIOL; Endimiani A, 2009, J ANTIMICROB CHEMOTH, V63, P427, DOI 10.1093/jac/dkn547; Frasson I, 2012, J CLIN MICROBIOL, V50, P3768, DOI 10.1128/JCM.01892-12; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Gasink LB, 2009, INFECT CONT HOSP EP, V30, P1180, DOI 10.1086/648451; Kassis-Chikhani N, 2013, ANTIMICROB AGENTS CH, V57, P618, DOI 10.1128/AAC.01712-12; Keynan Y, 2007, INT J ANTIMICROB AG, V30, P385, DOI 10.1016/j.ijantimicag.2007.06.019; Lavigne JP, 2006, CLIN MICROBIOL INFEC, V12, P1199, DOI 10.1111/j.1469-0691.2006.01536.x; Marchaim D, 2008, ANTIMICROB AGENTS CH, V52, P1413, DOI 10.1128/AAC.01103-07; Monteiro J, 2009, ANTIMICROB AGENTS CH, V53, P333, DOI 10.1128/AAC.00736-08; Naas T, 2005, ANTIMICROB AGENTS CH, V49, P4423, DOI 10.1128/AAC.49.10.4423-4424.2005; Naas T, 2008, ANTIMICROB AGENTS CH, V52, P1257, DOI 10.1128/AAC.01451-07; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Padilla E, 2010, ANTIMICROB AGENTS CH, V54, P177, DOI 10.1128/AAC.00715-09; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; Robledo IE, 2010, ANTIMICROB AGENTS CH, V54, P1354, DOI 10.1128/AAC.00899-09; Sahly H, 2008, ANTIMICROB AGENTS CH, V52, P3029, DOI 10.1128/AAC.00010-08; Siu LK, 2012, MICROB DRUG RESIST, V18, P380, DOI 10.1089/mdr.2011.0241; Villegas MV, 2007, ANTIMICROB AGENTS CH, V51, P1553, DOI 10.1128/AAC.01405-06; Villegas MV, 2006, ANTIMICROB AGENTS CH, V50, P2880, DOI 10.1128/AAC.00186-06	26	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67847	10.1371/journal.pone.0067847	http://dx.doi.org/10.1371/journal.pone.0067847			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844109	Green Submitted, Green Published, gold			2022-12-27	WOS:000321341000109
J	Lonskaya, I; Partridge, J; Lalchandani, RR; Chung, A; Lee, T; Vicini, S; Hoe, HS; Lim, ST; Conant, K				Lonskaya, Irina; Partridge, John; Lalchandani, Rupa R.; Chung, Andrew; Lee, Taehee; Vicini, Stefano; Hoe, Hyang-Sook; Lim, Seung T.; Conant, Katherine			Soluble ICAM-5, a Product of Activity Dependent Proteolysis, Increases mEPSC Frequency and Dendritic Expression of GluA1	PLOS ONE			English	Article							LONG-TERM POTENTIATION; AMPA RECEPTOR TRAFFICKING; AMYLOID PRECURSOR PROTEIN; CELL-ADHESION MOLECULES; CENTRAL-NERVOUS-SYSTEM; SYNAPTIC PLASTICITY; MATRIX METALLOPROTEINASES; NMDA RECEPTOR; HIPPOCAMPAL-NEURONS; SPINE ENLARGEMENT	Matrix metalloproteinases (MMPs) are zinc dependent endopeptidases that can be released from neurons in an activity dependent manner to play a role in varied forms of learning and memory. MMP inhibitors impair hippocampal long term potentiation (LTP), spatial memory, and behavioral correlates of drug addiction. Since MMPs are thought to influence LTP through a beta(1) integrin dependent mechanism, it has been suggested that these enzymes cleave specific substrates to generate integrin binding ligands. In previously published work, we have shown that neuronal activity stimulates rapid MMP dependent shedding of intercellular adhesion molecule-5 (ICAM-5), a synaptic adhesion molecule expressed on dendrites of the telencephalon. We have also shown that the ICAM-5 ectodomain can interact with beta(1) integrins to stimulate integrin dependent phosphorylation of cofilin, an event that occurs with dendritic spine maturation and LTP. In the current study, we investigate the potential for the ICAM-5 ectodomain to stimulate changes in alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptor (AMPAR) dependent glutamatergic transmission. Single cell recordings show that the ICAM-5 ectodomain stimulates an increase in the frequency, but not the amplitude, of AMPA mini excitatory post synaptic currents (mEPSCs). With biotinylation and precipitation assays, we also show that the ICAM-5 ectodomain stimulates an increase in membrane levels of GluA1, but not GluA2, AMPAR subunits. In addition, we observe an ICAM-5 associated increase in GluA1 phosphorylation at serine 845. Concomitantly, ICAM-5 affects an increase in GluA1 surface staining along dendrites without affecting an increase in dendritic spine number. Together these data are consistent with the possibility that soluble ICAM-5 increases glutamatergic transmission and that post-synaptic changes, including increased phosphorylation and dendritic insertion of GluA1, could contribute. We suggest that future studies are warranted to determine whether ICAM-5 is one of a select group of synaptic CAMs whose shedding contributes to MMP dependent effects on learning and memory.	[Lonskaya, Irina; Chung, Andrew; Lee, Taehee; Hoe, Hyang-Sook; Lim, Seung T.; Conant, Katherine] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA; [Partridge, John; Vicini, Stefano] Georgetown Univ, Med Ctr, Dept Physiol & Pharmacol, Washington, DC 20007 USA; [Partridge, John; Lalchandani, Rupa R.; Vicini, Stefano; Hoe, Hyang-Sook; Lim, Seung T.; Conant, Katherine] Georgetown Univ, Med Ctr, Interdisciplinary Program Neurosci, Washington, DC 20007 USA	Georgetown University; Georgetown University; Georgetown University	Conant, K (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA.	kec84@georgetown.edu		Vicini, Stefano/0000-0001-8671-5194; Tuan, Rupa Lalchandani/0000-0002-2525-4993	National Multiple Sclerosis Society; National Institutes of Mental Health [MH096822]; von Matsch Professorship in Neurological diseases; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH096822] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); von Matsch Professorship in Neurological diseases; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by the National Multiple Sclerosis Society, the National Institutes of Mental Health (MH096822), and the von Matsch Professorship in Neurological diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson T, 2008, J NEUROPHYSIOL, V100, P2605, DOI 10.1152/jn.90476.2008; Adesnik H, 2007, J NEUROSCI, V27, P4598, DOI 10.1523/JNEUROSCI.0325-07.2007; Alenghat FJ, 2009, J CELL BIOCHEM, V106, P529, DOI 10.1002/jcb.22001; Bajor M, 2013, NEUROCHEM RES, V38, P1113, DOI 10.1007/s11064-012-0919-6; Beique JC, 2006, P NATL ACAD SCI USA, V103, P19535, DOI 10.1073/pnas.0608492103; Bernard-Trifilo JA, 2005, J NEUROCHEM, V93, P834, DOI 10.1111/j.1471-4159.2005.03062.x; Bilousova TV, 2006, J NEUROCHEM, V97, P44, DOI 10.1111/j.1471-4159.2006.03701.x; Bourne J, 2011, RACE CLASS, V52, P1, DOI 10.1177/0306396810392114; Brown TE, 2008, SYNAPSE, V62, P886, DOI 10.1002/syn.20562; Brown Travis E, 2007, Learn Mem, V14, P214, DOI 10.1101/lm.476207; Chan CS, 2006, J NEUROSCI, V26, P223, DOI 10.1523/JNEUROSCI.4110-05.2006; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; Conant K, 2010, NEUROSCIENCE, V166, P508, DOI 10.1016/j.neuroscience.2009.12.061; Conant K, 2012, CURR HIV RES, V10, P384, DOI 10.2174/157016212802138733; Conant K, 2011, J NEUROCHEM, V118, P521, DOI 10.1111/j.1471-4159.2010.07153.x; Dumanis SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017203; Dziembowska M, 2012, J NEUROSCI, V32, P14538, DOI 10.1523/JNEUROSCI.6028-11.2012; Emond MR, 2010, J PHYSIOL-LONDON, V588, P1929, DOI 10.1113/jphysiol.2010.187229; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Furutani Y, 2007, J NEUROSCI, V27, P8866, DOI 10.1523/JNEUROSCI.1047-07.2007; Goel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018264; Gu JP, 2010, NAT NEUROSCI, V13, P1208, DOI 10.1038/nn.2634; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; He KW, 2009, P NATL ACAD SCI USA, V106, P20033, DOI 10.1073/pnas.0910338106; Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009; Howell MD, 2012, NEUROSCIENCE, V217, P6, DOI 10.1016/j.neuroscience.2012.05.034; Huang Z, 2006, J NEUROSCI, V26, P11208, DOI 10.1523/JNEUROSCI.3526-06.2006; Huntley GW, 2012, NAT REV NEUROSCI, V13, P743, DOI 10.1038/nrn3320; Jordan BA, 2009, TRENDS NEUROSCI, V32, P392, DOI 10.1016/j.tins.2009.04.001; Kean MJ, 2009, J CELL SCI, V122, P4089, DOI 10.1242/jcs.052761; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kerrisk ME, 2013, J NEUROSCI, V33, P6742, DOI 10.1523/JNEUROSCI.0528-13.2013; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Kramar EA, 2006, P NATL ACAD SCI USA, V103, P5579, DOI 10.1073/pnas.0601354103; Kwon HB, 2011, NATURE, V474, P100, DOI 10.1038/nature09986; Larsen PH, 2006, J NEUROSCI, V26, P2207, DOI 10.1523/JNEUROSCI.1880-05.2006; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee KJ, 2010, NEUROSCIENCE, V169, P344, DOI 10.1016/j.neuroscience.2010.04.078; Lee KFH, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/704103; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; Lim CJ, 2008, MOL BIOL CELL, V19, P4930, DOI 10.1091/mbc.E08-06-0564; Makino H, 2009, NEURON, V64, P381, DOI 10.1016/j.neuron.2009.08.035; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Matsuno H, 2006, J NEUROSCI, V26, P1776, DOI 10.1523/JNEUROSCI.2651-05.2006; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Meighan PC, 2007, J NEUROCHEM, V102, P2085, DOI 10.1111/j.1471-4159.2007.04682.x; Michaluk P, 2007, J BIOL CHEM, V282, P16036, DOI 10.1074/jbc.M700641200; Michaluk P, 2011, J CELL SCI, V124, P3369, DOI 10.1242/jcs.090852; Milward EA, 2007, J NEUROIMMUNOL, V187, P9, DOI 10.1016/j.jneuroim.2007.04.010; Mortillo S, 2012, J COMP NEUROL, V520, P2041, DOI 10.1002/cne.23027; MURASE K, 1989, NEUROSCI LETT, V103, P56, DOI 10.1016/0304-3940(89)90485-0; Nagy V, 2006, J NEUROSCI, V26, P1923, DOI 10.1523/JNEUROSCI.4359-05.2006; Niedringhaus M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042631; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Ning L, 2013, J CELL SCI, V126, P77, DOI 10.1242/jcs.106674; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Partridge JG, 2009, J NEUROPHYSIOL, V102, P3038, DOI 10.1152/jn.00272.2009; Pauly T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002681; Pozo K, 2012, P NATL ACAD SCI USA, V109, P1323, DOI 10.1073/pnas.1113736109; Rivera S, 2010, J NEUROSCI, V30, P15337, DOI 10.1523/JNEUROSCI.3467-10.2010; Sbai O, 2008, MOL CELL NEUROSCI, V39, P549, DOI 10.1016/j.mcn.2008.08.004; Selcher JC, 2012, BRAIN RES, V1435, P8, DOI 10.1016/j.brainres.2011.11.029; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi Y, 2006, J NEUROSCI, V26, P1813, DOI 10.1523/JNEUROSCI.4091-05.2006; Szepesi Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063314; Tian L, 2007, J CELL BIOL, V178, P687, DOI 10.1083/jcb.200612097; Van Hove I, 2012, J NEUROCHEM, V123, P203, DOI 10.1111/j.1471-4159.2012.07900.x; Wang XB, 2008, P NATL ACAD SCI USA, V105, P19520, DOI 10.1073/pnas.0807248105; Warren MS, 2012, J NEUROSCI, V32, P2824, DOI 10.1523/JNEUROSCI.3942-11.2012; Wiera G, 2013, HIPPOCAMPUS, V23, P529, DOI 10.1002/hipo.22112; Wilczynski GM, 2008, J CELL BIOL, V180, P1021, DOI 10.1083/jcb.200708213	74	32	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e69136	10.1371/journal.pone.0069136	http://dx.doi.org/10.1371/journal.pone.0069136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844251	gold, Green Published, Green Submitted			2022-12-27	WOS:000321341000184
J	Ma, X; Wehland, M; Aleshcheva, G; Hauslage, J; Wasser, K; Hemmersbach, R; Infanger, M; Bauer, J; Grimm, D				Ma, Xiao; Wehland, Markus; Aleshcheva, Ganna; Hauslage, Jens; Wasser, Kai; Hemmersbach, Ruth; Infanger, Manfred; Bauer, Johann; Grimm, Daniela			Interleukin-6 Expression under Gravitational Stress Due to Vibration and Hypergravity in Follicular Thyroid Cancer Cells	PLOS ONE			English	Article							RANDOM POSITIONING MACHINE; PROTEIN-KINASE-C; GENE-EXPRESSION; ENDOTHELIAL-CELLS; GROWTH-FACTOR; SIMULATED MICROGRAVITY; SIGNALING PATHWAYS; PARABOLIC FLIGHT; IL-6 EXPRESSION; CARCINOMA CELLS	It is known that exposing cell lines in vitro to parabolic flights changes their gene expression and protein production patterns. Parabolic flights and spaceflight in general are accompanied by transient hypergravity and vibration, which may impact the cells and therefore, have to be considered too. To estimate the possible impact of transient hypergravity and vibration, we investigated the effects of these forces separately using dedicated ground-based facilities. We placed follicular thyroid ML-1 and CGTH W-1 cancer cells in a specific centrifuge (MuSIC Multi Sample Incubator Centrifuge; SAHC Short Arm Human Centrifuge) simulating the hypergravity phases that occur during one (P1) and 31 parabolas (P31) of parabolic flights, respectively. On the Vibraplex device, the same cell lines were treated with vibration waves corresponding to those that occur during a whole parabolic flight lasting for two hours. After the various treatments, cells were harvested and analyzed by quantitative real-time PCR, focusing on the genes involved in forming (ACTB, MYO9, TUBB, VIM, TLN1, and ITGB1) and modulating (EZR, RDX, and MSN) the cytoskeleton, as well as those encoding growth factors (EGF, CTGF, IL6, and IL8) or protein kinases (PRKAA1 and PRKCA). The analysis revealed alterations in several genes in both cell lines; however, fewer genes were affected in ML-1 than CGTH W-1 cells. Interestingly, IL6 was the only gene whose expression was changed in both cell lines by each treatment, while PKCA transcription remained unaffected in all experiments. We conclude that a PKCa-independent mechanism of IL6 gene activation is very sensitive to physical forces in thyroid cells cultured in vitro as monolayers.	[Ma, Xiao; Grimm, Daniela] Aarhus Univ, Inst Biomed, Aarhus, Denmark; [Wehland, Markus; Aleshcheva, Ganna; Infanger, Manfred; Grimm, Daniela] Otto Von Guericke Univ, Clin Plast Aesthet & Hand Surg, Magdeburg, Germany; [Hauslage, Jens; Wasser, Kai; Hemmersbach, Ruth] German Aerosp Ctr DLR, Inst Aerosp Med, Cologne, Germany; [Bauer, Johann] Max Planck Inst Biochem, D-82152 Martinsried, Germany	Aarhus University; Otto von Guericke University; Helmholtz Association; German Aerospace Centre (DLR); Max Planck Society	Grimm, D (corresponding author), Aarhus Univ, Inst Biomed, Aarhus, Denmark.	daniela.grimm@farm.au.dk		Grimm, Daniela/0000-0002-4991-3105; Wehland, Markus/0000-0002-8160-859X; Hauslage, Jens/0000-0003-2184-7000	German Space Agency DLR [50WB1124]; European Space Agency [CORA-GBF-2010-203, 4000102119]; Aarhus University, Denmark	German Space Agency DLR(Helmholtz AssociationGerman Aerospace Centre (DLR)); European Space Agency(European Space AgencyEuropean Commission); Aarhus University, Denmark	This study was supported by the German Space Agency DLR (BMWi grant 50WB1124), as well as by the European Space Agency (ESA grant CORA-GBF-2010-203 with contract number 4000102119) and Aarhus University, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aust G, 1996, EXP CLIN ENDOCR DIAB, V104, P64, DOI 10.1055/s-0029-1211705; Bin Kwon Y, 2007, J DERMATOL SCI, V46, P91, DOI 10.1016/j.jdermsci.2007.01.007; Bordin L, 2003, BIOCHEMISTRY-US, V42, P4485, DOI 10.1021/bi026842n; Breitkreutz D, 2007, J CANCER RES CLIN, V133, P793, DOI 10.1007/s00432-007-0280-3; Candido J, 2013, J CLIN IMMUNOL, V33, pS79, DOI 10.1007/s10875-012-9847-0; Chung KF, 2006, CURR DRUG TARGETS, V7, P675, DOI 10.2174/138945006777435263; Copland IB, 2007, J CELL PHYSIOL, V210, P133, DOI 10.1002/jcp.20840; Crenshaw HC, 1996, EXP CELL RES, V227, P285, DOI 10.1006/excr.1996.0278; Ershler WB, 2000, ANNU REV MED, V51, P245, DOI 10.1146/annurev.med.51.1.245; Goretzki P E, 1990, Recent Results Cancer Res, V118, P48; Grimm D, 1997, THYROID, V7, P859, DOI 10.1089/thy.1997.7.859; GRIMM D, 1995, THYROID, V5, P155, DOI 10.1089/thy.1995.5.155; Grimm D, 2002, FASEB J, V16, P604, DOI 10.1096/fj.01-0673fje; Grosse J, 2012, FASEB J, V26, P5124, DOI 10.1096/fj.12-215749; Grosse J, 2012, FASEB J, V26, P639, DOI 10.1096/fj.11-194886; GRUBECKLOEBENSTEIN B, 1989, CLIN EXP IMMUNOL, V77, P324; Hammond TG, 1999, NAT MED, V5, P359, DOI 10.1038/7331; Infanger M, 2007, CARDIOVASC PATHOL, V16, P291, DOI 10.1016/j.carpath.2007.04.001; Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Lee CP, 2008, MOL CELL PROTEOMICS, V7, P1297, DOI 10.1074/mcp.M700535-MCP200; Lin JD, 1996, J SURG ONCOL, V63, P112, DOI 10.1002/(SICI)1096-9098(199610)63:2<112::AID-JSO8>3.3.CO;2-4; Ma X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064402; Ma X, 2012, ELECTROPHORESIS, V33, P1349, DOI 10.1002/elps.201100598; Mackay DJG, 1997, J CELL BIOL, V138, P927, DOI 10.1083/jcb.138.4.927; Neisch AL, 2011, CURR OPIN CELL BIOL, V23, P377, DOI 10.1016/j.ceb.2011.04.011; Nelson PT, 2007, J NEUROPATH EXP NEUR, V66, P461, DOI 10.1097/01.jnen.0000240474.27791.f3; Park CC, 2009, EXPERT REV PROTEOMIC, V6, P243, DOI 10.1586/EPR.09.46; Pietsch J, 2013, INT J MOL SCI, V14, P1164, DOI 10.3390/ijms14011164; Pietsch J, 2012, PROTEOMICS, V12, P2539, DOI 10.1002/pmic.201200070; Pietsch J, 2011, PROTEOMICS, V11, P2095, DOI 10.1002/pmic.201000817; Pietsch J, 2011, MICROGRAVITY SCI TEC, V23, P381, DOI 10.1007/s12217-011-9258-5; Populo H, 2012, INT J MOL SCI, V13, P1886, DOI 10.3390/ijms13021886; Riecke K, 2002, ARCH TOXICOL, V76, P360, DOI 10.1007/s00204-002-0338-6; Rothermund L, 2002, AM J HYPERTENS, V15, P644, DOI 10.1016/S0895-7061(02)02956-4; Schmidt W, 2004, MICROGRAVITY SCI TEC, V15, P42, DOI 10.1007/BF02870951; Schonberger J, 2000, J MOL MED, V78, P102, DOI 10.1007/s001090000085; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sugihara E, 2013, INT J CANCER, V132, P1249, DOI 10.1002/ijc.27961; Szabo-Fresnais N, 2008, MOL CELL ENDOCRINOL, V284, P28, DOI 10.1016/j.mce.2007.12.017; Ulbrich C, 2008, J CELL BIOCHEM, V104, P1324, DOI 10.1002/jcb.21710; Ulbrich C, 2011, CELL PHYSIOL BIOCHEM, V28, P185, DOI 10.1159/000331730; van Loon JJWA, 2007, ADV SPACE RES, V39, P1161, DOI 10.1016/j.asr.2007.02.016; Wehland M, 2013, CELL PHYSIOL BIOCHEM, V31, P432, DOI 10.1159/000343380; Wise GE, 2003, J DENT RES, V82, P298, DOI 10.1177/154405910308200411; Zampetaki A, 2005, AM J PHYSIOL-HEART C, V288, pH2946, DOI 10.1152/ajpheart.00919.2004	47	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68140	10.1371/journal.pone.0068140	http://dx.doi.org/10.1371/journal.pone.0068140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844163	Green Submitted, Green Published, gold			2022-12-27	WOS:000321341000139
J	Wang, ZJ; Dong, YC; Desneux, N; Niu, CY				Wang, Zhijian; Dong, Yongcheng; Desneux, Nicolas; Niu, Changying			RNAi Silencing of the HaHMG-CoA Reductase Gene Inhibits Oviposition in the Helicoverpa armigera Cotton Bollworm	PLOS ONE			English	Article							COENZYME-A REDUCTASE; JUVENILE-HORMONE BIOSYNTHESIS; BOMBYX-MORI; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; PHEROMONE BIOSYNTHESIS; MEVALONATE PATHWAY; MOLECULAR-CLONING; GERMAN-COCKROACH; IPS-PINI; EXPRESSION	RNA interference (RNAi) has considerable promise for developing novel pest control techniques, especially because of the threat of the development of resistance against current strategies. For this purpose, the key is to select pest control genes with the greatest potential for developing effective pest control treatments. The present study demonstrated that the 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA reductase; HMGR) gene is a potential target for insect control using RNAi. HMGR is a key enzyme in the mevalonate pathway in insects. A complete cDNA encoding full length HMGR (encoding an 837-aa protein) was cloned from Helicoverpa armigera (Lepidoptera: Noctuidae). The HaHMGR (H. armigera HMGR) knockdown using systemic RNAi in vivo inhibited the fecundity of the females, effectively inhibited ovipostion, and significantly reduced vitellogenin (Vg) mRNA levels. Moreover, the oviposition rate of the female moths was reduced by 98% by silencing HaHMGR compared to the control groups. One-pair experiments showed that both the proportions of valid mating and fecundity were zero. Furthermore, the HaHMGR-silenced females failed to lay eggs (approximate 99% decrease in oviposition) in the semi-field cage performance. The present study demonstrated the potential implications for developing novel pest management strategies using HaHMGR RNAi in the control of H. armigera and other insect pests.	[Wang, Zhijian; Dong, Yongcheng; Niu, Changying] Huazhong Agr Univ, Hubei Key Lab Insect Resource Applicat & Sustaina, Plant Sci & Technol Coll, Wuhan, Peoples R China; [Desneux, Nicolas] French Natl Inst Agr Res INRA, Sophia Antipolis, France	Huazhong Agricultural University; INRAE	Niu, CY (corresponding author), Huazhong Agr Univ, Hubei Key Lab Insect Resource Applicat & Sustaina, Plant Sci & Technol Coll, Wuhan, Peoples R China.	niuchangying88@163.com	Dong, YongCheng/ABG-7107-2021; Desneux, Nicolas/J-6262-2013		National Natural Science Foundation of China [IBN-31071690]; Fundamental Research Funds for the Central Universities [2011PY055]; International Atomic Energy Agency [16015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); International Atomic Energy Agency(International Atomic Energy Agency)	This study was financially supported by the National Natural Science Foundation of China (grant IBN-31071690), the Fundamental Research Funds for the Central Universities (2011PY055), and International Atomic Energy Agency (via Research Contract No. 16015 to CN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belles X, 2005, ANNU REV ENTOMOL, V50, P181, DOI 10.1146/annurev.ento.50.071803.130356; BJOSTAD LB, 1984, INSECT BIOCHEM, V14, P275, DOI 10.1016/0020-1790(84)90060-X; Bochar DA, 1999, MOL GENET METAB, V66, P122, DOI 10.1006/mgme.1998.2786; Burse A, 2008, INSECT BIOCHEM MOLEC, V38, P76, DOI 10.1016/j.ibmb.2007.09.006; Chandler D, 2011, PHILOS T R SOC B, V366, P1987, DOI 10.1098/rstb.2010.0390; CLARK AJ, 1959, J BIOL CHEM, V234, P2578; Duportets L, 2000, INSECT MOL BIOL, V9, P385, DOI 10.1046/j.1365-2583.2000.00200.x; Eigenheer AL, 2003, GENE, V316, P127, DOI 10.1016/S0378-1119(03)00749-2; FEYEREISEN R, 1987, MOL CELL ENDOCRINOL, V53, P227, DOI 10.1016/0303-7207(87)90178-X; FEYEREISEN R, 1987, J BIOL CHEM, V262, P2676; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FONAGY A, 1992, J PESTIC SCI, V17, P47; GERTLER FB, 1988, MOL CELL BIOL, V8, P2713, DOI 10.1128/MCB.8.7.2713; Gong L, 2012, B ENTOMOL RES, V102, P600, DOI 10.1017/S0007485312000168; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Keeling CI, 2004, NATURWISSENSCHAFTEN, V91, P324, DOI 10.1007/s00114-004-0523-y; Kinjoh T, 2007, INSECT BIOCHEM MOLEC, V37, P808, DOI 10.1016/j.ibmb.2007.03.008; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MARTINEZGONZALEZ J, 1993, EUR J BIOCHEM, V213, P233, DOI 10.1111/j.1432-1033.1993.tb17753.x; MONGER DJ, 1982, J BIOL CHEM, V257, P1921; NIJHOUT HF, 1994, INSECT HORMONES, P267; OLENDER EH, 1992, J BIOL CHEM, V267, P4223; OZAWA R, 1995, REGUL PEPTIDES, V57, P319, DOI 10.1016/0167-0115(95)00045-D; Santos AC, 2004, DEV CELL, V6, P283, DOI 10.1016/S1534-5807(04)00023-1; Shahraki GH, 2011, NEOTROP ENTOMOL, V40, P607, DOI 10.1590/S1519-566X2011000500013; Shakesby AJ, 2009, INSECT BIOCHEM MOLEC, V39, P1, DOI 10.1016/j.ibmb.2008.08.008; Sheng ZT, 2008, ARCH INSECT BIOCHEM, V69, P143, DOI 10.1002/arch.20268; Tao XY, 2012, MOL ECOL, V21, P4371, DOI 10.1111/j.1365-294X.2012.05548.x; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Tittiger C, 1999, CELL MOL LIFE SCI, V55, P121, DOI 10.1007/s000180050275; Tittiger C, 2003, MOL CELL ENDOCRINOL, V199, P11, DOI 10.1016/S0303-7207(02)00358-1; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; Van Doren M, 1998, NATURE, V396, P466, DOI 10.1038/24871; Zapata R, 2003, PEST MANAG SCI, V59, P1111, DOI 10.1002/ps.736; Zapata R, 2002, ARCH INSECT BIOCHEM, V49, P177, DOI 10.1002/arch.10018; Zhao J, 2010, INSECT BIOCHEM MOLEC, V40, P113, DOI 10.1016/j.ibmb.2010.01.001	37	40	47	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67732	10.1371/journal.pone.0067732	http://dx.doi.org/10.1371/journal.pone.0067732			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844078	gold, Green Published, Green Submitted			2022-12-27	WOS:000321341000087
J	Diwan, V; Lundborg, CS; Tamhankar, AJ				Diwan, Vishal; Lundborg, Cecilia Stalsby; Tamhankar, Ashok J.			Seasonal and Temporal Variation in Release of Antibiotics in Hospital Wastewater: Estimation Using Continuous and Grab Sampling	PLOS ONE			English	Article							VETERINARY ANTIBIOTICS; AQUATIC ENVIRONMENT; SOUTH CHINA; WASTEWATERS; MATRICES; INDIA; IDENTIFICATION; CIPROFLOXACIN; SPECTROMETRY; SUBSTANCES	The presence of antibiotics in the environment and their subsequent impact on resistance development has raised concerns globally. Hospitals are a major source of antibiotics released into the environment. To reduce these residues, research to improve knowledge of the dynamics of antibiotic release from hospitals is essential. Therefore, we undertook a study to estimate seasonal and temporal variation in antibiotic release from two hospitals in India over a period of two years. For this, 6 sampling sessions of 24 hours each were conducted in the three prominent seasons of India, at all wastewater outlets of the two hospitals, using continuous and grab sampling methods. An in-house wastewater sampler was designed for continuous sampling. Eight antibiotics from four major antibiotic groups were selected for the study. To understand the temporal pattern of antibiotic release, each of the 24-hour sessions were divided in three sub-sampling sessions of 8 hours each. Solid phase extraction followed by liquid chromatography/tandem mass spectrometry (LC-MS/MS) was used to determine the antibiotic residues. Six of the eight antibiotics studied were detected in the wastewater samples. Both continuous and grab sampling methods indicated that the highest quantities of fluoroquinolones were released in winter followed by the rainy season and the summer. No temporal pattern in antibiotic release was detected. In general, in a common timeframe, continuous sampling showed less concentration of antibiotics in wastewater as compared to grab sampling. It is suggested that continuous sampling should be the method of choice as grab sampling gives erroneous results, it being indicative of the quantities of antibiotics present in wastewater only at the time of sampling. Based on our studies, calculations indicate that from hospitals in India, an estimated 89, 1 and 25 ng/L/day of fluroquinolones, metronidazole and sulfamethoxazole respectively, might be getting released into the environment per 100 hospital beds.	[Diwan, Vishal; Lundborg, Cecilia Stalsby; Tamhankar, Ashok J.] Karolinska Inst, Dept Publ Hlth Sci, Global Hlth IHCAR, Stockholm, Sweden; [Diwan, Vishal] RD Gardi Med Coll, Dept Publ Hlth & Environm, Ujjain, Madhya Pradesh, India; [Tamhankar, Ashok J.] RD Gardi Med Coll, Dept Environm Med, IIMAR, Ujjain, Madhya Pradesh, India	Karolinska Institutet	Diwan, V (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Global Hlth IHCAR, Stockholm, Sweden.	vishaldiwan@hotmail.com		Stalsby Lundborg, Cecilia/0000-0001-6525-1861; Tamhankar, Ashok/0000-0003-0731-1680; Diwan, Vishal/0000-0001-7948-8579	Swedish Research Council [K2007-70X-20514-01-3]; Asia Link [348-2006-6633]; Erasmus Mundus External Cooperation Window India-Lot 15; Swedish Institute	Swedish Research Council(Swedish Research CouncilEuropean Commission); Asia Link; Erasmus Mundus External Cooperation Window India-Lot 15; Swedish Institute	This study was funded by the Swedish Research Council (K2007-70X-20514-01-3) and Asia Link (348-2006-6633). VD is a recipient of scholarships from Erasmus Mundus External Cooperation Window India-Lot 15 and the Swedish Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beausse J, 2004, TRAC-TREND ANAL CHEM, V23, P753, DOI 10.1016/j.trac.2004.08.005; Brown KD, 2006, SCI TOTAL ENVIRON, V366, P772, DOI 10.1016/j.scitotenv.2005.10.007; Diwan V, 2009, INDIA CURRENT SCI, V97, P1753; Diwan V, 2012, J ANTIMICROB CHEMOTH, V67, P857, DOI 10.1093/jac/dkr564; Diwan V, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-414; Eurachem, FITN PURP AN METH; Group GARP-INW, 2011, SIT AN ANT US RES IN; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Hartmann A, 1999, ARCH ENVIRON CON TOX, V36, P115, DOI 10.1007/s002449900449; Hoang TTT, 2011, ENVIRON SCI POLLUT R, V18, P835, DOI 10.1007/s11356-011-0475-7; Duong HA, 2008, CHEMOSPHERE, V72, P968, DOI 10.1016/j.chemosphere.2008.03.009; Huang C.H., 2011, J CONT WATER RES ED, V1, P324, DOI [10.1142/9789812799555_0004, DOI 10.1142/9789812799555_0004]; ICH Topic QB, 1996, VAL AN PROC METH STE; Jiang L, 2011, CHEMOSPHERE, V82, P822, DOI 10.1016/j.chemosphere.2010.11.028; Karthikeyan KG, 2006, SCI TOTAL ENVIRON, V361, P196, DOI 10.1016/j.scitotenv.2005.06.030; Kim SC, 2007, ENVIRON SCI TECHNOL, V41, P50, DOI 10.1021/es060737+; Kotwani A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-99; Kummerer K, 2009, CHEMOSPHERE, V75, P417, DOI 10.1016/j.chemosphere.2008.11.086; Kummerer K, 2009, CHEMOSPHERE, V75, P435, DOI 10.1016/j.chemosphere.2008.12.006; Kummerer K, 2001, CHEMOSPHERE, V45, P957, DOI 10.1016/S0045-6535(01)00144-8; Leung HW, 2012, ENVIRON INT, V42, P1, DOI 10.1016/j.envint.2011.03.004; Lindberg R, 2004, CHEMOSPHERE, V57, P1479, DOI 10.1016/j.chemosphere.2004.09.015; Martins AF, 2008, CLEAN-SOIL AIR WATER, V36, P264, DOI 10.1002/clen.200700171; Pathak A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038641; Pena A, 2010, ANAL BIOANAL CHEM, V396, P2929, DOI 10.1007/s00216-010-3581-3; Segura PA, 2009, ENVIRON HEALTH PERSP, V117, P675, DOI 10.1289/ehp.11776; Sui Q, 2012, CHEMOSPHERE, V89, P280, DOI 10.1016/j.chemosphere.2012.04.037; Suzuki S, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00067; Xu Wei-hai, 2006, Huanjing Kexue, V27, P2458; Zhou LJ, 2012, J CHROMATOGR A, V1244, P123, DOI 10.1016/j.chroma.2012.04.076	30	36	36	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68715	10.1371/journal.pone.0068715	http://dx.doi.org/10.1371/journal.pone.0068715			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861936	Green Published, Green Submitted, gold			2022-12-27	WOS:000321692000031
J	Tagliabue, M; McIntyre, J				Tagliabue, Michele; McIntyre, Joseph			When Kinesthesia Becomes Visual: A Theoretical Justification for Executing Motor Tasks in Visual Space	PLOS ONE			English	Article							MULTISENSORY SPATIAL REPRESENTATIONS; POSTERIOR CORPUS-CALLOSUM; EYE-HAND COORDINATION; REFERENCE FRAMES; PROPRIOCEPTIVE LOCALIZATION; INTERHEMISPHERIC-TRANSFER; POSITION-INFORMATION; INTERMANUAL TRANSFER; SENSORIMOTOR CONTROL; SENSORY INTEGRATION	Several experimental studies in the literature have shown that even when performing purely kinesthetic tasks, such as reaching for a kinesthetically felt target with a hidden hand, the brain reconstructs a visual representation of the movement. In our previous studies, however, we did not observe any role of a visual representation of the movement in a purely kinesthetic task. This apparent contradiction could be related to a fundamental difference between the studied tasks. In our study subjects used the same hand to both feel the target and to perform the movement, whereas in most other studies, pointing to a kinesthetic target consisted of pointing with one hand to the finger of the other, or to some other body part. We hypothesize, therefore, that it is the necessity of performing inter-limb transformations that induces a visual representation of purely kinesthetic tasks. To test this hypothesis we asked subjects to perform the same purely kinesthetic task in two conditions: INTRA and INTER. In the former they used the right hand to both perceive the target and to reproduce its orientation. In the latter, subjects perceived the target with the left hand and responded with the right. To quantify the use of a visual representation of the movement we measured deviations induced by an imperceptible conflict that was generated between visual and kinesthetic reference frames. Our hypothesis was confirmed by the observed deviations of responses due to the conflict in the INTER, but not in the INTRA, condition. To reconcile these observations with recent theories of sensori-motor integration based on maximum likelihood estimation, we propose here a new model formulation that explicitly considers the effects of covariance between sensory signals that are directly available and internal representations that are 'reconstructed' from those inputs through sensori-motor transformations.	[Tagliabue, Michele; McIntyre, Joseph] Univ Paris 05, Inst Neurosci & Cognit, Sorbonne Paris Cite, Ctr Etud Sensorimotricite,CNRS,UMR 8194, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Tagliabue, M (corresponding author), Univ Paris 05, Inst Neurosci & Cognit, Sorbonne Paris Cite, Ctr Etud Sensorimotricite,CNRS,UMR 8194, Paris, France.	michele.tagliabue@parisdescartes.fr	McIntyre, Joseph/K-6395-2015	McIntyre, Joseph/0000-0003-4974-4257	French space agency (Centre national d'etudes spatiales)	French space agency (Centre national d'etudes spatiales)(Centre National D'etudes Spatiales)	This work was supported by the French space agency (Centre national d'etudes spatiales). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamovich SV, 1998, J NEUROPHYSIOL, V79, P2833, DOI 10.1152/jn.1998.79.6.2833; APPELLE S, 1972, PSYCHOL BULL, V78, P266, DOI 10.1037/h0033117; Baud-Bovy G, 1998, J NEUROSCI, V18, P1528; Baud-Bovy G, 2004, EXP BRAIN RES, V157, P197, DOI 10.1007/s00221-004-1833-1; Bays PM, 2007, J PHYSIOL-LONDON, V578, P387, DOI 10.1113/jphysiol.2006.120121; Beurze SM, 2006, J NEUROPHYSIOL, V96, P352, DOI 10.1152/jn.01362.2005; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; Burns JK, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00221; Charron JF, 1996, NEUROPSYCHOLOGIA, V34, P873, DOI 10.1016/0028-3932(96)00002-4; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fabri M, 2005, COGNITIVE BRAIN RES, V24, P73, DOI 10.1016/j.cogbrainres.2004.12.003; Fabri M, 2001, J COGNITIVE NEUROSCI, V13, P1071, DOI 10.1162/089892901753294365; Fiehler K, 2010, EXP BRAIN RES, V203, P485, DOI 10.1007/s00221-010-2251-1; FLANDERS M, 1992, BEHAV BRAIN SCI, V15, P309, DOI 10.1017/S0140525X00068813; Ghahramani Z, 1997, ADV PSYCHOL, V119, P117; Goble DJ, 2008, J NEUROPHYSIOL, V99, P3063, DOI 10.1152/jn.90259.2008; Henriques DYP, 1998, J NEUROSCI, V18, P1583; Howard I. P., 1982, HUMAN VISUAL ORIENTA; Jones SAH, 2012, NEUROPSYCHOLOGIA, V50, P1462, DOI 10.1016/j.neuropsychologia.2012.02.031; Jones SAH, 2010, EXP BRAIN RES, V204, P373, DOI 10.1007/s00221-009-2079-8; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Luyat M, 2005, NEUROSCI LETT, V385, P215, DOI 10.1016/j.neulet.2005.05.044; McGuire LMM, 2009, NAT NEUROSCI, V12, P1056, DOI 10.1038/nn.2357; McIntyre J, 1998, J NEUROSCI, V18, P8423, DOI 10.1523/JNEUROSCI.18-20-08423.1998; McIntyre J, 1997, J NEUROPHYSIOL, V78, P1601, DOI 10.1152/jn.1997.78.3.1601; McIntyre J, 2008, J NEUROSCI, V28, P1246, DOI 10.1523/JNEUROSCI.2066-07.2008; MonWilliams M, 1997, P ROY SOC B-BIOL SCI, V264, P1007, DOI 10.1098/rspb.1997.0139; Nefs HT, 2005, EXP BRAIN RES, V163, P123, DOI 10.1007/s00221-005-2227-8; O'Reilly JX, 2012, EUR J NEUROSCI, V35, P1169, DOI 10.1111/j.1460-9568.2012.08010.x; Oruc I, 2003, VISION RES, V43, P2451, DOI 10.1016/S0042-6989(03)00435-8; Pouget A, 2002, NAT REV NEUROSCI, V3, P741, DOI 10.1038/nrn914; Pouget A, 2002, COGNITION, V83, pB1, DOI 10.1016/S0010-0277(01)00163-9; Rao AK, 2001, EXP BRAIN RES, V138, P438, DOI 10.1007/s002210100717; Sabes PN, 2011, PROG BRAIN RES, V191, P195, DOI 10.1016/B978-0-444-53752-2.00004-7; Sarlegna FR, 2007, EXP BRAIN RES, V176, P267, DOI 10.1007/s00221-006-0613-5; Schlicht EJ, 2007, J NEUROPHYSIOL, V97, P4203, DOI 10.1152/jn.00160.2007; Sober SJ, 2005, NAT NEUROSCI, V8, P490, DOI 10.1038/nn1427; Soechting J F, 1990, J Cogn Neurosci, V2, P32, DOI 10.1162/jocn.1990.2.1.32; SOECHTING JF, 1989, J NEUROPHYSIOL, V62, P595, DOI 10.1152/jn.1989.62.2.595; Sternad D, 2007, EXP BRAIN RES, V176, P559, DOI 10.1007/s00221-006-0640-2; Tagliabue M, 2012, NEUROSCI LETT, V513, P78, DOI 10.1016/j.neulet.2012.02.011; Tagliabue M, 2011, J NEUROSCI, V31, P1397, DOI 10.1523/JNEUROSCI.0623-10.2011; TILLERY SIH, 1991, J NEUROSCI, V11, P770; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; van Beers RJ, 1998, EXP BRAIN RES, V122, P367, DOI 10.1007/s002210050525; van der Horst BJ, 2008, EXP BRAIN RES, V187, P491, DOI 10.1007/s00221-008-1390-0; vanBeers RJ, 1996, EXP BRAIN RES, V111, P253, DOI 10.1007/BF00227302	48	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68438	10.1371/journal.pone.0068438	http://dx.doi.org/10.1371/journal.pone.0068438			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861903	Green Submitted, gold, Green Published			2022-12-27	WOS:000321425300062
J	Teruel, M; McKinney, C; Balsa, A; Pascual-Salcedo, D; Rodriguez-Rodriguez, L; Ortiz, AM; Gomez-Vaquero, C; Gonzalez-Gay, MA; Smith, M; Witte, T; Merriman, T; Lie, BA; Martin, J				Teruel, Maria; McKinney, Cushla; Balsa, Alejandro; Pascual-Salcedo, Dora; Rodriguez-Rodriguez, Luis; Ortiz, Ana M.; Gomez-Vaquero, Carmen; Gonzalez-Gay, Miguel A.; Smith, Malcolm; Witte, Torsten; Merriman, Tony; Lie, Benedicte A.; Martin, Javier			Association of CD247 Polymorphisms with Rheumatoid Arthritis: A Replication Study and a Meta-Analysis	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; GENOME-WIDE ASSOCIATION; T-CELLS; EXPRESSION; GENE; RISK	Given the role of CD247 in the response of the T cells, its entailment in autoimmune diseases and in order to better clarify the role of this gene in RA susceptibility, we aimed to analyze CD247 gene variants previously associated with other autoimmune diseases (rs1052237, rs2056626 and rs864537) in a large independent European Caucasian population. However, no evidence of association was found for the analyzed CD247 single-nucleotide polymorphisms (SNPs) with RA and with the presence/absence of anti-cyclic citrullinated polypeptide. We performed a meta-analysis including previously published GWAS data from the rs864537 variant, revealing an overall genome-wide significant association between this CD247 SNP and RA with anti-CCP (OR = 0.90, CI 95% = 0.87-0.93, P-overall = 2.1x10(-10)). Our results show for first time a GWAS-level association between this CD247 polymorphism and RA risk.	[Teruel, Maria; Martin, Javier] Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [McKinney, Cushla; Merriman, Tony] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Balsa, Alejandro; Pascual-Salcedo, Dora] Hosp Univ La Paz, Rheumatol Serv, Madrid, Spain; [Rodriguez-Rodriguez, Luis] Hosp Clin San Carlos, Rheumatol Serv, Madrid, Spain; [Ortiz, Ana M.] Hosp Univ La Princesa, Inst Invest Sanitaria Princesa, Rheumatol Serv, Madrid, Spain; [Gomez-Vaquero, Carmen] Hosp Univ Bellvitge, Rheumatol Serv, Barcelona, Spain; [Gonzalez-Gay, Miguel A.] Hosp Univ Marques de Valdecilla, Div Rheumatol, Santander, Spain; [Smith, Malcolm] Flinders Med Ctr, Dept Med, Adelaide, SA, Australia; [Smith, Malcolm] Repatriat Gen Hosp, Adelaide, SA, Australia; [Witte, Torsten] Sch Med, Clin Immunol & Rheumatol, Hannover, Germany; [Lie, Benedicte A.] Univ Oslo, Dept Med Genet, Oslo, Norway; [Lie, Benedicte A.] Oslo Univ Hosp, Oslo, Norway	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Otago; Hospital Universitario La Paz; Hospital Clinico San Carlos; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Hospital Universitario Marques de Valdecilla (HUMV); Flinders Medical Centre; Flinders University South Australia; University of Oslo; University of Oslo	Teruel, M (corresponding author), Inst Parasitol & Biomed Lopez Neyra, Granada, Spain.	mteruel@ipb.csic.es	Martín, Javier/AAV-5209-2021; McKinney, Cushla/A-7407-2012; Martín, María/HDL-9512-2022; Martin, Javier/B-8141-2008; González-Gay, Miguel A./B-2306-2008; Balsa, Alejandro/ABF-6456-2020; Rodriguez-Rodriguez, Luis/H-5880-2013; Witte, Torsten/B-5783-2016; Teruel, Maria/V-3205-2017	McKinney, Cushla/0000-0002-7051-6876; Martin, Javier/0000-0002-2202-0622; González-Gay, Miguel A./0000-0002-7924-7406; Rodriguez-Rodriguez, Luis/0000-0002-2869-7861; Teruel, Maria/0000-0002-5315-2660; Merriman, Tony/0000-0003-0844-8726	Instituto de Salud Carlos III (ISCIII) [RD12/0009/0004]; European IMI BTCure Program; Ministerio Economia y Competividad [JCI-2010-08227]	Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); European IMI BTCure Program; Ministerio Economia y Competividad	This work was supported by two Spanish grants from RETICS Program, RD12/0009/0004 (RIER) from Instituto de Salud Carlos III (ISCIII), within the VI PN de I+D+i 2008-2011 (FEDER) and also by grants from the European IMI BTCure Program. MT was supported by Ministerio Economia y Competividad through the program Juan de la Cierva (JCI-2010-08227). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Berg L, 2000, CLIN EXP IMMUNOL, V120, P174, DOI 10.1046/j.1365-2249.2000.01180.x; Dieude P, 2011, ANN RHEUM DIS, V70, P1695, DOI 10.1136/ard.2010.147009; Gorman CL, 2008, J IMMUNOL, V180, P1060, DOI 10.4049/jimmunol.180.2.1060; Matsuda M, 1998, SCAND J IMMUNOL, V47, P254; Maurice MM, 1997, J IMMUNOL, V159, P2973; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Radstake TRDJ, 2010, NAT GENET, V42, P426, DOI 10.1038/ng.565; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Takeuchi T, 2004, INT REV IMMUNOL, V23, P273, DOI 10.1080/08830180490452594; Takeuchi T, 2012, ANN RHEUM DIS, V71, P78, DOI 10.1136/annrheumdis-2011-200641; Warchol T, 2009, TISSUE ANTIGENS, V74, P68, DOI 10.1111/j.1399-0039.2009.01264.x; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004	15	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68295	10.1371/journal.pone.0068295	http://dx.doi.org/10.1371/journal.pone.0068295			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861880	Green Published, gold, Green Submitted			2022-12-27	WOS:000321425300056
J	Xia, J; Zhang, CR; Zhang, S; Li, FF; Feng, MG; Wang, XW; Liu, SS				Xia, Jun; Zhang, Chang-Rong; Zhang, Shan; Li, Fang-Fang; Feng, Ming-Guang; Wang, Xiao-Wei; Liu, Shu-Sheng			Analysis of Whitefly Transcriptional Responses to Beauveria bassiana Infection Reveals New Insights into Insect-Fungus Interactions	PLOS ONE			English	Article							GENE-EXPRESSION ANALYSIS; DNA-REPAIR PROTEINS; BEMISIA-TABACI; ENTOMOPATHOGENIC FUNGUS; ABC TRANSPORTER; IMMUNE-RESPONSE; METARHIZIUM-ANISOPLIAE; ACYRTHOSIPHON-PISUM; QUANTITATIVE PCR; ISOCITRATE LYASE	Background: The fungal pathogen, Beauveria bassiana, is an efficient biocontrol agent against a variety of agricultural pests. A thorough understanding of the basic principles of insect-fungus interactions may enable the genetic modification of Beauveria bassiana to enhance its virulence. However, the molecular mechanism of insect response to Beauveria bassiana infection is poorly understood, let alone the identification of fungal virulent factors involved in pathogenesis. Methodology/Principal Findings: Here, next generation sequencing technology was applied to examine the expression of whitefly (Bemisia tabaci) genes in response to the infection of Beauveria bassiana. Results showed that, compared to control, 654 and 1,681 genes were differentially expressed at 48 hours and 72 hours post-infected whiteflies, respectively. Functional and enrichment analyses indicated that the DNA damage stimulus response and drug metabolism were important anti-fungi strategies of the whitefly. Mitogen-activated protein kinase (MAPK) pathway was also likely involved in the whitefly defense responses. Furthermore, the notable suppression of general metabolism and ion transport genes observed in 72 hours post-infected B. tabaci might be manipulated by fungal secreted effectors. By mapping the sequencing tags to B. bassiana genome, we also identified a number of differentially expressed fungal genes between the early and late infection stages. These genes are generally associated with fungal cell wall synthesis and energy metabolism. The expression of fungal cell wall protein genes might play an important role in fungal pathogenesis and the dramatically up-regulated enzymes of carbon metabolism indicate the increasing usage of energy during the fungal infection. Conclusions/Significance: To our knowledge, this is the first report on the molecular mechanism of fungus-whitefly interactions. Our results provide a road map for future investigations on insect-pathogen interactions and genetically modifying the fungus to enhance its efficiency in whitefly control.	[Xia, Jun; Zhang, Chang-Rong; Zhang, Shan; Li, Fang-Fang; Wang, Xiao-Wei; Liu, Shu-Sheng] Inst Insect Sci, Minist Agr, Key Lab Agr Entomol, Hangzhou, Zhejiang, Peoples R China; [Feng, Ming-Guang] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Ministry of Agriculture & Rural Affairs; Zhejiang University	Wang, XW (corresponding author), Inst Insect Sci, Minist Agr, Key Lab Agr Entomol, Hangzhou, Zhejiang, Peoples R China.	xwwang@zju.edu.cn; shshliu@zju.edu.cn			Fundamental Research Funds for the Central Universities [2013FZA6013]; National Natural Science Foundation of China [31021003]; National Basic Research Program of China [2009CB119203]; Qianjiang Talent Plan [2011R10012]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Qianjiang Talent Plan	This work was supported by the Fundamental Research Funds for the Central Universities (no. 2013FZA6013), the National Natural Science Foundation of China (31021003), the National Basic Research Program of China (2009CB119203) and the Qianjiang Talent Plan (2011R10012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2005, INSECT BIOCHEM MOLEC, V35, P709, DOI 10.1016/j.ibmb.2005.02.019; Alleyne M, 1997, J INSECT PHYSIOL, V43, P143, DOI 10.1016/S0022-1910(96)00090-X; Altincicek B, 2008, INSECT MOL BIOL, V17, P711, DOI 10.1111/j.1365-2583.2008.00835.x; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; Boyce JD, 2009, INFECT IMMUN, V77, P1532, DOI 10.1128/IAI.01144-08; Brown J.K., 2007, APSNET FEATUR, V1, P25, DOI [10.1094/APSnetFeature-2007-0107, DOI 10.1094/APSNETFEATURE-2007-0107, DOI 10.1094/APSNETFEATURE-2007-010]; Brown JK, 2002, ADV BOT RES, V36, P65, DOI 10.1016/S0065-2296(02)36059-2; Chen JM, 2010, P NATL ACAD SCI USA, V107, P20774, DOI 10.1073/pnas.1009223107; Chengxiang H, 2011, GENE, V484, P35, DOI 10.1016/j.gene.2011.05.023; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Clarkson JM, 1996, TRENDS MICROBIOL, V4, P197, DOI 10.1016/0966-842X(96)10022-6; Collette JR, 2011, CURR OPIN MICROBIOL, V14, P668, DOI 10.1016/j.mib.2011.09.007; Dalton R, 2006, NATURE, V443, P898, DOI 10.1038/443898a; Daniel C, 2010, J APPL ENTOMOL, V134, P675, DOI 10.1111/j.1439-0418.2009.01486.x; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Dong YM, 2012, INSECT BIOCHEM MOLEC, V42, P126, DOI 10.1016/j.ibmb.2011.11.005; Dunn MF, 2009, MICROBIOL-SGM, V155, P3166, DOI 10.1099/mic.0.030858-0; Padilla-Guerrero IE, 2011, MICROBIOL-SGM, V157, P199, DOI 10.1099/mic.0.042697-0; Fan YH, 2007, APPL ENVIRON MICROB, V73, P295, DOI 10.1128/AEM.01974-06; Fang WG, 2010, FUNGAL GENET BIOL, V47, P602, DOI 10.1016/j.fgb.2010.03.011; Farenhorst M, 2009, P NATL ACAD SCI USA, V106, P17443, DOI 10.1073/pnas.0908530106; Faria M, 2001, CROP PROT, V20, P767, DOI 10.1016/S0261-2194(01)00110-7; FENG MG, 1994, BIOCONTROL SCI TECHN, V4, P3, DOI 10.1080/09583159409355309; Gao QA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001264; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Gwynn DM, 2005, P ROY SOC B-BIOL SCI, V272, P1803, DOI 10.1098/rspb.2005.3089; HAJEK AE, 1994, ANNU REV ENTOMOL, V39, P293, DOI 10.1146/annurev.en.39.010194.001453; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Horowitz AR, 2011, WHITEFLY, BEMISIA TABACI (HOMOPTERA: ALEYRODIDAE) INTERACTION WITH GEMINIVIRUS-INFECTED HOST PLANTS: BEMISIA TABACI, HOST PLANTS AND GEMINIVIRUSES, P293, DOI 10.1007/978-94-007-1524-0_11; Huang LL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008098; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Jiu M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000182; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Kobae Y, 2006, PLANT CELL PHYSIOL, V47, P309, DOI 10.1093/pcp/pcj001; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Leshkowitz D, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-79; Li JM, 2011, INSECT SCI, V18, P11, DOI 10.1111/j.1744-7917.2010.01386.x; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liu P, 2005, J BACTERIOL, V187, P6039, DOI 10.1128/JB.187.17.6039-6045.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu DD, 2008, APPL MICROBIOL BIOT, V81, P515, DOI 10.1007/s00253-008-1695-8; Luan JB, 2011, J VIROL, V85, P3330, DOI 10.1128/JVI.02507-10; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mayer AM, 2002, PHYTOCHEMISTRY, V60, P551, DOI 10.1016/S0031-9422(02)00171-1; Monge RA, 2006, MICROBIOL-SGM, V152, P905, DOI 10.1099/mic.0.28616-0; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Nauen R., 2005, Pflanzenschutz-Nachrichten Bayer, V58, P485; Nauen R., 2008, Bayer CropScience Journal, V61, P245; Nelson N, 1999, EMBO J, V18, P4361, DOI 10.1093/emboj/18.16.4361; PENDLAND JC, 1993, J BACTERIOL, V175, P5962, DOI 10.1128/JB.175.18.5962-5969.1993; Perraud AL, 2004, MOL IMMUNOL, V41, P657, DOI 10.1016/j.molimm.2004.04.013; Piper PW, 1997, CELL STRESS CHAPERON, V2, P12, DOI 10.1379/1466-1268(1997)002<0012:HTIPMH>2.3.CO;2; Qin Y, 2010, APPL ENVIRON MICROB, V76, P4611, DOI 10.1128/AEM.00302-10; Saito T, 2005, APPL ENTOMOL ZOOL, V40, P169, DOI 10.1303/aez.2005.169; Sattelle David B., 2008, Invertebrate Neuroscience, V8, P107, DOI 10.1007/s10158-008-0076-4; Scanga CA, 2004, INFECT IMMUN, V72, P2400, DOI 10.1128/IAI.72.4.2400-2404.2004; Schar J, 2010, J BACTERIOL, V192, P1774, DOI 10.1128/JB.01132-09; Seal SE, 2006, CRIT REV PLANT SCI, V25, P23, DOI 10.1080/07352680500365257; Serebrov VV, 2006, BIOL BULL+, V33, P581, DOI 10.1134/S1062359006060082; Shi WB, 2009, EXP APPL ACAROL, V48, P229, DOI 10.1007/s10493-009-9238-2; Song JQ, 2011, CELL HOST MICROBE, V9, P115, DOI 10.1016/j.chom.2011.01.011; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Sun D, 2011, B ENTOMOL RES, V1, P1; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tanabe M, 2006, INFECT IMMUN, V74, P3687, DOI 10.1128/IAI.01837-05; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; Toledo AV, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.3501; Toller IM, 2011, P NATL ACAD SCI USA, V108, P14944, DOI 10.1073/pnas.1100959108; Torrado-Leon E, 2006, MYCOPATHOLOGIA, V162, P411, DOI 10.1007/s11046-006-0077-y; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Vassiliou V, 2011, INSECT SCI, V18, P30, DOI 10.1111/j.1744-7917.2010.01387.x; Veitch NJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-124; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wall DM, 2005, INFECT IMMUN, V73, P6736, DOI 10.1128/IAI.73.10.6736-6741.2005; Wang CS, 2005, EUKARYOT CELL, V4, P937, DOI 10.1128/EC.4.5.937-947.2005; Wang P, 2010, INSECT SCI, V17, P508, DOI 10.1111/j.1744-7917.2010.01353.x; Wang XW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-458; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wraight SP, 2000, BIOL CONTROL, V17, P203, DOI 10.1006/bcon.1999.0799; Wu M, 2011, INFECT IMMUN, V79, P75, DOI 10.1128/IAI.00815-10; Xiao GH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00483; Xie W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035181; Yin Y, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000269; Zibaee A, 2009, BIOCONTROL SCI TECHN, V19, P485, DOI 10.1080/09583150902847127	87	25	29	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68185	10.1371/journal.pone.0068185	http://dx.doi.org/10.1371/journal.pone.0068185			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861870	Green Submitted, Green Published, gold			2022-12-27	WOS:000321425300050
J	Herrera, VL; Pasion, KA; Tan, GA; Moran, AM; Ruiz-Opazo, N				Herrera, Victoria L.; Pasion, Khristine A.; Tan, Glaiza A.; Moran, Ann Marie; Ruiz-Opazo, Nelson			Sex-Specific Effects on Spatial Learning and Memory, and Sex-Independent Effects on Blood Pressure of a < 3.3 Mbp Rat Chromosome 2 QTL Region in Dahl Salt-Sensitive Rats	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; COGNITIVE PERFORMANCE; HYPERTENSION; DEMENTIA; NAVIGATION; IMPAIRMENT; RISK; GENE; MICE	Epidemiological studies have consistently found that hypertension is associated with poor cognitive performance. We hypothesize that a putative causal mechanism underlying this association is due to genetic loci affecting both blood pressure and cognition. Consistent with this notion, we reported several blood pressure (BP) quantitative trait loci (QTLs) that co-localized with navigational performance (Nav)-QTLs influencing spatial learning and memory in Dahl rats. The present study investigates a chromosome 2 region harboring BP-f4 and Nav-8 QTLs. We developed two congenic strains, S.R2A and S.R2B introgressing Dahl R-chromosome 2 segments into Dahl S chromosome 2 region spanning BP-f4 and Nav-8 QTLs. Radiotelemetric blood pressure analysis identified only S.R2A congenic rats with lower systolic blood pressure (females: -26.0 mmHg, P = 0.003; males: -30.9 mmHg, P < 1x10(-5)), diastolic blood pressure (females: -21.2 mmHg, P = 0.01; males: -25.7 mmHg, P < 1x10(-5)), and mean arterial pressure (females: -23.9 mmHg, P = 0.004; males: -28.0 mmHg, P < 1x10(-5)) compared with corresponding Dahl S controls, confirming the presence of BP-f4 QTL on rat chromosome 2. The S.R2B congenic segment did not affect blood pressure. Testing of S.R2A, S.R2B, and Dahl S male rats in the Morris water maze (MWM) task revealed significantly decreased spatial navigation performance in S.R2A male congenic rats when compared with Dahl S male controls (P < 0.05). The S.R2B congenic segment did not affect performance of the MWM task in males. The S.R2A female rats did not differ in spatial navigation when compared with Dahl S female controls, indicating that the Nav-8 effect on spatial navigation is male-specific. Our results suggest the existence of a single QTL on chromosome 2 176.6-179.9 Mbp region which affects blood pressure in both males and females and cognition solely in males.	[Herrera, Victoria L.; Pasion, Khristine A.; Tan, Glaiza A.; Moran, Ann Marie; Ruiz-Opazo, Nelson] Boston Univ, Sch Med, Dept Med, Sect Cardiovasc Med, Boston, MA 02118 USA	Boston University	Ruiz-Opazo, N (corresponding author), Boston Univ, Sch Med, Dept Med, Sect Cardiovasc Med, Boston, MA 02118 USA.	nruizo@bu.edu		Ruiz-Opazo, Nelson/0000-0001-8234-1332; Herrera, Victoria/0000-0001-8991-2134	NIH [RO1 HL086532]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086532] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grant RO1 HL086532 to N.R-O. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Deng AY, 2001, MAMM GENOME, V12, P612, DOI 10.1007/s00335-001-2054-6; Elias MF, 2007, HYPERTENSION, V49, P439, DOI 10.1161/01.HYP.0000256361.68158.24; Fisher PJ, 1999, HUM MOL GENET, V8, P915, DOI 10.1093/hmg/8.5.915; Forette F, 2002, ARCH INTERN MED, V162, P2046, DOI 10.1001/archinte.162.18.2046; Freitag MH, 2006, STROKE, V37, P33, DOI 10.1161/01.STR.0000196941.58869.2d; Glorioso N, 2011, PHYSIOL GENOMICS, V43, P1219, DOI 10.1152/physiolgenomics.00012.2011; Guo ZC, 1999, ARCH NEUROL-CHICAGO, V56, P991, DOI 10.1001/archneur.56.8.991; Hebert LE, 2004, NEUROLOGY, V62, P2021, DOI 10.1212/01.WNL.0000129258.93137.4B; Herrera VLM, 2006, PHYSIOL GENOMICS, V26, P172, DOI 10.1152/physiolgenomics.00285.2005; Herrera VLM, 2008, PHYSIOL GENOMICS, V35, P316, DOI 10.1152/physiolgenomics.00044.2008; Herrera VLM, 2005, PHYSIOL GENOMICS, V23, P257, DOI 10.1152/physiolgenomics.00144.2005; Herrera VLM, 1998, J CLIN INVEST, V102, P1102, DOI 10.1172/JCI3868; Kaneko Y, 2005, PHYSIOL GENOMICS, V20, P157, DOI 10.1152/physiolgenomics.00108.2004; Kilander L, 1998, HYPERTENSION, V31, P780, DOI 10.1161/01.HYP.31.3.780; Kivipelto M, 2001, NEUROLOGY, V56, P1683, DOI 10.1212/WNL.56.12.1683; Knecht S, 2008, HYPERTENSION, V51, P663, DOI 10.1161/HYPERTENSIONAHA.107.105577; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Ruiz-Opazo N, 2004, MOL MED, V10, P36, DOI 10.2119/2003-00044.Herrera; Ruiz-Opazo N, 2004, PHYSIOL GENOMICS, V16, P329, DOI 10.1152/physiolgenomics.00162.2003; Ruiz-Opazo N, 2004, HYPERTENSION, V43, P797, DOI 10.1161/01.HYP.0000120153.04064.8d; Ruiz-Opazo N, 2006, PHYSIOL GENOMICS, V26, P145, DOI 10.1152/physiolgenomics.00019.2006; Seshadri S, 2001, ARCH INTERN MED, V161, P2343, DOI 10.1001/archinte.161.19.2343; Skoog I, 1996, LANCET, V347, P1141, DOI 10.1016/S0140-6736(96)90608-X	25	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67673	10.1371/journal.pone.0067673	http://dx.doi.org/10.1371/journal.pone.0067673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861781	Green Published, Green Submitted, gold			2022-12-27	WOS:000323350700020
J	Montrucchio, DP; Cordova, MM; Santos, ARS				Montrucchio, Deise Prehs; Cordova, Marina Machado; Soares Santos, Adair Roberto			Plant Derived Aporphinic Alkaloid S-(+)-Dicentrine Induces Antinociceptive Effect in Both Acute and Chronic Inflammatory Pain Models: Evidence for a Role of TRPA1 Channels	PLOS ONE			English	Article							RECEPTOR POTENTIAL CHANNELS; SUBSTANTIA-GELATINOSA NEURONS; ION-CHANNEL; ALPHA-1-ADRENOCEPTOR ANTAGONIST; MOLECULAR-MECHANISMS; COLD; DICENTRINE; CONTRIBUTES; INHIBITION; HYPERALGESIA	S-(+)-Dicentrine is an aporphinic alkaloid found in several plant species, mainly from Lauraceae family, which showed significant antinociceptive activity in an acute model of visceral pain in mice. In this work, we extended the knowledge on the antinociceptive properties of S-(+)-dicentrine and showed that this alkaloid also attenuates mechanical and cold hypersensitivity associated with cutaneous inflammation induced by Complete Freund's Adjuvant in mice. Given orally, S-(+)-dicentrine (100 mg/kg) reversed CFA-induced mechanical hypersensitivity, evaluated as the paw withdrawal threshold to von Frey hairs, and this effect lasted up to 2 hours. S-(+)-Dicentrine also reversed CFA-induced cold hypersensitivity, assessed as the responses to a drop of acetone in the injured paw, but did not reverse the heat hypersensitivity, evaluated as the latency time to paw withdrawal in the hot plate (50 degrees C). Moreover, S-(+)-dicentrine (100 mg/kg, p.o.) was effective in inhibit nociceptive responses to intraplantar injections of cinnamaldehyde, a TRPA1 activator, but not the responses induced by capsaicin, a TRPV1 activator. When administered either by oral or intraplantar routes, S-(+)- dicentrine reduced the licking time (spontaneous nociception) and increased the latency time to paw withdrawal in the cold plate (cold hypersensitivity), both induced by the intraplantar injection of cinnamaldehyde. Taken together, our data adds information about antinociceptive properties of S-(+)-dicentrine in inflammatory conditions, reducing spontaneous nociception and attenuating mechanical and cold hypersensitivity, probably via a TRPA1-dependent mechanism. It also indicates that S-(+)-dicentrine might be potentially interesting in the development of new clinically relevant drugs for the management of persistent pain, especially under inflammatory conditions.	[Montrucchio, Deise Prehs] Univ Fed Parana, Dept Farm, Setor Ciencias Saude, BR-80060000 Curitiba, PR, Brazil; [Montrucchio, Deise Prehs; Soares Santos, Adair Roberto] Univ Fed Santa Maria, Programa Posgrad Farmacol, BR-97119900 Santa Maria, RS, Brazil; [Montrucchio, Deise Prehs; Cordova, Marina Machado; Soares Santos, Adair Roberto] Univ Fed Santa Catarina, Lab Neurobiol Dor & Inflamacao, Dept Ciencias Fisiol, Florianopolis, SC, Brazil	Universidade Federal do Parana; Universidade Federal de Santa Maria (UFSM); Universidade Federal de Santa Catarina (UFSC)	Santos, ARS (corresponding author), Univ Fed Santa Maria, Programa Posgrad Farmacol, BR-97119900 Santa Maria, RS, Brazil.	adair.santos@ufsc.br	Santos, Adair/C-5565-2013	Santos, Adair/0000-0002-6435-4698	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES); Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC), Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC), Brazil	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES) and Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade EL, 2012, PHARMACOL THERAPEUT, V133, P189, DOI 10.1016/j.pharmthera.2011.10.008; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen KS, 1997, J NAT PROD, V60, P645, DOI 10.1021/np9700735; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Cordova MM, 2011, NEUROSCI LETT, V495, P173, DOI 10.1016/j.neulet.2011.02.007; Cortright DN, 2007, BBA-MOL BASIS DIS, V1772, P978, DOI 10.1016/j.bbadis.2007.03.003; da Costa DSM, 2010, PAIN, V148, P431, DOI 10.1016/j.pain.2009.12.002; del Camino D, 2010, J NEUROSCI, V30, P15165, DOI 10.1523/JNEUROSCI.2580-10.2010; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; EDDY NB, 1953, J PHARMACOL EXP THER, V107, P385; Eid SR, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-48; Fernandes ES, 2012, BRIT J PHARMACOL, V166, P510, DOI 10.1111/j.1476-5381.2012.01851.x; Ferreira J, 2001, NEUROPHARMACOLOGY, V41, P1006, DOI 10.1016/S0028-3908(01)00142-3; Flatters SJL, 2004, PAIN, V109, P150, DOI 10.1016/j.pain.2004.01.029; Huang JJ, 2006, SEMIN CELL DEV BIOL, V17, P638, DOI 10.1016/j.semcdb.2006.11.002; Huang RL, 1998, PLANTA MED, V64, P212, DOI 10.1055/s-2006-957411; Jiang LH, 2011, CURR DRUG TARGETS, V12, P724; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Klafke JZ, 2012, NEUROSCIENCE, V222, P136, DOI 10.1016/j.neuroscience.2012.07.022; Knowlton WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025894; Knowlton WM, 2010, PAIN, V150, P340, DOI 10.1016/j.pain.2010.05.021; KONDO Y, 1990, J PHARMACOBIO-DYNAM, V13, P426, DOI 10.1248/bpb1978.13.426; Konkimalla VB, 2010, BIOCHEM PHARMACOL, V79, P1092, DOI 10.1016/j.bcp.2009.11.025; Kosugi M, 2007, J NEUROSCI, V27, P4443, DOI 10.1523/JNEUROSCI.0557-07.2007; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lennertz RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043597; Levine JD, 2007, BBA-MOL BASIS DIS, V1772, P989, DOI 10.1016/j.bbadis.2007.01.008; Luszczki JJ, 2007, PROG NEURO-PSYCHOPH, V31, P529, DOI 10.1016/j.pnpbp.2006.11.020; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Montrucchio DP, 2012, PLANTA MED, V78, P1543, DOI 10.1055/s-0032-1315026; Moran MM, 2011, NAT REV DRUG DISCOV, V10, P601, DOI 10.1038/nrd3456; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; Palmer JA, 2008, NEUROSCIENCE, V154, P1554, DOI 10.1016/j.neuroscience.2008.04.047; Pertovaara A, 2011, EUR J PHARMACOL, V666, P1, DOI 10.1016/j.ejphar.2011.05.027; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; Premkumar LS, 2013, LIFE SCI, V92, P415, DOI 10.1016/j.lfs.2012.08.010; Reeh P W, 2001, Curr Opin Pharmacol, V1, P45, DOI 10.1016/S1471-4892(01)00014-5; Santos ARS, 1999, J PHARMACOL EXP THER, V289, P417; Stevigny C., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P173, DOI 10.2174/1568011053174864; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Stucky CL, 2009, BRAIN RES REV, V60, P2, DOI 10.1016/j.brainresrev.2008.12.018; TENG CM, 1991, BRIT J PHARMACOL, V104, P651, DOI 10.1111/j.1476-5381.1991.tb12484.x; Tsai TH, 2008, J NAT PROD, V71, P289, DOI 10.1021/np070564h; Uta D, 2010, EUR J NEUROSCI, V31, P1960, DOI 10.1111/j.1460-9568.2010.07255.x; Wang HB, 2005, NEURON, V46, P9, DOI 10.1016/j.neuron.2005.03.011; Wang S, 2008, BRAIN, V131, P1241, DOI 10.1093/brain/awn060; Weng YQ, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-75; YU SM, 1993, BRIT J PHARMACOL, V108, P1055, DOI 10.1111/j.1476-5381.1993.tb13505.x; YU SM, 1992, BRIT J PHARMACOL, V106, P797, DOI 10.1111/j.1476-5381.1992.tb14415.x; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	55	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67730	10.1371/journal.pone.0067730	http://dx.doi.org/10.1371/journal.pone.0067730			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861794	Green Submitted, Green Published, gold			2022-12-27	WOS:000323350700029
J	Santiquet, N; Robert, C; Richard, FJ				Santiquet, Nicolas; Robert, Claude; Richard, Francois J.			The Dynamics of Connexin Expression, Degradation and Localisation Are Regulated by Gonadotropins during the Early Stages of In Vitro Maturation of Swine Oocytes	PLOS ONE			English	Article							GAP-JUNCTION PROTEIN; CUMULUS CELLS; INTERCELLULAR COMMUNICATION; GENE-EXPRESSION; MESSENGER-RNA; DIFFERENTIAL EXPRESSION; FOLLICULAR DEVELOPMENT; PROTEASOME INHIBITORS; MEIOTIC RESUMPTION; PORCINE OOCYTES	Gap junctional communication (GJC) plays a primordial role in oocyte maturation and meiotic resumption in mammals by directing the transfer of numerous molecules between cumulus cells and the oocyte. Gap junctions are made of connexins (Cx), proteins that regulate GJC in numerous ways. Understanding the dynamic regulation of connexin arrangements during in vitro maturation (IVM) could provide a powerful tool for controlling meiotic resumption and consequently in vitro development of fully competent oocytes. However, physiological events happening during the early hours of IVM may still be elucidated. The present study reports the dynamic regulation of connexin expression, degradation and localization during this stage. Cx43, Cx45 and Cx60 were identified as the main connexins expressed in swine COC. Cx43 and Cx45 transcripts were judged too static to be a regulator of GJC, while Cx43 protein expression was highly responsive to gonadotropins, suggesting that it might be the principal regulator of GJC. In addition, the degradation of Cx43 expressed after 4.5 h of IVM in response to equine chorionic gonadotropin appeared to involve the proteasomal complex. Cx43 localisation appeared to be associated with GJC. Taken together, these results show for the first time that gonadotropins regulate Cx43 protein expression, degradation and localisation in porcine COC during the first several hours of IVM. Regulation of Cx43 may in turn, via GJC, participate in the development of fully competent oocytes.	[Santiquet, Nicolas; Robert, Claude; Richard, Francois J.] Univ Laval, Dept Anim Sci, Ctr Rech Biol Reprod, FSAA, Quebec City, PQ, Canada	Laval University	Richard, FJ (corresponding author), Univ Laval, Dept Anim Sci, Ctr Rech Biol Reprod, FSAA, Quebec City, PQ, Canada.	Francois.Richard@fsaa.ulaval.ca		Robert, Claude/0000-0001-9690-8088; Richard, Francois J./0000-0003-0226-2971	NSERC operating grant	NSERC operating grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by an NSERC operating grant to Francois J. Richard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackert CL, 2001, INTERCELLULAR COMMUN; Beardslee MA, 1998, CIRC RES, V83, P629, DOI 10.1161/01.RES.83.6.629; Blomstrand F, 1999, NEUROSCIENCE, V92, P255, DOI 10.1016/S0306-4522(98)00738-6; BORNSLAEGER EA, 1985, BIOL REPROD, V33, P698, DOI 10.1095/biolreprod33.3.698; BRISSETTE JL, 1994, P NATL ACAD SCI USA, V91, P6453, DOI 10.1073/pnas.91.14.6453; Cheng Y, 2005, J REPROD DEVELOP, V51, P627, DOI 10.1262/jrd.17035; Conti M, 2012, MOL CELL ENDOCRINOL, V356, P65, DOI 10.1016/j.mce.2011.11.002; Cottrell GT, 2005, BBA-BIOMEMBRANES, V1711, P126, DOI 10.1016/j.bbamem.2004.11.013; Darrow BJ, 1996, CIRC RES, V79, P174, DOI 10.1161/01.RES.79.2.174; DARROW BJ, 1995, CIRC RES, V76, P381, DOI 10.1161/01.RES.76.3.381; Defamie N, 2001, CARCINOGENESIS, V22, P1537, DOI 10.1093/carcin/22.9.1537; deFeijter AW, 1996, MOL CARCINOGEN, V16, P203, DOI 10.1002/(SICI)1098-2744(199608)16:4<203::AID-MC4>3.3.CO;2-F; DEKEL N, 1981, DEV BIOL, V86, P356, DOI 10.1016/0012-1606(81)90193-7; Dermietzel R, 1998, VIRCHOWS ARCH, V432, P177, DOI 10.1007/s004280050153; Dhein S, 2010, N-S ARCH PHARMACOL, V381, P221, DOI 10.1007/s00210-009-0473-1; Elenes S, 2001, BIOPHYS J, V81, P1406, DOI 10.1016/S0006-3495(01)75796-7; Eugenin EA, 2012, J NEUROIMMUNE PHARM, V7, P499, DOI 10.1007/s11481-012-9352-5; FALLON RF, 1981, J CELL BIOL, V90, P521, DOI 10.1083/jcb.90.2.521; Gabriel HD, 1998, J CELL BIOL, V140, P1453, DOI 10.1083/jcb.140.6.1453; Gershon E, 2008, MOL CELL ENDOCRINOL, V282, P18, DOI 10.1016/j.mce.2007.11.001; Granot I, 1997, MOL REPROD DEV, V47, P231, DOI 10.1002/(SICI)1098-2795(199707)47:3&lt;231::AID-MRD1&gt;3.0.CO;2-M; Granot I, 2002, BIOL REPROD, V66, P568, DOI 10.1095/biolreprod66.3.568; GRANOT I, 1994, J BIOL CHEM, V269, P30502; GrazulBilska AT, 1997, BIOL REPROD, V57, P947, DOI 10.1095/biolreprod57.5.947; Grikscheit K, 2008, CELL COMMUN ADHES, V15, P185, DOI 10.1080/15419060802013943; GUAN XJ, 1995, TOXICOL APPL PHARM, V130, P79, DOI 10.1006/taap.1995.1011; Hesketh GG, 2009, J CARDIOVASC PHARM, V54, P263, DOI 10.1097/FJC.0b013e3181ba0811; Itahana K, 1998, ENDOCRINOLOGY, V139, P320, DOI 10.1210/en.139.1.320; Itahana K, 1996, ENDOCRINOLOGY, V137, P5036, DOI 10.1210/en.137.11.5036; Johnson ML, 1999, ENDOCRINE, V10, P43, DOI 10.1385/ENDO:10:1:43; Juneja SC, 1999, BIOL REPROD, V60, P1263, DOI 10.1095/biolreprod60.5.1263; Kar R, 2012, ARCH BIOCHEM BIOPHYS, V524, P2, DOI 10.1016/j.abb.2012.03.008; Kidder GM, 2002, REPRODUCTION, V123, P613, DOI 10.1530/rep.0.1230613; King TJ, 2004, CANCER RES, V64, P7191, DOI 10.1158/0008-5472.CAN-04-0624; Kjenseth A, 2010, CELL SIGNAL, V22, P1267, DOI 10.1016/j.cellsig.2010.03.005; KOVAL M, 1995, J CELL BIOL, V130, P987, DOI 10.1083/jcb.130.4.987; Laird DW, 2010, TRENDS CELL BIOL, V20, P92, DOI 10.1016/j.tcb.2009.11.001; Laird DW, 1999, CANCER RES, V59, P4104; LAIRD DW, 1991, BIOCHEM J, V273, P67, DOI 10.1042/bj2730067; LARSEN WJ, 1987, DEV BIOL, V122, P61, DOI 10.1016/0012-1606(87)90332-0; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lenhart JA, 1998, BIOL REPROD, V58, P583, DOI 10.1095/biolreprod58.2.583; Luciano AM, 2011, BIOL REPROD; Manthey D, 1999, J BIOL CHEM, V274, P14716, DOI 10.1074/jbc.274.21.14716; MAYERHOFER A, 1995, MOL REPROD DEV, V41, P331, DOI 10.1002/mrd.1080410308; McConkey DJ, 2008, DRUG RESIST UPDATE, V11, P164, DOI 10.1016/j.drup.2008.08.002; McLachlan E, 2007, J MEMBRANE BIOL, V218, P107, DOI 10.1007/s00232-007-9052-x; Melton CM, 2001, COMP BIOCHEM PHYS B, V130, P43, DOI 10.1016/S1096-4959(01)00403-1; Mese G, 2007, J INVEST DERMATOL, V127, P2516, DOI 10.1038/sj.jid.5700770; Moreau P, 2012, BLOOD, V120, P947, DOI 10.1182/blood-2012-04-403733; Musil LS, 2000, J BIOL CHEM, V275, P25207, DOI 10.1074/jbc.275.33.25207; Nelles E, 1996, P NATL ACAD SCI USA, V93, P9565, DOI 10.1073/pnas.93.18.9565; Nicholson BJ, 2000, BRAZ J MED BIOL RES, V33, P369, DOI 10.1590/S0100-879X2000000400002; Nitta M, 2010, J ANIM SCI, V88, P3269, DOI 10.2527/jas.2009-2781; Norris RP, 2008, DEVELOPMENT, V135, P3229, DOI 10.1242/dev.025494; Norris RP, 2009, DEVELOPMENT, V136, P1869, DOI 10.1242/dev.035238; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Okazaki T, 2003, MOL CELL ENDOCRINOL, V209, P43, DOI 10.1016/j.mce.2003.08.002; Okuma A, 1996, J REPROD FERTILITY, V107; Ortiz-Lazareno PC, 2008, IMMUNOLOGY, V124, P534, DOI 10.1111/j.1365-2567.2008.02806.x; PETTERS RM, 1993, J REPROD FERTIL, P61; Pincus G, 1935, J EXP MED, V62, P665, DOI 10.1084/jem.62.5.665; Rackauskas M, 2007, BIOPHYS J, V92, P1952, DOI 10.1529/biophysj.106.099358; Rackauskas M, 2010, MEDICINA-LITHUANIA, V46, P1, DOI 10.3390/medicina46010001; RACOWSKY C, 1989, EUR J CELL BIOL, V49, P244; RACOWSKY C, 1984, J REPROD FERTIL, V72, P107, DOI 10.1530/jrf.0.0720107; ROGERS M, 1990, MOL CARCINOGEN, V3, P335, DOI 10.1002/mc.2940030605; SALMON ED, 1984, J CELL BIOL, V99, P2165, DOI 10.1083/jcb.99.6.2165; Santiquet NW, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099754; Sasseville M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-47; Sasseville M, 2009, MOL ENDOCRINOL, V23, P700, DOI 10.1210/me.2008-0320; SCHILLER PC, 1992, MOL ENDOCRINOL, V6, P1433, DOI 10.1210/me.6.9.1433; Sela-Abramovich S, 2006, ENDOCRINOLOGY, V147, P2280, DOI 10.1210/en.2005-1011; SHERIZLY I, 1988, HUM REPROD, V3, P761, DOI 10.1093/oxfordjournals.humrep.a136780; Shimada M, 2003, BIOL REPROD, V68, P1142, DOI 10.1095/biolreprod.102.010082; Shimada M, 2001, BIOL REPROD, V64, P1255, DOI 10.1095/biolreprod64.4.1255; Shimizu S, 2012, BIOCH BIOPHYSICAL RE; Shirley RB, 2005, NEOPLASIA, V7, P1104, DOI 10.1593/neo.05520; Shu YM, 2008, HUM REPROD, V23, P504, DOI 10.1093/humrep/dem344; Simon AM, 1997, NATURE, V385, P525, DOI 10.1038/385525a0; Sommersberg B, 2000, BIOL REPROD, V63, P1661, DOI 10.1095/biolreprod63.6.1661; Sun QY, 2001, MOL REPROD DEV, V59, P192, DOI 10.1002/mrd.1022; Thomas RE, 2004, BIOL REPROD, V70, P548, DOI 10.1095/biolreprod.103.021204; Vaccari S, 2009, BIOL REPROD, V81, P595, DOI 10.1095/biolreprod.109.077768; VALDIMARSSON G, 1993, MOL REPROD DEV, V36, P7, DOI 10.1002/mrd.1080360103; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veenstra RD, 1996, J BIOENERG BIOMEMBR, V28, P327, DOI 10.1007/BF02110109; Veitch GI, 2004, J CELL SCI, V117, P2699, DOI 10.1242/jcs.01124; Wang Q, 2010, J PHARMACOL EXP THER, V333, P903, DOI 10.1124/jpet.109.165274; Weber PA, 2004, BIOPHYS J, V87, P958, DOI 10.1529/biophysj.103.036350; WIESEN JF, 1993, ENDOCRINOLOGY, V133, P741, DOI 10.1210/en.133.2.741; Wright CS, 2001, REPRODUCTION, V121, P77, DOI 10.1530/rep.0.1210077; Yoshida T, 2005, CANCER RES, V65, P5662, DOI 10.1158/0008-5472.CAN-05-0693	93	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68456	10.1371/journal.pone.0068456	http://dx.doi.org/10.1371/journal.pone.0068456			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861906	gold, Green Submitted, Green Published			2022-12-27	WOS:000323350700087
J	Wada, N; Hashinaga, T; Otabe, S; Yuan, XH; Kurita, Y; Kakino, S; Ohoki, T; Nakayama, H; Fukutani, T; Tajiri, Y; Yamada, K				Wada, Nobuhiko; Hashinaga, Toshihiko; Otabe, Shuichi; Yuan, Xiaohong; Kurita, Yayoi; Kakino, Satomi; Ohoki, Tsuyoshi; Nakayama, Hitomi; Fukutani, Tomoka; Tajiri, Yuji; Yamada, Kentaro			Selective Modulation of Wnt Ligands and Their Receptors in Adipose Tissue by Chronic Hyperadiponectinemia	PLOS ONE			English	Article							NF-KAPPA-B; BETA-CATENIN; SIGNALING PATHWAY; FRIZZLED HOMOLOGS; CELL-ADHESION; PPAR-GAMMA; ADIPONECTIN; ACTIVATION; DIFFERENTIATION; ADIPOGENESIS	Background: Adiponectin-transgenic mice had many small adipocytes in both subcutaneous and visceral adipose tissues, and showed higher sensitivity to insulin, longer life span, and reduced chronic inflammation. We hypothesized that adiponectin regulates Wnt signaling in adipocytes and thereby modulates adipocyte proliferation and chronic inflammation in adipose tissue. Materials and Methods: We examined the expression of all Wnt ligands and their receptors and the activity of Wnt signaling pathways in visceral adipose tissue from wild-type mice and two lines of adiponectin-transgenic mice. The effects of adiponectin were also investigated in cultured 3T3-L1 cells. Results: The Wnt5b, Wnt6, Frizzled 6 (Fzd6), and Fzd9 genes were up-regulated in both lines of transgenic mice, whereas Wnt1, Wnt2, Wnt5a, Wnt9b, Wnt10b, Wnt11, Fzd1, Fzd2, Fzd4, Fzd7, and the Fzd coreceptor low-density-lipoprotein receptor-related protein 6 (Lrp6) were reduced. There was no difference in total beta-catenin levels in whole-cell extracts, non-phospho-beta-catenin levels in nuclear extracts, or mRNA levels of beta-catenin target genes, indicating that hyperadiponectinemia did not affect canonical Wnt signaling. In contrast, phosphorylated calcium/calmodulin-dependent kinase II (p-CaMKII) and phosphorylated Jun N-terminal kinase (p-JNK) were markedly reduced in adipose tissue from the transgenic mice. The adipose tissue of the transgenic mice consisted of many small cells and had increased expression of adiponectin, whereas cyclooxygenase-2 expression was reduced. Wnt5b expression was elevated in preadipocytes of the transgenic mice and decreased in diet-induced obese mice, suggesting a role in adipocyte differentiation. Some Wnt genes, Fzd genes, and p-CaMKII protein were down-regulated in 3T3-L1 cells cultured with a high concentration of adiponectin. Conclusion: Chronic hyperadiponectinemia selectively modulated the expression of Wnt ligands, Fzd receptors and LRP coreceptors accompanied by the inhibition of the Wnt/Ca2+ and JNK signaling pathways, which may be involved in the altered adipocyte cellularity, endogenous adiponectin production, and anti-inflammatory action induced by hyperadiponectinemia.	[Wada, Nobuhiko; Hashinaga, Toshihiko; Otabe, Shuichi; Yuan, Xiaohong; Kurita, Yayoi; Kakino, Satomi; Ohoki, Tsuyoshi; Nakayama, Hitomi; Fukutani, Tomoka; Tajiri, Yuji; Yamada, Kentaro] Kurume Univ, Sch Med, Div Endocrinol & Metab, Dept Med, Kurume, Fukuoka 830, Japan	Kurume University	Yamada, K (corresponding author), Kurume Univ, Sch Med, Div Endocrinol & Metab, Dept Med, Kurume, Fukuoka 830, Japan.	yamada@med.kurume-u.ac.jp			Japan Society for the Promotion of Science [21591154]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Grant-in-Aid for Scientific Research (C) 21591154 from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuwon KM, 2005, AM J PHYSIOL-REG I, V288, pR1220, DOI 10.1152/ajpregu.00397.2004; Behrens J, 2000, ANN NY ACAD SCI, V910, P21; Bilkovski R, 2011, INT J OBESITY, V35, P1450, DOI 10.1038/ijo.2011.6; Bilkovski R, 2010, J BIOL CHEM, V285, P6170, DOI 10.1074/jbc.M109.054338; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Endo H, 2009, GUT, V58, P1637, DOI 10.1136/gut.2009.183624; Flaherty MP, 2008, TRENDS CARDIOVAS MED, V18, P260, DOI 10.1016/j.tcm.2008.12.001; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; HINCK L, 1994, J CELL BIOL, V124, P729, DOI 10.1083/jcb.124.5.729; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Isakson P, 2009, DIABETES, V58, P1550, DOI 10.2337/db08-1770; Jung MY, 2012, J IMMUNOL, V188, P2592, DOI 10.4049/jimmunol.1102588; Katoh M, 2005, INT J ONCOL, V26, P1129; Katoh M, 2009, INT J MOL MED, V23, P763, DOI 10.3892/ijmm_00000190; Kikuchi A, 2000, BIOCHEM BIOPH RES CO, V268, P243, DOI 10.1006/bbrc.1999.1860; Kim J, 2010, J IMMUNOL, V185, P1274, DOI 10.4049/jimmunol.1000181; Koyanagi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005765; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Longo KA, 2002, J BIOL CHEM, V277, P38239, DOI 10.1074/jbc.M206402200; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Miyazaki T, 2005, BIOCHEM BIOPH RES CO, V333, P79, DOI 10.1016/j.bbrc.2005.05.076; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Nishizuka M, 2008, FEBS LETT, V582, P3201, DOI 10.1016/j.febslet.2008.08.011; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Otabe S, 2007, AM J PHYSIOL-ENDOC M, V293, pE210, DOI 10.1152/ajpendo.00645.2006; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Papkoff J, 1996, MOL CELL BIOL, V16, P2128; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sato A, 2010, EMBO J, V29, P41, DOI 10.1038/emboj.2009.322; Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016; Schulte DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032437; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; Sen M, 2008, J IMMUNOL, V181, P4441, DOI 10.4049/jimmunol.181.7.4441; Swain Rajeeb Kumar, 2005, Cell Commun Signal, V3, P12, DOI 10.1186/1478-811X-3-12; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; van Tienen FHJ, 2009, BIOCHEM BIOPH RES CO, V387, P207, DOI 10.1016/j.bbrc.2009.07.004; Wunnenberg-Stapleton K, 1999, DEVELOPMENT, V126, P5339	44	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67712	10.1371/journal.pone.0067712	http://dx.doi.org/10.1371/journal.pone.0067712			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861788	Green Submitted, Green Published, gold			2022-12-27	WOS:000323350700026
J	Xia, MR; Wang, JH; He, Y				Xia, Mingrui; Wang, Jinhui; He, Yong			BrainNet Viewer: A Network Visualization Tool for Human Brain Connectomics	PLOS ONE			English	Article							STRUCTURAL CORTICAL NETWORKS; GRAPH-THEORETICAL ANALYSIS; GENDER-RELATED DIFFERENCES; AGE-RELATED-CHANGES; SMALL-WORLD; FUNCTIONAL CONNECTIVITY; MODULAR ORGANIZATION; TOPOLOGICAL PATTERNS; ARCHITECTURE; EFFICIENCY	The human brain is a complex system whose topological organization can be represented using connectomics. Recent studies have shown that human connectomes can be constructed using various neuroimaging technologies and further characterized using sophisticated analytic strategies, such as graph theory. These methods reveal the intriguing topological architectures of human brain networks in healthy populations and explore the changes throughout normal development and aging and under various pathological conditions. However, given the huge complexity of this methodology, toolboxes for graph-based network visualization are still lacking. Here, using MATLAB with a graphical user interface (GUI), we developed a graph-theoretical network visualization toolbox, called BrainNet Viewer, to illustrate human connectomes as ball-and-stick models. Within this toolbox, several combinations of defined files with connectome information can be loaded to display different combinations of brain surface, nodes and edges. In addition, display properties, such as the color and size of network elements or the layout of the figure, can be adjusted within a comprehensive but easy-to-use settings panel. Moreover, BrainNet Viewer draws the brain surface, nodes and edges in sequence and displays brain networks in multiple views, as required by the user. The figure can be manipulated with certain interaction functions to display more detailed information. Furthermore, the figures can be exported as commonly used image file formats or demonstration video for further use. BrainNet Viewer helps researchers to visualize brain networks in an easy, flexible and quick manner, and this software is freely available on the NITRC website (www.nitrc.org/projects/bnv/).	[Xia, Mingrui; Wang, Jinhui; He, Yong] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	Beijing Normal University	Xia, MR (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	mxia@mail.bnu.edu.cn; yong.he@bnu.edu.cn	He, Yong/C-2161-2009; Xia, Mingrui/J-3267-2019; Wang, jinhui/AAF-8668-2019; He, Yong/Q-5756-2018	Xia, Mingrui/0000-0003-4615-9132; He, Yong/0000-0002-7039-2850	Natural Science Foundation [81030028, 30870667]; National Science Fund for Distinguished Young Scholars [81225012]; Beijing Natural Science Foundation [Z111107067311036, 7102090]	Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study was supported by the Natural Science Foundation (Grant Nos. 81030028 and 30870667), the National Science Fund for Distinguished Young Scholars (Grant No. 81225012, YH), and Beijing Natural Science Foundation (Grant No. Z111107067311036 and 7102090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Bai F, 2012, J NEUROSCI, V32, P4307, DOI 10.1523/JNEUROSCI.5061-11.2012; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Batalle D, 2012, NEUROIMAGE, V60, P1352, DOI 10.1016/j.neuroimage.2012.01.059; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Brodmann K, 1909, VERGLEICHENDE LOKALI; Brown JA, 2011, P NATL ACAD SCI USA, V108, P20760, DOI 10.1073/pnas.1109038108; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chang C, 2010, FILM COMMENT, V46, P81; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; Cui ZX, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00042; Dai ZJ, 2012, NEUROIMAGE, V59, P2187, DOI 10.1016/j.neuroimage.2011.10.003; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davison Andrew P, 2008, Front Neuroinform, V2, P11, DOI 10.3389/neuro.11.011.2008; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fair DA, 2012, P NATL ACAD SCI USA, V109, P6769, DOI 10.1073/pnas.1115365109; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fang P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045972; Fornito A, 2011, J NEUROSCI, V31, P3261, DOI 10.1523/JNEUROSCI.4858-10.2011; Gerhard Stephan, 2011, Front Neuroinform, V5, P3, DOI 10.3389/fninf.2011.00003; Gleeson P, 2007, NEURON, V54, P219, DOI 10.1016/j.neuron.2007.03.025; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Guye M, 2010, MAGN RESON MATER PHY, V23, P409, DOI 10.1007/s10334-010-0205-z; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; He B, 2011, J NEUROSCI METH, V195, P261, DOI 10.1016/j.jneumeth.2010.11.015; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Hong SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057831; Hosseini SMH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040709; Hwang K, 2013, CEREB CORTEX, V23, P2380, DOI 10.1093/cercor/bhs227; Jones DT, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039731, 10.1371/journal.pone.0044294]; Kang J, 2011, NEUROIMAGE, V56, P1222, DOI 10.1016/j.neuroimage.2011.03.033; Khundrakpam BS, 2013, CEREB CORTEX, V23, P2072, DOI 10.1093/cercor/bhs187; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Liang X, 2013, P NATL ACAD SCI USA, V110, P1929, DOI 10.1073/pnas.1214900110; Liang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032766; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Liu JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027049; Liu M, 2013, HUM BRAIN MAPP; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Mangin JF, 2004, NEUROIMAGE, V23, pS129, DOI 10.1016/j.neuroimage.2004.07.019; Margulies DS, 2013, NEUROIMAGE, V80, P445, DOI 10.1016/j.neuroimage.2013.04.111; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Nordlie Eilen, 2010, Front Neuroinform, V3, P39, DOI 10.3389/neuro.11.039.2009; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Schmitt JE, 2008, CEREB CORTEX, V18, P1737, DOI 10.1093/cercor/bhm211; Seo EH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053922, 10.1371/journal.pone.0076875]; Sequeira KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053204; Shattuck DW, 2008, NEUROIMAGE, V39, P1064, DOI 10.1016/j.neuroimage.2007.09.031; Shu N, 2011, CEREB CORTEX, V21, P2565, DOI 10.1093/cercor/bhr039; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Taylor PN, 2013, BIOL CYBERN, V107, P83, DOI 10.1007/s00422-012-0534-2; Tian LX, 2011, NEUROIMAGE, V54, P191, DOI 10.1016/j.neuroimage.2010.07.066; Tomasi D, 2012, MOL PSYCHIATR, V17, P549, DOI 10.1038/mp.2011.81; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2013, EUR NEUROPSYCHOPHARM, V23, P19, DOI 10.1016/j.euroneuro.2012.06.007; van den Heuvel MP, 2012, P NATL ACAD SCI USA, V109, P11372, DOI 10.1073/pnas.1203593109; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Wang JH, 2013, BIOL PSYCHIAT, V73, P472, DOI 10.1016/j.biopsych.2012.03.026; Wang L, 2013, HUM BRAIN MAPP; Wang L, 2010, NEUROIMAGE, V50, P862, DOI 10.1016/j.neuroimage.2010.01.044; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wen W, 2011, CURR OPIN PSYCHIATR, V24, P219, DOI 10.1097/YCO.0b013e32834591f8; Wen W, 2011, J NEUROSCI, V31, P1204, DOI 10.1523/JNEUROSCI.4085-10.2011; Wu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055347; Wu K, 2012, HUM BRAIN MAPP, V33, P552, DOI 10.1002/hbm.21232; Xia MR, 2011, BRAIN CONNECT, V1, P349, DOI 10.1089/brain.2011.0062; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yan CG, 2011, CEREB CORTEX, V21, P449, DOI 10.1093/cercor/bhq111; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006; Yap PT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024678; Yi Liye, 2012, PLoS One, V7, pe44758, DOI 10.1371/journal.pone.0044758; Zalesky A, 2011, BIOL PSYCHIAT, V69, P80, DOI 10.1016/j.biopsych.2010.08.022; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223	93	1983	2017	26	237	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68910	10.1371/journal.pone.0068910	http://dx.doi.org/10.1371/journal.pone.0068910			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861951	Green Published, gold, Green Submitted			2022-12-27	WOS:000323350700108
J	Campanholle, G; Mittelsteadt, K; Nakagawa, S; Kobayashi, A; Lin, SL; Gharib, SA; Heinecke, JW; Hamerman, JA; Altemeier, WA; Duffield, JS				Campanholle, Gabriela; Mittelsteadt, Kristen; Nakagawa, Shunsaku; Kobayashi, Akio; Lin, Shuei-Liong; Gharib, Sina A.; Heinecke, Jay W.; Hamerman, Jessica A.; Altemeier, William A.; Duffield, Jeremy S.			TLR-2/TLR-4 TREM-1 Signaling Pathway Is Dispensable in Inflammatory Myeloid Cells during Sterile Kidney Injury	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; ACTIVATING RECEPTOR; CUTTING EDGE; LIVER-INJURY; MACROPHAGES; RESPONSES; ROLES; NEUTROPHILS; MODULATION; PERICYTES	Inflammatory macrophages are abundant in kidney disease, stimulating repair, or driving chronic inflammation and fibrosis. Damage associated molecules (DAMPs), released from injured cells engage pattern recognition receptors (PRRs) on macrophages, contributing to activation. Understanding mechanisms of macrophage activation during kidney injury may lead to strategies to alleviate chronic disease. We identified Triggering-Receptor-in-Myeloid-cells (TREM)-1, a regulator of TLR signaling, as highly upregulated in kidney inflammatory macrophages and tested the roles of these receptors in macrophage activation and kidney disease. Kidney DAMPs activated macrophages in vitro, independently of TREM-1, but partially dependent on TLR-2/-4, MyD88. In two models of progressive interstitial kidney disease, TREM-1 blockade had no impact on disease or macrophage activation in vivo, but TLR-2/-4, or MyD88 deficiency was anti-inflammatory and anti-fibrotic. When MyD88 was mutated only in the myeloid lineage, however, there was no bearing on macrophage activation or disease progression. Instead, TLR-2/-4 or MyD88 deficiency reduced activation of mesenchyme lineage cells resulting in reduced inflammation and fibrosis, indicating that these pathways play dominant roles in activation of myofibroblasts but not macrophages. To conclude, TREM-1, TLR2/4 and MyD88 signaling pathways are redundant in myeloid cell activation in kidney injury, but the latter appear to regulate activation of mesenchymal cells.	[Campanholle, Gabriela; Nakagawa, Shunsaku; Duffield, Jeremy S.] Univ Washington, Div Nephrol, Seattle, WA 98195 USA; [Campanholle, Gabriela; Mittelsteadt, Kristen; Nakagawa, Shunsaku; Gharib, Sina A.; Altemeier, William A.; Duffield, Jeremy S.] Univ Washington, Ctr Lung Biol, Dept Med & Pathol, Seattle, WA 98195 USA; [Campanholle, Gabriela; Mittelsteadt, Kristen; Nakagawa, Shunsaku; Heinecke, Jay W.; Altemeier, William A.; Duffield, Jeremy S.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Heinecke, Jay W.] Univ Washington, Diabet & Obes Ctr Excellence, Seattle, WA 98195 USA; [Kobayashi, Akio] Brigham & Womens Hosp, Boston, MA 02115 USA; [Kobayashi, Akio] Harvard Univ, Sch Med, Boston, MA USA; [Lin, Shuei-Liong] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Hamerman, Jessica A.] Virginia Mason, Benaroya Res Inst, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; National Taiwan University; National Taiwan University Hospital; Benaroya Research Institute; Virginia Mason Medical Center	Duffield, JS (corresponding author), Univ Washington, Div Nephrol, Seattle, WA 98195 USA.	jeremysd@u.washington.edu	Lin, Shuei-Liong/AGR-2002-2022	Lin, Shuei-Liong/0000-0002-1041-5571; Nakagawa, Shunsaku/0000-0002-1285-122X; Altemeier, William/0000-0001-8860-405X; GHARIB, SINA A./0000-0002-2480-4367	National Institutes of Health (NIH) Genzyme GRIP Award, University of Washington [DK84077, DK87389, DK93493, DK94768]; NIH [HL086883, AI 073441]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073441, R01AI081948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094933, R01DK084077, R01DK093493, RC1DK087389, P30DK017047, R24DK094768] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Genzyme GRIP Award, University of Washington; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Duffield Lab is funded by National Institutes of Health (NIH) Grants (DK84077, DK87389, DK93493, DK94768) Genzyme GRIP Award, University of Washington. This work was also supported by NIH Grants HL086883 (to W.A.A.) and AI 073441 (to J.A.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders HJ, 2010, J AM SOC NEPHROL, V21, P1270, DOI 10.1681/ASN.2010030233; Anders HJ, 2004, J AM SOC NEPHROL, V15, P854, DOI 10.1097/01.ASN.0000121781.89599.16; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Bakker ABH, 2000, IMMUNITY, V13, P345, DOI 10.1016/S1074-7613(00)00034-0; Bleharski JR, 2003, J IMMUNOL, V170, P3812, DOI 10.4049/jimmunol.170.7.3812; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Castano AP, 2009, SCI TRANSLATIONAL ME, V1; Chau BN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003205; Chun CD, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-57; Chung DH, 2002, EUR J IMMUNOL, V32, P59, DOI 10.1002/1521-4141(200201)32:1<59::AID-IMMU59>3.0.CO;2-U; Derive Marc, 2010, Self Nonself, V1, P225, DOI 10.4161/self.1.3.12891; Duffield JS, 2010, SEMIN NEPHROL, V30, P234, DOI 10.1016/j.semnephrol.2010.03.003; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; El Mezayen R, 2007, IMMUNOL LETT, V111, P36, DOI 10.1016/j.imlet.2007.04.011; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Gibot S, 2008, CRIT CARE MED, V36, P504, DOI 10.1097/01.CCM.0B013E318161FAF3; Gibot S, 2007, EUR J IMMUNOL, V37, P456, DOI 10.1002/eji.200636387; Gibot S, 2006, J INFECT DIS, V194, P975, DOI 10.1086/506950; Goncalves GM, 2011, SCAND J IMMUNOL, V73, P428, DOI 10.1111/j.1365-3083.2011.02523.x; Grgic I, 2012, KIDNEY INT, V82, P172, DOI 10.1038/ki.2012.20; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Harlow E., 1999, USING ANTIBODIES LAB; Huang H, 2011, HEPATOLOGY, V54, P999, DOI 10.1002/hep.24501; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Ichimura T, 2008, J CLIN INVEST, V118, P1657, DOI 10.1172/JCI34487; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kamei K, 2009, J HEPATOBILIARY PANC, V17, P305; Klesney-Tait J, 2013, J CLIN INVEST, V123, P138, DOI 10.1172/JCI64181; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Lin SL, 2009, J IMMUNOL, V183, P6733, DOI 10.4049/jimmunol.0901473; Lin SL, 2010, P NATL ACAD SCI USA, V107, P4194, DOI 10.1073/pnas.0912228107; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Majesky MW, 2011, ARTERIOSCL THROM VAS, V31, P1530, DOI 10.1161/ATVBAHA.110.221549; Murakami Y, 2009, ARTHRITIS RHEUM-US, V60, P1615, DOI 10.1002/art.24554; Nelson PJ, 2012, J AM SOC NEPHROL, V23, P194, DOI 10.1681/ASN.2011070680; Netea MG, 2006, J LEUKOCYTE BIOL, V80, P1454, DOI 10.1189/jlb.1205758; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Pulskens WP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003596; Rosin DL, 2011, J AM SOC NEPHROL, V22, P416, DOI 10.1681/ASN.2010040430; Schenk M, 2007, J CLIN INVEST, V117, P3097, DOI 10.1172/JCI30602; Schrimpf C, 2012, J AM SOC NEPHROL, V23, P868, DOI 10.1681/ASN.2011080851; Sharif O, 2008, IMMUNOBIOLOGY, V213, P701, DOI 10.1016/j.imbio.2008.07.008; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Wu J, 2012, CANCER RES, V72, P3977, DOI 10.1158/0008-5472.CAN-12-0938; Wu MH, 2011, INFECT IMMUN, V79, P2709, DOI 10.1128/IAI.00144-11; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yasuda T, 2008, CRIT CARE MED, V36, P2048, DOI 10.1097/CCM.0b013e31817b8824; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	53	44	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68640	10.1371/journal.pone.0068640	http://dx.doi.org/10.1371/journal.pone.0068640			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844229	Green Submitted, Green Published, gold			2022-12-27	WOS:000321733000020
J	Dishowitz, MI; Mutyaba, PL; Takacs, JD; Barr, AM; Engiles, JB; Ahn, J; Hankenson, KD				Dishowitz, Michael I.; Mutyaba, Patricia L.; Takacs, Joel D.; Barr, Andrew M.; Engiles, Julie B.; Ahn, Jaimo; Hankenson, Kurt D.			Systemic Inhibition of Canonical Notch Signaling Results in Sustained Callus Inflammation and Alters Multiple Phases of Fracture Healing	PLOS ONE			English	Article							OSTEOBLAST DIFFERENTIATION; FUTURE-DIRECTIONS; BONE REGENERATION; TRANSGENIC MICE; CELLS; ARTHRITIS; ACTIVATION; REPAIR; THROMBOSPONDIN-2; PROLIFERATION	The Notch signaling pathway is an important regulator of embryological bone development, and many aspects of development are recapitulated during bone repair. We have previously reported that Notch signaling components are upregulated during bone fracture healing. However, the significance of the Notch pathway in bone regeneration has not been described. Therefore, the objective of this study was to determine the importance of Notch signaling in regulating bone fracture healing by using a temporally controlled inducible transgenic mouse model (Mx1-Cre; dnMAML(f/-)) to impair RBPjk-mediated canonical Notch signaling. The Mx1 promoter was synthetically activated resulting in temporally regulated systemic dnMAML expression just prior to creation of bilateral tibial fractures. This allowed for mice to undergo unaltered embryological and post-natal skeletal development. Results showed that systemic Notch inhibition prolonged expression of inflammatory cytokines and neutrophil cell inflammation, and reduced the proportion of cartilage formation within the callus at 10 days-post-fracture (dpf) Notch inhibition did not affect early bone formation at 10dpf, but significantly altered bone maturation and remodeling at 20dpf. Increased bone volume fraction in dnMAML fractures, which was due to a moderate decrease in callus size with no change in bone mass, coincided with increased trabecular thickness but decreased connectivity density, indicating that patterning of bone was altered. Notch inhibition decreased total osteogenic cell density, which was comprised of more osteocytes rather than osteoblasts. dnMAML also decreased osteoclast density, suggesting that osteoclast activity may also be important for altered fracture healing. It is likely that systemic Notch inhibition had both direct effects within cell types as well as indirect effects initiated by temporally upstream events in the fracture healing cascade. Surprisingly, Notch inhibition did not alter cell proliferation. In conclusion, our results demonstrate that the Notch signaling pathway is required for the proper temporal progression of events required for successful bone fracture healing.	[Dishowitz, Michael I.; Barr, Andrew M.] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA; [Mutyaba, Patricia L.; Takacs, Joel D.; Hankenson, Kurt D.] Univ Penn, Sch Vet Med, Dept Clin Studies, New Bolton Ctr, Philadelphia, PA 19104 USA; [Engiles, Julie B.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Ahn, Jaimo; Hankenson, Kurt D.] Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Hankenson, KD (corresponding author), Univ Penn, Sch Vet Med, Dept Clin Studies, New Bolton Ctr, Philadelphia, PA 19104 USA.	kdhank@vet.upenn.edu	Hankenson, Kurt/AFS-9417-2022; Engiles, Julie/K-1916-2015; Hankenson, Kurt/ABI-1547-2020	Hankenson, Kurt/0000-0001-6361-143X; Engiles, Julie/0000-0001-9057-2093; 	Congressionally Directed Medical Research Program [W81XWH-10-1-0825]; Osteosynthesis and Trauma Care Foundation; Penn Center for Musculoskeletal Disorders (National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases) [P30 AR050950]; Ruth L. Kirschstein National Research Service Award (NIH/National Institute of Dental and Craniofacial Research) [F31DE020231]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F31DE020231] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T35OD010919] Funding Source: NIH RePORTER	Congressionally Directed Medical Research Program(United States Department of Defense); Osteosynthesis and Trauma Care Foundation; Penn Center for Musculoskeletal Disorders (National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases); Ruth L. Kirschstein National Research Service Award (NIH/National Institute of Dental and Craniofacial Research); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Congressionally Directed Medical Research Program (W81XWH-10-1-0825), the Osteosynthesis and Trauma Care Foundation, and the Penn Center for Musculoskeletal Disorders (National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases P30 AR050950). MID was supported by a Ruth L. Kirschstein National Research Service Award (NIH/National Institute of Dental and Craniofacial Research F31DE020231). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alblowi J, 2009, AM J PATHOL, V175, P1574, DOI 10.2353/ajpath.2009.090148; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Audige L, 2005, CLIN ORTHOP RELAT R, P221, DOI 10.1097/01.blo.0000163836.66906.74; Bai S, 2008, J BIOL CHEM, V283, P6509, DOI 10.1074/jbc.M707000200; Bastian O, 2011, J LEUKOCYTE BIOL, V89, P669, DOI 10.1189/jlb.0810446; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Braithwaite RS, 2003, J AM GERIATR SOC, V51, P364, DOI 10.1046/j.1532-5415.2003.51110.x; Buie HR, 2008, J BONE MINER RES, V23, P2048, DOI 10.1359/JBMR.080808; Canalis E, 2013, ENDOCRINOLOGY, V154, P623, DOI 10.1210/en.2012-1732; Caparbo VF, 2009, CLIN RHEUMATOL, V28, P71, DOI 10.1007/s10067-008-0985-y; Cappellen D, 2002, J BIOL CHEM, V277, P21971, DOI 10.1074/jbc.M200434200; Cardoso L, 2009, J BONE MINER RES, V24, P597, DOI 10.1359/JBMR.081210; Carragee EJ, 2011, SPINE J, V11, P695, DOI 10.1016/j.spinee.2011.08.418; Chigurupati S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001167; Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66; Dishowitz MI, 2012, J ORTHOP RES, V30, P296, DOI 10.1002/jor.21518; Dong YF, 2010, DEVELOPMENT, V137, P1461, DOI 10.1242/dev.042911; Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7; Emerton KB, 2010, BONE, V46, P577, DOI 10.1016/j.bone.2009.11.006; Engin FZ, 2008, NAT MED, V14, P299, DOI 10.1038/nm1712; Ferguson C, 1999, MECH DEVELOP, V87, P57, DOI 10.1016/S0925-4773(99)00142-2; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Gerstenfeld LC, 2005, J BONE MINER RES, V20, P1715, DOI 10.1359/JBMR.050702; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Hankenson KD, 2000, J BONE MINER RES, V15, P851, DOI 10.1359/jbmr.2000.15.5.851; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Kohn A, 2012, DEVELOPMENT, V139, P1198, DOI 10.1242/dev.070649; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lubberts E, 2001, J IMMUNOL, V167, P1004, DOI 10.4049/jimmunol.167.2.1004; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Maillard I, 2008, CELL STEM CELL, V2, P356, DOI 10.1016/j.stem.2008.02.011; Maillard I, 2006, J EXP MED, V203, P2239, DOI 10.1084/jem.20061020; Mead TJ, 2009, P NATL ACAD SCI USA, V106, P14420, DOI 10.1073/pnas.0902306106; Mountziaris PM, 2011, TISSUE ENG PART B-RE, V17, P393, DOI [10.1089/ten.teb.2011.0182, 10.1089/ten.TEB.2011.0182]; Niki Y, 2001, J CLIN INVEST, V107, P1127, DOI 10.1172/JCI11530; Oldershaw RA, 2008, STEM CELLS, V26, P666, DOI 10.1634/stemcells.2007-0806; Ostroukhova M, 2006, J CLIN INVEST, V116, P996, DOI 10.1172/JCI26490; Salie R, 2010, BONE, V46, P680, DOI 10.1016/j.bone.2009.10.022; Shitaye H, 2010, POSTNATAL EXPRESSION; Tao JN, 2010, J BONE MINER RES, V25, P2175, DOI 10.1002/jbmr.115; Taylor DK, 2009, J BONE MINER RES, V24, P1043, DOI [10.1359/jbmr.090101, 10.1359/JBMR.090101]; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923; Vortkamp A, 1998, MECH DEVELOP, V71, P65, DOI 10.1016/S0925-4773(97)00203-7; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Zanotti S, 2008, ENDOCRINOLOGY, V149, P3890, DOI 10.1210/en.2008-0140	46	42	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68726	10.1371/journal.pone.0068726	http://dx.doi.org/10.1371/journal.pone.0068726			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844237	Green Submitted, Green Published, gold			2022-12-27	WOS:000321733000025
J	El-Halfawy, OM; Valvano, MA				El-Halfawy, Omar M.; Valvano, Miguel A.			Chemical Communication of Antibiotic Resistance by a Highly Resistant Subpopulation of Bacterial Cells	PLOS ONE			English	Article							POLYMYXIN-B RESISTANCE; ESCHERICHIA-COLI-CELLS; BURKHOLDERIA-CENOCEPACIA; PSEUDOMONAS-AERUGINOSA; OXIDATIVE STRESS; POLYAMINES; GENE; LIPOPOLYSACCHARIDE; PEPTIDE; AMINOARABINOSE	The overall antibiotic resistance of a bacterial population results from the combination of a wide range of susceptibilities displayed by subsets of bacterial cells. Bacterial heteroresistance to antibiotics has been documented for several opportunistic Gram-negative bacteria, but the mechanism of heteroresistance is unclear. We use Burkholderia cenocepacia as a model opportunistic bacterium to investigate the implications of heterogeneity in the response to the antimicrobial peptide polymyxin B (PmB) and also other bactericidal antibiotics. Here, we report that B. cenocepacia is heteroresistant to PmB. Population analysis profiling also identified B. cenocepacia subpopulations arising from a seemingly homogenous culture that are resistant to higher levels of polymyxin B than the rest of the cells in the culture, and can protect the more sensitive cells from killing, as well as sensitive bacteria from other species, such as Pseudomonas aeruginosa and Escherichia coli. Communication of resistance depended on upregulation of putrescine synthesis and YceI, a widely conserved low-molecular weight secreted protein. Deletion of genes for the synthesis of putrescine and YceI abrogate protection, while pharmacologic inhibition of putrescine synthesis reduced resistance to polymyxin B. Polyamines and YceI were also required for heteroresistance of B. cenocepacia to various bactericidal antibiotics. We propose that putrescine and YceI resemble "danger" infochemicals whose increased production by a bacterial subpopulation, becoming more resistant to bactericidal antibiotics, communicates higher level of resistance to more sensitive members of the population of the same or different species.	[El-Halfawy, Omar M.; Valvano, Miguel A.] Univ Western Ontario, Ctr Human Immunol, London, ON, Canada; [El-Halfawy, Omar M.; Valvano, Miguel A.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada; [El-Halfawy, Omar M.] Univ Alexandria, Fac Pharm, Dept Pharmaceut Microbiol, Alexandria, Egypt; [Valvano, Miguel A.] Queens Univ Belfast, Ctr Infect & Immun, Belfast, Antrim, North Ireland	Western University (University of Western Ontario); Western University (University of Western Ontario); Egyptian Knowledge Bank (EKB); Alexandria University; Queens University Belfast	Valvano, MA (corresponding author), Univ Western Ontario, Ctr Human Immunol, London, ON, Canada.	m.valvano@qub.ac.uk	Valvano, Miguel A/G-8759-2012; El-Halfawy, Omar/AAE-2491-2020	Valvano, Miguel A/0000-0001-8229-3641; El-Halfawy, Omar/0000-0003-2829-5851	Cystic Fibrosis Canada and a Marie Curie Career Integration Grant [618095]; Ontario Graduate Scholarship	Cystic Fibrosis Canada and a Marie Curie Career Integration Grant; Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This research was supported by a grant from Cystic Fibrosis Canada and a Marie Curie Career Integration Grant, project 618095. O.M.E. was supported by an Ontario Graduate Scholarship. M.A.V. held a Canada Research Chair in Infectious Diseases and Microbial Pathogenesis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JM, 2009, J ANTIMICROB CHEMOTH, V64, P454, DOI 10.1093/jac/dkp244; Bernier SP, 2011, MOL MICROBIOL, V81, P705, DOI 10.1111/j.1365-2958.2011.07724.x; Cardona ST, 2005, PLASMID, V54, P219, DOI 10.1016/j.plasmid.2005.03.004; Dubey GP, 2011, CELL, V144, P590, DOI 10.1016/j.cell.2011.01.015; FAY GD, 1972, APPL MICROBIOL, V23, P710, DOI 10.1128/AEM.23.4.710-713.1972; Flannagan RS, 2008, ENVIRON MICROBIOL, V10, P1652, DOI 10.1111/j.1462-2920.2008.01576.x; Gao JL, 2004, MOL MICROBIOL, V53, P1757, DOI 10.1111/j.1365-2958.2004.04240.x; Gill SS, 2010, PLANT SIGNAL BEHAV, V5, P26, DOI 10.4161/psb.5.1.10291; Hamad MA, 2012, MOL MICROBIOL, V85, P962, DOI 10.1111/j.1365-2958.2012.08154.x; HIRSCH JG, 1952, J EXP MED, V95, P191, DOI 10.1084/jem.95.2.191; Johnson L, 2012, J BACTERIOL, V194, P813, DOI 10.1128/JB.05230-11; Joshi GS, 2011, MOL MICROBIOL, V82, P9, DOI 10.1111/j.1365-2958.2011.07809.x; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; KREUZER K, 1975, GENETICS, V81, P457; Kwon DH, 2006, ANTIMICROB AGENTS CH, V50, P1615, DOI 10.1128/AAC.50.5.1615-1622.2006; Kwon DH, 2007, ANTIMICROB AGENTS CH, V51, P2070, DOI 10.1128/AAC.01472-06; Larque E, 2007, NUTRITION, V23, P87, DOI 10.1016/j.nut.2006.09.006; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Loutet SA, 2006, J BACTERIOL, V188, P2073, DOI 10.1128/JB.188.6.2073-2080.2006; Loutet SA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-472; Loutet SA, 2011, ENV MICROBIOL REP, V3, P278, DOI 10.1111/j.1758-2229.2010.00222.x; Loutet SA, 2010, INFECT IMMUN, V78, P4088, DOI 10.1128/IAI.00212-10; Loutet SA, 2009, MICROBIOL-SGM, V155, P2029, DOI 10.1099/mic.0.027607-0; Marolda Cristina L., 2006, V347, P237; Nikaido H, 2001, SEMIN CELL DEV BIOL, V12, P215, DOI 10.1006/scdb.2000.0247; Ortega XP, 2007, J BACTERIOL, V189, P3639, DOI 10.1128/JB.00153-07; Peeters E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-90; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rosales-Reyes R, 2012, MICROBIOL-SGM, V158, P2315, DOI 10.1099/mic.0.060988-0; Ross BM, 2009, RAPID COMMUN MASS SP, V23, P3973, DOI 10.1002/rcm.4340; Schmerk CL, 2011, J BACTERIOL, V193, P6712, DOI 10.1128/JB.05979-11; Sisinni L, 2010, FEBS J, V277, P1896, DOI 10.1111/j.1742-4658.2010.07612.x; SOKOL PA, 1979, J CLIN MICROBIOL, V9, P538; Tkachenko AG, 2006, BIOCHEMISTRY-MOSCOW+, V71, P185, DOI 10.1134/S0006297906020118; Tkachenko AG, 2012, RES MICROBIOL, V163, P83, DOI 10.1016/j.resmic.2011.10.009; Vega NM, 2012, NAT CHEM BIOL, V8, P431, DOI [10.1038/NCHEMBIO.915, 10.1038/nchembio.915]; Wortham BW, 2007, ADV EXP MED BIOL, V603, P106; Wright RM, 2001, J CLIN PATHOL, V54, P803, DOI 10.1136/jcp.54.10.803; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zhang MH, 2000, CRIT CARE MED, V28, pN60, DOI 10.1097/00003246-200004001-00007	40	55	60	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68874	10.1371/journal.pone.0068874	http://dx.doi.org/10.1371/journal.pone.0068874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844246	Green Submitted, gold, Green Published			2022-12-27	WOS:000321733000030
J	Kellner, S; Kollar, LB; Ochel, A; Ghate, M; Helm, M				Kellner, Stefanie; Kollar, Laura Bettina; Ochel, Antonia; Ghate, Manjunath; Helm, Mark			Structure-Function Relationship of Substituted Bromomethylcoumarins in Nucleoside Specificity of RNA Alkylation	PLOS ONE			English	Article							COVALENT ATTACHMENT; RIBOSOMAL-RNA; DNA; PSEUDOURIDINE; CHEMISTRY; DERIVATIZATION; FLUOROPHORES; NUCLEOTIDES; YEAST; TOOL	Selective alkylation of RNA nucleotides is an important field of RNA biochemistry, e. g. in applications of fluorescent labeling or in structural probing experiments, yet detailed structure-function studies of labeling agents are rare. Here, bromomethylcoumarins as reactive compounds for fluorescent labeling of RNA are developed as an attractive scaffold on which electronic properties can be modulated by varying the substituents. Six different 4-bromomethylcoumarins of various substitution patterns were tested for nucleotide specificity of RNA alkylation using tRNA from Escherichia coli as substrate. Using semi-quantitative LC-MS/MS analysis, reactions at mildly acidic and slightly alkaline pH were compared. For all tested compounds, coumarin conjugates with 4-thiouridine, pseudouridine, guanosine, and uridine were identified, with the latter largely dominating. This data set shows that selectivity of ribonucleotide alkylation depends on the substitution pattern of the reactive dye, and even more strongly on the modulation of the reaction conditions. The latter should be therefore carefully optimized when striving to achieve selectivity. Interestingly, the highest selectivity for labeling of a modified nucleoside, namely of 4-thiouridine, was achieved with a compound whose selectivity was somewhat less dependent on reaction conditions than the other compounds. In summary, bromomethylcoumarin derivatives are a highly interesting class of compounds, since their selectivity for 4-thiouridine can be efficiently tuned by variation of substitution pattern and reaction conditions.	[Kellner, Stefanie; Kollar, Laura Bettina; Ochel, Antonia; Helm, Mark] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, D-55122 Mainz, Germany; [Ghate, Manjunath] Nirma Univ, Inst Pharm, Ahmadabad, Gujarat, India	Johannes Gutenberg University of Mainz; Nirma University	Helm, M (corresponding author), Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, D-55122 Mainz, Germany.	mhelm@uni-mainz.de	Helm, Mark/AAD-5433-2022; Ghate, Manjunath/E-7576-2015	/0000-0003-3224-7502; Ghate, Manjunath/0000-0001-7564-903X; Helm, Mark/0000-0002-0154-0928	DFG [HE3397/4, INST 247/622-1]	DFG(German Research Foundation (DFG))	This work was in part supported by the DFG (HE3397/4 and INST 247/622-1) to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	BAKIN A, 1993, BIOCHEMISTRY-US, V32, P9754, DOI 10.1021/bi00088a030; Behm-Ansmant I, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/408053; BURGER A, 1947, J ORG CHEM, V12, P342, DOI 10.1021/jo01166a021; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Durairaj A, 2008, RAPID COMMUN MASS SP, V22, P3727, DOI 10.1002/rcm.3789; EHRESMANN C, 1987, NUCLEIC ACIDS RES, V15, P9109, DOI 10.1093/nar/15.22.9109; El-Sagheer AH, 2010, P NATL ACAD SCI USA, V107, P15329, DOI 10.1073/pnas.1006447107; Emmerechts G, 2005, J CHROMATOGR B, V825, P233, DOI 10.1016/j.jchromb.2005.06.041; Fauster K, 2012, ACS CHEM BIOL, V7, P581, DOI 10.1021/cb200510k; Ghate M, 2003, EUR J MED CHEM, V38, P297, DOI 10.1016/S0223-5234(03)00016-3; Giege R, 1999, COMPREHENSIVE NATURA, P63; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Jahn K, 2011, BIOCONJUGATE CHEM, V22, P95, DOI 10.1021/bc100422k; Jao CY, 2008, P NATL ACAD SCI USA, V105, P15779, DOI 10.1073/pnas.0808480105; Jurkowski TP, 2008, RNA, V14, P1663, DOI 10.1261/rna.970408; JUZUMIENE DI, 1995, J BIOL CHEM, V270, P12794, DOI 10.1074/jbc.270.21.12794; KASAI H, 1979, NUCLEIC ACIDS RES, V7, P231, DOI 10.1093/nar/7.1.231; Kellner S, 2011, NUCLEIC ACIDS RES, V39, P7348, DOI 10.1093/nar/gkr449; Keri RS, 2010, EUR J MED CHEM, V45, P2597, DOI 10.1016/j.ejmech.2010.02.048; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Kimoto M, 2010, J AM CHEM SOC, V132, P4988, DOI 10.1021/ja100806c; Lee TH, 2007, BIOPHYS J, V92, P3275, DOI 10.1529/biophysj.106.094623; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P11063, DOI 10.1073/pnas.1106501108; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; Meyer KC, 2012, DIFFUSE LUNG DISEASE: A PRACTICAL APPROACH, SECOND EDITION, P3, DOI 10.1007/978-1-4419-9771-5_1; Motorin Y, 2011, NUCLEIC ACIDS RES, V39, P1943, DOI 10.1093/nar/gkq825; Ouellet J, 2011, BIOPHYS J, V101, P1148, DOI 10.1016/j.bpj.2011.07.007; PEATTIE DA, 1980, P NATL ACAD SCI-BIOL, V77, P4679, DOI 10.1073/pnas.77.8.4679; PLUMBRIDGE JA, 1980, NUCLEIC ACIDS RES, V8, P827; PREJEAN JD, 1984, DRUG METAB REV, V15, P619, DOI 10.3109/03602538409029975; Proudnikov D, 1996, NUCLEIC ACIDS RES, V24, P4535, DOI 10.1093/nar/24.22.4535; Qin PZF, 1999, METHODS, V18, P60, DOI 10.1006/meth.1999.0757; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SINGER B, 1976, NATURE, V264, P333, DOI 10.1038/264333a0; Singer B, 2010, PYRIMIDINES NUCLEOSI, P269; Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942; SPRINZL M, 1974, EUR J BIOCHEM, V49, P595, DOI 10.1111/j.1432-1033.1974.tb03863.x; Threlfall RN, 2012, ORG BIOMOL CHEM, V10, P746, DOI 10.1039/c1ob06614e; Underwood JG, 2010, NAT METHODS, V7, P995, DOI 10.1038/NMETH.1529; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilkinson KA, 2005, J AM CHEM SOC, V127, P4659, DOI 10.1021/ja0436749; Wintermeyer W, 1979, Methods Enzymol, V59, P110; Xie Y, 2010, J AM CHEM SOC, V132, P11896, DOI 10.1021/ja105244t; YANG CH, 1974, BIOCHEMISTRY-US, V13, P3615, DOI 10.1021/bi00714a033; YANG CH, 1973, J BIOCHEM-TOKYO, V73, P1243, DOI 10.1093/oxfordjournals.jbchem.a130197; YOSHIDA M, 1968, BIOCHIM BIOPHYS ACTA, V157, P455, DOI 10.1016/0005-2787(68)90145-7	46	9	9	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67945	10.1371/journal.pone.0067945	http://dx.doi.org/10.1371/journal.pone.0067945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844135	Green Submitted, gold, Green Published			2022-12-27	WOS:000321733000118
J	Kypriotou, M; Boechat, C; Huber, M; Hohl, D				Kypriotou, Magdalini; Boechat, Cloe; Huber, Marcel; Hohl, Daniel			Spontaneous Atopic Dermatitis-Like Symptoms in a/a ma ft/ma ft/J Flaky Tail Mice Appear Early after Birth	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; OF-FUNCTION MUTATIONS; NF-KAPPA-B; ICHTHYOSIS VULGARIS; BARRIER FUNCTION; CORNIFIED ENVELOPE; STRATUM-CORNEUM; ALLERGIC INFLAMMATION; FILAGGRIN DEFICIENCY; TOPICAL APPLICATION	Loss-of-function mutations in human profilaggrin gene have been identified as the cause of ichthyosis vulgaris (IV), and as a major predisposition factor for atopic dermatitis (AD). Similarly, flaky tail (a/a ma ft/ma ft/J) mice were described as a model for IV, and shown to be predisposed to eczema. The aim of this study was to correlate the flaky tail mouse phenotype with human IV and AD, in order to dissect early molecular events leading to atopic dermatitis in mice and men, suffering from filaggrin deficiency. Thus, 5-days old flaky tail pups were analyzed histologically, expression of cytokines was measured in skin and signaling pathways were investigated by protein analysis. Human biopsies of IV and AD patients were analyzed histologically and by real time PCR assays. Our data show acanthosis and hyperproliferation in flaky tail epidermis, associated with increased IL1 beta and thymic stromal lymphopoietin (TSLP) expression, and Th2-polarization. Consequently, NFkB and Stat pathways were activated, and IL6 mRNA levels were increased. Further, quantitative analysis of late epidermal differentiation markers revealed increased Small proline-rich protein 2A (Sprr2a) synthesis. Th2-polarization and Sprr2a increase may result from high TSLP expression, as shown after analysis of 5-days old K14-TSLP tg mouse skin biopsies. Our findings in the flaky tail mouse correlate with data obtained from patient biopsies of AD, but not IV. We propose that proinflammatory cytokines are responsible for acanthosis in flaky tail epidermis, and together with the Th2-derived cytokines lead to morphological changes. Accordingly, the a/a ma ft/ma ft/J mouse model can be used as an appropriate model to study early AD onset associated with profilaggrin deficiency.	[Kypriotou, Magdalini; Boechat, Cloe; Huber, Marcel; Hohl, Daniel] CHU Vaudois, Beaumont Hosp, Serv Dermatol & Venereol, Lab Cutaneous Biol, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Hohl, D (corresponding author), CHU Vaudois, Beaumont Hosp, Serv Dermatol & Venereol, Lab Cutaneous Biol, Lausanne, Switzerland.	Daniel.Hohl@chuv.ch	Huber, Marcel/M-8822-2016; Hohl, Daniel M/N-7554-2016	Huber, Marcel/0000-0003-3821-2378; 	National Swiss Foundation [31003A-120343]; Gottfried und Julia Bangerter-Rhyner-Stiftung	National Swiss Foundation(Swiss National Science Foundation (SNSF)); Gottfried und Julia Bangerter-Rhyner-Stiftung	The project was funded by the National Swiss Foundation Project #31003A-120343 and by the Gottfried und Julia Bangerter-Rhyner-Stiftung (http://www.bangerter-stiftung.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelova-Fischer I, 2010, J INVEST DERMATOL, V130, P2505, DOI 10.1038/jid.2010.143; Baron SE, 2012, CLIN EXP DERMATOL, V37, P7, DOI 10.1111/j.1365-2230.2012.04336.x; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Bieber T, 2010, ANN DERMATOL, V22, P125, DOI 10.5021/ad.2010.22.2.125; Bonilla IE, 2002, J NEUROSCI, V22, P1303, DOI 10.1523/JNEUROSCI.22-04-01303.2002; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Chappaz S, 2007, BLOOD, V110, P3862, DOI 10.1182/blood-2007-02-074245; Dale BA, 1997, J INVEST DERMATOL, V108, P179, DOI 10.1111/1523-1747.ep12334205; Demehri S, 2012, CANCER CELL, V22, P494, DOI 10.1016/j.ccr.2012.08.017; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; Di Piazza M, 2012, CANCER CELL, V22, P479, DOI 10.1016/j.ccr.2012.08.016; Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9; Dumortier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009258; Fallon PG, 2009, NAT GENET, V41, P602, DOI 10.1038/ng.358; Fernandez MI, 2011, BLOOD, V118, P3862, DOI 10.1182/blood-2010-12-323089; FROST P, 1966, ARCH DERMATOL, V94, P113, DOI 10.1001/archderm.94.2.113; GRECO MA, 1995, J INVEST DERMATOL, V104, P204, DOI 10.1111/1523-1747.ep12612759; Holzmann S, 2004, J INVEST DERMATOL, V122, P1165, DOI 10.1111/j.0022-202X.2004.22520.x; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Jutel M, 2011, CURR ALLERGY ASTHM R, V11, P139, DOI 10.1007/s11882-011-0178-7; Kamekura R, 2010, HISTOCHEM CELL BIOL, V133, P339, DOI 10.1007/s00418-009-0674-1; Kawasaki H, 2010, INT IMMUNOLOGY, V22, piii63; Kawasaki H, 2012, J ALLERGY CLIN IMMUN, V129, P1538, DOI 10.1016/j.jaci.2012.01.068; Keratinocytes Nickoloff BJ, 1994, J AM ACAD DERMATOL, V30, P535; Kezic S, 2012, J ALLERGY CLIN IMMUN, V129, P1031, DOI 10.1016/j.jaci.2011.12.989; Koch PJ, 2000, J CELL BIOL, V151, P389, DOI 10.1083/jcb.151.2.389; Lee HC, 2007, P NATL ACAD SCI USA, V104, P914, DOI 10.1073/pnas.0607305104; Leung DYM, 2004, J CLIN INVEST, V113, P651, DOI 10.1172/JCI200421060; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mildner M, 2010, J INVEST DERMATOL, V130, P2286, DOI 10.1038/jid.2010.115; Moniaga CS, 2013, AM J PATHOL, V182, P841, DOI 10.1016/j.ajpath.2012.11.039; Moniaga CS, 2010, AM J PATHOL, V176, P2385, DOI 10.2353/ajpath.2010.090957; Mueller A, 2003, P NATL ACAD SCI USA, V100, P1292, DOI 10.1073/pnas.242741699; Nakamura H, 2002, GENE THER, V9, P1221, DOI 10.1038/sj.gt.3301724; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Nozaki I, 2005, LAB INVEST, V85, P109, DOI 10.1038/labinvest.3700213; O'Regan GM, 2008, J ALLERGY CLIN IMMUN, V122, P689, DOI 10.1016/j.jaci.2008.08.002; Obarzanek-Fojt M, 2011, EUR J CELL BIOL, V90, P279, DOI 10.1016/j.ejcb.2010.11.001; Oji V, 2010, J AM ACAD DERMATOL, V63, P607, DOI 10.1016/j.jaad.2009.11.020; Okano J, 2012, J CELL SCI, V125, P1827, DOI 10.1242/jcs.101550; Okulicz JF, 2003, INT J DERMATOL, V42, P95, DOI 10.1046/j.1365-4362.2003.01308.x; Oyoshi MK, 2010, J ALLERGY CLIN IMMUN, V126, P976, DOI 10.1016/j.jaci.2010.08.041; Oyoshi MK, 2009, J ALLERGY CLIN IMMUN, V124, P485, DOI 10.1016/j.jaci.2009.05.042; Pradervand S, 2004, EMBO J, V23, P4517, DOI 10.1038/sj.emboj.7600454; Presland RB, 2000, J INVEST DERMATOL, V115, P1072, DOI 10.1046/j.1523-1747.2000.00178.x; Quentmeier H, 2001, LEUKEMIA, V15, P1286, DOI 10.1038/sj.leu.2402175; Rice RH, 1999, ANAT RECORD, V254, P231; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Sandilands A, 2007, NAT GENET, V39, P650, DOI 10.1038/ng2020; Sandilands A, 2007, J INVEST DERMATOL, V127, P1282, DOI 10.1038/sj.jid.5700876; Schafer M, 2012, EMBO MOL MED, V4, P364, DOI 10.1002/emmm.201200219; Scharschmidt TC, 2009, J ALLERGY CLIN IMMUN, V124, P496, DOI 10.1016/j.jaci.2009.06.046; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shan LY, 2010, J IMMUNOL, V184, P7134, DOI 10.4049/jimmunol.0902515; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Stern LE, 2001, J PEDIATR SURG, V36, P190, DOI 10.1053/jpsu.2001.20050; Tanaka A, 2007, J INVEST DERMATOL, V127, P855, DOI 10.1038/sj.jid.5700603; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; TOSHITANI A, 1993, J INVEST DERMATOL, V100, P299, DOI 10.1111/1523-1747.ep12469875; Vercelli D, 2009, NAT GENET, V41, P512, DOI 10.1038/ng0509-512; Vermeij WP, 2011, J INVEST DERMATOL, V131, P1435, DOI 10.1038/jid.2010.433; Vermeij WP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011957; Yano S, 2008, J CELL PHYSIOL, V214, P1, DOI 10.1002/jcp.21300; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Zimmermann N, 2005, AM J RESP CELL MOL, V32, P428, DOI 10.1165/rcmb.2004-0269OC	66	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67869	10.1371/journal.pone.0067869	http://dx.doi.org/10.1371/journal.pone.0067869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844115	Green Published, gold, Green Submitted			2022-12-27	WOS:000321733000110
J	Wang, CL; Zhao, Y; Su, YY; Li, RM; Lin, YF; Zhou, XD; Ye, L				Wang, Chenglin; Zhao, Yuan; Su, Yingying; Li, Ruimin; Lin, Yunfeng; Zhou, Xuedong; Ye, Ling			C-Jun N-Terminal Kinase (JNK) Mediates Wnt5a-Induced Cell Motility Dependent or Independent of RhoA Pathway in Human Dental Papilla Cells	PLOS ONE			English	Article							WNT SIGNALING PATHWAY; BETA-CATENIN; TYROSINE PHOSPHORYLATION; FOCAL ADHESIONS; TISSUE INTERACTIONS; ACTIN ORGANIZATION; APICAL PAPILLA; EXPRESSION; PAXILLIN; POLARITY	Wnt5a plays an essential role in tissue development by regulating cell migration, though the molecular mechanisms are still not fully understood. Our study investigated the pathways involved in Wnt5a-dependent cell motility during the formation of dentin and pulp. Over-expression of Wnt5a promoted cell adhesion and formation of focal adhesion complexes (FACs) in human dental papilla cells (hDPCs), while inhibiting cell migration. Instead of activating the canonical Wnt signal pathway in hDPCs, Wnt5a stimulation induced activation of the JNK signal in a RhoA-dependent or independent manner. Inhibiting JNK abrogated Wnt5a-induced FACs formation but not cytoskeletal rearrangement. Both dominant negative RhoA (RhoA T19N) and constitutively active RhoA mutants (RhoA Q63L) blocked the Wnt5a-dependent changes in hDPCs adhesion, migration and cytoskeletal rearrangement here too, with the exception of the formation of FACs. Taken together, our study suggested that RhoA and JNK signaling have roles in mediating Wnt5a-dependent adhesion and migration in hDPCs, and the Wnt5a/JNK pathway acts both dependently and independently of the RhoA pathway.	[Wang, Chenglin; Zhao, Yuan; Su, Yingying; Li, Ruimin; Lin, Yunfeng; Zhou, Xuedong; Ye, Ling] Sichuan Univ, State Key Lab Oral Dis, Chengdu 610064, Sichuan, Peoples R China; [Wang, Chenglin; Zhao, Yuan; Su, Yingying; Li, Ruimin; Lin, Yunfeng; Zhou, Xuedong; Ye, Ling] Sichuan Univ, West China Sch Stomatol, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University	Ye, L (corresponding author), Sichuan Univ, State Key Lab Oral Dis, Chengdu 610064, Sichuan, Peoples R China.	yeling@scu.edu.cn	ZHOU, XUE/F-6129-2013; wang, meng/GWZ-9558-2022; ye, ling/AFP-0048-2022; Lin, Yunfeng/H-3393-2011	ye, ling/0000-0002-8417-7676; Lin, Yunfeng/0000-0003-1224-6561; Zhou, Xuedong/0000-0002-9319-7302; Wang, Chenglin/0000-0002-6117-6996	NSFC [81070801, 81200759]; New Century Excellent Talents Fund [NCET-10-0577]; Innovative Research Team of Education Department of Sichuan Province [13TD0038]; Sichuan Province Science and Technology Support Program [2012SZ0034]; Scientific Research Foundation of Sichuan University Young Teachers [2012SCU11900-4]	NSFC(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents Fund(Program for New Century Excellent Talents in University (NCET)); Innovative Research Team of Education Department of Sichuan Province; Sichuan Province Science and Technology Support Program; Scientific Research Foundation of Sichuan University Young Teachers	This work was supported by NSFC Grant 81070801 and 81200759, New Century Excellent Talents Fund NCET-10-0577, Innovative Research Team of Education Department of Sichuan Province 13TD0038, Sichuan Province Science and Technology Support Program 2012SZ0034 and Scientific Research Foundation of Sichuan University Young Teachers 2012SCU11900-4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts AS, 1998, EMBO J, V17, P4075, DOI 10.1093/emboj/17.14.4075; Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Allen WE, 1997, J CELL SCI, V110, P707; Aman A, 2010, DEV BIOL, V341, P20, DOI 10.1016/j.ydbio.2009.11.014; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Banyard J, 2000, ONCOGENE, V19, P580, DOI 10.1038/sj.onc.1203338; Bikkavilli RK, 2008, J CELL SCI, V121, P234, DOI 10.1242/jcs.021964; Biz MT, 2010, CELL TISSUE RES, V340, P459, DOI 10.1007/s00441-010-0961-0; Block MR, 2008, EUR J CELL BIOL, V87, P491, DOI 10.1016/j.ejcb.2008.02.012; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Chai Y, 2003, MICROSC RES TECHNIQ, V60, P469, DOI 10.1002/jemt.10287; Christiansen JH, 2000, CURR OPIN CELL BIOL, V12, P719, DOI 10.1016/S0955-0674(00)00158-7; Cox EA, 2001, MOL BIOL CELL, V12, P265, DOI 10.1091/mbc.12.2.265; Dejmek J, 2005, CANCER RES, V65, P9142, DOI 10.1158/0008-5472.CAN-05-1710; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Endo Y, 2005, J BIOL CHEM, V280, P777, DOI 10.1074/jbc.M406391200; Even-Ram S, 2009, EXTRACELLULAR MATRIX; Fuerer C, 2008, EMBO REP, V9, P134, DOI 10.1038/sj.embor.7401159; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Huang CL, 2005, J CLIN ONCOL, V23, P8765, DOI 10.1200/JCO.2005.02.2871; Huang GTJ, 2008, J ENDODONT, V34, P645, DOI 10.1016/j.joen.2008.03.001; Ikeda E, 2006, BIOCHEM BIOPH RES CO, V342, P1257, DOI 10.1016/j.bbrc.2006.02.101; Javelaud D, 2003, J BIOL CHEM, V278, P24624, DOI 10.1074/jbc.M301942200; Katoh M, 2005, ONCOL REP, V14, P1583; Katoh M, 2009, INT J MOL MED, V23, P763, DOI 10.3892/ijmm_00000190; Kikuchi A, 2012, ACTA PHYSIOL, V204, P17, DOI 10.1111/j.1748-1716.2011.02294.x; Kikuchi A, 2009, TRENDS CELL BIOL, V19, P119, DOI 10.1016/j.tcb.2009.01.003; Kim GH, 2005, DEV DYNAM, V232, P958, DOI 10.1002/dvdy.20262; Kirchner J, 2003, J CELL SCI, V116, P975, DOI 10.1242/jcs.00284; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Kremenevskaja N, 2005, ONCOGENE, V24, P2144, DOI 10.1038/sj.onc.1208370; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Lickert H, 2000, J BIOL CHEM, V275, P5090, DOI 10.1074/jbc.275.7.5090; Lin MK, 2011, DEV DYNAM, V240, P432, DOI 10.1002/dvdy.22550; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Medrek C, 2009, J BIOL CHEM, V284, P10968, DOI 10.1074/jbc.M804923200; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mlodzik M, 2002, TRENDS GENET, V18, P564, DOI 10.1016/S0168-9525(02)02770-1; Nakamura K, 2000, J BIOL CHEM, V275, P27155; Nomachi A, 2008, J BIOL CHEM, V283, P27973, DOI 10.1074/jbc.M802325200; Obara N, 2006, CELL TISSUE RES, V325, P197, DOI 10.1007/s00441-005-0136-6; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Peng L, 2010, INT ENDOD J, V43, P404, DOI 10.1111/j.1365-2591.2010.01693.x; Peng L, 2010, ARCH ORAL BIOL, V55, P108, DOI 10.1016/j.archoralbio.2009.12.002; Peng L, 2009, BIOCHEM BIOPH RES CO, V390, P1072, DOI 10.1016/j.bbrc.2009.10.136; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sarkar L, 1999, MECH DEVELOP, V85, P197, DOI 10.1016/S0925-4773(99)00095-7; Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016; Sonoyama W, 2008, J ENDODONT, V34, P166, DOI 10.1016/j.joen.2007.11.021; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Subauste MC, 2000, J BIOL CHEM, V275, P9725, DOI 10.1074/jbc.275.13.9725; Teramoto H, 1996, J BIOL CHEM, V271, P25731, DOI 10.1074/jbc.271.42.25731; THESLEFF I, 1981, DIFFERENTIATION, V18, P75, DOI 10.1111/j.1432-0436.1981.tb01107.x; Thesleff I, 1996, ANAT REC, V245, P151; Thesleff I, 1995, CONNECT TISSUE RES, V32, P9, DOI 10.3109/03008209509013700; THOMAS HF, 1989, ARCH ORAL BIOL, V34, P27, DOI 10.1016/0003-9969(89)90043-5; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Tsubouchi A, 2002, J CELL BIOL, V159, P673, DOI 10.1083/jcb.200202117; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; Vicente-Manzanares M, 2011, J CELL SCI, V124, P3923, DOI 10.1242/jcs.095653; Wang CL, 2010, J ENDODONT, V36, P238, DOI 10.1016/j.joen.2009.09.007; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314	78	3	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e69440	10.1371/journal.pone.0069440	http://dx.doi.org/10.1371/journal.pone.0069440			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844260	gold, Green Published, Green Submitted			2022-12-27	WOS:000321733000035
J	Tura, A; Sbrignadello, S; Mambelli, E; Ravazzani, P; Santoro, A; Pacini, G				Tura, Andrea; Sbrignadello, Stefano; Mambelli, Emanuele; Ravazzani, Paolo; Santoro, Antonio; Pacini, Giovanni			Sodium Concentration Measurement during Hemodialysis through Ion-Exchange Resin and Conductivity Measure Approach: In Vitro Experiments	PLOS ONE			English	Article							SELECTIVE ELECTRODES; POTASSIUM; PLASMA; DIALYSIS	Sodium measurement during hemodialysis treatment is important to preserve the patient from clinical events related to hypo- or hyper-natremia Usually, sodium measurement is performed through laboratory equipment which is typically expensive, and requires manual intervention. We propose a new method, based on conductivity measurement after treatment of dialysate solution through ion-exchange resin. To test this method, we performed in vitro experiments. We prepared 40 ml sodium chloride (NaCl) samples at 280, 140, 70, 35, 17.5, 8.75, 4.375 mEq/l, and some "mixed samples", i.e., with added potassium chloride (KCl) at different concentrations (4.375-17.5 mEq/l), to simulate the confounding factors in a conductivity-based sodium measurement. We measured the conductivity of all samples. Afterwards, each sample was treated for 1 min with 1 g of Dowex G-26 resin, and conductivity was measured again. On average, the difference in the conductivity between mixed samples and corresponding pure NaCl samples (at the same NaCl concentration) was 20.9%. After treatment with the exchange resin, it was 14.7%, i.e., 42% lower. Similar experiments were performed with calcium chloride and magnesium chloride as confounding factors, with similar results. We also performed some experiments on actual dialysate solution during hemodialysis sessions in 15 patients, and found that the correlation between conductivity measures and sodium concentration improved after resin treatment (R=0.839 before treatment, R=0.924 after treatment, P<0.0001). We conclude that ion-exchange resin treatment coupled with conductivity measures may improve the measurement of sodium compared to conductivity measures alone, and may become a possible simple approach for continuous and automatic sodium measurement during hemodialysis.	[Tura, Andrea; Sbrignadello, Stefano; Ravazzani, Paolo; Pacini, Giovanni] CNR, Inst Biomed Engn, Padua, Italy; [Mambelli, Emanuele; Santoro, Antonio] St Orsola Marcello Malpighi Hosp, Nephrol Dialysis & Hypertens Unit, Bologna, Italy	Consiglio Nazionale delle Ricerche (CNR); IRCCS Azienda Ospedaliero-Universitaria di Bologna	Tura, A (corresponding author), CNR, Inst Biomed Engn, Padua, Italy.	tura@isib.cnr.it	Ravazzani, Paolo/B-9139-2015	Ravazzani, Paolo/0000-0003-0282-3329; Sbrignadello, Stefano/0000-0002-3795-2887				Awan SA, 2005, IEEE T INSTRUM MEAS, V54, P516, DOI 10.1109/TIM.2005.843582; Burnett RW, 2000, CLIN CHEM LAB MED, V38, P1065, DOI 10.1515/CCLM.2000.159; Caduff A, 2011, DIABETOLOGIA, V54, P2678, DOI 10.1007/s00125-011-2210-9; Charra Bernard, 2007, Hemodial Int, V11, P21, DOI 10.1111/j.1542-4758.2007.00148.x; Goureau Y, 1990, ASAIO Trans, V36, pM444; Gourzi M., 2003, Journal of Medical Engineering & Technology, V27, P276, DOI 10.1080/0309190031000098845; Gourzi M., 2005, Journal of Medical Engineering & Technology, V29, P22, DOI 10.1080/03091900410001720247; Guyton AC, 1999, J AM SOC NEPHROL, V10, P2248; Hecking M, 2011, AM J NEPHROL, V33, P39, DOI 10.1159/000322572; Kim Gheun-Ho, 2009, Electrolyte Blood Press, V7, P31, DOI 10.5049/EBP.2009.7.2.31; Kitiyakara C, 2003, J AM SOC NEPHROL, V14, P2775, DOI 10.1097/01.ASN.0000092145.90389.65; LADENSON JH, 1977, J LAB CLIN MED, V90, P654; Locatelli F, 1995, INT J ARTIF ORGANS, V18, P716, DOI 10.1177/039139889501801106; MAAS AHJ, 1985, CLIN CHEM, V31, P482; Musso CG, 2009, INT UROL NEPHROL, V41, P357, DOI 10.1007/s11255-009-9548-7; PETITCLERC T, 1992, BLOOD PURIFICAT, V10, P309, DOI 10.1159/000170062; PETITCLERC T, 1993, INT J ARTIF ORGANS, V16, P585, DOI 10.1177/039139889301600804; PETITCLERC T, 1995, NEPHROL DIAL TRANSPL, V10, P212; Santos SFF, 2008, CLIN J AM SOC NEPHRO, V3, P522, DOI 10.2215/CJN.03360807; Sbrignadello S, 2013, J SPECTROSC, V2013, DOI 10.1155/2013/571372; Titze J, 2002, AM J PHYSIOL-RENAL, V283, pF134, DOI 10.1152/ajprenal.00323.2001; Tura A, 2007, BIOPHYS CHEM, V129, P235, DOI 10.1016/j.bpc.2007.06.001; Tura A, 2010, SENSORS-BASEL, V10, P5346, DOI 10.3390/s100605346; WORTH HGJ, 1985, ANN CLIN BIOCHEM, V22, P343, DOI 10.1177/000456328502200402	24	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e69227	10.1371/journal.pone.0069227	http://dx.doi.org/10.1371/journal.pone.0069227			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844253	Green Submitted, Green Published, gold			2022-12-27	WOS:000321341000186
J	Wu, P; Han, SH; Chen, T; Qin, GX; Li, L; Guo, XJ				Wu, Ping; Han, Shaohua; Chen, Tao; Qin, Guangxing; Li, Long; Guo, Xijie			Involvement of MicroRNAs in Infection of Silkworm with Bombyx mori Cytoplasmic Polyhedrosis Virus (BmCPV)	PLOS ONE			English	Article							WING DEVELOPMENT; EXPRESSION; IDENTIFICATION; MOSQUITO; BIOGENESIS; REOVIRIDAE; SUPPRESSES; APOPTOSIS; PATTERNS; DEFENSE	Bombyx mori cytoplasmic polyhedrosis virus (BmCPV) is one of the most important pathogens of silkworm. MicroRNAs (miRNAs) have been demonstrated to play key roles in regulating host-pathogen interaction. However, there are limited reports on the miRNAs expression profiles during insect pathogen challenges. In this study, four small RNA libraries from BmCPV-infected midgut of silkworm at 72 h post-inoculation and 96 h post-inoculation and their corresponding control midguts were constructed and deep sequenced. A total of 316 known miRNAs (including miRNA*) and 90 novel miRNAs were identified. Fifty-eight miRNAs displayed significant differential expression between the infected and normal midgut (P value <= 0.01 and fold change > = 2.0 or < = 0.5), among which ten differentially expressed miRNA were validated by qRT-PCR method. Further bioinformatics analysis of predicted target genes of differentially expressed miRNAs showed that the miRNA targets were involved in stimulus and immune system process in silkworm.	[Wu, Ping; Han, Shaohua; Chen, Tao; Qin, Guangxing; Li, Long; Guo, Xijie] Jiangsu Univ Sci & Technol, Sericultural Res Inst, Zhenjiang, Jiangsu, Peoples R China; [Wu, Ping; Chen, Tao; Li, Long; Guo, Xijie] Minist Agr, Qual Inspect Ctr Sericulture Prod, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University of Science & Technology; Ministry of Agriculture & Rural Affairs	Guo, XJ (corresponding author), Jiangsu Univ Sci & Technol, Sericultural Res Inst, Zhenjiang, Jiangsu, Peoples R China.	guoxijie@126.com	Guo, Xijie/GPX-9247-2022		National Basic Research Program of China [2012CB114600]; Natural Science Foundation of Jiangsu [BK2010353]; Technology and Science Support Project of Zhengjiang [NY2011028]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of Jiangsu(Natural Science Foundation of Jiangsu Province); Technology and Science Support Project of Zhengjiang	This project was financially supported by the National Basic Research Program of China (Grant No. 2012CB114600), the Natural Science Foundation of Jiangsu (No. BK2010353), and Technology and Science Support Project of Zhengjiang (No. NY2011028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Asgari S, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00048; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bejarano F, 2010, DEV BIOL, V338, P63, DOI 10.1016/j.ydbio.2009.11.025; Biryukova I, 2009, DEV BIOL, V327, P487, DOI 10.1016/j.ydbio.2008.12.036; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Bryant B, 2010, P NATL ACAD SCI USA, V107, P22391, DOI 10.1073/pnas.1016230107; Cao J, 2008, INSECT BIOCHEM MOLEC, V38, P1066, DOI 10.1016/j.ibmb.2008.09.008; Chawla G, 2011, INT REV CEL MOL BIO, V286, P1, DOI 10.1016/B978-0-12-385859-7.00001-X; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cheng TC, 2008, DEV COMP IMMUNOL, V32, P464, DOI 10.1016/j.dci.2007.03.010; Clarke TE, 2002, J GEN VIROL, V83, P1565, DOI 10.1099/0022-1317-83-7-1565; Deng ZL, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-115; Dsouza M, 1997, TRENDS GENET, V13, P497, DOI 10.1016/S0168-9525(97)01347-4; Eun SH, 2013, DEVELOPMENT, V140, P23, DOI 10.1242/dev.086397; FUJIIKAWATA I, 1970, J MOL BIOL, V51, P247, DOI 10.1016/0022-2836(70)90140-3; Graham RI, 2006, J INVERTEBR PATHOL, V91, P79, DOI 10.1016/j.jip.2005.11.003; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hussain M, 2008, J VIROL, V82, P9164, DOI 10.1128/JVI.01109-08; Hussain M, 2010, J VIROL, V84, P612, DOI 10.1128/JVI.01794-09; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Jopling CL, 2008, BIOCHEM SOC T, V36, P1220, DOI 10.1042/BST0361220; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kumarswamy R, 2010, CELL BIOL INT, V34, P851, DOI 10.1042/CBI20100035; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; Liu SP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-148; Liu SP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-85; Liu SP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-455; Lu LF, 2009, IMMUNOLOGY, V127, P291, DOI 10.1111/j.1365-2567.2009.03092.x; MAGNOLER A, 1974, J INVERTEBR PATHOL, V23, P263, DOI 10.1016/0022-2011(74)90089-5; Manavella P, 2012, PLANT PHYSL; Martin EC, 2014, MOL CARCINOGEN, V53, P38, DOI 10.1002/mc.21946; Mead EA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-244; Nairz K, 2006, DEV BIOL, V291, P314, DOI 10.1016/j.ydbio.2005.11.047; Narayanan K, 2004, CURR SCI INDIA, V86, P800; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Padmanabhan C, 2009, CURR OPIN PLANT BIOL, V12, P465, DOI 10.1016/j.pbi.2009.06.005; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641; RUBINSTEIN R, 1976, VIROLOGY, V69, P323, DOI 10.1016/0042-6822(76)90219-1; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Shapiro A, 2005, J VIROL, V79, P9430, DOI 10.1128/JVI.79.15.9430-9438.2005; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Simon-Mateo C, 2006, J VIROL, V80, P2429, DOI 10.1128/JVI.80.5.2429-2436.2006; Singh CP, 2012, J VIROL, V86, P7867, DOI 10.1128/JVI.00064-12; Singh J, 2010, VIROLOGY, V407, P120, DOI 10.1016/j.virol.2010.07.033; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Tanaka H, 2009, INSECT MOL BIOL, V18, P71, DOI 10.1111/j.1365-2583.2009.00851.x; Tsang WP, 2009, CARCINOGENESIS, V30, P953, DOI 10.1093/carcin/bgp094; Varghese J, 2007, GENE DEV, V21, P2277, DOI 10.1101/gad.439807; Varghese J, 2010, GENE DEV, V24, P2748, DOI 10.1101/gad.1995910; Wang XG, 2012, POULTRY SCI, V91, P139, DOI 10.3382/ps.2011-01656; Wu P, 2011, MOL BIOL REP, V38, P333, DOI 10.1007/s11033-010-0112-4; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Yao HP, 2006, J ZHEJIANG U SC A S2, V7, P350, DOI DOI 10.1631/JZUS.2006.AS0350; Yun EY, 2009, DEV COMP IMMUNOL, V33, P1064, DOI 10.1016/j.dci.2009.05.008; Zhang XF, 2012, INSECT BIOCHEM MOLEC, V42, P381, DOI 10.1016/j.ibmb.2012.01.006; Zhou HB, 2010, BLOOD, V116, P5885, DOI 10.1182/blood-2010-04-280156; Zhu HF, 2010, CHAOS, V20, DOI 10.1063/1.3368727	65	48	55	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68209	10.1371/journal.pone.0068209	http://dx.doi.org/10.1371/journal.pone.0068209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844171	gold, Green Published, Green Submitted			2022-12-27	WOS:000321341000144
J	Zeng, F; Qin, W; Yang, Y; Zhang, DH; Liu, JX; Zhou, GY; Sun, JB; Lu, SF; Tang, Y; Chen, Y; Lan, L; Yu, SG; Li, Y; Gao, X; Gong, QY; Tian, J; Liang, FR				Zeng, Fang; Qin, Wei; Yang, Yue; Zhang, Danhua; Liu, Jixin; Zhou, Guangyu; Sun, Jinbo; Lu, Shengfeng; Tang, Yong; Chen, Yuan; Lan, Lei; Yu, Shuguang; Li, Ying; Gao, Xin; Gong, Qiyong; Tian, Jie; Liang, Fanrong			Regional Brain Structural Abnormality in Meal-Related Functional Dyspepsia Patients: A Voxel-Based Morphometry Study	PLOS ONE			English	Article							MATTER ABNORMALITIES; GASTRIC DISTENSION; ANXIETY; REGISTRATION; DEPRESSION; ROBUST	Background and Aims: Brain dysfunction in functional dyspepsia (FD) has been identified by multiple neuroimaging studies. This study aims to investigate the regional gray matter density (GMD) changes in meal-related FD patients and their correlations with clinical variables, and to explore the possible influence of the emotional state on FD patients's brain structures. Methods: Fifty meal-related FD patients and forty healthy subjects (HS) were included and underwent a structural magnetic resonance imaging scan. Voxel-based morphometry analysis was employed to identify the cerebral structure alterations in meal-related FD patients. Regional GMD changes' correlations with the symptoms and their durations, respectively, have been analyzed. Results: Compared to the HS, the meal-related FD patients showed a decreased GMD in the bilateral precentral gyrus, medial prefrontal cortex (MPFC), anterior cingulate cortex (ACC) and midcingulate cortex (MCC), left orbitofrontal cortex (OFC) and right insula (p<0.05, FWE Corrected, Cluster size>50). After controlling for anxiety and depression, the meal-related FD patients showed a decreased GMD in the bilateral middle frontal gyrus, left MCC, right precentral gyrus and insula (p<0.05, FWE Corrected, Cluster size>50). Before controlling psychological factors, the GMD decreases in the ACC were negatively associated with the symptom scores of the Nepean Dyspepsia Index (NDI) (r = -0.354, p = 0.048, Bonferroni correction) and the duration of FD (r = -0.398, p = 0.02, Bonferroni correction) respectively. Conclusions: The regional GMD of meal-related FD patients, especially in the regions of the homeostatic afferent processing network significantly differed from that of the HS, and the psychological factors might be one of the essential factors significantly affecting the regional brain structure of meal-related FD patients.	[Zeng, Fang; Zhang, Danhua; Tang, Yong; Chen, Yuan; Lan, Lei; Yu, Shuguang; Li, Ying; Liang, Fanrong] Chengdu Univ Tradit Chinese Med, Teaching Hosp 3, Chengdu, Sichuan, Peoples R China; [Qin, Wei; Liu, Jixin; Zhou, Guangyu; Sun, Jinbo; Tian, Jie] Xidian Univ, Life Sci Res Ctr, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China; [Yang, Yue] Sichuan Acad Med Sci, Psychosomat Med Dept, Chengdu, Sichuan, Peoples R China; [Yang, Yue] Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China; [Lu, Shengfeng] Nanjing Univ Tradit Chinese Med, Key Lab Acupuncture & Med Res Minister Educ, Nanjing, Jiangsu, Peoples R China; [Gao, Xin] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Gong, Qiyong] Sichuan Univ, West China Hosp, Ctr Med Imaging, Dept Radiol,Huaxi MR Res Ctr, Chengdu 610064, Sichuan, Peoples R China; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China	Chengdu University of Traditional Chinese Medicine; Xidian University; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Nanjing University of Chinese Medicine; University of Pennsylvania; Sichuan University; Chinese Academy of Sciences; Institute of Automation, CAS	Gao, X (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	jerric@pcbi.upenn.edu; 0001170@cdutcm.edu.cn	秦, 伟/J-9770-2016; tian, jie/M-6336-2013; Gong, Qiyong/W-3052-2019; JinBo, Sun/GLT-2082-2022; Tian, Jie/H-1190-2011	秦, 伟/0000-0003-4583-0406; Gong, Qiyong/0000-0002-5912-4871; Tian, Jie/0000-0003-0498-0432; Liang, Fanrong/0000-0003-2210-2027; Yu, Shuguang/0000-0002-1413-8989; Zhou, Guangyu/0000-0003-0897-6465	Youth Foundation of National Natural Science Foundation of China [81001504]; State Key Program for Basic Research of China [2012CB518501]; Youth Foundation of Sichuan Province [2012JQ0052]	Youth Foundation of National Natural Science Foundation of China; State Key Program for Basic Research of China(State Key Development Program for Basic Research of China); Youth Foundation of Sichuan Province	This study was supported by the "Youth Foundation of National Natural Science Foundation of China (NO. 81001504)'', the "State Key Program for Basic Research of China (NO. 2012CB518501)'' and the "Youth Foundation of Sichuan Province (NO. 2012JQ0052)''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JLR, 2007, TR07JA1 FMRIB; Andersson JLR, TR07JA2 FMRIB; Aro P, 2009, GASTROENTEROLOGY, V137, P94, DOI 10.1053/j.gastro.2009.03.039; Blankstein U, 2010, GASTROENTEROLOGY, V138, P1783, DOI 10.1053/j.gastro.2009.12.043; Bora E, 2012, J AFFECT DISORDERS, V138, P9, DOI 10.1016/j.jad.2011.03.049; Brook RA, 2012, DIGEST DIS SCI, V57, P109, DOI 10.1007/s10620-011-1822-8; Brun Rita, 2010, Therap Adv Gastroenterol, V3, P145, DOI 10.1177/1756283X10362639; Chen JYW, 2011, BRAIN RES, V1392, P121, DOI 10.1016/j.brainres.2011.03.069; Chou LT, 2001, J CLIN GASTROENTEROL, V33, P127, DOI 10.1097/00004836-200108000-00007; Chunfang W, 1986, CHIN J NERV MENL DIS, V12, P267; Davis KD, 2008, NEUROLOGY, V70, P153, DOI 10.1212/01.wnl.0000295509.30630.10; Ghoshal UC, 2011, J NEUROGASTROENTEROL, V17, P235, DOI 10.5056/jnm.2011.17.3.235; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; HAUG TT, 1994, J PSYCHOSOM RES, V38, P281, DOI 10.1016/0022-3999(94)90033-7; HAUG TT, 1995, SCAND J GASTROENTERO, V30, P97, DOI 10.3109/00365529509093244; Hsu YC, 2009, AM J GASTROENTEROL, V104, P2534, DOI 10.1038/ajg.2009.328; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Lorena SLS, 2004, J CLIN GASTROENTEROL, V38, P230, DOI 10.1097/00004836-200403000-00007; Mayer EA, 2009, NEUROGASTROENT MOTIL, V21, P579, DOI 10.1111/j.1365-2982.2009.01304.x; Mayer EA, 2011, NAT REV NEUROSCI, V12, P453, DOI 10.1038/nrn3071; Mayer EA, 2011, ANNU REV MED, V62, P381, DOI 10.1146/annurev-med-012309-103958; Ringel Y, 2006, DIGEST DIS, V24, P278, DOI 10.1159/000092881; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Seminowicz DA, 2010, GASTROENTEROLOGY, V139, P48, DOI 10.1053/j.gastro.2010.03.049; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Talley NJ, 2010, EXPERT REV GASTROENT, V4, P5, DOI 10.1586/EGH.09.73; Talley NJ, 1999, AM J GASTROENTEROL, V94, P2390; Tian XP, 2009, WORLD J GASTROENTERO, V15, P3173, DOI 10.3748/wjg.15.3173; Van Oudenhove L, 2010, GASTROENTEROLOGY, V139, P36, DOI 10.1053/j.gastro.2010.04.015; Van Oudenhove L, 2010, AM J GASTROENTEROL, V105, P913, DOI 10.1038/ajg.2010.39; Vandenberghe J, 2007, GASTROENTEROLOGY, V132, P1684, DOI 10.1053/j.gastro.2007.03.037; Veldhuijzen DS, 2013, PAIN, V154, P548, DOI 10.1016/j.pain.2012.12.019; Wang GJ, 2008, NEUROIMAGE, V39, P1824, DOI 10.1016/j.neuroimage.2007.11.008; Wu WY, 1990, SHANGHAI ARCH PSYC S, V2, P44; Zeng F, 2011, GASTROENTEROLOGY, V141, P499, DOI 10.1053/j.gastro.2011.05.003; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zhou GY, 2013, AM J GASTROENTEROL, V108, P260, DOI 10.1038/ajg.2012.405; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	41	23	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68383	10.1371/journal.pone.0068383	http://dx.doi.org/10.1371/journal.pone.0068383			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844192	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000156
J	Falck-Ytter, T; Rehnberg, E; Bolte, S				Falck-Ytter, Terje; Rehnberg, Erik; Bolte, Sven			Lack of Visual Orienting to Biological Motion and Audiovisual Synchrony in 3-Year-Olds with Autism	PLOS ONE			English	Article							PERCEPTION; RECOGNITION; DISORDERS; COGNITION; SPECTRUM; CHILDREN; INFANTS; RATHER	It has been suggested that children with autism orient towards audiovisual synchrony (AVS) rather than biological motion and that the opposite pattern is to be expected in typical development. Here, we challenge this notion by showing that 3-year-old neurotypical children orient to AVS and to biological motion in point-light displays but that 3-year-old children with autism orient to neither of these types of information. Thus, our data suggest that two fundamental mechanisms are disrupted in young children with autism: one that supports orienting towards others' movements and one that supports orienting towards multimodally specified events. These impairments may have consequences for socio-cognitive development and brain organization.	[Falck-Ytter, Terje; Rehnberg, Erik; Bolte, Sven] Karolinska Inst, Dept Womens & Childrens Hlth, Ctr Neurodev Disorders, Stockholm, Sweden; [Falck-Ytter, Terje] Uppsala Univ, Dept Psychol, Uppsala, Sweden	Karolinska Institutet; Uppsala University	Falck-Ytter, T (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Ctr Neurodev Disorders, Stockholm, Sweden.	terje.falck-ytter@ki.se	Bölte, Sven/AAH-8675-2019	Bölte, Sven/0000-0002-4579-4970; Falck-Ytter, Terje/0000-0001-9714-0197	Bank of Sweden Tercentenary Foundation [P12-0270:1]; Swedish Research Council, FAS [259-2012-24]; Swedish Research Council, FORMAS [259-2012-24]; Swedish Research Council, VINNOVA [259-2012-24]; ESF COST Action [BM1004]	Bank of Sweden Tercentenary Foundation; Swedish Research Council, FAS(Swedish Research Council); Swedish Research Council, FORMAS(Swedish Research CouncilSwedish Research Council Formas); Swedish Research Council, VINNOVA(Swedish Research CouncilVinnova); ESF COST Action(European Cooperation in Science and Technology (COST))	This research was supported by The Bank of Sweden Tercentenary Foundation (P12-0270:1; www.rj.se) and the Swedish Research Council, FAS, FORMAS and VINNOVA (259-2012-24; www.vr.se; www.fas.se; www.formas.se; www.vinnova.se). The work of TFY and SB was supported by the ESF COST Action BM1004 Enhancing the Scientific Study of Early Autism (ESSEA; www.cost-essea.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annaz D, 2012, J AUTISM DEV DISORD, V42, P401, DOI 10.1007/s10803-011-1256-3; Bahrick LE, 2004, CURR DIR PSYCHOL SCI, V13, P99, DOI 10.1111/j.0963-7214.2004.00283.x; Bebko JM, 2006, J CHILD PSYCHOL PSYC, V47, P88, DOI 10.1111/j.1469-7610.2005.01443.x; Bidet-Ildei C, DEV PSYCHOL; Blake R, 2003, PSYCHOL SCI, V14, P151, DOI 10.1111/1467-9280.01434; Chawarska K, BIOL PSYCHIAT; Constantino J. N., 2005, SOCIAL RESPONSIVENES; Elsabbagh M., 2013, BIOL PSYCHIAT; Falck-Ytter T, 2011, NEUROPSYCHOLOGIA, V49, P2131, DOI 10.1016/j.neuropsychologia.2011.03.040; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Kim SH, 2012, J CHILD PSYCHOL PSYC, V53, P143, DOI 10.1111/j.1469-7610.2011.02458.x; Klin A, 2003, PHILOS T R SOC B, V358, P345, DOI 10.1098/rstb.2002.1202; Klin A, 2008, DEVELOPMENTAL SCI, V11, P40, DOI 10.1111/j.1467-7687.2007.00608.x; Klin A, 2009, NATURE, V459, P257, DOI 10.1038/nature07868; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Mullen E. M, 1995, MULLEN SCALES EARLY; Pavlova M, 2000, PERCEPT PSYCHOPHYS, V62, P889, DOI 10.3758/BF03212075; Simion F, 2008, P NATL ACAD SCI USA, V105, P809, DOI 10.1073/pnas.0707021105; Vallortigara G, 2005, PLOS BIOL, V3, P1312, DOI 10.1371/journal.pbio.0030208; Wolff JJ, 2012, AM J PSYCHIAT, V169, P589, DOI 10.1176/appi.ajp.2011.11091447	21	48	50	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68816	10.1371/journal.pone.0068816	http://dx.doi.org/10.1371/journal.pone.0068816			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	181TS	23861945	Green Published, Green Submitted, gold			2022-12-27	WOS:000321692000033
J	Igarashi, M; Dung, VC; Suzuki, E; Ida, S; Nakacho, M; Nakabayashi, K; Mizuno, K; Hayashi, Y; Kohri, K; Kojima, Y; Ogata, T; Fukami, M				Igarashi, Maki; Vu Chi Dung; Suzuki, Erina; Ida, Shinobu; Nakacho, Mariko; Nakabayashi, Kazuhiko; Mizuno, Kentaro; Hayashi, Yutaro; Kohri, Kenjiro; Kojima, Yoshiyuki; Ogata, Tsutomu; Fukami, Maki			Cryptic Genomic Rearrangements in Three Patients with 46,XY Disorders of Sex Development	PLOS ONE			English	Article							COPY NUMBER VARIATION; ALAGILLE SYNDROME; HOXD CLUSTER; DELETION; REVERSAL; DMRT1; GENES; GENITALIA; REGION; 20P	Background: 46,XY disorders of sex development (46, XY DSD) are genetically heterogeneous conditions. Recently, a few submicroscopic genomic rearrangements have been reported as novel genetic causes of 46, XY DSD. Methodology/Principal Findings: To clarify the role of cryptic rearrangements in the development of 46, XY DSD, we performed array-based comparative genomic hybridization analysis for 24 genetic males with genital abnormalities. Heterozygous submicroscopic deletions were identified in three cases (cases 1-3). A similar to 8.5 Mb terminal deletion at 9p24.1-24.3 was detected in case 1 that presented with complete female-type external genitalia and mental retardation; a similar to 2.0 Mb interstitial deletion at 20p13 was identified in case 2 with ambiguous external genitalia and short stature; and a similar to 18.0 Mb interstitial deletion at 2q31.1-32 was found in case 3 with ambiguous external genitalia, mental retardation and multiple anomalies. The genital abnormalities of case 1 could be ascribed to gonadal dysgenesis caused by haploinsufficiency of DMRT1, while those of case 3 were possibly associated with perturbed organogenesis due to a deletion of the HOXD cluster. The deletion in case 2 affected 36 genes, none of which have been previously implicated in sex development. Conclusions/Significance: The results indicate that cryptic genomic rearrangements constitute an important part of the molecular bases of 46, XY DSD and that submicroscopic deletions can lead to various types of 46, XY DSD that occur as components of contiguous gene deletion syndromes. Most importantly, our data provide a novel candidate locus for 46, XY DSD at 20p13.	[Igarashi, Maki; Suzuki, Erina; Ogata, Tsutomu; Fukami, Maki] Natl Res Inst Child Hlth & Dev, Dept Mol Endocrinol, Tokyo, Japan; [Vu Chi Dung] Vietnam Natl Hosp Pediat, Dept Endocrinol Metab & Genet, Hanoi, Vietnam; [Ida, Shinobu; Nakacho, Mariko] Osaka Med Ctr, Dept Gastroenterol & Endocrinol, Osaka, Japan; [Ida, Shinobu; Nakacho, Mariko] Res Inst Maternal & Child Hlth, Osaka, Japan; [Nakabayashi, Kazuhiko] Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Tokyo, Japan; [Mizuno, Kentaro; Hayashi, Yutaro; Kohri, Kenjiro; Kojima, Yoshiyuki] Nagoya City Univ, Grad Sch Med Sci, Dept Nephrourol, Nagoya, Aichi, Japan; [Kojima, Yoshiyuki] Fukushima Med Univ, Sch Med, Dept Urol, Fukushima, Japan; [Ogata, Tsutomu] Hamamatsu Univ Sch Med, Dept Pediat, Hamamatsu, Shizuoka 4313192, Japan	National Center for Child Health & Development - Japan; Osaka Medical Center for Cancer & Cardiovascular Diseases; National Center for Child Health & Development - Japan; Nagoya City University; Fukushima Medical University; Hamamatsu University School of Medicine	Fukami, M (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Mol Endocrinol, Tokyo, Japan.	fukami-m@ncchd.go.jp	Mizuno, Kentaro/H-8950-2019; Fukami, Maki/ABE-4694-2020	Mizuno, Kentaro/0000-0002-9624-2009; Fukami, Maki/0000-0001-9971-4035; Igarashi, Maki/0000-0003-3362-3872; Ogata, Tsutomu/0000-0001-7178-9991	Ministry of Education, Culture, Sports, Science and Technology [22132004]; Ministry of Health, Labor and Welfare; Japan Society for the Promotion of Science (JSPS) [23390249, 24791103]; Takeda Foundation; National Center for Child Health and Development [23A-1, 24-7]; Grants-in-Aid for Scientific Research [23390249, 22227002] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Foundation(Takeda Science Foundation (TSF)); National Center for Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Grant-in-Aid for Scientific Research on Innovative Areas (22132004) from the Ministry of Education, Culture, Sports, Science and Technology, by the Grant for Research on Intractable Diseases from the Ministry of Health, Labor and Welfare, by the Grant-in-Aid for Scientific Research (B) (23390249) and for Young Scientists (B) (24791103) from the Japan Society for the Promotion of Science (JSPS), by the Grant from the Takeda Foundation and by the Grant from National Center for Child Health and Development (23A-1 and 24-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann JC, 2011, WILLIAMS TXB ENDOCRI, P868; ALAWADI SA, 1983, J MED GENET, V20, P464, DOI 10.1136/jmg.20.6.464; ANAD F, 1990, J MED GENET, V27, P729, DOI 10.1136/jmg.27.12.729; Calvari V, 2000, GENOMICS, V65, P203, DOI 10.1006/geno.2000.6160; Cobb J, 2005, DEVELOPMENT, V132, P3055, DOI 10.1242/dev.01885; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Del Campo M, 1999, AM J HUM GENET, V65, P104, DOI 10.1086/302467; Dimitrov B, 2011, J MED GENET, V48, P98, DOI 10.1136/jmg.2010.079491; Domenice S, 2004, BRAZ J MED BIOL RES, V37, P145, DOI 10.1590/S0100-879X2004000100020; FISHER E, 1994, NAT GENET, V7, P5, DOI 10.1038/ng0594-5; Gijsbers ACJ, 2011, HORM RES PAEDIAT, V76, P208, DOI 10.1159/000330406; Kamath BM, 2009, HUM MUTAT, V30, P371, DOI 10.1002/humu.20863; Kim S, 2007, DEV BIOL, V307, P314, DOI 10.1016/j.ydbio.2007.04.046; Lalani SR, 2009, J MED GENET, V46, P168, DOI 10.1136/jmg.2008.061002; Ledig S, 2010, HUM REPROD, V25, P2637, DOI 10.1093/humrep/deq167; Ledig S, 2012, EUR J ENDOCRINOL, V167, P119, DOI 10.1530/EJE-12-0136; Lee C, 2007, NAT GENET, V39, pS48, DOI 10.1038/ng2092; Lepretre F, 2001, CYTOGENET CELL GENET, V94, P142, DOI 10.1159/000048806; McGill AK, 2010, AM J MED GENET A, V152A, P1000, DOI 10.1002/ajmg.a.33339; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Onesimo R, 2012, AM J MED GENET A, V158A, P2266, DOI 10.1002/ajmg.a.35489; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618; Slavotinek A, 1999, AM J MED GENET, V86, P75, DOI 10.1002/(SICI)1096-8628(19990903)86:1<75::AID-AJMG15>3.0.CO;2-J; Tannour-Louet M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015392; TEEBI AS, 1992, AM J MED GENET, V42, P35, DOI 10.1002/ajmg.1320420109; White S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017793; Ying M, 2007, BBA-MOL CELL RES, V1773, P804, DOI 10.1016/j.bbamcr.2007.03.006	27	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68194	10.1371/journal.pone.0068194	http://dx.doi.org/10.1371/journal.pone.0068194			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861871	Green Published, gold, Green Submitted			2022-12-27	WOS:000321692000018
J	Salomon, C; Ryan, J; Sobrevia, L; Kobayashi, M; Ashman, K; Mitchell, M; Rice, GE				Salomon, Carlos; Ryan, Jennifer; Sobrevia, Luis; Kobayashi, Miharu; Ashman, Keith; Mitchell, Murray; Rice, Gregory E.			Exosomal Signaling during Hypoxia Mediates Microvascular Endothelial Cell Migration and Vasculogenesis	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; BLOOD; INHIBITION; PROTEOMICS; MECHANISM; BIOMARKER; PROTEINS	Vasculogenesis and angiogenesis are critical processes in fetal circulation and placental vasculature development. Placental mesenchymal stem cells (pMSC) are known to release paracrine factors (some of which are contained within exosomes) that promote angiogenesis and cell migration. The aims of this study were: to determine the effects of oxygen tension on the release of exosomes from pMSC; and to establish the effects of pMSC-derived exosomes on the migration and angiogenic tube formation of placental microvascular endothelial cells (hPMEC). pMSC were isolated from placental villi (8-12 weeks of gestation, n = 6) and cultured under an atmosphere of 1%, 3% or 8% O-2. Cell-conditioned media were collected and exosomes (exo-pMSC) isolated by differential and buoyant density centrifugation. The dose effect (5-20 mu g exosomal protein/ml) of pMSC-derived exosomes on hPMEC migration and tube formation were established using a real-time, live-cell imaging system (Incucyte (TM)). The exosome pellet was resuspended in PBS and protein content was established by mass spectrometry (MS). Protein function and canonical pathways were identified using the PANTHER program and Ingenuity Pathway Analysis, respectively. Exo-pMSC were identified, by electron microscopy, as spherical vesicles, with a typical cup-shape and diameters around of 100 nm and positive for exosome markers: CD63, CD9 and CD81. Under hypoxic conditions (1% and 3% O-2) exo-pMSC released increased by 3.3 and 6.7 folds, respectively, when compared to the controls (8% O-2; p<0.01). Exo-pMSC increased hPMEC migration by 1.6 fold compared to the control (p<0.05) and increased hPMEC tube formation by 7.2 fold (p<0.05). MS analysis identified 390 different proteins involved in cytoskeleton organization, development, immunomodulatory, and cell-to-cell communication. The data obtained support the hypothesis that pMSC- derived exosomes may contribute to placental vascular adaptation to low oxygen tension under both physiological and pathological conditions.	[Salomon, Carlos; Ryan, Jennifer; Sobrevia, Luis; Kobayashi, Miharu; Ashman, Keith; Mitchell, Murray; Rice, Gregory E.] Univ Queensland, Clin Res Ctr, Herston, Qld, Australia; [Sobrevia, Luis] Pontificia Univ Catolica Chile, Fac Med, Sch Med, Cellular & Mol Physiol Lab,Div Obstet & Gynaecol, Santiago, Chile	University of Queensland; Pontificia Universidad Catolica de Chile	Salomon, C (corresponding author), Univ Queensland, Clin Res Ctr, Herston, Qld, Australia.	c.salomongallo@uq.edu.au	RICE, GREGORY E/F-2412-2010; Mitchell, Murray/A-8639-2010; Salomon, Carlos F/L-2167-2013; Sobrevia, Luis/H-9608-2016; Ashman, Keith/G-2328-2011	RICE, GREGORY E/0000-0001-7177-0246; Mitchell, Murray/0000-0002-6167-7176; Salomon, Carlos F/0000-0003-4474-0046; Sobrevia, Luis/0000-0001-5802-2243	CONICYT (Pasantia Doctoral en el Extranjero BECAS Chile) [ACT-73 PIA]; FONDECYT [1110977]; CONICYT; Faculty of Medicine/PUC	CONICYT (Pasantia Doctoral en el Extranjero BECAS Chile); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Faculty of Medicine/PUC	This research was supported by CONICYT (ACT-73 PIA, Pasantia Doctoral en el Extranjero BECAS Chile) and FONDECYT (1110977). CS holds CONICYT-PhD fellowships and Faculty of Medicine/PUC-PhD fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abumaree MH, 2012, STEM CELL REV; Afroze SH, 2011, MOL CELL BIOCHEM, V354, P291, DOI 10.1007/s11010-011-0829-y; Alderton GK, 2012, NAT REV CANCER, V12, P447, DOI 10.1038/nrc3304; Atay S, 2011, EXP CELL RES, V317, P1192, DOI 10.1016/j.yexcr.2011.01.014; Bang C, 2012, INT J BIOCHEM CELL B, V44, P2060, DOI 10.1016/j.biocel.2012.08.007; Biancone L, 2012, NEPHROL DIAL TRANSPL, V27, P3037, DOI 10.1093/ndt/gfs168; Boomsma RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035685; Bullerdiek J, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-27; Burlacu A, 2012, STEM CELLS DEV; Byeon YE, 2010, CYTOTHERAPY, V12, P626, DOI 10.3109/14653249.2010.481665; Cantaluppi V, 2012, CELL TRANSPLANT, V21, P1305, DOI 10.3727/096368911X627534; Chen YS, 2012, STEM CELL TRANSL MED, V1, P83, DOI 10.5966/sctm.2011-0022; Corrado C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042310; Dai S, 2008, MOL THER, V16, P782, DOI 10.1038/mt.2008.1; De Luca A, 2012, J CELL BIOCHEM, V113, P3363, DOI 10.1002/jcb.24212; English A.C, 2012, PLOS ONE, V7, pe47768; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; Gross JC, 2012, NATURE CELL BIOL, V14, P1036; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Hegmans JPJJ, 2004, AM J PATHOL, V164, P1807, DOI 10.1016/S0002-9440(10)63739-X; Higginbotham JN, 2011, CURR BIOL, V21, P779, DOI 10.1016/j.cub.2011.03.043; Hofmann NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044468; Im E, 2007, J BIOL CHEM, V282, P29122, DOI 10.1074/jbc.M702637200; Jauniaux Eric, 2003, Reprod Biomed Online, V7, P250; Jung JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044572; King HW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-421; Kosaka N, 2013, J BIOL CHEM, V288, P10849, DOI 10.1074/jbc.M112.446831; Kshirsagar SK, 2012, PLACENTA; Lai RC, 2010, STEM CELL RES, V4, P214, DOI 10.1016/j.scr.2009.12.003; Lee C, 2012, CIRCULATION; Li Guo, 2011, Adv Exp Med Biol, V720, P51, DOI 10.1007/978-1-4614-0254-1_5; Li YY, 2011, ELECTROPHORESIS, V32, P1976, DOI 10.1002/elps.201000598; Liang JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046158; Liu Y, 2008, EXP CELL RES, V314, P774, DOI 10.1016/j.yexcr.2007.10.008; Meckes DG, 2010, P NATL ACAD SCI USA, V107, P20370, DOI 10.1073/pnas.1014194107; Mincheva-Nilsson L, 2006, J IMMUNOL, V176, P3585, DOI 10.4049/jimmunol.176.6.3585; Mineo M, 2012, ANGIOGENESIS, V15, P33, DOI 10.1007/s10456-011-9241-1; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Pisitkun T, 2012, PROTEOM CLIN APPL, V6, P268, DOI 10.1002/prca.201100108; RODESCH F, 1992, OBSTET GYNECOL, V80, P283; Salomon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040578; Steigman Shaun A, 2007, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01e02s1; Thebaud B, 2012, CIRCULATION, V126, P2553, DOI 10.1161/CIRCULATIONAHA.112.146738; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Thon JN, 2012, BLOOD, V120, P1975, DOI 10.1182/blood-2012-04-420968; Tolosa JM, 2012, PLACENTA, V33, P933, DOI 10.1016/j.placenta.2012.08.004; Vrijsen KR, 2010, J CELL MOL MED, V14, P1064, DOI 10.1111/j.1582-4934.2010.01081.x; Welt FG, 2012, CIRC HEART FAIL; Welton JL, 2010, MOL CELL PROTEOMICS, V9, P1324, DOI 10.1074/mcp.M000063-MCP201; Xu RX, 2009, CLIN EXP PHARMACOL P, V36, P176, DOI 10.1111/j.1440-1681.2008.05041.x; Zhang HG, 2012, BIOTECH HISTOCHEM, V87, P161, DOI 10.3109/10520291003659042; Zhang HC, 2012, STEM CELLS DEV; Zhang YA, 2010, ELECTROPHORESIS, V31, P3797, DOI 10.1002/elps.201000401; Zhang ZY, 2012, BIOMATERIALS, V33, P2656, DOI 10.1016/j.biomaterials.2011.12.025; Zhu W, 2012, CANCER LETT, V315, P28, DOI 10.1016/j.canlet.2011.10.002	55	228	242	9	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68451	10.1371/journal.pone.0068451	http://dx.doi.org/10.1371/journal.pone.0068451			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861904	gold, Green Published, Green Submitted			2022-12-27	WOS:000321692000028
J	Boote, C; Dooley, EP; Gardner, SJ; Kamma-Lorger, CS; Hayes, S; Nielsen, K; Hjortdal, J; Sorensen, T; Terrill, NJ; Meek, KM				Boote, Craig; Dooley, Erin P.; Gardner, Steven J.; Kamma-Lorger, Christina S.; Hayes, Sally; Nielsen, Kim; Hjortdal, Jesper; Sorensen, Thomas; Terrill, Nicholas J.; Meek, Keith M.			Quantification of Collagen Ultrastructure after Penetrating Keratoplasty - Implications for Corneal Biomechanics	PLOS ONE			English	Article							RAY-SCATTERING TECHNIQUES; WOUND DEHISCENCE; ORIENTATION; ORGANIZATION; FIBRILS; TISSUE; STROMA; EYES	Purpose: To quantify long-term changes in stromal collagen ultrastructure following penetrating keratoplasty (PK), and evaluate their possible implications for corneal biomechanics. Methods: A pair of 16 mm post-mortem corneo-scleral buttons was obtained from a patient receiving bilateral penetrating keratoplasty 12 (left)/28 (right) years previously. Small-angle x-ray scattering quantified collagen fibril spacing, diameter and spatial order at 0.5 mm or 0.25 mm intervals along linear scans across the graft margin. Corresponding control data was collected from two corneo-scleral buttons with no history of refractive surgery. Wide-angle x-ray scattering quantified collagen fibril orientation at 0.25 mm (horizontal) x0.25 mm (vertical) intervals across both PK specimens. Quantification of orientation changes in the graft margin were verified by equivalent analysis of data from a 13 year post-operative right PK specimen obtained from a second patient in a previous study, and comparison made with new and published data from normal corneas. Results: Marked changes to normal fibril alignment, in favour of tangentially oriented collagen, were observed around the entire graft margin in all PK specimens. The total number of meridional fibrils in the wound margin was observed to decrease by up to 40%, with the number of tangentially oriented fibrils increasing by up to 46%. As a result, in some locations the number of fibrils aligned parallel to the wound outnumbered those spanning it by up to five times. Localised increases in fibril spacing and diameter, with an accompanying reduction in matrix order, were also evident. Conclusions: Abnormal collagen fibril size and spatial order within the PK graft margin are indicative of incomplete stromal wound remodelling and the long term persistence of fibrotic scar tissue. Lasting changes in collagen fibril orientation in and around PK wounds may alter corneal biomechanics and compromise the integrity of the graft-host interface in the long term.	[Boote, Craig; Dooley, Erin P.; Gardner, Steven J.; Kamma-Lorger, Christina S.; Hayes, Sally; Meek, Keith M.] Cardiff Univ, Sch Optometry & Vis Sci, Struct Biophys Grp, Cardiff CF10 3AX, S Glam, Wales; [Nielsen, Kim; Hjortdal, Jesper] Aarhus Univ Hosp, Dept Ophthalmol, DK-8000 Aarhus, Denmark; [Sorensen, Thomas; Terrill, Nicholas J.] Diamond Light Source, Didcot, Oxon, England	Cardiff University; Aarhus University; Diamond Light Source	Meek, KM (corresponding author), Cardiff Univ, Sch Optometry & Vis Sci, Struct Biophys Grp, Cardiff CF10 3AX, S Glam, Wales.	meekkm@cf.ac.uk	Terrill, Nick J/D-2639-2017; Sørensen, Thomas Lykke-Møller/AAA-7052-2020	Terrill, Nick J/0000-0002-8783-1282; Boote, Craig/0000-0003-0348-6547; Hayes, Sally/0000-0001-8550-0108; Sorensen, Thomas Lykke-Moller/0000-0003-3873-3499	Medical Research Council [G0600755, MR/K000837/1]; MRC [MR/K000837/1, G0600755] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Medical Research Council (Grants G0600755 and MR/K000837/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abahussin M, 2009, INVEST OPHTH VIS SCI, V50, P5159, DOI 10.1167/iovs.09-3669; Aghamohammadzadeh H, 2004, STRUCTURE, V12, P249, DOI 10.1016/j.str.2004.01.002; Boote C, 2006, INVEST OPHTH VIS SCI, V47, P901, DOI 10.1167/iovs.05-0893; Boote C, 2005, J STRUCT BIOL, V149, P1, DOI 10.1016/j.jsb.2004.08.009; Boote C, 2003, INVEST OPHTH VIS SCI, V44, P2941, DOI 10.1167/iovs.03-0131; Boote C, 2012, INVEST OPHTH VIS SCI, V53, P2786, DOI 10.1167/iovs.11-9305; Boote C, 2011, BIOPHYS J, V101, P33, DOI 10.1016/j.bpj.2011.05.029; BORCHERDING MS, 1975, EXP EYE RES, V21, P59, DOI 10.1016/0014-4835(75)90057-3; Boyce BL, 2008, BIOMATERIALS, V29, P3896, DOI 10.1016/j.biomaterials.2008.06.011; CALKINS JL, 1981, INVEST OPHTH VIS SCI, V21, P322; CINTRON C, 1973, EXP EYE RES, V17, P251, DOI 10.1016/0014-4835(73)90176-0; Connon CJ, 2003, WOUND REPAIR REGEN, V11, P71, DOI 10.1046/j.1524-475X.2003.11111.x; Dawson DG, 2005, AM J OPHTHALMOL, V139, P168, DOI 10.1016/j.ajo.2004.08.078; Daxer A, 1997, INVEST OPHTH VIS SCI, V38, P121; FARLEY MK, 1987, AM J OPHTHALMOL, V104, P44, DOI 10.1016/0002-9394(87)90291-1; Farrell R., 2000, PRINCIPLES PRACTICE, P629; Hayes S, 2010, EYE, V24, P728, DOI 10.1038/eye.2009.159; Kamma-Lorger CS, 2009, EXP EYE RES, V88, P953, DOI 10.1016/j.exer.2008.12.005; Kamma-Lorger CS, 2009, MOL VIS, V15, P378; LANG GK, 1986, AM J OPHTHALMOL, V101, P28, DOI 10.1016/0002-9394(86)90461-7; Meek Keith M, 2009, Biophys Rev, V1, P83, DOI 10.1007/s12551-009-0011-x; Meek KM, 2009, PROG RETIN EYE RES, V28, P369, DOI 10.1016/j.preteyeres.2009.06.005; Meek KM, 2003, MATRIX BIOL, V22, P467, DOI 10.1016/S0945-053X(03)00081-7; Meek KM, 2001, PROG RETIN EYE RES, V20, P95, DOI 10.1016/S1350-9462(00)00016-1; Meek KM, 1999, J REFRACT SURG, V15, P695; MELLES GR, 1990, ARCH OPHTHALMOL-CHIC, V108, P1460, DOI 10.1001/archopht.1990.01070120108039; MORRISON JC, 1982, ARCH OPHTHALMOL-CHIC, V100, P1835; MORRISON JC, 1982, OPHTHALMOLOGY, V89, P715; MORRISON JC, 1983, ARCH OPHTHALMOL-CHIC, V101, P1927; Nguyen TD, 2011, BIOMECH MODEL MECHAN, V10, P323, DOI 10.1007/s10237-010-0237-3; Pettinelli DJ, 2005, ARCH OPHTHALMOL-CHIC, V123, P853, DOI 10.1001/archopht.123.6.853; Pramanik S, 2006, OPHTHALMOLOGY, V113, P1633, DOI 10.1016/j.ophtha.2006.02.058; RAWE IM, 1994, BIOPHYS J, V67, P1743, DOI 10.1016/S0006-3495(94)80648-4; SEN DK, 1969, ACTA OPHTHALMOL, V47, P1041; SMELSER GK, 1965, EXP EYE RES, V4, P349, DOI 10.1016/S0014-4835(65)80051-3; Steele C, 2009, OPTOMETRY TODAY, V24, P28; Vrana E, 2008, J BIOMED MATER RES A, V84A, P454, DOI 10.1002/jbm.a.31442	37	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68166	10.1371/journal.pone.0068166	http://dx.doi.org/10.1371/journal.pone.0068166			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861866	gold, Green Accepted, Green Published			2022-12-27	WOS:000321425300047
J	Han, YG; Xu, L; Yang, PL; Ren, SM				Han, Yuguo; Xu, Lei; Yang, Peiling; Ren, Shumei			Study on the Growth and the Photosynthetic Characteristics of Low Energy C+ Ion Implantation on Peanut	PLOS ONE			English	Article							BEAM	Employing the Nonghua 5 peanut as experimental material, the effects of low energy C+ ion implantation on caulis height, root length, dry weight, photosynthetic characteristics and leaf water use efficiency (WUE) of Peanut Ml Generation were studied. Four fluences were observed in the experiment. The results showed that ion implantation harmed the peanut seeds because caulis height, root length and dry weight all were lower in the treatments than in CK, and the harm was aggravated with the increase of ion fluence. Both P-n and T-r show a saddle-shape curve due to midday depression of photosynthesis. Low fluence of low energy C+ ion implantation could increase the diurnal average Pn of peanut. The diurnal variation of Tr did not change as significantly as Pn. The light saturation point (LSP) was restrained by the ions. After low energy C+ ion implantation, WUE was enhanced. When the fluence increased to a certain level, the WUE began to decrease.	[Han, Yuguo] Beijing Forestry Univ, Sch Soil & Water Conservat, Minist Educ, Key Lab Soil & Water Conservat & Desertificat Com, Beijing, Peoples R China; [Xu, Lei] China Irrigat & Drainage Dev Ctr, Beijing, Peoples R China; [Yang, Peiling; Ren, Shumei] China Agr Univ, Coll Water Resources & Civil Engn, Beijing 100094, Peoples R China	Beijing Forestry University; China Agricultural University	Han, YG (corresponding author), Beijing Forestry Univ, Sch Soil & Water Conservat, Minist Educ, Key Lab Soil & Water Conservat & Desertificat Com, Beijing, Peoples R China.	yghan@bjfu.edu.cn			New Teachers Foundation of Beijing Forestry University	New Teachers Foundation of Beijing Forestry University	Funding for this work was supported by the New Teachers Foundation of Beijing Forestry University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng Guowang, 2004, Nuclear Techniques, V27, P281; KRAFT G, 1993, ADV RADIAT BIOL, V17, P1; Li JH, 2003, J PEANUT SCI, V31, P23; Li JL, 2000, NUCL TECHNIQUES, V23, P219; Mao Peihong, 2004, Nuclear Techniques, V27, P285; Shek DTL, 2011, THESCIENTIFICWORLDJO, V11, P42, DOI 10.1100/tsw.2011.2; SLATER JV, 1963, RADIAT RES, V19, P218; SMITH HH, 1963, SCIENCE, V142, P595, DOI 10.1126/science.142.3592.595; [宋云 Song Yun], 2004, [分子植物育种, Molecular Plant Breeding], V2, P301; Wang JW, 2002, SEED, V9, P125; Wang WD, 2004, J HENAN AGR SCI, V6, P18; [王卫东 Wang Weidong], 2003, [激光生物学报, Acta laser biology sinica], V12, P360; [王新绘 Wang Xingui], 2004, [激光生物学报, Acta laser biology sinica], V13, P294; Wei ZQ, 1996, ACTA BIOPHYSICA SINI, V12, P315; Wu LF, 2001, RADIAT ENVIRON BIOPH, V40, P53, DOI 10.1007/s004110000078; Xie JH, 1998, NUCL TECHNIQUES, V17, P508; Xu L, 2009, 2009 INTERNATIONAL CONFERENCE ON ENGINEERING COMPUTATION, P265, DOI 10.1109/ICEC.2009.72; Xuan Y, 2004, CHINESE AGR SCI B, V20, P32; YU ZL, 1993, NUCL INSTRUM METH B, V80-1, P1328, DOI 10.1016/0168-583X(93)90793-6; Yu ZL, 2000, IEEE T PLASMA SCI, V28, P128, DOI 10.1109/27.842882; Yu ZL, 1994, J ANHUI AGR U, V21, P221; 谢克强, 2004, [核农学报, Acta Agriculturae Nucleatae Sinica], V18, P303	22	0	0	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68769	10.1371/journal.pone.0068769	http://dx.doi.org/10.1371/journal.pone.0068769			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861939	gold, Green Published, Green Submitted			2022-12-27	WOS:000321425300079
J	Jiang, X; Dong, M; Cheng, JQ; Huang, SC; He, YT; Ma, KF; Tang, BS; Guo, Y				Jiang, Xin; Dong, Ming; Cheng, Jinquan; Huang, Sichun; He, Yitao; Ma, Kefu; Tang, Bingshan; Guo, Yi			Decreased Leukocyte Telomere Length (LTL) Is Associated with Stroke but Unlikely to Be Causative	PLOS ONE			English	Article							PREMATURE MYOCARDIAL-INFARCTION; CORONARY-ARTERY-DISEASE; CIGARETTE-SMOKING; RISK; STRESS; CELLS; WOMEN; LIFE; ATHEROSCLEROSIS; MEN	Aims: Interindividual variability in telomere length is highly heritable. Leukocyte telomere length (LTL) shortening has been shown to be associated with the process of atherosclerosis. But whether the inheritance of LTL is related to stroke is still unclear. The aim of this study was to test if telomere shortening was associated with stroke and whether this association was mainly due to inheritance or acquired cardiovascular risk factors. Methods: Our study was focused on stroke in patients and their siblings. 450 subjects were recruited into this study: 150 patients with ischemic stroke as case group, 150 siblings of patients free of stroke (sibling group) and 150 healthy people as normal control. LTL was measured by real-time Polymerase Chain Reactions. The association between LTL and the cardiovascular risk factors was also determined. Results: A significant decrease of LTL was found in case group when comparing with sibling (0.92 +/- 0.77 vs 1.68 +/- 1.24, p < 0.001) and normal groups (0.92 +/- 0.77 vs 1.95 +/- 1.07, p < 0.001), but no significant difference was found between sibling group and healthy control (p = 0.330). Shorter telomere length was independently associated with hypertension (p = 0.029, OR = 2.189, 95% CI: 1.084-4.421), recent social pressure (p = 0.001, OR = 3.121, 95% CI: 1.597-6.101), age (p = 0.004, OR = 1.055, 95% CI: 1.017-1.093), HDL (p = 0.022, OR = 0.227, 95% CI: 0.064-0.810) and diabetes (p = 0.018, OR = 3.174, 95% CI: 1.221-8.252). Additionally, shortened length of telomere (p = 0.017, OR = 3.996, 95% CI: 1.283-12.774) was an independent risk biomarker for stroke among case and sibling groups. Conclusion: The present study has demonstrated that decreased LTL might be associated with ischemic stroke but unlikely to be causative.	[Jiang, Xin] Jinan Univ, Clin Med Coll 2, Dept Geriatr, Shenzhen, Guangdong, Peoples R China; [Dong, Ming] Shenzhen Univ, Coll Med, Shenzhen, Guangdong, Peoples R China; [Cheng, Jinquan] Shenzhen Ctr Dis Control & Prevent, Shenzhen, Guangdong, Peoples R China; [Huang, Sichun; He, Yitao; Ma, Kefu; Tang, Bingshan; Guo, Yi] Jinan Univ, Clin Med Coll 2, Dept Neurol, Shenzhen, Guangdong, Peoples R China	Jinan University; Shenzhen University; Shenzhen Center for Disease Control & Prevention (SZCDC); Jinan University	Guo, Y (corresponding author), Jinan Univ, Clin Med Coll 2, Dept Neurol, Shenzhen, Guangdong, Peoples R China.	10473101@qq.com			Medical Scientific Research Foundation of Guangdong Province, China [A2009589]	Medical Scientific Research Foundation of Guangdong Province, China	This paper was supported by Medical Scientific Research Foundation of Guangdong Province, China (No: A2009589). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaikalakoteswari A, 2007, ATHEROSCLEROSIS, V195, P83, DOI 10.1016/j.atherosclerosis.2006.12.003; [Anonymous], 1998, J CLIN EPIDEMIOL, V41, P105; Aviv A, 2012, MUTAT RES-FUND MOL M, V730, P68, DOI 10.1016/j.mrfmmm.2011.05.001; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Chen W, 2009, ATHEROSCLEROSIS, V205, P620, DOI 10.1016/j.atherosclerosis.2009.01.021; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; De Felice B, 2012, GENE, V500, P101, DOI 10.1016/j.gene.2012.03.040; Dei Cas A, 2011, NUTR METAB CARDIOVAS, V21, P512, DOI 10.1016/j.numecd.2009.11.011; Ding H, 2012, STROKE, V43, P658, DOI 10.1161/STROKEAHA.111.637207; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Fitzpatrick AL, 2011, J GERONTOL A-BIOL, V66, P421, DOI 10.1093/gerona/glq224; Fuster JJ, 2006, CIRC RES, V99, P1167, DOI 10.1161/01.RES.0000251281.00845.18; Fyhrquist F, 2011, J Hum Hypertens, V25, P711, DOI 10.1038/jhh.2011.57; Gardner JP, 2005, CIRCULATION, V111, P2171, DOI 10.1161/01.CIR.0000163550.70487.0B; Graakjaer J, 2006, ANN NY ACAD SCI, V1067, P311, DOI 10.1196/annals.1354.042; Graakjaer J, 2006, HUM GENET, V119, P344, DOI 10.1007/s00439-006-0137-x; Kontush A, 2005, ATHEROSCLEROSIS, V182, P277, DOI 10.1016/j.atherosclerosis.2005.03.001; Kurz DJ, 2006, ARTERIOSCL THROM VAS, V26, pE114, DOI 10.1161/01.ATV.0000222961.24912.69; Mahmoudi M, 2008, CIRC RES, V103, P717, DOI 10.1161/CIRCRESAHA.108.182899; McGrath M, 2007, CANCER EPIDEM BIOMAR, V16, P815, DOI 10.1158/1055-9965.EPI-06-0961; Mukherjee M, 2009, HEART, V95, P669, DOI 10.1136/hrt.2008.150250; Nofer Jerzy-Roch, 2005, Expert Rev Cardiovasc Ther, V3, P1071, DOI 10.1586/14779072.3.6.1071; Nordfjall K, 2010, EUR J HUM GENET, V18, P385, DOI 10.1038/ejhg.2009.178; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Ornish D, 2008, LANCET ONCOL, V9, P1048, DOI 10.1016/S1470-2045(08)70234-1; Salpea KD, 2008, J MOL MED, V86, P815, DOI 10.1007/s00109-008-0347-x; Satoh M, 2008, ATHEROSCLEROSIS, V198, P347, DOI 10.1016/j.atherosclerosis.2007.09.040; Satoh M, 2009, CLIN SCI, V116, P827, DOI 10.1042/CS20080404; Simon NM, 2006, BIOL PSYCHIAT, V60, P432, DOI 10.1016/j.biopsych.2006.02.004; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; van der Harst P, 2007, J AM COLL CARDIOL, V49, P1459, DOI 10.1016/j.jacc.2007.01.027; Warlow CP, 1998, LANCET, V352, pSIII1	33	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68254	10.1371/journal.pone.0068254	http://dx.doi.org/10.1371/journal.pone.0068254			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861874	gold, Green Published, Green Submitted			2022-12-27	WOS:000321425300052
J	Katsel, P; Tan, WL; Fam, P; Purohit, DP; Haroutunian, V				Katsel, Pavel; Tan, Weilun; Fam, Peter; Purohit, Dushyant P.; Haroutunian, Vahram			Cycle Checkpoint Abnormalities during Dementia: A Plausible Association with the Loss of Protection against Oxidative Stress in Alzheimer's Disease	PLOS ONE			English	Article							MULTIPLE BRAIN-REGIONS; NEURONAL CELL-DEATH; GENE-EXPRESSION; ATAXIA-TELANGIECTASIA; TAU PHOSPHORYLATION; ELDERLY-PATIENTS; DNA-REPLICATION; RATING-SCALE; G2/M PHASE; SCHIZOPHRENIA	Background: Increasing evidence suggests an association between neuronal cell cycle (CCL) events and the processes that underlie neurodegeneration in Alzheimer's disease (AD). Elevated levels of oxidative stress markers and mitochondrial dysfunction are also among early events in AD. Recent studies have reported the role of CCL checkpoint proteins and tumor suppressors, such as ATM and p53 in the control of glycolysis and oxidative metabolism in cancer, but their involvement in AD remains uncertain. Methods and Findings: In this postmortem study, we measured gene expression levels of eight CCL checkpoint proteins in the superior temporal cortex (STC) of persons with varying severities of AD dementia and compare them to those of cognitively normal controls. To assess whether the CCL changes associated with cognitive impairment in AD are specific to dementia, gene expression of the same proteins was also measured in STC of persons with schizophrenia (SZ), which is also characterized by mitochondrial dysfunction. The expression of CCL-checkpoint and DNA damage response genes: MDM4, ATM and ATR was strongly upregulated and associated with progression of dementia (cognitive dementia rating, CDR), appearing as early as questionable or mild dementia (CDRs 0.5-1). In addition to gene expression changes, the downstream target of ATM-p53 signaling - TIGAR, a p53-inducible protein, the activation of which can regulate energy metabolism and protect against oxidative stress was progressively decreased as severity of dementia evolved, but it was unaffected in subjects with SZ. In contrast to AD, different CCL checkpoint proteins, which include p53, CHEK1 and BRCA1 were significantly downregulated in SZ. Conclusions: These results support the activation of an ATM signaling and DNA damage response network during the progression of AD dementia, while the progressive decrease in the levels of TIGAR suggests loss of protection initiated by ATM-p53 signaling against intensifying oxidative stress in AD.	[Katsel, Pavel; Tan, Weilun; Haroutunian, Vahram] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Fam, Peter; Haroutunian, Vahram] James J Peters VA Med Ctr, Dept Psychiat, Bronx, NY USA; [Haroutunian, Vahram] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Purohit, Dushyant P.] Mt Sinai Sch Med, Dept Pathol, New York, NY USA	Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Katsel, P (corresponding author), Mt Sinai Sch Med, Dept Psychiat, New York, NY USA.	pavel.katsel@mssm.edu			National Institutes of Health [P01-AG02219, P50-AG05138, MH066392, MH064673]; Veteran Administration MIRECC, Leir Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH066392, R01MH064673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG002219, P50AG005138] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran Administration MIRECC, Leir Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (P01-AG02219, P50-AG05138, MH066392 and by MH064673 to VH), Veteran Administration MIRECC, Leir Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Arendt T, 2012, MOL NEUROBIOL, V46, P125, DOI 10.1007/s12035-012-8262-0; Bajic VP, 2011, CELL MOL BIOL LETT, V16, P359, DOI 10.2478/s11658-011-0011-2; Barley K, 2009, SCHIZOPHR RES, V112, P54, DOI 10.1016/j.schres.2009.04.019; Benes FM, 2003, ARCH GEN PSYCHIAT, V60, P359, DOI 10.1001/archpsyc.60.4.359; Benes FM, 2009, P NATL ACAD SCI USA, V106, P11731, DOI 10.1073/pnas.0903066106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bonda DJ, 2009, AGING-US, V1, P382, DOI 10.18632/aging.100044; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Budhraja V, 2003, BMC BIOL, V1, DOI 10.1186/1741-7007-1-1; Chen JM, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-60; Chen YZ, 2000, J BIOL CHEM, V275, P8929, DOI 10.1074/jbc.275.12.8929; Conejero-Goldberg C, 2008, J MOL NEUROSCI, V35, P143, DOI 10.1007/s12031-008-9044-z; Copani A, 1999, FASEB J, V13, P2225, DOI 10.1096/fasebj.13.15.2225; Cosentino C, 2011, EMBO J, V30, P546, DOI 10.1038/emboj.2010.330; Cotman CW, 1996, BRAIN PATHOL, V6, P493, DOI 10.1111/j.1750-3639.1996.tb00878.x; Davis KL, 1999, JAMA-J AM MED ASSOC, V281, P1401, DOI 10.1001/jama.281.15.1401; delaMonte SM, 1997, J NEUROL SCI, V152, P73, DOI 10.1016/S0022-510X(97)00131-7; Di Domenico F, 2009, NEUROCHEM RES, V34, P727, DOI 10.1007/s11064-009-9924-9; Dooneief G, 1996, NEUROLOGY, V46, P1746, DOI 10.1212/WNL.46.6.1746; Ekins S, 2006, DRUG METAB DISPOS, V34, P495, DOI 10.1124/dmd.105.008458; Evans Teresa A, 2007, Int J Med Sci, V4, P140; Fillenbaum GG, 1996, AGING-CLIN EXP RES, V8, P379, DOI 10.1007/BF03339599; Girard PM, 2002, ONCOGENE, V21, P4191, DOI 10.1038/sj.onc.1205596; Green DR, 2006, CELL, V126, P30, DOI 10.1016/j.cell.2006.06.032; Haroutunian V, 1998, ARCH NEUROL-CHICAGO, V55, P1185, DOI 10.1001/archneur.55.9.1185; Haroutunian V, 1999, ARCH NEUROL-CHICAGO, V56, P713, DOI 10.1001/archneur.56.6.713; Haroutunian V, 2009, NEUROBIOL AGING, V30, P561, DOI 10.1016/j.neurobiolaging.2007.07.021; Haroutunian V, 2008, ARCH NEUROL-CHICAGO, V65, P1211, DOI 10.1001/archneur.65.9.1211; Haroutunian V, 2006, AM J PSYCHIAT, V163, P1834, DOI 10.1176/appi.ajp.163.10.1834; Harris PLR, 2000, NEUROBIOL AGING, V21, P837, DOI 10.1016/S0197-4580(00)00218-9; Herrup Karl, 2012, Front Biosci (Elite Ed), V4, P2101; Herzog KH, 1998, SCIENCE, V280, P1089, DOI 10.1126/science.280.5366.1089; Hooper C, 2007, NEUROSCI LETT, V418, P34, DOI 10.1016/j.neulet.2007.03.026; Kallhoff-Munoz V, 2008, J NEUROSCI, V28, P11421, DOI 10.1523/JNEUROSCI.2873-08.2008; Katsel P, 2005, SCHIZOPHR RES, V79, P157, DOI 10.1016/j.schres.2005.06.007; Katsel P, 2005, SCHIZOPHR RES, V77, P241, DOI 10.1016/j.schres.2005.03.020; Katsel P, 2009, PLOS ONE, V4, P7642; Katsel P, 2008, NEUROPSYCHOPHARMACOL, V33, P2993, DOI 10.1038/npp.2008.19; Katsel P, 2007, NEUROCHEM RES, V32, P845, DOI 10.1007/s11064-007-9297-x; Kerns D, 2010, SCHIZOPHR RES, V120, P150, DOI 10.1016/j.schres.2010.04.012; Kitamura Y, 1997, BIOCHEM BIOPH RES CO, V232, P418, DOI 10.1006/bbrc.1997.6301; Liu DX, 2001, CELL TISSUE RES, V305, P217, DOI 10.1007/s004410100396; Lu PJ, 1999, NATURE, V399, P784; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Madan E, 2012, BRIT J CANCER, V107, P516, DOI 10.1038/bjc.2012.260; Mariani TJ, 2002, FASEB J, V16, P321, DOI 10.1096/fj.02-0351fje; Maurer I, 2001, SCHIZOPHR RES, V48, P125, DOI 10.1016/S0920-9964(00)00075-X; McShea A, 1997, AM J PATHOL, V150, P1933; McShea A, 2007, BBA-MOL BASIS DIS, V1772, P467, DOI 10.1016/j.bbadis.2006.09.010; Middleton FA, 2002, J NEUROSCI, V22, P2718, DOI 10.1523/JNEUROSCI.22-07-02718.2002; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; MIRRA SS, 1987, GUIDE CERAD PROTOCOL; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Mosch B, 2007, J NEUROSCI, V27, P6859, DOI 10.1523/JNEUROSCI.0379-07.2007; MULLAART E, 1990, NEUROBIOL AGING, V11, P169, DOI 10.1016/0197-4580(90)90542-8; Nagy Z, 1997, ACTA NEUROPATHOL, V94, P6, DOI 10.1007/s004010050665; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Ogawa O, 2003, ACTA NEUROPATHOL, V105, P524, DOI 10.1007/s00401-003-0684-3; Ogawa O, 2003, AGING CELL, V2, P105, DOI 10.1046/j.1474-9728.2003.00042.x; Pei JJ, 1998, BRAIN RES, V797, P267, DOI 10.1016/S0006-8993(98)00296-0; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Previll LA, 2007, NEUROCHEM RES, V32, P639, DOI 10.1007/s11064-006-9146-3; Purohit DP, 1998, ARCH GEN PSYCHIAT, V55, P205, DOI 10.1001/archpsyc.55.3.205; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Shiloh Y, 1996, J CLIN IMMUNOL, V16, P254, DOI 10.1007/BF01541389; SMITH TW, 1995, J NEUROPATH EXP NEUR, V54, P297, DOI 10.1097/00005072-199505000-00002; Sourlingas TG, 2003, PSYCHIAT RES, V118, P55, DOI 10.1016/S0165-1781(03)00041-6; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Sultana R, 2007, NEUROCHEM RES, V32, P655, DOI 10.1007/s11064-006-9123-x; Thakur A, 2008, INT J CLIN EXP PATHO, V1, P134; Tseng HC, 2002, FEBS LETT, V523, P58, DOI 10.1016/S0014-5793(02)02934-4; Uberti D, 2008, NEURODEGENER DIS, V5, P209, DOI 10.1159/000113704; Yang Y, 2006, J NEUROSCI, V26, P775, DOI 10.1523/JNEUROSCI.3707-05.2006; Yang Y, 2001, J NEUROSCI, V21, P2661, DOI 10.1523/JNEUROSCI.21-08-02661.2001; Yang Y, 2003, J NEUROSCI, V23, P2557; Yurov YB, 2001, BRAIN DEV-JPN, V23, pS186, DOI 10.1016/S0387-7604(01)00363-1; Yurov YB, 2008, SCHIZOPHR RES, V98, P139, DOI 10.1016/j.schres.2007.07.035; Zhang J, 2008, P NATL ACAD SCI USA, V105, P8772, DOI 10.1073/pnas.0711355105; Zhu X, 2008, NEUROPATH APPL NEURO, V34, P457, DOI 10.1111/j.1365-2990.2007.00908.x; Zhu XW, 2004, J NEUROSCI RES, V75, P698, DOI 10.1002/jnr.20028; Zindy F, 1999, P NATL ACAD SCI USA, V96, P13462, DOI 10.1073/pnas.96.23.13462	85	44	44	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68361	10.1371/journal.pone.0068361	http://dx.doi.org/10.1371/journal.pone.0068361			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861893	Green Published, gold, Green Submitted			2022-12-27	WOS:000321425300059
J	Lemay, DG; Ballard, OA; Hughes, MA; Morrow, AL; Horseman, ND; Nommsen-Rivers, LA				Lemay, Danielle G.; Ballard, Olivia A.; Hughes, Maria A.; Morrow, Ardythe L.; Horseman, Nelson D.; Nommsen-Rivers, Laurie A.			RNA Sequencing of the Human Milk Fat Layer Transcriptome Reveals Distinct Gene Expression Profiles at Three Stages of Lactation	PLOS ONE			English	Article							GROWTH-FACTOR-I; MAMMARY-GLAND; DELAYED-ONSET; INSULIN-RESISTANCE; PROTEIN-SYNTHESIS; RISK-FACTORS; IDENTIFICATION; FREQUENCY; INFLAMMATION; NETWORKS	Aware of the important benefits of human milk, most U.S. women initiate breastfeeding but difficulties with milk supply lead some to quit earlier than intended. Yet, the contribution of maternal physiology to lactation difficulties remains poorly understood. Human milk fat globules, by enveloping cell contents during their secretion into milk, are a rich source of mammary cell RNA. Here, we pair this non-invasive mRNA source with RNA-sequencing to probe the milk fat layer transcriptome during three stages of lactation: colostral, transitional, and mature milk production. The resulting transcriptomes paint an exquisite portrait of human lactation. The resulting transcriptional profiles cluster not by postpartum day, but by milk Na:K ratio, indicating that women sampled during similar postpartum time frames could be at markedly different stages of gene expression. Each stage of lactation is characterized by a dynamic range (10(5)-fold) in transcript abundances not previously observed with microarray technology. We discovered that transcripts for isoferritins and cathepsins are strikingly abundant during colostrum production, highlighting the potential importance of these proteins for neonatal health. Two transcripts, encoding beta-casein (CSN2) and alpha-lactalbumin (LALBA), make up 45% of the total pool of mRNA in mature lactation. Genes significantly expressed across all stages of lactation are associated with making, modifying, transporting, and packaging milk proteins. Stage-specific transcripts are associated with immune defense during the colostral stage, up-regulation of the machinery needed for milk protein synthesis during the transitional stage, and the production of lipids during mature lactation. We observed strong modulation of key genes involved in lactose synthesis and insulin signaling. In particular, protein tyrosine phosphatase, receptor type, F (PTPRF) may serve as a biomarker linking insulin resistance with insufficient milk supply. This study provides the methodology and reference data set to enable future targeted research on the physiological contributors of sub-optimal lactation in humans.	[Lemay, Danielle G.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Ballard, Olivia A.; Hughes, Maria A.; Morrow, Ardythe L.; Nommsen-Rivers, Laurie A.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Ballard, Olivia A.; Morrow, Ardythe L.; Horseman, Nelson D.; Nommsen-Rivers, Laurie A.] Univ Cincinnati, Coll Med, Cincinnati, OH USA	University of California System; University of California Davis; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Nommsen-Rivers, LA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA.	laurie.nommsen-rivers@cchmc.org		Lemay, Danielle/0000-0003-3318-0485	Cincinnati Children's Hospital Perinatal Institute; National Center for Research Resources (NCRR) [P51RR000169-49S1]; National Center for Advancing Translational Sciences [NIH 8 UL1 TR000077-04]; National Institutes of Health (NIH) [HD13021]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD013021] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER	Cincinnati Children's Hospital Perinatal Institute; National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by the Cincinnati Children's Hospital Perinatal Institute (http://www.cincinnatichildrens.org/service/p/perinatal/default/); Cincinnati Diabetes and Obesity Center (http://diabetes.uc.edu/Research/Overview.aspx); National Center for Research Resources (NCRR) (P51RR000169-49S1); the National Center for Advancing Translational Sciences (NIH 8 UL1 TR000077-04); and National Institutes of Health (NIH) HD13021. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; AROSIO P, 1986, CLIN CHIM ACTA, V161, P201, DOI 10.1016/0009-8981(86)90213-5; Barboza M, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015248; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Berlato C, 2009, ENDOCRINOLOGY, V150, P2924, DOI 10.1210/en.2008-0668; Bernier-Dodier P, 2010, J DAIRY SCI, V93, P555, DOI 10.3168/jds.2009-2320; Bionaz M, 2007, PHYSIOL GENOMICS, V29, P312, DOI 10.1152/physiolgenomics.00223.2006; Bionaz M, 2011, BIOINFORM BIOL INSIG, V5, P83, DOI 10.4137/BBI.S7003; Chagnon MJ, 2004, BIOCHEM CELL BIOL, V82, P664, DOI 10.1139/O04-120; Chapman DJ, 1999, J AM DIET ASSOC, V99, P450, DOI 10.1016/S0002-8223(99)00109-1; Christensen B, 2010, J BIOL CHEM, V285, P7929, DOI 10.1074/jbc.M109.075010; Dallas DC, 2013, J PROTEOME RES, V12, P2295, DOI 10.1021/pr400212z; Declercq E, 2009, AM J PUBLIC HEALTH, V99, P929, DOI 10.2105/AJPH.2008.135236; Dewey KG, 2003, PEDIATRICS, V112, P607, DOI 10.1542/peds.112.3.607; Edmond KM, 2006, PEDIATRICS, V117, pE380, DOI 10.1542/peds.2005-1496; Filteau SM, 1999, IMMUNOLOGY, V97, P595, DOI 10.1046/j.1365-2567.1999.00834.x; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Garcia-San Frutos M, 2012, MECH AGEING DEV, V133, P489, DOI 10.1016/j.mad.2012.06.001; Garrido D, 2012, MOL CELL PROTEOMICS, V11, P775, DOI 10.1074/mcp.M112.018119; Gartner LM, 2005, PEDIATRICS, V115, P496, DOI 10.1542/peds.2004-2491; Geraghty SR, 2010, J HUM LACT, V26, P49, DOI 10.1177/0890334409347467; Gunderson EP, 2010, DIABETES, V59, P495, DOI 10.2337/db09-1197; Hauck FR, 2011, PEDIATRICS, V128, P103, DOI 10.1542/peds.2010-3000; Hill P D, 1994, J Hum Lact, V10, P79, DOI 10.1177/089033449401000212; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Institute of Medicine Committee on Obesity Prevention Policies for Young Children, 2011, EARLY CHILDH OB PREV; Ip S, 2007, BREASTFEEDING MATERN; Jackson JG, 2004, J NUTR BIOCHEM, V15, P517, DOI 10.1016/j.jnutbio.2003.10.009; Jensen RG., 1995, HDB MILK COMPOSITION, P919; Koren S, 2007, BEST PRACT RES CL EN, V21, P621, DOI 10.1016/j.beem.2007.08.004; Kumar L, 2007, BIOINFORMATION, V2, P5, DOI 10.6026/97320630002005; Lemay DG, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-56; Li RW, 2008, PEDIATRICS, V122, pS69, DOI 10.1542/peds.2008-1315i; Littlejohn MD, 2010, PHYSIOL GENOMICS, V41, P21, DOI 10.1152/physiolgenomics.00108.2009; Macheda ML, 2003, CELL TISSUE RES, V311, P91, DOI 10.1007/s00441-002-0661-5; Maningat PD, 2009, PHYSIOL GENOMICS, V37, P12, DOI 10.1152/physiolgenomics.90341.2008; Manso MA, 2007, J CHROMATOGR A, V1146, P110, DOI 10.1016/j.chroma.2007.01.100; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Menzies KK, 2009, FUNCT INTEGR GENOMIC, V9, P197, DOI 10.1007/s10142-008-0103-x; NEVILLE MC, 1991, AM J CLIN NUTR, V54, P81, DOI 10.1093/ajcn/54.1.81; Nommsen-Rivers LA, 2011, BREASTFEED MED; Nommsen-Rivers LA, 2010, AM J CLIN NUTR, V92, P574, DOI 10.3945/ajcn.2010.29192; PATTON S, 1986, LIPIDS, V21, P170, DOI 10.1007/BF02534441; PATTON S, 1988, BIOCHIM BIOPHYS ACTA, V965, P146, DOI 10.1016/0304-4165(88)90050-5; Retnakaran R, 2009, DIABETIC MED, V26, P1198, DOI 10.1111/j.1464-5491.2009.02841.x; Roncada P, 2013, J PROTEOMICS; Sanchez-Juanes F, 2009, BIOL CHEM, V390, P31, DOI 10.1515/BC.2009.003; Shennan DB, 2000, PHYSIOL REV, V80, P925, DOI 10.1152/physrev.2000.80.3.925; Shields SL, 2011, J DAIRY RES, V78, P301, DOI 10.1017/S0022029911000410; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; U.S. Department of Health and Human Services, 2011, SURG GEN CALL ACTION; Wall EH, 2010, J DAIRY SCI, V93, P4062, DOI 10.3168/jds.2010-3162; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484	55	121	126	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67531	10.1371/journal.pone.0067531	http://dx.doi.org/10.1371/journal.pone.0067531			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861770	Green Submitted, Green Published, gold			2022-12-27	WOS:000321425300016
J	Lalmohamed, A; MacGregor, AJ; de Vries, F; Leufkens, HGM; van Staa, TP				Lalmohamed, Arief; MacGregor, Alexander J.; de Vries, Frank; Leufkens, Hubertus G. M.; van Staa, Tjeerd P.			Patterns of Risk of Cancer in Patients with Metal-on-Metal Hip Replacements versus Other Bearing Surface Types: A Record Linkage Study between a Prospective Joint Registry and General Practice Electronic Health Records in England	PLOS ONE			English	Article							KNEE REPLACEMENT; NATIONWIDE-COHORT; ARTHROPLASTY; IMPLANTS; OSTEOARTHRITIS; FRACTURE; SURGERY	Background: There are concerns that metal-on-metal hip implants may cause cancer. The objective of this study was to evaluate patterns and timing of risk of cancer in patients with metal-on-metal total hip replacements (THR). Methods: In a linkage study between the English National Joint Registry (NJR) and the Clinical Practice Research Datalink (CPRD), we selected all THR surgeries (NJR) between 2003 and 2010 (n = 11,540). THR patients were stratified by type of bearing surface. Patients were followed up for cancer and Poisson regression was used to derive adjusted relative rates (RR). Results: The risk of cancer was similar in patients with hip resurfacing (RR 0.69; 95% Confidence Interval [CI] 0.39-1.22) or other types of bearing surfaces (RR 0.96; 95% CI 0.64-1.43) compared to individuals with stemmed metal-on-metal THR. The pattern of cancer risk over time did not support a detrimental effect of metal hip implants. There was substantial confounding: patients with metal-on-metal THRs used fewer drugs and had less comorbidity. Conclusions: Metal-on-metal THRs were not associated with an increased risk of cancer. There were substantial baseline differences between the different hip implants, indicating possibility of confounding in the comparisons between different types of THR implants.	[Lalmohamed, Arief; de Vries, Frank; Leufkens, Hubertus G. M.; van Staa, Tjeerd P.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [Lalmohamed, Arief] Univ Med Ctr Utrecht, Dept Clin Pharm, Utrecht, Netherlands; [MacGregor, Alexander J.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [de Vries, Frank; van Staa, Tjeerd P.] Southampton Gen Hosp, Med Res Council MRC Lifecourse Epidemiol Unit, Southampton SO9 4XY, Hants, England; [de Vries, Frank] Maastricht Univ Med Ctr, Dept Clin Pharm & Toxicol, Maastricht, Netherlands; [de Vries, Frank] CAPHRI, Maastricht, Netherlands; [van Staa, Tjeerd P.] Med & Healthcare Prod Regulatory Agcy, London, England	Utrecht University; Utrecht University; Utrecht University Medical Center; University of East Anglia; University of Southampton; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; The Medicines & Healthcare Products Regulatory Agency	van Staa, TP (corresponding author), Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands.	tjeerd.vanstaa@mhra.gsi.gov.uk	de Vries, Frank/E-4934-2011	de Vries, Frank/0000-0003-3837-8319; van Staa, Tjeerd/0000-0001-9363-742X; MacGregor, Alex/0000-0003-2163-2325	Netherlands Organization for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, the Hague, the Netherlands) [017.007.010]	Netherlands Organization for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, the Hague, the Netherlands)(Netherlands Organization for Scientific Research (NWO)Netherlands Government)	Support was provided by the Netherlands Organization for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, the Hague, the Netherlands; grant 017.007.010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, NAT JOINT REG ENGL W; Bozic KJ, 2010, CLIN ORTHOP RELAT R, V468, P2357, DOI 10.1007/s11999-010-1262-3; CASE CP, 1994, J BONE JOINT SURG BR, V76B, P701, DOI 10.1302/0301-620X.76B5.8083255; Datamonitor Healthcare, 2007, REP HIP KNEE REPL MA; Gillespie W, 2000, J BONE JOINT SURG BR, V82B, P475, DOI 10.1302/0301-620X.82B4.10452; HARRIS WH, 1990, NEW ENGL J MED, V323, P725, DOI 10.1056/NEJM199009133231106; Keegan GM, 2008, CRIT REV TOXICOL, V38, P645, DOI [10.1080/10408440701845534, 10.1080/10408440701845534 ]; Lalmohamed A, 2012, ARCH INTERN MED, V172, P1229, DOI 10.1001/archinternmed.2012.2713; Lalmohamed A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5085; Lalmohamed A, 2012, CALCIFIED TISSUE INT, V90, P144, DOI 10.1007/s00223-011-9558-1; Lewold S, 1996, INT J CANCER, V68, P30, DOI 10.1002/(SICI)1097-0215(19960927)68:1<30::AID-IJC6>3.0.CO;2-Y; LUMB GD, 1994, SCI TOTAL ENVIRON, V148, P185, DOI 10.1016/0048-9697(94)90395-6; Makela KT, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4646; MATHIESEN EB, 1995, J BONE JOINT SURG BR, V77B, P345, DOI 10.1302/0301-620X.77B3.7744912; NYREN O, 1995, JNCI-J NATL CANCER I, V87, P28, DOI 10.1093/jnci/87.1.28; Olsen JH, 1999, INT J CANCER, V81, P719, DOI 10.1002/(SICI)1097-0215(19990531)81:5<719::AID-IJC8>3.0.CO;2-D; Onega T, 2006, CANCER EPIDEM BIOMAR, V15, P1532, DOI 10.1158/1055-9965.EPI-06-0127; Paavolainen P, 1999, J ARTHROPLASTY, V14, P272, DOI 10.1016/S0883-5403(99)90051-7; Paavolainen P, 1999, ACTA ORTHOP SCAND, V70, P609, DOI 10.3109/17453679908997851; Parry MC, 2010, BIOMATERIALS, V31, P4477, DOI 10.1016/j.biomaterials.2010.02.038; Pouwels S, 2009, STROKE, V40, P3281, DOI 10.1161/STROKEAHA.109.554055; Ravi T, 2001, J BONE JOINT SURG AM, V83, P774; Signorello LB, 2001, J NATL CANCER I, V93, P1405, DOI 10.1093/jnci/93.18.1405; Smith AJ, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2383; Thomas E, 2000, INT J CANCER, V88, P497, DOI 10.1002/1097-0215(20001101)88:3<497::AID-IJC27>3.3.CO;2-A; VISURI T, 1991, ORTHOPEDICS, V14, P137; Visuri T, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-78	27	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e65891	10.1371/journal.pone.0065891	http://dx.doi.org/10.1371/journal.pone.0065891			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861740	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000323350700004
J	Ortmann, M; Knief, A; Deuster, D; Brinkheetker, S; Zwitserlood, P; Zehnhoff-Dinnesen, AA; Dobel, C				Ortmann, Magdalene; Knief, Arne; Deuster, Dirk; Brinkheetker, Stephanie; Zwitserlood, Pienie; Zehnhoff-Dinnesen, Antoinette Am; Dobel, Christian			Neural Correlates of Speech Processing in Prelingually Deafened Children and Adolescents with Cochlear Implants	PLOS ONE			English	Article							MISMATCH NEGATIVITY MMN; INTERMODAL SELECTIVE ATTENTION; EVENT-RELATED POTENTIALS; HUMAN AUDITORY-CORTEX; WORKING-MEMORY; PHONOLOGICAL AWARENESS; PHONEME REPRESENTATIONS; LANGUAGE-DEVELOPMENT; EVOKED-POTENTIALS; PERCEPTION	Prelingually deafened children with cochlear implants stand a good chance of developing satisfactory speech performance. Nevertheless, their eventual language performance is highly variable and not fully explainable by the duration of deafness and hearing experience. In this study, two groups of cochlear implant users (CI groups) with very good basic hearing abilities but non-overlapping speech performance (very good or very bad speech performance) were matched according to hearing age and age at implantation. We assessed whether these CI groups differed with regard to their phoneme discrimination ability and auditory sensory memory capacity, as suggested by earlier studies. These functions were measured behaviorally and with the Mismatch Negativity (MMN). Phoneme discrimination ability was comparable in the CI group of good performers and matched healthy controls, which were both better than the bad performers. Source analyses revealed larger MMN activity (155-225 ms) in good than in bad performers, which was generated in the frontal cortex and positively correlated with measures of working memory. For the bad performers, this was followed by an increased activation of left temporal regions from 225 to 250 ms with a focus on the auditory cortex. These results indicate that the two CI groups developed different auditory speech processing strategies and stress the role of phonological functions of auditory sensory memory and the prefrontal cortex in positively developing speech perception and production.	[Ortmann, Magdalene; Dobel, Christian] Univ Munster, Inst Biomagnetismus & Biosignalanal, Munster, Germany; [Ortmann, Magdalene] Univ Cologne, Jean Uhrmacher Inst Clin ENT Res, D-50931 Cologne, Germany; [Knief, Arne; Deuster, Dirk; Brinkheetker, Stephanie; Zehnhoff-Dinnesen, Antoinette Am] Univ Hosp Muenster, Dept Phoniatr & Pedaudiol, Munster, Germany; [Zwitserlood, Pienie] Univ Munster, Dept Psychol, Munster, Germany	University of Munster; University of Cologne; University of Munster; University of Munster	Ortmann, M (corresponding author), Univ Munster, Inst Biomagnetismus & Biosignalanal, Munster, Germany.	ortmannm@uni-muenster.de	Deuster, Dirk/L-4635-2014; Wiltbank, Milo C/B-1506-2010	Deuster, Dirk/0000-0002-3476-3300; Wiltbank, Milo C/0000-0001-8188-0991	Deutsche Forschungsgemeinschaft [DFG] [DO 711/7-1]; Konrad-Adenauer-Stiftung; FAZIT-Stiftung	Deutsche Forschungsgemeinschaft [DFG](German Research Foundation (DFG)); Konrad-Adenauer-Stiftung; FAZIT-Stiftung	This work was supported by the Deutsche Forschungsgemeinschaft [DFG DO 711/7-1 to C.D., A.Z.D. and P.Z., http://www.dfg.de), the Konrad-Adenauer-Stiftung (PhD grant to M.O., www.kas.de) and the FAZIT-Stiftung (PhD grant to M.O., www.fazit-stiftung.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHO K, 1992, ELECTROEN CLIN NEURO, V82, P356, DOI 10.1016/0013-4694(92)90005-3; Alho K, 1998, PSYCHOPHYSIOLOGY, V35, P211, DOI 10.1111/1469-8986.3520211; Anderson Ilona, 2008, Cochlear Implants Int, V9, P119, DOI 10.1179/cim.2008.9.3.119; Angermaier MJW, 1977, PSYCHOLINGUISTISCHER; Baddeley A, 1998, PSYCHOL REV, V105, P158, DOI 10.1037/0033-295X.105.1.158; Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; BATES M, 1995, P NATL ACAD SCI USA, V92, P9977, DOI 10.1073/pnas.92.22.9977; Bollinger J, 2010, J NEUROSCI, V30, P14399, DOI 10.1523/JNEUROSCI.1547-10.2010; Bortz J, 2010, STAT SOZIALWISSENSCH, P655; Ceponiene R, 1999, DEV PSYCHOL, V35, P709, DOI 10.1037/0012-1649.35.3.709; Cheour M, 1998, NAT NEUROSCI, V1, P351, DOI 10.1038/1561; Colletti L, 2011, INT J PEDIATR OTORHI, V75, P504, DOI 10.1016/j.ijporl.2011.01.005; Comerchero MD, 1999, CLIN NEUROPHYSIOL, V110, P24, DOI 10.1016/S0168-5597(98)00033-1; COWAN N, 1984, PSYCHOL BULL, V96, P341, DOI 10.1037/0033-2909.96.2.341; Debener S, 2008, PSYCHOPHYSIOLOGY, V45, P20, DOI 10.1111/j.1469-8986.2007.00610.x; DehaeneLambertz G, 1997, NEUROREPORT, V8, P919, DOI 10.1097/00001756-199703030-00021; Dillon CM, 2006, VOLTA REV, V106, P121; Dillon CM, 2004, INT CONGR SER, V1273, P304, DOI 10.1016/j.ics.2004.07.042; Dobel C, 2009, J COGNITIVE NEUROSCI, P1; Dobel C, 2009, PHILOS T R SOC B, V364, P3697, DOI 10.1098/rstb.2009.0158; Doeller CF, 2003, NEUROIMAGE, V20, P1270, DOI 10.1016/S1053-8119(03)00389-6; Ecalle J, 2009, DYSLEXIA, V15, P218, DOI [10.1002/dys.373, 10.1002/DYS.373]; Eggermont JJ, 2002, AUDIOL NEURO-OTOL, V7, P71, DOI 10.1159/000057656; EIMAS PD, 1971, SCIENCE, V171, P303, DOI 10.1126/science.171.3968.303; EIMAS PD, 1985, SCI AM, V252, P46, DOI 10.1038/scientificamerican0185-46; Eulitz C, 2004, J COGNITIVE NEUROSCI, V16, P577, DOI 10.1162/089892904323057308; Fakhri M, 2012, BEHAV NEUROL, V25, P351, DOI 10.1155/2012/824049; Fiori A, 2010, HNO, V58, P934, DOI 10.1007/s00106-010-2088-8; Francis AL, 2007, J SPEECH LANG HEAR R, V50, P1445, DOI 10.1044/1092-4388(2007/100); Friesen LM, 2010, HEARING RES, V259, P95, DOI 10.1016/j.heares.2009.10.012; Gazzaley A, 2011, NEUROPSYCHOLOGIA, V49, P1410, DOI 10.1016/j.neuropsychologia.2010.12.022; Geers AE, 2003, EAR HEARING, V24, p59S, DOI 10.1097/01.AUD.0000051690.43989.5D; Gillon GT, 2007, PHONOLOGICAL AWARENE, P270; Giraud AL, 2001, AUDIOL NEURO-OTOL, V6, P381, DOI 10.1159/000046847; Gomot M, 2000, NEUROREPORT, V11, P3109, DOI 10.1097/00001756-200009280-00014; Halgren E, 2011, HUM BRAIN MAPP, V32, P1260, DOI 10.1002/hbm.21106; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Harris Margaret, 2004, J Deaf Stud Deaf Educ, V9, P253, DOI 10.1093/deafed/enh016; Hauk O, 2004, NEUROIMAGE, V21, P1612, DOI 10.1016/j.neuroimage.2003.12.018; Ille N, 2002, J CLIN NEUROPHYSIOL, V19, P113, DOI 10.1097/00004691-200203000-00002; Jacobsen T, 2001, PSYCHOPHYSIOLOGY, V38, P723, DOI 10.1017/S0048577201000993; Jemel B, 2002, BRAIN TOPOGR, V15, P13, DOI 10.1023/A:1019944805499; Keller F, 1969, FREIBURGER SPRACHVER; Kelly AS, 2005, CLIN NEUROPHYSIOL, V116, P1235, DOI 10.1016/j.clinph.2005.02.011; KRAUS N, 1993, HEARING RES, V65, P118, DOI 10.1016/0378-5955(93)90206-G; KRAUS N, 1992, EAR HEARING, V13, P158, DOI 10.1097/00003446-199206000-00004; Kronenberger WG, 2011, J SPEECH LANG HEAR R, V54, P1182, DOI 10.1044/1092-4388(2010/10-0119); KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; Kuhl PK, 2006, DEVELOPMENTAL SCI, V9, pF13, DOI 10.1111/j.1467-7687.2006.00468.x; Kujala T, 2007, BIOL PSYCHOL, V74, P1, DOI 10.1016/j.biopsycho.2006.06.001; KURTZBERG D, 1995, EAR HEARING, V16, P105, DOI 10.1097/00003446-199502000-00008; Lai YX, 2011, BRAIN RES, V1367, P170, DOI 10.1016/j.brainres.2010.10.036; Locke JL, 1997, BRAIN LANG, V58, P265, DOI 10.1006/brln.1997.1791; Lonka E, 2004, AUDIOL NEURO-OTOL, V9, P160, DOI 10.1159/000077265; Luck SJ, 2005, INTRO EVENT RELATED, P376; Lyxell B, 2008, INT J AUDIOL, V47, pS47, DOI 10.1080/14992020802307370; Maess B, 2006, BRAIN RES, V1096, P163, DOI 10.1016/j.brainres.2006.04.037; Maillart C, 2006, INT J LANG COMM DIS, V41, P253, DOI 10.1080/13682820500221667; McCarthy JJ, 1968, ILLINOIS TEST PSYCHO; Menning H, 2002, LEARN MEMORY, V9, P253, DOI 10.1101/lm.49402; Miller BL, 2006, HUMAN FRONTAL LOBES, P666; Miyamoto RT, 1999, ACTA OTO-LARYNGOL, V119, P219; Murty VP, 2011, NEUROIMAGE, V57, P1264, DOI 10.1016/j.neuroimage.2011.05.006; Naatanen R, 2005, PSYCHOPHYSIOLOGY, V42, P25, DOI 10.1111/j.1469-8986.2005.00256.x; Naatanen R, 1999, PSYCHOL BULL, V125, P826, DOI 10.1037/0033-2909.125.6.826; Naatanen R, 2001, PSYCHOPHYSIOLOGY, V38, P1, DOI 10.1017/S0048577201000208; Naatanen R, 2011, PSYCHOPHYSIOLOGY, V48, P4, DOI 10.1111/j.1469-8986.2010.01114.x; Opitz B, 2002, NEUROIMAGE, V15, P167, DOI 10.1006/nimg.2001.0970; Opitz B, 1999, PSYCHOPHYSIOLOGY, V36, P142, DOI 10.1017/S0048577299980848; PAAVILAINEN P, 1991, ELECTROEN CLIN NEURO, V78, P466, DOI 10.1016/0013-4694(91)90064-B; Pantev C, 1998, AUDIOL NEURO-OTOL, V3, P183, DOI 10.1159/000013789; Peyk P, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/861705; Picton TW, 1999, AUDIOL NEURO-OTOL, V4, P64, DOI 10.1159/000013823; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; Ponton CW, 2001, HEARING RES, V154, P32, DOI 10.1016/S0378-5955(01)00214-3; Ponton CW, 2000, AUDIOL NEURO-OTOL, V5, P167, DOI 10.1159/000013878; Pulvermuller F, 2005, J COGNITIVE NEUROSCI, V17, P884, DOI 10.1162/0898929054021111; Pulvermuller F, 2006, PROG NEUROBIOL, V79, P49, DOI 10.1016/j.pneurobio.2006.04.004; Pulvermuller F, 2010, NAT REV NEUROSCI, V11, P351, DOI 10.1038/nrn2811; Rinne T, 2005, NEUROIMAGE, V26, P66, DOI 10.1016/j.neuroimage.2005.01.017; Roman S, 2005, HEARING RES, V201, P10, DOI 10.1016/j.heares.2004.08.021; Rutman AM, 2010, J COGNITIVE NEUROSCI, V22, P1224, DOI 10.1162/jocn.2009.21257; Rvachew S, 2003, AM J SPEECH-LANG PAT, V12, P463, DOI 10.1044/1058-0360(2003/092); Sandmann P, 2012, BRAIN, V135, P555, DOI 10.1093/brain/awr329; Sandmann P, 2009, BRAIN, V132, P1967, DOI 10.1093/brain/awp034; Sarant JZ, 2001, EAR HEARING, V22, P18, DOI 10.1097/00003446-200102000-00003; Scherg M, 1989, J Cogn Neurosci, V1, P336, DOI 10.1162/jocn.1989.1.4.336; Schneider P, 2005, NAT NEUROSCI, V8, P1241, DOI 10.1038/nn1530; Schneiders JA, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00173; Shalgi S, 2007, NEUROPSYCHOLOGIA, V45, P1878, DOI 10.1016/j.neuropsychologia.2006.11.023; Shestakova A, 2002, NEUROREPORT, V13, P1813, DOI 10.1097/00001756-200210070-00025; Shtyrov Y, 2004, EUR J NEUROSCI, V19, P1083, DOI 10.1111/j.0953-816X.2004.03126.x; STAHL SA, 1994, J EDUC PSYCHOL, V86, P221, DOI 10.1037/0022-0663.86.2.221; STREETER LA, 1976, NATURE, V259, P39, DOI 10.1038/259041a0; Surakka V, 1998, COGNITIVE BRAIN RES, V7, P159, DOI 10.1016/S0926-6410(98)00021-4; Sussman E, 2001, COGNITIVE BRAIN RES, V12, P431, DOI 10.1016/S0926-6410(01)00067-2; Svirsky MA, 2000, PSYCHOL SCI, V11, P153, DOI 10.1111/1467-9280.00231; Swan D, 1997, J EXP CHILD PSYCHOL, V66, P18, DOI 10.1006/jecp.1997.2375; Tavabi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004452; Todd J, 2010, NEUROPSYCHOLOGIA, V48, P3009, DOI 10.1016/j.neuropsychologia.2010.06.009; Todd J, 2010, BRAIN RES, V1310, P113, DOI 10.1016/j.brainres.2009.11.019; Tsao FM, 2004, CHILD DEV, V75, P1067, DOI 10.1111/j.1467-8624.2004.00726.x; Wass M, 2008, SCAND J PSYCHOL, V49, P559, DOI 10.1111/j.1467-9450.2008.00680.x; Watson DR, 2007, AUDIOL NEURO-OTOL, V12, P65, DOI 10.1159/000097793; Wechsler D., 1997, TECHNICAL MANUAL, Vthird; WOODS DL, 1992, ELECTROEN CLIN NEURO, V82, P341, DOI 10.1016/0013-4694(92)90004-2; Zanto TP, 2009, J NEUROSCI, V29, P3059, DOI 10.1523/JNEUROSCI.4621-08.2009; Zatorre RJ, 2008, PHILOS T R SOC B, V363, P1087, DOI 10.1098/rstb.2007.2161	108	20	22	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67696	10.1371/journal.pone.0067696	http://dx.doi.org/10.1371/journal.pone.0067696			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	204FO	23861784	Green Published, gold, Green Submitted			2022-12-27	WOS:000323350700023
J	Gorrindo, P; Lane, CJ; Lee, EB; McLaughlin, B; Levitt, P				Gorrindo, Phillip; Lane, Christianne Joy; Lee, Evon Batey; McLaughlin, BethAnn; Levitt, Pat			Enrichment of Elevated Plasma F-2t-Isoprostane Levels in Individuals with Autism Who Are Stratified by Presence of Gastrointestinal Dysfunction	PLOS ONE			English	Article							SPECTRUM DISORDERS; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; GUT MICROBIOTA; OXIDANT STRESS; CHILDREN; SYMPTOMS; F-2-ISOPROSTANES; POPULATION; PREVALENCE	Etiology is unknown in the majority of individuals with autism spectrum disorder (ASD). One strategy to investigate pathogenesis is to stratify this heterogeneous disorder based on a prominent phenotypic feature that enriches for homogeneity within population strata. Co-occurring gastrointestinal dysfunction (GID) characterizes a subset of children with ASD. Our current objective was to investigate a potential pathophysiological measure to test the hypothesis that children with both ASD and GID have a more severe metabolic dysfunction than children with ASD-only, given that the highly metabolically active brain and gastrointestinal system may additively contribute measurable impairment. Plasma levels of F-2t-Isoprostanes (F-2-IsoPs), a gold standard biomarker of oxidative stress, were measured in 87 children in four groups: ASD-GID, ASD-only, GID-only and Unaffected. F-2-IsoP levels were elevated in all 3 clinical groups compared to the Unaffected group, with the ASD-GID group significantly elevated above the ASD-only group (mean, SD in pg/mg: ASD-GID 53.6, 24.4; ASD-only 36.5, 13.3; p = 0.007). Adjusting for age, sex, and triglyceride levels, F-2-IsoP levels remained significantly different between study groups, with a moderate effect size of eta(2)(p) = 0.187 (p = 0.001). Elevation in peripheral oxidative stress is consistent with, and may contribute to, the more severe functional impairments in the ASD-GID group. With unique medical, metabolic, and behavioral features in children with ASD-GID, the present findings serve as a compelling rationale for both individualized approaches to clinical care and integrated studies of biomarker enrichment in ASD subgroups that may better address the complex etiology of ASD.	[Gorrindo, Phillip] Vanderbilt Univ, Med Scientist Training Program, Nashville, TN 37235 USA; [Lane, Christianne Joy] Univ So Calif, Keck Sch Med, Dept Biostat, Los Angeles, CA 90033 USA; [Lee, Evon Batey; McLaughlin, BethAnn] Vanderbilt Univ, Kennedy Ctr Res Human Dev, Nashville, TN 37235 USA; [Lee, Evon Batey] Vanderbilt Univ, Dept Pediat, Nashville, TN USA; [Lee, Evon Batey] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [Lee, Evon Batey] Vanderbilt Univ, Dept Psychiat, Nashville, TN 37235 USA; [McLaughlin, BethAnn] Vanderbilt Univ, Dept Neurol, Nashville, TN 37235 USA; [McLaughlin, BethAnn] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [McLaughlin, BethAnn] Vanderbilt Univ, JB Marshall Neurovasc Lab, Nashville, TN 37235 USA; [Levitt, Pat] Univ So Calif, Keck Sch Med, Dept Pediat, Los Angeles, CA 90033 USA; [Levitt, Pat] Childrens Hosp Los Angeles, Inst Dev Mind, Los Angeles, CA 90027 USA	Vanderbilt University; University of Southern California; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Southern California; Children's Hospital Los Angeles	Gorrindo, P (corresponding author), Vanderbilt Univ, Med Scientist Training Program, 221 Kirkland Hall, Nashville, TN 37235 USA.	phillip.gorrindo@Vanderbilt.Edu	McLaughlin, BethAnn/D-9580-2012	McLaughlin, BethAnn/0000-0003-0228-6500; Gorrindo, Phillip/0000-0002-0296-8790	National Institutes of Health awards National Institute of Child Health and Human Development [R21HD065289]; National Institute of General Medical Sciences [T32GM07347]; National Center for Research Resources [TL1RR024978]; National Center for Advancing Translational Sciences [UL1TR000445]; Marino Autism Research Institute; Pediatric Clinical Research Center at Vanderbilt University; Scott Family Foundation; Vanderbilt Autism Treatment Network Site; Autism Speaks; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD065289] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER	National Institutes of Health awards National Institute of Child Health and Human Development; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Marino Autism Research Institute; Pediatric Clinical Research Center at Vanderbilt University; Scott Family Foundation; Vanderbilt Autism Treatment Network Site; Autism Speaks; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health awards National Institute of Child Health and Human Development R21HD065289 (PL), National Institute of General Medical Sciences T32GM07347 for the Vanderbilt Medical Scientist Training Program (PG), National Center for Research Resources TL1RR024978 (PG), and National Center for Advancing Translational Sciences UL1TR000445 for the Vanderbilt Institute for Clinical and Translational Research. Additional support was provided by the Marino Autism Research Institute, the Pediatric Clinical Research Center at Vanderbilt University, The Scott Family Foundation, and the Vanderbilt Autism Treatment Network Site, a program funded by Autism Speaks. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers E, 2012, PEDIATR CARDIOL, V33, P562, DOI 10.1007/s00246-012-0166-2; Anney RJL, 2011, EUROPEAN J HUMAN GEN; Baber KF, 2008, J PEDIATR GASTR NUTR, V47, P299, DOI 10.1097/MPG.0b013e31816c4372; Berg JM, 2012, GENOME BIOL, V13, DOI [10.1186/gb4034, 10.1186/gb-2012-13-7-247]; Black C, 2002, BRIT MED J, V325, P419, DOI 10.1136/bmj.325.7361.419; Bowers K, 2011, J NEURODEV DISORD, V3, P132, DOI 10.1007/s11689-011-9077-4; Buie T, 2010, PEDIATRICS, V125, pS1, DOI 10.1542/peds.2009-1878C; Buie T, 2010, PEDIATRICS, V125, pS19, DOI 10.1542/peds.2009-1878D; Campbell DB, 2009, PEDIATRICS, V123, P1018, DOI 10.1542/peds.2008-0819; Constantino J.N., 2012, MOL PSYCHIAT; Constantino JN, 2003, J AUTISM DEV DISORD, V33, P427, DOI 10.1023/A:1025014929212; Constantino JN, 2003, ARCH GEN PSYCHIAT, V60, P524, DOI 10.1001/archpsyc.60.5.524; Cracowski JL, 2002, AM J GASTROENTEROL, V97, P99; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; Geschwind DH, 2009, ANNU REV MED, V60, P367, DOI 10.1146/annurev.med.60.053107.121225; Giulivi C, 2010, JAMA-J AM MED ASSOC, V304, P2389, DOI 10.1001/jama.2010.1706; Gorrindo P, 2012, AUTISM RES, V5, P101, DOI 10.1002/aur.237; Gotham K, 2007, J AUTISM DEV DISORD, V37, P613, DOI 10.1007/s10803-006-0280-1; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Ibrahim SH, 2009, PEDIATRICS, V124, P680, DOI 10.1542/peds.2008-2933; James SJ, 2006, AM J MED GENET B, V141B, P947, DOI 10.1002/ajmg.b.30366; Kadiiska MB, 2005, FREE RADICAL BIO MED, V38, P698, DOI 10.1016/j.freeradbiomed.2004.09.017; Kadiiska MB, 2005, FREE RADICAL BIO MED, V38, P711, DOI 10.1016/j.freeradbiomed.2004.10.024; Kelly PJ, 2008, STROKE, V39, P100, DOI 10.1161/STROKEAHA.107.488189; Klei L, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-9; Levy SE, 2007, BIOL PSYCHIAT, V61, P492, DOI 10.1016/j.biopsych.2006.07.013; Lu AT, 2010, MOL PSYCHIAT; Melnyk S, 2011, J AUTISM DEV DISORDE; Milne GL, 2007, NAT PROTOC, V2, P221, DOI 10.1038/nprot.2006.375; Ming X, 2005, PROSTAG LEUKOTR ESS, V73, P379, DOI 10.1016/j.plefa.2005.06.002; Molloy CA, 2003, AUTISM, V7, P165, DOI 10.1177/1362361303007002004; Morrow JD, 1999, METHOD ENZYMOL, V300, P3; Oberg BP, 2004, KIDNEY INT, V65, P1009, DOI 10.1111/j.1523-1755.2004.00465.x; Oliveira G, 2005, DEV MED CHILD NEUROL, V47, P185, DOI 10.1017/S0012162205000332; Proudfoot JM, 2009, J LIPID RES, V50, P716, DOI 10.1194/jlr.M800607-JLR200; Rice K, 2012, J AM ACAD CHILD PSY, V51, P238, DOI 10.1016/j.jaac.2011.12.017; Rudie JD, 2012, NEURON IN PRESS; Scott-Van Zeeland AA, 2009, SCI TRANSL MED, V2, P1; State M., 2011, NAT NEUROSCI, V14, P1; Valicenti-McDermott M, 2006, J DEV BEHAV PEDIATR, V27, pS128, DOI 10.1097/00004703-200604002-00011; Walker L. S., 2000, MANUAL QUESTIONNAIRE; Wang LW, 2011, J DEV BEHAV PEDIATR, V32, P351, DOI 10.1097/DBP.0b013e31821bd06a; Yao YM, 2006, ARCH NEUROL-CHICAGO, V63, P1161, DOI 10.1001/archneur.63.8.1161; Zeiger SLH, 2009, FREE RADICAL BIO MED, V47, P1422, DOI 10.1016/j.freeradbiomed.2009.08.011	46	23	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68444	10.1371/journal.pone.0068444	http://dx.doi.org/10.1371/journal.pone.0068444			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844202	Green Submitted, Green Published, gold			2022-12-27	WOS:000321733000007
J	Uriyo, JG; Abubakar, A; Swai, M; Msuya, SE; Stray-Pedersen, B				Uriyo, Jacqueline G.; Abubakar, Amina; Swai, Mark; Msuya, Sia E.; Stray-Pedersen, Babill			Prevalence and Correlates of Common Mental Disorders among Mothers of Young Children in Kilimanjaro Region of Tanzania	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; POSTNATAL DEPRESSION; RISK-FACTORS; DOMESTIC VIOLENCE; RURAL-COMMUNITY; HEALTH; WOMEN; COUNTRIES; SYMPTOMS; HIV/AIDS	Background: Although poor maternal mental health is a major public health problem, with detrimental effects on the individual, her children and society, information on its correlates in low-income countries is sparse. Aims: This study investigates the prevalence of common mental disorders (CMD) among at-risk mothers, and explores its associations with sociodemographic factors. Methods: This population-based survey of mothers of children aged 0-36 months used the 14-item Shona Symptom Questionnaire (SSQ). Mothers whose response was "yes" to 8 or more items on the scale were defined as "at risk of CMD." Results: Of the 1,922 mothers (15-48 years), 28.8% were at risk of CMD. Risk of CMD was associated with verbal abuse, physical abuse, a partner who did not help with the care of the child, being in a polygamous relationship, a partner with low levels of education, and a partner who smoked cigarettes. Cohabiting appeared to be protective. Conclusions: Taken together, our results indicate the significance of the quality of relations with one's partner in shaping maternal mental health. The high proportion of mothers who are at risk of CMD emphasizes the importance of developing evidence-based mental health programmes as part of the care package aimed at improving maternal well-being in Tanzania and other similar settings.	[Uriyo, Jacqueline G.; Stray-Pedersen, Babill] Univ Oslo, Rikshosp, Oslo Univ Hosp, Div Women & Children, N-0027 Oslo, Norway; [Uriyo, Jacqueline G.] Kilimanjaro Christian Med Univ Coll, Moshi, Tanzania; [Abubakar, Amina] Tilburg Univ, Dept Psychol, NL-5000 LE Tilburg, Netherlands; [Swai, Mark] KCMC Hosp, Moshi, Tanzania; [Msuya, Sia E.] Kilimanjaro Christian Med Univ Coll, Dept Community Hlth, Moshi, Tanzania	University of Oslo; National Hospital Norway; Tilburg University	Uriyo, JG (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Div Women & Children, N-0027 Oslo, Norway.	j.g.uriyo@medisin.uio.no/	Abubakar, Amina/F-1479-2017	Abubakar, Amina/0000-0002-3686-7904	Letten Foundation, Oslo, Norway	Letten Foundation, Oslo, Norway	This research study was funded by Letten Foundation, Oslo, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiodun OA, 2006, GEN HOSP PSYCHIAT, V28, P133, DOI 10.1016/j.genhosppsych.2005.11.002; Abramsky T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-109; Adewuya AO, 2008, INT J PSYCHIAT MED, V38, P43, DOI 10.2190/PM.38.1.d; Ali B S, 2002, J Pak Med Assoc, V52, P513; Ali NS, 2012, SCI WORLD J, DOI 10.1100/2012/653098; Ali NS, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-384; Amuri M, 2011, AIDS CARE, V23, P378, DOI 10.1080/09540121.2010.507739; [Anonymous], 2011, TANZ DEM HLTH SURV 2; Antelman G, 2007, JAIDS-J ACQ IMM DEF, V44, P470, DOI 10.1097/QAI.0b013e31802f1318; Bhagwanjee A, 1998, PSYCHOL MED, V28, P1137, DOI 10.1017/S0033291798006965; Black MM, 2007, J CHILD PSYCHOL PSYC, V48, P764, DOI 10.1111/j.1469-7610.2007.01752.x; Coleman R, 2006, SOC PSYCH PSYCH EPID, V41, P720, DOI 10.1007/s00127-006-0085-8; de Paffer AT, 2012, SAO PAULO MED J, V130, P84, DOI 10.1590/S1516-31802012000200003; Deyessa Negussie, 2009, Clin Pract Epidemiol Ment Health, V5, P8, DOI 10.1186/1745-0179-5-8; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Fisher J, 2010, B WORLD HEALTH ORGAN, V88, P737, DOI 10.2471/BLT.09.067066; Genberg BL, 2009, SOC SCI MED, V68, P2279, DOI 10.1016/j.socscimed.2009.04.005; Husain N, 2006, ARCH WOMEN MENT HLTH, V9, P197, DOI 10.1007/s00737-006-0129-9; Kaaya S F, 2010, Tanzan J Health Res, V12, P36; Korste Roos, 2012, CHALLENGES MENTAL HL; Leung WC, 2002, INT J GYNECOL OBSTET, V79, P159, DOI 10.1016/S0020-7292(02)00236-9; Mbatia J, 2010, PSYCHIAT SERV, V61, P1028, DOI 10.1176/ps.2010.61.10.1028; McKinney CM, 2010, ALCOHOL CLIN EXP RES, V34, P655, DOI 10.1111/j.1530-0277.2009.01134.x; Mirza I, 2004, BMJ-BRIT MED J, V328, P794, DOI 10.1136/bmj.328.7443.794; Nakku Juliet E M, 2006, Afr Health Sci, V6, P207; National Bureau of Statistics (NBS), 2006, KIL REG DISTR PROJ; Nayak MB, 2010, BRIT J PSYCHIAT, V196, P192, DOI 10.1192/bjp.bp.109.068049; Patel V, 1997, ACTA PSYCHIAT SCAND, V95, P469, DOI 10.1111/j.1600-0447.1997.tb10134.x; Patel V, 2001, BRIT MED J, V322, P482, DOI 10.1136/bmj.322.7284.482; Patel V, 2006, BRIT J PSYCHIAT, V189, P547, DOI 10.1192/bjp.bp.106.022558; Pike IL, 2006, CULT MED PSYCHIAT, V30, P299, DOI 10.1007/s11013-006-9022-2; Rabbani Fauziah, 2000, JPMA (Journal of the Pakistan Medical Association), V50, P306; Rahman A, 2003, PSYCHOL MED, V33, P1161, DOI 10.1017/S0033291703008286; Rahman A, 2007, J AFFECT DISORDERS, V100, P115, DOI 10.1016/j.jad.2006.10.004; Sawyer A, 2010, J AFFECT DISORDERS, V123, P17, DOI 10.1016/j.jad.2009.06.027; Simsek Z, 2008, J PUBLIC HEALTH-UK, V30, P487, DOI 10.1093/pubmed/fdn025; Stewart RC, 2010, SOC PSYCH PSYCH EPID, V45, P551, DOI 10.1007/s00127-009-0094-5; Vikram Patel, 2004, GENDER MENTAL HLTH R; Winston M, 2000, SOC PSYCH PSYCH EPID, V35, P569, DOI 10.1007/s001270050281; World Health Organization, 2008, MAT MENT HLTH CHILD; Zofia PM, 2009, GINEKOL POL, V80, P280	41	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e69088	10.1371/journal.pone.0069088	http://dx.doi.org/10.1371/journal.pone.0069088			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182HT	23844249	Green Accepted, gold, Green Published			2022-12-27	WOS:000321733000033
J	da Silva, RV; Malvezi, AD; Augusto, LD; Kian, D; Tatakihara, VLH; Yamauchi, LM; Yamada-Ogatta, SF; Rizzo, LV; Schenkman, S; Pinge, P				da Silva, Rosiane V.; Malvezi, Aparecida D.; Augusto, Leonardo da Silva; Kian, Danielle; Tatakihara, Vera Lucia H.; Yamauchi, Lucy M.; Yamada-Ogatta, Sueli F.; Rizzo, Luiz V.; Schenkman, Sergio; Pinge-Filho, Phileno			Oral Exposure to Phytomonas serpens Attenuates Thrombocytopenia and Leukopenia during Acute Infection with Trypanosoma cruzi	PLOS ONE			English	Article							TRANS-SIALIDASE; CHAGAS-DISEASE; PROTECTIVE IMMUNITY; OXIDATIVE STRESS; TOMATO PARASITE; ANTIGENS; ANEMIA; SERA; NEURAMINIDASE; DIAGNOSIS	Mice infected with Trypanosoma cruzi, the agent of Chagas disease, rapidly develop anemia and thrombocytopenia. These effects are partially promoted by the parasite trans-sialidase (TS), which is shed in the blood and depletes sialic acid from the platelets, inducing accelerated platelet clearance and causing thrombocytopenia during the acute phase of disease. Here, we demonstrate that oral immunization of C57BL/6 mice with Phytomonas serpens, a phytoflagellate parasite that shares common antigens with T. cruzi but has no TS activity, reduces parasite burden and prevents thrombocytopenia and leukopenia. Immunization also reduces platelet loss after intraperitoneal injection of TS. In addition, passive transfer of immune sera raised in mice against P. serpens prevented platelet clearance. Thus, oral exposure to P. serpens attenuates the progression of thrombocytopenia induced by TS from T. cruzi. These findings are not only important for the understanding of the pathogenesis of T. cruzi infection but also for developing novel approaches of intervention in Chagas disease.	[da Silva, Rosiane V.; Malvezi, Aparecida D.; Tatakihara, Vera Lucia H.; Pinge-Filho, Phileno] Univ Estadual Londrina, Dept Ciencias Patol, Lab Imunopatol Expt, Londrina, Parana, Brazil; [Kian, Danielle; Yamauchi, Lucy M.; Yamada-Ogatta, Sueli F.] Univ Estadual Londrina, Dept Microbiol, Londrina, Parana, Brazil; [Rizzo, Luiz V.] Inst Israelita Ensino & Pesquisa Albert Einstein, Sao Paulo, Brazil; [Augusto, Leonardo da Silva; Schenkman, Sergio] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil	Universidade Estadual de Londrina; Universidade Estadual de Londrina; Hospital Israelita Albert Einstein; Universidade Federal de Sao Paulo (UNIFESP)	Pinge, P (corresponding author), Univ Estadual Londrina, Dept Ciencias Patol, Lab Imunopatol Expt, Londrina, Parana, Brazil.	pingefilho@uel.br	Pinge-Filho, Phileno/G-2844-2012; Yamada-Ogatta, Sueli Fumie/C-7020-2019; Rizzo, Luiz Vicente/B-4458-2009; Schenkman, Sergio/A-9227-2013	Yamada-Ogatta, Sueli Fumie/0000-0003-1183-146X; Schenkman, Sergio/0000-0001-9353-8480; da Silva Augusto, Leonardo/0000-0003-0430-8216	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico (CNPq); Fundacao Araucaria; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) fellowship	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) fellowship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Conselho Nacional de Desenvolvimento Cientifico (CNPq), and Fundacao Araucaria. Rosiane V. da Silva was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) fellowship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bregano JW, 2003, FEMS IMMUNOL MED MIC, V39, P257, DOI 10.1016/S0928-8244(03)00256-6; BRIONES MRS, 1995, J MOL EVOL, V41, P120, DOI 10.1007/BF00170663; Buscaglia CA, 1999, BLOOD, V93, P2025, DOI 10.1182/blood.V93.6.2025.406k19_2025_2032; Camargo EP, 1999, ADV PARASIT, V42, P29, DOI 10.1016/S0065-308X(08)60148-7; CAMARGO EP, 1990, PARASITOL TODAY, V6, P22, DOI 10.1016/0169-4758(90)90388-K; de Souza TDCB, 2011, PROTEIN J, V30, P212, DOI 10.1007/s10930-011-9322-4; Cardoso J.E., 1980, Memorias do Instituto Oswaldo Cruz, V75, P97, DOI 10.1590/S0074-02761980000200009; Claster S, 2002, J INFECT DIS, V185, pS105, DOI 10.1086/340202; CSETE M, 1985, CURR TOP MICROBIOL, V117, P153; DA SILVA L. H. P., 1953, Folia Clinica et Biologica, V20, P191; Dacie J.V., 1995, PRACTICAL HAEMATOLOG; dC-Rubin SSC, 2012, CELL MICROBIOL, V14, P1522, DOI 10.1111/j.1462-5822.2012.01831.x; DETITTO EH, 1988, CLIN IMMUNOL IMMUNOP, V46, P157, DOI 10.1016/0090-1229(88)90016-5; DOLLET M, 1984, ANNU REV PHYTOPATHOL, V22, P115, DOI 10.1146/annurev.py.22.090184.000555; Estevam M, 2012, FEMS IMMUNOL MED MIC, V64, P334, DOI 10.1111/j.1574-695X.2011.00917.x; Giorgi ME, 2010, GLYCOCONJUGATE J, V27, P549, DOI 10.1007/s10719-010-9300-7; Frasch ACC, 2000, PARASITOL TODAY, V16, P282, DOI 10.1016/S0169-4758(00)01698-7; GAZZINELLI RT, 1991, J PROTOZOOL, V38, P320, DOI 10.1111/j.1550-7408.1991.tb01366.x; Goncalves CCM, 2002, AM J TROP MED HYG, V66, P91, DOI 10.4269/ajtmh.2002.66.91; Graca-de Souza VK, 2010, BIOL RES, V43, P233, DOI [/S0716-97602010000200011, 10.4067/S0716-97602010000200011]; IKEDE B O, 1977, Acta Tropica, V34, P53; JANKEVICIUS JV, 1989, J PROTOZOOL, V36, P265, DOI 10.1111/j.1550-7408.1989.tb05361.x; Junqueira C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001560; LEGUIZAMON MS, 1994, J INFECT DIS, V170, P1570, DOI 10.1093/infdis/170.6.1570; LOPES JD, 1981, AM J TROP MED HYG, V30, P1183, DOI 10.4269/ajtmh.1981.30.1183; Malvezi AD, 2004, FEMS IMMUNOL MED MIC, V41, P69, DOI 10.1016/j.femsim.2004.01.005; Marcondes MCG, 2000, MICROBES INFECT, V2, P347, DOI 10.1016/S1286-4579(00)00333-6; Marques AF, 2010, GLYCOBIOLOGY, V20, P1528; MCGHEE RB, 1980, MICROBIOL REV, V44, P140, DOI 10.1128/MMBR.44.1.140-173.1980; MEDINAACOSTA E, 1994, EUR J BIOCHEM, V225, P333, DOI 10.1111/j.1432-1033.1994.00333.x; Moncayo A, 2006, ANN TROP MED PARASIT, V100, P663, DOI 10.1179/136485906X112248; Paul REL, 2003, MOL CELLS, V15, P139; PEREIRACHIOCCOLA VL, 1994, INFECT IMMUN, V62, P2973, DOI 10.1128/IAI.62.7.2973-2978.1994; Pinge-Filho P, 2005, IMMUNOL LETT, V96, P283, DOI 10.1016/j.imlet.2004.09.010; Py M, 2011, CURR NEUROL NEUROSCI, V11, P536, DOI 10.1007/s11910-011-0225-8; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; REPKA D, 1985, Revista Brasileira de Biologia, V45, P309; Santiago HC, 2005, J IMMUNOL, V175, P8165, DOI 10.4049/jimmunol.175.12.8165; Schauer R, 2011, CHEMBIOCHEM, V12, P2246, DOI 10.1002/cbic.201100421; SCHENKMAN S, 1994, J BIOL CHEM, V269, P7970; SCHENKMAN S, 1992, J EXP MED, V175, P567, DOI 10.1084/jem.175.2.567; Shikanai-Yasuda MA, 2012, CLIN INFECT DIS, V54, P845, DOI 10.1093/cid/cir956; SOUZA MDC, 1974, J PROTOZOOL, V21, P579, DOI 10.1111/j.1550-7408.1974.tb03705.x; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; Tatakihara VLH, 2008, FEMS IMMUNOL MED MIC, V52, P47, DOI 10.1111/j.1574-695X.2007.00340.x; Toso A, 2011, REV MED CHILE, V139, P258, DOI /S0034-98872011000200017; Tribulatti MV, 2005, INFECT IMMUN, V73, P201, DOI 10.1128/IAI.73.1.201-207.2005; VICKERMAN K, 1994, INT J PARASITOL, V24, P1317, DOI 10.1016/0020-7519(94)90198-8	48	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68299	10.1371/journal.pone.0068299	http://dx.doi.org/10.1371/journal.pone.0068299			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844182	Green Submitted, Green Published, gold			2022-12-27	WOS:000321341000151
J	Gil-Farina, I; Di Scala, M; Vanrell, L; Olague, C; Vales, A; High, KA; Prieto, J; Mingozzi, F; Gonzalez-Aseguinolaza, G				Gil-Farina, Irene; Di Scala, Marianna; Vanrell, Lucia; Olaguee, Cristina; Vales, Africa; High, Katherine A.; Prieto, Jesus; Mingozzi, Federico; Gonzalez-Aseguinolaza, Gloria			IL12-Mediated Liver Inflammation Reduces the Formation of AAV Transcriptionally Active Forms but Has No Effect over Preexisting AAV Transgene Expression	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSES; GENE-TRANSFER; T-CELLS; VECTORS; HEPATOCYTES; HEMOPHILIA; ACTIVATION; ADENOVIRUS; ELIMINATE; PATHWAY	Recombinant adenoassociated viral vectors (rAAV) have proven to be excellent candidates for gene therapy clinical applications. Recent results showed that cellular immunity to AAV represents a major challenge facing the clinical use of systemic administration of these vectors. Interestingly, no preclinical animal model has previously fully reproduced the clinical findings. The aim of the present work was to enhance the T cell immune response against AAV capsid in mice by the administration of a rAAV expressing the immunostimulatory cytokine IL-12. Our results indicate that although IL-12 expression enhanced the AAV capsid-specific immune response it failed to eliminate transduced hepatocytes and long-term expression was achieved. We found that AAV-mediated transgene expression is altered by IL-12-induced liver inflammation. However, IL-12 expression has no effect over preexisting AAV-mediated transgene expression. IL-12 down-regulates AAV mediated transgene expression via induction of IFN-gamma production by NK and T cells, but without altering the transduction efficiency measured by viral genomes. Our results indicate that liver inflammation affects the formation of transcriptionally active AAV vector genomes through an unknown mechanism that can be avoided by the use of DNA-demethylating or anti-inflammatory agents.	[Gil-Farina, Irene; Di Scala, Marianna; Vanrell, Lucia; Olaguee, Cristina; Vales, Africa; Prieto, Jesus; Gonzalez-Aseguinolaza, Gloria] Ctr Appl Med Res, Div Hepatol & Gene Therapy, Pamplona, Spain; [High, Katherine A.; Mingozzi, Federico] Childrens Hosp Philadelphia, Howard Hughes Med Inst, Ctr Cellular & Mol Therapeut, Philadelphia, PA 19104 USA; [Prieto, Jesus] Univ Navarra, Univ Navarra Clin, Liver Unit, E-31080 Pamplona, Spain; [Prieto, Jesus] Univ Navarra, Univ Navarra Clin, Ctr Invest Biomed Red Area Temat Enfermedades Hep, E-31080 Pamplona, Spain	University of Navarra; Howard Hughes Medical Institute; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Navarra	Gonzalez-Aseguinolaza, G (corresponding author), Ctr Appl Med Res, Div Hepatol & Gene Therapy, Pamplona, Spain.	ggasegui@unav.es	High, Katherine A./AAB-9322-2020; Gonzalez-Aseguinolaza, Gloria/H-9928-2015	Gonzalez-Aseguinolaza, Gloria/0000-0002-1600-4562; Prieto, Jesus/0000-0002-1091-9593; Di Scala, Marianna/0000-0002-4460-6472; Gil-Farina, Irene/0000-0002-9839-1411; High, Katherine/0000-0002-0805-6223; Vanrell, Lucia/0000-0002-3255-4820	FPI; Fondo de Investigaciones Sanitarias; European Union VII Framework program (FP7-health) [AIPGENE-2010-261506]; UTE project CIMA; Fundacion Barrie de la Maza y Condesa de Fenosa; Centro de Investigacion Biomedica en Red en el Area tematica de Enfermedades Hepaticas y Digestivas Instituto de Salud Carlos III; Ministerio Educacion y Ciencia/Ministerio de Ciencia e Innovacion [SAF 2006-03623, SAF2009-08524]; Fundacion Mutua Madrilena	FPI(Spanish Government); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); European Union VII Framework program (FP7-health); UTE project CIMA; Fundacion Barrie de la Maza y Condesa de Fenosa; Centro de Investigacion Biomedica en Red en el Area tematica de Enfermedades Hepaticas y Digestivas Instituto de Salud Carlos III; Ministerio Educacion y Ciencia/Ministerio de Ciencia e Innovacion; Fundacion Mutua Madrilena(Instituto de Salud Carlos III)	IGF and LV are in receipt of FPI grants, MDS is in receipt of a fellowship from Fondo de Investigaciones Sanitarias. This work was supported by grants from European Union VII Framework program (FP7-health: AIPGENE-2010-261506), UTE project CIMA, Fundacion Barrie de la Maza y Condesa de Fenosa, Centro de Investigacion Biomedica en Red en el Area tematica de Enfermedades Hepaticas y Digestivas Instituto de Salud Carlos III, SAF 2006-03623 and SAF2009-08524 (Ministerio Educacion y Ciencia/Ministerio de Ciencia e Innovacion) and Fundacion Mutua Madrilena. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002865; Breous E, 2011, GASTROENTEROLOGY, V141, P348, DOI 10.1053/j.gastro.2011.04.002; Jayandharan GR, 2011, P NATL ACAD SCI USA, V108, P3743, DOI 10.1073/pnas.1012753108; Kramer MG, 2003, MOL THER, V7, P375, DOI 10.1016/S1525-0016(02)00060-6; Li CW, 2007, J VIROL, V81, P7540, DOI 10.1128/JVI.00529-07; Li H, 2007, MOL THER, V15, P792, DOI 10.1038/sj.mt.6300090; Li H, 2011, MOL THER, V19, P2021, DOI 10.1038/mt.2011.81; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Martino AT, 2013, BLOOD, V121, P2224, DOI 10.1182/blood-2012-10-460733; Martino AT, 2011, BLOOD, V117, P6459, DOI 10.1182/blood-2010-10-314518; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Reboredo M, 2008, GENE THER, V15, P277, DOI 10.1038/sj.gt.3303073; Rogers GL, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00194; Sabatino DE, 2005, MOL THER, V12, P1023, DOI 10.1016/j.ymthe.2005.09.009; Stauffer JK, 2012, HEPATOLOGY, V56, P1567, DOI 10.1002/hep.25674; Suzuki M, 2013, MOL THER, V21, P796, DOI 10.1038/mt.2012.277; Vanrell L, 2011, MOL THER, V19, P1245, DOI 10.1038/mt.2011.37; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Wang LL, 2007, HUM GENE THER, V18, P185, DOI 10.1089/hum.2007.001; Washburn ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010585; Zaiss AK, 2002, J VIROL, V76, P4580, DOI 10.1128/JVI.76.9.4580-4590.2002; Zhu JG, 2009, J CLIN INVEST, V119, P2388, DOI 10.1172/JCI37607; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	24	18	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67748	10.1371/journal.pone.0067748	http://dx.doi.org/10.1371/journal.pone.0067748			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844082	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000090
J	Karper, JC; Ewing, MM; de Vries, MR; de Jager, SCA; Peters, EAB; de Boer, HC; van Zonneveld, AJ; Kuiper, J; Huizinga, EG; Brondijk, THC; Jukema, JW; Quax, PHA				Karper, Jacco C.; Ewing, Mark M.; de Vries, Margreet R.; de Jager, Saskia C. A.; Peters, Erna A. B.; de Boer, Hetty C.; van Zonneveld, Anton-Jan; Kuiper, Johan; Huizinga, Eric G.; Brondijk, T. Harma C.; Jukema, J. Wouter; Quax, Paul H. A.			TLR Accessory Molecule RP105 (CD180) Is Involved in Post-Interventional Vascular Remodeling and Soluble RP105 Modulates Neointima Formation	PLOS ONE			English	Article							RECEPTOR HOMOLOG RP105; TOLL-LIKE RECEPTOR-4; TRANSGENIC MICE; IN-VIVO; TOLL-LIKE-RECEPTOR-4; EXPRESSION; RESTENOSIS; MUSCLE; ATHEROSCLEROSIS; PROLIFERATION	Background: RP105 (CD180) is TLR4 homologue lacking the intracellular TLR4 signalling domain and acts a TLR accessory molecule and physiological inhibitor of TLR4-signaling. The role of RP105 in vascular remodeling, in particular post-interventional remodeling is unknown. Methods and Results: TLR4 and RP105 are expressed on vascular smooth muscle cells (VSMC) as well as in the media of murine femoral artery segments as detected by qPCR and immunohistochemistry. Furthermore, the response to the TLR4 ligand LPS was stronger in VSMC from RP105(-/-) mice resulting in a higher proliferation rate. In RP105(-/-) mice femoral artery cuff placement resulted in an increase in neointima formation as compared to WT mice (4982 +/- 974 mu m(2) vs. 1947 +/- 278 mu m(2), p = 0.0014). Local LPS application augmented neointima formation in both groups, but in RP105(-/-) mice this effect was more pronounced (10316 +/- 1243 mu m(2) vs. 4208 +/- 555 mu m(2), p = 0.0002), suggesting a functional role for RP105. For additional functional studies, the extracellular domain of murine RP105 was expressed with or without its adaptor protein MD1 and purified. SEC-MALSanalysis showed a functional 2: 2 homodimer formation of the RP105-MD1 complex. This protein complex was able to block the TLR4 response in whole blood ex-vivo. In vivo gene transfer of plasmid vectors encoding the extracellular part of RP105 and its adaptor protein MD1 were performed to initiate a stable endogenous soluble protein production. Expression of soluble RP105-MD1 resulted in a significant reduction in neointima formation in hypercholesterolemic mice (2500 +/- 573 vs. 6581 +/- 1894 mu m(2), p < 0.05), whereas expression of the single factors RP105 or MD1 had no effect. Conclusion: RP105 is a potent inhibitor of post-interventional neointima formation.	[Karper, Jacco C.; Ewing, Mark M.; de Vries, Margreet R.; Peters, Erna A. B.; Quax, Paul H. A.] LUMC, Dept Surg, Leiden, Netherlands; [Karper, Jacco C.; Ewing, Mark M.; de Vries, Margreet R.; Peters, Erna A. B.; de Boer, Hetty C.; van Zonneveld, Anton-Jan; Quax, Paul H. A.] LUMC, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [Ewing, Mark M.; de Vries, Margreet R.; Jukema, J. Wouter] LUMC, Dept Cardiol, Leiden, Netherlands; [de Jager, Saskia C. A.; Kuiper, Johan] Leiden Univ, Dept Biopharmaceut, NL-2300 RA Leiden, Netherlands; [de Boer, Hetty C.; van Zonneveld, Anton-Jan] LUMC, Dept Nephrol, Leiden, Netherlands; [Huizinga, Eric G.; Brondijk, T. Harma C.] Univ Utrecht, Dept Chem, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Utrecht University	Quax, PHA (corresponding author), LUMC, Dept Surg, Leiden, Netherlands.	p.h.a.quax@lumc.nl	Brondijk, Harma/AAD-6485-2019; Quax, Paul/ABD-5294-2020; van Zonneveld, Anton Jan/D-8060-2018; Quax, Paul/W-8520-2019; de+Jager, Saskia/ABC-4264-2020; de Vries, Margreet/Z-5653-2019; Jukema, J. Wouter/ABD-6503-2021; de+Jager, Saskia/AAE-1132-2022	Brondijk, Harma/0000-0002-0234-673X; Quax, Paul/0000-0002-6853-5760; van Zonneveld, Anton Jan/0000-0002-1676-7738; Jukema, J. Wouter/0000-0002-3246-8359; de Jager, Saskia/0000-0002-5233-0066	Dutch Top Institute Pharma project [D1-101]; Foundation "De Drie Lichten'' in the Netherlands	Dutch Top Institute Pharma project; Foundation "De Drie Lichten'' in the Netherlands	This study was (partly) performed within the framework of the Dutch Top Institute Pharma project D1-101. This project has been supported by the Foundation "De Drie Lichten'' in the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2010, J EXP MED, V207, P1579, DOI 10.1084/jem.20100155; Akashi-Takamura S, 2008, CURR OPIN IMMUNOL, V20, P420, DOI 10.1016/j.coi.2008.07.001; Arkenbout EK, 2002, CIRCULATION, V106, P1530, DOI 10.1161/01.CIR.0000028811.03056.BF; de Graaf R, 2006, MICROBES INFECT, V8, P1859, DOI 10.1016/j.micinf.2006.02.024; Divanovic S, 2005, J ENDOTOXIN RES, V11, P363, DOI 10.1179/096805105X67300; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Divanovic S, 2007, J LEUKOCYTE BIOL, V82, P265, DOI 10.1189/jlb.0107021; Eefting D, 2007, ATHEROSCLEROSIS, V193, P335, DOI 10.1016/j.atherosclerosis.2006.09.032; Eefting D, 2010, CARDIOVASC RES, V88, P367, DOI 10.1093/cvr/cvq203; Freudenberg J, 2010, HUM MOL GENET, V19, P3863, DOI 10.1093/hmg/ddq304; Hadley JS, 2007, SHOCK, V27, P466, DOI 10.1097/01.shk.0000245033.69977.c5; Hollestelle SCG, 2004, CIRCULATION, V109, P393, DOI 10.1161/01.CIR.0000109140.51366.72; Jukema JW, 2012, NAT REV CARDIOL, V9, P79, DOI 10.1038/nrcardio.2011.148; Jukema JW, 2012, NAT REV CARDIOL, V9, P53, DOI 10.1038/nrcardio.2011.132; Karper JC, 2011, ARTERIOSCL THROM VAS, V31, P1033, DOI 10.1161/ATVBAHA.111.223271; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Lardenoye JHP, 2000, CIRC RES, V87, P248, DOI 10.1161/01.RES.87.3.248; McMahon JM, 2001, GENE THER, V8, P1264, DOI 10.1038/sj.gt.3301522; MIYAKE K, 1995, J IMMUNOL, V154, P3333; Miyake K, 1998, J IMMUNOL, V161, P1348; Monraats PS, 2005, FASEB J, V19, P1998, DOI 10.1096/fj.05-4634com; Monraats PS, 2005, CIRCULATION, V112, P2417, DOI 10.1161/CIRCULATIONAHA.105.536268; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; Schepers A, 2006, ARTERIOSCL THROM VAS, V26, P2063, DOI 10.1161/01.ATV.0000235694.69719.e2; Shimamoto A, 2006, CIRCULATION, V114, pI270, DOI 10.1161/CIRCULATIONAHA.105.000901; Shimizu T, 2011, J MOL BIOL, VS0022-2836, P01026; Tada Y, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2529; Tanne A, 2009, J EXP MED, V206, P2205, DOI 10.1084/jem.20090188; Timmers L, 2008, CIRC RES, V102, P257, DOI 10.1161/CIRCRESAHA.107.158220; Vink A, 2002, CIRCULATION, V106, P1985, DOI 10.1161/01.CIR.0000032146.75113.EE; Ward MR, 2000, CIRCULATION, V102, P1186, DOI 10.1161/01.CIR.102.10.1186; Yoon SI, 2011, NAT STRUCT MOL BIOL, V18, P1028, DOI 10.1038/nsmb.2106; Zhang YP, 2009, EUR CYTOKINE NETW, V20, P148, DOI 10.1684/ecn.2009.0156	34	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67923	10.1371/journal.pone.0067923	http://dx.doi.org/10.1371/journal.pone.0067923			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844130	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000120
J	Li, XY; Pu, JX; Jiang, SY; Su, J; Kong, LM; Mao, BY; Sun, HD; Li, Y				Li, Xingyao; Pu, Jianxin; Jiang, Shiyou; Su, Jia; Kong, Lingmei; Mao, Bingyu; Sun, Handong; Li, Yan			Henryin, an ent-kaurane Diterpenoid, Inhibits Wnt Signaling through Interference with beta-Catenin/TCF4 Interaction in Colorectal Cancer Cells	PLOS ONE			English	Article							BETA-CATENIN; COLON-CANCER; RESPONSE ELEMENT; ACTIVATION; EXPRESSION; PATHWAY; COMPLEX; GROWTH; APC; ANTAGONISTS	Aberrant Wnt/beta-catenin signaling has been strongly associated with the tumorigenesis of human colorectal cancer. Inhibitors of this pathway may then offer therapeutic strategies as well as chemoprevention for this malignant disease. Henryin is an ent-kaurane diterpenoid isolated from Isodon rubescens var. lushanensis, a plant long been used in folk medicine to prevent inflammation and gastrointestinal disease. In the present study, we report that henryin selectively inhibits the proliferation of human colorectal cancer cells with a GI(50) value in the nano-molar range. Microarray analysis and reporter assays showed that henryin worked as a novel antagonist of Wnt signaling pathway. Henryin reduced the expression of Cyclin D1 and C-myc, and induced G1/S phase arrest in HCT116 cells. Concurrently, henryin did not affect the cytosol-nuclear distribution of soluble beta-catenin, but impaired the association of beta-catenin/TCF4 transcriptional complex likely through directly blocking the binding of beta-catenin to TCF4. We also then analyzed the structure-activity relationship among the ent-kaurane type diterpenoids. Our data suggests that henryin, as a novel inhibitor of Wnt signaling, could be a potential candidate for further preclinical evaluation for colon cancer treatment, and as such warrants further exploration.	[Li, Xingyao; Pu, Jianxin; Su, Jia; Kong, Lingmei; Sun, Handong; Li, Yan] Chinese Acad Sci, State Key Lab Phytochem & Plant Resources West Ch, Kunming Inst Bot, Kunming, Peoples R China; [Jiang, Shiyou; Mao, Bingyu] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Li, Xingyao; Jiang, Shiyou; Su, Jia; Kong, Lingmei] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Sun, HD (corresponding author), Chinese Acad Sci, State Key Lab Phytochem & Plant Resources West Ch, Kunming Inst Bot, Kunming, Peoples R China.	hdsun@mail.kib.ac.cn; liyanb@mail.kib.ac.cn	Mao, Bingyu/L-9955-2014	Jiang, Shi-You/0000-0001-9406-4934; Mao, Bingyu/0000-0002-7993-3158	100 Talents Program of the Chinese Academy of Sciences; West Light Foundation of the Chinese Academy of Sciences; Major State Basic Research Development Program of China [2009CB522300]; Natural Science Foundation of China [81173076, 81172939]; Recruited Top Talent of Sciences and Technology of Yunnan Province, China [2009C1120]	100 Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences); Major State Basic Research Development Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Recruited Top Talent of Sciences and Technology of Yunnan Province, China	This work was supported by both the 100 Talents Program (YL) and the West Light Foundation (JP) of the Chinese Academy of Sciences, the Major State Basic Research Development Program of China (No. 2009CB522300), the Natural Science Foundation of China (No. 81173076, 81172939), and the Recruited Top Talent of Sciences and Technology of Yunnan Province (2009C1120), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen HJ, 2012, BIOCHEM PHARMACOL, V84, P1143, DOI 10.1016/j.bcp.2012.08.011; Choi H, 2010, BIOCHEM BIOPH RES CO, V391, P915, DOI 10.1016/j.bbrc.2009.11.164; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; de Sousa EMF, 2011, CLIN CANCER RES, V17, P647, DOI 10.1158/1078-0432.CCR-10-1204; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; He BC, 2011, MOL PHARMACOL, V79, P211, DOI 10.1124/mol.110.068668; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; Jaiswal AS, 2002, ONCOGENE, V21, P8414, DOI 10.1038/sj.onc.1205947; Kang Y.-J., 2012, MOL PHARM; Kim JY, 2006, J BIOL CHEM, V281, P10865, DOI 10.1074/jbc.M513378200; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Leung CH, 2006, MOL PHARMACOL, V70, P1946, DOI 10.1124/mol.106.028480; LI J, 1984, Acta Botanica Yunnanica, V6, P453; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Oshima H, 2012, J GASTROENTEROL, V47, P97, DOI 10.1007/s00535-011-0523-6; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Su Y, 2009, CARCINOGENESIS, V30, P331, DOI 10.1093/carcin/bgn279; Suh Y, 2009, CARCINOGENESIS, V30, P300, DOI 10.1093/carcin/bgn269; Sun HD, 2006, NAT PROD REP, V23, P673, DOI 10.1039/b604174d; Tarapore RS, 2012, CARCINOGENESIS, V33, P483, DOI 10.1093/carcin/bgr305; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; Waaler J, 2011, CANCER RES, V71, P197, DOI 10.1158/0008-5472.CAN-10-1282; Wang W, 2011, CELL RES, V21, P730, DOI 10.1038/cr.2011.30; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; Zhang HB, 2010, CHEM PHARM BULL, V58, P56, DOI 10.1248/cpb.58.56; Zhang QS, 2007, P NATL ACAD SCI USA, V104, P7444, DOI 10.1073/pnas.0702136104; Zhang T, 2001, CANCER RES, V61, P8664	37	37	38	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68525	10.1371/journal.pone.0068525	http://dx.doi.org/10.1371/journal.pone.0068525			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844215	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000169
J	Otsuka, T; Kitami, O; Kondo, K; Ota, H; Oshima, S; Tsuchiya, A; Shirai, T; Fujii, K; Nakamure, M; Shoji, Y; Nakamura, H; Masuda, Y; Komiyama, K; Yoshida, K; Ishikawa, Y; Iwaya, A; Takahashi, S; Okazaki, M; Hotomi, M; Yamanaka, N				Otsuka, Taketo; Kitami, Osamu; Kondo, Kouji; Ota, Hisayuki; Oshima, Shinsuke; Tsuchiya, Akio; Shirai, Takatoshi; Fujii, Koyata; Nakamure, Michihide; Shoji, Yasuhiro; Nakamura, Hisano; Masuda, Yasuko; Komiyama, Kenichi; Yoshida, Kazunaga; Ishikawa, Yukio; Iwaya, Atsushi; Takahashi, Sugata; Okazaki, Minoru; Hotomi, Muneki; Yamanaka, Noboru			Incidence Survey of Acute Otitis Media in Children in Sado Island, Japan-Sado Otitis Media Study (SADOMS)	PLOS ONE			English	Article							LIFE	Background: Acute otitis media (AOM) is one of the most common forms of bacterial infection and cause for clinic visits in children. The incidence of AOM was 0.9-1.2 episodes per person-year during the first 2 years of life in previous reports conducted before 2000. The aim of this study was to 1) evaluate the latest AOM incidence in pediatric outpatients and 2) identify the bacterial pathogens from these patients and ascertain their serotypes and resistance. Methods: The study was conducted in a closed population, involving all pediatricians and otolaryngologists in Sado Island allowing accurate determination of AOM incidence. In each month, one week was assigned as "surveillance week", and all outpatients with acute illness aged 0-18 years examined during the surveillance weeks were enrolled. AOM was diagnosed on the basis of otoscopic findings and clinical symptoms were recorded. Specimens were collected from the nasopharynx or middle ear cavity of AOM patients and examined for bacteria. Antimicrobial susceptibilities, serotypes, and molecular typing for resistance were determined among Streptococcus pneumoniae and Haemophilus influenzae. Results: In total, 8,283 clinic visits were conducted, and 354 episodes (4.3%, 95% CI: 3.9-4.7%) among 312 children were diagnosed as AOM. The incidence of AOM was highest in children of 1 year of age (0.54 episodes/child/year, 95% CI: 0.44-0.64). Serotype coverage of 7- and 13-valent pneumococcal conjugate vaccines in this study were 38.0% (95% CI: 29.3-47.3) and 62.8% (95% CI: 53.6-71.4), respectively. Of 122 H. influenzae isolates available for typing, 120 were nontypeable and 2 were type b. A high proportion of S. pneumoniae isolates (46%) showed resistance to penicillin. Approximately half of H. influenzae isolates had genetic markers for beta-lactamase-negative ampicillin-resistance. Conclusions: Approximately 4-5% of pediatric outpatients, even without AOM-related symptoms, had AOM in our study. Pediatricians as well as otolaryngologists should check the tympanic membrane findings of all pediatric outpatients.	[Otsuka, Taketo; Fujii, Koyata; Nakamure, Michihide; Shoji, Yasuhiro; Nakamura, Hisano; Okazaki, Minoru] Sado Gen Hosp, Dept Pediat, Sado, Niigata, Japan; [Kitami, Osamu] Shiseido Otolaryngol Clin, Sado, Niigata, Japan; [Kondo, Kouji] Kondo Clin, Sado, Niigata, Japan; [Ota, Hisayuki; Oshima, Shinsuke; Tsuchiya, Akio] Sado Gen Hosp, Dept Otolaryngol, Sado, Niigata, Japan; [Shirai, Takatoshi; Iwaya, Atsushi] Ryotsu Hosp, Dept Pediat, Sado, Niigata, Japan; [Masuda, Yasuko; Komiyama, Kenichi; Yoshida, Kazunaga; Ishikawa, Yukio] Sado Gen Hosp, Dept Clin Lab, Sado, Niigata, Japan; [Takahashi, Sugata] Niigata Univ, Dept Otolaryngol, Niigata, Japan; [Hotomi, Muneki; Yamanaka, Noboru] Wakayama Med Univ, Dept Otolaryngol Head & Neck Surg, Wakayama, Japan	Niigata University; Wakayama Medical University	Otsuka, T (corresponding author), Sado Gen Hosp, Dept Pediat, Sado, Niigata, Japan.	ootsukataketo@hotmail.com						[Anonymous], 2008, M100S18 CLIN LAB STA; Auinger P, 2003, PEDIATRICS, V112, P514, DOI 10.1542/peds.112.3.514; CARLSON LH, 1999, EVIDENCE BASED OTITI, P105; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; FADEN H, 1990, PEDIATR INFECT DIS J, V9, P623; Hotomi M, 2007, ANTIMICROB AGENTS CH, V51, P3969, DOI 10.1128/AAC.00422-07; Hotomi M, 2010, AURIS NASUS LARYNX, V37, P594, DOI 10.1016/j.anl.2010.02.005; Lieberthal AS, 2004, PEDIATRICS, V113, P1451, DOI 10.1542/peds.113.5.1451; Nagai K, 2001, J ANTIMICROB CHEMOTH, V48, P915, DOI 10.1093/jac/48.6.915; Roy E, 2007, J HEALTH POPUL NUTR, V25, P414; Shaikh N, 2012, ACAD PEDIATR, V12, P214, DOI 10.1016/j.acap.2012.01.007; Subcommittee of Clinical Practice Guideline for Diagnosis and Management of Acute Otitis Media in Children (Japan Otological Society Japan Society for Pediatric Otorhinolaryngology Japan Society for Infectious Diseases in Otolaryngology), 2012, Auris Nasus Larynx, V39, P1, DOI 10.1016/j.anl.2011.09.008; Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P2562, DOI 10.1128/AAC.40.11.2562; Syrjanen RK, 2005, PEDIATR INFECT DIS J, V24, P801, DOI 10.1097/01.inf.0000178072.83531.4f; TaitKamradt A, 1997, ANTIMICROB AGENTS CH, V41, P2251, DOI 10.1128/AAC.41.10.2251; TEELE DW, 1989, J INFECT DIS, V160, P83, DOI 10.1093/infdis/160.1.83; Wada A, 2013, PEDIAT INFE IN PRESS	17	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68711	10.1371/journal.pone.0068711	http://dx.doi.org/10.1371/journal.pone.0068711			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844235	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000178
J	Singh, A; Yamamoto, M; Kam, SHY; Ruan, J; Gauvreau, GM; O'Byrne, PM; FitzGerald, JM; Schellenberg, R; Boulet, LP; Wojewodka, G; Kanagaratham, C; De Sanctis, JB; Radzioch, D; Tebbutt, SJ				Singh, Amrit; Yamamoto, Masatsugu; Kam, Sarah H. Y.; Ruan, Jian; Gauvreau, Gail M.; O'Byrne, Paul M.; FitzGerald, J. Mark; Schellenberg, Robert; Boulet, Louis-Philippe; Wojewodka, Gabriella; Kanagaratham, Cynthia; De Sanctis, Juan B.; Radzioch, Danuta; Tebbutt, Scott J.			Gene-Metabolite Expression in Blood Can Discriminate Allergen-Induced Isolated Early from Dual Asthmatic Responses	PLOS ONE			English	Article							INHALATION CHALLENGE; AIRWAY INFLAMMATION; CELLS; RESOLUTION; IMMEDIATE	Some asthmatic individuals undergoing allergen inhalation challenge develop an isolated early response whereas others develop a dual response (early plus late response). In the present study we have used transcriptomics (microarrays) and metabolomics (mass spectrometry) of peripheral blood to identify molecular patterns that can discriminate allergen-induced isolated early from dual asthmatic responses. Peripheral blood was obtained prior to (pre-) and 2 hours post allergen inhalation challenge from 33 study participants. In an initial cohort of 14 participants, complete blood counts indicated significant differences in neutrophil and lymphocyte counts at pre-challenge between early and dual responders. At post-challenge, significant genes (ALOX15, FADS2 and LPCAT2) and metabolites (lysolipids) were enriched in lipid metabolism pathways. Enzymes encoding for these genes are involved in membrane biogenesis and metabolism of fatty acids into pro-inflammatory and anti-inflammatory mediators. Correlation analysis indicated a strong negative correlation between ALOX15, FADS2, and IL5RA expression with 2-arachidonoylglycerophosphocholine levels in dual responders. However, measuring arachidonic acid and docosahexaenoic acid levels in a validation cohort of 19 participants indicated that the free form of DHA (nmoles/mu g of protein) was significantly (p = 0.03) different between early and dual responders after allergen challenge. Collectively these results may suggest an imbalance in lipid metabolism which dictates pro- (anti-)inflammatory and pro-resolving mechanisms. Future studies with larger sample sizes may reveal novel mechanisms and therapeutic targets of the late phase asthmatic response.	[Singh, Amrit; Yamamoto, Masatsugu; Kam, Sarah H. Y.; Ruan, Jian; Schellenberg, Robert; Tebbutt, Scott J.] Univ British Columbia, St Pauls Hosp, James Hogg Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Singh, Amrit; Yamamoto, Masatsugu; Kam, Sarah H. Y.; Ruan, Jian; FitzGerald, J. Mark; Tebbutt, Scott J.] Inst Heart Lung Hlth, Vancouver, BC, Canada; [Singh, Amrit; Tebbutt, Scott J.] NCE CECR PROOF Ctr Excellence, Vancouver, BC, Canada; [Gauvreau, Gail M.; O'Byrne, Paul M.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Yamamoto, Masatsugu; FitzGerald, J. Mark; Schellenberg, Robert; Tebbutt, Scott J.] Univ British Columbia, Dept Med, Div Resp Med, Vancouver, BC, Canada; [FitzGerald, J. Mark] Vancouver Gen Hosp, Vancouver Coastal Hlth Res Inst, Vancouver, BC, Canada; [Boulet, Louis-Philippe] Univ Laval, Ctr Pneumol Hop, Ste Foy, PQ G1K 7P4, Canada; [Wojewodka, Gabriella; Kanagaratham, Cynthia; De Sanctis, Juan B.; Radzioch, Danuta] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [De Sanctis, Juan B.] Cent Univ Venezuela, Inst Immunol, Caracas, Venezuela	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; McMaster University; University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute; Laval University; McGill University; University of Central Venezuela	Tebbutt, SJ (corresponding author), Univ British Columbia, St Pauls Hosp, James Hogg Res Ctr, Vancouver, BC V5Z 1M9, Canada.	Scott.Tebbutt@hli.ubc.ca	Yamamoto, Masatsugu/AAH-7093-2020; De Sanctis, Juan B./H-5050-2019	Yamamoto, Masatsugu/0000-0003-0596-555X; De Sanctis, Juan B./0000-0002-5480-4608; Tebbutt, Scott/0000-0002-7908-1581; Radzioch, Danuta/0000-0002-1601-2757; O'Byrne, Paul/0000-0003-0979-281X	AllerGen NCE Inc. (Allergy, Genes and Environment Network)	AllerGen NCE Inc. (Allergy, Genes and Environment Network)	This study was funded by AllerGen NCE Inc. (Allergy, Genes and Environment Network). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamko DJ, 2012, CHEST, V141, P1295, DOI 10.1378/chest.11-2028; Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; BARNES PJ, 1992, THORAX, V47, P979, DOI 10.1136/thx.47.11.979; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; Chiang N, 2005, PROSTAG LEUKOTR ESS, V73, P163, DOI 10.1016/j.plefa.2005.05.003; COCKCROFT DW, 1983, CHEST, V84, P505, DOI 10.1378/chest.84.4.505; EBINA M, 1990, AM REV RESPIR DIS, V141, P1327, DOI 10.1164/ajrccm/141.5_Pt_1.1327; Feltenmark S, 2008, P NATL ACAD SCI USA, V105, P680, DOI 10.1073/pnas.0710127105; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gauvreau Gail M., 2007, V14, P21, DOI 10.1159/000107052; Gauvreau GM, 2011, AM J RESP CRIT CARE, V183, P1007, DOI 10.1164/rccm.201008-1210OC; Gauvreau GM, 2000, AM J RESP CRIT CARE, V161, P1473, DOI 10.1164/ajrccm.161.5.9908090; Gonzalez I, 2009, J BIOL SYST, V17, P173, DOI 10.1142/S0218339009002831; GOUNNI AS, 1994, NATURE, V367, P183, DOI 10.1038/367183a0; Hakonarson H, 2001, AM J RESP CELL MOL, V25, P761, DOI 10.1165/ajrcmb.25.6.4628; Hamann J, 2007, EUR J IMMUNOL, V37, P2797, DOI 10.1002/eji.200737553; Hammad H, 2008, NAT REV IMMUNOL, V8, P193, DOI 10.1038/nri2275; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hansel Nadia N, 2007, Proc Am Thorac Soc, V4, P32, DOI 10.1513/pats.200606-132JG; Hatzivlassiou M, 2010, ALLERGY, V65, P355, DOI 10.1111/j.1398-9995.2009.02184.x; Hochreiter S, 2006, BIOINFORMATICS, V22, P943, DOI 10.1093/bioinformatics/btl033; Hotelling H, 1936, BIOMETRIKA, V28, P321, DOI 10.2307/2333955; Huber P. H., 1981, ROBUST STAT; Jarjour NN, 1997, AM J RESP CRIT CARE, V155, P1515, DOI 10.1164/ajrccm.155.5.9154851; Kam SHY, 2012, J ASTHMA, V49, P219, DOI 10.3109/02770903.2011.654300; Lattka E, 2010, CURR OPIN LIPIDOL, V21, P64, DOI 10.1097/MOL.0b013e3283327ca8; Levy BD, 2007, J IMMUNOL, V178, P496, DOI 10.4049/jimmunol.178.1.496; Levy BD, 2012, CLIN CHEST MED, V33, P559, DOI 10.1016/j.ccm.2012.06.006; Levy BD, 2010, PROSTAG LEUKOTR ESS, V82, P327, DOI 10.1016/j.plefa.2010.02.003; LIU MC, 1991, AM REV RESPIR DIS, V144, P51, DOI 10.1164/ajrccm/144.1.51; Luskin AT, 2005, J ALLERGY CLIN IMMUN, V115, pS539, DOI 10.1016/j.jaci.2005.01.027; Matsumoto K, 2002, J ALLERGY CLIN IMMUN, V109, P281, DOI 10.1067/mai.2002.121144; Murray J J, 1985, Trans Assoc Am Physicians, V98, P275; NAYLOR BERNARD, 1962, THORAX, V17, P69, DOI 10.1136/thx.17.1.69; Perogamvros I, 2012, NAT REV ENDOCRINOL, V8, P717, DOI 10.1038/nrendo.2012.134; Rzehak P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013261; SCHLENK H, 1960, ANAL CHEM, V32, P1412, DOI 10.1021/ac60167a011; Seeds MC, 2009, AM J RESP CELL MOL, V41, P358, DOI 10.1165/rcmb.2008-0192OC; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Singh A, 2012, PROTEOMICS CLIN APPL; Symth GK, 2004, STAT APPL GENETICS M; Talloen W, 2007, BIOINFORMATICS, V23, P2897, DOI 10.1093/bioinformatics/btm478; Team RDC, 2009, R LANG ENV STAT COMP; Tesfaigzi Y, 2008, CURR MOL MED, V8, P408, DOI 10.2174/156652408785160961; Tulic MK, 2001, RESP RES, V2, P333, DOI 10.1186/rr83; Verstraelen S, 2008, TOXICOL IN VITRO, V22, P1419, DOI 10.1016/j.tiv.2008.05.008; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; WENZEL SE, 1989, AM REV RESPIR DIS, V139, P450, DOI 10.1164/ajrccm/139.2.450; Wood JJ, 1998, AM J RESP CRIT CARE, V157, P99, DOI 10.1164/ajrccm.157.1.9704125; Yamamoto M., 2012, BMC GENOMICS, V13; Yao PL, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-89	54	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67907	10.1371/journal.pone.0067907	http://dx.doi.org/10.1371/journal.pone.0067907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844124	Green Published, gold			2022-12-27	WOS:000321341000117
J	Steinmann, C; Blaedel, KL; Christensen, AS; Jensen, JH				Steinmann, Casper; Blaedel, Kristoffer L.; Christensen, Anders S.; Jensen, Jan H.			Interface of the Polarizable Continuum Model of Solvation with Semi-Empirical Methods in the GAMESS Program	PLOS ONE			English	Article							ELECTROSTATIC INTERACTION; ENERGY GRADIENTS; OPTIMIZATION; MOLECULES; CONVERGENCE; GEOMETRY; PDB2PQR; SOLUTE; SCF	An interface between semi-empirical methods and the polarized continuum model (PCM) of solvation successfully implemented into GAMESS following the approach by Chudinov et al (Chem. Phys. 1992, 160, 41). The interface includes energy gradients and is parallelized. For large molecules such as ubiquitin a reasonable speedup (up to a factor of six) is observed for up to 16 cores. The SCF convergence is greatly improved by PCM for proteins compared to the gas phase.	[Steinmann, Casper] Univ Southern Denmark, Dept Phys Chem & Pharm, Odense, Denmark; [Blaedel, Kristoffer L.; Christensen, Anders S.; Jensen, Jan H.] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark	University of Southern Denmark; University of Copenhagen	Jensen, JH (corresponding author), Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark.	jhjensen@chem.ku.dk	Jensen, Jan Halborg/G-4338-2010; Svendsen, Casper/T-6775-2018	Jensen, Jan Halborg/0000-0002-1465-1010; Svendsen, Casper/0000-0002-5638-1346				Barone V, 1998, J PHYS CHEM A, V102, P1995, DOI 10.1021/jp9716997; Cances E, 1997, J CHEM PHYS, V107, P3032, DOI 10.1063/1.474659; Caricato M, 2004, J PHYS CHEM A, V108, P6248, DOI 10.1021/jp048888r; Chaban G, 1997, THEOR CHEM ACC, V97, P88, DOI 10.1007/s002140050241; CHUDINOV GE, 1992, CHEM PHYS, V160, P41, DOI 10.1016/0301-0104(92)87090-V; Cossi M, 2003, J COMPUT CHEM, V24, P669, DOI 10.1002/jcc.10189; DEWAR MJS, 1977, J AM CHEM SOC, V99, P4899, DOI 10.1021/ja00457a004; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; DEWAR MJS, 1977, THEOR CHIM ACTA, V46, P89, DOI 10.1007/BF00548085; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; FISCHER TH, 1992, J PHYS CHEM-US, V96, P9768, DOI 10.1021/j100203a036; KLAMT A, 1993, J CHEM SOC PERK T 2, P799, DOI 10.1039/p29930000799; Li H, 2003, THEOR CHEM ACC, V109, P71, DOI 10.1007/s00214-002-0427-x; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li H, 2004, J COMPUT CHEM, V25, P1449, DOI 10.1002/jcc.20072; LUQUE FJ, 1993, J PHYS CHEM-US, V97, P4386, DOI 10.1021/j100119a022; Mennucci B, 2012, WIRES COMPUT MOL SCI, V2, P386, DOI 10.1002/wcms.1086; MIERTUS S, 1981, CHEM PHYS, V55, P117, DOI 10.1016/0301-0104(81)85090-2; NEGRE M, 1992, CHEM PHYS LETT, V196, P27, DOI 10.1016/0009-2614(92)85924-Y; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; PASCUALAHUIR JL, 1987, J COMPUT CHEM, V8, P778, DOI 10.1002/jcc.540080605; PULAY P, 1982, J COMPUT CHEM, V3, P556, DOI 10.1002/jcc.540030413; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; STEWART JJP, 1989, J COMPUT CHEM, V10, P209, DOI 10.1002/jcc.540100208; Su PF, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3077917; Thellamurege NM, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4773280; Tomasi J, 1999, J MOL STRUC-THEOCHEM, V464, P211, DOI 10.1016/S0166-1280(98)00553-3; Tomasi J, 2005, CHEM REV, V105, P2999, DOI 10.1021/cr9904009	29	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67725	10.1371/journal.pone.0067725	http://dx.doi.org/10.1371/journal.pone.0067725			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844075	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000084
J	Lin, P; Huang, ZX				Lin, Pei; Huang, Zhongxi			Correlation Analysis Connects Cancer Subtypes	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; MOLECULAR SUBTYPES; METASTASIS; EXPRESSION; THROMBIN; GENE; CLASSIFICATION; PHENOTYPE	We provided a cross-tissue comparative analysis of between-subtype molecular commonality for ovarian cancer, breast cancer, hepatocellular carcinoma, glioma, lung squamous carcinoma and nasopharyngeal carcinoma. Our analysis showed that molecular subtypes with similar phenotype or similar clinical outcome could be correlated by their transcriptional profile and pathway profile. Pathway dysregulation across multiple cancer subtypes was also revealed by Gene Set Enrichment Analysis. Dysregulation of 'complement and coagulation cascades' was observed in a total of eleven subtypes across five tissues, implicating that the role of this process in personalized immune-based therapy may be worth further exploring.	[Lin, Pei; Huang, Zhongxi] Southern Med Univ, Sch Basic Med Sci, Canc Res Inst, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Huang, ZX (corresponding author), Southern Med Univ, Sch Basic Med Sci, Canc Res Inst, Guangzhou, Guangdong, Peoples R China.	zxhuang123@yeah.net		Lin, Pei/0000-0002-1218-8800	National Natural Sciences Foundation of China [30400496, 90612020]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Sciences Foundation of China (grant number: 30400496 and 90612020, URL http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Cheng WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034705; Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; ESUMI N, 1991, CANCER RES, V51, P4549; Fosbrink M, 2009, EXP MOL PATHOL, V86, P87, DOI 10.1016/j.yexmp.2008.12.005; Groger CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051136; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Hu L, 2004, BLOOD, V104, P2746, DOI 10.1182/blood-2004-03-1047; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kolev M, 2011, ARCH IMMUNOL THER EX, V59, P407, DOI 10.1007/s00005-011-0146-x; Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655; MUELLER BM, 1992, P NATL ACAD SCI USA, V89, P11832, DOI 10.1073/pnas.89.24.11832; NIERODZIK ML, 1991, J CLIN INVEST, V87, P229, DOI 10.1172/JCI114976; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Prins RM, 2011, CLIN CANCER RES, V17, P1603, DOI 10.1158/1078-0432.CCR-10-2563; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang ZY, 2009, J AM SOC NEPHROL, V20, P593, DOI 10.1681/ASN.2008040434; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Walter V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056823; Zhu L, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-29	29	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e69747	10.1371/journal.pone.0069747	http://dx.doi.org/10.1371/journal.pone.0069747			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861980	Green Published, Green Submitted, gold			2022-12-27	WOS:000321692000050
J	Yamanaka, T; Raffaelli, D; White, PCL				Yamanaka, Tsuyuko; Raffaelli, David; White, Piran C. L.			Non-Linear Interactions Determine the Impact of Sea-Level Rise on Estuarine Benthic Biodiversity and Ecosystem Processes	PLOS ONE			English	Article							INTERTIDAL HABITAT; HUMBER ESTUARY; MACROFAUNA; ZOOPLANKTON; DIVERSITY; RESPONSES; BEACHES; ECOLOGY; BIOMASS; FUTURE	Sea-level rise induced by climate change may have significant impacts on the ecosystem functions and ecosystem services provided by intertidal sediment ecosystems. Accelerated sea-level rise is expected to lead to steeper beach slopes, coarser particle sizes and increased wave exposure, with consequent impacts on intertidal ecosystems. We examined the relationships between abundance, biomass, and community metabolism of benthic fauna with beach slope, particle size and exposure, using samples across a range of conditions from three different locations in the UK, to determine the significance of sediment particle size beach slope and wave exposure in affecting benthic fauna and ecosystem function in different ecological contexts. Our results show that abundance, biomass and oxygen consumption of intertidal macrofauna and meiofauna are affected significantly by interactions among sediment particle size, beach slope and wave exposure. For macrofauna on less sloping beaches, the effect of these physical constraints is mediated by the local context, although for meiofauna and for macrofauna on intermediate and steeper beaches, the effects of physical constraints dominate. Steeper beach slopes, coarser particle sizes and increased wave exposure generally result in decreases in abundance, biomass and oxygen consumption, but these relationships are complex and non-linear. Sea-level rise is likely to lead to changes in ecosystem structure with generally negative impacts on ecosystem functions and ecosystem services. However, the impacts of sea-level rise will also be affected by local ecological context, especially for less sloping beaches.	[Yamanaka, Tsuyuko; Raffaelli, David; White, Piran C. L.] Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England; [Yamanaka, Tsuyuko] Univ Liverpool, Sch Environm Sci, Liverpool L69 3BX, Merseyside, England	University of York - UK; University of Liverpool	White, PCL (corresponding author), Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England.	piran.white@york.ac.uk	White, Piran Crawfurd Limond/AAH-6851-2021	White, Piran Crawfurd Limond/0000-0002-7496-5775	University of York	University of York(European Commission)	The work was supported by the University of York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; BANSE K, 1982, MAR ECOL PROG SER, V9, P281, DOI 10.3354/meps009281; BARRY JP, 1995, SCIENCE, V267, P672, DOI 10.1126/science.267.5198.672; Bolam SG, 2002, ECOL MONOGR, V72, P599, DOI 10.1890/0012-9615(2002)072[0599:DBAEPI]2.0.CO;2; Bulling MT, 2006, MAR ECOL PROG SER, V311, P295, DOI 10.3354/meps311295; Bulling M, 2008, OECOLOGIA, V158, P511, DOI 10.1007/s00442-008-1160-5; Bulling MT, 2010, PHILOS T RO IN PRESS; Dyson KE, 2007, P ROY SOC B-BIOL SCI, V274, P2547, DOI 10.1098/rspb.2007.0922; Feller R.J., 1988, P181; Fujii T, 2007, ESTUAR COAST SHELF S, V75, P101, DOI 10.1016/j.ecss.2007.02.027; Fujii T, 2008, MAR ECOL PROG SER, V371, P23, DOI 10.3354/meps07652; Galbraith H, 2002, WATERBIRDS, V25, P173, DOI 10.1675/1524-4695(2002)025[0173:GCCASL]2.0.CO;2; GERLACH SA, 1985, MAR ECOL PROG SER, V26, P161, DOI 10.3354/meps026161; GOSSCUSTARD JD, 1990, DEV HYDROB, V57, P189; Hall S.J., 1994, P333; Hofmann GE, 2010, ANNU REV ECOL EVOL S, V41, P127, DOI 10.1146/annurev.ecolsys.110308.120227; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Ieno EN, 2006, MAR ECOL PROG SER, V311, P263, DOI 10.3354/meps311263; IPCC Working Group I, 2007, CLIMATE CHANGE 2007; Kennish MJ, 2002, ENVIRON CONSERV, V29, P78, DOI 10.1017/S0376892902000061; Koch EW, 2009, FRONT ECOL ENVIRON, V7, P29, DOI 10.1890/080126; Kurihara H, 2004, J OCEANOGR, V60, P743, DOI 10.1007/s10872-004-5766-x; LEACH JH, 1970, LIMNOL OCEANOGR, V15, P514, DOI 10.4319/lo.1970.15.4.0514; Lercari D, 2006, ESTUAR COAST SHELF S, V68, P27, DOI 10.1016/j.ecss.2005.12.017; Lohbeck KT, 2012, NAT GEOSCI, V5, P346, DOI [10.1038/ngeo1441, 10.1038/NGEO1441]; MCLACHLAN A, 1990, J COASTAL RES, V6, P57; MCLACHLAN A, 1981, S AFR J ZOOL, V16, P219; McLachlan A, 1996, MAR ECOL PROG SER, V131, P205, DOI 10.3354/meps131205; McLachlan A, 2006, ECOLOGY SANDY SHORES; McLachlan A., 1993, J COASTAL RES, V15, P27, DOI DOI 10.2307/25735721; McLusky D.S., 2004, ESTUARINE ECOSYSTEM; Palumbi SR, 2009, FRONT ECOL ENVIRON, V7, P204, DOI 10.1890/070135; PETHICK J, 1993, GEOGR J, V159, P162, DOI 10.2307/3451406; Pinheiro J, 2006, NLME 3 1 90 R PACKAG; Pinheiro J, 2001, MIXED EFFECTS MODELS; Raffaelli D, 1996, INTERTIDAL ECOLOGY; Raffaelli DG, 2006, MAR ECOL PROG SER, V311, P285, DOI 10.3354/meps311285; Richardson AJ, 2008, ICES J MAR SCI, V65, P279, DOI 10.1093/icesjms/fsn028; Rodriguez GJ, 2002, ESTUARINE COASTAL SH, V58, P63; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; Solan M, 2006, MAR ECOL PROG SER, V311, P175, DOI 10.3354/meps311175; THOMAS MLH, 1986, OPHELIA, V25, P1; White PCL, 2010, ISSUES ENV IN PRESS; Yamanaka T, 2012, J ANIM ECOL, V81, P463, DOI 10.1111/j.1365-2656.2011.01921.x; Yamanaka T, 2010, ESTUAR COAST SHELF S, V88, P267, DOI 10.1016/j.ecss.2010.03.023; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	46	10	10	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2013	8	7							e68160	10.1371/journal.pone.0068160	http://dx.doi.org/10.1371/journal.pone.0068160			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181TS	23861863	Green Published, Green Submitted, gold			2022-12-27	WOS:000321692000017
J	Gentle, NL; Paximadis, M; Puren, A; Tiemessen, CT				Gentle, Nikki L.; Paximadis, Maria; Puren, Adrian; Tiemessen, Caroline T.			Genetic Variability in Markers of HLA-C Expression in Two Diverse South African Populations	PLOS ONE			English	Article							HIV-1 INFECTION; CLASS-I; ASSOCIATION; DETERMINANTS; ALLELES; LINKAGE	An insertion-deletion (indel) polymorphism within the 39 untranslated region (UTR) of HLA-C has been shown to be involved in the regulation of HLA-C expression. Individuals who carry a deletion at this position exhibit increased HLA-C expression, which associates with lower viral set point in HIV-1 infected individuals. This 263 indel (rs67384697) is reported to be in strong linkage disequilibrium (LD) with a single nucleotide polymorphism (SNP) 35 kilobases upstream of HLA-C (-35T/C; rs9264942) in Caucasian individuals, making this SNP a potential marker for both HLA-C expression and HIV-1 disease progression. We therefore examined genetic variation within the HLA-C 3' UTR of 265 Black and Caucasian South Africans by direct sequencing and identified haplotypes encompassing the 263 indel and another indel at position 230 in both populations. Concomitant evaluation of variability at the -35 SNP revealed this polymorphism to be an inappropriate marker for the 263 indel in these populations. These findings provide important insights into genetic variability within the regulatory regions of HLA-C that have potential implications for our understanding of the regulation of HLA-C expression and its impact on HIV-1 disease progression.	[Gentle, Nikki L.; Paximadis, Maria; Puren, Adrian; Tiemessen, Caroline T.] Natl Inst Communicable Dis, Ctr HIV & STIs, Natl Hlth Lab Serv, Johannesburg, Gauteng, South Africa; [Gentle, Nikki L.; Paximadis, Maria; Puren, Adrian; Tiemessen, Caroline T.] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, Gauteng, South Africa	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand	Paximadis, M (corresponding author), Natl Inst Communicable Dis, Ctr HIV & STIs, Natl Hlth Lab Serv, Johannesburg, Gauteng, South Africa.	paxim@nicd.ac.za	Puren, Adrian/AAC-2065-2020; Puren, Adrian/W-1679-2018	Puren, Adrian/0000-0001-7531-4010; Puren, Adrian/0000-0001-7531-4010; Tiemessen, Caroline/0000-0002-0991-1690; Gentle, Nikki/0000-0001-7988-4491	National Research Foundation; University of the Witwatersrand's Medical Faculty Research Endowment Fund	National Research Foundation; University of the Witwatersrand's Medical Faculty Research Endowment Fund	This work was funded in part by the National Research Foundation and University of the Witwatersrand's Medical Faculty Research Endowment Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apps R, 2013, SCIENCE, V340, P87, DOI 10.1126/science.1232685; CEPPELLINI R, 1955, ANN HUM GENET, V20, P97; Corrah TW, 2011, J VIROL, V85, P3367, DOI 10.1128/JVI.02276-10; Dalmasso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003907; Excoffier Laurent, 2003, Human Genomics, V1, P7; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Han YF, 2008, AIDS, V22, P541, DOI 10.1097/QAD.0b013e3282f470e4; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Kulkarni S, 2011, NATURE, V472, P495, DOI 10.1038/nature09914; LEWONTIN RC, 1964, GENETICS, V49, P49; Middleton D, 2003, TISSUE ANTIGENS, V61, P403, DOI 10.1034/j.1399-0039.2003.00062.x; O'hUigin C, 2011, AM J HUM GENET, V89, P424, DOI 10.1016/j.ajhg.2011.07.024; Paximadis M, 2012, HUM IMMUNOL, V73, P80, DOI 10.1016/j.humimm.2011.10.013; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Robinson J, 2011, NUCLEIC ACIDS RES, V39, pD1171, DOI 10.1093/nar/gkq998; Shrestha S, 2009, AIDS, V23, P673, DOI 10.1097/QAD.0b013e328325d414; SLATKIN M, 1994, GENETICS, V137, P331; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486; van Manen D, 2009, AIDS, V23, P19, DOI 10.1097/QAD.0b013e32831db247; Xu Y, 2011, TISSUE ANTIGENS, V78, P102, DOI 10.1111/j.1399-0039.2011.01710.x	24	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e67780	10.1371/journal.pone.0067780	http://dx.doi.org/10.1371/journal.pone.0067780			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861805	Green Published, Green Submitted, gold			2022-12-27	WOS:000321425300029
J	Ma, MPC; Robinson, PJ; Chircop, M				Ma, Maggie P. C.; Robinson, Phillip J.; Chircop, Megan			Sorting Nexin 9 Recruits Clathrin Heavy Chain to the Mitotic Spindle for Chromosome Alignment and Segregation	PLOS ONE			English	Article							HUMAN CANCER-CELLS; MEDIATED ENDOCYTOSIS; AURORA-A; CYTOKINESIS FAILURE; TYROSINE PHOSPHORYLATION; SOMATIC-CELLS; DYNAMIN-I; PROTEIN; MITOSIS; ORGANIZATION	Sorting nexin 9 (SNX9) and clathrin heavy chain (CHC) each have roles in mitosis during metaphase. Since the two proteins directly interact for their other cellular function in endocytosis we investigated whether they also interact for metaphase and operate on the same pathway. We report that SNX9 and CHC functionally interact during metaphase in a specific molecular pathway that contributes to stabilization of mitotic spindle kinetochore (K)-fibres for chromosome alignment and segregation. This function is independent of their endocytic role. SNX9 residues in the clathrin-binding low complexity domain are required for CHC association and for targeting both CHC and transforming acidic coiled-coil protein 3 (TACC3) to the mitotic spindle. Mutation of these sites to serine increases the metaphase plate width, indicating inefficient chromosome congression. Therefore SNX9 and CHC function in the same molecular pathway for chromosome alignment and segregation, which is dependent on their direct association.	[Ma, Maggie P. C.; Robinson, Phillip J.; Chircop, Megan] Univ Sydney, Childrens Med Res Inst, Westmead, NSW 2145, Australia	Children's Medical Research Institute - Australia; University of Sydney	Chircop, M (corresponding author), Univ Sydney, Childrens Med Res Inst, Westmead, NSW 2145, Australia.	mchircop@cmri.org.au	Robinson, Phillip J/G-4008-2011	Robinson, Phillip J/0000-0002-7878-0313	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by research grants to MC and PJR from the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; Barr AR, 2008, MOL CELL BIOL, V28, P7199, DOI 10.1128/MCB.01040-08; Barr AR, 2007, J CELL SCI, V120, P2987, DOI 10.1242/jcs.013136; Boersema PJ, 2010, MOL CELL PROTEOMICS, V9, P84, DOI 10.1074/mcp.M900291-MCP200; Booth DG, 2011, EMBO J, V30, P906, DOI 10.1038/emboj.2011.15; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; Cheeseman Liam P, 2011, Commun Integr Biol, V4, P409, DOI 10.4161/cib.4.4.15250; Chircop M, 2010, BIOCHIM BIOPHYS ACTA, V1813, P1689; Chircop M, 2010, CELL MOL LIFE SCI, V67, P3725, DOI 10.1007/s00018-010-0401-z; Dell'Angelica EC, 2001, TRENDS CELL BIOL, V11, P315, DOI 10.1016/S0962-8924(01)02043-8; Dislich B, 2011, BIOCHEM J, V433, P75, DOI 10.1042/BJ20100709; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; Fabbro M, 2004, J BIOL CHEM, V279, P31251, DOI 10.1074/jbc.M405372200; Fielding AB, 2012, P NATL ACAD SCI USA, V109, P6572, DOI 10.1073/pnas.1117401109; Fu WX, 2010, J CELL SCI, V123, P3645, DOI 10.1242/jcs.075911; Gerald NJ, 2001, CELL MOTIL CYTOSKEL, V48, P213, DOI 10.1002/1097-0169(200103)48:3<213::AID-CM1010>3.0.CO;2-V; Gergely F, 2003, GENE DEV, V17, P336, DOI 10.1101/gad.245603; Giet R, 2002, J CELL BIOL, V156, P437, DOI 10.1083/jcb.200108135; Hill TA, 2009, J MED CHEM, V52, P3762, DOI 10.1021/jm900036m; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Hirst J, 2008, TRAFFIC, V9, P1354, DOI 10.1111/j.1600-0854.2008.00764.x; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Joshi S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-78; Joshi S, 2010, MOL CANCER THER, V9, P1995, DOI 10.1158/1535-7163.MCT-10-0161; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; KIRCHHAUSEN T, 1981, CELL, V23, P755, DOI 10.1016/0092-8674(81)90439-6; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; LeRoy PJ, 2007, CANCER RES, V67, P5362, DOI 10.1158/0008-5472.CAN-07-0122; Lin CH, 2010, J CELL BIOL, V189, P1097, DOI 10.1083/jcb.200911120; Liu ZH, 2009, J CELL BIOL, V186, P473, DOI 10.1083/jcb.200902071; Lundmark R, 2004, J BIOL CHEM, V279, P42694, DOI 10.1074/jbc.M407430200; Lundmark R, 2003, J BIOL CHEM, V278, P46772, DOI 10.1074/jbc.M307334200; Luo W, 2008, J PROTEOME RES, V7, P3447, DOI 10.1021/pr800187n; Ma MPC, 2012, J CELL SCI, V125, P4372, DOI 10.1242/jcs.105981; Mayer BJ, 2001, J CELL SCI, V114, P1253; Morita M, 2010, J BIOCHEM, V148, P533, DOI 10.1093/jb/mvq116; Moritz A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000998; Odell LR, 2010, J MED CHEM, V53, P5267, DOI 10.1021/jm100442u; Park J, 2010, J CELL SCI, V123, P1742, DOI 10.1242/jcs.064170; Rieder CL, 2005, CHROMOSOMA, V114, P310, DOI 10.1007/s00412-005-0028-2; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Royle SJ, 2006, CELL MOL LIFE SCI, V63, P1823, DOI 10.1007/s00018-005-5587-0; Royle SJ, 2005, NATURE, V434, P1152, DOI 10.1038/nature03502; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Schobel S, 2008, J BIOL CHEM, V283, P14257, DOI 10.1074/jbc.M801531200; Shimizu H, 2009, J CELL SCI, V122, P3145, DOI 10.1242/jcs.052795; Smith CM, 2012, TRAFFIC, V13, P1628, DOI 10.1111/tra.12001; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; Tanenbaum ME, 2010, CHROMOSOMA, V119, P415, DOI 10.1007/s00412-010-0267-8; Tsai CF, 2008, J PROTEOME RES, V7, P4058, DOI 10.1021/pr800364d; Wolf-Yadlin A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100094; Yamauchi T, 2008, EMBO J, V27, P1852, DOI 10.1038/emboj.2008.118; Yarar D, 2008, TRAFFIC, V9, P133, DOI 10.1111/j.1600-0854.2007.00675.x; Zhang J, 2009, J BIOL CHEM, V284, P21659, DOI 10.1074/jbc.M109.007278	56	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e68387	10.1371/journal.pone.0068387	http://dx.doi.org/10.1371/journal.pone.0068387			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861900	gold, Green Published, Green Submitted			2022-12-27	WOS:000321425300061
J	Regnstrom, K; Yan, JL; Nguyen, L; Callaway, K; Yang, YL; Diep, L; Xing, WM; Adhikari, A; Beroza, P; Hom, RK; Riley, B; Rudolph, D; Jobling, MF; Baker, J; Johnston, J; Konradi, A; Bova, MP; Artis, RD				Regnstroem, Karin; Yan, Jiangli; Lan Nguyen; Callaway, Kari; Yang, Yanli; Diep, Linnea; Xing, Weimei; Adhikari, Anirban; Beroza, Paul; Hom, Roy K.; Riley, Brigit; Rudolph, Don; Jobling, Michael F.; Baker, Jeanne; Johnston, Jennifer; Konradi, Andrei; Bova, Michael P.; Artis, Rick D.			Label Free Fragment Screening Using Surface Plasmon Resonance as a Tool for Fragment Finding - Analyzing Parkin, a Difficult CNS Target	PLOS ONE			English	Article							DOMAIN; SPR	Surface Plasmon Resonance (SPR) is rarely used as a primary High-throughput Screening (HTS) tool in fragment-based approaches. With SPR instruments becoming increasingly high-throughput it is now possible to use SPR as a primary tool for fragment finding. SPR becomes, therefore, a valuable tool in the screening of difficult targets such as the ubiquitin E3 ligase Parkin. As a prerequisite for the screen, a large number of SPR tests were performed to characterize and validate the active form of Parkin. A set of compounds was designed and used to define optimal SPR assay conditions for this fragment screen. Using these conditions, more than 5000 pre-selected fragments from our in-house library were screened for binding to Parkin. Additionally, all fragments were simultaneously screened for binding to two off target proteins to exclude promiscuous binding compounds. A low hit rate was observed that is in line with hit rates usually obtained by other HTS screening assays. All hits were further tested in dose responses on the target protein by SPR for confirmation before channeling the hits into Nuclear Magnetic Resonance (NMR) and other hit-confirmation assays.	[Regnstroem, Karin; Yan, Jiangli; Lan Nguyen; Callaway, Kari; Yang, Yanli; Diep, Linnea; Xing, Weimei; Adhikari, Anirban; Beroza, Paul; Hom, Roy K.; Riley, Brigit; Rudolph, Don; Jobling, Michael F.; Baker, Jeanne; Johnston, Jennifer; Konradi, Andrei; Bova, Michael P.; Artis, Rick D.] Elan Pharmaceut, San Francisco, CA USA		Regnstrom, K (corresponding author), Elan Pharmaceut, San Francisco, CA USA.	Karin.Regnstrom@gmail.com	yang, yang/HGT-7999-2022; Yang, Ya-Li/GYU-4320-2022; Lang, Ming/HIK-0758-2022	Johnston, Jennifer/0000-0002-4867-9230	Elan Pharmaceuticals	Elan Pharmaceuticals	Funding for all experiments was provided by Elan Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The following authors are paid employees of Elan Pharmaceuticals, who funded this study: Karin Regnstrom, Jiangli Yan, Lan Nguyen, Kari Callaway, Yanli Yang, Linnea Diep, Anirban Adhikari, Paul Beroza, Roy Hom, Don Rudolph, Michael Jobling, Brigit Riley, Jeanne Baker, Jennifer Johnston, Andrei Konradi, Michael Bova, and Rick Artis. There are no patents, other products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Andersson K, 2006, EXPERT OPIN DRUG DIS, V1, P439, DOI 10.1517/17460441.1.5.439; Auger KR, 2005, METHOD ENZYMOL, V399, P701, DOI 10.1016/S0076-6879(05)99046-0; Burchell L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034748; Chaugule VK, 2011, EMBO J, P1; Chen D, 2011, CURR CANCER DRUG TAR, V11, P239, DOI 10.2174/156800911794519752; Congreve M, 2003, DRUG DISCOV TODAY, V8, P876, DOI 10.1016/S1359-6446(03)02831-9; Danielson UH, 2009, CURR TOP MED CHEM, V9, P1725, DOI 10.2174/156802609790102392; Dawson TM, 2010, MOVEMENT DISORD, V25, pS32, DOI 10.1002/mds.22798; Dueber EC, 2011, SCIENCE, V334, P376, DOI 10.1126/science.1207862; ERIKSSON AE, 1988, PROTEINS, V4, P274, DOI 10.1002/prot.340040406; Erlanson DA, 2004, J MED CHEM, V47, P3463, DOI 10.1021/jm040031v; Ertl P, 2000, J MED CHEM, V43, P3714, DOI 10.1021/jm000942e; Giannetti AM, 2011, METHOD ENZYMOL, V493, P169, DOI 10.1016/B978-0-12-381274-2.00008-X; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Huang JN, 2005, METHOD ENZYMOL, V399, P740, DOI 10.1016/S0076-6879(05)99049-6; Kahle PJ, 2004, EMBO REP, V5, P681, DOI 10.1038/sj.embor.7400188; Kentsis A, 2002, P NATL ACAD SCI USA, V99, P15404, DOI 10.1073/pnas.202608799; Kentsis A, 2002, P NATL ACAD SCI USA, V99, P667, DOI 10.1073/pnas.012317299; Kobayashi M, 2010, J BIOMOL SCREEN, V15, P978, DOI 10.1177/1087057110375614; Marblestone JG, 2010, J BIOMOL SCREEN, V15, P1220, DOI 10.1177/1087057110380456; Martin YC, 2002, J MED CHEM, V45, P4350, DOI 10.1021/jm020155c; Myszka D., 2011, DRUG DISCOVERY W WIN, V12, P51; Navratilova I, 2010, ACS MED CHEM LETT, V1, P44, DOI 10.1021/ml900002k; Oprea TI, 2001, J CHEM INF COMP SCI, V41, P1308, DOI 10.1021/ci010366a; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; PARKER MW, 1990, J MOL BIOL, V213, P221, DOI 10.1016/S0022-2836(05)80183-4; Perspicace S, 2009, J BIOMOL SCREEN, V14, P337, DOI 10.1177/1087057109332595; Rankin Carolyn A, 2011, Open Biochem J, V5, P9, DOI 10.2174/1874091X01105010009; Reynolds CH, 2008, J MED CHEM, V51, P2432, DOI 10.1021/jm701255b; Schlehe JS, 2008, J BIOL CHEM, V283, P13771, DOI 10.1074/jbc.M707494200; Tomoo K, 2008, BBA-PROTEINS PROTEOM, V1784, P1059, DOI 10.1016/j.bbapap.2008.04.009; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	32	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2013	8	7							e66879	10.1371/journal.pone.0066879	http://dx.doi.org/10.1371/journal.pone.0066879			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DW	23861750	Green Published, gold, Green Submitted			2022-12-27	WOS:000321425300009
J	Das, S; Banerjee, B; Hossain, M; Thangamuniyandi, M; Dasgupta, S; Chongdar, N; Kumar, GS; Basu, G				Das, Supratik; Banerjee, Baisakhi; Hossain, Maidul; Thangamuniyandi, Muruganandan; Dasgupta, Saumya; Chongdar, Nipa; Kumar, Gopinatha Suresh; Basu, Gautam			Characterization of DNA Binding Property of the HIV-1 Host Factor and Tumor Suppressor Protein Integrase Interactor 1 (INI1/hSNF5)	PLOS ONE			English	Article							RHABDOID TUMORS; COMPLEX; YEAST; REPRESSION; TRANSCRIPTION; SWI2/SNF2; REGION; SNF5	Integrase Interactor 1 (INI1/hSNF5) is a component of the hSWI/SNF chromatin remodeling complex. The INI1 gene is either deleted or mutated in rhabdoid cancers like ATRT (Atypical terratoid and rhabdoid tumor). INI1 is also a host factor for HIV-1 replication. INI1 binds DNA non-specifically. However, the mechanism of DNA binding and its biological role are unknown. From agarose gel retardation assay (AGRA), Ni-NTA pull-down and atomic force microscopy (AFM) studies we show that amino acids 105-183 of INI1 comprise the minimal DNA binding domain (DBD). The INI1 DBD is absent in plants and in yeast SNF5. It is present in Caenorhabditis elegans SNF5, Drosophila melanogaster homologue SNR1 and is a highly conserved domain in vertebrates. The DNA binding property of this domain in SNR1, that is only 58% identical to INI1/hSNF5, is conserved. Analytical ultracentrifugation studies of INI1 DBD and INI1 DBD: DNA complexes at different concentrations show that the DBD exists as a monomer at low protein concentration and two molecules of monomer binds one molecule of DNA. At high protein concentration, it exists as a dimer and binds two DNA molecules. Furthermore, isothermal calorimetry (ITC) experiments demonstrate that the DBD monomer binds DNA with a stoichiometry (N) of similar to 0.5 and K-d = 0.94 mu M whereas the DBD dimer binds two DNA molecules sequentially with K'(d1) = 222 mu M and K'(d2) = 1.16 mu M. Monomeric DBD binding to DNA is enthalpy driven (Delta H = -29.9 KJ/mole). Dimeric DBD binding to DNA is sequential with the first binding event driven by positive entropy (Delta H'(1) = 115.7 KJ/mole, T Delta S'(1) = 136.8 KJ/mole) and the second binding event driven by negative enthalpy (Delta H'(2) = -106.3 KJ/mole, T Delta S'(2) = -75.7 KJ/mole). Our model for INI1 DBD binding to DNA provides new insights into the mechanism of DNA binding by INI1.	[Das, Supratik] Univ Calcutta, Dept Biochem, Kolkata, India; [Banerjee, Baisakhi] Univ Calcutta, Dr BC Guha Ctr Genet Engn & Biotechnol, Kolkata, India; [Hossain, Maidul; Kumar, Gopinatha Suresh] CSIR Indian Inst Chem Biol, Biophys Chem Lab, Kolkata, India; [Thangamuniyandi, Muruganandan] CSIR Indian Inst Chem Biol, Kolkata, India; [Dasgupta, Saumya; Chongdar, Nipa] Bose Inst, Dept Biophys, Kolkata, India	University of Calcutta; University of Calcutta; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Department of Science & Technology (India); Bose Institute	Das, S (corresponding author), West Bengal State Univ, Dept Biochem, Kolkata, India.	radas_03@yahoo.com	KUMAR, P. SURESH/AAT-8951-2020; Kumar, Gopinatha Suresh/W-1461-2019; Kumar, Dr Suresh/HHZ-2615-2022; DASGUPTA, SAUMYA/ABF-3864-2020; Hossain, Maidul/AAW-7669-2021	KUMAR, P. SURESH/0000-0003-3222-2604; Kumar, Dr Suresh/0000-0002-2539-6553; DASGUPTA, SAUMYA/0000-0003-2995-6324; Hossain, Maidul/0000-0003-1408-2273; Chongdar, Nipa/0000-0002-3894-2285	Council for Scientific and Industrial Research, Government of India [13(8350-A)/Pool/2009]	Council for Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was funded by a contingency grant of the Scientist's Pool Scheme fellowship from the Council for Scientific and Industrial Research, Government of India to SD [Sanction No. 13(8350-A)/Pool/2009]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boese A, 2009, J GEN VIROL, V90, P2503, DOI 10.1099/vir.0.013656-0; CAIRNS BR, 1994, P NATL ACAD SCI USA, V91, P1950, DOI 10.1073/pnas.91.5.1950; Caramel J, 2008, CANCER RES, V68, P6154, DOI 10.1158/0008-5472.CAN-08-0115; Da GP, 2006, P NATL ACAD SCI USA, V103, P2057, DOI 10.1073/pnas.0510949103; Das S, 2009, J BIOL CHEM, V284, P19903, DOI 10.1074/jbc.M808141200; DINGWALL AK, 1995, MOL BIOL CELL, V6, P777, DOI 10.1091/mbc.6.7.777; KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; Kar SR, 2001, BIOCHEMISTRY-US, V40, P13378, DOI 10.1021/bi011289f; Kingston RE, 1996, GENE DEV, V10, P905, DOI 10.1101/gad.10.8.905; Klochendler-Yeivin A, 2006, MOL CELL BIOL, V26, P2661, DOI 10.1128/MCB.26.7.2661-2674.2006; Lesbats P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001280; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; Morozov A, 1998, P NATL ACAD SCI USA, V95, P1120, DOI 10.1073/pnas.95.3.1120; Morozov A, 2007, CLIN CANCER RES, V13, P4721, DOI 10.1158/1078-0432.CCR-07-0054; Quinn J, 1996, NATURE, V379, P844, DOI 10.1038/379844a0; Ray A, 2009, MOL CELL BIOL, V29, P6206, DOI 10.1128/MCB.00503-09; Roberts CWM, 2009, CANCER BIOL THER, V8, P412, DOI 10.4161/cbt.8.5.8019; Singh M, 2006, BIOL CHEM, V387, P1469, DOI 10.1515/BC.2006.184; Tsikitis M, 2005, P NATL ACAD SCI USA, V102, P12129, DOI 10.1073/pnas.0505300102; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wilsker D, 2004, NUCLEIC ACIDS RES, V32, P1345, DOI 10.1093/nar/gkh277; Zhang ZK, 2002, MOL CELL BIOL, V22, P5975, DOI 10.1128/MCB.22.16.5975-5988.2002	22	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e66581	10.1371/journal.pone.0066581	http://dx.doi.org/10.1371/journal.pone.0066581			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861745	Green Submitted, gold, Green Published			2022-12-27	WOS:000323350700006
J	Gaboriaud, C; Gupta, RK; Martin, L; Lacroix, M; Serre, L; Teillet, F; Arlaud, GJ; Rossi, V; Thielens, NM				Gaboriaud, Christine; Gupta, Rajesh Kumar; Martin, Lydie; Lacroix, Monique; Serre, Laurence; Teillet, Florence; Arlaud, Gerard J.; Rossi, Veronique; Thielens, Nicole M.			The Serine Protease Domain of MASP-3: Enzymatic Properties and Crystal Structure in Complex with Ecotin	PLOS ONE			English	Article							MANNAN-BINDING-LECTIN; CATALYTIC DOMAIN; PATHWAY ACTIVATION; SUBSTRATE SPECIFICITIES; FACTOR-I; REVEALS; C1S; MBL; RECOGNITION; INHIBITOR	Mannan-binding lectin (MBL), ficolins and collectin-11 are known to associate with three homologous modular proteases, the MBL-Associated Serine Proteases (MASPs). The crystal structures of the catalytic domains of MASP-1 and MASP-2 have been solved, but the structure of the corresponding domain of MASP-3 remains unknown. A link between mutations in the MASP1/3 gene and the rare autosomal recessive 3MC (Mingarelli, Malpuech, Michels and Carnevale,) syndrome, characterized by various developmental disorders, was discovered recently, revealing an unexpected important role of MASP-3 in early developmental processes. To gain a first insight into the enzymatic and structural properties of MASP-3, a recombinant form of its serine protease (SP) domain was produced and characterized. The amidolytic activity of this domain on fluorescent peptidyl-aminomethylcoumarin substrates was shown to be considerably lower than that of other members of the C1r/C1s/MASP family. The E. coli protease inhibitor ecotin bound to the SP domains of MASP-3 and MASP-2, whereas no significant interaction was detected with MASP-1, C1r and C1s. A tetrameric complex comprising an ecotin dimer and two MASP-3 SP domains was isolated and its crystal structure was solved and refined to 3.2 angstrom. Analysis of the ecotin/MASP-3 interfaces allows a better understanding of the differential reactivity of the C1r/C1s/MASP protease family members towards ecotin, and comparison of the MASP-3 SP domain structure with those of other trypsin-like proteases yields novel hypotheses accounting for its zymogen-like properties in vitro.	[Gaboriaud, Christine; Gupta, Rajesh Kumar; Martin, Lydie; Lacroix, Monique; Serre, Laurence; Teillet, Florence; Arlaud, Gerard J.; Rossi, Veronique; Thielens, Nicole M.] IBS, Direct Sci Vivant, Commissariat Energie Atom & Energies Alternat, Grenoble, France; [Gaboriaud, Christine; Gupta, Rajesh Kumar; Martin, Lydie; Lacroix, Monique; Teillet, Florence; Arlaud, Gerard J.; Rossi, Veronique; Thielens, Nicole M.] IBS, CNRS, Grenoble, France; [Gaboriaud, Christine; Gupta, Rajesh Kumar; Martin, Lydie; Lacroix, Monique; Serre, Laurence; Teillet, Florence; Arlaud, Gerard J.; Rossi, Veronique; Thielens, Nicole M.] Univ Grenoble Alpes, IBS, Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Gaboriaud, C (corresponding author), IBS, Direct Sci Vivant, Commissariat Energie Atom & Energies Alternat, Grenoble, France.	christine.gaboriaud@ibs.fr	Thielens, Nicole M/F-2512-2013; Rossi, Véronique/AAF-3412-2021	Thielens, Nicole M/0000-0002-7354-0302; Rossi, Véronique/0000-0002-6700-3578; SERRE, laurence/0000-0002-6794-1492; gaboriaud, christine/0000-0001-5308-0516; Gupta, Rajesh Kumar/0000-0001-8820-0661	Commissariat a l'Energie Atomique; Centre National de la Recherche Scientifique; Universite Joseph Fourier (Grenoble, France); French National Research Agency [ANR-09-PIRI-0021]; Embassy of France in India	Commissariat a l'Energie Atomique(French Atomic Energy Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Joseph Fourier (Grenoble, France); French National Research Agency(French National Research Agency (ANR)); Embassy of France in India	This work was supported by the Commissariat a l'Energie Atomique, the Centre National de la Recherche Scientifique, the Universite Joseph Fourier (Grenoble, France) and partly by a grant from the French National Research Agency (ANR-09-PIRI-0021). RKG was supported by a post-doctoral scholarship of the Embassy of France in India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARLAUD GJ, 1979, BIOCHIM BIOPHYS ACTA, V576, P151, DOI 10.1016/0005-2795(79)90494-X; ARLAUD GJ, 1979, MOL IMMUNOL, V16, P445, DOI 10.1016/0161-5890(79)90069-5; Beattie J, 2006, BIOCHEM J, V395, P1, DOI 10.1042/BJ20060086; Bricogne G., 2009, BUSTER; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Budayova-Spano M, 2002, STRUCTURE, V10, P1509, DOI 10.1016/S0969-2126(02)00881-X; Budayova-Spano M, 2002, EMBO J, V21, P231, DOI 10.1093/emboj/21.3.231; Cortesio CL, 2006, ARCH BIOCHEM BIOPHYS, V449, P164, DOI 10.1016/j.abb.2006.02.006; Dahl MR, 2001, IMMUNITY, V15, P127, DOI 10.1016/S1074-7613(01)00161-3; Degn SE, 2012, J IMMUNOL, V189, P3957, DOI 10.4049/jimmunol.1201736; Degn SE, 2009, J IMMUNOL, V183, P7371, DOI 10.4049/jimmunol.0902388; Di Cera E, 2009, IUBMB LIFE, V61, P510, DOI 10.1002/iub.186; Dobo J, 2009, J IMMUNOL, V183, P1207, DOI 10.4049/jimmunol.0901141; Dommett RM, 2006, TISSUE ANTIGENS, V68, P193, DOI 10.1111/j.1399-0039.2006.00649.x; Eggers CT, 2001, J MOL BIOL, V308, P975, DOI 10.1006/jmbi.2001.4754; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endo Y, 2011, INT J BIOCHEM CELL B, V43, P705, DOI 10.1016/j.biocel.2011.02.003; Gaboriaud C, 2004, TRENDS IMMUNOL, V25, P368, DOI 10.1016/j.it.2004.04.008; Gaboriaud C, 2000, EMBO J, V19, P1755, DOI 10.1093/emboj/19.8.1755; Gillmor SA, 2000, J MOL BIOL, V299, P993, DOI 10.1006/jmbi.2000.3812; Hansen S, 2010, J IMMUNOL, V185, P6096, DOI 10.4049/jimmunol.1002185; Harmat V, 2004, J MOL BIOL, V342, P1533, DOI 10.1016/j.jmb.2004.07.014; Heja D, 2012, P NATL ACAD SCI USA, V109, P10498, DOI 10.1073/pnas.1202588109; Heja D, 2012, J BIOL CHEM, V287, P20290, DOI 10.1074/jbc.M112.354332; Huntington JA, 2009, J THROMB HAEMOST, V7, P159, DOI 10.1111/j.1538-7836.2009.03365.x; Iwaki D, 2006, J IMMUNOL, V177, P8626, DOI 10.4049/jimmunol.177.12.8626; Jin L, 2005, J BIOL CHEM, V280, P4704, DOI 10.1074/jbc.M411309200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keshi H, 2006, MICROBIOL IMMUNOL, V50, P1001, DOI 10.1111/j.1348-0421.2006.tb03868.x; Kidmose RT, 2012, P NATL ACAD SCI USA, V109, P15425, DOI 10.1073/pnas.1208031109; Lacroix M, 2001, J BIOL CHEM, V276, P36233, DOI 10.1074/jbc.M105688200; Lechtenberg BC, 2010, P NATL ACAD SCI USA, V107, P14087, DOI 10.1073/pnas.1005255107; Loew D, 2000, BIOCHEMISTRY-US, V39, P10812, DOI 10.1021/bi0003341; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCGRATH ME, 1994, EMBO J, V13, P1502, DOI 10.1002/j.1460-2075.1994.tb06411.x; Megyeri M, 2013, J BIOL CHEM, V288, P8922, DOI 10.1074/jbc.M112.446500; Megyeri M, 2009, J IMMUNOL, V183, P3409, DOI 10.4049/jimmunol.0900879; Moller-Kristensen M, 2007, INT IMMUNOL, V19, P141, DOI 10.1093/intimm/dxl131; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niu WL, 2011, BIOCHEMISTRY-US, V50, P6301, DOI 10.1021/bi200878c; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; Perona JJ, 1997, BIOCHEMISTRY-US, V36, P5381, DOI 10.1021/bi9617522; Pozzi N, 2012, CURR OPIN STRUC BIOL, V22, P421, DOI 10.1016/j.sbi.2012.05.006; Presanis JS, 2004, MOL IMMUNOL, V40, P921, DOI 10.1016/j.molimm.2003.10.013; Rooryck C, 2011, NAT GENET, V43, P197, DOI 10.1038/ng.757; Rossi V, 1998, J BIOL CHEM, V273, P1232, DOI 10.1074/jbc.273.2.1232; Rossi V, 2001, J BIOL CHEM, V276, P40880, DOI 10.1074/jbc.M105934200; Roversi P, 2011, P NATL ACAD SCI USA, V108, P12839, DOI 10.1073/pnas.1102167108; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Sekine H, 2013, ADV EXP MED BIOL, V735, P41, DOI 10.1007/978-1-4614-4118-2_3; Sirmaci A, 2010, AM J HUM GENET, V87, P679, DOI 10.1016/j.ajhg.2010.09.018; Skjoedt MO, 2010, J BIOL CHEM, V285, P8234, DOI 10.1074/jbc.M109.065805; Sorensen R, 2005, SPRINGER SEMIN IMMUN, V27, P299, DOI 10.1007/s00281-005-0006-z; Stover CM, 1999, J IMMUNOL, V162, P3481; Takahashi M, 1999, INT IMMUNOL, V11, P859, DOI 10.1093/intimm/11.5.859; Teillet F, 2005, J IMMUNOL, V174, P2870, DOI 10.4049/jimmunol.174.5.2870; Thielens NM, 2001, J IMMUNOL, V166, P5068, DOI 10.4049/jimmunol.166.8.5068; Tsiftsoglou SA, 2004, J IMMUNOL, V173, P367, DOI 10.4049/jimmunol.173.1.367; Wang SX, 2003, BIOCHEMISTRY-US, V42, P7959, DOI 10.1021/bi027320a; Wang SX, 2001, BIOCHEMISTRY-US, V40, P10038, DOI 10.1021/bi010712h; Waugh SM, 2000, NAT STRUCT BIOL, V7, P762, DOI 10.1038/78992; Yang SQ, 1998, J MOL BIOL, V279, P945, DOI 10.1006/jmbi.1998.1748; Zundel S, 2004, J IMMUNOL, V172, P4342, DOI 10.4049/jimmunol.172.7.4342	65	13	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67962	10.1371/journal.pone.0067962	http://dx.doi.org/10.1371/journal.pone.0067962			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861840	Green Published, Green Submitted, gold			2022-12-27	WOS:000323350700066
J	Grivna, M; Eid, HO; Abu-Zidan, FM				Grivna, Michal; Eid, Hani O.; Abu-Zidan, Fikri M.			Pediatric and Youth Traffic-Collision Injuries in Al Ain, United Arab Emirates: A Prospective Study	PLOS ONE			English	Article							SAFETY BELTS; SEAT-BELTS; CHILD; TRAUMA; INTERVENTIONS; PREVENTION; INCREASE; REVIEWS; DEATH; RISK	Aim: To study the mechanism of road traffic collisions (RTC), use of safety devices, and outcome of hospitalized pediatric and youth RTC injured patients so as to give recommendations regarding prevention of pediatric RTC injuries. Methods: All RTC injured children and youth (0-19-year-olds) who were admitted to Al Ain City's two major trauma centers or who died after arrival to these centers were prospectively studied from April 2006 to October 2007. Demography of patients, road-user and vehicle types, crash mechanism, usage of safety devices, injured body regions, injury severity, Revised Trauma Score, Glasgow Coma Scale, intensive care unit admissions, hospital stay and mortality were analyzed. Results: 245 patients were studied, 69% were vehicle occupants, 15% pedestrians, 9% motorcyclists and 5% bicyclists. 79% were males and 67% UAE citizens. The most common mechanism of RTC was rollover of vehicle (37%) followed by front impact collision (32%). 32 (13%) of vehicle occupants were ejected from car. 63% of ejected occupants and 70% of motorcyclists sustained head injuries. Only 2% (3/170) vehicle passengers used seatbelts and 13% (3/23) motorcyclists a helmet. Conclusions: Male drivers and UAE nationals were at high risk of RTC as drivers and as motorcyclists. Ejection rate was high because safety restraint use was extremely low in our community. More education and law enforcement focusing especially on car/booster seat use is needed.	[Grivna, Michal] UAE Univ, Coll Med & Hlth Sci, Publ Hlth, Al Ain, U Arab Emirates; [Eid, Hani O.; Abu-Zidan, Fikri M.] UAE Univ, Dept Surg, Coll Med & Hlth Sci, Trauma Grp, Al Ain, U Arab Emirates	United Arab Emirates University; United Arab Emirates University	Abu-Zidan, FM (corresponding author), UAE Univ, Dept Surg, Coll Med & Hlth Sci, Trauma Grp, Al Ain, U Arab Emirates.	fabuzidan@uaeu.ac.ae	Abu-Zidan, Fikri/GWE-2835-2022	Grivna, Michal/0000-0003-2349-0922	Interdisciplinary UAE University grant [02-07-8-1/4]	Interdisciplinary UAE University grant	This study was supported by an Interdisciplinary UAE University grant (No. 02-07-8-1/4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 2012, ACCIDENT ANAL PREV, V49, P249, DOI 10.1016/j.aap.2011.09.033; Abbas AK, 2011, ANN SAUDI MED, V31, P347, DOI 10.4103/0256-4947.83208; Abbas AK, 2011, WORLD J EMERG SURG, V6, DOI 10.1186/1749-7922-6-18; Abu Dhabi Tourism Authority, 2008, AB DHAB MIN, V5, P14; Abu-Zidan FM, 2012, WORLD J SURG, V36, P255, DOI 10.1007/s00268-011-1386-y; Al Kilani HHY, 2001, MIDDLE E J EMERG MED, V1, P1; Al-Houqani M, 2013, ACCIDENT ANAL PREV, V50, P1052, DOI 10.1016/j.aap.2012.08.010; Allen JP, 2008, AM J PREV MED, V35, pS289, DOI 10.1016/j.amepre.2008.06.017; Arnett JJ, 2002, INJURY PREV, V8, P17; Ashton SJ, 1983, P 27 C AM ASS AUT ME, V27, P65; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barss P, 2008, TRAFFIC INJ PREV, V9, P256, DOI 10.1080/15389580802040352; Bergeron E, 2006, J TRAUMA, V60, P300, DOI 10.1097/01.ta.0000197393.64678.6b; Crankson SJ, 2006, PEDIATR SURG INT, V22, P641, DOI 10.1007/s00383-006-1715-7; Dinh-Zarr TB, 2001, AM J PREV MED, V21, P48, DOI 10.1016/S0749-3797(01)00378-6; Dunbar G, 2001, J EXP PSYCHOL-APPL, V7, P227, DOI 10.1037//1076-898X.7.3.227; Durkin MS, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.6.e74; Eid H. O., 2007, SMJ Singapore Medical Journal, V48, P693; Eid HO, 2009, INJURY, V40, P703, DOI 10.1016/j.injury.2008.07.012; Elliott MR, 2006, ARCH PEDIAT ADOL MED, V160, P617, DOI 10.1001/archpedi.160.6.617; Elvik R, 2009, HDB ROAD SAFETY MEAS, V64, P172; EVANS L, 1986, ACCIDENT ANAL PREV, V18, P229, DOI 10.1016/0001-4575(86)90007-2; Everison R, 2008, ROAD TRAFFIC INJURIE; Grivna M, 2013, TRAFFIC INJ PREV, V14, P274, DOI 10.1080/15389588.2012.711498; Grivna M, 2012, INT J INJ CONTROL SA, V19, P278, DOI 10.1080/17457300.2012.696660; Hefny AF, 2012, ACCIDENT ANAL PREV, V49, P245, DOI 10.1016/j.aap.2011.05.003; Heiman L, 1988, VEHICLE OCCUPANT PRO, pVII; Henary Basem Y, 2003, Annu Proc Assoc Adv Automot Med, V47, P105; Hinds JD, 2007, INJURY, V38, P1131, DOI 10.1016/j.injury.2007.06.012; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Maurer E, 2004, TRAUMA, P87; Ministry of Health UAE, 2007, ANN REP 2006, P5; Mullin B, 2000, Inj Prev, V6, P32, DOI 10.1136/ip.6.1.32; National Highway Traffic Safety Administration (NHTSA), 2001, 809471 NHTSA DOT HS; National Highway Traffic Safety Administration (NHTSA), 1997, TRAFF SAF FACTS 1997; NHTSA's National Center for Statistics and Analysis, 2010, SEAT BELT US REAR SE; ORSAY EM, 1988, JAMA-J AM MED ASSOC, V260, P3598, DOI 10.1001/jama.260.24.3598; Oyebite K, 2008, WORLD REPORT CHILD I, P1; Peden M, 2004, WORLD REPORT ROAD TR, V44-46, P136; RUTHERFORD WH, 1985, ARCH EMERG MED, V2, P221; The United Nations Children's Fund (UNICEF), 2011, STAT WORLDS CHILDR 2; United Arab Emirates National Bureau of Statistics, 2013, METH EST POP UAE; Zaza S, 2001, AM J PREV MED, V21, P31, DOI 10.1016/S0749-3797(01)00377-4	43	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68636	10.1371/journal.pone.0068636	http://dx.doi.org/10.1371/journal.pone.0068636			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861931	gold, Green Published			2022-12-27	WOS:000323350700096
J	Li, B; Dong, SH; Wu, JJ; Zhang, JY; Chen, G; Dong, QJ; Zhu, XH; Wang, XL				Li, Biao; Dong, Shihua; Wu, Jiajun; Zhang, Jianye; Chen, Gang; Dong, Quanjiang; Zhu, Xinhong; Wang, Xiaolong			Preparation of 5 '-O-(1-Thiotriphosphate)-Modified Oligonucleotides Using Polymerase-Endonuclease Amplification Reaction (PEAR)	PLOS ONE			English	Article							ANTISENSE OLIGONUCLEOTIDES; IN-VIVO; INHIBITION; ADJUVANT; DELIVERY; DUPLEXES; MIRNA	Antisense oligonucleotides (ASODNs) have been widely used as an important tool for regulating gene expression, and developed into therapeutics. Natural ODNs are susceptible to nuclease degradation, nucleic acid analogues, however, have less side effects, stronger stability and more potent activities. Large-scale de novo synthesis of a certain oligonucleotide has been very difficult and costly. In a previous preliminary study, we developed the polymerase-endonuclease amplification reaction (PEAR) for amplification and large-scale preparation of natural antisense ODNs. Here we extended the method in preparation of a widely used modified oligonucleotide with 5'-O-(1-Thiotriphosphate) modifications. Using electrospray ionization liquid chromatography mass spectrometry (ESI/LC/MS) detection, the purity of the PEAR product was measured as high as 100.0%. Using PEAR a large amount of a specific oligonucleotide can be produced starting from a small amount of synthetic seeds. It is suggested that PEAR can be a useful tool for large-scale production of modified oligonucleotides.	[Li, Biao; Dong, Shihua; Wu, Jiajun; Zhang, Jianye; Chen, Gang; Wang, Xiaolong] Ocean Univ China, Dept Biotechnol, Qingdao, Shandong, Peoples R China; [Dong, Quanjiang; Zhu, Xinhong] Qingdao Municipal Hosp, Qingdao, Shandong, Peoples R China	Ocean University of China; Qingdao Municipal Hospital	Wang, XL (corresponding author), Ocean Univ China, Dept Biotechnol, Qingdao, Shandong, Peoples R China.	Xiaolong@ouc.edu.cn	dong, quanjiang/AAD-3581-2019; Chen, gang/AAZ-5181-2021; Wu, JiaJun/GQH-7885-2022		National Science Foundation of China [81072567, 30600463]; Shandong Provincial Science Foundation [ZR2010HM056]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Science Foundation	This research was supported by the National Science Foundation of China through grants 81072567 and 30600463, and partially by Shandong Provincial Science Foundation grant ZR2010HM056. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allerson CR, 2005, J MED CHEM, V48, P901, DOI 10.1021/jm049167j; Astriab-Fisher A, 2004, BIOCHEM PHARMACOL, V68, P403, DOI 10.1016/j.bcp.2004.03.040; Butler M, 2005, NEUROSCIENCE, V131, P705, DOI 10.1016/j.neuroscience.2004.11.038; Cooper CL, 2004, J CLIN IMMUNOL, V24, P693, DOI 10.1007/s10875-004-6244-3; Dahl F, 2004, P NATL ACAD SCI USA, V101, P4548, DOI 10.1073/pnas.0400834101; Davis S, 2006, NUCLEIC ACIDS RES, V34, P2294, DOI 10.1093/nar/gkl183; Davis S, 2009, NUCLEIC ACIDS RES, V37, P70, DOI 10.1093/nar/gkn904; Friedberg JW, 2009, BRIT J HAEMATOL, V146, P282, DOI 10.1111/j.1365-2141.2009.07773.x; Hail Mark E., 2004, American Biotechnology Laboratory, V22, P12; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lohmann JS, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-49; Lu YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1053; McGowan MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049006; Menova P, 2012, CHEM COMMUN, V48, P6921, DOI 10.1039/c2cc32930a; Modarresi F, 2012, NAT BIOTECHNOL, V30, P453, DOI 10.1038/nbt.2158; Nakagawa O, 2010, J AM CHEM SOC, V132, P8848, DOI 10.1021/ja102635c; Persico AM, 1998, NEUROSCIENCE, V82, P1115; Roush W, 1997, SCIENCE, V276, P1192, DOI 10.1126/science.276.5316.1192; Senti G, 2009, CLIN EXP ALLERGY, V39, P562, DOI 10.1111/j.1365-2222.2008.03191.x; Van Ness J, 2003, P NATL ACAD SCI USA, V100, P4504, DOI 10.1073/pnas.0730811100; Veedu RN, 2008, J AM CHEM SOC, V130, P8124, DOI 10.1021/ja801389n; Veedu RN, 2007, CHEMBIOCHEM, V8, P490, DOI 10.1002/cbic.200600501; Veedu RN, 2009, ORG BIOMOL CHEM, V7, P1404, DOI 10.1039/b819946a; Wang XL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008430; Weiler J, 2006, GENE THER, V13, P496, DOI 10.1038/sj.gt.3302654	26	2	3	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67558	10.1371/journal.pone.0067558	http://dx.doi.org/10.1371/journal.pone.0067558			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861771	Green Published, gold, Green Submitted			2022-12-27	WOS:000323350700017
J	Rosa, RD; Vergnes, A; de Lorgeril, J; Goncalves, P; Perazzolo, LM; Saune, L; Romestand, B; Fievet, J; Gueguen, Y; Bachere, E; Destoumieux-Garzon, D				Rosa, Rafael Diego; Vergnes, Agnes; de Lorgeril, Julien; Goncalves, Priscila; Perazzolo, Luciane Maria; Saune, Laure; Romestand, Bernard; Fievet, Julie; Gueguen, Yannick; Bachere, Evelyne; Destoumieux-Garzon, Delphine			Functional Divergence in Shrimp Anti-Lipopolysaccharide Factors (ALFs): From Recognition of Cell Wall Components to Antimicrobial Activity	PLOS ONE			English	Article							BLACK TIGER SHRIMP; ANTI-LPS FACTOR; PENAEUS-MONODON; LITOPENAEUS-VANNAMEI; MOLECULAR-CLONING; GENE-EXPRESSION; NMR STRUCTURE; PEPTIDES; HEMOCYTES; MECHANISM	Antilipopolysaccharide factors (ALFs) have been described as highly cationic polypeptides with a broad spectrum of potent antimicrobial activities. In addition, ALFs have been shown to recognize LPS, a major component of the Gram-negative bacteria cell wall, through conserved amino acid residues exposed in the four-stranded beta-sheet of their three dimensional structure. In penaeid shrimp, ALFs form a diverse family of antimicrobial peptides composed by three main variants, classified as ALF Groups A to C. Here, we identified a novel group of ALFs in shrimp (Group D ALFs), which corresponds to anionic polypeptides in which many residues of the LPS binding site are lacking. Both Group B (cationic) and Group D (anionic) shrimp ALFs were produced in a heterologous expression system. Group D ALFs were found to have impaired LPS-binding activities and only limited antimicrobial activity compared to Group B ALFs. Interestingly, all four ALF groups were shown to be simultaneously expressed in an individual shrimp and to follow different patterns of gene expression in response to a microbial infection. Group B was by far the more expressed of the ALF genes. From our results, nucleotide sequence variations in shrimp ALFs result in functional divergence, with significant differences in LPS-binding and antimicrobial activities. To our knowledge, this is the first functional characterization of the sequence diversity found in the ALF family.	[Rosa, Rafael Diego; Vergnes, Agnes; de Lorgeril, Julien; Saune, Laure; Romestand, Bernard; Fievet, Julie; Gueguen, Yannick; Bachere, Evelyne; Destoumieux-Garzon, Delphine] Univ Montpellier 2, Univ Montpellier 1, Inst Francais Rech Exploitat Mer, Inst Rech Dev,CNRS,UMR5119, F-34095 Montpellier, France; [Goncalves, Priscila; Perazzolo, Luciane Maria] Univ Fed Santa Catarina, Dept Cell Biol Embryol & Genet, Lab Immunol Appl Aquaculture, Florianopolis, SC, Brazil; Ifremer, UMR5119, ECOSYM, F-34095 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universidade Federal de Santa Catarina (UFSC); Ifremer	Destoumieux-Garzon, D (corresponding author), Univ Montpellier 2, Univ Montpellier 1, Inst Francais Rech Exploitat Mer, Inst Rech Dev,CNRS,UMR5119, F-34095 Montpellier, France.	ddestoum@ifremer.fr	Rosa, Rafael Diego/L-6944-2019; Gueguen, Yannick/O-3248-2014; Destoumieux-Garzón, Delphine/O-3328-2014; de Lorgeril, Julien/O-7488-2014; VERGNES, Agnès/O-3659-2014; Bachere, Evelyne/O-6117-2014	Rosa, Rafael Diego/0000-0002-4076-3163; Gueguen, Yannick/0000-0002-8749-9582; Destoumieux-Garzón, Delphine/0000-0002-8793-9138; de Lorgeril, Julien/0000-0002-6400-5455; Saune, Laure/0000-0003-3490-5396; Goncalves, Priscila/0000-0001-7299-3169; Perazzolo, Luciane Maria/0000-0002-5539-4911	IFREMER; CNRS; CNPq-Brazil; CAPES Brazil	IFREMER; CNRS(Centre National de la Recherche Scientifique (CNRS)); CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study received financial support from IFREMER and CNRS. RDR was supported by a doctoral fellowship from CNPq-Brazil and PG by a master fellowship provided by CAPES Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andra J, 2007, BIOCHEM J, V406, P297, DOI 10.1042/BJ20070279; Bhunia A, 2011, J BIOL CHEM, V286, P24394, DOI 10.1074/jbc.M110.189662; Bhunia A, 2010, J BIOL CHEM, V285, P3883, DOI 10.1074/jbc.M109.065672; Carriel-Gomes MC, 2007, MEM I OSWALDO CRUZ, V102, P469, DOI 10.1590/S0074-02762007005000028; de la Vega E, 2008, MOL IMMUNOL, V45, P1916, DOI 10.1016/j.molimm.2007.10.039; de Lorgeril J, 2008, MOL IMMUNOL, V45, P3438, DOI 10.1016/j.molimm.2008.04.002; Goncalves P, 2012, MOL IMMUNOL, V51, P363, DOI 10.1016/j.molimm.2012.03.032; Gross PS, 2001, DEV COMP IMMUNOL, V25, P565, DOI 10.1016/S0145-305X(01)00018-0; Gueguen Y, 2006, J BIOL CHEM, V281, P313, DOI 10.1074/jbc.M510850200; Gueguen Y, 2006, DEV COMP IMMUNOL, V30, P283, DOI 10.1016/j.dci.2005.04.003; Hetru C, 1997, Methods Mol Biol, V78, P35; HOESS A, 1993, EMBO J, V12, P3351, DOI 10.1002/j.1460-2075.1993.tb06008.x; Jimenez-Vega F, 2007, J SHELLFISH RES, V26, P1169, DOI 10.2983/0730-8000(2007)26[1169:IOLVAA]2.0.CO;2; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Liu FS, 2005, MAR BIOTECHNOL, V7, P600, DOI 10.1007/s10126-005-5006-4; Liu Y, 2012, FISH SHELLFISH IMMUN, V32, P724, DOI 10.1016/j.fsi.2012.01.021; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynn DJ, 2007, IMMUNOL LETT, V110, P86, DOI 10.1016/j.imlet.2007.03.007; Mekata T, 2010, LETT APPL MICROBIOL, V50, P112, DOI 10.1111/j.1472-765X.2009.02763.x; Mora P, 2008, J PEPT SCI, V14, P963, DOI 10.1002/psc.1033; MORITA T, 1985, J BIOCHEM, V97, P1611, DOI 10.1093/oxfordjournals.jbchem.a135218; Nagoshi H, 2006, MOL IMMUNOL, V43, P2061, DOI 10.1016/j.molimm.2005.12.009; O'Leary NA, 2006, GENE, V371, P75, DOI 10.1016/j.gene.2005.11.028; O'Neil DA, 1999, J IMMUNOL, V163, P6718; Ponprateep S, 2012, FISH SHELLFISH IMMUN, V32, P26, DOI 10.1016/j.fsi.2011.10.010; Rosa RD, 2010, ISJ-INVERT SURVIV J, V7, P262; Rosa RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025594; Rosa RD, 2008, FISH SHELLFISH IMMUN, V25, P693, DOI 10.1016/j.fsi.2008.08.001; Schmitt P, 2012, DEV COMP IMMUNOLOGY; Schmitt P, 2010, J BIOL CHEM, V285, P29208, DOI 10.1074/jbc.M110.143388; Schmitt P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-23; Somboonwiwat K, 2006, J BIOCHEM MOL BIOL, V39, P26; Somboonwiwat K, 2005, DEV COMP IMMUNOL, V29, P841, DOI 10.1016/j.dci.2005.02.004; Somboonwiwat K, 2008, DEV COMP IMMUNOL, V32, P1170, DOI 10.1016/j.dci.2008.03.008; Supungul P, 2004, DIS AQUAT ORGAN, V61, P123, DOI 10.3354/dao061123; Supungul P, 2002, MAR BIOTECHNOL, V4, P487, DOI 10.1007/s10126-002-0043-8; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TANAKA S, 1982, BIOCHEM BIOPH RES CO, V105, P717, DOI 10.1016/0006-291X(82)91493-0; Tassanakajon A, 2010, MAR BIOTECHNOL, V12, P487, DOI [10.1007/s10126-010-9288-9, 10.1007/s10126-011-9381-8]; Tharntada S, 2008, FISH SHELLFISH IMMUN, V24, P46, DOI 10.1016/j.fsi.2007.07.010; Tharntada S, 2009, J GEN VIROL, V90, P1491, DOI 10.1099/vir.0.009621-0; Thomas P, 2012, MOL BIOL REP, V39, P6943, DOI 10.1007/s11033-012-1521-3; Wang KJ, 2007, MOL IMMUNOL, V44, P1961, DOI 10.1016/j.molimm.2006.09.036; Yang Y, 2009, BIOPOLYMERS, V91, P207, DOI 10.1002/bip.21119; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yedery RD, 2009, FISH SHELLFISH IMMUN, V27, P275, DOI 10.1016/j.fsi.2009.05.009	46	61	62	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67937	10.1371/journal.pone.0067937	http://dx.doi.org/10.1371/journal.pone.0067937			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861837	Green Published, gold			2022-12-27	WOS:000323350700064
J	van Zwieten, A; Meyer, J; Hermens, DF; Hickie, IB; Hawes, DJ; Glozier, N; Naismith, SL; Scott, EM; Lee, RSC; Guastella, AJ				van Zwieten, Anita; Meyer, Johanna; Hermens, Daniel F.; Hickie, Ian B.; Hawes, David J.; Glozier, Nicholas; Naismith, Sharon L.; Scott, Elizabeth M.; Lee, Rico S. C.; Guastella, Adam J.			Social Cognition Deficits and Psychopathic Traits in Young People Seeking Mental Health Treatment	PLOS ONE			English	Article							CALLOUS-UNEMOTIONAL TRAITS; ANTISOCIAL PERSONALITY-DISORDER; PROCESS SCREENING DEVICE; ANXIETY STRESS SCALES; IDENTIFICATION TEST AUDIT; SEVERE CONDUCT PROBLEMS; DEPRESSION ANXIETY; ALCOHOL-USE; CONSTRUCT-VALIDITY; PREDICTIVE UTILITY	Antisocial behaviours and psychopathic traits place an individual at risk for criminality, mental illness, substance dependence, and psychosocial dysfunction. Social cognition deficits appear to be associated with psychopathic traits and are believed to contribute to interpersonal dysfunction. Most research investigating the relationship of these traits with social cognition has been conducted either in children or adult forensic settings. We investigated whether psychopathic traits were associated with social cognition in 91 young people presenting for mental healthcare (aged between 15 and 25 years). Participants completed symptom severity measures, neuropsychological tests, the Reading the Mind in the Eyes Test of social cognition (RMET), and the Antisocial Process Screening Device (APSD) to assess psychopathic personality traits. Correlation analyses showed poorer social cognition was associated with greater psychopathic traits (r = -.36, p = .01). Interestingly, social cognition performance predicted unique variance in concurrent psychopathic personality traits above gender, IQ sustained attention, and working memory performance. These findings suggest that social cognitive impairments are associated with psychopathic tendencies in young people presenting for community mental healthcare. Research is needed to establish the directionality of this relationship and to determine whether social cognition training is an effective treatment amongst young people with psychopathic tendencies.	[van Zwieten, Anita; Meyer, Johanna; Hermens, Daniel F.; Hickie, Ian B.; Hawes, David J.; Glozier, Nicholas; Naismith, Sharon L.; Scott, Elizabeth M.; Lee, Rico S. C.; Guastella, Adam J.] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia; [Meyer, Johanna] Univ Florida, Coll Med, Gainesville, FL USA	University of Sydney; State University System of Florida; University of Florida	Guastella, AJ (corresponding author), Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia.	adam.guastella@sydney.edu.au	Hickie, Ian B/K-8975-2015; Lee, Rico Sze Chun/B-6693-2015; Hawes, David/AAE-6800-2021; van Zwieten, Anita/ABC-7544-2020	Hickie, Ian B/0000-0001-8832-9895; van Zwieten, Anita/0000-0003-4564-5825; Naismith, Sharon/0000-0001-9076-2778; Hermens, Daniel/0000-0002-8570-2663; Hawes, David/0000-0003-3260-1225; Glozier, Nick/0000-0002-0476-9146	NHMRC Australia Fellowship [464914]; NSW Ministry of Health, Mental Health and Drug Alcohol Office; NHMRC Clinical Research Fellowship [402864]; NHMRC Program Grant [350241]; ARC linkage Grant [LP110100513]; Centres of Clinical Research Excellence Grant [264611]; pharmaceutical industry Servier; pharmaceutical industry Pfizer; pharmaceutical industry AstraZeneca; pharmaceutical industry Eli Lilly	NHMRC Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NSW Ministry of Health, Mental Health and Drug Alcohol Office; NHMRC Clinical Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Program Grant(National Health and Medical Research Council (NHMRC) of Australia); ARC linkage Grant(Australian Research Council); Centres of Clinical Research Excellence Grant; pharmaceutical industry Servier; pharmaceutical industry Pfizer; pharmaceutical industry AstraZeneca; pharmaceutical industry Eli Lilly	AJG, DFH, and IBH were supported by an NHMRC Australia Fellowship awarded to IBH (No. 464914). DFH was supported by a grant from the NSW Ministry of Health, Mental Health and Drug & Alcohol Office. SLN was funded by an NHMRC Clinical Research Fellowship (No. 402864). This research was further supported by an NHMRC Program Grant (No. 350241), an ARC linkage Grant (LP110100513) and a Centres of Clinical Research Excellence Grant (No. 264611). EMS and IBH have received educational and research programs/grants that are supported by the pharmaceutical industry (including Servier, Pfizer, AstraZeneca, and Eli Lilly). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; AITB. Army Individual Test Battery, 1944, ARM IND TEST BATT MA; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; APA, 2000, DIAGN STAT MAN MENT; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Beaver KM, 2012, PSYCHIAT QUART, V83, P145, DOI 10.1007/s11126-011-9190-2; Bennett S, 2005, AGGRESS VIOLENT BEH, V10, P263, DOI 10.1016/j.avb.2004.07.001; Bergman H, 2002, ALCOHOL ALCOHOLISM, V37, P245, DOI 10.1093/alcalc/37.3.245; Blair J, 1996, J FORENSIC PSYCHIATR, V7, P15, DOI 10.1080/09585189608409914; Blair RJR, 2005, J CHILD PSYCHOL PSYC, V46, P327, DOI 10.1111/j.1469-7610.2004.00356.x; Blair RJR, 2000, COGNITIVE DEV, V15, P421, DOI 10.1016/S0885-2014(01)00039-9; Blair RJR, 2001, J NEUROL NEUROSUR PS, V71, P727, DOI 10.1136/jnnp.71.6.727; Brook M, 2013, J ABNORM PSYCHOL, V122, P156, DOI 10.1037/a0030261; BUCHANAN RW, 1994, ARCH GEN PSYCHIAT, V51, P804; Cale EM, 2002, CLIN PSYCHOL REV, V22, P1179, DOI 10.1016/S0272-7358(01)00125-8; Caputo AA, 1999, CRIM JUSTICE BEHAV, V26, P338, DOI 10.1177/0093854899026003004; Cauffman E, 2009, PSYCHOL ASSESSMENT, V21, P528, DOI 10.1037/a0017367; Corruble E, 1996, J AFFECT DISORDERS, V37, P157, DOI 10.1016/0165-0327(95)00091-7; Craig JS, 2004, SCHIZOPHR RES, V69, P29, DOI 10.1016/S0920-9964(03)00154-3; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; Cunningham-Williams RM, 1998, AM J PUBLIC HEALTH, V88, P1093, DOI 10.2105/AJPH.88.7.1093; Dadds MR, 2008, J AM ACAD CHILD PSY, V47, P455, DOI 10.1097/CHI.0b013e31816407f1; Dadds MR, 2006, BRIT J PSYCHIAT, V189, P280, DOI 10.1192/bjp.bp.105.018150; Daza P, 2002, J PSYCHOPATHOL BEHAV, V24, P195, DOI 10.1023/A:1016014818163; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; Dolan M, 2004, PSYCHOL MED, V34, P1093, DOI 10.1017/S0033291704002028; Dybek I, 2006, J STUD ALCOHOL, V67, P473, DOI 10.15288/jsa.2006.67.473; Falkenbach DM, 2003, BEHAV SCI LAW, V21, P787, DOI 10.1002/bsl.562; Fertuck EA, 2009, PSYCHOL MED, V39, P1979, DOI 10.1017/S003329170900600X; Fite PJ, 2009, ASSESSMENT, V16, P103, DOI 10.1177/1073191108319893; Forth A. E., 2003, HARE PCL YOUTH VERSI; Frick P.J., 2006, HDB PSYCHOPATHY, P353; Frick PJ, 2000, PSYCHOL ASSESSMENT, V12, P382, DOI 10.1037//1040-3590.12.4.382; Frick PJ., 2001, ANTISOCIAL PROCESS S; Goodwin RD, 2003, PSYCHIAT RES, V117, P159, DOI 10.1016/S0165-1781(02)00320-7; Haas SM, 2011, J ABNORM CHILD PSYCH, V39, P541, DOI 10.1007/s10802-010-9480-4; Hamilton BA, 2011, J AFFECT DISORDERS, V131, P84, DOI 10.1016/j.jad.2010.10.052; Hare R. D., 2003, HARE PSYCHOPATHY CHE, V2nd; Hawes DJ, 2005, J CONSULT CLIN PSYCH, V73, P737, DOI 10.1037/0022-006X.73.4.737; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Hermens DF, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002229; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Hodgins S, 2009, PERSONALITY PERSONAL; Hussong AM, 2004, DEV PSYCHOPATHOL, V16, P1029, DOI 10.1017/S095457940404012X; Kee KS, 2006, SCHIZOPHR RES, V87, P228, DOI 10.1016/j.schres.2006.06.001; Kettle JWL, 2008, SCHIZOPHR RES, V99, P96, DOI 10.1016/j.schres.2007.11.011; Kimonis ER, 2006, BEHAV SCI LAW, V24, P21, DOI 10.1002/bsl.668; Kimonis ER, 2012, CLIN CASE STUD, V11, P234, DOI 10.1177/1534650112448835; Krueger RF, 2002, J ABNORM PSYCHOL, V111, P411, DOI 10.1037//0021-843X.111.3.411; Kruh IP, 2005, CRIM JUSTICE BEHAV, V32, P69, DOI 10.1177/0093854804270629; Loney BR, 2003, J CLIN CHILD ADOLESC, V32, P66, DOI 10.1207/15374420360533077; Lorber CM, 2011, INT J OFFENDER THER, V55, P1291, DOI 10.1177/0306624X11386012; Losel F, 2012, OXFORD HDB CRIME PRE; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Lynam DR, 2007, J ABNORM PSYCHOL, V116, P155, DOI 10.1037/0021-843X.116.1.155; Marsh AA, 2008, AM J PSYCHIAT, V165, P712, DOI 10.1176/appi.ajp.2007.07071145; Merikangas KR, 1998, ADDICT BEHAV, V23, P893, DOI 10.1016/S0306-4603(98)00076-8; Moffitt TE, 2003, CAUSES OF CONDUCT DISORDER AND JUVENILE DELINQUENCY, P49; MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674; Munoz LC, 2007, SCAND J PSYCHOL, V48, P299, DOI 10.1111/j.1467-9450.2007.00560.x; Munoz LC, 2009, J AM ACAD CHILD PSY, V48, P554, DOI 10.1097/CHI.0b013e31819c2419; Murrie DC, 2002, PSYCHOL ASSESSMENT, V14, P390, DOI 10.1037//1040-3590.14.4.390; Norton PJ, 2007, ANXIETY STRESS COPIN, V20, P253, DOI 10.1080/10615800701309279; Pardini DA, 2003, J AM ACAD CHILD PSY, V42, P364, DOI 10.1097/00004583-200303000-00018; Poythress NG, 2006, ASSESSMENT, V13, P107, DOI 10.1177/1073191105284279; Poythress NG, 2006, CRIM JUSTICE BEHAV, V33, P26, DOI 10.1177/0093854805282518; Premkumar P, 2008, EUR PSYCHIAT, V23, P14, DOI 10.1016/j.eurpsy.2007.10.004; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Richell RA, 2003, NEUROPSYCHOLOGIA, V41, P523, DOI 10.1016/S0028-3932(02)00175-6; Robertson G, 2006, WIDE RANGE ACHIEVEME; Rubin A, 2006, J STUD ALCOHOL, V67, P454, DOI 10.15288/jsa.2006.67.454; Rutherford MD, 2002, J AUTISM DEV DISORD, V32, P189, DOI 10.1023/A:1015497629971; SAHAKIAN BJ, 1992, J ROY SOC MED, V85, P399; Salekin RT, 2004, J ABNORM PSYCHOL, V113, P416, DOI 10.1037/0021-843x.113.3.416; Sareen J, 2004, J NERV MENT DIS, V192, P178, DOI 10.1097/01.nmd.0000116460.25110.9f; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Scott E, 2009, AUSTRALAS PSYCHIATRY, V17, P189, DOI 10.1080/10398560802657322; Scott EM, 2013, J AFFECT DISORDERS, V144, P208, DOI 10.1016/j.jad.2012.06.031; Scott EM, 2012, MED J AUSTRALIA, V196, P136, DOI 10.5694/mja11.10481; Shamay-Tsoory SG, 2010, CORTEX, V46, P668, DOI 10.1016/j.cortex.2009.04.008; Silverthorn P, 2001, J PSYCHOPATHOL BEHAV, V23, P171, DOI 10.1023/A:1010917304587; Spain SE, 2004, BEHAV SCI LAW, V22, P85, DOI 10.1002/bsl.576; Stellwagen KK, 2013, PERS INDIV DIFFER, V54, P123, DOI 10.1016/j.paid.2012.08.019; Stuss DT, 2001, PSYCHOL ASSESSMENT, V13, P230, DOI 10.1037//1040-3590.13.2.230; Sylvers PD, 2011, PSYCHOL SCI, V22, P1280, DOI 10.1177/0956797611420730; Ullrich S, 2009, PERSONAL MENT HEALTH, V3, P151, DOI 10.1002/pmh.70; Vitacco MJ, 2005, J CONSULT CLIN PSYCH, V73, P466, DOI 10.1037/0022-006X.73.3.466; Vitacco MJ, 2003, ASSESSMENT, V10, P143, DOI 10.1177/1073191103010002005; Waschbusch DA, 2007, CHILD PSYCHIAT HUM D, V37, P293, DOI 10.1007/s10578-006-0033-6; Wechsler D., 2001, WECHSLER TEST ADULT; Woodworth M, 2008, CHILD CARE HLTH DEV, V34, P234, DOI 10.1111/j.1365-2214.2007.00792.x	91	13	13	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67753	10.1371/journal.pone.0067753	http://dx.doi.org/10.1371/journal.pone.0067753			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	204FO	23861799	Green Published, gold, Green Submitted			2022-12-27	WOS:000323350700032
J	Bunyavanich, S; Silberg, JL; Lasky-Su, J; Gillespie, NA; Lange, NE; Canino, G; Celedon, JC				Bunyavanich, Supinda; Silberg, Judy L.; Lasky-Su, Jessica; Gillespie, Nathan A.; Lange, Nancy E.; Canino, Glorisa; Celedon, Juan C.			A Twin Study of Early-Childhood Asthma in Puerto Ricans	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; DUTCH TWINS; DISEASE SEVERITY; REPORTED ASTHMA; UNITED-STATES; RISK-FACTORS; CHILDREN; HISPANICS; BEHAVIOR; LIFE	Background: The relative contributions of genetics and environment to asthma in Hispanics or to asthma in children younger than 3 years are not well understood. Objective: To examine the relative contributions of genetics and environment to early-childhood asthma by performing a longitudinal twin study of asthma in Puerto Rican children <= 3 years old. Methods: 678 twin infants from the Puerto Rico Neo-Natal Twin Registry were assessed for asthma at age 1 year, with follow-up data obtained for 624 twins at age 3 years. Zygosity was determined by DNA microsatellite profiling. Structural equation modeling was performed for three phenotypes at ages 1 and 3 years: physician-diagnosed asthma, asthma medication use in the past year, and >= 1 hospitalization for asthma in the past year. Models were additionally adjusted for early-life environmental tobacco smoke exposure, sex, and age. Results: The prevalences of physician-diagnosed asthma, asthma medication use, and hospitalization for asthma were 11.6%, 10.8%, 4.9% at age 1 year, and 34.1%, 40.1%, and 8.5% at 3 years, respectively. Shared environmental effects contributed to the majority of variance in susceptibility to physician-diagnosed asthma and asthma medication use in the first year of life (84%-86%), while genetic effects drove variance in all phenotypes (45%-65%) at age 3 years. Early-life environmental tobacco smoke, sex, and age contributed to variance in susceptibility. Conclusion: Our longitudinal study in Puerto Rican twins demonstrates a changing contribution of shared environmental effects to liability for physician-diagnosed asthma and asthma medication use between ages 1 and 3 years. Early-life environmental tobacco smoke reduction could markedly reduce asthma morbidity in young Puerto Rican children.	[Bunyavanich, Supinda] Mt Sinai, Icahn Sch Med, Dept Pediat, New York, NY USA; [Bunyavanich, Supinda] Mt Sinai, Icahn Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Bunyavanich, Supinda] Mt Sinai, Icahn Sch Med, Mindich Child Hlth & Dev Inst, New York, NY USA; [Bunyavanich, Supinda; Lasky-Su, Jessica; Lange, Nancy E.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Bunyavanich, Supinda; Lasky-Su, Jessica; Lange, Nancy E.] Harvard Univ, Sch Med, Boston, MA USA; [Silberg, Judy L.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA USA; [Gillespie, Nathan A.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA USA; [Gillespie, Nathan A.] Queensland Inst Med Res, Herston, Qld 4006, Australia; [Canino, Glorisa] Univ Puerto Rico, Sch Med, Behav Sci Res Inst, San Juan, PR 00936 USA; [Celedon, Juan C.] Childrens Hosp Pittsburgh, Div Pulm Med Allergy & Immunol, Pittsburgh, PA 15213 USA; [Celedon, Juan C.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Celedon, Juan C.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Celedon, Juan C.] Univ Pittsburgh, Dept Internal Med, Sch Med, Pittsburgh, PA USA; [Celedon, Juan C.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Virginia Commonwealth University; Virginia Commonwealth University; QIMR Berghofer Medical Research Institute; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bunyavanich, S (corresponding author), Mt Sinai, Icahn Sch Med, Dept Pediat, New York, NY USA.	supinda@post.harvard.edu		Lasky-Su, Jessica/0000-0001-6236-4705	National Institutes of Health [R01 HD0496685-03, R01 HL079966, T32 HL007427, 1K08AI09353801]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079966, T32HL007427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI093538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants R01 HD0496685-03, R01 HL079966, T32 HL007427, and 1K08AI09353801 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CLIN RESP J; Bayona Manuel, 2002, P R Health Sci J, V21, P213; Beckett WS, 1996, AM J RESP CRIT CARE, V154, P894, DOI 10.1164/ajrccm.154.4.8887582; Becklake MR, 1999, THORAX, V54, P1119, DOI 10.1136/thx.54.12.1119; Borrelli B, 2011, AM J HEALTH PROMOT, V25, pS91, DOI 10.4278/ajhp.100624-ARB-214; Boudreaux ED, 2003, PEDIATRICS, V111, pE615, DOI 10.1542/peds.111.5.e615; Butz AM, 2011, MATERN CHILD HLTH J, V15, P460, DOI 10.1007/s10995-010-0606-7; CARR W, 1992, AM J PUBLIC HEALTH, V82, P59, DOI 10.2105/AJPH.82.1.59; CARTERPOKRAS OD, 1993, AM J PUBLIC HEALTH, V83, P580, DOI 10.2105/AJPH.83.4.580; Castro-Rodriguez JA, 2011, CURR OPIN ALLERGY CL, V11, P157, DOI 10.1097/ACI.0b013e3283464c4a; Cohen RT, 2006, CLIN CHEST MED, V27, P401, DOI 10.1016/j.ccm.2006.04.004; Comhair SAA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018574; Cowan K, 2012, CURR OPIN PEDIATR, V24, P344, DOI 10.1097/MOP.0b013e32835357ab; Cunningham J, 1996, AM J RESP CRIT CARE, V153, P218, DOI 10.1164/ajrccm.153.1.8542119; Eisner MD, 2002, THORAX, V57, P973, DOI 10.1136/thorax.57.11.973; Fitzpatrick AM, 2006, J ALLERGY CLIN IMMUN, V118, P1218, DOI 10.1016/j.jaci.2006.08.019; Galanter JM, 2011, J ALLERGY CLIN IMMUN, V128, P37, DOI 10.1016/j.jaci.2011.03.050; Gilliland FD, 2001, AM J RESP CRIT CARE, V163, P429, DOI 10.1164/ajrccm.163.2.2006009; Goodwin RD, 2009, J ASTHMA, V46, P726, DOI 10.1080/02770900903072051; Hunninghake GM, 2006, AM J RESP CRIT CARE, V173, P143, DOI 10.1164/rccm.200508-1232SO; Hunt A, 2011, ENVIRON INT, V37, P1196, DOI 10.1016/j.envint.2011.04.013; Kindlund K, 2010, THORAX, V65, P146, DOI 10.1136/thx.2009.117101; Koeppen-Schomerus G, 2001, ARCH DIS CHILD, V85, P398, DOI 10.1136/adc.85.5.398; Lange NE, 2011, J ALLERGY CLIN IMMUN, V127, P734, DOI 10.1016/j.jaci.2010.11.010; Le Souef PN, 2006, CLIN EXP ALLERGY, V36, P1353, DOI 10.1111/j.1365-2222.2006.02608.x; Lichtenstein P, 1997, ALLERGY, V52, P1079, DOI 10.1111/j.1398-9995.1997.tb00179.x; Mackay D, 2010, NEW ENGL J MED, V363, P1139, DOI 10.1056/NEJMoa1002861; MAGNUS P, 1983, CLIN GENET, V24, P103; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Moorman Jeanne E., 2011, Morbidity and Mortality Weekly Report, V60, P84; Neale MC, 1992, METHODOLOGY GENETIC; Nystad W, 2005, INT J EPIDEMIOL, V34, P1302, DOI 10.1093/ije/dyi061; Oh SS, 2012, J ALLERGY CLIN IMMUN, V129, P1478, DOI 10.1016/j.jaci.2012.03.017; Ortqvist AK, 2009, PEDIATRICS, V124, pE737, DOI 10.1542/peds.2009-0305; Osterman Michelle J K, 2011, Natl Vital Stat Rep, V59, P1; OWNBY DR, 1990, J ALLERGY CLIN IMMUN, V86, P279, DOI 10.1016/S0091-6749(05)80088-0; Ramsey CD, 2005, PEDIATR PULM, V39, P268, DOI 10.1002/ppul.20177; SMITH C, 1974, AM J HUM GENET, V26, P454; Thomsen SF, 2010, CLIN EXP ALLERGY, V40, P1054, DOI 10.1111/j.1365-2222.2010.03525.x; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; van Beijsterveldt TCEM, 2008, TWIN RES HUM GENET, V11, P143, DOI 10.1375/twin.11.2.143; Willemsen G, 2008, TWIN RES HUM GENET, V11, P132, DOI 10.1375/twin.11.2.132; Wu T, 2010, EUR RESPIR J, V36, P261, DOI 10.1183/09031936.00123909	43	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e68473	10.1371/journal.pone.0068473	http://dx.doi.org/10.1371/journal.pone.0068473			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844206	gold, Green Submitted, Green Published			2022-12-27	WOS:000321733000010
J	Henriques, A; Rodriguez-Caballero, A; Nieto, WG; Langerak, AW; Criado, I; Lecrevisse, Q; Gonzalez, M; Pais, ML; Paiva, A; Almeida, J; Orfao, A				Henriques, Ana; Rodriguez-Caballero, Arancha; Nieto, Wendy G.; Langerak, Anton W.; Criado, Ignacio; Lecrevisse, Quentin; Gonzalez, Marcos; Pais, Maria L.; Paiva, Artur; Almeida, Julia; Orfao, Alberto			Combined Patterns of IGHV Repertoire and Cytogenetic/Molecular Alterations in Monoclonal B Lymphocytosis versus Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							CHRONIC LYMPHOPROLIFERATIVE DISORDERS; CELL LYMPHOCYTOSIS; NATURAL-HISTORY; CLL; GENE; STANDARDIZATION; CLASSIFICATION; IMMUNOGLOBULIN; PROGNOSIS; NOTCH1	Background: Chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis (MBL) with (MBLhi) or without (MBLlo) absolute B-lymphocytosis precedes most CLL cases, the specific determinants for malignant progression remaining unknown. Methodology/Principal Findings: For this purpose, simultaneous iFISH and molecular analysis of well-established cytogenetic alterations of chromosomes 11, 12, 13, 14 and 17 together with the pattern of rearrangement of the IGHV genes were performed in CLL-like cells from MBL and CLL cases. Our results based on 78 CLL-like MBL and 117 CLL clones from 166 subjects living in the same geographical area, show the existence of three major groups of clones with distinct but partially overlapping patterns of IGHV gene usage, IGHV mutational status and cytogenetic alterations. These included a group enriched in MBLlo clones expressing specific IGHV subgroups (e.g. VH3-23) with no or isolated good-prognosis cytogenetic alterations, a second group which mainly consisted of clinical MBLhi and advanced stage CLL with a skewed but different CLL-associated IGHV gene repertoire (e.g. VH1-69), frequently associated with complex karyotypes and poor-prognosis cytogenetic alterations, and a third group of clones with intermediate features, with prevalence of mutated IGHV genes, and higher numbers of del(13q)(+) clonal B-cells. Conclusions/Significance: These findings suggest that the specific IGHV repertoire and IGHV mutational status of CLL-like B-cell clones may modulate the type of cytogenetic alterations acquired, their rate of acquisition and/or potentially also their clinical consequences. Further long-term follow-up studies investigating the IGHV gene repertoire of MBLlo clones in distinct geographic areas and microenvironments are required to confirm our findings and shed light on the potential role of some antigen-binding BCR specificities contributing to clonal evolution.	[Henriques, Ana; Rodriguez-Caballero, Arancha; Nieto, Wendy G.; Criado, Ignacio; Lecrevisse, Quentin; Almeida, Julia; Orfao, Alberto] Univ Salamanca, Dept Med & Cytometry Serv, Canc Res Ctr IBMCC, USAL CSIC, E-37008 Salamanca, Spain; [Henriques, Ana; Rodriguez-Caballero, Arancha; Nieto, Wendy G.; Criado, Ignacio; Lecrevisse, Quentin; Almeida, Julia; Orfao, Alberto] Inst Biomed Res Salamanca IBSAL, Salamanca, Spain; [Henriques, Ana; Pais, Maria L.; Paiva, Artur] Portuguese Inst Blood & Transplantat IP, Blood & Transplantat Ctr Coimbra, Coimbra, Portugal; [Langerak, Anton W.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Immunol, Rotterdam, Netherlands; [Gonzalez, Marcos] Univ Salamanca, Serv Hematol, Univ Hosp Salamanca, IBMCC,IBSAL, E-37008 Salamanca, Spain; [Gonzalez, Marcos] Univ Salamanca, Dept Med, E-37008 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca; Universidade de Coimbra; Erasmus University Rotterdam; Erasmus MC; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca	Orfao, A (corresponding author), Univ Salamanca, Dept Med & Cytometry Serv, Canc Res Ctr IBMCC, USAL CSIC, E-37008 Salamanca, Spain.	orfao@usal.es	Orfao, Alberto/B-5801-2017; Henriques, Ana/B-7587-2019; Paiva, Artur/AFM-0035-2022; Paiva, Artur/AAH-2330-2022; Criado, Ignacio/ABF-7031-2020	Henriques, Ana/0000-0002-5096-791X; Paiva, Artur/0000-0002-6562-5859; Paiva, Artur/0000-0002-6562-5859; Criado, Ignacio/0000-0003-4120-343X	Fundacao para a Ciencia e Tecnologia of Portugal [SFRH/BD/31609/2006]; Fundacion Cientifica de la Asociacion Espanola contra el Cancer [AECC-2008]; Red Tematica de Investigacion Cooperativa en Cancer del Instituto de Salud Carlos III - FONDOS FEDER [RD06/0020/0035]; Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Madrid, Spain [FIS PI06/0824-FEDER, PS09/02430-FEDER, FIS PI12/00905]; Gerencia Regional de Salud de Castilla y Leon and Ayuda al Grupo de Excelencia de Castilla y Leon, Consejeria de Educacion [GR37, GRS206/A/08]; Consejeria de Sanidad, Junta de Castilla y Leon, Valladolid, Spain [SAN/1778/2009]; Fundacion Memoria D. Samuel Solorzano, Universidad de Salamanca, Salamanca, Spain [FS/1-2010]	Fundacao para a Ciencia e Tecnologia of Portugal(Portuguese Foundation for Science and Technology); Fundacion Cientifica de la Asociacion Espanola contra el Cancer; Red Tematica de Investigacion Cooperativa en Cancer del Instituto de Salud Carlos III - FONDOS FEDER; Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Madrid, Spain; Gerencia Regional de Salud de Castilla y Leon and Ayuda al Grupo de Excelencia de Castilla y Leon, Consejeria de Educacion; Consejeria de Sanidad, Junta de Castilla y Leon, Valladolid, Spain(Junta de Castilla y Leon); Fundacion Memoria D. Samuel Solorzano, Universidad de Salamanca, Salamanca, Spain	AH was supported by a grant from the Fundacao para a Ciencia e Tecnologia of Portugal (SFRH/BD/31609/2006), ARC was supported by a grant from Fundacion Cientifica de la Asociacion Espanola contra el Cancer (AECC-2008). This work was financially supported by the following grants: Red Tematica de Investigacion Cooperativa en Cancer del Instituto de Salud Carlos III - FONDOS FEDER (RD06/0020/0035); FIS PI06/0824-FEDER, PS09/02430-FEDER and FIS PI12/00905, from the Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Madrid, Spain; GRS206/A/08 from the Gerencia Regional de Salud de Castilla y Leon and Ayuda al Grupo GR37 de Excelencia de Castilla y Leon, Consejeria de Educacion; SAN/1778/2009, Consejeria de Sanidad, Junta de Castilla y Leon, Valladolid, Spain and FS/1-2010 Fundacion Memoria D. Samuel Solorzano, Universidad de Salamanca, Salamanca, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agathangelidis A, 2012, BLOOD, V119, P4467, DOI 10.1182/blood-2011-11-393694; Almeida J, 2011, LEUKEMIA, V25, P718, DOI 10.1038/leu.2010.305; Arcaini L, 2009, BLOOD CELL MOL DIS, V42, P286, DOI 10.1016/j.bcmd.2009.01.004; Buhler A, 2010, CLIN CANCER RES, V16, P373, DOI 10.1158/1078-0432.CCR-09-2948; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Casabonne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052808; Chu CC, 2008, BLOOD, V112, P5122, DOI 10.1182/blood-2008-06-162024; Costa ES, 2010, LEUKEMIA, V24, P1927, DOI 10.1038/leu.2010.160; Dagklis A, 2009, BLOOD, V114, P26, DOI 10.1182/blood-2008-09-176933; Del Giudice I, 2012, HAEMATOL-HEMATOL J, V97, P437, DOI 10.3324/haematol.2011.060129; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Gonzalez D, 2003, LEUKEMIA, V17, P1398, DOI 10.1038/sj.leu.2402964; Kalina T, 2012, LEUKEMIA, V26, P1986, DOI 10.1038/leu.2012.122; Kern W, 2012, BR J HAEMAT IN PRESS, DOI [10.1111/j.1365-2141.2011.09010.x, DOI 10.1111/J.1365-2141.2011.09010.X.IN]; Kostareli E, 2008, SRP ARK CELOK LEK, V136, P319, DOI 10.2298/SARH0806319K; Lanasa MC, 2011, LEUKEMIA, V25, P1459, DOI 10.1038/leu.2011.117; Lanasa MC, 2010, LEUKEMIA, V24, P133, DOI 10.1038/leu.2009.192; Landgren O, 2009, NEW ENGL J MED, V360, P659, DOI 10.1056/NEJMoa0806122; Lenze D, 2006, BLOOD, V107, P1141, DOI 10.1182/blood-2005-04-1722; Marti GE, 2005, BRIT J HAEMATOL, V130, P325, DOI 10.1111/j.1365-2141.2005.05550.x; MARTIN T, 1992, J EXP MED, V175, P983, DOI 10.1084/jem.175.4.983; Nieto WG, 2010, CYTOM PART B-CLIN CY, V78B, pS24, DOI 10.1002/cyto.b.20543; Nieto WG, 2009, BLOOD, V114, P33, DOI 10.1182/blood-2009-01-197368; Quijano S, 2008, CYTOM PART B-CLIN CY, V74B, P139, DOI 10.1002/cyto.b.20390; Rawstron AC, 2008, NEW ENGL J MED, V359, P575, DOI 10.1056/NEJMoa075290; Rawstron AC, 2007, BRIT J HAEMATOL, V139, P724, DOI 10.1111/j.1365-2141.2007.06863.x; Rawstron Andy C, 2009, Hematology Am Soc Hematol Educ Program, P430, DOI 10.1182/asheducation-2009.1.430; Rossi D, 2012, BLOOD, V119, P521, DOI 10.1182/blood-2011-09-379966; Sanchez ML, 2002, LEUKEMIA, V16, P1460, DOI 10.1038/sj.leu.2402584; Scarfo L, 2012, LEUKEMIA, V26, P1703, DOI 10.1038/leu.2012.20; Scarfo L, 2010, SEMIN CANCER BIOL, V20, P384, DOI 10.1016/j.semcancer.2010.08.005; Schwaenen C, 2004, P NATL ACAD SCI USA, V101, P1039, DOI 10.1073/pnas.0304717101; Shanafelt TD, 2010, LEUKEMIA, V24, P512, DOI 10.1038/leu.2009.287; Shanafelt TD, 2008, LEUKEMIA RES, V32, P1458, DOI 10.1016/j.leukres.2007.11.030; Shanafelt TD, 2009, J CLIN ONCOL, V27, P3959, DOI 10.1200/JCO.2008.21.2704; Swerdlow SH, 2008, WHO CLASSIFICATION T; Tobin G, 2004, BLOOD, V104, P2879, DOI 10.1182/blood-2004-01-0132; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Vardi A, 2013, BLOOD; Zenz T, 2011, BLOOD REV, V25, P131, DOI 10.1016/j.blre.2011.02.002	40	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67751	10.1371/journal.pone.0067751	http://dx.doi.org/10.1371/journal.pone.0067751			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844084	Green Published, gold, Green Submitted			2022-12-27	WOS:000321733000099
J	Ge, YJ; Waldemer, RJ; Nalluri, R; Nuzzi, PD; Chen, J				Ge, Yejing; Waldemer, Rachel J.; Nalluri, Ramakrishna; Nuzzi, Paul D.; Chen, Jie			RNAi Screen Reveals Potentially Novel Roles of Cytokines in Myoblast Differentiation	PLOS ONE			English	Article							SKELETAL-MUSCLE; MYOGENIC DIFFERENTIATION; MAMMALIAN TARGET; P38 MAPK; CHEMOKINE; FUSION; INTERLEUKIN-6; RECRUITMENT; INHIBITION; ACTIVATION	Cytokines are cell-secreted signaling molecules that modulate various cellular functions, with the best-characterized roles in immune responses. The expression of numerous cytokines in skeletal muscle tissues and muscle cells has been reported, but their function in skeletal myogenesis, the formation of skeletal muscle, has been largely underexplored. To systematically examine the potential roles of cytokines in skeletal myogenesis, we undertook an RNAi screen of 134 mouse cytokine genes for their involvement in the differentiation of C2C12 myoblasts. Our results have uncovered 29 cytokines as strong candidates for novel myogenic regulators, potentially conferring positive and negative regulation at distinct stages of myogenesis. These candidates represent a diverse collection of cytokine families, including interleukins, TNF-related factors, and chemokines. Our findings suggest the fundamental importance of cytokines in the cell-autonomous regulation of myoblast differentiation, and may facilitate future identification of novel therapeutic targets for improving muscle regeneration and growth in health and diseases.	[Ge, Yejing; Waldemer, Rachel J.; Nalluri, Ramakrishna; Nuzzi, Paul D.; Chen, Jie] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign	Chen, J (corresponding author), Univ Illinois, Dept Cell & Dev Biol, Urbana, IL USA.	jiechen@illinois.edu		Waldemer-Streyer, Rachel/0000-0002-7199-9443; Chen, Jie/0000-0002-7887-3747	National Institutes of Health [AR048914, GM089771]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089771] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the National Institutes of Health to JC (AR048914 & GM089771). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter J, 2008, J BIOL CHEM, V283, P23224, DOI 10.1074/jbc.M801379200; BADER D, 1982, J CELL BIOL, V95, P763, DOI 10.1083/jcb.95.3.763; Bae GU, 2008, J BIOL CHEM, V283, P8301, DOI 10.1074/jbc.M706730200; Baeza-Raja B, 2004, MOL BIOL CELL, V15, P2013, DOI 10.1091/mbc.E03-08-0585; Chong SW, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-54; Dahlqvist C, 2003, DEVELOPMENT, V130, P6089, DOI 10.1242/dev.00834; Griffin CA, 2010, J CELL SCI, V123, P3052, DOI 10.1242/jcs.066241; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Hara M, 2011, J EXP MED, V208, P715, DOI 10.1084/jem.20101059; Henningsen J, 2011, MOL BIOSYST, V7, P311, DOI 10.1039/c0mb00209g; Henningsen J, 2010, MOL CELL PROTEOMICS, V9, P2482, DOI 10.1074/mcp.M110.002113; Hirata A, 2003, AM J PATHOL, V163, P203, DOI 10.1016/S0002-9440(10)63644-9; Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2; Iezzi S, 2004, DEV CELL, V6, P673, DOI 10.1016/S1534-5807(04)00107-8; Jansen Katie M., 2008, V475, P115, DOI 10.1007/978-1-59745-250-2_7; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Krop IE, 2001, P NATL ACAD SCI USA, V98, P9796, DOI 10.1073/pnas.171138398; Lacotte S, 2009, ANN NY ACAD SCI, V1173, P310, DOI 10.1111/j.1749-6632.2009.04813.x; Langen RCJ, 2001, FASEB J, V15, P1169, DOI 10.1096/fj.00-0463; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Melchonna R, 2010, MUSCLE NERVE, V41, P828, DOI 10.1002/mus.21611; Miyake T, 2009, J BIOL CHEM, V284, P19679, DOI 10.1074/jbc.M109.017319; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Naya FJ, 1999, CURR OPIN CELL BIOL, V11, P683, DOI 10.1016/S0955-0674(99)00036-8; Odemis V, 2007, J CELL SCI, V120, P4050, DOI 10.1242/jcs.010009; Okazaki S, 1996, CELL PROLIFERAT, V29, P173; Pajcini KV, 2008, J CELL BIOL, V180, P1005, DOI 10.1083/jcb.200707191; Park IH, 2005, J BIOL CHEM, V280, P32009, DOI 10.1074/jbc.M506120200; Parker MH, 2003, NAT REV GENET, V4, P497, DOI 10.1038/nrg1109; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Shigematsu H, 2005, INT J CANCER, V113, P600, DOI 10.1002/ijc.20622; Sun YT, 2010, J CELL BIOL, V189, P1157, DOI 10.1083/jcb.200912093; Tanno T, 2010, CURR OPIN HEMATOL, V17, P184, DOI 10.1097/MOH.0b013e328337b52f; Tato Cristina M, 2008, Cell, V132, DOI 10.1016/j.cell.2008.01.001; Tato CM, 2008, CELL, V132, P1062; Waite KA, 2003, NAT REV GENET, V4, P763, DOI 10.1038/nrg1178; Xiao F, 2011, CELL RES, V21, P350, DOI 10.1038/cr.2010.144; Yoon MS, 2008, J CELL SCI, V121, P282, DOI 10.1242/jcs.022566; Zhan M, 2007, J CELL SCI, V120, P692, DOI 10.1242/jcs.03372; Zlotnik A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-243	42	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68068	10.1371/journal.pone.0068068	http://dx.doi.org/10.1371/journal.pone.0068068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844157	gold, Green Submitted, Green Published			2022-12-27	WOS:000321341000137
J	Massol, S; Dunabeitia, JA; Carreiras, M; Grainger, J				Massol, Stephanie; Andoni Dunabeitia, Jon; Carreiras, Manuel; Grainger, Jonathan			Evidence for Letter-Specific Position Coding Mechanisms	PLOS ONE			English	Article							PRINTED WORD PERCEPTION; MODEL; CODE; RECOGNITION; SYMBOLS; ORDER	The perceptual matching (same-different judgment) paradigm was used to investigate precision in position coding for strings of letters, digits, and symbols. Reference and target stimuli were 6 characters long and could be identical or differ either by transposing two characters or substituting two characters. The distance separating the two characters was manipulated such that they could either be contiguous, separated by one intervening character, or separated by two intervening characters. Effects of type of character and distance were measured in terms of the difference between the transposition and substitution conditions (transposition cost). Error rates revealed that transposition costs were greater for letters than for digits, which in turn were greater than for symbols. Furthermore, letter stimuli showed a gradual decrease in transposition cost as the distance between the letters increased, whereas the only significant difference for digit and symbol stimuli arose between contiguous and non-contiguous changes, with no effect of distance on the non-contiguous changes. The results are taken as further evidence for letter-specific position coding mechanisms.	[Massol, Stephanie; Andoni Dunabeitia, Jon; Carreiras, Manuel] Basque Ctr Cognit Brain & Language, Donostia San Sebastian, Spain; [Carreiras, Manuel] IKERBASQUE Basque Fdn Sci, Bilbao, Spain; [Grainger, Jonathan] CNRS, Marseille, France; [Grainger, Jonathan] Aix Marseille Univ, Marseille, France	Basque Foundation for Science; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Massol, S (corresponding author), Basque Ctr Cognit Brain & Language, Donostia San Sebastian, Spain.	s.massol@bcbl.eu	Massol, Stéphanie/N-8174-2017; Carreiras, Manuel/D-5267-2009; Grainger, Jonathan/C-9299-2009; Duñabeitia, Jon Andoni/C-8503-2014	Massol, Stéphanie/0000-0002-4855-4489; Carreiras, Manuel/0000-0001-6726-7613; Duñabeitia, Jon Andoni/0000-0002-3312-8559; Basque Center on Cognition, Brain and Language, BCBL./0000-0002-8345-6892	Basque Government [PI2012-74]; Spanish Government [PSI2012-32123, PSI2009-08889/PSIC, PSI2011-26924, CSD2008-00048]; ERC (European Research Council) [295362, 230313]; Fyssen Foundation, Paris, France	Basque Government(Basque Government); Spanish Government(Spanish GovernmentEuropean Commission); ERC (European Research Council)(European Research Council (ERC)); Fyssen Foundation, Paris, France	This study was partially supported by grant PI2012-74 from the Basque Government, grants PSI2012-32123, PSI2009-08889/PSIC, PSI2011-26924, and CSD2008-00048 from the Spanish Government, and ERC (European Research Council) advanced grants 295362 and 230313. Stephanie Massol is supported by the Fyssen Foundation, Paris, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dunabeitia JA, 2012, J COGNITIVE NEUROSCI, V24, P1610, DOI 10.1162/jocn_a_00180; Dunabeitia JA, 2009, VIS COGN, V17, P617, DOI 10.1080/13506280902764489; Ashby FG, 1996, PSYCHOL REV, V103, P165, DOI 10.1037/0033-295X.103.1.165; Davis CJ, 2010, PSYCHOL REV, V117, P713, DOI 10.1037/a0019738; Dehaene S, 2005, TRENDS COGN SCI, V9, P335, DOI 10.1016/j.tics.2005.05.004; Dunabeitia JA, 2007, COGNITION, V105, P691, DOI 10.1016/j.cognition.2006.12.001; Garcia-Orza J, 2011, ATTEN PERCEPT PSYCHO, V73, P2573, DOI 10.3758/s13414-011-0206-7; Garcia-Orza J, 2010, Q J EXP PSYCHOL, V63, P1603, DOI 10.1080/17470210903474278; Gomez P, 2008, PSYCHOL REV, V115, P577, DOI 10.1037/a0012667; Grainger J, 2003, MENTAL LEXICON: SOME WORDS TO TALK ABOUT WORDS, P1; Grainger J, 2004, TRENDS COGN SCI, V8, P58, DOI 10.1016/j.tics.2003.11.006; Grainger J, 2008, LANG COGNITIVE PROC, V23, P1, DOI 10.1080/01690960701578013; Grainger J, 2006, J EXP PSYCHOL HUMAN, V32, P865, DOI 10.1037/0096-1523.32.4.865; Grainger J, 2010, J EXP PSYCHOL HUMAN, V36, P673, DOI 10.1037/a0016888; Guerrera C, 2008, LANG COGNITIVE PROC, V23, P117, DOI 10.1080/01690960701579722; Hannagan T, 2012, COGNITIVE SCI, V36, P575, DOI 10.1111/j.1551-6709.2012.01236.x; HUMPHREYS GW, 1990, COGNITIVE PSYCHOL, V22, P517, DOI 10.1016/0010-0285(90)90012-S; Lee CH, 2009, J MEM LANG, V60, P530, DOI 10.1016/j.jml.2009.01.002; Logan GD, 1996, PSYCHOL REV, V103, P603, DOI 10.1037/0033-295X.103.4.603; Lupker SJ, 2008, LANG COGNITIVE PROC, V23, P93, DOI 10.1080/01690960701579714; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; Norris D, 2006, PSYCHOL REV, V113, P327, DOI 10.1037/0033-295X.113.2.327; OCONNOR RE, 1981, MEM COGNITION, V9, P78, DOI 10.3758/BF03196953; Perea M, 2005, PERCEPT PSYCHOPHYS, V67, P301, DOI 10.3758/BF03206493; Perea M, 2004, J MEM LANG, V51, P231, DOI 10.1016/j.jml.2004.05.005; Perea M, 2003, MEM COGNITION, V31, P829, DOI 10.3758/BF03196438; Perea M, 2008, J EXP PSYCHOL HUMAN, V34, P237, DOI 10.1037/0096-1523.34.1.237; Perea M, 2009, Q J EXP PSYCHOL, V62, P1881, DOI 10.1080/17470210902923374; Perea M, 2008, EXP PSYCHOL, V55, P384, DOI 10.1027/1618-3169.55.6.384; Peressotti F, 1999, PERCEPT PSYCHOPHYS, V61, P691, DOI 10.3758/BF03205539; PROCTOR RW, 1981, PSYCHOL REV, V88, P291, DOI 10.1037/0033-295X.88.4.291; RATCLIFF R, 1981, PSYCHOL REV, V88, P552, DOI 10.1037/0033-295X.88.6.552; Schoonbaert S, 2004, LANG COGNITIVE PROC, V19, P333, DOI 10.1080/01690960344000198; Whitney C, 2001, PSYCHON B REV, V8, P221, DOI 10.3758/BF03196158	34	31	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68460	10.1371/journal.pone.0068460	http://dx.doi.org/10.1371/journal.pone.0068460			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	176XV	23844204	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000162
J	Serrat, R; Lopez-Domenech, G; Mirra, S; Quevedo, M; Garcia-Fernandez, J; Ulloa, F; Burgaya, F; Soriano, E				Serrat, Roman; Lopez-Domenech, Guillermo; Mirra, Serena; Quevedo, Marti; Garcia-Fernandez, Jordi; Ulloa, Fausto; Burgaya, Ferran; Soriano, Eduardo			The Non-Canonical Wnt/PKC Pathway Regulates Mitochondrial Dynamics through Degradation of the Arm-Like Domain-Containing Protein Alex3	PLOS ONE			English	Article							BETA-CATENIN; KINASE-C; EPITHELIAL-CELLS; PROGENITOR CELLS; COLON-CANCER; STEM-CELLS; PKC-DELTA; WNT5A; DIFFERENTIATION; PROLIFERATION	The regulation of mitochondrial dynamics is vital in complex cell types, such as neurons, that transport and localize mitochondria in high energy-demanding cell domains. The Armcx3 gene encodes a mitochondrial-targeted protein (Alex3) that contains several arm-like domains. In a previous study we showed that Alex3 protein regulates mitochondrial aggregation and trafficking. Here we studied the contribution of Wnt proteins to the mitochondrial aggregation and dynamics regulated by Alex3. Overexpression of Alex3 in HEK293 cells caused a marked aggregation of mitochondria, which was attenuated by treatment with several Wnts. We also found that this decrease was caused by Alex3 degradation induced by Wnts. While the Wnt canonical pathway did not alter the pattern of mitochondrial aggregation induced by Alex3, we observed that the Wnt/PKC non-canonical pathway regulated both mitochondrial aggregation and Alex3 protein levels, thereby rendering a mitochondrial phenotype and distribution similar to control patterns. Our data suggest that the Wnt pathway regulates mitochondrial distribution and dynamics through Alex3 protein degradation.	[Serrat, Roman; Lopez-Domenech, Guillermo; Mirra, Serena; Quevedo, Marti; Ulloa, Fausto; Burgaya, Ferran; Soriano, Eduardo] Univ Barcelona, Dept Cell Biol, Barcelona, Spain; [Serrat, Roman; Lopez-Domenech, Guillermo; Mirra, Serena; Quevedo, Marti; Ulloa, Fausto; Burgaya, Ferran; Soriano, Eduardo] Inst Res Biomed Barcelona, Dev Neurobiol & Regenerat Lab, Barcelona, Spain; [Serrat, Roman; Lopez-Domenech, Guillermo; Mirra, Serena; Quevedo, Marti; Ulloa, Fausto; Burgaya, Ferran; Soriano, Eduardo] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Garcia-Fernandez, Jordi] Univ Barcelona, Fac Biol, Dept Genet, Barcelona, Spain; [Garcia-Fernandez, Jordi] Univ Barcelona, Inst Biomed, Barcelona, Spain; [Soriano, Eduardo] Fdn CIEN, Madrid, Spain	University of Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; CIBERNED; University of Barcelona; University of Barcelona	Soriano, E (corresponding author), Univ Barcelona, Dept Cell Biol, Barcelona, Spain.	esoriano@ub.edu	Soriano, Eduardo/AAB-3216-2019; mirra, serena/AAG-4925-2021; López Doménech, Guillermo López Doménech/X-6075-2018; Reñé, Román Serrat/A-2500-2017; Garcia-Fernandez, Jordi/B-3839-2013; Ulloa, Fausto/AAB-2787-2019	Soriano, Eduardo/0000-0002-3204-9285; López Doménech, Guillermo López Doménech/0000-0002-3114-2082; Reñé, Román Serrat/0000-0001-5530-2135; Garcia-Fernandez, Jordi/0000-0001-5677-5970; 	Ministerio de Economia y Competitividad [MINECO], Spain [BFU2008-3980]; MINECO [BFU2010-21507]; Instituto de Salud Carlos III [PI12-02108]	Ministerio de Economia y Competitividad [MINECO], Spain(Spanish Government); MINECO(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by grants BFU2008-3980 (Ministerio de Economia y Competitividad [MINECO], Spain) to ES, BFU2010-21507 (MINECO) to FU and PI12-02108 (Instituto de Salud Carlos III) to FB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JH, 2010, BONE, V47, P140, DOI 10.1016/j.bone.2010.04.593; Luna-Ulloa LB, 2011, IUBMB LIFE, V63, P915, DOI 10.1002/iub.559; Brocardo M, 2008, J BIOL CHEM, V283, P5950, DOI 10.1074/jbc.M708775200; Chada SR, 2003, J EXP BIOL, V206, P1985, DOI 10.1242/jeb.00263; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chang DTW, 2006, PROG NEUROBIOL, V80, P241, DOI 10.1016/j.pneurobio.2006.09.003; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Chen S, 2007, MOL CELL NEUROSCI, V36, P472, DOI 10.1016/j.mcn.2007.08.004; Chen S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002804; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Deng L, 2009, CELL PROLIFERAT, V42, P721, DOI 10.1111/j.1365-2184.2009.00639.x; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Garcia-Frigola C, 2004, MOL BRAIN RES, V122, P133, DOI 10.1016/j.molbrainres.2003.12.014; GAVEL Y, 1990, PROTEIN ENG, V4, P33, DOI 10.1093/protein/4.1.33; Han XJ, 2011, ACTA MED OKAYAMA, V65, P1; Hollenbeck Peter J., 1996, Frontiers in Bioscience (online), V1, pD91; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Kinoshita N, 2003, GENE DEV, V17, P1663, DOI 10.1101/gad.1101303; Kowalczyk JE, 2009, NEUROCHEM INT, V55, P157, DOI 10.1016/j.neuint.2009.01.009; Koyanagi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005765; Kurochkin IV, 2001, BIOCHEM BIOPH RES CO, V280, P340, DOI 10.1006/bbrc.2000.4125; Lee JM, 2010, MOL CELL, V37, P183, DOI 10.1016/j.molcel.2009.12.022; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Liang HL, 2007, J EXP MED, V204, P3077, DOI 10.1084/jem.20062692; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu XG, 2009, INT J BIOCHEM CELL B, V41, P1972, DOI 10.1016/j.biocel.2009.05.013; Lopez-Domenech G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1829; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; MCMAHON AP, 1989, CELL, V58, P1075, DOI 10.1016/0092-8674(89)90506-0; Medrano EE, 2007, PIGM CELL RES, V20, P258, DOI 10.1111/j.1600-0749.2007.00383.x; Mezhybovska M, 2009, BRIT J CANCER, V101, P1596, DOI 10.1038/sj.bjc.6605342; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Mou ZM, 2009, J BIOL CHEM, V284, P13629, DOI 10.1074/jbc.M901177200; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Samarzija I, 2009, BIOCHEM BIOPH RES CO, V386, P449, DOI 10.1016/j.bbrc.2009.06.033; Santos A, 2010, CYTOTHERAPY, V12, P924, DOI 10.3109/14653241003774011; Saotome M, 2008, P NATL ACAD SCI USA, V105, P20728, DOI 10.1073/pnas.0808953105; Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003; Smalley MJ, 1999, CANCER METAST REV, V18, P215, DOI 10.1023/A:1006369223282; Spinsanti P, 2008, J NEUROCHEM, V104, P1588, DOI 10.1111/j.1471-4159.2007.05111.x; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Wang ZY, 2009, J AM SOC NEPHROL, V20, P1919, DOI 10.1681/ASN.2009030253; Winter EE, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-54; WONG GT, 1994, MOL CELL BIOL, V14, P6278, DOI 10.1128/MCB.14.9.6278; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038; Yoon JC, 2010, GENE DEV, V24, P1507, DOI 10.1101/gad.1924910; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Yu JM, 2006, MOL CELL BIOCHEM, V288, P17, DOI 10.1007/s11010-005-9113-3; Zhang X, 2007, NAT CELL BIOL, V9, P743, DOI 10.1038/ncb1603	56	22	27	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67773	10.1371/journal.pone.0067773	http://dx.doi.org/10.1371/journal.pone.0067773			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844091	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000095
J	Chen, SF; Lin, YS; Jao, SW; Chang, YC; Liu, CL; Lin, YJ; Nieh, S				Chen, Su-Feng; Lin, Yaoh-Shiang; Jao, Shu-Wen; Chang, Yun-Ching; Liu, Chia-Lin; Lin, Yu-Ju; Nieh, Shin			Pulmonary Adenocarcinoma in Malignant Pleural Effusion Enriches Cancer Stem Cell Properties during Metastatic Cascade	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PROGNOSTIC IMPACT; DRUG-RESISTANCE; BREAST-CANCER; TUMOR-GROWTH; E-CADHERIN; EXPRESSION; CD133; SURVIVAL; OPINION	Background: Metastasis occurs in a series of discrete steps involving invasion, angiogenesis, lymphovascular space permeation, and establishment of secondary tumors. Malignant pleural effusion (MPE), a type of tumor metastasis, is usually a poor prognostic sign for patients with pulmonary adenocarcinoma, although its underlying mechanism has received less attention than other types of metastases have. The objective of the current study was to confirm whether cancer stem cells (CSCs) in MPE contribute to the "metastatic cascade'' through the epithelial - mesenchymal transition (EMT), anoikis, and adaptation in the microenvironment. Methods: Pulmonary tissue and corresponding cell blocks of MPE samples from 20 patients with primary adenocarcinoma were analyzed by immunohistochemical staining with CSC-representative markers (CD133, Nanog, and OCT-4) and EMT-associated markers (E-cadherin and vimentin). Correlations between these variables and clinico-pathological parameters were analyzed. Primary cultures from eight cases of MPE were investigated to characterize the CSC properties, including marker expression, sphere formation, and differentiation. Results: Expressions of CSC-representative markers for 20 cases of MPE cell blocks were quite diverse and variable ranging from 15% to 90%. Stronger expression of CSC-representative markers and alteration of EMT-associated markers were found at the invasive fronts and in MPEs compared with the expression in primary pulmonary tumor tissues. The expression of OCT-4 in MPEs significantly related to distant metastasis and stage, as well as inversely correlated with patient survival. Primary cultures confirmed the CSC properties in MPE. Five of eight cases of MPE yielded adequate cell clusters, which also showed variable expressions of CSC markers in addition to sphere formation and the ability for differentiation and metastasis. Conclusion: This pilot study offers a better understanding of the metastatic cascade. Establishing a model of MPE will provide further insight into the role of CSCs in metastasis and may explain the high therapeutic failure rates for patients with MPE.	[Chen, Su-Feng] China Med Univ, Dept Dent Hyg, Taichung, Taiwan; [Lin, Yaoh-Shiang] Kaohsiung Vet Gen Hosp, Dept Otolaryngol, Kaohsiung, Taiwan; [Jao, Shu-Wen] Natl Def Med Ctr, Div Colon & Rectal Surg, Taipei, Taiwan; [Jao, Shu-Wen; Chang, Yun-Ching; Liu, Chia-Lin; Lin, Yu-Ju; Nieh, Shin] Triserv Gen Hosp, Taipei, Taiwan; [Chang, Yun-Ching; Liu, Chia-Lin] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Lin, Yu-Ju; Nieh, Shin] Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan	China Medical University Taiwan; Kaohsiung Veterans General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center	Nieh, S (corresponding author), Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan.	niehshin1014@yahoo.com.tw	Yang, Xiaohan/AAM-2449-2020; Yang, Xiaohan/A-6975-2011	Yang, Xiaohan/0000-0001-5207-4210; Yang, Xiaohan/0000-0001-5207-4210	National Science Council, Republic of China [NSC100-2320-B-016-009]; Tri-Service General Hospital [TSGH-C101-076]	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital	This study was partly supported by the National Science Council, Republic of China, Grant Nos. NSC100-2320-B-016-009 and by the Tri-Service General Hospital, Grant No. TSGH-C101-076. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antic T, 2012, DIAGN CYTOPATHOL, V40, P311, DOI 10.1002/dc.21563; Avizienyte E, 2002, NAT CELL BIOL, V4, P632, DOI 10.1038/ncb829; Basak SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005884; Bertrand K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/534139; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen KL, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-72; Chen SF, 2007, HISTOPATHOLOGY, V51, P173, DOI 10.1111/j.1365-2559.2007.02755.x; Chen SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031864; Cheng DS, 2000, CHEST, V118, P1747, DOI 10.1378/chest.118.6.1747; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Elloul S, 2010, CLIN EXP METASTAS, V27, P161, DOI 10.1007/s10585-010-9315-2; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Gatenby RA, 2008, NAT REV CANCER, V8, P56, DOI 10.1038/nrc2255; Geiger TR, 2009, BBA-REV CANCER, V1796, P293, DOI 10.1016/j.bbcan.2009.07.006; Guo HS, 2012, ONCOL REP, V27, P880, DOI 10.3892/or.2011.1559; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Hackbarth JS, 2010, CLIN BIOCHEM, V43, P1051, DOI 10.1016/j.clinbiochem.2010.05.016; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Horst D, 2009, J PATHOL, V219, P427, DOI 10.1002/path.2597; Hsu IL, 2009, LUNG CANCER, V65, P371, DOI 10.1016/j.lungcan.2008.12.007; Ishigami S, 2010, ANTICANCER RES, V30, P2453; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Keam B, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2834; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Li F, 2007, CELL RES, V17, P3, DOI 10.1038/sj.cr.7310118; Liotta LA, 2004, NATURE, V430, P973, DOI 10.1038/430973a; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Mancini R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021320; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Moncharmont C, 2012, CANCER LETT, V322, P139, DOI 10.1016/j.canlet.2012.03.024; NAGASAWA T, 1983, ACTA CYTOL, V27, P119; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Park SY, 2007, ARCH PATHOL LAB MED, V131, P1561; Perona R, 2011, CLIN TRANSL ONCOL, V13, P289, DOI 10.1007/s12094-011-0656-3; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; Rafii S, 2002, NAT REV CANCER, V2, P826, DOI 10.1038/nrc925; Rapp UR, 2008, CELL CYCLE, V7, P45, DOI 10.4161/cc.7.1.5203; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Sikora JJ, 2004, CANCER DETECT PREV, V28, P325, DOI 10.1016/j.cdp.2004.04.003; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Thelmo MC, 2010, FETAL PEDIATR PATHOL, V29, P45, DOI 10.3109/15513810903266625; Tiwari N, 2012, SEMIN CANCER BIOL, V22, P194, DOI 10.1016/j.semcancer.2012.02.013; Viale G, 2008, JNCI-J NATL CANCER I, V100, P207, DOI 10.1093/jnci/djm289; Wei L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3042; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476	53	79	85	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e54659	10.1371/journal.pone.0054659	http://dx.doi.org/10.1371/journal.pone.0054659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23861841	Green Published, gold, Green Submitted			2022-12-27	WOS:000319167000001
J	Xu, CB; Li, XM; Zhang, LH				Xu, Chengbin; Li, Xuemei; Zhang, Lihong			The Effect of Calcium Chloride on Growth, Photosynthesis, and Antioxidant Responses of Zoysia japonica under Drought Conditions	PLOS ONE			English	Article							WHEAT TRITICUM-AESTIVUM; PROLINE METABOLISM; OXIDATIVE STRESS; WATER-DEFICIT; SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION; TOLERANCE; ACID; L.; INVOLVEMENT	Few attempts have been made to study the alleviating effects of signal molecules on zoysiagrass (Zoysia japonica) under drought stress. Calcium chloride has been shown to ameliorate the adverse effects of drought stress on many plants. It is necessary to investigate how to enhance drought tolerance of zoysiagrass using calcium chloride. The study elucidated the effects of calcium chloride on zoysiagrass under drought conditions by investigating the following parameters: biomass, chlorophyll (Chl) content, net photosynthetic rate (Pn), chlorophyll fluorescence, antioxidant enzymes, proline content, and malondialdehyde (MDA) content. Experimental conditions consisted of an aqueous CaCl2 solution at 5, 10, and 20 mM sprayed on zoysiagrass leaves for 3 d, following by an inducement of drought conditions by withholding water for 16 d. Under drought conditions, all CaCl2 pretreatments were found to increase the above-ground fresh biomass, as well as below-ground fresh and dry biomass. The resulting Chl (a, b, a +b) contents of the 5 and 10 mM CaCl2 pretreatment groups were higher than those of the control. In the later stages of drought conditions, the chlorophyll fluorescence parameter Fv/Fm was higher in leaves treated with 10 mM CaCl2 than in the leaves of the other two treatment groups. Zoysiagrass pretreated with 10 mM CaCl2 possessed both the maximum observed Pn and antioxidant enzyme activities. Meanwhile, lower MDA and proline contents were recorded in the plants pretreated with 5 and 10 mM CaCl2 under drought conditions. As a whole, the drought tolerance of zoysiagrass was improved to some extent by the application of a moderate calcium concentration.	[Xu, Chengbin; Zhang, Lihong] Liaoning Univ, Sch Environm Sci, Shenyang 110036, Peoples R China; [Li, Xuemei] Shenyang Normal Univ, Coll Chem & Life Sci, Shenyang, Peoples R China	Liaoning University; Shenyang Normal University	Zhang, LH (corresponding author), Liaoning Univ, Sch Environm Sci, Shenyang 110036, Peoples R China.	lihongzhang132@163.com		Roe, Oluf Dimitri/0000-0002-4870-5822	National Nature Science Foundation of China [31070285, 31270369]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by the National Nature Science Foundation of China (31070285, 31270369). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal SB, 2007, ENVIRON EXP BOT, V59, P21, DOI 10.1016/j.envexpbot.2005.09.009; Ahmed M, 2011, AGR WATER MANAGE, V98, P1808, DOI 10.1016/j.agwat.2011.07.003; Antosiewicz DM, 2004, ENVIRON POLLUT, V129, P237, DOI 10.1016/j.envpol.2003.10.025; Arshi A, 2006, ACTA PHYSIOL PLANT, V28, P137, DOI 10.1007/s11738-006-0040-z; Guimaraes FVA, 2011, PLANT GROWTH REGUL, V65, P55, DOI 10.1007/s10725-011-9574-1; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Ben Amor N, 2010, ACTA PHYSIOL PLANT, V32, P453, DOI 10.1007/s11738-009-0420-2; BEYER WF, 1987, ANAL BIOCHEM, V161, P559, DOI 10.1016/0003-2697(87)90489-1; CHANCE B, 1955, METHOD ENZYMOL, V2, P764, DOI 10.1016/S0076-6879(55)02300-8; Cousson A, 2009, BIOL PLANTARUM, V53, P53, DOI 10.1007/s10535-009-0008-0; de Carvalho MHC, 2008, PLANT SIGNAL BEHAV, V3, P156, DOI 10.4161/psb.3.3.5536; Diaz-Espejo A, 2007, PLANT CELL ENVIRON, V30, P922, DOI 10.1111/j.1365-3040.2007.001686.x; Dobra J, 2011, J PLANT PHYSIOL, V168, P1588, DOI 10.1016/j.jplph.2011.02.009; Du HM, 2008, ACTA HORTIC, P207; Fu JM, 2001, ENVIRON EXP BOT, V45, P105, DOI 10.1016/S0098-8472(00)00084-8; Hojati M, 2011, J PLANT PHYSIOL, V168, P782, DOI 10.1016/j.jplph.2010.11.009; Huang B, 1999, PLANT SOIL, V208, P179, DOI 10.1023/A:1004472314631; Ishibashi Y, 2011, J PLANT PHYSIOL, V168, P1562, DOI 10.1016/j.jplph.2011.02.003; Israr M, 2011, J HAZARD MATER, V186, P1520, DOI 10.1016/j.jhazmat.2010.12.021; Issam N, 2012, PLANT GROWTH REGUL, V68, P37, DOI 10.1007/s10725-012-9691-5; Jaleel CA, 2007, COLLOID SURFACE B, V60, P110, DOI 10.1016/j.colsurfb.2007.06.006; Ku HM, 2012, BIOL PLANTARUM, V56, P337, DOI 10.1007/s10535-012-0095-1; Levitt J, 1980, CHILLING FREEZING HI; Liang X, 2009, J HYDROL, V376, P243, DOI 10.1016/j.jhydrol.2009.07.035; Ma QQ, 2006, J PLANT PHYSIOL, V163, P165, DOI 10.1016/j.jplph.2005.04.023; Ma R, 2005, J ARID ENVIRON, V63, P177, DOI 10.1016/j.jaridenv.2005.01.021; Mafakheri A, 2010, AUST J CROP SCI, V4, P580; Maggio A, 2002, PLANT J, V31, P699, DOI 10.1046/j.1365-313X.2002.01389.x; Mao Pei Sheng, 2009, Grassland Science, V55, P1, DOI 10.1111/j.1744-697X.2009.00129.x; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Monclus R, 2006, NEW PHYTOL, V169, P765, DOI 10.1111/j.1469-8137.2005.01630.x; Nayyar H, 2002, BIOL PLANTARUM, V45, P65, DOI 10.1023/A:1015132019686; Shan CJ, 2010, PLANT SCI, V178, P130, DOI 10.1016/j.plantsci.2009.11.002; Shao HB, 2008, CR BIOL, V331, P587, DOI 10.1016/j.crvi.2008.03.012; Sharma P, 2005, PLANT GROWTH REGUL, V46, P209, DOI 10.1007/s10725-005-0002-2; Shoresh M, 2011, FREE RADICAL BIO MED, V51, P1221, DOI 10.1016/j.freeradbiomed.2011.03.036; Siddiqui MH, 2011, PROTOPLASMA, V248, P503, DOI 10.1007/s00709-010-0197-6; Soares-Cordeiro AS, 2009, PHOTOSYNTHETICA, V47, P304, DOI 10.1007/s11099-009-0047-y; Tan W, 2011, J PLANT PHYSIOL, V168, P2063, DOI 10.1016/j.jplph.2011.06.009; Tattini M, 2009, ENVIRON EXP BOT, V65, P72, DOI 10.1016/j.envexpbot.2008.01.005; Upadhyaya H, 2011, PLANT CELL REP, V30, P495, DOI 10.1007/s00299-010-0958-x; Wang KH, 2012, J PLANT PHYSIOL, V169, P492, DOI 10.1016/j.jplph.2011.12.007; Wang Y, 2009, BIOL PLANTARUM, V53, P179, DOI 10.1007/s10535-009-0030-2; Wang Y, 2009, PROG NAT SCI-MATER, V19, P435, DOI 10.1016/j.pnsc.2008.07.016; Willekens H, 1997, EMBO J, V16, P4806, DOI 10.1093/emboj/16.16.4806; Xu X, 2008, TREE PHYSIOL, V28, P1751, DOI 10.1093/treephys/28.11.1751; Zehra A, 2012, S AFR J BOT, V78, P122, DOI 10.1016/j.sajb.2011.05.016; Zhao HJ, 2007, PLANT GROWTH REGUL, V51, P255, DOI 10.1007/s10725-007-9167-1; Zhou B, 2009, BIOL PLANTARUM, V53, P63, DOI 10.1007/s10535-009-0009-z	49	104	116	5	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e68214	10.1371/journal.pone.0068214	http://dx.doi.org/10.1371/journal.pone.0068214			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23936312	Green Submitted, Green Published, gold			2022-12-27	WOS:000321341000145
J	Yang, GK; Maahs, DM; Perkins, BA; Cherney, DZI				Yang, Gary K.; Maahs, David M.; Perkins, Bruce A.; Cherney, David Z. I.			Renal Hyperfiltration and Systemic Blood Pressure in Patients with Uncomplicated Type 1 Diabetes Mellitus	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; HEMODYNAMIC FUNCTION; ENDOTHELIAL FUNCTION; GLOMERULAR HYPERFILTRATION; ARTERIAL STIFFNESS; HYPERGLYCEMIA; INHIBITION; HUMANS; RESPONSES; HYPERTENSION	Background: Patients with type 1 diabetes mellitus (DM) and renal hyperfiltration also exhibit systemic microvascular abnormalities, including endothelial dysfunction. The effect of renal hyperfiltration on systemic blood pressure (BP) is less clear. We therefore measured BP, renal hemodynamic function and circulating renin angiotensin aldosterone system (RAAS) mediators in type 1 DM patients with hyperfiltration (n = 36, DM-H, GFR >= 135 ml/min/1.73 m(2)) or normofiltration (n = 40, DM-N), and 56 healthy controls (HC). Since renal hyperfiltration represents a state of intrarenal RAAS activation, we hypothesized that hyperfiltration would be associated with higher BP and elevated levels of circulating RAAS mediators. Methods: BP, glomerular filtration rate (GFR -inulin), effective renal plasma flow (paraaminohippurate) and circulating RAAS components were measured in DM-H, DM-N and HC during clamped euglycemia (4-6 mmol/L). Studies were repeated in DM-H and DM-N during clamped hyperglycemia (9-11 mmol/L). Results: Baseline GFR was elevated in DM-H vs. DM-N and HC (167 +/- 6 vs. 11562 and 115 +/- 2 ml/min/1.73 m(2), p<0.0001). Baseline systolic BP (SBP, 117 +/- 2 vs. 111 +/- 2 vs. 109 +/- 1, p = 0.004) and heart rate (76 +/- 1 vs. 67 +/- 1 vs. 61 +/- 1, p<0.0001) were higher in DM-H vs. DM-N and HC. Despite higher SBP in DM-H, plasma aldosterone was lower in DM-H vs. DM-N and HC (42 +/- 5 vs. 86 +/- 14 vs. 276 +/- 41 ng/dl, p = 0.01). GFR (p<0.0001) and SBP (p<0.0001) increased during hyperglycemia in DM-N but not in DM-H. Conclusions: DM-H was associated with higher heart rate and SBP values and an exaggerated suppression of systemic aldosterone. Future work should focus on the mechanisms that explain this paradox in diabetes of renal hyperfiltration coupled with systemic RAAS suppression.	[Yang, Gary K.] Univ Toronto, Fac Med, Toronto, ON M5G 1L7, Canada; [Maahs, David M.] Univ Colorado Denver, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA; [Perkins, Bruce A.] Univ Toronto, Toronto Gen Hosp, Div Endocrinol, Dept Med, Toronto, ON M5G 1L7, Canada; [Cherney, David Z. I.] Univ Toronto, Toronto Gen Hosp, Div Nephrol, Dept Med, Toronto, ON M5G 1L7, Canada	University of Toronto; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Cherney, DZI (corresponding author), Univ Toronto, Toronto Gen Hosp, Div Nephrol, Dept Med, Toronto, ON M5G 1L7, Canada.	david.cherney@uhn.on.ca	Perkins, Bruce A/L-3726-2017	Yang, Gary/0000-0002-3039-4392; Maahs, David/0000-0002-4602-7909	Kidney Foundation of Canada; Canadian Diabetes Association-KRESCENT Program; Heart and Stroke Foundation of Canada; Canadian Institutes of Health Research	Kidney Foundation of Canada; Canadian Diabetes Association-KRESCENT Program; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	DC was also supported by a Kidney Foundation of Canada Scholarship and a Canadian Diabetes Association-KRESCENT Program Joint New Investigator Award. Operating funds were provided by the Heart and Stroke Foundation of Canada and the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cherney DZI, 2010, DIABETIC MED, V27, P1358, DOI 10.1111/j.1464-5491.2010.03121.x; Cherney DZI, 2008, DIABETES, V57, P688, DOI 10.2337/db07-1230; Cherney DZI, 2012, DIABETES CARE, V35, P2324, DOI 10.2337/dc12-0773; Cherney DZI, 2012, AM J PHYSIOL-REG I, V303, pR710, DOI 10.1152/ajpregu.00286.2012; Cherney DZI, 2010, NEPHROL DIAL TRANSPL, V25, P4093, DOI 10.1093/ndt/gfq564; Cherney DZI, 2010, DIABETES CARE, V33, P2068, DOI 10.2337/dc10-0767; Cherney DZI, 2010, AM J PHYSIOL-REG I, V299, pR206, DOI 10.1152/ajpregu.00027.2010; Cherney DZI, 2010, DIABETES CARE, V33, P1344, DOI 10.2337/dc09-2340; Cherney DZI, 2010, DIABETES CARE, V33, P361, DOI 10.2337/dc09-1303; Cherney DZI, 2005, KIDNEY INT, V68, P1722, DOI 10.1111/j.1523-1755.2005.00588.x; Chillaron JJ, 2011, J DIABETES COMPLICAT, V25, P232, DOI 10.1016/j.jdiacomp.2011.03.006; Christiansen EH, 1998, EUR HEART J, V19, P1735, DOI 10.1053/euhj.1998.1090; DAVIDSON WD, 1963, J LAB CLIN MED, V62, P351; Ficociello LH, 2009, DIABETES CARE; FLORAS JS, 1993, J HYPERTENS, V11, P647, DOI 10.1097/00004872-199306000-00009; FLORIJN KW, 1994, KIDNEY INT, V46, P252, DOI 10.1038/ki.1994.267; Harrison-Bernard LM, 2009, ADV PHYSIOL EDUC, V33, P270, DOI 10.1152/advan.00049.2009; Hopkins PN, 1996, J HYPERTENS, V14, P199, DOI 10.1097/00004872-199602000-00008; Imano E, 2001, DIABETES RES CLIN PR, V52, P185, DOI 10.1016/S0168-8227(01)00219-4; Jacobsen P, 2003, J INTERN MED, V254, P464, DOI 10.1046/j.1365-2796.2003.01216.x; Jerums G, 2010, DIABETOLOGIA, V53, P2093, DOI 10.1007/s00125-010-1794-9; JUNG K, 1990, NEPHRON, V54, P360, DOI 10.1159/000185900; KALINYAK JE, 1993, J AM SOC NEPHROL, V4, P1337; KIKKAWA R, 1986, RENAL PHYSIOL BIOCH, V9, P187; Magee GM, 2009, DIABETOLOGIA, V52, P691, DOI 10.1007/s00125-009-1268-0; Marcovecchio ML, 2009, DIABETOLOGIA, V52, P1173, DOI 10.1007/s00125-009-1327-6; Miller JA, 1999, J AM SOC NEPHROL, V10, P1778; Miller JA, 1996, CLIN SCI, V90, P189, DOI 10.1042/cs0900189; Miller JA, 2003, DIABETES, V52, P1806, DOI 10.2337/diabetes.52.7.1806; Pecis M, 1997, DIABETES CARE, V20, P1329, DOI 10.2337/diacare.20.8.1329; Price DA, 1999, J AM SOC NEPHROL, V10, P2382; Ritz E, 2007, CURR HYPERTENS REP, V9, P409, DOI 10.1007/s11906-007-0075-6; Rodrigues TD, 2006, DIABETES RES CLIN PR, V74, P135, DOI 10.1016/j.diabres.2006.03.016; ROSENBERG ME, 1994, KIDNEY INT, V45, P403, DOI 10.1038/ki.1994.52; Rosolowsky ET, 2008, DIABETES RES CLIN PR, V82, pS46, DOI 10.1016/j.diabres.2008.09.018; Ruggenenti P, 2012, DIABETES CARE, V35, P2061, DOI 10.2337/dc11-2189; Sasson AN, 2012, WORLD J DIABETES, V3, P1, DOI 10.4239/wjd.v3.i1.1; Sochett EB, 2006, J AM SOC NEPHROL, V17, P1703, DOI 10.1681/ASN.2005080872; SOWERS JR, 1995, HYPERTENSION, V26, P869, DOI 10.1161/01.HYP.26.6.869; Thulesen J, 1999, NEPHRON, V81, P172, DOI 10.1159/000045274; Torbjornsdotter TB, 2004, DIABETES CARE, V27, P510, DOI 10.2337/diacare.27.2.510; Vervoort G, 2005, EUR J CLIN INVEST, V35, P330, DOI 10.1111/j.1365-2362.2005.01497.x; ZATZ R, 1986, J CLIN INVEST, V77, P1925, DOI 10.1172/JCI112521	43	54	54	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68908	10.1371/journal.pone.0068908	http://dx.doi.org/10.1371/journal.pone.0068908			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861950	Green Published, Green Submitted, gold			2022-12-27	WOS:000323350700107
J	Ali, K; Warusevitane, A; Lally, F; Sim, J; Sills, S; Pountain, S; Nevatte, T; Allen, M; Roffe, C				Ali, Khalid; Warusevitane, Anushka; Lally, Frank; Sim, Julius; Sills, Sheila; Pountain, Sarah; Nevatte, Tracy; Allen, Martin; Roffe, Christine			The Stroke Oxygen Pilot Study: A Randomized Controlled Trial of the Effects of Routine Oxygen Supplementation Early after Acute Stroke-Effect on Key Outcomes at Six Months	PLOS ONE			English	Article							VALIDATION; SCALE	Introduction: Post-stroke hypoxia is common, and may adversely affect outcome. We have recently shown that oxygen supplementation may improve early neurological recovery. Here, we report the six-month outcomes of this pilot study. Methods: Patients with a clinical diagnosis of acute stroke were randomized within 24 h of admission to oxygen supplementation at 2 or 3 L/min for 72 h or to control treatment (room air). Outcomes (see below) were assessed by postal questionnaire at 6 months. Analysis was by intention-to-treat, and statistical significance was set at p <= 0.05. Results: Out of 301 patients randomized two refused/withdrew consent and 289 (148 in the oxygen and 141 in the control group) were included in the analysis: males 44%, 51%; mean (SD) age 73 (12), 71 (12); median (IQR) National Institutes of Health Stroke Scale score 6 (3, 10), 5 (3, 10) for the two groups respectively. At six months 22 (15%) patients in the oxygen group and 20 (14%) in the control group had died; mean survival in both groups was 162 days (p = 0.99). Median (IQR) scores for the primary outcome, the modified Rankin Scale, were 3 (1, 5) and 3 (1, 4) for the oxygen and control groups respectively. The covariate-adjusted odds ratio was 1.04 (95% CI 0.67, 1.60), indicating that the odds of a lower (i.e. better) score were non-significantly higher in the oxygen group (p = 0.86). The mean differences in the ability to perform basic (Barthel Index) and extended activities of daily living (NEADL), and quality of life (EuroQol) were also non-significant. Conclusions: None of the key outcomes differed at 6 months between the groups. Although not statistically significant and generally of small magnitude, the effects were predominantly in favour of the oxygen group; a larger trial, powered to show differences in longer-term functional outcomes, is now on-going.	[Ali, Khalid] Acad Dept Geriatr, Brighton, E Sussex, England; [Ali, Khalid] Sussex Med Sch, Brighton, E Sussex, England; [Warusevitane, Anushka; Lally, Frank; Sills, Sheila; Pountain, Sarah; Nevatte, Tracy; Roffe, Christine] North Staffordshire Combined Healthcare Trust, Stoke Stroke Res Grp, Stoke On Trent, Staffs, England; [Lally, Frank; Roffe, Christine] Keele Univ, Inst Sci & Technol Med, Keele, Staffs, England; [Sim, Julius] Keele Univ, Hlth Serv Res Unit, Keele, Staffs, England; [Allen, Martin] Univ Hosp North Staffordshire, Dept Resp Med, Stoke On Trent, Staffs, England	University of Brighton; Keele University; Keele University	Roffe, C (corresponding author), North Staffordshire Combined Healthcare Trust, Stoke Stroke Res Grp, Stoke On Trent, Staffs, England.	christine.roffe@northstaffs.nhs.uk	Roffe, Christine/AAT-5611-2020; Paul, Soumitra/E-5821-2015; Gayen, Dipak/N-8906-2017	Roffe, Christine/0000-0002-5259-6649; Ali, Nusrat/0000-0001-7356-6759; Paul, Soumitra/0000-0001-7560-5512; Datta, Swapan/0000-0003-2961-8915; Gayen, Dipak/0000-0002-4563-0992; SARKAR, SAILENDRA NATH/0000-0002-4059-8612	North Staffordshire Medical Institute; British Geriatrics Society	North Staffordshire Medical Institute; British Geriatrics Society	The authors would like to thank the North Staffordshire Medical Institute for funding the purchase of the pulse oximeters and the British Geriatrics Society for supporting Dr. KM Ali with a Specialist Registrar Research Start Up Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali K, 2006, STROKE, V37, P865, DOI 10.1161/01.STR.0000204053.36966.80; Ali Khalid, 2007, J Stroke Cerebrovasc Dis, V16, P239, DOI 10.1016/j.jstrokecerebrovasdis.2007.07.004; Appelros P, 2004, CEREBROVASC DIS, V17, P21, DOI 10.1159/000073894; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Bravata DM, 2010, ARCH INTERN MED, V170, P804, DOI 10.1001/archinternmed.2010.92; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Cabello JB, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007160.pub2; Collin C, 1988, Int Disabil Stud, V10, P61; Counsell C, 2002, STROKE, V33, P1041, DOI 10.1161/hs0402.105909; Dennis M, 2009, LANCET, V373, P1958, DOI 10.1016/S0140-6736(09)60941-7; Dennis M, 2012, STROKE, V43, P851, DOI 10.1161/STROKEAHA.111.639708; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Ellul J, 1998, AGE AGEING, V27, P115, DOI 10.1093/ageing/27.2.115; Indredavik B, 1999, STROKE, V30, P917, DOI 10.1161/01.STR.30.5.917; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; Lees KR, 2012, STROKE, V43, P1163, DOI 10.1161/STROKEAHA.111.641423; Lewis S, 2008, J NEUROL NEUROSUR PS, V79, P397, DOI 10.1136/jnnp.2007.126045; Nouri F., 1987, CLIN REHABIL, V1, P301, DOI [DOI 10.1177/026921558700100409, 10.1177/026921558700100409]; Nuutinen J, 2006, ACTA NEUROL SCAND, V113, P100, DOI 10.1111/j.1600-0404.2005.00550.x; Robinson TG, 2005, J HYPERTENS, V23, P455; Roffe C, 2003, STROKE, V34, P2641, DOI 10.1161/01.STR.0000095188.65567.4F; Roffe C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019113; Ronning OM, 1999, STROKE, V30, P2033, DOI 10.1161/01.STR.30.10.2033; Rowat AM, 2006, CEREBROVASC DIS, V21, P166, DOI 10.1159/000090528; Sandercock P, 2012, LANCET, V379, P2352, DOI 10.1016/S0140-6736(12)60768-5; Schulz KF, 2011, INT J SURG, V9, P672, DOI 10.1016/j.ijsu.2011.09.004; Silva Y, 2005, CEREBROVASC DIS, V19, P23, DOI 10.1159/000081908; Singhal AB, 2005, STROKE, V36, P797, DOI 10.1161/01.STR.0000158914.66827.2e; Sulter G, 2000, J NEUROL SCI, V179, P65, DOI 10.1016/S0022-510X(00)00378-6; TEASDALE G, 1978, J NEUROL NEUROSUR PS, V41, P603, DOI 10.1136/jnnp.41.7.603; THORVALDSEN P, 1995, STROKE, V26, P361, DOI 10.1161/01.STR.26.3.361; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wright CC, 2003, J CLIN EPIDEMIOL, V56, P833, DOI 10.1016/S0895-4356(03)00155-0; Young FB, 2005, STROKE, V36, P2187, DOI 10.1161/01.STR.0000181089.41324.70	35	77	81	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e59274	10.1371/journal.pone.0059274	http://dx.doi.org/10.1371/journal.pone.0059274			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23844166	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000319872300001
J	Xu, C; Wang, CS; Sun, XY; Zhang, R; Gleason, ML; Eiji, T; Sun, GY				Xu, Chao; Wang, Chunsheng; Sun, Xinyao; Zhang, Rong; Gleason, Mark L.; Eiji, Tanaka; Sun, Guangyu			Multiple Group I Introns in the Small-Subunit rDNA of Botryosphaeria dothidea: Implication for Intraspecific Genetic Diversity	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; SCYTALIDIUM-DIMIDIATUM; TERTIARY INTERACTIONS; POPULATION-STRUCTURE; SECONDARY; PISTACHIO; REPRESENTATION; PATHOGENICITY; HYALINUM; BINDING	Botryosphaeria dothidea is a widespread and economically important pathogen on various fruit trees, and it often causes die-back and canker on limbs and fruit rot. In characterizing intraspecies genetic variation within this fungus, group I introns, rich in rDNA of fungi, may provide a productive region for exploration. In this research, we analysed complete small subunit (SSU) ribosomal DNA (rDNA) sequences of 37 B. dothidea strains, and found four insertions, designated Bdo.S943, Bdo.S1199-A, Bdo.S1199-B and Bdo.S1506, at three positions. Sequence analysis and structure prediction revealed that both Bdo.S943 and Bdo.S1506 belonged to subgroup IC1 of group I introns, whereas Bdo.S1199-A and Bdo.S1199-B corresponded to group IE introns. Moreover, Bdo.S1199-A was found to host an open reading frame (ORF) for encoding the homing endonuclease (HE), whereas Bdo.S1199-B, an evolutionary descendant of Bdo.S1199-A, included a degenerate HE. The above four introns were novel, and were the first group I introns observed and characterized in this species. Differential distribution of these introns revealed that all strains could be separated into four genotypes. Genotype III (no intron) and genotype IV (Bdo.S1199-B) were each found in only one strain, whereas genotype I (Bdo.S1199-A) and genotype II (Bdo.S943 and Bdo.S1506) occurred in 95% of the strains. There is a correlation between B. dothidea genotypes and hosts or geographic locations. Thus, these newly discovered group I introns can help to advance understanding of genetic differentiation within B. dothidea.	[Xu, Chao; Wang, Chunsheng; Sun, Xinyao; Zhang, Rong; Sun, Guangyu] Northwest A&F Univ, Coll Plant Protect, Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Gleason, Mark L.] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA USA; [Eiji, Tanaka] Ishikawa Prefectural Univ, Nonoichi, Ishikawa, Japan	Northwest A&F University - China; Iowa State University; Ishikawa Prefecture University	Sun, GY (corresponding author), Northwest A&F Univ, Coll Plant Protect, Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	sgy@nwsuaf.edu.cn	Zhang, Xinyu/S-4946-2016	Zhang, Xinyu/0000-0001-8154-9334; CAI, LEI/0000-0002-8131-7274; chao, xu/0000-0002-6398-4129; Tanaka, Eiji/0000-0003-4752-8825	National Natural Science Foundation of China [31170015, 31171797]; 111 Project from Education Ministry of China [B07049]; Top Talent Project of Northwest AF University; earmarked fund for Modern Agro-industry Technology Research System [nycytx-08-04-04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project from Education Ministry of China(Ministry of Education, China - 111 Project); Top Talent Project of Northwest AF University; earmarked fund for Modern Agro-industry Technology Research System	This work was supported by National Natural Science Foundation of China (31170015, 31171797), the 111 Project from Education Ministry of China (B07049), Top Talent Project of Northwest A&F University and the earmarked fund for Modern Agro-industry Technology Research System (nycytx-08-04-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr ME, 1972, PRELIMINARY STUDIES, P525; Belfort M, 1995, J BIOL CHEM, V270, P30237, DOI 10.1074/jbc.270.51.30237; BURKE JM, 1987, NUCLEIC ACIDS RES, V15, P7217, DOI 10.1093/nar/15.18.7217; CECH TR, 1988, GENE, V73, P259, DOI 10.1016/0378-1119(88)90492-1; CECH TR, 1994, NAT STRUCT BIOL, V1, P273, DOI 10.1038/nsb0594-273; CECH TR, 1990, ANNU REV BIOCHEM, V59, P543, DOI 10.1146/annurev.bi.59.070190.002551; Cech TR, 2002, BIOCHEM SOC T, V30, P1162, DOI 10.1042/BST0301162; Choi IY, 2011, PLANT DIS, V95, P227, DOI 10.1094/PDIS-05-10-0371; De Rijk P, 2003, BIOINFORMATICS, V19, P299, DOI 10.1093/bioinformatics/19.2.299; Flick KE, 1998, NATURE, V394, P96, DOI 10.1038/27952; Goddard MR, 1999, P NATL ACAD SCI USA, V96, P13880, DOI 10.1073/pnas.96.24.13880; Hall TA., NUCL ACIDS S SER OXF, V41, P95; Haugen P, 2005, TRENDS GENET, V21, P111, DOI 10.1016/j.tig.2004.12.007; Haugen P, 2004, MOL BIOL EVOL, V21, P129, DOI 10.1093/molbev/msh005; Haugen P, 2002, EUR J BIOCHEM, V269, P1641, DOI 10.1046/j.1432-1327.2002.02802.x; Jurica MS, 1999, CELL MOL LIFE SCI, V55, P1304, DOI 10.1007/s000180050372; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lehnert V, 1996, CHEM BIOL, V3, P993, DOI 10.1016/S1074-5521(96)90166-0; Li ZJ, 2005, NUCLEIC ACIDS RES, V33, P2118, DOI 10.1093/nar/gki517; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Ma ZH, 2004, PHYTOPATHOLOGY, V94, P326, DOI 10.1094/PHYTO.2004.94.4.326; Ma ZH, 2002, PHYTOPATHOLOGY, V92, P519, DOI 10.1094/PHYTO.2002.92.5.519; Ma ZH, 2001, PHYTOPATHOLOGY, V91, P665, DOI 10.1094/PHYTO.2001.91.7.665; Machouart M, 2004, FEMS MICROBIOL LETT, V238, P455, DOI 10.1016/j.femsle.2004.08.011; Machouart M, 2011, FUNGAL BIOL-UK, V115, P1038, DOI 10.1016/j.funbio.2011.05.002; Machouart-Dubach M, 2002, FEMS MICROBIOL LETT, V208, P187, DOI 10.1111/j.1574-6968.2002.tb11080.x; MICHAILIDES TJ, 1991, PHYTOPATHOLOGY, V81, P566, DOI 10.1094/Phyto-81-566; MICHEL F, 1989, NATURE, V342, P391, DOI 10.1038/342391a0; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; Muller KM, 2001, MOL BIOL EVOL, V18, P1654, DOI 10.1093/oxfordjournals.molbev.a003954; Nikoh N, 2001, MOL BIOL EVOL, V18, P1631, DOI 10.1093/oxfordjournals.molbev.a003952; Slippers B, 2004, MYCOLOGIA, V96, P83, DOI 10.2307/3761991; Suh SO, 1999, J MOL EVOL, V48, P493, DOI 10.1007/PL00006493; Takizawa K, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-94; Tang W, 2012, PLANT DIS, V96, P486, DOI 10.1094/PDIS-08-11-0635; Taylor A, 2005, AUSTRALAS PLANT PATH, V34, P187, DOI 10.1071/AP05018; WEAVER DJ, 1974, PHYTOPATHOLOGY, V64, P1429, DOI 10.1094/Phyto-64-1429; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Zhang Y, 2000, RNA, V6, P937, DOI 10.1017/S1355838200991726; Zhang Y, 2009, FEBS LETT, V583; Zhou Z, 2011, SCI AGR SINICA, V6, P009; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	42	28	31	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67808	10.1371/journal.pone.0067808	http://dx.doi.org/10.1371/journal.pone.0067808			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	24098811	Green Submitted, Green Published, gold			2022-12-27	WOS:000321341000101
J	Chen, SY; Huang, X; Yan, XQ; Liang, Y; Wang, YZ; Li, XF; Peng, XJ; Ma, XY; Zhang, LX; Cai, YY; Ma, T; Cheng, LQ; Qi, DM; Zheng, HJ; Yang, XH; Li, XX; Liu, GS				Chen, Shuangyan; Huang, Xin; Yan, Xueqing; Liang, Ye; Wang, Yuezhu; Li, Xiaofeng; Peng, Xianjun; Ma, Xingyong; Zhang, Lexin; Cai, Yueyue; Ma, Tian; Cheng, Liqin; Qi, Dongmei; Zheng, Huajun; Yang, Xiaohan; Li, Xiaoxia; Liu, Gongshe			Transcriptome Analysis in Sheepgrass (Leymus chinensis): A Dominant Perennial Grass of the Eurasian Steppe	PLOS ONE			English	Article							FREEZING TOLERANCE; SSR-MARKERS; ARABIDOPSIS-THALIANA; COLD-ACCLIMATION; MICROSATELLITE MARKERS; PHYLOGENETIC ANALYSIS; GENOME ANNOTATION; GENE DISCOVERY; SALT TOLERANCE; TRITICEAE	Background: Sheepgrass [Leymus chinensis (Trin.) Tzvel.] is an important perennial forage grass across the Eurasian Steppe and is known for its adaptability to various environmental conditions. However, insufficient data resources in public databases for sheepgrass limited our understanding of the mechanism of environmental adaptations, gene discovery and molecular marker development. Results: The transcriptome of sheepgrass was sequenced using Roche 454 pyrosequencing technology. We assembled 952,328 high-quality reads into 87,214 unigenes, including 32,416 contigs and 54,798 singletons. There were 15,450 contigs over 500 bp in length. BLAST searches of our database against Swiss-Prot and NCBI non-redundant protein sequences (nr) databases resulted in the annotation of 54,584 (62.6%) of the unigenes. Gene Ontology (GO) analysis assigned 89,129 GO term annotations for 17,463 unigenes. We identified 11,675 core Poaceae-specific and 12,811 putative sheepgrass-specific unigenes by BLAST searches against all plant genome and transcriptome databases. A total of 2,979 specific freezing-responsive unigenes were found from this RNAseq dataset. We identified 3,818 EST-SSRs in 3,597 unigenes, and some SSRs contained unigenes that were also candidates for freezing-response genes. Characterizations of nucleotide repeats and dominant motifs of SSRs in sheepgrass were also performed. Similarity and phylogenetic analysis indicated that sheepgrass is closely related to barley and wheat. Conclusions: This research has greatly enriched sheepgrass transcriptome resources. The identified stress-related genes will help us to decipher the genetic basis of the environmental and ecological adaptations of this species and will be used to improve wheat and barley crops through hybridization or genetic transformation. The EST-SSRs reported here will be a valuable resource for future gene-phenotype studies and for the molecular breeding of sheepgrass and other Poaceae species.	[Chen, Shuangyan; Huang, Xin; Yan, Xueqing; Liang, Ye; Li, Xiaofeng; Peng, Xianjun; Ma, Xingyong; Zhang, Lexin; Cai, Yueyue; Ma, Tian; Cheng, Liqin; Qi, Dongmei; Li, Xiaoxia; Liu, Gongshe] Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing, Peoples R China; [Huang, Xin; Yan, Xueqing; Liang, Ye; Ma, Xingyong; Zhang, Lexin; Cai, Yueyue; Li, Xiaoxia] Chinese Acad Sci, Grad Schoo1, Beijing, Peoples R China; [Wang, Yuezhu; Zheng, Huajun] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China; [Yang, Xiaohan] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; United States Department of Energy (DOE); Oak Ridge National Laboratory	Chen, SY (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing, Peoples R China.	sychen@ibcas.ac.cn; lixx258258@163.com; liugs@ibcas.ac.cn	Yang, Xiaohan/AAM-2449-2020; Yang, Xiaohan/A-6975-2011	Yang, Xiaohan/0000-0001-5207-4210; Yang, Xiaohan/0000-0001-5207-4210	National High Technology Research and Development Program of China ("863") [2011AA100209]; National Natural Science Foundation of China [30970291, 31170316]; Key Project of the Chinese Academy of Sciences [KSCX2-EW-J-1]; Project of Ningxia Agricultural Comprehensive Development Office [NNTK-11-04, NTKJ-2012-03]	National High Technology Research and Development Program of China ("863")(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of the Chinese Academy of Sciences(Chinese Academy of Sciences); Project of Ningxia Agricultural Comprehensive Development Office	This work was supported by the National High Technology Research and Development Program of China ("863", 2011AA100209), the National Natural Science Foundation of China (30970291; 31170316), the Key Project of the Chinese Academy of Sciences (KSCX2-EW-J-1), and the Project of Ningxia Agricultural Comprehensive Development Office (NNTK-11-04; NTKJ-2012-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2006, J BIOL CHEM, V281, P37636, DOI 10.1074/jbc.M605895200; Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; Bai WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012125; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-51; Bossolini E, 2007, PLANT J, V49, P704, DOI 10.1111/j.1365-313X.2006.02991.x; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Bushman BS, 2008, GENOME, V51, P779, DOI 10.1139/G08-062; Chalupska D, 2008, P NATL ACAD SCI USA, V105, P9691, DOI 10.1073/pnas.0803981105; Chen PD, 2005, THEOR APPL GENET, V111, P941, DOI 10.1007/s00122-005-0026-z; Chen ZZ, 2005, PROG BIOCHEM BIOPHYS, V32, P187; Cheung F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-272; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Chinnusamy V, 2010, METHODS MOL BIOL, V639, P39, DOI 10.1007/978-1-60761-702-0_3; Cho YG, 2000, THEOR APPL GENET, V100, P713, DOI 10.1007/s001220051343; Cordeiro GM, 2001, PLANT SCI, V160, P1115, DOI 10.1016/S0168-9452(01)00365-X; da Maia LC, 2009, GENET MOL BIOL, V32, P822, DOI 10.1590/S1415-47572009005000091; Der JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-99; Deschamps S, 2010, PLANT GENOME-US, V3, P53, DOI 10.3835/plantgenome2009.09.0026; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Fan X, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-247; Fursova OV, 2009, GENE, V429, P98, DOI 10.1016/j.gene.2008.10.016; Garg R, 2011, PLANT PHYSIOL, V156, P1661, DOI 10.1104/pp.111.178616; Gupta PK, 2003, MOL GENET GENOMICS, V270, P315, DOI 10.1007/s00438-003-0921-4; He RF, 2012, AM J BOT, V99, P232, DOI 10.3732/ajb.1100429; Hiremath PJ, 2011, PLANT BIOTECHNOL J, V9, P922, DOI 10.1111/j.1467-7652.2011.00625.x; [马红媛 Hongyuan Ma], 2007, [植物学通报, Chinese Bulletin of Botany], V24, P181; JIANG JM, 1994, EUPHYTICA, V73, P199, DOI 10.1007/BF00036700; Jin H, 2006, PLANT SCI, V170, P1081, DOI 10.1016/j.plantsci.2006.01.002; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; La Rota M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-23; Lee H, 2002, EMBO J, V21, P2692, DOI 10.1093/emboj/21.11.2692; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Liu X, 2001, ACTA BOT SIN, V43, P948; Liu ZP, 2008, MOL PHYLOGENET EVOL, V46, P278, DOI 10.1016/j.ympev.2007.10.009; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Ma PD, 2012, APPL BIOCHEM BIOTECH, V166, P479, DOI 10.1007/s12010-011-9443-4; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Maruyama K, 2004, PLANT J, V38, P982, DOI 10.1111/j.1365-313X.2004.02100.x; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Moellering ER, 2010, SCIENCE, V330, P226, DOI 10.1126/science.1191803; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Niu SL, 2008, J EXP BOT, V59, P1431, DOI 10.1093/jxb/ern051; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Novillo F, 2007, P NATL ACAD SCI USA, V104, P21002, DOI 10.1073/pnas.0705639105; Palmer NA, 2012, BIOENERG RES, V5, P649, DOI 10.1007/s12155-011-9171-1; Peng XJ, 2011, PLANT CELL REP, V30, P1493, DOI 10.1007/s00299-011-1058-2; Qi LL, 2008, THEOR APPL GENET, V117, P1155, DOI 10.1007/s00122-008-0853-9; Reyes JC, 2006, CURR OPIN PLANT BIOL, V9, P21, DOI 10.1016/j.pbi.2005.11.010; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sha LN, 2008, BIOCHEM GENET, V46, P605, DOI 10.1007/s10528-008-9175-5; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Skinner JS, 2005, PLANT MOL BIOL, V59, P533, DOI 10.1007/s11103-005-2498-2; Subbarao GV, 2007, PLANT SOIL, V299, P55, DOI 10.1007/s11104-007-9360-z; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Sun YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053632; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Troncoso-Ponce MA, 2011, PLANT J, V68, P1014, DOI 10.1111/j.1365-313X.2011.04751.x; Vannini C, 2004, PLANT J, V37, P115, DOI 10.1046/j.1365-313X.2003.01938.x; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Victoria FC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-15; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Vogel JP, 2006, THEOR APPL GENET, V113, P186, DOI 10.1007/s00122-006-0285-3; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; Wang LJ, 2009, BIOTECHNOL LETT, V31, P313, DOI 10.1007/s10529-008-9864-5; Wang RZ, 2008, J PLANT GROWTH REGUL, V27, P39, DOI 10.1007/s00344-007-9029-0; WANG RRC, 1994, GENOME, V37, P231, DOI 10.1139/g94-032; Wang W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-465; Wang YX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034225, 10.1371/journal.pone.0039525, 10.1371/journal.pone.0037152]; Wang YH, 2007, CLIMATIC CHANGE, V82, P437, DOI 10.1007/s10584-006-9145-z; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; Wood CC, 2006, P NATL ACAD SCI USA, V103, P14631, DOI 10.1073/pnas.0606385103; Xin ZG, 2007, PLANT J, V49, P786, DOI 10.1111/j.1365-313X.2006.02994.x; Xiong LM, 2002, P NATL ACAD SCI USA, V99, P10899, DOI 10.1073/pnas.162111599; Xu ZZ, 2006, PLANTA, V224, P1080, DOI 10.1007/s00425-006-0281-5; Xu ZZ, 2009, J EXP BOT, V60, P3737, DOI 10.1093/jxb/erp216; Young ET, 2000, GENETICS, V154, P1053; ZHANG HB, 1991, AM J BOT, V78, P871, DOI 10.2307/2445166; Zhang L, 2010, J ENVIRON QUAL, V39, P251, DOI 10.2134/jeq2009.0109; Zhang WD, 2004, GRASS FORAGE SCI, V59, P180, DOI 10.1111/j.1365-2494.2004.00419.x; Zhou Q, 2008, J GENET GENOMICS, V35, P639, DOI 10.1016/S1673-8527(08)60085-5; Zhu JH, 2005, P NATL ACAD SCI USA, V102, P9966, DOI 10.1073/pnas.0503960102; Zhu J, 2008, P NATL ACAD SCI USA, V105, P4945, DOI 10.1073/pnas.0801029105	88	79	85	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67974	10.1371/journal.pone.0067974	http://dx.doi.org/10.1371/journal.pone.0067974			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861841	gold, Green Published, Green Submitted			2022-12-27	WOS:000323350700067
J	Chan, CM; Chang, HH; Wang, VC; Huang, CL; Hung, CF				Chan, Chi-Ming; Chang, Hsun-Hsien; Wang, Vin-Chi; Huang, Chuen-Lin; Hung, Chi-Feng			Inhibitory Effects of Resveratrol on PDGF-BB-Induced Retinal Pigment Epithelial Cell Migration via PDGFR beta, PI3K/Akt and MAPK pathways	PLOS ONE			English	Article							EXPERIMENTAL PROLIFERATIVE VITREORETINOPATHY; EXTRACELLULAR-MATRIX PROTEINS; VASCULAR SMOOTH-MUSCLE; GROWTH-FACTOR RECEPTOR; BREAST-CANCER CELLS; IN-VIVO; (-)-EPIGALLOCATECHIN GALLATE; DIABETIC-RETINOPATHY; ADJUNCTIVE TREATMENT; ARPE19 CELLS	Purpose: In diseases such as proliferative vitreoretinopathy (PVR), proliferative diabetic retinopathy, and age-related macular degeneration, retinal pigment epithelial (RPE) cells proliferate and migrate. Moreover, platelet-derived growth factor (PDGF) has been shown to enhance proliferation and migration of RPE cells in PVR. Even resveratrol can suppress the migration and adhesion of many cell types, its effects on RPE cell migration and adhesion remain unknown. In this study, we investigated the inhibitory effects of resveratrol on RPE cell migration induced by PDGF-BB, an isoform of PDGF, and adhesion to fibronectin, a major ECM component of PVR tissue. Methods: The migration of RPE cells was assessed by an electric cell-substrate impedance sensing migration assay and a Transwell migration assay. A cell viability assay was used to determine the viability of resveratrol treated-cells. The cell adhesion to fibronectin was examined by an adhesion assay. The interactions of resveratrol with PDGF-BB were analyzed by a dot binding assay. The PDGF-BB-induced signaling pathways were determined by western blotting and scratch wound healing assay. Results: Resveratrol inhibited PDGF-BB-induced RPE cell migration in a dose-dependent manner, but showed no effects on ARPE19 cell adhesion to fibronectin. The cell viability assay showed no cytotoxicity of resveratrol on RPE cells and the dot binding assay revealed no direct interactions of resveratrol with PDGF-BB. Inhibitory effects of resveratrol on PDGF-BB-induced platelet-derived growth factor receptor beta (PDGFR beta) and tyrosine phosphorylation and the underlying pathways of PI3K/Akt, ERK and p38 activation were found; however, resveratrol and PDGF-BB showed no effects on PDGFR alpha and JNK activation. Scratch wound healing assay demonstrated resveratrol and the specific inhibitors of PDGFR, PI3K, MEK or p38 suppressed PDGF-BB-induced cell migration. Conclusions: These results indicate that resveratrol is an effective inhibitor of PDGF-BB-induced RPE cell migration via PDGFRb, PI3K/Akt and MAPK pathways, but has no effects on the RPE cell adhesion to fibronectin.	[Chan, Chi-Ming] Cardinal Tien Hosp, Dept Ophthalmol, New Taipei City, Taiwan; [Chan, Chi-Ming; Wang, Vin-Chi; Hung, Chi-Feng] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Chang, Hsun-Hsien; Hung, Chi-Feng] Harvard Univ, Childrens Hosp Informat Program, Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol,Med Sch, Boston, MA USA; [Wang, Vin-Chi] Cardinal Tien Hosp, Neurol Ctr, New Taipei City, Taiwan; [Huang, Chuen-Lin] Cardinal Tien Hosp, Med Res Ctr, New Taipei City, Taiwan; [Huang, Chuen-Lin] Natl Def Med Ctr, Dept Physiol & Biophys, Grad Inst Physiol, Taipei, Taiwan	Cardinal Tien Hospital; Fu Jen Catholic University; Harvard University; Boston Children's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT); Broad Institute; Cardinal Tien Hospital; Cardinal Tien Hospital; National Defense Medical Center	Hung, CF (corresponding author), Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan.	054317@gmail.com	Hung, Chi-Feng/AAL-4977-2021; Chan, Chi-Ming/GWZ-3612-2022	Hung, Chi-Feng/0000-0003-3478-5451; Troughton, Richard/0000-0001-7484-4036	National Science Council, Taipei, Taiwan [NSC97-2320-B-030-001-MY3]; Cardinal Tien Hospital, Taipei, Taiwan [FU10008]	National Science Council, Taipei, Taiwan(Ministry of Science and Technology, Taiwan); Cardinal Tien Hospital, Taipei, Taiwan	This work was supported by the research grants from the National Science Council (NSC97-2320-B-030-001-MY3) and from Cardinal Tien Hospital (FU10008), Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Akiyama H, 2006, J CELL PHYSIOL, V207, P407, DOI 10.1002/jcp.20583; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Bai Y, 2010, CANCER SCI, V101, P488, DOI 10.1111/j.1349-7006.2009.01415.x; Betsholtz C, 2001, BIOESSAYS, V23, P494, DOI 10.1002/bies.1069; Brown VA, 2010, CANCER RES, V70, P9003, DOI 10.1158/0008-5472.CAN-10-2364; Campochiaro PA, 1997, ARCH OPHTHALMOL-CHIC, V115, P237, DOI 10.1001/archopht.1997.01100150239014; CAMPOCHIARO PA, 1994, J CELL SCI, V107, P2459; Cao LM, 2010, INVEST OPHTH VIS SCI, V51, P6658, DOI 10.1167/iovs.10-5524; Cardillo JA, 1997, OPHTHALMOLOGY, V104, P1166, DOI 10.1016/S0161-6420(97)30167-5; Chan CM, 2010, MOL VIS, V16, P586; Chan CM, 2009, BIOCHEM BIOPH RES CO, V388, P172, DOI 10.1016/j.bbrc.2009.07.155; Chan CM, 2008, MOL VIS, V14, P2528; CHARTERIS DG, 1995, BRIT J OPHTHALMOL, V79, P953, DOI 10.1136/bjo.79.10.953; Charteris DG, 2002, EYE, V16, P369, DOI 10.1038/sj.eye.6700194; Chen QH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015288; Cicha I, 2011, J ATHEROSCLER THROMB, V18, P1031, DOI 10.5551/jat.8136; Csiszar A, 2011, ANN NY ACAD SCI, V1215, P117, DOI 10.1111/j.1749-6632.2010.05848.x; de Silva DJ, 2008, BRIT J OPHTHALMOL, V92, P954, DOI 10.1136/bjo.2007.131540; Frombaum M, 2012, BIOCHIMIE, V94, P269, DOI 10.1016/j.biochi.2011.11.001; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; HAMILTON CW, 1982, AM J OPHTHALMOL, V94, P473, DOI 10.1016/0002-9394(82)90241-0; Haugland HK, 1997, ANTICANCER RES, V17, P1035; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hinton DR, 1998, EXP CELL RES, V239, P11, DOI 10.1006/excr.1997.3873; HISCOTT P, 1994, BRIT J OPHTHALMOL, V78, P219, DOI 10.1136/bjo.78.3.219; Ho J, 2011, OPHTHALMOLOGY, V118, P687, DOI 10.1016/j.ophtha.2010.08.010; Hughes AD, 1996, GEN PHARMACOL-VASC S, V27, P1079, DOI 10.1016/S0306-3623(96)00060-2; Ikuno Y, 2000, INVEST OPHTH VIS SCI, V41, P3107; Ikuno Y, 2002, INVEST OPHTH VIS SCI, V43, P2406; Kim Dong Shoo, 2007, Nutr Res Pract, V1, P285, DOI 10.4162/nrp.2007.1.4.285; Kiselev KV, 2011, APPL MICROBIOL BIOT, V90, P417, DOI 10.1007/s00253-011-3184-8; LEAVESLEY DI, 1993, J CELL BIOL, V121, P163, DOI 10.1083/jcb.121.1.163; Lee MF, 2011, J AGR FOOD CHEM, V59, P11853, DOI 10.1021/jf202426k; Lei HT, 2011, INVEST OPHTH VIS SCI, V52, P5016, DOI 10.1167/iovs.11-7442; Lei HT, 2010, EXP EYE RES, V90, P376, DOI 10.1016/j.exer.2009.11.003; Li XR, 2003, CYTOKINE GROWTH F R, V14, P91, DOI 10.1016/S1359-6101(02)00090-4; Lubbers J, 2011, CELL BIOL TOXICOL, V27, P95, DOI 10.1007/s10565-010-9173-3; Marques FZ, 2009, INT J BIOCHEM CELL B, V41, P2125, DOI 10.1016/j.biocel.2009.06.003; Mori K, 2002, INVEST OPHTH VIS SCI, V43, P2001; Ong ET, 2011, TOXICOL APPL PHARM, V256, P198, DOI 10.1016/j.taap.2011.08.013; Pastor JC, 2002, PROG RETIN EYE RES, V21, P127, DOI 10.1016/S1350-9462(01)00023-4; Pastor JC, 1998, SURV OPHTHALMOL, V43, P3, DOI 10.1016/S0039-6257(98)00023-X; Patel KR, 2010, CANCER RES, V70, P7392, DOI 10.1158/0008-5472.CAN-10-2027; Penumathsa SV, 2009, CAN J PHYSIOL PHARM, V87, P275, DOI 10.1139/Y09-013; Petrovski G, 2011, ANN NY ACAD SCI, V1215, P22, DOI 10.1111/j.1749-6632.2010.05843.x; Powell RJ, 1996, J VASC SURG, V24, P51, DOI 10.1016/S0741-5214(96)70144-1; Praidou A, 2009, CURR EYE RES, V34, P152, DOI 10.1080/02713680802585920; ROBBINS SG, 1994, INVEST OPHTH VIS SCI, V35, P3649; Rosenkranz S, 1999, GROWTH FACTORS, V16, P201, DOI 10.3109/08977199909002130; Saishin Y, 2003, INVEST OPHTH VIS SCI, V44, P3656, DOI 10.1167/iovs.02-1143; SCHEIFFARTH OF, 1988, GRAEF ARCH CLIN EXP, V226, P357, DOI 10.1007/BF02172967; Seo MS, 2000, AM J PATHOL, V157, P995, DOI 10.1016/S0002-9440(10)64612-3; SmithThomas L, 1996, CURR EYE RES, V15, P739, DOI 10.3109/02713689609003457; Suzuki Y, 2011, JPN J OPHTHALMOL, V55, P256, DOI 10.1007/s10384-011-0004-8; Szekeres T, 2011, ANN NY ACAD SCI, V1215, P89, DOI 10.1111/j.1749-6632.2010.05864.x; Tang FY, 2008, MOL NUTR FOOD RES, V52, P683, DOI 10.1002/mnfr.200700325; Venkatesan B, 2009, AM J PHYSIOL-HEART C, V297, pH874, DOI 10.1152/ajpheart.00311.2009; VINORES SA, 1995, EXP EYE RES, V60, P607, DOI 10.1016/S0014-4835(05)80003-X; WAGNER M, 1995, CURR EYE RES, V14, P373, DOI 10.3109/02713689508999935; WALTMAN SR, 1978, DIABETES, V27, P85, DOI 10.2337/diabetes.27.2.85; Wang KT, 2011, J AGR FOOD CHEM, V59, P3649, DOI 10.1021/jf104718g; Xianfeng-Huang, 2011, ANTI-CANCER AGENT ME, V11, P479; Yu W, 2012, J CELL BIOCHEM, V113, P752, DOI 10.1002/jcb.23431; Zheng YP, 2003, JPN J OPHTHALMOL, V47, P158, DOI 10.1016/S0021-5155(02)00698-6	64	70	78	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56819	10.1371/journal.pone.0056819	http://dx.doi.org/10.1371/journal.pone.0056819			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457620	Green Published, Green Submitted, gold			2022-12-27	WOS:000315602700096
J	Geraldi, NR; Macreadie, PI				Geraldi, Nathan R.; Macreadie, Peter I.			Restricting Prey Dispersal Can Overestimate the Importance of Predation in Trophic Cascades	PLOS ONE			English	Article							MEDIATED INDIRECT INTERACTIONS; FOOD-WEB; ECOSYSTEM FUNCTION; FIELD EVIDENCE; OYSTER REEFS; BEHAVIOR; ECOLOGY; DENSITY; DRIFT; FISH	Predators can affect prey populations and, via trophic cascades, predators can indirectly impact resource populations (2 trophic levels below the predator) through consumption of prey (density-mediated indirect effects; DMIEs) and by inducing predator-avoidance behavior in prey (trait-mediated indirect effects; TMIEs). Prey often employ multiple predator-avoidance behaviors, such as dispersal or reduced foraging activity, but estimates of TMIEs are usually on individual behaviors. We assessed direct and indirect predator effects in a mesocosm experiment using a marine food chain consisting of a predator (toadfish - Opsanus tau), prey (mud crab - Panopeus herbstii) and resource (ribbed mussel - Geukensia demissa). We measured dispersal and foraging activity of prey separately by manipulating both the presence and absence of the predator, and whether prey could or could not disperse into a predator-free area. Consumption of prey was 9 times greater when prey could not disperse, probably because mesocosm boundaries increased predator capture success. Although predator presence did not significantly affect the number of crabs that emigrated, the presence of a predator decreased resource consumption by prey, which resulted in fewer resources consumed for each prey that emigrated in the presence of a predator, and reduced the overall TMIE. When prey were unable to disperse, TMIEs on mussel survival were 3 times higher than the DMIEs. When prey were allowed to disperse, the TMIEs on resource survival increased to 11-times the DMIEs. We found that restricting the ability of prey to disperse, or focusing on only one predator-avoidance behavior, may be underestimating TMIEs. Our results indicate that the relative contribution of behavior and consumption in food chain dynamics will depend on which predator-avoidance behaviors are allowed to occur and measured.	[Geraldi, Nathan R.] Univ N Carolina, Inst Marine Sci, Morehead City, NC 28557 USA; [Macreadie, Peter I.] Univ Technol Sydney, Sch Environm, Sydney, NSW 2007, Australia	University of North Carolina; University of North Carolina Chapel Hill; University of Technology Sydney	Macreadie, PI (corresponding author), Univ Technol Sydney, Sch Environm, Sydney, NSW 2007, Australia.	geraldi@email.unc.edu	Geraldi, Nathan/AAA-3645-2020	Geraldi, Nathan/0000-0002-2669-3867	North Carolina Coastal Recreational Fishing License Grant; National Estuary Research Reserve Fellowship; Cooperative Insitute for Coastal and Esturine Environnmetal Technology; NOAA Ecological Effects of Sea Level Rise Program; American Australian Association; UTS International Researcher Development Grant	North Carolina Coastal Recreational Fishing License Grant; National Estuary Research Reserve Fellowship; Cooperative Insitute for Coastal and Esturine Environnmetal Technology; NOAA Ecological Effects of Sea Level Rise Program; American Australian Association; UTS International Researcher Development Grant	Funding was provided by a North Carolina Coastal Recreational Fishing License Grant, National Estuary Research Reserve Fellowship, Cooperative Insitute for Coastal and Esturine Environnmetal Technology, NOAA Ecological Effects of Sea Level Rise Program, the American Australian Association, and a UTS International Researcher Development Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2008, EVOL ECOL RES, V10, P333; Abrams PA, 2007, ECOLOGY, V88, P2555, DOI 10.1890/06-1381.1; Beckerman AP, 2010, FUNCT ECOL, V24, P1, DOI 10.1111/j.1365-2435.2009.01673.x; Belovsky GE, 2011, ECOL LETT, V14, P335, DOI 10.1111/j.1461-0248.2011.01591.x; Beschta RL, 2007, WEST N AM NATURALIST, V67, P613, DOI 10.3398/1527-0904(2007)67[613:IWHANY]2.0.CO;2; Bolnick DI, 2005, ECOLOGY, V86, P2771, DOI 10.1890/04-1249; CARPENTER SR, 1988, BIOSCIENCE, V38, P764, DOI 10.2307/1310785; Childress MJ, 2003, ANIM BEHAV, V66, P389, DOI 10.1006/anbe.2003.2217; COOPER SD, 1990, ECOLOGY, V71, P1503, DOI 10.2307/1938287; Creel S, 2005, ECOLOGY, V86, P3387, DOI 10.1890/05-0032; Cronin JT, 2004, ECOLOGY, V85, P2134, DOI 10.1890/03-0591; DIEHL S, 1993, OIKOS, V68, P151, DOI 10.2307/3545321; Dill LM, 2003, ECOLOGY, V84, P1151, DOI 10.1890/0012-9658(2003)084[1151:BMIIIM]2.0.CO;2; Eggleston DB, 1998, J EXP MAR BIOL ECOL, V223, P111, DOI 10.1016/S0022-0981(97)00154-8; Englund G, 1997, ECOLOGY, V78, P2316; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; FORRESTER GE, 1994, ECOLOGY, V75, P1208, DOI 10.2307/1937447; FRASER DF, 1992, ECOLOGY, V73, P959, DOI 10.2307/1940172; Grabowski JH, 2005, ECOLOGY, V86, P1312, DOI 10.1890/04-1216; Grabowski JH, 2004, ECOLOGY, V85, P995, DOI 10.1890/03-0067; GRAY GA, 1961, ECOLOGY, V42, P274, DOI 10.2307/1932079; Griffin CAM, 2006, ECOL LETT, V9, P335, DOI 10.1111/j.1461-0248.2005.00880.x; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; HUANG CF, 1991, OECOLOGIA, V85, P530, DOI 10.1007/BF00323765; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; Laundre JW, 2010, ECOLOGY, V91, P2995, DOI 10.1890/08-2345.1; Laundre JW, 2001, CAN J ZOOL, V79, P1401, DOI 10.1139/cjz-79-8-1401; Macreadie PI, 2012, MAR ECOL PROG SER, V466, P145, DOI 10.3354/meps09986; Macreadie PI, 2011, MAR ECOL PROG SER, V429, P87, DOI 10.3354/meps09115; Madin EMP, 2010, ECOLOGY, V91, P3563, DOI 10.1890/09-2174.1; MCDONALD J, 1982, MAR ECOL PROG SER, V8, P173, DOI 10.3354/meps008173; McIntosh AR, 2002, FRESHWATER BIOL, V47, P1497, DOI 10.1046/j.1365-2427.2002.00889.x; McIntosh AR, 1999, OECOLOGIA, V118, P256, DOI 10.1007/s004420050726; Micheli F, 1999, CONSERV BIOL, V13, P869, DOI 10.1046/j.1523-1739.1999.98233.x; MURDOCH WW, 1969, ECOL MONOGR, V39, P335, DOI 10.2307/1942352; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Okuyama T, 2007, ECOL LETT, V10, P264, DOI 10.1111/j.1461-0248.2007.01019.x; Orrock JL, 2008, ECOLOGY, V89, P2426, DOI 10.1890/07-1024.1; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; Peacor SD, 1997, ECOLOGY, V78, P1146, DOI 10.1890/0012-9658(1997)078[1146:TMIIIA]2.0.CO;2; Peacor SD, 2001, P NATL ACAD SCI USA, V98, P3904, DOI 10.1073/pnas.071061998; Peckarsky BL, 1996, ECOLOGY, V77, P1888, DOI 10.2307/2265792; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Preisser EL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002465; Ripple WJ, 2006, FOREST ECOL MANAG, V230, P96, DOI 10.1016/j.foreco.2006.04.023; Schmitz OJ, 1997, ECOLOGY, V78, P1388, DOI 10.1890/0012-9658(1997)078[1388:BMTCEO]2.0.CO;2; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; Schmitz OJ, 2001, ECOLOGY, V82, P2072, DOI 10.1890/0012-9658(2001)082[2072:EOTPSO]2.0.CO;2; Schmitz OJ, 2008, ECOLOGY, V89, P2436, DOI 10.1890/07-1030.1; Schmitz OJ, 2008, SCIENCE, V319, P952, DOI 10.1126/science.1152355; Schmitz OJ, 2007, ECOLOGY, V88, P2415, DOI 10.1890/06-0937.1; SIH A, 1994, ECOLOGY, V75, P1199, DOI 10.2307/1937446; Stachowicz JJ, 1999, MAR ECOL PROG SER, V188, P169, DOI 10.3354/meps188169; Stallings CD, 2008, ECOLOGY, V89, P2090, DOI 10.1890/07-1671.1; Toscano BJ, 2012, MAR ECOL PROG SER, V445, P65, DOI 10.3354/meps09461; Trussell GC, 2002, ECOL LETT, V5, P241, DOI 10.1046/j.1461-0248.2002.00304.x; Trussell GC, 2006, ECOL LETT, V9, P1245, DOI 10.1111/j.1461-0248.2006.00981.x; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; Winkelmann C, 2008, AQUAT ECOL, V42, P483, DOI 10.1007/s10452-007-9101-7; Wirsing AJ, 2011, FRONT ECOL ENVIRON, V9, P335, DOI 10.1890/090226	61	60	60	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55100	10.1371/journal.pone.0055100	http://dx.doi.org/10.1371/journal.pone.0055100			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408957	Green Published, Green Submitted, gold			2022-12-27	WOS:000315157200017
J	Li, XM; Yan, QY; Xie, SQ; Hu, W; Yu, YH; Hu, ZH				Li, Xuemei; Yan, Qingyun; Xie, Shouqi; Hu, Wei; Yu, Yuhe; Hu, Zihua			Gut Microbiota Contributes to the Growth of Fast-Growing Transgenic Common Carp (Cyprinus carpio L.)	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; DIET-INDUCED OBESITY; HOST METABOLISM; ENERGY; COMMUNITIES; ABSORPTION; ZEBRAFISH; DIVERSITY; SEQUENCES; ECOLOGY	Gut microbiota has shown tight and coordinated connection with various functions of its host such as metabolism, immunity, energy utilization, and health maintenance. To gain insight into whether gut microbes affect the metabolism of fish, we employed fast-growing transgenic common carp (Cyprinus carpio L.) to study the connections between its large body feature and gut microbes. Metagenome-based fingerprinting and high-throughput sequencing on bacterial 16S rRNA genes indicated that fish gut was dominated by Proteobacteria, Fusobacteria, Bacteroidetes and Firmicutes, which displayed significant differences between transgenic fish and wild-type controls. Analyses to study the association of gut microbes with the fish metabolism discovered three major phyla having significant relationships with the host metabolic factors. Biochemical and histological analyses indicated transgenic fish had increased carbohydrate but decreased lipid metabolisms. Additionally, transgenic fish has a significantly lower Bacteroidetes: Firmicutes ratio than that of wild-type controls, which is similar to mammals between obese and lean individuals. These findings suggest that gut microbiotas are associated with the growth of fast growing transgenic fish, and the relative abundance of Firmicutes over Bacteroidetes could be one of the factors contributing to its fast growth. Since the large body size of transgenic fish displays a proportional body growth, which is unlike obesity inhuman, the results together with the findings from others also suggest that the link between obesity and gut microbiota is likely more complex than a simple Bacteroidetes: Firmicutes ratio change.	[Li, Xuemei; Yan, Qingyun; Yu, Yuhe] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China; [Yan, Qingyun; Xie, Shouqi; Hu, Wei] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China; [Hu, Zihua] SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Ctr Computat Res, Dept Ophthalmol,Dept Biostat,Dept Med, Buffalo, NY 14260 USA; [Li, Xuemei] Chinese Acad Fishery Sci, Yangtze River Fisheries Res Inst, Minist Agr China, Key Lab Freshwater Biodivers Conservat, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Chinese Academy of Fishery Sciences; Yangtze River Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs	Yu, YH (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China.	yhyu@ihb.ac.cn; zihuahu@ccr.buffalo.edu		Ware, James/0000-0002-6110-5880; Cook, Stuart/0000-0001-6628-194X; Walsh, Roddy/0000-0001-5092-8825; Barton, Paul/0000-0002-1165-7767	Major State Basic Research Development Program of China [2009CB118705]; National Natural Science Foundation of China [31172084, 31071896]; State Key Laboratory of Freshwater Ecology and Biotechnology [2012FB03]; Knowledge Innovation Program of the Chinese Academy of Sciences [Y15E04]; Youth Innovation Promotion Association, CAS [Y22Z07]	Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Freshwater Ecology and Biotechnology(Chinese Academy of Sciences); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Youth Innovation Promotion Association, CAS	This work was supported by the Major State Basic Research Development Program of China (2009CB118705), the National Natural Science Foundation of China (31172084, 31071896), the State Key Laboratory of Freshwater Ecology and Biotechnology (2012FB03), the Knowledge Innovation Program of the Chinese Academy of Sciences (Y15E04), and the Youth Innovation Promotion Association, CAS (Y22Z07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Backhed F, 2011, ANN NUTR METAB, V58, P44, DOI 10.1159/000328042; Berryman DE, 2010, J GERONTOL A-BIOL, V65, P31, DOI 10.1093/gerona/glp175; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Costello EK, 2010, ISME J, V4, P1375, DOI 10.1038/ismej.2010.71; Duan M, 2011, AQUACULTURE, V317, P175, DOI 10.1016/j.aquaculture.2011.04.013; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Erman A, 2011, INT J OBESITY, V35, P1511, DOI 10.1038/ijo.2011.23; Friedman JM, 2004, NAT MED, V10, P563, DOI 10.1038/nm0604-563; Fu C, 2007, J FISH BIOL, V70, P347, DOI 10.1111/j.1095-8649.2007.01301.x; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Guan B, 2008, AQUACULTURE, V284, P217, DOI 10.1016/j.aquaculture.2008.06.028; Guo X, 2008, LETT APPL MICROBIOL, V47, P367, DOI 10.1111/j.1472-765X.2008.02408.x; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li DL, 2007, CHINESE SCI BULL, V52, P1501, DOI 10.1007/s11434-007-0217-x; Li XM, 2012, J MICROBIOL, V50, P29, DOI 10.1007/s12275-012-1340-1; Li XM, 2011, J WORLD AQUACULT SOC, V42, P539, DOI 10.1111/j.1749-7345.2011.00496.x; Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; RAUP DM, 1979, J PALEONTOL, V53, P1213; Rawls JF, 2004, P NATL ACAD SCI USA, V101, P4596, DOI 10.1073/pnas.0400706101; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Robinson CJ, 2010, MICROBIOL MOL BIOL R, V74, P453, DOI 10.1128/MMBR.00014-10; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Rowan AK, 2003, FEMS MICROBIOL ECOL, V43, P195, DOI 10.1111/j.1574-6941.2003.tb01059.x; Santacruz A, 2009, OBESITY, V17, P1906, DOI 10.1038/oby.2009.112; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Semova I, 2012, CELL HOST MICROBE, V12, P277, DOI 10.1016/j.chom.2012.08.003; Stevens CE, 1998, PHYSIOL REV, V78, P393, DOI 10.1152/physrev.1998.78.2.393; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Velagapudi VR, 2010, J LIPID RES, V51, P1101, DOI 10.1194/jlr.M002774; Wang YP, 2001, CHINESE SCI BULL, V46, P1174; Wu SG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040727, 10.1371/journal.pone.0030440]; Yan QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030603; Yu YH, 2008, FEMS MICROBIOL ECOL, V63, P328, DOI 10.1111/j.1574-6941.2007.00430.x; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106; Zhu Z, 1992, TRANSGENIC FISH, P92, DOI [10.1142/9789814503600_0006, DOI 10.1142/9789814503600_0006]; Zhu Z, 1992, AGR BIOTECHNOLOGY, P106	52	89	97	4	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64577	10.1371/journal.pone.0064577	http://dx.doi.org/10.1371/journal.pone.0064577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23861798	Green Submitted, gold, Green Published			2022-12-27	WOS:000319799900057
J	Cheng, HR; Liu, CJ; Tseng, TC; Su, TH; Yang, HI; Chen, CJ; Kao, JH				Cheng, Huei-Ru; Liu, Chun-Jen; Tseng, Tai-Chung; Su, Tung-Hung; Yang, Hwai-I; Chen, Chien-Jen; Kao, Jia-Horng			Host Genetic Factors Affecting Spontaneous HBsAg Seroclearance in Chronic Hepatitis B Patients	PLOS ONE			English	Article							SURFACE-ANTIGEN SEROCLEARANCE; VIRUS-INFECTION; HEPATOCELLULAR-CARCINOMA; FOLLOW-UP; DNA LEVEL; DETERMINANTS; ASSOCIATION; CLEARANCE; PROGNOSIS; TAIWAN	Spontaneous clearance of hepatitis B surface antigen (HBsAg) in chronic hepatitis B (CHB) patients usually indicates a remission of hepatitis activity and a favorable outcome. Two single nucleotide polymorphisms (SNP), rs3077 near HLA-DPA1 region and rs9277535 near HLA-DPB1 region, have been shown to be associated with HBV persistence after acute HBV infection. However, little is known about the impact of these 2 SNPs on spontaneous HBsAg clearance in CHB patients. In this case-control study, a total of 100 male HBeAg-negative chronic HBV carriers who cleared HBsAg spontaneously (case group) and 100 age-matched HBeAg-negative male patients with persistent HBsAg positivity (control group) were enrolled. We investigated the relationship between these 2 SNPs and HBsAg clearance. There was a higher frequency of rs9277535 non-GG genotype in the case group (57% vs. 42%). Patients with rs9277535 non-GG genotype had a higher chance to clear HBsAg [Odds ratio (OR): 1.83, 95% confidence interval (CI): 1.04 similar to 3.21, P = 0.034]. Compared to GG haplotype of rs3077 and rs9277535, GA haplotype had a higher chance of achieving spontaneous HBsAg loss (OR: 2.17, 95% CI: 1.14 similar to 4.16, P = 0.030). In conclusion, rs9277535 non-GG genotype is associated with a higher likelihood of spontaneous HBsAg seroclearance in CHB patients.	[Cheng, Huei-Ru; Liu, Chun-Jen; Kao, Jia-Horng] Natl Taiwan Univ, Grad Inst Clin Med, Taipei 10764, Taiwan; [Liu, Chun-Jen; Su, Tung-Hung; Kao, Jia-Horng] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei 10764, Taiwan; [Liu, Chun-Jen; Su, Tung-Hung; Kao, Jia-Horng] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Liu, Chun-Jen; Su, Tung-Hung; Kao, Jia-Horng] Natl Taiwan Univ, Coll Med, Hepatitis Res Ctr, Taipei 10764, Taiwan; [Kao, Jia-Horng] Natl Taiwan Univ, Dept Med Res, Coll Med, Taipei 10764, Taiwan; [Tseng, Tai-Chung] Buddhist Tzu Chi Gen Hosp, Taipei Branch, Dept Internal Med, Taipei, Taiwan; [Yang, Hwai-I] China Med Univ Hosp, Mol & Genom Epidemiol Ctr, Taichung, Taiwan; [Yang, Hwai-I] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Yang, Hwai-I; Chen, Chien-Jen] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Buddhist Tzu Chi General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Academia Sinica - Taiwan	Kao, JH (corresponding author), Natl Taiwan Univ, Grad Inst Clin Med, Taipei 10764, Taiwan.	kaojh@ntu.edu.tw	Kao, Jia-Horng/AAB-8947-2019; Ekanayake, Kanchana/P-8817-2016; Rooney, Kieron/I-6252-2018; Cheng, Hoi Lun/AAK-8937-2021; O'Connor, Helen/C-1289-2014; Research Institute, ANZAC/CAE-9030-2022; Steinbeck, Kate/AAX-6197-2020; Chen, Chien-Jen/C-6976-2008; Yang, Hwai-I/A-9470-2008; Chen, Chien-Jen/N-4723-2019	Kao, Jia-Horng/0000-0002-2442-7952; Rooney, Kieron/0000-0001-6563-7617; Cheng, Hoi Lun/0000-0002-2144-9195; O'Connor, Helen/0000-0002-6198-4141; Yang, Hwai-I/0000-0002-3433-942X; LIU, CHUN-JEN/0000-0002-6202-0993; SU, TUNG-HUNG/0000-0002-6747-7941	National Taiwan University; National Science Council, and Department of Health, Executive Yuan, Taiwan; National Taiwan University Hospital, Taiwan	National Taiwan University(National Taiwan University); National Science Council, and Department of Health, Executive Yuan, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital, Taiwan	The work was supported by grants from the National Taiwan University; the National Science Council, and Department of Health, Executive Yuan, Taiwan; National Taiwan University Hospital, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; CHEN DS, 1993, SCIENCE, V262, P369, DOI 10.1126/science.8211155; Chen YC, 2002, GASTROENTEROLOGY, V123, P1084, DOI 10.1053/gast.2002.36026; Chu CM, 2007, HEPATOLOGY, V45, P1187, DOI 10.1002/hep.21612; Chu CM, 2010, ANTIVIR THER, V15, P133, DOI 10.3851/IMP1497; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Guo XC, 2011, HEPATOLOGY, V53, P422, DOI 10.1002/hep.24048; Handunnetthi L, 2010, GENES IMMUN, V11, P99, DOI 10.1038/gene.2009.83; HSU HY, 1986, J MED VIROL, V18, P301, DOI 10.1002/jmv.1890180402; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kao JH, 2003, INTERVIROLOGY, V46, P400, DOI 10.1159/000074999; Kao JH, 2002, LANCET INFECT DIS, V2, P395, DOI 10.1016/S1473-3099(02)00315-8; Kim JH, 2008, HEPATO-GASTROENTEROL, V55, P578; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024221; LIAW YF, 1991, HEPATOLOGY, V13, P627, DOI 10.1002/hep.1840130403; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Liu J, 2010, GASTROENTEROLOGY, V139, P474, DOI 10.1053/j.gastro.2010.04.048; McMahon BJ, 2001, ANN INTERN MED, V135, P759, DOI 10.7326/0003-4819-135-9-200111060-00006; Nishida N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039175; Simonetti J, 2010, HEPATOLOGY, V51, P1531, DOI 10.1002/hep.23464; Su TH, 2010, ANTIVIR THER, V15, P1133, DOI 10.3851/IMP1696; Tseng TC, 2012, HEPATOLOGY, V55, P68, DOI 10.1002/hep.24615; Tseng TC, 2011, GASTROENTEROLOGY, V141, P517, DOI 10.1053/j.gastro.2011.04.046; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017608; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Yeh SH, 2004, J HEPATOL, V41, P659, DOI 10.1016/j.jhep.2004.06.031	27	91	93	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53008	10.1371/journal.pone.0053008	http://dx.doi.org/10.1371/journal.pone.0053008			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23861932	Green Submitted, gold, Green Published			2022-12-27	WOS:000314705800028
J	Cheng, HL; Bryant, CE; Rooney, KB; Steinbeck, KS; Griffin, HJ; Petocz, P; O'Connor, HT				Cheng, Hoi Lun; Bryant, Christian E.; Rooney, Kieron B.; Steinbeck, Katharine S.; Griffin, Hayley J.; Petocz, Peter; O'Connor, Helen T.			Iron, Hepcidin and Inflammatory Status of Young Healthy Overweight and Obese Women in Australia	PLOS ONE			English	Article							TRANSFERRIN RECEPTOR; SERUM HEPCIDIN; DEFICIENCY; HYPOFERREMIA; ADULTS; LEVEL; RISK; DIET	Background and Aims: Evidence suggests obesity-related inflammation alters iron metabolism potentially increasing the risk of iron deficiency. This cross-sectional study aimed to investigate iron, hepcidin and inflammatory status in young, healthy overweight and obese women. Methods: 114 young (18-25 years), healthy comorbidity-free women with a body mass index (BMI) >= 27.5 kg/m(2) were recruited. Biochemical data were analysed using mean +/- standard deviation or median (interquartile range) and multivariate modelling. Biochemical markers were also stratified according to varying degrees of overweight and obesity. Results: Anaemia (haemoglobin <120 g/l) and iron deficiency (serum ferritin <15.0 mu g/l) were prevalent in 10% and 17% of participants respectively. Mean/median soluble transferrin receptor was 1.61 +/- 0.44 mg/l; hepcidin 6.40 (7.85) ng/ml and C-reactive protein (CRP) 3.58 (5.81) mg/l. Multivariate modelling showed that BMI was a significant predictor of serum iron (coefficient = -0.379; standard error = 0.139; p = 0.008), transferrin saturation (coefficient = -0.588; standard error = 0.222; p = 0.009) and CRP (coefficient = 0.127; standard error = 0.024; p<0.001). Stratification of participants according to BMI showed those with >= 35.0 kg/m(2) had significantly higher CRP (p<0.001) than those in lower BMI categories. Conclusions: Increasing obesity was associated with minor disturbances in iron metabolism. However, overall outcomes indicated simple iron deficiency (hypoferritinaemia) was the primary iron-related abnormality with no apparent contribution of inflammation or hepcidin, even in those with BMI >35.0 kg/m(2). This indicates that obesity alone may not be sufficient to induce clinically significant disturbances to iron metabolism as previously described. This may be attributed to the lack of comorbidity in this cohort.	[Cheng, Hoi Lun; Rooney, Kieron B.; Griffin, Hayley J.; O'Connor, Helen T.] Univ Sydney, Fac Hlth Sci, Discipline Exercise & Sport Sci, Sydney, NSW 2006, Australia; [Bryant, Christian E.] Univ Sydney, Anzac Res Inst, Sydney, NSW 2006, Australia; [Steinbeck, Katharine S.] Univ Sydney, Acad Dept Adolescent Med, Sydney, NSW 2006, Australia; [Petocz, Peter] Macquarie Univ, Dept Stat, Sydney, NSW 2109, Australia	University of Sydney; University of Sydney; ANZAC Research Institute; University of Sydney; Macquarie University	Cheng, HL (corresponding author), Univ Sydney, Fac Hlth Sci, Discipline Exercise & Sport Sci, Sydney, NSW 2006, Australia.	hche3056@uni.sydney.edu.au	Kao, Jia-Horng/AAB-8947-2019; Ekanayake, Kanchana/P-8817-2016; Rooney, Kieron/I-6252-2018; Cheng, Hoi Lun/AAK-8937-2021; O'Connor, Helen/C-1289-2014; Research Institute, ANZAC/CAE-9030-2022; Steinbeck, Kate/AAX-6197-2020; Chen, Chien-Jen/C-6976-2008; Yang, Hwai-I/A-9470-2008; Chen, Chien-Jen/N-4723-2019	Kao, Jia-Horng/0000-0002-2442-7952; Rooney, Kieron/0000-0001-6563-7617; Cheng, Hoi Lun/0000-0002-2144-9195; O'Connor, Helen/0000-0002-6198-4141; Yang, Hwai-I/0000-0002-3433-942X; LIU, CHUN-JEN/0000-0002-6202-0993; SU, TUNG-HUNG/0000-0002-6747-7941	Meat and Livestock Australia	Meat and Livestock Australia(Meat and Livestock Australia)	This work was supported by a grant from Meat and Livestock Australia. The authors declare that Meat and Livestock Australia had no influence on any part of the analysis or interpretation of data, including the conclusions drawn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeberli I, 2009, INT J OBESITY, V33, P1111, DOI 10.1038/ijo.2009.146; Ahmed F, 2008, ASIA PAC J CLIN NUTR, V17, P40; [Anonymous], 2000, WHO TECH REP SER, P894; ARBER N, 1994, DIGEST DIS SCI, V39, P2656, DOI 10.1007/BF02087705; Ausk KJ, 2008, OBESITY, V16, P2356, DOI 10.1038/oby.2008.353; Ball K, 2009, OBESITY, V17, P66, DOI 10.1038/oby.2008.497; Bansal SS, 2010, RAPID COMMUN MASS SP, V24, P1251, DOI 10.1002/rcm.4512; Cheng HL, 2012, OBES REV, V13, P150, DOI 10.1111/j.1467-789X.2011.00938.x; Corwin EJ, 2003, J NUTR, V133, P4139, DOI 10.1093/jn/133.12.4139; Franklin M, 2010, CLIN CHEM, V57, pA171; Ganz Tomas, 2012, Biochim Biophys Acta, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Griffin HJ, 2013, DIABETES OBES METAB, V15, P572, DOI 10.1111/dom.12056; HALLBERG L, 1966, ACTA OBSTET GYN SCAN, V45, P320, DOI 10.3109/00016346609158455; Karl JP, 2009, J AM COLL NUTR, V28, P37, DOI 10.1080/07315724.2009.10719759; Koulaouzidis A, 2009, SCAND J GASTROENTERO, V44, P126, DOI 10.1080/00365520802555983; Lagergren J, 2011, NAT REV GASTRO HEPAT, V8, P340, DOI 10.1038/nrgastro.2011.73; Macdougall IC, 2010, CLIN J AM SOC NEPHRO, V5, P1681, DOI 10.2215/CJN.05990809; Murray-Kolb LE, 2007, AM J CLIN NUTR, V85, P778, DOI 10.1093/ajcn/85.3.778; O'Connor H, 2011, ASIA PAC J CLIN NUTR, V20, P206; Pasricha SR, 2011, HAEMATOL-HEMATOL J, V96, P1099, DOI 10.3324/haematol.2010.037960; Pynaert I, 2007, ANN NUTR METAB, V51, P172, DOI 10.1159/000103278; Skikne BS, 2008, AM J HEMATOL, V83, P872, DOI 10.1002/ajh.21279; Suominen P, 1998, BLOOD, V92, P2934, DOI 10.1182/blood.V92.8.2934.420k07_2934_2939; Tussing-Humphreys LM, 2010, OBESITY, V18, P2010, DOI 10.1038/oby.2009.490; Tussing-Humphreys LM, 2009, J AM DIET ASSOC, V109, P297, DOI 10.1016/j.jada.2008.10.044; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; WHO, 2001, AN DEF; World Health Organization, 2011, WAIST CIRC WAIST HIP, Vi-vi; Yanoff LB, 2007, INT J OBESITY, V31, P1412, DOI 10.1038/sj.ijo.0803625	29	91	93	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68675	10.1371/journal.pone.0068675	http://dx.doi.org/10.1371/journal.pone.0068675			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861932	Green Published, gold, Green Submitted			2022-12-27	WOS:000323350700097
J	Lee, HY; Seo, JS; Cho, JH; Jung, H; Kim, JK; Lee, JS; Rhee, S; Choi, YD				Lee, Han Yong; Seo, Ju-Seok; Cho, Jang Hee; Jung, Harin; Kim, Ju-Kon; Lee, Jong Seob; Rhee, Sangkee; Choi, Yang Do			Oryza sativa COI Homologues Restore Jasmonate Signal Transduction in Arabidopsis coi1-1 Mutants	PLOS ONE			English	Article							METHYL JASMONATE; TRANSCRIPTION FACTOR; ACID BIOSYNTHESIS; MALE-STERILITY; GENE ENCODES; PROTEINS; DEFENSE	CORONATINE INSENSITIVE 1 (COI1) encodes an E3 ubiquitin ligase complex component that interacts with JAZ proteins and targets them for degradation in response to JA signaling. The Arabidopsis genome has a single copy of COI1, but the Oryza sativa genome has three closely related COI homologs. To examine the functions of the three OsCOIs, we used yeast two-hybrid assays to examine their interactions with JAZ proteins and found that OsCOIs interacted with OsJAZs and with JAZs, in a coronatine dependent manner. We also tested whether OsCOI1a and OsCOI1b could complement Arabidopsis coi1-1 mutants and found that overexpression of either gene in the coi1-1 mutant resulted in restoration of JA signal transduction and production of seeds, indicating successful complementation. Although OsCOI2 interacted with a few OsJAZs, we were not able to successfully complement the coi1-1 mutant with OsCOI2. Molecular modeling revealed that the three OsCOIs adopt 3D structures similar to COI1. Structural differences resulting from amino acid variations, especially among amino acid residues involved in the interaction with coronatine and JAZ proteins, were tested by mutation analysis. When His-391 in OsCOI2 was substituted with Tyr-391, OsCOI2 interacted with a wider range of JAZ proteins, including OsJAZ1, 2, 5 similar to 9 and 11, and complemented coi1-1 mutants at a higher frequency than the other OsCOIs and COI1. These results indicate that the three OsCOIs are orthologues of COI1 and play key roles in JA signaling.	[Lee, Han Yong; Seo, Ju-Seok; Cho, Jang Hee; Rhee, Sangkee; Choi, Yang Do] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Jung, Harin; Kim, Ju-Kon] Myongji Univ, Sch Biotechnol & Environm Engn, Yongin, South Korea; [Lee, Jong Seob] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea	Seoul National University (SNU); Myongji University; Seoul National University (SNU)	Rhee, S (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	srheesnu@snu.ac.kr; choiyngd@snu.ac.kr			Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea through the National Center for GM Crops [PJ008053, PJ007971]	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea through the National Center for GM Crops	This work was supported by a grant from the Next-Generation BioGreen 21 Program (project nos. PJ008053 to YDC and PJ007971 to JKK), Rural Development Administration, Republic of Korea through the National Center for GM Crops. A graduate research assistantship to HYL, JSS and HJ from the Brain Korea 21 project of the MOEST is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta IF, 2010, JASMONATES ARABIDOPS, P1; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Carpenter CD, 1998, METH MOL B, V82, P85; Cheong JJ, 2003, TRENDS GENET, V19, P409, DOI 10.1016/S0168-9525(03)00138-0; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chini A, 2009, FEBS J, V276, P4682, DOI 10.1111/j.1742-4658.2009.07194.x; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; FEYS BJF, 1994, PLANT CELL, V6, P751, DOI 10.1105/tpc.6.5.751; Ishiguro S, 2001, PLANT CELL, V13, P2191, DOI 10.1105/tpc.13.10.2191; Katsir L, 2008, CURR OPIN PLANT BIOL, V11, P428, DOI 10.1016/j.pbi.2008.05.004; Kim EH, 2009, PLANT PHYSIOL, V149, P1751, DOI 10.1104/pp.108.134684; Koo AJK, 2009, PHYTOCHEMISTRY, V70, P1571, DOI 10.1016/j.phytochem.2009.07.018; McConn M, 1996, PLANT CELL, V8, P403, DOI 10.1105/tpc.8.3.403; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Park JH, 2002, PLANT J, V31, P1, DOI 10.1046/j.1365-313X.2002.01328.x; Sanders PM, 2000, PLANT CELL, V12, P1041, DOI 10.1105/tpc.12.7.1041; Sasaki Y, 2001, DNA RES, V8, P153, DOI 10.1093/dnares/8.4.153; Seo JS, 2011, PLANT J, V65, P907, DOI 10.1111/j.1365-313X.2010.04477.x; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Shin B, 2002, PLANT J, V30, P23, DOI 10.1046/j.1365-313X.2002.01264.x; Steiner-Lange S, 2003, PLANT J, V34, P519, DOI 10.1046/j.1365-313X.2003.01745.x; Stintzi A, 2000, P NATL ACAD SCI USA, V97, P10625, DOI 10.1073/pnas.190264497; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368; Yang DL, 2012, P NATL ACAD SCI USA, V109, pE1192, DOI 10.1073/pnas.1201616109; Yang XY, 2007, PLANT CELL REP, V26, P219, DOI 10.1007/s00299-006-0229-z; Ye M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036214	28	70	92	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e52802	10.1371/journal.pone.0052802	http://dx.doi.org/10.1371/journal.pone.0052802			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23320078	Green Submitted, gold, Green Published			2022-12-27	WOS:000313429800020
J	Zhang, HD; Song, J; Ren, H; Xu, ZR; Wang, XN; Shan, LF; Fang, J				Zhang, Huidan; Song, Jin; Ren, Hui; Xu, Zhangrun; Wang, Xiaonan; Shan, Lianfeng; Fang, Jin			Detection of Low-Abundance KRAS Mutations in Colorectal Cancer Using Microfluidic Capillary Electrophoresis-Based Restriction Fragment Length Polymorphism Method with Optimized Assay Conditions	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; K-RAS MUTATIONS; CONTEMPORARY SAMPLE STACKING; REAL-TIME PCR; MICROCHIP ELECTROPHORESIS; FLUORESCENCE DETECTION; 1ST-LINE TREATMENT; ANTIBODY THERAPY; ENERGY-TRANSFER; DNA	Constitutively active KRAS mutations have been found to be involved in various processes of cancer development, and render tumor cells resistant to EGFR-targeted therapies. Mutation detection methods with higher sensitivity will increase the possibility of choosing the correct individual therapy. Here, we established a highly sensitive and efficient microfluidic capillary electrophoresis-based restriction fragment length polymorphism (mu CE-based RFLP) platform for low-abundance KRAS genotyping with the combination of mu CE and RFLP techniques. By using our self-built sensitive laser induced fluorescence (LIF) detector and a new DNA intercalating dye YOYO-1, the separation conditions of mu CE for Phi 174 HaeIII DNA marker were first optimized. Then, a Mav I digested 107-bp KRAS gene fragment was directly introduced into the microfluidic device and analyzed by mu CE, in which field amplified sample stacking (FASS) technique was employed to obtain the enrichment of the RFLP digestion products and extremely improved the sensitivity. The accurate analysis of KRAS statuses in HT29, LS174T, CCL187, SW480, Clone A, and CX-1 colorectal cancer (CRC) cell lines by mu CE-based RFLP were achieved in 5 min with picoliter-scale sample consumption, and as low as 0.01% of mutant KRAS could be identified from a large excess of wild-type genomic DNA (gDNA). In 98 paraffin-embedded CRC tissues, KRAS codon 12 mutations were discovered in 28 (28.6%), significantly higher than that obtained by direct sequencing (13, 13.3%). Clone sequencing confirmed these results and showed this system could detect at least 0.4% of the mutant KRAS in CRC tissue slides. Compared with direct sequencing, the new finding of the mu CE-based RFLP platform was that KRAS mutations in codon 12 were correlated with the patient's age. In conclusion, we established a sensitive, fast, and cost-effective screening method for KRAS mutations, and successfully detected low-abundance KRAS mutations in clinical samples, which will allow provision of more precise individualized cancer therapy.	[Zhang, Huidan; Song, Jin; Wang, Xiaonan; Fang, Jin] China Med Univ, Minist Publ Hlth, Key Lab Cell Biol, Dept Cell Biol, Shenyang, Peoples R China; [Zhang, Huidan; Song, Jin; Wang, Xiaonan; Fang, Jin] China Med Univ, Minist Educ, Key Lab Med Cell Biol, Shenyang, Peoples R China; [Ren, Hui] Shenyang Anal Rectum Hosp, Dept Colon Surg, Shenyang, Peoples R China; [Xu, Zhangrun] Northeastern Univ, Res Ctr Analyt Sci, Shenyang, Peoples R China; [Shan, Lianfeng] China Med Univ, Coll Basic Med Sci, Dept Math, Shenyang, Peoples R China	China Medical University; China Medical University; Northeastern University - China; China Medical University	Fang, J (corresponding author), China Med Univ, Minist Publ Hlth, Key Lab Cell Biol, Dept Cell Biol, Shenyang, Peoples R China.	jfang61@gmail.com	Zhang, Huidan/K-8399-2015; Zhang, Hai-Lin/H-2715-2017	Chen, Guifen/0000-0002-5459-660X; Zhang, Hai-Lin/0000-0002-7426-2885	National Natural Science Foundation of China [30901727, 20975019, 20875103, 20375047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Natural Science Foundation of China (Grant No. 30901727, 20975019, 20875103, 20375047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamine R, 2009, J PHARMACEUT BIOMED, V50, P947, DOI 10.1016/j.jpba.2009.06.034; Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Angulo B, 2010, J MOL DIAGN, V12, P292, DOI 10.2353/jmoldx.2010.090139; Assenat E, 2011, ONCOLOGIST, V16, P1557, DOI 10.1634/theoncologist.2011-0141; Beard NR, 2003, ELECTROPHORESIS, V24, P732, DOI 10.1002/elps.200390088; BENSON SC, 1993, NUCLEIC ACIDS RES, V21, P5720, DOI 10.1093/nar/21.24.5720; BENSON SC, 1993, NUCLEIC ACIDS RES, V21, P5727, DOI 10.1093/nar/21.24.5727; Bornholdt J, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-53; CAPELLA G, 1991, ENVIRON HEALTH PERSP, V93, P125, DOI 10.2307/3431180; Cavallini A, 2010, ANTICANCER RES, V30, P5251; Chowdhury J, 2007, J MOL DIAGN, V9, P521, DOI 10.2353/jmoldx.2007.070014; DELATTRE O, 1989, LANCET, V2, P353; Evenhuis CJ, 2009, ELECTROPHORESIS, V30, P897, DOI 10.1002/elps.200800643; Fang Q, 2002, ANAL CHEM, V74, P1223, DOI 10.1021/ac010925c; Gebauer P, 2009, ELECTROPHORESIS, V30, pS27, DOI 10.1002/elps.200900053; Gotz S, 2007, ANAL BIOANAL CHEM, V387, P183, DOI 10.1007/s00216-006-0820-8; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jia ZJ, 2004, ANAL CHEM, V76, P5597, DOI 10.1021/ac0494477; Jiang GF, 2000, BIOSENS BIOELECTRON, V14, P861, DOI 10.1016/S0956-5663(99)00056-1; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kleparnik K, 2007, CHEM REV, V107, P5279, DOI 10.1021/cr0101860; Ko JMY, 1998, CANCER LETT, V134, P169, DOI 10.1016/S0304-3835(98)00257-2; Lanthaler AJ, 2011, DIAGN MOL PATHOL, V20, P90, DOI 10.1097/PDM.0b013e31820e5f9a; Li J, 2008, NAT MED, V14, P579, DOI 10.1038/nm1708; LODA M, 1994, HUM PATHOL, V25, P564, DOI 10.1016/0046-8177(94)90220-8; Loupakis F, 2012, CANCER-AM CANCER SOC, V118, P1523, DOI 10.1002/cncr.26460; Luo JD, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj008; Lurje G, 2008, CLIN CANCER RES, V14, P7884, DOI 10.1158/1078-0432.CCR-07-5165; Ma WW, 2009, CA-CANCER J CLIN, V59, P111, DOI 10.3322/caac.20003; Mala Z, 2009, J CHROMATOGR A, V1051, P147; Mala Z, 2007, ELECTROPHORESIS, V28, P243, DOI 10.1002/elps.200600397; Mala Z, 2009, ELECTROPHORESIS, V30, P215, DOI 10.1002/elps.200800433; Mao C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036653; Marchetti A, 2009, NEW ENGL J MED, V360, P833, DOI 10.1056/NEJMc082346; Mayo Skye C, 2009, Expert Rev Gastroenterol Hepatol, V3, P131, DOI 10.1586/egh.09.8; Milano G, 2008, ANN ONCOL, V19, P2033, DOI 10.1093/annonc/mdn416; Minucci A, 2008, J SEP SCI, V31, P2694, DOI 10.1002/jssc.200800216; Molinari F, 2011, CLIN CANCER RES, V17, P4901, DOI 10.1158/1078-0432.CCR-10-3137; Nachamkin I, 2001, J CLIN MICROBIOL, V39, P754, DOI 10.1128/JCM.39.2.754-757.2001; Nishikawa T, 2002, CLIN CHIM ACTA, V318, P107, DOI 10.1016/S0009-8981(01)00806-3; Ohno K, 2008, ELECTROPHORESIS, V29, P4443, DOI 10.1002/elps.200800121; OUDEJANS JJ, 1991, INT J CANCER, V49, P875, DOI 10.1002/ijc.2910490613; Petersen NJ, 2004, ELECTROPHORESIS, V25, P253, DOI 10.1002/elps.200305747; Qin JH, 2005, ELECTROPHORESIS, V26, P219, DOI 10.1002/elps.200406158; Sarasqueta AF, 2011, J MOL DIAGN, V13, P199, DOI 10.1016/j.jmoldx.2010.10.006; Schimanski CC, 2010, INT J COLORECTAL DIS, V25, P181, DOI 10.1007/s00384-009-0843-7; Schimanski CC, 1999, CANCER RES, V59, P5169; Scholtka B, 2009, CANCER EPIDEMIOL, V33, P123, DOI 10.1016/j.canep.2009.05.001; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Sood A, 2012, CLIN COLORECTAL CANC, V11, P143, DOI 10.1016/j.clcc.2011.12.001; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Waldner MJ, 2010, MOL ASPECTS MED, V31, P171, DOI 10.1016/j.mam.2010.02.005; Weidlich S, 2011, BRIT J CANCER, V105, P246, DOI 10.1038/bjc.2011.197; Winder T, 2010, CANCER TREAT REV, V36, P550, DOI 10.1016/j.ctrv.2010.03.005; Wu CM, 2005, CANCER GENET CYTOGEN, V158, P55, DOI 10.1016/j.cancergencyto.2004.08.030; Xiao SX, 1997, PROG BIOCHEM BIOPHYS, V24, P375; Xu F, 2004, J CHROMATOGR A, V1051, P147, DOI 10.1016/j.chroma.2004.05.019; Yang YZ, 2006, ANAL CHEM, V78, P4752, DOI 10.1021/ac051735v; Zhang HD, 2011, LAB INVEST, V91, P788, DOI 10.1038/labinvest.2010.200; Zou HZ, 2009, GASTROENTEROLOGY, V136, P459, DOI 10.1053/j.gastro.2008.10.023	61	203	206	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54510	10.1371/journal.pone.0054510	http://dx.doi.org/10.1371/journal.pone.0054510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23750250	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500082
J	Li, X; Yao, XP; Wang, YB; Hu, FL; Wang, F; Jiang, LY; Liu, YP; Wang, D; Sun, GZ; Zhao, YS				Li, Xia; Yao, Xiaoping; Wang, Yibaina; Hu, Fulan; Wang, Fan; Jiang, Liying; Liu, Yupeng; Wang, Da; Sun, Guizhi; Zhao, Yashuang			MLH1 Promoter Methylation Frequency in Colorectal Cancer Patients and Related Clinicopathological and Molecular Features	PLOS ONE			English	Article							REVISED BETHESDA GUIDELINES; MICROSATELLITE INSTABILITY; HMLH1 PROMOTER; LYNCH-SYNDROME; COLON-CANCER; INSTITUTE WORKSHOP; GENE METHYLATION; BRAF MUTATION; HEREDITARY; HYPERMETHYLATION	Purpose: To describe the frequency of MLH1 promoter methylation in colorectal cancer (CRC); to explore the associations between MLH1 promoter methylation and clinicopathological and molecular factors using a systematic review and meta-analysis. Methods: A literature search of the PubMed and Embase databases was conducted to identify relevant articles published up to September 7, 2012 that described the frequency of MLH1 promoter methylation or its associations with clinicopathological and molecular factors in CRC. The pooled frequency, odds ratio (OR) and 95% confidence intervals (95% CI) were calculated. Results: The pooled frequency of MLH1 promoter methylation in unselected CRC was 20.3% (95% CI: 16.8-24.1%). They were 18.7% (95% CI: 14.7-23.6%) and 16.4% (95% CI: 11.9-22.0%) in sporadic and Lynch syndrome (LS) CRC, respectively. Significant associations were observed between MLH1 promoter methylation and gender (pooled OR = 1.641, 95% CI: 1.215-2.215; P = 0.001), tumor location (pooled OR = 3.804, 95% CI: 2.715-5.329; P<0.001), tumor differentiation (pooled OR = 2.131, 95% CI: 1.464-3.102; P<0.001), MSI (OR: 27.096, 95% CI: 13.717-53.526; P<0.001). Significant associations were also observed between MLH1 promoter methylation and MLH1 protein expression, BRAF mutation (OR = 14.919 (95% CI: 6.427-34.631; P<0.001) and 9.419 (95% CI: 2.613-33.953; P = 0.001), respectively). Conclusion: The frequency of MLH1 promoter methylation in unselected CRC was 20.3%. They were 18.7% in sporadic CRC and 16.4% in LS CRC, respectively. MLH1 promoter methylation may be significantly associated with gender, tumor location, tumor differentiation, MSI, MLH1 protein expression, and BRAF mutation.	[Li, Xia; Yao, Xiaoping; Wang, Yibaina; Hu, Fulan; Wang, Fan; Jiang, Liying; Liu, Yupeng; Zhao, Yashuang] Harbin Med Univ, Coll Publ Hlth, Dept Epidemiol, Harbin, Heilongjiang Pr, Peoples R China; [Wang, Da] Harbin Med Univ, Dept Sci & Technol Adm, Harbin, Heilongjiang Pr, Peoples R China; [Sun, Guizhi] Harbin Med Univ, Canc Hosp, Dept Surg, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Zhao, YS (corresponding author), Harbin Med Univ, Coll Publ Hlth, Dept Epidemiol, Harbin, Heilongjiang Pr, Peoples R China.	zhao_yashuang@263.net	Wang, Fan/I-6099-2019; Zhao, Yashuang/I-6145-2019; li, xia/HHZ-7468-2022; Li, Xiaobing/B-1267-2019; Liu, YuPeng/P-3181-2018	Wang, Fan/0000-0002-9869-9504; Liu, Guowen/0000-0002-2672-6104; Li, Xiaobing/0000-0001-9105-6365; Liu, YuPeng/0000-0002-8652-1987	National Natural Science Foundation of China for Priority Areas [NSFC 30972538]; Education Bureau of Heilongjiang Province [11531100]; Graduate Foundation; Scientific Research of Heilongjiang Province [YJSCX2009-224HLJ]; Harbin Medical University [HCXB2009009]	National Natural Science Foundation of China for Priority Areas; Education Bureau of Heilongjiang Province; Graduate Foundation; Scientific Research of Heilongjiang Province; Harbin Medical University	This study was supported by grants from National Natural Science Foundation of China for Priority Areas (NSFC 30972538), Education Bureau of Heilongjiang Province (11531100), and the Graduate Foundation, supported by the Scientific Research of Heilongjiang Province (YJSCX2009-224HLJ) and Harbin Medical University (HCXB2009009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Aguilera O, 2010, J APPL PHYSIOL, V109, P243, DOI 10.1152/japplphysiol.00068.2010; Ahlquist T, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-94; Anacleto C, 2005, NEOPLASIA, V7, P331, DOI 10.1593/neo.04502; Arnold CN, 2004, CANCER BIOL THER, V3, P73, DOI 10.4161/cbt.3.1.590; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Belshaw NJ, 2004, CANCER EPIDEM BIOMAR, V13, P1495; Bettstetter M, 2007, CLIN CANCER RES, V13, P3221, DOI 10.1158/1078-0432.CCR-06-3064; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; Boland CR, 1998, CANCER RES, V58, P5248; Brandes JC, 2005, CARCINOGENESIS, V26, P1152, DOI 10.1093/carcin/bgi058; Cunningham JM, 1998, CANCER RES, V58, P3455; de Vogel S, 2009, ANN ONCOL, V20, P1216, DOI 10.1093/annonc/mdn782; Deng GR, 2004, CLIN CANCER RES, V10, P191, DOI 10.1158/1078-0432.CCR-1118-3; Deng GR, 1999, CANCER RES, V59, P2029; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DerSimonian R, 1996, STAT MED, V15, P1237, DOI 10.1002/(SICI)1097-0258(19960630)15:12<1237::AID-SIM301>3.0.CO;2-N; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Dykes SL, 2003, CANCER-AM CANCER SOC, V98, P48, DOI 10.1002/cncr.11445; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fox EJ, 2006, J MOL DIAGN, V8, P68, DOI 10.2353/jmoldx.2006.050084; Garagnani P, 2012, CURR PHARM DES; Gay LJ, 2011, NUTR CANCER, V63, P1000, DOI 10.1080/01635581.2011.596987; Gazzoli I, 2002, CANCER RES, V62, P3925; GLOBOCAN, 2008, CANC FACT SHEET; Grady WM, 2001, CANCER RES, V61, P900; Hampel H, 2005, NEW ENGL J MED, V352, P1851, DOI 10.1056/NEJMoa043146; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang Q, 2012, DIAGN MOL PATHOL, V21, P24, DOI 10.1097/PDM.0b013e318230effd; Iacopetta B, 2006, INT J CANCER, V119, P2272, DOI 10.1002/ijc.22237; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Issa JP, 1999, CRIT REV ONCOL HEMAT, V32, P31, DOI 10.1016/S1040-8428(99)00019-0; Jass JR, 2002, EUR J CANCER, V38, P858, DOI 10.1016/S0959-8049(02)00041-2; Julie C, 2008, AM J GASTROENTEROL, V103, P2825, DOI 10.1111/j.1572-0241.2008.02084.x; Kane MF, 1997, CANCER RES, V57, P808; Kondo Y, 2004, CANCER METAST REV, V23, P29, DOI 10.1023/A:1025806911782; Kuismanen SA, 1999, P NATL ACAD SCI USA, V96, P12661, DOI 10.1073/pnas.96.22.12661; Kumar K, 2009, CLIN CANCER RES, V15, P1155, DOI 10.1158/1078-0432.CCR-08-1029; Lawes DA, 2005, BRIT J CANCER, V93, P472, DOI 10.1038/sj.bjc.6602708; Lee KH, 2011, LANGENBECK ARCH SURG, V396, P1017, DOI 10.1007/s00423-011-0812-9; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Leung WK, 2005, AM J GASTROENTEROL, V100, P2274, DOI 10.1111/j.1572-0241.2005.50412.x; Lind GE, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-28; Mathers JC, ADV GENET, V71, P3; Menigatti M, 2009, ONCOGENE, V28, P899, DOI 10.1038/onc.2008.444; Menigatti M, 2001, GENE CHROMOSOME CANC, V31, P357, DOI 10.1002/gcc.1154; Mirchev M, 2007, J IMAB ANN P SCI PAP, P95; Miyakura Y, 2004, CLIN GASTROENTEROL H, V2, P147, DOI 10.1016/S1542-3565(03)00314-8; Nagasaka T, 2004, J CLIN ONCOL, V22, P4584, DOI 10.1200/JCO.2004.02.154; Nakagawa H, 2001, CANCER RES, V61, P6991; Oliveira C, 2004, HUM MOL GENET, V13, P2303, DOI 10.1093/hmg/ddh238; Park IJ, 2007, J KOREAN MED SCI, V22, pS91, DOI 10.3346/jkms.2007.22.S.S91; Peltomaki P, 1997, GASTROENTEROLOGY, V113, P1146, DOI 10.1053/gast.1997.v113.pm9322509; Peyssonnaux C, 2001, BIOL CELL, V93, P53, DOI 10.1016/S0248-4900(01)01125-X; Potocnik U, 2001, CANCER GENET CYTOGEN, V126, P85, DOI 10.1016/S0165-4608(00)00399-X; Poynter JN, 2008, CANCER EPIDEM BIOMAR, V17, P3208, DOI 10.1158/1055-9965.EPI-08-0512; Raedle J, 2001, ANN INTERN MED, V135, P566, DOI 10.7326/0003-4819-135-8_Part_1-200110160-00007; RodriguezBigas MA, 1997, J NATL CANCER I, V89, P1758, DOI 10.1093/jnci/89.23.1758; Samowitz WS, 2005, GASTROENTEROLOGY, V129, P837, DOI 10.1053/j.gastro.2005.06.020; Shannon BA, 2001, CANCER LETT, V167, P91, DOI 10.1016/S0304-3835(01)00431-1; Shi XZ, 2006, BIOMED CHROMATOGR, V20, P815, DOI 10.1002/bmc.606; Sobin LH, 1997, CANCER, V80, P1803, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9; Strazzullo M, 2003, CANCER-AM CANCER SOC, V98, P1540, DOI 10.1002/cncr.11651; Tannergard P, 1997, HUM GENET, V101, P51, DOI 10.1007/s004390050585; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Velayos FS, 2005, J GASTROINTEST SURG, V9, P329, DOI 10.1016/j.gassur.2004.05.007; Vilkin A, 2009, CANCER-AM CANCER SOC, V115, P760, DOI 10.1002/cncr.24019; Wallner M, 2006, CLIN CANCER RES, V12, P7347, DOI 10.1158/1078-0432.CCR-06-1264; Ward R, 2001, GUT, V48, P821, DOI 10.1136/gut.48.6.821; Ward RL, 2005, J PATHOL, V207, P377, DOI 10.1002/path.1851; Yamamoto H, 2002, GENE CHROMOSOME CANC, V33, P322, DOI 10.1002/gcc.10010; Yiu R, 2005, DIS COLON RECTUM, V48, P2061, DOI 10.1007/s10350-005-0171-0; Zhou HH, 2008, WORLD J GASTROENTERO, V14, P7329, DOI 10.3748/wjg.14.7329	78	84	96	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59064	10.1371/journal.pone.0059064	http://dx.doi.org/10.1371/journal.pone.0059064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23861826	gold, Green Published, Green Submitted			2022-12-27	WOS:000317263900009
